# Copyright (c) 1966-2016 Johns Hopkins University. Use of this file adheres to the terms specified at http://omim.org/help/agreement.
# Generated: 2016-05-26
# See end of file for additional documentation on specific fields
# Sort	Month	Day	Year	Cyto Location	Gene Symbols	Confidence	Gene Name	MIM Number	Mapping Method	Comments	Phenotypes	Mouse Gene Symbol
1.1	5	13	13	1pter-p36.13	CTRCT8, CCV	P	Cataract, congenital, Volkmann type	115665	Fd	linked to Rh in Scottish family	Cataract 8, multiple types (2)	
1.2	9	25	01	1p36.23	ENO1, PPH, MPB1	C	Enolase-1, alpha	172430	S, F, R, REa		Enolase deficiency (1)	4(Eno1)
1.3	12	22	87	1pter-p36	ERPL1, HLM2	C	Endogenous retroviral pol gene-like sequence 1 (oncogene HLM2)	131190	REa, F			
1.4	4	14	11	1p36.11	HMGCL	P	3-hydroxy-3-methylglutaryl-Coenzyme A lyase	613898	REa, A		HMG-CoA lyase deficiency, 246450 (3)	4(Hmgcl)
1.5	4	30	15	1p36.33	AGRN, CMS8	P	Agrin	103320	REa		Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3)	4(Agrn)
1.6	3	15	92	1p36.33	GNB1	C	Guanine nucleotide-binding protein, beta polypeptide-1	139380	REa, A			4(Gnb1)
1.7	10	2	07	1p35.2	SDC3, SYND3, SDCN	C	Syndecan 3	186357	REc, R, H		{Obesity, association with}, 601665 (3)	4(Synd3)
1.8	8	28	98	1pter-p22.1	SAI1, MTS1, TFS1	C	Suppression of anchorage independence-1 (malignant transformation suppression-1)	154280	S, H			4(Tfs1)
1.9	10	6	08	1p36.33	ATAD3A	P	ATPase family, AAA domain-containing, member 3A	612316	REc			
1.10	10	6	08	1p36.33	ATAD3B, TOB3, KIAA1273	C	ATPase family, AAA domain-containing, member 3B	612317	R, REc			
1.11	5	6	13	1p36.33	C1orf86, FAAP20	P	Chromosome 1 open reading frame 86	615183	REc			
1.12	7	3	06	1p36.33	CALML6, CAGLP	P	Calmodulin-like 6	610171	REc			
1.13	9	30	10	1p36.33	CCNL2	P	Cyclin L2	613482	REc			4(Ccnl2)
1.14	3	23	14	1p36.33	CPSF3L, INTS11, RC68	P	Cleavage and polyadenylation-specific factor 3-like	611354	REc			
1.15	10	13	15	1p36.33	FAM132A, C1QDC2, C1QTNF12	P	Family with sequence similarity 132, member A	616593	REc			
1.16	11	1	13	1p36.33	GLTPD1, CPTP	P	Glycolipid transfer protein domain-containing protein 1	615467	REc			
1.17	12	19	14	1p36.33	ISG15, G1P2, IFI15, IMD38	P	ISG15 ubiquitin-like modifier	147571	REa, REc		Immunodeficiency 38, 616126 (3)	
1.18	3	23	09	1p36.33	MIR200A, MIRN200A	P	Micro RNA 200A	612090	REc			
1.19	3	23	09	1p36.33	MIR200B, MIRN200B	P	Micro RNA 200B	612091	REc			
1.20	3	23	09	1p36.33	MIR429, MIRN429	P	Micro RNA 429	612094	REc			
1.21	2	20	07	1p36.33	NOC2L, NIR	P	Nucleolar complex-associated protein 2, S. cerevisiae, homolog of	610770	REc			
1.22	8	18	14	1p36.33	PERM1, C1orf170	P	PPARGC1-and ESRR-induced regulator, muscle, 1	615921	REc			
1.23	1	21	16	1p36.33	SAMD11, MRS	P	Sterile alpha motif domain-containing protein 11	616765	REc			
1.24	10	10	11	1p36.33	SDF4, CAB45	P	Stromal cell-derived factor 4	614282	REc			
1.25	4	24	01	1p36.33	TAS1R3, T1R3	C	Taste receptor type 1, member 3	605865	REn, REc			4(Tas1r3)
1.26	12	2	14	1p36.33	TMEM240, C1orf70, SCA21	C	Transmembrane protein 240	616101	REc, Fd		Spinocerebellar ataxia 21, 607454 (3)	
1.27	10	27	89	1p36.23	CA6	C	Carbonic anhydrase VI	114780	REa, A, REc, R			
1.28	2	18	08	1p36.33	NADK	P	NAD kinase	611616	REc			
1.29	4	4	16	1p36.23	PER3, FASPS3	P	Period, Drosophila, homolog of, 3	603427	REc	mutation identified in 1 FASPS3 family	?Advanced sleep phase syndrome, familial, 3, 616882 (3)	
1.30	7	18	06	1p36.32	ACTRT2, ARPT2, ARPM2	P	Actin-related protein T2	608535	REc			
1.31	5	21	07	1p36.32	AJAP1, SHREW1	P	Adherens junction-associated protein 1	610972	R, REc			
1.32	2	2	16	1p36.32	CEP104, GLYBP, KIAA0562, JBTS25	C	Centrosomal protein, 104kD	616690	R, REc		Joubert syndrome 25, 616781 (3)	
1.33	8	29	13	1p36.33	MIB2	C	Mindbonb, Drosophila, homolog of, 2	611141	A, REc			
1.34	4	8	13	1p36.32	MIR551A	P	Micro RNA 551A	615148	REc			
1.35	10	25	12	1p36.32	PEX10, NALD, PBD6A, PBD6B	C	Peroxisome biogenesis factor 10	602859	REc		Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3); Peroxisome biogenesis disorder 6B, 614871 (3)	
1.36	7	9	09	1p36.32	PLCH2, PLCL4	P	Phospholipase C, eta-2	612836	REc			
1.37	8	27	15	1p36.32	TPRG1L, FAM79A	P	Tumor protein p63 regulated 1-like	611460	R, REc			
1.38	4	8	03	1p36.32-p36.13	DYT13	P	Dystonia 13, torsion	607671	Fd		Dystonia 13, torsion (2)	
1.39	4	16	11	1p36.32-p35.3	KONDS	P	Kondoh syndrome (mental retardation, microcephaly, growth retardation, joint contractures, and facial dysmorphism)	606242	Fd	linked to rs966321 and rs1441834	Kondoh syndrome (2)	
1.40	10	5	11	1p36.31	GPR153	P	G protein-coupled receptor 153	614269	REc			4(Gpr153)
1.41	3	24	06	1p36.31	HES2	P	Hairy/enhancer of split, Drosophila, homolog of, 2	609970	REc			
1.42	3	24	06	1p36.31	HES3	P	Hairy/enhancer of split, Drosophila, homolog of, 3	609971	REc			
1.43	3	24	06	1p36.33	HES4	P	Hairy/enhancer of split, Drosophila, homolog of, 4	608060	REc			
1.44	3	24	06	1p36.32	HES5	P	Hairy/enhancer of split, Drosophila, homolog of, 5	607348	REc			
1.45	3	12	15	1p36.31	KLHL21, KIAA0469	C	Kelch-like 21	616262	R, REc			
1.46	4	27	16	1p36.31	RNF207, C1orf188	P	RING finger protein 207	616923	REc			
1.47	1	20	09	1p36.31	THAP3	P	THAP domain-containing protein 3	612532	REc			
1.48	11	4	93	1p36.31	RPL22, EAP	C	Ribosomal protein L22	180474	Ch, REc	fused with AML1 in t(3;21)		
1.49	9	18	12	1p36.31	DNAJC11	P	DNAJ/HSP40 homolog, subfamily C, member 11	614827	REc			
1.50	1	5	12	1p36.31-p36.13	DFNB96	P	Deafness, autosomal recessive 96	614414	Fd	between rs3817914 and rs477558	Deafness, autosomal recessive 96 (2)	
1.51	8	18	12	1p36.33	AURKAIP1, AKIP, AIP	P	Aurora kinase A-interacting protein 1	609183	R, REc			
1.52	8	2	13	1p36.33	B3GALT6, SEMDJL1, EDSP2	P	UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6	615291	REc		Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3); Ehlers-Danlos syndrome, progeroid type, 2, 615349 (3)	4(B3galt6)
1.53	1	27	11	1p36.33	CDK11B, CDC2L1, P58, CDK11	C	Cyclin-dependent kinase 11B	176873	REa, A, Pcm, A			
1.54	1	27	11	1p36.33	CDK11A, CDC2L2	P	Cyclin-dependent kinase 11A	116951	A			
1.55	8	4	99	1p36.32	DFFB, CAD, DFF2	C	DNA fragmentation factor, 40kD, beta subunit	601883	A			
1.56	9	11	12	1p36.33	GABRD, GEFSP5, EIG10, EJM7	C	Gamma-aminobutyric acid (GABA) A receptor, delta	137163	REa, R, REc		{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	
1.57	12	24	08	1p36.32	MEGF6, EGFL3	P	Multiple epidermal growth factor-like domains 6	604266	R			
1.58	6	15	99	1p36.33	TNFRSF18, AITR, GITR	P	Tumor necrosis factor receptor superfamily, member 18	603905	R			
1.59	3	30	99	1p36.31	KCNAB2, KCNA2B	P	Potassium voltage-gated channel, shaker-related subfamily, beta member 2	601142	A			
1.60	11	1	99	1p36.33	MMP23A, MMP21, MIFR	P	Matrix metalloproteinase 23A	603320	REc			
1.61	11	1	99	1p36.33	MMP23B, MMP22	P	Matrix metalloproteinase 23B	603321	REc			
1.62	1	12	11	1p36.22	MTHFR	P	Methylenetetrahydrofolate reductase	607093	A		Homocystinuria due to MTHFR deficiency, 236250 (3); {Schizophrenia, susceptibility to}, 181500 (3); {Vascular disease, susceptibility to} (3); {Neural tube defects, susceptibility to}, 601634 (3); {Thromboembolism, susceptibility to}, 188050 (3)	4(Mthfr)
1.63	9	9	13	1p36.32	PRDM16, MEL1, LVNC8, CMD1LL	P	PR domain-containing protein 16	605557	REc, Ch		Left ventricular noncompaction 8, 615373 (3); Cardiomyopathy, dilated, 1LL, 615373 (3)	
1.64	8	9	99	1p36.3	PTPRZ2	P	Protein-tyrosine phosphatase, receptor-type, zeta-2	604008	A			
1.65	1	20	98	1p36.13	RNU1A, RNU1	C	RNA, U1A small nuclear	180680	REa, A	?same as A12M2		3(Rnu1b1)
1.66	10	5	12	1p36.33-p36.32	SKI, SGS	C	Avian sarcoma viral (v-ski) oncogene homolog	164780	REa, A, Ch	formerly mapped to 1q22-q24	Shprintzen-Goldberg syndrome, 182212 (3)	
1.67	12	23	02	1p36.31	TNFRSF25, TNFRSF12, DR3, LARD	C	Tumor necrosis factor receptor superfamily, member 25	603366	A, Ch			
1.68	9	28	10	1p36.22	UBE4B, UFD2A, KIAA0684	P	Ubiquitination factor E4B	613565	REc			
1.69	4	6	13	1p36.22	UBIAD1, TERE1, SCCD	C	UbiA prenyltransferase domain-containing protein 1	611632	A, Fd		Corneal dystrophy, Schnyder type, 121800 (3)	
1.70	3	20	08	1p36.33	VWA1, WARP	P	von Willebrand factor A domain-containing protein 1	611901	REc			
1.71	6	20	01	1p36.32	WDR8	P	WD repeat-containing protein 8	606040	A			
1.72	11	22	13	1p36.31	ZBTB48, HKR3	C	Zinc finger- and BTB domain-containing protein 48	165270	REa, A			
1.73	2	6	94	1p36.12	HTR1D	C	5-hydroxytryptamine (serotonin) receptor-1D	182133	REa, A			4(Htr1d)
1.74	6	10	98	1p36.22	DFFA, DFF1	C	DNA fragmentation factor, 45kD, alpha subunit	601882	A			
1.75	3	10	11	1p36.22	MASP2	P	Mannan-binding lectin serine protease 2	605102	A, R		MASP2 deficiency, 613791 (3)	
1.76	1	4	13	1p36.22	PLOD1, LH1, LLH, EDS6	P	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase)	153454	REa, A		Ehlers-Danlos syndrome, type VI, 225400 (3)	4(Plod)
1.77	9	15	96	1p36.33	SCNN1D	P	Sodium channel, voltage-gated, type I, delta polypeptide	601328	A			
1.78	12	18	98	1p36.22	TNFRSF1B, TNFR2, TNFBR	C	Tumor necrosis factor receptor superfamily, member 1B	191191	REa, A, Fd			4(Tnfr1)
1.79	12	14	98	1p36.32	TNFRSF14, HVEM, TR2	P	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)	602746	A			
1.80	1	11	07	1p36.21	CASP9, APAF3	P	Caspase 9, apoptosis-related cysteine protease	602234	A			
1.81	3	16	06	1p36.31	ESPN	P	Espin, mouse, homolog of	606351	R, H		Deafness, autosomal recessive 36, 609006 (3); Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)	4(espn)
1.82	2	28	08	1p36.33	MRPL20	P	Mitochondrial ribosomal protein L20	611833	R			
1.83	2	17	11	1p36.12	C1QA	C	Complement component 1, q subcomponent, A chain	120550	REa, REb		C1q deficiency, 613652 (3)	
1.84	2	17	11	1p36.12	C1QB	C	Complement component 1, q subcomponent, B chain	120570	REa, REb		C1q deficiency, 613652 (3)	(C1qb)
1.85	2	17	11	1p36.12	C1QC, C1QG	P	Complement component 1, q subcomponent, C chain	120575	REn, REb		C1q deficiency, 613652 (3)	
1.86	9	9	08	1p36.13	FBXO42, FBX42, KIAA1332	P	F-box only protein 42	609109	REc			4(Fbox42)
1.87	9	9	08	1p36.22	FBXO6, FBX6, FBG2	C	F-box only protein 6	605647	REc			4(Fbxo6)
1.88	1	8	07	1p36.13	HSPB7, CVHSP	P	Heat-shock 27kD protein 7	610692	REc			
1.89	7	18	14	1p36.23	UTS2	P	Urotensin II	604097	REc			
1.90	12	30	04	1p36.22	APITD1	P	Apoptosis-inducing, TAF9-like domain 1	609130	REa, REc			
1.91	7	17	09	1p36.22	CTNNBIP1, ICAT	P	Catenin, beta-interacting protein 1	607758	R, REc			
1.92	3	20	09	1p36.22	DRAXIN, C1orf187	P	Dorsal repulsive axon guidance protein	612682	REc			
1.93	7	27	09	1p36.22	EXOSC10, PMSCL2	P	Exosome component 10	605960	R, REc			
1.94	5	24	13	1p36.22	LZIC	P	Leucine zipper and CTNNBIP1 domains-containing protein	610458	REc			
1.95	9	25	12	1p36.22	NMNAT1, NMNAT, PNAT1, LCA9	C	Nicotinamide nucleotide adenylyltransferase 1	608700	REc		Leber congenital amaurosis 9, 608553 (3)	
1.96	9	9	08	1p36.22	PTCHD2, DISP3, KIAA1337	P	Patched domain-containing protein 2	611251	REc			
1.97	2	28	07	1p36.22	SLC25A33	P	Solute carrier family 25 (mitochondrial carrier), member 33	610816	REc			4(Slc25A33)
1.98	12	18	07	1p36.22	SPSB, SSB1	P	SPRY domain- and SOCS box-containing 1	611657	R, REc			
1.99	9	22	08	1p36.22	CASZ1, SRG	P	Castor zinc finger protein 1	609895	A, REc			4(Srg)
1.100	2	11	08	1p36.21	CTRC, CLCR	P	Chymotrypsin	601405	REc		{Pancreatitis, chronic, susceptibility to}, 167800 (3)	
1.101	7	20	15	1p36.21	EFHD2, SWS1	P	EF-hand domain family, member D2	616450	REc			
1.102	9	9	08	1p36.22	FBXO44, FBX44, FBX6A, FBG3	C	F-box only protein 44	609111	REc			4(Fbxo44)
1.103	2	28	06	1p36.21	GBD2	P	Gallbladder disease 2	609918	between D1S1597 and D1S47		Gallbladder disease 2 (2)	
1.104	5	6	13	1p36.21	LRRC38	P	Leucine-rich repeat-containing protein 38	615212	REc			
1.105	12	10	13	1p36.21	PDPN, TI1A, T1A2, GP36, OTS8, AGGRUS	P	Podoplanin	608863	REc, R			
1.106	3	12	07	1p36.21	SLC25A34	P	Solute carrier family 25, member 34	610817	REc			4(Slc25A34)
1.107	9	2	12	1p36.21	CELA2A, ELA2A	P	Chymotrypsin-like elastase family, member 2A	609443	REc, R			
1.108	9	2	12	1p36.21	CELA2B, ELA2B	P	Chymotrypsin-like elastase family, member 2B	609444	REc			
1.109	3	31	15	1p36.22	KIF1B, CMT2A, CMT2A1, NBLST1	C	Kinesin family member 1B	605995	Fd, REc, D	mutation identified in 1 CMT2A1 family	?Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma, 171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)	4(Kif1b)
1.110	8	7	15	1p36.22	MFN2, KIAA0214, CMT2A2, HMSN6A	C	Mitofusin 2	608507	R, REa, REc		Charcot-Marie-Tooth disease, type 2A2, 609260 (3); Hereditary motor and sensory neuropathy VIA, 601152 (3)	
1.111	11	17	15	1p36.22	MTOR, FRAP1, SKS	P	Mechanistic target of rapamycin	601231	R, A		Smith-Kingsmore syndrome, 616638 (3)	
1.112	7	8	09	1p36.13	NBPF1, KIAA1693	P	Neuroblastoma breakpoint family, member 1	610501	R, REc	pseudogenes on 3 and 5		
1.113	9	15	11	1p36.12	NBPF3	P	Neuroblastoma breakpoint family, member 3	612992	REc, A			
1.114	4	29	14	1p36.22	NPPA, PND, ANP, ATFB6, ATRST2	C	Natriuretic peptide precursor A	108780	REa, A, H		Atrial fibrillation, familial, 6, 612201 (3); Atrial standstill 2, 615745 (3)	4(Pnd)
1.115	5	9	95	1p36.22	NPPB, BNP	C	Natriuretic peptide precursor B	600295	H, REa, A, REn			4(Nppb)
1.116	10	25	12	1p36.22	PEX14, PBD13A	P	Peroxisome biogenesis factor 14	601791	R, REc		Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3)	
1.117	5	23	14	1p36.22	PIK3CD, APDS, IMD14	P	Phosphatidylinositol 3-kinase, catalytic, 110kD, delta	602839	A, R		Immunodeficiency 14, 615513 (3)	
1.118	3	12	08	1p36.2	SCZD12	P	Schizophrenia 12	608543	Fd	max lod at D1S1612	{Schizophrenia 12}, 181500 (2)	
1.119	8	4	99	1p36.23	SLC2A5, GLUT5	C	Solute carrier family 2 (facilitated glucose transporter), member 5	138230	REa, A, REc, R			
1.120	10	11	06	1p36.23	SLC2A7, GLUT7	P	Solute carrier family 2 (facilitated glucose transporter), member 7	610371	REc			
1.121	10	5	10	1p36.22	TARDBP, TDP43, ALS10	C	TAR DNA-binding protein	605078	R, REc	pseudogenes on 2, 6, 8, 13, 20	Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3); Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	4(Tardbp)
1.122	4	10	90	1p36.22	PGD	C	6-phosphogluconate dehydrogenase	172200	F, S			4(Pgd)
1.123	3	16	10	1p36.13	PAX7, RMS2	C	Paired box homeotic gene-7	167410	Psh, H, REa, A	fused with FKHR in rhabdomyosarcoma	Rhabdomyosarcoma 2, alveolar, 268220 (3)	4(Pax7)
1.124	3	24	88	1p35.3	FGR, SRC2	P	Oncogene FGR	164940	A, REb, REa, Fd	same as SRC2		4(Fgr)
1.125	9	22	97	1p36.2-p36.1	GLC3B	P	Glaucoma 3, primary infantile, B	600975	Fd		Glaucoma 3, primary infantile, B (2)	
1.126	9	7	00	1p36.23	RERE	P	RE repeats-encoding gene	605226	REc, Ch			
1.127	12	24	08	1p36.23	SLC45A1, DNB5	P	Solute carrier family 45, member 1	605763	REc			
1.128	10	3	11	1p36.13	ZBTB17, ZNF151, MIZ1	P	Zinc finger- and BTB domain-containing protein 17	604084	A			
1.129	1	1	95	1p36.12	CDA	C	Cytidine deaminase	123920	A, Psh			
1.130	2	19	08	1p35.3	EPB41, EL1	C	Erythrocyte surface protein band 4.1	130500	F, REb		Elliptocytosis-1, 611804 (3)	4(Elp1)
1.131	5	4	12	1p36.11	RHCE	C	Rhesus system C and E polypeptides	111700	F, D, Fd	?order: C-E-D	[Blood group, Rhesus], 111690 (3); Rh-null disease, amorph type (3)	
1.132	5	25	05	1p36.11	RHD	C	Rhesus system D polypeptide	111680	F, D, Fd		[Rh-negative blood type] (3)	
1.133	5	23	12	1p36.13	AKR7A2, AKR7, AFAR	P	Aldo-keto reductase family 7, member A2	603418	REn	pseudogenes on Xq25 and 1p12		
1.134	8	8	13	1p36.13	AKR7A3, AFAR2	P	Aldo-keto reductase family 7, member A3	608477	REc, A			
1.135	8	8	13	1p36.13	AKR7A4, AFAR3	P	Aldo-keto reductase family 7, member A4	608478	REc, A			
1.136	12	22	08	1p36.13	ARHGEF10L, GRINCHGEF, KIAA1626	P	RHO guanine nucleotide exchange factor 10-like protein	612494	REc			
1.137	12	22	08	1p36.13	ARHGEF19, WGEF	P	RHO guanine nucleotide exchange factor 19	612496	REc			4(Arhgef19)
1.138	10	13	15	1p36.12	ASAP3, UPLC1, CENTB6, DDEFL1, ACAP4	P	ARF GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 3	616594	REc			
1.139	3	30	16	1p36.13	EMC1, KIAA0090, CAVIPMR	P	Endoplasmic reticulum membrane protein complex, subunit 1	616846	Psh		Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	
1.140	7	17	09	1p36.21	FBLP1, MIGFILIN	P	Filamin-binding LIM protein 1	607747	REc			
1.141	9	28	15	1p36.13	MINOS1, MIO10, MIC10	P	Mitochondrial inner membrane organizing system protein 1	616574	REc			
1.142	2	18	08	1p36.13	NECAP2	P	NECAP endocytosis-associated protein 2	611624	R, REc			
1.143	1	28	08	1p36.13	OTUD3, KIAA0459	P	OTU domain-containing protein 3	611758	R, REc			
1.144	1	16	07	1p36.13	PADI1	C	Peptidylarginine deiminase, type I	607934	REc, REn			
1.145	1	16	07	1p36.13	PADI2	C	Peptidylarginine deiminase, type II	607935	REc, REn			
1.146	1	16	07	1p36.13	PADI3	P	Peptidylarginine deiminase, type III	606755	REc, REN			
1.147	1	16	07	1p36.13	PADI4, PADI5, PAD	C	Peptidylarginine deiminase, type IV	605347	REc, REn		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
1.148	8	21	12	1p36.13	PQLC2	P	PQ loop repeat-containing protein 2	614760	REc			
1.149	9	30	10	1p36.21-p36.13	SPEN, MINT, SHARP, HIAA0929	P	SPEN, Drosophila, homolog of	613484	REc			
1.150	7	22	14	1p36.13	UBR4, ZUBR1, RBAF600, KIAA1307	P	Ubiquitin protein ligase E3 component n-recognin 4	609890	R, REc			
1.151	9	22	08	1q21.2	APH1A	P	Anterior pharynx defective 1, C. elegans, homolog of, A	607629	R, REc			
1.152	1	11	95	1p36.12	ID3	C	Inhibitor of DNA binding 3, dominant negative, helix-loop-helix protein	600277	RE, A			
1.153	10	24	97	1p36.13	D1S1733E, DAN	P	Differential-screening-selected gene aberrant in neuroblastoma	600613	A	aberrant in some neuroblastomas		4(D4H1S1733E)
1.154	1	29	16	1p36.11	MAN1C1	P	Mannosidase, alpha, class 1C, member 1	616772	REc			
1.155	1	3	05	1p36.13-p34.3	ANIB3	P	Aneurysm, intracranial berry, 3	609122	Fd		Aneurysm, intracranial berry, 3 (2)	
1.156	10	24	14	1p36.13-p34.3	EA8	P	Episodic ataxia, type 8	616055	Fd	between rs2743201 and rs215791	Episodic ataxia, type 8 (2)	
1.157	8	23	09	1p36.12	B6QTL1	P	Vitamin B6 plasma level QTL 1	612957	Fd	associated with rs4654748	{Vitamin B6 plasma level QTL 1} (2)	
1.158	1	9	13	1p36.12	CAMK2N1	P	Calcium/calmodulin-dependent protein kinase II inhibitor 1	614986	REc			
1.159	8	18	14	1p36.12	EIF4G3, EIF4GII	P	Eukaryotic translation initiation factor 4-gamma, 3	603929	REc			
1.160	7	17	09	1p36.12	EPHA8, EEK, HEK3	P	Ephrin receptor EphA8 (eph- and elk-related kinase)	176945	REa, REc			
1.161	11	3	14	1p36.12	HP1BP3, HP1BP74	P	Heterochromatin protein 1-binding protein 3	616072	REc			
1.162	3	3	16	1p36.12	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	P	Lysine-specific demethylase 1A	609132	R, REc		Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	
1.163	7	20	12	1p36.12	KIF17, KIAA1405	P	Kinesin family member 17	605037	REc			
1.164	4	27	09	1p36.12	MUL1, MULAN, C1orf166	P	Mitochondrial ubiquitin ligase activator of NFKB1	612037	REc			
1.165	3	1	01	1p36.12	PLA2G2D, SPLASH	C	Phospholipase A2, group IID	605630	R			4(Pla2g2d)
1.166	5	25	13	1p36.12	TCEA3	P	Transcription elongation factor A, 3	604128	REc			
1.167	2	2	16	1p36.12	UBXN10	P	UBX domain protein 10	616783	REc			
1.168	4	5	11	1p36.12-p35.1	BFIS4, BFIC4	P	Seizures, benign familial infantile, 4	612627	Fd	between D1S2864 and D1S2830	Seizures, benign familial infantile, 4 (2)	
1.169	7	7	14	1p36.1-p35.3	AHDC1, MRD25	P	AT-hook DNA-binding motif-containing protein 1	615790	REc		Xia-Gibbs syndrome, 615829 (3)	
1.170	7	20	12	1p36.11	CD52, CDW52	P	CD52 molecule	114280	REc			
1.171	2	25	15	1p36.11	CNKSR1, CNK1	P	Connector enhancer of KSR 1	603272	R, REc			
1.172	6	22	14	1p36.13	CROCC, ROOTLETIN, KIAA0445	P	Ciliary rootlet coiled-coil protein	615776	REc			
1.173	4	6	11	1p36.11	DHDDS, HDS, RP59	P	Dehydrodolichyl diphosphate synthase	608172	REc		Retinitis pigmentosa 59, 613861 (3)	
1.174	4	6	11	1p36.11	FCN3, HAKA1	P	Ficolin 3	604973	R, REc		Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	
1.175	3	11	14	1p36.11	GRHL3, SOM, TFCP2L4, VWS2	C	Grainyhead-like 3	608317	REc, Fd		Van der Woude syndrome 2, 606713 (3)	
1.176	10	7	02	1p36.12	HNRPR, HNRNPR	P	Heterogeneous nuclear ribonucleoprotein R	607201	R			
1.177	2	11	13	1p36.11	IFNLR1, IL28RA	P	Interferon, lambda receptor 1	607404	REc			
1.178	4	27	09	1p36.11	LIN28, LIN28A	P	Lin28, C. elegans, homolog of	611043	REc, H			4(Lin28)
1.179	12	30	14	1p36.11	LYPLA2, APT2	P	Lysophospholipase II	616143	REc			
1.180	2	8	12	1p36.11	MAP3K6, MAPKKK6, ASK2	P	Mitogen-activated protein kinase kinase kinase 6	604468	REc			
1.181	2	23	16	1p36.11	MYOM3	P	Myomesin 3	616832	REc			4(Myom3)
1.182	8	19	13	1p36.11	NUDC	P	Nuclear distribution gene C, A. nigulans, homolog of	610325	REc, A			
1.183	4	29	14	1p36.11	PAFAH2	P	Platelet-activating factor acetylhydrolase 2	602344	REc			
1.184	7	17	09	1p36.11	PAQR7, MPRA, PGLP	P	Progestin and ADIPOQ receptor family, member 7	607779	REc			
1.185	8	20	12	1p36.11	PIGV, HPMRS1	P	Phosphatidylinositol glycan, class V	610274	REc		Hyperphosphatasia with mental retardation syndrome 1, 239300 (3)	
1.186	3	11	08	1p36.11	PNRC2	P	Proline-rich nuclear receptor coactivator 2	611882	REc			
1.187	7	19	12	1p36.11	SFN	P	Stratifin	601290	REc			
1.188	3	7	14	1p36.11	SH3BGRL3	C	SH3 domain-binding glutamic acid-rich protein-like protein 3	615679	REc, A			
1.189	1	17	13	1p36.11	SLC30A2, ZNT2, TNZD	P	Solute carrier family 30 (zinc transporter), member 2	609617	REc		Zinc deficiency, transient neonatal, 608118 (3)	4(Slc30a2)
1.190	7	27	09	1p36.11	SRRM1, SRM160	P	Serine/arginine repetitive matrix 1 (ser/arg-related nuclear matrix protein, 160kD)	605975	R, REc			
1.191	7	18	14	1p36.11	STPG1, MAPO2, C1orf201	P	Sperm-tail PG-rich repeat-containing protein 1	615826	REc			4(Stpg1)
1.192	7	17	09	1p36.11	SYF2, P29	P	SYF2 RNA splicing factor, S. cerevisiae, homolog of	607090	R, REc			
1.193	2	14	08	1p36.11	SYTL1, SLP1, JFC1	P	Synaptotagmin-like protein 1	608042	R, REc			
1.194	6	22	14	1p36.11	TMEM50A, SMP1	P	Transmembrane protein 50A	605348	REc	between RHD and RHCE		
1.195	5	24	13	1p36.11	TMEM57, FLJ10747	C	Transmembrane protein 57	610301	REc, H			4(Tmem57)
1.196	2	10	14	1p36.11	TRIM63, RNF28, SMRZ, MURF1	P	Tripartite motif containing 63	606131	A			
1.197	2	19	16	1p36.11	TRNP1	P	TMF1-regulated nuclear protein 1	616824	REc			
1.198	5	29	15	1p36.11	UBXN11, SOC	P	UBX domain protein 11	609151	REc			
1.199	12	22	15	1p36.11	ZNF593, ZT86	P	Zinc finger protein 593	616698	REc			
1.200	1	29	16	1p36.11	ZNF683, HOBIT	P	Zinc finger protein 683	616775	REc			
1.201	4	24	01	1p36.11	WASF2, WAVE2, SCAR2	P	Wiskott-Aldrich syndrome protein family, member 2	605875	REc	?pseudogene on Xp11.21		
1.202	8	28	97	1p36.13	CAPZB, CAPPB	P	Capping protein (actin filament) muscle Z-line, beta	601572	A			
1.203	1	8	16	1p36.12	CDC42, TKS	P	Cell division cycle 42 (GTP-binding protein, 25kD)	116952	H, R, REc		Takenouchi-Kosaki syndrome, 616737 (3)	4(cdc42)
1.204	1	1	95	1p35.3	CHC1, RCC1	C	Regulator of chromosome condensation	179710	REb, A			4(Chc1)
1.205	5	25	14	1p36.12	DDOST, OST, OST48, CDG1R	P	Dolichyl-diphosphooligosaccharide-protein glycosyltransferase	602202	A	mutation (cmpd het) identified in 1 CDG1R patient	?Congenital disorder of glycosylation, type Ir, 614507 (3)	
1.206	7	16	09	1p36.21	DHRS3, RETSDR1	P	Short-chain dehydrogenase/reductase family, member 3	612830	A, R			
1.207	4	6	11	1p36.12	ECE1	C	Endothelin converting enzyme 1	600423	A, R, Psh		Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3); {Hypertension, essential, susceptibility to}, 145500 (3)	
1.208	5	6	13	1p36.13	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	C	Ephrin receptor EphA2	176946	A, REa, Fd		Cataract 6, multiple types, 116600 (3)	
1.209	4	11	97	1p36.11	EXTL1	P	Exostosin-like 1	601738	R, A			
1.210	8	28	02	1p36.11	HMGN2, HMG17	C	High-mobility group nucleosomal binding protein 2	163910	REa, A			
1.211	4	1	01	1p36.12	HSPG2, PLC, SJS, SJA, SJS1	C	Heparan sulfate proteoglycan of basement membrane (perlecan)	142461	A, REa, LD		Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	4(Plc)
1.212	2	28	03	1p36.11	MDS2	P	Myelodysplasia syndrome gene 2	607305	A	fused with ETV6 in myelodysplastic syndrome		
1.213	3	6	01	1p36.11	NR0B2, SHP	P	Nuclear receptor subfamily 0, group B, member 2	604630	REa, A		Obesity, mild, early-onset, 601665 (3)	
1.214	11	3	98	1p35.3	RNU17A, RNE1	C	RNA, U17a small nucleolar	180645	REn	in IVS1 of CHC1		
1.215	11	3	98	1p35.3	RNU17B	P	RNA, U17b small nucleolar	603239	REn			
1.216	12	15	99	1p35.3	RNU17D, U17HG	P	RNA, U17d small nucleolar	603238	REn			
1.217	8	30	09	1p36.11	RPS6KA1, RSK1	P	Ribosomal protein S6 kinase, 90kD, 1	601684	REa, REc			
1.218	2	20	98	1p36.21	RSC1A1, RS1	P	Regulatory solute carrier protein, family 1, member 1	601966	A			
1.219	12	19	11	1p36.11	SRSF10, FUSIP1, TASR, TASR1, TASR2	P	Splicine factor, serine/arginine-rich, 10	605221	REc	pseudogenes on chr. 9, 12, 20		
1.220	2	15	96	1p36.11	TCEB3	P	Transcription elongation factor B (SIII), polypeptide 3 (110kD, elongin A)	600786	A			
1.221	9	2	09	1q21.1	TRNAN1, TRN1, TRN	P	tRNA asparagine	189880	REa, RE			
1.222	8	1	14	1p36.12	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	C	eph tyrosine kinase 3 (ephrin receptor EphB2)	600997	Psh, A, Fd		{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	4(Ephb2)
1.223	4	23	96	1p36.1-p35	MEMO1	P	Methylation modifier for class I HLA	601201	D			
1.224	10	22	95	1p36.13	MFAP2, MAGP, MAGP1	P	Microfibrillar-associated protein-2	156790	REa, A			4(Mfap2)
1.225	2	26	95	1p36.12	RAP1GA1	P	RAP1, GTPase activating protein 1	600278	A, REa			
1.226	2	4	09	1p36.11	RPL11, DBA7	C	Ribosomal protein L11	604175	REa, R, A		Diamond-Blackfan anemia 7, 612562 (3)	
1.227	3	15	13	1p36.13	SDHB, SDH2, SDHIP, PGL4, CWS2	C	Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)	185470	S, REa, A	1 of 2 polypeptides	Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden syndrome 2, 612359 (3); Gastrointestinal stromal tumor, 606764 (3)	
1.228	4	2	15	1p36.11	SLC9A1, NHE1, APNH, LIKNS	C	Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive)	107310	A, F, Fd	mutation identified in 1 LIKNS family	?Lichtenstein-Knorr syndrome, 616291 (3)	4(Apnh, Nhe1)
1.229	7	17	01	1p36.11	STMN1, LAP18, SMN	P	Stathmin	151442	REa, A			4(Lap18)
1.230	1	1	95	1p36.11	GPR3	C	G protein-coupled receptor-3	600241	A			
1.231	3	17	94	1p35.3	OPRD1	P	Opioid receptor, delta-1	165195	H, A			4(Nbor, Oprd1)
1.232	8	12	09	1p36.12	ALPL, HOPS, TNSALP	C	Alkaline phosphatase, liver/bone/kidney	171760	S, H, Fd, F, A		Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood, 241510 (3); Odontohypophosphatasia, 146300 (3); Hypophosphatasia, adult, 146300 (3)	4(Akp2)
1.233	3	17	06	1p36.31	ACOT7, BACH, LACH	P	Acyl-CoA thioesterase 7	602587	REc			
1.234	2	15	06	1p36	AD7CNTP	P	Alzheimer disease neuronal thread protein	607413	R, REc			
1.235	1	25	99	1p36.13	ALDH4A1, ALDH4, P5CDH	P	Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase)	606811	A		Hyperprolinemia, type II, 239510 (3)	
1.236	11	7	08	1p36	ALPQTL2	P	Alkaline phosphatase, plasma level of, QTL 2	612367	Fd	linkage with rs1780324	{Alkaline phosphatase, plasma level of, QTL 2} (2)	
1.237	11	1	13	1p36.13	ATP13A2, PARK9, KRPPD, CLN12	C	ATPase, type 13A2	610513	REc, Fd	mutation identified in 1 family with CLN12	Kufor-Rakeb syndrome, 606693 (3); ?Ceroid lipofuscinosis, neuronal, 12, 606693 (3)	4(Atp13a2)
1.238	10	6	09	1p36	BCC1	P	Basal cell carcinoma, susceptibility to, 1	605462	Fd	associated with rs7538876	{Basal cell carcinoma, susceptibility to, 1} (2)	
1.239	5	14	02	1p36	BMND3	C	Bone mineral density QTL 3	606928	Fd	?another locus at 3p21	[Bone mineral density QTL 3] (2)	
1.240	8	31	12	1p36.31-p36.23	CAMTA1, KIAA0833, CANPMR	P	Calmodulin-binding transcription activator 1	611501	REc		Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3)	
1.241	2	20	07	1p36.31	CHD5	C	Chromodomain helicase DNA-binding protein 5	610771	REc, H			4(Chd5)
1.242	6	19	98	1p36.22	CLCN6	P	Chloride channel 6	602726	REa, A			
1.243	11	3	09	1p36.13	CLCNKA	C	Chloride channel, kidney, A	602024	Fd, REc	11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB	Bartter syndrome, type 4b, digenic, 613090 (3)	
1.244	8	24	04	1p36.13	CLCNKB	C	Chloride channel, kidney, B	602023	Fd, REc	unequal crossingover with CLCNKA	Bartter syndrome, type 3, 607364 (3); Bartter syndrome, type 4b, digenic, 613090 (3)	
1.245	3	3	15	1p36.22	CLSTN1, KIAA0911	P	Calsyntenin 1	611321	REc			4(Clstn1)
1.246	1	4	93	1p36	CMM, MLM, DNS	P	Cutaneous malignant melanoma/dysplastic nevus	155600	F, Fd, D	some linkage studies negative; see 9p	{Melanoma, cutaneous malignant, 1} (2)	
1.247	12	30	09	1p36.11	CNR2, CB2, CX5	P	Cannabinoid receptor 2	605051	R, REc			
1.248	4	22	15	1p36.33	DVL1, DRS2	C	Dishevelled 1 (homologous to Drosophila dsh)	601365	Psh, A		Robinow syndrome, autosomal dominant 2, 616331 (3)	
1.249	2	01	01	1p36.22	CORT	C	Cortistatin	602784	H, R, REc			4(Cort)
1.250	1	20	09	1p36	DEL1p36, C1DELp36	P	Chromosome 1p36 deletion syndrome	607872	Ch	contiguous gene deletion syndrome	Chromosome 1p36 deletion syndrome (4)	
1.251	3	13	06	1p36.23	DJ1, PARK7	P	Oncogene DJ-1	602533	Fd, R		Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	
1.252	2	23	95	1p36.12	E2F2	P	E2F transcription factor 2	600426	A			
1.253	4	18	97	1p35.3	EYA3	P	Eyes absent, Drosophila, homolog of, 3	601655	A, H			4(Eya3)
1.254	9	9	08	1p36.22	FBXO2, FBX2, FBG1, NFB42	C	F-box only protein 2	607112	REc			4(Fbxo2)
1.255	5	29	12	1p36.22	H6PD, GDH, G6PDH, CORTRD1	C	Hexose-6-phosphate dehydrogenase	138090	S, F	digenic triallelic mutations with HSD11B1	Cortisone reductase deficiency 1, 604931 (3)	
1.256	6	9	09	1p36	IBD7	P	Inflammatory bowel disease 7	605225	Fd	associated with rs6426833	{Inflammatory bowel disease 7} (2)	
1.257	4	17	01	1p36.31	ICMT	P	Isoprenylcysteine carboxylmethyltransferase	605851	R			
1.258	1	15	16	1p36.11	KDF1, C1orf172	C	Keratinocyte differentiation factor 1	616758	REc, H			4(Kdf1)
1.259	4	2	01	1p36.12	LUZP1	P	Leucine zipper protein 1	601422	H, R			4(Luzp)
1.260	3	9	00	1p36.22	MAD2L2, MAD2B	P	Mitotic arrest-deficient 2, S. cerevisiae, homolog-like 2	604094	R	pseudogene on 14q21-q23		
1.261	9	16	03	1p36.23	MIG6, RALT	P	Mitogen-inducible gene 6	608069	R, REc			
1.262	3	23	09	1p36.22	MIR34A, MIRN34A	P	Micro RNA 34A	611172	REc			
1.263	2	23	09	1p36	MS4	P	Multiple sclerosis, susceptibility to, 4	612596	Fd	associated with rs10492972	{Multiple sclerosis, susceptibility to, 4} (2)	
1.264	7	22	11	1p36	MYP14	P	Myopia 14	610320	Fd	between D1S552 and D1S1622	Myopia 14 (2)	
1.265	12	30	02	1p36.31	NPHP4, SLSN4	P	Nephrocystin 4	607215	Fd, REc		Nephronophthisis 4, 606966 (3); Senior-Loken syndrome 4, 606996 (3)	
1.266	7	9	06	1p36.32	PANK4	P	Pantothenate kinase 4	606162	REn			
1.267	6	1	04	1p36.12	PINK1, PARK6	C	PTEN-induced putative kinase 1	608309	R, REc, Fd		Parkinson disease 6, early onset, 605909 (3)	
1.268	9	9	13	1p36.31	PLEKHG5, KIAA0720, DSMA4, CMTRIC	C	Pleckstrin homology domain-containing protein, family G, member 5	611101	REc, Fd, R, Fd		Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3); Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	
1.269	9	28	96	1p36.21	PRDM2, RIZ	P	PR domain-containing protein 2 (retinoblastoma protein-binding zinc-finger protein RIZ)	601196	REc, A			4(Riz)
1.270	7	09	06	1p36.33	PRKCZ, PKC2	P	Protein kinase C, zeta form	176982	REc			
1.271	11	29	99	1p36.11	RUNX3, CBFA3, PEBP2A3, AML2	C	Runt-related transcription factor 3	600210	A, REa			4(Aml2, Cbfa3)
1.272	7	31	06	1p36	SCAR4, SCASI	P	Spinocerebellar ataxia, autosomal recessive 4	607317	Fd		Spinocerebellar ataxia, autosomal recessive 4 (2)	
1.273	6	4	13	1p36.32	SMIM1, VEL	P	Small integral membrane protein 1	615242	REc		[Blood group, Vel system], 615264 (3)	
1.274	2	12	03	1p36.31	TAS1R1, T1R1	C	Taste receptor type 1, member 1	606225	R, REc			4(T1r1)
1.275	2	12	03	1p36.13	TAS1R2, T1R2	C	Taste receptor type 1, member 2	606226	R, REc			4(T1r2)
1.276	1	15	14	1p36.33	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	P	Tumor necrosis factor receptor superfamily, member 4	600315	A	mutation identified in 1 IMD16 family	?Immunodeficiency 16, 615593 (3)	4(Ox40)
1.277	12	18	98	1p36.22	TNFRSF8, CD30, D1S166E	P	Tumor necrosis factor receptor superfamily, member 8 (CD30 antigen; Ki-1 antigen)	153243	A			4(Cd30)
1.278	12	18	98	1p36.23	TNFRSF9, ILA, CD137	P	Tumor necrosis factor receptor superfamily, member 9 (interleukin-activated receptor; Ly63, mouse, homolog of)	602250	REa			(Cd157)
1.279	10	15	97	1p36.32	TP73	P	p53-related protein	601990	D	imprinted	?Neuroblastoma (1)	
1.280	9	2	09	1p36.13	TRNAE1, TRNE, TRE	P	tRNA glutamic acid	180640	A			
1.281	7	9	06	1p36.23	VAMP3	P	Vesicle-associated membrane protein 3	603657	REc			
1.282	6	27	08	1p36.12	ZBTB40, KIAA0478	P	Zinc finger- and BTB domain-containing protein 40	612106	REc			
1.283	1	2	08	1p36.12	ZNF436, KIAA1710	P	Zinc finger protein 436	611703	REc			
1.284	5	29	02	1p36.11	GALE	C	UDP galactose-4-epimerase	606953	S, LD		Galactose epimerase deficiency, 230350 (3)	
1.285	3	12	96	1p36.13	HTR6	P	5-hydroxytryptamine (serotonin) receptor-6	601109	REa			
1.286	11	1	06	1p36.11	LDLRAP1, ARH, FHCB2, FHCB1	C	Low density lipoprotein receptor adaptor protein 1	605747	Fd		Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	
1.287	6	14	11	1p36.13	PADI6	P	Peptidylarginine deiminase, type VI	610363	REn			
1.288	11	15	11	1p36.11	SEPN1, SELN, RSMD1, CFTD	C	Selenoprotein N	606210	REc, Fd		Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3)	
1.289	11	1	04	1p36-p34	DYX8	P	Dyslexia, susceptibility to, 8	608995	Fd	between D1S552 and D1S1622	{Dyslexia, susceptibility to, 8} (2)	
1.290	12	23	14	1p36.13	PLA2G5, FRFB	P	Phospholipase A2, group V	601192	A		[Fleck retina, familial benign], 228980 (3)	4(Pla2g5)
1.291	5	4	00	1p34.3	PABPC4, PABP4, IPABP, APP1	P	Polyadenylate-binding protein, cytoplasmic, 4	603407	Psh, R			
1.292	12	3	91	1p36.22	SRM, SPS1	C	Spermidine synthase-1	182891	REa, A, Psh	?pseudogene on 3p14-q21		
1.293	4	29	16	1p36.11	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	P	AT rich interactive domain 1A, SWI-like	603024	A		Coffin-Siris syndrome 2, 614607 (3)	
1.294	1	15	13	1p35.3	ATP1F1, IF1	P	ATPase inhibitory factor 1	614981	REc			
1.295	3	28	11	1p36.11	CATSPER4	P	Cation channel, sperm-associated, 4	609121	REc			4(Catsper4)
1.296	1	27	04	1p35.1	CSMD2, KIAA1884	P	Cub and Sushi multiple domains 2	608398	REc			
1.297	7	17	09	1p35.3	GMEB1	P	Glucocorticoid modulatory element-binding protein 1	604409	R, REc			
1.298	11	3	14	1p35.3	MECR, NRBF1	P	Mitochondrial trans-2-enoyl-CoA reductase	608205	REc			
1.299	11	7	08	1p35.3	MED18	P	Mediator complex subunit 18	612384	REc			
1.300	2	21	07	1p36.11	PDIK1L	P	PDLIM1-interacting kianse 1-like	610785	REc			
1.301	7	16	12	1p35.3	PHACTR4	P	Phosphatase and actin regulator 4	608726	R, REc			
1.302	2	1	11	1p35.3	PTPRU, GLEPP1, PTPU2	C	Protein tyrosine phosphatase, receptor type, U	602454	REc			
1.303	5	13	03	1p35.3	SEST2, HI95	P	Sestrin 2	607767	A			9(Sest2)
1.304	12	19	11	1p35.3	SRSF4, SFRS4, SRp75	P	Splicing factor, serine/arginine-rich, 4	601940	R, REc			
1.305	9	22	08	1p35.3	TAF12	P	TAF12 RNA polymerase II, TATA box-binding protein-associated factor, 20kD	600773	R, REc			
1.306	12	18	14	1p34.3	MEAF6, C1orf149, EAF6	P	MYST/ESA1-associated factor 6	611001	R, REc			
1.307	11	30	06	1p34.3	ADPRHL2, ARH3	P	ADP-ribosylhydrolase-like 2	610624	REc			
1.308	4	26	11	1p34.1	TOE1	P	Target of EGR1	613931	REc			
1.309	1	9	13	1p34.3	ZC3H12A, MCPIP, MCPIP1	P	Zinc finger CCCH domain-containing protein 12A	610562	REc			
1.310	8	8	13	1p35.2	HCRTR1, OX1R	P	Hypocretin receptor 1	602392	REc, R			
1.311	7	16	09	1p35.2	NKAIN1	P	Na+/K+ transporting ATPase-interacting 1	612871	REc			4(Nkain1)
1.312	9	22	08	1p35.2	PUM1, KIAA0099	P	Pumilio, Drosophila, homolog of, 1	607204	REa, REc			
1.313	4	2	12	1p35.2	SERINC2	P	Serine incorporator 2	614549	REc			
1.314	7	27	09	1p35.2	SNRNP40, SPF38, PRPF8BP	P	Small nuclear ribonucleoprotein 40kDa (U5)	607797	R, REc			
1.315	11	3	14	1p35.2	TINAGL1, TINAGRP	P	Tubulointerstitial nephritis antigen-like protein 1	616064	REc			
1.316	9	24	08	1p36.11	RCAN3, DSCR1L2, MCIP3	P	Regulator of calcineurin 3	605860	REc			4(Dscr1l2)
1.317	11	23	11	1p35.2	CCDC28B, MGC1203	P	Coiled-coil comain-containing protein 28B	610162	REc		{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	
1.318	8	29	02	1p34.3	DNALI1, P28	P	Dynein, axonemal, light intermediate polypeptide 1	602135	REa, R			
1.319	3	20	08	1p35.1	FNDC5, FRCP2	P	Fibronectin type III domain-containing protein 5	611906	R, REc, H			4(Fndc5)
1.320	2	18	96	1p34.3	GJA4, CX37	C	Gap junction protein, alpha-4, 37kD (connexin 37)	121012	REa, A, REc			(Gja4)
1.321	10	7	10	1p34.3	GJB3, CX31, DFNA2B	C	Gap junction protein, beta-3	603324	REn, REc, Psh, A	same YAC as GJA4	Erythrokeratodermia variabilis et progressiva, 133200 (3); Deafness, autosomal dominant 2B, 612644 (3); Deafness, autosomal recessive (3); Deafness, autosomal dominant, with peripheral neuropathy (3); Deafness, digenic, GJB2/GJB3, 220290 (3)	
1.322	11	29	00	1p34.3	GJB4, CX30.3	P	Gap junction protein, beta-4	605425	REn, Fd		Erythrokeratodermia variabilis with erythema gyratum repens, 133200 (3)	
1.323	11	29	00	1p34.3	GJB5, CX31.1	P	Gap junction protein, beta-5	604493	R, REc			
1.324	3	26	07	1p35.1	IBRDC3, NKLAM	P	IBR domain-containing protein 3	610872	R, REc			
1.325	5	26	13	1p35.2	KPNA6	P	Karyopherin alpha-6	610563	R, REc			
1.326	1	14	16	1p35.1	TRIM62, DEAR1	P	Tripartite motif-containing protein 62	616755	A			
1.327	7	17	14	1p35.1	ZBTB8OS, ARCH	P	Zinc finger- and BTB domain-containing protein 8, opposite strand	615891	REc			
1.328	4	2	16	1p35.1	ZSCAN20, ZNF31, KOX29	P	Zinc finger- and SCAN domain-containing protein 20	611315	REc			
1.329	6	10	98	1p35.2	BAI2	P	Brain-specific angiongenesis inhibitor-2	602683	A			
1.330	8	21	91	1p35	EBVS1	P	Epstein-Barr virus integration site	132850	A			
1.331	3	21	93	1p35.3	G1P3, IFI616	C	Interferon, alpha-inducible protein (clone IFI-6-16)	147572	A, T			
1.332	5	26	98	1p35.2	MATN1, CRTM, CMP	C	Matrilin 1, cartilage matrix protein	115437	REa, A, Fd			
1.333	3	19	10	1p36.13	PLA2G2A, PLA2B, PLA2L, MOM1	C	Phospholipase A2, group IIA, platelets, synovial fluid	172411	REa, Fd		{Colorectal cancer}, 114500 (3)	4(Pla2g2a)
1.334	7	27	09	1p35.3	PPP1R8, NIPP1, ARD1	P	Protein phosphatase-1, regulatory subunit-8	602636	REa, REc			
1.335	3	1	01	1p35.2	PTP4A2, PTP4A, PRL2, HH13	P	Protein tyrosine phosphatase, type 4A, 2	601584	REc			
1.336	4	7	94	1p35.3	RPA2	P	Replication protein A2, 32kD	179836	Psh, A			
1.337	12	2	08	1p36.12	WNT4, SERKAL	P	Wingless-type MMTV integration site family, member 4	603490	A, R		SERKAL syndrome, 611812 (3); Mullerian aplasia and hyperandrogenism, 158330 (3)	4(Wnt4)
1.338	2	10	06	1p35.1	YARS, CMTDIC, TYRRS, YTS, YRS	C	Tyrosyl-tRNA synthetase	603623	Fd, REc		Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	
1.339	8	26	15	1p35.3	YTHDF2	P	YTH N6-methyladenosine RNA-binding protein 2	610640	Ch, Rec	fused with AML1 in t(1;21)		
1.340	12	3	14	1p34.3	CSF3R, GCSFR	C	Colony-stimulating factor-3 receptor (granulocyte)	138971	A, REb, Psh, REa	mutation identified in 1 hereditary neutrophilia family	?Neutrophilia, hereditary, 162830 (3)	
1.341	5	22	14	1p35.2	LCK, IMD22	C	Lymphocyte-specific protein tyrosine kinase	153390	A, H, Ch	LCK/TCRB fusion in leukemia; mutation identified in 1 IMD22 patient	?Immunodeficiency 22, 615758 (3)	4(Lck)
1.342	9	29	96	1p35.3	PTAFR	C	Platelet-activating factor receptor	173393	REa, A			
1.343	6	8	15	1p35.1	HPCA, DYT2	P	Hippocalcin, 23kD, Ca2+-binding protein	142622	REa, REc		Dystonia 2, torsion, autosomal recessive, 224500 (3)	
1.344	4	23	08	1p34.3	MRPS15	P	Mitochondrial ribosomal protein S15	611979	R, REc			
1.345	5	11	16	1p34.3	AGO1, EIF2C1, GERP95, EIF2C	P	Argonaute 1, RISC catalytic component	606228	A			
1.346	7	1	02	1p34.2	CITED4	P	CBP/P300-interacting transactivator, with glu/asp-rich carboxy terminal domain, 4	606815	A			
1.347	6	27	08	1p34.3	EIF2C3, AGO3	C	Eukaryotic translation initiation factor 2C, subunit 3 (argonaute 3)	607355	R, REc, H			4(Ago3)
1.348	7	23	03	1p34.3	EIF2C4, AGO4, KIAA1567	P	Eukaryotic translation initiation factor 2C, 4 (argonaute 4)	607356	R, REc, H			4(Eif2c4)
1.349	8	18	98	1p34.2	GUCA2A, GUCA2	P	Guanylate cyclase activator 2A (guanylin 2, intestinal, heat-stable)	139392	A			4(Guca2)
1.350	1	22	07	1p35.1	TSSK3, STK22C, STK22D	C	Testis-specific serine/threonine kinase 3	607660	A			4(Stk22d)
1.351	1	30	12	1p34.2	EBNA1BP2, EBP2	P	EBNA1-binding protein 2	614443	REc			
1.352	4	17	13	1p34.3	AKIRIN1	P	Akirin 1	615164	REc			
1.353	9	10	12	1p34.3	C1orf109	P	Chromosome 1 openreading frame 109	614799	REc			
1.354	3	24	06	1p34.3	CDCA8	P	Cell division cycle-associated protein 8	609977	REc	possible pseudogene on chr.7		
1.355	9	10	07	1p34.3	EPHA10	P	Ephrin receptor EphA10	611123	REc			
1.356	2	28	06	1p34.3	GBD3	P	Gallbladder disease 3	609919	Fd	new D2S255	Gallbladder disease 3 (2)	
1.357	4	1	08	1p34.3	GJA9, CX59	P	Gap junction protein, alpha-9	611923	REc			
1.358	5	16	05	1p34.3	GNL2, NGP1	P	Guanine nucleotide-binding protein-like 2	609365	R, REc			
1.359	6	13	12	1p34.2	HEYL	P	Hariy/enhancer of split-related with YRPW motif-like protein	609034	R, A			
1.360	7	7	13	1p34.3	KIAA0319L, KIAA1837	P	KIAA0319-like	613535	R, REc			
1.361	2	2	14	1p34.2	MYCL, LMYC	C	Oncogene MYC, lung carcinoma-derived	164850	REa, A, F, REn			4(Lmyc1)
1.362	2	16	04	1p34.3	NCDN, KIAA0607	P	Neurochondrin	608458	R, REc			
1.363	1	15	09	1p34.3	RSPO1, FLJ40906	P	Roof plate-specific spondin, mouse, homolog of, 1	609595	REc		Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3); Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	
1.364	3	11	08	1p35.1	S100PBP, S100PBPR	P	S100P-binding protein	611889	REc			
1.365	4	10	14	1p34.3	SF3A3, SF3A60, SAP61, PRP9	P	Splicing factor 3A, subunit 3	605596	REc			
1.366	6	30	05	1p34.3	STK40, SHIK	P	Serine/threonine protein kinase 40	609437	R, REc			
1.367	1	18	12	1p34.3	TFAP2E	P	Transcription factor AP2-epsilon	614428	REc			
1.368	7	13	15	1p34.3	THRAP3, TRAP150	P	Thyroid hormone receptor-associated protein 3	603809	REc			
1.369	5	21	07	1p34.3	TRAPPC3, BET3	P	Trafficking protein particle complex, subunit 3	610955	R, REc			
1.370	6	30	05	1p34.3	UTP11L, CGI94	P	UTP11-like protein	609440	R, REc			
1.371	8	27	15	1p34.3	ZMYM4, ZNF262, KIAA0425	P	Zinc finger, MYM-type 4	613568	REc			
1.372	1	29	01	1p34.3	CLASPIN	P	Claspin, Xenopus, homolog of	605434	REc			
1.373	2	25	15	1p34.2	MED8	P	Mediator complex subunit 8	607956	R, REc			
1.374	1	23	08	1p35.1	SYNC1	P	Syncoilin 1	611750	REc			
1.375	5	25	13	1p35.1	AZIN2, ODC1L, KIAA1945	P	Antizyme inhibitor 2	608353	REc			
1.376	5	26	13	1p34.2	NT5C1A, CN1A, CNI, CN1	P	5'-nucleotidase, cytosolic, IA	610525	REc			
1.377	2	25	10	1p34.3	COL8A2, FECD1, PPCD2	C	Collagen VIII, alpha-2 polypeptide	120252	A		Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal dystrophy, posterior polymorphous 2, 609140 (3)	
1.378	7	23	13	1p34.3-p32.2	CTRCT34, CATC3	P	Cataract 34, multiple types	612968	Fd	between D1S2729 and D1S2890	Cataract 34, multiple types (2)	
1.379	7	6	05	1p34.1	MUTYH, MYH	P	MutY, E. coli, homolog of	604933	A		Adenomas, multiple colorectal, 608456 (3); Gastric cancer, somatic, 613659 (3); Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)	
1.380	11	12	12	1p34.2	BMP8B, OP2	P	Bone morphogenetic protein-8b (osteogenic protein 2)	602284	H, REc			4(Bmp8)
1.381	11	30	06	1p34.2	CLDN19, HOMG5	C	Claudin 19	610036	REc, Fd		Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	4(Cldn19)
1.382	2	20	08	1p34.2	ELOVL1, SSC1	P	Elongation of very long chain fatty acids-like 1	611813	REc			
1.383	10	12	14	1p34.2	FOXJ3, KIAA1041	P	Forkhead box J3	616035	REc			
1.384	7	30	15	1p34.2	MFSD2A, MCPH15	P	Major facilitator superfamily domain-containing protein 2A	614397	REc		Microcephaly 15, primary, autosomal recessive, 616486 (3)	
1.385	4	8	13	1p34.2	MIR30C1	P	Micro RNA 30C-1	615151	REc			
1.386	8	19	04	1p34.3	NOR1	P	Oxidored-nitro domain-containing protein 1	608854	REc			
1.387	5	24	13	1p34.2	OXCT2, FLJ0030	P	3-oxoacid CoA transferase 2	610289	REc			
1.388	7	27	09	1p34.1	PIK3R3	P	Phosphatidylinositol 3-kinase, regulatory, 3	606076	R, REc			
1.389	8	8	13	1p34.2	PPIE, CYP33	P	Peptidyl-prolyl isomerase E	602435	REc, Psh, REa			
1.390	2	20	98	1p34.3	PSMB2	P	Proteasome subunit, beta type, 2	602175	A			
1.391	12	17	15	1p34.2	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	C	Solute carrier family 2 (facilitated glucose transporter), member 1	138140	REa, A, Fd	probably in 1p33	GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3); GLUT1 deficiency syndrome 2, childhood onset, 612126 (3); {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3); Dystonia 9, 601042 (3); Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	
1.392	4	22	16	1p34.2	SMAP2, SMAP1L	P	Small ADP-ribosylation factor GTPase-activating protein 2	616916	REc			
1.393	11	1	13	1p34.2	SZT2, KIAA0467, EIEE18	P	Seizure threshold 2, mouse, homolog of	615463	REc		Epileptic encephalopathy, early infantile, 18, 615476 (3)	
1.394	12	11	12	1p34.2	WDR65	C	WD repeat-containing protein 65	614259	REc, H, Fd			1(Wdr65)
1.395	9	24	08	1p34.3	YRDC, IRIP	P	YRDC domain-containing protein	612276	REc			4(Yrdc)
1.396	5	21	02	1p34.2	CDC20	C	Cell division cycle 20, S. cerevisiae, homolog of	603618	R	pseudogene on 9q13-q21		
1.397	6	15	99	1p34.3	NDUFS5	C	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kD	603847	REa, R			
1.398	5	7	03	1p32.3	OSBPL9, ORP9	C	Oxysterol-binding protein-like protein 9	606737	REc			
1.399	7	17	14	1p34.2	CTPS1, CTPS, IMD24	C	Cytidine 5'-triphosphate synthetase 1	123860	REa, A		Immunodeficiency 24, 615897 (3)	
1.400	2	25	15	1p34.1	DNMAP1, DMAP1	P	DNMT1-associated protein 1	605077	REc			
1.401	5	31	05	1p34.1	EIF2B3	P	Eukaryotic translation initiation factor 2B, subunit 3	606273	R, REc		Leukoencephalopathy with vanishing white matter, 603896 (3)	
1.402	10	3	07	1p35.2	EIF3I, EIF3S2, TRIP1	P	Eukaryotic translation initiation factor 3, subunit I	603911	A	pseudogene on 7q32		
1.403	9	9	08	1p34.2	FOXO6	P	Forkhead box O6	611457	REc			4(Foxo6)
1.404	2	24	97	1p35.2-p35.1	HDAC1, RPD3L1	P	Histone deacetylase-1	601241	A			
1.405	9	7	12	1p34.1	IPO13, IMP13, KIAA0724, RANBP13	P	Importin 13	610411	R, REc			
1.406	5	29	12	1p34.2-p34.1	KDM4A, JMJD2A, JHDM3A, KIAA0677	C	Lysine-specific demethylase 4A	609764	R, REc			
1.407	8	24	04	1p34.1	KIF2C, KNSL6, MCAK	P	Kinesin family, member 2C	604538	R, REc			
1.408	12	30	14	1p34.1	LURAP1, LRAP35A	P	Leucine-rich adaptor protein 1	616129	REc			
1.409	9	24	08	1p34.1	MAST2, MAST205, KIAA0807	P	Microtubule-associated serine/threonine kinase 2	612257	R, REc			
1.410	1	20	06	1p34.1	MMACHC	C	MMACHC gene	609831	REn, Fd		Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)	
1.411	9	16	12	1p34.1	NASP	P	Nuclear autoantigenic sperm protein	603185	REc			
1.412	3	17	94	1p34.1	PAGA	P	Proliferation-associated gene A	176763	A	pseudogene PAGB on 9p22		
1.413	2	1	11	1p34.1	PLK3, CNK, PRK	P	Polo-like kinase 3	602913	REc	previously assigned to 8p21 by FISH		
1.414	4	13	98	1p34.3	POU3F1	P	POU domain, class 3, transcription factor-1	602479	A			4(Pou3f1)
1.415	5	17	04	1p34.2	PPIH	P	Peptidyl-prolyl isomerase H	606095	R			
1.416	2	23	08	1p34.2	RIMS3, NIM3, KIAA0137	C	Protein regulating synaptic membrane exocytosis 3	611600	R, REc			
1.417	12	30	14	1p34.1	RNF220	P	RING finger protein 220	616136	REc			
1.418	1	9	13	1p34.1	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	P	ST3 beta-galactoside alpha-2,3-sialyltransferase 3	606494	R, REc		Mental retardation, autosomal recessive 12, 611090 (3); Epileptic encephalopathy, early infantile, 15, 615006 (3)	
1.419	1	4	08	1p34.1	TCTEX1D4	P	TCTEX1 domain-containing 4	611713	REc			
1.420	12	21	09	1p34.1	TSPAN1, NET1	P	Tetraspanin 1	613170	REn			
1.421	3	31	11	1p33	UQCRH	P	Ubiquinol-cytochrome c reductase hinge protein	613844	REc	pseudogene on 1p36		
1.422	10	4	05	1p34.1	ZNF393	P	Zinc finger protein-393	609602	REc, H			4(Znf393)
1.423	8	4	97	1p34.1-p32	PTOS1	P	Ptosis, congenital 1, autosomal dominant	178300	A		Ptosis, hereditary congenital, 1 (2)	
1.424	2	1	95	1p34.1	RPS8	C	Ribosomal protein S8	600357	REa, Psh, A			
1.425	8	24	09	1p35.1	AK2	C	Adenylate kinase-2, mitochondrial	103020	S, F, R		Reticular dysgenesis, 267500 (3)	4(Ak2)
1.426	3	21	93	1p35.2	COL16A1	C	Collagen XVI, alpha-1 polypeptide	120326	A, REa			
1.427	8	21	07	1p34.1	DPH2, DPH2L2	P	DPH2, S. cerevisiae, homolog of	603456	A			
1.428	6	6	91	1p34.2	EDN2	C	Endothelin-2	131241	REa, A	vasoactive intestinal contractor (VIC) = mouse and rat equivalent		
1.429	5	29	98	1p33-p32	ELAVL4, HUD, PNEM	C	Embryonic lethal, abnormal vision, Drosophila, homolog of, like-4 (Hu antigen D)	168360	A, H		Neuropathy, paraneoplastic sensory (1)	4(Hud)
1.430	12	28	05	1p34.2	ERMAP, SC, RD	C	Erythroblast membrane-associated protein	609017	REc, H, F		[Blood group, Scianna system], 111750 (3); [Blood group, Radin], 111620 (3)	4(Ermap)
1.431	6	22	99	1p34.3	FHL3, SLIM2	P	Four-and-a-half LIM domains-3	602790	R			
1.432	9	18	08	1p36.11	FUCA1	C	Fucosidase, alpha-L- 1, tissue	612280	S, F, R, A, REa	8cM distal to RH; pseudogene on 2q31-q32	Fucosidosis, 230000 (3)	4(Fuca)
1.433	2	4	02	1p34.2	HIVEP3, KRC	P	Human immunodeficiency virus type 1 enhancer-binding protein 3	606649	REc			
1.434	10	9	94	1p34.3	INPP5B	P	Inositol polyphosphate-5-phosphatase, 75kD	147264	REa, A			4(Inpp5b)
1.435	3	6	09	1p34.2	KCNQ4, DFNA2A	P	Potassium voltage-gated channel, KQT-like subfamily, member 4	603537	A		Deafness, autosomal dominant 2A, 600101 (3)	
1.436	11	13	96	1p35.2	LAPTM5	P	Lysosomal-associated multispanning membrane protein-5	601476	A			
1.437	10	09	07	1p32.3	LRP8, APOER2, MCI1	C	Low density lipoprotein receptor-related protein 8 (Apolipoportein E receptor 2)	602600	REa, A, Fd		{Myocardial infarction, susceptibility to}, 608446 (3)	
1.438	6	7	10	1p35.1	MARCKSL1, MLP, MRP	C	MARCKS-like protein 1	602940	H, Psh, A			4(Mlp)
1.439	3	9	12	1p34.2	MPL, TPOR, MPLV, THCYT2	C	Myeloproliferative leukemia virus, homolog of	159530	A		Thrombocytopenia, congenital amegakaryocytic, 604498 (3); Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	
1.440	2	3	15	1p34.2	P3H1, LEPRE1, GROS1, OI8	C	Prolyl 3-hydroxylase 1	610339	Psh, R, REc		Osteogenesis imperfecta, type VIII, 610915 (3)	
1.441	5	19	06	1p35.2	PEF1	P	Peflin	610033	REc			
1.442	3	6	08	1p34.3	RRAGC, RAGC	P	RAS-related GTP-binding protein C	608267	R, REc			
1.443	6	23	15	1p34.2	SCMH1	P	Sex comb on midleg, Drosophila, homolog of, 1	616396	A			4(Scmh1)
1.444	8	31	01	1p34.3	SFPQ, PSF	P	Splicing factor, proline- and glutamine-rich	605199	Ch	fusion gene with TFE3 in RCC		
1.445	11	19	10	1p34.1	UROD	C	Uroporphyrinogen decarboxylase	613521	S, A, REa		Porphyria cutanea tarda, 176100 (3); Porphyria, hepatoerythropoietic, 176100 (3)	4(Urod)
1.446	2	23	12	1p34.2	YBX1, NSEP1, YB1, DBPB	P	Y box binding protein 1 (major histocompatibility complex, class II, Y box-binding protein I)	154030	A			
1.447	6	23	05	1p34.2	ZMPSTE24, FACE1, STE24, MADB	C	Zinc metalloproteinase STE24	606480	A, R		Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3); Restrictive dermopathy, lethal, 275210 (3)	
1.448	10	9	94	1p34.3	GRIK3, GLUR7	P	Glutamate receptor, ionotropic, kainate 3	138243	REa, A			
1.449	5	29	98	1p34.2	GUCA2B, UGN	P	Guanylate cyclase activator 2B (uroguanylin)	601271	A			4(Guca1b)
1.450	7	2	98	1p32.3	MAGOH	P	Mago nashi, Drosophila, homolog of, proliferation-associated	602603	R			4(Magoh)
1.451	4	4	02	1p34.1	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	C	Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase	606822	Fd, LD		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	
1.452	1	1	95	1p34.2	TIE, JTK14, TIE1	P	Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains	600222	A			
1.453	5	28	98	1p33	FOXD2, FKHL17, FREAC9	P	Forkhead box D2	602211	A			
1.454	8	31	10	1p34-p32	MACST	P	Macrostomia	613545	Ch	max lod at D1S2797	Macrostomia (2)	
1.455	9	11	91	1p33	CYP4B1	P	Cytochrome P450, subfamily IVB, polypeptide 1	124075	REa			4(Cyp4a)
1.456	11	4	91	1p31.3	DDIT1, GADD45	P	DNA damage-inducible transcript-1	126335	REa			
1.457	7	28	15	1p33	AGBL4, CCP6	P	ATP/GTP-binding protein-like 4	616476	REc			
1.458	1	11	07	1p33	CYP4A11	C	Cytochrome P450, subfamily IVA, polypeptide 11	601310	Psh, REc			
1.459	8	2	13	1p33	CYP4A22	P	Cytochrome P450, family 4, subfamily A, polypeptide 22	615341	REc			
1.460	1	9	13	1p33	CYP4X1, CYPIVX1	P	Cytochrome P450, family 4, subfamily X, polypeptide 1	614999	REc			
1.461	5	28	15	1p33	DMBX1, OTX3	P	Diencephalon/mesencephalon homeobox 1	607410	REc			
1.462	11	19	13	1p33	FAAH	C	Fatty acid amide hydrolase	602935	R, REc		{Drug addiction, susceptibility to}, 606581 (3)	4(Faah)
1.463	3	18	11	1p32.3	FAF1, HFAF1	P	Fas-associated factor 1	604460	REc			
1.464	10	13	09	1p33	KNCN, KINO, L5	P	Kinocilin	611455	REc			4(Kncn)
1.465	8	29	02	1p33	MAP17	P	Membrane-associated protein 17	607178	REc, H	near SLC in human, mouse, chicken, zebrafish		
1.466	7	17	09	1p33	MKNK1, MNK1	P	Mitogen-activated protein kinase-interacting serine/threonine kinase 1	606724	R, REc			
1.467	11	3	94	1p34.3	MTF1	P	Metal-regulatory transcription factor 1	600172	A			
1.468	9	9	13	1p33	NSUN4	P	NPO2/SUN domain family, member 4	615394	REc			
1.469	4	6	11	1p33	OFC13	P	Orofacial cleft 13	613857	Fd	associated with rs3827730	Orofacial cleft 13 (2)	
1.470	6	23	15	1p33	SKINTL, SKINTP	P	SKINT1-like pseudogene	616392	REc			
1.471	1	29	96	1p34.1	SLC6A9, GLYT1	C	Solute carrier family 6 (neurotransmitter transporter, glycine), member 9	601019	A			4(Slc6a9)
1.472	5	3	11	1p33	SPATA6, SRF1, HASH	P	Spermatogenesis-associated protein 6	613947	REc			
1.473	12	27	13	1p33	STIL, SIL, MCPH7	C	SCL/TAL1-interrupting locus	181590	REn, REc	within about 250kb of SCL	Microcephaly 7, primary, autosomal recessive, 612703 (3)	
1.474	12	10	12	1p33	TRABD2B, TIKI2	P	TRAB domain-containing protein 2B	614913	REc			
1.475	9	8	06	1p34.1	BEST4, VMD2L2	P	Bestrophin 4	607336	A			
1.476	9	10	12	1p32.3	DMRTA2	P	Doublesex- and MAB3-related transcription factor A2	614804	REc			
1.477	5	4	09	1p33-p32	BMND14	P	Bone mineral density quantitative trait locus 14	612728	Fd	associated with rs17131547	[Bone mineral density QTL 14] (2)	
1.478	12	30	14	1p34.2	COL9A2, EDM2, STL5	C	Collagen IX, alpha-2 polypeptide	120260	REa, A, REn, Fd	mutation identified in1 STL5 family	Epiphyseal dysplasia, multiple, 2, 600204 (3); {Intervertebral disc disease, susceptibility to}, 603932 (3); ?Stickler syndrome, type V, 614284 (3)	4(Col9a2)
1.479	12	6	01	1p34.3	MYCBP	P	MYC-binding protein	606535	A			
1.480	5	2	01	1p34.1	AKR1A1, ALR	P	Aldo-keto reductase family 1, member A1 (aldehyde reductase)	103830	A			
1.481	8	9	99	1p34.1	B4GALT2	P	Beta-1,4-galactosyltransferase 2	604013	A, REc			
1.482	6	15	99	1p32.3	DIO1, TXDI1	P	Deiodinase, iodothyronine, type I	147892	A			4(Dio1)
1.483	9	22	95	1p22.1	TGFBR3	P	Transforming growth factor, beta receptor III (betaglycan, 300kD)	600742	Psh, A			
1.484	10	31	01	1p32.3	DHCR24, KIAA0018	C	24-dehydrocholesterol reductase	606418	REa, REc		Desmosterolosis, 602398 (3)	
1.485	1	27	11	1p33-p31.1	FWS	P	Forsythe-Wakeling syndrome	613606	Fd	between rs2354462 and rs718883	Forsythe-Wakeling syndrome (2)	
1.486	3	17	94	1p35.2	FABP3	C	Fatty acid-binding protein 3, muscle	134651	REa, A			4(Fabph1)
1.487	3	24	06	1p32.3	ACOT11, THEA, BFIT, BFIT1, BFIT2, KIAA0707	C	Acyl-CoA thioesterase 11	606803	REa, R, H			4(Thea)
1.488	11	19	13	1p34.1	ATP6V0B, ATP6F	P	ATPase, H+ transporting, lysosomal 21kD, V0 subunit c''	603717	A, R			4(Atp6v0b)
1.489	12	24	08	1q32.3	BATF3	P	Basic leucine zipper transcription factor, ATF-like, 3	612470	REc			
1.490	6	30	15	1p32.3	C1orf177, LEM	P	Chromosome 1 open reading frame 177	616446	REc			
1.491	2	13	14	1p32.3	COA7, RESA1, SELRC1, C1orf163	P	Cytochrome C oxidase assembly factor	615623	REc			
1.492	8	19	13	1p32.3	GLIS1	P	Glis family zinc finger protein 1	610378	REc, R			4(Glis1)
1.493	11	3	14	1p32.3	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	C	Proprotein convertase, subtilisin/kexin-type, 9	607786	REc, Fd		Hypercholesterolemia, familial, 3, 603776 (3); {Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	
1.494	5	17	04	1p32.3	PODN	P	Podocan	608661	REc			
1.495	7	3	06	1p32.3	TMEM48, NDC1	P	Transmembrane protein 48	610115	R, REc			
1.496	6	30	05	1p32.3	TXNDC12, TLP19, ERP18	P	Thioredoxin domain-containing protein 12	609448	REc			
1.497	5	13	09	1p32.3	USP24, KIAA1057	P	Ubiquitin-specific protease 24	610569	R, REc			
1.498	11	11	14	1p32.3	ZFYVE9, MADHIP, SARA	P	Zinc finger, FYVE domain containing 9	603755	REc			
1.499	3	23	12	1p34.3	SNIP1, PMRED	P	SMAD nuclear interacting protein 1	608241	REc		Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)	
1.500	9	10	12	1p32.3	DMRTB1	P	Doublesex- and MAB3-related transcription factor B1	614805	REc			
1.501	7	2	98	1p32.3	NRD1	C	Nardilysin (N-arginine dibasic convertase)	602651	A			
1.502	6	9	08	1p32.3	PARS2	P	Prolyl-tRNA synthetase 2	612036	REc			
1.503	7	7	15	1p32.1	FGGY, FLJ10986	P	FGGY carbohydrate kinase domain-containing protein	611370	REc			
1.504	4	17	08	1p32.1	HOOK1, HK1	C	Hook, Drosophila, homolog of, 1	607820	REc, A			4(Hook1)
1.505	3	5	08	1p32.3	MRPL37	P	Mitochondrial ribosomal protein L37	611843	REc			
1.506	8	1	08	1p32.1	MYSM1, 2ADUB, KIAA1915	P	MYB-like, SWIRM, and MPN domains-containing protein 1	612176	REc			
1.507	11	22	13	1p31.3	DNAJC6, DJC6, KIAA0473, PARK19	P	DNAJ, E. coli, homolog of, subfamily C, member 6	608375	R, REc		Parkinson disease 19, juvenile-onset, 615528 (3)	
1.508	6	18	99	1p31.3	USP1	P	Ubiquitin-specific protease 1	603478	A, R			
1.509	4	14	11	1p32.2	C8A	C	Complement component-8, alpha polypeptide	120950	F, A, Ch, Fd		C8 deficiency, type I, 613790 (3)	
1.510	3	10	11	1p32.2	C8B	C	Complement component-8, beta polypeptide	120960	F, A, Ch, H, Fd		C8 deficiency, type II, 613789 (3)	4(C8b)
1.511	10	6	08	1p32.3	CDCP2	P	Cub domain-containing protein 2	612320	REc	?associated with PARK10		
1.512	6	18	99	1p32.3	CDKN2C, INK4C	P	Cyclin-dependent kinase inhibitor 2C	603369	A			
1.513	10	3	11	1p32.3	CPT2, IIAE4	C	Carnitine palmitoyltransferase II	600650	REa, A	formerly at 1p13	Myopathy due to CPT II deficiency, 255110 (3); CPT deficiency, hepatic, type II, 600649 (3); CPT II deficiency, lethal neonatal, 608836 (3); {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)	
1.514	11	13	94	1p32.3	EPS15	P	Epidermal growth factor receptor pathway substrate-15	600051	REc			
1.515	7	17	06	1p33	FOXE3, FKHL12, ASMD	P	Forkhead box E3	601094	A		Anterior segment mesenchymal dysgenesis, 107250 (3); Aphakia, congenital primary, 610256 (3)	
1.516	6	22	14	1p32.3	GPX7, NPGPX	P	Glutathione peroxidase 7	615784	REc			
1.517	5	24	13	1p35.2	KHDRBS1, SAM68	P	KH domain-containing, RNA-binding, signal transduction-associated protein 1	602489	REc			
1.518	1	30	01	1p34.2	NFYC, CBFC	C	Nuclear transcription factor Y, gamma	605344	REc, H			4(Nfyc)
1.519	5	15	11	1p32.3	ORC1, ORC1L	P	Origin recognition complex, subunit 1, S. cerevisiae, homolog	601902	Psh, A		Meier-Gorlin syndrome 1, 224690 (3)	
1.520	4	10	15	1p32	PARK10, AAOPD	C	Parkinson disease 10	606852	Fd	max lod at D1S2652; ?associated with CDCP2	{Parkinson disease 10} (2)	
1.521	1	5	12	1p34.2	PPT1, CLN1	C	Palmitoyl-protein thioesterase 1	600722	Fd, LD, REn, A, REc		Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	
1.522	3	1	06	1p34.1	PRNPIP, PINT1	P	Prion protein-interacting protein	609917	REc, R			
1.523	7	14	14	1p34.1	PTCH2	P	Patched, Drosophila, homolog of, 2	603673	R, Psh		Medulloblastoma, 155255 (3); Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3)	4(Ptch2)
1.524	9	10	14	1p34.2	PTPRF, LAR, BNAH2	P	Protein tyrosine phosphatase, receptor type, f polypeptide	179590	A	mutation identified in 1 BNAH2 family	?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3)	4(Ptprf)
1.525	1	25	12	1p34.1	RAD54L, HR54, HRAD54	P	RAD54, S. cerevisiae, homolog-like	603615	A		{Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3); Adenocarcinoma, colonic, somatic (3)	
1.526	1	26	93	1p34.2	RLF	C	Rearranged L-myc fusion sequence	180610	REa, REn	<800kb from MYCL1		
1.527	8	21	14	1p32	SCA37	P	Spinocerebellar ataxia 37	615945	Fd	between D1S200 and D1S2742	Spinocerebellar ataxia 37 (2)	
1.528	7	3	06	1p32.3	SCP2	C	Sterol carrier protein-2	184755	Psh, REa		Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)	4(Scp2)
1.529	9	3	10	1p32	STQTL23	P	Stature quantitative trait locus 23	613548	Fd	linked to rs628667	{Stature QTL 23} (2)	
1.530	6	10	02	1p32.1	TACSTD2, TROP2, M1S1	C	Tumor-associated calcium signal transducer 2	137290	REa, A		Corneal dystrophy, gelatinous drop-like, 204870 (3)	
1.531	8	27	15	1p33	TAL1, TCL5, SCL	C	T-cell acute lymphocytic leukemia-1	187040	Ch, RE	proximal to MYCL1	Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	4(Scl)
1.532	5	25	13	1p34.1	TESK2	P	Testis-specific protein kinase 2	604746	A			
1.533	2	12	08	1p33	CMPK1, CMPK, UMPK, UMK, CMK	C	Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic	191710	S, R, F			
1.534	6	18	99	1p32.2	DAB1	P	Disabled, Drosophila, homolog 1	603448	R, H			4(Dab1)
1.535	2	8	11	1p32-p31	DEL1p32p31, C1DELp32p31	P	Chromosome 1p32-p31 deletion syndrome	613735	Ch	contiguous gene (4.93Mb) deletion syndrome	Chromosome 1p32-p31 deletion syndrome (4)	
1.536	8	21	91	1p32.1	JUN	C	Avian sarcoma virus 17 (v-jun) oncogene homolog	165160	REa, A, H			4(Jun)
1.537	2	16	04	1p34.3	MACF1, ACF7, KIAA1251	C	Microtubule-actin cross-linking factor 1	608271	R, REc, A			4(Macf1)
1.538	4	11	11	1p31.1	NEXN, NELIN, CMD1CC, CMH20	P	Nexilin, rat, homolog of	613121	REc		Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, hypertrophic, 20, 613876 (3)	
1.539	4	16	98	1p31.3	NTRKR1, ROR1	P	Neurotrophic tyrosine kinase, receptor-related 1	602336	A			
1.540	9	13	89	1p32.3	RAB3B	P	Brain antigen RAB3B	179510	REb, A			
1.541	2	17	09	1p32.3	RNF11	P	Ring finger protein 11	612598	Psh, R			
1.542	1	22	09	1p31.3	SLC35D1, UGTREL7, KIAA0260	C	Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1	610804	R, A		Schneckenbecken dysplasia, 269250 (3)	
1.543	8	8	91	1p21.2	VCAM1	P	Vascular cell adhesion molecule-1	192225	REa, A			3(Vcam1)
1.544	3	21	93	1p34.1	IPP	P	Intracisternal A particle-promoted polypeptide	147485	REa			4(Ipp)
1.545	3	1	05	1p31.3	AK3	C	Adenylate kinase-3, mitochondrial	103030	REc, H			4(Ak3)
1.546	4	2	16	1p31.3	ATG4C, APG4C	P	Autophagy 4, S. cerevisiae, homolog of, C	611339	REc			
1.547	8	3	12	1p31.3	DIRAS3, ARHI	P	DIRAS family, GTP-binding RAS-like protein 3	605193	Psh, A			
1.548	6	26	14	1p31.3	DOCK7, KIAA1771, EIEE23	P	Dedicator of cytokinesis 7	615730	REc		Epileptic encephalopathy, early infantile, 23, 615859 (3)	4(Dock7)
1.549	9	23	13	1p31.3	GNG12	P	Guanine nucleotide-binding protein, gamma 12	615405	REc, R			6(Gng12)
1.550	9	23	13	1p31.3	GNG12AS1	P	GNG12 antisense RNA 1	615406	REc			
1.551	1	12	11	1p31.3	IL23R, IBD17	P	Interleukin 23 receptor	607562	REc		{Inflammatory bowel disease 17, protection against}, 612261 (3); {Psoriasis, protection against}, 605606 (3)	
1.552	1	17	08	1p31.3	INADL, PATJ	P	INAD, Drosophila, homolog of	603199	REc, R			
1.553	7	17	09	1p31.3	ITGB3BP, NRIF3	P	Integrin, beta-3, binding protein of	605494	R, REc			
1.554	7	10	93	1p31.3	JAK1	C	Janus kinase 1 (a protein-tyrosine kinase)	147795	REa, A, Fd	related gene on 9p24		4(Jak1)
1.555	5	4	12	1p31.3	KANK4	P	KN motif- and ankyrin repeat domain-containing protein 4	614612	REc			
1.556	3	8	16	1p31.3	MEIR1, KIAA1610	P	Mesoderm induction-early response protein 1	616848	REc			
1.557	3	23	09	1p31.3	MIR101-1, MIRN101-1	P	Micro RNA 101-1	612511	REc	another locus, MIRN101-2, on 9p24		
1.558	3	14	13	1p31.3	OPHLC, C1DUPp31.3, DUP1p31.3	P	Omphalocele due to duplication of 1p31.3	164750	Ch	duplication of 710kb at 1p31.3	Omphalocele due to duplication of 1p31.3 (4)	
1.559	3	14	06	1p31.3	RAVER2, KIAA1579	P	Raver2, mouse, homolog of	609953	R, REc			
1.560	7	14	14	1p31.3	SERBP1, PAIRBP1	P	Serpine1 mRNA-binding protein 1	607378	REc			
1.561	8	20	08	1p31.3	SGIP1	P	SH3-domain GRB2-like (endophilin)-interacting protein 1	611540	REc			
1.562	12	5	02	1p32.3	SSBP3	P	Single-stranded DNA-binding protein 3	607390	REc			
1.563	8	19	13	1p31.3	TM2D1, BBP	P	TM2 domain-containing protein 1	610080	R, REc			
1.564	5	6	03	1p32.3	TTC4	P	Tetratricopeptide repeat domain 4	606753	A	pseudogene on 7p14-p13		
1.565	5	26	13	1p31.1	TYW3	P	tRNA-wybutosine-synthesizing protein 3, S. cerevisiae, homolog of	611245	REc			
1.566	9	23	13	1p31.3	WLS, GPR177, EVI	P	WNTless, Drosophila, homolog of	611514	REc, R			
1.567	7	2	98	1p32.1	CYP2J2	P	Cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase), polypeptide 2	601258	REa, A			4(Cyp2j2)
1.568	9	22	95	1p31.3	NFIA	P	Nuclear factor I/A	600727	A			4(Nfia)
1.569	11	13	12	1p31.3-p31.1	POROK5, DSAP3	P	Porokeratosis 5, disseminated superficial actinic	612293	between D1S438 and D1S464		Porokeratosis 5, disseminated superficial actinic (2)	
1.570	4	24	08	1p31.3	DEPDC1	P	DEP domain-containing 1	612002	REc			
1.571	6	9	98	1p31.3	IL12RB2	C	Interleukin 12 receptor, beta-2	601642	A, Psh, R			
1.572	9	10	09	1p31.2	PBC3	P	Biliary cirrhosis, primary, 3	613008	Fd	associated with rs3790567	{Biliary cirrhosis, primary, 3} (2)	
1.573	6	15	95	1p31.1	PTGER3, EP3	P	Prostaglandin E receptor 3, EP3 subtype	176806	A			3(Ptger3)
1.574	6	30	15	1p31.1	ADGRL2, LPHN2, LPHH1, CIRL2, CL2, KIAA0786	P	Adhesion G protein-coupled receptor L2	607018	Ch, REc			
1.575	6	30	15	1p31.1	ADGRL4, ETL, ELTD1	C	Adhesion G protein-coupled receptor L4	616419	R, H, REc			3(Adgrl4)
1.576	4	5	13	1p31.1	ANKRD13C	P	Ankyrin repeat domain-containing protein 13C	615125	RE			
1.577	5	31	05	1p31.1	CTH	C	Cystathionine gamma-lyase	607657	R, REc	previously assigned to chr.16	Cystathioninuria, 219500 (3); Homocysteine, total plasma, elevated (3)	
1.578	4	2	16	1p31.1	DNAJB4, HLJ1	P	DNAJ/HSP40 homolog, subfamily B, member 4	611327	REc			
1.579	1	29	16	1p31.1	FAM73A, MIGA1	P	Miga, Drosophila, homolog of, 1	616773	REc			
1.580	5	25	13	1p31.1	FPGT, GFPP	P	Fucose-1-phosphate guanylyltransferase	603609	REc			
1.581	6	1	09	1p31.1	FUBP1, FUBP, FBP	P	Far upstream element-binding protein 1	603444	REc			
1.582	5	25	13	1p31.1	HHLA3	P	Human endogenous retrovirus-H long terminal repeat-associating 3	604372	REc			
1.583	6	11	11	1p31.1	IFI44L	P	Interferon-induced protein 44-like	613975	REc			
1.584	3	14	07	1p31.1	IFI44, P44	P	Interferon-induced protein 44	610468	R, REc			
1.585	12	3	07	1p31.1	LHX8	P	LIM homeobox 8	604425	REc			
1.586	1	30	12	1p31.1	LRRC7, DENSIN, KIAA1365	C	Leucine-rich repeat-containing protein 7	614453	Psh, REc			
1.587	12	21	09	1p31.1	NEGR1, KILON	P	Neuronal growth regulator 1	613173	REc			
1.588	7	27	09	1p31.1	PIGK, GPI8	P	Phosphatidylinositol glycan, class K	605087	REa, REc			
1.589	4	18	11	1p31.1	PRKACB	P	Protein kinase, cAMP-dependent, catalytic, beta	176892	REa, A, REc			
1.590	6	16	95	1p31.1	PTGFR	P	Prostaglandin F receptor (FP)	600563	A			3(Ptgfr)
1.591	12	19	11	1p31.1	SRSF11, SFRS11	P	Splicing factor, serine/arginine-rich, 11	602010	REc			
1.592	8	19	13	1p31.1	ST6GALNAC3, SIAT7C	P	ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	610133	R, REc			
1.593	7	8	09	1p31.1	ST6GALNAC5, SIAT7E	P	ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6 sialyltransferase 5	610134	REc			
1.594	12	4	14	1p31.1	TNNI3K, CCDD	P	TNNI3-interacting kinase	613932	REc	mutation identified in 1 CCDD family	?Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3)	
1.595	4	8	13	1p31.1	USP33, VDU1	C	Ubiquitin-specific protease 33	615146	R, REc			
1.596	11	1	01	1p31.3	INSL5	P	Insulin-like 5	606413	R			
1.597	6	27	08	1p22.3	LPAR3, EDG7, LPA3	P	Lysophosphatidic acid receptor 3	605106	R, H			3(Edg7)
1.598	4	27	12	1p31.1-p21.1	SPG29	P	Spastic paraplegia 29, autosomal dominant	609727	Fd	max lod at D1S2865	Spastic paraplegia 29, autosomal dominant (2)	
1.599	6	26	02	1p31.1	ACADM, MCAD	P	Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain	607008	REa,A		Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	3(Acadm)
1.600	1	12	07	1p31.1	AK5	P	Adenylate kinase 5	608009	R			
1.601	5	8	97	1p31	AIR	P	Acute insulin response	601676	Fd		Acute insulin response (2)	
1.602	11	19	11	1p31.3	FOXD3, AIS1, VAMAS2	C	Forkhead box D3	611539	Fd, Psh, H		{Autoimmune disease, susceptibility to, 1}, 607836 (3)	4(Foxd3)
1.603	1	7	11	1p31.3	ANGPTL3, ANGPT5, FHBL2	C	Angiopoietin-like 3	604774	R, H		Hypobetalipoproteinemia, familial, 2, 605019 (3)	4(Angptl3, hypl)
1.604	4	17	07	1p31	ASRT4	P	Asthma-related traits, susceptibility to, 4	610906	Fd	max lod at D1S2890	{Asthma-related traits, susceptibility to, 4} (2)	
1.605	11	3	09	1p32.3	BSND	P	Barttin	606412	Fd, REc		Bartter syndrome, type 4a, 602522 (3); Sensorineural deafness with mild renal dysfunction, 602522 (3)	
1.606	11	6	98	1q22	CLK2	C	CDC-like kinase 2	602989	Psh, REn	near GDLD and PRKAA2; conflicting assignment 1q21		
1.607	6	20	91	1p21.2	DBT, BCATE2	C	Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex)	248610	REa, A	pseudogene on 3q24	Maple syrup urine disease, type II, 248600 (3)	
1.608	12	11	12	1p31.3	LEPR, OBR, LEPRD	P	Leptin receptor	601007	H, REc, R, Fd		Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	4(Lepr)
1.609	9	7	10	1p31.3	LEPROT, OBRGRP	P	Leptin receptor overlapping transcript	613461	REc	transcribed in same direction as LEPR		
1.610	6	2	98	1p31.1	MSH4	P	mutS, E. coli, homolog of, 4	602105	A			
1.611	7	17	14	1p31	OFC14	P	Orofacial cleft 14	615892	Fd		Orofacial cleft 14 (2)	
1.612	3	26	02	1p31	PAOD1	P	Peripheral arterial occlusive disease 1	606787	Fd		Peripheral arterial occlusive disease 1 (2)	
1.613	10	9	94	1p31.3	PDE4B, DPDE4	C	Phosphodiesterase-4B, cAMP-specific (dunce-like phosphodiesterase E4)	600127	RE, A			4(Pde4b)
1.614	6	3	14	1p31.3	PGM1, GSD14, CDG1T	C	Phosphoglucomutase-1	171900	F, S, R	distal to ACADM; formerly 1p22.1	Congenital disorder of glycosylation, type It, 614921 (3)	4(Pgm2)
1.615	3	9	98	1p31.1	PIN1L	P	Peptidyl-prolyl cis/trans isomerase, NIMA-interacting-like	602051	A	?transcribed pseudogene		
1.616	8	17	98	1p32.2	PRKAA2, AMPK	P	Protein kinase, AMP-activated, alpha-2 catalytic subunit	600497	Psh, A			
1.617	2	12	01	1p31.1	RABGGTB	C	Rab geranylgeranyltransferase, beta subunit	179080	REa, A			3(Rabggtb)
1.618	3	10	11	1p31.3	RPE65, RP20, LCA2	C	Retinal pigment epithelium-specific protein, 65kD	180069	REa, A, Fd		Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20, 613794 (3)	3(Rpe65)
1.619	7	9	06	1p22.3	SEP15	P	Selenoprotein, 15kD	606254	REc			
1.620	1	11	95	1p31.1	CRYZ	P	Crystallin, zeta (quinone reductase)	123691	REa, A			
1.621	8	12	01	1p31-p21	AVSD1, AVCD	P	Atrioventricular septal defect, susceptibility to, 1	606215	Fd		{Atrioventricular septal defect, susceptibility to, 1} (2)	
1.622	1	30	01	1p31.3	ALG6, CDG1C	P	Alg6, S. cerevisiae, homolog of	604566	REc		Congenital disorder of glycosylation, type Ic, 603147 (3)	
1.623	3	11	16	1p22.3	CLCA1, CACC1	P	Chloride channel accessory 1	603906	A			
1.624	3	11	16	1p22.3	CLCA2	P	Chloride channel accessory 2	604003	R			
1.625	3	11	16	1p22.3	CLCA3	P	Chloride channel accessory 3	604337	R, REc			
1.626	3	11	16	1p22.3	CLCA4, CACC2	P	Chloride channel accessory 4	616857	REc			3(Clca4)
1.627	5	19	06	1p22.3	COL24A1	P	Collagen, type XXIV, alpha-1	610025	REc, R			
1.628	01	26	00	1p22.3	CYR61, IGFBP10	C	Cysteine-rich angiogenic inducer, 61 (insulin-like growth factor-binding protein-10)	602369	A			3(Igfbp10)
1.629	3	11	09	1p31.1-p22.3	DNASE2B, DLAD	P	Deoxyribonuxlease II beta	608057	A			
1.630	1	30	01	1p22.3	LMO4	P	LIM domain only 4	603129	A			3(Lmo4)
1.631	11	11	14	1p22.2	BARHL2	P	BARH-like 2	605212	R			
1.632	8	28	09	1p22.3	MCOLN3	P	Mucolipin 3	607400	R, H, REc			3(Mcoln3)
1.633	1	28	08	1p22.2	CCBL2, KAT3	P	Cysteine conjugate beta-lyase 2	610656	REc			3(Kat3)
1.634	4	3	14	1p22.2	HFM1, MER3, POF9	P	Hfm1, ATP-dependent DNA helicase, S. cerevisiae, homolog of	615684	REc		Premature ovarian failure 9, 615724 (3)	
1.635	12	23	08	1p22.2	GBP1	C	Guanylate binding protein 1, interferon-inducible, 67kD	600411	REa, REc			3(Gbp1)
1.636	12	24	08	1p22.2	GBP2	P	Guanylate-binding protein 2, interferon-inducible	600412	REc			
1.637	12	24	08	1p22.2	GBP3	P	Guanylate-binding protein 3	600413	REc			
1.638	12	24	08	1p22.2	GBP4	P	Guanylate-binding protein 4	612466	REc			
1.639	12	24	08	1p22.2	GBP5	C	Guanylate-binding protein 5	611467	REc			
1.640	12	24	08	1p22.2	GBP6	P	Guanylate-binding protein 6	612467	REc			
1.641	12	24	08	1p22.2	GBP7	P	Guanylate-binding protein 7	612468	REc			
1.642	7	22	09	1p22.2	LRRC8B, TALRRP, KIAA0231	P	Leucine-rich repeat-containing protein 8B	612888	REc			5(Lrrc8b)
1.643	7	22	09	1p22.2	LRRC8C, FAD158, AD158	P	Leucine-rich repeat-containing protein 8C	612889	REc			5(Lrrc8c)
1.644	7	22	09	1p22.2	LRRC8D, LRRC5	P	Leucine-rich repeat-containing protein 8D	612890	REc			5(Lrrc8d)
1.645	11	30	06	1p22.2	PKN2, PRKCL2, PRK2, PAK2	P	Protein kinase N2	602549	REc, R			
1.646	7	18	14	1p22.2	GTF2B, TFIIB, TF2B	P	General transcription factor IIb	189963	REc			
1.647	4	27	12	1p22.2	ZNF326, ZIRD	P	Zinc finger protein 326	614601	REc			
1.648	8	25	11	1p22.2	ZNF644, MYP21	P	Zinc finger protein 644	614159	REc		Myopia 21, autosomal dominant, 614167 (3)	
1.649	7	21	14	1p22.1	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	C	ATP-binding transporter, retina-specific	601691	R, REc, Fd		Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3); Cone-rod dystrophy 3, 604116 (3); {Macular degeneration, age-related, 2}, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe, 248200 (3)	
1.650	1	14	07	1p22.1	ARHGAP29, PARG1	P	RHO GTPase-activating protein 29	610496	R, REc			
1.651	7	18	14	1p22.1	BCAR3, SH2D3B, NSP2	P	Breast cancer antiestrogen resistance 3	604704	REc			
1.652	2	12	13	1p22.1	BRDT	P	Bromodomain, testis-specific	602144	R, REc			
1.653	5	23	13	1p22.1	DNTTIP2, ERBP, FCF2	P	DNTT-interacting protein 2	611199	REc			
1.654	11	13	96	1p22.1	DR1	P	Down-regulator of transcription 1, TBP-binding (negative cofactor 2)	601482	A			
1.655	4	2	12	1p22.1	FAM69A	P	Family with sequence similarity 69, member A	614542	REc			
1.656	9	16	12	1p22.1	FNBP1L, TOCA1, C1orf39	P	Formin binding protein 1-like	608848	REc			
1.657	11	2	11	1p22.1	GCLM, GLCLR	C	Glutamate-cysteine ligase, modifier subunit	601176	REa, A, REc		{Myocardial infarction, susceptibility to}, 608446 (3)	3(Glclr)
1.658	3	22	06	1p22.1	MTF2, PCL2, M96	P	Metal-regulatory transcription factor 2	609882	R, REc			
1.659	10	13	09	1p22.1	RPAP2, C1orf82	P	RNA polymerase II-associated protein 2	611476	R, REc			
1.660	2	3	09	1p22.1	RPL5, DBA6	C	Ribosomal protein L5	603634	R, RE, REc		Diamond-Blackfan anemia 6, 612561 (3)	
1.661	3	25	16	1p22.1	TMED5	C	Transmembrane p24 trafficking protein 5	616876	REc			
1.662	2	2	01	1p31.1	ZNF265, ZIS	P	Zinc finger protein-265	604347	A, R			
1.663	8	17	12	1p22.1-p13.3	DFNB32	P	Deafness, autosomal recessive 32	608653	Fd	max lod at D1S21401	Deafness, autosomal recessive 32 (2)	
1.664	10	20	15	1p22.3	BCL10, IMD37	P	B-cell leukemia/lymphoma 10	603517	Ch	mutation identified in 1 IMD37 patient	Lymphoma, MALT, somatic, 137245 (3); {Lymphoma, follicular, somatic}, 605027 (3); {Male germ cell tumor, somatic}, 273300, (3); {Sezary syndrome, somatic}, (3); {Mesothelioma, somatic}, 156240 (3); ?Immunodeficiency 37, 616098 (3)	
1.665	11	24	98	1p22.1	CDC7L1, CDC7	P	Cell division cycle 7, S. Cerevisiae, homolog-like 1	603311	R			5(Cdc7l1)
1.666	11	2	04	1p22	CMM4	P	Melanoma, cutaneous malignant, 4	608035	Fd	between D1S430 and D1S2664	{Melanoma, cutaneous malignant, 4} (2)	
1.667	12	5	95	1p22.3	CTBS, CTB	P	Chitobiase, di-N-acetyl-	600873	Psh, A			
1.668	9	9	08	1p13.2	CSDE1, D1S155E, UNR	P	Cold-shock domain-containing E1, RNA-binding	191510	REn	130bp 5' to NRAS		
1.669	11	6	00	1p22.3	DDAH1	P	Dimethylarginine dimethylaminohydrolase-1	604743	R, A			
1.670	5	19	09	1p21.3	DPYD, DPD	C	Dihydropyrimidine dehydrogenase	612779	REa, A		Dihydropyrimidine dehydrogenase deficiency, 274270 (3); 5-fluorouracil toxicity, 274270 (3)	
1.671	12	24	08	1p22.1	EVI5, NB4S	P	Ecotropic viral integration site 5	602942	Ch			
1.672	11	11	09	1p22.1	GFI1, ZNF163, SCN2	C	Growth factor independent 1	600871	REa, A		Neutropenia, severe congenital 2, autosomal dominant, 613107 (3); Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	5(Gfi1)
1.673	12	5	95	1p22.3	GNG5	P	Guanine nucleotide-binding protein (G protein), gamma 5	600874	Psh, A			
1.674	7	17	09	1p22.3	HS2ST1	P	Heparan sulfate 2-O-sulfotransferase 1	604844	R, REc			
1.675	2	14	13	1p22	KAZA2	P	Kala-azar, susceptibility to, 2	611381	Fd		{Kala-azar, susceptibility to, 2} (2)	
1.676	8	28	09	1p22.3	MCOLN2	P	Mucolipin 2	607399	R, H, REc	incorrectly assigned to chr.3		3(Mcoln2)
1.677	10	25	11	1p21.3	MIR137, MIRN137	P	Micro RNA 137	614304	REc			
1.678	7	1	05	1p13.1	TRIM45	P	Tripartite motif-containing protein 45	609318	REc			
1.679	1	4	93	1p22	UOX	P	Urate oxidase, pseudogene	191540	REa, A	nonsense mutations responsible for absence of enzyme in man and hominoid primates	[Urate oxidase deficiency] (1)	
1.680	3	27	15	1p21.3	ABCD3, PXMP1, PMP70, CBAS5	P	ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD)	170995	REa, A	mutation identified in 1 CBAS5 family	?Bile acid synthesis defect, congenital, 5, 616278 (3)	3(Pmp70)
1.681	2	20	98	1p21.3	CNN3	P	Calponin 3, acidic	602374	A			
1.682	10	7	88	1p21.3	F3, TFA	C	Coagulation factor III	134390	S, REb, Fd, A			
1.683	4	22	02	1p22.1	GLML, GVM, VMGLOM	C	Glomulin	601749	Fd, REc		Glomuvenous malformations, 138000 (3)	
1.684	4	30	15	1p21.3	ALG14, CMS15	P	Alg14, S. cerevisiae, homolog of	612866	REc	mutation identified in 1 CMSWTA family	?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3)	
1.685	5	16	06	1p21.3-p21.2	LPPR4, PRG1, KIAA0455	P	Lipid phosphate phosphatase-related protein type 4	607813	REc			
1.686	7	17	14	1p21.3	RWDD3, RSUME	P	RWD domain-containing protein 3	615875	REc			
1.687	12	10	12	1p21.3	SNX7	P	Sorting nexin 7	614904	REc			
1.688	5	11	07	1p13.2	CHIA, TSA1902, CHIT2	P	Chitinase, acidic	606080	R			
1.689	3	1	06	1p21.3-p13.3	RP32	P	Retinitis pigmentosa-32	609913	Fd	max lod at D1S485	Retinitis pigmentosa 32 (2)	
1.690	8	21	07	1p21.2	DPH5, HSPC143	P	DPH5, S. crevisiae, homolog of	611075	R, REc			
1.691	12	7	07	1p21.2	FRRS1, SDR2	P	Ferric chelate reductase 1	611578	R, REc			
1.692	5	11	16	1p21.2	GPR88, STRG, COCPMR	C	G protein-coupled receptor 88	607468	A, REc	mutation identified in 1 COCPMR family	?Chorea, childhood-onset, with psychomotor retardation, 616939 (3)	
1.693	3	20	14	1p21.2	PALMD, PALML	C	Palmelphin	610182	REc, R, H			3(Palmd)
1.694	5	26	13	1p21.2	RTCD1, RPC	P	RNA terminal phosphate cyclase domain-containing protein 1	611286	REc, R			
1.695	6	2	15	1p21.2	SASS6, SAS6, MCPH14	P	Sas6, C. elegans, homolog of	609321	REc	mutation identified in 1 MCPH14 family	?Microcephaly 14, primary, autosomal recessive, 616402 (3)	
1.696	2	25	08	1p21.2	SLC30A7, ZNT7	C	Solute carrier family 30 (zinc transporter), member 7	611149	REc, H			3(Slc30a7)
1.697	6	13	07	1p21.1-p13.3	MRT4	P	Mental retardation, autosomal recessive, 4	611107	Fd	between D2S429 and D1S187	Mental retardation, autosomal recessive, 4 (2)	
1.698	1	11	07	1p13.2	DDX20	C	DEAD/H box 20	606168	R, REc			
1.699	7	16	14	1p21.1-q21.3	HYPT5, MUHH2	P	Hypotrichosis 5	612841	Fd	max lod at D1S2881	Hypotrichosis 5 (2)	
1.700	3	26	07	1p21.2	AGL, GDE	C	Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)	610860	REc, A		Glycogen storage disease IIIa, 232400 (3); Glycogen storage disease IIIb, 232400 (3)	
1.701	10	23	87	1p21.1	AMY1A	C	Amylase, salivary, alpha-1A	104700	F, A, REa	multiple amylase genes		3(Amy1)
1.702	10	31	91	1p21.1	AMY1B	C	Amylase, salivary, alpha-1B	104701	REn			
1.703	11	4	91	1p21.1	AMY1C	C	Amylase, salivary, alpha-1C	104702	REn			
1.704	9	14	88	1p21.1	AMY2A	C	Amylase, pancreatic, alpha-2A	104650	F, A, REa			3(Amy2)
1.705	6	4	90	1p21.1	AMY2B	C	Amylase, pancreatic, alpha-2B	104660	F, A, REa, Fd	distal to NGFB		
1.706	2	25	11	1p21.1	COL11A1, STL2	C	Collagen XI, alpha-1 polypeptide	120280	REb, A		Stickler syndrome, type II, 604841 (3); Marshall syndrome, 154780 (3); {Lumbar disc herniation, susceptibility to}, 603932 (3); Fibrochondrogenesis 1, 228520 (3)	3(Col11a1)
1.707	12	22	00	1p13.3	CELSR2, EGFL2, MEGF3	P	Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 2)	604265	Psh, R			
1.708	1	24	02	1p21.2	CDC14A	P	Cell division cycle 14, S. cerevisiae, homolog A	603504	R	?7p11		
1.709	7	18	12	1q21.1	FAM72D	P	Family with sequence similarity 72, member D	614712	REc			
1.710	6	4	99	1p13.3	KCNC4	C	Potassium voltage-gated channel, Shaw-related subfamily, member 4	176265	REa, A			
1.711	4	6	15	1p13.2	MAGI3, KIAA1634	C	Membrane-associated guanylate kinase, WW and PDZ domains-containing, 3	615943	R, H			3(Magi3)
1.712	11	11	14	1p21.1	OLFM3, NOE3	P	Olfactomedin 3	607567	REc			3(Olfm3)
1.713	7	27	09	1p13.3	PROK1, PK1, PRK1, EGVEGF	P	Prokineticin 1	606233	R, REc			
1.714	2	16	04	1p21.3	PTBP2, NPTB	P	Polypyrimidine tract-binding protein 2	608449	REc			
1.715	9	18	08	1p21.2	S1PR1, EDG1, S1P1	P	Sphingosine-1-phosphate receptor 1	601974	REc			
1.716	12	3	01	1p21.2	SLC35A3, AMRS	P	Solute carrier family 35 (UDP-GlcNAc transporter), member 3	605632	A	mutation identified in 1 family	?Arthrogryposis, mental retardation, and seizures, 615553 (3)	
1.717	5	23	06	1p21	STQTL7	P	Stature quantitative trait locus 7	609822	Fd	max lod at D1S1631	{Stature QTL 7} (2)	
1.718	8	9	01	1p13.2	BCAS2, DAM1	P	Breast carcinoma amplified sequence 2	605783	A			
1.719	11	4	93	1p13.3	CD53, MOX44	C	CD53 antigen	151525	REa, A			3(Cd53)
1.720	1	9	95	1p13.3	KCNA3	C	Potassium voltage-gated channel, shaker-related subfamily, member 3	176263	REa, A	mapped probably in error to chr.13		
1.721	3	30	00	1p21-p13.3	WS2B	P	Waardenburg syndrome, type 2B	600193	Fd		Waardenburg syndrome, type 2B (2)	
1.722	5	9	95	1p13.2	ADORA3	C	Adenosine A3 receptor	600445	Fd, REn, H			3(Adora3)
1.723	11	3	09	1p13.3	ALX3, FND1	P	Aristaless-like homeobox 3	606014	R		Frontonasal dysplasia 1, 136760 (3)	
1.724	11	9	13	1p13.2	AMPD1, MMDD	P	Adenosine monophosphate deaminase-1, muscle	102770	REa, A		Myopathy due to myoadenylate deaminase deficiency, 615511 (3)	3(Ampd1)
1.725	10	27	97	1p13.3	CSF1, MCSF	C	Colony-stimulating factor-1 (macrophage)	120420	A, REa, H	incorrectly assigned to chr.5		3(Csfm)
1.726	8	26	15	1p13.3	AHCYL1, DCAL, IRBIT	P	Adenosylhomocysteine-like 1	607826	Psh, REc			
1.727	3	12	14	1p13.3	AMIGO1, ALI2, KIAA1163	P	Adhesion molecule with Ig-like domain 1	615689	REc			
1.728	6	3	14	1p13.3	AMPD2, SPG63, PCH9	C	Adenosine monophosphate deaminase-2, isoform L	102771	H, REa, A	mutation identified in 1 SPG63 family	?Spastic paraplegia 63, 615686 (3); Pontocerebellar hypoplasia, type 9, 615809 (3)	3(Ampd2)
1.729	1	13	16	1p13.3	CEPT1	C	Choline/ethanolamine phosphotransferase 1	616751	REn, REc			
1.730	5	25	13	1p13.2	CHI3L2, YKL39	P	Chitinase 3-like 2	601526	REc			
1.731	7	17	09	1p13.3	CYMP	P	Chymosin pseudogene	118943	Psh, REc			
1.732	3	14	13	1p13.3-p13.2	DENND2D	P	DENN/MADD domain-containing protein 2D	615111	REc			
1.733	1	9	13	1p13.3	EPS8L3, EPS8R3	P	EPS8-like protein 3	614989	REc			3(Eps8l3)
1.734	7	17	09	1p13.3	GPR61	P	G protein-coupled receptor 61	606916	Psh, REc			
1.735	9	12	93	1p13.3	GSTM1	C	Glutathione S-transferase M1	138350	A, REa, Fd, Psh, REn			
1.736	9	12	93	1p13.3	GSTM2, GST4	C	Glutathione S-transferase M2, muscle	138380	Psh, A, REn			
1.737	9	12	93	1p13.3	GSTM3, GST5	P	Glutathione S-transferase M3, brain	138390	Psh, A, REn			
1.738	11	4	93	1p13.3	GSTM4	C	Glutathione S-transferase M4	138333	A, REn, Psh			
1.739	7	14	14	1p13.3	HENMT1, C1orf59, HEN1	P	Hen1 methyltransferase, arabidopsis, homolog of	612178	REc			
1.740	5	19	15	1p13.3	KCNA2, EIEE32	P	Potassium channel, voltage-gated, Shaker-related subfamily, member 2	176262	REc		Epileptic encephalopathy, early infantile, 32, 616366 (3)	12(Kcna2)
1.741	5	24	13	1p13.3	KIAA1324, EIG121	C	KIAA1324 gene	611298	R, REc			
1.742	8	28	09	1p13.3	GSTM5	P	Glutathione S-transferase M5	138385	Psh, A, REn	pseudogene on chr.3		
1.743	7	31	15	1p13.3	DRAM2, TMEM77, CORD21	P	Damage-regulated autophagy modulator 2	613360	REc		Cone-rod dystrophy 21, 616502 (3)	
1.744	8	19	13	1p13.3	MIR197	P	Micro rNA 197	611189	REc			
1.745	9	12	08	1p13.3	NTNG1, LMNT1, KIAA0976	P	Netrin G1	608818	R, REc			
1.746	3	6	08	1p13.3	PRMT6	P	Protein arginine N-methyltransferase 6	608274	REc			
1.747	7	10	93	1p13.2	RAP1A, KREV1	C	RAS-related protein RAP1A	179520	A	pseudogene on 14q24.3		
1.748	3	23	15	1p13.3	SLC6A17, NTT4, MRT48	P	Solute carrier family 6 (neurotransmitter transporter), member 17	610299	REc		Mental retardation, autosomal recessive 48, 616269 (3)	
1.749	1	31	11	1p13.3	SORT1, NT3, LDLCQ6	P	Sortilin	602458	A, REc		[Low density lipoprotein cholesterol level QTL6], 613589 (3)	
1.750	9	10	07	1p13.3	UBL4B	P	Ubiquitin-like 4B	611127	REc, H			3(Ubl4b)
1.751	12	4	09	1p13.3	VAV3	P	Vav3 oncogene	605541	REc			
1.752	4	10	14	1p13.3	WDR47, NEMITIN, KIAA0893	P	WD repeat-containing protein 47	615734	REc			
1.753	6	3	15	1p13.2	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	C	Potassium voltage-gated channel, Shal-related subfamily, member 3	605411	A, R, Fd		Spinocerebellar ataxia 19, 607346 (3); Brugada syndrome 9, 616399 (3)	
1.754	12	28	08	1p13.2	DCLRE1B, SNM1B, APOLLO	P	DNA cross-link repair protein 1B	609683	REc			
1.755	5	4	00	1p12	WARS2	P	Tryptophanyl-tRNA synthetase 2	604733	R			
1.756	4	15	08	1p13.1	CASQ2	P	Calsequestrin, fast-twitch, skeletal muscle-2	114251	A		Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)	
1.757	4	27	12	1p13.2	AP4B1, SPG47, CPSQ5	P	Adaptor-related protein complex 4, beta-1 subunit	607245	R, REc		Spastic paraplegia 47, autosomal recessive, 614066 (3)	
1.758	2	25	15	1p13.2	ATP5F1	P	ATP synthase, H+ transporting, mitochondrial FO complex, subunit B, isoform 1	603270	REc			
1.759	9	21	11	1p13.2	C1orf88, PIFO	P	Chromosome 1 open reading frame 88 (pitchfork, mouse, homolog of)	614234	REc			
1.760	7	17	09	1p13.2	CAPZA1, CAPPA1	P	Capping protein, muscle Z-line, alpha-1	601580	REc			3(Capza1)
1.761	3	14	13	1p13.2	CTTNBP2NL	P	CTTNBP2 N terminus-like protein	615100	REc			
1.762	10	23	15	1p13.3	LAMTOR5, HBXIP, XIP	P	Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 5	608521	R, REc			
1.763	1	31	07	1p13.2	MOV10, KIAA1631	P	Moloney leukemia virus 10, mouse, homolog of	610742	R, REc			
1.764	1	4	16	1p13.2	NRAS, ALPS4, NS6, CMNS, NCMS	C	Neuroblastoma RAS viral (v-ras) oncogene homolog	164790	REa, A	cen-CD2-NGFB-NRAS	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Noonan syndrome 6, 613224 (3); Epidermal nevus, somatic, 162900 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Colorectal cancer, somatic, 114500 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Neurocutaneous melanosis, somatic, 249400 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	3(Nras)
1.765	5	25	13	1p13.2	OVGP1	P	Oviductal glycoprotein 1	603578	REc			
1.766	3	22	06	1p13.2	PPM1J, PP2CZ, PPP2CZ	P	Protein phosphatase, magnesium-dependent, 1J	609957	REc			
1.767	8	3	12	1p13.2	RHOC, ARHC, ARH9, RHOH9	P	RAS homolog gene family, member C (oncogene RHO H9)	165380	REa, A	incorrectly assigned to chr.5		
1.768	7	18	14	1p13.2	RSBN1, ROSBIN	P	Round spermatid basic protein 1	615858	REc			
1.769	12	18	07	1p13.2	SIKE	P	Suppressor of IKK-epsilon	611656	REc			
1.770	7	27	09	1p13.2	SYT6	P	Synaptotagmin 6	607718	R, REc			
1.771	12	2	09	1p13.2	TSPAN2, NET3	P	Tetraspanin 2	613133	REc			
1.772	1	17	08	1p13.2	WDR77, MEP50	P	WD repeat-containing protein 77	611734	R, REc			
1.773	11	24	14	1p13.2	SLC16A1, MCT1, HHF7, MCT1D	P	Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	Psh, A		Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3); Monocarboxylate transporter 1 deficiency, 616095 (3)	
1.774	11	20	95	1p13.1	CD2	C	CD2 antigen (p50), sheep red blood cell receptor	186990	REa, A, RE			3(Ly37)
1.775	7	13	12	1p13.3	GPSM2, LGN, PINS, DFNB82, CMCS	P	G protein signaling modulator 2	609245	REc		Chudley-McCullough syndrome, 604213 (3)	
1.776	4	30	93	1p12	HSD3B1	C	Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 1 (placental, peripheral)	109715	Fd, A			3(Hsd3b1)
1.777	4	6	16	1p12	HSD3B2	C	Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal)	613890	A		Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3)	3(Hsd3b2)
1.778	4	15	98	1p13.3	KCNA10	P	Potassium voltage-gated channel, shaker-related subfamily, member 10	602420	A			
1.779	8	19	13	1p13.2	OLFML3, OLF44	P	Olfactomedin-like 3	610088	REc			
1.780	11	24	14	1p13.2	NGF, NGFB, HSAN5	C	Nerve growth factor, beta	162030	REa, H, A, Fd, RE	same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel	Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	3(Ngfb)
1.781	12	2	09	1p13.3	PSRC1, DDA3	P	Proline/serine-rich coiled-coil protein 1	613126	REc, H			3(Psrc1)
1.782	3	6	08	1p13.1	SLC22A15, FLIPT1	P	Solute carrier family 22 (organic cation transporter), member 15	608275	REc			
1.783	10	2	12	1p13.1	TTF2	P	Transcription termination factor, RNA polymerase II	604718	REc			
1.784	3	29	06	1p13-p12	VCTN1, B7H4, B7X, B7S1	P	V-set domain containing T cell activation inhibitor 1	608162	REc, H			3(B7h4)
1.785	3	20	06	1p34.2	PPCS	P	Phosphopantothenoylcysteine synthetase	609853	REc			
1.786	3	20	06	1p12	REG4	P	Regenerating islet-derived family, member 4	609846	REc			
1.787	6	30	98	1p13.1	PTGFRN, FPRP	P	Prostaglandin F2 receptor negative regulator	601204	Psh, REc			
1.788	10	12	90	1p13.1	CD58, LFA3	C	CD58 antigen (lymphocyte function-associated antigen 3)	153420	S, REa, A, RE	?same as MSK1; gene cloned		
1.789	6	4	12	1p13.3	GNAI3, ARCND1	C	Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3	139370	REa, A, Fd		Auriculocondylar syndrome 1, 602483 (3)	3(Gnai3)
1.790	4	6	11	1p13.3	GNAT2, ACHM4	C	Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2	139340	REa, A		Achromatopsia-4, 613856 (3)	3(Gnat2)
1.791	7	17	09	1p12	HAO2, HAOX2	P	Hydroxyacid oxidase 2	605176	REc			
1.792	2	5	15	1p13.1	IGSF3, LCDD	P	Immunoglobulin superfamily, member 3	603491	A, RE	mutation identified in 1 LCDD family	?Lacrimal duct defect, 149700 (3)	
1.793	3	15	13	1p13.2	LRIG2, LIG2, KIAA0806, UFS2	C	Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2	608869	A, H		Urofacial syndrome 2, 615112 (3)	3(Lrig2)
1.794	2	2	01	1p12	MAN1A2	P	Mannosidase, alpha, class 1A, member 2	604345	A			3(Man1a2)
1.795	9	10	98	1p13.3	PSMA5, PSC5	P	Proteasome component 5	176844	REc			
1.796	5	25	00	1p13.2	PHTF1	P	Putative homeodomain transcription factor 1	604950	A			
1.797	3	27	09	1p13.2	PTPN22, PEP, PTPN8, LYP	P	Protein tyrosine phosphatase, nonreceptor-type 22	600716	A		{Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)	
1.798	6	28	01	1p13.3	RBM15, SPEN, OTT	P	One-twenty two protein (RNA binding motif protein 15; Spen, Drosophila, homolog of)	606077	Ch		Megakaryoblastic leukemia, acute (2)	
1.799	7	27	09	1p13.3	SARS, SERS	P	Seryl-tRNA synthetase	607529	R, REc			
1.800	6	9	98	1p13.2	SYCP1, SCP1	P	Synaptonemal complex protein-1	602162	A			
1.801	12	24	08	1p12	TBX15	P	T-box 15	604127	A		Cousin syndrome, 260660 (3)	3(Tbx15)
1.802	8	14	15	1p13.2	TRIM33, TIF1G, RFG7, PTC7	P	Tripartite motif-containing protein 33	605769	A	fused with RET to form PTC7		
1.803	9	4	08	1p13.2	TSHB, CHNG4	C	Thyroid-stimulating hormone, beta polypeptide	188540	REa, RE, Fd	centromeric to NGFB	Hypothryoidism, congenital, nongoitrous 4, 275100 (3)	3(Tshb)
1.804	7	24	15	1p13.1	VANGL1, STBM2	P	Vang-like 1	610132	REc		Caudal regression syndrome, 600145 (3); {Neural tube defects, susceptibility to}, 182940 (3)	
1.805	5	23	00	1p13	VUR	P	Vesicoureteral reflux	193000	Fd		Vesicoureteral reflux (2)	
1.806	3	2	98	1p13.2	WNT13, XWNT2	P	Wingless-type MMTV integration site family, member 13	601968	A			
1.807	5	9	01	1p12	HMGCS2	C	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial	600234	A		HMG-CoA synthase-2 deficiency, 605911 (3)	
1.808	5	4	00	1p12	WDR3	P	WD repeat-containing protein 3	604737	A			
1.809	1	29	01	1p12	ADAM30	P	A disintegrin and metalloproteinase domain 30	604779	R			
1.810	4	12	92	1p13.1	ATP1A1	C	ATPase, Na+K+ transporting, alpha-1 polypeptide	182310	REa, REb, A, Fd			3(Atp1a1)
1.811	5	16	11	1p12	NOTCH2, AGS2, HJCYS	P	Notch, Drosophila, homolog of, 2	600275	REa, A		Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)	3(Notch2)
1.812	6	11	11	1p12	FAM46C	P	Family with sequence similarity 46, member C	613952	REc			
1.813	1	6	97	1p11.2	FCGR1B	P	Fc fragment of IgG, high affinity Ib, receptor for (CD64)	601502	REa, A			
1.814	8	2	13	1p13.3	LRIF1, RIF1	P	Ligand-dependent nuclear receptor-interacting factor 1	615354	REc			
1.815	9	21	11	1p13.3	NBPF4	P	Neuroblastoma breakpoint family, member 4	613994	REc, A			
1.816	9	21	11	1p13.3	NBPF5	P	Neuroblastoma breakpoint family, member 5	613995	REc, A			
1.817	9	21	11	1p13.3	NBPF6	P	Neuroblastoma breakpoint family, member 6	613996	REc, A			
1.818	9	21	11	1p12	NBPF7	P	Neuroblastoma breakpoint family, member 7	613997	REc, A			
1.819	10	12	14	1p12	PHGDH, NLS1, PHGDHD	P	Phosphoglycerate dehydrogenase	606879	A, R		Phosphoglycerate dehydrogenase deficiency, 601815 (3); Neu-Laxova syndrome 1, 256520 (3)	
1.820	9	24	15	1p12	SPAG17, PF6	P	Sperm-associated antigen 17	616554	REc			
1.821	7	18	12	1p11.2	SRGAP2C	P	SLIT-ROBO Rho GTPase-activating protein 2C	614704	REc			
1.822	3	6	98	1p21.2	EXTL2	P	Exostosin-like 2	602411	A			3(Extl2)
1.823	1	9	95	1p13.1	NHLH2, HEN2	P	Nescient helix loop helix 2	162361	REa, A			3(Nscl2)
1.824	7	18	12	1p11.2	FAM72B	P	Family with sequence similarity 72, member B	614711	REc			
1.825	10	15	02	1p11	MNRI	P	Meningioma, radiation-induced	606190	Ch		Meningioma, radiation-induced (2)	
1.826	5	4	12	1p	ANON1	P	Anorexia nervosa, susceptibility to, 1	606788	Fd		{Anorexia nervosa, susceptibility to, 1} (2)	
1.827	2	5	01	1p	PSORS7	P	Psoriasis susceptibility 7	605606	Fd		{Psoriasis susceptibility 7} (2)	
1.828	1	2	91	1q44	ADSS	P	Adenylosuccinate synthetase (Ade(-)H-complementing)	103060	S			13(Nid)
1.829	11	14	91	1q23.3	HSPA6	P	Heat-shock 70kD protein-6 (HSP70B')	140555	REa			
1.830	11	14	91	1q23.3	HSPA7	P	Heat-shock 70kD protein-7 (HSP70B)	140556	REa			
1.831	8	28	97	1q	LRE2	P	LINE retrotransposable element-2	151628	REa	inserted in DMD gene		
1.832	2	2	16	1q22	PMF1	C	Polyamine-modulated factor 1	609176	R, A, REc			
1.833	4	19	12	1q21.1	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	P	RNA-binding motif protein 8A	605313	Psh, R	pseudogene on chr.14	Thrombocytopenia-absent radius syndrome, 274000 (3)	
1.834	4	17	01	1q21.3	TMOD4	P	Tropomodulin 4, muscle	605834	R			3(Tmod4)
1.835	8	24	09	1q22	DPM3, CDG1O	P	Dolichyl-phosphate mannosyltransferase 3	605951	REc		Congenital disorder of glycosylation, type Io, 612937 (3)	
1.836	7	20	09	1q12-q21.3	GNRHR2	P	Gonadotropin-releasing hormone receptor 2	612875	REc	?processed pseudogene		
1.837	6	3	94	1q21.3	S100A9, CAGB, CFAG	P	S100 calcium-binding protein A9 (calgranulin B)	123886	REa			3(Cagb)
1.838	9	13	89	1q12-q22	TRNL	P	tRNA asparagine-like	189890	REa, RE			
1.839	9	12	93	1q24.2	DPT	P	Dermatopontin	125597	REa			
1.840	11	9	95	1q22	MEF2D	P	MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D)	600663	REc			3(Mef2d)
1.841	1	16	01	1q12-q24	CORD8	P	Cone-rod dystrophy 8	605549	Fd		Cone-rod dystrophy 8 (2)	
1.842	7	16	09	1q23.3	DDR2, NTRKR3, TKT	P	Discoidin domain receptor family, member 2	191311	Psh		Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	
1.843	4	6	15	1q21.2	ACP6, LPAP, ACPL1	P	Acid phosphatase 6, lysophosphatide	611471	A			
1.844	8	30	07	1q21	AD13	P	Alzheimer disease-13	611152	Fd	max lod D1S498	{Alzheimer disease-13} (2)	
1.845	9	12	13	1q21.2	ADAMTSL4, TSRC1, ECTOL2	P	ADAMTS-like 4	610113	REc, H		Ectopia lentis, isolated, autosomal recessive, 225100 (3); Ectopia lentis et pupillae, 225200 (3)	3(Adamtsl4)
1.846	6	18	99	1q21.3	ANXA9, ANX31	P	Annexin A9 (annexin XXXI)	603319	A			
1.847	8	27	15	1q21.3	ARNT	C	Aryl hydrocarbon receptor nuclear translocator	126110	REa, Fd, A			3(Arnt)
1.848	5	26	98	1q21.2	BCL9	P	B-cell CLL/lymphoma-9	602597	A, Ch			
1.849	5	11	00	1q21.2	CA14	P	Carbonic anhydrase XIV	604832	A			
1.850	2	24	15	1q23.2	CASQ1, VMCQA	C	Calsequestrin, fast-twitch, skeletal muscle-1	114250	REa, A		Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3)	
1.851	8	2	13	1q21.3	CELF3, TNRC4, BRUNOL1	P	CUGbp- and ELAV-like family, member 3	612678	REc			
1.852	9	28	09	1q21.1	CHD1L, ALC1	P	Chromodomain helicase DNA-binding protein 1-like	613039	A			
1.853	9	9	02	1q21.3	CHRNB2, EFNL3	C	Cholinergic receptor, nicotinic, beta polypeptide-2	118507	REa, H, A	linked to AMY in mouse	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	3(Acrb2)
1.854	11	28	01	1q21.3	CTMP	P	C-terminal modulator protein	606388	REc			
1.855	9	2	96	1q21.3	CTSK	P	Cathepsin K	601105	REn, Fd		Pycnodysostosis, 265800 (3)	
1.856	6	3	94	1q21.3	CTSS	P	Cathepsin S	116845	A			3(Ctss)
1.857	6	9	98	1q22	DAP3	P	Death associated protein 3	602074	A			
1.858	3	25	13	1q21.2	ECM1, URBWD	C	Extracellular matrix protein-1	602201	REc, A		Urbach-Wiethe disease, 247100 (3)	
1.859	1	6	97	1q21.1	FCGR1C	P	Fc fragment of IgG, high affinity Ic, receptor for (CD64)	601503	REa, A			
1.860	4	18	08	1q21.3	FLG, ATOD2	C	Filaggrin	135940	REa, A, REn, Fd		Ichthyosis vulgaris, 146700 (3); {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	3(flg)
1.861	2	17	12	1q22	GBA	C	Glucosidase, acid beta	606463	S, A, D, Fd	pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, type I, 230800 (3); Gaucher disease, type II, 230900 (3); Gaucher disease, type III, 231000 (3); Gaucher disease, type IIIC, 231005 (3); Gaucher disease, perinatal lethal, 608013 (3); {Parkinson disease, late-onset, susceptibility to}, 168600 (3); {Lewy body dementia, susceptibility to}, 127750 (3)	3(Gba)
1.862	8	28	97	1q22	GENEY	P	Gene Y	600986	REn			3(GeneY)
1.863	12	11	07	1q23.1	HDGF	P	Hepatoma-derived growth factor	600339	Psh, A, REc	previously assigned to Chr.X		
1.864	3	11	03	1q21.2	HIST2H2AA, H2AFO, H2A	P	Histone 2, H2aa	142720	A			
1.865	1	14	13	1q21.2	HIST2H2AB, H2AB	P	Histone gene cluster 2, H2A histone family, member B	615014	REc			
1.866	3	12	03	1q21.2	HIST2H3C, H3F2	P	Histone 2, H3c	142780	REa, A			
1.867	9	13	89	1q21.2	H4FN, H4F2	P	H4 histone, family 2	142750	REa, A	100-200 histone genes; some on chromosome 6 and 12, as well as perhaps 7		
1.868	1	15	04	1q21.1	HJV, HFE2A	C	Hemojuvelin	608374	Fd, REc	between D1S442 and D1S2347	Hemochromatosis, type 2A, 602390 (3)	
1.869	4	30	01	1q23.1	IRTA1	P	Immunoglobulin superfamily receptor translocation-associated gene 1	605876	REc	fused with IGHA1 in multiple myeloma		
1.870	4	30	01	1q23.1	IRTA2	P	Immunoglobulin superfamily receptor translocation-associated gene 2	605877	REc			
1.871	11	4	93	1q21.3	IVL	C	Involucrin	147360	REa, A, REn			
1.872	3	10	00	1q21.3	JTB, PAR	P	Jumping translocation breakpoint	604671	Ch			
1.873	3	4	10	1q21.3	KPRP	P	Keratinocyte proline-rich protein	613260	REc			
1.874	2	17	09	1q21.3	LCE1A, LEP1	P	Late cornified envelope protein 1A	612603	REc, H			3(Lce1a)
1.875	2	17	09	1q21.3	LCE1B, LEP2	P	Late cornified envelope protein 1B	612604	REc, H			3(Lce1b)
1.876	2	17	09	1q21.3	LCE1C, LEP3	P	Late cornified envelope 1C	612605	REc, H			3(Lce1c)
1.877	2	17	09	1q21.3	LCE1D, LEP4	P	Late cornified envelope protein 1D	612606	REc, H			3(Lce1d)
1.878	2	17	09	1q21.3	LCE1E	P	Late cornified envelope protein 1E	612607	REc, H			3(Lce1e)
1.879	2	17	09	1q21.3	LCE1F, LEP6	P	Late cornified envelope protein 1F	612608	REc, H			3(Lce1f)
1.880	2	18	09	1q21.3	LCE2A, LEP9	P	Late cornified envelope protein 2A	612609	REc, H			3(Lce2a)
1.881	2	18	09	1q21.3	LCE2B, LEP10, XP5	P	Late cornified envelope protein 2B	612610	REc, H			3(Lce2b)
1.882	2	18	09	1q21.3	LCE2C, LEP11	P	Late cornified envelope protein 2C	612611	REc, H			3(Lce2c)
1.883	2	18	09	1q21.3	LCE2D, LEP12	P	Late cornified envelope protein 2D	612612	REc, H			3(Lce2d)
1.884	2	23	09	1q21.3	LCE3A, LEP13	P	Late cornified envelope protein 3A	612613	REc, H			3(Lce3a)
1.885	2	23	09	1q21.3	LCE3B, LEP14	P	Late cornified envelope protein 3B	612614	REc, H			3(Lce3b)
1.886	2	23	09	1q21.3	LCE3C, LEP15	P	Late cornified envelope protein 3C	612615	REc, H			3(Lce3c)
1.887	2	23	09	1q21.3	LCE3D, LEP16	P	Late cornified envelope protein 3D	612616	REc, H	within intron 2 of LCE3C		3(Lce3d)
1.888	2	23	09	1q21.3	LCE3E, LEP17	P	Late cornified envelope protein 3E	612617	REc, H			3(Lce3e)
1.889	2	23	09	1q21.3	LCE4A, LEP8	P	Late cornified envelope protein 4A	612618	REc, H			3(Lce4a)
1.890	2	23	09	1q21.3	LCE5A, LEP18	P	Late cornified envelope protein 5A	612619	REc, H			3(Lce5a)
1.891	8	20	07	1q21.3	LELP1	P	Late cornified envelope-like proline-rich 1	611042	REc			
1.892	10	7	10	1q21.3	LOR	C	Loricrin	152445	REa, A, REn		Vohwinkel syndrome with ichthyosis, 604117 (3)	3(lor)
1.893	7	4	95	1q21.2	MCL1	P	Myeloid cell leukemia sequence 1 (BCL2-related)	159552	REa, A			3(Mcl1)
1.894	8	27	15	1q21.3	MLLT11, AF1Q	P	Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 11	604684	Ch			
1.895	2	26	08	1q21.3	MRPL9	P	Mitochondrial ribosomal protein L9	611824	R			
1.896	4	24	08	1q21.2	MRPS21	P	Mitochondrial ribosomal protein S21	611984	R, REc	9 pseudogenes		
1.897	8	3	99	1q22	MTX1, MTXN	P	Metaxin 1	600605	H, REn	between GBA and TSP3		3(Mtxn)
1.898	7	12	13	1q22	MUC1, PUM, MCKD1	C	Mucin 1, transmembrane	158340	REa, A, Fd	5cM proximal to SPTA1	Medullary cystic kidney disease 1, 174000 (3)	3(Muc1)
1.899	12	13	00	1q21.1	PDZK1	P	PDZ domain-containing 1	603831	Psh, R			
1.900	10	29	03	1q21.3	PGRPIA	P	Peptidoglycan recognition protein, intermediate, alpha	608197	REc			
1.901	10	29	03	1q21.3	PGRPIB	P	Peptidoglycan recognition protein, intermediate, beta	608198	REc			
1.902	7	2	01	1q21.1	PIAS3	P	Protein inhibitor of activated STAT3	605987	Psh, R			
1.903	1	14	09	1q22	PKLR, PK1	C	Pyruvate kinase, liver and RBC type	609712	REa, A, REn		Pyruvate kinase deficiency, 266200 (3); Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	3(Pk1)
1.904	10	21	96	1q23.1	PRCC, RCCP1	C	Papillary renal cell carcinoma, translocation-associated	179755	Ch	t(X;1)(p11;q21); fuses with TFE3 in RCCP	Renal cell carcinoma, papillary, 605074 (3)	
1.905	2	20	98	1q21.3	PSMB4	P	Proteasome subunit, beta type, 4	602177	A			
1.906	4	16	03	1q21	PSORS4	C	Psoriasis susceptibility 4	603935	Fd		{Psoriasis susceptibility 4} (2)	
1.907	2	14	01	1q21	PTCPRN, PRN1	P	Papillary thyroid carcinoma with papillary renal neoplasia	605642	Fd		Thyroid carcinoma, papillary, with papillary renal neoplasia (2)	
1.908	10	17	00	1q21	RFH1, AORF	P	Renal failure, progressive, with hypertension	161900	Fd		Nephropathy-hypertension (2)	
1.909	10	28	15	1q21.3	RORC, RORG, RZRG, IMD42	P	RAR-related orphan receptor C	602943	Psh, A		Immunodeficiency 42, 616622 (3)	3(Rorc)
1.910	7	27	09	1q21.3	RPS27, MPS1	P	Ribosomal protein S27	603702	R, RE, REc			
1.911	11	17	94	1q21.3	S100A1	C	S100 protein, alpha polypeptide	176940	REb, A, REn			
1.912	3	4	10	1q21.3	RPTN	P	Repetin	613259	REc, A, H			3(Rptn)
1.913	11	17	94	1q21.3	S100A2, S100L	P	S100 calcium-binding protein A2	176993	REn			
1.914	11	17	94	1q21.3	S100A3, S100E	P	S100 calcium-binding protein A3	176992	REn			
1.915	11	17	94	1q21.3	S100A4, CAPL	P	S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)	114210	REa, H, REn			3(Capl)
1.916	11	17	94	1q21.3	S100A5, S100D	P	S100 calcium-binding protein A5	176991	REn, A			
1.917	11	17	94	1q21.3	S100A6, CACY	C	S100 calcium-binding protein A6 (calcyclin)	114110	A, REn			3(Cacy)
1.918	2	9	95	1q21.3	S100A7	C	S100 calcium-binding protein A7	600353	REc, A, Fd			
1.919	11	26	02	1q21.3	S100A8, CAGA, CFAG	C	S100 calcium-binding protein A8 (calgranulin A)	123885	S, REa	over-expressed in 1q21-linked psoriasis		3(Caga)
1.920	7	11	94	1q21.3	S100A10, CAL1L	C	S100 calcium-binding protein A10 (annexin II ligand, calpactin I, light polypeptide (p11))	114085	H, REn	on chr.3 in mouse		
1.921	10	14	98	1q21.3	S100A11	P	S100 calcium-binding protein A11	603114	A			
1.922	10	14	98	1q21.3	S100A12, CAAF1, CGRP	P	S100 calcium-binding protein A12	603112	REc	between S100A8 and S100A9		
1.923	3	9	98	1q21.3	S100A13	P	S100 calcium-binding protein A13	601989	REc			
1.924	1	11	07	1q21.3	S100A14, BCMP84	P	S100 Calcium-binding protein A14	607986	A, REn			
1.925	5	13	02	1q22	SCAMP3, PROPIN1	P	Secretory carrier membrane protein 3	606913	REc			
1.926	9	9	11	1q23.3	SDHC, PGL3	C	Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD	602413	A, S, M		Paragangliomas 3, 605373 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3)	
1.927	1	4	00	1q21.3	SETDB1	C	SET domain protein, bifurcated, 1	604396	REa, A, R			
1.928	3	10	00	1q23.1	SH2D2A, TSAD	P	SH2 domain protein 2A	604514	Psh, A			
1.929	6	16	95	1q21.3	SHC1	C	SHC (Src homology 2 domain-containing) transforming protein-1	600560	REa, A			
1.930	10	4	02	1q23.2	SLAMF8, BLAME	P	SLAM family, member 8	606620	R			
1.931	2	15	02	1q21.3	SLC39A1, ZIRTL	P	Solute carrier family 39 (zinc transporter), member 3 (zinc/iron-regulated transporter-like)	604740		REc		3(Zirtl)
1.932	3	23	06	1q21.3	SMCP, MCSP, MCS	P	Sperm mitochondria-associated cysteine-rich protein	601148	A			
1.933	5	19	15	1q21.3	SPRR4	P	Small proline-rich protein 4	616363	REc			
1.934	3	11	09	1q23.1	SPTA1, EL2, SPH3, HS3, HPP	C	Spectrin, alpha, erythrocytic-1	182860	REa, A, Fd	17cM proximal to FY	Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3); Spherocytosis, type 3, 270970 (3)	1(Spna1)
1.935	7	4	95	1q22	THBS3, TSP3	L	Thrombospondin 3	188062	H			3(Thbs3)
1.936	6	16	99	1q21.3	TUFT1	C	Tuftelin 1	600087	A	?mutant in amelogenesis imperfecta		
1.937	1	7	02	1q21.1	TXNIP, VDUP1	P	Thioredoxin-interacting protein	606599	R, H			3(Txnip)
1.938	6	5	08	1q22	UBQLN4, A1U, C1orf6	P	Ubiquitin 4	605440	REc			
1.939	2	25	08	1q21.3	VPS72, CFL1, YL1	P	Vacuolar protein sorting 72, yeast, homolog of	600607	RE			
1.940	9	22	08	1q22	ARHGEF2, GEFH1, KIAA0651	P	RHO guanine nucleotide exchange factor 2	607560	R, REc			
1.941	8	25	04	1q21-q22	ASPG3	P	Asperger syndrome, susceptibility to, 3	608781	Fd	max lod at D1S484	{Asperger syndrome susceptibility 3} (2)	
1.942	5	11	00	1q23.3	DUSP1, YVH1	P	Dual-specificity phosphatase 12	604835	R			
1.943	11	5	97	1q22	EFNA1, EPLG1, TNFAIP4	P	eph-related receptor tyrosine kinase ligand 1 (tumor necrosis factor, alpha-induced protein 4)	191164	A			3(Epl1)
1.944	11	5	97	1q21.3	EFNA3, EPLG3	P	eph-related receptor tyrosine kinase ligand 3 (ephrin A3)	601381	A			3(Epl3)
1.945	11	5	97	1q21.3	EFNA4, EPLG4	P	eph-related receptor tyrosine kinase ligand 4 (ephrin-A4)	601380	A			3(Epl4)
1.946	2	28	08	1q23.1	MRPL24	P	Mitochondrial ribosomal protein L24	611836	R			
1.947	1	11	07	1q23.3	NIT1	P	Nitrilase 1	604618	REc, R			1(Nit1)
1.948	4	18	94	1q21.3	NPR1, ANPRA	P	Natriuretic peptide receptor A/guanylate cyclase A	108960	REa, A			
1.949	6	6	00	1q23.1	NTRK1, TRKA, MTC	C	Neurotrophic tyrosine kinase, receptor, type 1	191315	REa, A	TRK = chimera of TPM3 and NTRK1	Insensitivity to pain, congenital, with anhidrosis, 256800 (3); Medullary thyroid carcinoma, familial, 155240 (3)	
1.950	10	20	99	1q21.3	SELENBP1, SP56	P	Selenium-binding protein 1	604188	A			
1.951	7	10	93	1q21.3	SPRR1A	P	Small proline-rich protein 1A	182265	REa, A, REn			
1.952	7	10	93	1q21.3	SPRR1B	P	Small proline-rich protein 1B	182266	REa, A			
1.953	7	10	93	1q21.3	SPRR2A	P	Small proline-rich protein 2A	182267	REa, A, REn	about 7 SPRR2 genes		
1.954	7	10	93	1q21.3	SPRR2B	P	Small proline-rich protein 2B	182268	REa, A			
1.955	7	10	93	1q21-q22	SPRR2C	P	Small proline-rich protein 2C	182269	REa, A	prob. pseudogene		
1.956	7	10	93	1q21.3	SPRR3	P	Small proline-rich protein 3	182271	REa, A, REn			
1.957	7	18	13	1q21.2	VPS45A, VPS45, SCN5	P	Vacuolar protein sorting 45, yeast, homolog of, A	610035	A		Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	
1.958	1	11	07	1q23.3	ADAMTS4	C	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 4 (aggrecanase 1)	603876	R, REc			
1.959	4	30	91	1q23.2	APCS, SAP	C	Amyloid P component, serum	104770	REa, A, Fd	probably close to CRP	{?Amyloidosis, secondary, susceptibility to} (1)	1(Sap)
1.960	2	20	03	1q23.3	APOA2	C	Apolipoprotein A-II	107670	REa, A, Fd, RE		Apolipoprotein A-II deficiency (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3)	1(Apoa2)
1.961	5	2	06	1q23.2	ATP1A2, FHM2, MHP2	C	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	REa, A, Fd, RE		Migraine, familial hemiplegic, 2, 602481 (3); Alternating hemiplegia of childhood, 104290 (3); Migraine, familial basilar, 602481 (3)	1(Atpa3)
1.962	1	17	03	1q21-q23	BMND2	C	Bone mineral density QTL 2	605833	Fd		[Bone mineral density QTL 2] (2)	
1.963	3	21	93	1q23.1	CD1A	C	Thymocyte antigen CD1A	188370	A, REa, REn	genes A, B, C, D in cluster		3(Ly38)
1.964	3	21	93	1q23.1	CD1B	C	Thymocyte antigen CD1B	188360	A, REa, REn			
1.965	3	21	93	1q23.1	CD1C	C	Thymocyte antigen CD1C	188340	A, REa, REn			
1.966	3	21	93	1q23.1	CD1D	C	Thymocyte antigen CD1D	188410	A, REa, H, REn			3(Cd1d)
1.967	10	9	94	1q23.1	CD1E	C	Thymocyte antigen CD1E	188411	A, REa, REn			
1.968	7	2	98	1q23.1	CD5L	P	CD5 antigen-like (scavenger receptor cysteine rich family)	602592	R, A			
1.969	5	1	91	1q23.2	CRP	C	C-reactive protein	123260	REa, A			1(Crp)
1.970	9	22	96	1q21-q23	DFNA7	P	Deafness, autosomal dominant 7	601412	Fd		Deafness, autosomal dominant 7 (2)	
1.971	1	27	04	1q21-q23	DFNA49	P	Deafness, autosomal dominant 49	608372	Fd	max lod at D1S3784 and D1S3786	Deafness, autosomal dominant 49 (2)	
1.972	9	8	11	1q21-q23	ERVK-7, HERV-KIII, HERV-K102	P	Endogenous retrovirus group K, member 7	614013	R, REc			
1.973	12	5	95	1q23.1	ETV3, PE1	P	ets variant gene 3	164873	REa, A			
1.974	8	6	15	1q23.3	FCGR2A, IGFR2, CD32	C	Fc fragment of IgG, low affinity IIa, receptor for (CD32)	146790	REb, REn, Fd, RE	FCG2 and FCG3 within 250kb	{Lupus nephritis, susceptibility to}, 152700 (3); {Malaria, severe, susceptibility to}, 611162 (3); {Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3)	1(Ly17, Cd32)
1.975	3	11	03	1q21.2	HIST2H2BE, H2B	P	Histone 2, H2be	601831	REa, A			
1.976	3	11	03	1q21.2	HIST2H2AC, H2AFQ	P	Histone 2, H2ac	602797	REc			
1.977	10	24	00	1q23.1	INSRR, IRR	C	Insulin receptor-related receptor	147671	REa, R			
1.978	3	23	09	1q23.1	PYHIN1, IFIX	P	Pyrin and Hin domain family, member 1	612677	REc			
1.979	12	21	09	1q21-q23	SLEB14	P	Systemic lupus erythematosus, susceptibility to, 14	613145	Fd	associated with rs3093061	{Systemic lupus erythematosus, susceptibility to, 14} (2)	
1.980	12	5	95	1q22	SSR2	P	Signal sequence receptor, beta	600867	A			
1.981	2	21	14	1q23.2	VANGL2, LTAP	P	Vang-like 2 (loop-tail, mouse, homolog of)	600533	REc, H		Neural tube defects, 182940 (3)	1(Lp)
1.982	5	4	00	1q23.2	TAGLN2	P	Transgelin 2	604634	REc, H			1(Tagln2)
1.983	2	28	03	1q23.2	ATP1A4, ATP1AL2	P	ATPase, Na+/K+ transporting, alpha-4 polypeptide	607321	REc			1(Atp1a4)
1.984	3	15	11	1p11.2	C1orf152, COAS3	P	Chromosome 1 open reading frame 152	608609	REc			
1.985	11	11	14	1q21.1	CD160, BY55	P	CD160 antigen	604463	REc			
1.986	12	17	08	1q21.1	DEL1q21, C1DELq21	P	Chromosome 1q21.1 deletion syndrome	612474	Ch	contiguous gene deletion syndrome	Chromosome 1q21.1 deletion syndrome (4)	
1.987	12	17	08	1q21.1	DUP1q21, C1DUPq21	P	Chromosome 1q21.1 duplication syndrome	612475	Ch	contiguous gene duplication syndrome	Chromosome 1q21.1 duplication syndrome (4)	
1.988	3	9	00	1q21.1	FMO5	C	Flavin-containing monooxygenase 5	603957	Psh, REc, A			
1.989	5	3	13	1q21.2	GJA8, CX50, CTRCT1, CZP1, CAE1	C	Gap junction membrane channel protein alpha-8 (connexin 50)	600897	A, F		Cataract 1, multiple types, 116200 (3)	3(Gja8)
1.990	7	16	09	1q21.1	GPR89A	P	G protein-coupled receptor 89A	612821	REc			
1.991	7	16	09	1q21.2	GPR89B, GPHR	P	G protein-coupled receptor 89B	612806	REc			
1.992	3	12	07	1q21.1	HYDIN2, KIAA1864	P	Hydin, mouse, homolog of, 2	610813	R, REc	duplicated copy 16q22.2		
1.993	5	25	13	1q21.1	ITGA10	P	Integrin, alpha-10	604042	REc			
1.994	9	22	09	1q21.1	NBLST6	P	Neuroblastoma, susceptibility to, 6	613017	Ch	?contiguous gene deletion or duplication disease	{Neuroblastoma, susceptibility to, 6} (2)	
1.995	9	21	11	1q21.1	NBPF10	P	Neuroblastoma breakpoint family, member 10	614000	REc			
1.996	9	21	11	1q21.2	NBPF11	P	Neuroblastoma breakpoint family, member 11	614001	REc, A			
1.997	9	21	11	1q21.1	NBPF12, COAS1, KIAA1245	P	Neuroblastoma breakpoint family, member 12	608607	REc, A			
1.998	9	21	11	1p11.2	NBPF8	P	Neuroblastoma breakpoint family, member 8	613998	REc, A			
1.999	9	21	11	1q21.2	NBPF9	P	Neuroblastoma breakpoint family, member 9	613999	REc, A			
1.1000	9	21	11	1q21.2	NBPF14	P	Neuroblastoma breakpoint, member 14	614003	REc, A			
1.1001	2	5	07	1q21.1	NBPF15, MGC8902	P	Neuroblastoma breakpoint family, member 15	610414	REc, A	contains 6 copies of DUF1220 domain		
1.1002	9	21	11	1q21.1	NBPF16	P	Neuroblastoma breakpoint family, member 16	614005	REc, A			
1.1003	9	21	11	1q21.2	NBPF19	P	Neuroblastoma breakpoint family, member 19	614006	REc			
1.1004	9	21	11	1q21.1	NBPF20	P	Neuroblastoma breakpoint family, member 20	614007	REc			
1.1005	6	24	15	1q21.1	NBPF17P, NBPF23	P	Neuroblastoma breakpoint family, member 17, pseudogene	612970	REc			
1.1006	1	20	99	1q23.2	PEA15, HMAT1, PED	C	Phosphoprotein enriched in astrocytes, 15kD	603434	R, A			
1.1007	12	12	12	1q21.1	PEX11B, PEX14B	P	Peroxisome biogenesis 11B	603867	REc		Peroxisome biogenesis disorder 14B, 614920 (3)	
1.1008	3	15	11	1q21.2	PDE4DIP, MMGL, KIAA0454, KIAA0477	C	Phosphodiesterase 4D-interacting protein	608117	R, REc, A			
1.1009	3	15	11	1q21.1	PPIAL4A, COAS2	P	Peptidylprolyl isomerase A (cyclophilin A)-like 4A	608608	REc			
1.1010	11	11	14	1q21.1	PRKAB2	P	Protein kinase, AMP-activated, noncatalytic, beta-2	602741	REc			
1.1011	7	18	12	1q21.1	SRGAP2B	P	SLIT-ROBO Rho GTPase-activating protein 2B	614703	REc			
1.1012	7	18	12	1q21.1	SRGAP2D	P	SLIT-ROBO Rho GTPase-activating protein 2D	614705	A			
1.1013	8	1	12	1q21.1	UAQTL6	P	Uric acid concentration, serum, quantitative trait locus 6	614747	Fd	associated with C/T variant at chr1_142697422	[Uric acid concentration, serum, QTL6] (2)	
1.1014	7	13	98	1q21.3	PIK4CB	P	Phosphatidylinositol 4-kinase, catalytic, beta polypeptide	602758	REa, A, R			
1.1015	10	23	02	1q21.3	RFX5	C	Regulatory factor X, 5 (influences HLA class II expression)	601863	A		Bare lymphocyte syndrome, type II, complementation group C, 209920 (3); Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	
1.1016	12	21	09	1q21.2	BOLA1	P	BolA, E. coli, homolog of, 1	613181	REc			
1.1017	6	22	14	1q21.2	CIART, CHRONO, GM129	P	Circadian-associated repressor of transcription	615782	REc			
1.1018	7	17	09	1q21.3	ENSA	P	Endosulfine, alpha	603061	REc			
1.1019	11	24	14	1q21.2	FALEC, FAL1	P	Focally amplified long noncoding RNA in epithelial cancer	616092	REc			
1.1020	3	9	16	1q21.1	FAM72C	P	Family with sequence similarity 72, member C	616853	REc			
1.1021	4	16	14	1q21.2	GJA5, CX40, ATFB11	C	Gap junction protein, alpha-5, 40kD (connexin 40)	121013	REa, A, REc		Atrial fibrillation, familial, 11, 614049 (3); Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	3(Gja5)
1.1022	9	2	08	1q21.3	GOLPH3L, GPP34R	P	Golgi phosphoprotein 3-like	612208	R, REc			
1.1023	5	15	15	1q21.2	PRPF3, HPRP3, RP18	C	Precursor mRNA-processing factor 3, S. cerevisiae, homolog of	607301	Fd, A		Retinitis pigmentosa 18, 601414 (3)	
1.1024	4	16	03	1q22	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	C	Lamin A/C	150330	A, Fd, R		Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3); Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); Restrictive dermopathy, lethal, 275210 (3); Heart-hand syndrome, Slovenian type, 610140 (3); Malouf syndrome, 212112 (3)	3(Lmna)
1.1025	1	23	08	1q21.2	OTUD7B, CEZANNE	P	OTU domain-containing protein 7B	611748	R, REc			
1.1026	6	2	15	1q21.2	PLEKHO1, CKIP1	P	Pleckstrin homology domain-containing protein, family O, member 1	608335	R, REc			
1.1027	6	5	12	1q21.2	SF3B4, SF3B49, SAP49, AFD1	P	Splicing factor 3B, subunit 4	605593	R, REc		Acrofacial dysostosis 1, Nager type, 154400 (3)	
1.1028	5	21	07	1q22	SMG5, EST1B, KIAA1089	P	SMG5, C. elegans, homolog of	610962	R, REc			
1.1029	6	22	12	1q21.2	SV2A, SV2	P	Synaptic vesicle glycoprotein 2A	185860	REc, R			
1.1030	8	5	14	1q21.2	TARS2, COXPD21	P	Threonyl-tRNA synthetase 2	612805	REc	mutation identified in one COXPD21 family	?Combined oxidative phosphorylation deficiency 21, 615918 (3)	
1.1031	2	26	16	1q21.3	ZNF687, KIAA1441, PDB6	P	Zinc finger protein 687	610568	REc, Ch	fused with AML1 in t(1;21)	Paget disease of bone 6, 616833 (3)	
1.1032	11	4	04	1q23.3	F11R, JAM1	P	F11 receptor (junctional adhesion molecule 1)	605721	REc			
1.1033	5	27	05	1q21.2	FCGR1A, IGFR1, CD64	C	Fc fragment of IgG, high affinity Ia, receptor for (CD64)	146760	REa, H, A		[IgG receptor I, phagocytic, familial deficiency of] (3)	3(Fcgr1)
1.1034	8	9	99	1p12	SEC22L1, SEC22B	P	Secretion deficient 22, S. Cerevisiae, homolog-like 1	604029	R			
1.1035	6	30	08	1q21.3	TNFAIP8L2, TIPE2	P	Tumor necrosis factor-alpha-induced protein 8-like 2	612112	REc, H			3(Tnfaip8l2)
1.1036	12	21	09	1q23.1	FCRL1, FCRH1	P	Fc receptor-like protein 1	606508	REc			
1.1037	11	27	01	1q23.1	FCRH3	P	Fc receptor-like protein 3	606510	REc			
1.1038	12	28	08	1q23.2	IGSF4B, TSLL1, NECL1, SYNCAM3	P	Immunoglobulin superfamily, member 4B	609743	A, H			1(Igsf4b)
1.1039	11	27	01	1q23.1	SPAP1, SPAP1A, SPAP1B, SPAP1C	P	SH2 domain-containing phosphatase anchor protein 1	606509	REc			
1.1040	1	30	01	1q21.3	ADAM15, MDC15	P	A disintegrin and metalloproteinase domain 15	605548	A			
1.1041	1	14	13	1q21.3	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	C	Adenosine deaminase, RNA-specific	146920	A, REc, REa		Dyschromatosis symmetrica hereditaria, 127400 (3); Aicardi-Goutieres syndrome 6, 615010 (3)	3(Adar)
1.1042	9	22	08	1q21.3	ATP8B2, ATPID	P	ATPase, class I, type 8B, member 2	605867	REc			
1.1043	7	20	12	1q21.3	BNIPL, BNIPS, BNIPL1, BNIPL2	P	BCL2/adenovirus E1B 19kD protein-interacting protein 2-like	611275	R, REc			
1.1044	4	19	12	1q21.3	CERS2, LASS2	P	Ceramide synthase 2	606920	R			
1.1045	9	2	11	1q21.3	CHTOP, C10orf77, SRAG, FOP	P	Chromatin target of PRMT1	614206	REc			
1.1046	1	13	11	1q21.3	CKS1B, CKS1	P	CDC28 protein kinase 1B	116900	REc	previously to 8q21 by FISH		
1.1047	8	4	97	1q23.1	CRABP2, RBP6	C	Cellular retinoic acid-binding protein-2	180231	A, REc			
1.1048	6	20	07	1q21.3	CREB3L4, CREB4, AIBZIP	C	cAMP responsive element binding protein 3-like 4	607138	REc, A			
1.1049	10	27	08	1q21.3	CRTC2, TORC2	P	CREB-regulated transcription coactivator 2	608972	R, REc			
1.1050	11	30	06	1q21.3	FLAD1, FADS	P	Flavin adenine dinucleotide synthetase, S. cerevisiae, homolog of	610595	REc			
1.1051	3	31	15	1q21.3	FLG2, IFPS	P	Filaggrin family, member 2	616284	REc			
1.1052	6	7	11	1q21.3	HAX1, SCN3	C	HCLS1-associated protein X1	605998	R, REc		Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	
1.1053	1	18	06	1q21.3	HORMAD1, NOHMA	P	HORMA domain-containing 1	609824	REc, H			3(Nohma)
1.1054	2	16	10	1q21.3	HRM2	P	Hair morphology 2 (curly hair)	139450	Fd	associated with rs11803731	Hair, curly (2)	
1.1055	4	10	15	1q21.3	HRNR	P	Hornerin	616293	REc, H			3(Hrnr)
1.1056	8	1	12	1q21.3	IL6R, IL6RQ, IL6Q	C	Interleukin-6 receptor	147880	REa, A	IL6R-like gene on chr.9	[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3); [Interleukin 6, serum level of, QTL], 614752 (3)	
1.1057	3	23	14	1q21.3	INTS3, INT3, SOSSA	P	Integrator complex subunit 3	611347	REc			
1.1058	9	10	03	1q21.3	KCNN3, SK3, SKCA3	C	Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 3	602983	A, Psh, R			
1.1059	9	16	12	1q21.3	LINGO4, LRRN6D	P	Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 4	609794	REc			
1.1060	5	25	13	1q21.3	OAZ3, AZ3	P	Ornithine decarboxylase antizyme 3	605138	REc			
1.1061	11	13	15	1q21.3	PMVK, PMK, POROK1	P	Phosphomevalonate kinase	607622	Psh, REc		Porokeratosis 1, multiple types, 175800 (3)	
1.1062	1	13	16	1q21.3	POGZ, KIAA0461, MRD37, WHSUS	P	POGO transposable element with ZNF domain	614787	REc		White-Sutton syndrome, 616364 (3)	
1.1063	7	27	09	1q21.3	PYGO2	P	Pygopus, Drosophila, homolog of, 2	606903	R, REc			
1.1064	2	1	11	1q21.3	RAB13	P	RAB13, member RAS oncogene family	602672	REc	previously assigned to 12q13 by in situ hybridization		
1.1065	7	2	02	1q22	RHBG	P	Rhesus blood group, B glycoprotein	607079	A, H			3(Rhbg)
1.1066	7	18	12	1q21.2	RPRD2	P	Regulation of nuclear pre-mRNA domain-containing 2	614695	REc			
1.1067	10	2	12	1q21.3	PSMD4, S5A, RPN10	P	Proteasome 26S subunit, non-ATPase, 4	601648	REc			3(Psmd4)
1.1068	8	19	09	1q21.3	SCNM1, MGC3180	P	Sodium channel modifier 1	608095	REc			
1.1069	4	21	15	1q21.3	SEMA6C, KIAA1869	P	Semaphorin 6C	609294	REc			16(Sema6c)
1.1070	2	25	15	1q21.3	SHE	P	SH2 domain-containing protein E	610482	R, REc			
1.1071	7	27	09	1q21.3	SLC27A3, FATP3	P	Solute carrier family 27 (fatty acid transporter), member 3	604193	R, REc			
1.1072	8	21	08	1q21.3	SNX27, MRT1	P	Sorting nexin 27	611541	R, REc			
1.1073	12	21	09	1q21.3	TCHH, THH, THL, TRHY	C	Trichohyalin	190370	A, RE	cluster = FLG, IVL, LOR, THL		
1.1074	3	7	14	1q21.3	THEM5, ACOT15	P	Thioesterase superfamily member 5	615653	REc, H, REn			3(Them5)
1.1075	7	20	15	1q21.3	UBAP2L, NICE4	P	Ubiquitin-associated protein 2-like	616472	REc			
1.1076	9	20	14	1q21.3	ZBTB7B, ZFP67, CKROX, THPOK	P	Zinc finger- and BTB domain-containing protein 7B	607646	REc			
1.1077	3	21	93	1q23.3	CD48, BCM1, BLAST1	C	CD48 antigen (B-cell membrane protein)	109530	REa, A, REn			1(Bcm1)
1.1078	4	27	09	1q23.3	ITLN1, INTL, LFR, HL1	C	Intelectin 1	609873	Psh, A, REc			
1.1079	4	27	09	1q23.3	ITLN2, HL2	P	Intelectin 2	609874	Psh, A			
1.1080	9	11	95	1q23.3	LY9	P	T-lymphocyte surface antigen Ly-9	600684	REn	within 410kb of CD48		1(Ly9)
1.1081	10	4	05	1q21.2	ANP32E, LANPL	P	Acidic leucine-rich nuclear phosphoprotein 32 family, member E	609611	REc			
1.1082	10	2	12	1q22	ASH1L, KIAA1420, ASH1	P	ash1 (absent, small, or homeotic), Drosophila, homolog of	607999	REc			
1.1083	3	3	95	1q23.1	IFI16	C	Interferon, gamma-inducible protein 16	147586	REa, A			
1.1084	3	8	00	1q23.1	AIM2	P	Absent in melanoma 2	604578	A			
1.1085	2	12	09	1q23.3	CD244, NAIL, NKR2B4, SLAMF4	P	CD244 antigen	605554	REc		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
1.1086	7	6	07	1q23.3	FCGR2B, CD32	P	Fc fragment of IgG, low affinity IIb, receptor for	604590	REc		{Systemic lupus erythematosus, susceptibility to}, 152700 (3); {Malaria, resistance to}, 611162 (3)	
1.1087	11	13	15	1q22	FDPS, FPS, POROK9	P	Farnesyl diphosphate synthase	134629	R, REc		Porokeratosis 9, multiple types, 616631 (3)	
1.1088	8	19	13	1q22	GON4L, KIAA1606	P	GON4-like protein	610393	REc			
1.1089	3	24	06	1q22	HCN3, KIAA1535	P	Hyperpolerization-activated cyclic nucleotide-gated potassium channel 3	609973	R, REc			
1.1090	12	4	02	1q21.3	LENEP, LEP503	P	Lens epithelial protein	607377	A			
1.1091	7	15	13	1q22	LAMTOR2, MAPBPIP, p14	P	Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	610389	R, REc		Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	
1.1092	8	20	07	1q22	MEX3A	P	Mex-3, C. elegans, homolog of, A	611007	REc			
1.1093	3	23	09	1q22	MIR9-1, MIRN9-1	P	Micro RNA 9-1	611186	REc			
1.1094	3	3	95	1q23.1	MNDA	P	Myeloid cell nuclear differentiation antigen	159553	REa, REn			
1.1095	7	25	12	1q23.3	MPZ, CMT1B, CMTDID, CHM, DSS	C	Myelin protein zero	159440	REb, A, F, Fd, D		Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome, 180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	1(Mpp)
1.1096	7	12	94	1q23.2	NHLH1, HEN1	P	Nescient helix loop helix 1	162360	H, REa, A	closely linked to Sap in mouse		1(Nscl)
1.1097	4	19	12	1q22	PAQR6	P	Progestin and ADIPOQ receptor family, member 6	614579	REc			
1.1098	9	12	96	1q23.3	PPOX	P	Protoporphyrinogen oxidase	600923	A		Porphyria variegata, 176200 (3)	
1.1099	10	25	12	1q23.2	PEX19, PXF, HK33, D1S2223E, PBD12A	C	Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein)	600279	REa, A		Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	
1.1100	7	29	09	1q22	RAB25, RAB11C	C	Ras-associated protein RAB25	612942	R, REc			
1.1101	8	7	13	1q22	RIT1, RIT, ROC1, NS8	P	Ric-like protein without CAAX motif 1	609591	REc		Noonan syndrome 8, 615355 (3)	3(Rit)
1.1102	11	30	06	1q22	SEMA4A, SEMB, RP35, CORD10	P	Semaphorin 4A	607292	REc		Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283 (3)	
1.1103	9	2	08	1q23.3	SH2D1B, EAT2	P	SH2 domain-containing 1B	608510	A			
1.1104	3	12	07	1q22	SLC25A44	P	Solute carrier family 25, member 44	610824	REc			3(Slc25a44)
1.1105	1	21	11	1q22	SLC50A1, RAG1AP1	P	Solute carrier family 50 (sugar transporter), member 1	613683	REc			
1.1106	4	17	13	1q21.3	SNAPIN, SNAPAP, BLOC1S7, BLOS7	P	SNAP-associated protein	607007	R, REc			
1.1107	7	16	02	1q23.3	USP21, USP23	P	Ubiquitin-specific protease 21	604729	R			
1.1108	3	31	15	1q22	YY1AP1, YAP, HCCA2	P	YY1 associated protein 1	607860	REc			
1.1109	6	23	98	1q24.1	ALDH9A1, ALDH9, E3	P	Aldehyde dehydrogenase 9 family, member A1	602733	A, REa			
1.1110	8	13	15	1q23.3	ATF6, ACHM7	P	Activating transcription factor-6	605537	REc		Achromatopsia 7, 616517 (3)	
1.1111	8	5	14	1q24.2	CD247, CD3Z, TCRZ, IMD25	C	CD247 antigen	186780	REa, A, REn	mutation identified in one IMD25 patient	?Immunodeficiency 25, 610163 (3)	1(T3z, Cd3z)
1.1112	3	17	06	1q23.2	IGSF9, KIAA1355	C	Immunoglobulin superfamily, member 9	609738	REc, REn, H			1(Igsf9)
1.1113	8	17	98	1q23.3	LMX1A, LMX1	P	LIM homeo box transcription factor-1, alpha	600298	A			
1.1114	2	8	11	1q23.2	NCSTN	P	Nicastrin	605254	REn		Acne inversa, familial, 1, 142690 (3)	
1.1115	5	9	95	1q24.2	OTF1, OCT1	C	Octamer-binding transcription factor-1	164175	REa, REn, A			1(Otf1)
1.1116	5	2	94	1q23.3	RXRG	P	Retinoid X receptor, gamma	180247	H, A			1(Rxrg)
1.1117	8	24	04	1q23.3	SLAMF1, SLAM, CDW150, CD150	P	SLAM family, member 1	603492	REc			
1.1118	8	2	13	1q21.3	TPM3, NEM1, CFTD, CAPM1	C	Tropomyosin 3	191030	REa, A	TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd	Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3); CAP myopathy 1, 609284 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3)	1(Tpm3)
1.1119	4	15	04	1q23.3	USF1, HYPLIP1	C	Upstream stimulatory factor-1	191523	REa, A, Fd		{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)	1(Usf1)
1.1120	7	1	05	1q24.1	UCK2, TSA903	P	Uridine/cytidine kinase 2	609329	REc			
1.1121	3	22	06	1q23.2	CCDC19, NESG1	P	Coiled-coil domain-containing 19	605152	REc			
1.1122	4	19	01	1q21.3	PIP5K1A	P	Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha	603275	A			
1.1123	2	2	07	1q24.2	ATP1B1	C	ATPase, Na+K+ transporting, beta-1 polypeptide	182330	REa, A, REn		[Blood pressure regulation QTL], 145500 (2)	1(Atp1b1)
1.1124	8	9	99	1q23.3	B4GALT3	P	Beta-1,4-galactosyltransferase 3	604014	A			
1.1125	6	8	01	1q23	BDET	P	Bleeding disorder, east Texas type	605913	Fd		Bleeding disorder, east Texas type (2)	
1.1126	1	23	90	1q23	D1S61, D1S111, MS336	P	Minisatellite 33.6	157560	REa, A			
1.1127	7	13	99	1q22	CCT3, TRIC5	P	Chaperonin-containing TCP1, subunit 3, gamma (TCP1 (t-complex-1) ring complex, polypeptide 5)	600114	A			3(Tric5)
1.1128	5	4	12	1q24.2	F5, THPH2, RPRGL1	C	Coagulation factor V (proaccelerin, labile factor)	612309	REa, A, Fd, REn	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Budd-Chiari syndrome}, 600880 (3); Thrombophilia due to activated protein C resistance, 188055 (3); {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	1(Cf5)
1.1129	11	11	14	1q24.3	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	C	Fas ligand (TNF superfamily, member 6)	134638	A		Autoimmune lymphoproliferative syndrome, type IB, 601859 (3); {Lung cancer, susceptibility to}, 211980 (3)	1(Fas1)
1.1130	7	10	91	1q23.2	FCER1A	C	Fc IgE receptor, alpha polypeptide	147140	REa, A			1(Fcer1a)
1.1131	8	11	91	1q23.3	FCER1G	P	Fc fragment of IgE, high affinity I, receptor for, gamma polypeptide	147139	H, A	probably on 1q close to CD32		1(Fcer1a)
1.1132	7	31	08	1q23.3	FCGR2C, CD32C	P	Fc fragment of IgG, low affinity IIc, receptor for	612169	REc		Thrombocytopenic purpura, autoimmune, 188030 (1)	
1.1133	3	25	14	1q23.3	FCGR3A, CD16, IGFR3, IMD20	C	Fc fragment of IgG, low affinity III, receptor for (CD16)	146740	REb, REn	FCGR2A and FCGR3A within 250kb antigen	Immunodeficiency 20, 615707 (3)	
1.1134	8	3	12	1q23.3	FCGR3B	P	Fc fragment of IgG, low affinity IIIb, receptor for	610665	REc		Neutropenia, alloimmune neonatal (3)	
1.1135	7	12	02	1q23.3	FREB	P	Fc receptor homolog expressed in B cells	606891	REc			
1.1136	4	14	05	1q23	LFS3	P	Li-Fraumeni syndrome 3	609266	Fd		Li-Fraumeni syndrome 3 (2)	
1.1137	3	8	00	1q24.1	MGST3	P	Glutatione S-transferase, microsomal, 3	604564	A			
1.1138	2	2	07	1q23.3	RGS5	P	Regulator of G protein signaling-5	603276	Psh, R		[Blood pressure regulation QTL], 145500 (2)	
1.1139	8	25	04	1q23.3	NDUFS2	P	NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kD	602985	REc, A		Mitochondrial complex I deficiency, 252010 (3)	
1.1140	2	6	08	1q23.3	NUF2, NUF2R, CDCA1	P	NUF2, S. cerevisiae, homolog of	611772	R			
1.1141	2	9	92	1q23.3	PBX1	C	Pre-B cell leukemia transcription factor-1	176310	Ch, A	t(1;19); pseudogene PBXP1 on chr.3	Leukemia, acute pre-B-cell (2)	1(Pbx)
1.1142	6	15	99	1q25.1	TNFSF18, AITRL, GITRL	P	Tumor necrosis factor ligand superfamily, member 18	603898	R			
1.1143	8	30	02	1q24.2	XCL1, SCYC1, SCM1, LTN, LPTN	C	Chemokine, C motif, ligand 1 (lymphotactin)	600250	H, REa, A			1(Lptn)
1.1144	8	30	02	1q24.2	XCL2, SCYC2, XCL2, SCM1B	P	Chemokine, C motif, ligand 2	604828	A			
1.1145	2	4	02	1q23.3	SLAMF7, CRACC, CS1	C	SLAM family, member 7	606625	REc			
1.1146	4	17	01	1q24.2	TBX19	P	T-box 19	604614	R		Adrenocorticotropic hormone deficiency, 201400 (3)	
1.1147	7	1	15	1q23.2	COPA, AILJK	P	Coatomer protein complex, subunit alpha	601924	A		{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3)	
1.1148	4	30	93	1q24.3	FMO1	P	Flavin-containing monooxygenase 1, fetal liver	136130	Psh, A			
1.1149	6	4	08	1q24.3	FMO2	P	Flavin-containing monooxygenase 2, pulmonary	603955	Psh, REc	probably cluster of FMO genes at 1q23-q25		
1.1150	10	26	97	1q24.3	FMO3, TMAU	P	Flavin-containing monooxygenase 3	136132	Psh		Trimethylaminuria, 602079 (3)	
1.1151	6	4	08	1q24.3	FMO4	P	Flavin-containing monooxygenase 2, adult liver	136131	REc			
1.1152	4	23	08	1q25.1	MRPS14	P	Mitochondrial ribosomal protein S14	611978	R, REc			
1.1153	6	9	98	1q24.3	PIGC, GPI2	C	Phosphatidylinositol glycan, class C	601730	REc, A			
1.1154	7	14	11	1q24.2	SELE, ELAM1	C	Selectin E (endothelial leukocyte adhesion molecule-1)	131210	REn		[Blood pressure regulation QTL], 145500 (2)	1(Elam)
1.1155	7	14	11	1q24.2	SELL, LYAM1, LAM1, LNHR	C	Selectin L (lymphocyte adhesion molecule 1)	153240	A, REn			1(Lnhr)
1.1156	1	27	14	1q24.2	SELP, GRMP	C	Selectin P (granulocyte membrane protein, 140kD; antigen CD62)	173610	REn, A	in same 300kb segment as LYAM1, ELAM1	{Atopy, susceptibility to}, 147050 (3)	1(Grmp)
1.1157	3	1	12	1q25.1	SERPINC1, AT3, AT3D, THPH7	C	Antithrombin III	107300	F, D, A, REa, Fd	~17cM distal to FY	Thrombophilia due to antithrombin III deficiency, 613118 (3)	1(At3)
1.1158	2	22	13	1q21.3	GATAD2B, KIAA1150, p68, MRD18	P	GATA zinc finger domain-containing protein 2B	614998	REc		Mental retardation, autosomal dominant 18, 615074 (3)	
1.1159	1	30	02	1q23.2	IGSF8, PGRL, CD81P3	C	Immunoglobulin superfamily, member 8	606644	REc, R			
1.1160	4	15	08	1q23.1	ISG20L2	P	Interferon-stimulated exonuclease gene 20-kD-like 2	611930	REc			
1.1161	6	13	12	1q23.1	KIRREL, NEPH1	P	Kin of IRRE-like	607428	REc			
1.1162	8	18	04	1q23.3	KIS	P	Kinase-interacting stathmin	608849	R			
1.1163	11	11	14	1q23.1	NES	P	Nestin	600915	REc			
1.1164	12	10	13	1q23.3	NR1I3, CAR, MB67	P	Nuclear receptor subfamily 1, group I, member 3	603881	REc			
1.1165	8	3	12	1q23.1	PEAR1	P	Platelet endothelial aggregation receptor 1	610278	REc, R			
1.1166	8	24	04	1q23.2-q23.3	SLAMF6, NTBA	P	SLAM family, member 6	606446	R, REc			
1.1167	11	19	13	1q22	TMEM79, MATT	P	Transmembrane protein 79	615531	REc, H			3(Tmem79)
1.1168	12	21	10	1q23.2	DARC, FY, GPD, WBCQ1	C	Duffy antigen receptor for chemokines (glycoprotein D)	613665	F, Fc, Fd, A	by A, 1q22-q23	[Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection against}, 611162 (3); [White blood cell count QTL], 611862 (3)	1(Fy, Darc)
1.1169	7	18	14	1q23.2	DCAF8, WDR42A, GAN2	P	DDB1- and CUL4-associated factor 8	615820	REc	mutation identified in 1 GAN2 family	?Giant axonal neuropathy 2, autosomal dominant, 610100 (3)	
1.1170	7	7	14	1q23.2	KCNJ9, GIRK3	P	Potassium inwardly-rectifying channel, subfamily J, member 9	600932	A			
1.1171	9	1	11	1q23.2	KCNJ10, SESAME	C	Potassium inwardly-rectifying channel, subfamily J, member 10	602208	H, REc		SESAME syndrome, 612780 (3); Enlarged vestibular aqueduct, digenic, 600791 (3)	1(Kcnj10)
1.1172	8	23	06	1q23.2	PIGM	P	Phosphatidylinositol glycan, class M	610273	R, REc		Glycosylphosphatidylinositol deficiency, 610293 (3)	
1.1173	2	23	08	1q24.2	TIPRL, TIP41, TIP	P	TIP41-like protein	611807	REc			
1.1174	10	3	11	1q23.3	ARHGAP30	P	RHO GTPase-activating protein 30	614264	REc			
1.1175	12	3	14	1q23.3	CFAP126, FLTP	P	Cilia- and flagella-associated protein 126	616119	REc			
1.1176	1	11	07	1q23.3	DEDD, DEFT	C	Death effector domain-containing protein	606841	R, REc			
1.1177	12	5	03	1q25.1	GAS5	P	Growth arrest-specific 5	608280	REc			
1.1178	2	10	11	1q23.3	HSD17B7	P	17-beta-hydroxysteroid dehydrogenase VII	606756	REc			
1.1179	1	1	10	1q23.3	NOS1AP, CAPON, KIAA0464	P	Nitric oxide synthase 1 (neuronal) adaptor protein	605551	R, REc			
1.1180	9	9	10	1q23.3	PFDN2	P	Prefoldin 2	613466	REc			
1.1181	2	1	11	1q23.3	PVRL4, PRR4, EDSS1	P	Poliovirus receptor-like 4	609607	REc		Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	
1.1182	2	21	10	1q23.3	QTV	P	QT interval, variation in	610141	Fd	associated with rs12143842	[QT interval, variation in] (2)	
1.1183	5	5	09	1q23.3	RGS4	P	Regulator of G protein signaling 4	602516	REc			
1.1184	2	13	12	1q24.2	SLC19A2, THTR1, TRMA, THMD1	C	Solute carrier family 19 (thiamine transporter), member 2	603941	Fd, REc		Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	
1.1185	10	12	14	1q23.3	TSTD1, KAT	P	Thiosulfate sulfurtransferase (rhodanese)-like domain-containing protein 1	616041	REc			
1.1186	5	25	13	1q23.3	UAP1, SPAG2	P	ADP-N-acetylglucosamine pyrophosphorylase 1	602862	REc			
1.1187	5	26	13	1q23.3	UFC1	P	Ubiquitin-fold modifier-conjugating enzyme 1	610554	REc			
1.1188	1	20	11	1p32.3	ZCCHC11, KIAA0191	C	Zinc finger CCHC domain-containing protein 11	613692	R, REc			
1.1189	4	9	15	1q24.2	ADCY10, SAC, HCA2	P	Adenylyl cyclase 10, soluble	605205	REc		{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	
1.1190	11	30	00	1q24	DFNM1	P	Deafness, nonsyndromic, modifier 1	605429	Fd		{Deafness, nonsyndromic, modifier 1} (2)	
1.1191	3	9	00	1q25.1	GPR52	P	G protein-coupled receptor 52	604106	REc			
1.1192	9	9	10	1q24.2	NME7, MN23H7	P	Nonmetastatic cells 7, protein expressed in	613465	REc			
1.1193	7	28	11	1q24.2	PRRX1, PMX1, PHOX1, AGOTC	C	Paired-related homeobox gene 1	167420	H, Fd, A		Agnathia-otocephaly complex, 202650 (3)	1(Pmx)
1.1194	5	26	13	1q24.2	RCSD1, CAPZIP	P	RCSD domain-containing protein 1	610579	REc			
1.1195	3	2	98	1q25.1	TNR	C	Tenascin R (restrictin, janusin)	601995	A, R			4(Tnr)
1.1196	3	29	12	1q25.2	TOR1AIP1, LAP1, LAP1B	P	Torsin A-interacting protein 1	614512	REc			
1.1197	3	29	12	1q25.2	TOR1AIP2, LULL1	P	Torsin A-interacting protein 2	614513	REc			
1.1198	9	19	13	1q25.2	QSOX1	P	Quiescin Q6 sulfhydryl oxidase 1	603120	A			
1.1199	2	4	92	1q25.2	ABL2, ABLL, ARG	C	Abelson murine leukemia viral (v-abl) oncogene homolog 2 (arg, Abelson-related gene)	164690	REa, A, Ch	fused with ETV6 in AML	Leukemia, acute myeloid, with eosinophilia (1)	1(Abll)
1.1200	8	10	05	1q25.3-q31.1	HMCN1, FBLN6, FIBL6, ARMD1	P	Hemicentin (fibulin 6)	608548	REc		{Macular degeneration, age-related, 1}, 603075 (3)	
1.1201	1	23	01	1q31.1	PRG4, CACP, MSF, SZP, HAPO	C	Proteoglycan 4 (megakaryocyte stimulating factor; hemangiopoietin)	604283	Fd, A		Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	1(Prg4)
1.1202	8	28	01	1q25.1	SIP	P	SIAH1-interacting protein	606186	REc			
1.1203	5	12	09	1q24.1	TADA1L, STAF42	P	Transcriptional adaptor 1-like	612763	REc			
1.1204	5	13	02	1q24.3	VAMP24	P	Vesicle-associated membrane protein 4	606909	R, REc			
1.1205	3	25	15	2q24-q32	SPG23	P	Spastic paraplegia 23	270750	Fd	max lod at D1S2692	Spastic paraplegia 23 (2)	
1.1206	5	6	13	1q24.1	LRRC52	P	Leucine-rich repeat-containing protein 52	615218	REc			
1.1207	9	10	09	1q24.1	MAEL	P	Maelstrom, Drosophila, homolog of	611368	REc			
1.1208	1	29	08	1q25.1-q25.2	RFWD2, COP1	P	Ring finger- and WD repeat domain-containing protein 2	608067	REc	pseudogenes on chr. 3, 9, 18		
1.1209	6	3	14	1q24.1	TMCO1, CFSMR	P	Transmembrane and coiled-coil domains protein 1	614123	REc		Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3)	
1.1210	7	24	12	1q24.2	BRP44, MPC2	P	Brain protein 44	614737	REc			
1.1211	3	27	12	1q24.2	DCAF6, IQWD1, NRIP	P	DDB1 and CUL4 associated factor 6	610494	R, REc			
1.1212	4	15	11	1q24.2	GORAB, SCYL1BP1, NTKLBP1, GO	P	Golgin, RAB6-interacting	607983	R, REc		Geroderma osteodysplasticum, 231070 (3)	
1.1213	9	24	08	1q24.2	GPR161	P	G protein-coupled receptor 161	612250	R, REc			
1.1214	7	17	09	1q24.2	KIFAP3, SMAP	P	Kinesin-associated protein 3	601836	R, REc			
1.1215	6	4	13	1q24.2	METTL18, C1orf156	P	Methyltransferase-like 18	615255	REc			
1.1216	4	6	15	1q24.2	SCYL3, PACE1	P	SCY1-like 3, S. cerevisiae, homolog of	608192	REc			
1.1217	1	17	08	1q25.2	C1orf76, NDSP	P	Neuroblastoma-derived secretory protein	611727	REc			
1.1218	7	18	12	1q24.3	DNM3, KIAA0820	P	Dynamin 3	611445	REc			
1.1219	3	23	09	1q24.3	MIR199A2, MIRN199A2	P	Micro RNA 199A2	610720	REc			
1.1220	3	23	09	1q24.3	MIR214, MIRN214	P	Micro RNA 214	610721	REc			
1.1221	7	18	11	1q24.3	MIR3120	P	Micro RNA 3120	614722	REc	in intron 13 of DNM3 in sense orientation		
1.1222	10	24	12	1q24.3	MYOC, TIGR, GLC1A, JOAG, GPOA	C	Myocilin (trabecular meshwork-induced glucocorticoid response protein)	601652	REc, R, Fd, A		Glaucoma 1A, primary open angle, 137750 (3)	1(Tigr)
1.1223	8	30	07	1q25	AD14	P	Alzheimer disease 14	611154	Fd	max lod at D1S218	{Alzheimer disease-14} (2)	
1.1224	7	13	09	1q25.2	ASTN1, ASTN	P	Astrotactin 1	600904	A			1(Astn)
1.1225	12	17	07	1q25.3	C1orf25, TRM1L	P	Trm1-like	611673	REc			
1.1226	4	30	09	1q25.3	DHX9, DDX9, NDHII	C	DEAH (Asp-Glu-Ala-His) box polypeptide 9	603115	H			1(Ddx9)
1.1227	8	21	07	1q25.2	FAM20B	P	Family with sequence similarity 20, member B	611063	R, REc			
1.1228	10	2	09	1q25.2	LHX4, CPHD4	C	LIM homeo box gene 4	602146	A, Ch	fused to IGH in ALL	Pituitary hormone deficiency, combined, 4, 262700 (3)	
1.1229	5	31	05	1q25.3	NCF2	C	Neutrophil cytosolic factor-2, 65kD	608515	REa, A		Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)	1(Ncf2)
1.1230	9	7	07	1q25.3	NPL, C1orf13, C112	P	N-acetylneuraminate pyruvate lyase	611412	REc			
1.1231	5	3	07	1q25	PDON2	P	Periodontitis, aggressive, 2	608526	Fd	between D1S196 and D1S533	Periodontitis, aggressive, 2 (2)	
1.1232	12	24	08	1q31.1	PLA2G4A, PLA2G4	P	Phospholipase A2, group IVA, cytosolic	600522	A		Phospholipase A2, group IV A, deficiency of (3)	
1.1233	8	20	07	1q25.3	RGSL1	P	Regulator of G protein signaling-like 1	611012	REc			
1.1234	8	2	07	1q25	RGSL2	P	Regulator of G protein signaling-like 2	611013	REc	related to AD linked to 1q25		
1.1235	1	24	02	1q25.3	RNASEL, RNS4, PRCA1, HPC1	C	Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)	180435	A, Fd		Prostate cancer 1, 601518 (3)	
1.1236	5	21	07	1q25.3	SMG7, EST1C, KIAA0250	C	SMG7, C. elegans, homolog of	610964	R, REc			
1.1237	3	12	96	1q25.2	SOAT1, STAT, ACAT	P	Sterol O-acyltransferase 1 (acyl-Coenzyme A: cholesterol acyltransferase 1)	102642	A, REa			
1.1238	4	18	05	1q25.1	TNFSF4, GP34, OX4OL	P	Tumor necrosis factor ligand superfamily, member 4	603594	A, H		{Myocardial infarction, susceptibility to}, 608446 (3)	1(Tnfsf4)
1.1239	1	1	95	1q31.1	TPR	C	Tumor potentiating region (translocated promoter region)	189940	REa, A	fused with MET in chemically induced tumor		
1.1240	5	28	15	1q25.3	TSEN15, SEN15, C1orf19	P	tRNA splicing endonuclease 15, S. cerevisiae, homolog of	608756	REc			
1.1241	3	8	91	1q22	BGLAP	P	Bone gamma-carboxyglutamic acid protein	112260	REa, REb			3(Bglap)
1.1242	4	29	97	1q25.3	CACNA1E, CACNL1A6	P	Calcium channel, voltage-dependent, alpha 1E subunit	601013	A			
1.1243	10	4	04	1q31.2	HRPT2, C1orf28	C	Parafibromin	607393	Fd, REc		Hyperparathyroidism-jaw tumor syndrome, 145001 (3); Hyperparathyroidism, familial primary, 145000 (3); Parathyroid adenoma with cystic changes, 145001 (3); Parathyroid carcinoma, 608266 (3)	
1.1244	2	21	02	1q25.3	LAMC2, LAMNB2, LAMB2T	C	Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)	150292	A, Fd		Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	
1.1245	10	25	10	1q25.2	PDCN, NPHS2, SRN1	C	Podocin	604766	REc, Fd	modifies phenotype of NPHS1 mutations to FSGS	Nephrotic syndrome, type 2, 600995 (3)	
1.1246	6	19	98	1q25.3	RGS16	P	Regulator of G protein signaling-16	602514	A			
1.1247	3	31	03	1q25.2	TOR3A, ADIR	P	Torsin family 3, member A (ATP-dependent interferon-responsive protein)	607555	REc			
1.1248	12	16	93	1q31.1	PDC	C	Phosducin, pineal gland	171490	H, REa, A			1(Pdc)
1.1249	7	10	92	1q32.1	ATP2B4, ATP2B2, PMCA4	P	ATPase, Ca++ transporting, plasma membrane, 4	108732	REa, A, Fd			
1.1250	10	8	07	1q25.1	CENPL	P	Centromeric protein L	611503	REc			
1.1251	6	14	07	1q25.1	DARS2, ASPRS. LBSL	P	Aspartyl-tRNA synthetase 2	610956	R, REc		Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	
1.1252	12	17	15	1q25.1	KIAA0040	C	KIAA0040 gene	616696	Psh, REc			
1.1253	7	17	09	1q25.1	PRDX6	P	Peroxiredoxin 6	602316	REc			
1.1254	10	30	06	1q25.1	RC3H1, KIAA2025	P	Roquin	609424	REc			
1.1255	6	9	15	1q25.3	XPR1, SYG1, IBGC6	P	Xenotropic and polytropic retrovirus receptor	605237	R		Basal ganglia calcification, idiopathic, 6, 616413 (3)	1(Xpr1)
1.1256	2	20	98	1q32.1	LAD1	L	Ladinin	602314	H			1(Lad1)
1.1257	8	3	12	1q25.2	RASAL2, NGAP	P	Ras protein activator-like 2	606136	REc			
1.1258	7	13	09	1q25.2	SEC16B, LZTR2, RGPR, SEC16S	P	Sec16, S. cerevisiae, homolog of, B	612855	REc			
1.1259	5	13	15	1q25.2-q25.3	ACBD6	P	Acyl-CoA-binding domain-containing protein 6	616352	REc			
1.1260	12	27	13	1q25.2-q25.3	LINC-COX2	P	Long intergenic noncoding RNA COX2	615492	REn			
1.1261	1	1	95	1q31.1	PTGS2	P	Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)	600262	REa, A			
1.1262	1	16	07	1q25.3	APOBEC4	P	Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 4	609908	REc			
1.1263	11	11	14	1q25.3	ARPC5, ARC16	P	Actin-related protein 2/3 complex, subunit 5	604227	REc			
1.1264	7	17	09	1q25.3	IER5	P	Immediate-early response gene 5	607177	R, REc			
1.1265	5	26	13	1q25.3	IVNS1ABP, NS1BP, ND1	P	Influenza virus NS1A protein-binding protein	609209	REc, R			
1.1266	8	17	98	1q25.3	MR1, HLALS	P	Major histocompatibility complex, class I-related	600764	A			
1.1267	9	11	12	1q25.3	NMNAT2, PNAT2, KIAA0479	P	Nicotinamide nucleotide adenylyltransferase 2	608701	REc			
1.1268	7	27	09	1q25.3	RGL1, RGL	P	Ral guanine nucleotide dissociation stimulator-like 1	605667	R, REc			
1.1269	11	2	04	1q25.3	RNF2, RING2, RING1B, HIPI3, DING, BAP1	P	RING finger protein 2	608985	R, REc			
1.1270	4	19	06	1q25.3	VDAC4	C	Voltage-dependent anion channel 4	610030	Psh, REc			
1.1271	7	31	08	1q31.3	ASPM, MCPH5	C	Abnormal spindle-like, microcephaly-associated	605481	Fd, REc		Microcephaly 5, primary, autosomal recessive, 608716 (3)	
1.1272	5	23	00	1q31.2	B3GALT2, GLCT2	P	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 2	603018	REc			
1.1273	12	13	00	1q31	BOS2	P	Branchiootic syndrome 2	120502	Fd		Branchiootic syndrome 2 (2)	
1.1274	5	12	09	1q31	CELIAC7	P	Celiac disease, susceptibility to, 7	612005	Fd	associated with rs2816316	{Celiac disease, susceptibility to, 7} (2)	
1.1275	1	24	93	1q32.1	CTSE	C	Cathepsin E	116890	REa, A, Fd	closely linked to REN		
1.1276	3	29	06	1q25.3	GLUL, GLNS	C	Glutamate-ammonia ligase (glutamine synthase)	138290	Psh, A, REc	pseudogene on chr.9	Glutamine deficiency, congenital, 610015 (3)	
1.1277	3	12	15	1q32.1	KIF14, KIAA0042, MKS12	C	Kinesin family member 14	611279	Psh, REc, H	mutation identified in 1 MKS12 family	?Meckel syndrome 12, 616258 (3)	1(Kif14)
1.1278	10	29	96	1q31.2	RGS2, G0S8	P	G0 to G1 switch regulatory 8, 24kD	600861	A			
1.1279	10	15	09	1q25.3	LAMC1, LAMB2	C	Laminin, gamma-1 (formerly LAMB2)	150290	REa, Fd	at least 3 genes, ?linked		1(Lamb2)
1.1280	3	21	07	1q32.3	LQK1	P	LQK1 protein	610864	REc			
1.1281	1	24	03	1q31	MGR6, FHM3	P	Migraine, several forms	607516	Fd		{Migraine with or without aura, susceptibility to, 6} (2); {Migraine, familial hemiplegic, 4} (2)	
1.1282	2	6	08	1q32.1	NAV1, POMFIL3, KIAA1151	P	Neuron navigator 1	611628	R			
1.1283	8	17	98	1q32.1	PFKFB2	P	Fructose-2,6-bisphosphatase, cardiac isozyme	171835	REa, A			
1.1284	6	27	02	1q32.1	PHLDA3, TIH1	P	Pleckstrin homology-like domain, family A, member 3	607054	REc			1(Phlda3)
1.1285	10	15	09	1q31	PVOP1	P	Pelvic organ prolapse, susceptibility to, 1	176780	Fd	associated with rs10911193	{Pelvic organ prolapse, susceptibility to, 1} (2)	
1.1286	6	11	97	1q31.2	RGS1, IER1, IR20	P	Regulator of G-protein signaling 1	600323	A			
1.1287	6	23	15	1q32.1	UBE2T, HSPC150, FANCT	P	Ubiquitin-conjugating enzyme E2T	610538	R, REc		Fanconi anemia, complementation group T, 616435 (3)	
1.1288	3	8	07	1q31.2	TROVE2, RO60, SSA2	C	TROVE domain family, member 2	600063	A			
1.1289	4	17	13	1q32.1	CDK18, PCTK3	P	Cyclin-dependent kinase 18	169190	A			
1.1290	7	27	11	1q32.1	CHIT, CHITD	C	Chitotriosidase	600031	Fd, A		[Chitotriosidase deficiency], 614122 (3)	
1.1291	1	1	12	1q32.1	IL10, CSIF, GVHDS	C	Interleukin-10	124092	Psh, R		{HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease, protection against}, 614395 (3); {Rheumatoid arthritis, progression of}, 180300 (3)	
1.1292	7	17	09	1q32.1	KIF21B, KIAA0449	P	Kinesin family member 21B	608322	R, REc			1(Kif21b)
1.1293	6	26	01	1q31.3	LHX9	P	LIM homeo box gene 9	606066	REc			1(Lhx9)
1.1294	7	22	09	1q31.3-q32.1	PTPRC, CD45, LCA	C	Protein tyrosine phosphatase, receptor type, c polypeptide	151460	A, S		{Hepatitic C virus, susceptibility to}, 609532 (3); Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	1(Ly5)
1.1295	3	8	07	1q32.1	SLC41A1	P	Solute carrier family 41, member 1	610801	REc			1(Slc41a1)
1.1296	7	22	09	1q31.3	CFHR1, FHR1, HFL1, CFHL1	P	Complement factor H-related 1	134371	R		{Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
1.1297	7	22	09	1q31.3	CFHR2, FHR2, HFL3, CFHL2	C	Complement factor H-related 2	600889	REc, R	in same 165kb YAC as F13B		
1.1298	7	22	09	1q31.3	CFHR3, FHR3, HLF4, CFHL3	P	Complement factor H-related 3	605336	R		{Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
1.1299	7	22	09	1q31.3	CFHR4, FHR4, CFHL4	P	Complement factor H-related 4	605337	R			
1.1300	3	28	11	1q31.3	CRB1, RP12, LCA8	C	Crumbs, Drosophila, homolog of, 1	604210	Fd, REc		Retinitis pigmentosa-12, autosomal recessive, 600105 (3); Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3)	
1.1301	3	21	93	1q31.3	F13B	C	Coagulation factor XIII, B polypeptide	134580	Fd, A, RE		Factor XIIIB deficiency, 613235 (3)	1(F13b)
1.1302	12	3	90	1q32.1	MYOG, MYF4	C	Myogenic factor-4; myogenin	159980	REa, A			1(Myog)
1.1303	6	4	97	1q31-q42	PHA2A, PHA2	P	Pseudohypoaldosteronism type IIA	145260	Fd		Pseudohypoaldosteronism, type IIA (2)	
1.1304	7	14	11	1q32.1	PIGR	C	Polymeric immunoglobulin receptor	173880	REa, A, Fd			
1.1305	1	20	11	1q42.13	PSEN2, AD4, STM2, CMD1V	C	Presenilin 2	600759	Psh, REc, REn		Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697 (3)	
1.1306	12	30	05	1q31.1	PSNP2	P	Supranuclear palsy, progressive, 2	609454	Fd	between D1S238 and D1S2823	Supranuclear palsy, progressive, 2 (2)	
1.1307	12	18	08	1q31.2	RGS21	P	Regulator of G protein signaling 21	612407	REc			1(Rgs1)
1.1308	4	4	02	1q31.2	GLRX2, GRX2	P	Glutaredoxin 2	606820	REc			
1.1309	3	15	10	1q31.3	DENND1B, FAM31B, C1orf18	P	DENN/MADD domain-containing 1B	613292	REc			
1.1310	12	21	10	1q32.3	FLVCR1, AXPC1, PCARP	P	Feline leukemia virus subgroup C receptor 1	609144	R		Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	
1.1311	4	25	06	1q31.3	KCNT2, SLICK	P	Potassium channel, subfamily T, member 2	610044	REc			
1.1312	5	11	09	1q32.1	MIR181A1, MIR213, MIRN181A1	P	Micro RNA 181A1	612742	REc			
1.1313	5	11	09	1q32.1	MIR181B1, MIRN181B1	P	Micro RNA 181B1	612744	REc			
1.1314	4	15	02	1q31.3	NEK7	P	Never-in-mitosis gene A-related kinase 7	606848	Psh, R			
1.1315	7	5	90	1q32.1	TNNI1	C	Troponin-I, skeletal, slow	191042	REa, Psh			1(Tnni1)
1.1316	4	16	14	1q31.3-q32.1	NYS7	C	Nystagmus 7, congenital, autosomal dominant	614826	Fd	between D1S218 and D1S2655	Nystagmus 7, congenital, autosomal dominant (2)	
1.1317	8	17	98	1q32.1	AVPR1B, AVPR3	P	Arginine vasopressin receptor-1B	600264	A			
1.1318	5	9	97	1q32.1	BTG2, PC3	P	B-cell translocation gene 2 (pheochromocytoma cell-3)	601597	REa, A			
1.1319	7	9	90	1q32.2	C4BPA	C	Complement component 4-binding protein, alpha polypeptide	120830	F, REa, A, RE	same RE fragment as C4BPB		1(C4bp)
1.1320	7	9	90	1q32.1	C4BPB	P	Complement component 4-binding protein, beta polypeptide	120831	RE, A			
1.1321	4	22	10	1q32.1	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	C	Calcium channel, voltage-dependent, L type, alpha 1S subunit	114208	H, REa, A, Fd	in mouse, mutation causes muscular dysgenesis	Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	1(Cchl1a3, mdg)
1.1322	3	11	92	1q32.2	CD34	C	CD34 antigen	142230	REa, A			1(Cd34)
1.1323	3	10	11	1q32.2	CD55, DAF, CROM	C	CD55 antigen (blood group Cromer)	125240	REa, A		[Blood group Cromer], 613793 (3)	
1.1324	12	21	12	1q31.3	CFHR5, CFHL5, FHR5, CFHR5D	P	Complement factor H-related 5	608593	A, R, REc		Nephropathy due to CFHR5 deficiency, 614809 (3)	
1.1325	7	6	07	1q32.2	CR1, C3BR	C	Complement component (3b/4b) receptor-1	120620	F, REa, A, RE		CR1 deficiency (1); {?SLE susceptibility} (1); [Blood group, Knops system], 607486 (3); {Malaria, severe, resistance to}, 611162 (3)	
1.1326	4	30	01	1q32.2	CR1L	P	Complement component receptor 1-like	605886	REc			
1.1327	7	6	12	1q32.2	CR2, C3DR, SLEB9, CVID7	C	Complement component (3d/Epstein-Barr virus) receptor-2	120650	F, REa, A, RE		{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3); Immunodeficiency, common variable, 7, 614699 (3)	1(Cr2)
1.1328	5	12	99	1q32.1	CSRP1, CSRP	C	Cysteine and glycine-rich protein-1	123876	REa, A			3(Csrp)
1.1329	3	20	09	1q32.1	CYB5BR1, NQO3A2, B5R.1	P	Cytochrome b5 reductase 1	608341	REc			
1.1330	11	13	98	1q32.1	ELF3, ESX	P	E74-like factor 3 (ETS domain transcription factor, serine box, epithelial-specific)	602191	A			
1.1331	1	1	95	1q32.1	ELK4, SAP1	P	ELK4, ETS-domain protein (SRF accessory protein 1)	600246	A			1(Elk4)
1.1332	7	18	12	1q32.1	FAM72A, LMPIP, UGENE	P	Family with sequence similarity 72, member A	614710	REc			
1.1333	9	8	11	1q32	GFND1	P	Glomerulopathy with fibronectin deposits 1	137950	Fd	max lod at D1S2782	Glomerulopathy with fibronectin deposits 1 (2)	
1.1334	5	12	11	1q31.3	HF1, CFH, HUS, ARMD4, AHUS1	C	H factor-1 (complement factor H)	134370	F, REa, RE, H, Fd		{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)	1(Cfh)
1.1335	3	10	05	1q32.2	HHAT, MART2, SKI1	C	Hedgehog acyltransferase	605743	REc			
1.1336	2	28	01	1q32.1	IL19	P	Interleukin 19	605687	R			
1.1337	2	7	01	1q32.1	IL20	P	Interleukin 20	605619	R			1(Il20)
1.1338	6	27	01	1q32.1	IL24, ST16, MDA7	C	Interleukin 24 (suppression of tumorigenicity 16)	604136	R			
1.1339	7	22	09	1q32.1	KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A	P	Lysine-specific demethylase 5B	605393	A			
1.1340	10	23	14	1q32.1	KISS1, HH13	C	KISS1 metastasis suppressor	603286	A, R	mutation identified in 1 HH13 family	?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3)	
1.1341	2	12	15	1q32.2	LAMB3, AI1A	P	Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)	150310	Fd		Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Amelogenesis imperfecta, type IA, 104530 (3)	
1.1342	2	4	02	1q32.1	LGR6	P	Leucine-rich repeat-containing G protein-coupled receptor-6	606653	A			
1.1343	11	11	14	1q32.1	LMOD1, SMLMOD, 1D	P	Leiomodin 1	602715	REc			
1.1344	8	17	09	1q32.2	MCP, CD46, AHUS2	C	Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)	120920	REa, A, REn		{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	
1.1345	6	19	98	1q32.1	MDM4	P	Mouse double minute 4, homolog of	602704	A			1(Mdm4)
1.1346	5	29	12	1q32.1	NUAK2, SNARK	P	NUAK family, SNF1-like kinase, 2	608131	A			
1.1347	2	2	10	1q32	PARK16	P	Parkinson disease 16	613164	Fd	associated with rs823128	{Parkinson disease 16} (2)	
1.1348	3	25	15	1q32	PFHB2	P	Progressive familial heart block, type II	140400	Fd	between D1S70 and D1S505	Progressive familial heart block, type II (2)	
1.1349	7	14	98	1q32.1	PIK3C2B	P	Phosphatidylinositol 3-kinase, class 2, beta polypeptide	602838	A			
1.1350	3	6	01	1q32.1	PKP1	C	Plakophilin-1	601975	Psh, A		Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	
1.1351	10	15	97	1q32.1	PRELP	P	Proline arginine-rich end leucine-rich repeat protein	601914	A			
1.1352	1	27	11	1q32-q41	PTPN14, PEZ	C	Protein tyrosine phosphatase, nonreceptor-type, 14	603155	A, REn, Fd		Choanal atresia and lymphedema, 613611 (3)	
1.1353	3	9	00	1q32.1	RAB7L1	P	RAB7-like 1	603949	A			
1.1354	12	18	95	1q32.1	RBBP5, RBQ3	P	Retinoblastoma-binding protein-5	600697	Psh, A			
1.1355	11	3	09	1q32.1	REN, HNFJ2	C	Renin	179820	REa, A, D, Fd, Ch	~24cM distal to AT3	[Hyperproreninemia] (3); Renal tubular dysgenesis, 267430 (3); Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)	1(Ren1)
1.1356	2	14	13	1q32.1	SNRPE, HYPT11	C	Small nuclear ribonucleoprotein polypeptide E	128260	REa, A, F		Hypotrichosis 11, 615059 (3)	
1.1357	5	4	00	1q32.1	SOX13, ICA12	P	SRY-box 13	604748	A			
1.1358	7	6	00	1q32.1	TIMM17A, TIM17A	P	Translocase of inner mitochondrial membrane 17, yeast, homolog of, A	605057	A			
1.1359	7	26	10	1q32.1	TNNT2, CMH2, CMD1D, RCM3, LVNC6	C	Troponin-T2, cardiac	191045	REa, Fd, A		Cardiomyopathy, hypertrophic, 2, 115195 (3); Cardiomyopathy, dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)	
1.1360	2	18	98	1q32.3	TRAF5	P	TNF receptor-associated factor 5	602356	A			1(Traf5)
1.1361	12	21	06	1q31.2	UCHL5, UCH37	P	Ubiquitin carboxyl-terminal hydrolase L5	610667	REc			
1.1362	1	9	13	1q32.2	CAMK1G, CLICK3	P	Calcium/calmodulin-dependent protein kinase IG	614994	REc			
1.1363	3	15	16	1q41	CENPF, CILD31, STROMS	P	Centromere autoantigen F, 400kD	600236	A		Stromme syndrome, 243605 (3)	1(Cenpf)
1.1364	1	30	12	1q32.2	G0S2	P	G0/G1 switch gene 2	614447	REc			
1.1365	5	29	12	1q32.2	HSD11B1, HSD11, HSD11L, CORTRD2	C	Hydroxysteroid, 11-beta, dehydrogenase 1	600713	REa, REc	digenic triallelic mutations with H6PD	Cortisone reductase deficiency 2, 614662 (3)	
1.1366	12	21	12	1q32.2	IRF6, VWS, LPS, PIT, PPS1, OFC6	C	Interferon regulatory factor 6	607199	REc, Fd	OFC6 in enhancer 5' of IRF6	van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome 1, 119500 (3); {Orofacial cleft 6}, 608864 (3)	
1.1367	7	9	15	1q32.2	KCNH1, EAG, TMBTS, ZLS1	P	Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)	603305	Psh		Temple-Baraitser syndrome, 611816 (3); Zimmermann-Laband syndrome 1, 135500 (3)	
1.1368	1	20	99	1q32.1	RABIF, RASGFR3, MSS4	P	Rab-interacting factor (Ras-specific guanine-releasing factor-3; mammalian suppressor of SEC4)	603417	A			
1.1369	4	25	12	1q32.1	ADIPOR1, CGI45	C	Adiponectin receptor 1	607945	REc			1(Adipor1)
1.1370	5	18	95	1q32.1	ADORA1, RDC7	P	Adenosine A1 receptor	102775	A			
1.1371	10	23	15	1q32.1	ARL8A, GIE2	P	ADP-ribosylation factor-like 8A	616597	REc			
1.1372	11	1	13	1q32.1	BLACAT1, LINC00912	P	Bladder cancer-associated transcript 1, noncoding	615480	REc			
1.1373	12	30	14	1q32.1	C1orf186, RHEX	P	Chromosome 1 open reading frame 186	616088	REc			
1.1374	3	24	11	1q32.1	CAMSAP1L, CAMSAP2, KIAA1078	P	Calmodulin-regulated spectrin-associated protein 1-like 1	613775	REc			
1.1375	4	23	08	1q32.1	CHI3L1, GP39, YKL40, ASRT7	C	Chitinase 3-like 1 (cartilage glycoprotein-39)	601525	REa, REc		{Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related traits, susceptibility to, 7}, 611960 (3)	
1.1376	9	9	13	1q32.1	CNTN2, TAX, TAX1, FAME5	C	Contactin 2 (transiently-expressed axonal glycoprotein)	190197	A	1 family identified with mutation	?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	
1.1377	11	11	13	1q32.1	DDX59, OFD5	P	DEAD box polypeptide 59	615464	REc		Orofaciodigital syndrome V, 174300 (3)	
1.1378	8	16	13	1q32.1	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1	P	Dual serine/threonine and tyrosine protein kinase	612666	R, REc, Fd		{Congenital anomalies of kidney and urinary tract, susceptibility to}, 610805 (3)	
1.1379	1	24	10	1q32.1	EIF2D, HCA56	P	Eukaryotic translation initiation factor 2D	613709	REc, H			1(Eif2d)
1.1380	3	20	06	1q32.1	ETNK2, EKI2	P	Ethanolamine kinase 2	609859	REc			1(Etnk2)
1.1381	1	1	95	1q32.1	FMOD	P	Fibromodulin	600245	Psh, A			
1.1382	12	29	00	1q32.1	GAC1	P	Glioma amplification on chromosome 1	605492	A			
1.1383	2	20	98	1q32.1	GPR25	P	G protein-coupled receptor-25	602174	A			
1.1384	2	12	09	1q32.1	IBD23	C	Inflammatory bowel disease 23	612381	Fd	associated with rs3024505	{Inflammatory bowel disease 23} (2)	
1.1385	7	17	09	1q32.1	IKBKE	P	I-kappa-B kinase-epsilon	605048	R, REc			
1.1386	3	29	12	1q32.1	KLHDC8A	P	Kelch domain-containing protein 8A	614503	REc			
1.1387	3	30	12	1q32.1	KLHL12, DKIR	P	Kelch-like 12	614522	REc			
1.1388	2	25	15	1q32.1	LEMD1	P	LEM domain-containing protein 1	610480	R, REc			
1.1389	12	10	13	1q32.1	MAPKAPK2, MK2	P	Mitogen-activated protein kinase-activated protein kinase 2	602006	REc			
1.1390	11	4	93	1q32.1	MYBPH	C	Myosin-binding protein H	160795	A			
1.1391	4	10	14	1q32.1	NFASC, KIAA0756	P	Neurofascin	609145	REc, R			
1.1392	1	28	00	1q32.1	NR5A2, FTF, HB1F	P	Nuclear receptor subfamily 5, group A, member 2 (fetoprotein transcription factor)	604453	A			
1.1393	3	20	08	1q32.1	NUCKS1, NUCKS	P	Nuclear casein kinase and cyclin-dependent kinase substrate 1	611912	REc, H			1(Nucks1)
1.1394	7	27	09	1q32.1	PEPP3, KIAA0969	P	Phosphatidylinositol 3-phosphate-binding PH domain protein 3	607771	R, REc			
1.1395	8	20	01	1q32.1	PPP1R12B, MYPT2	P	Protein phosphatase 1, regulatory subunit 12B (myosin phosphatase target subunit 2)	603768	A			
1.1396	2	16	16	1q32.1	PPP1R15B, CREP, MSSGM2	P	Protein phosphatase 1, regulatory subunit 15B	613257	REc		Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	
1.1397	8	16	12	1q32.1	PPFIA4	P	Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha 4	603145	REc			
1.1398	11	27	94	1q32.1	PTPN7	P	Protein tyrosine phosphatase, nonreceptor-type, 7	176889	A, Ch			
1.1399	1	17	06	1q32.1	SLC45A3, PRST, PCANAP6, IPCA6	P	Solute carrier family 45, member 3 (prostein)	605097	R			
1.1400	4	30	15	1q32.1	SYT2, CMS7, MYSPC	P	Synaptotagmin-2	600104	H, REc		Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3)	1(Syt2)
1.1401	4	2	03	1q32.1	RASSF5, NORE1	P	Ras association (RalGDS/AF-6) domain family 5 (Nore1, mouse, homolog of)	607020	REc			1(Nore1)
1.1402	8	8	13	1q32.1	SLC26A9	P	Solute carrier family 26 (sulfate transporter), member 9	608481	REc			
1.1403	3	14	07	1q32.1	SRGAP2, KIAA0456	P	Slit-robo GTPase-activating protein, rho, 2	606524	R, REc			
1.1404	6	5	08	1q32.1	YOD1, OTUD2, DUBA8	P	YOD1 OTU deubiquitinating enzyme 1, S. cerevisiae, homolog of	612023	REc			
1.1405	12	15	10	1q32.1	ZBED6	P	Zinc finger BED domain-containing protein 6	613512	REc	in intron 1 of ZC3H11A		
1.1406	12	15	10	1q32.1	ZC3H11A, KIAA0663	P	Zinc finger CCCH domain-containing protein 11A	613513	REc			
1.1407	11	30	06	1q32.3	DTL, RAMP, DCAF2, CDT2	P	Denticleless, Drosophila, homolog of	610617	A			
1.1408	6	10	98	1q32.1	RNPEP	P	Arginyl aminopeptidase (aminopeptidase B)	602675	A			
1.1409	10	23	87	1q42.13	GUK1	C	Guanylate kinase-1	139270	S, D			
1.1410	10	23	87	1q32.1-q42	GUK2	C	Guanylate kinase-2	139280	S, D	genetic independence of GUK1 and GUK2 unproved		
1.1411	2	3	05	1q32.1	DYRK3	C	Dual-specificity tyrosine phosphorylation-regulated kinase 3	603497	TM, REc			1(Dyrk3)
1.1412	9	7	10	1q32.1	FAIM3, TOSO, FCMR	C	Fas apoptotic inhibitory molecule 3	606015	R, REn			
1.1413	3	23	09	1q32.2	MIR29C, MIRN29C	P	Micro RNA 29C	610784	REc			
1.1414	12	21	09	1q32.2	MIR205, MIRN205	P	Micro RNA 205	613147	REc			
1.1415	7	27	09	1q32.2	PLXNA2, OCT, PLXN2	P	Plexin A2 (OCT transmembrane protein)	601054	REa, REc			
1.1416	12	17	07	1q32.1	SARG, C1orf116	P	Specifically androgen-regulated gene	611680	REc			
1.1417	9	21	11	1q32.2	SYT14, SCAR11	P	Synaptotagmin 14	610949	REc		Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)	
1.1418	12	20	96	1q32.3	PROX1	P	Prospero-related homeo box 1	601546	REc			(Prox1)
1.1419	12	27	13	1q32.3	NEK2, RP67	C	Never in mitosis gene a-related kinase 2	604043	A, REc	pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family	?Retinitis pigmentosa 67, 615565 (3)	
1.1420	5	25	10	1q32.3	ATF3	P	Activating transcription factor 3	603148	REc			
1.1421	1	30	01	1q32.1	FCAMR	P	Fc fragment of IgA and IgM, receptor for	605484	A			1(Fcamr)
1.1422	3	24	14	1q32.3	INTS7, INT7	P	Integrator complex subunit 7	611350	R, REc			
1.1423	3	4	08	1q32.3	NENF, CIR2	C	Neuron-derived neurotrophic factor	611874	REc			
1.1424	4	3	09	1q32.3	RD3, LCA12, C1orf36	P	Retinal degeneration 3, mouse, homolog of	180040	REc, H		Leber congenital amaurosis 12, 610612 (3)	1(rd3)
1.1425	2	25	08	1q32.3	SLC30A1, ZNT1	P	Solute carrier family 30 (zinc transporter), member 1	609521	REc			
1.1426	2	25	15	1q32.3	VASH2	P	Vasohibin 2	610471	REc			
1.1427	7	22	11	1q32.2	TRAF3IP3, T3JAM	P	TRAF3-interacting protein 3	608255	REc			1(T3jam)
1.1428	10	30	08	1q41	AIDA	P	Axin interactor, dorsalization-associated	612375	REc			
1.1429	7	18	14	1q41	BPNT1	P	3'(2'),5'-bisphosphate nucleotidase 1	604053	REc			
1.1430	9	16	12	1q41	DUSP10, MKP5	P	Dual-specificity phosphatase 10	608867	REc			
1.1431	8	24	98	1q41	ESRRG	P	Estrogen-related receptor, gamma	602969	Psh			
1.1432	3	26	16	1q41	GPATCH2, GPATC2	P	G-patch domain-containing protein 2	616836	REc			
1.1433	5	30	03	1q42.12	H3F3A, H3F3	P	H3 histone, family 3A	601128	REc			
1.1434	12	26	14	1q41	IARS2, CAGSSS	P	Isoleucyl-tRNA synthetase 2	612801	REc	mutation identified in 1 CAGSSS family	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3)	
1.1435	12	29	06	1q32.3	SMYD2	P	SET and MYND domain-containing protein 2	610663	R, REc			
1.1436	11	16	98	1q41	KCNK2, TREK	P	Potassium channel, subfamily K, member 2	603219	R			
1.1437	3	4	10	1q41	KCTD3	P	Potassium channel tetramerization domain-containing protein 3	613272	REc			
1.1438	6	1	12	1q32.3	LINC00538, YIYA	P	Long intergenic noncoding RNA 538	614635	REc			
1.1439	9	21	15	1q41	LYPLAL1	P	Lysophospholipase-like 1	616548	REc			
1.1440	7	17	09	1q41	MARK1, KIAA1477	P	MAP/microtubule affinity-regulating kinase 1	606511	R, REc			
1.1441	3	23	09	1q41	MIR194-1, MIRN194-1	P	Micro RNA 194-1	610940	REc			
1.1442	3	23	09	1q41	MIR215, MIRN215	P	Micro RNA 215	610943	REc			
1.1443	7	27	11	1q41	MOSC1, MARC1	P	Molybdenum cofactor sulfurase C-terminal domain-containing protein 1	614126	REc			
1.1444	7	27	11	1q41	MOSC2, MARC2	P	Molybdenum cofactor sulfurase C-terminal domain-containing protein 2	614127	REc			
1.1445	2	2	16	1q32.3	NSL1, DC8, C1orf48	P	NSL1, MIS12 kinetochore complex component	609174	REc			
1.1446	6	4	97	1q32.3	PPP2R5A	P	Protein phosphatase-2, regulatory subunit B (B56), alpha isoform	601643	A			
1.1447	9	17	11	1q41	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	P	RAB3 GTPase-activating protein (noncatalytic) subunit 2	609275	R, REc, Fd		Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)	
1.1448	4	26	12	1q41	RMD1	C	Rippling muscle disease 1	600332	Fd, REc		Rippling muscle disease-1 (2)	
1.1449	8	19	13	1q41	RRP15	P	Ribosomal RNA-processing 15, S. cerevisiae, homolog of	611193	REc			
1.1450	4	19	12	1q41	SLC30A10, ZNT10, HMDPC	P	Solute carrier family 30 (zinc transporter), member 10	611146	REc		Hypermanganesemia with dystonia, polycythemia, and cirrhosis, 613280 (3)	
1.1451	5	23	07	1q41	SPATA17, MSRG11	P	Spermatogenesis-associated protein 17	611032	REc, H			1(Spata17)
1.1452	7	18	14	1q41	SUSD4	P	Sushi domain-containing protein 4	615827	REc			
1.1453	9	14	12	1q41	TGFB2, LDS4	C	Transforming growth factor, beta-2	190220	REa, A, Fd		Loeys-Dietz syndrome 4, 614816 (3)	1(Tgfb2)
1.1454	12	5	13	1q41	TLR5, TIL3, SLEB1, MELIOS	C	Toll-like receptor-5	603031	A		{Legionaire disease, susceptibility to}, 608556 (3); {Systemic lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3); {Melioidosis, susceptibility to}, 615557 (3)	
1.1455	3	25	16	1q32.1	TMEM9, TMEM9A, DERM4	P	Transmembrane protein 9	616877	REc			
1.1456	12	8	00	1q42.2	TSNAX, TRAX	C	Translin-associated factor X	602964	A, RE, H			8(Tsnax)
1.1457	1	27	04	1q41	USH2A, RP39	C	Usherin	608400	Fd		Usher syndrome, type 2A, 276901 (3); Retinitis pigmentosa 39, 613809 (3)	1(Ush2a)
1.1458	12	21	09	1q41-q42	AUTS11	P	Autism, susceptibility to, 11	610836	Fd	associated with rs12740310, rs3737296, and rs12310279	{Autism susceptibility 11} (2)	
1.1459	9	22	08	1q41	CAPN2	P	Calpain, large polypeptide L2	114230	REa, REb			
1.1460	5	22	07	1q42.13	CDC42BPA, PK428, MRCKA	P	CDC42-binding protein kinase alpha	603412	A			
1.1461	1	31	11	1q41-q42	DEL1q41q42, C1DELq41q42	P	Chromosome 1q41-q42 deletion syndrome	612530	Ch	contiguous gene deletion of 1.7Mb	Chromosome 1q41-q42 deletion syndrome (4)	
1.1462	8	9	99	1q41	EPRS, PARS	C	Glutamyl-prolyl-tRNA synthetase	138295	REa, A			1(Eprs)
1.1463	5	12	99	1q42.13	GALNT2	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2	602274	A			
1.1464	3	21	93	1q41	HLX1	C	H2.0 (Drosophilia)-like homeo box-1	142995	A, Fd			1(Hlx1)
1.1465	4	16	98	1q42.11	NVL	C	Nuclear valosin-containing protein-like	602426	A, REa			
1.1466	10	16	92	1q42.12	ITPKB	P	Inositol 1,4,5-trisphosphate 3-kinase B	147522	A			
1.1467	7	30	15	1q43	CHRM3, PBS, EGBRS	P	Cholinergic receptor, muscarinic, 3	118494	A, REa	mutation identified in 1 PBS family	?Prune belly syndrome, 100100 (3)	
1.1468	1	7	14	1q41-q44	OTSC10	P	Otosclerosis 10	615589	Fd		Otosclerosis 10 (2)	
1.1469	1	29	01	1q42.13	ABCB10, MTABC2	P	ATP-binding cassette, subfamily B, member 10	605454	REc	pseudogene on 15q13-q14		
1.1470	9	12	96	1q42.13	ARF1	P	ADP-ribosylation factor-1	103180	A			
1.1471	10	6	09	1q42	BCC2	P	Basal cell carcinoma, susceptibility to, 2	613058	Fd	associated with rs801114	{Basal cell carcinoma, susceptibility to, 2} (2)	
1.1472	7	17	09	1q42.2	CAPN9	P	Calpain 9	606401	R, REc			
1.1473	3	3	03	1q41	DISPA	P	Dispatched, Drosophila, homolog of, A	607502	R			
1.1474	2	21	06	1q42.12	DNAH14, HL18	P	Dynein, axonemal, heavy chain 14	603341	REc			
1.1475	12	16	05	1q42	EA3	P	Episodic ataxia, type 3	606554	Fd	max lod at D1S235	Episodic ataxia, type 3 (2)	
1.1476	1	11	16	1q42.2	GNPAT, DHAPAT, RCDP2	P	Glyceronephosphate O-acyltransferase	602744	TM		Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	
1.1477	1	14	13	1q42.13	HIST3H2A	P	Histone gene cluster 3, H2A histone	615015	REc			
1.1478	1	31	13	1q42.13	HIST3H2BB, H2Bb	P	Histone gene cluster 3, H2B histone family, member B	615046	REc			
1.1479	3	11	03	1q42.13	HIST3H3, H3FT, H3T	P	Histone 3, H3	602820	REa, A			
1.1480	8	8	91	1q42	HRES1	P	HTLV-1 related endogenous sequence	143025	REa, A			
1.1481	4	10	00	1q42	MDC1B	P	Muscular dystrophy, congenital, 1B	604801	Fd		Muscular dystrophy, congenital, 1B (2)	
1.1482	9	7	10	1q41	MIA3, TANGO1, TANGO, KIAA0268	C	Melanoma inhibitory activity family, member 3	613455	REc, R			
1.1483	9	2	12	1q42.2	MLK4, KIAA1804	C	Mixed-lineage kinase 4	614793	REc			
1.1484	11	19	13	1q42.12	PARP1, ADPRT, PPOL, PARP	C	Poly(ADP-ribose) polymerase 1	173870	REa, A	?processed pseudogenes on chr.13 and 14		
1.1485	6	8	89	1q42	PEPC	C	Peptidase C	170000	S, R, Fd	1q25, 1q32 = conflicting localizations		1(Pep3)
1.1486	4	4	07	1q42.13	RHOU, WRCH1	P	Ras homolog gene family, member U	606366	R			
1.1487	7	20	01	1q42.13	RNF16	P	RING finger protein-16	606123	REa, R			11(Rnf16)
1.1488	2	1	01	1q41	TAF1A, RAFI48, SL1	C	TATA box-binding protein-associated factor 1A	604903	R, A			
1.1489	5	26	13	1q42.2	TRIM67	P	Tripartite motif-containing protein 67	610584	REc			
1.1490	2	17	15	1q42.13	WNT3A	P	Wingless-type MMTV integration site family, member 3A	606359	A			
1.1491	10	10	01	1q42.13	WNT14	C	Wingless-type MMTV integration site family, member 14	602863	REc, A			
1.1492	4	20	15	1q43	ACTN2, CMD1AA, CMH23	C	Actinin, alpha-2	102573	REa, A, Fd		Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3); Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3)	13(Actn2)
1.1493	10	4	05	1q42.2	AGT, SERPINA8	C	Angiotensinogen	106150	A, REa		{Hypertension, essential, susceptibility to}, 145500 (3); {Preeclampsia, susceptibility to} (3); Renal tubular dysgenesis, 267430 (3)	8(Agt)
1.1494	12	26	14	1q42.2	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	C	Egl9, C. elegans, homolog of, 1	606425	R, REc, A		Erythrocytosis, familial, 3, 609820 (3); [Hemoglobin, high altitude adaptation], 609070 (3)	
1.1495	7	17	01	1q43	EXO1, HEX1	P	Exonuclease 1, S. cerevisiae, homolog of	606063	A			
1.1496	7	1	97	1q42.2	KCNK1, TWIK1	P	Potassium channel, subfamily K, member 1	601745	A			
1.1497	4	18	05	1q43	LGALS8, PCTA1	P	Lectin, galactoside-binding, soluble, 8	606099	R			
1.1498	10	12	90	1q42.13	RAB4A, RAB4	P	Ras-associated protein RAB4A	179511	A			1(Rab4a)
1.1499	10	19	15	1q42.3	TBCE, KCS, KCS1, HRD	C	Tubulin-specific chaperone E	604934	Fd		Kenny-Caffey syndrome, type 1, 244460 (3); Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	
1.1500	5	4	00	1q42.3	TM7SF1	P	Transmembrane 7 superfamily, member 1	604658	REa, A			
1.1501	7	17	09	1q42.12	ACBD3, GOCAP1, GOLPH1, GCP60	P	Acyl-Coenzyme A binding domain containing 3	606809	R, REc			
1.1502	3	11	16	1q42.13	ACTA1, ASMA, NEM3, CFTD1, SHPM	C	Actin, alpha-1, skeletal muscle	102610	REa, H, A	mutation identified in 1 SHPM family	Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3); Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores, 161800 (3); Myopathy, congenital, with fiber-type disproportion 1, 255310 (3); ?Myopathy, scapulohumeroperoneal, 616852 (3)	8(Actsk1)
1.1503	5	12	06	1q42.2	DISC1, SCZD9	C	Disrupted in schizophrenia 1	605210	Ch, H, RE		{Schizophrenia, susceptibility to}, 604906 (3); {Schizoaffective disorder, susceptibility to}, 181500 (3)	8(Disc1)
1.1504	9	20	01	1q42.2	DISC2	P	Disrupted in schizophrenia 2	606271	Ch	noncoding antisense RAN	Schizophrenia, 181500 (2)	
1.1505	4	21	99	1q42.12	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	C	Transforming growth factor, beta-4 (endometrial bleeding-associated factor)	601877	A		Left-right axis malformations (3)	1(lefty2)
1.1506	6	8	05	1q42.12	EPHX1	C	Epoxide hydroxylase 1, microsomal xenobiotic	132810	REa, A		?Fetal hydantoin syndrome (1); Diphenylhydantoin toxicity (1); Hypercholanemia, familial, 607748 (3); {Preeclampsia, susceptibility to}, 189800 (3)	1(Eph1)
1.1507	8	16	11	1q43	FH, HLRCC, MCUL1, FMRD	C	Fumarate hydratase	136850	S, R, D, Psh		Fumarase deficiency, 606812 (3); Leiomyomatosis and renal cell cancer, 150800 (3)	
1.1508	2	25	14	1q42.12	LBR, PHA	C	Lamin B receptor	600024	A, Fd		Pelger-Huet anomaly, 169400 (3); Greenberg skeletal dysplasia, 215140 (3); ?Reynolds syndrome, 613471 (3)	
1.1509	4	21	99	1q42.12	LEFTB, LEFTY1	P	Left-right determination, factor B	603037	REn			1(lefty1)
1.1510	3	20	06	1q42.12	MIXL1, MIXL, MIX	C	MIX1 homeobox-like protein 1	609852	R, A, H			1(Mixl1)
1.1511	6	4	98	1q41	TP53BP2, ASPP2	P	Tumor protein p53-binding protein-2	602143	A			
1.1512	12	28	08	1q42.3	ARID4B, SAP180, RBP1L1, RBBP1L1, BRCAA1	P	AT-rich interactive domain-containing protein 4B	609696	REc, A			
1.1513	7	20	06	1q43	RYR2, VTSIP, ARVD2, ARVC2	C	Ryanodine receptor-2 (cardiac)	180902	REa, A, Fd		Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	13(Ryr2)
1.1514	7	18	14	1q42.11	DEGS1, DES1, MLD	P	Delta(4)-desaturase, sphingolipid, 1	615843	REc			
1.1515	10	15	91	1q42.11-q42.13	RN5S1@	C	RNA, 5S cluster 1	180420	A	25-30% at 1q31 (RN5S3@)		
1.1516	9	9	08	1q42.11	FBXO28, FBX28, KIAA0483	P	F-box only protein 28	609100	REc			1(Fbxo28)
1.1517	8	18	14	1q42.12	SRP9, ALURBP	P	Signal recognition particle, 9-kD	600707	REc			
1.1518	1	20	16	1q42.13	CCSAP, CSAP, C1orf96	P	Centriole-, cilia-, and spindle-associated protein	616762	REc			
1.1519	6	13	12	1q42.12	ENAH, ENA, MENA, NDPP1	P	Enabled, Drosophila, homolog of	609061	REc			1(Enah)
1.1520	3	7	14	1q42.13	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	C	Gap junction protein, gamma-2 (47kD)	608803	REc		Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic paraplegia 44, autosomal recessive, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)	
1.1521	7	7	15	1q42.13	IBA57, C1orf69, MMDS3, SPG74	P	IBA57, S. cerevisiae, homolog of	615316	REc	mutation identified in 1 MMDS3 family and 1 SPG74 family	?Multiple mitochondrial dysfunctions syndrome 3, 615330 (3); ?Spastic paraplegia 74, autosomal recessive, 616451 (3)	
1.1522	3	11	08	1q42.13	MRPL55	P	Mitochondrial ribosomal protein L55	611859	REc			
1.1523	7	17	09	1q42.13	NUP133	P	Nucleoporin, 133kD	607613	R, REc			
1.1524	2	4	16	1q42.13	PGBD5	P	Piggybac transposable element-derived 5	616791	REc			
1.1525	6	19	15	1q42.12	PYCR2, HLD10	P	Pyrroline-5-carboxylate reductase 2	616406	REc		Leukodystrophy, hypomyelinating, 10, 616420 (3)	
1.1526	2	22	11	1q42.13	RNF186, RACO1	P	Ring finger protein 187	613754	REc			
1.1527	1	31	15	1q42.13	TRIM11	P	Tripartite motif-containing protein 11	607868	R, REc			
1.1528	12	30	14	1q42.13	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	C	AARF domain-containing kinase 3	606980	R, REc, Fd		Coenzyme Q10 deficiency, primary, 4, 612016 (3)	
1.1529	12	18	07	1q42.2	ARV1	P	ARV1, S. cerevisiae, homolog of	611647	R, REc			
1.1530	7	31	15	1q42.2	COA6, C1orf31, CEMCOX4	P	Cytochrome c oxidase assembly factor 6	614772	REc		Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3)	
1.1531	7	17	09	1q42.2	COG2, LDLC	P	Component of oligomeric golgi complex 2	606974	R, REc			
1.1532	7	1	13	1q42.2	EXOC8, EXO84, SEC84	P	Exocyst complex component 8	615283	REc			
1.1533	2	19	08	1q42.2	SIPA1L2, KIAA1389	P	SIPA1-like protein 2	611609	R, REc			
1.1534	2	4	15	1q42.2	SPRTN, DVC1, C1orf124, RJALS	P	SprT-like N-terminal domain protein	616086	REc		Ruijs-Aalfs syndrome, 616200 (3)	
1.1535	10	10	14	1q42-q43	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	C	EDAR-associated death domain	606603	REc		Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3); Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	13(Edaradd)
1.1536	10	8	98	1q42.2-q43	PCAP	P	Predisposing for prostate cancer	602759	Fd		{Prostate cancer, susceptibility to}, 176807 (2)	
1.1537	1	5	07	1q42.2-q43	SHFL1, SHFLD	P	Split-hand/foot malformation with long bone deficiency 1	119100	Fd	between rs1124110 and rs535043	Split-hand/foot malformation with long bone deficiency 1 (2)	
1.1538	10	7	13	1q42.3	ERO1LB	P	Endoplasmic reticulum oxidoreduction 1-like beta	615437	REc			13(Ero1l)
1.1539	4	23	13	1q42.3	B3GALNT2, MGC39558, MDDGA11	P	Beta-1,3-N-acetylgalactosaminyltransferase 2	610194	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3)	
1.1540	5	25	13	1q42.3	GNG4	P	Guanine nucleotide-binding protein, gamma 4	604388	REc			
1.1541	7	23	13	1q42.3	IRF2BP2	P	Interferon regulatory factor 2-binding protein 2	615332	REc			
1.1542	1	30	15	1q42.3	LYST, CHS1	C	Lysosomal trafficking regulator	606897	Fd		Chediak-Higashi syndrome, 214500 (3)	13(Lyst, bg)
1.1543	9	18	08	1q42.2	TARBP1, TRP185	P	TAR RNA-binding protein 1	605052	R, REc			
1.1544	3	23	14	1q43	BECN2, BECN1L1	P	Beclin 2	615687	REc, H			1(Becn2)
1.1545	2	21	02	1q43	CHML, REP2	C	Choroideremia-like	118825	REa, REc			
1.1546	2	4	15	1q43	FMN2, MRT47	P	Formin 2	606373	H, REc		Mental retardation, autosomal recessive 47, 616193 (3)	1(Fmn2)
1.1547	5	28	02	1q42.3	GGPS1, GGPPS1	P	Geranylgeranyl diphosphate synthase 1	606982	A			
1.1548	9	12	08	1q43	GREM2, PRDC	P	Gremlin 2 homolog, cystine knot superfamily	608832	REc			
1.1549	2	21	02	1q43	KMO	P	Kynurenine 3-monooxygenase	603538	REc			
1.1550	7	12	13	1q43	MTR, HMAG	C	5-methyltetrahydrofolate-homocysteine methyltransferase 1	156570	S, A		Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	13(Mtr)
1.1551	6	8	89	1q42.3	NID	P	Nidogen	131390	A			
1.1552	2	18	02	1q43	OPN3, ECPN	P	Opsin 3	606695	Psh, A			
1.1553	4	20	11	1q43	RGS7	C	Regulator of G protein signaling 7	602517	REc			1(Rgs7)
1.1554	12	15	10	1q43	ZP4, ZPB	P	Zona pellucida glycoprotein 4	613514	REc			
1.1555	12	4	08	1q43-q44	DFNB45	P	Deafness, autosomal recessive 45	612433	Fd	between D1S547 and D1S2836	Deafness, autosomal recessive 45 (2)	
1.1556	10	16	14	1q43-q44	SDCCAG8, CCCAP, SLSN7, BBS16	P	Serologically defined colon cancer antigen 8	613524	REc		Senior-Loken syndrome 7, 613615 (3); Bardet-Biedl syndrome 16, 615993 (3)	
1.1557	3	15	07	1q44	AHCTF1, ELYS	P	AT hook containing transcription factor 1	610853	REc			
1.1558	8	22	14	1q43-q44	AKT3, PKBG, MPPH2	P	v-Akt murine thymoma viral oncogene homolog 3	611223	A		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	1(Akt3)
1.1559	9	21	09	1q43	CEP170, KIAA0470	P	Centrosomal protein, 170kD	613023	R, REc			
1.1560	9	7	10	1q44	CNST	P	Consortin	613439	REc			
1.1561	2	21	14	1q44	COX20, FAM36A	P	Cytochrome c oxidase 20, S. cerevisiae, homolog of	614698	REc		Mitochondrial complex IV deficiency, 220110 (3)	
1.1562	7	20	12	1q44	DESI2, PPPDE1	P	Desumoylating isopeptidase 2	614638	REc			
1.1563	4	13	15	1q44	HNRNPU, HNRPU, SAFA	P	Heterogeneous nuclear ribonucleoprotein U	602869	REc			
1.1564	9	8	11	1q44	KIF26B	P	Kinesin family member 26B	614026	REc			
1.1565	12	4	14	1q44	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	C	NLR family, pyrin domain containing 3	606416	REn, Fd		Familial cold-induced inflammatory syndrome 1, 120100 (3); Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)	
1.1566	1	5	16	1q44	OR2W3	P	Olfactory receptor family 2 subfamily W member 3	616729	REc			
1.1567	12	17	07	1q44	OR13G1	P	Olfactory receptor, family 13, subfamily G, member 1	611677	REc			
1.1568	6	27	14	1q44	SMYD3	P	SET and MYND domain-containing protein 3	608783	REc			
1.1569	11	11	14	1q44	TFB2M	P	Transcription factor B2, mitochondrial	607055	R, REc			
1.1570	3	23	93	1q44	ZNF124	P	Zinc finger protein-124 (HZF-16)	194631	A			
1.1571	5	12	15	1q44	ZNF695, SBZF3	P	Zinc finger protein 695	616348	REc			
1.1572	11	22	13	1q44	ZBTB18, ZNF238, RP58, MRD22	C	Zinc finger and BTB domain containing 18	608433	A, REc, Psh	mutation identified in 1 family	?Mental retardation, autosomal dominant 22, 612337 (3)	
1.1573	4	19	11	1q44	ZNF496, NIZP1, ZFP496	P	Zinc finger protein 496	613911	REc			11(Znf496)
1.1574	11	3	11	Chr.1	SPGF2, ASG	P	Spermatogenic failure 2	108420	Ch	inversion of chromosome 1	Spermatogenic failure 2 (2)	
2.1	7	22	13	2pter-p24	CTRCT29	P	Cataract 29, coralliform	115800	Fd	between D2S297 and D2S2269	Cataract 29, coralliform (2)	
2.2	6	14	10	2p25.3	ADI1, SIPL	P	Acireductone dioxygenase 1	613400	REc			
2.3	5	4	12	2p25.3	COLEC11, CLK1, 3MC2	P	Collectin 11	612502	REc		3MC syndrome 2, 265050 (3)	
2.4	4	2	16	2p25.3	FAM110C	P	Family with sequence similarity 110, member C	611395	REc			
2.5	7	29	14	2p25.3	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA	C	Peroxidasin, Drosophila, homolog of	605158	REa, R, A		Corneal opacification and other ocular anomalies, 269400 (3)	
2.6	2	19	10	2p25.3	TMEM18	P	Transmembrane protein 18	613220	REc			
2.7	8	31	12	2p25.3	TRAPPC12, TTC15	P	Trafficking protein particle complex, subunit 12	614139	REc			
2.8	2	12	08	2p25.2	CMPK2	P	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial	611787	REc			
2.9	8	27	09	2p25.1	ITGB1BP1, ICAP1, ICAP1A, ICAP1B	P	Integrin cytoplasmic domain-associated protein 1 beta	607153	R, REc			
2.10	12	28	08	2p25.2	RSAD2, VIPERIN	P	Radical S-adenosyl methionine domain containing 2	607810	R, REc			
2.11	11	4	04	2p25.3	TSSC1	C	Tumor-suppressing subtransferable fragment candidate gene 1	608998	REc, H	previously assigned to 11p15.5		12(Tssc1)
2.12	12	23	05	2p25.1	GRHL1, LBP32, MGR	P	Grainyhead-like 1	609786	R, REc			
2.13	1	22	08	2p25.1	GREB1	P	GREB1 protein	611736	R, REc			
2.14	7	17	09	2p25.1	HPCAL1	P	Hippocalcin-like 1	600207	REa, REc			
2.15	6	22	14	2p25.1	KIDINS220, ARMS	P	Kinase D-interacting substrate, 220kD	615759	REc			
2.16	10	13	09	2p25.1	MBOAT2, LPCAT4	P	Membrane-bound O-acyltransferase domain-containing 2	611949	R, REc			
2.17	2	4	15	2p25.1	NOL10, PQBP5	P	Nucleolar protein 10	616197	REc			
2.18	8	6	13	2p25.1	NTSR2	P	Neurotensin receptor 2	605538	REc			
2.19	6	12	12	2p25.1	TYHAQ	P	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta isoform	609009	REa, REc	pseudogene on chr.22		
2.20	3	14	06	2p25.1-p24.3	DFNB47	P	Deafness, neurosensory, autosomal recessive 47	609946	Fd	max lod at D2S1400 and D2S262	Deafness, neurosensory, autosomal recessive 47 (2)	
2.21	7	7	89	2p25.3	ACP1	C	Acid phosphatase 1, soluble	171500	D, S, A			12(Acp1)
2.22	11	3	14	2p25.1	ADAM17, TACE, NISBD1	P	A disintegrin and metalloproteinase domain 17	603639	R	mutation identified in 1 NISBD1 family	?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3)	12(Tace)
2.23	12	18	08	2p25	ALLC	P	Allantoicase	612396	Psh, REc	nonfunctional in humans		
2.24	1	15	96	2p25.1	ID2	P	Inhibitor of DNA binding 2, dominant negative	600386	REa, A			
2.25	8	27	09	2p23.3	ITSN2, SH3D1B, SWAP, KIAA1256	P	Intersectin 2	604464	REc			
2.26	5	21	99	2p25.1	KCNF1, KH1	P	Potassium voltage-gated channel, subfamily F, member 1	603787	A			
2.27	2	13	14	2p25.1	KLF11, TIEG2, FKLF1, FKLF, MODY7	P	Kruppel-like factor 11	603301	Psh		Maturity-onset diabetes of the young, type VII, 610508 (3)	12(Klf11)
2.28	5	27	05	2p25.1	ODC1	C	Ornithine decarboxylase-1	165640	REa, A	pseudogene ODCP on 7q31-qter	{Colonic adenoma recurrence, reduced risk of}, 114500 (3)	12(Odc)
2.29	10	11	05	2p25	PEE2	P	Preeclampsia/eclampsia 2	609402	Fd		Preeclampsia/eclampsia 2 (2)	
2.30	7	29	15	2p25.3	RNASEH1, PEOB2	C	Ribonuclease H1	604123	Psh	pseudogenes on chr. 17 and chr.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3)	12(Rnaseh1)
2.31	2	4	09	2p25.3	RPS7, DBA8	C	Ribosomal protein S7	603658	A		Diamond-Blackfan anemia 8, 612563 (3)	
2.32	7	17	14	2p25.2	SOX11, MRD27	P	SRY (sex-determining region Y)-box 11	600898	A		Mental retardation, autosomal dominant, 27, 615866 (3)	
2.33	2	1	01	2p25.1	RAF1B, RAFI63, SL1	C	TATA box-binding protein-associated factor 1B	604904	R, A			
2.34	7	11	11	2p23.3	SAP14, SF3B14, P14	P	Spliceosome-associated protein, 14kD	607835	REc			
2.35	5	12	09	2p23.3	SUPT7L, SUPT7H, SPT7l, KIAA0764, STAF65G	P	Suppressor of TY 7-like	612762	R, REc			
2.36	9	29	09	2p25.3	TPO, TPX, TDH2A	C	Thyroid peroxidase	606765	REa, A, Fd		Thyroid dyshormonogenesis 2A, 274500 (3)	12(Tpo)
2.37	5	19	06	2p25-p22	ETM2, ETM	P	Tremor, hereditary essential, 2	602134	Fd	max lod at D2S272	Tremor, hereditary essential, 2 (2)	
2.38	6	10	03	2p25-p24	HYT3	P	Hypertension, essential, susceptibility to, 3	607329	Fd		{Hypertension, essential, susceptibility to, 3}, 145500 (2)	
2.39	8	22	07	2p25.1	PDIA6, ERP5	P	Protein disulfide isomerase, family A, member 6	611099	A			
2.40	4	10	90	2p25.1	RRM2	P	Ribonucleotide reductase, M2 polypeptide	180390	REa, A	pseudogenes on 1p, 1q, Xp		12(Rrm2)
2.41	7	27	09	2p25-p12	PPKP3	L	Keratoderma, palmoplantar, punctate type III	101850	Fd	max lod at ACP1 and IGKC	?Keratoderma, palmoplantar, punctate type 3 (2)	
2.42	4	6	15	2p24.3	FAM84A, NSE1	P	Family with sequence similarity 84, member A	611234	R, REc			
2.43	12	30	14	2p24.3	GACAT3, LINC01458	P	Gastric cancer-associated transcript 3, noncoding	616132	REc			
2.44	9	20	14	2p24.3	MYCNUT	P	MYCN upstream transcript, noncoding	615968	REc			
2.45	12	24	08	2p24.2	GEN1	P	GEN1, Drosophila, homolog of	612449	REc			
2.46	8	29	08	2p24.2	MSGN1	P	Mesogenin 1	612209	REc			
2.47	5	24	13	2p24.2	NT5C1B, CN1B, AIRP	P	5'-nucleotidase, cytosolic, Ib	610526	REc, R			
2.48	2	9	16	2p24.2	RDH14, SDR7C4, PAN2	P	Retinol dehydrogenase 14	616796	REc			
2.49	10	4	05	2p24.2	SMC6L1, SMC6	P	Structural maintenance of chromosomes 6-like 1	609387	R, REc			
2.50	5	19	06	2p24.1	HS1BP3, FLJ14249, ETM2	C	HS1-binding protein 3	609359	REc			
2.51	7	21	11	2p24.3	MYCN, NMYC, ODED, MODED	C	Oncogene NMYC	164840	REa, A, Fd	proximal to APOB	Feingold syndrome, 164280 (3)	12(Nmyc1)
2.52	8	27	09	2p24.3	MYCNOS, NCYM	P	Oncogene NCYM, opposite strand	605374	R, REc			
2.53	8	3	12	2p24.1	RHOB, ARHB, ARH6, RHOH6	P	RAS homolog gene family, member B (oncogene RHO H6)	165370	REa, A			
2.54	6	29	94	2p24.1	SDC1	C	Syndecan 1	186355	REa, H	close to NMYC in mouse		12(Synd1)
2.55	2	11	14	2p24.1	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	P	WD repeat-containing protein 35	613602	REc		Cranioectodermal dysplasia 2, 613610 (3); Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	
2.56	11	1	10	2p23.3	ZNF513, RP58	P	Zinc finger protein 513	613598	REc		Retinitis pigmentosa 58, 613617 (3)	
2.57	8	2	13	2p24.1-p23.3	ATAD2B, KIAA1240	P	ATPase family, AAA domain-containing, member 2B	615347	R, REc			
2.58	7	8	10	2p23.2	C2orf71	P	Chromosome 2 open reading frame 71	613425	REc		Retinitis pigmentosa 54, 613428 (3)	
2.59	12	9	13	2p24.1	APOB, FLDB, LDLCQ4	C	Apolipoprotein B (including Ag(x) antigen)	107730	REa, A	1 gene for liver apo-B100 and gut apo-B48; Ag linked	Hypobetalipoproteinemia, 615558 (3); Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)	12(Apob)
2.60	3	8	07	2p24-p22	CLQTL2	P	Cholesterol level quantitative trait locus 2	610760	Fd	max lod at D2S1360	[Cholesterol level QTL 2] (2)	
2.61	5	24	01	2p25.1	DDEF2, PAP	C	Development- and differentiation-enhancing factor 2	603817	R			
2.62	5	13	96	2p24.3	DDX1	P	DEAD/H box-1	601257				
2.63	1	3	06	2p24	GEFSP4	P	Generalized epilepsy with febrile seizures plus, type 4	609800	Fd	max lod at D2S305	Epilepsy, generalized, with febrile seizures plus, type 4 (2)	
2.64	6	15	99	2p24.2	KCNS3, KV9.3	P	Potassium voltate-gated channel, delayed-rectifier, subfamily S, member 3	603888	REc			
2.65	2	23	05	2p24	KTCN4	P	Keratoconus 4	609271	Fd	between D2S305 and D2S2373	Keratoconus 4 (2)	
2.66	9	1	15	2p25.3	MYT1L, KIAA1106, MRD39	P	Myelin transcription factor 1-like	613084	Psh, H		Mental retardation, autosomal dominant 39, 616521 (3)	12(Myt1l)
2.67	9	7	04	2p24.1	ODD, OSR1	P	ODD-skipped, Drosophila, homolog of	608891	REc			
2.68	3	9	00	2p25.1	ROCK2	P	RHO-associated coiled-coil-containing protein kinase 2	604002	R, A			
2.69	6	9	06	2p11.2	VPS24, CHMP3, NEDF	P	Vacuolar protein sorting 24, yeast, homolog of	610052	R, REc			
2.70	7	17	01	2p24.1	GDF7	P	Growth/differentiation factor 7	604651	A			
2.71	4	15	09	2p24.1	MATN3, EDM5, HOA, OS2	C	Matrilin 3	602109	A, Fd		Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis susceptibility 2}, 140600 (3); Spondyloepimetaphyseal dysplasia, 608728 (3)	12(Matn3)
2.72	7	29	15	2p24.3	NBAS, NAG, SOPH, ILFS2	P	Neuroblastoma-amplified sequence	608025	A		Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3); Infantile liver failure syndrome 2, 616483 (3)	
2.73	10	13	05	2p23.3	TCF23	P	Transcription factor 23	609635	REc			5(Tcf23)
2.74	1	11	95	2p23.3	ADCY3	C	Adenylate cyclase-3	600291	REa, A			
2.75	6	3	98	2p23.3	CENPA	C	Centromere protein A, 17kD	117139	R, Psh			5(Cenpa)
2.76	8	29	08	2p23.3	ABHD1, LABH1	P	Abhydrolase domain-containing 1	612195	REc			5(Abhd1)
2.77	8	3	14	2p23.3	AGBL5, CCP5	P	AATP/GTP-binding protein-like 5	615900	REc			
2.78	9	2	09	2p23.3	ASXL2, KIAA1685	P	Additional sex combs-like 2	612991	REc			
2.79	2	25	15	2p23.3	C2orf44, WDCP	P	WD repeat- and coiled-coil-containing protein	616234	REc			
2.80	10	08	07	2p23.3	CENPO	P	Centromeric protein O	611504	R, REc			
2.81	7	14	14	2p23.3	CGREF1, CGR11	P	Cell growth regulator with EF-hand domain 1	606137	REc			
2.82	5	23	11	2p23.3	DNAJC5G	P	DNAJ/HSP40 homolog, subfamily C, member 5, gamma	613946	REc			
2.83	8	17	10	2p23.3	DNAJC27, RBJ	P	DNAJ/HSP40 homolog, subfamily, C, member 27	613527	REc			
2.84	1	27	04	2p23.3	DPYSL5, CRMP5, CRAM	P	Dihydropyrimidinase-like 5	608383	R, REc			5(Dpysl5)
2.85	7	12	13	2p23.3	DRC1, CCDC164, C2orf39, CILD21	P	Dynein regulatory complex, subunit 1, Chlamydomonas, homolog of	615288	REc		Ciliary dyskinesia, primary, 21, 615294 (3)	
2.86	2	9	16	2p23.3	EFR3B, KIAA0953	P	Efr3, S. cerevisiae, homolog of, B	616797	R, REc			
2.87	10	29	03	2p23.3	EIF2B4	P	Eukaryotic translation initiation factor 2B, subunit 4	606687	R		Leukoencephaly with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
2.88	8	27	09	2p23.3	FKBP1B, PKBP1L	P	FK506-binding protein 1B	600620	R, REc			
2.89	3	20	08	2p23.3	FNDC4, FRCP1	P	Fibrinectin type III domain-containing protein 4	611905	R, REc, H			5(Fndc4)
2.90	5	29	15	2p23.3	IFT172, SLB, KIAA1179, SRTD10, RP71	P	Intraflagellar transport 172, Chlamydomonas, homolog of	607386	R, REc		Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3); Retinitis pigmentosa 71, 616394 (3)	
2.91	1	7	09	2p23.3	POMC	C	Proopiomelanocortin (adrenocorticotropin/beta-lipotropin)	176830	REa, A		Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3); {Obesity, early-onset, susceptibility to}, 601665 (3)	12(Pomc1)
2.92	10	12	14	2p23.3	PPM1G, PP2CG	P	Protein phosphatase, magnesium/manganese-dependent, 1G	605119	REc			
2.93	3	31	09	2p23.3	RAB10	P	Ras-associated protein	612672	REc			
2.94	7	18	14	2p23.3	SLC5A6, SMVT	P	Solute carrier family 5 (sodium dependent vitamin transporter), member 6	604024	REc			
2.95	2	25	08	2p23.3	SLC30A3, ZNT3	P	Solute carrier family 30 (zinc transporter), member 3	602878	REc			5(Slc30a3)
2.96	4	6	15	2p23.3	TMEM214	P	Transmembrane protein 214	615301	REc			
2.97	8	3	12	2p23.3	TP53I3, PIG3	P	Tumor protein p53-inducible protein 3	605171	REc			
2.98	8	13	15	2p23.3	TRIM54, RNF30, MURF3	P	Tripartite motif containing 54	606474	R, REc			
2.99	10	13	09	2p23.3	XAB1, MBDIN	P	XPA-binding protein	611479	REc			
2.100	8	27	09	2p23.3	EMILIN1, EMILIN	P	Elastin microfibril interfacer 1	130660	REc			
2.101	11	1	10	2p23.3	GCKR, GKRP, FGQTL5	C	Glucokinase (hexokinase 4) regulatory protein	600842	A, Fd, REc		[Fasting plasma glucose level QTL 5], 613463 (3)	
2.102	6	23	11	2p23.3	KHK	P	Ketohexokinase (fructokinase)	614058	A, Fd, REc, Psh		[Fructosuria], 229800 (3)	
2.103	8	27	09	2p23.3	SLC4A1AP	P	Solute carrier family 4 (anion exchanger), member 1, adaptor protein	602655	REc			
2.104	8	27	01	2p23.3	MAPRE3, EB3, RP3, EBF3	C	Microtubule-associated protein, RP/EB family, member 3	605788	A, R			
2.105	3	14	06	2p23.3-p22.3	GINGF3, HGF3, GGF3	P	Fibromatosis, gingival, 3	609955	Fd	between D2S2221 and D2S1788	Fibromatosis, gingival, 3 (2)	
2.106	10	13	13	2p23.2	BRE, BRCC4, BRCC45	P	Brain and reproductive organ-expressed protein	610497	REc, R			
2.107	8	31	11	2p23.2	FOSL2	P	FOS-like antigen-2	601575	A			
2.108	1	27	04	2p23.1	GALNT14	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14	608225	REc			
2.109	6	16	06	2p23.2	PLB1, PLB, FLJ30866	P	Phospholipase B1	610179	R, REc			
2.110	9	10	07	2p23.2	RBKS	P	Ribokinase	611132	REc			
2.111	9	8	11	2p23.2	SPDYA, SPY1, RINGOA	P	Speedy, xenopus, homolog of, A	614029	REc			
2.112	2	4	15	2p23.2	WDR43, UTP5, KIAA0007	P	WD repeat-containing protein 43	616195	REc, Psh			
2.113	1	31	08	2p23.1	LBH	P	Limb bud and heart development, mouse, homolog of	611763	R, REc			
2.114	9	28	11	2p23.1	LCLAT1, ALCAT1, AGPAT8	P	Lysocardiolipin acyltransferase 1	614241	REc			17(Lclat1)
2.115	12	28	08	2p23.1	YPEL5	P	Yippee-like 5	609726	REc			17(Ypel5)
2.116	9	24	08	2q32.1	DNAJC10, ERDJ5, JPDI	P	DNAJ/HSP40 homolog, subfamily C, member 10	607987	REc			
2.117	9	22	09	2p23.2-p23.1	ALK, NBLST3	C	Anaplastic lymphoma kinase (Ki-1)	105590	Ch, H		{Neuroblastoma, susceptibility to, 3}, 613014 (3)	17(Alk)
2.118	7	17	14	2p23.3	DNMT3A, TBRS	P	DNA methyltransferase 3A	602769	A		Tatton-Brown-Rahman syndrome, 615879 (3)	
2.119	3	19	08	2p23.3	HADHA, MTPA	C	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit	600890	A		LCHAD deficiency, 609016 (3); Trifunctional protein deficiency, 609015 (3); HELLP syndrome, maternal, of pregnancy, 609016 (3); Fatty liver, acute, of pregnancy, 609016 (3)	
2.120	3	19	08	2p23.3	HADHB	C	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit	143450	A		Trifunctional protein deficiency, 609015 (3)	
2.121	8	2	13	2p23.3	KCNK3, TASK, PPH4	P	Potassium channel, subfamily K, member 3	603220	R		Pulmonary hypertension, primary, 4, 615344 (3)	5(Kcnk3)
2.122	11	20	98	2p23.3	KIF3C	P	Kinesin family member 3C	602845	A			12(Kif3c)
2.123	12	29	99	2p23.3	NCOA1, SRC1	P	Nuclear receptor coactivator 1	602691	A			
2.124	6	18	01	2p23.3	NRBP	P	Nuclear receptor-binding protein	606010	A			
2.125	6	16	95	2p23.2	PPP1CB	P	Protein phosphatase-1, catalytic subunit, beta isoform	600590	REa, A			12(Ppp1cb)
2.126	11	28	01	2p23.3	PREB	P	Prolactin regulatory element-binding protein	606395	A			5(Preb)
2.127	10	21	02	2p23.1	SRD5A2	C	Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2)	607306	REa, A		Pseudovaginal perineoscrotal hypospadias, 264600 (3)	
2.128	8	17	99	2p23.3	DTNB	P	Dystrobrevin, beta	602415	A			12(Dtnb)
2.129	8	4	09	2p23.3	OTOF, DFNB9, NSRD9, AUNB1	C	Otoferlin	603681	Fd, REc	symbolized DFNB6 by authors	Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy, autosomal recessive, 1, 601071 (3)	
2.130	8	17	98	2p22.1	SLC8A1, NCX1	C	Solute carrier family 8, member 1 (sodium-calcium exchanger-1)	182305	REa, A			
2.131	4	18	05	2p23.3	SNX17	P	Sorting nexin 17	605963	R, REc			
2.132	3	18	03	2p23.1	XDH	C	Xanthine dehydrogenase (xanthine oxidase)	607633	REb, A		Xanthinuria, type I, 278300 (3)	17(Xd)
2.133	12	27	10	2p23.3	MPV17, MTDPS6	P	Mpv17 transgene, mouse, glomerulosclerosis, homolog of	137960	REa, A		Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)	5(Mpv17)
2.134	3	18	08	2p23.3	UCN, UROC	P	Urocortin	600945	REa, REc			
2.135	5	16	05	2p22.2-p22.1	ARL3IP2, ATL2	P	ADP-ribosylation-like factor 6-interacting protein 2 (atlastin 2)	609368	REc			
2.136	6	9	08	2p22.3	DPY30	P	DPY30, C. elegans, homolog of	612032	REc			
2.137	7	23	15	2p22.3	MIR558	P	Micro RNA 558	616473	REc	BIRC6 is host gene		
2.138	12	4	14	2p22.3	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	P	NLR family, caspase recruitment domain-containing 4	606831	REc	mutation identified in 1 FCAS4 family	Autoinflammation with infantile enterocolitis, 616050 (3); ?Familial cold autoinflammatory syndrome 4, 616115 (3)	
2.139	4	26	10	2p22.3-p21	CANDF1, CMCT	P	Candidiasis, familial, 1	114580	Fd	between D2S367 and D2S2240	Candidiasis, familial, 1, autosomal dominant (2)	
2.140	7	16	09	2p22.2	CEBPZ, CBF, NOC1	P	CCAAT/enhancer-binding protein, zeta	612828	REc			
2.141	9	23	08	2p22.2	FAM82A1, FAM82A, RMD2	P	Family with sequence similarity 82, member A1	611872	REc			
2.142	7	18	14	2p22.2	FEZ2	P	Fasciculation and elongation protein zeta 2	604826	REc			
2.143	8	1	14	2p22.2	NDUFAF7, MIDA	P	NADH dehydrogenase (ubiquinone) complex I, assembly factor 7	615898	REc			
2.144	8	27	09	2p22.2	QPCT, QC	P	Glutaminyl-peptide cyclotransferase	607065	R, REc			
2.145	9	20	14	2p22.1	GEMIN6	P	GEM-associated protein 6	607006	REc			
2.146	3	31	15	2p22.1	MAP4K3, GLK	P	Mitogen-activated protein kinase kinase kinase kinase 3	604921	REc			
2.147	9	17	11	2p22.1-p21	HNFJ3	P	Hyperuricemic nephropathy, familial juvenile, 3	614227	Fd	between rs372139 and rs896986	Hyperuricemic nephropathy, familial juvenile, 3 (2)	
2.148	5	26	13	2p22.1	HNRNPLL, HNRPLL, SRRF	P	Heterogeneous nuclear ribonucleoprotein L-like	611208	REc			
2.149	3	24	14	2p23.2	MRPL33	P	Mitochondrial ribosomal protein L33	610059	R			
2.150	8	21	12	2p22.2	STRN	P	Striatin, calmodulin-binding protein	614765	REc, A			
2.151	1	7	09	2p22.3	BIRC6, KIAA1289	P	Baculoviral IAP repeat-containing protein-6	605638	R, REc			
2.152	8	28	01	2p22.2	CRIM1	P	Cysteine-rich motor neuron protein 1	606189	R, A			
2.153	10	24	12	2p22.2	CYP1B1, GLC3A	C	Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1	601771	REa, REn, A, Fd		Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3); Peters anomaly, 604229 (3)	
2.154	1	2	03	2p21	EML4, ROPP120	P	Echinoderm microtubule associated protein like-4	607442	R, A			
2.155	2	12	08	2p22.3	MEMO1, MEMO, C2orf4	P	Mediator of cell motility 1	611786	REc			
2.156	1	16	08	2p21-p16	MSH2, COCA1, FCC1, HNPCC1	C	mutS, E. coli, homolog of, 2	609309	Fd, REa, Ch		Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3); Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome, 276300 (3)	
2.157	8	27	09	2p24.1	PUM2, KIAA0235	P	Pumilio, Drosophila, homolog of, 2	607205	REa, REc			
2.158	12	19	11	2p22.1	SRSF7, SFRS7	P	Splicing factor, arginine/serine-rich 7, 35kD	600572	A			
2.159	2	25	08	2p22.3	SLC30A6, ZNT6	P	Solute carrier family 30 (zinc transporter), member 6	611148	REc, H			17(Slc30a6)
2.160	9	28	15	2p22.1	SOS1, GINGF, GF1, HGF, NS4	C	Son of sevenless, Drosophila, homolog of, 1	182530	A, Fd, REc	mutation identified in 1 GINGF1 family	?Fibromatosis, gingival, 1, 135300 (3); Noonan syndrome 4, 610733 (3)	17(Sos1)
2.161	4	27	12	2p22.3	SPAST, SPG4	C	Spastin	604277	Fd		Spastic paraplegia 4, autosomal dominant, 182601 (3)	
2.162	1	28	08	2p22.1	THUMPD2, C2orf8	P	THUMP domain-containing 2	611751	A			
2.163	7	12	92	2p16.3	HTLF	P	Human T-cell leukemia virus enhancer factor	143089	REa, A			
2.164	10	24	14	2p22.1	GALM, GLAT	P	Galactose mutarotase	137030	S			
2.165	12	8	00	2p21	ABCG5	P	ATP-binding cassette, subfamily G, member 5	605459	REc		Sitosterolemia, 210250 (3)	
2.166	1	14	09	2p21	ABCG8, GBD4	P	ATP-binding cassette, subfamily G, member 8	605460	REc		Sitosterolemia, 210250 (3); Gallbladder disease 4, 611465 (3)	
2.167	7	13	15	2p23.3	CAD, CDG1Z	P	CAD trifunctional protein of pyrimidine biosynthesis	114010	REa, A, S, D	mutation identified in 1 CDG1Z family	?Congenital disorder of glycosylation, type Iz, 616457 (3)	
2.168	3	13	15	2p21	CALM2, LQT15	P	Calmodulin-2	114182	Psh, A		Long QT syndrome 15, 616249 (3)	
2.169	6	4	13	2p21	CAMKMT, C2orf34	P	Calmodulin lysine N-methyltransferase	609559	REc			
2.170	8	27	09	2p22.2	CDC42EP3, CEP3, BORG2	P	CDC42 effector protein 3	606133	R, REc			
2.171	8	27	09	2p21	COX7A2L, COX7RP, EB1	P	Cytochrome c oxidase subunit VIIA, polypeptide 2-like	605771	R, REc			
2.172	5	22	14	2p21	CRIPT, SSMDF	P	Cystine-rich PDZ binding protein	604594	REc		Short stature with microcephaly and distinctive facies, 615789 (3)	
2.173	4	21	10	2p21	DEL2p21, C2DELp21	P	Homozygous 2p21 deletion syndrome	606407	Ch	contiguous gene syndrome disrupting SLC3A1 and PREPL genes	Hypotonia-cystinuria syndrome (4)	
2.174	5	2	01	2p23.1	EHD3	P	EH domain-containing 3	605891	R			
2.175	12	19	11	2p21	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	C	Epithelial cellular adhesion molecule	185535	A, REa	previously assigned to 4q	Diarrhea 5, with tufting enteropathy, congenital, 613217 (3); Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	
2.176	9	9	08	2p16.3	FBXO11, FBX11, VIT1, PRMT9	P	F-box only protein 11	607871	REc	?2p16		17(Fbxo11)
2.177	3	25	14	2p21	HAAO	P	3-hydroxyanthranilate 3,4-dioxygenase	604521	REc			
2.178	8	27	09	2p21	KCNG3, KV6.3	C	Potassium voltage-gated channel, subfamily G, member 3	606767	REc			
2.179	10	7	08	2p21	LEPQTL1, LSL	P	Leptin serum levels quantitative trait locus 1	601694	Fd		[Leptin serum levels QTL1] (2)	
2.180	4	9	09	2p16.3	LHCGR, LHR, LCGR	P	Luteinizing hormone/choriogonadotropin receptor	152790	A		Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3); Luteinizing hormone resistance, female, 238320 (3); Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	
2.181	1	22	09	2p25.1	LPIN1	P	Lipin 1	605518	REc	related to LSL	Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)	12(Lpin1)
2.182	9	20	14	2p21	LRPPRC, LRP130, LSFC	C	Leucine-rich PPR motif-containing protein	607544	R, Fd, Ld		Leigh syndrome, French-Canadian type, 220111 (3)	
2.183	8	5	11	2p21	PKDCC, VLK, SGK493	P	Protein kinase domain-containing protein, cytoplasmic, mouse, homolog of	614150	REc			
2.184	4	30	09	2p21	PLEKHH2	P	Pleckstrin homology domain-containing protein, family H, member 2	612723	REc			
2.185	10	19	01	2p21	PPM1B	P	Protein phosphatase, magnesium-dependent, 1, beta isoform	603770	R	formerly PP2CB		
2.186	4	21	10	2p21	PREPL, KIAA0436	C	Prolyl endopeptidase-like	609557	R, REc, D			
2.187	8	4	99	2p21	PRKCE, PKCE	P	Protein kinase C, epsilon	176975	REc			
2.188	7	1	02	2p22.2	PRKCN	P	Protein kinase C, nu	607077	R			
2.189	7	11	93	2p22.2	PRKR	C	Protein kinase, interferon-inducible double stranded RNA dependent	176871	A			17(Prkr)
2.190	8	3	12	2p21	RHOQ, ARHQ, TC10	P	Ras-homolog gene family, member Q	605857	R			
2.191	4	15	11	2p21	SIX3, HPE2	C	Sine oculis homeo box, Drosophila, homolog of, 3	603714	Ch, REc, A, R, Fd		Holoprosencephaly-2, 157170 (3); Schizencephaly, 269160 (3)	17(Six3)
2.192	7	12	02	2p21	SOCS5, CIS6, KIAA0671	P	Suppressor of cytokine signaling 5	607094	A	also signals at 3p22		
2.193	5	1	91	2p16.2	SPTBN1	P	Spectrin, beta, nonerythrocytic-1 (beta-fodrin)	182790	REa, A			
2.194	2	18	08	2p21	THADA, KIAA1767	P	Thyroid adenoma-associated gene	611800	REc			
2.195	5	19	15	2p21	TTC7A, TTC7, KIAA1140, MINAT, GIDID	P	Tetratricopeptide repeat domain 7A	609332	R, REc		Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	17(Ttc7a)
2.196	6	10	08	2p21	ZFP36L2, ERF2, TIS11D	P	Zinc finger protein 36-like 2	612053	REc	incorrectly mapped to 6p21.3		
2.197	1	27	11	2p21	MCFD2, F5F8D2	P	Multiple coagulation factor deficiency protein 2	607788	REc		Factor V and factor VIII, combined deficiency of, 613625 (3)	
2.198	2	11	08	2p21	EPAS1, MOP2, HIF2A, ECYT4	C	Endothelial PAS domain protein 1	603349	A, R		Erythrocytosis, familial, 4, 611783 (3)	
2.199	1	4	11	2p16.3	FSHR, ODG1	C	Follicle stimulating hormone receptor	136435	A, Fd		Ovarian dysgenesis 1, 233300 (3); Ovarian response to FSH stimulation, 276400 (3); Ovarian hyperstimulation syndrome, 608115 (3)	
2.200	2	4	96	2p21	PIGF	P	Phosphatidylinositol glycan, class F	600153	A	pseudogene on 5		17(Pigf)
2.201	8	25	04	2p21-p13	SCA25	P	Spinocerebellar ataxia 25	608703	Fd		Spinocerebellar ataxia 25 (2)	
2.202	3	7	14	2p21-p12	DFNA58	P	Deafness, autosomal dominant 58	615654	Fd	between D2S2259 and D2S2114	Deafness, autosomal dominant 58 (2)	
2.203	9	9	10	2p16.3	GTF2A1L, ALF	P	General transcription factor IIA, 1-like	605358	Psh, REc			
2.204	11	19	11	2p16.3	NRXN1, PTHSL2, SCZD17	P	Neurexin 1	600565	R, REc		Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia, susceptibility to, 17}, 614332 (3)	
2.205	4	21	10	2p21	SLC3A1, ATR1, D2H, NBAT	C	Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1	104614	REa, Fd, A		Cystinuria, 220100 (3)	
2.206	10	4	12	2p16.3	STON1, STN1, SBLF, SALF	P	Stonin 1	605357	REc, Psh			
2.207	1	26	12	2p16.2	ERLEC1, C2orf30	P	Erlectin (endoplasmic reticulum lectin 1)	611229	REc			
2.208	4	28	10	2p16.2	ACYP2, ACYP	P	Acylphosphatase 2, muscle type	102595	REc			
2.209	8	27	09	2p16.2	PSME4, PA200, KIAA0077	P	Proteasome activator subunit 4	607705	REa, REc			
2.210	7	16	09	2p16.1	BCL11A, CTIP1, EVI9, KIAA1809	P	B-cell CLL/lymphoma 11A	606557	A			
2.211	12	28	08	2p16.1	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV	P	Coiled-coil domain-containing protein 88A	609736	R, REc			11(Ape)
2.212	9	8	14	2p16.1	HBFQTL5	P	Fetal hemoglobin quantitative trait locus 5	142335	Fd	associated with rs11886868	[Fetal hemoglobin QTL5] (2)	
2.213	3	23	09	2p16.1	MIR216, MIRN216	P	Micro RNA 216	610944	REc			
2.214	3	14	13	2p16.1	MIR217	P	Micro RNA 217	615096	REc			
2.215	3	17	16	2p16.1	PAPOLG	C	Poly(A) polymerase, gamma	616865	REc			
2.216	9	30	03	2p16.1	PHF9, FANCL	P	PHD finger protein 9	608111	R		Fanconi anemia, complementation group L, 614083 (3)	
2.217	11	29	12	2p16.1	PNPT1, OLD35, COXPD13, DFNB70	C	Polyribonucleotide nucleotidyltransferase 1	610316	R, REc		Combined oxidative phosphorylation deficiency 13, 614932 (3); Deafness, autosomal recessive 70, 614934 (3)	
2.218	2	5	16	2p16.1	PPP4R3B, PP4R3B, SMEK2, KIAA1387	P	Protein phosphatase 4, regulatory subunit 3, beta	610352	REc, R			
2.219	3	17	16	2p16-p15	PUS10, DOBI	P	Pseudouridylate synthase 10	612787	REc			
2.220	3	31	16	2p16.1	RPS27A, UBA80, HUBCEP80, CEP80, UBCEP1	P	Ribosomal protein S27a	191343	R, REc			
2.221	1	20	09	2p16.1-p15	DEL2p16.1-p15, C2DELp161-p15	P	Chromosome 2p16.1-p15 deletion syndrome	612513	Ch	contiguous gene deletion syndrome	Chromosome 2p16.1-p15 deletion syndrome (4)	
2.222	4	19	06	2p16	ASRT3	P	Asthma-related traits, susceptibility to, 3	609958	Fd	max lod at rs2063871	{Asthma-related traits, susceptibility to, 3} (2)	
2.223	9	7	00	2p16	CNC2	P	Carney complex, type II	605244	Fd		Carney complex, type II (2)	
2.224	6	2	99	2p16.1	EFEMP1, FBNL, DHRD	C	EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like)	601548	A, Fd, REc, R		Doyne honeycomb degeneration of retina, 126600 (3)	
2.225	2	21	02	2p16.2	GPR75	P	G protein-coupled receptor 75	606704	REc			
2.226	12	1	11	2p16.3	MSH6, GTBP, HNPCC5	C	MutS, E. coli, homolog of, 6	600678	REc, H	0.5 Mb from MSH2	Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3); Endometrial cancer, familial, 608089 (3); Mismatch repair cancer syndrome, 276300 (3)	
2.227	3	15	96	2p15	MDH1	C	Malate dehydrogenase, soluble	154200	S, D, A	proximal to APOB		11(Mor2)
2.228	9	3	10	2p16	STQTL24	P	Stature quantitative trait locus 24	613549	Fd	linked to rs1520446	{Stature QTL 24} (2)	
2.229	5	11	98	2p15	XPO1, CRM1	P	Exportin-1 (required for chromosome region maintenance)	602559	A			
2.230	11	29	99	2p16-p15	DYX3	P	Dyslexia, susceptibility to, 3	604254	Fd		{Dyslexia, susceptibility to, 3} (2)	
2.231	7	1	11	2p16-p15	GLC1H	P	Glaucoma 1, open angle, H	611276	Fd	between D2S123 AND D2S2165	Glaucoma 1, open angle, H (2)	
2.232	4	28	97	2p14	PPP3R1, CALNB1	P	Protein phosphatase-3 (formerly 2B), regulatory subunit B (19kD), alpha isoform (calcineurin B, type I)	601302	REa, A			
2.233	1	29	01	2p21	SIX2	P	Sine oculis homeo box, Drosophila, homolog of, 2	604994	R			17(Six2)
2.234	5	29	98	2p16.1	VRK2	P	Vaccinia-related kinase-2	602169	R			
2.235	9	22	08	2p16.2	ASB3	P	Ankyrin repeat-containing SOCS box protein 3	605760	REc			11(Asb3)
2.236	6	16	99	2p16.1	MTIF2	P	Mitochondrial translational initiation factor 2	603766	A, Psh			
2.237	11	3	05	2p15	COMMD1, MURR1	P	Copper metabolism Murr1 domain-containing 1	607238	R			
2.238	6	26	13	2p15	B3GNT2, B3GNT1, B3GNT	P	Beta-1,3-N-acetylglucosyaminyltransferase 2	605581	REc			
2.239	5	26	05	2p15	CCT4, CCTD, SRB	P	Chaperonin containing T-complex polypeptide 1, subunit 4	605142	H, REc			11(mf)
2.240	4	23	08	2p15	EHBP1, KIAA0903, HPC12	P	EH domain-binding protein 1	609922	R, REc		{Prostate cancer, hereditary, 12}, 611868 (3)	
2.241	10	27	10	2p15	FAM161A, RP28	P	Family with sequence similarity 161, member A	613596	REc, Fd		Retinitis pigmentosa 28, 606068 (3)	
2.242	10	25	12	2p15	PEX13, ZWS, NALD, PBD11A, PBD11B	P	Peroxisome biogenesis factor 13 (peroxin 13)	601789	A		Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3); Peroxisome biogenesis disorder 11B, 614885 (3)	
2.243	12	17	12	2p15	TMEM17	P	Transmembrane protein 17	614950	REc			
2.244	7	1	13	2p15	USP34, KIAA0570	P	Ubiquitin-specific protease 34	615295	R, REc			
2.245	1	29	15	2p15	WDPCP, C2orf86, BBS15, CHDTHP	P	WD repeat-containing planar cell polarity effector	613580	REc	mutation identified in 1 BBS15 family and 1 CHDTHP patient	?Bardet-Biedl syndrome 15, 615992 (3); ?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	
2.246	12	29	09	2p14	ETAA1, ETAA16	P	Ewing tumor-associated antigen 1	613196	REc, A			
2.247	10	24	11	2p13.3	NFU1, HIRIP, MMDS1	P	NFU1 iron-sulfur cluster scaffold, S. cerevisiae, homolog of	608100	R, M		Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	
2.248	11	11	14	2p14	ACTR2, ARP2	P	Actin-related protein 2	604221	REc			
2.249	5	23	07	2p13.3	C2orf13, APFL	P	Aprataxin- and PNK-like factor	611035	REc			
2.250	4	8	16	2p14	CEP68, KIAA0582	C	Centrosomal protein, 68kD	616889	R, REc			
2.251	4	1	96	2p14	RAB1, RAB1A	P	RAB1, member RAS oncogene family	179508	REa, R			11(Rab1)
2.252	11	25	15	2p14	SLC1A4, SATT, ASCT1, SPATCCM	P	Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4	600229	A, REc		Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	
2.253	10	11	07	2p14	SPRED2	P	Sprouty-related EVH1 domain-containing protein 2	609292	REc			11(Spred2)
2.254	6	1	12	2p15-p14	VPS54, VPS54L, WR	P	Vacuolar protein sorting 54, S. Cerevisiae, homolog of	614633	H, REc			14(Vps54)
2.255	7	3	06	2p14-p13.3	HRPT3	P	Hyperparathyroidism 3	610071	Fd	between D2S2368 and D2S358	Hyperparathyroidism 3 (2)	
2.256	12	17	95	2p13.3	ADD2	C	Adducin-2, beta	102681	REa, A			6(Add2)
2.257	11	6	94	2p13.2	EMX1	C	Empty spiracles, Drosophila, homolog of, 1	600034	REa, A	close to VAX2		6(Dmx1)
2.258	4	18	97	2p14	MEIS1	P	Meis1, mouse, homolog of	601739	A			11(Meis1)
2.259	7	20	09	2p14-p13	RLS7	P	Restless legs syndrome, susceptibility to, 7	612853	Fd	associated with rs2300478	{Restless legs syndrome 7} (2)	
2.260	11	29	00	2p16.1	RTN4, NOGO	C	Neurite outgrowth inhibitor (reticulon 4)	604475	R			
2.261	10	23	87	2p15	UGP2, UGPP2	C	Uridyl diphosphate glucose pyrophosphorylase-2	191760	REa, A			
2.262	4	15	09	2p13.2	SPR	P	Sepiapterin reductase	182125	A		Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)	1(Spr)
2.263	11	29	01	2q21.3	CCNT2	P	Cyclin T2	603862	R			
2.264	6	23	15	2p13.3	AAK1, KIAA1048	P	Adaptor protein 2-associated kinase 1	616405	R, REc			
2.265	3	3	16	2p13.3	BMP10	P	Bone morphogenetic protein 10	608748	REc			
2.266	3	20	15	2p13.3	FAM136A	P	Family with sequence similarity 136, member A	616275	REc			
2.267	6	27	05	2p13.3	GKN1, CA11	C	Gastrokine 1	606402	REc			
2.268	8	27	02	2p13.1	LOXL3	P	Lysyl oxidase-like 3	607163	REc			
2.269	1	6	09	2p13.3	MCEE	P	Methylmalonyl-CoA epimerase	608419	REc		Methylmalonyl-CoA epimerase deficiency, 251120 (3)	
2.270	8	27	09	2p13.3	NAGK, GNK	P	N-acetylglucosamine kinase	606828	R, REc			
2.271	8	20	07	2p13.3	PAIP2B	P	Polyadenylate-binding protein-interacting protein 2B	611018	R, REc			
2.272	9	2	12	2p14	PELI1	P	Pellino, Drosophila, homolog of, 1	614797	REc			
2.273	5	22	07	2p13.3	PCYOX1, PCL1, KIAA0908	P	Prenylcysteine oxidase 1	610995	R, REc			
2.274	9	7	12	2p13.3	PROKR1, PKR1, GPR73	P	Prokineticin receptor 1	607122	REc, R			
2.275	5	25	13	2p13.3	SNRPG	P	Small nuclear ribonucleoprotein polypeptide G	603542	REc			
2.276	3	21	02	2p13.2	DYSF, LGMD2B, MMD1	C	Dysferlin	603009	Fd, A		Muscular dystrophy, limb-girdle, type 2B, 253601 (3); Myopathy, distal, with anterior tibial onset, 606768 (3); Miyoshi muscular dystrophy 1, 254130 (3)	6(Dysf)
2.277	4	18	12	2p13.2	CYP26B1, CYP26A2, P450RAI2, RHFCA	P	Cytochrome P450, subfamily XXVIB, polypeptide 1	605207	REc		Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	
2.278	9	9	08	2p13.2	FBXO41, FBX41, KIAA1940	P	F-box only protein 41	609108	REc			6(Fbxo41)
2.279	8	27	09	2p13.2	EXOC6B, SEC15B, KIAA0919	P	Exocyst complex component 6B	607880	R, REc			
2.280	11	19	11	2p13.2	ZNF638, NP220	P	Zinc finger protein 638	614349	REc			
2.281	6	3	14	2p13.1	ACTG2, ACTA3, VSCM	C	Actin, gamma-2, smooth muscle, enteric	102545	REa, A		Visceral myopathy, 155310 (3)	
2.282	9	12	13	2p13.3	ANTXR1, TEM8, ATR, GAPO	P	Anthrax toxin receptor 1	606410	REc		{Hemangioma, capillary infantile, susceptibility to}, 602089 (3); GAPO syndrome, 230740 (3)	
2.283	1	18	12	2p13.3	ASPRV1, SASP, TAPS, MUNO	P	Aspartic peptidase, retroviral-like 1	611765	REc			
2.284	3	20	16	2p13.1	BOLA3, MMDS2	P	BolA, E. coli, homolog of, 3	613183	REc, M		Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3)	
2.285	8	27	09	2p13.1	DUSP11, PIR1	P	Dual specificity phosphatase-11, RNA/RNP complex-interacting	603092	TM, REc			
2.286	4	23	13	2p13.1	MOGS, GCS1, CDG2B	P	Mannosyl-oligosaccharide glucosidase	601336	A, Psh		Congenital disorder of glycosylation, type IIb, 606056 (3)	
2.287	9	12	13	2p13.1	STAMBP, AMSH, MICCAP	C	STAM binding protein	606247	A, REc		Microcephaly-capillary malformation syndrome, 614261 (3)	
2.288	6	13	12	2p13.1	TET3, KIAA0401	P	TET oncogene family, member 3	613555	R, REc			
2.289	2	26	02	2p13.1	NAT8, TSC510	P	N-acetyltransferase 8	606716	R			
2.290	5	25	13	2p13.1	NAT8B, CML2	P	N-acetyltransferase 8B	608190	REc			
2.291	7	17	02	2p13.1	TLX2, HOX11L1	P	T-cell leukemia, homeobox 2	604240	REc			
2.292	4	10	02	2p13.1	ALMS1, ALSS, KIAA0328	C	Alstrom syndrome gene	606844	LD, Fd, REc		Alstrom syndrome, 203800 (3)	
2.293	2	9	92	2p13.3	ANXA4, ANX4	P	Annexin A4 (placental anticoagulant protein II)	106491	Psh, A			6(Anx4)
2.294	11	30	06	2p13.3	ARHGAP25, KAIA0053	C	RHO GTPase-activating protein 25	610587	Psh, REc			
2.295	6	16	99	2p13.1	AUP1	P	Ancient ubiquitous protein 1	602434	REc			6(Aup1)
2.296	12	26	13	2p13.2	CCT7	P	Chaperonin containing T-complex polypeptide 1, subunit 7	605140	REc			
2.297	3	7	14	2p13.3	CD207, LANGERIN, CLEC4K	P	CD207 antigen	604862	R	mutation identified in 1 patient	?[Birbeck granule deficiency], 613393 (3)	6(Langerin)
2.298	3	3	09	2p13.1	DCTN1, HMN7B	C	Dynactin 1 (p150, glued, Drosophila, homolog of)	601143	A, R		Neuropathy, distal hereditary motor, type VIIB, 607641 (3); {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Perry syndrome, 168605 (3)	
2.299	12	21	10	2p13.1	DGUOK, DGK, MTDPS3	P	Deoxyguanosine kinase, mitochondrial	601465	Fd, REc		Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)	
2.300	12	15	98	2p13.1	DOK1	P	Downstream of tyrosine kinase 1	602919	R			6(Dok1)
2.301	8	24	92	2p13.2	EGR4, NGFIC	P	Early growth response-4	128992	A			6(Egr4)
2.302	4	30	15	2p13.3	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	C	Glutamine-fructose-6-phosphate transaminase	138292	A		Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	
2.303	7	9	15	2p13.1	INO80B, PAPA1, HMGA1L4	P	INO80 complex, subunit B	616456	A			
2.304	8	27	02	2p13.1	LBX2	P	Lady bird-like homeo box 2	607164	Psh, R			6(Lbx2)
2.305	11	27	94	2p13.3	MAD	P	MAD protein (MAX-binding protein)	600021	A			
2.306	8	20	98	2p13	OFC2	P	Orofacial cleft-2	602966	Fd	?relation to TGFA	Orofacial cleft-2 (2)	
2.307	11	6	94	2p15	OTX1	P	Orthodenticle, Drosophila, homolog of, 1	600036	REa, A			
2.308	10	28	99	2p13	PEE1, PREG1	C	Preeclampsia/eclampsia 1	189800	Fd	?distinct loci at 2p25 and 9p13	Preeclampsia/eclampsia 1 (2)	
2.309	4	23	98	2p13.1	RTKN	P	Rhotekin	602288	Psh			6(Rtkn)
2.310	4	10	15	2p13	PARK3	P	Parkinson disease 3	602404	Fd		{Parkinson disease 3} (2)	
2.311	6	28	99	2p13.1	SEMAW	P	Semaphorin W	603706	R			6(Semawa)
2.312	12	27	13	2p13.2	SFXN5	P	Sideroflexin 5	615572	REc			
2.313	5	6	03	2p13.1	SLC4A5, NBC4	P	Solute carrier family 4, sodium bicarbonate cotransporter, member 5	606757	REc			
2.314	7	10	93	2p13.3	TGFA	C	Transforming growth factor, alpha	190170	REa, A			6(Tgfa)
2.315	4	17	13	2p13.3	TIA1, WDM	P	TIA1 cytotoxic granule-associated RNA-binding protein	603518	A, Fd		Welander distal myopathy, 604454 (3)	
2.316	12	31	99	2p13.3	VAX2	P	Ventral anterior homeo box 2	604295	R			6(Vax2)
2.317	6	3	02	2p14	C1D, SUNCOR	P	Nuclear DNA-binding protein C1D	606997	REc	pseudogene on chr.10		
2.318	3	9	98	2p13.3	PCBP1	P	Poly(rC)-binding protein-1	601209	A			
2.319	8	27	09	2p13.2	RAB11RIP5, RIP11, KIAA0857	P	Rab11 family-interacting protein 5	605536	R, REc			
2.320	5	1	91	2p16.1	REL	P	Oncogene REL, avian reticuloendotheliosis	164910	REa			11(Rel)
2.321	7	22	13	2p12	CTRCT27, CCNP	P	Cataract 27, nuclear progressive	607304	Fd	near D2S2333	Cataract 27, nuclear progressive (2)	
2.322	5	27	05	2p11.2	CD8A	C	CD8 antigen, alpha polypeptide (p32)	186910	REa, A	distal to IGK	CD8 deficiency, familial, 608957 (3)	6(Ly2)
2.323	9	12	93	2p11.2	CD8B1, CD8B	C	CD8 antigen, beta polypeptide 1 (p37)	186730	REa, H	pseudogene, CD8B2, on 2q12		6(Ly3)
2.324	1	6	11	2p12	DFNA43	P	Deafness, autosomal dominant 43	608394	Fd	max lod at D2S139	Deafness, autosomal dominant 43 (2)	
2.325	8	14	00	2p11.2	EIF2AK3, PEK, PERK, WRS	C	Eukaryotic translation initiation factor 2-alpha kinase 3	604032	A, R, Fd		Wolcott-Rallison syndrome, 226980 (3)	
2.326	9	23	08	2p13.3	FIGLA, POF6	P	Factor in germline alpha, mouse, homolog of	608697	REc		Premature ovarian failure 6, 612310 (3)	
2.327	3	13	07	2p11.2	GGCX, VKCFD1	P	Gamma-glutamyl carboxylase	137167	REa, A		Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3); Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	
2.328	4	11	97	2p12	HK2	P	Hexokinase-2, muscle	601125	Fd	no recombination with TGFA		
2.329	7	24	15	2p11.2	IGKC, IGKCD	C	Immunoglobulin kappa constant region	147200	REa, A		Kappa light chain deficiency, 614102 (3)	6(Igkc)
2.330	4	15	08	2p12	IGKJ@	C	Immunoglobulin kappa light chain joining gene cluster	146970	REa, A	5 genes		
2.331	4	15	08	2p12	IGKV@	C	Immunoglobulin kappa light chain variable gene cluster	146980	REa, A	25+ genes in 4 classes; orphon gene 1.5Mb telomeric of IGKC		6(Igkv)
2.332	6	18	91	2p11.2	IGKDEL	P	Immunoglobulin kappa polypeptide deleting element	146780	RE			6(Igkrs)
2.333	2	5	16	1p36.12	PLA2G2F	P	Phospholipase A2, group IIf	616793	REc			4(Pla2g2f)
2.334	3	26	07	2p12	LRRTM1	P	Leucine-rich repeat transmembrane protein 1	610867	REn, H			6(Lrrtm1)
2.335	3	26	07	2p12	LRRTM4	P	Leucine-rich repeat transmembrane protein 4	610870	REn, H			6(Lrrtm4)
2.336	3	5	08	2p13.1	MRPL53	P	Mitochondrial ribosomal protein L53	611857	R, REc	pseudogene on 1		
2.337	3	17	94	2p12	PAP	C	Pancreatitis-associated protein	167805	REa, A, REc			
2.338	10	7	02	2p12	POLE4	P	Polymerase, DNA, epsilon-4	607269	REc			
2.339	4	10	15	2p13.1	HTRA2, OMI, PARK13, PRSS25	C	HTRA serine peptidase 2	606441	REc, A		{Parkinson disease 13}, 610297 (3)	
2.340	3	14	96	2p12	REG1A, PSPS1, REG	C	Regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein)	167770	A, Psh, REc			12(Reg1)
2.341	2	28	06	2p12	REG3G, PAP1B	P	Regnerating islet-derived 3-gamma	609933	REc			
2.342	10	4	93	2p12	REGL, PSPS2	P	Regenerating islet-derived, rat, homolog-like (pancreatic stone protein-like; pancreatic thread protein-like)	167771	A			?3(Reg2)
2.343	5	28	02	2p13.1	WBP1	P	WW domain-binding protein 1	606961	A			
2.344	2	1	11	2p12-p11.2	DEL2p12p11.2, C2DELp12p11.2	P	Chromosome 2p12-p11.2 deletion syndrome	613564	Ch	contiguous gene deletion syndrome	Chromosome 2p12-p11.2 deletion syndrome (4)	
2.345	5	21	07	2p11.2	SFTPB, SFTB3, SMDP1	C	Pulmonary surfactant-associated protein B, 18kD	178640	REa, A		Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	6(Sftp3)
2.346	5	13	02	2p11.2	VAMP8	P	Vesicle-associated membrane protein 8	603177	R			6(Vamp8)
2.347	8	11	98	2p12	CTNNA2, CAPR, CTNR	P	Catenin, alpha-2 (cadherin-associated protein, related)	114025	A			6(Capr)
2.348	1	31	00	2p11.2	GNLY, D2S69E, TLA519	P	Granulysin (T-lymphocyte activation gene 519)	188855	A			
2.349	3	5	03	2p12-q22	HSR	P	Hand skill, relative	139900	Fd		[Handedness] (2)	
2.350	5	2	94	2p22.3	LTBP1	P	Latent transforming growth factor beta binding protein 1	150390	REa			
2.351	9	29	13	2p11.2	ELMOD3, RBED1, DFNB88	P	ELMO/CED12 domain-containing protein 3	615427	REc	one family identified with mutation	?Deafness, autosomal recessive 88, 615429 (3)	
2.352	2	21	06	2p11.2	DNAH6, HL2	C	Dynein, axonemal, heavy chain 6	603336	A, R, REc			
2.353	10	21	08	2p11.2	FOXI3	P	Forkhead box I3	612351	REc			
2.354	2	20	09	2p11.2	IMMT, HMP	C	Inner membrane protein, mitochondrial (mitofilin)	600378	REc, R	pseudogene on chr.21		
2.355	7	18	12	2p11.2	KCMF1, DEBT91, FIGC	P	Potassium channel modulatory factor 1	614719	REc, H			
2.356	10	24	11	2p11.2	KDM3A, JMJD1A, JHDM2A, TSGA, KIAA0742	P	Lysine-specific demethylase 3A	611512	R, REc			
2.357	8	4	97	2p11.2	MAT2A, MATA2, SAMS2	P	Methionine adenosyltransferase II, alpha	601468	A			
2.358	3	5	08	2p11.2	MRPL35	P	Mitochondrial ribosomal protein L35	611841	REc	pseudogenes on 6, 10, and X		
2.359	5	19	15	2p11.2	PARTICL	P	Promoter of MAT2A antisense radiation-induced circulating long noncoding RNA	616350	REc	overlaps promoter of MAT2A on opposite strand		
2.360	7	9	15	2p11.2	POLR1A, RPA194, AFDCIN	P	Polymerase I, RNA, subunit A	616404	REc		Acrofacial dysostosis, Cincinnati type, 616462 (3)	
2.361	12	10	12	2p11.2	PTCD3	P	Pentatricopeptide repeat domain-containing protein 3	614918	REc			
2.362	1	21	15	2p11.2	REEP1, C2ORF23, SPG31, HMN5B	P	Receptor expression-enhancing protein 1	609139	Fc, R, REc	mutation identified in 1 HMN5B family	Spastic paraplegia 31, autosomal dominant, 610250 (3); ?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	
2.363	4	23	09	2p11.2	RGPD1, RGP1	P	RANBP2-like and GRIP domain-containing protein 1	612704	REn			
2.364	4	23	09	2p11.2	RGPD2, RGP2	P	RANBP2-like and GRIP domain-containing protein 2	612705	REn			
2.365	12	22	08	2p11.2	RNF181	P	Ring finger protein 181	612490	R, REc			
2.366	2	17	15	2p11.2	RPIA, RPI, RPIAD	P	Ribose 5-phosphate isomerase A	180430	R, REc	mutation identified in 1 RPAID patient	?Ribose 5-phosphate isomerase deficiency, 608611 (3)	
2.367	5	31	05	2p11.2	SIAT9, ST3GALV	C	Sialyltransferase 9	604402	REc, Fd		Amish infantile epilepsy syndrome, 609056 (3)	
2.368	12	27	10	2p11.2	SUCLG1, SUCLA1, MTDPS9	P	Succinate-CoA ligase, alpha subunit	611224	R, REc		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	
2.369	6	13	12	2p11.2	TCF7L1	P	Transcription factor 7-like 1	604652	REc			
2.370	3	4	10	2p11.2	TGOLN2, TGN46, TGN38	P	Trans-golgi network protein 2, 46kD	603062	A			
2.371	8	19	13	2p11.2	THNSL2, THS2	P	Threonine synthase-like 2	611261	REc			
2.372	1	14	16	2p11.2	TMEM150A, TMEM150	P	Transmembrane protein 150A	616757	REc			
2.373	3	7	14	2p11.2	TMSB10	P	Thymosin, beta-10	188399	REc			
2.374	12	10	12	2p11.2	TRABD2A, TIKI1	P	TRAB domain-containing protein 2A	614912	REc			
2.375	2	23	08	2p11.2	USP39, SAD1	P	Ubiquitin-specific protease 39	611594	REc			
2.376	8	27	09	2p11.2	VAMP5	P	Vesicle-associated membrane protein 5 (myobrevin)	607029	R, REc			
2.377	6	24	99	2p11.2	ZFP103, KF1	P	Zinc finger protein 103, mouse, homolog of	602507	A			
2.378	9	19	00	2p12	C2orf3, TCF9, GCF	P	GC factor	189901	A			
2.379	1	30	07	2q11.2	ANKRD23, DARP	P	Ankyrin repeat domain-containing protein 23	610736	REc			
2.380	2	28	08	2p12	MRPL19, MRPL15, KIAA0104	C	Mitochondrial ribosomal protein L19	611832	Psh, R			
2.381	4	23	08	2q11.1	MRPS5	P	Mitochondrial ribosomal protein S5	611972	R, REc			
2.382	1	25	88	2p11.2	FABP1	C	Fatty acid-binding protein, liver	134650	REa, A			6(Fabpl)
2.383	7	15	04	2p12	TACR1, TAC1R, NK1R	C	Tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor)	162323	REa, Psh, Fd			
2.384	9	2	08	2p11.2	PLGLB1, PLGL, PRGB	P	Plasminogen-like B1	173340	REa, A			
2.385	9	20	00	2p14	PLEK	L	Pleckstrin	173570	H			11(Plek)
2.386	12	4	95	2p24.2	VSNL1	P	Visinin-like 1	600817	Fd			
2.387	1	5	99	2p13.3	ATP6B1, VPP3	C	ATPase, H+ transporting, lysosomal, beta polypeptide, 58kD (vacuolar proton pump, subunit 3)	192132	REa, R, Fd		Renal tubular acidosis with deafness, 267300 (3)	8(Atp6b1)
2.388	3	8	91	2q11.2	COX5B	P	Cytochrome c oxidase, subunit Vb	123866	REa	7 pseudogenes on 4, 6, 7, 11, 12, 13, and 22		
2.389	2	14	02	2cen-q13	GLC1B	P	Glaucoma 1, open angle, B (adult-onset)	606689	Fd		Glaucoma 1B, primary open angle, adult onset, (2)	
2.390	10	23	87	2q14.2	INHBB	P	Inhibin, beta-2	147390	REa			1(Inhbb)
2.391	10	23	87	2q11.1	MAL	P	T-lymphocyte maturation-associated protein	188860	REa			
2.392	12	19	90	2q14.2	RALB	P	RAS-like protein B	179551	REa			
2.393	1	1	95	2p11.2	CAPG	P	Capping protein (actin filament), gelsolin-like	153615	Psh, A			
2.394	3	24	05	2q	AUTS5	P	Autism, susceptibility to, 5	606053	Fd	max lod at D2S188	{Autism susceptibility 5} (2)	
2.395	2	28	06	2q	COPD	P	Pulmonary disease, chronic obstructive, severe early-onset	606963	Fd	?SERPINE2	Pulmonary disease, chronic obstructive, severe early-onset (2)	
2.396	10	7	98	2q11.2	CNGA3, CNG3, ACHM2	P	Cyclic nucleotide-gated channel, alpha-3	600053	Fd, R		Achromatopsia-2, 216900 (3)	
2.397	10	15	98	2q11.2	DUSP2, PAC1	C	Dual-specificity phosphatase-2	603068	REa, A			
2.398	7	26	10	2q11.2	TMEM127	P	Transmembrane protein 127	613403	REc		{Pheochromocytoma, susceptibility to}, 171300 (3)	
2.399	4	25	08	2q11-q12	CELIAC8	P	Celiac disease, susceptibility to, 8	612006	Fd	associated with rs917997 and rs13015714	{Celiac disease, susceptibility to, 8} (2)	
2.400	12	17	12	2q13	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	C	Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)	604095	Fd, R		Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3); Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)	
2.401	10	3	11	2q13	RANBP2, NUP358, ANE1, IIAE3	P	RAN-binding protein 2	601181	A		{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	10(Ranbp2)
2.402	3	20	08	2q11-q14	NNO3	P	Nanophthalmos 3	611897	Fd	max lod at D2S2265	Nanophthalmos 3 (2)	
2.403	8	17	98	2q14.1	SLC20A1, GLVR1	P	Solute carrier family 20, phosphate transporter, member 1 (Gibbon ape leukemia virus receptor-1)	137570	REa, A			2(Slc20a1)
2.404	9	9	10	2q11.1	KCNIP3, KCHIP3, CSEN, DREAM	P	Potassium channel-interacting protein 3	604662	REc			
2.405	1	30	01	2q11.2	ACTR1B, ARP1B, CTRN2	P	Actin-related protein 1B	605144	REa, A			
2.406	4	23	98	2q12.3	SULT1C1	P	Sulfotransferase 1C1	602385	Psh			
2.407	6	18	15	2q11.2	ADRA2B, ADRA2L1, FAME2	C	Adrenergic, alpha-2B-, receptor	104260	REa, REc, Fd		Epilepsy, myoclonic, familial adult, 2, 607876 (3)	
2.408	12	7	07	2q11.2	ARID5A, MRF1	P	AT-rich interactive domain-containing protein 5A	611583	R, REc			
2.409	8	17	98	2q11.2	BRRN1	P	Barren, Drosophila, homolog of, 1	602332	REa, REc, R			
2.410	7	31	15	2q11.2	COA5, C2orf64, PET191, CEMCOX3	P	Cytochrome c oxidase assembly factor 5	613920	REc	mutation identified in 1 CEMCOX3 family	?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3)	
2.411	8	27	09	2q11.2	CHST10, HNK1ST	P	Carbohydrate sulfotransferase 10	606376	R, REc			
2.412	8	31	12	2q11.2	CIAO1, WDR39	P	WD repeat-containing protein CIAO1	604333	A, R			
2.413	8	31	09	2q11.2	CNNM3, ACDP3	C	Cyclin M3	607804	R, REc	previously assigned to 2p12-p11.2		
2.414	8	31	09	2q11.2	CNNM4, ACDP4	C	Cyclin M4	607805	R, Fd, REc		Jalili syndrome, 217080 (3)	1(Cnnm4)
2.415	9	30	09	2q24.1	CYTIP, PSCDBP, HE	P	Cytohesin 1 interacting protein	604448	Re, R			
2.416	6	23	15	2q11.2	GPAT2	P	Glycerol-3-phosphate acyltransferase 2, mitochondrial	616431	REc			
2.417	2	9	00	2q12.1	IL1RL1	C	Interleukin 1 receptor-like 1	601203	REa, A, R			
2.418	10	24	00	2q11.2	INPP4A, INPP4	P	Inositol polyphosphate-4-phosphatase, type I, 107kD	600916	A			
2.419	4	4	16	2q11.2	LMAN2L, VIPL, MRT52	P	LMAN2-like protein	609552	REc	mutation identified in 1 MRT52 family	?Mental retardation, autosomal recessive, 52, 616887 (3)	
2.420	4	30	15	2q11.2	LIPT1, LIPT1D	P	Lipoyltransferase 1	610284	A		Lipoyltransferase 1 deficiency, 616299 (3)	
2.421	9	21	15	2q11.2	LYG2, LYSG2	P	Lysozyme G-like 2	616547	REc			
2.422	2	25	15	2q11.2	MAP4K4, HGK, NIK, KIAA0687	P	Mitogen-activated protein kinase kinase kinase kinase 4	604666	REc			
2.423	2	28	08	2q11.2	MRPL30, MRPL28	P	Mitochondrial ribosomal protein L30	611838	R			
2.424	12	17	07	2q11.2	PDCL3, PHLP3, VIAF	P	Phosducin-like 3	611678	R, REc			
2.425	8	3	12	2q11.2	REV1L, REV1	P	Rev1, S. cerevisiae, homolog of	606134	REc			
2.426	1	1	96	2q12.1	SLC9A2	C	Solute carrier family 9 (sodium/hydrogen exchanger), member 2	600530	REa, A			1(Slc9a2)
2.427	2	19	10	2q11.2	SNRNP200, ASCC3L1, KIAA0788, RP33	P	Small nuclear ribonucleoprotein 200kD (U5)	601664	R, REc, Fd		Retinitis pigmentosa 33, 610359 (3)	
2.428	12	22	15	2q11.2	STARD7, GTT1	P	START domain-containing protein 4	616712	REc			
2.429	1	27	04	2q12.3	SULT1C2	P	Sulfotransferase family 1C, member 2	608357	REc			
2.430	3	7	14	2q11.2	TMEM131, KIAA0257, CC28	C	Transmembrane protein 131	615659	REc, R			
2.431	8	27	02	2q11.2	TSGA10	P	Testis-specific protein 10	607166	Psh, A			
2.432	2	4	09	2q11.2	TXNDC9, PHLP3	P	Thioredoxin domain-containing protein 9	612564	REc			
2.433	5	23	16	2q11.2	VWA3B, SCAR22	P	von Willebrand factor A domain-containing protein 3B	614884	REc	mutation identified in 1 SCAR22 family	?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3)	
2.434	3	1	01	2q11.1	ZNF2	C	Zinc finger protein-2	194500	REa, A			
2.435	5	5	00	2q12.1	GPR45	P	G protein-coupled receptor 45	604838	A			
2.436	10	17	96	2q11.2	LAF4	C	Lymphoid nuclear protein related to AF4	601464	A, Ch			1(Laf4)
2.437	2	19	04	2q12.3	ST6GALII, KIAA1877	C	Beta-galactoside alpha-2,6-sialyltransferase II	608472	R, REc			
2.438	3	1	00	2q12.1	IL18R1, IL1RRP	P	Interleukin 18 receptor 1	604494	R			
2.439	3	10	00	2q12.1	IL18RAP, ACPL	P	Interleukin 18 receptor accessory protein	604509	R			
2.440	8	17	98	2q11.2-q12.1	IL1R1, IL1RA	P	Interleukin-1 receptor, type I	147810	REa, A			1(Il1r)
2.441	2	9	00	2q12.1	IL1RL2, IL1RRP2	P	Interleukin 1 receptor-like 2	604512	R			
2.442	3	8	00	2q11.2	MGAT4A	P	Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A	604623	A			
2.443	5	12	00	2q12.2	NCK2	P	NCK adaptor protein 2	604930	A			
2.444	12	23	05	2q12.2	UXS1, UGD	P	UDP-glucuronate decarboxylase 1	609749	R, REc			
2.445	10	24	12	2q11.2	ZAP70, SRK, STD, STCD	C	Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)	176947	A		Selective T-cell defect, 269840 (3)	1(Zap70)
2.446	8	17	01	2q13	BCL2L11, BIM	P	BCL2-like 11	603827	A	?2p13		
2.447	7	9	06	2q14.2	MARCO	P	Macrophage receptor with collagenous structure	604870	A			1(Marco)
2.448	6	23	98	2q12.2	FHL2, DRAL	P	Four and a half LIM domains-2 (Down-regulated in rhabdomyosarcoma LIM protein)	602633	A			
2.449	9	28	00	2q12-q14	IGKV1OR2-108, IGO1	P	Immunoglobulin orphon (transposed element) 1	147185	A			
2.450	8	27	01	2q14.1	PAX8	C	Paired box homeotic gene-8	167415	REa, A		Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	2(Pax8)
2.451	1	5	93	2q14.2	DBI	I	Diazepam-binding inhibitor	125950	A, REa	?on 6q21-qter		
2.452	12	21	98	2q11.2	IL1R2, IL1RB	P	Interleukin-1 receptor, type II	147811	REa, A			1(Il1rb)
2.453	9	10	07	2q37.1	SNORD82, RNU82	P	Small nucleolar RNA, C/D box, 82	611133	REc			
2.454	2	26	95	2q37.1	NCL	P	Nucleolin	164035	REa			
2.455	9	1	11	2q14.1	IL37, IL1F7, FIL1Z, IL1H4, IL1RP1	P	Interleukin 37	605510	R			
2.456	4	23	08	2q12.1	MRPS9	P	Mitochondrial ribosomal protein S9	611975	R, REc			
2.457	4	13	98	2q12.1	POU3F3	P	POU domain, class 3, transcription factor-3	602480	A	previously mapped to 3p14.2		1(Pou3f3)
2.458	4	30	09	2q12.1	SLC9A4, NHE4	P	Solute carrier family 9 (sodium/hydrogen exchanger), member 4	600531	REa			1(Slc9a4)
2.459	8	27	09	2q12.1-q12.2	TGFBRAP1, TRAP1	P	Transforming growth factor-beta receptor-associated protein 1	606237	REc			
2.460	9	2	08	2q12.2	PLGLA, PRGA	P	Plasminogen-like A	612212	R, REc			
2.461	4	23	09	2q12.3	GCC2, GCC185, KIAA0336	C	GRIP and coiled-coil domains-containing protein 2	612711	R, REc			
2.462	1	28	13	2q12.3	SLC5A7, CHT1, HMN7A	P	Solute carrier family 5 (choline transporter), member 7	608761	REc, R		Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)	
2.463	4	23	09	2q12.2	RGPD3, RGP3	P	RANBP2-like and GRIP domain-containing protein 3	612706	REn			
2.464	4	23	09	2q12.3	RGPD4, RGP4	P	RANBP2-like and GRIP domain-containing protein 4	612707	REn			
2.465	4	23	09	2q13	RGPD5, RGP5, BS63	P	RANBP2-like and GRIP domain-containing protein 5	612708	REn			
2.466	4	23	09	2q13	RGPD6, RGP6	P	RANBP2-like and GRIP domain-containing protein 6	612709	REn			
2.467	4	23	09	2q12.3-q13	RGPD7, RGP7	P	RANBP2-like and GRIP domain-containing protein 7	612710	REn			
2.468	4	23	09	2q14.1	RGPD8, RGP8, RANBP2L1	C	RANBP2-like and GRIP domain-containing protein 8	602752	A, REc			
2.469	3	6	08	2q14.1	DPP10, DPRP3, KIAA1492	P	Dipeptidyl peptidase X	608209	REc			
2.470	8	8	13	2q13	ANAP1, APC1	P	Anaphase-promoting complex, subunit 1	608473	Psh, A, R			
2.471	1	12	15	2q14.1	CKAP2L, RADMIS	P	Cytoskeleton-associated protein 2-like	616174	REc		Filippi syndrome, 272440 (3)	
2.472	3	31	03	2q13	COMA	P	Cogan-type congenital oculomotor apraxia	257550	D	independent gene or feature of nephronophthisis	Oculomotor apraxia, congenital, Cogan-type (2)	
2.473	3	17	08	2q13	FBLN7, TM14	P	Fibulin 7	611551	REc			
2.474	10	15	97	2q13	MALL, BENE	C	mal, T-cell differentiation protein-like	602022	REn, REc			
2.475	9	1	11	2q14.1	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	C	Interleukin 36 receptor antagonist	605507	R, REc		Psoriasis 14, pustular, 614204 (3)	
2.476	9	1	11	2q14.1	IL36A, IL1F6, FIL1E	C	Interleukin 36, alpha	605509	REc, R			
2.477	9	1	11	2q14.1	IL36B, IL1F8, IL1H2, FIL1H	C	Interleukin 36, beta	605508	R, REc			
2.478	9	1	11	2q14.1	IL36G, IL1F9, IL1H1, IL1RP2	C	Interleukin 36, gamma	605542	REc, R			
2.479	6	16	99	2q11.2	NPAS2, MOP4	P	Neuronal PAS domain protein 2	603347	R, Psh			1(Npas2)
2.480	6	16	04	2q13	NPHP1, NPH1, SLSN1, JBTS4	C	Nephrocystin	607100	Fd		Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1, 266900 (3); Joubert syndrome 4, 609583 (3)	
2.481	1	30	12	2q14.1	PSD4, EFA6B, TIC	P	Pleckstrin and Sec7 domains-containing protein 4	614442	REc			
2.482	11	27	00	2q14.1	RABL2A	P	RAB-like 2A	605412	A			
2.483	1	22	08	2q13	SEPT10	P	Septin 10	611737	REc	pseudogene on 8q22.1-q12		
2.484	12	4	03	2q14.1	TTL	P	Tubulin-tyrosine ligase	608291	REc			2(Ttl)
2.485	3	1	12	2q14.3	PROC, PC, THPH3, THPH4	C	Protein C (inactivator of coagulation factors Va and VIIIa)	612283	REa, A		Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	
2.486	8	21	07	2q14.1	CBWD2	P	Cobalamin synthetase W domain-containing protein 2	611079	REc			
2.487	8	21	07	2q14.1	FOXD4L1	P	Forkhead box D4-like 1	611084	REc			
2.488	3	22	93	2q14.2	EN1	C	Engrailed-1	131290	REa			1(En1)
2.489	10	11	07	2q14.3	BIN1, AMPHL	P	Box-dependent MYC-interacting protein-1 (amphiphysin-like)	601248	Psh, A		Myopathy, centronuclear, autosomal recessive, 255200 (3)	18(Bin1)
2.490	6	22	14	2q13	BUB1	C	Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of (mitotic checkpoint gene BUB1)	602452	A, R		Colorectal cancer with chromosomal instability, somatic (3)	2(Bub1)
2.491	8	27	09	2q14.2-q14.3	CLASP1, KIAA0622	P	CLIP-associated protein 1	605852	R, REc			
2.492	5	26	13	2q14.3	CNTNAP5, CASPR5	P	Contactin-associated protein-like 5	610519	REc			
2.493	1	17	08	2q14.2	EPB41L5, KIAA1548	P	Erythrocyte membrane protein band 4.1-like 5	611730	R, REn			
2.494	12	10	14	2q14.2	GLI2, HPE9, CJS	C	GLI-Kruppel family member GLI2 (oncogene GLI2)	165230	REa, A		Holoprosencephaly-9, 610829 (3); Culler-Jones syndrome, 615849 (3)	
2.495	6	11	98	2q14.1	IL1A	C	Interleukin-1, alpha	147760	H, REa, A	within 430kb of IL1B, IL1RN		2(Il1a)
2.496	5	27	05	2q14.1	IL1B	C	Interleukin-1, beta	147720	REa, A, H	within 430kb of IL1RN, IL1A	{Gastric cancer risk after H. pylori infection}, 137215 (3)	2(Il1b)
2.497	7	1	13	2q14.1	IL1F10, IL1HY2	P	Interleukin 1 family, member 10	615296	REc			
2.498	12	23	05	2q14.2	TFCP2L1, CRTR1, LBP9	P	Transcription factor CP2-like 1	609785	R, REc			
2.499	6	9	08	2p14	WDR92, LOC116143, MONAD	P	WD repeat-containing protein 92	610729	R, REc			
2.500	11	14	14	2q14.3	GYPC, GE, GPC	P	Glycophorin C	110750	A		{Malaria, resistance to}, 611162 (3); [Blood group, Gerbich], 616089 (3)	
2.501	9	14	89	2q14-q21	LCO	P	Liver cancer oncogene	165320	REa, REb, A		?Hepatocellular carcinoma (1)	
2.502	2	10	95	2q14-q21	VIS1, HIS1	P	Viral integration site 1	164755	A			2(His1)
2.503	11	9	99	2q14-q22	CMD1H	P	Cardiomyopathy, dilated, 1H	604288	Fd		Cardiomyopathy, dilated, 1H (2)	
2.504	4	22	10	2q14.1	ACTR3, ARP3	P	Actin-related protein 3	604222	REc			
2.505	12	24	08	2q14.1	BMIQ13	P	Body mass index quantitative trait locus 13	612459	Fd	associated with rs7566605	[Body mass index QTL13] (2)	
2.506	12	4	08	2q14.1-q14.2	INSIG2	P	Insulin-induced gene 2	608660	REc			
2.507	11	8	95	2q14.2	SCTR	P	Secretin receptor	182098	A			
2.508	4	6	11	2q13	MERTK, RP38	C	Mer tyrosine kinase protooncogene	604705	A, Fd		Retinitis pigmentosa 38, 613862 (3)	
2.509	7	9	06	2q14.1	DDX18	P	DEAD/H box 18	606355	R, REc			
2.510	1	28	08	2q12.2	C2orf40, ECRG4	P	Esophageal cancer-related gene 4	611752	REc			
2.511	11	19	11	2q14.2	C1QL2, CTRP10, C1QTNF10	P	Complement component 1, q subcomponent-like 2	614330	REc			
2.512	7	9	09	2q14.1	IL1RN, MVCD4, DIRA	C	Interleukin-1 receptor antagonist	147679	REa, Fd, A		{Gastric cancer risk after H. pylori infection}, 137215 (3); {Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3)	
2.513	11	20	15	2q14.2	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	P	RNA, U4, small nuclear, AT-AC form	601428	REc, Fd		Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3); Roifman syndrome, 616651 (3)	
2.514	5	24	13	2q14.2	STEAP3, TSAP6, AHMIO2	P	Six-transmembrane epithelial antigen of prostate 3	609671	A	1 family identifed with mutation	?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3)	1(Steap3)
2.515	4	23	08	2q14.3	MKI67IP, NIFK, NOPP34	P	MKI67-interacting nucleolar phosphoprotein	611970	R, REc			
2.516	2	24	16	2q14.3	LIMS2, PINCH2, LGMD2W	P	LIM and senescent cell antigen-like domains 2	607908	REc	mutation identified in 1 LGMD2W family	Muscular dystrophy, limb-girdle, type 2W, 616827 (3)	
2.517	6	27	14	2q14.3	MAP3K2, MEKK2	P	Mitogen-activated protein kinase kinase kinase 2	609487	REc, R			
2.518	12	28	08	2q14.3	SAP130	P	Sin3A-associated protein, 130kD	609697	R, REc			
2.519	8	27	09	2q14.3	UGGT1, HUGT1	P	UDP-glucose glycoprotein glucosyltransferase 1	605897	REc			
2.520	4	27	12	2q14.3-q21.3	DYT21	P	Dystonia 21	614588	Fd		Dystonia 21 (2)	
2.521	4	16	03	2q22.1	CXCR4, D2S201E, NPY3R, WHIMS	C	Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3)	162643	Psh, A		WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)	
2.522	6	2	15	2q14.3	ERCC3, XPB, TTD2	C	Excision-repair cross-complementing rodent repair deficiency, complementation group 3	133510	S, A		Xeroderma pigmentosum, group B, 610651 (3); Trichothiodystrophy 2, photosensitive, 616390 (3)	
2.523	10	15	98	2q14.3	GPR17	C	G protein-coupled receptor-17	603071	REa, A			
2.524	10	17	12	2q14.3	HS6ST1, HS6ST, HH15	P	Heparan sulfate 6-O-sulfotransferase 1	604846	R, REc		{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3)	
2.525	1	23	09	2q21.3	LCT, LAC, LPH	C	Lactase (lactase-phlorizin hydrolase)	603202	REa, Fd, A, Psh		Lactase deficiency, congenital, 223000 (3)	
2.526	2	5	09	2q21.3	MCM6	C	Minichromosome maintenance deficient (mis5, S. pombe) 6	601806	A	mutations in introns 9 and 13	Lactase persistence/nonpersistence, 223100 (3)	
2.527	7	1	97	2q21.2-q21.3	MGAT5	P	Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl- glucosaminyltransferase	601774	A			
2.528	3	23	09	2q21.3	MIR128-1, MIRN128-1, MIR128A	P	Micro RNA 128-1	611774	REc			
2.529	9	1	15	2q21	NMTC3	P	Nonmedullary thyroid carcinoma 3	606240	Fd		{Thyroid carcinoma, nonmedullary, 3} (2)	
2.530	11	20	98	2q21.2	GPR39	P	G protein-coupled receptor-39	602886	A			
2.531	3	17	94	2q24.3	SCN7A, SCN6A	P	Sodium channel, voltage-gated, type VII, alpha polypeptide	182392	Pcm			
2.532	9	23	08	2q21.1	ADHD5	P	Attention deficit-hyperactivity disorder, susceptibility to, 5	612311	Fd	max lod at rs985162	{Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)	
2.533	11	16	15	2q21.1	CFC1, CRYPTIC, HTX2	P	Cryptic protein	605194	R		Heterotaxy, visceral, 2, autosomal, 605376 (3)	
2.534	9	7	10	2q21.1	FAM128A, MOZART2A	P	Family with sequence similarity 128, member A	613449	REc			
2.535	9	7	10	2q21.1	FAM128B, MOZART2B	P	Family with sequence similarity 128, member B	613450	REc			
2.536	9	2	09	2q21.1	IMP4, BXDC4	P	Imp4, S. cerevisiae, homolog of	612981	REc			
2.537	12	27	01	2q14.3	MYO7B	P	Myosin VIIb	606541	R, A			18(Myo7b)
2.538	6	7	10	2q21.1	POTEE, POTE2	C	POTE ankyrin domain family, member E	608914	REc, A	5 POTE2 genes within 2Mb segment		
2.539	8	18	12	2q21.1	POTEKP, ACT, ACTBL3, POTEK, FKSG30	P	POTE ankyrin domain family, member K, pseudogene	611266	REc			
2.540	8	27	09	2q21.1	PTPN18, BDP1	P	Protein-tyrosine phosphatase, nonreceptor-type, 18	606587	R, REc			
2.541	3	2	01	2q14.3	TSN	P	Translin	600575	REa, A			
2.542	7	22	09	2q21.1	RAB6C, WTH3	P	Ras-associated protein RAB6C	612909	REc			
2.543	5	24	13	2q21.1	SMPD4, NSMASE3, KIAA1418	P	Sphingomyelin phosphodiesterase 4, neutral membrane	610457	REc			
2.544	12	4	03	2q21.1-q22	CHDS2	P	Coronary heart disease, susceptibility to, 2	608316	Fd		{Coronary heart disease, susceptibility to, 2} (2)	
2.545	2	26	16	2q21.1	CCDC115, CCP1, CDG2O	P	Coiled-coil domain-containing protein 115	613734	REc		Congenital disorder of glycosylation, type IIo, 616828 (3)	1(Ccdc115)
2.546	5	24	13	2q21.2	LYPD1, PHTS	P	LY6/PLAUR domain-containing protein 1	610450	REc			
2.547	3	14	13	2q21.2	NCKAP5, NAP5	P	NCK-associated protein 5	608789	REc			
2.548	7	1	13	2q21.3	DARS, HBSL	P	Aspartyl tRNA synthetase	603084	REc		Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3)	
2.549	3	22	06	2q21.3	RAB3GAP1, WARBM1, P130	P	RAB3 GTPase-activating protein, catalytic subunit	602536	REc		Warburg micro syndrome 1, 600118 (3)	
2.550	5	19	16	2q21.3	ZRANB3	P	Zinc finger RANBP2-type domain-containing protein 3	615655	REc			
2.551	5	29	15	2q21.3	UBXN4, UBXD2, KIAA2042, ERASIN	P	UBX domain protein 4	611216	REc, R			
2.552	6	30	08	2q21.1	ARHGEF4, ASEF	P	RHO guanine nucleotide exchange factor 4	605216	A			
2.553	7	3	06	2q22.3	GTDC1	P	Glycosyltransferase-like domain containing 1	610165	REc			
2.554	1	13	16	2q22.1	HNMT, MRT51	P	Histamine N-methyltransferase	605238	A, REc		{Asthma, susceptibility to}, 600807 (3); Mental retardation, autosomal recessive 51, 616739 (3)	
2.555	6	4	98	2q23.3	NEB, NEM2	C	Nebulin	161650	REa, Ch, A, R, Fd		Nemaline myopathy 2, autosomal recessive, 256030 (3)	2(Neb)
2.556	4	19	07	2q22.3	ZEB2, ZFHX1B, SMADIP1, SIP1	C	Zinc finger E box-binding homeobox 2	605802	Ch		Mowat-Wilson syndrome, 235730 (3)	
2.557	11	21	02	2p16.3	KCNK12, THIK2	P	Potassium channel, subfamily K, member 12	607366	REc			
2.558	4	6	11	2q23.3	CACNB4, EJM6, EA5, EIG9	C	Calcium channel, voltage-dependent, beta 4 subunit	601949	A, Psh, R		{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3); {Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)	2(Cacnb4)
2.559	11	16	10	2q24.1	NR4A2, NURR1, NOT, TINUR	P	Nuclear receptor subfamily 4, group A, member 2	601828	A, REa			2(Nurr1)
2.560	3	15	11	2q23.1	ORC4, ORC4L	P	Origin recognition complex, subunit 4, S. cerevisiae, homolog of	603056	A, REa		Meier-Gorlin syndrome 2, 613800 (3)	
2.561	8	27	09	2q24.3	GRB14	P	Growth factor receptor-bound protein 14	601524	REc			
2.562	5	2	08	2q22-q24	MAFD5	P	Major affective disorder 5	611535	Fd		{Major affective disorder 5} (2)	
2.563	7	18	14	2q22.1	NXPH2, NPH2	P	Neurexophlin 2	604635	REc			
2.564	11	21	14	2q22.2	KYNU, KYNUU	P	Kynureninase	605197	REc	mutation identified in 1 KYNUU family	?Hydroxykynureninuria, 236800 (3)	
2.565	1	24	09	2q22.3-q23.1	ACVR2A, ACVR2	P	Activin A receptor, type IIA	102581	A			
2.566	5	26	13	2q22.2-q22.3	ARHGAP15, BM046	P	Rho GTPase-activating protein 15	610578	R, REc			
2.567	3	27	12	2q31.1	DCAF17, C20orf37	P	DDB1- and CUL4-associated factor 17	612515	REc		Woodhouse-Sakati syndrome, 241080 (3)	
2.568	1	1	95	2q24.2	DPP4, CD26, ADCP2	C	Dipeptidylpeptidase IV (CD26; adenosine deaminase complexing protein-2)	102720	S, REa, A			
2.569	8	18	98	2q24.2	FAP, FAPA	P	Fibroblast activation protein, alpha subunit	600403	REa, A			
2.570	8	1	08	2q23.3	RPRM	P	Reprimo	612171	A			
2.571	5	2	06	2q24.1	ACVR1, ACVRLK2, ALK2, FOP	C	Activin A receptor, type I	102576	REa, A		Fibrodysplasia ossificans progressiva, 135100 (3)	
2.572	2	28	01	2q24.2	BAZ2B	P	Bromodomain adjacent to zinc finger domain, 2B	605683	REa, R			
2.573	5	25	00	2q24.2	PLA2R1, PLA2R	P	Phospholipase A2 receptor 1	604939	A			
2.574	10	31	08	2q23.3	ARL5	P	ADP-ribosylation factor-like 5	608960	R			
2.575	2	11	11	2q24.3	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	C	Sodium channel, voltage-gated, type II, alpha subunit	182390	REa, Pcm, A	4 related genes on chr.2	Seizures, benign familial infantile, 3, 607745 (3); Epileptic encephalopathy, early infantile, 11, 613721 (3)	2(Scn2a)
2.576	1	17	01	2q24.2	SLC4A10	C	Solute carrier family 4 (sodium bicarbonate cotransporter-like), member 10	605556	A, REa, R			
2.577	8	9	99	2q23-q24.3	DFNA16	P	Deafness, autosomal dominant 16	603964	Fd		Deafness, autosomal dominant 16 (2)	
2.578	3	8	00	2q24.2	TBR1	L	T-box, brain, 1	604616	H			2(Tbr1)
2.579	4	6	01	2q23-q31	DFNB27	P	Deafness, autosomal recessive 27	605818	Fd		Deafness, autosomal recessive 27 (2)	
2.580	11	29	99	2q24.1	PKP4	P	Plakophilin-4	604276	A, REa			
2.581	8	20	07	2q23.1	EPC2	P	Enhancer of polycomb, Drosophila, homolog of, 2	611000	R, REc			
2.582	8	1	14	2q23.1-q23.2	KIF5C, NKHC2, CDCBM2	P	Kinesin family member 5C	604593	R, REc		Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	
2.583	10	15	07	2q23.1	MBD5, KIAA1461, MRD1	P	Methyl-CpG-binding domain protein 5	611472	R, REc		Mental retardation, autosomal dominant 1, 156200 (3)	
2.584	4	20	10	2q23.2	LYPD6	P	LY6/PLAUR domain-containing protein 6	613359	REc			
2.585	4	8	08	2q23.2	C2orf25, MMADHC	P	Chromosome 2 open reading frame 25	611935	REc		Homocystinuria, cblD type, variant 1, 277410 (3); Methylmalonic aciduria, cblD type, variant 2, 277410 (3); Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	
2.586	7	29	15	2q23.3	ARL6IP6, AIP6	P	ADP-ribosylation factor-like 6-interacting protein 6	616495	REc			
2.587	3	31	15	2q23.3	FMNL2, KIAA1902	P	Formin-like 2	616285	REc			
2.588	6	29	99	2q23.3	NMI	P	NMYC interactor	603525	A	previously assigned to 22q13.3		
2.589	8	17	09	2q23.3	PRPF40A, HYPA, FNBP3, FBP11	P	Precursor mRNA-processing factor 40, S. cerevisiae, homolog of, A	612941	REc			
2.590	8	3	12	2q23.3	RND3, RHOE, ARHE	P	RHO family GTPase 3	602924	REc, R			
2.591	7	9	06	2q23.3	STAM2	P	Signal-transducing adaptor molecule 2	606244	R, REc			
2.592	8	27	09	2q23.3	TNFAIP6	C	Tumor necrosis factor, alpha-induced protein-6	600410	Psh, REc			
2.593	1	20	09	2q31.1	ABCB11, BSEP, SPGP, PFIC2, BRIC2	C	ATP-binding cassette, subfamily B, member 11 (bile salt export pump)	603201	Fd, LD, REc		Cholestasis, progressive familial intrahepatic 2, 601847 (3); Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	
2.594	9	22	08	2q24.2	CD302, DCL1, KIAA0022	C	CD302 antigen	612246	R, REc			
2.595	8	19	13	2q24.3	COBLL1, COBLR1, KIAA0977	P	COBL-like protein 1	610318	REc			2(Cobll1)
2.596	4	7	15	2q24.2	IFIH1, MDA5, AGS7, SGMRT1	C	Interferon induced with helicase C domain 1	606951	REc		Aicardi-Goutieres syndrome 7, 615846 (3); Singleton-Merten syndrome 1, 182250 (3)	
2.597	12	14	10	2q24.3	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	C	Sodium channel, voltage-gated, type I, alpha polypeptide	182389	REA, A, FD		Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)	2(Scn1a)
2.598	6	7	94	2q24.3	SCN3A	C	Sodium channel, voltage-gated, type III, alpha polypeptide	182391	H, Psh, A			2(Scn3a)
2.599	12	30	14	2q24.3	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	C	Sodium channel, voltage-gated, type IX, alpha subunit	603415	REc, Fd		Erythermalgia, primary, 133020 (3); Paroxysmal extreme pain disorder, 167400, (3); Insensitivity to pain, congenital, 243000 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); {Dravet syndrome, modifier of}, 607208 (3); HSAN2D, autosomal recessive, 243000 (3)	
2.600	8	24	09	2q31.1	SLC25A12, ARALAR	C	Solute carrier family 25 (mitochondrial carrier, Aralar), member 12	603667	A, REa, R, REc		Hypomyelination, global cerebral, 612949 (3)	
2.601	11	17	10	2q24.3	GALNT3, HHS, HFTC	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3	601756	A		Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	
2.602	8	21	07	2q31.1	LRP2, DBS	C	Low density lipoprotein-related protein 2	600073	A		Donnai-Barrow syndrome, 222448 (3)	
2.603	4	30	15	2q31.1	CHRNA1, ACHRD, CMS1B, CMS1A	C	Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle	100690	REa, A		Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3); Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	2(Acra)
2.604	7	8	10	2q24-q32	FGQTL1	P	Fasting plasma glucose level QTL 1	612108	Fd	associated with rs560887	[Fasting plasma glucose level QTL 1] (2)	
2.605	7	8	10	2q31.1	G6PC2, IGRP	C	Glucose-6-phosphatase, catalytic, 2	608058	REc, R, H			2(Igrp)
2.606	6	15	99	2q24-q32	MMDK, MDK	P	Mesomelic dysplasia, Kantaputra type	156232	Fd		Mesomelic dysplasia, Kantaputra type (2)	
2.607	1	11	95	2q37.1	NPPC	L	Natriuretic peptide precursor C	600296	H			1(Nppc)
2.608	4	22	10	2q24.1	ACVR1C, ALK7	P	Activin A receptor, type IC	608981	A			
2.609	8	19	13	2q24.1	ERMN, JN, KIAA1189	P	Ermin	610072	R, REc			
2.610	1	27	04	2q23.3-q24.1	GALNT13, KIAA1918	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13	608369	R, REc			
2.611	3	27	09	2q24.1	GPD2	C	Glycerol-3-phosphate dehydrogenase 2 (mitochondrial)	138430	A, Psh, REc	pseudogene on 19	{Diabetes, type 2, susceptibility to}, 125853 (3)	
2.612	12	2	96	2q24.1	KCNJ3, GIRK1	P	Potassium inwardly-rectifying channel, subfamily J, member 3	601534	REa, A, Fd			
2.613	5	8	09	2q24.1	SYNSTH	P	Synesthesia	612759	Fd	max lod at D2S142	Synesthesia (2)	
2.614	4	22	10	2q24.1-q31.1	INTLQ2	P	Intelligence quantitative trait locus 3	610295	Fd		{Intelligence QTL3} (2)	
2.615	4	6	13	2q24.1	GALNT5, GALNACT5	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5	615129	REc			
2.616	8	27	09	2q24.2	GCA	P	Grancalcin	607030	R, REc			
2.617	2	12	15	2q24.2	ITGB6, AI1H	P	Integrin, beta-6	147558	REa, REc		Amelogenesis imperfecta, type IH, 616221 (3)	
2.618	3	6	08	2q24.2	KCNH7, ERG3, HERG3, Kv11.3	P	Potassium channel, voltage-gated, subfamily H, member 7	608169	R, REc			
2.619	6	7	10	2q24.2	MARCH7	P	Membrane-associated RING-CH finger protein 7	613334	REc			
2.620	8	27	09	2q24.2	PSMD14, POH1, PAD1	P	Proteasome 26S subunit, non-ATPase, 14	607173	R, REc			
2.621	3	29	16	2q24.2	RBMS1, MSSP, SCR2	P	RNA-binding motif protein, single strand-interacting, 1	602310	REc			
2.622	4	2	16	2q24.2	TANC1, KIAA1728	P	Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 1	611397	REc			
2.623	3	18	13	2q24.2	TANK, ITRAF	P	TRAF family member-associated NF-Kappa-B activator	603893	REc			
2.624	11	11	14	2q24.3	B3GALT1	P	UDP-GAL:beta-GlcNAc beta-1,3-galactosyltransferase, polypeptide 1	603093	REc			
2.625	8	2	13	2q24.3	CERS6, LASS6	P	Ceramide synthase 6	615336	REc			
2.626	12	23	05	2q24.3	CMYA3, XIRP2	P	Cardiomyopathy-associated protein 3	609778	R, REc			
2.627	2	18	09	2q24.3	IDDM19	P	Diabetes mellitus, insulin-dependent, 19	610155	Fd	associated with rs1990760	{Diabetes mellitus, insulin-dependent, 19} (2)	
2.628	8	26	15	2q24.3	SLC38A11	P	Solute carrier family 38 (amino acid transporter), member 11	616526	REc			
2.629	8	27	09	2q24.3	STK39, SPAK	P	Serine/threonine protein kinase 39	607648	R, REc			
2.630	2	11	14	2q24.3	TTC21B, THM1, NPHP12, SRTD4, ATD4	P	Tetratricopeptide repeat domain 21B	612014	REc		Nephronophthisis 12, 613820 (3); Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	
2.631	1	11	16	2q31.2	AGPS, ADHAPS, RCDP3	P	Alkylglycerone-phosphate synthase	603051	A		Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	2(Agps)
2.632	10	16	14	2q31.1	BBS5	C	BBS gene 5	603650	REc, Fd		Bardet-Biedl syndrome 5, 615983 (3)	
2.633	10	12	14	2q31.2	CCDC141, CAMDI	P	Coiled-coil domain-containing protein 141	616031	REc			
2.634	4	21	16	2q31.1	CDCA7, JPO1, ICF3	P	Cell division cycle-associated 7	609937	A		Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	
2.635	8	17	15	2q31.1	GAD1, SCP, CPSQ1	C	Glutamate decarboxylase-1, brain, 67kD	605363	REa, H, A, Psh, Fd, LD	mutation identified in 1 CPSQ1 family	?Cerebral palsy, spastic quadriplegic, 1, 603513 (3)	2(Gad1)
2.636	12	9	98	2q31	IDDM7	P	Insulin-dependent diabetes mellitus-7	600321	H, Fd		{Diabetes mellitus, insulin-dependent, 7} (2)	
2.637	1	24	01	2q32.1	ITGAV, VNRA	C	Integrin, alpha-V (vitronectin receptor, alpha polypeptide)	193210	REa, A, REc			
2.638	5	14	08	2q31.1	LNP, KIAA1715	P	Lunapark	610236	REc, H			2(Lnp)
2.639	3	23	09	2q31.1	MIR10B, MIRN10B	P	Micro RNA 10B	611576	REc			
2.640	1	7	02	2q33.1	MPP4, DLG6	P	Membrane protein, palmitoylated 4	606575	REc			
2.641	5	9	95	2q31.2	NFE2L2, NRF2	P	Nuclear factor, erythroid-derived 2-like 2	600492	A			
2.642	10	28	08	2q31	PNKD2	P	Paroxysmal nonkinesigenic dyskinesia 2	611147	Fd	between D2S2188 and D2S364	Paroxysmal nonkinesigenic dyskinesia 2 (2)	
2.643	12	9	09	2q31	SHFM5	P	Split-hand/foot malformation 5	606708	Fd	between EVX2 and D2S294	Split-hand/foot malformation 5 (2)	
2.644	7	1	97	2q31.1	SP3	P	Sp3 transcription factor	601804	Psh, A			
2.645	1	18	11	2q31.2	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	C	Titin	188840	REa, R		Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy, dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal, with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	2(Ttn)
2.646	4	17	01	2q32.1	CALCRL, CGRPR, CRLR	P	Calcitonin receptor-like	114190	R			
2.647	1	4	93	2q31.1	EVX2	P	Even-skipped homeo box-2	142991	REn	13kb 5' to HOX4I		2(Evx2)
2.648	2	26	93	2q31.1	HOXD3, HOX4A	C	Homeo box-D3	142980	RE			2(Hox4.1)
2.649	4	1	14	2q31.1	HOXD4, HOX4B	C	Homeo box-D4	142981	A, RE			2(Hox4.2)
2.650	2	26	93	2q31.1	HOXD9, HOX4C	C	Homeo box-D9	142982	RE			2(Hox4.3)
2.651	7	19	04	2q31.1	HOXD10, HOX4D	C	Homeo box-D10	142984	REa, RE		Vertical talus, congenital, 192950 (3); Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	2(Hox4.4)
2.652	2	26	93	2q31.1	HOXD8, HOX4E	C	Homeo box-D8	142985	RE			2(Hox4.5)
2.653	2	26	93	2q31.1	HOXD11, HOX4F	C	Homeo box-D11	142986	RE			2(Hox4.6)
2.654	2	26	93	2q31.1	HOXD1, HOX4G	C	Homeo box-D1	142987	RE			2(Hox4.7)
2.655	2	26	93	2q31.1	HOXD12, HOX4H	P	Homeo box-D12	142988	REc	upstream from HOX4A-G		2(Hox4.8)
2.656	5	9	16	2q31.1	HOXD13, HOX4I, SPD1, BDSD	C	Homeo box-D13	142989	REc, Fd	mutation identified in 1 BDSD family	Synpolydactyly 1, 186000 (3); Brachydactyly, type E, 113300 (3); Brachydactyly, type D, 113200 (3); Syndactyly, type V, 186300 (3); ?Brachydactyly-syndactyly syndrome, 610713 (3)	2(Hox4.9)
2.657	7	16	92	2q31.3	ITGA4, CD49D	C	Integrin, alpha-4 (antigen CD49D, alpha-4 subunit of VLA-4 receptor)	192975	Psh, A			
2.658	9	23	08	2q31.1	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	C	Chimerin 1 (GTPase-activating protein, rho, 2)	118423	REa, A, Fd		Duane retraction syndrome 2, 604356 (3)	
2.659	12	30	92	2q32.1	TFPI, LACI	C	Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)	152310	REa, A			
2.660	4	15	09	2q32.1	FRZB, FRZB1, SRFP3, OS1	P	Frizzled-related protein	605083	REc		{Osteoarthritis susceptibility 1}, 165720 (3)	
2.661	11	19	11	2q32.2	PMS1, PMSL1, HNPCC3	P	Postmeiotic segregation increased, S. cerevisiae, like 1	600258	REa, A			
2.662	9	22	08	2q31.1	ATP5G3	P	ATP synthase, mitochondrial, C subunit-3	602736	REa, REc			
2.663	9	10	12	2q31.1	CIR1	P	CBF1-interacting corepressor	605228	REc			
2.664	8	18	08	2q31.1	DHRS9, RDHTBE	P	Short-chain dehydrogenase/reductase family, member 9	612131	REc			
2.665	1	5	11	2q31.1	DUP2q31.1, C2DUPq31.1	P	Chromosome 2q31.1 duplication syndrome	613681	Ch	duplication of 9 HOXD genes and MTX2	Chromosome 2q31.1 duplication syndrome (4)	
2.666	2	21	06	2q31.1	DYNC1I2, DNCI2, IC2	P	Dynein, cytoplasmic-1, intermediate chain-2	603331	REc, H			2(Dnci2)
2.667	1	10	09	2q31.1	ITGA6	P	Integrin, alpha-6	147556	REa, REc		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)	
2.668	4	10	14	2q31.1	KLHL41, KBTBD10, SARCOSIN, NEM9	P	Kelch-like family member 41	607701	R, REc		Nemaline myopathy 9, 615731 (3)	
2.669	8	3	12	2q31.1	METAP1D, MAP1D	P	Methionyl aminopeptidase type 1D (mitochondrial)	610267	REc			
2.670	4	17	12	2q31.1	MTX2	P	Metaxin 2	608555	REc			
2.671	3	3	03	2q24.3	NOSTRIN	P	Nitric oxide synthase trafficker	607496	REc			
2.672	8	30	11	2q31.1	OLA1, GTBP9	P	OBG-like ATPase 1	611175	REc			
2.673	9	9	13	2q31.1	PDK1	P	Pyruvate dehydrogenase kinase, isoenzyme 1	602524	REc			
2.674	8	27	09	2q31.1	PPIG	P	Peptidyl-prolyl isomerase G (cyclophilin G)	606093	R, REc			
2.675	12	17	12	2q31.1	SCRN3, SES3	P	Secernin 3	614967	REc			
2.676	7	14	14	2q24.3	SPC25, SPBC25	P	SPC25, NDC80 kinetochore complex component	609395	REc			
2.677	4	28	10	2q31.1	SSB, LARP3	P	Sjogren syndrome antigen B	109090	A, Psh, REc			
2.678	3	31	11	2q31.1	UBR3	P	Ubiquitin protein ligase E3 component N-recognin 3	613831	REc			3(Ubr3)
2.679	2	9	15	2q31.1	WIPF1, WASPIP, WIP, WAS2	P	WAS/WASL-interacting protein family, member 1	602357	REc	mutation identified in 1 WAS2 patient	?Wiskott-Aldrich syndrome 2, 614493 (3)	
2.680	4	9	16	2q31.1	ZAK, MLTK, MRK, SFMMP	P	Leucine zipper- and sterile alpha motif-containing kinase	609479	R, REc		Split-foot malformation with mesoaxial polydactyly, 616890 (3)	
2.681	4	24	06	2q31.1	MYO3B	P	Myosin IIIB	610040	REc			
2.682	6	30	06	2q31.2	PJVK, DFNB59	P	Pejvakin	610219	Fd		Deafness, autosomal recessive 59, 610220 (3)	
2.683	11	11	14	2q31.2	FKBP7, FKBP23	P	FK506-binding protein 7	607062	REc			
2.684	2	1	11	2q31.2	HNRPA3, D10S102, FBRNP	P	Heterogeneous nuclear ribonucleoprotein A3	605372	REc, REn			
2.685	3	8	07	2q31.2	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	P	Phosphodiesterase 11A	604961	REc, Fd		Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	
2.686	3	18	08	2q31.2	PLEKHA3, FAPP1	P	Pleckstrin homology domain-containing protein, family A, member 3	607774	REc			
2.687	10	27	08	2q31.2-q31.3	ZNF385B, ZFN533	P	Zinc finger protein 385B	612344	REc			
2.688	10	27	08	2q31.2	DEL2q31	P	Chromosome 2q31.2 deletion syndrome	612345	Ch	contiguous gene deletion syndrome	Chromosome 2q31.2 deletion syndrome (4)	
2.689	11	4	98	2q31.1	HAT1	P	Histone acetyltransferase-1	603053	TM			
2.690	2	27	13	2q31.3	CERKL, RP26	P	Ceramide kinase-like	608381	REc		Retinitis pigmentosa 26, 608380 (3)	
2.691	5	6	13	2q31.3	CWC2, KIAA1604, NCM	P	CWC22 spliceosome-associated protein, X. cerevisiae, homolog of	615186	REc			
2.692	2	21	12	2q31.3	MIR1258	C	Micro RNA 1258	614488	REc	on opposite strand from ZNF385B		
2.693	2	24	12	2q33.1	NDUFB3	P	NADH-ubiquinone oxidoreductase 1 beta subcomplex, 3	603839	R	pseudogenes on chr. 1, 9, and 14	Mitochondrial complex I deficiency, 252010 (3)	
2.694	6	24	08	2q31.2	PRKRA, PACT, RAX, DYT16	C	Protein kinase, interferon-inducible double-stranded RNA-dependent activator	603424	REc		Dystonia 16, 612067 (3)	
2.695	12	27	13	2q31.3	SCHLAP1, PCAT114, LINC00913	P	SWI/SNF complex antagonist associated with prostate cancer 1, noncoding	615568	REc			
2.696	8	8	13	2q31.3	SSFA2, CS1	P	Sperm-specific antigen 2	118990	REc			
2.697	1	16	14	2q31.3-q32.1	DA10	P	Arthrogryposis, distal, type 10	187370	Fd	max lod at D2S364	Arthrogryposis, distal, type 10 (2)	
2.698	11	7	01	2q31.1	ATF2, CREB2	C	Activating transcription factor 2	123811	REa, A			
2.699	1	8	95	2q31.1	DLX1	P	Distal-less homeo box-1	600029	REa, A, H			
2.700	1	8	95	2q31.1	DLX2, TES1	C	Distal-less homeo box-2	126255	REa, A			2(Dlx2)
2.701	1	15	96	2q32.2	INPP1	P	Inositol polyphosphate-1-phosphatase	147263	Psh, A			1(Inpp1)
2.702	5	11	00	2q33.3	KLF7, UKLF	P	Kruppel-like factor 7	604865	A			
2.703	8	27	09	2q32.3	MYO1B	P	Myosin IB	606537	R, REc			
2.704	11	4	99	2q31.3	NEUROD1, NIDDM	C	Neurogenic differentiation 1	601724	A		{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Maturity-onset diabetes of the young 6, 606394 (3)	2(Neurod)
2.705	11	30	00	2q32.3	PCGEM1	P	Prostate-specific gene PCGEM1	605443	A			
2.706	3	17	03	2q32.2	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	C	Solute carrier family 40 (iron-regulated transporter), member 1	604653	A		Hemochromatosis, type 4, 606069 (3)	1(Slc11a3)
2.707	3	1	02	2q32.3	SDPR, SDR	P	Serum deprivation response phosphatidylserine-binding protein	606728	A			
2.708	5	29	01	2q32.3	TMEFF2, HPP1, TR	P	Transmembrane protein with EGF-like and 2 follistatin-like domains 2	605734	A			
2.709	1	11	89	2q34	RPE	C	Ribulose 5-phosphate 3-epimerase	180480	S, D			
2.710	8	8	91	2q32.2	GLS, GLS1	P	Glutaminase	138280	REa, A			1(Gls)
2.711	6	22	14	2q32.1	FSIP2	P	Fibrous sheath-interacting protein 2	615796				
2.712	12	5	03	2q32.1	NUP35, NP44	P	Nucleoporin, 35kD	608140	R, REc			
2.713	5	7	03	2q31.2	OSBPL6, ORP6	C	Oxysterol-binding protein-like protein 6	606734	REc			
2.714	8	30	09	2q32.1	PDE1A	P	Phosphodiesterase-1A	171890	REc			
2.715	2	21	10	2q31.3-q32.1	PPP1R1C, IPP5	P	Protein phosphatase 1, regulatory subunit 1C	613240	REc			
2.716	9	10	09	2q32.1	SCZD14	P	Schizophrenia 14	612361	associated with rs1344706		{Schizophrenia, susceptibility to, 14} (2)	
2.717	10	19	99	2q31.3	UBE2E3, UBCH9	C	Ubiquitin-conjugating enzyme E2E 3	604151	A, REa, R			
2.718	9	23	08	2q32.1	ZNF804A, C2orf10	P	Zinc finger protein 804A	612282	REc			
2.719	5	11	00	2q32.1	NCKAP1, NAP1	C	NCK-associated protein 1	604891	REa, A			
2.720	10	27	97	2q32.1-q32.3	ARVD4	P	Arrhythmogenic right ventricular dysplasia 4	602087	Fd		Arrhythmogenic right ventricular dysplasia 4 (2)	
2.721	4	10	90	2q34	MYL1	C	Myosin, light polypeptide-1, alkali; skeletal, fast	160780	REa, H			1(Mylt)
2.722	3	15	13	2q32.2	C2orf88, SMAKAP	P	Small membrane protein kinase A-anchoring protein	615117	REc			
2.723	11	30	15	2q32.2	COL3A1	C	Collagen III, alpha-1 polypeptide	120180	REa, A	in same 35kb segment as COL5A2	Ehlers-Danlos syndrome, type IV, 130050 (3)	1(Col3a1)
2.724	4	13	15	2q32.2	COL5A2, EDSC	C	Collagen V, alpha-2 polypeptide	120190	REa, A	very close to COL3A1	Ehlers-Danlos syndrome, classic type, 130000 (3)	
2.725	12	23	05	2q32.2	FLJ25415	P	FLJ25415 gene	609803	REc			
2.726	8	13	11	2q32.2	GDF8, MSTN, MSLHP	P	Growth differentiation factor-8 (myostatin)	601788	H, R		Muscle hypertrophy, 614160 (3)	1(Cmpt, Gdf8)
2.727	1	8	07	2q32.2	HIBCH	P	3-hydroxyisobutyryl-CoA hydrolase	610690	REc		3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)	
2.728	9	29	10	2q32.2	MFSD6, MMR2	P	Major facilitator superfamily domain-containing protein 6	613476	REc			
2.729	8	26	15	2q32.2	NEMP2, TMEM194B	P	Nuclear envelope integral membrane protein 2	616497	REc			
2.730	4	7	10	2q32.2	ORMDL1	P	ORM1-like protein 1	610073	REc	pseudogene on 10p14		
2.731	1	29	07	2q33.1	SUMO1, UBL1, SMT3, OFC10	C	Small ubiquitin-like modifier 1	601912	A, Ch		Orofacial cleft 10, 613705 (3)	1(Sumo1)
2.732	12	26	14	2q32.2	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	P	Signal transducer and activator of transcription-1	600555	A		Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3); Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3); Immunodeficiency 31C, autosomal dominant, 614162 (3)	1(Stat1)
2.733	7	18	12	2q32.2-q32.3	STAT4, SLEB11	P	Signal transducer and activator of transcription-4	600558	A		{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)	1(Stat4)
2.734	2	3	06	2q32.1-q32.2	GULP1, CED6	P	PTB domain-containing engulfment adaptor protein 1	608165	REc			
2.735	6	26	08	2q32.3	OBFC2A, SSB2	P	Oligonucleotide/oligosaccharide-binding fold-containing protein 2A	612103	REc			
2.736	5	4	12	2q32.3	STK17B, DRAK2	P	Serine/threonine protein kinase 17b	604727	REc			
2.737	4	23	98	2q32.2	NAB1	P	NGFI-A-binding protein, ERG1-binding protein	600800	A			1(Nab1)
2.738	7	10	08	2q33.3	CREB1	C	cAMP-response element-binding protein-1	123810	REa, A	fusion gene with EWSR1	Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)	1(Creb1)
2.739	7	1	02	2q33.3	ADAM23, MDC3	P	A disintegrin and metalloproteinase domain 23	603710	R			
2.740	9	21	12	2q33.1	ALS2, ALSJ, PLSJ, IAHSP	C	Alsin	606352	Fd, REc		Amyotrophic lateral sclerosis 2, juvenile, 205100 (3); Primary lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)	
2.741	2	27	03	2q33.2	ALS2CR8, CARF	P	Amyotrophic lateral sclerosis 2 chromosome region, candidate 8 (calcium response factor)	607586	REc			
2.742	7	14	98	2q33.1	AOX1	C	Aldehyde oxidase-1	602841	Psh, A			
2.743	4	8	13	2q35	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	C	bcs1, S. cerevisiae, homolog-like	603647	REc, Fd, LD		Mitochondrial complex III deficiency, nuclear type 1, 124000 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3); GRACILE syndrome, 603358 (3)	
2.744	2	13	14	2q33.1-q33.2	BMPR2, PPH1, POVD1	C	Bone morphogenetic receptor, type II	600799	Fd		Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3); Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3); Pulmonary venoocclusive disease 1, 265450 (3)	
2.745	7	26	10	2q33.1	BOLL, BOULE	P	BOL-like (Boule, Drosophila, homolog of)	606165	R, A, H			1(Boule)
2.746	11	18	14	2q33.1	CASP8, MCH5, ALPS2B	C	Caspase 8, apoptosis-related cysteine protease	601763	A	mutation identified in 1 ALPS2B family	?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3); Hepatocellular carcinoma, somatic, 114550 (3); {Breast cancer, protection against}, 114480 (3); {Lung cancer, protection against}, 211980 (3)	1(Casp8)
2.747	12	7	07	2q33.1	CFLAR, FLIP, CASPER, FLAME1, CASH	P	CASP8- and FADD-like apoptosis regulator	603599	A, R			
2.748	8	16	99	2q33.1	CLK1, CLK, STY	P	CDC-like kinase 1	601951	A			
2.749	7	24	15	2q33.2	CTLA4, IDDM12, CELIAC3, ALPS5	C	Cytotoxic T-lymphocyte-associated serine esterase-4	123890	A, REn		{Hashimoto thyroiditis}, 140300 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3); {Diabetes mellitus, insulin-dependent, 12}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3); Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	1(Ctla4)
2.750	11	6	01	2q32.2	DIRC1	P	Disrupted in renal cancer 1	606423	REc			
2.751	1	12	99	2q33.1	FZD7	P	Frizzled, Drosophila, homolog of, 7	603410	A			
2.752	1	30	01	2q33.2	ICOS, AILIM, CVID1	P	Inducible costimulator	604558	R		Immunodeficiency, common variable, 1, 607594 (3)	
2.753	4	19	01	2q33.1	NIF3L1	P	Ngg1 interacting factor 3, S. pombe, homolog of, like 1	605778	REc			1(Nif3l1)
2.754	4	9	96	2q33.1	ORC2, ORC2L	P	Origin recognition complex, subunit 2, S. cerevisiae, homolog of	601182	A			
2.755	2	18	02	2q33.1	PLDL1, PLCE, PLCL	P	Phospholipase C-like 1	600597	RE			
2.756	7	14	14	2q33.1	PPIL3	P	Peptidyl-prolyl isomerase-like 3	615811	REc			
2.757	10	21	96	2q34	PTHR2	P	Parathyroid hormone receptor 2	601469	A			
2.758	2	28	07	2q33	RLS4	P	Restless legs syndrome, susceptibility to, 4	610439	Fd	between D2S311 and D2S317	{Restless legs syndrome 4} (2)	
2.759	5	27	14	2q33.1	SATB2, KIAA1034, GLSS	C	Special AT-rich sequence-binding protein 2	608148	REc		Glass syndrome, 612313 (3)	
2.760	7	21	15	2q33.1	CASP10, MCH4, ALPS2	P	Caspase 10, apoptosis-related cysteine protease	601762	Psh, REc, A		Autoimmune lymphoproliferative syndrome, type II, 603909 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3); Gastric cancer, somatic, 613659 (3)	
2.761	8	24	92	2q33.2	CD28	C	CD28 antigen (Tp44)	186760	A, REn			1(Cd28)
2.762	4	30	15	2q37.1	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	C	Cholinergic receptor, nicotinic, delta polypeptide	100720	H, REa, A, LD, RE	mutation identified in 1 CMS3A patient and 1 CMS3C family	?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3); Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3); ?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	1(Acrd)
2.763	4	22	15	2q37.1	CHRNG, ACHRG	C	Cholinergic receptor, nicotinic, gamma polypeptide	100730	H, REa, LD, RE, Fd	tightly linked to CHRND by RE	Escobar syndrome, 265000 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	1(Acrg)
2.764	5	14	04	2q33.3	EEF1B2, EEF1B1	P	Eukaryotic translation elongation factor-1, beta-2	600655	Psh	pseudogene on chr.15		
2.765	7	1	97	2q33.3	FZD5	L	Polarity gene 'frizzled,' Drosophila, homolog of	601723	H			1(Mfz5)
2.766	12	5	91	2q35	IGFBP2	C	Insulin-like growth factor-binding protein-2, 36kD	146731	REa, A			1(Igfbp2)
2.767	1	5	06	2q33.2	NBEAL1, ALS2CR17	P	Neurobeachin-like 1	609816	REc			
2.768	8	25	04	2q33.3	NDUFS1	P	NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kD	157655	A		Mitochondrial complex I deficiency, 252010 (3)	
2.769	5	19	09	2q33.1	STRADB, ILPIP, ALS2CR2	P	STE20-related kinase adaptor beta	607333	REn	pseudogenes on chromosomes 1 and 9		
2.770	2	28	06	2q33.1	TRAK2, GRIF1, ALS2CR3, KIAA0549, OIP98	C	Gamma-aminobutyric acid receptor-interacting factor 1	607334	REn			
2.771	5	22	91	2q33-q35	CHE2	P	Cholinesterase, serum, 2	177500	F	linkage to chr. 16 markers?		
2.772	4	4	00	2q33.3	CRYGA, CRYG1	C	Crystallin, gamma A	123660	REa, A			1(Cryg1)
2.773	9	12	13	2q33.3	CRYGB, CRYG2, CTRCT39	C	Crystallin, gamma B	123670	REa, A		Cataract 39, multiple types, autosomal dominant, 615188 (3)	1(Len2)
2.774	5	3	13	2q33.3	CRYGC, CRYG3, CTRCT2, CCL	C	Crystallin, gamma C	123680	REa, A		Cataract 2, multiple types, 604307 (3)	
2.775	5	3	13	2q33.3	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	C	Crystallin, gamma D	123690	REa, A		Cataract 4, multiple types, 115700 (3)	1(Crygd, Lop2)
2.776	1	29	04	2q35	IHH, BDA1	C	Indian hedgehog	600726	REa, A, Fd		Acrocapitofemoral dysplasia, 607778 (3); Brachydactyly, type A1, 112500 (3)	
2.777	2	28	06	2q36.1	PI7, PN1, SERPINE2	P	Protease inhibitor 7 (protease nexin I)	177010	REa, M	near MYL1; ?COPD susceptibility		
2.778	10	10	11	2q33-q36	EJM9	P	Epilepsy, juvenile myoclonic, susceptibility to, 9	614280	Fd	max lod at D2S2248	{Epilepsy, juvenile myoclonic, susceptibility to, 9} (2)	
2.779	10	26	99	2q35	IGFBP5, IBP5	L	Insulin-like growth factor-binding protein 5	146734	H			1(Igfbp5)
2.780	1	4	93	2q35	INHA	C	Inhibin, alpha	147380	REa, RE	proximal to PAX3		1(Inha)
2.781	8	29	02	2q36.3	CCL20, SCYA20, MIP3A, LARC	P	Chemokine, C-C motif, ligand 20	601960	R, Psh			
2.782	8	18	98	2q35	CYP27A1, CYP27, CTX	P	Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase)	606530	REa		Cerebrotendinous xanthomatosis, 213700 (3)	1(Cyp27)
2.783	2	18	09	2q33.1	ANIB9	P	Aneurysm, intracranial berry, 9	612586	Fd	associated with rs700651	{Aneurysm, intracranial berry, 9} (2)	
2.784	12	30	14	2q33.1	CDK15, PFTAIRE2, ALS2CR7	P	Cyclin-dependent kinase 15	616147	REc			
2.785	3	24	14	2q32.3	DNAH7, KIAA0944	C	Dynein, axonemal, heavy chain 7	610061	R, REc			
2.786	1	30	15	2q33.1	FTCDNL1, FONG	P	Formiminotransferase cyclodeaminase N-terminal like	614308	REc			
2.787	7	18	14	2q33.1	GTF3C3, TFIIIC102	P	General transcription factor 3C, polypeptide 3	604888	REc			
2.788	4	27	12	2q33.1	HSPD1, SPG13, HSP60, HLD4	C	Heat-shock 60kD protein 1	118190	Fd, REn, A		Spastic paraplegia 13, autosomal dominant, 605280 (3); Leukodystrophy, hypomyelinating, 4, 612233 (3)	
2.789	9	4	02	2q33.1	HSPE1, HSP10	C	Heat-shock 10kD protein	600141	REn			
2.790	6	23	15	2q33.1	MARS2, SPAX3, COXPD25	P	Methionyl-tRNA synthetase 2	609728	R, REc, Fd	mutation identified in 1 COXPD25 family	Spastic ataxia 3, autosomal recessive, 611390 (3); ?Combined oxidative phosphorylation deficiency 25, 616430 (3)	
2.791	2	1	11	2q33.1	MOBKL3, PREI3, MOB1, MOB3	P	MOB1, Mps One Binder kinase activator-like 3, yeast, homolog of	609361	R, REc			
2.792	1	8	16	2q33.1	NOP58, NOP5	P	Nop58, S. cerevisiae, homolog of	616742	REc			
2.793	2	25	16	2q33.1	PGAP1, MRT42	P	Post-GPI attachment to proteins 1	611655	REc		Mental retardation, autosomal recessive 42, 615802 (3)	
2.794	10	26	11	2q33.1	SF3B1, SF3B155, SAP155, MDS	P	Splicing factor 3B, subunit 1	605590	R, REc		Myelodysplastic syndrome, somatic, 614286 (3)	1(Sf3b1)
2.795	12	4	08	2q33.1	SGOL2, SGO2, TRIPIN	P	Shugoshin-like 2	612425	REc			
2.796	4	15	11	2q33.1	SPATS2L, SGNP	P	Spermatogenesis-associated serine-rich protein 2-like	613817	REc			
2.797	1	18	12	2q33.1	TMEM237, ALS2CR4, JBTS14	P	Transmembrane protein 237	614423	REc		Joubert syndrome 14, 614424 (3)	
2.798	10	28	15	2q33.2	WDR12	C	WD repeat-containing protein 12	616620	A, REc			1(Wdr12)
2.799	11	4	13	2q33.3	FASTKD2, KIAA0971	P	FAST kinase domains 2	612322	R, REc	mutation identified in 1 family	?Mitochondrial complex IV deficiency, 220110 (3)	
2.800	2	6	07	2q33.3	GPR1	P	G protein-coupled receptor-1	600239	R	conflicting assignment to 15q21.6		
2.801	6	4	13	2q33.3	METTL21A, FAM119A	P	Methyltransfearse-like 21A	615257	REc			
2.802	4	15	09	2q33.3	OS4, GOA1	P	Osteoarthritis susceptibility 4	610839	Fd	max lod at D2S2358	{Osteoarthritis susceptibility 4} (2)	
2.803	1	14	13	2q34	IDH1	C	Isocitrate dehydrogenase, soluble	147700	S, D		{Glioma, susceptibility to, somatic}, 137800 (3)	1(Idh1)
2.804	1	18	13	2q35	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	C	ATP-binding cassette, subfamily A, member 12	607800	R, H, Fd		Ichthyosis, congenital, autosomal recessive 4A, 601277 (3); Ichthyosis, autosomal recessive 4B (harlequin), 242500 (3)	1(Abca12)
2.805	11	22	13	2q33.3	C2orf80, GONDA1	P	Chromosome 2 open reading frame 80	615536	REc			
2.806	8	24	04	2q35	CTDSP1, NLIIF, SCP1	P	C-terminal domain of RNA polymerase II polypeptide A, small phosphatase of, 1	605323	REc			
2.807	11	19	13	2q34	ERBB4, HER4, ALS19	P	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4	600543	A		Amyotrophic lateral sclerosis 19, 615515 (3)	
2.808	9	8	11	2q35	FN1, FN, LETS, FNZ, GFND2	C	Fibronectin-1	135600	S, REa, A		Glomerulopathy with fibronectin deposits 2, 601894 (3); Plasma fibronectin deficiency, 614101 (1)	1(Fn1)
2.809	8	24	12	2q34	KANSL1L, C2orf67, MSL1V2	P	KAT8 regulatory NSL complex subunit 1-like	613833	REc			
2.810	9	5	01	2q34	LANCL1, GPR69A	C	LanC-like 1 (G protein-coupled receptor 69A)	604155	R, A			
2.811	12	9	98	2q34	IDDM13	P	Insulin-dependent diabetes mellitus-13	601318	Fd		{Diabetes mellitus, insulin-dependent, 13} (2)	
2.812	2	23	12	2q34	IKZF2, ANF1A2, HELIOS	P	Ikaros family zinc finger 2	606234	REc			
2.813	5	25	00	2q33.3	NRP2, VEGF1265R2, NPN2	P	Neuropilin 2	602070	REa, R			
2.814	8	1	08	2q34	SPAG16, PF20	P	Sperm-associated antigen 16	612173	A, H			1(Spag16)
2.815	1	10	89	2q34	TCL4	P	T-cell leukemia/lymphoma-4	186860	Ch, RE		Leukemia/lymphoma, T-cell (2)	
2.816	4	27	11	2q34	ACADL, LCAD	P	Acyl-Coenzyme A dehydrogenase, long chain	609576	A			1(Acadl)
2.817	9	18	08	2q36.1	ACSL3, FACL3, ACS3	C	Acyl-CoA synthetase long-chain family member 3	602371	Psh, A			
2.818	10	4	05	2q35	BARD1	C	BRCA1-associated RING domain 1	601593	Psh, REc		{Breast cancer, susceptibility to}, 114480 (3)	
2.819	10	23	87	2q34	MAP2	P	Microtubule-associated protein-2	157130	REa, A			
2.820	12	11	02	2q34-q35	SLEN2	P	Systemic lupus erythematosus with nephritis, susceptibility to, 2	607966	Fd		{Systemic lupus erythematosus with nephritis, susceptibility to, 2} (2)	
2.821	6	19	00	2q35	ZNF142	C	Zinc finger protein-142	604083	R, A			
2.822	8	7	14	2q35	CRYBA2, CTRCT42	P	Crystallin, beta A2	600836	REa	mutation identified in 1 CTRCT42 family	?Cataract 42, 115900 (3)	1(cryba2)
2.823	4	19	16	2q34-q36	DUP2q35, C2DUPq35, SDTY1, SD1	P	Chromosome 2q35 duplication syndrome (syndactyly, type I)	185900	Fd		Syndactyly, type 1, with or without craniosynostosis (4)	
2.824	1	24	02	2q35	SMARCAL1, HARP, SIOD	P	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like	606622	REc		Schimke immunoosseous dysplasia, 242900 (3)	1(Smarcal1)
2.825	1	16	07	2q37.3	AQP12A, AQPX2, AQP12	C	Aquaporin 12A	609789	REc			
2.826	5	25	13	2q35	AAMP	P	Angio-associated migratory cell protein	603488	REc			
2.827	2	1	11	2q35	ARPC2, ARC34	P	Actin-related protein 2/3 complex, subunit 2	604224	REc			
2.828	8	29	08	2q35	ATG9A, APG9L1	P	Autophagy 9, S. cerevisiae, homolog of, A	612204	REc			
2.829	6	7	04	2q35	ATIC, PURH, AICAR	P	5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase	601731	REc		AICA-ribosiduria due to ATIC deficiency, 608688 (3)	
2.830	10	5	11	2q35	CCDC108	P	Coiled-coil domain-containing protein 108	614270	REc			
2.831	1	24	01	2q35	CDK5R2, NCK5AI	P	Cyclin-dependent kinase 5, regulatory subunit 2	603764	A			
2.832	9	12	13	2q34	CPS1, PHN	C	Carbamoyl-phosphate synthetase 1, mitochondrial	608307	REa, Fd, A	urea cycle enzyme	Carbamoylphosphate synthetase I deficiency, 237300 (3); {Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3); {Venoocclusive disease after bone marrow transplantation} (3)	1(Cps)
2.833	7	8	11	2q35	CXCR1, IL8RA	C	Chemokine, CXC motif, receptor 1	146929	REa, A, Psh		{AIDS, slow progression to}, 609423 (3)	
2.834	2	8	11	2q35	CXCR2, IL8RB, IL8R2	C	Chemokine, CXC motif, receptor 2	146928	A, REa, Psh			1(Il8r2)
2.835	8	2	13	2q35	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	C	Desmin	125660	REa, A	1 family with LGMD2R identified with mutation	Myopathy, myofibrillar, 1, 601419 (3); Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3); ?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	1(Des)
2.836	4	24	15	2q35	DNAJB2, HSJ1, HSPF3, DSMA5, CMT2T	P	DnaJ, E. coli, homolog of, subfamily B, member 2 (heat-shock protein, DNAJ-like 1)	604139	R, REc	mutation identified in 1 CMT2T family	Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3); ?Charcot-Marie-Tooth disease, axonal, type 2T, 616233 (3)	
2.837	3	23	14	2q35	DNPEP, ASPEP, DAP	P	Aspartyl aminopeptidase	611367	REc			
2.838	11	19	13	2q35	GMPPA, AAMR	P	GDP-mannose pyrophosphorylase A	615495	REc		Alacrima, achalasia, and mental retardation syndrome, 615510 (3)	
2.839	6	2	06	2q35	GPBAR1, BG37	P	G protein-coupled bile acid receptor 1	610147	REc			
2.840	6	7	10	2q35	MARCH4, RNF174, KIAA1399	P	Membrane-associated RING-CH finger protein 4	608208	R, REc			
2.841	3	23	09	2q35	MIR26B, MIRN26B	P	Micro RNA 26B	612152	REc			
2.842	3	23	09	2q35	MIR375, MIRN375	P	Micro RNA 375	611173	REc			
2.843	5	31	05	2q35	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	C	Myofibrillogenesis regulator 1	609023	Fd, REc		Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	
2.844	1	2	08	2q35	MREG, DSU	P	Melanoregulin	609207	REc, H			1(Dsu)
2.845	2	10	04	2q35	MTBS1	P	Mycobacterium tuberculosis, susceptibility to infection by	607949	Fd		{Tuberculosis, susceptibility to} (2)	
2.846	9	22	09	2q35	NBLST5	P	Neuroblastoma, susceptibility to, 5	613016	Fd	associated with rs6435862, rs3768716	{Neuroblastoma, susceptibility to, 5} (2)	
2.847	1	14	09	2q35	NHEJ1, XLF	P	Nonhomologous end-joining factor 1	611290	REc		Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	
2.848	8	24	09	2q35	OBSL1, KIAA0657, 3M2	C	Obscurin-like 1	610991	R, REc		3-M syndrome 2, 612921 (3)	
2.849	8	27	09	2q35	PECR, TERP	P	Peroxisomal trans-2-enoyl-CoA reductase	605843	REc			
2.850	1	28	10	2q34	PIKFYVE, PIP5K3	C	Phosphatidylinositol kinase, FYVE-finger containing	609414	Fd, REc		Corneal fleck dystrophy, 121850 (3)	
2.851	11	19	09	2q35	PRKAG3	P	Protein kinase, AMP-activated, noncatalytic, gamma 3	604976	REc			
2.852	5	4	09	2q35	RESP18	P	Regulated endocrine-specific protein 18	612721	REc			
2.853	9	22	14	2q35	RNF25, AO7	P	Ring finger protein 25	616014	REc			
2.854	3	29	10	2q35	RPL37A	P	Ribosomal protein L37A	613314	REc			
2.855	8	27	08	2q35	RQCD1, RCD1, CNOT9	P	Required for cell differentiation 1, S. pombe, homolog of	612054	REc			
2.856	12	21	09	2q35	NRAMP1, NRAMP, SLC11A1	C	Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1	600266	REn, REc, Psh, H, Fd	within 220 kb of VIL1	{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3); {Buruli ulcer, susceptibility to}, 610446 (3)	1(Nramp)
2.857	9	19	14	2q35	SPEG, APEG1, CNM5	P	SPEG complex locus	615950	REc		Centronuclear myopathy 5, 615959 (3)	
2.858	3	25	03	2q35	STK36, FU, KIAA1278	C	Serine/threonine protein kinase 36	607652	R, REn			
2.859	8	19	13	2q35	TMBIM1, RECS1	P	Transmembrane BAX inhibitor motif-containing protein 1	610364	REc, R			
2.860	7	5	15	2q35	TUBA4A, TUBA1, ALS22	P	Tubulin, alpha-4A	191110	REc		Amyotrophic lateral sclerosis 22 with or without frontotemoral dementia, 616208 (3)	1(Tuba4a)
2.861	2	12	16	2q34	UNC80, C2orf21, KIAA1843	P	Unc-80 homolog, NALCN activator	612636	R, REc		Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	
2.862	5	5	00	2q35	WNT6	P	Wingless-type MMTV integration site family, member 6	604663	A			1(Wnt6)
2.863	7	22	11	2q35	WNT10A, SSPS, STHAG4, OODD	C	Wingless-type MMTV integration site family, member 10A	606268	REc, Fd		Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)	
2.864	6	6	94	2q35	XRCC5	C	X-ray repair, complementing defective, repair in Chinese hamster cells-5	194364	REa, R, A	included in YAC contig spanning 2q33-q34		1(Xrcc5)
2.865	9	29	10	2q35	ZFAND2B, AIRAPL	P	Zinc finger AN1 domain-containing protein 2B	613474	REc			
2.866	1	22	08	2q35	ACCN4, ASIC4, BNAC4	C	Cation channel, amiloride-sensitive, neuronal, 4	606715	R, REc			
2.867	5	22	03	2q36.1	KCNE4, MIRP3	P	Potassium channel, voltage-gated, ISK-related subfamily, member 4	607775	REc			
2.868	1	11	05	2q35-q36	PSHK2	P	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	Fd	max lod at D2S1338	Pseudohyperkalemia, familial, 2, due to red cell leak (2)	
2.869	2	3	99	2q36.1	SCG2, CHGC	P	Secretogranin II (chromogranin C)	118930	A			1(Scg2)
2.870	6	4	90	2q35	TNP1	P	Transition protein-1	190231	REa, A			1(Tp1)
2.871	2	18	08	2q35	TNS1, TNS	P	Tensin 1	600076	REa, H			1(Tns)
2.872	2	10	04	2q35	VIL1	C	Villin-1	193040	A		Cholestasis, progressive canalicular (1)	1(Vil)
2.873	6	4	97	2q35	PTPRN, IA2	P	Protein tyrosine phosphatase, receptor type N (islet cell antigen 2)	601773	A, R			1(Ptprn)
2.874	3	5	95	2q37.3	GPC1	P	Glypican 1	600395	A			
2.875	2	25	16	2q35	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	P	ATP-binding cassette, subfamily B, member 6	605452	A, Fd		Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood group, Langereis system], 111600 (3); Dyschromatosis universalis hereditaria 3, 615402 (3); Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	
2.876	4	20	04	2q36	ACRPV	P	Acropectorovertebral dysplasia (F syndrome)	102510	Fd		Acropectorovertebral dysplasia (2)	
2.877	7	18	14	2q36.3	AGFG1, HRB, RIP, RAB	P	ADP-ribosylation factor GTPase-activating protein with FG repeats 1	600862	A			
2.878	12	23	05	2q36.1	FARSLB, FRSB	P	Phenylalanine-tRNA synthetase-like, beta subunit	609690	REc			
2.879	8	27	09	2q35	FEV	P	Fifth Ewing sarcoma variant	607150	REa, REc	fused with EWS in tumors		
2.880	5	23	11	2q36	IGAN2	P	IgA nephropathy, susceptibility to, 2	613944	Fd	between D2S1323 adn D2S362	{IgA nephropathy, susceptibility to, 2} (2)	
2.881	1	11	07	2q36.3	IRS1	P	Insulin receptor substrate-1	147545	REa, A		{Diabetes mellitus, noninsulin-dependent}, 125853 (3); {Coronary artery disease, susceptibility to} (3)	1(Irs1)
2.882	9	9	13	2q36.1	MRPL44, COXPD16	P	Mitochondrial ribosomal protein L44	611849	R, REc	Mutation identified in 1 family	?Combined oxidative phosphorylation deficiency 16, 615395 (3)	
2.883	10	9	94	2q35	SLC2C, AE3	C	Anion exchanger 3, neuronal	106195	A, Psh, Fd			1(Ae3)
2.884	12	18	07	2q36.3	SPHKAP, SKIP, KIAA1678	P	SPHK1 interactor, AKAP domain containing	611646	R, REc			
2.885	9	12	02	2q35	STK11IP, KIAA1898, LIP1	P	Serine/threonine kinase 11 interacting protein	607172	R			
2.886	11	22	99	2q37.3	AGXT, SPAT	C	Alanine-glyoxylate aminotransferase, liver-specific peroxisomal	604285	A, REa		Hyperoxaluria, primary, type 1, 259900 (3)	
2.887	5	4	12	2q36.3	COL4A3	C	Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	REa, A, RE	noncollagenous domain = Goodpasture antigen	Alport syndrome, autosomal recessive, 203780 (3); Hematuria, benign familial, 141200 (3); Alport syndrome, autosomal dominant, 104200 (3)	
2.888	5	8	97	2q36.3	COL4A4	C	Collagen IV, alpha-4 polypeptide	120131	REa, A	head-to-head with COL4A4 in same YAC	Alport syndrome, autosomal recessive, 203780 (3); Hematuria, familial benign (3)	
2.889	2	8	13	2q37.1	ECEL1, XCE, DA5D	P	Endothelin-converting enzyme-like 1	605896	A		Arthrogryposis, distal, type 5D, 615065 (3)	
2.890	2	18	98	2q37.2	GBX2	P	Gastrulation brain homeo box-2	601135	Psh, A			1(Gbx2)
2.891	5	12	89	2q24.2	GCG	C	Glucagon	138030	REa, A		[?Hyperproglucagonemia] (1)	2(Gcg)
2.892	8	15	97	2q37.1	INPP5D, SHIP	P	Inositol polyphosphate-5-phosphatase, 145kD	601582	A			1(Inpp5d)
2.893	4	7	14	2q37.1	PDE6D, JBTS22	C	Phosphodiesterase 6D, cGMP-specific, rod, delta	602676	A, R	mutation identified in 1 JBTS22 family	?Joubert syndrome 22, 615665 (3)	1(Pde6d)
2.894	8	27	09	2q37.1	PTMA, TMSA	P	Prothymosin, alpha (gene sequence 28)	188390	REa, REc			
2.895	2	14	01	2q37.3	RAMP1	C	Receptor activity-modifying protein 1	605153	R			1(Ramp1)
2.896	12	1	14	2q36.1	AP1S3, PSORS15	P	Adaptor-related protein complex 1, sigma-3 subunit	615781	REc		{Psoriasis 15, pustular, susceptibility to}, 616106 (3)	
2.897	4	14	10	2q35	CHPF, CSS2	C	Chondroitin polymerizing factor	610405	REc			
2.898	8	3	12	2q36.1	MOGAT1, MGAT1, DGAT2L1	P	Monoacylglycerol O-acyltransferase 1	610268	REc, R			
2.899	2	23	12	2q36.1	PAX3, WS1, HUP2, CDHS, WS3	C	Paired box homeotic gene-3	606597	Ch, Fd, H, A, Psh		Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type 3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)	1(Sp)
2.900	7	16	09	2q36.1	SGPP2, SPP2	P	Sphingosine-1-phosphate phosphatase 2	612827	REc			
2.901	2	21	10	2q36.1-q36.3	SPDA3	P	Spondyloarthropathy, susceptibility to, 3	613238	Fd	max lod at D2S2228	{Spondyloarthropathy, susceptibility to, 3} (2)	
2.902	12	10	10	2q36.2	RJBS	P	Rajab syndrome	613658	Fd	between D2S351 and D2S2390	Rajab syndrome (2)	
2.903	10	13	09	2q36.2	DOCK10, KIAA0694, ZIZ3	P	Dedicator of cytokinesis 10	611518	R, REc			
2.904	2	27	12	2q36.2	CUL3, PHA2E	P	Cullin 3	603136	R, REc		Pseudohypoaldosteronism, type IIE, 614496 (3)	
2.905	8	27	12	2q36.3	MFF, C2orf33	P	Mitochondrial fission factor	614785	REc			
2.906	12	10	13	2q36.3	NYPA2, KIAA1486	P	Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 2	615478	REc, R			
2.907	8	17	09	2q36.3	PID1, NYGGF4	P	Phosphotyrosine interaction domain-containing 1	612930	REc			
2.908	2	13	12	2q36.3	SLC19A3, THMD2, BBGD	C	Solute carrier family 19 (folate transporter), member 3	606152	A, H, Fd		Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	1(Slc19a3)
2.909	10	15	13	2q36.3	TM4SF20, SLI5	P	Transmembrane 4 L6 family, member 20	615404	REc		{Specific language impairment 5}, 615432 (3)	
2.910	8	27	09	2q36.3	TRIP12	P	Thyroid hormone receptor interactor 12	604506	REa, REc			
2.911	3	14	96	2q37.1	HTR2B	P	5-hydroxytryptamine (serotonin) receptor-2B	601122	A			
2.912	4	12	92	2q37.1	ALPP	C	Alkaline phosphatase, placental (Regan isozyme)	171800	REb, REa, A, RE			4(Akp2)
2.913	4	12	92	2q37.1	ALPPL2	P	Alkaline phosphatase, placental-like 2	171810	REa, A			
2.914	9	22	08	2q37.3	ASB1	P	Ankyrin repeat-containing SOCS box protein 1	605758	R, REc			1(Asb1)
2.915	10	14	15	2q37	BDMR, C2DELq37, DEL2q37	P	Chromosome 2q37 deletion syndrome	600430	Ch		Chromosome 2q37 deletion syndrome (4)	
2.916	7	20	15	2q37.3	COL6A3, DYT27, BTHLM1, UCMD1	C	Collagen VI, alpha-3 polypeptide	120250	REa, A	close to CRBP1	Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3); Dystonia 27, 616411 (3)	1(Col6a3)
2.917	8	11	15	2q37.3	ACKR3, CXCR7, CMKOR1, GPR159, RDC1	P	Atypical chemokine receptor 3	610376	A			
2.918	4	29	03	2q36.3	DNER	P	Delta-and notch-like egf-related receptor	607299	REc			
2.919	3	9	00	2q37.1	GPR55	P	G protein-coupled receptor 55	604107	A			
2.920	12	29	99	2q37.3	HDLBP, VGL	P	High-density lipoprotein-binding protein	142695	REa, A			
2.921	3	28	12	2q37	IBGC2	P	Basal ganglia calcification, idiopathic, 2	606656	Fd		Basal ganglia calcification, idiopathic, 2 (2)	
2.922	9	1	05	2q37.1	ITM2C, BRI3	P	Integral membrane protein 2C	609554	REc			
2.923	8	25	11	2q37.1	KCNJ13, SVD, LCA16	C	Potassium inwardly-rectifying channel, subfamily J, member 13	603208	R, Fd		Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital amaurosis 16, 614186 (3)	
2.924	10	3	11	2q37.3	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	P	Kinesin family member 1A	601255	Psh, A	incorrectly assigned to chr.9	Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy, hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)	
2.925	5	31	05	2q37.3	MLPH	P	Melanophilin	606526	R, H		Griscelli syndrome, type 3, 609227 (3)	1(Mlph)
2.926	1	8	01	2q37.1	NEU2, SIAL2	P	Neuraminidase 2	605528	A, R			
2.927	7	17	01	2q37.1	NGEF	P	Neuronal guanine nucleotide exchange factor	605991	REc, A			1(Ngef)
2.928	10	1	07	2q37.3	SEPT2, NEDD5, DIFF6	P	Septin 2	601506	A			
2.929	3	26	02	2q37.1	TRPM8, TRPP8	P	Transient receptor potential cation channel, subfamily M, member 8	606678	REc			
2.930	6	7	10	2q37.1	UGT1A1, UGT1, GNT1, BILIQTL1	C	UDP glycosyltransferase 1 family, polypeptide A1	191740	REa		Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome], 143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transient neonatal, 237900 (3); [Bilirubin, serum level of, QTL1], 601816 (3)	1(Ugt1)
2.931	11	1	01	2q37.1	UGT1A3, UGT1C	P	UDP-glycosyltransferase 1 family, polypeptide A3	606428	REa, REn			
2.932	11	1	01	2q37.1	UGT1A4, UGT1D	P	UDP-glycosyltransferase 1 family, polypeptide A4	606429	REa, REn			
2.933	11	1	01	2q37.1	UGT1A5	P	UDP-glycosyltransferase 1 family, polypeptide A5	606430	REa, REn			
2.934	11	1	01	2q37.1	UGT1A8	P	UDP-glycosyltransferase 1 family, polypeptide A8	606433	REa, REn			
2.935	11	1	01	2q37.1	UGT1A6	P	UDP-glycosyltransferase 1 family, polypeptide A6	606431	REa, REn			
2.936	11	1	01	2q37.1	UGT1A7	P	UDP-glycosyltransferase 1 family, polypeptide A7	606432	REa, REn			
2.937	11	1	01	2q37.1	UGT1A9	P	UDP-glycosyltransferase 1 family, polypeptide A9	606434	REa, REn			
2.938	11	1	01	2q37.1	UGT1A10	P	UDP-glycosyltransferase 1 family, polypeptide A10	606435	REa, REn			
2.939	6	10	98	2q37.1	SPP2	P	Secreted phosphoprotein-2, 24kD	602637	R, A			
2.940	6	22	01	2q37.1	ALPI	C	Alkaline phosphatase, intestinal	171740	A, REa, RE, REc	close to ALPP; proximal to PAX3		1(Akp3)
2.941	7	20	12	2q37.1	ARL4C, ARL7	P	ADP-ribosylation factor-like 4C	604787	REc			
2.942	5	19	09	2q37.1	ATG16L1, APG16L, IBD10	C	Autophagy 16-like 1	610767	REc		{Inflammatory bowel disease 10}, 611081 (3)	
2.943	7	22	13	2q37.1	B3GNT7	P	Beta-1,3-N-acetylglucosaminyltransferase 7	615313	REc			
2.944	8	1	08	2q37.1	CAB39	P	Calcium-binding protein 39	612174	R, REc			
2.945	9	22	14	2q37.1	COPS7B	P	COP9 signalosome, subunit 7B	616010	REc			
2.946	1	9	07	2q37.1	DGKD	P	Diacylglycerol kinase, delta, 130kD	601826	REc			
2.947	2	18	08	2q37.1	EFHD1	P	EF-hand domain family, member D1	611617	REc			
2.948	2	21	06	2q37.1	EIF4E2, EIF4EL3, 4EHP	C	Eukaryotic translation initiation factor 4E family, member 2	605895	R, REc			
2.949	9	9	08	2q36.3	FBXO36, FBX36	P	F-box only protein 36	609105	REc			1(Fbxo36)
2.950	4	10	15	2q37.1	GIGYF2, KIAA0642, PARK11	C	GRB10-interacting GYF protein 2	612003	R, REc, Fd		{Parkinson disease 11}, 607688 (3)	1(Gigyf2)
2.951	3	23	09	2q37.1	HJURP	P	Holliday junction recognition protein	612667	REc			
2.952	3	23	06	2q37.1	MYP12	P	Myopia 12	609995	Fd	max lod at D2S2344	Myopia 12 (2)	
2.953	5	19	06	2q37.1	NMUR1, GPR66, FM3	P	Neuromedin U receptor 1	604153	REc			
2.954	4	15	11	2q37.1	PRSS56, MCOP6	P	Protease, serine, 56	613858	REc, Fd		Microphthalmia, isolated 6, 613517 (3)	
2.955	2	25	14	2q37.1	SCARNA5	P	Small Cajal body-specific RNA 5	615640	REc	within intron 9 of ATG16L1		
2.956	2	25	14	2q37.1	SCARNA6	P	Small Cajal body-specific RNA 6	615641	REc	within intron 12 of ATG16L1		
2.957	7	7	05	2q37.1	SP100	P	Nuclear antigen SP100	604585	R, REc			
2.958	10	11	06	2q37.1	SP110, IFI41, IFI75, VODI	C	SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)	604457	R, Fd		Hepatic venoocclusive disease with immunodeficiency, 235550 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
2.959	4	23	09	2q37.1	SAG, RP47	C	S-antigen; retina and pineal gland (arrestin)	181031	REa, A, Fd		Oguchi disease-1, 258100 (3); Retinitis pigmentosa 47, 613758 (3)	1(Sag)
2.960	9	7	10	2q37.1	STQTL21	P	Stature quantitative trait locus 21	613440	Fd	associated with rs6717918	{Stature QTL 21} (2)	
2.961	9	10	09	2q37.1	TIGD1	P	TIGGER transposable element-derived gene 1	612972	REc			
2.962	5	24	13	2q37.1	USP40	P	Ubiquitin-specific protease 40	610570	REc, R			
2.963	2	5	01	2q37.2	SH3BP4, BOG25	P	SH3 domain-binding protein 4	605611	A			
2.964	7	20	01	2q37.1-q37.3	HPE6	P	Holoprosencephaly 6	605934	Ch		Holoprosencephaly-6 (2)	
2.965	3	16	12	2q37.1	DIS3L2, PRLMNS	P	Dis3 mitotic control, S. cerevisiae, homolog-like 2	614184	REc		Perlman syndrome, 267000 (3)	
2.966	10	13	15	2q37.3	HDAC4, HDACA	P	Histone deacetylase 4	605314	A, Ch			
2.967	4	2	16	2q37.3	ATG4B, APG4B, KIAA0943	P	Autophagy 4, S. cerevisiae, homolog of, B	611338	REc			
2.968	4	17	09	2q37.3	CAPN10, NIDDM1	C	Calpain-10	605286	A, REc		{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)	
2.969	9	22	14	2q37.3	COPS8, CSN8	P	COP9 signalosome, subunit 8	616011	REc, H			1(Csn8)
2.970	10	23	08	2q37.3	D2HGDH, D2HGD	P	D-2-hydroxyglutarate dehydrogenase	609186	REc		D-2-hydroxyglutaric aciduria, 600721 (3)	
2.971	5	25	13	2q37.3	DTYMK, TYMK, CDC8	P	Deoxythymidylate kinase	188345	REc			
2.972	3	14	13	2q37.3	FAM132B, CTRP15	P	Family with sequence similarity 132, member B	615099	REc			1(Fam132b)
2.973	2	7	07	2q37.3	GAL3ST2, GP3ST	P	Galactose-3-O-sulfotransferase 2	608237	REc			
2.974	6	19	98	2q37.3	GPR35	P	G protein-coupled receptor-35	602646	A			
2.975	8	31	06	2q37.3	HES6	P	Hairy/enhancer of split, Drosophils, homolog of, 6	610331	R, REc			
2.976	3	15	04	2q37.3	ING5	P	Inhibitor of growth-5	608525	R, REc			
2.977	7	1	11	2q37.3	LRRFIP1, GCF2, TRIP, FLAP1	P	Leucine-rich repeat in FLII-interacting protein 1	603256	REc			
2.978	5	6	13	2q37.3	MIR149	P	Micro RNA 149	615209	REc			
2.979	1	13	15	2q37.3	MTERF4, MTERFD2	P	Mitochondrial transcription termination factor 4	615393	REc			
2.980	2	11	15	2q37.3	NDUFA10	P	NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 10	603835	REa, REc	mutation identified in 1 Leigh syndrome patient	?Leigh syndrome, 256000 (3)	
2.981	5	25	13	2q37.3	NEU4	P	Neuraminidase 4	608527	REc			1(Neu4)
2.982	6	12	03	2q37.3	OTOSP	P	Otospiralin	607877	A, R			
2.983	3	3	03	2q37.3	PASK, KIAA0135	P	Pas domain-containing serine-threonine kinase	607505	REc			
2.984	1	6	11	2q37.3	PDCD1, SLEB2	C	Programmed cell death 1	600244	A, Fd		{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3); {Multiple sclerosis, disease progression, modifier of}, 126200 (3)	
2.985	5	13	13	2q37.3	PER2, FASPS1, KIAA0347	P	Period, Drosophila, homolog of, 2	603426	Fd, A, REc		Advanced sleep phase syndrome, familial, 1, 604348 (3)	
2.986	8	20	98	2q37.3	PPP1R7, SDS22	P	Protein phosphatase 1, regulatory subunit 7	602877	REa, REc			
2.987	10	28	09	2q37.3	RAB17	P	Ras-associated protein	602206	REc			
2.988	9	28	00	2q37.3	RNPEPL1	P	Arginyl aminopeptidase-like 1 (aminopeptidase B-like)	605287	REn			
2.989	8	21	07	2q37.3	SCLY, SCL	P	Selenocysteine lyase	611056	R, REc			
2.990	11	18	15	2q37.3	SNED1, SNEP	P	SUSHI, NIDOGEN, and EGF-like domains protein 1	616634	REc			1(Sned1)
2.991	9	20	14	2q37.3	STK25, SOK1, YSK1	P	Serine/threonine protein kinase 25	602255	REc			
2.992	1	20	09	2q37.3	THAP4	P	THAP domain-containing protein 4	612533	REc			
2.993	1	2	08	2q37.3	TMEM16G, PCANAP5, IPCA5, DTMPP, NGEP	P	Transmembrane protein 16G	605096	REc			
2.994	11	4	15	2q37.3	TRAF3IP1, MIPT3, SLSN9	P	TNF receptor-associated factor 3-interacting protein 1	607380	REc		Senior-Loken syndrome 9, 616629 (3)	
2.995	8	11	15	2q37.3	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	P	Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of)	607556	REc		Focal facial dermal dysplasia 3, Setleis type, 227260 (3); Barber-Say syndrome, 209885 (3); Ablepharon-macrostomia syndrome, 200110 (3)	
2.996	4	6	00	Chr.2	TSE2	P	Transsuppressor of expression 2	601136	M			
3.1	3	10	11	3pter-p25	DEL3pterp25, C3DELpterp25	P	3p- syndrome (chromosome 3pter-p25 deletion syndrome)	613792	Ch	contiguous gene deletion syndrome	3p- syndrome (4)	
3.2	12	22	89	3p22.1	CCK	C	Cholecystokinin	118440	REb, REa			9(Cck)
3.3	3	10	11	3p22.2	CX3CR1, GPR13, V28	P	Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13)	601470	REa		{Rapid progression to AIDS from HIV1 infection}, 609423 (3); {Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3)	
3.4	2	15	96	3p21.31	SEP	P	SEP transmembrane protein	601053	REa			
3.5	3	17	05	3p26.2	CRBN, MRT2	C	Cereblon	609262	Fd, REc	between D3S3525 and D3S1560	Mental retardation, autosomal recessive 2, 607417 (3)	
3.6	12	17	07	3p26.1	EGO	P	Eosinophil granule ontogeny	611662	REc			
3.7	1	8	01	3p25.3	OGG1	C	8-hydroxyguanine DNA glycosylase	601982	A		Renal cell carcinoma, clear cell, somatic, 144700 (3)	6(Ogg1)
3.8	3	5	95	3p25.3	OXTR	C	Oxytocin receptor	167055	A, Psh	3p25 by others; within 7-10kb of CAV3		
3.9	10	23	15	3p26.1	ARL8B, GIE1	P	ADP-ribosylation factor-like 8B	616596	REc			
3.10	2	28	03	3p26.3	CHL1, CALL, L1CAM2	C	CHL1, mouse, homolog of (L1 cell adhesion molecule 2)	607416	A, D			6(Chl1)
3.11	4	3	03	3p26.1	EDEM, KIAA0212	P	ER degradation-enhancing alpha-mannosidase-like protein	607673	R			
3.12	4	19	12	3p26.1	GRM7, MGLUR7	P	Glutamate receptor, metabotropic, 7	604101	R, REc			
3.13	2	7	13	3p26.1	ITPR1, SCA15, SCA16, SCA29	C	Inositol 1,4,5-triphosphate receptor, type 1	147265	REa, A, Fd, REc		Spinocerebellar ataxia 15, 606658 (3); Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3)	6(Itpr1)
3.14	8	24	09	3p26.1-p25.1	ARHI2	P	Age-related hearing impairment 2	612976	Fd	associated with rs11928865, rs779701, and rs779706	{Age-related hearing impairment 2} (2)	
3.15	9	30	10	3p26.1	BHLHE40, HLHB2, STRA13, DEC1	P	Basic helix-loop-helix family, member E40	604256	A			
3.16	5	30	00	3p12.3	CNTN3, PANG	P	Contactin 3 (plasmocytoma-associated neuronal glycoprotein)	601325	REa, H			6(Pang)
3.17	5	1	08	3p26	HPC5	P	Prostate cancer, hereditary, 5	609299	Fd	between D3S1270 and D3S4559	{Prostate cancer, hereditary, 5}, 176807 (2)	
3.18	3	8	04	3p26	IBD9	P	Inflammatory bowel disease 9	608448	Fd		{Inflammatory bowel disease 9} (2)	
3.19	3	20	06	3p26.1	SETMAR, METNASE	P	SET and Mariner transposase domains-containing protein	609834	REc			
3.20	5	23	06	3p26	STQTL5	P	Stature quantitative trait locus 5	608982	Fd	max lod between D3S1297 and D3S1304	{Stature QTL 5} (2)	
3.21	10	29	03	3p26.1	SUMF1, FGE	P	Sulfatase-modifying factor-1	607939	REc, H		Multiple sulfatase deficiency, 272200 (3)	6(Sumf1)
3.22	5	25	05	3p25.3	ATP2B2, PMCA2	C	ATPase, Ca++ transporting, plasma membrane, 2	108733	REa		{Deafness, autosomal recessive 12, modifier of}, 601386 (3)	
3.23	12	12	00	3p25.3	BRPF1, BR140	P	Bromodomain- and PHD finger-containing protein 1, 140kD	602410	A			
3.24	6	9	08	3p26.3-p26.2	CNTN4	C	Contactin 4	607280	REc, Fd			
3.25	10	17	02	3p26.3	CNTN6, NB3	P	Contactin 6	607220	A			
3.26	2	20	03	3p25.3	GHRL	P	Ghrelin	605353	REc		{Obesity, susceptibility to}, 601665 (3)	
3.27	11	5	02	3p25.3	VHL	C	VHL gene	608537	Fd, D, RE		von Hippel-Lindau syndrome, 193300 (3); Renal cell carcinoma, somatic, 144700 (3); Pheochromocytoma, 171300 (3); Hemangioblastoma, cerebellar, somatic (3); Erythrocytosis, familial, 2, 263400 (3)	
3.28	9	12	08	3p26-p24.2	MYMY1, MYMY	P	Moyamoya disease	252350	Fd	max lod at D3S3050	Moyamoya disease (2)	
3.29	6	7	94	3p26.2	IL5RA	C	Interleukin-5 receptor, alpha	147851	REa, A			6(Il5r)
3.30	5	11	00	3p25.3	LMCD1	P	LIM and cysteine-rich domains 1	604859	R			6(Lmcd1)
3.31	11	11	14	3p25.3	ARPC4, ARC20	P	Actin-related protein 2/3 complex, subunit 4	604226	REc			
3.32	5	9	12	3p25.3	ATG7, APG7L, GSA7	P	Autophagy 7, S. cerevisiae, homolog of	608760	REc, R			
3.33	2	25	14	3p25.3	BRK1, C3orf10, HSPC300	P	BRICK1, SCAR/WAVE actin-nucleating complex subunit	611183	REc			
3.34	8	28	09	3p25.3	CAMK1, CAMKI	P	Calcium/calmodulin-dependent protein kinase I	604998	REa, REc			
3.35	4	24	03	3p25.3	CRELD1, AVSD2	C	Cysteine-rich protein with EGF-like domains 1	607170	R, REc, H		{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3); Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	6(Creld1)
3.36	3	14	01	3p25.3	FANCD2, FANCD, FACD, FAD	P	Fanconi anemia, complementation group D2	613984	M		Fanconi anemia, complementation group D2, 227646 (3)	
3.37	1	9	13	3p25.3	IL17RE	P	Interleukin 17 receptor E	614995	REc			
3.38	4	6	10	3p25.3	IRAK2	P	Interleukin 1 receptor-associated kinase 2	603304	REc			
3.39	9	24	14	3p25.3	JAGN1, SCN6	P	Jagunal, Drosophila, homolog of, 1	616012	REc		Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3)	6(Jagn1)
3.40	8	22	07	3p25.3	MTMR14, C3orf29, HJUMPY	P	Myotubularin-related protein 14	611089	REc		{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	
3.41	4	29	14	3p25.3	SETD5, KIAA1757	P	SET domain-containing protein 5	615743	REc		Mental retardation, autosomal dominant 23, 615761 (3)	
3.42	2	2	10	3p25.3	SLC6A11, GAT3, GAT4	P	Solute carrier family 6 (neurotransmitter transporter, GABA), member 11	607952	REc			
3.43	4	26	10	3p25.3	TADA3, TADA3L, ADA3	P	Transcriptional adaptor 3	602945	R, REc			
3.44	7	6	15	3p25.3	IL17RC, IL17RL, CANDF9	P	Interleukin 17 receptor C	610925	REc		Candidiasis, familial, 9, 616445 (3)	
3.45	1	27	04	3p22.1	TRAK1, OIP106, KIAA1042	C	Trafficking protein, kinesin-binding 1	608112	R, REc			9(hyrt)
3.46	5	7	03	3p23	OSBPL10, ORP10	C	Oxysterol-binding protein-like protein 10	606738	REc			
3.47	2	25	15	3p25.2	CAND2, TIP120B, KIAA0667	P	Cullin-associated neddylation -dissociated 2	610403	R, REc			
3.48	8	19	13	3p25.2-p25.1	IQSEC1, KIAA0763	P	IQ motif- and Sec7 domain-containing protein 1	610166	R, REc			
3.49	12	17	12	3p25.2	TAMM41, RAM41, C3orf31	P	Translocator assembly and maintenance, mitochondrial, S. cerevisiae, homolog of	614948	REc			
3.50	4	15	03	3p25.2-p25.1	UVM2	C	Melanoma, uveal, susceptibility to, 2	606661	Ch, D		{Melanoma, uveal, susceptibility to, 2} (2)	
3.51	11	29	04	3p25.1	BTD	P	Biotinidase	609019	A		Biotinidase deficiency, 253260 (3)	
3.52	11	2	11	3p25.3	CAV3, LGMD1C, LQT9	C	Caveolin-3	601253	A, REc	within 7-10kb of OXTR	Muscular dystrophy, limb-girdle, type IC, 607801 (3); Rippling muscle disease, 606072 (3); Creatine phosphokinase, elevated serum, 123320 (3); Myopathy, distal, Tateyama type, 614321 (3); Cardiomyopathy, familial hypertrophic, 192600 (3); Long QT syndrome 9, 611818 (3)	
3.53	5	23	13	3p25.3	CIDEC, FSP27, CIDE3, FPLD5	P	Cell death-inducing DFFA-like effector C	612120	REc	1 patient identified with mutation	?Lipodystrophy, familial partial, type 5, 615238 (3)	
3.54	4	30	15	3p25.1	COLQ, EAD, CMS5	C	Collagenic tail of endplate acetylcholinesterase	603033	A, R		Myasthenic syndrome, congenital, 5, 603034 (3)	
3.55	5	24	13	3p25.3	LHFPL4	P	LHFP-like protein 4	610240	REc			
3.56	2	2	04	3p25.2	MKRN2	P	Makorin 2	608426	REc			6(Mkrn2)
3.57	4	24	08	3p25.1	MRPS25	P	Mitochondrial ribosomal protein S25	611987	R, REc			
3.58	10	21	99	3p25.1	NR2C2, TR4, TAK1	P	Nuclear receptor subfamily 2, group C, member 2	601426	REa, A			
3.59	3	27	09	3p25.2	PPARG, PPARG1, PPARG2, CIMT1, GLM1	C	Peroxisome proliferator activated receptor, gamma	601487	REa, Fd, A	PPARG1, PPARG2 from same gene	Obesity, severe, 601665 (3); [Obesity, resistance to] (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3); Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)	
3.60	8	3	14	3p25.2	RAF1, CRAF, NS5, CMD1NN	C	Oncogene RAF1	164760	REa, Fd, A		Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3); Cardiomyopathy, dilated, 1NN, 615916 (3)	6(Raf1)
3.61	10	28	02	3p25.3	SRGAP3, KIAA0411, MEGAP	C	Slit-robo GTPase-activating protein, rho, 3	606525	R, Ch			
3.62	8	19	99	3p25	ST11, PETS1	P	Suppression of tumorigenicity 11, pancreas	602011	D		?Pancreatic endocrine tumors (1)	
3.63	11	2	04	3p25.2	SYN2	C	Synapsin II	600755	REa, H, REn		{Schizophrenia, susceptibility to}, 181500 (3)	6(Syn2)
3.64	10	3	02	3p25.2	TIMP4	P	Tissue inhibitor of metalloproteinase 4	601915	A			6(Timp4)
3.65	3	27	13	3p25.1	TMEM43, ARVD5, ARVC5, EDMD7	C	Transmembrane protein 43	612048	REc, Fd		Arrhythmogenic right ventricular dysplasia 5, 604400 (3); Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	
3.66	7	18	06	3p25.1	WNT7A	C	Wingless-type MMTV integration site family, member 7A	601570	A, Fd		Ulna and fibula, absence of, with severe limb deficiency, 276820 (3); Fuhrmann syndrome, 228930 (3)	
3.67	2	19	10	3p25.1	XPC, XPCC	C	XPC gene	613208	REa, A, RE		Xeroderma pigmentosum, group C, 278720 (3)	6(Xpc)
3.68	10	5	11	3p24.3	PLCL2, KIAA1092	C	Phospholipase C-like 2	614276	R, REc			
3.69	9	19	00	3p25.3	RAD18	P	Rad18, S. cerevisiae, homolog of	605256	A, R			
3.70	5	7	97	3p25.3	SEC13L1, D3S1231E, SEC13R	P	SEC13, S. cerevisiae, like 1	600152	Psh, A			6(Sec13n)
3.71	10	9	94	3p25.1	FBLN2	P	Fibulin-2	135821	A			6(Fbln2)
3.72	6	19	15	3p25.3	SLC6A1, GABATR, MAE	P	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1	137165	A		Myoclonic-atonic epilepsy, 616421 (3)	
3.73	5	27	05	3p25-p22	OVCAS1	P	Ovarian cancer, susceptibility to, 1	607893	Fd	between D3S1597 and D3S3611	{Ovarian cancer, susceptibility to} (2)	
3.74	3	5	95	3p25.1	SLC6A6, TAUT	C	Solute carrier family 6 (neurotransmitter transporter, taurine), member 6	186854	REa, A			6(Slc6a6)
3.75	9	10	07	3p25.1	ANKRD28, PITK, KIAA0379	C	Ankyrin repeat domain-containing protein 28	611122	R, REc			
3.76	2	18	16	3p25.1	CCDC174, HSPC212, IHPM	C	Coiled-coil domain-containing protein 174	616735	Psh, REc		Hypotonia, infantile, with psychomotor retardation, 616816 (3)	
3.77	8	21	07	3p25.1	CHDH4, MIA40	P	Coiled-coil-helix-coiled-coil-helix domain-containing protein 4	611077	REc			
3.78	12	4	03	3p25.1	EAF1	P	ELL-associated factor 1	608315	R, REc			
3.79	8	31	12	3p25.1	FGD5	P	FYVE, RhoGEF, and PH domain-containing protein 5	614788	REc			
3.80	4	6	13	3p25.1	GALNT15, GALNACT15	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15	615131	REc			
3.81	6	22	14	3p25.1	HACL1, HPCL2	P	2-hydroxyacyl-CoA lyase 1	604300	REc			
3.82	8	28	09	3p25.1	NUP210, GP210, KIAA0906	P	Nucleoporin, 210kD	607703	R, REc			
3.83	11	19	10	3p25.1	SH3BP5, SAB	P	SH3 domain-binding protein 5	605612	REc, A	previously mapped to 1q431		14(Sh3bp5)
3.84	11	19	14	3p26.2	TRNT1, SIFD	P	tRNA nucleotidyltransferase, CCA-adding, 1	612907	REc	pseudogenes on chromosomes 1 and 22	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3)	
3.85	11	21	02	3p25.1	LSM3	P	LSM3 protein	607283	REc			
3.86	11	15	08	3p25.2	TSEN2, SEN2, PCH2B	P	tRNA splicing endonuclease 2, S. cerevisiae, homolog of	608753	REc		Pontocerebellar hypoplasia type 2B, 612389 (3)	
3.87	8	20	10	3p25.1-p23	LGMD1H	P	Muscular dystrophy, limb-girdle, type 1H	613530	Fd	between D3S1263 and D3S1277	Muscular dystrophy, limb-girdle, type 1H (2)	
3.88	10	23	15	3p25.1	COL6A4P1, DVWA, DIVA, LOC344875	P	Collagen, type VI, alpha 4, pseudogene 1	612397	REc			
3.89	8	21	07	3p25.1	DPH3, KTI11, ZCSL2, DELGIP1	P	DPH3, S. cerevisiae, homolog of	608959	R, REc			
3.90	4	15	09	3p24.3	OS6	P	Osteoarthritis susceptibility 6	612401	Fd	associated with rs11718863 and rs7639618	{Osteoarthritis susceptibility 6} (2)	
3.91	2	4	15	3p24.3	SGOL1, SGO, SGO1, CAID	P	Shugoshin-like 1	609168	REc		Chronic atrial and intestinal dysrhythmia, 616201 (3)	
3.92	4	29	14	3p24.3	TBC1D5, KIAA0210	C	TBC1 domain family, member 5	615740	REc, R			
3.93	9	4	08	3p24.2	THRB, ERBA2, THR1, PRTH	C	Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)	190160	REa, A, RE, Fd		Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance, autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)	
3.94	8	3	12	3p24.2	UBE2E1, UBCH6	P	Ubiquitin-conjugating enzyme E2E 1	602916	REc			
3.95	10	2	12	3p24.2	NR1D2, RVR, BD73	P	Nuclear receptor subfamily 1, group D, member 2	602304	REc			
3.96	8	31	06	3p24.2	OXSM, KS	P	3-oxoacyl-ACP synthase, mitochondrial	610324	REc			14(Oxsm)
3.97	12	27	13	3p24.2	RPL15, DBA12	P	Ribosomal protein L15	604174	REa, R, REc	mutation identified in 1 family	?Diamond-Blackfan anemia 12, 615550 (3)	
3.98	3	5	98	3p24.3	UBE2E2	P	Ubiquitin-conjugating enzyme E2E 2 (homologous to yeast UBC4/5)	602163	A			
3.99	1	2	08	3p24.2-p23	FEB9	P	Febrile seizures, familial, 9	611634	Fd	between D3S3727 and D3S3567	Febrile seizures, familial, 9 (2)	
3.100	3	1	06	3p24.1	AZI2, AZ2, NAP1, TILP	P	5-azacytidine-induced gene 2, mouse, homolog of	609916	REc			
3.101	1	28	14	3p24-p23	GADL1	P	Glutamate decarboxylase-like 1	615601	REc			
3.102	12	22	00	3p21.31	CELSR3, EGFL1, MEGF2	P	Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 1)	604264	R			
3.103	8	20	15	3p24	ATOD9	P	Dermatitis, atopic, 9	613519	Fd	max lod at D3S1768	{Dermatitis, atopic, susceptibility to, 9} (2)	
3.104	12	30	98	3p24.3	CAF	P	CREBBP-associated factor	602303	A			17(Caf)
3.105	11	28	01	3p25.1	CAPN7, PALBH	P	Calpain 7	606400	R			
3.106	10	17	00	3p22.3	CCR4, CKR4, CMKBR4	P	Chemokine (C-C) receptor-4	604836	R, REc			
3.107	4	17	13	3p24.1	CMC1, C3orf68	P	Cytochrome C oxidase assembly mitochondrial protein 1, S. cerevisiae, homolog of	615166	REc			
3.108	4	15	03	3p24.3	DAZL, DAZH, SPGYLA	P	Deleted in azoospermia-like	601486	A, R	?founding member of DAZ gene family	{Spermatogenic failure, susceptibility to} (3)	
3.109	6	9	15	3p24.2	NGLY1, PNG1, CDDG, CDG1V	P	N-glycanase 1	610661	R, REc		Congenital disorder of deglycosylation, 615273 (3)	
3.110	11	19	13	3p24.2	RARB, HAP, MCOPS12	C	Retinoic acid receptor, beta polypeptide	180220	REa, A	= HAP = HBV-activated protein	Microphthalmia, syndromic 12, 615524 (3)	14(Rarb)
3.111	1	30	01	3p24.2	TOP2B	P	Topoisomerase (DNA) II, beta, 180kD	126431	REa, Fd			
3.112	8	27	01	3p24.1	RBMS3	P	RNA-binding motif protein, single strand-interacting, 3	605786	A			
3.113	9	22	03	3p24-p22	HSN1B	P	Hereditary sensory neuropathy, type IB	608088	Fd	max lod at D3S2338	Neuropathy, hereditary sensory, type IB (2)	
3.114	8	18	98	3p24.3	RAB5A, RAB5	P	RAS-associated protein RAB5A	179512	A			
3.115	4	23	98	3p22.3-p22.2	STAC	P	SRC homology three (SH3) and cysteine-rich domain	602317	R, H			9(Stac)
3.116	3	14	06	3p24-p21	ASPG4	P	Asperger syndrome, susceptibility to, 4	609954	Fd	max lod at D3S2432	{Asperger syndrome susceptibility 4} (2)	
3.117	6	9	98	3p24.3	SATB1	P	Special AT-rich sequence binding protein-1	602075	A			
3.118	1	14	14	3p23	STT3B, SIMP, CDG1X	P	STT3B, subunit of the oligosaccharyltransferase complex (catalytic)	608605	REc	mutation identified in 1 family	?Congenital disorder of glycosylation, type Ix, 615597 (3)	
3.119	12	23	05	3p22.3	UBP1, LBP1A, LBP1B	P	Upstream binding protein 1	609784	R, REc			
3.120	8	4	09	3p22.2	ACAA1	P	Acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase)	604054	REa, A			
3.121	1	17	08	3p21.31	CDCP1, SIMA135	P	CUB domain-containing protein 1	611735	A			
3.122	1	11	89	3p23-p21	SCLC1	C	Small-cell cancer of lung	182280	Ch, D	centromeric to ERBA2	Small-cell cancer of lung (2)	
3.123	6	16	99	3p21.31	SMARCC1, BAF155	P	SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily C, member 1	601732	R, Psh			
3.124	6	28	02	3p21.31	TDGF1	C	Teratocarcinoma-derived growth factor-1	187395	REa, A		Forebrain defects (3)	9(Tdgf1)
3.125	8	28	09	3p22.3	CLASP2	P	CLIP-associated protein 2	605853	R, REc			
3.126	12	5	11	3p22.3	CMTM6, CKLFSF6	P	CKLF-like marvel transmembrane domain-containing 6	607889	REc			9(Cklfsf6)
3.127	12	5	11	3p22.3	CMTM7, CKLFSF7	P	CKLF-like marvel transmembrane domain-containing 7	607890	REc			9(Cklfsf7)
3.128	12	5	11	3p22.3	CMTM8, CKLFSF8	P	CKLF-like marvel transmembrane domain-containing 8	607891	REc			9(Cklfsf8)
3.129	12	21	09	3p22.2	DCLK3, DCK3, CLR	P	Doublecortin-like kinase 3	613167	REc			9(Dclk2)
3.130	7	17	14	3p22.3	DYNC1LI1, LIC1	P	Dynein, cytoplasmic 1, light intermediate chain 1	615890	REc			
3.131	8	28	09	3p22.3	FBXL2, FBL2	P	F-box and leucine-rich repeat protein 2	605652	R, REc			
3.132	2	11	08	3p22.3	GPD1L, KIAA0089	P	Glycerol-3-phosphate dehydrogenase 1-like	611778	REc, Fd		Brugada syndrome 2, 611777 (3)	
3.133	9	16	03	3p22.3	PDCD6IP, AIP1, ALIX, KIAA1375	P	Programmed cell death 6-interacting protein	608074	R			
3.134	12	23	05	3p22.2	CMYA1, XIN	P	Cardiomyopathy-associated protein 1	609777	R, REc			
3.135	2	2	14	3p22.2	DDH2	P	Developmental dysplasia of the hip 2	615612	Fd	between rs4481097 and rs4626072	Developmental dysplasia of the hip 2 (2)	
3.136	9	8	11	3p22.2	LRRFIP2	P	Leucine-rich repeat in FLII-interacting protein 2	614043	REc			
3.137	3	23	09	3p22.2	MIR26A, MIRN26A1	P	Micro RNA 26A1	612151	REc			
3.138	12	4	13	3p22.2	SCN10A, FEPS2	C	Sodium channel, voltage-gated, type X, alpha subunit	604427	Psh, REc		Episodic pain syndrome, familial, 2, 615551 (3)	
3.139	12	3	13	3p22.2	SCN11A, HSAN7, FEPS3	C	Sodium channel, voltage-gated, type XI, alpha subunit	604385	R, REc		Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3); Episodic pain syndrome, familial, 3, 615552 (3)	9(Scn11a)
3.140	8	25	11	3p22.1-p21.3	ANO10, TMEM16K, SCAR10	P	Anoctamin 10	613726	REc		Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	
3.141	2	14	13	3p22.1	CTNNB1, MRD19	C	Catenin (cadherin-associated protein), beta 1, 88kD	116806	A, REn, Psh, REc		Mental retardation, autosomal dominant 19, 615075 (3); Colorectal cancer, somatic, 114500 (3); Pilomatricoma, somatic, 132600 (3); Ovarian cancer, somatic, 167000 (3); Hepatocellular carcinoma, somatic, 114550 (3)	9(Catnb)
3.142	2	25	15	3p22.2	EPM2AIP1, KIAA0766	C	EPM2A-interacting protein 1	607911	R, REc, H			9(Epm2aip1)
3.143	8	2	13	3p22.1	KLHL40, SYRP, KBTBD5, NEM8	P	Kelch-like 40	615340	REc		Nemaline myopathy 8, autosomal recessive, 615348 (3)	
3.144	2	21	14	3p22.1	NKTR	P	Natural tumor-killer recognition sequence	161565	REa, REc	mouse gene close to Cck		9(Nktr)
3.145	3	21	14	3p22.1	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8	P	Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2	614828	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3)	
3.146	7	14	14	3p22.1	SEC22C	P	Secretion deficient 22, S. cerevisiae, homolog of, C	604028	REc			
3.147	3	17	16	3p22.1	SLC25A38, SIDBA2	P	Solute carrier family 25, member 38	610819	REc		Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3)	9(Slc25a38)
3.148	6	22	12	3p22.1	SNORA62, RNU108, RNE2	P	Small nucleolar RNA, H/ACA box, 62	180646	REc			
3.149	8	25	11	3p21.31	NBEAL2, KIAA0540, GPS, BDPLT4	P	Neurobeachin-like 2	614169	REc		Gray platelet syndrome, 139090 (3)	
3.150	11	28	01	3p22.2	AXUD1	P	Axin1 upregulated	606458	R			
3.151	9	9	08	3p22.1	CCR8, CMKBR8, CMKBRL2, CKRL1	P	Chemokine (C-C) receptor 8	601834	Psh			
3.152	10	6	11	3p22.3	CRTAP, CASP, OI7	C	Cartilage-associated protein	605497	A		Osteogenesis imperfecta, type VII, 610682 (3)	9(Crtap)
3.153	10	4	12	3p22	HHV8S	P	Human herpesvirus 8, susceptibility to	614836	Fd		{Human herpesvirus 8, susceptibility to} (2)	
3.154	3	23	09	3p22.3	MIR128-2, MIR128B, MIRN128-2	P	Micro RNA 128-2	611769	REc			
3.155	1	29	01	3p24.1	SLC4A7, NBC2, NBC3	P	Solute carrier family 4, sodium bicarbonate cotransporter, member 7	603353	A			
3.156	4	7	14	3p24.1	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	C	Transforming growth factor, beta receptor II, 70-80kD	190182	A, REa, Fd		Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3); Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome 2, 610168 (3)	9(Tgbfr2)
3.157	5	9	95	3p22.1	VIPR1	P	Vasoactive intestinal peptide receptor 1	192321	A	incorrectly assigned to 2q37		9(Vipr1)
3.158	7	8	95	3p21.31	TGM4	P	Transglutaminase-4, prostate	600585	A			
3.159	11	13	07	3p22.2	ACVR2B, ACTRIIB, HTX4	C	Activin A receptor, type IIB	602730	REc, A		Heterotaxy, visceral, 4, autosomal, 613751 (3)	
3.160	2	19	02	3p22.1	CYP8B1, CYP12	P	Cytochrome P450, subfamily VIIIB, polypeptide 1	602172	A, R			9(Cyp8b1)
3.161	4	17	00	3p22.2	DLEC1, DLC1	P	Deleted in lung and esophageal cancer 1	604050	REn		Lung cancer, 211980 (1); Esophageal cancer, 133239 (1)	
3.162	8	9	99	3p22.2	GOLGA4	P	Golgi autoantigen, golgin subfamily a, 4	602509	REc			
3.163	2	22	11	3p22.2	EXOG, ENDOGL1, ENGL	P	Endo/exonuclease, ENDOG-like	604051	A			
3.164	9	18	12	3p22.2	MYD88, MYD88D	P	Myeloid differentiation primary response gene 88	602170	Psh		Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3); Macroglobulinemia, Waldenstrom, somatic, 153600 (3)	9(Myd88)
3.165	8	9	99	3p22.2	OSR1	P	Oxidative stress-responsive 1	604046	REn			
3.166	8	25	11	3p22.2	PLCD1, NDNC3	P	Phospholipase C, delta-1	602142	A		Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	
3.167	8	5	97	3p21.31	TNA	C	Tetranectin (plasminogen-binding protein)	187520	Psh, R			
3.168	8	9	99	3p22.2	XYLB	P	Xylulokinase, H. influenzae, homolog of	604049	REn			
3.169	6	9	10	3p21.31	PTHR1, PTHR, PFE	C	Parathyroid hormone receptor-1	168468	REa, A, Psh		Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3); Chondrodysplasia, Blomstrand type, 215045 (3); Eiken syndrome, 600002 (3); Failure of tooth eruption, primary, 125350 (3)	
3.170	2	28	03	3p22.1	MOBP	C	Myelin-associated oligodendrocyte basic protein	600948	R, H			9(Mobp)
3.171	1	30	01	3p21.31	PFKFB4	P	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	605320	A			
3.172	6	18	90	3p21.31	ZNF35, HF10	P	Zinc finger protein-35 (HF.10)	194533	REa, A			
3.173	1	5	12	3p21.31	C3orf77, TOPAZ1	P	Testis- and ovary-specific PAZ domain protein 1	614412	REc			9(Topaz1)
3.174	2	2	11	3p22.3	GLB1, MPS4B	C	Galactosidase, beta-1	611458	S, EM, A	3p14.2-p11 excluded	GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II, 230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	9(Bgl)
3.175	8	28	09	3p22.2	GORASP1, GOLPH5, GRASP65, P65	C	Golgi reassembly stacking protein 1, 65kD	606867	R, A			
3.176	5	12	09	3p22.1	LYZL4	P	Lysozyme-like 4	612750	REc			
3.177	7	31	08	3p22.2	WDR48, KIAA1449	P	WD repeat-containing protein 48	612167	REc			
3.178	2	14	08	3p22.1	MYRIP, SLAC2C	P	Myosin VIIA- and RAB-interacting protein	611790	REc			
3.179	6	7	10	3p21.32	MIR138-1, MIRN138-1	P	Micro RNA 138-1	613394	REc			
3.180	12	18	08	3p21.31	ALS2CL	P	ALS2 C-termina-like protein	612402	REc			9(Als2cl)
3.181	3	14	14	3p21.31	AMIGO3, ALI3	P	Adhesion molecule with Ig-like domain 3	615691	REc			
3.182	3	9	00	3p21.31	BSN, ZNF231	C	Bassoon, mouse, homolog of	604020	A, R, Psh			
3.183	1	9	13	3p21.31	CAMKV, 1G5	P	CAM kinase-like vesicle-associated	614993	REc			9(Camkv)
3.184	6	19	15	3p21.31	DHX30, DDX30, RETCOR, KIAA0890	C	DEAH box polypeptide 30	616423	R, REc			
3.185	3	7	13	3p21.31	ELP6, TMEM103, C3orf75	P	Elongator acetyltransferase complex, subunit 6	615020	REc			
3.186	6	1	12	3p21.31	EXOSC7, RRP42	P	Exosome component 7	606488	REc			
3.187	8	7	13	3p21.31	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	P	GDP-mannose pyrophosphorylase B	615320	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	
3.188	8	28	09	3p21.31	IHPK1, IP6K1, KIAA0263	C	Inositol hexaphosphate kinase 1	606991	R, Ch			
3.189	2	25	15	3p21.31	KIF9	P	Kinesin family member 9	607910	R, REc			
3.190	11	24	14	3p21.31	KLHDC8B, CHL	P	Kelch domain-containing protein 8B	613169	A, REc		{Hodgkin lymphoma, susceptibility to}, 236000 (3)	
3.191	4	25	08	3p21.31	LTF	C	Lactotransferrin	150210	REa, A			9(Ltf)
3.192	3	29	13	3p21.31	MIR191	P	Micro RNA 191	615150	REc			
3.193	8	27	15	3p21.31	MON1A, SAND1	P	Mon1, S. cerevisiae, homolog of, A	611464	R, REc			6(Mon1a)
3.194	8	24	09	3p21.31	NDUFAF3	P	NADH dehydrogenase 1 alpha subcomplex, assembly factor 3	612911	REc		Mitochondrial complex I deficiency, 252010 (3)	
3.195	4	25	12	3p21.31	P4HTM, PH4	P	Prolyl 4-hydroxylase, transmembrane	614584	REc			
3.196	2	25	15	3p21.31	PRSS50	P	Protease, serine, 50	607950	REa, R			
3.197	2	24	12	3p21.31	RNF123, KPC1	P	Ring finger protein 123	614472	REc			
3.198	10	30	06	3p21.31	SCAP	P	SREBP cleavage-activating protein	601510	R, REc			
3.199	2	25	15	3p21.1	SELK, HSPC030	P	Selenoprotein K	607916	REc			
3.200	1	19	11	3p21.31	SLC25A20, CACT, CAC	P	Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase)	613698	A	pseudogene on 6p12	Carnitine-acylcarnitine translocase deficiency, 212138 (3)	
3.201	7	14	14	3p21.31	TMA7, HSPC016	P	Translation machinery-associated 7, S. cerevisiae, homolog of	615808	REc			
3.202	2	5	16	3p21.31	TRAIP, TRIP, RNF206, SCKL9	C	TRAF-interacting protein	605958	R, REc		Seckel syndrome 9, 616777 (3)	
3.203	6	16	99	3p21.31	USP4, UNP	C	Ubiquitin-specific protease-4	603486	A, H, REc			9(Unp)
3.204	2	24	12	3p21.31	USP19, KIAA0891	P	Ubiquitin-specific protease 19	614471	REc			
3.205	2	1	11	3p21.31	WDR6	P	WD repeat-containing protein 6	606031	REc	previously assigned to 15q21 by FISH		
3.206	1	5	06	3p21.31	ZD1	P	Zygodactyly 1	609815	Fd	max lod at D3S2409	Zygodactyly 1 (2)	
3.207	8	11	15	3p22.1	ACKR2, CCBP2, CMKBR9, D6, CCR9, CCR10	C	Atypical chemokine receptor 2	602648	R, A			
3.208	11	19	11	3p21.1	BAP1, TPDS	C	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	603089	A, R		Tumor predisposition syndrome, 614327 (3)	
3.209	7	2	02	3p21.31	CACNA2D2, KIAA0558	C	Calcium channel, voltage-dependent, alpha-2/delta subunit 2	607082	R, REc			
3.210	3	2	98	3p21.31	CAMP, FALL39	P	Cathelicidin antimicrobial peptide	600474	A			
3.211	12	19	11	3p21.2	CISH, BACTS2	P	Cytokine inducible SH2-containing protein	602441	Ch		{Tuberculosis, susceptibility to}, 607948 (3); {Malaria, susceptibility to}, 611162 (3); {Bacteremia, susceptibility to}, 614383 (3)	9(Cish)
3.212	9	9	08	3p21.31	CCR3, CKR3, CMKBR3	P	Chemokine (C-C) receptor 3	601268	R, REc			
3.213	9	9	08	3p21.31	CCR9	P	Chemokine, CC motif, receptor 9	604738	R, A			
3.214	12	2	14	3p21.31	COL7A1, NDNC8	C	Collagen VII, alpha-1 polypeptide	120120	REa, A		Epidermolysis bullosa dystrophica, AD, 131750 (3); Epidermolysis bullosa dystrophica, AR, 226600 (3); Epidermolysis bullosa, pretibial, 131850 (3); EBD, Bart type, 132000 (3); EBD, localisata variant (3); Transient bullous of the newborn, 131705 (3); Epidermolysis bullosa pruriginosa, 604129 (3); Toenail dystrophy, isolated, 607523 (3); EBD inversa, 226600 (3)	
3.215	4	26	08	3p21.31	CYB561D2, 101F6	P	Cytochrome b-561 domain containing 2	607068	REc			
3.216	12	7	98	3p21.1	DNAH1, HL11, DNAHC1, HDHC7	P	Dynein, axonemal, heavy chain-1	603332	Psh, A			14(Dnah1)
3.217	9	28	00	3p22.1	ENTPD3, CD39L3	P	Ectonucleoside triphosphate diphosphohydrolase 3	603161	R, Psh			
3.218	8	6	13	3p21.31	FYCO1, CATC2, CTRCT18	P	FYVE and coiled-coil domain containing 1	607182	REc, Fd		Cataract 18, autosomal recessive, 610019 (3)	
3.219	6	27	02	3p21.31	FUS2	P	FUS2 gene	607073	REc			
3.220	8	25	11	3p21.31	GPX1, GPXD	C	Glutathione peroxidase-1	138320	S, REa, Psh, A	?pseudogene on 3p11-p12	Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)	
3.221	6	16	99	3p21.31	HYAL2, LUCA2	P	Hyaluronoglucosaminidase 2	603551	REc, H			9(Hyal2)
3.222	8	31	99	3p21.31	HYAL3, LUCA3	P	Hyaluronoglucosaminidase 3	604038	REn			
3.223	9	9	08	3p21.3	IBD12	P	Inflammatory bowel disease 12	612241	Fd		{Inflammatory bowel disease 12} (2)	
3.224	9	28	98	3p21.31	IFRD2	P	Interferon-related developmental regulator-2	602725	REc			
3.225	3	9	00	3p22.2	ITGA9	P	Integrin, alpha-9	603963	REn			
3.226	7	12	13	3p21.31	LARS2, PRLTS4	P	Leucyl-tRNA synthetase, mitochondrial	604544	REc		Perrault syndrome 4, 615300 (3)	
3.227	2	22	00	3p21.31	LIMD1	P	LIM domain-containing protein 1	604543	REc			9(Limd1)
3.228	9	11	02	3p21.31	LRRC2	P	Leucine-rich repeat-containing 2	607180	REc			
3.229	10	16	14	3p21.31	LZTFL1, BBS17	P	Leucine zipper transcription factor-like 1	606568	REc		Bardet-Biedl syndrome 17, 615994 (3)	9(Lztfl1)
3.230	3	10	98	3p21.2	MAPKAP3, 3PK	P	Mitogen-activated protein kinase-activated protein kinase-3	602130	REc			
3.231	12	28	08	3q21.3	MGLL, MGL, HUK5	C	Monoglyceride lipase	609699	REc, H, R			6(Mgll)
3.232	1	16	08	3p22.2	MLH1, COCA2, HNPCC2	C	mutL, E. coli, homolog of, 1	120436	Fd, A		Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Mismatch repair cancer syndrome, 276300 (3); Muir-Torre syndrome, 158320 (3)	
3.233	4	25	08	3p21.31	NME6	P	Nonmetastatic cells 6, protein expressed in	608294	R			
3.234	1	20	95	3p21.31	MST1R, RON	P	Macrophage stimulating 1 receptor (c-met-related tyrosine kinase)	600168	A			
3.235	6	27	02	3p21.31	NPR2L, NPRL2	P	Npr2, S. cerevisiae, homolog of	607072	REc			
3.236	1	3	02	3p21.31	PTPN23, KIAA1471, HDPTP	P	Protein-tyrosine phosphatase, nonreceptor-type, 23	606584	R, REc			
3.237	2	12	07	3p21.31	RASSF1	C	RAS association domain family protein 1	605082	D, REc	epigenetically inactivated	Lung cancer, 211980 (2)	
3.238	8	3	12	3p21.31	RHOA, ARHA, ARH12, RHOH12	C	Ras homolog gene family, member A (oncogene RHO H12)	165390	A, Psh			
3.239	4	29	02	3p21.31	RMB5, LUCA15	P	RNA-binding motif protein 5	606884	REc			
3.240	4	29	02	3p21.31	RBM6, DEF3	P	RNA-binding motif protein 6	606886	REc			9(Rbm6)
3.241	10	12	14	3p22.1	RPSA, LAMR1, LAMBR, ICAS	P	Ribosomal protein SA	150370	A		Asplenia, isolated congenital, 271400 (3)	9(Lamr1)
3.242	4	30	09	3p21.31	RTP3, TMEM7	P	Receptor-transporting protein 3	607181	REc			
3.243	1	14	02	3p21.31	SACM1L, SAC1, KIAA0851	P	SAC1 suppressor of actin mutations 1-like	606569	REc			
3.244	3	15	96	3p21.31	SEMA3F, SEMA4	P	Semaphorin III/F	601124	REc			
3.245	7	8	96	3p21.31	SEMA5	P	Semaphorin A(V)	601281	REc			
3.246	4	26	10	3p21.31	SHISA5, SCOTIN	P	Shisa, Xenopus, homolog of, 5	607290	REc	pseudogene on Xq13.1-q13.3		
3.247	4	20	10	3p21.31	SLC6A20, XT3	P	X transporter protein 3	605616	REc		Hyperglycinuria, 138500 (3); Iminoglycinuria, digenic, 242600 (3)	9(Xt3)
3.248	5	2	06	3p21.31	SLC26A6	P	Solute carrier family 26 (anion transporter), member 6	610068	REc			
3.249	6	27	02	3p21.31	SLC38A3, SN1, G17	P	Solute carrier family 38, member 3	604437	REc			
3.250	12	27	01	3p21.2	TLR9	P	Toll-like receptor 9	605474	REc			
3.251	11	11	14	3p21.31	TMEM115, PL6	P	Transmembrane protein 115	607069	REc			
3.252	3	9	98	3p21.3	TRR	P	Transfer RNA arginine	601994	REc, A			
3.253	3	18	08	3p21.31	UCN2, SRP, UR	P	Urocortin II	605902	REc			
3.254	4	4	05	3p21.31	FUS1	P	FUS1 gene	607052	REc			
3.255	2	28	94	3p21.31	UQCRC1	P	Ubiquinol-cytochrome c reductase core protein I	191328	REn	close upstream of COL7A1		
3.256	10	15	13	3p21.31	ZMYND10, BLU	P	Zinc finger MYND domain-containing protein 10	607070	REc		Ciliary dyskinesia, primary, 22, 615444 (3)	
3.257	6	1	07	3p21.31	ATRIP	C	ATR-interacting protein	606605	REc			
3.258	3	8	00	3p24.1	EOMES, TBR2	P	Eomesodermin, Xenopus laevis, homolog of	604615	R	?translocation separating regulatory element from promoter		9(Tbr2)
3.259	2	11	15	3p21.31	HYAL1, MPS9	C	Hyaluronoglucosaminidase 1	607071	A	mutation identified in 1 MPS9 patient	?Mucopolysaccharidosis type IX, 601492 (3)	9(Hyal1)
3.260	6	16	99	3p21.31	PRKAR2A	C	Protein kinase, cAMP-dependent, regulatory, type II, alpha	176910	REa, Psh			
3.261	2	23	16	3p21.31	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	P	SET domain-containing protein 2	612778	A, REc		Luscan-Lumish syndrome, 616831 (3)	
3.262	7	14	09	3p21.31	TREX1, AGS1, CRV, HERNS	C	3' repair exonuclease 1	606609	REc, Fd		Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3); Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
3.263	4	19	06	3p21.2	PARP3, ADPRTL3	C	Poly(ADP-ribose) polymerase 3	607726	REc, A, H			9(Adprtl3)
3.264	8	28	02	3p21.31	XCR1, CCXCR1, GPR5	P	Chemokine, C motif, receptor 1 (G protein-coupled receptor-5)	600552	A			
3.265	2	22	10	3p21.1	TNNC1, CMD1Z, CMH13	C	Troponin-C1, slow	191040	Psh, REa, R		Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, hypertrophic, 13, 613243 (3)	7(Tnnc1)
3.266	2	23	09	3p21.31	IMPDH2, IMPD2	C	Inosine-5'-monophosphate dehydrogenase, type II	146691	Psh, A		[IMPDH2 enzyme activity, variation in] (3)	
3.267	9	23	13	3p21.2	PCBP4, MGC10	P	Poly(rC)-binding protein 4	608503	REc, A			9(Pcbp4)
3.268	9	10	12	3p21.2	POC1A, PIX2, SOFT	P	POC1 centriolar protein, Chlamydomonas, homolog of, A	614783	REc		Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	
3.269	3	14	06	3p21.2	PPM1M, PP2CE	P	Protein phosphatase 1M (protein phosphatase 2C, eta isoform)	608979	R, REc			
3.270	6	21	01	3p21.31	AMT, NKH, GCE	P	Aminomethyltransferase (glycine cleavage system protein T)	238310	REa		Glycine encephalopathy, 605899 (3)	
3.271	4	8	02	3p21.2	GRM2, MGLUR2	C	Glutamate receptor, metabotropic, 2	604099	Psh, R			
3.272	10	2	09	3p14.3	HESX1, RPX, CPHD5	P	Homeo box gene expressed in ES cells	601802	A		Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency, combined, 5, 182230 (3); Growth hormone deficiency with pituitary anomalies, 182230 (3)	14(Hesx1)
3.273	10	6	92	3p21.1	ITIH1	C	Inter-alpha (globulin) inhibitor, H1 polypeptide	147270	A, H			14(Intin1)
3.274	10	6	92	3p21.1	ITIH3	C	Inter-alpha (globulin) inhibitor, H3 polypeptide	146650	A, H			14(Intin3)
3.275	2	7	06	3p14.3	SPATA12, SRG5	P	Spermatogenesis-associated protein 12	609869	REc			
3.276	6	19	98	3p14.3	SLAP	P	Sarcolemmal-associated protein	602701	A			
3.277	5	27	05	3p21.1	ITIH4, PK120, ITIHL1	P	Inter-alpha (globulin) inhibitor, H4 polypeptide	600564	A		{Hypercholesterolemia, susceptibility to}, 143890 (3)	14(Itih4)
3.278	2	24	06	3p21.2	ACY1, ACY1D	C	Aminoacylase-1	104620	S, REa, REn		Aminoacylase 1 deficiency, 609924 (3)	9(Acy)
3.279	7	8	95	3p21.2	ALAS1	C	Aminolevulinate, delta-, synthase-1	125290	REa, A, R, Psh			
3.280	7	16	09	3p21.2	ARMET, ARP	P	Arginine-rich protein, mutated in early stage tumors	601916	REc, D			
3.281	11	1	13	3p21.1	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	C	Calcium channel, voltage-dependent, L type, alpha 1D subunit	114206	REa, H, REc		Sinoatrial node dysfunction and deafness, 614896 (3); Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	14(Cch1a2)
3.282	11	28	01	3p21.1-p14.3	CACNA2D3	P	Calcium channel, voltage-dependent, alpha-2/delta subunit 3	606399	REc			
3.283	8	28	09	3p14.2	CADPS, CAPS	P	Ca(2+)-dependent activator protein for secretion	604667	Psh, REc			
3.284	3	20	06	3p21.1	DCP1A, SMIF	C	Decapping enzyme 1, X. cerevisiae, homolog of, A	607010	R, REc			
3.285	2	21	06	3p14.3	DNAH12, DNAHC3, HL19	P	Dynein, heavy chain-5	603340	REa, REc			
3.286	4	26	10	3p14.3-p14.2	FAM107A, DRR1, TU3A	C	Family with sequence similarity 107, member A (downregulated in renal cell carcinoma 1)	608295	REc, A			
3.287	4	19	05	3p21.1	GNL3, NS, E2IG3	P	Guanine nucleotide-binding protein-like 3	608011	R, REc			
3.288	5	13	02	3p21.2	GPR62	P	G protein-coupled receptor 62	606917	REc			
3.289	1	29	01	3p21.1	IL17RB, IL17BR, IL17RH1	P	Interleukin 17, receptor B	605458	R			
3.290	10	13	09	3p21.2	MIRLET7G, LET7G, MIRNLET7G	P	Micro RNA Let7G	612102	REc			
3.291	5	24	02	3p21.1	NEK4, STK2, NRK2	P	NIMA (never in mitosis gene a)-related kinase 4 (serine/threonine protein kinase-2)	601959	REa			
3.292	11	22	13	3p21.1	NISCH, IRAS, KIAA0975	P	Nischarin	615507	REc			
3.293	9	28	12	3p13	PROK2, PK2, BV8, HH4	C	Prokineticin 2	607002	R		Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	6(Prok2)
3.294	2	17	09	3p21.2	RBM15B, OTT3, HUMAGCGB	P	RNA-binding motif protein 15B	612602	REc			
3.295	5	15	08	3p21.1	RFT1, CDG1N	C	RFT1, S. cerevisiae, homolog of	611908	REc		Congenital disorder of glycosylation, type In, 612015 (3)	
3.296	9	9	13	3p21.1	SFMBT1, RU1	P	SCM-like protein with 4 MBT domains 1	607319	REc			
3.297	8	19	13	3p21.1	SPCS1, SPC12	P	Signal peptidase complex, subunit 1, S. cerevisiae, homolog of	610358	R, REc			
3.298	8	28	09	3p21.2	TWF2, PTK9L, A6RP	P	Twinfilin, actin-binding protein, Drosophila, homolog of, 2	607433	R, REc			
3.299	9	9	10	3p21.2	WDR82, TMEM113	P	WD repeat-containing protein 82	611059	R, REc			
3.300	8	11	15	3p14.3	APPL1, APPL, MODY14	P	Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1	604299	A		{Maturity-onset diabetes of the young, type 14}, 616511 (3)	
3.301	1	18	12	3p14.3	DNASE1L3, SLEB16	P	Deoxyribonuclease I-like 3	602244	A, R		Systemic lupus erythematosus 16, 614420 (3)	
3.302	1	14	02	3p21.33	ABHD5, CGI58, IECN2, NCIE2	C	Abhydrolase domain containing 5	604780	Fd, REc		Chanarin-Dorfman syndrome, 275630 (3)	
3.303	6	7	94	3p21.31	APEH, D3S48E	C	N-acylaminoacyl-peptide hydrolase	102645	REa, A, D			
3.304	8	28	09	3p21.31	ARIH2, ARI2, TRIAD1	P	Ariadne, Drisophila, homolog of, 2	605615	R, REc			
3.305	11	4	93	3p21.31	CDC25A	P	Cell division cycle 25A	116947	REa, Psh, A			
3.306	5	28	08	3p21	CELIAC9	P	Celiac disease, susceptibility to, 9	612007	Fd	associated with rs6441961	{Celiac disease, susceptibility to, 9} (2)	
3.307	9	9	08	3p21.31	CCR1, CMKBR1, CKR1, HM145	P	Chemokine (C-C) receptor 1	601159	A			9(Cmkbr1)
3.308	9	8	08	3p21.31	CCR2, CMKBR2	C	Chemokine (C-C) receptor 2	601267	REn		{HIV infection, susceptibility/resistance to} (3)	
3.309	1	27	04	3p21.31	CCRL2	P	Chemokine, CC motif, receptor-like protein 2	608379	REc			
3.310	1	13	09	3p21.31	CCR5, CMKBR5, CCCKR5, IDDM22	C	Chemokine (C-C) receptor 5	601373	REc, R		{HIV infection, susceptibility/resistance to} (3); {West nile virus, susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	
3.311	9	9	08	3p21.31	CXCR6, STRL33, BONZO	P	Chemokine, CXC motif, receptor 6	605163	REa, Psh			
3.312	9	4	15	3p21.31	DAG1, DAG, MDDGC9, MDDGA9	P	Dystrophin-associated glycoprotein-1	128239	REa, A		Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3); Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	9(Dag1)
3.313	11	20	98	3p21.2	DUSP7, MKPX, PYST2	P	Dual-specificity phosphatase-7	602749	Psh, A			9(Dusp7)
3.314	9	9	08	3p21.31	FBXW12, FBW12, FBXO35, FBXO12	P	F-box and WD40 domain protein 12	609075	REc			
3.315	4	15	11	3p21.2	GLYCTK, GLYCTK1	P	Glycerate kinase	610516	REc		D-glyceric aciduria, 220120 (3)	
3.316	8	10	98	3p21.31	GNAI2, GNAI2B, GIP	C	Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2	139360	REa, A	on 12p13-p12, GNAI2L	Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia, idiopathic, 192605 (3)	9(Gnai2)
3.317	6	12	15	3p21.31	GNAT1, CSNBAD3, CSNB1G	C	Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1	139330	REa, A	mutation identified in 1 CSNG1G family	Night blindness, congenital stationary, autosomal dominant 3, 610444 (3); ?Night blindness, congenital stationary, type 1G, 616389 (3)	9(Gnat1)
3.318	1	25	11	3p21	HSCR6	P	Hirschsprung disease, susceptibility to, 6	606874	Fd		{Hirschsprung disease, susceptibility to, 6} (2)	
3.319	9	30	02	3p21.31	IHPK2, IP6K2	P	Inositol hexaphosphate kinase 2	606992	REc			
3.320	9	6	11	3p21.31	LAMB2, LAMS, NPHS5	C	Laminin, beta-2 (laminin S)	150325	REa, A		Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3); Pierson syndrome, 609049 (3)	
3.321	5	9	97	3p21.31	MAP4	P	Microtubule-associated protein 4	157132	A			9(Map4)
3.322	8	27	92	3p21.31	MST1, HGFL	P	Macrophage-stimulating-1 (hepatocyte growth factor-like)	142408	REn, H			9(Hgfl)
3.323	7	16	09	3p21.31	NCKIPSD, AF3P21, SPIN90	P	NCK-interacting protein with SH3 domain	606671	Ch			
3.324	10	13	09	3p21.31	NICN1	P	Nicolin 1	611516	REc	processed pseudogene on X		9(Nicn1)
3.325	7	13	09	3p21.1	PBRM1, PB1, BAF180	P	Polybromo 1, chicken, homolog of	606083	R, REc			
3.326	4	15	11	3p21	PSC	P	Cholangitis, primary sclerosing	613806	Fd		Cholangitis, primary sclerosing (2)	
3.327	4	29	14	3p21.31	QARS, GLNRS, MSCCA	P	Glutaminyl-tRNA synthetase	603727	REa, REc		Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	
3.328	9	24	09	3p22.2	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	C	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	Fd, A		Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)	
3.329	5	12	09	3p22.1	SNRK, KIAA0096	P	SNF-related kinase	612760	REc			
3.330	1	11	07	3p22.1	SS18L2	P	SS18-like gene 2	606473	A			
3.331	12	17	15	3p21.31	ZNF589, SZF1	P	Zinc finger protien 589	616702	A			
3.332	12	7	95	3p21.31	TCTA	P	T-cell leukemia translocation altered gene	600690	Ch			
3.333	12	11	02	3p21.31	TMIE, DFNB6	C	Transmembrane inner ear-expressed gene	607237	Fd, H		Deafness, autosomal recessive 6, 600971 (3)	?9(sr)
3.334	1	6	14	3p21.31	UBE7, UBE1L	P	Ubiquitin-activating enzyme-7	191325	RE			
3.335	1	30	01	3p13	GPR27, SREB1	P	G protein-coupled receptor 27	605187	R			
3.336	11	8	94	3p25.3	HRH1	P	Histamine receptor, subclass H1	600167	REa, A			6(Hrh1)
3.337	8	25	11	3p14.3	WNT5A	P	Wingless-type MMTV integration site family, member 5A	164975	Psh, A		Robinow syndrome, autosomal dominant 1, 180700 (3)	
3.338	3	14	96	3p14.1	TMF1	P	TATA element modulatory factor 1	601126	A			
3.339	6	30	08	3p14.3	ARHGEF3, XPLN	P	RHO guanine nucleotide exchange factor 3	612115	A			
3.340	3	11	09	3p21-p13	MPVQTL2	P	Mean platelet volume quantitative trait locus 2	612574	Fd	associated with rs12485738	[Mean platelet volume QTL2] (2)	
3.341	12	22	14	3q22.3	A4GNT	P	Alpha-1,4-N-acetylglucosaminyltransferase	616709	R			
3.342	9	30	98	3p14.3	ACOX2, BRCACOX	C	Acyl-Coenzyme A oxidase 2, branched chain	601641	A, Psh			
3.343	7	29	15	3p14.3	FAM208A, RAP140, C3orf63, KIAA1105	C	Family with sequence similarity 208, member A	616493	REc, R			
3.344	1	31	12	3p14.3	FLNB, SCT, AOI, LRS1	C	Filamin B	603381	REa, REc, A, R, Fd		Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome, 150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)	
3.345	7	11	11	3p14.3	HESRG	P	Embryonic stem cell-related protein	611473	REc			
3.346	3	17	08	3p14.3	PXK, MONAKA	P	PXK domain-containing serine/threonine kinase	611450	REc			
3.347	9	23	13	3p14.3	RPP14	P	Ribonuclease P, 14kD subunit	606112	REc			
3.348	2	12	16	3p14.1	SLC25A26, SAMC, COXPD28	P	Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26	611037	REc		Combined oxidative phosphorylation deficiency 28, 616794 (3)	
3.349	4	23	09	3p21.1	TKT	P	Transketolase	606781	REa, A			
3.350	1	29	01	3p14.1	ADAMTS9	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 9	605421	A, Psh			
3.351	6	11	13	3p14.3	IL17RD, SEF, HH18	P	Interleukin 17, receptor D (Sef, zebrafish, homolog of)	606807	REc		Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3)	
3.352	5	28	13	3p14.2	FAM3D	P	Family with sequence similarity 3, member D	608619	REc, R			
3.353	8	5	02	3p14.2	FRA3B, FHIT	C	Fragile histidine triad gene	601153	REf, H	deleted in RCC		14(Fhit, Fra14A2)
3.354	3	22	93	3p14.2	PTPRG, PTPG	C	Protein tyrosine phosphatase, receptor type, gamma polypeptide	176886	REa, A, Fd			
3.355	6	1	09	3p14.2	FEZF2, ZNF312, FEZL, TOF	P	FEZ family zinc finger 2	607414	REc			
3.356	1	22	04	3p14.3	ARF4, ARF2	P	ADP-ribosylation factor 4	601177	REc, R			
3.357	2	15	12	3p14.1	ATXN7, SCA7, OPCA3	C	Ataxin 7	607640	Fd, REc		Spinocerebellar ataxia 7, 164500 (3)	
3.358	2	15	12	3p14.1	ATXN7AS1, SCAANT1	P	ATXN7 antisense noncoding transcript 1	614481	REc			
3.359	7	12	13	3p14.1	EOGT, EOGT1, C3orf64, AOS4	P	EGF domain-specific O-linked N-acetylglucosamine transferase	614789	REc		Adams-Oliver syndrome 4, 615297 (3)	
3.360	4	24	15	3p13	FOXP1, QRF1	P	Forkhead box P1	605515	REc		Mental retardation with language impairment and with or without autistic features, 613670 (3)	
3.361	10	23	15	3p14.1	KBTBD8, TAKRP, KIAA1842	P	KELCH repeat- and BTB/POZ domain-containing protein 8	616607	REc			
3.362	1	5	15	3p14.1	LMOD3, NEM10	P	Leiomodin 3	616112	REc		Nemaline myopathy 10, 616165 (3)	
3.363	3	3	09	3p14.1	MAGI1, BAIAP1, WWP3, TNRC19	P	Membrane-associated guanylate kinase, WW and PDZ domains-containing, 1	602625	A			
3.364	5	25	13	3p14.1	SUCLG2	P	Succinate-CoA ligase, GDP-forming, beta subunit	603922	REc			
3.365	4	23	08	3p14.1	THOC7, NIF3L1BP1	P	THO complex, subunit 7	611965	R, REc			
3.366	4	23	07	3p14.1-q12.3	HYT7	P	Hypertension, essential, susceptibility to, 7	610948	Fd		{Hypertension, essential, susceptibility to, 7} (2)	
3.367	5	4	12	3p13	MITF, WS2A, CMM8	C	Microphthalmia-associated transcription factor	156845	REa, A, Fd		Waardenburg syndrome, type 2A, 193510 (3); Waardenburg syndrome/ocular albinism, digenic, 103470 (3); Tietz albinism-deafness syndrome, 103500 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3)	6(mi)
3.368	1	12	11	3p14.1	ARL6IP5	P	ADP-ribosylation-like factor 6-interacting protein 5	605709	REc			
3.369	2	16	04	3p21.2	DOCK3	C	Dedicator of cytokinesis 3	603123	R, Ch			
3.370	2	21	06	3p13	EIF4E3	P	Eukaryotic translation initiation factor 4E family, member 3	609896	R, REc			
3.371	2	25	09	3p14.1	LRIG1, LIG1	C	Leucine-rich repeats- and immunoglobulin-like domains-containing protein 1	608868	A, H			6(Lrig1)
3.372	3	25	16	3p14.1	PRICKLE2	P	Prickle-like 2	608501	REc			
3.373	3	3	10	3p13	EBLN2	P	Endogenous Borna-like N element-containing protein 2	613250	REc			
3.374	4	20	04	3p14-q13	KTCN3	P	Keratoconus 3	608586	Fd		Keratoconus 3 (2)	
3.375	8	28	09	3q13.31	ATP6V1A1, HO68	P	ATPase, H+ transporting, lysosomal alpha polypeptide, 70-kD, isoform 1	607027	R, REc			
3.376	3	29	10	3p13	GXYLT2, GLT8D4	P	Glucoside xylosyltransferase 2	613322	REc			
3.377	12	28	08	3p13	PDZRN3, KIAA1095	P	PDZ domain-containing ring finger protein 3	609729	REc			
3.378	4	7	11	3p13	PPP4R2, PP4R2	P	Protein phosphatase 4, regulatory subunit 2	613822	REc			
3.379	8	30	09	3p13	RYBP, YEAF1	P	Ring1- and YY1-binding protein	607535	R, REc			
3.380	4	6	16	3p13	SAMMSON, LINC01212	P	Survival-associated mitochondrial melanoma-specific oncogenic noncoding RNA	616895	REc			
3.381	12	14	10	3p13	SHQ1	P	Shq1, S. cerevisiae, homolog of	613663	REc			
3.382	7	22	11	3p14.3	PDHB, PDHBD	P	Pyruvate dehydrogenase, E1 beta polypeptide	179060	REa		Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	
3.383	3	29	07	3p12.3	ROBO2, SAX3, KIAA1568	P	Roundabout, Drosophila, homolog of, 2	602431	REc		Vesicoureteral reflux 2, 610878 (3)	16(Robo2)
3.384	9	21	12	3p12.2	GBE1, GSD4, APBD	P	Glycogen branching enzyme	607839	REa		Glycogen storage disease IV, 232500 (3); Polyglucosan body disease, adult form, 263570 (3)	
3.385	8	4	98	3p11.2-p11.1	HTR1F, HTR1EL, MR77	P	5-hydroxytryptamine receptor 1F	182134	R, A, Psh			
3.386	3	22	06	3p12.1	IGSF4D, SYNCAM2, NECL3	P	Immunoglobulin superfamily, member 4D	609938	REc			16(Igsf4d)
3.387	9	11	02	3p12.3	ROBO1, DUTT1, SAX3	P	Roundabout, Drosophila, homolog of, 1	602430	REc, D			
3.388	1	24	04	3p11.1	CGGBP1	C	CGG triplet repeat binding protein 1	603363	REc, REa, A			
3.389	9	28	10	3q11.2	ARL6, BBS3, RP55	C	ADP-ribosylation factor-like 6	608845	Fd, REc	mutation identified in 1 RPS55 family	Bardet-Biedl syndrome 3, 600151 (3); {Bardet-Biedl syndrome 1, modifier of}, 209900 (3); ?Retinitis pigmentosa 55, 613575 (3)	
3.390	4	30	02	3p12-q13	DYX5	P	Dyslexia, susceptibility to, 5	606896	Fd	?same locus as SSD	{Dyslexia, susceptibility to, 5} (2)	
3.391	9	15	04	3q13.12-q13.13	IFT57, ESRRBL1, HIPPI	C	Intraflagellar transport 57, chlamydomonas, homolog of (HIP1 protein interactor)	606621	R, REc			
3.392	2	10	04	3p12-q13	SSD	P	Speech-sound disorder	608445	Fd	?same locus as DYX5	{Speech-sound disorder} (2)	
3.393	1	25	11	3p12-q13.2	PBC1	P	Biliary cirrhosis, primary, 1	109720	Fd	associated with rs6441286	Biliary cirrhosis, primary, 1 (2)	
3.394	5	3	93	3q25.33	IL12A	P	Interleukin-12A (natural killer cell stimulatory factor-1, cytotoxic lymphocyte maturation factor-1, p35)	161560	REa, Psh			
3.395	7	11	93	3q13.31	ZNF80	P	Zinc finger protein-80 (pT17)	194553	REa			
3.396	7	18	12	3p11.2	CHMP2B, DMT1, VPS2B, ALS17	C	CHMP family, member 2B	609512	Fd, REc		Dementia, familial, nonspecific, 600795 (3); Amyotrophic lateral sclerosis 17, 614696 (3)	
3.397	8	18	98	3p11.1	EPHA3, ETK1, HEK	P	Ephrin receptor EphA3 (human embryo kinase 1)	179611	REa, A			
3.398	10	2	09	3p11.2	POU1F1, PIT1, CPHD1	C	POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1)	173110	Fd, A		Pituitary hormone deficiency, combined, 1, 613038 (3)	16(Pit1,dw)
3.399	9	11	02	3p	CRCL	P	Creatinine clearance QTL	607135	Fd	in African Americans	Creatinine clearance QTL (2)	
3.400	8	25	04	3p21.31	MYL3, CMH8	C	Myosin, light polypeptide-3, alkali; ventricular, skeletal, slow	160790	REa, H		Cardiomyopathy, hypertrophic, 8, 608751 (3)	9(Mylc)
3.401	11	24	14	3p21.1	PRKCD, CVID9, ALPS3	P	Protein kinase C, delta	176977	REa, H	mutation identified in 1 family	Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	14(Pkcd)
3.402	9	8	11	3cen-q13	ERVK-5, HERV-KII	P	Endogenous retrovirus group K, member 5	614012	R, REc			
3.403	9	18	00	3q13.33	COX17	P	Cytochrome c oxidase assembly protein COX17	604813	R	pseudogene on chr. 13?		
3.404	10	20	99	3q12.3	RPL24	P	Ribosomal protein L24	604180	REa, R			
3.405	5	1	91	3q21.3	RPN1	C	Ribophorin I	180470	REa, Ch			6(Rpn1)
3.406	10	7	14	3q12.2	TFG, HMSNP, SPG57	P	TRK-fused gene	602498	A	fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family	Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3); ?Spastic paraplegia 57, autosomal recessive, 615658 (3)	
3.407	11	19	09	3q11.1-q11.2	ARL13B, ARL2L1, JBTS8	C	ADP-ribosylation factor-like 13B	608922	REc		Joubert syndrome 8, 612291 (3)	
3.408	10	13	15	3q11.2	DHFRL1	P	Dihydrofolate reductase-like 1	616588	REc			
3.409	5	25	13	3q11.2	EPHA6, HEK12, EHK2	P	Ephrin receptor EphA6	600066	REc			
3.410	12	30	14	3q12.3	IMPG2, IPM200, RP56, VMD5	P	Interphotoreceptor matrix proteoglycan 2	607056	R, A		Retinitis pigmentosa 56, 613581 (3); Macular dystrophy, vitelliform, 5, 616152 (3)	
3.411	3	1	12	3q11.1	PROS1, THPH5, THPH6	C	Protein S, alpha	176880	REa, REc	pseudogene PROSP contiguous on chr.3	Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3); Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	
3.412	4	1	96	3q11.2	GPR15	P	G protein-coupled receptor-15	601166	A			
3.413	3	16	10	3q11.2-q13.12	CAMPD1	P	Camptodactyly 1	114200	Fd	between D3S2465 and D3S3044	Camptodactyly 1 (2)	
3.414	4	30	09	3q11.2	CPOX	P	Coproporphyrinogen oxidase	612732	REa, A		Coproporphyria, 121300 (3); Harderoporphyria, 121300 (3)	
3.415	9	27	01	3q12.2	TARSH	P	Target of Nesh-SH3	606279	R			
3.416	8	20	07	3q12.1	TMEM30C, CDC50C	P	Transmembrane protein 30C	611030	REc			
3.417	11	28	88	3q13.2	MOX2	C	MRC OX-2 antigen	155970	REa, A			
3.418	7	11	91	3q12.1	COL8A1	P	Collagen VIII, alpha-1 polypeptide	120251	A			
3.419	2	21	13	3q12.1	DCBLD2, ESDN	P	Discoidin, CUB, and LCCL domain-containing protein 2	608698	REc, Psh			
3.420	9	2	09	3q12.1	FILIP1L	P	Filamin A-interacting protein 1-like	612993	REc			
3.421	6	10	08	3q11.2	MINA, MINA53, MDIG	P	MYC-induced nuclear antigen	612049	REc			
3.422	8	30	09	3q12.1	ST3GAL6, ST3GALVI	P	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	607156	R, REc			
3.423	7	17	14	3q12.3	CEP97	P	Centrosomal protein, 97kD	615864	REc			
3.424	9	22	08	3q12.2	GPR128	P	G protein-coupled receptor 128	612307	REc			
3.425	1	29	16	3q12.2	NIT2	P	Nitrilase family member 2	616769	REc			
3.426	4	27	16	3q12.2	TMEM45A, DERP7, DNAPTP4	P	Transmembrane protein 45A	616928	REc			
3.427	8	19	13	3q21.3	CHST13, C4ST3	P	Carbohydrate sulfotransferase 13	610124	REc			
3.428	5	6	13	3q12.3	PCNP	P	PEST-containing nuclear protein	615210	REc			
3.429	7	9	09	3q12.3	SENP7, KIAA1707	P	Sentrin-specific protease family, member 7	612846	REc			
3.430	10	7	13	3q12.3	TRMT10C, RG9MTD1, MRPP1	P	tRNA methyltransferase 10, S. cerevisiae, homolog of, C	615423	REc			
3.431	8	18	14	3q12.3	ZPLD1	P	Zona pellucida-like domain-containing protein 1	615915	REc			
3.432	8	28	09	3q13.31	GAP43	P	Neuron growth-associated protein 43	162060	REa, REc			16(Gap43)
3.433	5	22	03	3q13.2	GCET2, HGAL	P	Germinal center-expressed transcript 2	607792	REc			
3.434	10	18	10	3q13.33	GOLGB1, GCP372	P	Golgi autoantigen, golgin subfamily B, 1	602500	REc			
3.435	9	29	96	3q13.33	HCLS1	P	Hematopoietic cell-specific Lyn substrate 1	601306	A			
3.436	9	21	11	3q21.1-q21.2	KALRN, HAPIP, DUO, CHDS5	C	Kalirin	604605	Fd, REc		{Coronary heart disease, susceptibility to, 5}, 608901 (3)	
3.437	4	14	05	3q27.1	MAGEF1	P	Melanoma antigen, family F, 1	609267	Psh, REc			
3.438	1	28	00	3q13.13	MORC1	C	MORC family CW-type zinc finger 1 (microrchidia, mouse, homolog of)	603205	H, A			16(Morc)
3.439	8	30	09	3q13.13	PVRL3, PRR3	P	Poliovirus receptor-like 3	607147	R, REc			
3.440	5	25	00	3q13.13	TRAT1, TRIM	P	T-cell receptor-associated transmembrane adaptor 1	604962	A			
3.441	4	16	11	3q21.2	UMPS, OPRT	C	Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase)	613891	S, A		Orotic aciduria, 258900 (3)	
3.442	1	3	02	3q13.33	NR1I2, PXR, SXR, PARq	P	Nuclear receptor subfamily 1, group I, member 2	603065	R, A			
3.443	1	13	09	3q13.2	CD200R1, MOX2R, OX2R	P	CD200 receptor 1	607546	REc			
3.444	12	13	00	3q13.13	GUCA1C, GCAP3	P	Guanylate cyclase activator 1C	605128	Psh, A			
3.445	11	25	96	3q13.1	MHS4	P	Malignant hyperthermia susceptibility 4	600467	Fd		{Malignant hyperthermia susceptibility 4} (2)	
3.446	12	10	15	3q13.11	CBLB	P	CAS-BR-M murine ecotropic retroviral transforming sequence B	604491	Psh, A			
3.447	7	20	09	3q12.3	NFKBIZ, INAP, MAIL, IKBZ	P	Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, zeta	608004	REc			16(Inap)
3.448	2	19	97	3q13.11	ALCAM	P	Activated leukocyte cell adhesion molecule	601662	A			
3.449	3	24	06	3p12.1	VGLL3, VGL3	P	Vestigial-like 3	609980	REc			
3.450	1	14	00	3q13.12	CD47, MER6, IAP	C	CD47 antigen (Rh-related antigen; integrin-associated protein)	601028	S, A			
3.451	10	28	15	3q13.12	DUBR, DUM, LINC0883	P	DPPA2 upstream-binding RNA, noncoding	616619	REc			16(Dubr)
3.452	8	25	11	3q13.1-q13.2	CD96, TACTILE	C	CD96 antigen	606037	R, REc, Ch		C syndrome, 211750 (3)	
3.453	1	30	12	3q13.13	DPPA2, PESCRG1, ECAT15-2	P	Developmental pluripotency-associated gene 2	614445	REc			16(Dppa2)
3.454	7	27	11	3q13.13	DPPA4	P	Developmental pluripotency-associated gene 4	614125	REc			
3.455	5	25	13	3q13.13	HHLA2	P	Human endogenous retrovirus-H long terminal repeat-associating 2	604371	REc			
3.456	1	5	09	3q13.13	KIAA1524, p90	C	KIAA1524 gene	610643	R, REc			
3.457	3	1	06	3q13.13	MYH15	P	Myosin, heavy chain 15	609929	REc			
3.458	7	14	14	3q13.13	RETNLB, RELMB, FIZZ2	P	Resistin-like protein, beta	605645	REc			
3.459	2	25	15	3q13.2	BTLA	P	B- and T-lymphocyte attenuator	607925	REc			
3.460	4	23	08	3q13.2	C3orf52, TTMP	P	Chromosome 3 open reading frame 52	611956	REc			
3.461	3	6	07	3q13.31	NAT13, NAT5, SAN	P	N-acetyltransferase 13	610834	REc			
3.462	5	24	13	3q13.2	PHLDB2	P	Pleckstrin homology-like domain, family B, member 2	610298	REc, R			
3.463	4	30	09	3q13.2	SLC9A10	P	Solute carrier family 9, member 10	612738	REc			
3.464	11	3	11	3q13.2	SPICE1, CCDC52	P	Spindle- and centriole-associated protein 1	613447	REc			
3.465	9	9	13	3q13.2	TAGLN3, NP24, NP22	P	Transgelin 3	607953	REc, R			
3.466	12	5	03	3q13.2	URB, SSG1	P	Urb, mouse, homolog of	608298	R, H, REc			16(Urb)
3.467	5	28	13	3q13.13	ZBED2	P	Zinc finger BED domain-containing protein 2	615246	REc			
3.468	9	16	14	3q13.31	ZBTB20, ZNF288, DPZF, PRIMS	C	Zinc finger and BTB-domain containing 20	606025	A, R		Primrose syndrome, 259050 (3)	
3.469	2	28	03	3q13.33	PLA1A, PSPLA1	P	Phosphatidylserine-specific phospholipase A1-alpha	607460	A, H			16(Pla1a)
3.470	6	7	12	3q13.2-q13.33	STUT3	P	Stuttering, familial persistent, 3	614655	Fd	max lod at D3S1310	Stuttering, familial persistent, 3 (2)	
3.471	8	31	12	3q21.1	ADCY5, FDFM	C	Adenylate cyclase-5	600293	REa, A		Dyskinesia, familial, with facial myokymia, 606703 (3)	16(Adcy5)
3.472	11	3	98	3q13.31	LSAMP, LAMP	P	Limbic system-associated membrane protein	603241	A			16(Lsamp)
3.473	5	4	12	3q13.32-q13.33	ARHGAP31, CDGAP, KIAA1204, AOS1	P	Rho GTPase-activating protein 31	610911	R, REc		Adams-Oliver syndrome 1, 100300 (3)	
3.474	7	9	07	3q13.33	ARGFX	P	Arginine-fifty homeobox	611164	REc	pseudogenes on 5q23.2 and 17q11.2		
3.475	8	9	99	3q13.32	B4GALT4	P	Beta-1,4-galactosyltransferase 4	604015	REc			
3.476	7	3	06	3q13.31	DRD3, ETM1, FET1	P	Dopamine receptor D3	126451	REb, A		{Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor, susceptibility to}, 190300 (3)	
3.477	5	3	13	3q13.33	FSTL1, FRP, MIR198	P	Follistatin-like 1	605547	R, REc	FSTL1 mRNA can encode a protein or produce an micoRNA		
3.478	5	25	00	3q13.33	GSK3B	P	Glycogen synthase kinase 3-beta	605004	A, R, Psh			
3.479	8	27	08	3q21.2	MUC13	P	Mucin 13, cell surface-associated	612181	A			
3.480	5	4	00	3q13.33	POLQ	P	Polymerase, DNA, theta	604419	R			
3.481	10	15	09	3q13.33	POPDC2, POP2	P	Popeye domain-containing protein 2	605823	R, REc			
3.482	5	26	05	3q13.33	STXBP5L, LLGL4	P	Syntaxin-binding protein 5-like	609381	REc			
3.483	7	13	09	3q13.31	TIGIT	P	T-cell immunoreceptor with immunoglobulin and ITIM domains	612859	REc			
3.484	4	15	11	3q22.1	TRH	C	Thyrotropin-releasing hormone	613879	REa, H, A		Thyrotropin-releasing hormone deficiency, 275120 (1)	6(Trh)
3.485	4	23	98	3q13.32	UPK1B	P	Uroplakin 1B	602380	A			
3.486	4	17	13	3q13.33	MAATS1, AAT1, C3orf15	P	MYCBP-associated testis-expressed protein 1	609910	REc			
3.487	3	16	04	3q21.3	ZNF9, CNBP1, DM2, PROMM	C	Zinc finger protein-9 (a cellular retroviral nucleic acid-binding protein)	116955	REa, A, Fd		Myotonic dystrophy 2, 602668 (3)	
3.488	9	29	13	3q13.31	DEL3q13.31, C13DELq13.31	P	Chromosome 3q13.31 deletion syndrome	615433	Ch		Chromosome 3q13.31 deletion syndrome (4)	
3.489	10	24	14	3q13.31	TUSC7, LSAMPAS3, LOC285194	P	Tumor suppressor candidate 7, noncoding	616057	REc			
3.490	6	13	12	3q13.33	ADPRH	P	ADP-ribosylarginine hydrolase	603081	REc			
3.491	11	11	14	3q13.33	EAF2	P	ELL-associated factor 2	607659	REc			
3.492	4	19	12	3q13.33	GPR156, GABABL	C	G protein-coupled receptor 156	610464	REc			
3.493	8	8	13	3q13.33	GTF2E1, TF2E1	P	General transcription factor IIE, polypeptide 1	189962	REc			
3.494	4	29	14	3q13.33	HGD, AKU	C	Homogentisate 1,2-dioxygenase (homogentisate oxidase)	607474	Fd, H, Psh, A, REc		Alkaptonuria, 203500 (3)	16(aku)
3.495	5	25	13	3q13.33	NDUFB4	P	NADH-ubiquinone oxidoreductase 1 beta subcomplex, 4	603840	REc			
3.496	4	7	14	3q13.33	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4	P	Protein O-glucosyltransferase 1	615618	REc		Dowling-Degos disease 4, 615696 (3)	
3.497	10	2	12	3q13.33	SLC15A2, PEPT2	P	Solute carrier family 15 (H+/peptide transporter), member 2	602339	REc			
3.498	11	19	13	3q13.33	TIMMDC1, C3orf1	P	Translocase of inner mitochondrial membrane domain-containing protein 1	615534	REc			
3.499	12	4	03	3q21.3	ABTB1, BPOZ	P	Ankyrin repeat and BTB/POZ domain containing 1	608308	R			
3.500	4	1	01	3q21	ATOD1	P	Dermatitis, atopic, 1	603165	Fd	max lod at D3S3606	{Dermatitis, atopic, susceptibility to, 1} (2)	
3.501	12	9	95	3q13.33	CD80, CD28LG, LAB7	C	CD80 antigen (CD28 antigen ligand 1, B7-1 antigen)	112203	REa, Psh, A			3(Cd80)
3.502	3	2	98	3q13.33	CD86, CD28LG2, LAB72	P	CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)	601020	A			16(Cd86)
3.503	10	23	15	3q22.1	COL6A4P2	P	Collagen, type VI, alpha-4, pseudogene 2	616612	REC			9(Col6a4)
3.504	10	23	15	3q22.1	COL6A5, COL29A1	P	Collagen, type VI, alpha-5	611916	REc			
3.505	10	24	15	3q22.1	COL6A6	P	Collagen, type VI, alpha-6	616613	REc			9(Col6a6)
3.506	1	13	16	3q21.1	CSTA, STFA, STF1, AREI, PSS4	P	Cystatin A (stefin A)	184600	REa, D		Peeling skin syndrome 4, 607936 (3)	16(Stf1)
3.507	10	30	02	3q21.1	DIRC2, RCC4	C	Disrupted in renal carcinoma 2	602773	Ch, REc	t(2;3)(q35;q21) in renal cell carcinoma	Renal cell carcinoma, 144700 (1)	
3.508	12	21	09	3q21.1	DTX3L, BBAP	P	DTX3-like	613143	REc	head-to-head with PARP9		
3.509	7	8	10	3q21	FGQTL6, BWQTL3, PGQTL1	P	Fasting plasma glucose level QTL 6; Birth weight QTL 3; Plasma glucose, 2-hour, QTL 1	613460	Fd	associated with rs11708067 and rs11708067	[Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2); [Plasma glucose, 2-hour, QTL 1] (2)	
3.510	12	19	05	3q21.3	GP9	P	Glycoprotein IX, platelet	173515	REb, REc		Bernard-Soulier syndrome, type C, 231200 (3)	
3.511	4	10	14	3q21.3	GATA2, DCML, MONOMAC, IMD21	P	GATA-binding protein-2	137295	REa, REc		Immunodeficiency 21, 614172 (3); Emberger syndrome, 614038 (3); {Myelodysplastic syndrome, susceptibility to}, 614286 (3); {Leukemia, acute myeloid, susceptibility to}, 601626 (3)	6(Gata2)
3.512	6	5	12	3q21.3-q22.1	IFT122, WDR10, CED1	P	Intraflagellar transport 122, homolog of	606045	A		Cranioectodermal dysplasia 1, 218330 (3)	
3.513	2	14	01	3q21.1	KPNA1, RCH2, SRP1	P	Karyopherin, alpha-1	600686	A			
3.514	5	11	06	3q22.2	KY	P	Kyphoscoliosis peptidase	605739	R			9(ky)
3.515	8	18	97	3q21.3	MCM2, CDCL1	P	Minichromosome maintenance deficient, S. cerevisiae, 2, homolog of (mitotin)	116945	A			
3.516	3	10	11	3q21.1	MYLK, MLCK, AAT7	C	Myosin-light-polypeptide kinase	600922	Psh, REc	pseudogene on 3p13	Aortic aneurysm, familial thoracic 7, 613780 (3)	
3.517	10	26	98	3q22.3	NCK	C	Non-catalytic region of tyrosine kinase	600508	A, REn, REa			
3.518	6	10	08	3q21.1	PARP9, BAL1, BAL	C	Poly(ADP-ribose) polymerase 9	612065	A, REa, REc, REn			
3.519	6	24	08	3q21.1	PARP15, BAL3	P	Poly(ADP-ribose) polymerase 15	612066	REc			
3.520	12	14	99	3q21	PSORS5	P	Psoriasis susceptibility 5	604316	Fd		{Psoriasis susceptibility 5} (2)	
3.521	3	3	03	3q21.3	RAB7, CMT2B, PSN	C	Ras-associated protein RAB7	602298	Psh, A, Fd		Charcot-Marie-Tooth disease, type 2B, 600882 (3)	9(Rab7)
3.522	6	16	99	3q21.3	RUVBL1, NMP238, TIP49	P	RUVB, E. coli, homolog-like 1	603449	A			
3.523	1	24	12	3q22.1-q22.2	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2	P	Solute carrier organic anion transporter family, member 2A1	601460	Psh, A		Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	
3.524	9	1	11	3q22.1	TF, TFQTL1	C	Transferrin	190000	S, H, REa, D, A		Atransferrinemia, 209300 (3)	9(Trf)
3.525	2	22	07	3q21.3	TXNRD3, TRXR3, TR2	P	Thioredoxin reductase 3	606235	REc			
3.526	11	3	11	3q21.2	ZNF148, ZFP148	C	Zinc finger protein-148	601897	REc, A			
3.527	12	27	01	3q21.3	KLF15, KKLF	P	Kruppel-like factor 15	606465	A			
3.528	11	2	99	3q21.3	MBD4, MED1	P	Methyl-CpG-binding domain protein 4	603574	A			6(Mdb4)
3.529	12	13	06	3q21-q22	HCFP1, MBS2	P	Facial paresis, hereditary congenital, 1	601471	Fd		Facial paresis, hereditary congenital, 1 (2)	
3.530	12	23	05	3q22.1	NEK11	P	Never in mitosis gene A-related kinase 11	609779	REc			
3.531	6	21	01	3q22.3	PCCB	C	Propionyl Coenzyme A carboxylase, beta polypeptide	232050	REa, A, D	pccB complementation group	Propionicacidemia, 606054 (3)	
3.532	12	22	89	3q23	RBP1, CRBP1	C	Retinol-binding protein-1, cellular	180260	REa, A	close to CRBP2		9(Crbp)
3.533	10	4	93	3q22.1	ACPP	C	Acid phosphatase, prostate	171790	REa, A			
3.534	11	5	97	3q22.2	EPHB1, EPHT2, NET	P	eph tyrosine kinase 2 (ephrin receptor EphB1)	600600	Psh, A			
3.535	5	29	12	3q23	GRK7, GPRK7	P	G protein-coupled receptor kinase 7	606987	R			
3.536	12	29	99	3q22.1	ATP2C1, BCPM, HHD	C	ATPase, Ca(2+)-sequestering	604384	Fd, REc		Hailey-Hailey disease, 169600 (3)	
3.537	6	4	97	3q21-q24	GLC1C	C	Glaucoma 1, open angle, C	601682	Fd		Glaucoma 1C, primary open angle (2)	
3.538	6	27	02	3q23	PCOLCE2	P	Procollagen C-endopeptidase enhancer-2	607064	REc			
3.539	1	31	13	3q22.1	RHO, RP4, OPN2, CSNBAD1	C	Rhodopsin (opsin 2)	180380	REa, A, Fd		Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3); Night blindness, congenital stationary, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)	6(Rho)
3.540	5	19	15	3q24	AGTR1, AGTR1A, AT2R1	C	Angiotensin receptor 1	106165	REa		{Hypertension, essential}, 145500 (3); Renal tubular dysgenesis, 267430 (3)	
3.541	5	24	12	3q22.1	BFSP2, CP49, CP47, CTRCT12	C	Beaded filament structural protein 2 (cytoskeletal protein, 49 kD)	603212	REa		Cataract 12, multiple types, 611597 (3)	
3.542	8	25	11	3q25.1	CLRN1, USH3A, USH3, RP61	C	Clarin 1	606397	Fd, REc	frequent in Finland; ?digenic interaction with MYO7A	Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180 (3)	3(Ush3)
3.543	1	27	11	3q25.1	MED12L, NOPAR, KIAA1635	C	Mediator complex subunit 12-like	611318	Psh, REc			
3.544	2	3	99	3q25.1	TM4SF1, M3S1, TAAL6	P	Transmembrane-4 superfamily, member 1	191155	REa			
3.545	9	8	11	3q21-q25.2	ERVK-4, HERV-KI	P	Endogenous retrovirus group K, member 4	614011	R, REc			
3.546	1	12	15	3q25.2	MME, CD10, CALLA, NEP	C	Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen)	120520	REa, A		[Neutral endopeptidase deficiency], 614692 (1); Membranous glomerulonephritis, antenatal, 614692 (1)	9(Mme)
3.547	1	1	95	3q27.3	SIAT1	P	Sialyltransferase-1 (beta-galactoside alpha-2,6-sialyltransferase)	109675	REa, A			
3.548	9	2	12	3q26.2	TERC, TRC3, TR, DKCA1, PFBMFT2	P	Telomerase RNA component	602322	H, Fd		Dyskeratosis congenita, autosomal dominant 1, 127550 (3); {Aplastic anemia}, 614743 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	3(Terc)
3.549	10	15	97	3q27.1	EPHB3, ETK2	P	EPH-like tyrosine kinase-2	601839	Psh			
3.550	12	2	99	3q21.3	PLXNA1, NOVP, NOV, PLXN1	P	Plexin A1 (NOV transmembrane protein)	601055	REa			
3.551	12	22	87	3q23	RBP2, CRBP2	P	Retinol-binding protein-2, cellular	180280	REa	close to CRBP1		9(Crbp2)
3.552	1	12	07	3q21.1	C3orf28, E2IG5	P	E2-induced gene 5	608017	R, REc			
3.553	8	13	13	3q13.3-q21.1	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	C	Calcium-sensing receptor	601199	Fd, REa	15cM from RHO	Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism, neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 601198 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3); {Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3); Hypercalciuric hypercalcemia (3); {Calcium, serum level of} (3)	16(Gprc2a)
3.554	9	9	08	3q13.33	FBXO40, FBX40, KIAA1195	C	F-box only protein 40	609107	R, REc			16(Fbxo40)
3.555	3	28	11	3q13.33	ILDR1, DFNB42	P	Immunoglobulin-like domain-containing receptor 1	609739	REc		Deafness, autosomal recessive 42, 609646 (3)	
3.556	3	31	05	3q13.33	IQCB1, NPHP5, KIAA0036	P	IQ motif-containing protein B1	609237	REc		Senior-Loken syndrome 5, 609254 (3)	
3.557	11	01	07	3q21.2	OSBPL11, ORP11	P	Oxysterol-binding protein-like protein 11	606739	REc	previously assigned to chr.8		
3.558	4	19	06	3q21.1	PARP14, KIAA1268	P	Poly(ADP-ribose) polymerase 14	610028	R, REc			
3.559	5	11	16	3q21.1	PDIA5, PDIR	P	Protein disulfide isomerase, family A, member 5	616942	REc			
3.560	8	18	14	3q21.1	PTPLB, HACD2	C	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member B	615939	REc			
3.561	1	28	08	3q21.1	ROPN1, ODF6	P	Rhophilin-associated tail protein 1	611757	REc			
3.562	11	25	08	3q21.1	SEC22A, SEC22L2	P	Secretion deficient 22, S. cerevisiae, homolog of, A	612442	R, REc			
3.563	9	6	11	3q21.2	HEG1, KIAA1237	P	Heart of glass, zebrafish, homolog of, 1	614182	REc			
3.564	7	14	14	3q21.2	ITGB5	P	Integrin, beta-5	147561	REc			
3.565	8	26	15	3p14.3	PDE12	P	Phosphodiesterase 12	616519	REc			
3.566	3	8	07	3q21.2-q21.3	SLC41A3	P	Solute carrier family 41, member 3	610803	R, REc			
3.567	8	30	09	3q21.2	SNX4	P	Sorting nexin 4	605931	R, REc			
3.568	1	27	11	3q21.3	ALDH1L1, FTHFD	P	Aldehyde dehydrogenase 1 family, member L1	600249	REc			
3.569	2	13	14	3q21.3	CHCHD6, CHCM1	P	Coiled-coil-helix-coiled-coil-helix domain-containing protein 6	615634	REc			
3.570	11	19	13	3q21.3	COPG1	P	Coatomer protein complex, subunit gamma-1	615525	REc			
3.571	6	21	13	3q21.3	DNAJB8, DJ6	P	DNAJ/HSP40 homolog, subfamily B, member 8	611337	REc, R			
3.572	9	9	13	3q21.3	EEFSEC, SELB, EFSEC	P	Eukaryotic elongation factor, selenocysteine-tRNA-specific	607695	REc			
3.573	11	11	14	3q21.3	H1FX, H1X	P	H1 histone family, member X	602785	REc			
3.574	5	12	09	3q21.3	ISY1, KIAA1160	P	ISY1 splicing factor, S. cerevisiae, homolog of	612764	R, REc			
3.575	10	29	15	3q21.3	PODXL2, EG	P	Podocalyxin-like 2	616627	REc			
3.576	5	12	15	3q21.3	UROC1, UROCD	P	Urocanase domain-containing protein 1	613012	REc	mutation identified in 1 UROCD patient	?Urocanase deficiency, 276880 (3)	
3.577	5	22	14	3q21.3	ZXDC	C	ZCD family zinc finger protein C	615746	REc			
3.578	6	4	98	3q25.1	AADAC, DAC	P	Arylacetamide deacetylase (esterase)	600338	R			
3.579	8	11	15	3q22.1	ACKR4, CCRL1, PPR1	P	Atypical chemokine receptor 4	606065	A			
3.580	6	19	01	3q22	DFNA18	P	Deafness, autosomal dominant 18	606012	Fd		Deafness, autosomal dominant 18 (2)	
3.581	9	9	10	3q22.1	NPHP3, NPH3, RHPD1, MKS7	C	Nephrocystin 3	608002	Fd, REc		Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia 1, 208540 (3); Meckel syndrome 7, 267010 (3)	
3.582	8	28	09	3q22.1	PLXND1	P	Plexin D1	604282	REn, REc			
3.583	3	31	15	3q22.2-q22.3	PP2R3A, PR72, PR130	P	Protein phosphatase 2, regulatory subunit B'', alpha	604944	R, REc			
3.584	9	4	02	3q22	SLSN3	P	Senior-Loken syndrome 3	606995	Fd	?allelic with NPHP3	Senior-Loken syndrome 3 (2)	
3.585	11	8	06	3q22.1	UBE1DC1, UBA5	P	Ubiquitin-activating enzyme E1-domain containing 1	610552	REc			
3.586	4	13	98	3q23	ATP1B3	P	ATPase, Na+/K+ transporting, beta 3 polypeptide	601867	A			9(Atp1b3)
3.587	1	21	97	3q23	RASA2, GAP1M	P	RAS p21 protein activator 2	601589	A			
3.588	8	30	07	3q22-q24	AD15	P	Alzheimer disease 15	611155	Fd	max lod at D3S1579	{Alzheimer disease-15} (2)	
3.589	1	6	12	3q23	ATR, FRP1, SCKL1, FCTCS	C	Ataxia-telangiectasia and Rad3-related (FRAP-related protein-1)	601215	A, Fd	mutation identified in 1 FCTCS family	Seckel syndrome 1, 210600 (3); ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	
3.590	4	20	11	3q22-q24	DWS, C3DELq22q24, DEL3q22q24	P	Dandy-Walker syndrome	220200	Ch	ZIC1 and ZIC4 good candidate genes	Dandy-Walker syndrome (4)	
3.591	6	12	07	3q22-q24	OTSC5	P	Otosclerosis 5	608787	Fd	max lod at D3S1569	Otosclerosis 5 (2)	
3.592	8	9	99	3q23	RNF7, ROC2, SAG	P	RING finger protein-7 (regulator of cullins 2; sensitive to apoptosis gene)	603863	A			
3.593	4	23	98	3q23	TRPC1, TRP1	P	Transient receptor potential channel 1	602343	A	also called Htrp-1		
3.594	5	4	00	3q22-q25	PABPL1	P	Polyadenylate-binding protein-like 1	173865	A			
3.595	10	18	11	3q22.1	ACAD11	P	Acyl-CoA dehydrogenase family, member 11	614288	REc			
3.596	5	25	13	3q22.1	CPNE4, CPN4	P	Copine IV	604208	REc			
3.597	5	19	15	3q22.1	DNAJC13, RME8, KIAA0678, PARK21	C	DNAJ/HSP40 homolog, subfamily C, member 13	614334	R, REc		Parkinson disease 21, 616361 (3)	
3.598	4	27	12	3q22.1	MRPL3, MRL3, COXPD9	P	Mitochondrial ribosomal protein L3	607118	R, REc		Combined oxidative phosphorylation deficiency 9, 614582 (3)	
3.599	7	18	14	3q22.1	RAB6B	P	Ras-associated protein RAB6B	615852	REc			
3.600	3	29	16	3q22.1	SRPRB, APMCF1	P	Signal recognition particle receptor, beta subunit	616883	REc			
3.601	1	4	16	3q22.1	TMCC1, KIAA0779	P	Transmembrane and coiled-coil domain family 1	616242	REc			
3.602	8	30	09	3q22.1	TOPBP1, KIAA0259	P	DNA topoisomerase II-binding protein 1	607760	R, REc			
3.603	5	29	12	3q22.2	AMOTL2, KIAA0989	P	Angiomotin-like 2	614658	REc			
3.604	2	23	12	3q22.2	ANAPC13, APC13, SWM1	P	Anaphase-promoting complex, subunit 13	614484	REc			
3.605	3	7	14	3q22.2	CEP63, SCKL6	P	Centrosomal protein, 63kD	614724	REc	mutation identified in 1 family	?Seckel syndrome 6, 614728 (3)	
3.606	10	2	12	3q22.2	RYK, RYK1	P	RYK receptor-like tyrosine kinase	600524	REc, Ch			9(Ryk1)
3.607	10	25	11	3q22.3	CEP70	P	Centrosomal protein, 70kD	614310	REc			
3.608	9	20	14	3q22.3	DBR1	P	Debranching enzyme 1, S. cerevisiae, homolog of	607024	REc			
3.609	12	11	15	3q22.3	ESYT3, FAM62C	P	Extended synaptotagmin-like protein 3	616692	REc			
3.610	2	2	04	3q22.3	MRAS, RRAS3	P	Muscle Ras viral oncogene homolog	608435	REc			
3.611	2	25	14	3q22.3	MSL2, KIAA1585	P	Male-specific lethal 2, Drosophila, homolog of	614802	REc			
3.612	9	9	08	3q22.3	PIK3CB, PI3KCB	P	Phosphatidylinositol 3-kinase, catalytic, beta	602925	R, REc			
3.613	3	3	15	3q23	CLSTN2	P	Calsyntenin 2	611323	REc			
3.614	9	30	02	3q23	COPB2	P	Coatomer protein complex, subunit beta-2	606990	A			
3.615	11	2	04	3q22.3	FOXL2, BPES, BPES1, PFRK, POF3	C	Forkhead transcription factor FOXL2	605597	Ch, Fd		Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)	
3.616	1	23	08	3q23	MRPS22, C3orf5, COXPD5	C	Mitochondrial ribosomal protein S22	605810	REc		Combined oxidative phosphorylation deficiency 5, 611719 (3)	
3.617	8	29	07	3q23	NMNAT3, PNAT3	P	Nicotinamide nucleotide adenylyltransferase 3	608702	R, REc			
3.618	4	19	12	3q23	PAQR9	P	Progestin and ADIPOQ receptor family, member 9	614580	REc			
3.619	8	28	09	3q23	PLS1	P	Plastin-1	602734	REa, REc			
3.620	10	19	99	3q24	PLSCR1, MMTRA1B	P	Phospholipid scramblase 1	604170	A			
3.621	3	10	03	3q24	PLSCR2	P	Phospholipid scramblase 2	607610	R			
3.622	3	10	03	3q24	PLSCR4	P	Phospholipid scramblase 4	607612	REc			
3.623	12	30	14	3q23	SLC25A36, PNC2	P	Solute carrier family 25 (mitochondrial carrier, pyrimidine nucleotide transporter), member 36	616149	REc			
3.624	6	5	00	3q22.3	SOX14	C	SRY-box 14	604747	A, R, REc			
3.625	12	18	07	3q23	SPSB4, SSB4	P	SPRY domain- and SOCS box-containing 4	611660	REc			
3.626	2	17	09	3q23	STQTL10	P	Stature quantitative trait locus 10	612221	Fd	associated with rs6440003	{Stature QTL 10} (2)	
3.627	3	5	98	3q23	TFDP2, DP2	P	Transcription factor Dp-2 (E2F dimerization partner 2)	602160	A			
3.628	2	17	09	3q23	ZBTB38	P	Zinc finger- and BTB domain-containing protein 38	612218	REc			
3.629	6	4	02	3q24-q25	CP	C	Ceruloplasmin	117700	F, H, REa, A	~15cM from TF	[Hypoceruloplasminemia, hereditary], 604290 (3); Cerebellar ataxia, 604290 (3); Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	9(Cp)
3.630	2	13	15	3q24	PLOD2, LH2, TLH, BRKS2	C	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2	601865	Psh, A		Bruck syndrome 2, 609220 (3)	9(Plod2)
3.631	8	29	08	3q24	C3orf58, DIA1	P	Chromosome 3 open reading frame 58	612200	REc			
3.632	6	2	06	3q24	CHST2	P	Carbohydrate sulfotransferase-2 (GlcNAc-6-O-sulfotransferase; N-acetylglucosamine-6-O-sulfotransferase)	603798	REc	mapped by FISH to 7q31		
3.633	8	28	09	3q24	CPA3	P	Carboxypeptidase A3, mast cell	114851	Psh, REc			
3.634	7	18	14	3q24	CPB1, PCPB, PASP	P	Carboxypeptidase B1, tissue	114852	REc			
3.635	8	28	15	3q25.31	GMPS	C	Guanine monophosphate synthetase	600358	A, Ch	fusion gene with MLL in AML		
3.636	11	28	01	3q25.1	GPR86	P	G protein-coupled receptor 86	606380	REc			
3.637	11	28	01	3q25.1	GPR87	P	G protein-coupled receptor 87	606379	REc			
3.638	7	16	01	3q24	HPS3	P	HPS gene 3	606118	HZ, Fd		Hermansky-Pudlak syndrome 3, 614072 (3)	3(Hps3)
3.639	12	27	13	3q24	SLC9A9, AUTS16	C	Solute carrier family 9 (sodium/hydrogen exchanger), member A9	608396	Ch, REc	mutation identified in 1 family	?{Autism susceptibility 16}, 613410 (3)	
3.640	7	11	11	3q25.1	SELT	P	Selenoprotein T	607912	REc			
3.641	7	17	12	3q25.1	WWTR1, TAZ	P	WW domain-containing transcription regulator 1	607392	R			
3.642	11	2	04	3q24	ZIC4	C	Zinc finger protein of cerebellum, 4	608948	R, D			9(Zic4)
3.643	10	20	15	3q24	ZIC1, CRS6	C	Zic family member-1	600470	A, D		Craniosynostosis 6, 616602 (3)	9(Zic1)
3.644	9	15	11	3q25.1	P2RY12, P2Y12, BDPLT8	P	Purinergic receptor P2Y, G protein-coupled, 12	600515	R		Bleeding disorder, platelet-type, 8, 609821 (3)	
3.645	9	9	08	3q25.31-q25.32	VEPH1, MELT, KIAA1692	P	Ventricular zone-expressed PH domain-containing protein, zebrafish, homolog of, 1	609594	R, REc			
3.646	2	5	14	3q24	GYG1, GSD15	P	Glycogenin 1	603942	A	mutation identified in 1 GSD15 patient	?Glycogen storage disease XV, 613507 (3); Polyglucosan body myopathy 2, 616199 (3)	
3.647	3	8	07	3q24-q26	HDLCQ5	P	High density lipoprotein cholesterol level QTL 5	610761	Fd	max lod at D3S3053	[High density lipoprotein cholesterol level QTL 5] (2)	
3.648	2	11	14	3q25.33	IFT80, KIAA1374, WDR56, SRTD2, ATD2	C	Intraflagellar transport 80, Chlamydomonas, homolog of	611177	R, REn		Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	
3.649	1	30	02	3q24-q26	UVM1	P	Melanoma, uveal, susceptibility to, 1	606660	Ch		{Melanoma, uveal, susceptibility to, 1} (2)	
3.650	2	3	13	3q26.1	B3GALT3, GLCT3, GLOB	P	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3	603094	REc		[Blood group, globoside system], 615021 (3); [Blood group, P1PK system, P(k) phenotype], 111400 (3)	
3.651	2	6	08	3q25.32	IQCJ	P	IQ motif-containing protein J	611622	REc			
3.652	12	27	01	3q25.1-q25.2	MBNL1, KIAA0428, EXP	P	Muscleblind-like protein	606516	R, REc			
3.653	6	23	98	3q25.2	P2RY1, P2Y1	C	Purinergic receptor P2Y, G-protein coupled, 1	601167	Psh, REc			
3.654	5	5	98	3q25.32	PTX3	C	Pentraxin-3	602492	REa, A			
3.655	5	28	98	3q25.1	SIAH2	P	Seven in absentia, Drosophila, homolog of, 2	602213	A			
3.656	8	30	09	3q25.1	TM4SF4, ILTMP	P	Transmembrane 4 superfamily, member 4	606567	R, REc			
3.657	5	28	08	3q25-q26	CELIAC10	P	Celiac disease, susceptibility to, 10	612008	Fd	associated with rs17810546	{Celiac disease, susceptibility to, 10} (2)	
3.658	4	10	14	3q25-q26	ETL6	P	Epilepsy, familial temporal lobe, 6	615697	Fd	between D3S1584 and D3S3520	Epilepsy, familial temporal lobe, 6 (2)	
3.659	8	12	98	3q25.32	SHOX2, SHOT, OG12	P	Short stature homeo box 2	602504	A, R			3(Og12)
3.660	2	3	06	3q26.1	SI	C	Sucrase-isomaltase	609845	REa, A, Fd		Sucrase-isomaltase deficiency, congenital, 222900 (3)	3(Sis)
3.661	8	18	04	3q23	XRN1, SEP1	P	Exoribonuclease 1	607994	R			
3.662	6	7	04	3q25-q27	ASPG1	P	Asperger syndrome, susceptibility to, 1	608638	Fd	max lod with D3S3037	{Asperger syndrome susceptibility 1} (2)	
3.663	5	16	07	3q25-q27	AUTS8	P	Autism, susceptibility to, 8	607373	Fd		{Autism susceptibility 8} (2)	
3.664	8	27	01	3q26.2	EIF5A2	P	Eukaryotic translation initiation factor 5A2	605782	R			
3.665	5	31	05	3q27.1	MCCC1, MCCA	C	3-Methylcrotonyl-CoA carboxylase 1	609010	R, A		3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	
3.666	8	26	04	3q26.2	PRKCI	P	Protein kinase C, iota	600539	H, REc	pseudogene on X		3(Prkci)
3.667	12	22	15	3q25.1	COMMD2	P	COMM domain-containing protein 2	616699	REc			
3.668	3	19	09	3q25.1	EIF2A	P	Eukaryotic translation initiation factor 2A	609234	REc			
3.669	8	29	96	3q25.32	MLF1	P	Myeloid leukemia factor-1	601402	Ch		Leukemia, acute myeloid, 601626 (1)	
3.670	8	19	13	3q25.1	P2RY14, BPR105, KIAA0001	C	Purinergic receptor P2Y, G protein-coupled, 14	610116	Psh, REn			
3.671	3	23	14	3q25.1	TMEM183B, C1ORF37DUP	P	Transmembrane protein 183B	611365	REc			
3.672	2	20	97	3q25.1	PFN2, PFL, D3S1319E	P	Profilin-2	176590	REc	mapped previously to chr.1		
3.673	11	16	98	3q24	SMARCA3, SNF2L3, HIP116	P	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3	603257	Psh, A			
3.674	4	30	09	3q25.2	DHX36, G4R1, RHAU, KIAA1488	P	DEAH (Asp-Glu-Ala-His) box polypeptide 36	612767	REc			
3.675	4	8	16	3q25.2	DWORF, LOC100507537	P	Dwarf open reading frame	616891	REc			
3.676	8	8	13	3q25.2	RAP2B	P	Ras-related protein 2B	179541	R, REc			
3.677	8	16	10	3q25.3	BWQTL2	P	Birth weight quantitative trait locus 2	613459	Fd	associated with rs900400	[Birth weight QTL 2] (2)	
3.678	4	7	05	3q25.32	LXN, ECI, TCI	P	Latexin	609305	R, REc			3(Lxn)
3.679	8	30	09	3q25.32	RARRES1, TIG1	P	Retinoic acid receptor responder 1	605090	R, REc			
3.680	5	5	10	3q25.31	CCNL1, ANIA6A	P	Cyclin L1	613384	REc			
3.681	8	27	15	3q25.31	LEKR1	P	Leucine-, glutamate-, and lysine-rich protein 1	613536	REc			
3.682	7	9	09	3q25.31	PLCH1, PLCL3, KIAA1069	P	Phospholipase C, eta-1	612835	REc			
3.683	4	27	12	3q25.31	SLC33A1, ACATN, AT1, SPG42, CCHLND	C	Solute carrier family 33 (acetyl-CoA transporter), member 1	603690	A, R, REc		Spastic paraplegia 42, autosomal dominant, 612539 (3); Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	3(Acatn)
3.684	6	13	12	3q25.31	SSR3, TRAPG	p	Signal sequence receptor, gamma	606213	R, REc			
3.685	12	17	08	3q25.31	TIPARP	P	TCDD-inducible poly(ADP-ribose) polymerase	612480	REc			
3.686	10	15	13	3q25.32	GFM1, EFG1, GFM, COXPD1	C	Mitochondrial elongation factor G1	606639	R, M, Fd, REc		Combined oxidative phosphorylation deficiency 1, 609060 (3)	
3.687	6	7	10	3q25.32	RSRC1, SRRP53	P	Arginine/serine-rich coiled-coil protein 1	613352	REc			
3.688	1	30	12	3q25.33	ARL14, ARF7	P	ADP-ribosylation factor-like 14	614439	REc			
3.689	2	25	14	3q25.33	SCARNA7	P	Small Cajal body-specific RNA 7	615644	REc			
3.690	4	1	15	3q21.3	ACAD9	C	Acyl-CoA dehydrogenase family, member 9	611103	REc		Mitochondrial complex I deficiency due to ACAD9 deficiency, 611126 (3)	
3.691	5	15	08	3q26	AFA1, MPB	P	Alopecia, androgenetic, 1	109200	Fd		Alopecia, androgenetic, 1 (2)	
3.692	3	7	14	3q27.1	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	C	Chloride channel-2	600570	Psh		{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3); {Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3); Leukoencephalopathy with ataxia, 615651 (3)	
3.693	3	20	08	3q26.31	FNDC3B, FAD104	P	Fibronectin domain III-containing protein 3B	611909	REc			3(Fndc3b)
3.694	10	9	94	3q26	MDS1	P	Myelodysplasia syndrome-1	600049	Ch, REc, A	cen--EVI1--MDS1--EAP--tel	Myelodysplasia syndrome-1 (3)	
3.695	1	8	16	3q26.2	MECOM, EVI1, RUSAT2	C	MDS1 and EVS1 complex locus	165215	A, Ch, REc		Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	3(Evi1)
3.696	4	13	05	3q26	MYP8	P	Myopia 8	609257	Fd		Myopia 8 (2)	
3.697	8	3	12	3q28	OSTN	P	Osteocrin	610280	REc, H			16(Ostn)
3.698	3	14	06	3q26.31	PLD1	C	Phospholipase D1, phosphatidylcholine-specific	602382	REa, A			3(Pld1)
3.699	10	7	99	3q26.1	SERPINI1, PI12	P	Protease inhibitor 12	602445	A		Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	
3.700	12	28	08	3q26.1	SLITRK3, KIAA0848	C	SLIT- and NTRK-like family, member 3	609679	R, REc, H			3(Slitrk3)
3.701	6	16	99	3q26.31	TNFSF10, TRAIL, APO2L	P	Tumor necrosis factor ligand superfamily, member 10	603598	A			
3.702	1	24	01	3q25.33	CAPC	P	Chromosome-associated protein C	605575	A			
3.703	11	4	98	3q25.31	KCNAB1, KCNA1B	C	Potassium voltage-gated channel, shaker-related subfamily, beta member 1	601141	Psh, A, REc			3(Kcna1b)
3.704	2	1	11	3q25.33	KPNA4, QIP1	P	Karyopherin alpha-4	602970	REc			
3.705	8	20	07	3q26.1	NMD3	P	NMD3, S. cerevisiae, homolog of	611021	R, REc			
3.706	1	25	05	3q26.1	PDCD10, TFAR15, CCM3	P	Programmed cell death 10	609118	REc, Fd		Cerebral cavernous malformations 3, 603285 (3)	
3.707	4	8	08	3q25.3-q26.1	PPM1L, PP2CE	P	Protein phosphatase 1-like	611931	REc			
3.708	9	7	12	3q26.1	SPTSSB, C3orf57, SSSPTB, ADMP	C	Serine palmitoyltransferase, small subunit B	610412	REc, R			
3.709	12	30	14	3q25.33	TRIM59, RNF104, MRF1, IFT80L	P	Tripartite motif-containing protein 59	616148	REc, H			3(Trim59)
3.710	8	8	91	3q26.1	BCHE, CHE1	C	Butyrylcholinesterase	177400	F, D, A	distal to CP, TF	Apnea, postanesthetic (3)	
3.711	6	13	95	3q26.31	ECT2	P	Epithelial cell transforming sequence 2 oncogene	600586	A, Psh			3(Ect2)
3.712	2	5	01	3q26.1	SERPIN12, PI14, MEPI	C	Protease inhibitor 14	605587	REn, A			
3.713	8	7	01	3q26.1-q26.3	MNG3	P	Multinodular goiter-3	606082	Fd		Goiter, multinodular, 3 (2)	
3.714	12	5	13	3q26.2	SLC2A2, GLUT2	C	Solute carrier family 2 (facilitated glucose transporter), member 2	138160	REa, A, Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Fanconi-Bickel syndrome, 227810 (3)	
3.715	7	11	11	3q26.2	ARPM1	P	Actin-related protein M1	608534	REc			
3.716	8	28	09	3q26.2	GOLIM4, GOLPH4, GPP130	P	Golgi integral membrane protein 4	606805	R, REc			
3.717	9	12	13	3q26.2	MYNN	P	Myoneurin	606042	REc			
3.718	2	2	11	3q26.2	SEC62, TLOC1, HTP1	P	Sec62, S. cerevisiae, homolog of	602173	REc			
3.719	5	29	13	3q26.2	SKIL, SNO	P	SKI-like	165340	REc			
3.720	4	3	14	3q26.2	SLC7A14, KIAA1613, RP68	P	Solute carrier family 7, member 14	615720	REc		Retinitis pigmentosa 68, 615725 (3)	
3.721	7	18	14	3q26.2	TRV-AAC1-1, TRNAV24	P	Transfer RNA valine (AAC) 1-1	615310	REc			
3.722	1	26	01	3q26.2	CLDN11, OTM, OSP	P	Claudin 11 (oligodendrocyte transmembrane protein)	601326	REa, A			
3.723	6	16	99	3q26.33	USP13, ISOT3	C	Ubiquitin-specific protease-13	603591	R, Psh, REc			
3.724	3	24	06	3q26.2-q26.3	TNIK, KIAA0551	P	TRAF2-and NCK-interacting kinase	610005	R, REc			
3.725	11	26	12	3q26.2-q26.31	APMR2	P	Alopecia-mental retardation syndrome 2	610422	Fd	between D3S1564 and D3S2427	Alopecia-mental retardation syndrome 2 (2)	
3.726	3	19	09	3q26.2-q26.33	FEB10	P	Febrile seizures, familial, 10	612637	Fd	between D3S3656 and D3S1232	Febrile seizures, familial, 10 (2)	
3.727	8	21	07	3q26.33	PEX5L, PEX5R, PXR2B	P	Peroxisome biogenesis factor 5-like	611058	REc			
3.728	11	1	13	3q27.2	TRA2B, SFRS10	P	Splicing factor, arginine/serine-rich, 10 (transformer 2, drosophila, homolog of, beta)	602719	R			
3.729	5	1	91	3q29	APOD	P	Apolipoprotein D	107740	REb, A			16(Apod)
3.730	8	20	07	3q26.33	ACTL6A, BAF53, BAF53A	P	Actin-like 6A	604958	REc			
3.731	3	15	11	3q26.33	CCDC39	P	Coiled-coil domain-containing protein 39	613798	REc		Ciliary dyskinesia, primary, 14, 613807 (3)	
3.732	4	30	15	3q26.33	SOX2OT, NCRNA00043	P	SOX2 overlapping transcript, noncoding	616338	REc			
3.733	4	21	10	3q26.33	DCUN1D1, RP42	P	DCN1 domain-containing protein 1	605905	REc	previously mapped to 6q16		
3.734	7	3	06	3q26.33	DNAJC19, TIM14	P	DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of)	608977	R, REc		3-methylglutaconic aciduria, type V, 610198 (3)	
3.735	5	6	13	3q26.33	GNB4, CMTD1F	P	Guanine nucleotide-binding protein, beta-4	610863	R, REc		Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3)	
3.736	2	13	15	3q26.31	GHSR, GHDP	P	Growth hormone secretagogue receptor	601898	REc		Growth hormone deficiency, isolated partial, 615925 (3)	
3.737	3	5	08	3q26.33	MRPL47	P	Mitochondrial ribosomal protein L47	611852	R, REc			
3.738	8	19	04	3q26.31	NAALADL2	P	N-acetylated alpha-linked acidic dipeptidase-like 2	608806	Ch, REc	?involved in Cornelia de Lange syndrome		
3.739	2	21	10	3q26.31	NCEH1, NCEH, KIAA1363	P	Neutral cholesterol ester hydrolase 1	613234	REc			
3.740	8	28	09	3q26.31	NLGN1	P	Neuroligin 1	600568	R, REc			
3.741	11	29	12	3q26.32	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	P	Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834	REa, A		Ovarian cancer, somatic, 167000 (3); Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Gastric cancer, somatic, 613659 (3); Hepatocellular carcinoma, somatic, 114550 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)	
3.742	4	30	15	3q26.31	SPATA16, SPGF6	C	Spermatogenesis-associated protein 16	609856	R, REc, Fd	mutation identified in 1 SPGF6 family	?Spermatogenic failure 6, 102530 (3)	
3.743	4	30	01	3q27.1	DCLAMP	P	Lysosome-associated membrane glycoprotein, dendritic cell-specific	605883	A			
3.744	1	22	07	3q26.33	SOX2, MCOPS3	C	SRY (sex determining region Y)-box 2	184429	A, D		Microphthalmia, syndromic 3, 206900 (3); Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	
3.745	3	9	12	3q27.1	THPO, MGDF, MPLLG, TPO, THCYT1	C	Thrombopoietin (megakaryocyte growth and development factor)	600044	A		Thrombocythemia 1, 187950 (3)	16(Thpo)
3.746	11	13	01	3q26.32	WIG1	P	Wildtype p53-induced gene	606452	A			
3.747	1	29	01	3q26.32	KCNMB3	C	Potassium large conductance calcium-activated channel, subfamily M, beta member 3	605222	A, Psh, R			
3.748	11	26	12	3q26.3-q27.3	APMR1	P	Alopecia-mental retardation syndrome 1	203650	Fd	max lod at D3S3583	Alopecia-mental retardation syndrome 1 (2)	
3.749	5	24	13	3q29	ATP13A3, AFURS1	P	ATPase, type 13A3	610232	REc			
3.750	11	11	14	3q26.32	KCNMB2	P	Potassium channel, calcium-activated, large conductance, subfamily M, beta member 2	605214	R, REc			
3.751	5	11	16	3q26.32	TBL1XR1, TBLR1, IRA1, C21, MRD41	P	Transducin-beta-like 1 receptor 1	608628	REc, R		Mental retardation, autosomal dominant 41 , 616944 (3); Pierpont syndrome, 602342 (3)	
3.752	3	27	13	3q26.32-q28	FAME4, FCMTE4	P	Epilepsy, familial adult myoclonic, 4	615127	Fd	between D3S3730 and D3S1580	Epilepsy, myoclonic, familial adult, 4 (2)	
3.753	9	20	00	3q27.1	ABCC5, MRP5, MOATC	C	ATP-binding cassette, subfamily C, member 5	605251	R, A			
3.754	2	17	09	3q27.3	ADIPOQ, APM1, GBP28, ADIPQTL1	P	Adipocyte-, C1q-, and collagen domain-containing	605441	A, REc		Adiponectin deficiency, 612556 (3)	16(Apm1)
3.755	7	8	95	3q27.3	AHSG	C	Alpha-2HS-glycoprotein	138680	F, S, D, REa, A, REn	linked to TF, CHE1; ?order = cen-TF-CHE1-AHSG		
3.756	6	22	04	3q27.1	ALG3, NOT56L, CDGS4, CDG1D	P	Alg3, S. cerevisiae, homolog of	608750	R		Congenital disorder of glycosylation, type Id, 601110 (3)	
3.757	9	9	14	3q27	AOMS1, SYNX	P	Abdominal obesity-metabolic syndrome QTL1	605552	Fd	epistatic gene on 17p12	Abdominal obesity-metabolic syndrome 1 (2)	
3.758	8	28	09	3q26.33	ATP11B, ATPIR	C	ATPase, class VI, type 11B	605869	REc			
3.759	4	3	01	3q27.3	BCL6	P	B-cell CLL/lymphoma-6	109565	Ch, A		Lymphoma, B-cell (2)	16(Bcl6)
3.760	6	16	99	3q27.1	CHRD	C	Chordin	603475	R, REc, REn	near THPO, CLCN2, EIF4G1		16(Chrd)
3.761	6	13	07	3q28	CLDN16, PCLN1, HOMG3	C	Claudin 16 (paracellin 1)	603959	Fd		Hypomagnesemia 3, renal, 248250 (3)	
3.762	8	6	13	3q27.3	CRYGS, CRYG8, CTRCT20	C	Crystallin, gamma S	123730	REa, Fd		Cataract 20, multiple types, 116100 (3)	
3.763	4	8	16	3q27.1	DVL3, DRS3	C	Dishevelled 3 (homologous to Drosophila dsh)	601368	Psh, A		Robinow syndrome, autosomal dominant 3, 616894 (3)	
3.764	1	28	14	3q27.2	EHHADH, PBFE, LBFP, FRTS3	C	Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase	607037	A, REn	mutation identified in 1 family	?Fanconi renotubular syndrome 3, 615605 (3)	
3.765	10	29	03	3q27.1	EIF2B5, LVWM, CACH, CLE	C	Eukaryotic translation initiation factor 2B, subunit 5	603945	Fd,R		Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
3.766	4	10	15	3q27.1	EIF4G1, EIF4G, PARK18	C	Eukaryotic translation initiation factor 4 gamma, 1	600495	Psh	amplified in squamous cell lung cancer	{Parkinson disease 18}, 614251 (3)	
3.767	7	5	01	3q27.3	FETUB	P	Fetuin B	605954	REc			
3.768	3	1	12	3q27.3	HRG, THPH11	C	Histidine-rich glycoprotein	142640	REa, A, Fd, REn		Thrombophilia due to HRG deficiency, 613116 (3); Thrombophilia due to elevated HRG, 613116 (1)	
3.769	7	3	06	3q27.1	HTR3C	P	5-hydroxytryptamine receptor 3C	610121	A, REn			
3.770	7	3	06	3q27.1	HTR3D	P	5-hydroxytryptamine receptor 3, subunit D	610122	A, REn			
3.771	7	3	06	3q27.1	HTR3E	P	5-hydroxytryptamine receptor 3, subunit E	610123	A, REn			
3.772	10	28	08	3q27.3	KNG1, KNG	C	Kininogen 1	612358	Psh, A, REn		[Kininogen deficiency], 228960 (3); [High molecular weight kininogen deficiency], 228960 (3)	
3.773	11	30	06	3q27.1	MAPO6D1, SL21	P	MAP6 domain-containing protein 1	610593	REc			
3.774	1	19	07	3q27.2	MAP3K13, LZK	C	Mitogen-activated protein kinase kinase kinase 13 (leucine zipper-bearing kinase)	604915	R, REc			
3.775	5	22	07	3q27.1	PARL	P	Presenilin-associated rhomboid-like protein	607858	R, REc			
3.776	3	5	95	3q27.3	RFC4	P	Replication factor C4, 37kD (activator 1, 37kD)	102577	Psh, A			
3.777	2	28	03	3q27.3	RPL39L	P	Ribosomal protein L39-like	607547	REc			
3.778	7	1	05	3q27.3	RTP4	P	Receptor-transporting protein 4	609350	R, REc			
3.779	1	19	07	3q27.2	SENP2, SMT3IP2, AXAM2, KIAA1331	P	Sentrin-specific protease family, member 2	608261	R, REc			
3.780	9	22	08	3q28	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	C	Tumor protein p63 (tumor protein p73-like)	603273	A, R		Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome, 603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)	16(Trp63)
3.781	6	16	99	3q27.2-q27.3	DGKG, DAGK3	P	Diacylglycerol kinase, gamma, 90-kD	601854	A			
3.782	7	16	14	3q27.2	LIPH, LAH2, ARWH2, HYPT7	C	Lipase H	607365	REc		Hypotrichosis 7, 604379 (3); Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	
3.783	10	10	14	3q27.3	MASP1, CRARF, 3MC1	P	Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor)	600521	A		3MC syndrome 1, 257920 (3)	16(Crarf)
3.784	9	7	00	3q27-q28	SPG14	P	Spastic paraplegia 14, autosomal recessive	605229	Fd		Spastic paraplegia 14, autosomal recessive (2)	
3.785	8	19	13	3q27.1	B3GNT5	P	Beta-1,3-N-acetylglucosaminyltransferase 5	615333	REc			
3.786	10	10	14	3q27.1	CAMK2N2, CAMKIIN	P	Calcium/calmodulin-dependent protein kinase II inhibitor 2	608721	R, REc			
3.787	2	25	14	3q27.1	ECE2, KIAA0604	C	Endothelin-converting enzyme 2	610145	REc, A, R			
3.788	5	24	13	3q27.1	KLHL24, KRIP6	P	Kelch-like 24	611295	REc			
3.789	8	28	09	3q27.1	MIR1224, MIRN1224	P	Micro RNA 1224	611620	REc			
3.790	8	28	09	3q27.1	PSMD2, S2, TRAP2	P	Proteasome 26S subunit, non-APTase, 2	606223	R, REc			
3.791	4	26	10	3q27.1	YEATS2, KIAA1197	P	YEATS domain-containing protein 2	613373	REc			
3.792	3	23	14	3q27.3	DNAJB11, HEDJ, DJ9, ABBP2	P	DNAJ/HSP40 homolog, subfamily B, member 11	611341	REc			
3.793	9	7	11	3q27.1	KLHL6, FLJ00029	P	Kelch-like 6	614214	REc			
3.794	7	14	14	3q27.3	RTP1	P	Receptor-transporting protein 1	609137	REc			
3.795	7	14	14	3q27.3	RTP2	P	REceptor-transporting protein 2	609138	REc			
3.796	5	3	11	3q27.3	SNORA63, RNU107, RNE3	P	Small nucleolar RNA, H/ACA box, 63	180647	REc			
3.797	4	2	16	3q27.3	SNORA81	P	Small nucleolar RNA, H/ACA box, 81	611334	REc	in intron 3 of EIF2A		
3.798	9	28	00	3q27.1	AP2M1, CLAPM1	P	Adaptor-related protein complex 2, mu 1 subunit	601024	REa, A			
3.799	8	20	15	3q28	CCDC50, C3orf6, DFNA44	C	Coiled-coil domain-containing protein 50	611051	Fd, REc	mutation identified in 1 DFNA44 family	?Deafness, autosomal dominant 44, 607453 (3)	
3.800	5	28	08	3q28	CELIAC11	P	Celiac disease, susceptibility to, 11	612009	Fd	associated with rs1464510	{Celiac disease, susceptibility to, 11} (2)	
3.801	8	28	09	3q27.3	EIF4A2	P	Eukaryotic translation initiation factor-4A, isoform 2	601102	R, REc	previously 18p11.2 by FISH		16(Eif4a2)
3.802	1	26	97	3q27.2	ETV5, ERM	C	ets variant gene 5 (ets-related molecule)	601600	A			
3.803	2	24	97	3q28-q29	FGF12, FHF1	C	Fibroblast growth factor-12	601513	REa, H, A			16(Fhf1)
3.804	5	4	99	3q26.33	FXR1	P	Fragile X mental retardation, autosomal homolog	600819	REa, A	pseudogene on 12q12		
3.805	1	30	12	3q28	GMNC, GEMC1	P	Geminin coiled-coil domain-containing protein	614448	REc			
3.806	8	6	07	3q27.2	IGF2BP2, IMP2	C	Insulin-like growth factor 2 mRNA-binding protein 2	608289	R, Fd		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
3.807	11	4	98	3q28	IL1RAP	P	Interleukin 1 receptor accessory protein	602626	A, R			
3.808	9	2	11	3q28	LNCR5	P	Lung cancer susceptibility 5	614210	Fd	associated with rs4488809	{Lung cancer susceptibility 5} (2)	
3.809	10	1	95	3q27-q28	LPP	P	Lipoma-preferred-partner gene	600700	Ch, RE	fused with HMGIC in lipoma; fused with MLL in leukemia	Lipoma (3); Leukemia, acute myeloid, 601626 (3)	
3.810	3	23	09	3q28	MIR28, MIRN28	P	Micro RNA 28	612154	REc			
3.811	6	19	01	3q27.1	POLR2H, RPB8	P	Polymerase II, RNA, subunit H	606023	R			
3.812	3	25	14	3q28	PYDC2, POP2	P	Pyrin domain-containing protein 2	615701	REc			
3.813	10	23	87	3q27.3	SST	C	Somatostatin	182450	REa			16(Smst)
3.814	8	27	12	3q28	TMEM207	P	Transmembrane protein 207	614786	REc			
3.815	7	19	06	3q28	CLDN1, SEMP1, ILVASC	C	Claudin 1	603718	REa, R, Fd		Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	
3.816	1	10	02	3q29	HRASLS	P	HRAS-like suppressor	606487	A			
3.817	1	7	03	3q29	HES1, HRY	P	Hairy and enhancer of split, Drosophila, homolog of	139605	A			
3.818	4	7	16	3q29	OPA1, NTG, NPG, BERHS, MTDPS14	C	Optic atrophy 1 gene	605290	Fd, REc	mutation identified in 1 MTDPS14 family	Optic atrophy 1, 165500 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Optic atrophy plus syndrome, 125250 (3); Behr syndrome, 210000 (3); ?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	?16(Bst)
3.819	2	25	15	3q29	ATP13A4	P	ATPase, type 13A4	609556	A			
3.820	1	24	13	3q29	BDH1, BDH	P	3-hydroxybutyrate dehydrogenase 1	603063	REc			
3.821	8	28	09	3q29	CENTB2, KIAA0041, ACAP2	P	Centaurin, beta-2	607766	Psh, REc			
3.822	3	23	14	3q29	CEP19, C3orf34, MOSPGF	P	Centrosomal protein, 19kD	615586	REc, Fd	mutation identified in 1 family	Morbid obesity and spermatogenic failure, 615703 (3)	
3.823	8	22	05	3q29	CPN2	P	Carboxypeptidase N, polypeptide 2, 83-KD	603104	A, H, Ch	conflicting assignment to chr.8		16(Cpn2)
3.824	6	22	05	3q29	DLG1	C	Discs, large, Drosophila, homolog of, 1	601014	REc	deleted in 3q29 microdeletion syndrome		16(Dlgh1)
3.825	9	9	08	3q29	FBXO45, FBX45	P	F-box only protein 45	609112	REc			16(Fbxo45)
3.826	5	2	16	3q29	FYTTD1, UIF	P	Forty-two-three domain-containingi protein 1	616933	REc			
3.827	8	8	13	3q29	GP5	P	Glycoprotein V, platelet	173511	A			
3.828	12	17	08	3q29	IQCG	P	IQ motif-containing protein G	612477	REc			
3.829	7	14	14	3q29	LMLN	P	Leishmanolysin-like	609380	REc			
3.830	2	22	07	3q29	LSG1	P	Large subunit GTPase 1, S. cerevisiae, homolog of	610780	R, REc			
3.831	10	23	87	3q29	MFI2, MAP97	P	Melanoma-associated antigen p97	155750	S, A			
3.832	4	15	08	3q29	DEL3q29, MICRODEL3q29	P	Chromosome 3q29 microdeletion syndrome	609425	Ch	contiguous gene deletion syndrome	Chromosome 3q29 microdeletion syndrome (4)	
3.833	5	24	13	3q29	MUC20	P	Mucin 20, cell surface-associated	610360	REc			
3.834	4	15	08	3q29	DUP3q29, MICRODUP3q29	P	Chromosome 3q29 microduplication syndrome	611936	Ch	contiguous gene duplication syndrome	Chromosome 3q29 microduplication syndrome (4)	
3.835	3	30	12	3q29	MIR570	P	Micro RNA 570	614538	REc			
3.836	8	8	91	3q29	MUC4	P	Mucin 4, tracheobronchial	158372	REa, A			
3.837	10	28	15	3q29	NCBP2, CBP20, NIP1	P	Nuclear CAP-binding protein 2	605133	REc			
3.838	7	22	13	3q29	NRROS, LRRC33	P	Negative regulator of oxygen species	615322	REc			
3.839	6	25	08	3q29	OSTA	P	Organic solute transporter, alpha	612084	REc			16(Osta)
3.840	2	3	15	3q28	P3H2, LEPREL1, MCVD	P	Prolyl 3-hydroxylase 2	610341	REc, H		Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	16(Leprel1)
3.841	6	22	05	3q29	PAK2, PAK65	P	p21-activated kinase 2	605022	REc	deleted in 3q29 microdeletion syndrome		
3.842	3	6	14	3q29	PCYT1A, CTPCT, PCYT1, SMDCRD	P	Phosphate cytidylyltransferase 1, choline, alpha isoform	123695	H, R		Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	16(Ctpct)
3.843	9	9	10	3q29	PIGX	P	Phosphatidylinositol glycan, class X	610276	REc			
3.844	12	17	07	3q29	PIGZ, SMP3	P	Phosphatidylinositol glycan, class Z	611671	REc			
3.845	5	8	97	3q29	PPP1R2, IPP2	P	Protein phosphatase-1, regulatory (inhibitor) subunit 2	601792	A	pseudogenes on chr. 5 and 6		
3.846	4	1	09	3q29	RNF168	P	RING finger protein 168	612688	REc		RIDDLE syndrome, 611943 (3)	
3.847	12	4	15	3q29	RUBCN, RUBICON, KIAA0226, SCAR15	P	RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein	613516	REc, R	mutation identified in 1 family	?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	
3.848	7	9	09	3q29	SENP5	P	Sentrin-specific protease family, member 5	612845	REc			
3.849	1	8	16	3q29	TFRC, TFR, CD71, IMD46	C	Transferrin receptor	190010	S, H, REa, A, R, F		Immunodeficiency 46, 616740 (3)	16(Trfr)
3.850	8	28	09	3q29	TNK2, ACK, ACK1	P	Tyrosine kinase, non-receptor, 2	606994	R, REc			
3.851	6	19	15	3q29	UBXN7, KIAA0794	P	UBX domain protein 7	616379	REc			
3.852	3	14	13	3q29	WDR53	P	WD repeat-containing protein 53	615110	REc			
3.853	4	2	12	3q29	XXYLT1, C3orf21	P	Xyloside xylosyltransferase 1	614552	REc			
3.854	5	28	98	3p21.2	RPL29, HIP	P	Ribosomal protein L29	601832	Psh, R, A			9(Rpl29)
3.855	1	13	09	3q29	RPL35A, DBA5	P	Ribosomal protein L35A	180468	REa, A	previous assignment to chr.18 in error	Diamond-Blackfan anemia 5, 612528 (3)	
4.1	1	7	02	4p16.3	ADD1	C	Adducin-1, alpha	102680	REa, REb		{Hypertension, essential, salt-sensitive}, 145500 (3)	5(Add1)
4.2	9	8	11	4p16.3	ATP5I, ATP5K	P	ATP synthase, H+ transporting, mitochondrial FO complex, subunit E	601519	REc			5(Atp5k)
4.3	7	20	12	4p16.3	C4orf48	P	chromosome 4 open reading frame 48	614690	REc			
4.4	8	17	09	4p16.3	CPLX1, CPX1	P	Complexin 1	605032	REc			
4.5	12	10	13	4p16.3	CRIPAK, FLJ3443	P	Cysteine-rich inhibitor of PAK1	610203	REc			
4.6	3	25	03	4p16.3	D4S234E, D4S234	P	D4S234E gene	607645	REc			
4.7	10	15	98	4p16.3	DGKQ, DAGK4	P	Diacylglycerol kinase, theta, 110kD	601207	REc, H			5(Dagk4)
4.8	10	11	06	4p16.3	FGFR3, ACH	C	Fibroblast growth factor receptor-3	134934	REn, Fd		Achondroplasia, 100800 (3); Hypochondroplasia, 146000 (3); Thanatophoric dysplasia, type I, 187600 (3); Crouzon syndrome with acanthosis nigricans, 612247 (3); Muenke syndrome, 602849 (3); Bladder cancer, somatic, 109800 (3); Colorectal cancer, somatic, 114500 (3); Cervical cancer, somatic, 603956 (3); LADD syndrome, 149730 (3); CATSHL syndrome, 610474 (3); Nevus, epidermal, somatic, 162900 (3); Thanatophoric dysplasia, type II, 187601 (3); Spermatocytic seminoma, somatic, 273300 (3); SADDAN, 616482 (3)	5(Fgfr3)
4.9	5	29	12	4p16.3	GRK4, GPRK2L, GPRK4	P	G protein-coupled receptor kinase 4	137026	RE, H			5(Gprk2l)
4.10	11	1	10	4p16.3	HAUS3, DGT3, C4orf15	P	HAUS augimn-like complex, subunit 3	613430	REc			
4.11	9	17	09	4p16.3	HTT, HD, IT15	C	Huntingtin	613004	Fd	distal to D4S10	Huntington disease, 143100 (3)	5(Hdh)
4.12	10	29	03	4p16.3	IDUA, IDA	P	Iduronidase, alpha-L-	252800	REa, A, S		Mucopolysaccharidosis Ih, 607014 (3); Mucopolysaccharidosis Is, 607016 (3); Mucopolysaccharidosis Ih/s, 607015 (3)	5(Idua)
4.13	2	1	00	4p16.3	LETM1	P	Leucine zipper/EF-hand-containing transmembrane protein 1	604407	A			
4.14	9	30	13	4p16.3	LRPAP1, A2MRAP, MYP23	C	Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1)	104225	A, REn		Myopia 23, autosomal recessive, 615431 (3)	
4.15	8	30	09	4p16.3	MAEA, EMP	P	Macrophage erythroblast attacher	606801	R, REc			
4.16	11	30	11	4p16.3	MDCMP	P	Muscular dystrophy, congenital, merosin-positive	609456	Fd	max lod at D4S432	Muscular dystrophy, congenital, merosin-positive (2)	
4.17	3	22	93	4p16.3	MYL5	P	Myosin, light polypeptide-5, regulatory	160782	RE			
4.18	1	29	14	4p16.3	NAT8L, CML3, NACED	P	N-acetyltransferase 8-like	610647	REc	mutation identified in 1 family	?N-acetylaspartate deficiency, 614063 (3)	
4.19	7	13	09	4p16.3	NOP14, NOL14, NOP14, RES425	P	Nop14, S. cerevisiae, homolog of	611526	REc			
4.20	12	22	09	4p16.3	PDE6B, PDEB, RP40, CSNBAD2	C	Phosphodiesterase-6B, cGMP-specific, rod, beta	180072	REa, A, Fd		Night blindness, congenital stationary, autosomal dominant 2, 163500 (3); Retinitis pigmentosa-40, 613801 (3)	5(Pdeb, rd)
4.21	5	2	16	4p16.3	PIGG, GPI7, MRT53	P	Phosphatidylinositol glycan anchor biosynthesis class G protein	616918	REc		Mental retardation, autosomal recessive 53, 616917 (3)	
4.22	11	20	98	4p16.3	RNF4	P	RING finger protein-4	602850	REn			
4.23	6	9	08	4p16.3	RNF212, ZHP3	P	Ring finger protein 212	612041	REn		Recombination rate QTL 1, 612042 (3)	
4.24	5	30	01	4p16.3	SH3BP2, CRPM	C	SH3-domain binding protein 2	602104	REn, Fd		Cherubism, 118400 (3)	
4.25	3	27	01	4p16.3	SLBP, HBP	P	Histone stem-loop binding protein	602422	REc			
4.26	8	19	13	4p16.3	SLC25A1, SAT1	P	Solute carrier family 26 (sulfate transporter), member 1	610130	R			
4.27	5	11	01	4p16.3	SPON2	P	Spondin 2	605918	R			
4.28	5	5	15	4p16.3	TACC3	P	Transforming, acidic, coiled-coil-containing protein 3	605303	Psh, R			5(Tacc3)
4.29	5	22	07	4p16.3	TETRAN, TPO1	P	Tetracycline transporter-like protein	610977	REc			
4.30	9	22	14	4p16.3	TMEM129	P	Transmembrane protein 129	615975	REc			
4.31	11	24	15	4p16.3	TMEM175	P	Transmembrane protein 175	616660	REc			
4.32	12	29	06	4p16.3	TNIP2, ABIN2, FLIP1	P	TNFAIP3-interacting protein 2	610669	R, REc			
4.33	5	26	12	4p16.3	UVSSA, KIAA1530, UVSS3	C	UV-stimulated scaffold protein A	614632	R, REc		UV-sensitive syndrome 3, 614640 (3)	
4.34	6	10	10	4p16.3	WHS	C	Wolf-Hirschhorn syndrome	194190	Ch	contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere	Wolf-Hirschhorn syndrome (4)	
4.35	6	10	10	4p16.3	WHSC1	P	WHS candidate 1 gene	602952	REc, Ch			
4.36	6	10	10	4p16.3	WHSC2	P	WHS candidate 2 gene	606026	REc			
4.37	2	25	15	4p16.3	ZBTB49, ZNF509	P	Zinc finger- and BTB domain-containing protein 49	616238	REc			
4.38	5	13	13	4p16.3	ZNF141, D4S90, PAPA6	P	Zinc finger protein-141 (clone pHZ-44)	194648	Psh, A, Ch	1 family identified with mutation	?Polydactyly, postaxial, type A6, 615226 (3)	
4.39	1	18	12	4p16.2	CYTL1, C17	P	Cytokine-like protein 1	607930	R, REc			
4.40	4	30	15	4p16.3	DOK7, C4orf25, CMS10	C	Downstream of tyrosine kinase 7	610285	REc	mutation identified in 1 FADS family	Myasthenic syndrome, congenital, 10, 254300 (3); ?Fetal akinesia deformation sequence, 208150 (3)	
4.41	5	23	13	4p16.1	JAKMIP1, JAMIP1, MARLIN1	P	Janus kinase and microtubule-interacting protein 1	611195	REc			
4.42	6	12	14	4p16.3	OTOP1	P	Otopetrin 1	607806	REc, H			5(Otop1)
4.43	4	17	07	4p16.3	POLN	P	Polymerase, DNA, nu	610887	REc, H			5(Poln)
4.44	7	16	13	4p16.3	RGS12	P	Regulator of G protein signaling 12	602512	REc, H			5(Rgs12)
4.45	2	23	09	4p16.3	ADRA2C, ADRA2L2	C	Adrenergic, alpha-2C-, receptor	104250	REa, Fd	linked to D4S10	{Congestive heart failure and beta-blocker response, modifier of} (3)	
4.46	1	5	12	4p16.1	AFAP1, AFAP, AFAP110	P	Actin filament-associated protein 1	608252	REc			
4.47	4	17	13	4p16.1	BLOC1S4, BLOS4, CNO	P	Biogenesis of lysosome-related organelles complex 1, subunit 4	605695	R, REc, H			5(cno)
4.48	1	11	16	4p15.33	BOD1L1, FAM44A	P	BOD1-like protein 1	616746	REc			
4.49	7	17	14	4p16.1	CLNK, MIST	P	Cytokine-dependent hematopoietic cell linker	611434	REc			
4.50	6	19	12	4p16.1	CPZ	P	Carboxypeptidase Z	603105	REc			
4.51	8	30	09	4p16.1	GPR78	P	G protein-coupled receptor 78	606921	REc			
4.52	6	27	08	4p16.1	HMX1, H6	P	Homeo box (H6 family) 1	142992	Psh, Fd		Oculoauricular syndrome, 612109 (3)	5(Hmx1)
4.53	1	16	07	4p16.1	HTRA3, PRSP	P	HTRA serine peptidase 3	608785	REc			
4.54	4	21	16	4p16.1	MRFAP1, PAM14, PGR1`	P	MORF4 family- associated protein 1	616905	REc			
4.55	12	17	12	4p16.2	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	C	Muscle segment homeo box, Drosophila, homolog of, 1 (homeo box 7)	142983	REa, A, D, Fd		Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3); Orofacial cleft 5, 608874 (3); Ectodermal dysplasia 3, Witkop type, 189500 (3)	5(Hox7)
4.56	4	13	10	4p15.33	NKX3-2, BAPX1, SMMD	C	Bagpipe homeo box, Drosophila, homolog of	602183	Fd		Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	5(Bapx1)
4.57	8	30	09	4p16.1	SORCS2, KIAA1329	P	SORCS receptor 2	606284	R, REc			
4.58	4	26	10	4p16.1	TADA2B, ADA2B	P	Transcriptional adaptor 2B	608790	REc			
4.59	10	11	12	4p16.1	TBC1D14, KIAA1322	P	TBC1 domain family, member 14	614855	R, REc			
4.60	7	21	15	4p16.1	USP17L9P, USP17	P	Ubiquitin-specific protease 17-like family member 9, pseudogene	607011	A			
4.61	1	14	14	4p16.1	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	C	Wolframin	606201	Fd	mutation identified in 1 CTRCT41 family	Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38, 600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3); ?Cataract 41, 116400 (3)	
4.62	4	8	98	4p16.2	CRMP1, DPYSL1, DRP1	P	Collapsin response mediator protein-1	602462	REc			
4.63	2	10	04	4p16.1	DRD5, DRD1B, DRD1L2	C	Dopamine receptor D5	126453	REa, A, REc, R, Psh, Fd	pseudogenes on 2p11 and 1q21	{Blepharospasm, primary benign}, 606798 (3); Dystonia, primary cervical (3); {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)	5(Drd5)
4.64	1	24	09	4p16.1	ABLIM2, KIAA1808	P	Actin-binding LIM protein family, member 2	612544	REc, H			5(Ablim2)
4.65	7	8	95	4p16	CRSA, CRS3	P	Craniosynostosis, Adelaide type	600593	Fd		Craniosynostosis, Adelaide type (2)	
4.66	11	4	98	4p16.3	CTBP1	P	C-terminal binding protein 1	602618	R			
4.67	3	22	00	4p16.2	EVC	P	Ellis-van Creveld syndrome gene	604831	Fd		Ellis-van Creveld syndrome, 225500 (3); Weyers acrodental dysostosis, 193530 (3)	
4.68	4	26	01	4p16.3	FGFRL1	P	Fibroblast growth factor receptor-like 1	605830	A			
4.69	3	9	98	4p16.3	GAK	P	Cyclin G associated kinase	602052	A			
4.70	3	11	09	4p16.1	GRPEL1, HMGE	P	GrpE, E. coli, homolog of	606173	REc			
4.71	5	4	00	4p16.3	HGFAC, HGFA	P	Hepatocyte growth factor activator	604552	A, REa			
4.72	5	7	03	4p15.32	KSP37	P	Killer-specific secretory protein, 37kD	607713	REc			
4.73	5	8	15	4p16.2	LBN, EVC2, WAD	C	Limbin	607261	H, REc, Fd		Ellis-van Creveld syndrome, 225500 (3); Weyers acrofacial dysostosis, 193530 (3)	5(Lbn)
4.74	1	13	09	4p16	PLSA1, PLSA	P	Primary lateral sclerosis, adult, 1	611637	Fd	max lod at D4S2936	Primary lateral sclerosis, adult, 1 (2)	
4.75	7	2	01	4p16.1	PPP2R2C, PR52	P	Protein phosphatase 2A, regulatory subunit B, gamma isoform	605997	R			
4.76	7	8	95	4p16.1	S100P	P	S100 calcium-binding protein P	600614	A			
4.77	9	6	11	4p16.3	ZFYVE28, LST2, KIAA1643	P	Zinc finger FYVE domain-containing protein 28	614176	R, REc			
4.78	1	24	09	4p16.1	SLC2A9, GLUT9, UAQTL2	P	Solute carrier family 2 (facilitated glucose transporter), member 9	606142	Psh, R		{Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia, renal, 2, 612076 (3)	
4.79	12	21	00	4p16-p15.2	SLEB3	P	Systemic lupus erythematosus, susceptibility to, 3	605480	Fd		{Systemic lupus erythematosus, susceptibility to, 3} (2)	
4.80	2	26	08	4p16-p15	MNDEC	P	Microtia with nasolacrimal duct imperforation and eye coloboma	611863	REn	copy number variant (CNV) association	Microtia with nasolacrimal duct imperforation and eye coloboma (1)	
4.81	4	27	12	4p16-p15	SPG38	P	Spastic paraplegia 38, autosomal dominant	612335	Fd	between D4S432 and D4S1599	Spastic paraplegia 38, autosomal dominant (2)	
4.82	4	22	10	4p16-q34	INTLQ1	P	Intelligence quantitative trait locus 1	603783	Fd	associated with D4S2943, MSX1, and D4S1607	{Intelligence QTL1} (2)	
4.83	8	30	09	4p15.32	FBXL5, FBL5	P	F-box and leucine-rich repeat protein 5	605655	R, REc			
4.84	7	18	14	4p15.33	HS3ST1, 3OST, 3OST1	P	Heparan sulfate (glucosamine)3-O-sulfotransferase 1	603244	REc			
4.85	9	9	13	4p15.33	RAB28, CORD18	P	Ras-associated protein 28	612994	REc		Cone-rod dystrophy 18, 615374 (3)	
4.86	1	13	11	4p15.32	BST1	P	Bone marrow stromal cell antigen 1	600387	REc	previously assigned to 14q32.3		
4.87	5	24	13	4p15.32	MED28, EG1, MAGICIN	P	Mediator complex subunit 28	610311	REc			
4.88	4	8	16	4p15.32	TAPT1, CMVFR, OCLSBG	P	Transmembrane anterior posterior transformation 1	612758	REc		Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	5(Tapt1)
4.89	1	13	09	4p15.2	GBA3, CBGL1	C	Glucosidase, beta, acid 3	606619	R, REc			
4.90	1	29	16	4p15.31	MIR218-1	C	Micro RNA 218-1	616770	REn, REc	within intron of SLIT2		5(Mir218-1)
4.91	4	15	09	4p15.32	QDPR, DHPR	C	Quinoid dihydropteridine reductase	612676	S, A, REa, D		Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	5(Qdpr)
4.92	2	28	07	4p15.2	SLC34A2	C	Solute carrier family 34 (sodium/phosphate cotransporter), member 2	604217	REc, Fd		Pulmonary alveolar microlithiasis, 265100 (3); ?Testicular microlithiasis, 610441 (3)	
4.93	1	12	99	4p16.1	ACOX3	P	Acyl-coenzyme A oxidase 3, pristanoyl	603402	A			
4.94	7	8	10	4p15.32	CC2D2A, KIAA1345, MKS6	C	Coiled-coil and C2 domains-containing protein 2A	612013	REc		Joubert syndrome 9, 612285 (3); Meckel syndrome 6, 612284 (3); COACH syndrome, 216360 (3)	
4.95	4	30	09	4p15.2	DHX15, DDX15, DBP1, HRH2	P	DEAH (Asp-Glu-Ala-His) box polypeptide 15	603403	A			
4.96	8	30	09	4p15.32	FGFBP1, FGFBP, HBP17	P	Fibroblast growth factor-binding protein 1	607737	R, REc			
4.97	11	13	01	4p15.3	HDL3, HLN2	P	Huntington disease-like 3	604802	Fd		Huntington disease-like 3 (2)	
4.98	10	29	03	4p15.3-p15.2	KCNIP4, KCHIP4	P	Kv channel-interacting protein 4	608182	REc			
4.99	8	30	09	4p15.31	NCAPG, CAPG	P	Non-SMC condensin I complex subunit G	606280	R, REc			
4.100	2	17	09	4p15.31	LCORL, MLR1	C	Ligand-dependent nuclear receptor corepressor-like protein	611799	R, REc			
4.101	3	23	09	4p15.32	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	C	Prominin 1	604365	Fd, REc		Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657 (3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)	
4.102	2	17	09	4p15.3	STQTL13	P	Stature quantitative trait locus 13	612226	Fd	associated with rs16896068	{Stature QTL 13} (2)	
4.103	12	1	03	4p15.2	SOD3	C	Superoxide dismutase-3, extracellular	185490	REa, R, Fd, A		[Superoxide dismutase, elevated extracellular] (3)	
4.104	8	30	09	4p15.2	ANAPC4, APC4	P	Anaphase-promoting complex, subunit 4	606947	R, REc			
4.105	9	23	08	4p15.2	GPR125	P	G protein-coupled receptor 125	612303	REc			
4.106	12	4	03	4p15.2	LGI2, KIAA1916	P	Leucine-rich gene, glioma-inactivated, 2	608301	REc			
4.107	6	27	08	4p15.2	PI4K2B	P	Phosphatidylinositol 4-kinase, type 2, beta	612101	R, REc			
4.108	9	10	12	4p15.2	RBPJ, RBPSUH, IGKJRB1, AOS3	P	Recombination signal-binding protein 1 for kappa J region	147183	REc	pseudogenes at 9q13, 9p13, and 3q25	Adams-Oliver syndrome 3, 614814 (3)	5(Rbpsuh)
4.109	3	28	11	4p15.2	SEPSECS, SLA, LP, PCH2D	P	O-phosphoserine tRNA-selenocysteine tRNA synthase	613009	R, REc		Pontocerebellar hypoplasia type 2D, 613811 (3)	
4.110	2	2	01	4p15.31	SLIT2	P	Slit, Drosophila, homolog of, 2	603746	A			
4.111	2	14	08	4p15.2	ZCCHC4	P	Zinc finger CCHC domain-containing protein 4	611792	R, REc			
4.112	6	15	99	4p15.2	CCKAR	C	Cholecystokinin A receptor	118444	Psh, H, A			5(Cckar)
4.113	3	27	09	4p15.2	PPARGC1A, PPARGC1	P	Peroxisome proliferator-activated receptor-gamma, coactivator 1, alpha	604517	R			
4.114	3	12	07	4p15.2	STIM2, KIAA1482	P	Stromal interaction molecule 2	610841	REc, R, H			5(Stim2)
4.115	3	1	01	4p14	UGDH, UDPGDH	P	UDP-glucose dehydrogenase	603370	H, R			5(Udgh)
4.116	9	9	03	4p14	KLHL5	P	Kelch-like 5	608064	REc			
4.117	4	23	08	4p15.1-q12	NPC1, NPCA1	P	Nasopharyngeal carcinoma 1	607107	Fd	?associated with acyl-CoA thioesterase 7-like	{Nasopharyngeal carcinoma 1} (2)	
4.118	5	22	03	4p14	CHRNA9	P	Cholinergic receptor, neuronal nicotinic, alpha polypeptide 9	605116	A, R			
4.119	3	20	06	4p14	TBC1D1, KIAA1108	P	TBC1 domain family, member 1	609850	REa, H			5(Tbc1d1)
4.120	5	9	95	4p15.32	CD38	C	CD38 antigen (p45); ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase	107270	S, A			
4.121	10	7	02	4p15	EPPS	P	Epilepsy, partial, with pericentral spikes	607221	Fd		Epilepsy, partial, with pericentral spikes (2)	
4.122	2	4	99	4p15.32	LDB2, CLIM1	C	LIM domain-binding factor-2	603450	R			
4.123	10	26	11	4p16.1	METTL19	P	Methyltransferase-like 19	614309	REc			
4.124	11	20	98	4p15.1	PCDH7, BHPCDH	P	Protocadherin-7	602988	Psh			
4.125	10	08	08	4p15-p14	BMIQ7	P	Body mass index quantitative trait locus 7	608410	near D4S2912		{Obesity, susceptibility to, BMIQ7} (2)	
4.126	4	14	05	4p14-p13	APBB2, FE65L1	C	Amyloid beta A4 precursor protein-binding, family B, member 2 (Fe65-like 1)	602710	R, REc		{Alzheimer disease, late-onset}, 104300 (3)	
4.127	8	30	09	4p14	ARAP2, CENTD1, KIAA0580	P	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	606645	R, REc			
4.128	11	20	98	4p14	HIP2	P	Huntingtin-interacting protein-2	602846	A			
4.129	9	10	07	4p14	KLB, BKL	P	Klotho, beta	611135	REc			
4.130	3	20	16	4p14	LIAS, PDHLD, HGCLAS	P	Lipoic acid synthase	607031	REc		Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	
4.131	12	10	13	4p14	MIR574, MIR574-3p	P	Micro RNA 574	615469	REc			
4.132	10	3	11	4p14	PDS5A, KIAA0648, SCC112	C	PDS5, regulator of cohesion maintenance, S. Cerevisiae, homolog of, A	613200	R, REc			
4.133	5	26	13	4p14	RELL1	P	Relt-like 1	611212	R, REc			
4.134	2	21	10	4p14	TLR1, TIL. LPRS5	P	Toll-like receptor-1	601194	A		{Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility to, 5}, 613223 (3)	
4.135	8	30	09	4p14	TLR6	P	Toll-like receptor 6	605403	REc			5(Tlr6)
4.136	12	27	13	4p13	UCHL1, PARK5, NDGOA	C	Ubiquitin C-terminal esterase L1	191342	A, Psh	mutation identified in 1 NDGOA family and 1 PARK5 family	?{Parkinson disease 5, susceptibility to}, 613643 (3); ?Neurodegeneration with optic atrophy, childhood onset, 615491 (3)	
4.137	1	9	13	4p14	UCH1LAS	P	Ubiquitin carboxyl-terminal esterase L1, antisense	614991	REn			
4.138	3	5	95	4p14	RFC1, RECC1	C	Replication factor C1, 145kD (activator 1, 145kD)	102579	A			5(Rfc1)
4.139	4	23	08	4p14	LOC344967	P	Acyl-CoA thioesterase 7-like	611963	REc	?associated with nasopharyngeal carcinoma		
4.140	4	10	15	4p14	WDR19, SRTD5, ATD5, NPHP13, CED4	P	WD repeat-containing protein 19	608151	R	mutation identified in 1 CED4 family and 1 SRTD5 family	Nephronophthisis 13, 614377 (3); ?Cranioectodermal dysplasia 4, 614378 (3); ?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3); Senior-Loken syndrome 8, 616307 (3)	
4.141	5	16	95	4p12	GABRA4	P	Gamma-aminobutyric acid (GABA) A receptor, alpha-4	137141	Psh	cluster with GABRA2, B1, G1; ?involved in autism		7(Gabra4)
4.142	10	23	87	4p14	PGM2	C	Phosphoglucomutase-2	172000	S			5(Pgm1)
4.143	1	30	91	4q21.21	BMP3	P	Bone morphogenetic protein-3	112263	H, REa			5(Bmp3)
4.144	8	21	92	4p12	GABRG1	P	Gamma-aminobutyric acid (GABA) A receptor, gamma-1	137166	Psh, REl			
4.145	3	5	98	4p14	ARHH, TTF	P	Ras homolog gene family, member H	602037	A			
4.146	2	19	10	4p12	GNPDA2, GNP2	P	Glucosamine-6-phosphate deaminase 2	613222	REc			
4.147	2	25	10	4p13	GRXCR1	P	Glutaredoxin, cysteine-rich, 1	613283	REc, H		Deafness, autosomal recessive 25, 613285 (3)	5(Grxcr1)
4.148	6	15	99	4p14	RPL9	P	Ribosomal protein L9	603686	Psh, A	pseudogene on Xpter-p21		
4.149	1	25	12	4p12	GABRA2	P	Gamma-aminobutyric acid (GABA) A receptor, alpha-2	137140	A		{Alcohol dependence, susceptibility to}, 103780 (3)	5(Gabra2)
4.150	7	11	93	4p12	GABRB1	P	Gamma-aminobutyric acid (GABA) A receptor, beta-1	137190	A, Fd			5(Gabrb1)
4.151	7	18	14	4p13	SLC30A9, C4orf1, HUEL	P	Solute carrier family 30 (zinc transporter), member 9	604604	A			
4.152	1	6	09	4p13-q21	NRCLP2	P	Narcolepsy 2	605841	Fd	max lod at D4S2987	Narcolepsy 2 (2)	
4.153	11	20	15	4p12	COMMD8	P	COMM domain-containing protein 8	616656	REc			
4.154	4	27	12	4p12	CORIN, CRN, TMPRSS10, ATC2, PEE5	P	Corin, serine peptidase	605236	A, REc		Preeclampsia/eclampsia 5, 614595 (3)	
4.155	4	21	10	4p12	COX7B2	P	Cytochrome C oxidase subunit VIIb2	609811	REc			
4.156	2	14	11	4p13	PMX2B, NBPHOX, PHOX2B, NBLST2	P	Paired mesoderm homeo box 2B	603851	R		Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)	
4.157	10	22	99	4p14	PTTG2	P	Pituitary tumor-transforming gene 2	604231	R			
4.158	12	13	95	4p12-p11	TEC	P	tec protein tyrosine kinase	600583	A			
4.159	10	12	94	4p12	TXK, BTKL	C	TXK tyrosine kinase	600058	A			5(Txk)
4.160	3	10	11	4p12	CNGA1, CNCG1, RP49	C	Cyclic nucleotide gated channel, alpha 1	123825	REa, Psh		Retinitis pigmentosa 49, 613756 (3)	5(Cncg)
4.161	2	25	15	4p11	SLAIN2, KIAA1458	P	SLAIN motif family, member 2	610492	REc, R, H			5(Slain2)
4.162	8	31	09	4p11	ZAR1	P	Zygote arrest 1	607520	REc			5(Zar1)
4.163	10	23	87	4p15.32	PEPS	C	Peptidase S	170250	S, EM			5(Pep7)
4.164	6	16	99	4p	MHW1	P	Mental health wellness 1	603663	Fd	at D4S2949	{Mental health wellness-1} (2)	
4.165	12	14	00	4p16.1	WDR1	P	WD repeat-containing protein 1	604734	R			
4.166	6	16	99	4q	MHW2	P	Mental health wellness 2	603664	Fd	at D4S397	{Mental health wellness-2} (2)	
4.167	10	8	96	4q	PSORS3	P	Psoriasis susceptibility 3	601454	Fd		{Psoriasis susceptibility 3} (2)	
4.168	9	20	00	4q25	RRH	L	Rhodopsin homolog, retinal pigment epithelium-derived (peropsin)	605224	H			3(Rrh)
4.169	2	28	07	4q	WM2	P	Macroglobulinemia, Waldenstrom, susceptibility to, 2	610430	Fd	between D4S2910 and D4S1539	{Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)	
4.170	12	17	07	4q12	PDCL2	P	Phosducin-like 2	611676	REc			5(Pdcl2)
4.171	5	5	00	4q12	CHIC2, BTL	P	Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia)	604332	Ch		{Leukemia, acute myeloid}, 601626 (3)	
4.172	8	30	09	4q12	HOPX, HOP	P	HOP homeobox	607275	R, REc			
4.173	7	15	09	4q12	SPATA18, SPETEX1	P	Spermatogenesis-associated protein 18	612814	REc			
4.174	10	12	94	4q13.3	AFM, ALBA, ALB2	C	Afamin	104145	REn, Psh	10kb 3' of AFP		
4.175	9	20	14	4q13.3	AFP, HPAFP, AFPD	C	Alpha-fetoprotein	104150	H, A, Fd, F	order: 5'-ALB-3'--5'-AFP-3'	[Hereditary persistence of alpha-fetoprotein], 615970 (3); Alpha-fetoprotein deficiency, 615969 (3)	5(Afp)
4.176	9	10	14	4q13.3	ALB, ANALBA, FDAH	C	Albumin	103600	F, A, REa	linked to GC	Analbuminemia, 616000 (3); [Dysalbuminemic hyperthyroxinemia], 615999 (3)	5(Alb1)
4.177	10	23	87	4q13.3	STATH	P	Statherin	184470	REa			
4.178	12	5	11	4q12	AASDH, ACSF4	P	Aminoadipate-semialdehyde dehydrogenase	614365	REc			
4.179	12	18	08	4q12	ARL9	P	ADP-ribosylation factor-like 9	612405	REc			
4.180	11	3	14	4q12	CEP135, KIAA0635, MCPH8	P	Centrosomal protein, 135kD	611423	REc	mutation identified in 1 MCPH8 family	?Microcephaly 8, primary, autosomal recessive, 614673 (3)	
4.181	8	27	01	4q12	CLOCK	P	Circadian locomotor output cycles kaput	601851	R, H			5(Clock)
4.182	6	1	12	4q12	DANCR, ANCR, KIAA0114	P	Differentiation-antagonizing noncoding RNA	614625	REc, R			
4.183	9	9	09	4q12	DCUN1D4, KIAA0276	P	DCN1 domain-containing protein 4	612977	R, REc			
4.184	7	7	09	4q12	EXOC1, SEC3	P	Exocyst complex component 1	607879	R, REc			
4.185	5	28	03	4q12	FIP1L1	P	Fip1-like 1	607686	REn, REc	fused to PDGFRA in hypereosinophilic syndrome		
4.186	9	4	14	4q13.3	GC, DBP	C	Group-specific component (vitamin D-binding protein)	139200	F, Fc, H, D, Ch, REa, A	4q13-q21.1 by in situ hybridization		5(Gc)
4.187	12	4	03	4q13.2	GRINL1B	P	Glutamate receptor, ionotropic, N-methyl D-aspartate-like 1B	608311	A			
4.188	3	23	15	4q12	GSX2, GSH2	P	GS homeobox 2	616253	REc			
4.189	9	14	11	4q12	IGFBP7, MAC25, RAMSVPS	P	Insulin-like growth factor-binding protein-7	602867	A, Psh		Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	
4.190	12	28	08	4q12	LNX1, LNX, PDZRN2	P	Ligand of numb protein X1	609732	R			
4.191	6	1	12	4q12	MIR4449	P	Micro RNA 4449	614627	REc			
4.192	7	18	06	4q12	MYP9	P	Myopia 9	609258	Fd		Myopia 9 (2)	
4.193	11	9	99	4q12	SGCB, LGMD2E	C	Sarcoglycan, beta (43kD dystrophin-associated glycoprotein)	600900	Psh, A, Fd, LD		Muscular dystrophy, limb-girdle, type 2E, 604286 (3)	
4.194	12	24	08	4q12	KDR	C	Kinase insert domain receptor	191306	REa, A, REn	?mutant in TAPVR1	Hemangioma, capillary infantile, somatic, 602089 (3); {Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	
4.195	10	4	12	4q12	KIT, PBT	C	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	REa, A, H, Ch, H, REn	same 700bp segment as PDGFRA	Piebaldism, 172800 (3); Gastrointestinal stromal tumor, familial, 606764 (3); Mast cell disease, 154800 (3); Leukemia, acute myeloid, 601626 (3); Germ cell tumors, 273300 (3)	5(Kit; W)
4.196	12	12	12	4q12	NOA1, C4orf14	P	Nitric oxide-associated protein 1	614919	REc			
4.197	6	16	94	4q12	PAICS, AIRC	P	Phosphoribosylaminoimidazole carboxylase	172439	S, REn	bifunctional enzyme; ade-D; 625bp from PPAT		
4.198	4	11	03	4q12	PDGFRA	C	Platelet-derived growth factor receptor, alpha polypeptide	173490	A, REa, REn	same 700bp segment as KIT; fused to BCR or FIP1L1	Gastrointestinal stromal tumor, somatic, 606764 (3); Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)	5(Pdgfra)
4.199	5	2	94	4q12	POL2RB	P	Polymerase (RNA) II (DNA directed) polypeptide B, 140kD	180661	A			
4.200	6	16	94	4q12	PPAT, GPAT	P	Phosphoribosylpyrophosphate amidotransferase	172450	S, H, A			
4.201	12	18	08	4q12	RASL11B	P	RAS-like, family 11, member B	612404	REc			
4.202	2	11	16	4q12	REST, NRSF, WT6	P	RE1-silencing transcription factor	600571	R, REc		{Wilms tumor 6, susceptibility to}, 616806 (3)	
4.203	6	1	12	4q12	SNORA26	P	Small nucleolar RNA, H/ACA box, 26	614626	REc, R			
4.204	11	19	11	4q12	SPINK2	P	Serine protease inhibitor, Kazal-type, 2	605753	Psh, REc			
4.205	1	5	12	4q12	SRD5A3, SRD5A2L, CDG1Q, KRIZI	C	Steroid 5-alpha-reductase 3	611715	REc, Fd		Congenital disorder of glycosylation, type Iq, 612379 (3); Kahrizi syndrome, 612713 (3)	
4.206	4	10	14	4q12	SRP72, BMFS1	P	Signal recognition particle, 72kD	602122	R, REc		Bone marrow failure syndrome 1, 614675 (3)	
4.207	1	22	07	4q12	TAPVR1	C	Total anomalous pulmonary venous return 1	106700	Fd	between D4S1630 and D4S3019; ?mutation in KDR	Total anomalous pulmonary venous return (2)	
4.208	7	18	12	4q12	TMEM165, FT27, CDG2K	P	Transmembrane protein 165	614726	REc		Congenital disorder of glycosylation, type IIk, 614727 (3)	
4.209	7	9	09	4q12	USP46	P	Ubiquitin-specific peptidase 46	612849	REc			
4.210	8	28	02	4q13.3	CXCL1, GRO1, MGSA	C	Chemokine, C-X-C, ligand 1 (GRO1 oncogene; melanoma growth stimulating activity, alpha)	155730	REa, A	apparently cluster of 3 GRO genes		5(Mgsa)
4.211	8	29	02	4q13.3	CXCL2, GRO2, MIP2A	P	Chemokine, C-X-C motif, ligand 2 (GRO2 oncogene)	139110	REa, A			5(Mip2a)
4.212	8	29	02	4q13.3	CXCL3, GRO3, MIP2B	P	Chemokine, C-X-C motif, ligand 3 (GRO3 oncogene)	139111	REa, A			5(Mip2b)
4.213	8	30	02	4q13.3	CXCL5, SCYB5, ENA78	P	Chemokine, C-X-C motif, ligand 5 (epithelial-derived neutrophil-activating peptide 78)	600324	Psh, REc			
4.214	8	30	02	4q13.3	CXCL6, SCYB6, GCP2	P	Chemokine, C-X-C motif, ligand 6 (granulocyte chemotactic protein-2)	138965	Psh, REc			
4.215	4	30	97	4q13.3	IL8	P	Interleukin-8	146930	REa, A			
4.216	10	6	92	4q13.3	PF4	C	Platelet factor 4	173460	REa, A, REn	6kb from PF4V1		
4.217	10	6	92	4q13.3	PF4V1	C	Platelet factor 4, variant 1 (PF4-like)	173461	A, REa, REn	same region as PF4 and IP10		
4.218	8	25	11	4q13.3	PPBP, CXCL7, SCYB7, CTAP3, TGB	C	Pro-platelet basic protein	121010	Psh, A, REn	less than 7kb from PF4		
4.219	6	18	04	4q13.3	PPBPL1, TGB2	P	Pro-platelet basic protein-like 1 (thromboglobulin, beta-2)	188035	REn	in cluster with PPBP, PF4, and PF4V1		
4.220	11	19	11	4q12-q13.1	MRT31	P	Mental retardation, autosomal recessive 31	614329	Fd	between rs11944876 and rs6551838	Mental retardation, autosomal recessive 31 (2)	
4.221	12	4	08	4q12-q13.1	DFNA27	P	Deafness, autosomal dominant 27	612431	Fd	max lod at D4S398	Deafness, autosomal dominant 27 (2)	
4.222	3	13	06	4q12-q13.2	DFNB55	P	Deafness, autosomal recessive 55	609952	Fd	max lod at D4S2638	Deafness, autosomal recessive 55 (2)	
4.223	8	18	98	4q13.2	CENPC1, CENPC	C	Centromere autoantigen C1	117141	A	?pseudogene on chr.12		5(Cenpc)
4.224	3	30	12	4q21.21	RASGEF1B, GPIG4	P	RASGEF domain family, member 1B	614532	REc			
4.225	3	13	06	4q13.1-q13.2	EPHA5, TYRO4, HEK7	P	Ephrin receptor EphA5	600004	A			
4.226	7	9	06	4q13.3	GRSF1	P	G-rich RNA sequence-binding factor 1	604851	A			
4.227	3	29	90	4q13.3	HTN1	P	Histatin-1	142701	REa, A	3 genes in a 15kb segment		
4.228	6	16	97	4q13.3	HTN3, HTN2, HIS2	P	Histatin-3	142702	REa, A			
4.229	12	13	00	4q13.3	UGT2A1	P	Uridine diphosphate glycosyltransferase 2 family, member A1	604716	A			
4.230	6	2	15	4q13.2	UGT2A3	P	Uridine diphosphate glucuronosyltransferase 2 family, member A3	616382	REc			5(Ugt2a3)
4.231	6	23	98	4q13.3	UGT2B4, UGT2B11	C	UDP-glucuronyltransferase, family 2, beta-4	600067	Psh, REn, A	cluster in order B7--B4--B15 in 195kb		5(Ugt2b4)
4.232	6	23	98	4q13.2	UGT2B7, UGT2B9	P	UDP-glucuronyltransferase, family 2, beta-7	600068	Psh, REn, A			
4.233	6	23	98	4q13.2	UGT2B15, UGT2B8	C	UDP-glucuronyltransferase, family 2, beta-15	600069	Psh, REn, A			
4.234	5	25	13	4q13.2	UGT2B17, BMND12	P	UDP-glucuronyltransferase, family 2, beta-17	601903	A		{Bone mineral density QTL 12, osteoporosis}, 612560 (3)	
4.235	11	19	11	4q13-q21	AIS4, VAMAS5	P	Autoimmune disease, susceptibility to, 4	609400	Fd	between D4S392 and D4S3042	{Autoimmune disease, susceptibility to, 4} (2)	
4.236	6	8	89	4q13.3	AREG	P	Amphiregulin	104640	REa, A			5(Areg)
4.237	10	1	95	4q13.3	BTC	L	Betacellulin	600345	H	tightly linked to Areg in mouse		5(Btc)
4.238	6	2	15	4q13.3	CSN3, CNS10, CSNK	C	Casein, kappa	601695	REc, A			
4.239	10	5	06	4q13.3	MUC7	P	Mucin 7, salivary	158375	A, Psh		{Asthma, protection against}, 600807 (3)	
4.240	9	22	11	4q21.1	SCARB2, CD36L2, LIMPII, AMRF, EPM4	C	Scavenger receptor class B, member 2	602257	Psh, Fd		Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	
4.241	6	30	15	4q13.1	ADGRL3, LPHN3, CIRL3, CL3, LEC3, KIAA0768	P	Adhesion G protein-coupled receptor L3	616417	REc			
4.242	3	3	03	4q31.21	GAB1	P	Grb2-associated binding protein 1	604439	A			8(Gab1)
4.243	11	20	95	4q13.3	STE, EST	P	Sulfotransferase, estrogen-preferring	600043	Psh, A			5(Ste)
4.244	5	5	98	4q21.21	PRKG2, PRKGR2	P	Protein kinase, cGMP-dependent, type II	601591	Psh			
4.245	5	2	07	4q13.2	SYT14L, SYTDEP, CHR415SYT	P	Synaptotagmin 14-like protein	610892	REc			
4.246	11	11	14	4q13.2	STAP1, BRDG1	P	Signal transducing adaptor family member 1	604298	REc			
4.247	1	9	08	4q13.2	TMPRSS11A, ECRG1	P	Transmembrane protease, serine 11A	611704	REc			
4.248	8	18	14	4q13.2	UGT2B10	P	Uridine diphosphate glycosyltransferase 2 family, member B10	600070	REc			
4.249	4	4	05	4q13.2	UGT2B28	P	Uridine diphosphate glycosyltransferase 2 family, member B28	606497	REc			
4.250	6	19	12	4q13.2	UGT2B11	P	Uridine diphosphate glycosyltransferase 2 family, member B11	603064	REc			
4.251	2	28	03	4q13.3	GPR74, NPFF2, NPGPR	P	G protein-coupled receptor 74	607449	R			
4.252	11	6	14	4q13.2-q21.3	ETL3, FMTLE	P	Epilepsy, familial temporal lobe, 3	611630	Fd	max lod at D4S1517	Epilepsy, familial temporal lobe, 3 (2)	
4.253	4	17	07	4q13.3	AMTN	P	Amelotin	610912	REc, H			5(Amtn)
4.254	9	20	14	4q13.3	ANKRD17, GTAR	P	Ankyrin repeat domain-containing protein 17	615929	REc			
4.255	9	8	11	4q13.3	MTHFD2L	P	Methylenetetrahydrofolate dehydrogenase 2-like, NADP(+)-dependent	614047	REc			
4.256	2	15	14	4q13.3	ODAM, APIN	P	Odontogenic ameloblast-associated protein	614843	REc			
4.257	2	23	08	4q13.3	PPBPL2	P	Pro-platelet basic protein-like 2	611591	R, REc			
4.258	7	14	14	4q13.3	PROL1, PRL1, BPLP	P	Proline-rich lacrimal protein 1	608936	REc			
4.259	2	18	09	4q13.3	RASSF6	P	Ras association domain family, member 6	612620	REc			
4.260	8	19	13	4q13.3	RUFY3, SINGAR1, RIPX	P	FUN and FYVE domains-containing protein 3	611194	REc			
4.261	2	23	08	4q13.3	SMR3B, SMR1B, PRL3, PBII	P	Submaxillary gland androgen-regulated protein 3, mouse, homolog of, B	611593	REc			
4.262	8	8	13	4q13.3	SULT1B1, ST1B2	P	Sulfotransferase family 1B, member 1	608436	REc			
4.263	8	19	13	4q13.2	TMPRSS11E, DESC1	P	Transmembrane protease, serine 11E	610399	REc			5(Tmprss11e)
4.264	9	12	93	4q13.3	DCK	C	Deoxycytidine kinase	125450	Psh, A			
4.265	1	29	01	4q13.3	ADAMTS3	C	A Disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 3	605011	R, REa			
4.266	7	16	09	4q21.3-q22.1	AFF1, MLLT2, AF4	C	AF4/FMR2 family, member 1	159557	Ch, H	fuses with ALL1		5(Af4)
4.267	3	23	15	4q13.3	AMBN, AI1F	C	Ameloblastin	601259		mutation identified in 1 AI1F family	Amelogenesis imperfecta, type IF, 616270 (3)	5(Ambn)
4.268	1	18	13	4q21.21	ANTXR2, CMG2, HFS	P	Anthrax toxin receptor 2	608041	Fd, REc		Hyaline fibromatosis syndrome, 228600 (3)	
4.269	6	6	91	4q21.21	ANXA3, ANX3	P	Annexin A3 (lipocortin III)	106490	Psh, REa, A			
4.270	11	30	06	4q21.2-q21.3	ARHGAP24, RCGAP72, FILGAP	P	RHO GTPase-activating protein 24	610586	REc			
4.271	12	15	10	4q21	DEL4q21, C4DELq21	P	Chromosome 4q21 deletion syndrome	613509	Ch	contigous gene deletion if at least 30 genes	Chromosome 4q21 deletion syndrome (4)	
4.272	6	15	99	4q21.23	CDS1	P	CDP-diacylglycerol synthase 1	603548	R, A			
4.273	8	29	02	4q21.1	CXCL9, MIG, SCYB9	P	Chemokine, C-X-C motif, ligand 9	601704	A, REn	close to INP10		
4.274	8	29	02	4q21.1	CXCL10, INP10	C	Chemokine, C-X-C motif, ligand 10 (interferon-inducible cytokine IP-10)	147310	A, REa, F	?involved in monocytic leukemia with t(4;11)(q21;q23)		
4.275	8	30	02	4q21.1	CXCL13, SCYB13, BCA1, BLC	P	Chemokine, C-X-C motif, ligand 13	605149	REc			
4.276	1	23	09	4q22.1	DMP1, ARHR, ARHP	C	Dentin matrix acidic phosphoprotein	600980	Fd, REn, Psh, A		Hypophosphatemic rickets, AR, 241520 (3)	
4.277	8	4	09	4q13.3	ENAM, AIH2, AI1C	C	Enamelin	606585	REc		Amelogenesis imperfecta, type IB, 104500 (3); Amelogenesis imperfecta, type IC, 204650 (3)	
4.278	8	3	14	4q21.21	FGF5, TCMGLY	C	Fibroblast growth factor-5	165190	REa, A		Trichomegaly, 190330 (3)	5(Fgf5)
4.279	5	28	03	4q21.21	FRAS1	P	FRAS1 gene	607830	Fd		Fraser syndrome, 219000 (3)	5(bl, Fras1)
4.280	7	16	09	4q22.1	HSD17B11, RETSDR2, PAN1B	P	17-beta-hydroxysteroid dehydrogenase XI	612831	R, REc			
4.281	3	30	00	4q13.3	IGJ	P	Immunoglobulin J polypeptide, linker protein for	147790	REa, A			5(Igj)
4.282	11	11	14	4q21.22	PLAC8	P	Placenta-specific gene 8	607515	H, REc			5(Plac8)
4.283	11	2	99	4q13.3	SLC4A4, NBC1, KNBC	P	Solute carrier family 4, sodium bicarbonate cotransporter, member 4	603345	Psh		Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	
4.284	1	18	11	4q22.1	SNCA, NACP, PARK1, PARK4	C	Synuclein, alpha (non A4 component of amyloid precursor)	163890	Psh, A, Fd		Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3); Parkinson disease 1, 168601 (3)	
4.285	2	18	08	4q13.3	UTP3, CRL1, CRLZ1	P	UTP3, S. crevisiae, homolog of	611614	REc			5(Utp3)
4.286	8	7	13	4q21.22-q21.23	COQ2, COQ10D1, MSA1	P	CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial)	609825	REc		Coenzyme Q10 deficiency, primary, 1, 607426 (3); {Multiple system atrophy, susceptibility to}, 146500 (3)	
4.287	9	22	09	4q22.3	HPGDS, PGDS	P	Prostaglandin D2 synthase, hematopoietic	602598	A			3(Pgds)
4.288	8	29	08	4q22.1	NAP1L5, DRLM	P	Nucleosome assembly protein 1-like 5	612203	REc			
4.289	11	3	09	4q22.1	PKD2	C	Polycystin-2	173910	Fd		Polycystic kidney disease 2, 613095 (3)	5(Pkd2)
4.290	8	9	99	4q22.3	UNC5C, UNC5H3	P	UNC5, C. elegans, homolog of, C	603610	R			3(Unc5c)
4.291	9	9	90	4q23	ADH5, FDH	C	Alcohol dehydrogenase (class III), chi polypeptide	103710	S, REa			
4.292	3	14	13	4q23	EIF4E, EIF4EL1, AUTS19	C	Eukaryotic translation initiation factor 4E	133440	Psh	pseudogene on 20	{Autism, susceptibility to, 19}, 615091 (3)	
4.293	9	12	93	4q21-q25	FECB	L	Fecundity gene, Boorla, of sheep, homolog of	134720	H	sheep chr.6		
4.294	2	18	96	4q22.1	IBSP	C	Integrin-binding sialoprotein (bone sialoprotein II)	147563	REa, A			5(Ibsp)
4.295	2	4	00	4q23	RAP1GDS1	P	RAP1, GTP-GDP dissociation stimulator 1	179502	A, REa, Ch	fusion partner with NUP98 in ALL	Lymphocytic leukemia, acute T-cell (3)	
4.296	1	27	97	4q22.1	SPP1, OPN	C	Secreted phosphoprotein-1 (osteopontin, bone sialoprotein)	166490	REa, REc			5(Spp1)
4.297	8	25	04	4q21-q31	OFC4	P	Orofacial cleft 4	608371	Fd, Ch		Orofacial cleft 4 (2)	
4.298	7	27	12	4q21.1	ART3	P	ADP-ribosyltransferase 3	603086	REa, A, REc			
4.299	7	11	14	4q21.1	C4orf26, AI2A4	P	Chromosome 4 open reading frame 26	614829	REc		Amelogenesis imperfecta, type IIA4, 614832 (3)	
4.300	7	20	12	4q21.1	CCNG2	P	Cyclin G2	603203	REc			
4.301	5	25	13	4q21.1	CDKL2, KKIAMRE, P56	P	Cyclin-dependent kinase-like 2	603442	REc			
4.302	5	24	13	4q13.3	COX18	P	Cytochrome c oxidase assembly protein COX18	610428	REc			
4.303	8	3	97	4q13.3	CSN1	C	Casein, alpha	115450	REa, A			
4.304	8	3	97	4q13.3	CSN2	C	Casein, beta	115460	Psh, A			5(Csn2)
4.305	5	7	01	4q22.1	MEPE	P	Matrix, extracellular, phosphoglycoprotein	605912	REa, R			
4.306	2	26	08	4q21.1	MRPL1	P	Mitochondrial ribosomal protein L1	611821	REc			
4.307	12	26	13	4q21.1	NAAA, ASAHL	P	N-acylethanolamine acid amidase	607469	A			
4.308	8	30	09	4q21.1	NUP54	P	Nucleoporin, 54kD	607607	R, REc			
4.309	10	15	13	4q21.21	PCAT4, GDEP	P	Prostate cancer-associated transcript 4	609717	R			
4.310	8	30	09	4q21.1	PPEF2	P	Protein phosphatase, EF hand calcium-binding domain-2	602256	Psh, REc			
4.311	11	11	14	4q21.1	RCHY1, ZNF363, PIRH2, ARNIP	P	Ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase	607680	REc, A			
4.312	1	27	04	4q21.22	SCD4, ACOD4	P	Stearoyl-CoA desaturase 4	608370	A, REc			
4.313	7	20	09	4q21.1	SEPT11	P	Septin 11	612887	REc			
4.314	4	18	07	4q21.1	SHROOM3, SHRM, KIAA1481	P	Shroom family member 3	604570	REa, REc			
4.315	1	20	09	4q21.1	THAP6	P	THAP domain-containing protein 6	612535	REc			
4.316	7	20	12	4q21.1	USO1, TAP, p115	P	USO1 vesicle docking protein, S. cerevisiae, homolog of	603344	REc			
4.317	12	1	98	4q21.22	HNRPD, AUF1, AUF1A	P	Heterogeneous nuclear ribonucleoprotein D	601324	REa, A			3(Hnrpd)
4.318	8	30	02	4q21.1	CXCL11, SCYB11, IP9, CXCL11, SCYB9B	C	Chemokine, C-X-C motif, ligand 11	604852	Psh, A, REc			5(Scyb11)
4.319	2	10	14	4q21.23	FAM175A, CCDC98, ABRAXAS, ABRA1	P	Family with sequence similarity 175, member A	611143	REc			
4.320	9	28	12	4q13.2	GNRHR, LHRHR, HH7	C	Gonadotropin-releasing hormone receptor	138850	REa, A, Psh	placed at 4q12 or 4q13 by some	Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	5(Gnrhr)
4.321	4	19	01	4q32.3	KLHL2, MAYVEN	P	Kelch-like 2	605774	REa			8(Klhl2)
4.322	5	5	98	4q21.23	NKX6A	P	NK homeo box, family 6, member A	602563	A			
4.323	4	19	12	4q21.21	PAQR3, RKTG	P	Progestin and ADIPOQ receptor family, member 3	614577	REc			
4.324	11	17	15	4q21.21	PRDM8, EPM10	P	PR domain-containing protein 8	616639	REc	mutation identified in 1 EPM10 family	?Epilepsy, progressive myoclonic, 10, 616640 (3)	
4.325	9	20	14	4q21.22	HNRNPDL, HNRPDL, JKTBP, LGMD1G	P	Heterogeneous nuclear ribonucleoprotein D-like protein	607137	A, REc, Fd		Muscular dystrophy, limb-girdle, type 1G, 609115 (3)	
4.326	9	22	14	4q21.22	COPS4, CSN4	P	COP9 signalosome, subunit 4	616008	REc			
4.327	4	20	10	4q21.22	LIN54	P	Lin54, C. elegans, homolog of	613367	REc			
4.328	3	30	12	4q21.22	SEC31A, SEC31L1, KIAA0905	P	Sec31, yeast, homolog of, A	610257	R, REc			
4.329	1	20	09	4q21.22	THAP9	P	THAP domain-containing protein 9	612537	REc			
4.330	9	21	11	4q21.23	AGPAT9, GPAT3, MAG1	P	1-acylglycerol-3-phosphate O-acyltransferase 9	610958	REc			
4.331	3	30	12	4q21.23	HELQ, HEL308	P	Helicase, POLQ-like	606769	H, REc			5(Hel308)
4.332	4	24	08	4q21.23	MRPS18C, MRPS18-1	P	Mitochondrial ribosomal protein S18C	611983	REc	6 pseudogenes		
4.333	4	27	00	4q21.23	HPSE, HSE1, HPA	P	Heparanase	604724	A, R			
4.334	1	22	97	4q21.3	PTPN13	C	Protein tyrosine phosphatase, nonreceptor-type, 13 (APO-1/CD95 (Fas)-associated phosphatase)	600267	A, Psh	633bp upstream of JNK3		5(Ptpn13)
4.335	6	21	05	4q22.1	DSPP, DPP, DGI1, DFNA39, DTDP2	C	Dentin sialophosphoprotein	125485	REa, A, F, Fd		Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420 (3)	
4.336	9	23	13	4q21.3	MAPK10, PRKM10, JNK3	C	Mitogen-activated protein kinase 10	602897	REa, A, REn			
4.337	4	20	10	4q21.3	SLC10A6, SOAT	P	Solute carrier family 10 (sodium/bile acid cotransporter family), member 6	613366	REc			
4.338	3	29	12	4q22.1	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	P	ATP-binding cassette, subfamily G, member 2	603756	R		[Junior blood group system], 614490 (3); [Uric acid concentration, serum, QTL1], 138900 (3)	6(Abcp)
4.339	8	26	02	4q23	ADH1A, ADH1	C	Alcohol dehydrogenase IA (class I), alpha polypeptide	103700	REa			
4.340	1	26	12	4q23	ADH1B, ADH2	C	Alcohol dehydrogenase IB (class I), beta polypeptide	103720	REa		{Alcohol dependence, protection against}, 103780 (3); {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	
4.341	11	14	10	4q23	ADH1C, ADH3	C	Alcohol dehydrogenase IC (class I), gamma polypeptide	103730	REa		{Alcohol dependence, protection against}, 103780 (3); {Parkinson disease, susceptibility to}, 168600 (3)	3(Adh3)
4.342	11	6	89	4q23	ADH4	P	Alcohol dehydrogenase (class II), pi polypeptide	103740	REa, A			
4.343	8	28	97	4q22.2	ATOH1, ATH1	P	Atonal, Drosophila, homolog of, 1	601461	REa, A			
4.344	8	9	01	4q22.3	ENH	P	Enigma-like LIM domain protein	605904	Psh			
4.345	1	30	15	4q22.1-q22.2	GRID2, SCAR18	C	Glutamate receptor, ionotropic, delta-2	602368	R, REc		Spinocerebellar ataxia, autosomal recessive 18, 616204 (3)	6(Grid2)
4.346	10	27	08	4q22	MUSQTL1	P	Musical aptitude quantitative trait locus 1	612343	Fd	near D4S423 and D4S2460	[Musical aptitude QTL 1] (2)	
4.347	1	2	91	4q22.3	PDHA2	P	Pyruvate dehydrogenase, E1-alpha polypeptide, testis specific form	179061	REa			19(Pdhal)
4.348	12	29	15	4q24	SLC39A8, BIGM103, CDG2N	P	Solute carrier family 39 (zinc transporter), member 8	608732	REc		Congenital disorder of glycosylation, type IIn, 616721 (3)	
4.349	9	12	11	4q22.3	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM	P	SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1	612761	A		Adermatoglyphia, 136000 (3)	
4.350	7	26	15	4q24	BANK1, FLJ20706, BANK	P	B-cell scaffold protein with ankyrin repeats 1	610292	REc			
4.351	12	18	07	4q24	CXXC4, IDAX	P	CXXC finger protein 4	611645	R, REc			
4.352	12	29	06	4q23	MTP	P	Microsomal triglyceride transfer protein, 88kD	157147	Psh, A		Abetalipoproteinemia, 200100 (3); {Metabolic syndrome, protection against}, 605552 (3)	3(Mtp)
4.353	10	8	07	4q24	CISD2, WFS2, ZCD2, ERIS	C	CDGSH iron sulfur domain protein 2	611507	Fd, REc		Wolfram syndrome 2, 604928 (3)	
4.354	8	9	05	4q24	MANBA, MANB1	C	Mannosidase, beta A, lysosomal	609489	H, REa	linked in mouse to Adl-3	Mannosidosis, beta, 248510 (3)	3(Bmn)
4.355	3	17	06	4q25	HADHSC, SCHAD, HHF4	C	L-3-hydroxyacyl-CoA dehydrogenase, short chain	601609	A		3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3); Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	
4.356	3	23	06	4q22-q27	MYP11	P	Myopia 11	609994	Fd	max lod at D4S1564	Myopia 11 (2)	
4.357	8	20	15	4q22.1	ATOD8	P	Dermatitis, atopic, 8	613518	Fd		{Dermatitis, atopic, susceptibility to, 8} (2)	
4.358	3	16	10	4q22.1	FAM13A, FAM13A1, KIAA0914	C	Family with sequence similarity 13, member A	613299	R, REc	overlaps with FAM13AOS		
4.359	3	16	10	4q22.1	FAM13AOS, FAM13A1OS	P	FAM13A opposite strand	613300	REc	overlaps with FAM13A		
4.360	11	11	14	2q24.3	FIGN	P	Fidgetin	605295	REc, H			2(Fign)
4.361	5	26	13	4q22.1	GPRIN3, GRIN3	P	G protein-regulated inducer of neurite outgrowth 3	611241	REc			
4.362	11	11	14	4q22.1	HERC3	P	HECT domain and RCC1-like domain 3	605200	A, REc			
4.363	8	18	08	4q22.1	HSD17B13, SCDR9	P	17-beta-hydroxysteroid dehydrogenase XIII	612127	REc			
4.364	4	23	08	4q22.1	KLHL8, KIAA1378	P	Kelch-like 8	611967	REc			
4.365	1	12	16	4q22.1	PIGY, HPMRS6	P	Phosphatidylinositol glycan, class Y	610662	REc		Hyperphosphatasia with mental retardation syndrome 6, 616809 (3)	
4.366	7	20	15	4q22.1	PPM1K, PP2CM, PTMP, MSUDMV	P	Protein phosphatase, PP2C domain-containing, 1K	611065	R, REc	mutation identified in 1 MSUDMV family	?Maple syrup urine disease, mild variant, 615135 (3)	
4.367	9	10	09	4q22.1	TIGD2	P	TIGGER transposable element-derived gene 2	612973	REc			
4.368	3	10	05	4q22.1	HERC5, CEB1	C	HECT domain and RCC1-like domain 5	608242	A, REa			
4.369	7	18	12	4q23	LAMTOR3, MP1, MAPBP	P	Late endocomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 3	603296	REc			
4.370	4	6	15	4q23	METAP1, KIAA0094	P	Methionyl aminopeptidase 1	610151	R, REc			
4.371	9	30	14	4q23	TRMT10A, RG9MTD2, MSSGM1	P	tRNA methyltransferase 10, S. cerevisiae, homolog of, A	616013	REc		Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	
4.372	12	21	09	4q23	TSPAN5, NET4	P	Tetraspanin 5	613136	REn			
4.373	3	1	00	4q23	TYS, HRZ	P	Sclerotylosis	181600	F, Fd		Huriez syndrome (2)	
4.374	8	26	02	4q23	ADH6	P	Alcohol dehydrogenase 6 (aldehyde reductase)	103735	REn			
4.375	12	19	96	4q23	ADH7	C	Alcohol dehydrogenase-7	600086	A			
4.376	3	8	16	4q22.3	BMPR1B, ALK6, AMDD, BDA2, BDA1D	P	Bone morphogenetic protein receptor, type IB	603248	A, R		Brachydactyly, type A2, 112600 (3); Acromesomelic dysplasia, Demirhan type, 609441 (3); Brachydactyly, type A1, D, 616849 (3)	
4.377	9	30	15	4q24	NFKB1, CVID12	C	Nuclear factor of kappa light chain gene enhancer in B-cells 1 (p105)	164011	REa, A		Immunodeficiency, common variable, 12, 616576 (3)	
4.378	7	9	06	4q25	LEF1	P	Lymphoid enhancer-binding factor-1	153245	REa, A		Sebaceous tumors, somatic (3)	3(Lef1)
4.379	2	16	11	4q24	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	P	ARS-interacting multifunctional protein 1	603605	REc, R		Leukodystrophy, hypomyelinating, 3, 260600 (3)	
4.380	8	18	14	4q24	GSTCD	P	Glutathione S-transferase C-terminal domain-containing protein	615912	REc			
4.381	4	7	94	4q23	H2AZ	P	H2AZ histone	142763	REa, A			
4.382	3	24	14	4q24	INTS12, INT12	P	Integrator complex subunit 12	611355	R, REc			
4.383	4	4	02	4q24	MGR1, MA	C	Migraine with or without aura, susceptibility to, 1	157300	Fd		{Migraine with or without aura, susceptibility to, 1} (2)	
4.384	2	12	08	4q24	NHEDC2, NHA2	P	NA+/H+ exchanger domain-containing protein 2	611789	REc, H			3(Nhedc1)
4.385	10	13	09	4q24	NHEDC1	P	Na+/H+ exchanger domain-containing protein 1	611527	REc			
4.386	5	24	13	4q24	NPNT, POEM	P	Nephronectin	610306	REc			
4.387	10	8	13	4q24	OCA5	P	Albinism, oculocutaneous, type V	615312	Fd	max lod at D4S961	Albinism, oculocutaneous, type V (2)	
4.388	6	11	02	4q25	PAPSS1, ATPSK1	C	3'-phosphoadenosine 5'-phosphosulfate synthase 1 (ATP sulfurylase/APS kinase-1)	603262	R, A			3(Atpsk1)
4.389	4	21	16	4q24	TBCK, IHPRF3	P	TBC1 domain-containing kinase	616899	REc		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3)	
4.390	10	26	11	4q24	TET2, KIAA1546, MDS	P	TET oncogene family, member 2	612839	REc		Myelodysplastic syndrome, somatic, 614286 (3)	
4.391	11	3	14	4q24	CENPE, MCPH13	P	Centromere autoantigen E, 312kD	117143	A	mutation identified in 1 MCPH13 family	?Microcephaly 13, primary, autosomal recessive, 616051 (3)	
4.392	8	30	09	4q24	DDIT4L, REDD2	P	DNA damage-inducible transcript 4-like	607730	R, REc			
4.393	8	30	09	4q24	PPP3CA, PPP2B, CALNA, CNA1	C	Protein phosphatase-3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha)	114105	REa, REc			
4.394	4	14	10	4q24-q28	HWE2	P	Epilepsy, hot water, 2	613340	Fd	between D4S1572 and D4S2277	Epilepsy, hot water, 2 (2)	
4.395	7	20	12	4q25	AGXT2L1	P	Alanine-glyoxylate aminotransferase 2-like 1	614682	REc			
4.396	1	28	08	4q25	ALPK1, LAK, KIAA1527	C	Alpha-kinase 1	607347	REc			
4.397	10	08	07	4q25	ATFB5	P	Atrial fibrillation, familial, 5	611494	Fd	association with rs2200733 and rs10033464	{Atrial fibrillation, familial, 5} (2)	
4.398	3	15	07	4q25	C4orf16, GBAR, 2C18	P	Gamma-1 adaptin brefeldin-A resistance protein	610851	REc			
4.399	10	15	13	4q25	CFI, FI, AHUS3, ARMD13	C	Complement factor I	217030	REa, Fd, A, RE	40kb distal to EGF	Complement factor I deficiency, 610984 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3); {Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	
4.400	2	12	15	4q25	COL25A1, CLAC, CFEOM5	P	Collagen, type XXV, alpha-1 polypeptide	610004	REc		Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	
4.401	1	28	13	4q25	CYP2U1, SPG56	P	Cytochrome P450, family 2, subfamily U, polypeptide 1	610670	R, REc		Spastic paraplegia 56, autosomal recessive, 615030 (3)	
4.402	1	9	08	4q25	EGF, URG, HOMG4	C	Epidermal growth factor (urogastrone)	131530	REa, H, F, RE	linked to ADH3; cen-ADH3-EGF-IL2-qter	Hypomagnesemia 4, renal, 611718 (3)	3(Egf)
4.403	11	5	97	4q25	ENPEP	P	Glutamyl aminopeptidase (aminopeptidase A)	138297	Psh, A, R, H			
4.404	8	20	08	4q25	ELOVL6, LCE, FACE	P	Elongation of very long chain fatty acids-like 6	611546	REc			
4.405	4	27	09	4q25	NOLA1, GAR1	P	Nucleolar protein family A, member 1	606468	R, REc			
4.406	2	12	13	4q25	LARP7, PIP7S, ALAZS	P	La ribonucleoprotein domain family, member 7	612026	R, REc		Alazami syndrome, 615071 (3)	
4.407	7	23	09	4q25	LGV1	P	Longevity 1, QTL	152430	Fd	maximum lod at D4S1564	[Longevity 1] (2)	
4.408	1	31	13	4q25	LRIT3, FIGLER4, CSNB1F	P	Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3	615004	REc		Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	
4.409	11	19	13	4q25	MIR297	P	Micro RNA 297	615520	REc			
4.410	4	27	12	4q25	MIR302A	P	Micro RNA 302A	614596	REc			
4.411	4	27	12	4q25	MIR302B	P	Micro RNA 302B	614597	REc			
4.412	4	27	12	4q25	MIR302C	P	Micro RNA 302C	614598	REc			
4.413	4	27	12	4q25	MIR302D	P	Micro RNA 302D	614599	REc			
4.414	4	27	12	4q25	MIR367	P	Micro RNA 367	614600	REc			
4.415	6	21	12	4q25	NEUROG2, NGN2, ATOH4	P	Neurogenin 2	606624	REc			
4.416	3	23	06	4q24	PPA2	P	Pyrophosphatase, inorganic, 2	609988	REc			
4.417	3	20	16	4q25	RPL34	P	Ribosomal protein L34	616862	REc			
4.418	3	13	15	4q25	SEC24B	P	Sec24-related gene family, member B	607184	R, REc			
4.419	12	07	07	4q25	SGMS2, SMS2	P	Sphingomyelin synthase 2	611574	R			
4.420	9	28	12	4q24	TACR3, NK3R, HH11	P	Tachykinin receptor 3	162332	REc		Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	
4.421	6	4	97	4q25	CASP6, MCH2	C	Caspase 6, apoptosis-related cysteine protease	601532	A, R			
4.422	12	18	07	4q25	PLA2G12A, GXII, ROSSY	P	Phospholipase A2, Group XIIA	611652	REc			
4.423	1	29	13	4q26	NDST4	P	N-deacetylase/N-sulfotransferase 4	615039	A, REn			
4.424	3	4	09	4q25	PITX2, IDG2, RIEG1, RGS, IGDS2	C	Paired-like homeodomain transcription factor-2	601542	Ch, Fd, RE		Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis, type 2, 137600 (3); Ring dermoid of cornea, 180550 (3); Peters anomaly, 604229 (3)	
4.425	2	21	06	4q26	PRSS12, BSSP3, MRT1	P	Protease, serine, 12	606709	A		Mental retardation, autosomal recessive 1, 249500 (3)	
4.426	9	12	08	4q25-q26	ANK2, LQT4	C	Ankyrin-2, nonerythrocytic	106410	REa, A, Fd		Long QT syndrome 4, 600919 (3); Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	
4.427	8	27	01	4q23	DAPP1, BAM32	P	Dual adaptor of phosphotyrosine and 3-phosphoinositides 1	605768	A			
4.428	7	5	92	4q28.1	FGF2, FGFB	C	Fibroblast growth factor-2 (basic)	134920	REa, A	many alternate names		3(Fgf2)
4.429	4	2	16	4q13.2	UBA6, UBE1L2	P	Ubiquitin activating enzyme 6	611361	R, REc			
4.430	2	28	03	4q21.1	GENEX3414	P	Genethonin 1	607406	R			
4.431	5	19	06	4q26	ARSJ	P	Arylsulfatase J	610010	REc			
4.432	8	30	09	4q26	CAMK2D	P	Calcium/calmodulin-dependent protein kinase II-delta	607708	R, REc			
4.433	8	7	15	4q26	METTL14, KIAA1627	C	Methyltransferase-like 14	616504	R, REc			
4.434	11	24	98	4q26	PDE5A	C	Phosphodiesterase 5A	603310	A, REc			
4.435	5	22	03	4q28.2	PGRMC2	P	Progesterone receptor membrane component 2	607735	REc			
4.436	4	7	15	4q26	SEC24D, KIAA0755, CLCRP2	P	Sec24-related gene family, member D	607186	R, REc		Cole-Carpenter syndrome 2, 616294 (3)	
4.437	1	22	13	4q26	UGT8, CGT	P	UDP glycosyltransferase 8 (cerebroside synthase)	601291	Psh, A			
4.438	7	9	90	4q27	IL2	C	Interleukin-2	147680	REa, A, F		Severe combined immunodeficiency due to IL2 deficiency (1)	3(Il2)
4.439	5	22	14	4q27	IL21, CVID11	P	Interleukin 21	605384	R	mutation identified in 1 CVID11 patient	?Immunodeficiency, common variable, 11, 615767 (3)	3(Il21)
4.440	3	28	11	4q26	MYOZ2, CMH16	P	Myozenin 2	605602	REc		Cardiomyopathy, hypertrophic, 16, 613838 (3)	
4.441	5	4	12	4q27	ANXA5, ENX2, RPRGL3	C	Annexin A5 (endonexin II)	131230	REa, A, D		{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	3(Anx5)
4.442	7	27	11	4q27	ADAD1, TENR	P	Adenosine deaminase domain-containing protein 1, testis-specific	614130	REc			
4.443	10	16	14	4q27	BBS7	C	BBS7 gene	607590	REc, REn		Bardet-Biedl syndrome 7, 615984 (3)	
4.444	1	7	06	4q27	BBS12, FLJ35630, C4orf24	C	BBS12 gene	610683	Fd, REc	1Mb centromeric to BBS	Bardet-Biedl syndrome 12, 615989 (3)	
4.445	8	24	92	4q27	CCNA, CCN1	C	Cyclin A	123835	A			3(Cyca)
4.446	2	23	08	4q27	CELIAC6, AIS5	P	Celiac disease, susceptibility to, 6	611598	Fd		{Celiac disease, susceptibility to, 6} (2); {Autoimmune disease, susceptibility to, 5} (2)	
4.447	8	30	09	4q27	EXOSC9, PMSCL1	P	Exosome component 9	606180	R, REc			
4.448	2	18	09	4q27	IDDM23	P	Diabetes mellitus, insulin-dependent, 23	612622	Fd	associated with rs6534347	{Diabetes mellitus, insulin-dependent, 23} (2)	
4.449	12	17	07	4q27	KIAA1109	C	KIAA1109 gene	611565	R, REc			
4.450	6	19	98	4q27	MAD2L1	C	Mitotic arrest deficient, yeast, homolog-like 1	601467	REa, R, A	previously mapped to 5q23-q31		
4.451	8	26	15	4q27	NDNF, C4orf31, NORD	P	Neuron-derived neurotrophic factor	616506	REc			
4.452	8	25	11	4q27	PRDM5, BCS2	P	PR domain-containing protein 5	614161	REc		Brittle cornea syndrome 2, 614170 (3)	
4.453	6	17	15	4q27	TRPC3, TRP3, SCA41	P	Transient receptor potential cation channel, subfamily C, member 3	602345	REc	mutation identified in one SCA41 patient	?Spinocerebellar ataxia 41, 616410 (3)	
4.454	8	9	99	4q31.3	PET112L	P	Pet112, S. cerevisiae, homolog-like	603645	TM			
4.455	1	12	15	4q28.1	PLK4, STK18, SAK, MCCRP2	P	Polo-like kinase 4 (serine/threonine protein kinase-18)	605031	A		Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	13(Sak)
4.456	11	19	11	4q27-q28.2	MRT29	P	Mental retardation, autosomal recessive 29	614333	Fd	between rs843571 and rs318539	Mental retardation, autosomal recessive 29 (2)	
4.457	9	19	14	4q31.3	FGA	C	Fibrinogen, alpha polypeptide	134820	RE, REa, H, D, LD, A		Dysfibrinogenemia, congenital, 616004 (3); Hypodysfibrinogenemia, congenital, 616004 (3); Amyloidosis, familial visceral, 105200 (3); Afibrinogenemia, congenital, 202400 (3)	
4.458	9	19	14	4q31.3	FGB	C	Fibrinogen, beta polypeptide	134830	RE, REa, D, LD, A	4q31 by A; proximal to GYPB/GYPA	Dysfibrinogenemia, congenital, 616004 (3); Afibrinogenemia, congenital, 202400 (3); Hypofibrinogenemia, congenital, 202400 (3)	
4.459	9	30	14	4q32.1	FGG	C	Fibrinogen, gamma polypeptide	134850	F, REa, H, RE, D, LD, A	linked to MN	Dysfibrinogenemia, congenital, 616004 (3); Hypofibrinogenemia, congenital, 202400 (3); Afibrinogenemia, congenital, 202400 (3); Hypodysfibrinogenemia, 616004 (3)	3(Fgg)
4.460	11	30	06	4q28.1	INTU, KIAA1284, PDZK6	C	Inturned, Drosophila, homolog of	610621	R, REc			
4.461	8	2	13	4q31.21	SMAD1, MADH1, MADR1, BSP1	P	Mothers against decapentaplegic, Drosophila, homolog of, 1	601595	Psh			
4.462	12	21	87	4q26	FABP2	P	Fatty acid-binding protein, intestinal	134640	REa, A			3(Fabpi)
4.463	2	28	13	4q31.21	GYPB, SS, MNS	C	Glycophorin B (includes Ss blood group)	111740	F, Fc, AAS, EM		[Blood group, Ss] (3); {Malaria, resistance to}, 611162 (3)	
4.464	4	30	91	4q31.21	GYPE, GPE	P	Glycophorin E	138590	REn, A	tandem: 5'-GYPA-GYPB-GYPE-3'; ?4q31.1		
4.465	3	2	98	4q31.1	MGST2, GST2	P	Microsomal glutathione S-transferase 2	601733	A			
4.466	10	23	87	4q28-q31	SF	C	Stoltzfus blood group	111800	F	~25cM from MNSs	[Blood group, Stoltzfus system] (2)	
4.467	2	17	09	4q31.21	HHIP, HIP	P	Hedgehog-interacting protein	606178	R, H			8(Hip)
4.468	9	24	14	4q28.1	FAT4, VMLDS2, HKLLS2	P	FAT tumor suppressor, Drosophila, homolog of, 4	612411	REc		Van Maldergem syndrome 2, 615546 (3); Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	
4.469	3	8	07	4q28.1	SLC25A31, ANT4, AAC4	P	Solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 31	610796	REc			
4.470	9	30	15	4q28.1	SPATA5, SPAF, EHLMRS	P	Spermatogenesis-associated protein 5	613940	REc		Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3)	
4.471	5	25	09	4q28.1	SPRY1	C	Sprouty, Drosophila, homolog of	602465	R, REc			
4.472	1	8	15	4q28.2	MFSD8, MGC33302, CLN7, CCMD	P	Major facilitator superfamily domain-containing protein 8	611124	REc, Fd		Ceroid lipofuscinosis, neuronal, 7, 610951 (3); Macular dystrophy with central cone involvement, 616170 (3)	
4.473	5	26	13	4q28.2	PHF17, JADE1	P	PHD finger protein 17	610514	R, REc			
4.474	5	26	13	4q28.2	SCLT1, CAP1A	P	Sodium channel and clathrin linker 1	611399	REc			
4.475	7	6	07	4q31.21	GYPA, MN, GPA	C	Glycophorin A (includes MN blood group)	111300	F, Fc, AAS, EM, A, D, Fc	male lod = 3.79 at theta 0.32 vs. GC	[Blood group, MN] (3); {Malaria, resistance to}, 611162 (3)	
4.476	6	4	99	4q31.1	NDUFC1	P	NADH-ubiquinone oxidoreductase 1, subcomplex C1	603844	R			
4.477	11	2	04	4q31.1	MAML3, MAM2, KIAA1816	C	Mastermind-like 3	608991	R, REc			
4.478	12	5	03	4q28.3	PCDH10, KIAA1400	P	Protocadherin 10	608286	R, REc			
4.479	2	25	15	4q28.3	SLC7A11, XCT	P	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 11	607933	R, REc			
4.480	10	5	10	4q31	AAA2	P	Aortic aneurysm, familial abdominal 2	609782	Fd	max lod at D4S1644	Aortic aneurysm, familial abdominal 2 (2)	
4.481	11	1	99	4q31.21	ABCE1, RNASELI, RNS4I	P	ATP-binding cassette, subfamily E, member 1 (ribonuclease L inhibitor)	601213	A			
4.482	11	30	00	4q31	DFNB26	P	Deafness, autosomal recessive 26	605428	Fd		Deafness, autosomal recessive 26 (2)	
4.483	8	28	02	4q34.1	HMGB2, HMG2	P	High-mobility group box 2 (high-mobility group (nonhistone chromosomal) protein 2)	163906	A			
4.484	6	13	95	4q31.21	IL15	P	Interleukin-15	600554	A			
4.485	4	8	10	4q32.1	LRAT, LCA14	C	Lecithin retinol acyltransferase	604863	A		Retinal dystrophy, early-onset severe, 613341 (3); Leber congenital amaurosis 14, 613341 (3); Retinitis pigmentosa, juvenile, 613341 (3)	
4.486	2	20	97	4q32.1	NPY2R	P	Neuropeptide Y receptor Y2	162642	REa, A			3(Npy2r)
4.487	12	5	03	4q28.3	PCDH18, KIAA1562	P	Protocadherin 18	608287	R, REc			
4.488	5	5	09	4q31	STQTL12	P	Stature quantitative trait locus 12	612224	Fd	associated with rs6854783	{Stature QTL 12} (2)	
4.489	5	26	05	4q31.1	UCP1	P	Uncoupling protein 1 (mitochondrial, proton carrier)	113730	A		{Obesity, susceptibility to}, 601665 (3)	8(Ucp)
4.490	2	18	98	4q32.2	NPY5R	C	Neuropeptide Y receptor Y5	602001	REa, REc, REn			8(Npy5r)
4.491	10	2	89	4q32.1	TDO2, TPH2, TRPO	C	Tryptophan oxygenase	191070	REa, A			
4.492	3	22	06	4q31-q34	PAND3	P	Panic disorder 3	609985	max lod at D4S413		Panic disorder 3 (2)	
4.493	7	21	03	4q31-q34	PSORS9	P	Psoriasis susceptibility 9	607857	Fd	max lod at D4S1597	{Psoraisis susceptibility 9} (2)	
4.494	9	9	08	4q31.1	CCRN4L, CCR4L, CCR4	P	Carbon catabolite repression 4-like	608468	REc, H			3(Ccrn4l)
4.495	3	11	09	4q31.1	ELMOD2	P	ELMO domain-containing protein 2	610196	REc			
4.496	1	29	01	4q34.1	GALNT7	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7	605005	REc			
4.497	3	10	09	4q31.1	LOC152586	P	LOC152586 gene	610310	REc			
4.498	6	24	13	4q31.1	NAA15, NARG1, NATH	P	N-alpha-acetyltransferase 15, NatA auxiliary subunit	608000	REc			
4.499	7	7	00	4q31.23	NR3C2, MLR, MCR	C	Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)	600983	REa, M, A		Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	
4.500	5	3	13	4q31.1	RAB33B, SMC2	P	Ras-associated protein RAB33B	605950	REc		Smith-McCort dysplasia 2, 615222 (3)	
4.501	6	30	15	4q31.1	SETD7, SET7, KIAA1717	P	SET domain-containing protein 7	606594	R, REc			
4.502	3	11	03	4q31.21	MMAA	P	MMAA gene	607481	REc		Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)	
4.503	1	12	99	4q31.21	SMARCA5, SNF2H	P	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 5	603375	A			
4.504	9	1	05	4q31.21	ZNF330, NOA36	P	Zinc finger protein 330	609550	A, REc			
4.505	1	6	09	4q31.23	ARHGAP10, GRAF2, PSGAP	P	RHO GTPase-activating protein 10	609746	R, REc			
4.506	2	28	94	4q31.22	BRN3B	P	Brn3b POU domain transcription factor	113725	REa, A			
4.507	5	19	15	4q31.22-q31.23	EDNRA, MFDA	C	Endothelin receptor type A	131243	REa		{Migraine, resistance to}, 157300 (3); Mandibulofacial dysostosis with alopecia, 616367 (3)	
4.508	10	1	09	4q31.21	FREM3	P	FRAS1-related extracellular matrix protein 3	608946	REc			
4.509	8	30	09	4q31.22	LSM6	P	LSM6 protein	607286	R, REc			
4.510	1	22	08	4q31.21	OTUD4, KIAA1046, HIN1	P	OTD domain-containing protein 4	611744	REc			
4.511	6	15	99	4q31.3	RPS3A	C	Ribosomal protein S3a	180478	REa, A, R			
4.512	8	24	09	4q31.3	PLRG1, PRL1	P	Pleiotropic regulator 1	605961	R, REc			
4.513	2	17	11	4q31.21	ANAPC10, DOC1, APC10	P	Anaphase-promoting complex, subunit 10	613745	REc			8(Anapc10)
4.514	4	26	11	4q31.23	TMEM184C, TMEM34	C	Transmembrane protein 184C	613937	REc			
4.515	12	21	09	4q31.2-q31.3	DCLK2, DCK2, CLIK2, CL2	P	Doublecortin-like kinase 2	613166	REc			3(Dclk2)
4.516	12	9	14	4q31.23	PRMT9, PRMT10	P	Protein arginine methyltransferase 9	616125	REc			
4.517	10	13	09	4q31.3	DCHS2, CDHJ, PCDHJ	P	Dachsous, Drosophila, homolog of, 2	612486	REc, H			3(Dchs2)
4.518	9	9	08	4q31.3	FBXW7, AGO, CDC4	P	F-box and WD40 domain protein 7	606278	R			
4.519	5	10	12	4q32.1	GLRB, HKPX2	C	Glycine receptor, beta subunit	138492	A		Hyperekplexia 2, autosomal recessive, 614619 (3)	3(Glrb)
4.520	1	4	16	4q31.3	KIAA0922, TMEM131L	P	KIAA0922 gene	616243	REc			
4.521	7	6	12	4q31.3	LRBA, LBA, CDC4L, CVID8	P	Lipopolysaccharide-responsive, beige-like anchor protein	606453	REc, R		Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	
4.522	7	17	14	4q31.3	MAB21L2, MCOPS14	P	MAB21, C. elegans, homolog-like 2	604357	REc		Microphthalmia, syndromic 14, 615877 (3)	
4.523	8	27	15	4q31.3	MND1	P	Meiotic nuclear division 1, S. cerevisiae, homolog of	611422	REc			
4.524	2	11	98	4q32.1	PPID	C	Peptidylprolyl isomerase D (cyclophilin D)	601753	REa, A			
4.525	10	19	99	4q31.3	SFRP2, SARP1	C	Secreted frizzled-related protein 2	604157	REa, R, H			3(Sfrp2)
4.526	12	13	06	4q31.3	SH3D19, EBP	P	SH3 domain protein 19	608674	REc, Ch	fused with AML1 in t(4;21)		
4.527	11	11	14	4q31.3	SNORD73A, RNU73	P	Small nucleolar RNA, C/D box 73A	603568	A			
4.528	7	7	15	4q31.3	TRIM2, KIAA0517, CMT2R	C	Tripartite motif-containing protein 2	614141	R, REc		Charcot-Marie-Tooth disease, type 2R, 615490 (3)	
4.529	12	17	15	4q32.1	ASIC5, HINAC	C	Acid-sensing ion channel family member 5	616693	REc, H			3(Asic5)
4.530	6	10	94	4q32.2	NPY1R	P	Neuropeptide Y receptor	162641	A			8(Npy1r)
4.531	12	18	07	4q31.3-q32.3	HSCR9	P	Hirschsprung disease, susceptibility to, 9	611644	Fd	between D4S3049 and D4S1566	{Hirschsprung disease, susceptibility to, 9} (2)	
4.532	4	22	09	4q32.1	ASAP	P	Aster-associated protein	610070	REc			
4.533	4	29	14	4q32.1	GUCY1A3, GUC1A3, GUCSA3, MYMY6	P	Guanylate cyclase 1, soluble, alpha 3	139396	A		Moyamoya 6 with achalasia, 615750 (3)	
4.534	8	18	98	4q32.1	GUCY1B3, GUC1B3, GUCSB3	P	Guanylate cyclase 1, soluble, beta 3	139397	A			
4.535	2	16	04	4q32.1	PDGFC	P	Platelet-derived growth factor C	608452	R, REc			
4.536	8	18	15	4q32.1	RXFP1, LGR7	P	Relaxin/insulin-like family peptide receptor 1	606654	A			
4.537	4	5	13	4q31.3	TLR2, TIL4	C	Toll-like receptor-2	603028	A		{Leprosy, susceptibility to}, 246300 (3); {Colorectal cancer, susceptibility to}, 114500 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
4.538	2	21	10	4q34.3	AGA	C	Aspartylglucosaminidase	613228	S, F, D, A		Aspartylglucosaminuria, 208400 (3)	8(Aga)
4.539	11	30	06	4p15.32	CPEB2	P	Cytoplasmic polyadenylation element-binding protein 2	610605	REc			5(Cpeb2)
4.540	3	1	94	4q32.1	GRIA2, GLUR2	C	Glutamate receptor, ionotropic, AMPA 2	138247	Psh, A			3(Glur2)
4.541	10	15	09	4q32.3	TLL1, TLL, ASD6	P	Tolloid-like 1	606742	A		Atrial septal defect 6, 613087 (3)	8(Tll1)
4.542	7	31	08	4q32-q34	RP29	P	Retinitis pigmentosa 29	612165	Fd	maximum lod at D4S415	Retinitis pigmentosa 29 (2)	
4.543	2	25	16	4q32.3	MSMO1, SC4MOL, ERG25, MCCPD	P	Methylsterol monooxygenase 1	607545	A		Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	
4.544	8	25	03	4q32.1	ETFDH, MADD	C	Electron transfer flavoprotein:ubiquinone oxidoreductase	231675	REa, A		Glutaric acidemia IIC, 231680 (3)	3(Etfdh)
4.545	2	5	15	4q32.1	C4orf46, RCDG1	P	Chromosome 4 open reading frame 46	616210	REc			
4.546	10	2	12	4q32.1	CTSO	P	Cathepsin O	600550	REc			
4.547	5	19	09	4q32.1	FNIP2, FNIPL, KIAA1450	C	Folliculin-interacting protein 2	612768	R, REc			
4.548	1	27	11	4q32.1-q32.2	TRIP4q32.1q32.2, C4TRIPq32.1q32.2	P	Chromosome 4q32.1-q32.2 triplication syndrome	613603	Ch		Chromosome 4q32.1-q32.2 triplication syndrome (4)	
4.549	1	28	08	4q33	AADAT, KAT2	C	Alpha-aminoadipate aminotransferase	611754	A, REc, H			8(Aadat)
4.550	6	7	10	4q32.2-q32.3	MARCH1	P	Membrane-associated RING-CH finger protein 1	613331	REc			
4.551	8	30	09	4q32.3	ANP32C, PP32R1	P	Acidic leucine-rich nuclear phosphoprotein 32 family, member C	606877	Psh, REc			
4.552	8	30	07	4q32.3	CINN	P	Cinnamon odor, pleasantness of	611109	Fd	max lod at AFM295YES	[Cinnamon odor, pleasantness of] (2)	
4.553	8	30	09	4q32.3	CPE	P	Carboxypeptidase E	114855	REa, H, REc			8(Cpe)
4.554	6	11	11	4q32.3	DDX60	P	DEAD box polypeptide 60	613974	REc			
4.555	1	4	16	4q32.3	DDX60L	P	DEAD box polypeptide 60-like	616725	REc			
4.556	12	17	07	4q32.3	HDLCQ4	P	High density lipoprotein cholesterol level QTL 4	610239	Fd	between D4S1597 and D4S1539	[High density lipoprotein cholesterol level QTL 4] (2)	
4.557	8	26	15	4q33	MFAP3L, KIAA0626	C	Microfibrillar-associated protein 3-like	616523	REc, Psh			
4.558	1	9	07	4q32.3	PALLD, KIAA0992, PNCA1	C	Palladin, mouse, homolog of	608092	R, REc, Fd		{Pancreatic cancer, susceptibility to, 1}, 606856 (3)	
4.559	1	11	07	4q32.3	SPOCK3	P	SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 3	607989	REc			
4.560	1	12	07	4q32.3	ANXA10	P	Annexin A10	608008	A			8(Anxa10)
4.561	4	8	98	4q33	CLCN3	C	Chloride channel-3	600580	REc, Fd, A			8(Clcn3)
4.562	11	10	05	4q34.1	HAND2, DHAND2, DHAND	P	Heart- and neural crest derivative-expressed 2	602407	R			
4.563	5	19	16	4q33	HPF1, C4orf27	P	Histone parylation factor 1	616614	REc			
4.564	2	11	14	4q33	NEK1, SRTD6, SRPS2A	P	Never in mitosis gene A-related kinase 1	604588	REc	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3)	
4.565	10	20	98	4q34.1	GLRA3	P	Glycine receptor, alpha-3 polypeptide	600421	A			8(Glra3)
4.566	4	3	03	4q34.1	MORF4, SEN1, CSRB	P	Mortality factor 4 (senescence-related, cellular, 1)	116960	M, A			
4.567	10	7	02	4q33-qter	HCA1	P	Hypercalciuria, absorptive, 1	607258	Ch		Hypercalciuria, absorptive (2)	
4.568	1	29	01	4q34.1	ADAM29	C	A disintegrin and metalloproteinase domain 29	604778	R			
4.569	9	28	96	4q34.2	GPM6A, M6A	C	Glycoprotein M6A	601275	A			
4.570	11	2	04	4q34.2	WDR17	P	WD repeat-containing protein 17	609005	A			
4.571	8	11	14	4q34.3	VEGFC, VRP, LMPH1D	P	Vascular endothelial growth factor C	601528	REc		Lymphedema, hereditary, ID, 615907 (3)	
4.572	4	20	10	4q34.3-q35.1	SCA30	L	Spinocerebellar ataxia 30	613371	Fd	between rs1397413 and rs2175476; max lod 3.0	?Spinocerebellar ataxia 30 (2)	
4.573	10	16	12	4q34.3-q35.2	HMSN5	P	Hereditary motor and sensory neuropathy V	600361	Fd	D4S1552 and D4S2930	Hereditary motor and sensory neuropathy V (2)	
4.574	9	18	08	4q35.1	ACSL1, FACL2, FACL1, LACS, ACS1	C	Acyl-CoA synthetase long-chain family member 1	152425	REb, A			
4.575	2	18	96	4q35.2	FAT1, FAT	P	FAT tumor suppressor, Drosophila, homolog of, 1	600976	A			
4.576	1	24	12	4q34.1	HPGD, PGDH1, PHOAR1	P	Hydroxyprostaglandin dehydrogenase 15-(NAD)	601688	REa, A		Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3); Digital clubbing, isolated congenital, 119900 (3)	
4.577	9	9	08	4q34.1	FBXO8, FBX8, FBS	P	F-box only protein 8	605649	REc			8(Fbxo8)
4.578	4	6	13	4q34.1	GALNTL6, GALNACT20	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6	615138	REc			
4.579	3	23	15	4q34.1	MIR4276	P	Micro RNA 4276	616274	REc			
4.580	7	20	12	4q34.1	SAP30	P	SIN3-associated polypeptide, 30kD	603378	REc			
4.581	8	16	12	4q34.1	SCRG1	P	Scraptie-responsive gene 1	603163	REc			
4.582	3	22	06	4q34.2	SPATA4, TSARG2	P	Spermatogenesis-associated protein 4	609879	REc			
4.583	1	31	13	4q34.2	ASB5	P	Ankyrin repeat- and SOCS box-containing protein 5	615050	REc			
4.584	5	7	01	4q35.1	ALP	P	Actinin-associated LIM protein	605889	A			
4.585	5	8	97	4q35.1	CASP3, CPP32	P	Caspase 3, apoptosis-related cysteine protease	600636	A, REc			
4.586	10	25	12	4q35.2	DBET	P	D4A4 binding element transcript, noncoding	614865	REc			
4.587	3	19	03	4q35.1	DCTD	P	Deoxycytidylate deaminase	607638	A			
4.588	3	22	01	4q35	DKBI	P	Dyskeratosis, hereditary benign intraepithelial	127600	Fd		Dyskeratosis, hereditary benign intraepithelial (2)	
4.589	6	18	01	4q35.2	DUX4	P	Double homeo box protein 4	606009	REc			
4.590	12	27	13	4q35.2	DUX4L9, DUX4C	P	Double homeobox 4-like 9	615581	REc			
4.591	12	22	08	4q35.2	F11	C	Coagulation factor XI (plasma thromboplastin antecedent)	264900	A, H, Fd	not closely linked to MNS	Factor XI deficiency, autosomal recessive, 612416 (3); Factor XI deficiency, autosomal dominant, 612416 (3)	8(cf11)
4.592	8	18	98	4q35.2	FRG1, FSG1	P	Facioscapulohumeral muscular dystrophy region gene-1	601278	REn			
4.593	11	22	05	4q35.2	FRG2	P	Facioscapulohumeral muscular dystrophy region gene 2	609032	REn			
4.594	7	19	04	4q35	FSHD1, FSHD1A	C	Facioscapulohumeral muscular dystrophy 1	158900	Fd, REc	due to D4Z4 macrosatellite repeat on 4q35	Facioscapulohumeral muscular dystrophy 1 (4)	?8(myd)
4.595	7	30	15	4q35.2	KLKB1, KLK3, PKKD	P	Kallikrein B plasma 1 (Fletcher factor)	229000	A	similar to F11	Fletcher factor (prekallikrein) deficiency, 612423 (3)	8(Kal3)
4.596	10	29	15	4q35.1	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	C	Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)	103220	REa, REb, A, Fd		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3); Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	8(Ant1)
4.597	4	3	13	4q35.1	TLR3, IIAE2	P	Toll-like receptor-3	603029	A		{Herpes simplex encephalitis, susceptibility to, 2} 613002 (3); {HIV1 infection, resistance to}, 609423 (3)	
4.598	9	27	01	4q35-qter	DFNA24	P	Deafness, autosomal dominant 24	606282	Fd		Deafness, autosomal dominant 24 (2)	
4.599	9	23	13	4q35.1	CCDC111, MYP22	P	Coiled-coil domain containing 111	615421	REc		Myopia 22, autosomal dominant, 615420 (3)	
4.600	8	18	14	4q35.1	CDKN2AIP, CARF	C	Cyclin-dependent kinase inhibitor 2A-interacting protein	615914	REc			
4.601	10	12	14	4q35.1	CFAP97, HMW, KIAA1430	P	Cilia- and flagella-associated protein 97	616047	R, REc			
4.602	5	31	05	4q35.1-q35.2	CYP4V2, BCD	C	Cytochrome P450, family 4, subfamily V, polypeptide 2	608614	Fd, REc		Bietti crystalline corneoretinal dystrophy, 210370 (3)	
4.603	3	2	06	4q35.1	ING2, ING1L	P	Inhibitor of growth 2	604215	A, R			
4.604	11	4	93	4q35.1	IRF2	P	Interferon regulatory factor-2	147576	A			
4.605	8	1	05	4q35.1	KMHN1	P	Cancer/testis antigen KM-HN-1	609488	REc			
4.606	10	8	07	4q35.1	MLF1IP, CENPU, CENP50	P	MLF1-interacting protein (centromere protein U)	611511	REc, H			8(Mlf1ip)
4.607	10	22	95	4q35.2	MTNR1A	P	Melatonin receptor 1A	600665	REa, Psh			8(Mtnr1a)
4.608	5	19	15	4q35.1	SORBS2, ARGBP2, KIAA0777	P	Sorbin and SH3 domains-containing protein 2	616349	REc			
4.609	2	5	15	4q35.1	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9	P	Teneurin transmembrane protein 3	610083	REc, R	mutation identified in one MCOPCB9 family	?Microphthalmia, isolated, with coloboma 9, 615145 (3)	
4.610	8	7	13	4q35.1	TRAPPC11, C4orf41, LGMD2S	P	Trafficking protein particle complex, subunit 11	614138	REc		Muscular dystrophy, limb-girdle, type 2S, 615356 (3)	
4.611	7	31	15	4q35.1	UFSP2, C4orf20, BHD	P	UFM1-specific protease 2	611482	REc	mutation identified in 1 BHD family	?Hip dysplasia, Beukes type, 142669 (3)	
4.612	10	2	12	4q35.2	DUX2	P	Double homeobox protein 2	611442	REc	?10q26.3		
4.613	4	19	12	4q35.2	ZFP42, REX1	P	Zinc finger protein 42	614572	REc, H			8(Zfp42)
4.614	1	7	14	4q32.3	ELA, LOC100506013	P	Elabela	615594	REc			
4.615	1	9	94	Chr.4	LAG5	P	Leukocyte antigen group 5	151450	S		Neutropenia, neonatal alloimmune (1)	
4.616	12	21	09	4p16.1	MIR95, MIRN95	P	Micro RNA 95	613185	REc			
4.617	10	23	87	Chr.4	TS13	P	Temperature sensitivity complementation, ts13	187320	S			
5.1	7	13	15	5p15.33	NDUFS6	P	NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kD	603848	R		Mitochondrial complex I deficiency, 252010 (3)	
5.2	1	11	93	5p15.31	ADCY2	C	Adenylyl cyclase-2, brain	103071	A, REa			13(Adcy2)
5.3	12	27	01	5p15.33	AHRR, KIAA1234	C	Arylhydrocarbon receptor repressor	606517	R, A			13(Ahrr)
5.4	8	17	01	5p15.33	IRX1	P	Iroquois homeo box protein 1	606197	A			
5.5	8	17	01	5p15.33	IRX2	P	Iroquois homeo box protein 2	606198	A			
5.6	7	3	06	5p15.33	IRX4	P	Iroquois homeobox protein 4	606199	REa, R, H			13(Irx4)
5.7	3	5	08	5p15.33	MRPL36	P	Mitochondrial ribosomal protein L36	611842	REc			
5.8	3	31	15	5p15.33	NKD2	P	Naked cuticle, Drosophila, homolog of, 2	607852	REc, R			
5.9	5	12	00	5p15.33	SLC12A7, KCC4	P	Solute carrier family 12 (potassium/chloride transporters), member 7	604879	R, REa			
5.10	1	31	13	5p15.33	SLC6A3, DAT1, PKDYS	C	Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	126455	Psh, A, Fd		{Nicotine dependence, protection against}, 188890 (3); Parkinsonism-dystonia, infantile, 613135 (3)	13(Dat1)
5.11	3	20	16	5p15.33	SLC9A3, NHE3, DIAR8	C	Solute carrier family 9 (sodium/hydrogen exchanger), member 3	182307	REa, Fd	pseudogene on chr.10	Diarrhea 8, secretory sodium, congenital, 616868 (3)	13(Slc9a3)
5.12	7	22	09	5p15.33	TPPP, P25, P24	P	Tubulin polymerization-promoting protein	608773	Psh, R			
5.13	2	25	15	5p15.33	AYTL2, LPCAT, LPCAT1	P	Acyltransferase-like 2	610472	REc			
5.14	10	6	09	5p15.33	BCC3	P	Basal cell carcinoma, susceptibility to, 3	613059	Fd		{Basal cell carcinoma, susceptibility to, 3} (2)	
5.15	5	26	13	5p15.33	CEI	P	Coordinated expression to IRXA2	610522	REc			
5.16	7	23	15	5p15.33	CEP72, KIAA1519	P	Centrosomal protein, 72kD	616475	REc			
5.17	2	17	09	5p15.33	CLPTM1L, CRR9	P	CLPTM1-like protein	612585	REc			
5.18	9	8	11	5p15.33	EXOC3, SEC6	P	Exocyst complex component 3	608186	REc			
5.19	11	26	09	5p15.33	GLM8	P	Glioma susceptibility 8	613033	Fd	associated with rs2736100	{Glioma susceptibility 8} (2)	
5.20	2	18	09	5p15.33	LNCR3	P	Lung cancer susceptibility 3	612571	Fd	associated with rs402710 and rs2736100	{Lung cancer susceptibility 3} (2)	
5.21	5	22	14	5p15.33	LSINCT5	P	Long stress-induced noncoding transcript 5	615764	REc			
5.22	11	11	14	5p15.33	PDCD6, ALG2	P	Programmed cell death 6	601057	REc			
5.23	9	9	09	5p15.33	SLC6A18, XTRP2	P	Solute carrier family 6 (neurotransmitter transporter), member 18	610300	REc			
5.24	4	20	10	5p15.33	SLC6A19, HND	C	Solute carrier family 6 (neurotransmitter transporter), member 19	608893	REc, Fd		Hartnup disorder, 234500 (3); Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	13(Slc6a19)
5.25	5	26	15	5p15.33	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	C	Telomerase reverse transcriptase	187270	R, D	deleted in cri du chat	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3); {Dyskeratosis congenita, autosomal recessive 4}, 613989 (3); {Dyskeratosis congenita, autosomal dominant 2}, 613989 (3); {Leukemia, acute myeloid}, 601626 (3); {Melanoma, cutaneous malignant, 9}, 615134 (3)	
5.26	7	18	14	5p15.33	TRIP13, 16E1BP	P	Thyroid hormone receptor interactor 13	604507	REc			
5.27	1	27	09	5p15.33-p15.2	MYP16	P	Myopia 16	612554	Fd	max lod at D5S2505	Myopia 16 (2)	
5.28	8	29	08	5p15.33-p13.1	MCDR3	P	Macular dystrophy, retinal, 3	608850	Fd	maximum lod at D5S630	Macular dystrophy, retinal, 3 (2)	
5.29	6	1	15	5p15.31	LINC01018, SRHC	P	Long intergenic noncoding RNA 1018	616385	REc			
5.30	10	30	08	5p15.31	MED10, NUT2	P	Mediator complex subunit 10	612382	REc			
5.31	6	7	12	5p15.31	NSUN2, TRM4, SAKI, MISU, MRT5	P	NOL1/NOP2/SUN domain family, member 2	610916	REc		Mental retardation, autosomal recessive 5, 611091 (3)	13(Nsun2)
5.32	6	22	14	2q11.2	SEMA4C, SEMAF, KIAA1739	P	Semaphorin 4C	604462	REc			
5.33	7	18	14	5p15.31	UBE2QL1	P	Ubiquitin-conjugating enzyme E2Q family-like protein 1	615832	REc			
5.34	12	19	11	5p15.31-p15.1	FAME3, FCMTE3	P	Epilepsy, myoclonic, familial adult, 3	613608	Fd	between D5S580 and D5S2096	Epilepsy, myoclonic, familial adult, 3 (2)	
5.35	7	31	06	5p15.31	MTRR	P	Methionine synthase reductase	602568	Psh, A		Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	
5.36	5	30	06	5p15.2	CCT5, KIAA0098, CCTE	P	chaperonin containing TCP1, subunit 5 (epsilon)	610150	REc, Fd		Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	
5.37	4	26	10	5p15.2	CMBL	P	Carboxymehtylenebutenolidase-like protein	613379	REc			15(Cmbl)
5.38	1	29	14	5p15.2	CTNND2, NPRAP	P	Catenin, delta-2	604275	Psh, A			
5.39	1	4	96	5p15.2	DAP	P	Death-associated protein	600954	REa			
5.40	3	16	10	5p15.2	MARCH6, TEB4, DOA10, KIAA0597	C	Membrane-associated RING-CH finger protein 6	613297	REc			
5.41	3	25	14	5p15.2	OTULIN, FAM105B, GUM	P	OTU deubiquitinase with linear linkage specificity	615712	REc			15(Otulin)
5.42	1	28	08	5p15.2	ROPN1L, ASP	P	ROPN1-like protein	611756	R, REc			
5.43	10	14	09	5p15.31	SEMA5A, SEMF	P	Semaphorin 5a	609297	REc			15(Sema5a)
5.44	7	1	02	5p14.3	CDH18, CDH14	P	Cadherin 18	603019	R, Fd			
5.45	2	17	09	5p15.2-p14	ADIPQTL2, CAQ5	P	Adiponectin, serum level of, QTL 2	606770	Fd	near D5S817	{Adiponectin, serum level of, QTL2} (2)	
5.46	11	2	02	5p15.2	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	C	Ank, mouse, homolog of	605145	R, Fd		Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2, 118600 (3)	15(ank)
5.47	7	14	06	5p15.2-p14.3	ANIB4	P	Aneurysm, intracranial berry, 4	610213	Fd	max lod at D5S1954	Aneurysm, intracranial berry, 4 (2)	
5.48	10	8	07	5q12.3	CEMPK, SOLT	P	Centromeric protein K	611502	REc			
5.49	11	13	09	5p15.1	FAM134B, HSAN2B	P	Family with sequence similarity 134, member B	613114	REc		Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	
5.50	8	31	09	5p15.1	FBXL7, FBL7	C	F-box and leucine-rich repeat protein 7	605656	R, REc			15(Fbxl7)
5.51	6	7	10	5p15.1	MARCH11	P	Membrane-associated RING-CH finger protein 11	613338	REc			
5.52	10	31	13	5p15.1	PVNH3	P	Periventricular nodular heterotopia 3	608098	A, Ch		Periventricular nodular heterotopia 3 (2)	
5.53	5	7	01	5p15.1	BASP1, CAP23, NAP22	P	Brain-abundant signal protein, membrane-attached, 1	605940	A			
5.54	7	1	02	5p13.3	CDH6	P	Cadherin 6	603007	R, Fd			
5.55	6	30	05	5p13.2	RLN3R1, SALPR, GPCR135	P	Relaxin 3 receptor 1	609445	R			
5.56	8	5	97	5p15.2	TRIO	P	Triple functional domain(PTPRF interacting)	601893	A			
5.57	11	12	96	5p15.1	MYO10	P	Myosin X	601481	A			15(Myo10)
5.58	6	11	11	5p15.1-p13.3	MYP19	P	Myopia 19, autosomal dominant	613969	Fd	highest lod at D5S419	Myopia 19 (2)	
5.59	4	3	09	5p15.32	ADAMTS16	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 16	607510	REc			
5.60	9	27	01	5p15.31	POLS, TRF4, POLK	P	Polymerase, DNA, sigma	605198	REc			
5.61	8	25	11	5p15.33	SDHA, SDH1, SDHF, CMD1GG, PGL5	C	Succinate dehydrogenase complex, subunit A, flavoprotein	600857	A	copy on 3q29	Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)	
5.62	12	9	91	5p15.31	SRD5A1	P	Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)	184753	REa, A	pseudogene on X		13(Srd5a1)
5.63	4	5	00	5p15.31	TRB7, T2R1	P	Taste receptor, family B, member 7	604796	REc			15(T2R19)
5.64	11	22	10	5p15	TST2	P	Tuberculin skin test reactivity quantitative trait locus	613637	Fd	max lod at 16:2.70Mb	[Tuberculin skin test reactivity QTL] (2)	
5.65	12	4	08	5p15.2	DNAH5, HL1, PCD, CILD3	C	Dynein, axonemal, heavy chain 5	603335	REn, Fd		Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	15(Dnahc5)
5.66	3	24	06	5p14.1	CDH9	P	Cadherin 9	609974	REc			
5.67	8	15	90	5p14	MLVI2	P	Moloney leukemia virus integration site-2	157960	REa, A			15(Mlvi2)
5.68	3	18	94	5p14.3	PMCHL1	P	Pro-melanin-concentrating hormone-like 1	176793	REa, A			
5.69	2	18	10	5p14.2	PRDM9	P	PR domain-containing protein 9	609760	REc			
5.70	3	8	00	5p14.2-p14.1	CDH10	P	Cadherin 10	604555	A			
5.71	9	14	95	5p14.3	CDH12, CDHB	P	Cadherin-12 (N-cadherin 2)	600562	A	pseudogene on 5q13 in SMA region		
5.72	10	23	87	5p12	HMGCS1	C	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1	142940	S, REa, A	like HMGCR, regulated transcriptionally by steroid		
5.73	11	9	05	5p13.3	RNASEN, DROSHA, RANSE3L, RN3	P	Ribonuclease III, nuclear	608828	A			15(Rnasen)
5.74	1	1	96	5p13.3	NPR3, ANPRC	P	Natriuretic peptide receptor C	108962	REa, A		?Hypertension, salt-resistant (1)	
5.75	9	2	08	5p13.3	GOLPH3, GPP34, MIDAS	P	Golgi phosphoprotein 3	612207	R, REc			
5.76	8	31	09	5p13.3	MTMR12, 3PAP, KIAA1682	P	Myotubularin-related protein 12	606501	R, REa, REc			
5.77	8	9	13	5p13.2	SLC45A2, MATP, AIM1, SHEP5, OCA4	P	Solute carrier family 45, member 2	606202	REc		Albinism, oculocutaneous, type IV, 606574 (3); [Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	
5.78	10	2	12	5p13.3	SUB1, PC4, p15	P	Sub1, S. cerevisiae, homolog of	600503	REc			
5.79	2	13	14	5p13.3	ZFR	P	Zinc finger RNA-binding protein	615635	REc			
5.80	12	17	14	5p13.3-p13.2	BDA1B	P	Brachydactyly, type A1, locus B	607004	Fd		Brachydactyly, type A1, B (2)	
5.81	12	10	98	5p13.2	RAD1	P	RAD1, S. pombe, homolog of	603153	A			
5.82	12	27	01	5p13.2	RAI14, KIAA1334	P	Retinoic acid-induced 14	606586	REa, A			
5.83	11	5	14	5p13.2	C5orf42, JBTS17, OFD6	P	Chromosome 5 open reading frame 42	614571	REc		Joubert syndrome 17, 614615 (3); Orofaciodigital syndrome VI, 277170 (3)	
5.84	2	23	09	5p13.2	MS3	P	Multiple sclerosis, susceptibility to, 3	612595	Fd	associated with rs6897932	{Multiple sclerosis, susceptibility to, 3} (2)	
5.85	10	12	14	5p13.2	NADK2, C5orf33, DECRD	P	NAD kinase 2, mitochondrial	615787	REc	mutation identified in 1 DECRD family	?2,4-dienoyl-CoA reductase deficiency, 616034 (3)	
5.86	1	17	07	5p13.3	PDZD2, PAPIN, PIN1, AIPC	C	PDZ domain containing 2	610697	R, REc			
5.87	12	27	13	5p13.2	PRLR, MFAB, HPRL	P	Prolactin receptor	176761	REa, A, REc	mutation identified in 1 family with HPRL	Multiple fibroadenomas of the breast, 615554 (3); ?Hyperprolactinemia, 615555 (3)	
5.88	6	2	15	5p13.2	RANBP3L	P	RAN-binding protein 3-like	616391	REc			
5.89	8	19	13	5p13.2	SPEF2, KPL2, KIAA1770	P	Sperm flagellar 2	610172	Psh, REc			
5.90	6	2	15	5p13.2	TTC23L	P	Tetratricopeptide repeat domain-containing protein 23-like	616344	REc			
5.91	6	2	15	5p13.2	UGT3A1	P	Uridine diphosphate glucuronosyltransferase 3 family, member A1	616383	REc			15(Ugt3a1)
5.92	6	2	15	5p13.2	UGT3A2	P	Uridine diphosphate glucuronosyltransferase 3 family, member A2	616384	REc			15(Ugt3a2)
5.93	10	26	11	5p13.2	AMACR, CBAS4, AMACRD	P	Alpha-methylacyl-CoA racemase	604489	TM		Alpha-methylacyl-CoA racemase deficiency, 614307 (3); Bile acid synthesis defect, congenital, 4, 214950 (3)	
5.94	11	11	14	5p13.1	FYB, SLAP130, ADAP	P	FYN-binding protein	602731	REc			
5.95	9	24	08	5p13.1	IBD18	P	Inflammatory bowel disease 18	612262	Fd	associated with rs1373692	{Inflammatory bowel disease 18} (2)	
5.96	2	10	04	5p13.1	LIFR, STWS, SWS, SJS2	C	Leukemia inhibitory factor receptor	151443	REa, Fd		Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	15(Lifr)
5.97	2	26	08	5p13.1	OSMR, OSMRB, PLCA1	C	Oncostatin M receptor	601743	REc, Fd		Amyloidosis, primary localized cutaneous, 1, 105250 (3)	
5.98	5	19	04	5p13.2	NIPBL, CDLS1	C	Nipped-B-like (delangin)	608667	Ch, REc		Cornelia de Lange syndrome 1, 122470 (3)	15(Nipbl)
5.99	12	14	99	5p13.1	PTGER4	P	Prostaglandin E receptor 4, EP4 subtype	601586	A			
5.100	3	23	06	5p13.1	CARD6, CINCIN1	C	Caspase recruitment domain-containing protein 6	609986	REc, H			15(Card6)
5.101	1	25	11	5p13.2	GDNF, HSCR3	C	Glial cell line derived neurotrophic factor	600837	A, Psh		Central hypoventilation syndrome, 209880 (3); {Pheochromocytoma, modifier of}, 171300 (3); {Hirschsprung disease, susceptibility to, 3}, 613711 (3)	
5.102	7	20	12	5p12	NNT, GCCD4	P	Nicotinamide nucleotide transhydrogenase	607878	A		Glucocorticoid deficiency 4, 614736 (3)	13(Nnt)
5.103	9	22	04	5p13	ADHD4	P	Attention deficit-hyperactivity disorder, susceptibility to, 4	608906	Fd		{Attention deficit-hyperactivity disorder}, 143465 (2)	
5.104	12	17	08	5p13.2	AGXT2, AGT2	P	Alanine-glyoxylate aminotransferase 2	612471	REc			
5.105	6	9	08	5p13.2	C1ATNF3, CTRP3, CORS26	P	C1q- and tumor necrosis factor-related protein 3	612045	A, H			15(C1qtnf3)
5.106	12	4	08	5p13.1	C6	C	Complement component-6	217050	A, H, RE, Fd, LD		C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)	15(C6)
5.107	7	3	06	5p13.1	C7	C	Complement component-7	217070	A, H, RE, Fd, LD		C7 deficiency, 610102 (3)	15(C7)
5.108	1	7	14	5p13.1	C9, C9D, ARMD15	C	Complement component-9	120940	REa, A, Fd, LD		C9 deficiency, 613825 (3); {Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)	
5.109	12	18	98	5p13.1	DAB2, DOC2	P	Disabled, Drosophila, homolog of, 2 (differentially expressed in ovarian cancer-2)	601236	A, REa			
5.110	2	16	10	5p13	DUP5p13, C5DUPp13	P	Chromosome 5p13 duplication syndrome	613174	Ch		Chromosome 5p13 duplication syndrome (4)	
5.111	1	20	09	5p13.2	IL7R, IL7RA, CD127	C	Interleukin-7 receptor	146661	REa, A		Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	
5.112	7	3	06	5p13	KYPSC1	P	Kyphoscoliosis 1	610170	Fd		Kyphoscoliosis 1 (2)	
5.113	5	22	14	5p13.2	NUP155, KIAA0791, ATFB15	C	Nucleoporin, 155kD	606694	A, R	mutation identified in 1 ATFB15 family	?Atrial fibrillation 15, 615770 (3)	
5.114	8	25	06	5p13.1	OXCT1, OXCT, SCOT	C	3-oxoacid CoA transferase 1	601424	A		Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	
5.115	9	23	96	5p13.2	SKP2	P	S-phase kinase-associated protein 2 (p45)	601436	A			
5.116	3	31	09	5p13.2	SLC1A3, EAAT1, EA6	C	Solute carrier family 1 (glial high affinity glutamate transporter), member 3	600111	A		Episodic ataxia, type 6, 612656 (3)	15(Eaat1)
5.117	5	2	06	5p12	FGF10	C	Fibroblast growth factor-10	602115	A		Aplasia of lacrimal and salivary glands, 180920 (3); LADD syndrome, 149730 (3)	
5.118	2	13	15	5p13-p12	GHR, GHIP	C	Growth hormone receptor	600946	REa, A		Laron dwarfism, 262500 (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3); Increased responsiveness to growth hormone (3); Growth hormone insensitivity, partial, 604271 (3)	15(Ghr)
5.119	10	23	87	5p13.3	TARS	P	Threonyl-tRNA synthetase	187790	S	linked to LARS		
5.120	7	18	06	5p13-q12	HYT6	P	Hypertension, essential, susceptibility to, 6	610262	Fd		{Hypertension, essential, susceptibility to, 6}, 145500 (2)	
5.121	5	24	13	5p12	ANXA2R, C5orf39, AX2R, AXIIR	P	Annexin A2 receptor	611296	Psh			
5.122	9	9	08	5p12	CCL28	P	Chemokine, C-C motif, ligand 28	605240	REc			13(Ccl28)
5.123	9	9	08	5p13.1	FBXO4, FBX4	C	F-box only protein 4	609090	A, REc			15(Fbxo4)
5.124	7	17	14	5p12	HCN1, BCNG1, EIEE24	P	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1	602780	REc		Epileptic encephalopathy, early infantile, 24, 615871 (3)	
5.125	8	20	07	5p12	PAIP1	P	Polyadenylate-binding protein-interacting protein 1	605184	REc			
5.126	11	20	98	5p13.1	PRKAA1	P	Protein kinase, AMP-activated, catalytic, alpha-1	602739	A			
5.127	5	4	00	5p12	ZNF131	P	Zinc finger protein -31	604073	A			
5.128	4	24	08	5p12	MRPS30	P	Mitochondrial ribosomal protein S30	611991	R, REc			
5.129	5	30	03	5p12	SEPP1	P	Selenoprotein P, plasma, 1	601484	REa, A, R			
5.130	9	12	08	5p	ASD1	P	Atrial septal defect 1	108800	Fd	max lod at D5S406	Atrial septal defect 1 (2)	
5.131	8	4	97	5p	MHS6	P	Malignant hyperthermia susceptibility 6	601888	Fd		{Malignant hyperthermia susceptibility 6} (2)	
5.132	10	20	99	5p13.1	RPL37	P	Ribosomal protein L37	604181	REa, R			
5.133	5	19	06	5q	BSZQTL2	P	Bone size quantitative trait locus 2	609657	Fd		{Bone size QTL} (2)	
5.134	3	5	95	5q11.1	ISL1	P	ISL1 transcription factor, LIM/homeodomain (islet-1)	600366	Fd	between D5S395 and D5S407; proximal 5q		
5.135	10	2	09	5q35.3	PROP1, CPHD2	P	Prophet of Pit1, paired-like homeodomain transcription factor	601538	H, R		Pituitary hormone deficiency, combined, 2, 262600 (3)	11(df, Prop1)
5.136	5	6	13	5q11.2	ANKRD55	P	Ankyrin repeat domain-containing protein 55	615189	REc			
5.137	10	1	95	5q11.2	IL6ST	C	Interleukin-6 signal transducer (gp130, oncostatin M receptor)	600694	A			
5.138	11	4	13	5q11.2	MOCS2, MPTS, MOCODB	P	Molybdenum cofactor synthesis-2	603708	R		Molybdenum cofactor deficiency B, 252160 (3)	
5.139	8	13	98	5q11.2	GZMA, CTLA3, HFSP	C	Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease)	140050	REa			13(Ctla3)
5.140	8	6	15	5q14.1	MSH3	P	mutS, E. coli, homolog of, 3	600887	REn	5' to DHFR	Endometrial carcinoma, somatic, 608089 (3)	13(Msh3)
5.141	2	1	11	5q14.1	ARSB, MPS6	C	Arylsulfatase B	611542	S		Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	13(As1)
5.142	11	16	00	5q13.3	IQGAP2	P	IQ motif-containing GTPase-activating protein-2	605401	Psh			
5.143	3	7	14	5q11.1	EMB, GP70	P	Embigin	615669	REc			
5.144	7	3	01	5q11.2	NDUFS4, AQDQ	P	NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kD (NADH-coenzyme Q reductase)	602694	REa, R		Leigh syndrome, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
5.145	10	4	12	5q11.2	ACTBL2	P	Actin, beta-like, 2	614835	REc			
5.146	7	17	14	5q11.2	CCNO, UNG2, CILD29	C	Cyclin O	607752	Psh, REc		Ciliary dyskinesia, primary, 29, 615872 (3)	
5.147	4	30	09	5q11.2	DHX29	P	DEAH (Asp-Glu-Ala-His) box polypeptide 29	612720	REc			
5.148	6	22	14	5q11.2	ESM1	P	Endothelial cell-specific molecule 1	601521	REc			
5.149	2	20	01	5q11.2	FST, FS	P	Follistatin	136470	A			
5.150	8	18	08	5q11.2	GPBP1, GPBP	P	GC-rich promoter-binding protein 1	608412	REc			
5.151	9	11	14	5q11.2	HSPB3, HSPL27, HMN2C, DHMN2C	P	Heat-shock 27kD protein 3	604624	A	mutation identified in 1 HMN2C family	?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	
5.152	7	22	11	5q11.2	IDAS	P	IDAS	614086	REc			
5.153	5	6	11	5q11.2	IL31RA, GLMR, GPL, PLCA2	P	Interleukin 31 receptor A	609510	REc, H		Amyloidosis, primary localized cutaneous, 2, 613955 (3)	13(Il31ra)
5.154	8	31	09	5q11.2	ITGA1, VLA1	P	Integrin, alpha-1	192968	H, REc			13(Vla1)
5.155	8	29	11	5q11.2	MAP3K1, MEKK1, MEKK, SRXY6	P	Mitogen-activated protein kinase kinase kinase 1	600982	REa, REc		46XY sex reversal 6, 613762 (3)	13(Mekk)
5.156	12	2	09	5q11.2	MIR449A, MIRN449A	C	Micro RNA 449A	613131	REc			
5.157	12	2	09	5q11.2	MIR449B, MIRN449B	P	Micro RNA 449B	613132	REc			
5.158	3	22	01	5q11.2	PELO	P	Pelota, Drosophila, homolog of	605757	A			
5.159	12	28	08	5q13.1-q13.2	SLC30A5, ZNT5, ZTL1	C	Solute carrier family 30 (zinc transporter), member 5	607819	REc			
5.160	3	31	15	5q11.2	SLC38A9, URLC11	P	Solute carrier family 38, member 9	616203	REc			
5.161	7	16	02	5q11.2	DDX4, VASA	P	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 4 (vasa, Drosophila, homolog of)	605281	R, A			13(Ddx4)
5.162	12	19	11	5q12.3	SREK1, SFRS12, SRRp508	P	Splicing regulatory glutamine/lysine-rich protein 1	609268	REc			
5.163	6	7	12	5q12.3	HTR1A, ADRB2RL1, PFMCD	C	5-hydroxytryptamine (serotonin) receptor-1A	109760	REa, A, Fd		Periodic fever, menstrual cycle dependent, 614674 (3)	13(Htr1a)
5.164	12	4	01	5q13.2	TAF9, TAF2G, TAFII32	C	TAF9 RNA polymerase II, TATA box-binding protein-associated factor, 32kD	600822	REa, Psh, A			
5.165	3	31	11	5q14.1	DHFR	C	Dihydrofolate reductase	126060	S, REa, H, D		Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)	13(Dhfr)
5.166	3	5	95	5q13.3	CRHBP	C	Corticotropin releasing hormone-binding protein	122559	Psh			13(Crhbp)
5.167	8	31	09	5q12.3	ADAMTS6	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 6	605008	REa, REc			
5.168	8	24	92	5q13.2	CCNB1	C	Cyclin B1	123836	A, REa			13(Cycb4)
5.169	1	23	13	5q12.3	CD180, LY64, RP105	P	CD180 antigen	602226	A			13(Ly64)
5.170	3	7	14	5q12	DEL5q12, C5DELq12	P	Chromosome 5q12 deletion syndrome	615668	Ch		Chromosome 5q12 deletion syndrome (4)	
5.171	6	11	02	5q12.3	ERBB2IP, ERBIN	C	ERBB2 interacting protein	606944	R, REc			
5.172	5	25	12	5q12.1	ERCC8, CKN1, CSA, UVSS2	C	Excision repair cross-complementing rodent repair deficiency, complementation group 8	609412	Psh		Cockayne syndrome, type A, 216400 (3); UV-sensitive syndrome 2, 614621 (3)	
5.173	2	2	16	5q13.3	GCNT4	P	Glucosyaminyl (N-acetyl) transferase 4, core 2	616782	A			
5.174	6	1	00	5q12.1	PART1	P	Prostate androgen-regulated transcript 1	604991	R, A			
5.175	5	4	12	5q11.2-q12.1	PDE4D, DPDE3, STRK1, ACRDYS2	C	Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3)	600129	REa, A, Fd		{Stroke, susceptibility to, 1}, 606799 (3); Acrodysostosis 2, with or without hormone resistance, 614613 (3)	13(Pde4D)
5.176	8	27	01	5q13.2	ANKRA2, ANKRA	P	Ankyrin repeat-containing protein, family A, member 2	605787	R, Psh			
5.177	8	29	08	5q14.1	CMYA5, MYOSPRYN, TRIM76	P	Cardiomyopathy-associated protein 5	612193	REc			13(Cmya5)
5.178	4	24	96	5q13.2	FOXD1, FKHL8	P	Forkhead box D1	601091	A			
5.179	5	31	05	5q13.2	MCCC2, MCCB	C	3-Methylcrotonyl-CoA carboxylase 2	609014	R		3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	
5.180	8	9	05	5q11.2	PLK2, SNK	P	Polo-like kinase 2	607023	R			
5.181	3	18	94	5q13.2	PMCHL2	P	Pro-melanin-concentrating hormone-like 2	176794	REa, A			
5.182	10	11	07	5q12-q14	EJM4	P	Myoclonic epilepsy, juvenile, 4	611364	Fd	max lod at D5S459	Myoclonic epilepsy, juvenile, 4 (2)	
5.183	10	12	10	5q14.2-q14.3	VCAN, CSPG2, WGN, WGN1, ERVR	C	Versican (chondroitin sulfate proteoglycan-2)	118661	REa, A, H, Fd		Wagner syndrome 1, 143200 (3)	13(Cspg2)
5.184	11	3	14	5q12.1	DEPDC1B	P	DEP domain-containing protein 1B	616073	REc			
5.185	2	1	11	5q12.1	DIMT1L, DIM1, HUSSY5	P	Dimethyladenosine transferase 1-like	612499	REc	previously assigned to 8p12		
5.186	1	30	12	5q12.1	ELOVL7	P	Elongation of very long chain fatty acids-like 6	614451	REc			
5.187	3	29	07	5q12.1	IPO11, RANBP11, SLRN	P	Importin 11	610889	REc			
5.188	9	23	13	5q12.1	KIF2A, CDCBM3	P	Kinesin, heavy chain, 2	602591	R		Cortical dysplasia, complex, with other brain malformations 3, 615411 (3)	
5.189	4	24	08	5q13.2	MRPS36	P	Mitochondrial ribosomal protein S36	611996	REc	6 pseudogenes		
5.190	1	27	11	5q12.1	NDUFAF2, NDUFA12L, MMTN, B17.2L	P	NADH dehydrogenase 1 alpha subcomplex, assembly factor 2	609653	REc	pseudogene on chr.2	Mitochondrial complex I deficiency, 252010 (3); Leigh syndrome, 256000 (3)	
5.191	9	20	14	5q12.1	ZSWIM6, KIAA1577, AFND	C	Zinc finger SWIM domain-containing protein 6	615951	Psh, REc		Acromelic frontonasal dysostosis, 603671 (3)	
5.192	2	28	03	5q13.2	BIRC1, NAIP	C	Baculoviral IAP repeat-containing 1 (neuronal apoptosis inhibitory protein)	600355	REn, H	?involved in SMA		13(Naip)
5.193	4	19	01	5q14.1	DMGDH, DMGDHD	P	Dimethylglycine dehydrogenase	605849	A		Dimethylglycine dehydrogenase deficiency, 605850 (3)	
5.194	4	21	97	5q13.2	GTF2H2	P	General transcription factor IIH, polypeptide 2 (44kD subunit)	601748	REc	2 copies		
5.195	9	28	00	5q13.2	SERF1A, H4F5, SMAM1	P	Small EDRK-rich factor 1A	603011	REc, D			13(M4f5)
5.196	9	30	03	5q13.2	SMN1, SMA1, SMA2, SMA3, SMA4	C	Survival of motor neuron 1, telomeric	600354	REn		Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2, 253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)	13(Smn)
5.197	10	13	09	5q12.3	NLN, KIAA1226, AGTBP	P	Neurolysin	611530	R, REc			
5.198	3	29	07	5q12.3	RGS7BP, R7BP	P	Regulator of G protein signaling 7-binding protein	610890	REc			13(Rgs7bp)
5.199	7	14	14	5q12.3	TRIM23, ARD1	P	Tripartite motif-containing protein 23	601747	REc			
5.200	9	22	14	5q12.3	RNF180, RINES	P	RING finger protein 180	616015	REc			
5.201	10	12	09	5q13.2	SMN2	P	Survival of motor neuron 2, centromeric	601627	REn		{Spinal muscular atrophy, type III, modifier of}, 253400 (3)	
5.202	9	30	02	5q13.2	BDP1, TFNR	P	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	607012	A			
5.203	12	11	01	5q13.3	EFG2	P	Elongation factor G2	606544	REc			
5.204	9	20	00	5q13.3	ENC1, PIG10	P	Ectodermal-neural cortex 1	605173	A			13(Enc1)
5.205	11	4	93	5q13.3	F2R, CF2R, PAR1	C	Coagulation factor II (thrombin) receptor	187930	A, R, REc	within 900kb of GPR11		13(Cf2r)
5.206	6	28	00	5q13.3	F2RL1, GPR11, PAR2	C	Cooagulation factor II, thrombin, receptor-like 1 (G protein-coupled receptor-11)	600933	A, R, REc	within 900kb of F2R		
5.207	8	24	98	5q13.3	F2RL2, PAR3	P	Coagulation factor II receptor-like 2 (protease-activated receptor 3)	601919	REn	order: PAR2-PAR1-PAR3		
5.208	11	23	09	5q13.3	HEXB	C	Hexosaminidase B, beta polypeptide	606873	S, Ch, D		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	13(Hex2)
5.209	3	22	93	5q13.2	MAP1B	C	Microtubule-associated protein-1B	157129	A, Fd			
5.210	8	25	11	5q13.3	PDE8B, PPNAD3, ADSD	C	Phosphodiesterase 8B	603390	R, Fd		Pigmented nodular adrenocortical disease, primary, 3, 614190 (3); Striatal degeneration, autosomal dominant, 609161 (3)	
5.211	9	22	14	5q13.1	PIK3R1, GRB1, AGM7, SHORT, IMD36	P	Phosphatidylinositol 3-kinase, regulatory, 1	171833	REa, A	mutation identified in 1 AGM7 family	?Agammaglobulinemia 7, autosomal recessive, 615214 (3); SHORT syndrome, 269880 (3); Immunodeficiency 36, 616005 (3)	13(Pik3r1)
5.212	7	16	09	5q11.2	RAB3C	P	Ras-associated protein RAB3C	612829	REc			
5.213	10	20	99	5q13.2	RAD17	C	RAD17, S. pombe, homolog of	603139	A, H			13(Rad17)
5.214	12	11	02	5q14.1	RASGRF2	P	Ras protein-specific guanine nucleotide-releasing factor 2	606614	A			13(Rasgrf2)
5.215	9	22	08	5q13	TSHQTL1	P	Thyroid-stimulating hormone level QTL 1	612306	Fd	associated with rs4704397	[Thyroid-stimulating hormone level QTL 1] (2)	
5.216	7	12	02	5q13-q14	AAT2, FAA2	P	Aortic aneurysm, familial thoracic 2	607087	Fd		Aortic aneurysm, familial thoracic 2 (2)	
5.217	9	3	15	5q14.2	XRCC4, SSMED	C	X-ray repair, complementing defective, repair in Chinese hamster cells-4	194363	S, REa, R	between D5S427 and D5S401	Short stature, microcephaly, and endocrine dysfunction, 616541 (3)	
5.218	4	24	02	5q13-q22	GINGF2, GGF2, HGF2	P	Fibromatosis, gingival, 2	605544	Fd	formerly GINGF2 used for a locus on 2p16-p13	Fibromatosis, gingival, 2 (2)	
5.219	9	21	11	5q14.3	HAPLN1, CRTL1	P	Hyaluronan and proteoglycan link protein 1	115435	A			
5.220	9	5	91	5q21.3	RPS20A	P	Ribosomal protein S20A	180463	REa	?pseudogene		
5.221	12	29	06	5q13.2	MARVELD2, MARVD2, TRIC, DFNB49	C	Marvel domain-containing protein 2 (tricellulin)	610572	REc, Fd, REc		Deafness, autosomal recessive 49, 610153 (3)	13(tric)
5.222	1	27	11	5q13.2	OCLN, BLCPMG	C	Occludin	602876	R, REc		Band-like calcification with simplified gyration and polymicrogyria, 251290 (3)	
5.223	2	20	01	5q13.3	POLK, POLQ, DINB1	P	Polymerase, DNA, kappa	605650	REa, A			
5.224	4	30	09	5q14.1	BHMT	P	Betaine-homocysteine methyltransferase	602888	REn			
5.225	5	7	01	5q14.1	BHMT2	P	Betaine-homocysteine methyltransferase 2	605932	A, R			13(Bhmt2)
5.226	5	5	15	5q13.2	CARTPT, CART	P	Cocaine- and amphetamine-regulated transcript prepropeptide	602606	REc	mutation identified in 1 family	{?Obesity, susceptibility to}, 601665 (3)	
5.227	3	24	11	5q13.2	CCDC125, KENAE	P	Coiled-coil domain-containing protein 125	613781	REc			
5.228	2	24	98	5q13.2	CDK7, STK1, CAK1	P	Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase)	601955	REa, REc	previously mapped to 2p15-cen		
5.229	4	10	14	5q13.2	CENPH	P	Centromeric protein H	605607	REc			
5.230	9	7	10	5q13.2	FCHO2	P	FCH domain-only protein 2	613438	REc			
5.231	11	5	99	5q14.1	JMY	P	Junction-mediating and regulatory protein	604279	A			
5.232	4	24	08	5q13.2	MRPS27, KIAA0264	P	Mitochondrial ribosomal protein S27	611989	R, REc			
5.233	11	10	13	5q13.2	PTCD2	P	Pentatricopeptide repeat domain-containing protein 2	615484	REc			
5.234	5	26	09	5q13.2	RGNEF, p190RHOGEF	P	Rgnef, mouse, homolog of	612790	REc			
5.235	12	10	12	5q13.2	TMEM174	P	Transmembrane protein 174	614909	REc			
5.236	4	19	06	5q13.2	TNPO1, KPNB2, MIP1	P	Transportin 1	602901	R			
5.237	2	4	15	5q13.2	UTP15	P	UTP15, U3 small nucleolar ribonucleoprotein, S. cerevisiae, homolog of	616194	REc			
5.238	4	6	15	5q13.2	ZNF366, DCSCRIPT	P	Zinc finger protein 366	610159	REc			
5.239	1	8	07	5q13.3	AGGF1, VG5Q, HUS84971, FLJ10283	P	Angiogenic factor with G patch and FHA domains 1	608464	Ch			
5.240	1	2	95	5q14.1	CKMT2	C	Creatine kinase, mitochondrial-2 (sarcomeric)	123295	Psh, A			
5.241	5	11	15	5q13.3	COL4A3BP, GPBP, CERT, MRD34	P	COL4A3-binding protein (ceramide transporter)	604677	REc		Mental retardation, autosomal dominant 34, 616351 (3)	
5.242	5	22	14	5q13.3	FAM169A, SLAP75, KIAA0888	P	Family with sequence similarity 169, member A	615769	REc			
5.243	3	8	00	5q14.1	OTP	C	Orthopedia, Drosophila, homolog of	604529	R, A			
5.244	10	29	09	5q14.3	RASA1, GAP, CMAVM, PKWS	C	RAS p21 protein activator 1 (GTPase activating protein)	139150	REa, A		Parkes Weber syndrome, 608355 (3); Capillary malformation-arteriovenous malformation, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)	13(Gap)
5.245	7	3	06	5q13.3	S100Z	P	S100 calcium-binding protein, zeta	610103	REc			
5.246	12	4	02	5q14.1	SSBP2	P	Single-stranded DNA-binding protein 2	607389	REc			
5.247	8	3	12	5q13.3	SV2C	P	Synaptic vesicle glycoprotein 2C	610291	REc			
5.248	12	22	08	5q13.3	TINP1, NSA2, HUSSY29	P	Transforming growth factor-beta-inducible nuclear protein 1	612497	REc			
5.249	5	31	13	5q13.3	ZBED3	P	Zinc finger BED domain-containing protein 3	615250	REc			
5.250	6	19	98	5q14.3	CCNH, CAK	P	Cyclin H	601953	REa, A, REc			
5.251	5	18	09	5q13.3	HMGCR, LDLCQ3	C	3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase	142910	REa, A		[Statins, attenuated cholesterol lowering by] (3); [Low density lipoprotein cholesterol level QTL 3] (3)	13(Hmgcr)
5.252	5	13	02	5q14.1	SCAMP1, SCAMP37	P	Secretory carrier membrane protein 1	606911	R			
5.253	6	15	99	5q14.3	COX7C	P	Cytochrome C oxidase, subunit VII C	603774	A, R	pseudogene on 13q14-q21		
5.254	4	1	96	5q15	GLRX, GRX	P	Glutaredoxin (thioltransferase)	600443	REa, A			
5.255	6	5	13	5q14	HBT	P	Telangiectasia, hereditary benign	187260	Fd	max lod at D5S641	Telangiectasia, hereditary benign (2)	
5.256	7	8	10	5q14.3	MEF2C, C5DELq14.3, DEL5q14.3	C	MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)	600662	A, REa		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3); Chromosome 5q14.3 deletion syndrome, 613443 (4)	13(mef2c)
5.257	7	7	14	5q15	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	P	Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1)	132890	A		Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	13(Tcfcoup1)
5.258	2	28	94	5q21.1	PAM	P	Peptidylglycine alpha-amidating monooxygenase	170270	REa, A			1(Pam)
5.259	10	28	11	5q14.1	ACOT12, CACH	P	Acyl-CoA thioesterase 12	614315	REc			13(Acot12)
5.260	5	31	05	5q14.1	AP3B1, ADTB3A, HPS2	P	Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a)	603401	REc		Hermansky-Pudlak syndrome 2, 608233 (3)	13(Ap3bi, pe)
5.261	12	28	08	5q14.1	LHFPL2, KIAA0206	C	LHFP-like protein 2	609718	R, REc			
5.262	7	27	11	5q14.1	PAPD4, GLD2	P	Poly(A) polymerase-associated domain-containing protein 4	614121	REc			
5.263	4	2	12	5q14.1	SERINC5, C5orf12, TPO1	P	Serine incorporator 5	614551	REc			
5.264	9	16	12	5q14.1	ZFYVE16, ENDOFIN, KIAA0305	P	Zinc finger FYVE domain-containing protein 16	608880	REc			
5.265	5	9	12	5q14.1-q21.3	KTCN5	P	Keratoconus 5	614622	Fd	between D5S2499 and D5S495	Keratoconus 5 (2)	
5.266	3	8	07	5q14.1-q14.2	ATG10, APG10	P	Autophagy 10, S. cerevisiae, homolog of	610800	R, REc			
5.267	7	9	06	5q14.1	HOMER1, HOMER1B, HOMER1C, HOMER1A	P	Homer, homlog 1 (Drosophila)	604798	R			
5.268	11	3	11	5q14.2	RPS23	P	Ribosomal protein S23	603683	Psh, R, REc			
5.269	4	2	16	5q14.2	SCARNA18	P	Small cajal body-specific RNA 18	611329	REc	in intron 1 of TMEM167		
5.270	11	3	11	5q14.2	VUR4	P	Vesicoureteral reflux 4	614317	Fd	closest marker rs1501656	Vesicoureteral reflux 4 (2)	
5.271	5	13	02	5q15	LNPEP	P	Leucyl-cystinyl aminopeptidase	151300	A			
5.272	12	24	08	5q14.3	ARRDC3, TLIMP, KIAA1376	P	Arrestin domain-containing 3	612464	REc			
5.273	1	4	16	5q14.3	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	C	Adhesion G protein-coupled receptor V1	602851	A, REc, R, Fd	mutation identified in 1 FEB4 family	?Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type 2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	13(Frings, mass1)
5.274	5	25	13	5q14.3	CETN3, CDC31	P	Centrin 3	602907	REc			
5.275	10	23	15	5q14.3	LINC00461, VISC	P	Long intergenic noncoding RNA 461	616611	REc			
5.276	3	23	09	5q14.3	MIR9-2, MIRN9-2	P	Micro RNA 9-2	611187	REc			
5.277	5	6	03	5q15	RHOBTB3, KIAA0878	P	Rho-related BTB domain-containing protein 3	607353	REc			
5.278	10	31	13	5q14.3-q15	PVNH5	P	Periventricular nodular heterotopia 5	612881	Ch	deletion range 6.3-17Mb, common range 5.8Mb	Periventricular nodular heterotopia 5 (4)	
5.279	5	19	06	5q15	ARSK	P	Arylsulfatase K	610011	REc			
5.280	6	10	08	5q15	ELL2	P	Elongation factor, RNA polymerase II, 2	601874	R, REc			
5.281	6	10	08	5q15	ERAP1, ALAP, ARTS1, PILSAP, KIAA0525	P	Endoplasmic reticulum aminopeptidase 1	606832	REc			
5.282	12	30	09	5q15	ERAP2, LRAP	P	Endoplasmic reticulum aminopeptidase 2	609497	REc			
5.283	5	24	13	5q15	LIX1	P	Limb expression 1, mouse, homolog of	610466	REc			
5.284	4	7	15	5q15	MCTP1	P	Multiple C2 domains-containing transmembrane protein 1	616296	REc			
5.285	4	27	12	5q15	TTC37, KIAA0372	P	Tetratricopeptide repeat domain 37	614589	REc		Trichohepatoenteric syndrome 1, 222470 (3)	
5.286	4	7	15	5q15	CAST, PLACK	P	Calpastatin	114090	A, REb		Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3)	
5.287	5	29	98	5q15-q21	CHD1	P	Chromodomain helicase DNA binding protein-1	602118	REc			
5.288	10	29	08	5q15	PCSK1, NEC1, PC1, PC3, BMIQ12	P	Proprotein convertase subtilisin/kexin type 1	162150	A		Obesity with impaired prohormone processing, 600955 (3); {Obesity, susceptibility to, BMIQ12}, 612362 (3)	13(Nec1)
5.289	11	30	06	5q35.2	CPEB4, KIAA1673	P	Cytoplasmic polyadenylation element-binding protein 4	610607	REa, REc			
5.290	12	5	13	5q22.2	MCC	C	Mutated in colorectal cancers	159350	REn, D		Colorectal cancer, somatic, 114500 (3)	18(Mcc)
5.291	9	14	05	5q21	MGR8	P	Migraine, susceptibility to, 8	609570	Fd		{Migraine, susceptibility to, 8} (2)	
5.292	7	14	98	5q21.1	PST, PST1	P	Polysialyltransferase	602547	A			
5.293	1	24	06	5q22.2	DCP2	C	Decapping enzyme 2, S. cerevisiae, homolog of	609844	REc			
5.294	2	27	01	5q23.1	DMXL1	P	DMX-like 1	605671	A, R			
5.295	4	30	91	5q21.3	FER, TYK3	C	fer (fps/fes related) tyrosine kinase	176942	REa, A			11(Fert)
5.296	10	26	97	5q21.3	MAN2A1, MANA2	P	Mannosidase, alpha, class 2A, member 1	154582	REa, A			
5.297	5	27	93	5q22.2	SRP19	C	Signal recognition particle 19kD	182175	REn	within 100kb of APC		
5.298	12	4	90	5q22.1	CAMK4	P	Ca(2+)-calmodulin-dependent protein kinase type IV of brain	114080	REa, A, H			18(Camk4)
5.299	10	23	15	5q21.1	C5orf30	P	Chromosome 5 open reading frame 30	616608	REc			
5.300	12	18	07	5q21.1	HISPPD1, PPIP5K2, VIP2, KIAA0433	P	Histidine acid phosphatase domain-containing protein 1	611648	R, REc			
5.301	3	31	09	5q15	RGMB, DRAGON	P	RGM domain family, member B	612687	R, REc			
5.302	6	13	12	5q21.1	SLCO4C1, OATP4C1	P	Solute carrier organic anion transporter family, member 4C1	609013	REc			
5.303	4	20	10	5q21.1	SLCO6A1, GST	P	Solute carrier organic anion transporter family, member 6A1	613365	REc			
5.304	8	9	01	5q22.3	KCNN2, SK2	P	Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 2	605879	REc			
5.305	9	9	08	5q21.3	FBXL17, FBL17, FBX13, FBXO13	P	F-box and leucine-rich repeat protein 17	609083	REc			17(Fbxl17)
5.306	8	18	04	5q23.1	FTMT	P	Ferritin, mitochondrial	608847	REc			
5.307	3	22	06	5q22.1	WDR36, TAWDRP, GLC1G	P	WD repeat-containing protein 36	609669	REc		Glaucoma 1, open angle, G, 609887 (3)	
5.308	11	17	14	5q21.3-q33.2	MDBS2	P	Macular dystrophy, butterfly-shaped pigmentary, 2	608970	Fd	between D5S433 and D5S410	Macular dystrophy, butterfly-shaped pigmentary, 2 (2)	
5.309	7	8	10	5q22	EOE2	P	Esophagitis, eosinophilic, 2	613412	Fd	association with rs3806932	{Esophagitis, eosinophilic, 2} (2)	
5.310	6	28	02	5q22.1	STARD4	P	Start domain-containing protein 4	607049	REc			
5.311	1	22	07	5q22.2	TSSK1, STK22D	P	Testis-specific serine/threonine kinase 1	610709	REc	pseudogene on chr22		16(Tssk1)
5.312	7	10	08	5q22.1-q22.2	EPB41L4A, EPB41L4, NBL4	P	Erythrocyte membrane protein band 4.1-like 4A	612141	A			
5.313	9	28	96	5q22.2	ZRSR1, U2AF1RS1	P	Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 1	601079	A			11(U2af1rs1)
5.314	8	9	99	5q22.3	CDO1	P	Cysteine dioxygenase, type 1	603943	Psh, A			18(Cdo1)
5.315	3	22	06	5q22.2	REEP5, D5S346, DP1, C5orf18	P	Receptor expression-enhancing protein 5	125265	REn			
5.316	8	31	09	5q22.1	C5orf13, P311, PTZ17	P	P311 protein	607332	R, REc			
5.317	9	9	08	5q22.1	TSLP	P	Thymic stromal lymphopoietin	607003	R			18(Tslp)
5.318	10	30	06	5q22.1-q32	GLC1M	P	Glaucoma 1, open angle, M	610535	Fd	between D5S2051 and D5S2090	Glaucoma 1, open angle, M (2)	
5.319	8	7	15	5q22.1	SLC25A46, HMSN6B	P	Solute carrier family 25, member 46	610826	REc		Neuropathy, hereditary motor and sensory, type VIB, 616505 (3)	8(Slc25a46)
5.320	11	21	14	5q22.2	APC, GS, FPC, BTPS2	C	Adenomatous polyposis coli	611731	D, Fd, REn	150kb distal to MCC	Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic, 613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3); Gardner syndrome, 175100 (3)	18(Min, Apc)
5.321	11	13	13	5q22.3	PGGT1B	P	Protein geranylgeranyltransferase type I, beta subunit	602031	REc			
5.322	7	1	05	5q22.3	TRIM36, RBCC728	C	Tripartite motif-containing protein 36	609317	R, REc			
5.323	8	3	00	5q35.3	ADAMTS2, NPI	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase)	604539	REa, H		Ehlers-Danlos syndrome, type VIIC, 225410 (3)	11(Adamts2)
5.324	3	16	99	5q31.1	CAMLG	P	Calcium-modulating cyclophilin ligand	601118	A			13(Camlg)
5.325	10	28	99	5q23.2	CSNK1G3	P	Casein kinase I, gamma-3	604253	R, A			
5.326	5	19	06	5q31.3	HBEGF, DTR, DTSF, HEGFL	C	Heparin-binding EGF-like growth factor (diphtheria toxin receptor)	126150	S, M		{Diphtheria, susceptibility to} (1)	18(Hegfl)
5.327	5	15	01	5q23.2	SNX2	P	Sorting nexin 2	605929	R			
5.328	12	4	14	5q23.3	FBN2, CCA, EOMD	P	Fibrillin-2	612570	Fd, A		Contractural arachnodactyly, congenital, 121050 (3); Macular degeneration, early-onset, 616118 (3)	18(Fbn2)
5.329	9	13	11	5q11.2	ITGA2, CD49B, BR, BDPLT9	P	Integrin, alpha-2 (CD49B; alpha-2 subunit of VLA-2 receptor; platelet antigen Br)	192974	S, Psh, A		?Glycoprotein Ia deficiency, 614200 (1)	
5.330	11	29	00	5q31.1	NEUROG1, NEUROD3	P	Neurogenin 1	601726	A			13(Neurod3)
5.331	6	15	99	5q31.2	NME5, NM23H5	P	Nonmetastatic cells 5, protein expressed in (nonmetastatic protein 23, homolog 5)	603575	R			
5.332	7	11	93	5q31.1	PPP2CA	P	Protein phosphatase-2 (formerly 2A), catalytic subunit, alpha isoform	176915	REa, A			
5.333	10	28	96	5q31.1	UBE2B, RAD6B	P	Ubiquitin-conjugating enzyme E2B (RAD6 homolog)	179095	A		?Male infertility (1)	
5.334	6	4	99	5q31.2	NRG2	P	Neuregulin 2	603818	R, REc			
5.335	8	18	98	5q33.3	FABP6, ILLBP	P	Fatty acid-binding protein 6, ileal (gastrotropin)	600422	H, REa			11(Illbp)
5.336	5	5	09	5q23-q35	SCZD1	P	Schizophrenia susceptibility locus, chromosome 5-related	181510	max lod at D5S820		{Schizophrenia}, 181500 (2)	
5.337	2	1	11	5q22.3-q23.1	AP3S1, CLAPS3	P	Adaptor-related protein complex 3, sigma 1 subunit	601507	REc	previously assigned to chr. 12 by FISH		
5.338	12	22	15	5q23.1	COMMD10	P	COMM domain-containing protein 10	616704	REc			
5.339	5	8	13	5q23.1	HSD17B4, PRLTS1	P	Hydroxysteroid (17-beta) dehydrogenase 4	601860	A		D-bifunctional protein deficiency, 261515 (3); Perrault syndrome 1, 233400 (3)	
5.340	6	9	06	5q23.1	LVRN	P	Laeverin	610046	R, REc			
5.341	8	18	14	5q23.1	PRR16, LARGEN	P	Proline-rich protein 16	615931	REc			
5.342	4	21	15	5q23.1	SEMA6A	P	Semaphorin 6A	605885	REc			
5.343	3	14	07	5q23.1	SRFBP1, P49	P	Serum response factor binding protein 1	610479	R, REc			
5.344	12	8	03	5q22.3	TIRP, TRAM	P	Toll/interleukin-1 receptor domain-containing protein	608321	REc			
5.345	6	30	08	5q23.1	TNFAIP8, SCCS2	P	Tumor necrosis factor-alpha-induced protein 8	612111	R, REc			
5.346	3	15	10	5q23.2	SNCAIP	C	Synuclein-alpha-interacting protein (synphilin 1)	603779	R			
5.347	4	10	15	5q23.2	CEP120, CCDC100, SRTD13	P	Centrosomal protein, 120kD	613446	REc		Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3)	
5.348	11	11	13	5q23.2	LMNB1, ADLD	C	Lamin B1	150340	H, A, Fd, REc		Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	18(Lmnb)
5.349	6	7	10	5q23.2	MARCH3	P	Membrane-associated RING-CH finger protein 3	613333	REc			
5.350	5	4	12	5q23.2	MEGF10, KIAA1780, EMARDD	P	Multiple epidermal growth factor-like domains 10	612453	REc		Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3); Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	
5.351	8	31	09	5q23.2	PPIC	P	Peptidyl-prolyl isomerase C	123842	R, REc			
5.352	3	31	15	5q23.2	RNUXA, PHAX	P	RNA, U small nuclear, export adaptor	604924	REc			
5.353	11	30	06	5q31.1	FNIP1, KIAA1961	P	Folliculin-interacting protein 1	610594	REc			
5.354	3	3	16	5q23.3-q31.1	LYRM7, MZM1L, MC3DN8	P	LYR motif-containing protein 7	615831	REc		Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	
5.355	11	20	95	5q23.3	SLC12A2, NKCC1	P	Solute carrier family 12 (sodium/potassium/chloride transporters), member 2	600840	A			
5.356	2	27	01	5q31.3	RNF14, ARA54	P	RING finger protein-14	605675	REa, R			
5.357	5	19	97	5q23.1	LOX	C	Lysyl oxidase	153455	REa, A			18(Lox)
5.358	9	18	08	5q31.1	ACSL6, FACL6, ACS2	P	Acyl-CoA synthetase long-chain family member 6	604443	Ch		Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)	
5.359	8	31	12	5q23.3	ADAMTS19	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 19	607513	REc			
5.360	5	19	15	5q31.1	AFF4, AF5Q31, CHOPS	P	AF4/FMR2 family, member 4	604417	Ch		CHOPS syndrome, 616368 (3)	
5.361	3	26	07	5q23.2	ALDH7A1, ATQ1, EPD, PDE	C	Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1)	107323	A, Fd		Epilepsy, pyridoxine-dependent, 266100 (3)	18(Atq1)
5.362	8	31	09	5q31.3	APBB3, FE65L2	P	Amyloid beta (A4) precursor protein-binding, family B, member 3	602711	R, REc			
5.363	8	27	15	5q31.3	ARHGAP26, GRAF	C	RHO GTPase-activating protein 26	605370	Ch, A		Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	
5.364	3	22	93	5q31.2	CDC25C	C	Cell division cycle 25C	157680	A, REn			
5.365	2	16	04	5q31.1	CDKL3, NKIAMRE	P	Cyclin-dependent kinase-like 3	608459	A			
5.366	4	13	10	5q23.3	CHSY3, CSS3	P	Chondroitin sulfate synthase 3	609963	REc			
5.367	4	8	16	5q31.2	CTNNA1, MDPT2	C	Catenin (cadherin-associated protein), alpha 1, 102kD	116805	A, REa		Macular dystrophy, patterned, 2, 608970 (3)	18(Catna1)
5.368	8	28	02	5q31.1	CXCL14, SCYB14, BRAK	P	Chemokine, C-X-C motif, ligand 14	604186	REc			
5.369	11	13	15	5q31.3	DIAPH1, DFNA1, LFHL1, SCBMS	C	Diaphanous, Drosophila, homolog of, 1	602121	Fd, REc		Deafness, autosomal dominant 1, 124900 (3); Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	
5.370	2	20	14	5q31	DFNA54	P	Deafness, autosomal dominant 54	615649	Fd	between D5S1972 and D5S410	Deafness, autosomal dominant 54 (2)	
5.371	4	29	14	5q31.2	ECSCR, ECSM2, ARIA	P	Endothelial cell surface-expressed chemotaxis and apoptosis regulator	615736	A, REc			
5.372	6	10	94	5q31.3	FGF1, FGFA	C	Fibroblast growth factor-1 (acidic)	131220	REa, A, D			
5.373	3	2	01	5q31.2	GFRA3	C	GDNF family receptor alpha-3	605710	A			
5.374	2	19	10	5q31.3	GNPDA1, GNP1, GNPI, KIAA0060	P	Glucosamine 6-phosphate deaminase 1	601798	A			
5.375	8	15	00	5q31.3	HDAC3	C	Histone deacetylase 3	605166	A			
5.376	10	11	05	5q31.2	HNRPA0	P	Heterogeneous nuclear ribonucleoprotein A0	609409	REc			
5.377	1	31	02	5q31	IBD5	C	Inflammatory bowel disease 5	606348	Fd		{Inflammatory bowel disease 5} (2)	
5.378	10	30	03	5q31.1	IL13, ALRH, BHR1	C	Interleukin-13	147683	REn, Fd		{Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis, susceptibility to}, 607154 (3)	
5.379	10	24	11	5q31.2	KDM3B, C5orf7, KIAA1082, JMJD1B	C	Lysine-specific demethylase 3B	609373	R, REc			
5.380	12	29	00	5q31.1	KIF3A	P	Kinesin family member 3A	604683	R			
5.381	3	12	03	5q31.2	KIF20A, RAB6KIFL	P	Kinesin family member 20A	605664	REc			
5.382	2	27	12	5q31.2	KLHL3, PHA2D	P	Kelch-like 3	605775	REc		Pseudohypoaldosteronism, type IID, 614495 (3)	
5.383	10	14	98	5q31.1	MADH5, SMAD5	P	Mothers against decapentaplegic, Drosophila, homolog of, 5	603110	REa, REc			
5.384	7	17	14	5q35.1	NEURL1B, NEUR2	P	Neuralized E3 ubiquitin protein ligase 1B	615893	REc			17(Neurl1b)
5.385	1	31	07	5q33.1	MYOZ3, FRP3	P	Myozenin 3	610735	REc			
5.386	2	18	98	5q31.2	NPY6R, PP2	C	Neuropeptide Y receptor Y6	601770	A, H	?nonfunctional pseudogene		18(Npy6r)
5.387	9	5	14	5q31.3	NR3C1, GCR, GRL, GCRST	C	Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	138040	S, REa, Fd, H, A, D, REn		Glucocorticoid resistance, 615962 (3)	18(Grl1)
5.388	11	2	04	5q31.1	P4HA2	P	Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2	600608	REc			
5.389	2	6	01	5q31.3	PCDH12, VECAD2	P	Protocadherin 12 (cadherin, vascular endothelial, 2)	605622	REc			
5.390	5	24	00	5q31	PCDHA@	P	Protocadherin-alpha gene cluster	604966	REc			
5.391	10	2	01	5q31.3	PCDHA1	P	Protocadherin-alpha 1	606307	REc			
5.392	10	2	01	5q31.3	PCDHA2	P	Protocadherin-alpha 2	606308	REc			
5.393	10	1	01	5q31.3	PCDHA3	P	Protocadherin-alpha 3	606309	REc			
5.394	10	2	01	5q31.3	PCDHA4	P	Protocadherin-alpha 4	606310	REc			
5.395	10	2	01	5q31.3	PCDHA5	P	Protocadherin-alpha 5	606311	REc			
5.396	10	2	01	5q31.3	PCDHA6	P	Protocadherin-alpha 6	606312	REc			
5.397	10	2	01	5q31.3	PCDHA7	P	Protocadherin-alpha 7	606313	REc			
5.398	10	2	01	5q31.3	PCDHA8	P	Protocadherin-alpha 8	606314	REc			
5.399	10	2	01	5q31.3	PCDHA9	P	Protocadherin-alpha 9	606315	REc			
5.400	10	2	01	5q31.3	PCDHA10	P	Protocadherin-alpha 10	606316	REc			
5.401	10	2	01	5q31.3	PCDHA11	P	Protocadherin-alpha 11	606317	REc			
5.402	10	2	01	5q31.3	PCDHA12	P	Protocadherin-alpha 12	606318	REc			
5.403	10	2	01	5q31.3	PCDHA13	P	Protocadherin-alpha 13	606319	REc			
5.404	10	2	01	5q31.3	PCDHAC1	P	Protocadherin-alpha, subfamily C, member 1	606320	REc			
5.405	10	2	01	5q31.3	PCDHAC2	P	Protocadherin-alpha, subfamily C, member 2	606321	REc			
5.406	5	24	00	5q31	PCDHB@	P	Protocadherin-beta gene cluster	604967	REc			
5.407	10	2	01	5q31.3	PCDHB1	P	Protocadherin-beta 1	606327	REc			
5.408	10	2	01	5q31.3	PCDHB2	P	Protocadherin-beta 2	606328	REc			
5.409	10	2	01	5q31.3	PCDHB3	P	Protocadherin-beta 3	606329	REc			
5.410	10	2	01	5q31.3	PCDHB4	P	Protocadherin-beta 4	606330	REc			
5.411	10	2	01	5q31.3	PCDHB5	P	Protocadherin-beta 5	606331	REc			
5.412	10	2	01	5q31.3	PCDHB6	P	Protocadherin-beta 6	606332	REc			
5.413	10	2	01	5q31.3	PCDHB7	P	Protocadherin-beta 7	606333	REc			
5.414	10	2	01	5q31.3	PCDHB8	P	Protocadherin-beta 8	606334	REc			
5.415	10	2	01	5q31.3	PCDHB9	P	Protocadherin-beta 9	606335	REc			
5.416	10	2	01	5q31.3	PCHB10	P	Protocadherin-beta 10	606336	REc			
5.417	10	2	01	5q31.3	PCDHB11	P	Protocadherin-beta 11	606337	REc			
5.418	10	2	01	5q31.3	PCDHB12	P	Protocadherin-beta 12	606338	REc			
5.419	10	2	01	5q31.3	PCDHB13	P	Protocadherin-beta 13	606339	REc			
5.420	10	2	01	5q31.3	PCDHB14	P	Protocadherin-beta 14	606340	REc			
5.421	10	2	01	5q31.3	PCDHB15	P	Protocadherin-beta 15	606341	REc			
5.422	10	2	01	5q31.3	PCDHB16	P	Protocadherin-beta 16	606345	REc			
5.423	5	24	00	5q31	PCDHG	P	Protocadherin-gamma gene cluster	604968	REc			
5.424	10	2	01	5q31.3	PCDHGA1	P	Protocadherin-gamma, subfamily A, member 1	606288	REc			
5.425	10	2	01	5q31.3	PCDHGA2	P	Protocadherin-gamma, subfamily A, member 2	606289	REc			
5.426	10	2	01	5q31.3	PCDHGA3	P	Protocadherin-gamma, subfamily A, member 3	606290	REc			
5.427	10	2	01	5q31.3	PCDHGA4	P	Protocadherin-gamma, subfamily A, member 4	606291	REc			
5.428	10	2	01	5q31.3	PCDHGA5	P	Protocadherin-gamma, subfamily A, member 5	606292	REc			
5.429	10	2	01	5q31.3	PCDHGA6	P	Protocadherin-gamma, subfamily A, member 6	606293	REc			
5.430	10	2	01	5q31.3	PCDHGA7	P	Protocadherin-gamma, subfamily A, member 7	606294	REc			
5.431	10	2	01	5q31.3	PCDHGA8	P	Protocadherin-gamma, subfamily A, member 8	606295	REc			
5.432	10	2	01	5q31.3	PCDHGA9	P	Protocadherin-gamma, subfamily A, member 9	606296	REc			
5.433	10	2	01	5q31.3	PCDHGA10	P	Protocadherin-gamma, subfamily A, member 10	606297	REc			
5.434	10	2	01	5q31.3	PCDHGA11	P	Protocadherin-gamma, subfamily A, member 11	606298	REc			
5.435	10	2	01	5q31.3	PCDHGA12	P	Protocadherin-gamma, subfamily A, member 12	603059	REc			
5.436	10	2	01	5q31.3	PCDHGB1	P	Protocadherin-gamma, subfamily B, member 1	606299	REc			
5.437	10	2	01	5q31.3	PCDHGB2	P	Protocadherin-gamma, subfamily B, member 2	606300	REc			
5.438	10	2	01	5q31.3	PCDHGB3	P	Protocadherin-gamma, subfamily B, member 3	606301	REc			
5.439	10	2	01	5q31.3	PCDHGB4	P	Protocadherin-gamma, subfamily B, member 4	603058	REc			
5.440	10	2	01	5q31.3	PCDHGB5	P	Protocadherin-gamma, subfamily B, member 5	606302	REc			
5.441	10	2	01	5q31.3	PCDHGB6	P	Protocadherin-gamma, subfamily B, member 6	606303	REc			
5.442	10	2	01	5q31.3	PCDHGB7	P	Protocadherin-gamma, subfamily B, member 7	606304	REc			
5.443	10	2	01	5q31.3	PCDHGC3	P	Protocadherin-gamma, subfamily C, member 3	603627	REc			
5.444	10	2	01	5q31.3	PCDHGC4	P	Protocadherin-gamma, subfamily C, member 4	606305	REc			
5.445	10	2	01	5q31.3	PCDHGC5	P	Protocadherin-gamma, subfamily C, member 5	606306	REc			
5.446	6	30	15	5q31	PDB4	P	Paget disease of bone 4	606263	Fd		Paget disease of bone 4 (2)	
5.447	7	9	06	5q31.3	PFDN1	P	Prefoldin 1	604897	R, REc			
5.448	11	1	12	5q31.1	PITX1, PTX1, BFT, POTX, CCF, LBNBG	P	Paired-like homeodomain transcription factor-1	602149	A		Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3); Liebenberg syndrome, 186550 (4)	13(Ptx1)
5.449	5	4	00	5q31.2	PKD2L2	P	Polycystin 2-like 2	604669	R, Psh			
5.450	7	13	98	5q32	POU4F3, BRN3C	C	POU domain, class 4, transcription factor-3	602460	REa, H		Deafness, autosomal dominant 15, 602459 (3)	18(pou4f3)
5.451	1	5	15	5q31.3	PURA, PUR1, MRD31	P	Purine-rich element binding protein A	600473	REa, A		Mental retardation, autosomal dominant 31, 616158 (3)	
5.452	10	12	09	5q31.1	RAD50, NBSLD	P	RAD50, S. cerevisiae, homolog of	604040	REc, REa		Nijmegen breakage syndrome-like disorder, 613078 (3)	
5.453	2	10	14	5q31.2	REEP2, C5orf19, SPG72	P	Receptor expression-enhancing protein 2	609347	R, REc	mutation identified in 1 family each SPG72 AR and AD	?Spastic paraplegia 72, autosomal recessive, 615625 (3); ?Spastic paraplegia 72, autosomal dominant, 615625 (3)	
5.454	5	6	13	5q31	RLS8	P	Restless legs syndrome, susceptibility to, 8	615197	Fd		{Restless legs syndrome 8} (2)	
5.455	12	7	05	5q31.2	SIL1, BAP, MSS	C	Sil1, S. cerevisiae, homolog of	608005	R, REc, Fd		Marinesco-Sjogren syndrome, 248800 (3)	
5.456	7	7	14	5q31.1	SKP1, SKP1A, TCEB1L, OCP2	C	S-phase kinase-associated protein 1 (p19A)	601434	A	pseudogene on chr.7		
5.457	4	7	09	5q31.1	SLC22A4, OCTN1	P	Solute carrier family 22 (organic cation transporter), member 4	604190	R		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
5.458	10	30	03	5q31.3	SLC25A2, ORNT2	P	Solute carrier family 25 (mitochondrial carrier, ornithine transporter), member 2	608157	R			
5.459	8	9	99	5q31.2	SPOCK	P	Testican	602264	A, REc	previously mapped to chr.21		
5.460	12	4	01	5q31.3	TAF7, TAF2F, TAFII55	P	TAF7 RNA polymerase II, TATA box-binding protein-associated factor, 55kD	600573	REc			18(Taf2f)
5.461	1	30	02	5q32	TCERG1, TAF2S, CA150	P	Transcription elongation regulator 1 (transcription factor CA150)	605409	R			18(Ca150)
5.462	1	19	07	5q31.1	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	C	Transforming growth factor, beta-induced, 68kD	601692	REc, Fd		Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy, lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)	
5.463	8	6	13	5q31.2	MYOT, TTOD, MFM3	C	Myotilin (titin immunoglobulin domain protein)	604103	R		Muscular dystrophy, limb-girdle, type 1A, 159000 (3); Myopathy, myofibrillar, 3, 609200 (3); Myopathy, spheroid body, 182920 (3)	
5.464	2	4	00	5q31.1	VDAC1	P	Voltage-dependent anion channel 1	604492	A			11(Vdac1)
5.465	4	1	09	5q31.3	VTRNA1-1, HVG1, VAULTRC1	P	Vault RNA 1-1	612695	REc			
5.466	3	31	09	5q31.3	VTRNA1-2, HVG2, VAULTRC2	P	Vault RNA 1-2	612696	REc			
5.467	4	1	09	5q31.3	VTRNA1-3, HVG3, VAULTRC3	P	Vault RNA 1-3	612697	REc			
5.468	12	17	12	5q31.1	VTRNA2-1, NC886, CBL3, VTRNA2	P	Vault RNA 2-1	614938	REn			
5.469	8	28	01	5q32	SLC6A7, PROT	P	Solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	606205	REa, A			18(Slc6a7)
5.470	10	30	03	5q31-q33	AITD2	P	Autoimmune thyroid disease, susceptibility to, 2	608174	Fd		{Autoimmune thyroid disease, susceptibility to, 2} (2)	
5.471	10	12	09	5q31-q33	ATOD6	P	Dermatitis, atopic, 6	605845	Fd	between D5S436 and D5S643	{Dermatitis, atopic, susceptibility to, 6} (2)	
5.472	9	14	95	5q32	CDX1	C	Caudal type homeo box transcription factor 1	600746	REc, H, REn	100kb distal to CSF1R		18(Cdx1)
5.473	3	17	06	5q31-q33	CELIAC2	P	Celiac disease, susceptibility to, 2	609754	Fd		{Celiac disease, susceptibility to, 2} (2)	
5.474	9	9	08	5q33.2	CNOT8, CALIF, POP2	P	CCR4-NOT transcription complex, subunit 8	603731	REc			
5.475	10	26	97	5q31-q33	EOS	P	Eosinophilia, familial	131400	Fd		Eosinophilia, familial (2)	
5.476	6	9	98	5q32	HTR4	P	5-hydroxytryptamine (serotonin) receptor-4	602164	A			
5.477	1	25	05	5q31-q33	PFBI	C	Plasmodium falciparum blood infection levels	248310	Fd		{Malaria, intensity of infection} (2)	
5.478	12	29	99	5q32	PPP2R2B	P	Protein phosphatase 2, regulatory subunit B, beta	604325	R, REc		Spinocerebellar ataxia 12, 604326 (3)	
5.479	7	22	09	5q31.1	SEPT8, KIAA0202	P	Septin 8	608418	REc			11(Sept8)
5.480	10	11	02	5q33.1	SLC36A1, LYAAT1, PAT1	P	Solute carrier family 36 (proton/amino acid symporter), member 1 (lysosomal amino acid transporter 1)	606561	REc			
5.481	9	30	99	5q31-q33	SM1	C	Schistosoma mansoni infection, susceptibility/resistance to	181460	Fd		{Schistosoma mansoni infection, susceptibility/resistance to} (2)	
5.482	4	4	02	5q32	SCGB3A2, UGRP1	P	Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1)	606531	H, A		{Asthma, susceptibility to}, 600807 (3)	18(Ugrp1)
5.483	11	15	05	5q31.1	C5orf20, DCNP1	P	Dendritic cell nuclear protein 1	609710	REc			
5.484	3	28	11	5q31.1	CATSPER3, CACRC	P	Cation channel, sperm-associated, 3	609120	REc			13(Catsper3)
5.485	7	11	93	5q31.3	CD14	C	CD14 antigen	158120	REa, A			18(Cd14)
5.486	6	15	99	5q31.2	CDC23, APC8	P	Cell division cycle 23 (anaphase-promoting complex 8)	603462	REc, A			
5.487	7	11	93	5q31.1	CSF2, GMCSF	C	Colony-stimulating factor-2 (granulocyte-macrophage)	138960	REa, A, RE, Fd	order: cen-CSF2-CSF1-FMS-qter		11(Csfgm)
5.488	7	11	93	5q31.2	EGR1	C	Early growth response-1	128990	REa, A			18(Egr1)
5.489	10	24	00	5q31.2	ETF1, RF1, ERF1	P	Eukaryotic translation termination factor-1	600285	R			
5.490	6	13	12	5q31.1	FBXL21, FBL21, FBXL3B, FBL3B	P	F-box and leucine-rich repeat protein 21	609087	REc			
5.491	4	29	14	5q31.1	GDF9	P	Growth/differentiation factor 9	601918	REc			
5.492	7	26	95	5q31.1	IGES	P	Immunoglobulin E concentration, serum	147061	Fd		{?Allergy and asthma susceptibility} (2)	
5.493	7	11	93	5q31.1	IL3	C	Interleukin-3	147740	REa, A, H, RE, D, Fd	9kb from CSF2; order: cen-5'IL3-5'CF2-qter		11(Il3)
5.494	7	11	93	5q31.1	IL4	C	Interleukin-4	147780	REa, A, RE			11(Il4)
5.495	3	22	93	5q31.1	IL5	C	Interleukin-5	147850	Ch, A, RE, REn	< 310kb from IL4		11(Il5)
5.496	7	11	93	5q31.1	IL9	C	Interleukin-9	146931	REa, A			13(Il9)
5.497	5	13	10	5q31.1	IRF1, MAR	C	Interferon regulatory factor-1	147575	Fd, REa, A, REn, D, Ch		Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia, acute (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3)	11(Irf1)
5.498	4	6	15	5q31.1	LEAP2	P	Liver-expressed antimicrobial peptide 2	611373	REc, R, H			11(Leap2)
5.499	2	24	15	5q31.1	MEIKIN	P	Meiotic kinetochore factor	616232	REc			
5.500	4	29	14	5q31.2	MZB1, PACAP, MGC29506	P	Marginal zone B and B1 cell-specific protein	609447	REc			
5.501	5	26	13	5q31.1	PHF15, JADE2, KIAA0239	P	PHD finger protein 15	610515	R, Psh, REc			11(Phf15)
5.502	3	14	07	5q31.1	RAPGEF6, RAGEF2, PDZGEF2	P	RAP guanine nucleotide exchange factor 6	610499	REc			
5.503	9	2	03	5q31.1	RIL	P	LIM domain protein ril	603422	REc		{Osteoporosis, susceptibility to}, 166710 (3)	
5.504	4	2	09	5q31.1	SAR1B, CMRD, SARA2, ANDD	P	Sar1a, S. cerevisiae, homolog 2	607690	REc		Chylomicron retention disease, 246700 (3)	
5.505	3	13	15	5q31.1	SEC24A	P	Sec24-related gene family, member A	607183	R, REc			
5.506	5	23	13	5q31.1	SHROOM1, APXL2, KIAA1960	P	SHROOM family member 1	611179	REc			
5.507	10	27	04	5q31.1	SLC22A5, OCTN2, CDSP, SCD	C	Solute carrier, family 22 (organic cation transporter), member 5	603377	Fd, H		Carnitine deficiency, systemic primary, 212140 (3)	11(jvs)
5.508	12	30	14	5q31.1	SLC25A48	P	Solute carrier family 25, member 48	616150	REc			
5.509	9	5	91	5q31.1	TCF7	P	Transcription factor-7, T-cell specific	189908	REa, A	originally called TCF-1		11(Tcf7)
5.510	4	8	13	5q31.1	UQCRQ, QPC, MC3DN4	P	Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD	612080	R, REc		Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	
5.511	4	23	15	5q31.1	WSPAR, lncTCF7	P	WNT signaling pathway activating noncoding RNA	616333	REc			
5.512	3	26	96	5q31.1	HSPA4	P	Heat-shock 70kD protein-4	601113	A			
5.513	2	9	14	5q31.1-q32	DFNA52, DFNA42	P	Deafness, autosomal dominant 52	607683	Fd	max lod at D5S2017	Deafness, autosomal dominant 52 (2)	
5.514	10	14	98	5q31.1	LECT2	P	Leukocyte cell-derived chemotaxin 2	602882	A, REa			13(Lect2)
5.515	9	11	12	5q34	GABRG2, GEFSP3, CAE2, ECA2	C	Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	REn, R, Psh	in alpha/beta/gamma cluster	Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3); {Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3); Febrile seizures, familial, 8, 611277 (3)	
5.516	1	31	01	5q31.1-q33.1	IDDM18	P	Insulin-dependent diabetes mellitus-18	605598	Fd	close to IL12B	{Diabetes mellitus, insulin-dependent, 18} (2)	
5.517	2	26	09	5q31.1-q33.1	PSORS11	P	Psoriasis susceptibility 11	612599	Fd	associated with rs10045431	{Psoriasis susceptibility 11} (2)	
5.518	4	7	94	5q34	GABRA6	C	Gamma-aminobutyric acid (GABA) A receptor, alpha-6	137143	REa, Fd, REc			
5.519	3	17	16	5q31.2	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	P	Heat-shock 70kD protein-9 (mortalin)	600548	A, REc		Anemia, sideroblastic, 4, 182170 (3); Even-plus syndrome, 616854 (3)	18,X(mot2)
5.520	4	29	14	5q31.2	MATR3, MPD2, ALS21	P	Matrin 3	164015	R, REc		Amyotrophic lateral sclerosis 21, 606070 (3)	
5.521	9	23	08	5q31.3	NDUFA2	C	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 (8kD, B8)	602137	A, R		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
5.522	10	17	12	5q23.3	HINT1, PRKCNH1, NMAN	P	Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1)	601314	A		Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	
5.523	3	26	07	5q31.2	LRRTM2, KIAA0416	P	Leucine-rich repeat transmembrane protein 2	610868	REc, H			18(Lrrtm2)
5.524	8	20	07	5q31.2	PAIP2, PAIP2A	P	Polyadenylate-binding protein-interacting protein 2	605604	R, REc			
5.525	1	20	06	5q31.1	PCBD2, DCOH2, DCOHM	P	Pterin-4-alpha-carbinolamine dehydratase 2	609836	REc			
5.526	3	23	09	5q31.1	TIFAB	P	TRAF-interacting protein with forkhead-associated domain, family member B	612663	REc			13(Tifab)
5.527	8	12	14	5q31.2	TMEM173, STING, MPYS, SAVI	P	Transmembrane protein 173	612374	REc		STING-associated vasculopathy, infantile-onset, 615934 (3)	
5.528	6	13	12	5q31.2	UBE2D2, UBCH5B, UBC4	P	Ubiquitin-conjugating enzyme E2D 2	602962	REc			
5.529	8	20	14	5q31.2	WNT8A	P	Wingless-type MMTV integration site family, member 8A	606360	REc			
5.530	8	31	09	5q31.2	SLC23A1, SVCT1	C	Solute carrier family 23 (nucleobase transporters), member 1 (sodium-dependent vitamin C transporter 1)	603790	R, REn, H	opposite orientation to MATR3		18(Slc23a1)
5.531	4	15	11	5q32	PDE6A, PDEA, RP43	C	Phosphodiesterase-6A, cGMP-specific, rod, alpha	180071	REa, REn, A		Retinitis pigmentosa 43, 613810 (3)	18(Pde6a)
5.532	10	30	06	5q31.3	ANKHD1, MASK, KIAA1085, VBARP	P	Ankyrin repeat and KH domain-containing protein 1	610500	REc			
5.533	6	1	12	5q31.3	CENTD3, ARAP3	P	Centaurin, delta-3	606647	R, REc			
5.534	5	12	09	5q31.2	CXXC5	P	CXXC finger protein 5	612752	REc			
5.535	5	25	05	5q31.3	DND1	P	Dead end, zebrafish, homolog of, 1	609385	REc			
5.536	11	3	15	5q31.3	HARS, USH3B, CMT2W	P	Histidyl-tRNA synthetase	142810	S, REc		Usher syndrome type 3B, 614504 (3); Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	
5.537	11	29	12	5q31.3	HARS2, HARSL, HARSR, HO3, PRLTS2	P	Histidyl-tRNA synthetase 2	600783	REc	mutation identified in 1 PRLTS2 family	?Perrault syndrome 2, 614926 (3)	
5.538	4	20	11	5q31.3	IK, RED	P	IK cytokine, downregulator of HLA II	600549	R, REc			
5.539	7	26	10	5q31.3	KCTD16, KIAA1317	P	Potassium channel tetramerization domain-containing 16	613423	R, REc			
5.540	4	29	14	5q31.3	KIAA0141, DELE	P	KIAA0141 gene	615741	REc			
5.541	6	10	08	5q31.3	NDFIP1, N4WBP5	P	NEDD4 family-interacting protein 1	612050	REc			
5.542	5	26	13	5q31.3	RELL2	P	Relt-like 2	611213	REc			
5.543	6	11	13	5q31.3	SPRY4, HH17	P	Sprouty, Drosophila, homolog of	607984	A		Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3)	
5.544	8	31	09	5q31.3	SRA1	P	Steroid receptor RNA activator 1	603819	REc			
5.545	10	25	12	5q31.1	H2AFY, MH2A1	P	H2A histone family, member Y	610054	R			
5.546	12	22	10	5q31.3-q32	HHT3, ORW3	P	Hereditary hemorrhagic telangiectasia, type 3	601101	Fd		Telangiectasia, hereditary hemorrhagic, type 3 (2)	
5.547	8	6	15	5q33.1	SPARC, ON, OI17	C	Osteonectin (secreted protein, acidic, cysteine-rich)	182120	REa, A		Osteogenesis imperfecta, type XVII, 616507 (3)	11(Sparc)
5.548	11	23	09	5q33.1	GM2A	C	GM2 ganglioside activator protein	613109	S, REa, Psh, A	pseudogene on chr.3	GM2-gangliosidosis, AB variant, 272750 (3)	11(Gm2a)
5.549	4	2	16	5q32	ABLIM3, KIAA0843	C	Actin-binding LIM protein family, member 3	611305	R, REc			
5.550	5	19	06	5q32	ARSI	P	Arylsulfatase I	610009	REc			
5.551	3	1	00	5q33.1	ATOX1, HAH1	C	Antioxidant protein 1 (ATX, yeast, homolog of)	602270	A			
5.552	8	31	09	5q32	CAMK2A, KIAA0968, CAMKA	P	Calcium/calmodulin-dependent protein kinase II-alpha	114078	H, R, REc			18(Camk2a)
5.553	6	10	94	5q33.1	CD74, DHLAG	C	CD74 antigen (invariant polypeptide of major histocompatibility class II antigen-associated)	142790	S, REb, REa, A			18(Ii)
5.554	1	9	13	5q32	CSF1R, FMS, HDLS	C	Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma)	164770	REa, A	FMS2 is 5' end	Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)	18(Fim2)
5.555	1	13	11	5q32	CSNK1A1	P	Casein kinase-1, alpha-1 polypeptide	600505	REc	previously assigned to 13q13		
5.556	1	30	01	5q32	DPYSL3, ULIP, DRP3	P	Dihydropyrimidinase-like 3	601168	A			
5.557	9	1	12	5q33.1	GLRA1, STHE, HKPX1	C	Glycine receptor, alpha-1 polypeptide	138491	Fd, R, A		Hyperekplexia, hereditary 1, autosomal dominant or recessive, 149400 (3)	11(spd)
5.558	7	7	14	5q32	GRXCR2, DFNB101	P	Glutaredoxin, cysteine-rich, 2	615762	REc	mutation identified in 1 DFNB101 family	?Deafness, autosomal recessive 101, 615837 (3)	18(Grxcr2)
5.559	3	23	06	5q31.3	HLA-HB1	P	Minor histocompatibility antigen HB-1	609961	REc			
5.560	3	27	13	5q33.3	ITK, EMT, LPFS1	C	T-cell-specific tyrosine kinase; homolog of mouse T-cell itk/tsk tyrosine kinase	186973	A		Lymphoproliferative syndrome 1, 613011 (3)	11(Itk)
5.561	5	23	13	5q32	JAKMIP2, JAMIP2, NECC1, KIAA0555	P	Janus kinase and microtubule-interacting protein 2	611197	REc, R			
5.562	9	23	14	5q32	LARS, LFIS, ILFS1	C	Leucyl-tRNA synthetase	151350	S, H, REc	mutation identified in 1 family	?Infantile liver failure syndrome 1, 615438 (3)	
5.563	10	13	15	5q32	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	C	Platelet-derived growth factor receptor, beta polypeptide	173410	REa, A, REn	fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	Myeloproliferative disorder with eosinophilia, 131440 (4); Basal ganglia calcification, idiopathic, 4, 615007 (3); Myofibromatosis, infantile, 1, 228550 (3); Premature aging syndrome, Penttinen type, 601812 (3); Kosaki overgrowth syndrome, 616592 (3)	18(Pdgfr)
5.564	5	13	10	5q33.1	RPS14, EMTB	C	Ribosomal protein S14	130620	S, REc		Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)	
5.565	6	7	10	5q32	SH3RF2, HEPP1	P	SH3 domain-containing RING finger protein 2	613377	REc			
5.566	8	20	10	5q32	SH3TC2, KIAA1985, MNMN	P	SH3 domain and tetratricopeptide repeat domain 2	608206	REc		Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of the median nerve, mild, 613353 (3)	
5.567	11	22	13	5q33.1	SMIM3, NID67	P	Small integral membrane protein 3	608324	REc			
5.568	12	20	11	5q32	SPINK1, PSTI, PCTT, TATI, TCP	C	Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)	167790	REb		Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)	
5.569	7	17	14	5q32	SPINK6	P	Serine peptidase inhibitor, KAZAL-type, 6	615868	REn			
5.570	5	6	13	5q32	SPINK13	P	Serine protease inhibitor, Kazal-type, 13	615205	REc			
5.571	9	18	01	5q32	SPINK5, LEKTI	P	Serine protease inhibitor, Kazal type, 5	605010	A, Fd		Netherton syndrome, 256500 (3); Atopy, 147050 (3)	
5.572	10	2	07	5q31.3	YIPF5, SMAP5, YIP1A	P	Yip1 domain family, member 5	611483	REc			
5.573	5	20	99	5q33.3	ADAM19, MLTNB	P	A disintegrin and metalloproteinase domain-19 (meltrin-beta, mouse, homolog of)	603640	R			11(Adam19)
5.574	11	5	99	5q33.1	FAT2, MEGF1	P	Fat tumor suppressor, Drosophila, homolog of, 2	604269	R			
5.575	8	28	01	5q35.1	GABRP	P	Gamma-aminobutyric acid receptor, pi	602729	REc			
5.576	6	15	99	5q31.3	PCDH1, PC42	P	Protocadherin 1 (cadherin-like 1)	603626	Psh			18(Pcdh1)
5.577	1	30	96	5q33.1	GPX3	C	Glutathione peroxidase-3, plasma	138321	REa, REn			
5.578	4	30	09	5q32	SLC26A2, DTD, DTDST, D5S1708, EDM4	C	Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718	Fd, REn	distal to APC	Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3); Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la Chapelle dysplasia, 256050 (3)	
5.579	1	31	11	5q32-q33	TCOF1, MFD1, TCS1	C	Treacle	606847	Ch, Fd	prox. to SPARC	Treacher Collins syndrome 1, 154500 (3)	18(Tcof1)
5.580	5	7	03	5q33.1	TNIP1, NAF1, KIAA0113	P	TNFAIP3-interacting protein 1	607714	REc			
5.581	3	5	98	5q33.3	TTC1, TPR1	P	Tetratricopeptide repeat domain-1	601963	REa			
5.582	6	13	95	5q33.2	MFAP3	P	Microfibrillar-associated protein-3	600491	REa			
5.583	12	4	14	5q33.1	NDST1, HSST, MRT46	C	N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase)	600853	REn		Mental retardation, autosomal recessive 46, 616116 (3)	
5.584	12	16	05	5q32	ADRB2	C	Adrenergic, beta-2-, receptor, surface	109690	S, REa, A, Fd, RE		{Asthma, nocturnal, susceptibility to}, 600807 (3); {Obesity, susceptibility to}, 601665 (3); Beta-2-adrenoreceptor agonist, reduced response to (3)	18(Adrb2)
5.585	2	1	90	5q33.1	ANXA6, CBP68	C	Annexin A6 (calcium-binding protein p68)	114070	REa, A, REn			
5.586	8	28	97	5q34	CCNG1	P	Cyclin G1	601578	A			11(Ccng1)
5.587	4	5	00	5q32	IL17B	P	Interleukin 17B	604627	R			
5.588	7	11	93	5q33.3	ADRA1B	C	Adrenergic, alpha-1B-, receptor	104220	REa, A, RE			11(Adra1)
5.589	3	1	94	5q33.2	GRIA1, GLUR1	C	Glutamate receptor, ionotropic, AMPA 1	138248	A, REa, R			11(Glur1)
5.590	2	28	08	5q33.2	MRPL22	P	Mitochondrial ribosomal protein L22	611835	R			
5.591	1	18	13	5q33.3	NIPAL4, ICHYN, ARCI6	C	NIPA-like domain-containing 4	609383	Fd, REc		Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	
5.592	4	17	06	5q32	PPARGC1B, PGC1B, PERC	P	Peroxisome proliferator-activated receptor-gamma, coactivator 1, beta	608886	REc		{Obesity, variation in}, 601665 (3)	
5.593	9	3	99	5q33.3	PTTG1, EAP1, TUTR1	P	Pituitary tumor-transforming gene 1	604147	A, R			
5.594	2	12	02	5q33.2-q33.3	SGCD, SGD, LGMD2F, CMD1L	C	Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)	601411	REa, A, Fd	mutant in Syrian hamster cardiomyopathy	Muscular dystrophy, limb-girdle, type 2F, 601287 (3); Cardiomyopathy, dilated, 1L, 606685 (3)	
5.595	12	29	06	5q35.3	F12, HAF, HAE3	C	Coagulation factor XII (Hageman factor)	610619	REa, A		Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III, 610618 (3)	
5.596	9	5	91	5q32	RPS20B	P	Ribosomal protein S20B	180464	REa	?pseudogene		
5.597	1	5	12	5q32	AFAP1L1	P	Actin filament-associated protein 1-like 1	614410	REc			
5.598	8	31	12	5q33.1	DCTN4, P62, DYN4	P	Dynactin 4	614758	REc			
5.599	12	24	13	5q32	FBXO38, FBX38, MOKA, HMN2D	C	F-box only protein 38	608533	REc		Neuronopathy, distal hereditary motor, type IID, 615575 (3)	18(Fbxo38)
5.600	9	2	11	5q33.1	G3BP1, G3BP	P	GTPase-activating protein SH3 domain-binding protein 1	608431	REc, R			
5.601	4	15	11	5q33.1	IRGM, LRG47, IFI1, IBD19	P	Immunity-related GTPase family, M	608212	REc		{Mycobacterium tuberculosis, protection against}, 607948 (3); Inflammatory bowel disease 19, 612278 (3)	
5.602	2	3	05	5q33.2	KIF4B	P	Kinesin family member 4B	609184	A			
5.603	3	23	09	5q32	MIR143, MIRN143	P	Micro RNA 143	612117	REc			
5.604	3	23	09	5q32	MIR145, MIRN145	P	Micro RNA 145	611795	REc			
5.605	3	23	09	5q32	MIR378, MIRN378	P	Micro RNA 378	611957	REc			
5.606	5	19	06	5q33.1	NMUR2, NMU2R, FM4	P	Neuromedin U receptor 2	605108	REc			
5.607	12	4	08	5q33.1	RBM22	P	RNA-binding motif protein 22	612430	REc			
5.608	4	20	10	5q33.1	SLC36A2, PAT2	P	Solute carrier family 36 (proton/amino acid symporter), member 2	608331	REc, H		Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	11(Slc36a2)
5.609	12	15	10	5q32	SPINK9, LEKTI2	P	Serine protease inhibitor, Kazal-type, 9	613511	REc			
5.610	3	22	07	5q33.1	SYNPO	P	Synptopodin	608155	R, REc			
5.611	12	18	08	5q33.1	ZNF300	C	Zinc finger protein 300	612429	REc			
5.612	3	4	10	5q33.1-q35.2	FECD5, FCD3	P	Corneal dystrophy, Fuchs endothelial, 5	613269	Fd	flanked by D5S470 and D5S2108	Corneal dystrophy, Fuchs endothelial, 5 (2)	
5.613	1	26	97	5q35.1	LCP2, SLP76	P	Lymphocyte cytosolic protein-2 (SH2 domain-containing leukocyte protein of 76kD)	601603	Fd			
5.614	1	27	04	5q33.2	GALNT10, GalNAcT10	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10	608043	R, REc			
5.615	8	31	09	5q33.2	GEMIN5	P	GEM-associated protein 5	607005	R, REc			
5.616	8	25	04	5q33.3	HAVCR1, HAVCR	P	Hepatitis A virus cellular receptor 1	606518	REc, H		{Atopy, resistance to}, 147050 (3)	
5.617	12	7	07	5q34	HMMR	C	Hyaluronan-mediated motility receptor (RHAMM)	600936	REa, H, REc		{Breast cancer, susceptibility to}, 114480 (3)	11(hmmr)
5.618	6	10	08	5q33.2	LARP1, LARP, KIAA0731	P	La ribonucleoprotein domain family, member 1	612059	REc	incorrectly mapped to chromosome 10		
5.619	8	19	13	5q33.2	SAP30L	P	SAP30-like protein	610398	REc			
5.620	1	30	02	5q33.3	TIM3	P	T-cell immunoglobulin- and mucin-domain-containing molecule	606652	REc			11(Tim3)
5.621	8	19	13	5q33.3	TIMED4, TIM4, SMUCKLER	P	T-cell immunoglobulin and mucin domains-containing protein 4	610096	REc, H			11(Tim4)
5.622	5	31	13	5q33.3	C5orf54, ZBED8, BUSTER3	P	Chromosome 5 open reading frame 54	615253	REc			
5.623	5	4	09	5q33.3	CLINT1, EPN4, EPNR, KIAA0171	C	Clathrin interactor 1 (epsin 4)	607265	R, Fd			
5.624	11	15	08	5q33.3	CYFIP2	P	Cytoplasmic FMRP interacting protein 2	606323	R, REc			
5.625	5	19	15	5q33.3	IL12B, NKSF2, IMD29	C	Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40)	161561	R, REn, A, REc	between GLR1 and GABRA1	Immunodeficiency 29, mycobacteriosis, 614890 (3)	11(Il12b)
5.626	8	31	09	5q33.3	MED7, CRSP9, CRSP33	P	Mediator complex subunit 7	605045	R, REc			
5.627	2	23	09	5q33.3	MIR146A, MIRN146A	P	Micro RNA 146A	610566	REc			
5.628	2	7	06	5q33.3	UBLCP1	P	Ubiquitin-like domain-containing CTD phosphatase 1	609867	REc			
5.629	12	14	95	5q35.1	DUSP1, CL100, PTPN10	C	Dual specificity phosphatase-1	600714	A, REc			
5.630	8	10	98	5q33.3	EBF, OLF1	P	Early B-cell factor (olfactory neuronal transcription factor 1)	164343	REa, A			11(Ebf)
5.631	1	23	01	5q35.1	FGF18	P	Fibroblast growth factor-18	603726	R			
5.632	12	7	07	5q35.1	FOXI1, FKHL10, FREAC6	C	Forkhead box I1	601093	A	some patients have digenic mutations with SLC26A4	Enlarged vestibular aqueduct, 600791 (3)	
5.633	5	6	04	5q35.1	KCNMB1	C	Potassium large conductance calcium-activated channel, subfamily M, beta member 1	603951	Psh, A		{Hypertension, diastolic, resistance to}, 608622 (3)	
5.634	12	21	09	5q34	MIR103-1, MIRN103-1	P	Micro RNA 103-1	613187	REc			
5.635	1	29	16	5q34	MIR218-2	C	Micro RNA 218-2	616771	REn, REc	in intron of SLIT3		11(Mir218-2)
5.636	9	23	13	5q35.1	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	C	NK2 homeobox-5 gene	600584	A, Psh, REc	near border with 5q35	Atrial septal defect 7, with or without AV conduction defects, 108900 (3); Tetrology of Fallot, 187500 (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3); Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)	17(Csx)
5.637	1	3	02	5q35.1	RANBP17	P	RAN-binding protein 17	606141	Ch			
5.638	12	26	14	5q34	RARS, HLD9	C	Arginyl-tRNA synthetase	107820	S, REc		Leukodystrophy, hypomyelinating, 9, 616140 (3)	
5.639	2	5	15	5q34	TENM2, ODZ2, TNM2, KIAA1127	P	Teneurin transmembrane protein 2	610119	REc			
5.640	8	13	99	5q35.1	USP12, UBH1	P	ubiquitin-specific protease 12 (ubiquitin-hydrolyzing enzyme 1)	603091	A			
5.641	1	12	95	5q34	GABRB2	P	Gamma-aminobutyric acid (GABA) A receptor, beta-2	600232	Psh			
5.642	4	29	14	5q34	GABRA1, EJM5, ECA4, EIEE19	C	Gamma-aminobutyric acid (GABA) A receptor, alpha-1	137160	A, R, Fd, REn	in same 200kb as GABRG2	{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3); {Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3); Epileptic encephalopathy, early infantile, 19, 615744 (3)	11(Gabra1)
5.643	6	15	99	5q35.3	GFPT2, GFAT2	P	Glutamine: fructose-6-phosphate amidotransferase 2	603865	R, H			11(Gfat2)
5.644	6	7	04	5q35.2	MSX2, CRS2, HOX8	C	msh, Drosophila, homeo box homolog of, 2	123101	Fd, REa, A		Craniosynostosis, type 2, 604757 (3); Parietal foramina 1, 168500 (3); Parietal foramina with cleidocranial dysplasia, 168550 (3)	
5.645	11	4	05	5q34-q35.2	NIDDM4	P	Diabetes mellitus, noninsulin-dependent, 4	608036	Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	
5.646	1	14	14	5q34	WWC1, KIBRA, KIAA0869, MEMRYQTL	P	WW, C2, and coiled-coil domain-containing 1	610533	REc		[Memory, enhanced, QTL], 615602 (3)	
5.647	8	28	01	5p13.3-p13.2	ADAMTS12	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 12	606184	REa, R			
5.648	8	18	98	5q35	AMCN, AMCN1	P	Arthrogryposis multiplex congenital, neurogenic	208100	Fd, LD		Arthrogryposis multiplex congenita, neurogenic (2)	
5.649	8	28	01	5q35.3	BTNL3	P	Butyrophilin-like protein 3	606192	REa, R			
5.650	2	28	94	5q35.3	CANX	P	Calnexin	114217	REa, A			
5.651	10	23	87	5q35	CHR	C	Chromate resistance (sulfate transport)	118840	S			
5.652	2	25	15	5q35.3	CLK4	P	CDC-like kinase 4	607969	REc			
5.653	6	9	06	5q35.3	COL23A1	P	Collagen, type XXIII, alpha-1	610043	REc			11(Col23a1)
5.654	5	29	12	5q35.3	GRK6, GPRK6	P	G protein-coupled receptor kinase 6	600869	REa			
5.655	1	31	13	5q35.3	GRM6, MGLUR6, CSNB1B	C	Glutamate receptor, metabotropic, 6	604096	REa, A		Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	
5.656	7	1	11	5q35.3	LTC4S	P	Leukotriene C4 synthase	246530	A		Leukotriene C4 synthase deficiency, 614037 (1)	
5.657	2	23	09	5q35.3	MAML1	C	Mastermind, Drosophila, homolog of, 1	605424	R, REc			
5.658	11	20	98	5q35.3	MAPK9, PRKM9, JNK2	P	Mitogen-activated protein kinase 9	602896	A			
5.659	11	4	98	5q35.3	MGAT1, GLYT1	C	Mannosyl (alpha-1,3-)-glycoprotein beta-1,2, N-acetylglucosaminyltransferase	160995	REa, A			11(Glyt1)
5.660	3	8	00	5q35.3	MGAT4B	P	Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B	604561	A			
5.661	9	2	12	5q35.3	NSD1, ARA267, STO, SOTOS1	C	Nuclear receptor binding SET domain protein 1	606681	A	fusion gene with NUP98 in AML	Sotos syndrome 1, 117550 (3); Leukemia, acute myeloid, 601626 (1); Beckwith-Wiedemann syndrome, 130650 (3)	
5.662	8	27	15	5q35.1	NPM1	P	Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin)	164040	Ch, A	fused with RARA in APL	Leukemia, acute myeloid, somatic, 601626 (3)	
5.663	7	9	06	5q34	PANK3	P	Pantothenate kinase 3	606161	REn			
5.664	3	25	02	5q35.3	SCGB3A1, HIN1	P	Secretoglobin, family 3A, member 1	606500	A			
5.665	6	7	10	5q35.3	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2	C	Solute carrier family 34 (sodium phosphate cotransporter), member 1	182309	Psh, A, R, REc		Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3); Fanconi renotubular syndrome 2, 613388 (3)	13(Slc17a2)
5.666	6	15	99	5q34-q35	SLIT3, SLIL2, MEGF5	P	Slit, Drosophila, homolog of, 3	603745	R			
5.667	6	21	05	5q35.2	SNCB	P	Synuclein, beta	602569	A		Dementia, Lewy body, 127750 (3)	
5.668	6	30	15	5q35.3	SQSTM1, P62, PDB3, FTDALS3	C	Sequestosome 1	601530	R, Fd		Paget disease of bone 3, 167250 (3); Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3)	
5.669	6	5	08	5q35.1	UBTD2, DCUBP, MGC30022	P	Ubiquitin domain-containing protein 2	610174	REc			
5.670	2	25	08	5q35.2	UIMC1, RAP80	P	Ubiquitin interaction motif containing 1	609433	A			
5.671	8	20	07	5q35.1	ATP6V0E, ATP6H	P	ATPase, H+ transporting, lysosomal 9kD V0 subunit e	603931	R, REc	previously mapped to Chr.2		
5.672	6	22	12	5q35.1	BNIP1, NIP1	P	BCL2/adenovirus E1B 19kD protein-interacting protein 1	603291	REc			
5.673	6	23	15	5q35.1	DOCK2, IMD40	P	Dedicator of cytokinesis 2	603122	R, Psh, REc		Immunodeficiency 40, 616433 (3)	
5.674	8	24	92	5q35.2	DRD1	C	Dopamine receptor D1	126449	REa, A, Fd, REn, R	same 300kb fragment as GRL		
5.675	5	13	09	5q35.1	FBXW11, FBXW1B, BTRC2, BTRCP2	C	F-box and WD40 domain protein 11	605651	R, A			11(Fbxw11)
5.676	3	29	10	5q35.1	SH3PXD2B, TKS4, KIAA1295, FTHS	P	SH3 and PX domains-containing protein 2B	613293	REc		Frank-ter Haar syndrome, 249420 (3)	11(Sh3pxd2b)
5.677	4	2	16	5q35.1	SNORA74B	P	Small nucleolar RNA, H/ACA box, 74B	611331	REc	in intron 3 of ATP6V0E1		
5.678	6	3	15	5q35.1	SPDL1, CCDC99, SPINDLY	P	Spindly apparatus coiled-coil protein 1	616401	REc			
5.679	3	31	15	5q35.2	STC2, STCRP	P	Stanniocalcin 2	603665	REc			
5.680	6	22	99	5q35.1	STK10, LOK	P	Serine/threonine protein kinase-10	603919	A			11(Stk10)
5.681	7	15	02	5q35.1	TLX3, HOX11L2, RNX	C	T-cell leukemia, homeobox 3	604640	R, A	activated in T-cell ALL		11(Hox11l2)
5.682	2	20	03	5q35.2	FGFR4	C	Fibroblast growth factor receptor-4	134935	REa, A, R	distal to DRD1	{Cancer progression/metastasis} (3)	13(Fgfr4)
5.683	1	11	16	5q35.2	BOD1, FAM44B	P	Biorientation of chromosomes in cell division 1	616745	REc			
5.684	9	29	10	5q35.2	CLTB	P	Clathrin, light polypeptide (Lcb)	118970	REa, A, REc	previously mapped to chr. 4		
5.685	8	17	09	5q35.2	CPLX2, CPX2	P	Complexin 2	605033	R, REc			
5.686	5	2	16	5q35.2	FAF2, ETEA, UBXD8, KIAA0887	P	Fas-associated factor family, member 2	616935	REc			
5.687	5	26	13	5q35.2	GPRIN1, GRIN1, KIAA1893	P	G protein-regulated inducer of neurite outgrowth 1	611239	REc			
5.688	9	28	96	5q35.2	HK3	C	Hexokinase-3, white cell	142570	A, Psh			
5.689	1	13	16	5q35.2	HMP19, NSG2	P	Hypothalamus golgi apparatus-expressed protein, 19kD	616752	REc			
5.690	7	7	09	5q35.2	MENOQ4	P	Menopause, natural, age at, QTL4	612886	Fd	associated with rs365132, rs7718874, rs402511, rs691141, rs2278493	{Menopause, natural, age at, QTL4} (2)	
5.691	7	13	09	5q35.2	NOP15, HSPC111	P	Nop16, S. cerevisiae, homolog of	612861	REc			
5.692	7	15	09	5q35.3	PFN3	P	Profilin 3	612812	REc			
5.693	12	29	13	5q35.2	SFXN1	P	Sideroflexin 1	615569	REc			13(Sfxn1)
5.694	8	31	09	5q35.2	THOC3, TEX1	P	THO complex 3 (Tex1, yeast, homolog of)	606929	R, REc			
5.695	7	7	09	5q35.2	UNC5A, UNC5H1	P	UNC5, C. elegans, homolog of, A	607869	REc			
5.696	5	5	16	5q35.3	B4GALT7, XGALT1, XGPT1, EDSSLA	C	Xylosylprotein 4-beta-galactosyltransferase, polypeptide 7	604327	REc, A		Ehlers-Danlos syndrome with short stature and limb anomalies, 130070 (3)	
5.697	2	2	14	5q35.3	BTNL8, BTN9.2	P	Butyrophilin-like protein 8	615606	REc			
5.698	9	9	08	5q35.3	CNOT6, CCR4, KIAA1194	P	CCR4-NOT transcription complex, subunit 6	608951	R, REc			
5.699	8	31	09	5q35.3	DBN1	P	Drebrin-1	126660	REb, REc			13(Dbn1)
5.700	3	25	16	5q35.3	DDX41, ABS, MPLPF	P	DEAD/H box 41	608170	R		{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3)	
5.701	7	26	10	5q35.3	DOK3, DOKL	P	Docking protein 3	611435	REc			
5.702	7	14	14	5q35.3	FAM193B, IRIZIO, KIAA1931	P	Family with sequence similarity 193, member B	615813	REc			
5.703	9	22	14	5q35.3	FLT4, VEGFR3, PCL, LMPH1A	C	fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3)	136352	A, R, Fd		Lymphedema, hereditary, IA, 153100 (3); Hemangioma, capillary infantile, somatic, 602089 (3)	11(Flt4)
5.704	8	8	13	5q35.3	GNB2L1, RACK1	P	Guanine nucleotide-binding protein, beta-2-like 1	176981	R, REc			
5.705	3	25	96	5q35.3	HNRPH1	P	Heterogeneous nuclear ribonucleoprotein H	601035	A			
5.706	6	30	05	5q35.3	MXD3, MAD3	P	MAX dimerization protein 3	609450	REc			
5.707	7	1	11	5q35.3	NOLA2, NHP2, DKCB2	P	Nucleolar protein family A, member 2	606470	R, REc		Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	
5.708	3	8	04	5q35.3	PDLIM7, ENIGMA	C	PDZ and LIM domain 7 (enigma)	605903	R			
5.709	5	19	15	5q35.3	PHYKPL, AGXT2L2, PHLU	P	5-phosphohydroxy-L-lysine phospho-lyase	614683	REc	mutation identified in 1 PHLU patient	[?Phosphohydroxylysinuria], 615011 (3)	
5.710	8	31	09	5q35.3	RGS14	P	Regulator of G protein signaling 14	602513	REc			
5.711	7	22	09	5q35.3	PRELID1, PRELI, PX19	P	PRELI domain-containing protein 1	605733	R, REc			
5.712	12	18	08	5q35.3	RAB24	P	Ras-associated protein 24	612415	R, REc			
5.713	8	19	13	5q35.3	RUFY1	P	RUN and FYVE domains-containing protein 1	610327	R, REc			
5.714	3	18	98	5q35.3	TCF17, KID1	P	Transcription factor-17	602444	A			11(Tcf17)
5.715	7	1	05	5q35.3	TRIM7, GNIP	P	Tripartite motif-containing protein 7	609315	R, REc			
5.716	10	30	06	5q35.3	TRIM41	P	Tripartite motif-containing 41	610530	REc			
5.717	7	17	14	5q35.3	TRK-CTT2-4, TRNAK2, TRK2	P	Transfer RNA lysine (CTT) 2-4	612996	REc			
5.718	10	24	14	5q35.3	TRP-TGG3-5, TRNAP3, TRP3	P	Transfer RNA-Pro (TGG) 3-5	189912	REa, A			
5.719	10	24	14	5q35.3	TRT-TGT6-1, TRNAT1, TRT1	P	Transfer RNA-Thr (TGT) 6-1	189913	REa, A			
5.720	7	18	14	5q35.3	TRV-AAC1-4, TRNAV1, TRV1	P	Transfer RNA valine (AAC) 1-4	189921	REc			
5.721	7	17	14	5q35.3	TRV-CAC1-2, TRNAV2, TRV2	P	Transfer RNA valine (CAC) 1-2	612995	REc			
5.722	4	21	10	5q35.3	ZFP62	P	Zinc finger protein 62	610281	R, REc			11(Zfp62)
5.723	7	10	15	6q22.31	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	C	Gap junction protein, alpha-1, 43kD (connexin 43)	121014	REa, REc	pseudogene on chr.5	Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III, 186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive, 257850 (3); Craniometaphyseal dysplasia, autosomal recessive, 218400 (3); Erythrokeratodermia variabilis et progressiva, 133200 (3); Palmoplantar keratoderma with congenital alopecia, 104100 (3)	10(Gja1)
6.1	1	16	07	6p21.2	ZFAND3, TEX27	P	Zinc finger AN1 domain-containing protein 3	607455	R, REc			
6.2	2	17	09	6pter-p24	DEL6pter, C6DELpter	P	Chromosome 6pter-p24 deletion syndrome	612582	Ch		Chromosome 6pter-p24 deletion syndrome (4)	
6.3	2	28	03	6p21.33	MDC1, NFBD1, KIAA0170	P	Mediator of DNA damage checkpoint protein 1	607593	Psh			
6.4	4	23	09	6p21.1	CNPY3, TNRC5, PRAT4A, ERDA5	P	Canopy 3, zebrafish, homolog of	610774	R, REc			
6.5	10	1	95	6p25.2	ELANH2, EI	C	Protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived	130135	Psh, R			
6.6	3	8	91	6p21.31	CLPS	C	Colipase, pancreatic	120105	REa			
6.7	5	9	07	6p21.31	ITPR3	C	Inositol 1,4,5-triphosphate receptor, type 3	147267	REa, A		{Diabetes, type 1, susceptibility to}, 222100 (2)	
6.8	2	12	16	6p25.3	DUSP22, LMWDSP2, MKPX, VHX, JKAP, JSP1	P	Dual-specificity phosphatase 22	616778	REc			
6.9	8	1	13	6p25.3	EXOC2, SEC5L1, SEC5	P	Exocyst complex component 2	615329	REc			
6.10	12	4	98	6p25.3	FOXF2, FKHL6, FREAC2	P	Forkhead box F2	603250	A, R			
6.11	11	15	05	6p25.3	HUS1B	P	Hydroxyurea-sensitive 1, S. pombe, homolog of, B	609713	REc			
6.12	12	4	03	6p24.3	CTAG3, CAGE1	P	Cancer/testis antigen 3	608304	REc			
6.13	4	22	10	6p25.3-p22.3	INTLQ3	P	Intelligence quantitative trait locus 3	610294	Fd		{Intelligence QTL3} (2)	
6.14	11	11	14	6p25.2	ECI2, PECI, DRS1	P	Enoyl-CoA delta isomerase 2	608024	R, REc			
6.15	7	20	12	6p25.2	FAM60B, X5L	C	Family with sequence similarity 50, member B	614686	A, REc			
6.16	9	10	09	6p25.2	PRPF4B, PRP4	P	Pre-mRNA processing factor 4, yeast, homolog of, B	602338	R, REc			
6.17	5	21	14	6p25.2	RIPK1, RIP1, RIP	P	Receptor-interacting serine/threonine kinase 1	603453	REc			
6.18	1	2	08	6p25.2	SLC22A23, C6orf85	P	Solute carrier family 22, member 23	611697	REc			19(Slc22a23)
6.19	4	29	14	6p25.2	TUBB2A, CDCBM5	P	Tubulin, beta-2A	615101	REc		Cortical dysplasia, complex, with other brain malformations 5, 615763 (3)	
6.20	10	24	12	6p25.2	TUBB2B, PMGYSA	P	Tubulin, beta-2B	612850	REc	TUBB2A is 70kb telomeric to TUBB2B	Polymicrogyria, symmetric or asymmetric, 610031 (3)	
6.21	6	8	15	6p24.3	TXNDC5, ERP46, ENDOPDI, HCC2	P	Thioredoxin domain-containing protein 5	616412	REc			13(Txndc5)
6.22	10	29	03	6p25.2	WRNIP1, WHIP	P	Werner helicase-interacting protein 1	608196	REc			
6.23	9	1	09	6p25.1	CDYL	P	Chromodomain protein on Y chromosome-like	603778	R, REc			13(Cdyl)
6.24	12	15	12	6p25.1	FARS2, FARS1, COXPD14	P	Phenylalanyl-tRNA synthetase 2, mitochondrial	611592	R, REc		Combined oxidative phosphorylation deficiency 14, 614946 (3)	
6.25	11	11	14	6p25.1	LY86, MD1	P	Lymphocyte antigen 86	605241	REc			
6.26	1	9	14	6p25.1	LYRM4, ISD11, C6orf149, COXPD19	P	LYR motif-containing protein 4	613311	REc	mutation identified in 1 family	?Combined oxidative phosphorylation deficiency 19, 615595 (3)	
6.27	9	10	09	6p25.1	NRN1, NRN	P	Neuritin 1	607409	R, REc			
6.28	9	10	09	6p25.1	RPP40	P	Ribonuclease P, 40kD subunit	606117	R, REc			
6.29	9	18	08	6p24.3	EEF1E1	P	Eukaryotic translation elongation factor 1, epsilon-1	609206	REc			
6.30	10	26	98	6p25.2	BPHL	P	Biphenyl hydrolase-like	603156	A			
6.31	1	27	09	6p25	CLLS4	P	Leukemia, chronic lymphocytic susceptibility to, 4	612558	Fd	associated with rs872071	{Leukemia, chronic lymphocytic susceptibility to, 4} (2)	
6.32	3	6	09	6p25.3	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	C	Forkhead, Drosophila, homolog-like 7	601090	A		Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld anomalies, 602482 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3); Iris hypoplasia and glaucoma, 601631 (3)	13(Fkhl7, ch, Mfl)
6.33	9	22	14	6p25.3	FOXCUT, LINC01379	P	FOXC1 upstream transcript, noncoding	615976	REc			
6.34	5	19	09	6p25.3	FOXQ1, HFH1	C	Forkhead box Q1	612788	A, REc, H			13(Foxq1)
6.35	11	20	98	6p25.3	GMDS	P	GDP-mannose 4,6-dehydratase	602884	A			
6.36	4	15	04	6p25	LRSL	P	Larsen-like syndrome	608545	Ch		Larsen-like syndrome (2)	
6.37	4	6	10	6p25.2	NQO2, NMOR2	C	NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2)	160998	REa		{?Breast cancer susceptibility}, 114480 (1)	
6.38	11	5	97	6p25.2	PI9, CAP3, SERPINB9	P	Protease inhibitor 9, ovalbumin type	601799	A			
6.39	5	28	98	6p24.3	RREB1	P	RAS-responsive element binding protein-1	602209	Psh, R, A			
6.40	7	28	14	6p25.2	SERPINB6, PI6, PTI, SPI3, DFNB91	C	Protease inhibitor 6 (placental thrombin inhibitor)	173321	Psh, R, A	mutation identified in 1 DFNB91 family	?Deafness, autosomal recessive 91, 613453 (3)	13(Spi3)
6.41	11	2	11	6p25.1	F13A1, F13A	C	Coagulation factor XIII, A polypeptide	134570	F, Fd, A, D		Factor XIIIA deficiency, 613225 (3); {Myocardial infarction, protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3)	
6.42	11	24	14	6p25.3	IRF4, LSIRF, SHEP8	C	Interferon regulatory factor-4	601900	A, Ch, Fd	disregulated in t(6;14)	[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)	
6.43	9	2	08	6p24.3	HULC	P	Highly upregulated in liver cancer	612210	REc			
6.44	9	1	95	6p24.3	OFC1, CL	C	Orofacial cleft-1 (cleft lip with or without cleft palate; isolated cleft palate)	119530	Fd, Ch	probable heterogeneity	Orofacial cleft-1 (2)	
6.45	4	17	13	6p24.3	BLOC1S5, BLOS5, MUTED	P	Biogenesis of lysosome-related organelles complex 1, subunit 5	607289	H, REc			13(mu)
6.46	3	15	07	6p24.3	SLC35B3, PAPST2	P	Solute carrier family 25 (3'-phosphoadenosine 5'-phosphosulfate transporter), member B3	610845	REc			
6.47	6	13	12	6p24.3	SSR1	P	Signal sequence receptor, alpha	600868	REc			
6.48	2	23	08	6p24.2	ELOVL2, SSC2	P	Elongation of very long chain fatty acids-like 2	611814	REc			
6.49	12	17	15	6p24.2	GCM2, GCMB	P	Glial cells missing, Drosophila, homolog of, 2	603716	REc		Hypoparathyroidism, familial isolated, 146200 (3)	
6.50	8	25	11	6p24.2	MAK, RP62	P	Male germ cell-associated kinase	154235	H, REc		Retinitis pigmentosa 62, 614181 (3)	13(Mak)
6.51	9	10	12	6p24.2	NEDD9, HEF1, CASL	P	Neural precursor cell expressed, developmentally downregulated 9	602265	R, REc			
6.52	12	28	08	6p24.2	PAK1IP1, PIP1	P	PAK1-interacting protein	607811	R, REc			
6.53	2	9	16	6p24.2	SYCP2L, C6orf177	P	Synaptonemal complex protein 2-like	616799	REc			
6.54	7	22	13	6p24.2	TMEM14C	P	Transmembrane protein 14C	615318	REc			
6.55	11	19	11	6p24.1	C6orf105, ADTRP	P	Chromosome 6 open reading frame 105 (androgen-dependent TFPI-regulating protein)	614348	REc			
6.56	5	26	13	6p24.2	ERVFRD-1	P	Endogenous retrovirus group FRD, member 1	610524	REc			
6.57	7	16	12	6p24.1	PHACTR1, KIAA1733	P	Phosphatase and actin regulator 1	608723	REc			
6.58	8	22	14	6p24.1	TBC1D7, PIG51, TBC7, MGCPH	P	TBC1 domain family, member 7	612655	REc		Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	
6.59	7	1	11	6p24.1-p22.3	DFNA21	P	Deafness, autosomal dominant 21	607017	Fd	previously mapped to 6p21.3	Deafness, autosomal dominant 21 (2)	
6.60	11	24	14	6p24.3	DSP, KPPS2, PPKS2, DCWHKTA	C	Desmoplakin	125647	REa, REc, Fd	splice variants result in DP I and DP II	Keratosis palmoplantaris striata II, 612908 (3); Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3); Arrhythmogenic right ventricular dysplasia 8, 607450 (3); Skin fragility-woolly hair syndrome, 607655 (3); Epidermolysis bullosa, lethal acantholytic, 609638 (3); Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	
6.61	11	19	11	6p24.3	OFCC1, MRDS1	P	OFC1 candidate gene 1	614287	REc			
6.62	6	27	08	6p24.3	TFAP2A, AP2TF, BOFS	C	Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha)	107580			Branchiooculofacial syndrome, 113620 (3)	13(Tcfap2)
6.63	2	18	98	6p24.3	BMP6	C	Bone morphogenetic protein-6	112266	REa, REc			
6.64	3	24	14	6p24.1	EDN1, ARCND3, QME, HDLCQ7	C	Endothelin-1	131240	REa, A, Fd		Auriculocondylar syndrome 3, 615706 (3); Question mark ears, isolated, 612798 (3); {High density lipoprotein cholesterol level QTL 7} (3)	13(Edn1)
6.65	5	6	15	6p24.3-p24.2	GCNT2, Ii, CTRCT13	C	Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme	600429	A	previously assigned to 9q21	[Blood group, Ii], 110800 (3); Cataract 13 with adult i phenotype, 116700 (3); Adult i phenotype without cataract, 110800 (3)	
6.66	8	18	97	6p22.3	JMJ	P	Jumonji	601594	A			13(jmj)
6.67	11	3	92	6p24.1	HIVEP1, ZNF40	C	Human immunodeficiency virus type I enhancer-binding protein-1	194540	REa, A, REc			
6.68	5	4	00	6p23	CD83, HB15, BL11	P	CD83 antigen	604534	REc			13(Cd83)
6.69	12	13	96	6p22.3	ATXN1, ATX1, SCA1	C	Ataxin-1	601556	F, Fd, A		Spinocerebellar ataxia 1, 164400 (3)	13(Sca1, Atx1)
6.70	2	22	00	6p22.3	DEK, D6S231E	P	DEK oncogene	125264	Ch	fused with CAN in t(6;9)	Leukemia, acute nonlymphocytic (2)	
6.71	8	24	12	6p23	ETM3	P	Tremor, hereditary essential, 3	611456	Fd	max lod at D6S1630 and D6S1605	Tremor, hereditary essential, 3 (2)	
6.72	3	18	94	6p22.3	GMPR, GMPR1	C	Guanosine monophosphate reductase	139265	REb, A			
6.73	1	22	08	6p22.3	MBOAT1	P	Membrane-bound O-acetyltransferase domain-containing 1	611732	REc			
6.74	5	23	16	6p23	MCUR1, CCDC90A, FMP32	P	Mitochondrial calcium uniporter regulator 1	616952	REc			
6.75	1	5	09	6p23	NOL7	P	Nucleolar protein 7	611533	A			
6.76	6	13	02	6p23	RANBP9, RANBPM	P	RAN-binding protein 9	603854	R, REc			
6.77	12	14	98	6p23	SCZD3	C	Schizophrenia susceptibility locus, chromosome 6-related	600511	Fd	?same as DTNBP1; cognitive deficit type	{Schizophrenia}, 181500 (2)	
6.78	9	10	09	6p23	SIRT5	P	Sirtuin, S. cerevisiae, homolog 5	604483	R, REc			
6.79	4	26	06	6p22.3	MYLIP, MIR	P	Myosin regulatory light chain-interacting protein	610082	REc			
6.80	8	19	98	6p22.2	SLC17A1, NPT1	P	Solute carrier family 17, sodium phosphate, member-1 (Sodium phosphate transport 1, kidney)	182308	REa			13(Slc17a1)
6.81	1	19	07	6p23-p21	SCAR3, SCABD	P	Spinocerebellar ataxia, autosomal recessive 3	271250	Fd		Spinocerebellar ataxia, autosomal recessive 3 (2)	
6.82	7	1	05	6p22.1	TRIM31, HCGI	C	Tripartite motif-containing protein 31	609316	REc, R			
6.83	8	20	09	6p21.1	MEA1, MEA	P	Male-enhanced antigen 1	143170	REb, REa			
6.84	9	2	09	6p22.1	TRNAM2, TRNAMI2, RNTMI2	P	tRNA methionine-2	180620	REa	2 of 12+ RNTMI genes are on chr. 6		
6.85	9	1	09	6p22.2	TRNAM1, TRMI2, TRM2, RNTMT1	P	tRNA methionine-1	180621	REa			
6.86	3	7	14	6p22.3	ACOT13, THEM2	P	Acyl-CoA thioesterase 13	615652	REc			
6.87	5	6	13	6p22.3	BWQTL4	P	Birth weight quantitative trait locus 4	615192	Fd	associated with rs7756992	[Birth weight QTL4] (2)	
6.88	10	23	15	6p22.3	CASC15, LINC00340	P	Cancer susceptibility candidate 15, noncoding	616610	REc			
6.89	8	6	07	6p22.3	CDKAL1	P	CDK5 regulatory subunit-associated protein 1-like 1	611259	REc		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
6.90	3	15	10	6p22.3	CIHL	L	Hearing loss, cisplatin-induced, susceptibility to	613290	Fd	associated with rs12201199	{?Hearing loss, cisplatin-induced, susceptibility to} (2)	
6.91	11	4	04	6p22.3	DTNBP1, HPS7	P	Dystrobrevin-binding protein 1 (dysbindin)	607145	R, Fd		{Schizophrenia}, 181500 (2); Hermansky-Pudlak syndrome 7, 614076 (3)	13(Dtnbp1)
6.92	2	26	16	6p22.3	GMNN, MGORS6	P	Geminin	602842	R, REc		Meier-Gorlin syndrome 6, 616835 (3)	
6.93	10	13	09	6p22.3	KDM1B, LSD2, AOF1	P	Lysine-specific demethylase 1B	613081	REc			
6.94	7	20	12	6p22.3	KIF13A	P	Kinesin family member 13A	605433	REc			
6.95	9	12	03	6p22.3	NHLRC1, EPM2A, EPM2B	C	NHL repeat-containing 1 gene (malin)	608072	REc, Fd		Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	
6.96	9	10	09	6p22.3	NUP153	P	Nucleoporin, 153kD	603948	R, REc			
6.97	7	29	15	6p21.1	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	P	Polymerase I, RNA, subunit C	610060	REc		Treacher Collins syndrome 3, 248390 (3); Leukodystrophy, hypomyelinating, 11, 616494 (3)	
6.98	6	12	07	6p22.3-p21.3	OTSC3	P	Otosclerosis 3	608244	Fd		Otosclerosis 3 (2)	
6.99	9	30	98	6p22.3	SOX4	P	SRY (sex determining region Y)-box 4	184430	REa, A			13(Sox4)
6.100	4	19	16	6p22.3	TPMT, TPMTD	P	Thiopurine S-methyltransferase	187680	Psh, A		{Thiopurines, poor metabolism of, 1}, 610460 (3)	
6.101	8	11	15	6p22.3	FAM65B, C6orf32, KIAA0386, PL48, DFNB104	P	Family with sequence similarity 65, member B	611410	R, REc	mutation identified in 1 DFNB104 family	?Deafness, autosomal recessive 104, 616515 (3)	
6.102	9	2	09	6p22.1	TRNAA1	P	tRNA alanine-1	601431	REa, A			
6.103	9	2	09	6p22.2	TRNAR3, TRR3	P	tRNA arginine-3	601432	REa, A			
6.104	5	23	16	6p22.3	TDP2, TTRAP	P	Tyrosyl-DNA phosphodiesterase 2	605764	REc		Spinocerebellar ataxia, autosomal recessive 23, 616949 (3)	
6.105	3	8	07	6p22.1	ZNF323	P	Zinc finger protein 323	610794	REc			
6.106	12	5	13	6p22.3-p22.2	CMAHP, CMAH	P	Cytidine monophospho-N-acetylneuraminic acid hydroxylase pseudogene	603209	A	mutation inactivates gene in humans		13(Cmah)
6.107	12	15	10	6p22.2	HISTH2AA, H2AFR, H2AA	P	Histone gene cluster 1, H2A histone family, member A	613499	REc			
6.108	2	21	06	6p22.2	HIST1H2BA, TSH2B	P	Histone 1, H2BA	609904	REc			
6.109	3	18	05	6p22.3	KIAA0319, DYX2, DYLX2, DLX2	C	KIAA0319 gene	609269	Fd, REc		{Dyslexia, susceptibility to, 2}, 600202 (3)	
6.110	9	22	08	6p22.2	LRRC16A, LRRC16, CARMIL	P	Leucine-rich repeat-containing protein 16A	609593	R, REc			13(Lrrc16)
6.111	7	22	13	6p22.2	TRNAR2	P	Transfer RNA arginine 2	615305	REc			
6.112	7	22	13	6p22.2	TRNAV21	P	Transfer RNA valine 21	615306	REc			
6.113	8	15	90	6p22.3	PRL	C	Prolactin	176760	REa, D	?between 6cen and GLO1		11(Prl)
6.114	8	24	09	6p22.1	ZSCAN12, ZNF96, KIAA0426	P	Zinc finger- and SCAN domain-containing protein 12	603978	R, REc			
6.115	2	1	11	6p22.2	BTN1A1, BTN	P	Butyrophilin	601610	REc			13(Btn)
6.116	2	1	11	6p22.2	BTN2A1, BTF1	P	Butyrophilin, subfamily 2, member A1	613590	REc			
6.117	2	1	11	6p22.2	BTN2A2, BTF2	P	Butyrophilin, subfamily 2, member A2	613591	REc			
6.118	2	1	11	6p22.2	BTN2A3	P	Butyrophilin, subfamily 2, member A3	613592	REc			
6.119	2	1	11	6p22.2	BTN3A1, BTF5, CD277	P	Butyrophilin, subfamily 3, member A1	613593	REc			
6.120	2	1	11	6p22.2	BTN3A2, BTF4	P	Butyrophilin, subfamily 3, member A2	613594	REc			
6.121	2	1	11	6p22.2	BTN3A3, BTF3	P	Butyrophilin, subfamily 3, member A3	613595	REc			
6.122	3	19	01	6p22.3	GPLD1, PIGPLD, GPIPLD	P	Phospholipase D1, glycosylphosphatidylinositol-specific	602515	A			13(Gpld1)
6.123	11	19	11	6p22.1	GPX5	P	Glutathione peroxidase 5 (epididymal)	603435	REc			13(Gpx5)
6.124	9	9	13	6p22.1	GPX6	P	Glutathione peroxidase 6	607913	REc			
6.125	3	6	08	6p22.3	KAAG1, RU2AS	P	Kidney-associated antigen 1	608211	A			
6.126	2	21	13	6p22.1	OR2J3, C3HEXS	P	Olfactory receptor, family 2, subfamily J, member 3	615016	REc		[C3HEX, ability to smell], 615082 (3)	
6.127	5	29	13	6p22.1	SCAND3, ZBED9, BUSTER4, KIAA1925	P	SCAN domain-containing protein 3	615254	REc			
6.128	7	22	09	6p22.1	STQTL18	P	Stature quantitative trait locus 18	612892	Fd	associated with rs10946808	{Stature QTL 18} (2)	
6.129	7	17	14	6p22.1	TRS-TGA4-1, TRNAS3, TRS3	P	Transfer RNA serine (TGA) 4-1	606172	REc			
6.130	7	22	13	6p22.1	TRNAT15	P	Transfer RNA threonine 15	615309	REc			
6.131	7	22	13	6p22.1	TRNAV12	P	Transfer RNA valine 12	615307	REc			
6.132	7	22	13	6p22.1	TRNAV17	P	Transfer RNA valine 17	615308	REc			
6.133	7	18	14	6p22.1	TRS-AGA2-4, TRNAS2, TRS2, TRNS	P	Transfer RNA serine (AGA) 2-4	189910	REc			
6.134	11	15	08	6p22.1	ZFP57, TNDM1	P	Zinc finger protein 57, mouse, homolog of	612192	R, REc, Fd, Ch		Diabetes mellitus, transient neonatal, 1, 601410 (3)	
6.135	7	16	02	6p22.1	TRIM39, RNF23, TFP	P	Tripartite motif-containing 39	605700	A			
6.136	7	6	15	6p22.3	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	C	Doublecortin domain-containing protein 2	605755	A	mutation identified in 1 DFNB66 family	Nephronophthisis 19, 616217 (3); ?Deafness, autosomal recessive 66, 610212 (3)	
6.137	5	26	09	6p22.1	ZKSCAN3, ZNF306	P	Zinc finger protein with KRAB and SCAN domains 3	612791	REc			
6.138	4	10	14	6p22.1	ZNRD1AS1, TCTEX4, HTEX4	C	ZNRD1 antisense RNA 1	615714	REc, H			17(Znrd1as1)
6.139	3	15	07	6p22.2	ZNF322A, ZNF489, ZNF322	P	Zinc finger protein 322A	610847	REc			
6.140	11	11	14	6p22.1	ZNRD1, TCTEX6, HTEX6	P	Zinc ribbon domain-containing protein 1	607525	REc			
6.141	7	23	15	6p22.1	ZSCAN26, SREZBP	P	Zinc finger- and SCAN domain-containing protein 26	616474	REc			
6.142	5	19	06	6p22.3	ALDH5A1, SSADH	C	Succinic semialdehyde dehydrogenase	610045	REa, REc		Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	
6.143	11	7	08	6p22	ALPQTL3	P	Alkaline phosphatase, plasma level of, QTL 3	612368	Fd	linkage with rs9467160	{Alkaline phosphatase, plasma level of, QTL3} (2)	
6.144	2	23	95	6p22.3	E2F3	P	E2F transcription factor 3	600427	A			
6.145	2	5	15	6p22.3	NBAT1	P	Neuroblastoma-associated transcript 1, noncoding	616206	REc			
6.146	9	22	09	6p22	NBLST4	P	Neuroblastoma, susceptibility to, 4	613015	Fd	associated with rs6939340, rs4712653, rs9295536	{Neuroblastoma, susceptibility to, 4} (2)	
6.147	11	17	15	6p22.3	NRSN1, VMP	P	Neurensin 1	616630	REc			
6.148	9	10	09	6p22.1	TRIM27, RFP	P	Tripartite motif-containing 27	602165	REc			
6.149	2	14	03	6p22.1	HIST1H1B, H1F5	P	Histone 1, H1b	142711	REa	~2Mb centromeric of H1F1 cluster		
6.150	1	14	13	6p22.1	HIST1H2AG, H2AG, H2AFP	P	Histone gene cluster 1, H2A histone family, member 6	615012	REc			
6.151	1	14	13	6p22.1	HIST1H2AH, H2AH	P	Histone gene cluster 1, H2A histone family, member H	615013	REc			
6.152	4	3	03	6p22.1	HIST1H2AI, H2AFC	P	Histone 1, H2ai	602787	REc			
6.153	4	3	03	6p22.1	HIST1H2AK, HIST1H2AI, H2AFD	P	Histone 1, H2ak	602788	REc			
6.154	4	3	03	6p22.1	HIST1H2AJ, HIST1H2AK, H2AFE	P	Histone 1, H2aj	602791	REc			
6.155	2	14	03	6p22.1	HIST1H2AL, H2AFI	P	Histone 1, H2al	602793	REc			
6.156	2	14	03	6p22.1	HIST1H2AM, H2AFN	P	Histone 1, H2am	602796	REc			
6.157	1	31	13	6p22.1	HIST1H2BJ, H2BJ	P	Histone gene cluster 1, H2B histone family, member J	615044	REc			
6.158	1	31	13	6p22.1	HIST1H2BK, H2BK	P	Histone gene cluster 1, H2B histone family, member K	615045	REc			
6.159	3	11	03	6p22.1	HIST1H2BL, H2BFC	P	Histone 1, H2bl	602800	REc			
6.160	3	11	03	6p22.1	HIST1H2BM, H2BFE	P	Histone 1, H2bm	602802	REc			
6.161	3	11	03	6p22.1	HIST1H2BN, H2BFD	P	Histone 1, H2bn	602801	REc			
6.162	4	3	03	6p22.1	HIST1H2BO, H2BFN	P	Histone 1, H2bo	602808	REc			
6.163	3	11	03	6p22.1	HIST1H3I, H3FF	P	Histone 1, H3i	602814	REc	in cluster of 16 histone genes centromeric of major cluster		
6.164	3	11	03	6p22.1	HIST1H3J, H3FJ	P	Histone 1, H3j	602817	REc	in 2nd cluster on 6p		
6.165	3	11	03	6p22.1	HIST1H3H, H3FK	P	Histone 1, H3h	602818	REc	in minor cluster on 6p		
6.166	3	11	03	6p22.1	HIST1H4J, H4FE	P	Histone 1, H4j	602826	REc			
6.167	3	11	03	6p22.1	HIST1H4K, H4FD	P	Histone 1, H4k	602825	REc			
6.168	3	11	03	6p22.1	HIST1H4L, H4FK	P	Histone 1, H4l	602831	REc			
6.169	6	13	95	6p22.3	ID4	P	Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein	600581	A			
6.170	8	27	02	6p22.1	PRSS16, TSSP	P	Protease, serine, 16	607169	REc			13(Prss16)
6.171	10	19	99	6p22.2	SLC17A4	P	Solute carrier family 17 (sodium phosphate), member 4	604216	REa, R			
6.172	6	11	11	6p21.31	FANCE, FACE	P	Fanconi anemia, complementation group E gene	613976	Fd, LD		Fanconi anemia, complementation group E, 600901 (3)	
6.173	10	29	99	6p21.33	ABCF1, ABC50	P	ATP-binding cassette 50, TNF-alpha stimulated	603429	A			
6.174	12	5	13	6p21.33	ATAT1, MEC17, C6orf134	P	Alpha-tubulin acetyltransferase 1	615556	REc			
6.175	4	27	10	6p21.3	ATPLS	L	Antiphospholipid syndrome, familial	107320	Fd	possible linkage with HLA-DRB1*14	?Antiphospholipid syndrome, familial (2)	
6.176	4	28	10	6p21.33	AIF1, IRT1	C	Allograft inflammatory factor 1	601833	R, REn	part of TNF block		
6.177	9	22	09	6p21.33	FL1	P	Follicular lymphoma, susceptibility to, 1	613024	Fd	associated with rs6457327	{Follicular lymphoma, susceptibility to, 1} (2)	
6.178	2	18	09	6p21.33	LNCR4	P	Lung cancer susceptibility 4	612593	Fd	associated with rs3117582 and rs3131379	{Lung cancer susceptibility 4} (2)	
6.179	3	23	09	6p21.33	MIR877, MIRN877	P	Micro RNA 877	611619	REc			
6.180	7	20	12	6p21.33	VWA7, C6orf27, G7C	P	von Willebrand factor A domain-containing protein 7	609693	REc			17(G7c)
6.181	12	18	07	6p22.1	ZKSCAN4, ZNF307	P	Zinc finger with KRAB and SCAN domains 4	611643	REc			
6.182	2	21	06	6p21.32	EGFL8	P	Epidermal growth factor-like 8	609897	R, REc			17(Eglf8)
6.183	12	15	10	6p21.32	HLA-DQA2, HLA-DXA	P	Major histocompatibility complex, class II, DQ alpha-2	613503	REc			
6.184	8	17	13	6p21.32	HLA-DQB2, HLA-DXB	P	Major histocompatibility complex, class II, DQ beta-2	615161	REc			
6.185	3	23	09	6p21.32	MRI219-1, MIRN219-1	P	Micro RNA 219-1	611500	REc			
6.186	5	23	16	6p21.32	CUTA, ACHAP, C6orf82	P	CutA, E. coli, homolog of	616953	REc			
6.187	3	10	16	6p21.31	BRPF3, KIAA1286	P	Bromodomain- and PHD finger-containing protein 3	616856	REc			
6.188	9	2	08	6p21.31	C6orf106	P	Chromosome 6 open reading frame 106	612217	REc			
6.189	5	23	13	6p21.31	DEF6, IBP, SLAT	P	Def6, mouse, homolog of	610094	REc, H			17(Def6)
6.190	8	12	14	6p21.31	KCTD20	P	Potassium channel tetramerization domain-containing protein 20	615932	REc			
6.191	4	14	15	6p21.31	LEMD2, NET25	P	LEM domain-containing protein 2	616312	REc			
6.192	1	18	13	6p21.31	PNPLA1, ARCI10	P	Patatin-like phospholipase domain-containing protein 1	612121	REc		Ichthyosis, congenital, autosomal recessive 10, 615024 (3)	
6.193	11	1	13	6p21.1	PRICKLE4, C6orf49, OBTP	P	Prickle, Drosophila, homolog of, 4	611389	REc			17(Prickle4)
6.194	3	7	14	6p21.31	RPL10A, CSA19	P	Ribosomal protein L10A	615660	REc			
6.195	7	3	13	6p21.31	SLC26A8, TAT1, SPGF3	P	Solute carrier family 26 (sulfate transporter), member 8	608480	REa, REc		Spermatogenic failure 3, 606766 (3)	
6.196	9	10	09	6p21.31	SNRPC	P	Small nuclear ribonucleoprotein polypeptide C	603522	R, REc			
6.197	7	22	09	6p21.31	STQTL19	P	Stature quantitative trait locus 19	612893	Fd	associated with rs1776897	{Stature QTL 19} (2)	
6.198	9	10	09	6p21.31	TAF11, TAF2I, TAFII28	P	TAF11 RNA polymerase II, TATA box-binding protein-associated factor, 28kD	600772	R, REc			
6.199	7	18	14	6p21.31	UQCC2, C6orf126, M19	P	Ubiquinol-cytochrome c reductase complex assembly factor 2	614461	REc	mutation identified in 1 MC3DN7 patient	?Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	
6.200	9	8	11	6p21.33	ABHD16A, BAT5, D6S82E	P	Abhydrolase domain-containing 16A	142620	RE			
6.201	1	11	95	6p21.32	AGER, RAGE	P	Advanced glycosylation end product-specific receptor	600214	RE, A	at junction of classes II, III MHC		
6.202	10	15	98	6p21.32	AGPAT1, LPAATA	P	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase-alpha)	603099	REn			
6.203	11	2	04	6p21.31	ANKS1, ODIN, KIAA0229	P	Ankyrin repeat and sterile alpha motif domains-containing protein 1	608994	R, REc			
6.204	9	10	09	6p21.32	ATF6B, CREBL1	P	Activating transcription factor 6 beta	600984	REc			
6.205	7	18	02	6p21.33	ATP6V1G2, ATP6G	P	ATPase, H+ transporting, lysosomal, 13kD, V1 subunit G isoform 2	606853	REc			
6.206	11	4	98	6p21.32	B3GALT4	C	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 4	603095	REc, REn			
6.207	9	8	11	6p21.33	BAG6, BAT3, D6S52E	P	BCL2-associated athanogene 6	142590	RE			
6.208	12	10	08	6p21.32	BRD2, RING3, FSRG1	P	Bromodomain-containing protein 2	601540	REn, Fd	between HLA-DNA and HLA-DMA		
6.209	11	7	08	6p21.32	BTNL2, SS2	P	Butyrophilin-like protein 2	606000	REc		{Sarcoidosis, susceptibility to, 2}, 612387 (3)	
6.210	12	27	13	6p21.33	C2, ARMD14	C	Complement component-2	613927	F, LD, RE	no crossover with BF	C2 deficiency, 217000 (3); {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	17(C2)
6.211	12	19	11	6p21.33	C4A, C4S, C4AD	C	Complement component-4A	120810	F, H, RE, Fd	order: HLA-B, C2, BF, C4A, C4B, CYP21, DR	C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3)	17(C4)
6.212	12	19	11	6p21.33	C4B, C4F, C4BD	C	Complement component-4B	120820	F, H, RE, Fd	10kb from C4S	C4B deficiency, 614379 (3)	17(C4)
6.213	9	15	10	6p21.31	C6orf1, LBH	P	Chromosome 6, open reading frame 1	611419	REc	opposite strand, tail-to-tail with HMGA1		
6.214	10	28	09	6p21.33	CCHCR1, HCR, C6ORF18	P	Coiled-coil alpha-helical rod protein 1	605310	REn	?role in psoriasis		
6.215	11	10	14	6p21.33	CDSN, HTSS1, HYPT2, PSS1	C	Corneodesmosin	602593	REn, Fd		Hypotrichosis 2, 146520 (3); Peeling skin syndrome 1, 270300 (3)	
6.216	1	14	14	6p21.33	CFB, BF, GBG, AHUS4, ARMD14, CFBD	C	Complement factor B	138470	F, RE	mutation identified in 1 CFBD family	{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3); ?Complement factor B deficiency, 615561 (3)	17(Bf)
6.217	3	9	12	6p21.32	COL11A2, STL3, DFNA13, DFNB53, FBCG2	C	Collagen XI, alpha-2 polypeptide	120290	REa, A, REn, Fd	45kb centromeric of HLA-DPB2; 3'--5'-cen	Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal dysplasia, 215150 (3); Weissenbacher-Zweymuller syndrome, 277610 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706 (3); Fibrochondrogenesis 2, 614524 (3)	17(Col11a2)
6.218	7	16	09	6p21.3	CTEPH1	P	Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to	612862	Fd	associated with DPB1*0202	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to} (2)	
6.219	10	11	96	6p21.33	CSNK2B	C	Casein kinase-2, beta polypeptide	115441	REb, A			
6.220	3	24	11	6p21.33	CYP21A2, CYP21, CA21H	C	Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)	613815	F, RE	linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3); Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	17(Cyp21)
6.221	10	26	98	6p21.32	DAXX	P	Deat-associated protein 6	603186	A			
6.222	11	6	00	6p21.33	DDAH2	P	Dimethylarginine dimethylaminohydrolase-2	604744	R, A			
6.223	9	8	11	6p21.33	DDX39B, BAT1, D6S81E	P	DEAD box polypeptide 39Bipt-1	142560	RE	5 BATs in 160kb segment including also TNFA, TNFB		
6.224	9	18	08	6p21.3	DFNA31	P	Deafness, autosomal dominant 31	608645	Fd	between D6S276 and D6S273	Deafness, autosomal dominant 31 (2)	
6.225	4	30	09	6p21.33	DHX16, DDX16, DBP2, PRP8	C	DEAH (Asp-Glu-Ala-His) box polypeptide 16	603405	R, A			
6.226	7	17	01	6p21.33	DOM3Z	P	DOM3, C. elegans, homolog of, Z	605996	REc			
6.227	4	26	11	6p21.33	DPCR1, C6orf37	P	Diffuse panbronchiolitis critical region gene 1	613928	REc			
6.228	6	1	11	6p21.33	EHMT2, GAT8, G9A, NG36	P	Euchromatic histone-lysine N-methyltransferase 2	604599	REc			
6.229	9	10	09	6p21.33	FLOT1	P	Flotillin 1	606998	R, REc			
6.230	1	29	01	6p21.33	G8	P	G8 protein	605447	REc			
6.231	9	14	95	6p21.33	GNL1, HSR1	P	Guanine nucleotide-binding protein-like 1	143024	REn			
6.232	9	8	11	6p21.33	GPANK1, BAT4, D6S54E	P	G patch domain- and ankyrin repeats-containing protein 1	142610	RE			
6.233	3	7	01	6p21.31	GRM4, MGLUR4	P	Glutamate receptor, metabotropic, 4	604100	R			
6.234	4	21	97	6p21.33	GTF2H4	P	General transcription factor IIH, polypeptide 4	601760	A			
6.235	6	7	10	6p21.33	HCP5, 6S2650E	P	Major histocompatibility complex, class I, gene P5-1	604676	REc			
6.236	6	22	14	6p22.1	HCG8, HCGVIII	P	HLA complex group 8	615801	REc			
6.237	6	22	14	6p22.1	HCG9, HCGIX, HCGIX4	P	HLA complex group 9, noncoding	615797	REc			
6.238	4	26	11	6p21.33	HCG22, PBMUCL2	P	HLA complex group 22	613918	REc			
6.239	3	11	03	6p22.2	HIST1H1A, H1F1	C	Histone 1, H1a	142709	Psh, A			
6.240	3	11	03	6p22.2	HIST1H1C, H1F2	P	Histone 1, H1c	142710	REa, A			13(Hist1)
6.241	3	11	03	6p22.2	HIST1H1D, H1F3	C	Histone 1, H1d	142210	A, Psh			
6.242	3	11	03	6p22.2	HIST1H1E, H1F4	C	Histone 1, H1e	142220	A	previously mapped to 12q		
6.243	3	11	03	6p22.2	HIST1H1T, H1FT	P	Histone 1, H1t	142712	REc			
6.244	2	14	03	6p22.2	HIST1H2AB, H2AFM	P	Histone 1, H2ab	602795	REc			
6.245	3	11	03	6p22.2	HIST1H2AC, H2AFL	P	Histone 1, H2ac	602794	REc			
6.246	3	11	03	6p22.2	HIST1H2AD, H2AFG	P	Histone 1, H2ad	602792	Rn			
6.247	3	11	03	6p22.2	HIST1H2AE, H2AFA	P	Histone 1, H2ae	602786	REc			
6.248	2	14	03	6p22.2	HIST1H2BB, H2BFF	P	Histone 1, H2bb	602803	REc			
6.249	3	11	03	6p22.2	HIST1H2BC, H2BFL	P	Histone 1, H2bc	602847	REc			
6.250	3	11	03	6p22.2	HIST1H2BD, H2BFB	P	Histone 1, H2bd	602799	REc			
6.251	2	14	03	6p22.2	HIST1H2BE, H2BFH	P	Histone 1, H2be	602805	REc			
6.252	4	3	03	6p22.2	HIST1H2BF, H2BFG	P	Histone 1, H2bf	602804	REc			
6.253	2	14	03	6p22.2	HIST1H2BG, H2BFA	P	Histone 1, H2bg	602798	REc			
6.254	3	11	03	6p22.2	HIST1H2BH, H2BFJ	P	Histone 1, H2bh	602806	REc			
6.255	3	11	03	6p22.2	HIST1H2BI, H2BFK	P	Histone 1, H2bi	602807	REc			
6.256	3	11	03	6p22.2	HIST1H3A, H3FA	P	Histone 1, H3a	602810	REc			
6.257	3	11	03	6p22.2	HIST1H3B, H3FL	P	Histone 1, H3fl	602819	REc	in major cluster on 6p		
6.258	3	11	03	6p22.2	HIST1H3C, H3FC	P	Histone 1, H3c	602812	REc			
6.259	3	11	03	6p22.2	HIST1H3D, H3FB	P	Histone 1, H3d	602811	REc			
6.260	12	14	01	6p22.2	HIST1H3E, H3FD, H3.1	P	Histone 1, H3e	602813	REc	in cluster of 35 histone genes		
6.261	3	11	03	6p22.2	HIST1H3F	P	Histone 1, H3f	602816	REc			
6.262	3	11	03	6p22.2	HIST1H3G, H3FH	P	Histone 1, H3g	602815	REc			
6.263	3	11	03	6p22.2	HIST1H4A, H4FA	P	Histone 1, H4a	602822	REc			
6.264	3	11	03	6p22.2	HIST1H4B, H4FI	P	Histone 1, H4b	602829	REc			
6.265	3	11	02	6p22.2	HIST1H4C, H4FG	P	Histone 1, H4c	602827	REc			
6.266	3	11	03	6p22.2	HIST1H4D, H4FB	P	Histone 1, H4d	602823	REc			
6.267	3	11	03	6p22.2	HIST1H4E, H4FJ	P	Histone 1, H4e	602830	REc			
6.268	3	11	03	6p22.2	HIST1H4F, H4FC	P	Histone 1, H4f	602824	REc			
6.269	3	11	03	6p22.2	HIST1H4G, H4FL	P	Histone 1, H4g	602832	REc			
6.270	3	11	93	6p22.2	HIST1H4H, H4FH	P	Histone 1, H4h	602828	REc			
6.271	2	14	03	6p22.1	HIST1H4I, H4FM, H4M	P	Histone 1, H4i	602833	A			
6.272	9	1	11	6p22.2	HFE, HLA-H, HFE1, MVCD7, TFQTL2	C	Hemochromatosis gene	613609	LD, F		Hemochromatosis, 235200 (3); {Microvascular complications of diabetes 7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease, susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)	13(Mr2, Hfe)
6.273	6	13	11	6p22.1	HLA-A	C	Major histocompatibility complex, class I, A	142800	F		{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)	17(H2)
6.274	6	13	11	6p21.33	HLA-B, SPDA1	C	Major histocompatibility complex, class I, B	142830	F, REn, Fd		{Spondyloarthropathy, susceptibility to, 1}, 106300 (3); {Abacavir hypersensitivity, susceptibility to} (3); {Synovitis, chronic, susceptibility to} (3); {Drug-induced liver injury due to flucloxacillin} (3); {Toxic epidermal necrolysis, susceptibility to}, 608579 (3); {Stevens-Johnson syndrome, susceptibility to}, 608579 (3)	
6.275	3	16	10	6p21.33	HLA-C, PSORS1	C	Major histocompatibility complex, class I, C	142840	F, REn		{Psoriasis susceptibility 1}, 177900 (3); {HIV-1 viremia, susceptibility to}, 609423 (3)	17(H2L)
6.276	5	24	90	6p22.1	HLA-F, HLA-CDA12, HLAF	C	Major histocompatibility complex, class I, F	143110	REn, Fd			
6.277	1	8	95	6p21.32	HLA-DMA, RING6	P	Major histocompatibility complex, class II, DM alpha	142855	D			
6.278	1	8	95	6p21.32	HLA-DMB, RING7	P	Major histocompatibility complex, class II, DM beta	142856	D			
6.279	7	6	95	6p21.32	HLA-DOB	P	Major histocompatibility complex, class II, DO beta	600629	RE			
6.280	10	23	87	6p21.32	HLA-DPA1, HLADP	C	Major histocompatibility complex, class II, DP alpha-1	142880	F, RE	2 different alpha, 2 different beta chains		
6.281	10	28	93	6p21.32	HLA-DPB1	C	Major histocompatibility complex, class II, DP beta-1	142858	F, RE		{Beryllium disease, chronic, susceptibility to} (3)	
6.282	10	31	07	6p21.32	HLA-DQA1, CELIAC1	C	Major histocompatibility complex, class II, DQ alpha-1	146880	F, RE		{Celiac disease, susceptibility to}, 212750 (3)	
6.283	10	31	07	6p21.32	HLA-DQB1, CELIAC1	P	Major histocompatibility complex, class II, DQ beta-1	604305	REc		{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3); {Multiple sclerosis, susceptibility to, 1}, 126200 (3); {Celiac disease, susceptibility to}, 212750 (3)	
6.284	9	7	12	6p21.32	HLA-DRB1, SS1	C	Major histocompatibility complex, class II, DR beta-1	142857	F, RE		{Pemphigoid, susceptibility to} (2); {Sarcoidosis, susceptibility to, 1}, 181000 (3); {Multiple sclerosis, susceptibility to, 1}, 126200 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
6.285	5	15	89	6p21.32	HLA-DRA	C	Major histocompatibility complex, class II, DR alpha	142860	F, RE	1 alpha, 3 different beta chains		17(H2I)
6.286	10	23	87	6p21.32	HLA-DNA	C	Major histocompatibility complex, class II, DN alpha	142930	F, RE			
6.287	5	5	09	6p21.3	HLA-DRB3, HLA-DR52	P	Major histocompatibility complex, class II, DR beta-3	612735	REn			
6.288	4	6	00	6p21.32	HLA-DRB5	P	Major histocompatibility complex, class II, DR beta-5	604776	REn			
6.289	6	8	89	6p22.1	HLA-E	P	Major histocompatibility complex, class I, E	143010	REn			
6.290	1	25	05	6p22.1	HLA-G	C	HLA-G histocompatibility antigen, class I	142871	REc, RE		{Asthma, susceptibility to}, 600807 (2)	17(Qa)
6.291	2	19	02	6p21.32	HSD17B8, FABGL, D6S2245E, HKE6	P	Hydroxysteroid (17-beta) dehydrogenase 8 (Ke6 gene, mouse, homolog of)	601417	REl			17(Ke6)
6.292	12	18	91	6p21.33	HSPA1A	C	Heat-shock 70kD protein-1A	140550	S, REa, A	also 14q22-q24, chr.21, and at least 1 other chromosome		17(Hsp70)
6.293	1	13	99	6p21.33	HSPA1B	P	Heat-shock 70kD protein-1B	603012	REc			
6.294	12	18	91	6p21.33	HSPA1L	P	Heat-shock 70kD protein-like-1	140559	REn			
6.295	10	22	08	6p21.3	IBD3	P	Inflammatory bowel disease 3	604519	Fd		{Inflammatory bowel disease 3} (2)	
6.296	6	11	01	6p21.3	IDDM1	P	Insulin-dependent diabetes mellitus-1	222100	F, LD	linkage or association, with HLA	{Diabetes mellitus, insulin-dependent-1} (2)	
6.297	11	3	98	6p21.33	IER3, DIF2, IEX1, PRG1, GLY96	P	Immediate early response-3	602996	A			
6.298	4	21	99	6p21.3	IGAD1	P	Immunoglobulin A deficiency	137100	Fd		Immunoglobulin A deficiency (2)	
6.299	4	24	88	6p21.3	IGLP1	C	Immune response to synthetic polypeptides-1	147080	F			
6.300	4	24	88	6p21.3	IGLP2	C	Immune response to synthetic polypeptides-2	147090	F			
6.301	3	9	92	6p21.3	IGAT	P	Immune response to synthetic polypeptide--IRGAT	146820	F	in B/D segment		
6.302	10	23	87	6p21.3	ISCW	P	Immune suppression to streptococcal antigen	146850	H, F	HLA-linked		
6.303	4	27	07	6p21.33	KIAA1949	C	Phostensin	610990	REc			
6.304	3	23	09	6p21.32	KIFC1, KNSL2, HSET	P	Kinesin family member C1	603763	REc			
6.305	1	31	08	6p21.31	LHFPL5, TMHS, DFNB67	C	LHFP-like protein 5	609427	H, REc, Fd		Deafness, autosomal recessive 67, 610265 (3)	17(Lhfp15)
6.306	9	10	09	6p21.33	LSM2, C6orf28	P	LSM2 protein	607282	R, REc			
6.307	1	6	09	6p21.33	LTA, TNFB	C	Lymphotoxin alpha (formerly tumor necrosis factor beta)	153440	REa, A, RE, Fd	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	{Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic arthritis, susceptibility to}, 607507 (3); {Leprosy, susceptibility to, 4}, 610988 (3)	17(Tnfb)
6.308	1	27	97	6p21.33	LTB, TNFC	P	Lymphotoxin B	600978	REn			
6.309	5	24	13	6p21.33	LY6G5B, G5B	P	Lymphocyte antigen 6 complex, locus G5B	610433	REc			
6.310	5	24	13	6p21.33	LY6G5C, G5C	P	Lymphocyte antigen 6 complex, locus G5C	610434	REc			
6.311	5	24	13	6p21.33	LY6G6C, G6C	P	Lymphocyte antigen 6 complex, locus G6C	610435	REc			
6.312	8	28	02	6p21.33	LY6G6D, MEGT1, G6D, C6orf23	P	Lymphocyte antigen 6 complex, locus G6D	606038	REn			
6.313	5	24	13	6p21.33	LY6G6E, G6E	P	Lymphocyte antigen 6 complex, locus G6E	610437	REc			
6.314	10	4	05	6p21.33	MCCD1	P	Mitochondrial coiled-coil domain 1	609624	REc			
6.315	12	14	95	6p21.33	MICA	P	MHC class I polypeptide-related sequence A	600169	REn			
6.316	3	18	98	6p21.33	MICB	P	MHC class I polypeptide-related sequence B	602436	REn			
6.317	1	7	95	6p21.31	MLN	C	Motilin	158270	REa, A, Fd			
6.318	11	4	13	6p21.2	MOCS1, MOCODA	C	Molybdenum cofactor synthesis-1	603707	LD, A		Molybdenum cofactor deficiency A, 252150 (3)	
6.319	7	27	15	6p22.1	MOG, NRCLP7	C	Myelin-oligodendrocyte glycoprotein	159465	A, REn	60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family	?Narcolepsy 7, 614250 (3)	17(Mog)
6.320	2	26	08	6p21.1	MRPL2	P	Mitochondrial ribosomal protein L2	611822	R			
6.321	2	26	08	6p21.1	MRPL14, MRPL32	P	Mitochondrial ribosomal protein L14	611827	R			
6.322	4	24	08	6p21.1	MRPS18A, MRPS18-3	P	Mitochondrial ribosomal protein S18A	611981	R, REc			
6.323	4	24	08	6p21.33	MRPS18B, MRPS18-2	P	Mitochondrial ribosomal protein S18B	611982	REc	pseudogenes on chromosomes 1 and 2		
6.324	10	18	11	6p21.33	MUC22, PBMUCL1	P	Mucin 22	613917	REc			
6.325	7	2	02	6p21.3	MYAS1	C	Myasthenia gravis with thymus hyperplasia	607085	Fd		Myasthenia gravis with thymus hyperplasia (2)	
6.326	3	20	08	6p21.33	NCR3, 1C7, NKP30, CD337, MALS	P	Natural cytotoxicity triggering receptor 3	611550	REc		{Malaria, mild, susceptibility to}, 609148 (3)	
6.327	6	1	99	6p21.33	NEP, EDDR1, NTRK4, TRKE	P	Neuroepithelial tyrosine kinase	600408	A			17(Nep)
6.328	12	3	03	6p21.33	NEU1, NEU, SIAL1	C	Neuraminidase 1 (lysosomal sialidase; sialidase 1)	608272	H, F, A		Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)	17(Neu1)
6.329	3	3	03	6p21.33	NFKBIL1	C	Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1	601022	REn, Fd		{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
6.330	12	9	91	6p21.1	NFYA	P	Transcription factor NF-Y, A subunit	189903	REa, A			17(Nfya)
6.331	8	29	91	6p21.3	NKS1, EC1	P	Susceptibility to lysis by alloreactive natural killer cells	272370	F			17(Hh1)
6.332	12	11	12	6p21.3	MBNP	L	Membranous nephropathy, susceptibility to	614692	Fd		{?Membranous nephropathy, susceptibility to} (2)	
6.333	11	4	98	6p21.32	NOTCH4, INT3	C	Notch, Drosophila, homolog of, 4	164951	A, REc			
6.334	11	3	09	6p21.3	NPCA2	P	Nasopharyngeal carcinoma, susceptibility to, 2	161550	Fd	associated with rs2517713 and rs2975042	{Nasopharyngeal carcinoma, susceptibility to, 2} (2)	
6.335	7	9	95	6p22.1	OR2H3, OLFR2	P	Olfactory receptor, family 2, subfamily H, member 3 (olfactory receptor 2)	600578	RE	in class I MHC region		
6.336	9	10	09	6p21.3	PBC2	P	Biliary cirrhosis, primary, 2	613007	Fd	associated with rs2856683	{Biliary cirrhosis, primary, 2} (2)	
6.337	9	10	09	6p21.3	PBCA	P	Pancreatic beta cell, agenesis of	600089	D	uniparental disomy	?Diabetes mellitus, insulin-dependent, neonatal (2)	
6.338	4	10	00	6p21.3	PBLT	P	Panbronchiolitis, diffuse	604809	Fd		Panbronchiolitis, diffuse (2)	
6.339	9	12	96	6p21.32	PBX2, HOX12, G17	P	Pre-B-cell leukemia transcription factor-2	176311	A			
6.340	4	27	12	6p21.3	PDCOS	P	Podoconiosis, susceptibility to	614590	Fd		{Podoconiosis, susceptibility to} (2)	
6.341	5	25	13	6p21.33	PPP1R10, PNUTS	P	Protein phosphatase 1, regulatory subunit 10	603771	REc			
6.342	9	8	11	6p21.33	PRRC2A, BAT2, D6S51E	P	Proline-rich coiled-coil protein 2A	142580	RE			
6.343	4	19	02	6p21.1	PTCRA	C	Pre-T-cell receptor, alpha-chain precursor	606817	A, REc			17(Ptcra)
6.344	11	20	98	6p21.32	PHF1	P	PHD finger protein-1	602881	A			
6.345	9	12	93	6p21.33	POU5F1, OTF3, OCT3	C	Pou domain, class 5, transcription factor 1 (octamer-binding transcription factor 3)	164177	REa, Fd, A, REn	OTF3L on 12; ?related pseudogene on chr.8		17(Otf3)
6.346	2	4	02	6p22.1	PPP1R11, TCTEX5	C	Protein phosphatase 1, regulatory subunit 11	606670	REc			17(Ppp1r11)
6.347	11	19	98	6p21.32	PPT2	P	Palmitoyl-protein thioesterase-2	603298	REc			
6.348	4	19	12	6p21.32	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	C	Proteasome subunit, beta type, 8 (large multifunctional protease-7)	177046	REn	between TAP1 and TAP2	Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	
6.349	8	19	98	6p21.32	PSMB9, LMP2, RING12	C	Proteasome subunit, beta type, 9	177045	REn	just centromeric to TAP1		17(Lmp2)
6.350	3	5	98	6p21.32	RAB2L	P	RAB2, member RAS oncogene family-like	602306	A			
6.351	10	19	88	6p21.33	RDBP	P	RD RNA-binding protein	154040	REn	between C4 and BF		17(rd)
6.352	3	5	98	6p21.32	RING1, RNF1	P	RING finger protein-1	602045	REc			
6.353	6	10	98	6p21.32	RNF5, RING5	P	RING finger protein-5	602677	A, R			
6.354	1	2	08	6p21.2	RNF8, KIAA0646	C	Ring finger protein 8	611685	R, Psh			
6.355	2	28	01	6p22.1	RNF9, RFB30, HERF1	P	RING finger protein-9	605701	REc			
6.356	4	29	03	6p22.1	RNF39, HZFW, HZF, LIRF	P	Ring finger protein 39	607524	REc			
6.357	12	14	95	6p21.32	RPS18	P	Ribosomal protein S18	180473	REn			17(Ke3)
6.358	10	23	87	6p21.3	RWS	L	Ragweed sensitivity	179450	F	?linkage or association, with HLA	?Ragweed sensitivity (2)	
6.359	3	22	93	6p21.32	RXRB	C	Retinoid X receptor, beta	180246	H, REa, Psh, A			17(Rxrb)
6.360	7	11	12	6p21.31	SCUBE3	P	Signal peptide-, CUB domain-, and EGF-like domains-containing protein 3	614708	REc			17(Scube3)
6.361	8	27	15	6p21.33	SEEK1, C6orf16, PSORS1C1	P	SEEK1 gene	613525	REc			
6.362	8	20	07	6p22.2	SLC17A2, NPT3	P	Solute carrier family 17 (sodium phosphate cotransporter), member 2	611049	REc			
6.363	2	25	16	6p22.2	SLC17A3, NPT4, UAQTL4, GOUT4	P	Solute carrier family 17 (sodium phosphate cotransporter), member 3	611034	REc, Fd		[Uric acid concentration, serum, QTL4], 612671 (3); {Gout susceptibility 4}, 612671 (3)	
6.364	6	1	04	6p21.32	SLC39A7, D6S2244E, HKE4	C	Solute carrier family 39 (zinc transporter), member 7 (Ke4 gene, mouse, homolog of)	601416	REl			17(Ke4)
6.365	4	24	09	6p21.33	SLC44A4, CTL4, C6orf29	P	Solute carrier family 44, member 4	606107	REc			
6.366	8	25	04	6p21.31	SPDEF, PDEF	P	SAM pointed domain-containing ETS transcription factor	608144	REc			
6.367	5	25	00	6p21.33	STK19	P	Serine/threonine protein kinase 19	604977	REc			
6.368	3	7	13	6p21.32	SYNGAP1, MRD5	C	Synaptic Ras GTPase activating protein 1	603384	REc		Mental retardation, autosomal dominant 5, 612621 (3)	
6.369	10	14	05	6p21.32	TAP1, ABCB2, TAP1, RING4, PSF1	C	Transporter 1, ATP-binding cassette, subfamily B	170260	REn	~7kb telomeric to TAP2	Bare lymphocyte syndrome, type I, 604571 (3)	17(Ham1)
6.370	2	10	04	6p21.32	TAP2, ABCB3, PSF2, RING11	C	Transporter 2, ATP-binding cassette, subfamily B	170261	REn	tel-TAP1-LMP2-LMP1-TAP2-cen	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3); Wegener-like granulomatosis (3)	17(Ham2)
6.371	10	25	02	6p21.32	TAPBP, TPSN	P	TAP-binding protein (tapasin)	601962	A, REa		Bare lymphocyte syndrome, type I, 604571 (3)	17(Tapbp)
6.372	1	1	96	6p21.33	TCF19, SC1	P	Transcription factor-19 (SC1)	600912	REc			
6.373	8	9	99	6p21.31	TEAD3, TEF5, TEAD5	P	TEA domain family member 3 (transcriptional enhancer factor 5)	603170	A, R			17(Tead3)
6.374	6	23	06	6p21.33	TNF, TNFA	P	Tumor necrosis factor (cachectin)	191160	REa, A, RE	5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	{Malaria, cerebral, susceptibility to}, 611162 (3); {Septic shock, susceptibility to} (3); {Asthma, susceptibility to}, 600807 (3); {Dementia, vascular, susceptibility to} (3); {Migraine without aura, susceptibility to}, 157300 (3)	17(Tnfa)
6.375	9	20	14	6p21.33-p21.32	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	P	Tenascin XB	600985	REn		Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3); Vesicoureteral reflux 8, 615963 (3)	
6.376	1	7	16	6p21.33	TUBB, TUBB5, M40, CDCBM6, CSCSC1	C	Tubulin, beta polypeptide	191130	REa, D		Cortical dysplasia, complex, with other brain malformations 6, 615771 (3); Symmetric circumferential skin creases, congenital, 1, 156610 (3)	
6.377	3	28	11	6p21.31	TULP1, RP14, LCA15	C	Tubby-like protein-1	602280	Fd, A		Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15, 613843 (3)	
6.378	8	20	08	6p22.1	UBD, FAT10	C	Ubiquitin D	606050	REc			
6.379	9	18	08	6p21.33	VARS, VARS1, G7A, VARS2	P	Valyl-tRNA synthetase	192150	REc			17(Vars2)
6.380	8	5	14	6p21.33	VARS2, KIAA1885, COXPD20	P	Valyl-tRNA synthetase 2	612802	REc		Combined oxidative phosphorylation deficiency 20, 615917 (3)	
6.381	11	19	11	6p21.3	VAMAS6	P	Vitiligo-associated multiple autoimmune disease susceptibility 6	193200	Fd	possible second locus on 1p31.3-p32.2	{Vitiligo-associated multiple autoimmune disease susceptibility 6} (2)	
6.382	7	18	14	6p21.32	VPS52, SACM2L	P	Vacuolar protein sorting 52 homolog (S. cerevisiae)	603443	REc			
6.383	8	27	15	6p21.32	WDR46, BING4	P	WD repreat-containing protein 46	611440	REc			
6.384	8	25	04	6p21.3	WG	P	Wegener granulomatosis	608710	Fd		Wegener granulomatosis (2)	
6.385	2	28	07	6p21.3	WM1	P	Macroglobulinemia, Waldenstrom, susceptibility to, 1	153600	Fd	linked to HLA	{Macroglobulinemia, Waldenstrom, susceptibility to, 1} (2)	
6.386	8	27	15	6p21.32	ZBTB22, BING1	P	Zinc finger- and BTB domain-containing protein 22	611439	REc			
6.387	12	4	95	6p22.1	ZNF173	P	Zinc finger protein-173	600830	REn			
6.388	10	20	99	6p22.1	ZNF184	P	Zinc finger protein-184	602277	REf			
6.389	3	5	98	6p22.1	ZNF192	P	Zinc finger protein-192	602240	REc			
6.390	3	5	98	6p22.1	ZNF193	P	Zinc finger protein-193	602246	REc			
6.391	11	17	98	6p21.3	ZNF204	P	Zinc finger protein-204	603282	A, Psh	?pseudogene		
6.392	8	26	98	6p21.31	BAK1	P	BCL2-antagonist/killer 1	600516	REa, H, REc	centromeric to MHC region		17(bak)
6.393	9	16	88	6p21.3-p21.2	CP20	L	Lymphocyte cytosolic protein, molecular weight 20kD	153380	LD			
6.394	5	31	05	6p21.31	FKBP5, FKBP51	P	FK506-binding protein 5	602623	REc		{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)	
6.395	1	20	11	6p21.2	GLO1	C	Glyoxalase I	138750	F, S, Fd	~3cM proximal to HLA		17(Glo1)
6.396	10	23	87	6p21.3-p21.2	LAP	L	Laryngeal adductor paralysis	150270	F	?linkage to HLA and GLO1	?Laryngeal adductor paralysis (2)	
6.397	12	4	95	6p21.31	MAPK14, CSBP1	P	Mitogen-activated protein kinase 14 (cytokine suppressive anti-inflammatory drug binding protein 1)	600289	Psh, A			
6.398	5	29	12	6p21.3-p21.2	MPVQTL4	P	Mean platelet volume quantitative trait locus 4	614644	Fd	associated with rs210134	Mean platelet volume QTL4 (2)	
6.399	11	5	92	6p21.31	TCP11, D6S230E	P	T-complex homolog tcp-11	186982	REa, R, A, REc	expressed only in testis at same time as ZNF76 (day 20 after birth)		17(tcp11)
6.400	11	5	92	6p21.31	ZNF76, D6S229E	P	Zinc finger protein-76 (expressed in testis)	194549	REa, R, A, REc	same 300kb fragment as TCP11		17(Znf76)
6.401	10	11	99	6p21.33	LST1, D6S49E, B144	P	Leukocyte-specific transcript 1 (B144 protein)	109170	RE, REn	10kb 3' from TNFA		
6.402	3	27	90	6p21.1	PGC	C	Preprogastricsin	169740	REa, F, REb	cen-PGG-GLO1-HLA		17(Upg1)
6.403	8	12	91	6p21.1	TCTE1	P	T-complex-associated-testis-expressed-1	186975	A, Fd			
6.404	3	7	13	6p21.2	AD17	P	Alzheimer disease 17	615080	Fd	associated with rs75932628T	Alzheimer disease 17 (2)	
6.405	11	20	15	6p21.2	C6orf89, BRAP, AMFION	P	Bombesin receptor-activated protein	616642	REc			
6.406	1	1	12	6p21.1	C6orf130	P	Chromosome 6 open reading frame 130	614393	REc			
6.407	2	4	15	6p21.2	CMTR1, MTR1, ISG95, FTSJD2, KIAA0082	C	CAP methyltransferase 1	616189	REc, R			
6.408	9	10	09	6p21.2	DAAM2, KIAA0381	P	Dishevelled-associated activator of morphogenesis 2	606627	R, REc			
6.409	11	11	14	6p21.2	FGD2	P	FYVE, RhoGEF, and PH domain-containing protein 2	605091	R, H			17(Fgd2)
6.410	7	15	09	6p21.2-p21.1	LRFN2, SALM1, KIAA1246	C	Leucine-rich repeat and fibronectin type III domain-containing protein 2	612808	R, REc, H			17(Lrfn2)
6.411	11	6	92	6p21.2	PIM1	C	Oncogene PIM1	164960	REa, D, Fd			17(Pim1)
6.412	10	17	95	6p21.2	CDKN1A, WAF1, CIP1, CDKN1	C	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)	116899	A			17(Waf1)
6.413	9	7	12	6p21.2	MTCH1, PSAP	P	Mitochondrial carrier homolog 1	610449	REc, R			
6.414	3	29	16	6p21.2	TBC1D22B, C6orf197	P	TBC1 domain family, member 22B	616880	REc			
6.415	6	2	15	6p21.2	TP53COR1	P	Tumor protein p53 pathway corepressor 1, noncoding	616343	REc			17(Tp53cor1)
6.416	12	11	02	6p21.1	TREM2	P	Triggering receptor expressed on myeloid cells 2	605086	REa		Nasu-Hakola disease, 221770 (3)	
6.417	4	30	09	6p12.3	CRISP1, AEGL1	P	Cysteine-rich secretory protein 1	601193	A			17(Aeg1)
6.418	1	2	03	6p21.1	GTPBP2	C	GTP-binding protein 2	607434	A, R, REc			17(Gtpbp2)
6.419	11	22	02	6p21.2	KCNK16, TALK1	P	Potassium channel, subfamily K, member 16	607369	REc			
6.420	11	22	02	6p21.2	KCNK17, TASK4, TALK2	C	Potassium channel, subfamily K, member 17	607370	REc			
6.421	1	16	96	6p12.3	MEP1A	C	Meprin A, alpha	600388	REa, R, REc, Fd			17(Mep1a)
6.422	9	23	96	6p21.31	PPARD, NUC1	P	Peroxisome proliferative activated receptor, delta	600409	Psh, A			
6.423	1	29	01	6p21.1	SLC22A7, OAT2	P	Solute carrier family 22 (organic anion transporter), member 7	604995	R			
6.424	3	5	98	6p21.1	SLC29A1, ENT1	P	Solute carrier family 29 (nucleoside transporters), member 1 (equilibrative nucleoside transporter-1)	602193	A			
6.425	3	6	14	6p21.2	TDRG1, LINC00532	P	Testis development-related gene 1, noncoding	615676	REc			
6.426	12	23	05	6p21.1	YIPF3, KLIP1	P	YIP1 domain family, member 3	609775	R			
6.427	10	18	11	6p12.3	PLA2G7, PAFAH, PAFAD	C	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)	601690	A		Platelet-activating factor acetylhydrolase deficiency, 614278 (3); {Asthma, susceptibility to}, 600807 (3); {Atopy, susceptibility to}, 147050 (3)	
6.428	2	18	96	6p22.1	ZNF165, LD65	C	Zinc finger protein-165	600834	REa, A, REc			
6.429	8	11	14	6p21.1	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	P	Alanyl-tRNA synthetase 2	612035	R, REc		Combined oxidative phosphorylation deficiency 8, 614096 (3); Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	
6.430	12	24	08	6p21.1	ABCC10, MRP7	C	ATP-binding cassette, subfamily C, member 10	612509	Psh, R, REc, A			
6.431	6	18	99	6p21.1	BYSL	P	By the ribosomal protein S6 gene, Drosophila, homolog-like (bystin)	603871	A			
6.432	4	17	14	6p21.1	CUL7, 3M1	P	Cullin 7	609577	REa, Fd		3-M syndrome 1, 273750 (3)	
6.433	6	13	12	6p21.1	CUL9, PARC, KIAA0708	P	Cullin 9	607489	REc			
6.434	9	15	10	6p21.1	FOXP4	P	Forkhead box P4	608924	REc			
6.435	4	28	10	6p21.1	GUCA1A, GCAP, COD3, CORD14	P	Guanylate cyclase activator 1A, retina	600364	Psh, A		Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)	
6.436	3	24	11	6p21.1	GUCA1B, GCAP2, GUCA2, RP48	P	Guanylate cyclase activator 1B, retina	602275	REa, A		Retinitis pigmentosa 48, 613827 (3)	
6.437	9	8	08	6p21.1	HSP90AB1, HSPCB, HSPC2, HSP90B	C	Heas-shock protein, 90kD, alpha, class B, member 1	140572	Psh, REn			
6.438	8	19	13	6p21.1	KLHDC3, PEAS	P	KELCH domain-containing protein 3	611248	REc			17(Klhdc3)
6.439	7	22	09	6p21.1	MED20, TRFP	P	Mediator complex subunit 20	612915	REc			
6.440	12	28	08	6p21.1	NCR2, LY95, NKP44	C	Natural cytotoxicity triggering receptor 2 (lymphocyte antigen 95, mouse, homolog of)	604531	REa, REc			17(Ncr2)
6.441	10	18	15	6p21.1	NFKBIE, IKBE	P	Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, epsilon	604548	REc			
6.442	10	26	15	6p21.1	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	C	Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1)	601498	REa, H, A		Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3); Peroxisome biogenesis disorder 4B, 614863 (3); Heimler syndrome 2, 616617 (3)	17(Pxaaa1)
6.443	5	28	99	6p21.2	PPIL1, CYPL1	C	Peptidylprolyl isomerase (cyclophilin)-like 1	601301	A, R	previously assigned to chr.2		
6.444	5	12	15	6p21.1	PPP2R5D, MRD35	P	Protein phosphatase-2, regulatory subunit B (B56), delta isoform	601646	A		Mental retardation, autosomal dominant 35, 616355 (3)	
6.445	11	30	10	6p21.1	PPR1	P	Photoparoxysmal response 1	132100	Fd	max lod at D6S2427	Photoparoxysmal response 1 (2)	
6.446	9	29	10	6p21.1	RRP36, C6orf153	P	Ribosomal RNA-processing factor, 36	613475	REc			
6.447	3	19	09	6p21.1	RSPH9, CILD12	P	Radial spoke head 9, Chlamydomonas, homolog of	612648	REc		Ciliary dyskinesia, primary, 12, 612650 (3)	
6.448	10	2	12	6p21.1	SRF	P	Serum response factor	600589	REc			
6.449	11	22	13	6p21.1	SUPT3H, SPT3	C	Suppressor of Ty 3, S. cerevisiae, homolog of	602947	REc			
6.450	8	18	14	6p21.1	TBCC, CFC	P	Tubulin-specific chaperone C	602971	REc			
6.451	3	23	09	6p21.1	TJAP1, PILT, TJP4	P	Tight junction-associated protein 1	612658	REc			
6.452	1	12	15	6p21.1	TOMM6, TOM6	P	Translocase of outer mitochondrial membrane 6, yeast, homolog of	616168	REc			
6.453	8	19	13	6p21.1	TRERF1, TREP132	P	Transcriptional regulating factor 1	610322	REc, R			
6.454	12	28	08	6p21.1	TREM1	P	Triggering receptor expressed on myeloid cells 1	605085	REa			17(Trem1)
6.455	12	28	08	6p21.1	TREML1, TLT1	P	Triggering receptor expressed on myeloid cells-like protein 1	609714	REc, H			17(Treml1)
6.456	12	28	08	6p21.1	TREML2, TLT2	P	Triggering receptor expressed on myeloid cells-like protein 2	609715	REc, H			17(Treml2)
6.457	12	28	08	6p21.1	TREML3, TLT3	P	Triggering receptor expressed on myeloid cells-like protein 3	609716	REc, H			17(Treml3)
6.458	4	1	08	6p21.1	UBR2, C6orf133, KIAA0349	C	Ubiquitin-protein ligase E3 component N-recognin 2	609134	R, A, H			17(Ubr2)
6.459	12	23	05	6p21.1	XPO5, KIAA1291	P	Exportin 5	607845	R, REc			
6.460	11	24	14	6p21.1	CLIC5, DFNB103	P	Chloride intracellular channel 5	607293	REc	mutation identified in 1 DFNB103 family	?Deafness, autosomal recessive 103, 616042 (3)	
6.461	4	23	08	6p21.1	MRPS10	P	Mitochondrial ribosomal protein S10	611976	REc	5 pseudogenes on chromosomes 1, 3, and 9		
6.462	7	3	06	6p12.3	TFAP2D, TFAP2BL1	P	Transcription factor AP2-delta	610161	REc			
6.463	2	21	03	6p21.1-p12.2	MGR3	P	Migraine with or without aura, susceptibility to, 3	607498	Fd	lod 5.78 at D6S452	{Migraine with or without aura, susceptibility to, 3} (2)	
6.464	6	25	97	6p21.1	PTK7	C	PTK7 protein tyrosine kinase 7	601890	REa, A			
6.465	2	26	02	6p12.3-p12.2	FCYT, PKHD1, ARPKD	C	Fibrocystin	606702	Fd, H		Polycystic kidney and hepatic disease, 263200 (3)	13(Pkhd1)
6.466	4	19	02	6p12.3	PGK2	C	Phosphoglycerate kinase-2 (testicular PGK)	172270	REa, A, REb	pseudogene on chr.12		17(Pgk2)
6.467	1	23	01	6p21.1	POLH, XPV	C	Polymerase, DNA, eta	603968	R, REa, A		Xeroderma pigmentosum, variant type, 278750 (3)	
6.468	5	7	01	6p12.3	CYP39A1	P	Cytochrome P450, subfamily XXXIXA (oxysterol 7-alpha-hydroxylase), polypeptide 1	605994	R			17(Cyp39a1)
6.469	2	25	16	6p12.3	RHAG, RH50A, OHST	C	Rhesus blood group-associated glycoprotein	180297	REa, A		Anemia, hemolytic, Rh-null, regulator type, 268150 (3); Rh-mod syndrome (3); Overhydrated hereditary stomatocytosis, 185000 (3)	
6.470	12	26	14	6p21.1	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	C	Peripherin 2, mouse, homolog of	179605	REa, A	digenic RP with ROM1	Retinitis pigmentosa 7 and digenic, 608133 (3); Leber congenital amaurosis 18, 608133 (3); Macular dystrophy, patterned, 1, 169150 (3); Retinitis punctata albescens, 136880 (3); Choriodal dystrophy, central areolar 2, 613105 (3); Macular dystrophy, vitelliform, 3, 608161 (3)	17(rds)
6.471	1	29	01	6p21.1	APOBEC2	P	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2	604797	R, H			17(Apobec2)
6.472	7	16	09	6p21.2	BTBD9, KIAA1880	P	BTB/POZ domain-containing protein 9	611237	REc			
6.473	7	12	92	6p21.1	CCND3	C	Cyclin D3	123834	REa, A	pseudogene also on 6p21		
6.474	8	11	98	6p21.1	CDC5L	C	Cell division cycle 5, S. pombe, homolog-like	602868	REc, A			
6.475	10	20	99	6p21.2	CPNE5, CPN5	P	Copine V	604209	REc			
6.476	9	5	07	6p21.2	DNAH8, HDHC9	P	Dynein, axonemal, heavy chain 8	603337	REc			
6.477	8	25	04	6p21	EJM3	P	Epilepsy, juvenile myoclonic 3	608816	Fd		Epilepsy, juvenile myoclonic 3 (2)	
6.478	7	22	09	6p21.31	ETV7, TEL2, TELB	C	ETS variant gene 7	605255	A, REc			
6.479	5	9	95	6p21.2	GLP1R	P	Glucagon-like peptide 1 receptor	138032	A			17(Glp1r)
6.480	5	23	11	6p21.31	HMGA1, HMGIY	P	High-mobility group AT-hook 1	600701	Psh, R		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
6.481	9	30	02	6p21.31	IHPK3, INSP6K3, IP6K3	P	Inositol hexaphosphate kinase 3	606993	REc	pseudogene on 6p24.1		
6.482	6	18	99	6p21.2	KCNK5, TASK2	P	Potassium channel, subfamily K, member 5	603493	R			
6.483	4	26	11	6p21.2	KIF6	P	Kinesin family member 6	613919	REc			
6.484	4	29	02	6p21	LATD	L	Laterality defects, autosomal dominant	601086	Fd	max lod 2.95 at theta = 0		
6.485	3	31	09	6p22.1	MAS1L, MRG	P	MAS1 oncogene-like	607235	REc			
6.486	10	4	05	6p21.2	MDGA1, GPIM	P	MAM domain-containing glycosylphosphatidylinositol anchor 1	609626	REc			
6.487	7	6	00	6p21.1	MDFI	P	MYOD family inhibitor	604971	R			17(Mdfi)
6.488	5	31	05	6p12.3	MUT, MCM	C	Methylmalonyl Coenzyme A mutase	609058	REa, A, F, D		Methylmalonic aciduria, mut(0) type, 251000 (3)	17(Mut)
6.489	12	27	01	6p21.31	PACSIN1, KIAA1379	P	Protein kinase C and casein kinase substrate in neurons 1	606512	R			
6.490	7	16	09	6p21	RLS6	P	Restless legs syndrome, susceptibility to, 6	611185	Fd	associated with rs9296249 and rs9357271	{Restless legs syndrome 6} (2)	
6.491	1	13	09	6p22.1	RPP21	P	Ribonuclease P/MRP, 21kD subunit	612524	REc			
6.492	3	15	13	6p21.1	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	C	Runt-related transcription factor 2	600211	A, REc, Ch, Fd		Cleidocranial dysplasia, 119600 (3); Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3); Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3); Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	17(Cbfa1)
6.493	4	27	12	6p21.33	SKIV2L, SKI2, SKI2W, THES2	P	Superkiller viralicidic activity 2, S. cerevisiae, homolog, like	600478	A		Trichohepatoenteric syndrome 2, 614602 (3)	
6.494	12	19	11	6p21.3-p21.2	SRSF3, SFRS3, SRP20	P	Splicing factor, arginine/serine-rich, 3	603364	R, REc			17(Sfrs3)
6.495	9	10	09	6p21.31	STK38, NDR	P	Serine/threonine protein kinase 38	606964	R, REc			
6.496	10	1	95	6p21.1	TFEB, TCFEB	L	Transcription factor EB	600744	H			17(Tcfeb)
6.497	5	29	12	6p21.1	TREML4, TLT4	P	Triggering receptor expressed on myeloid cells-like protein 4	614664	REc			17(Treml4)
6.498	10	8	07	6p12.3	CENPQ	P	Centromeric protein Q	611506	REc			
6.499	8	21	12	6p12.3	GLYATL3	P	Glycine N-acyltransferase-like 3	614763	REc			
6.500	10	5	11	6p12.3	GPR115	P	G protein-coupled receptor 115	614268	REc			
6.501	3	23	09	6p12.1	ICK, MRK, KIAA0936, ECO	P	Intestinal cell kinase	612325	R, REc		Endocrine-cerebroosteodysplasia, 612651 (3)	
6.502	3	7	14	6p12.3	OPN5, GRP136, PGR12	C	Opsin 5	609042	REc			
6.503	4	21	16	6p12.3	PTCHD4, PTCH53, C6orf138	P	Patched domain-containing protein 4	616908	REc			
6.504	9	24	08	6p12.3	RCAN2, ZAKI4, DSCR1L1, MCIP2, CSP2	P	Regulator of calcineurin 2	604876	R, REc			
6.505	7	8	11	6p12.3	SLC25A27, UCP4	P	Solute carrier family 25, member 17	613725	REc			
6.506	5	26	13	6p12.3	TDRD6	P	TUDOR domain-containing protein 6	611200	REc			
6.507	10	29	03	6p12.1	LRRC1, LANO	P	Leucine-rich repeat-containing protein 1	608195	REc			
6.508	3	24	06	6p12.1	COL21A1	C	Collagen, type XXI, alpha-1 polypeptide	610002	R, REc			
6.509	9	9	08	6p12.1	FBXO9, FBX9	P	F-box only protein 9	609091	REc			9(Fbxo9)
6.510	3	6	94	6p12.2	GSTA1	C	Glutathione S-transferase A1	138359	REn, REc			
6.511	12	6	91	6p12.2	GSTA2, GST2	C	Glutathione S-transferase A2	138360	A, REa			9(Gsta)
6.512	3	11	03	6p12.2	GSTA3	C	Glutathione S-transferase, alpha-3	605449	R, REc			
6.513	3	11	03	6p12.2	GSTA4	C	Glutathione S-transferase, alpha-4	605450	A, REc			
6.514	3	10	03	6p12.2	GSTA5	P	Glutathione S-transferase, alpha-5	607605	REc			
6.515	11	16	98	6p12.2	IL17A, IL17, CTLA8	P	Interleukin-17a	603149	A, REc	previously mapped to 2q31		1(Il17)
6.516	12	12	12	6p12.2	LINCMD1	P	Long intergenic noncoding RNA, muscle differentiation 1	614933	REc			
6.517	3	20	16	6p12.2	TMEM14A	P	Transmembrane protein 14A	616870	REc			
6.518	3	23	09	6p12.2	MIR133B, MIRN133B	P	Micro RNA 133B	610946	REc			
6.519	3	23	09	6p12.2	MIR206, MIRN206	P	Micro RNA 206	611599	REc			1(Mirn206)
6.520	8	8	13	6p12.2	TRAM2, KIAA0057	C	Translocation-associated membrane protein 2	608485	REc, Psh			
6.521	11	19	11	6p12.2-q12	MRT24	P	Mental retardation, autosomal recessive 24	614345	Fd	between rs651733 and rs1508668	Mental retardation, autosomal recessive 24 (2)	
6.522	9	1	09	6p12.1	BMP5	P	Bone morphogenetic protein-5	112265	REa, REc			
6.523	3	31	15	6p12.1	GCM1, GCMA	P	Glial cells missing, Drosophila, homolog of, 1	603715	A, REc			
6.524	9	8	11	6p12.1	MLIP, C6orf142	P	Muscular LMNA-interating protein	614106	REc			
6.525	12	7	04	6p12.2	RN7SK, 7SK	P	RNA, 7SK small nuclear	606515	REa			
6.526	3	25	14	6p12.1	ZNF451, COASTER	P	Zinc finger protein 451	615708	REc			
6.527	3	8	07	6p21.1	SLC35B2, PAPST1, SLL	P	Solute carrier family 35 (3'-phosphoadenosine 5')-phosphosulfate transporter), member B2	610788	REc			
6.528	4	19	12	6p12.2	PAQR8, C6orf33, LMPB1, MPRB	P	Progestin and ADIPOQ receptor family, member 8	607780	REn			
6.529	1	29	01	6p21.1	CAPN11	P	Calpain 11	604822	REa, R			
6.530	10	28	08	6p12.3	CD2AP, CMS	C	CD2-associated protein	604241	R, REc		Glomerulosclerosis, focal segmental, 3, 607832 (3)	
6.531	4	30	09	6p12.3	CRISP2, TPX1, TSP1	P	Cysteine-rich secretory protein 2	187430	REa			17(Tpx1)
6.532	5	23	13	6p12.3	DEFB114, DEFB14	P	Defensin, beta, 114	615243	REc			
6.533	9	20	14	6p12.1	ELOVL5, HELO1, SCA38	P	Elongation of very long chain fatty acids-like 5	611805	REc		Spinocerebellar ataxia 38, 615957 (3)	
6.534	1	6	09	6p12.1	GCLC, GLCLC	C	Glutamate-cysteine ligase, catalytic subunit	606857	REa, Psh, A, Fd		Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3); {Myocardial infarction, susceptibility to}, 608446 (3)	9(Glclc)
6.535	1	24	02	6p21.1	GNMT	P	Glycine N-methyltransferase	606628	A		Glycine N-methyltransferase deficiency, 606664 (3)	
6.536	6	22	15	6p12.2	IL17F, ML1, CANDF6	P	Interleukin 17F	606496	R	mutation identified in 1 CANDF6 family	?Candidiasis, familial, 6, autosomal dominant, 613956 (3)	
6.537	2	7	07	6p12.1	KLHL31, KLHL	P	Kelch-like 31	610749	REc, H			9(Klhl31)
6.538	11	4	98	6p12.2	MCM3	P	Minichromosome maintenance, S. cerevisiae, homolog of, 3	602693	A			
6.539	4	16	14	6p12	NYS2, NYSA	P	Nystagmus 2, congenital, autosomal dominant	164100	Fd		Nystagmus 2, congenital, autosomal dominant (2)	
6.540	5	4	00	6p12.3	TFAP2B, CHAR	C	Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta)	601601	A, Fd		Char syndrome, 169100 (3)	1(Tfap2b)
6.541	2	18	09	6p21.1	VEGF, MVCD1	C	Vascular endothelial growth factor	192240	A		{Microvascular complications of diabetes 1}, 603933 (3)	
6.542	3	3	03	6p12.1	TINAG, TIN1, TIN2	P	Tubulointerstitial nephritis antigen	606749	A			
6.543	10	1	95	6p11.2	PRIM2A	P	Primase polypeptide 2A, 58kD	176636	Psh, A			2(Prim2)
6.544	7	30	14	6p12.1	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	C	Dystonin (bullous pemphigoid antigen 1)	113810	A, REa	?mutation identified in 1 HSAN6 family	?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3); Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	1(Bpag1)
6.545	10	6	09	6p12.2	EFHC1, FLJ10466, EJM1, JAE, EJA1	C	EF hand domain (C-terminal)-containing 1	608815	REc		{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3); {Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	
6.546	7	22	13	6p12-q12	CTRCT28, ARCC1	P	Cataract 28	609026	Fd		{Cataract 28, age-related cortical, susceptibility to} (2)	
6.547	5	25	13	6p12.1	BAG2	P	BCL2-assoiated athanogene 2	603882	REc			
6.548	10	30	03	6p11	AITD1	P	Autoimmune thyroid disease, susceptibility to, 1	608173	Fd		{Autoimmune thyroid disease, susceptibility to, 1} (2)	
6.549	5	31	07	6p12.1-p11.2	RAB23	C	Ras-associated protein RAB23	606144	REc, Fd		Carpenter syndrome, 201000 (3)	
6.550	10	23	87	6p	CSCI	L	Corticosterone side-chain isomerase	122550	H	?linked to MHC		
6.551	3	29	10	6p21.31	RPS10, DBA9	P	Ribosomal protein S10	603632	R, RE		Diamond-Blackfan anemia 9, 613308 (3)	
6.552	4	14	05	6q	BPPV	P	Vertigo, benign paroxysmal positional	193007	Fd	max lod at D6S1556	Vestibulopathy, familial (2)	
6.553	8	9	99	6q23.2	RPS12	P	Ribosomal protein S12	603660	Psh, R			
6.554	8	31	10	6q11-q14	DEL6q11q14, C6DELq11q14	P	Chromosome 6q11-q14 deletion syndrome	613544	Ch	contiguous gene deletion syndrome	Chromosome 6q11-q14 deletion syndrome (4)	
6.555	5	24	13	6q11.1	KHDRBS2, SLM1	P	KH domain-containing, RNA-binding, signal transduction-associated protein 2	610487	REc			
6.556	9	30	04	6q12	ADHD3	P	Attention deficit-hyperactivity disorder, susceptibility to, 2	608905	Fd		{Attention deficit-hyperactivity disorder}, 143465 (2)	
6.557	6	10	98	6q12-q13	BAI3	P	Brain-specific angiogenesis inhibitor-3	602684	A			
6.558	9	5	03	6q14.1	COX7A2	P	Cytochrome c oxidase, subunit VIIa, polypeptide-2, liver	123996	R	previously thought to be on chr.4		
6.559	11	20	08	6q12	EYS, RP25	C	Eyes shut, Drosophila, homolog of	612424	Fd, REc		Retinitis pigmentosa 25, 602772 (3)	
6.560	10	23	87	6q14.2	ME1	C	Malic enzyme, cytoplasmic	154250	S			9(Mod1)
6.561	6	27	14	6q14.1	PGM3, AGM1, IMD23	C	Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1)	172100	S, F, OT, REa		Immunodeficiency 23, 615816 (3)	9(Pgm3)
6.562	5	22	03	6q12	PHF3, KIAA0244	C	PHD finger protein 3	607789	A, R			
6.563	3	1	01	6q12	PTP4A1, HH72, PRL1	P	Protein tyrosine phosphatase, type 4A, 1	601585	A			
6.564	12	4	03	6q13	DDX43, HAGE	P	DEAD/H box 43	606286	R			
6.565	10	11	07	6q13	RIMS1, RIM1, RIM, KIAA0340, CORD7	C	Regulating synaptic membrane exocytosis 1	606629	R, REc, Fd		Cone-rod dystrophy 7, 603649 (3)	
6.566	3	2	01	6q13	COL19A1, D6S228E, COL9A1L	P	Collagen XIX, alpha-1 polypeptide	120165	A, REa			1(Col19a1)
6.567	11	19	11	6q12-q15	MRT30	P	Mental retardation, autosomal recessive 30	614342	Fd	between rs4612125 and rs285651	Mental retardation, autosomal recessive 30 (2)	
6.568	1	30	01	6q12-q16	CMD1K	P	Cardiomyopathy, dilated, 1K	605582	Fd		Cardiomyopathy, dilated, 1K (2)	
6.569	5	29	91	6q14.3	CGA	C	Chorionic gonadotropin, alpha polypeptide	118850	REa, A	shared with LH, FSH, TSH		4(Tsha)
6.570	1	11	07	6q13	CD109	P	CD109 antigen	608859	REc			
6.571	12	8	14	6q13	COL9A1, EDM6, STL4	C	Collagen IX, alpha-1 polypeptide	120210	A	mutation identified in 1 EDM6 family	?Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome, type IV, 614134 (3)	1(Col9a1)
6.572	8	22	07	6q13	DPPA5, ESG1	P	Developmental pluripotency-associated gene 5	611111	R, REc			
6.573	3	3	03	6q13	GLCATS, KIAA1963	C	UDP-glucuronyltransferase S	607497	REc			1(Glcats)
6.574	8	20	92	6q14.1	HTR1B	P	5-hydroxytryptamine (serotonin) receptor-1B	182131	REa, A			
6.575	1	2	08	6q13	KHDC1	P	KH homology domain-containing protein 1	611688	REc			1(Khdc1)
6.576	3	7	13	6q13	KHDC3L, C6orf221, ECAT1, HYDM2	P	KH domain containing 3-like, subcortical maternal complex member	611687	REc		Hydatidiform mole, recurrent, 2, 614293 (3)	
6.577	10	17	12	6q13	LMBRD1, LMBD1, NESI, MAHCF	P	LMBR1 domain-containing protein 1	612625	REc		Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	
6.578	6	11	11	6q13	MB21D1, C6orf150	P	MAB21 domain-containing protein 1	613973	REc			
6.579	3	23	09	6q13	MIR30A, MIRN30A	P	Micro RNA 30A	612329	REc			
6.580	7	18	12	6q13	MTO1, COXPD10	P	Mitochondrial translation optimization 1, S. cerevisiae, homolog of	614667	REc		Combined oxidative phosphorylation deficiency 10, 614702 (3)	
6.581	1	7	11	6q14.1	MYO6, DFNA22, DFNB37	C	Myosin VI	600970	A, H, Fd		Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal recessive 37, 607821 (3); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	9(Sv, Myo6)
6.582	1	2	08	6q13	OOEP, KHDC2	P	Oocyte-expressed protein, Dog, homolog of	611689	REc			9(Ooep)
6.583	12	28	08	6q14.1	SENP6, SSP1, SUSP1	C	Sentrin-specific protease family, member 6	605003	REc, R			
6.584	4	21	16	6q13	SMAP1	P	Small ADP-ribosylation factor GTPase-activating protein 1	611372	REc			
6.585	10	15	04	6q14.1	IBTK	P	Inhibitor of Bruton agammaglobulinemia tyrosine kinase	606457	R			
6.586	7	20	15	6q13-q14	COL12A1, UCMD2, BTHLM2	P	Collagen, type XII, alpha-1	120320	REc	mutation identified in 1 UCMD2 family	?Ullrich congenital muscular dystrophy 2, 616470 (3); Bethlem myopathy 2, 616471 (3)	
6.587	12	30	14	6q14.1	IMPG1, IPM150, VMD4	P	Interphotoreceptor matrix proteoglycan-1	602870	Psh, A		Macular dystrophy, vitelliform, 4, 616151 (3)	
6.588	12	7	07	6q13-q16.1	OTSC7	P	Otosclerosis 7	611572	Fd	between D6S1036 and D6S300	Otosclerosis 7 (2)	
6.589	2	2	01	6q14.1	TTK, MPS1L1, PYT	C	TTK protein kinase	604092	REa, R			
6.590	5	5	09	6q13-q26	SCZD5	P	Schizophrenia susceptibility locus, chromosome 6q-related	603175	Fd	max lod at D6S1626 and D6S292	{Schizophrenia}, 181500 (2)	
6.591	10	30	06	6q14.1	BCKDHB, E1B	C	Branched chain keto acid dehydrogenase E1, beta polypeptide	248611	REa, A, REc		Maple syrup urine disease, type Ib, 248600 (3)	
6.592	8	20	98	6q13	EEF1A1, EF1A	P	Eukaryotic translation elongation factor-1, alpha-1	130590	A, Psh			
6.593	8	6	14	6q14.1	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	P	Elongation of very long chain fatty acids 4	605512	Fd, REc	mutation identified in 1 SCA34 family	Stargardt disease 3, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3); ?Spinocerebellar ataxia 34, 133190 (3)	
6.594	5	6	03	6q13	KCNQ5	P	Potassium channel, voltage-gated, KQT-like subfamily, member 5	607357	A			
6.595	7	20	09	6q14.1	PHIP	P	Pleckstrin homology domain-interacting protein	612870	R, REc			
6.596	8	19	98	6q15	CNR1	P	Cannabinoid receptor-1, brain	114610	Fd, A			4(Cnr1)
6.597	3	20	09	6q14.2	CYB5R4, NCB5OR	P	Cytochrome b5 reductase 4	608343	REc			
6.598	10	13	94	6q14.3	HTR1E	P	5-hydroxytryptamine (serotonin) receptor-1E	182132	Psh, A			
6.599	3	1	94	6q14-q15	M6P2	P	Membrane component, chromosome 6, polypeptide 2 (identified by monoclonal antibody MARB15)	155960	REa, A			
6.600	12	30	99	6q13	SLC17A5, SIASD, SLD	C	Solute carrier family 17 (sodium phosphate), member 5	604322	Fd, LD, REc		Salla disease, 604369 (3); Sialic acid storage disorder, infantile, 269920 (3)	
6.601	8	13	91	6q14.1	TPBG	P	Trophoblast glycoprotein	190920	REa			
6.602	12	29	06	6q15	ANKRD6, KIAA0957	P	Ankyrin repeat domain-containing protein 6	610583	R, REc			
6.603	10	5	07	6q14-q16	ATFB2	P	Atrial fibrillation, familial, 2	608988	Fd	max lod between D6S286 and D6S1021	Atrial fibrillation, familial, 2 (2)	
6.604	6	16	99	6q14-q16.2	PBCRA, CRAPB	P	Progressive bifocal chorioretinal atrophy	600790	Fd		Chorioretinal atrophy, progressive bifocal (2)	
6.605	5	22	92	6q15	GABRR1	P	Gamma-aminobutyric acid (GABA) A receptor, rho-1	137161	Psh, H			4(Gabbr1)
6.606	5	22	92	6q15	GABRR2	P	Gamma-aminobutyric acid (GABA) A receptor, rho-2	137162	Psh, H			4(Gabbr2)
6.607	7	8	11	6q14.3	NT5E, NT5	C	5' nucleotidase, ecto (CD73)	129190	S		Calcification of joints and arteries, 211800 (3)	
6.608	2	18	16	6q14.1	DOPEY1, DOP1, KIAA1117	P	DOPEY family member 1	616823	R, REc			
6.609	5	26	98	6q15	MAP3K7, TAK1	P	Mitogen-activated protein kinase kinase kinase 7	602614	Psh, REc			
6.610	9	2	09	6q14.1	FILIP, KIAA1275	C	Filamin A-interacting protein	607307	R, REc			
6.611	9	10	09	6q14.1	HMGN3, TRIP7	P	High-mobility group nucleosomal binding protein 3 (thyroid hormone receptor interactor 7)	604502	R, REc			
6.612	9	9	13	6q14.1	IRAK1BP1, SIMPL	P	Interleukin 1 receptor-associated kinase 1-binding protein 1	615375	REc			
6.613	9	10	07	6q14.1	LCA5, C6orf152	P	Lebercilin	611408	Fd, REc		Leber congenital amaurosis 5, 604537 (3)	
6.614	9	24	15	6q14.2	RIPPLY2, C6orf59, SCDO6	P	Ripply2, zebrafish, homolog of	609891	REc	mutation identified in 1 SCDO6 family	?Spondylocostal dysostosis 6, 616566 (3)	
6.615	3	7	14	6q14.1	SH3BGRL2	C	SH3 domain-binding glutamic acid-rich protein-like protein 2	615678	REc			
6.616	1	9	13	6q14.1	SHFLD2	P	Split-hand/foot malformation with long bone deficiency 2	610685	Fd	between rs623155 and rs1547251	Split-hand/foot malformation with long bone deficiency 2 (2)	
6.617	5	23	13	5q14.1	TBCA	P	Tubulin-specific chaperone A	610058	REc			
6.618	8	20	07	6q14.1	TMEM30A, CDC50A	P	Transmembrane protein 30A	611028	REc			
6.619	12	22	08	6q14.1	UBE2CBP, H10BH	P	Ubiquitin-conjugating enzyme E2C-binding protein	612495	REc			
6.620	4	29	16	6q14.2	MRAP2, C6orf117, BMIQ18	P	Melanocortin 2 receptor accessory protein 2	615410	REc	mutation identified in 1 BMIQ18 individual	{?Obesity, susceptibility to, BMIQ18}, 615457 (3)	
6.621	2	25	15	6q14.2	SNAP91, AP180, KIAA0656	P	Synaptosomal-associated protein, 91kD	607923	REc, R			
6.622	6	4	15	6q14.2-q14.3	CEP162, KIAA1009	P	Centrosomal protein, 162kD	610201	R, REc			
6.623	5	13	15	6q14.3	SNX14, SCAR20	P	Sorting nexin 14	616105	REc		Spinocerebellar ataxia, autosomal recessive 20, 616354 (3)	
6.624	12	9	15	6q14.3	SYNCRIP, NSAP1, GRYRBP, HNRNPQ	P	Synaptotagmin-binding cytoplasmic RNA-interacting protein	616686	REc			
6.625	12	3	15	6q14.3	TBX18, CAKUT2	P	T-box 18	604613	REc		Congenital anomalies of kidney and urinary tract 2, 143400 (3)	
6.626	2	5	15	6q14.3	ZNF292, ZFP292, KIAA0530	C	Zinc finger protein 292	616213	REc, R, H			4(Znf292)
6.627	4	17	13	6q15	AKIRIN2	P	Akirin 2	615165	REc			
6.628	11	28	01	6q15	BACH2	P	BTB and CNC homology 2	605394	A			
6.629	9	1	09	6q15	CASP8AP2, FLASH	P	Caspase 8-associated protein 2	606880	R, REc			
6.630	4	1	08	6q15	GJA10, CX62	P	Gap junction protein, alpha-10	611924	REc			
6.631	4	1	08	6q14-q15	GJB7, CX25	P	Gap junction protein, beta-7	611921	REc			
6.632	9	10	09	6q15	ORC3, ORC3L, LAT	P	Origin recognition complex, subunit 3, S. cerevisiae, homolog of	604972	H, REc			4(Orc3)
6.633	8	18	14	6q15	PM20D2, ACY1L2	P	Peptidase M20 domain-containing 2	615913	REc			
6.634	3	11	08	6q15	PNRC1, PROL2	P	Proline-rich nuclear receptor coactivator 1	606714	R, REc			
6.635	7	10	07	6q15	SLC35A1, CST, CDG2F	C	Solute carrier family 35 (CMP-sialic acid transporter), member 1	605634	R, REc		Congenital disorder of glycosylation, type IIf, 603585 (3)	
6.636	3	4	10	6q14.3	SNHG5, U50HG	P	Small nucleolar RNA host gene 5	613263	REc			
6.637	11	12	09	6q14.3	SNORD50A, RNU50	P	Small nucleolar RNA, C/D box, 50A	613117	REc			
6.638	3	4	10	6q14.3	SNORD50B	P	Small nucleolar RNA, C/D box	613264	REc			
6.639	2	4	15	6q15	UBE2J1, UBC6E	P	Ubiquitin-conjugating enzyme E2J 1	616175	REc			
6.640	3	6	08	6q15	RRAGD, RAGD	P	RAS-related GTP-binding protein D	608268	R, REc			
6.641	5	5	09	6q15	SPACA1, SAMP32	P	Sperm acrosome-associated 1	612739	REc			
6.642	4	22	02	6q16.1	FUT9	P	Fucosyltransferase 9	606865	A			
6.643	10	7	08	6q16.1	MANEA, ENDO	P	Mannosidase, endo-alpha	612327	REc			
6.644	5	9	95	6q16.1	POU3F2, OCT7	P	POU domain, class 3, transcription factor 2	600494	REa, A			4(Pou3f2)
6.645	6	18	99	6q15	RNGTT, HCE1, CAP1A	P	RNA guanylyltransferase and 5'-phosphatase	603512	RE, R			
6.646	8	19	14	6q16.1	EPHA7, HEK11	P	Ephrin receptor EphA7	602190	REc			
6.647	10	28	08	6q21	MICAL1, NICAL, MICAL	P	Microtubule-associated monooxygenase, calponin and LIM domains-containing 1	607129	R, REc			
6.648	2	2	14	6q16.1	MMS22L, C6orf167	P	MMS22-like protein	615614	REc			
6.649	7	22	09	6q16.1	NDUFAF4, HRPAP20, C6orf66	C	NADH dehydrogenase 1 alpha subcomplex, assembly factor 4	611776	REc, Fd		Mitochondrial complex I deficiency, 252010 (3)	
6.650	4	22	15	6q16.1	PNKY	P	Long intergenic noncoding RNA Pinky	616328	REc			
6.651	10	15	07	6q15	RARS2, RARSL, PCH6	C	Arginyl-tRNA synthetase 2	611524	REc, Fd		Pontocerebellar hypoplasia, type 6, 611523 (3)	
6.652	2	4	15	6q16.1	UFL1, KIAA0776, NLBP	P	UFM1-specific ligase 1	613372	R, REc			
6.653	11	1	13	6q16.1-q16.2	FBXL4, FBL4, MTDPS13	P	F-box and leucine-rich repeat protein 4	605654	REc		Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	4(Fbxl4)
6.654	2	2	10	6q16.1	FHL5, ACT	C	Four-and-a-half LIM domains 5	605126	REc, A			
6.655	5	13	02	6q16.1	GPR63	P	G protein-coupled receptor 63	606915	REc			
6.656	3	3	16	6q16.2	DHS6S1, MCDR1	P	DNase1 hypersensitivity, chromosome 6, site 1	616842	REn, Fd	upstream of PRDM13 and CCNC	Macular dystrophy, North Carolina type, 136550 (3)	
6.657	11	20	15	6q16.2	PNISR, SRRP130, SFRS18	P	PNN-interacting serine/arginine-rich protein	616653	REc			
6.658	1	8	16	6q16.2	PRDM13	P	PR domain-containing protein 13	616741	REc			
6.659	7	18	01	6q16.2	MCHR2, MCH2R, SLT, MCH2	P	Melanin-concentrating hormone receptor 2	606111	REc, R, A			
6.660	4	23	08	6q16.2-q22.1	LMPH1B	P	Lymphedema, hereditary, IB	611944	Fd	max lod at D6S1671	Lymphedema, hereditary, IB (2)	
6.661	9	8	11	6q16.3	ASCC3, p200	P	Activating signal cointegrator 1 complex, subunit 3	614217	REc			
6.662	4	5	00	6q16.3	SIM1	C	Single-minded, Drosophila, homolog of, 1	603128	A, R, Ch		Obesity, severe, 601665 (3)	10(Sim1)
6.663	9	11	12	6q16.3-q22.31	GEFSP8	P	Generalized epilepsy with febrile seizures plus, type 8	613828	Fd	between D6S962 and D6S287	Epilespy, generalized, with febrile seizures plus, type 8 (2)	
6.664	7	11	97	6q21	AIM1, ST4	C	Absent in melanoma 1	601797	M, A			10(Aim1)
6.665	9	9	13	6q21	AK9	P	Adenylate kinase 9	615358	REc			
6.666	10	24	00	6q21	APG5L	P	Autophagy 5, S. cerevisiae, homolog of	604261	A			
6.667	5	19	15	6q21	BEND3, KIAA1553	P	BEN domain-containing protein 3	616374	Psh, REc			
6.668	4	10	90	6q21	BKMA1	P	Banded krait minor satellite DNA-1	109780	A	related to heterogametic sex		17(Bkma1)
6.669	2	17	16	6q21	BVES, HBVES, POPDC1, LGMD2X	P	Blood vessel epicardial substance	604577	REc	mutation identified in 1 LGMD2X family	?Muscular dystrophy, limb-girdle, type 2X, 616812 (3)	
6.670	7	10	95	6q16.2	CCNC	C	Cyclin C	123838	A			
6.671	9	7	12	6q21	CD24	P	CD24 antigen	600074	A, Psh	pseudogenes at 15q21-q22; Yq11		
6.672	9	8	08	6q21	CD164	P	CD164 antigen	603356	A			
6.673	4	21	16	3q25.1	SUCNR1, GPR91	P	Succinate receptor 1	606381	REc			
6.674	7	18	12	6q21	CDK19, KIAA1028	P	Cyclin-dependent kinase 19	614720	REc, R			
6.675	8	8	13	6q21	DDO, DASOX	P	D-aspartate oxidase	124450	REc			
6.676	2	25	16	6q21	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	P	Fig4, S. cerevisiae, homolog of	609390	R, REc, Fd	mutation identified in 1 BTOP family	Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral sclerosis 11, 612577 (3); Yunis-Varon syndrome, 216340 (3); ?Polymicrogyria, bilateral temporooccipital, 612691 (3)	
6.677	9	9	08	6q21	FOXO3A, FOXO3, FKHRL1	P	Forkhead box O3A	602681	A			
6.678	1	4	93	6q21	FYN	P	FYN oncogene related to SRC, FGR, YES	137025	REa, A	proximal 6q21		10(Fyn)
6.679	4	30	15	6q22.1	GOPC, PIST, FIG, CAL	C	Golgi-associated PDZ and coiled-coil domains-containing protein	606845	REc			
6.680	10	15	07	6q16.3	GRIK2, GLUR6, MRT6	C	Glutamate receptor, ionotropic, kainate 2	138244	REa, R, Fd		Mental retardation, autosomal recessive, 6, 611092 (3)	
6.681	2	11	08	6q21	GTF3C6, C6orf51	P	General transcription factor 3C, polypeptide 6	611784	REc			
6.682	2	5	16	6q16.3	HACE1, KIAA1320, SPPRS	P	HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1	610876	REc		Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	
6.683	1	8	01	6q21	HDAC2	C	Histone deacetylase 2	605164	Psh, A			10(Hdac2)
6.684	2	13	06	6q22.31	HEY2, HERP1, GRL	P	Hairy/enhancer of split-related with YRPW motif 2	604674	A, R			
6.685	10	4	01	6q21	HTX3	L	Heterotaxy, visceral, 3, autosomal	606325	Ch		?Heterotaxy, visceral, 3, autosomal (2)	
6.686	12	9	98	6q21	IDDM15	C	Insulin-dependent diabetes mellitus-15	601666	Fd		{Diabetes mellitus, insulin-dependent, 15} (2)	
6.687	5	24	13	6q21	LAMA4, LAMA3, CMD1JJ	P	Laminin, alpha-4	600133	A, REb		Cardiomyopathy, dilated, 1JJ, 615235 (3)	
6.688	7	23	09	6q21	LGV2	P	Longevity 2	606460	Fd	associated with rs2802292	[Longevity 2] (2)	
6.689	8	20	07	6q16-q21	LIN28B	P	Lin28, C. elegans, homolog of, B	611044	REc, H			6(Lin28b)
6.690	1	31	11	6q21	MCOPS8, MMEP	P	Microphthalmia, syndromic 8	601349	Ch	translocation with 13q12	Microphthalmia, syndromic 8 (2)	
6.691	7	20	09	6q21	MENAQ2	P	Menarche, age at, QTL2	612882	Fd	associated with rs7759938	{Menarche, age at, QTL2} (2)	
6.692	5	14	09	6q22.31	NKAIN2, TCBA	P	Na+/K+ transporting ATPase interacting 2	609758	REc, Ch	fused with SUSP1 in T-cell lymphoma/leukemia		
6.693	6	4	99	6q21	NR2E1, TLX	P	Nuclear receptor subfamily 2, group E, member 1 (tailless, Drosophila, homolog of)	603849	REc			
6.694	10	3	07	6q21	OSTM1, GL, OPTB5	P	Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of)	607649	REc		Osteopetrosis, autosomal recessive 5, 259720 (3)	
6.695	5	24	12	6q21	PDSS2, DLP1, C6orf210, COQ10D3	C	Prenyl diphosphate synthase, subunit 2	610564	REc		Coenzyme Q10 deficiency, primary, 3, 614652 (3)	
6.696	10	14	09	6q21	POPDC3, POP3	P	Popeye domain-containing protein 3	605824	R, REc			
6.697	3	29	99	6q21	REV3L, POLZ, REV3	P	Rev-3, yeast, homolog-like (polymerase, DNA, zeta)	602776	REn	conflicting assignment on chr.1		
6.698	1	6	16	6q21	RTN4IP1, NIMP, OPA10	P	Reticulon 4-interacting protein 1	610502	REc		Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3)	
6.699	5	31	05	6q21	SEC63	P	Sec63, S. cerevisiae, homolog of	608648	A		Polycystic liver disease, 174050 (3)	
6.700	1	11	07	6q21	SESN1, SEST1, PA26	C	Sestrin 1	606103	REa, A, Ch			4(Pa26)
6.701	3	22	07	6q21	SLC22A16, FLIPT2, CT2	C	Solute carrier family 22 (organic cation transporter), member 16	608276	REc, A			
6.702	7	25	06	6q21	SNX3	C	Sorting nexin 3	605930	R, REc, Ch	t(6;13)(q21;q12)		
6.703	12	16	10	6q21	SOBP, JXC1, MRAMS	P	Sine oculis-binding protein, Drosophila, homolog of	613667	REc		Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	
6.704	11	15	13	6q21	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	P	TRAF3-interacting protein 2	607043	REc	mutation identified in 1 family with CANDF8	{Psoriasis susceptibility 13}, 614070 (3); ?Candidiasis, familial, 8, 615527 (3)	
6.705	7	22	09	6q21	TUBE1, TUBE	P	Tubulin, epsilon-1	607345	REc			
6.706	3	24	06	6q22.1	VGLL2, VGL2, VITO1	P	Vestigial-like 2	609979	REc			
6.707	7	1	11	6q21	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	C	Zinc finger- and BTB domain-containing protein 24	614064	R, REc		Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	
6.708	11	20	95	6q21	AMD1	C	S-adenosylmethionine decarboxylase-1	180980	REa	pseudogene AMD2 on Xq28		
6.709	8	18	04	6q21-q22	PLF	P	Pulmonary function	608852	Fd	close to D6S281	{Pulmonary function} (2)	
6.710	2	28	03	6q21	SLC16A10, TAT1	P	Solute carrier family 16 (monocarboxylic acid transporter), member 10	607550	R, A			
6.711	1	29	01	6q21	WASF1, WAVE, WAVE1, SCAR1	C	Wiskott-Aldrich syndrome protein family, member 1	605035	R, A			
6.712	6	12	95	6q21	GPR6	C	G protein-coupled receptor-6	600553	A			
6.713	6	18	99	6q21	PRDM1, BLIMP1	P	PR domain-containing protein 1 (B-lymphocyte-induced maturation protein 1)	603423	REc, Psh			10(Blimp1)
6.714	8	9	99	6q22.1	COL10A1	C	Collagen X, alpha-1 polypeptide	120110	REa, A		Metaphyseal chondrodysplasia, Schmid type, 156500 (3)	10(Col10a1)
6.715	1	7	02	6q22.1	FRK, RAK, GTK	P	FYN-related kinase	606573	REc			
6.716	8	11	91	6q24.1	NMBR	P	Neuromedin B receptor	162341	Psh			
6.717	11	22	13	6q22.1	DSE, SART2, EDSMC2	P	Dermatan sulfate epimerase	605942	REc	mutation identified in 1 family	?Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	
6.718	9	28	00	6q23.2	ENPP3, PDNP3	P	Ectonucleotide pyrophosphatase/phosphodiesterase 3	602182	A			
6.719	9	10	09	6q22.31	MAN1A1	P	Mannosidase, alpha, class 1A, member 1	604344	REc			
6.720	12	07	07	6q23.3	MYB	C	Avian myeloblastosis viral (v-myb) oncogene homolog	189990	REa, A, Ch		{T-cell acute lymphoblastic leukemia} (3)	10(Myb)
6.721	2	10	97	6q21	PREP	P	Prolyl endopeptidase	600400	A			
6.722	1	4	93	6q22.1	ROS1, MCF3	C	Avian UR2 sarcoma virus oncogene (v-ros) homolog 1	165020	REa, A			10(Ros1)
6.723	2	17	09	6q23.3	BCLAF1, BTF, KIAA0164	P	BCL2-associated transcription factor 1	612588	R, REc			
6.724	7	2	14	6q23.2	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	C	Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335	A, H		{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized, of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3); Cole disease, 615522 (3)	10(Ly41, Pca1)
6.725	11	3	98	6q23.1-q23.2	EPB41L2	P	Erythrocyte membrane protein band 4.1-like 2	603237	A			
6.726	3	18	10	6q22.31	FABP7, FABPB, BLBP	P	Fatty acid-binding protein 7	602965	REc			
6.727	1	7	14	6q22-q23	IGAN1	P	IgA nephropathy, susceptibility to, 1	161950	Fd		{IgA nephropathy, susceptibility to, 1} (2)	
6.728	6	11	03	6q22.33	LAMA2, LAMM	C	Laminin, alpha-2 (merosin)	156225	REa, A, Fd		Muscular dystrophy, congenital merosin-deficient, 607855 (3); Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)	10(dy, Lamm)
6.729	4	17	00	6q22-q23	SM2	P	Hepatic fibrosis susceptibility due to Schistosoma mansoni infection	604201	Fd	?polymorphism of INFGR1	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection} (2)	
6.730	10	15	13	6q22.31	TRDN, TDN, CPVT5	P	Triadin	603283	A		Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3)	
6.731	7	19	04	6q22.1	TSPYL1, TSPYL, SIDDT	C	Y-encoded testis-specific protein-like	604714	REa, A, H		Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	10(Tspyl)
6.732	8	19	04	6q21	WISP3, PPAC, PPD	C	Wnt-1 inducible signaling pathway protein 3	603400	R, A, Fd		Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3); Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	
6.733	6	7	10	6q22.33	ARHGAP18	P	RHO GTPase-activating protein 18	613351	REc			
6.734	8	9	05	6q22-q24	FEB5	P	Febrile seizures, familial, 5	609255	Fd	between D6S1572 and D6S472	Febrile seizures, familial, 5 (2)	
6.735	6	27	08	6q22-q24	FIQTL1	P	Fasting insulin level quantitative trait locus 1	606035	Fd	max lod at D6S1569	[Fasting insulin level quantitative trait locus 1] (2)	
6.736	10	18	00	6q23.3	MAP7, EMAP115	L	Microtubule-associated protein-7	604108	H			10(Map7)
6.737	9	8	11	6q22.1	BET3L, TRAPPC3L	P	Bet3, S. cerevisiae, homolog-like	614137	REc			
6.738	5	21	03	6q21	CDC40, PRP17	P	Cell division cycle 40, S. cerevisiae, homolog of	605585	REn			
6.739	4	25	14	6q22.1	KPNA5	P	Karyopherin alpha-5	604545	REc			
6.740	4	11	11	6q22.31	PLN, PLB, CMD1P, CMH18	C	Phospholamban	172405	REc, A		Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, hypertrophic, 18, 613874 (3)	
6.741	3	19	09	6q22.1	RSPH4A, CILD11	P	Radial spoke head 4, Chlamydomonas, homolog of, A	612647	REc		Ciliary dyskinesia, primary, 11, 612649 (3)	
6.742	8	17	15	6q22.31	MCM9, MCMDC1, ODG4	P	Minichromosome maintenance complex component 9	610098	REc		Ovarian dysgenesis 4, 616185 (3)	10(Mcm9)
6.743	8	18	08	6q22.33	RNF146	P	Ring finger protein 146	612137	REc			
6.744	6	29	94	6q21	MRACKS, MACS, PKCSL	C	Myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L)	177061	REb, REa	monomorphic		10(Macs)
6.745	4	16	14	6q22.1	RFX6, RFXDC1, MTCHRS	P	Regulatory factor X, 6	612659	REc		Mitchell-Riley syndrome, 615710 (3)	
6.746	5	26	13	6q22.33	RSPO3, PWTSR, CRISTIN1	P	R-spondin family member 3	610574	REc			10(Rspo3)
6.747	5	20	99	6q22.33	PTPRK	C	Protein-tyrosine phosphatase, receptor type, kappa	602545	REa, A, REc			10(Ptprk)
6.748	4	20	10	6q23.2	C6orf192	P	Chromosome 6 open reading frame 192	613361	REc			
6.749	8	23	05	6q22.31	HSF2	P	Heat-shock transcription factor 2	140581	R, REc			
6.750	2	3	05	6q22.31	ASF1A, CIA	P	Anti-silencing function 1, S. cerevisiae, homolog of, A	609189	REc			
6.751	5	11	16	6q22.31	CLVS2	P	Clavesin 2	616945	REc			
6.752	6	30	05	6q21-q22	HS3ST5, 3OST5	P	Heparan sulfate 3-O-sulfotransferase 5	609407	REc			
6.753	1	5	09	6q22.1	NUS1, NGBR, C6orf68	P	Nuclear undecaprenyl pyrophosphate synthase 1, S. cerevisiae, homolog of	610463	REc			
6.754	9	10	09	6q22.31	PKIB	P	Protein kinase, cAMP-dependent catalytic, inhibitor beta	606914	R, REc			
6.755	4	2	12	6q22.31	SERINC1, TMS2, KIAA1253	P	Serine incorporator 1	614548	REc			
6.756	1	29	07	6q22.31	SMPDL3A, ASML3A	P	Sphingomyelin phosphodiesterase, acid-like, 3A	610728	REc, R			
6.757	7	3	14	6q22.31	TBC1D32, BROMI	P	TBC1 domain family, member 32	615867	REc			10(Tbc1d32)
6.758	5	25	13	6q22.31	TPD52L1, D53	P	Tumor protein D52-like 1	604069	REc, A			10(Tdp52l1)
6.759	4	6	13	6q22.32	CEMPW, C6orf173, CUG2	P	Centromeric protein W	611264	REc			
6.760	8	18	08	6q22.33	ECHDC1	P	Enoyl coenzyme A hydratase domain-containing protein 1	612136	REc			
6.761	3	24	06	6q22.32	HINT3	P	Histidine triad nucleotide-binding protein 3	609998	REc			
6.762	6	23	99	6q23.3	MAP3K5, MEKK5, MAPKKK5, ASK1	P	Mitogen-activated protein kinase kinase kinase 5	602448	R			
6.763	12	23	05	6q22.31-q22.32	NCOA7, ERAP140	P	Nuclear receptor coactivator 7	609752	REc			
6.764	1	27	11	6q22.33	THEMIS, GASP, SPOT, C6ORF190	P	Thymocyte-expressed molecule involved in selection	613607	REc			10(Themis)
6.765	11	13	07	6q22.3-q23.1	HBFQTL2, FCP	P	Fetal hemoglobin quantitative trait locus 2	142470	Fd		Fetal hemoglobin quantitative trait locus 2 (2)	
6.766	10	9	96	6q25.1	PCMT1	P	Protein-L-isoaspartate (D-aspartate) O-methyltransferase	176851	REa, A			10(Pcmt1)
6.767	12	3	03	6q23.2	ARG1	C	Arginase, liver	608313	REa		Argininemia, 207800 (3)	
6.768	4	4	11	6q23	CMD1F, CDCD3, LGMD1D	P	Cardiomyopathy, dilated-1F, autosomal dominant	602067	Fd		Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D (2)	
6.769	4	25	05	6q23.2	EYA4, DFNA10, CMD1J	C	Eyes absent, Drosophila, homolog of, 4	603550	R, Fd, A		Deafness, autosomal dominant 10, 601316 (3); Cardiomyopathy, dilated, 1J, 605362 (3)	
6.770	3	15	10	6q23	HCHGQ1	P	Hematocrit/hemoglobin quantitative trait locus 1	609319	Fd		[Hematocrit/hemoglobin quantitative trait locus 1] (2)	
6.771	3	19	01	6q23.3	IL20RA	P	Interleukin 20 receptor, alpha	605620	REc			
6.772	2	25	12	6q23	RP63	P	Retinitis pigmentosa 63	614494	Fd	between D6S457 and D6S1656	Retinitis pigmentosa 63 (2)	
6.773	1	31	08	6q23	RA	P	Rheumatoid arthritis, susceptibility to	180300	REc	associated with SNP rs10499194 and rs6920220	{Rheumatoid arthritis, susceptibility to} (2)	
6.774	1	13	99	6q23.2	SGK1	P	Serum/glucocorticoid-regulated kinase 1	602958	A			
6.775	10	30	08	6q23	SLEB13	P	Systemic lupus erythematosus, susceptibility to, 13	612378	associated with rs5029939		{Systemic lupus erythematosus, susceptibility to, 13} (2)	
6.776	7	13	98	6q22.31	STL	P	Six-twelve leukemia gene	602532	REc			
6.777	1	13	16	6q23.3	TNFAIP3, A20, OTUD7C, AISBL	P	Tumor necrosis factor-alpha-induced protein 3	191163	REc		Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	
6.778	1	25	93	6q24.2	HIVEP2	P	Human immunodeficiency virus type I enhancer-binding protein-2	143054	REa, A			
6.779	5	2	08	6q23-q24	MAFD6, BPAD	P	Major affective disorder 6	611536	Fd		{Major affective disorder 6} (2)	
6.780	3	5	98	6q23-q24	NTT	P	Noncoding transcript in T cells	602154	A			
6.781	12	21	09	6q23.3	PBOV1, UROC28, UC28	P	Prostate and breast cancer overexpressed 1	605669	A			
6.782	11	23	98	6q23.2	TCF21, POD1	L	Transcription factor-21 (epicardin; podocyte-expressed 1)	603306	H			10(Tcf21)
6.783	12	17	07	6q23.2	VNN1, HDLCQ8	C	Vanin 1	603570	A, H, Psh		[High density lipoprotein cholesterol level QTL 8] (3)	10(Vnn1)
6.784	6	18	99	6q23.2	VNN2	C	Vanin 2	603571	A, Psh, REc			
6.785	2	20	02	6q23.2	VNN3	P	Vanin 3	606592	REc			10(Vnn3)
6.786	4	27	12	6q23-q24.1	SPG25	P	Spastic paraplegia 25, autosomal recessive, with disc herniation	608220	Fd		Spastic paraplegia 25, autosomal recessive (2)	
6.787	10	08	08	6q23-q25	BMIQ3	P	Body mass index quantitative trait locus 3	607446	Fd	max lod at D6S305	[Body mass index QTL3] (2)	
6.788	9	22	04	6q23-q25	LNCR1	P	Lung cancer 1	608935	Fd	max hlod at D6S2436	{Lung cancer susceptibility} (2)	
6.789	7	11	93	6q23.2	CTGF, NOV2	P	Connective tissue growth factor	121009	REa, A	proximal to MYB		
6.790	7	1	05	6q23.2	TAAR1, TA1	C	Trace amine-associated receptor 1	609333	R, REc			10(Taar1)
6.791	11	2	04	6q23.2	MOXD1, MOX	P	Monooxygenase, DBH-like, 1	609000	R, REc			
6.792	9	18	12	6q24.1	REPS1	P	RALBP1-associated EPS domain-containing protein 1	614825	REc			
6.793	9	1	09	6q23.3	ALDH8A1, ALDH12	P	Aldehyde dehydrogenase 8 family, member A1	606467	R, REc			
6.794	5	28	02	6q23.2	GPR102, TA5	C	G protein-coupled receptor 102	606927	REc, R			
6.795	9	26	11	6q23.2	MED23, MRT18	P	Mediator complex subunit 23	605042	REc		Mental retardation, autosomal recessive 18, 614249 (3)	
6.796	2	28	03	6q23.2	PNR	C	Putative neurotransmitter receptor	607405	A, REc			
6.797	8	19	13	6q23.2	SLC2A12, GLUT12	P	Solute carrier family 2 (facilitated glucose transporter), member 12	610372	REc, R			10(Slc2a12)
6.798	9	22	04	6q23.2	STX7	C	Syntaxin 7	603217	REa, REc			
6.799	12	5	03	6q23.2	TAR3, TA3	P	Trace amine receptor 3	608282	R			
6.800	10	24	14	6q23.2	TARID	P	TCF21 antisense RNA inducing promoter demethylation	616058	REc			
6.801	5	5	09	6q23.2	TAAR6, TRAR4	P	Trace amine-associated receptor 6	608923	REc			
6.802	9	15	04	6q23.3	AHI1	C	Abelson helper integration site 1	608894	Fd, REc, R		Joubert syndrome-3, 608629 (3)	
6.803	1	18	12	6q24.1	CITED2, MRG1, P35SRJ, VSD2, ASD8	P	CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2	602937	REc	?pseudogene on 1q22	Ventricular septal defect 2, 614431 (3); Atrial septal defect 8, 614433 (3)	
6.804	9	22	14	6q23.3	IFNGR1, IMD27A, IMD27B	C	Immune interferon, receptor for	107470	S, A, Fd, REc		Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3); {H. pylori infection, susceptibility to}, 600263 (3); {Tuberculosis, susceptibility to}, 607948 (3); Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3); {Tuberculosis infection, protection against}, 607948 (3); {Hepatitis B virus infection, susceptibility to}, 610424 (3)	10(Ifgr)
6.805	5	29	12	6q23.3	MPVQTL5	P	Mean platelet volume quantitative trait locus 5	614645	Fd	associated with rs9399137	Mean platelet volume QTL5 (2)	
6.806	7	1	05	6q23.3	OLIG3, BHLHB7	P	Oligodendrocyte lineage transcription factor 3	609323	REc			
6.807	7	17	14	6q23.3	PDE7B	P	Phosphodiesterase 7B, cAMP-specific, high-affinity	604645	REc			
6.808	1	11	16	6q23.3	PEX7, RCDP1, PBD9B	P	Peroxisomal biogenesis factor-7	601757	REa, R, REc		Rhizomelic chondrodysplasia punctata, type 1, 215100 (3); Peroxisome biogenesis disorder 9B, 614879 (3)	
6.809	1	7	09	6q23.3	SLC35D3	P	Solute carrier family 35, member D3	612519	REc, H			10(Slc35d3)
6.810	8	27	01	6q24.1	C6orf34, SOUL	P	Soul, chicken, homolog of	605825	REc			
6.811	2	27	03	6q24.3	EPM2A, MELF, EPM2	C	Laforin	607566	Fd		Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	
6.812	9	9	08	6q24.3	FBXO30, FBX30	P	F-box only protein 30	609101	REc			10(Fbxo30)
6.813	9	28	12	6q24.3	GRM1, MGLUR1, GRM1A, SCAR13	C	Glutamate receptor, metabotropic, 1	604473	REa, A		Spinocerebellar ataxia, autosomal recessive 13, 614831 (3)	
6.814	12	24	08	6q23.3	HBS1L, KIAA1038, ERFS	P	HBS1-like protein	612450	REc			
6.815	11	15	08	6q24.2	HYMAI	C	Hydatidiform mole-associated and imprinted transcript	606546	REc, Ch, Fd			
6.816	2	28	03	6q24.2	PLAGL1, ZAC, LOT1	C	Pleomorphic adenoma gene-like 1 (ZAC tumor suppressor)	603044	A, REc, Ch, Fd	relaxed imprinting in TNDM	{Diabetes mellitus, transient neonatal}, 601410 (1)	10(Zac)
6.817	3	13	06	6q24.2	STX11, FHL4, HPLH4, HLH4	C	Syntaxin-11	605014	Fd, REc		Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	
6.818	4	26	05	6q23.2	TAAR2, GPR58	P	Trace amine-associated receptor 2	604849	A			
6.819	7	8	96	6q24.2	UTRN, DMDL, DRP1	C	Utrophin (homologous to dystrophin)	128240	REa, F, Fd, A	near dy in mouse		10(Dmdl)
6.820	9	30	10	6q24-q25	DEL6q24q25, C6DELq25q25	P	Chromosome 6q24-q25 deletion syndrome	612863	Ch		Chromosome 6q25-q25 deletion syndrome (4)	
6.821	9	29	09	6q25.1	IYD, DEHAL1, TDH4	P	Iodotyrosine deiodinase	612025	REc		Thyroid dyshormonogenesis 4, 274800 (3)	
6.822	10	8	09	6q25.2	OPRM1	C	Opioid receptor, mu-1	600018	A			10(Oprm)
6.823	3	10	03	6q25.1	PPIL4	P	Peptidyl-prolyl isomerase-like 4	607609	REc, Psh			
6.824	2	17	09	6q24-q25	STQTL1	C	Stature quantitative trait locus 1	606255	Fd	associated with rs4896582 and rs3748069	{Stature QTL 1} (2)	
6.825	8	28	92	6q25.3	MAS1	C	Oncogene MAS1	165180	A, REa			17(Mas1)
6.826	4	17	07	6q24.1-q24.2	C6orf55, SBP1, LIP5, VTA1, DRG1	P	SKD1-binding protein 1	610902	R, REc			
6.827	8	2	13	6q24.1	CCDC28A, C6orf80	P	Coiled-coil domain-containing 28A	615353	REc			
6.828	7	31	15	6q24.2	GPR126, VIGR, LCCS9	C	G protein-coupled receptor 126	612243	REc, H		Lethal congenital contracture syndrome 9, 616503 (3)	10(Gpr126)
6.829	2	25	15	6q24.1	HECA, HDC	P	Headcase, Drosophila, homolog of	607977	REc			
6.830	1	30	02	6q23.3	IL22BP, IL22RA2	C	Interleukin 22-binding protein	606648	REc, R			
6.831	9	9	13	6q24.2	ADAT2, TAD2	P	Adenosine deaminase, tRNA-specific, 2	615388	REc			
6.832	2	24	12	6q24.2	FUCA2	C	Fucosidase, alpha-L- 2, plasma	136820	F	linked to PLG		
6.833	10	25	12	6q24.2	PEX3, PBD10A	C	Peroxisomal biogenesis factor-3	603164	REc, A		Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3)	
6.834	7	16	12	6q24.2	PHACTR2, KIAA0680	P	Phosphatase and actin regulator 2	608724	R, REc			
6.835	5	5	09	6q24.2-q25.2	DUH1, DUH	P	Dyschromatosis universalis hereditaria 1	127500	Fd	max lod at D6S1553	Dyschromatosis universalis hereditaria 1 (2)	
6.836	8	20	07	6q25.1	RAET1L	P	Retinoic acid early transcript 1L	611047	REc			
6.837	6	1	12	6q24.3	ADGB	P	Androglobin	614630	REc			
6.838	12	5	03	6q25.1	NUP43	P	Nucleoporin, 43kD	608141	R, REc			
6.839	2	21	10	6q25.1	PPP1R14C, KEPI	P	Protein phosphatase 1, regulatory subunit 14C	613242	REc			
6.840	7	22	09	6q24.3	RAB32	C	Ras-associated protein RAB32	612906	REc			
6.841	2	26	09	6q24.3-q25.1	SASH1, KIAA0790	C	Sterile alpha motifs- and SH3 domain-containing protein 1	607955	R, REc			
6.842	8	24	04	6q24.3	STXBP5	P	Syntaxin-binding protein 5 (tomosyn)	604586	R, REc			
6.843	6	30	08	6q25	BMND11	P	Bone mineral density quantitative trait locus 11	612114	Fd	associated with rs4870044, rs1038304, and rs1999805	[Bone mineral density QTL 11] (2)	
6.844	3	23	06	6q25.3	FNDC1, AGS8, KIAA1866	P	Fibronectin type III domain-containing protein 1	609991	R, REc			
6.845	1	7	09	6q25	IDDM21	P	Diabetes mellitus, insulin-dependent, 21	612521	Fd	associated with rs1738074	{Diabetes mellitus, insulin-dependent, 21} (2)	
6.846	2	12	16	6q25.2	MYCT1, MTLC	P	MYC target in myeloid cells 1	616805	REc			
6.847	11	12	12	6q25.1	RMND1, COXPD11	P	Required for meiotic nuclear division 1, S. cerevisiae, homolog of	614917	REc		Combined oxidative phosphorylation deficiency 11, 614922 (3)	
6.848	11	20	13	6q25.2	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	C	Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1)	608441	A, Fd, REc		Spinocerebellar ataxia, autosomal recessive 8, 610743 (3); Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	
6.849	5	31	05	6q25.1	SUMO4, IDDM5	C	Small ubiquitin-like modifier 4	608829	Fd, REc		{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)	
6.850	1	11	16	6q25.1	TAB2, MAP3K7IP2, KIAA0733, CHTD2	P	Tak1 (MAP3K7) binding protein 2	605101	R, REc		Congenital heart defects, nonsyndromic, 2, 614980 (3)	
6.851	9	10	09	6q25.3	TFB1M, CGI75	P	Transcription factor B1, mitochondrial	607033	R, REc			
6.852	2	28	01	6q25.1	ULBP1	P	UL16-binding protein 1	605697	REn			
6.853	2	28	01	6q25.1	ULBP2	P	UL16-binding protein 2	605698	REn			
6.854	2	28	01	6q25.1	ULBP3	P	UL16-binding protein 3	605699	REn			
6.855	9	9	08	6q25.2	FBXO5, FBX5, EMI1	P	F-box only protein 5	606013	A, H			10(Fbxo5)
6.856	12	29	89	6q25-q26	RCD1	L	Retinal cone dystrophy-1	180020	Ch		?Retinal cone dystrophy-1 (2)	
6.857	12	9	98	6q25-q27	IDDM8	P	Insulin-dependent diabetes mellitus-8	600883	Fd		{Diabetes mellitus, insulin-dependent, 8} (2)	
6.858	1	29	04	6q26	PACRG	P	Parkin coregulated gene	608427	REc	shares 5' regulatory region and both 3' UTRs with PARK2		17(Pacrg)
6.859	4	28	16	6q25.3	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	C	AT-rich interaction domain-containing protein 1B	614556	R, REc		Coffin-Siris syndrome 1, 135900 (3)	
6.860	4	30	15	6q25.1	ARMT1, C6orf211	P	Acidic residue methyltransferase 1	616332	REc			
6.861	8	19	13	6q25.1-q25.2	ESR1, ESR, ESTRR	C	Estrogen receptor 1	133430	REa, A		Estrogen resistance, 615363 (3); {HDL response to hormone replacement, augmented} (3); {Migraine, susceptibility to}, 157300 (3); {Atherosclerosis, susceptibility to} (3); {Myocardial infarction, susceptibility to}, 608446 (3); {Breast cancer}, 114480 (1)	10(Esr)
6.862	9	10	09	6q25.1	KATNA1	P	Katanin, p60 subunit, A1	606696	R, REc			
6.863	7	19	12	6q25.1	LATS1	P	Large tumor suppressor, Drosophila, homolog of, 1	603473	REc			
6.864	9	10	09	6q25.3	NOX3	P	NADPH oxidase 3	607105	REc			
6.865	2	12	07	6q25.1	UST	P	Uronyl 2-sulfotransferase	610752	R, REc			
6.866	6	13	07	6q25.1	ZC3H12D, p34, C6orf95	P	Zinc finger CCCH domain-containing protein 12D	611106	REc			
6.867	10	23	15	6q25.1	ZBTB2, ZNF437, KIAA1483	P	Zinc finger- and BTB domain-containing protein 2	616595	REc			
6.868	2	3	14	6q25.1	MTHFD1L, MTC1THFS	P	Methylenetetrahydrofolate dehydrogenase 1-like, NADP(+)-dependent	611427	REc			
6.869	9	30	14	6q25.2	SCAF8, KIAA1116	P	SR-related C-terminal domain-associated factor 8	616024	R, REc			
6.870	8	28	97	6q25.3	TCTEL1	P	T-complex-associated-testis-expressed 1-like 1	601554	A			
6.871	10	2	12	6q25.2-q25.3	TIAM2	P	T-cell lymphoma invasion and metastasis 2	604709	REc			
6.872	1	29	04	6q26	PRKN, PARK2, PDJ, LPRS2	C	Parkin	602544	Fd, D	shares 5' regulatory region and both 3' UTRs with PACRG	Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of lung, somatic, 211980 (3); Adenocarcinoma, ovarian, somatic, 167000 (3); {Leprosy, susceptibility to}, 607572 (3)	17(Park2)
6.873	5	28	08	6q25.3	CELIAC12	P	Celiac disease, susceptibility to, 12	612010	Fd	in LD block containing TAGAP	{Celiac disease, susceptibility to, 12} (2)	
6.874	4	6	15	6q25.3	EZR, VIL2, CVL	C	Ezrin	123900	REa, A	coamplified with MYB		
6.875	6	2	15	6q25.3	GTF2H5, TTD3, TFB5, C6orf175, TTDA	C	General transcription factor IIH, polypeptide 5	608780	REc, REn		Trichothiodystrophy 3, photosensitive, 616395 (3)	
6.876	2	28	08	6q25.3	MRPL18	P	Mitochondrial ribosomal protein L18	611831	REc			
6.877	7	25	14	6q25.3	RSPH3, RSHL2, RSP3, CILD32	P	Radial spoke head 3, Chlamydomonas, homolog of	615876	REc		Ciliary dyskinesia, primary, 32, 616481 (3)	
6.878	7	25	12	6q25.3	SERAC1, MEGDEL	P	Serine active site-containing protein 1	614725	REc		3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)	
6.879	7	9	09	6q25.3	SOD2, MNSOD, MVCD6	C	Superoxide dismutase-2, mitochondrial	147460	S, D, REa, A		{Microvascular complications of diabetes 6}, 612634 (3)	17(Sod2)
6.880	6	30	05	6q25.3	SYNJ2, KIAA0348	P	Synaptojanin 2	609410	R, H			17(Synj2)
6.881	12	28	08	6q25.3	TAGAP	P	T-cell activation GTPase-activating protein	609667	R, REc			
6.882	2	18	10	6q25.3	TMEM181, GPR178, KIAA1423	P	Transmembrane protein 181	613209	REc			
6.883	12	10	15	6q25.3	WTAP	C	Wilms tumor 1-associating protein	605442	REa, A			17(Wtap)
6.884	9	28	96	6q25.3	ACAT2	P	Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)	100678	A	encoded on strand opposite TCP1	?ACAT2 deficiency, 614055 (1)	
6.885	9	28	96	6q25.3	TCP1	C	T-complex locus TCP-1	186980	REa, H, A, Fd, REn	tightly linked to PLG; ~15cM proximal to TCP10; overlap with ACAT2		17(Tcp1)
6.886	9	2	12	6q26	AGPAT4	P	1-acylglycerol-3-phosphate O-acyltransferase 4	614795	REc			
6.887	3	3	10	6q25.3	AIRN, AIR	P	Antisense IGF2R RNA, noncoding	604893	REc			17(Airn)
6.888	9	20	14	6q26	CAHM, LINC00468	P	Colorectal adenocarcinoma hypermethylated gene, noncoding	615930	REc			
6.889	12	5	13	6q25.3	IGF2R, MPRI	C	Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent)	147280	REa, A	behaves as a tumor suppressor	Hepatocellular carcinoma, somatic, 114550 (3)	17(Igf2r)
6.890	9	10	09	6q26	MAP3K4, MEKK4, MTK1, MAPKKK4	P	Mitogen-activated protein kinase kinase kinase 4	602425	REa, REc			
6.891	9	4	14	6q26	PLG	C	Plasminogen	173350	REa, A, LD, F	20cM from TCP10A	Dysplasminogenemia, 217090 (3); Plasminogen deficiency, type I, 217090 (3)	17(Plg)
6.892	8	23	12	6q26	QKI, QK1	P	Quaking, mouse, homolog of	609590	REc			
6.893	6	9	98	6q25.3	SLC22A1, OCT1	P	Solute carrier family 22 (organic cation transporter), member 1	602607	Psh, A			
6.894	6	9	98	6q25.3	SLC22A2, OCT2	P	Solute carrier family 22 (organic cation transporter), member 2	602608	Psh, A			17(Slc22a2)
6.895	1	27	04	6q26-q27	DFNB38	P	Deafness, autosomal recessive 38	608219	Fd		Deafness, autosomal recessive 38 (2)	
6.896	9	24	08	6q27	FAM120B, PGCC1, CCPG, KIAA1838	P	Family with sequence similarity 120, member B	612266	REc			17(Fam120b)
6.897	12	17	07	6q25.3	LPAL2, APOARGC	P	Lipoprotein(a)-like 2	611682	REc			
6.898	11	19	11	6q26-q27	MRT28	P	Mental retardation, autosomal recessive 28	614347	Fd	between rs6935718 and rs3886091	Mental retardation, autosomal recessive 28 (2)	
6.899	11	22	88	6q25.2	VIP	C	Vasoactive intestinal peptide	192320	REa, A, REb			
6.900	9	10	09	6q25.3	SNX9, SH3PX1	P	Sorting nexin 9	605952	R, REc			
6.901	7	26	12	6q27	BRP44L, MPC1, MPYCD	P	Brain protein 44-like	614738	REc		Mitochondrial pyruvate carrier deficiency, 614741 (3)	
6.902	9	9	08	6q27	CCR6, CMKBR6, CKRL3, GPR29, GPRCY4	P	Chemokine (C-C) receptor 6	601835	REa			
6.903	9	10	09	6q27	DACT2, DPR2, DAPPER2	P	Dapper, antagonist of beta-catenin, 2	608966	REc			
6.904	11	27	13	6q27	ERMARD, C6orf70, PVNH6	P	Endoplasmic reticulum membrane-associated RNA degradation protein	615532	REc		?Periventricular nodular heterotopia 6, 615544 (3)	
6.905	5	21	03	6q27	FGFR1OP, FOP	P	Fibroblast growth factor receptor-1 oncogene partner	605392	REc	fusion gene with ZNF198, CEP1, and FGFR1	Myeloproliferative disorder (2)	
6.906	3	5	98	6q27	GPR31	P	G protein-coupled receptor-31	602043	A			
6.907	3	8	16	6q27	HPAT5	P	Human pluripotency-associated transcript 5, noncoding	616837	REc			
6.908	2	14	13	6q27	KAZA3	P	Kala-azar, susceptibility to, 3	611382	Fd		{Kala-azar, susceptibility to, 3} (2)	
6.909	3	22	06	6q27	KIF25, KNSL3	P	Kinesin family member 25	603815	A			
6.910	5	22	03	6q25-q26	LPA	C	Apolipoprotein Lp(a)	152200	REa, A, F, Fd	absent in mice	{Coronary artery disease, susceptibility to} (1); [LPA deficiency, congenital] (3)	
6.911	5	18	94	6q27	MLLT4, AF6	C	Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 4	159559	Ch, A	distal to OVCS		
6.912	12	14	95	6q27	PDCD2	C	Programmed cell death 2	600866	A, H			17(Pdcd2)
6.913	5	2	16	6q27	PDE10A, IOLOD, ADSD2	C	Phosphodiesterase 10A	610652	A, REc		Dyskinesia, limb and orofacial, infantile-onset, 616921 (3); Striatal degeneration, autosomal dominant, 616922 (3)	
6.914	10	13	09	6q27	PHF10, BAF45A	P	PHD finger protein 10	613069	REc			
6.915	6	9	06	6q27	PSMB1	P	Proteasome subunit, beta type, 1	602017	REc	incorrectly assigned to 7p		
6.916	8	24	09	6q27	RNASET2, RNASE6PL	P	Ribonuclease T2	612944	REc		Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	
6.917	12	9	98	6q27	RPS6KA2, RSK3	P	Ribosomal protein S6 kinase, 90kD, 2	601685	REa, A			
6.918	10	17	00	6q25.3	SLC22A3, EMT	C	Solute carrier family 22 (extraneuronal monoamine transporter), member 3	604842	A, REc			17(Slc22a3)
6.919	1	26	12	6q27	SMOC2, SMAP2, DTDP1	P	Secreted modular calcium-binding protein 2	607223	R, REc		Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	
6.920	4	29	14	6q27	T, TFT, SAVA	P	Brachyury, mouse, homolog of	601397	A, Fd		{Neural tube defects, susceptibility to}, 182940 (3); Sacral agenesis with vertebral anomalies, 615709 (3)	17(T)
6.921	11	15	10	6q27	TBP, SCA17, HDL4	C	TATA box binding protein	600075	REa, A, Fd		Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease, susceptibility to}, 168600 (3)	17(Tbp)
6.922	8	21	92	6q27	TCTE3	P	T-complex-associated-testis-expressed-3	186977	REa, A			
6.923	6	26	08	6q27	THBS2	C	Thrombospondin 2	188061	REa, A		{Lumbar disc herniation, susceptibility to}, 603932 (3)	17(Thbs2)
6.924	8	28	92	6q27	TCP10	C	T-complex 10 (a murine tcp homolog)	187020	Fd			17(Tcp10)
6.925	1	12	07	6q27	UNC93A	P	UNC93, C. elegans, homolog of, A	607995	REc			
6.926	9	10	09	Chr.6	BEVI	C	Baboon M7 virus replication	109180	S			
6.927	10	23	87	Chr.6	FEA	L	F9 embryonic antigen	137010	H			
6.928	9	10	09	Chr.6	LAKLG, LAKL	P	Lymphokine-activated killer cell ligand	153435	S			
6.929	10	23	87	Chr.6	MRBC	P	Monkey RBC receptor	158050	S			
6.930	10	23	87	Chr.6	TS546	P	Temperature sensitivity complementation, cell cycle specific, ts546 cells	187330	S			
7.1	9	12	93	7p22.3	PRKAR1B	P	Protein kinase, cAMP-dependent, regulatory, type I, beta	176911	Fd			
7.2	4	17	13	7p22.3	AMZ1, KIAA1950	P	Archaelysin family metallopeptidase 1	615168	REc			
7.3	3	29	12	7p22.3	BRAT1, BAAT1, C7orf27, RMFSL	P	BRCA1-associated ATM activator 1	614506	REc		Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	
7.4	5	10	04	7p22.3	CENTA1	P	Centaurin, alpha-1	608114	REc			
7.5	3	19	13	7p22.3	COX19	P	Cytochrome c oxidase assembly protein Cox19	610429	REc			
7.6	9	20	14	7p22.3	CYP2W1	P	Cytochrome P450, family 2, subfamily W, polypeptide 1	615967	REc			
7.7	12	17	12	7p22.3	ELFN1, PPP1R28	P	Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1	614964	REc			
7.8	9	8	10	7p22.3	GET4, C7orf20, CEE	P	Golgi to ER traffic protein 4, S. cerevisiae, homolog of	612056	REc			
7.9	10	25	12	7p22.3	HEATR2, CILD18	P	HEAT repeat-containing protein 2	614864	REc		Ciliary dyskinesia, primary, 18, 614874 (3)	
7.10	3	23	14	7p22.3	INTS1, INT1, KIAA1440	P	Integrator complex subunit 1	611345	REc			
7.11	9	22	14	7p22.3	MIR339	P	Micro RNA 339	615977	REc			
7.12	12	10	12	7p22.3	SNX8	P	Sorting nexin 8	614905	REc			
7.13	9	30	09	7p22.3	UNC84A, KIAA0810, SUN1	P	UNC84, C. elegans, homolog of, A	607723	R, REc			
7.14	1	16	07	7p22.3	ZFAND2A, AIRAP	P	Zinc finger AN1 domain-containing protein 2A	610699	REc			
7.15	9	28	11	7p22.3-p21.3	HYPT10	P	Hypotrichosis 10	614238	Fd	between D7S1532 and D7S3047	Hypotrichosis 10 (2)	
7.16	10	3	07	7p22.3	EIF3B, EIF3S9, PRT1	P	Eukaryotic translation initiation factor 3, subunit B	603917	REc			
7.17	3	11	08	7p22.3-p22.2	GNA12	P	Guanine nucleotide-binding protein, alpha-12	604394	R, REc			
7.18	10	18	15	7p22.2	SDK1	P	Sidekick, Drosophila, homolog of, 1	607216	REc			5(Sdk1)
7.19	6	9	08	7p13	TMED4	P	Transmembrane p24 trafficking protein 4	612038	REc			
7.20	9	18	12	7p22.1	AP5Z1, KIAA0415, SPG48	C	Adaptor-related protein complex 5, zeta-1 subunit	613653	R, REc		Spastic paraplegia 48, autosomal recessive, 613647 (3)	
7.21	9	30	09	7p22.1	CYTH3, PSCD3, ARNO3, GRP1	P	Cytohesin 3	605081	R, REc			
7.22	9	8	11	7p22.1	DAGLB	P	Diacylglycerol lipase, beta	614016	REc			
7.23	11	22	10	7p22.1	EIF2AK1, HRI	P	Eukaryotic translation initiation factor 2-alpha kinase 1	613635	REc			
7.24	10	28	15	7p22.1	FAM220A, SIPAR, ACPIN1, C7orf70	P	Family with sequence similarity 220, member A	616628	REc			5(Fam220A)
7.25	6	13	12	7p22.1	FBXL18, FBL18	P	F-box and leucine-rich repeat protein 18	609084	REc			
7.26	4	10	15	7p22.1	FOXK1, MNF	C	Forkhead box K1	616302	REc, H			5(Foxk1)
7.27	4	19	12	7p22.1	MMD2, PAQR10	P	Monocyte-to-macrophage differentiation-associated protein 2	614581	REc			
7.28	7	19	06	7p22.1	PAPOLB, TPAP	P	Poly(A) polymerase, beta	607436	REc			
7.29	10	2	07	7p22.1	RADIL, KIAA1849	P	RAP GTPase interactor	611491	REc			
7.30	11	11	14	7p22.1	RBAK	P	RB-associated KRAB repressor	608191	R, REc			
7.31	2	4	13	7p22.1	SLC29A4, PMAT, ENT4	P	Solute carrier family 29 (monoamine transporter), member 4	609149	REc			
7.32	10	4	05	7p22.1	STBMS1	P	Strabismus, susceptibility to, 1	185100	Fd	max lod at marker 1911/1912	{Strabismus, susceptibility to, 1} (2)	
7.33	6	13	95	7p21.2	MEOX2	P	Mesenchyme homeo box 2	600535	A			
7.34	5	24	13	7p22.1	AIMP2, JTV1	P	Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2	600859	A			
7.35	10	10	13	7p22.2	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	P	Caspase recruitment domain-containing protein 11	607210	R, REc		B-cell expansion with NFKB and T-cell anergy, 616452 (3); Immunodeficiency 11, 615206 (3)	
7.36	8	19	13	7p22.3	CHST12, C4ST2	P	Carbohydrate sulfotransferase 12	610129	R			
7.37	9	8	11	7p22	ERVK-6	P	Endogenous retroviral group K, member 6	605626	A			
7.38	8	18	02	7p22.1	FSCN1, SNL	P	Fascin homolog 1, actin-bundling protein (singed, Drosophila, homolog-like)	602689	A			
7.39	2	21	01	7p22	FHII	P	Hyperaldosteronism, familial, type II	605635	Fd		Hyperaldosteronism, familial, type II (2)	
7.40	6	11	02	7p22.3	FTSJ2, FJH1	P	FTSJ, E. coli, homolog of, 2	606906	R			
7.41	1	1	12	7p21.3	GLCCI1, TSSN1, GCTR	P	Clucocorticoid-induced transcript 1	614283	REc		{Glucocorticoid therapy, response to}, 614400 (3)	6(Glcci1)
7.42	6	21	10	7p22.3	GPER, CMKRL2, GPR30	P	G protein-coupled estrogen receptor 1	601805	Psh			
7.43	2	20	97	7p21.3	ICA1	P	Islet cell autoantigen 1, 69kD	147625	A			6(Ica1)
7.44	9	11	14	7p22.3	LFNG, SCDO3	C	Lunatic fringe	602576	REa, R, A	mutation identified in 1 SDO3 family	?Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)	5(Lfng)
7.45	8	29	01	7p22.3	MAD1L1, TXBP181	P	Mitotic arrest-deficient 1, yeast, homolog-like 1	602686	R		Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)	5(Mad1l1)
7.46	7	10	95	7p21.2	ETV1	P	ETS variant gene-1	600541	Ch, A	fused with EWS in some Ewing sarcoma		
7.47	8	21	07	7p22.3	FAM20C, DMP4	C	Family with sequence similarity 20, member C	611061	R, REc, Ch		Raine syndrome, 259775 (3)	
7.48	8	9	99	7p22.3	MAFK, NFE2U	P	V-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein K (nuclear factor erythroid 2, ubiquitous subunit)	600197	A			5(Nfe2u)
7.49	6	8	95	7p22.3	NUDT1, MTH1	P	Nudix-type motif 1	600312	A			
7.50	8	28	92	7p22.3	PDGFA	C	Platelet-derived growth factor, alpha polypeptide	173430	REa, A			
7.51	11	19	11	7p22.1	PMS2, PMSL2, HNPCC4	C	Postmeiotic segregation increased, S. cerevisiae, 2, homolog of	600259	REa, A		Mismatch repair cancer syndrome, 276300 (3); Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	
7.52	7	23	13	7p22.1	RNF216, TRIAD3, ZIN, CAHH	P	RING finger protein 216	609948	REc		Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	
7.53	4	7	94	7p21.3	RPA3	P	Replication protein A3, 14kD	179837	REa, Psh, A			
7.54	6	7	91	7p22.1	ZNF12	P	Zinc finger protein-12 (KOX3)	194536	REa, A			
7.55	12	4	90	7p14.1	RALA	P	RAS-like protein A (Simian leukemia viral (v-ral) oncogene homolog A, ras-related)	179550	REb, A			13(Ral)
7.56	7	1	11	7p22-p14	CPVT3	P	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	Fd	between D7S526 and D7S481	Ventricular tachycardia, catecholaminergic polymorphic, 3 (2)	
7.57	5	24	12	7p22.1	ACTB, BRWS1	C	Actin, beta	102630	REa, A	~20 pseudogenes also; mutation identified in twin DJO patients	?Dystonia, juvenile-onset, 607371 (3); Baraitser-Winter syndrome 1, 243310 (3)	5(Actb)
7.58	11	28	01	7p21.1	AGR2, AG2	P	Anterior gradient 2, Xenopus, homolog of	606358	R, A			
7.59	9	24	08	7p21.1	AGR3, BCMP11	P	Anterior gradient 3, Xenopus, homolog of	609482	REc			
7.60	3	23	06	7p21.3	COL28A1	P	Collagen, type XXVIII, alpha-1 polypeptide	609996	REc			6(Col28a1)
7.61	8	7	13	7p21.3	MIOS	P	Missing oocyte/meiosis regulator, Drosophila, homolog of	615359	REc			
7.62	5	25	13	7p21.3	NDUFA4	P	NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 4	603833	REc			
7.63	7	18	14	7p21.3	NXPH1, NPH1	P	Neurexophilin 1	604639	REc			
7.64	7	26	10	7p21.3	SCIN, KIAA1905	P	Scinderin	613416	R, REc			
7.65	9	24	08	7p21.3	THSD7A, KIAA0960	P	Thrombospondin type-1 domain-containing protein 7A	612249	R, REc			
7.66	7	27	10	7p21.3	TMEM106B	P	Transmembrane protein 106B	613413	REc			
7.67	4	26	11	7p21.2	AGMO, TMEM195	P	Alkylglycerol monooxygenase	613738	REc			
7.68	9	29	09	7p21.2	DGKB, DGK, KIAA0718	P	Diacylglycerol kinase, beta, 90kD	604070	R, REc			
7.69	10	12	14	7p21.2-p21.1	ISPD, MDDGA7, MDDGC7	P	Isoprenoid synthase domain-containing protein	614631	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	
7.70	10	30	07	7p21.1	PRPS1L1, PRPS3	P	Phosphoribosylpyrophosphate synthetase 1-like 1	611566	REa, R			
7.71	12	28	08	7p21.2	SOSTDC1, ECTODIN, USAG1	P	Sclerostin domain-containing protein 1	609675	REc			
7.72	7	8	10	7p21.2	FGQTL4	P	Fasting plasma glucose level QTL 4	613462	Fd	associated with rs2191349	[Fasting plasma glucose level QTL 4] (2)	
7.73	3	11	09	7p21.1	MACC1	P	Metastasis-associated gene in colon cancer 1	612646	REc			
7.74	4	18	05	7p21.1	SNX13, KIAA0713	P	Sorting nexin 13	606589	R, REc			
7.75	12	21	09	7p21.1	TSPAN13, NET6	P	Tetraspanin 13	613139	REn			
7.76	9	28	10	7p21.2-p14.3	EDSS2	P	Ectodermal dysplasia-syndactyly syndrome 2	613576	Fd	between D7S488 and D7S817	Ectodermal dysplasia-syndactyly syndrome 2 (2)	
7.77	12	3	08	7p15.3	DNAH11, DNAHC11, CILD7, DNAHBL	C	Dynein, axonemal, heavy chain-11	603339	REa, REn		Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	
7.78	1	24	09	7p15.3	IL6, IFNB2, BSF2, HSF, HGF	C	Interleukin-6 (interferon, beta-2)	147620	REa, A, Fd		{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)	5(Il6)
7.79	12	8	03	7p21.1	SP8, BTD	P	Transcription factor Sp8	608306	REc			
7.80	5	4	12	7p21.1	TWIST1, ACS3, SCS, CRS1	C	TWIST, Drosophila, homolog of, 1	601622	Fd, Ch, A, REa		Saethre-Chotzen syndrome, 101400 (3); Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3); Craniosynostosis, type 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3)	12(Twist)
7.81	12	4	03	7p21.1	TWISTNB	P	TWIST neighbor	608312	REc	pseudogene on 6q14.3		12(Twistnb)
7.82	3	5	98	7p14.3	CRHR2, CRFR2	P	Corticotropin releasing hormone receptor-2	602034	R, A			6(Crhr2)
7.83	12	11	01	7p21.1	HDAC9, MITR, HDAC7B, KIAA0744	C	Histone deacetylase 9	606543	R, REc			
7.84	4	7	94	7p21-p15	MDDC	P	Macular dystrophy, dominant cystoid	153880	Fd	?allelic to RP9	Macular dystrophy, dominant cystoid (2)	
7.85	9	30	02	7p15.3	MPP6, VAM1, PALS2	P	Membrane protein, palmitoylated 6	606959	A			6(Pals2)
7.86	4	1	08	7q22.1	TSC22D4, THG1	P	TSC22 domain family, member 4	611914	REc			
7.87	5	10	04	7p14.3	FAPP2	P	Phosphatidylinositol 4-phosphate adaptor protein 2	608639	REc			
7.88	2	11	08	7p21.1	ABCB5	C	ATP-binding cassette, subfamily B, member 5	611785	REc			
7.89	11	3	14	7p15.3	C7orf31	P	Chromosome 7 open reading frame 31	616071	REc			
7.90	8	10	98	7p14.3	CHN2, ARHGAP3, RHOGAP3	P	Chimerin 2 (GTPase-activating protein, rho, 3)	602857	A			
7.91	12	5	08	7p15.3	FAM126A, DRCTNNB1A, HLD5	P	Hyccin	610531	A		Leukodystrophy, hypomyelinating, 5, 610532 (3)	
7.92	9	28	05	7p15.2	HOXA1, HOX1F, BSAS	C	Homeo box-A1	142955	RE, A, Fd		Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem dysgenesis syndrome, 601536 (3)	6(Hox1.6)
7.93	8	24	09	7p15.3	KLHL7, RP42	P	Kelch-like 7	611119	REc		Retinitis pigmentosa 42, 612943 (3)	
7.94	5	8	12	7p15.3	MALSU1, C7orf30	P	Mitochondrial assembly of ribosomal large subunit 1	614624	REc			
7.95	9	30	09	7p15.3	STK31	P	Serine/threonine kinase 31	605790	R, REc			
7.96	12	18	13	7p15.3	TOMM7	P	Translocase of outer mitochondrial membrane 7, yeast, homolog of	607980	REc			
7.97	5	25	13	7p15.3	TRA2A	P	Transformer 2, Drosophila, homolog of	602718	REc			
7.98	5	11	00	7p14.3	INMT	P	Indolethylamine N-methyltransferase	604854	REa, A			
7.99	11	11	14	7p15.2	CBX3	P	Chromobox homolog 3	604477	R, REc			
7.100	1	14	09	7p15.3	CYCS, CYC, THC4	C	Cytochrome C, somatic	123970	REc		Thrombocytopenia 4, 612004 (3)	
7.101	8	8	13	7p15.2	HIBADH	P	3-hydroxyisobutyrate dehydrogenase	608475	REc, R			
7.102	7	1	11	7p15.2	HOTTIP, NCRNA00213	P	HOXA distal transcript antisense RNA	614060	REc			
7.103	9	20	14	7p15.2	HOXA11AS	P	Homeo box A11, antisense	607530	REc			6(Hoxa11s)
7.104	11	3	14	7p15.2	HOXAAS2	P	HOXA cluster antisense RNA 2	616068	REc			
7.105	5	15	11	7p15.2	MIR148A, MIRN148A	P	Micro RNA 148A	613786	REc			
7.106	6	22	14	7p15.2	SKAP2, SCAP2, SKAP55R	P	src kinase associated phosphoprotein 2	605215	REc			
7.107	2	21	13	7p15.2	SNX10, OPTB8	P	Sorting nexin 10	614780	REc		Osteopetrosis, autosomal recessive 8, 615085 (3)	
7.108	3	28	12	7p14.3	FKBP14, EDSKMH	P	FK506-binding protein 14	614505	REc		Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss, 614557 (3)	
7.109	5	9	95	7p15.3	NPY	C	Neuropeptide Y	162640	REa, H, A			6(Npy)
7.110	12	4	08	7p14.3	WIPF3, CR16	P	WAS/WASL-interacting protein family, member 3	612432	REc			
7.111	6	10	08	7p14.3	ZNRF2	P	Zinc finger and ring finger protein 2	612061	REc			
7.112	10	19	97	7p21.1	AHR	C	Aryl hydrocarbon receptor	600253	REa, A, Psh			
7.113	12	28	08	7p15.3	CDCA7L, R1, JPO2	P	Cell division cycle-associated protein 7-like	609685	REc			
7.114	11	30	06	7p15.3	DFNA5	C	DFNA5 gene	608798	Fd, REc, H		Deafness, autosomal dominant 5, 600994 (3)	6(Dfna5)
7.115	6	8	07	7p14.3	GARS, SMAD1, CMT2D, HMN5	C	Glycyl-tRNA synthetase	600287	A, Fd		Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal hereditary motor, type VA, 600794 (3)	
7.116	12	30	03	7p14.3	GSBS	P	G-substrate	604088	R		{Hypercholesterolemia, susceptibility to}, 143890 (3)	
7.117	10	7	13	7p15.2	HNRPA2B1, IBMPFD2	P	Heterogeneous nuclear ribonucleoprotein A2/B1	600124	A	mutation identified in 1 family	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)	
7.118	3	22	06	7p15.3	IGF2BP3, IMP3, KOC1, VICKZ3	P	Insulin-like growth factor 2 mRNA-binding protein 3	608259	A, H			6(Imp3)
7.119	6	22	14	7p15.2-p15.1	JAZF1, TIP27	P	JAZF1 gene	606246	Ch	fused with JJAZ1		
7.120	8	21	91	7p15	MYCLK1	P	Avian myelocytomatosis viral (v-myc) oncogene homolog like 1	164865	A			
7.121	3	2	10	7p15	MYP17, MYP4	P	Myopia 17	608367	Fd	previously assigned to 7q36 (MYP4)	Myopia 17 (2)	
7.122	5	7	03	7p15.3	OSBPL3, ORP3, KIAA0704	C	Oxysterol-binding protein-like protein 3	606732	R, REc			
7.123	6	13	95	7p15.3	SP4	P	Sp4 transcription factor	600540	Psh, A			
7.124	5	5	09	7p15	STQTL17	P	Stature quantitative trait locus 17	612737	Fd	associated with rs1635852 and rs849140	{Stature QTL 17} (2)	
7.125	9	30	09	7p15.2	TAX1BP1, TXBP151	P	TAX1-binding protein 1	605326	R, REc			
7.126	12	20	05	7p14.3	CPVL, HVLP	P	Carboxypeptidase, vitellogenic-like	609780	REc			
7.127	12	24	08	7p14.3	GGCT, GCTG, C7orf24	C	Gamma-glutamylcyclotransferase	137170	S, REc			6(Ggc)
7.128	7	16	09	7p14.3	GHRHR, GHRFR, IGHD1B	C	Growth hormone releasing hormone receptor	139191	REa, A		Growth hormone deficiency, isolated, type IB, 612781 (3)	6(Lit, Ghrhr)
7.129	1	23	07	7p14.3	NOD1, CARD4	P	Nucleotide-binding oligomerization domain protein 1	605980	REc			
7.130	7	11	11	7p14.1	TARP	P	T-cell antigen receptor, gamma subunit, alternate reading frame protein	609642	REc			
7.131	2	26	93	7p15.2	HOXA3, HOX1E	L	Homeo box-A3	142954	RE	homolog of Drosophila zen1, zen2		6(Hox1.5)
7.132	2	26	93	7p15.2	HOXA4, HOX1D	C	Homeo box-A4	142953	A, REa, H, RE	homolog of Drosophila Dfd		6(Hox1.4)
7.133	2	26	93	7p15.2	HOXA5, HOX1C	C	Homeo box-A5	142952	A, REa, H, RE			6(Hox1.3)
7.134	2	26	93	7p15.2	HOXA6, HOX1B	C	Homeo box-A6	142951	A, REa, H, RE			6(Hox1.2)
7.135	2	26	93	7p15.2	HOXA7, HOX1A	C	Homeo box-A7	142950	A, REa, H, RE	homolog of Drosophila Antp		6(Hox1.1)
7.136	2	26	93	7p15.2	HOXA9, HOX1G	C	Homeo box-A9	142956	RE, Ch	homolog of Drosophila Abd-B; fused to NUP98 in myeloid leukemia		6(Hox1.7)
7.137	2	26	93	7p15.2	HOXA10, HOX1H	C	Homeo box-A10	142957	A, REa, H, RE			
7.138	11	8	16	7p15.2	HOXA11, HOX1I, RUSAT1	C	Homeo box-A11	142958	A, REa, H, RE		Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	
7.139	5	17	02	7p15.2	HOXA13, HOX1J	C	Homeo box-A13	142959	RE, Fd		Hand-foot-uterus syndrome, 140000 (3); Guttmacher syndrome, 176305 (3)	6(Hoxa13, Hd)
7.140	3	23	09	7p15.2	MIR196B, MIRN196B	P	Micro RNA 196B	609688	REc			
7.141	4	21	04	7p14.3	AAA1	P	Asthma-associated alternatively spliced gene 1	608596	REc			
7.142	3	23	95	7p15.2	EVX1	P	Even-skipped homeo box-1 (homolog of Drosophila)	142996	REn	at 5' end of HOX1 cluster		
7.143	11	22	13	7p15.2	HOXA2, MCOHI	P	Homeobox A2	604685	REc		?Microtia, hearing impairment, and cleft palate (AR), 612290 (3); ?Microtia with or without hearing impairment (AD), 612290 (3)	
7.144	10	08	07	7p14.3	NEUROD6, ATOH2, MATH2	P	Neurogenic differentiation 6	611513	REc			
7.145	10	20	99	7p15.2	NFE2L3, NRF3	P	Nuclear factor erythroid 2-like 3	604135	A			
7.146	5	21	09	7p14.3	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	P	Neuropeptide S receptor 1	608595	REc		{Asthma, susceptibility to, 2}, 608584 (3)	
7.147	11	19	13	7p14.3	NT5C3A, NT5C3, UMPH1, PSN1	P	5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1)	606224	REc	pseudogenes on chr.4 and chr.7	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	
7.148	8	29	07	7p14.2	TBX20, ASD4	C	T-box 20	606061	REc		Atrial septal defect 4, 611363 (3)	
7.149	7	8	10	7p15-p13	FGQTL2, BWQTL1	P	Fasting plasma glucose level QTL 2; Birth weight QTL 1	613219	Fd	associated with rs4607517	[Fasting plasma glucose level QTL 2] (2); [Birth weight QTL 1] (2)	
7.150	8	12	15	7p13	GCK, HHF3	C	Glucokinase (hexokinase-4)	138079	Psh, Fd	proximal to TCRB	MODY, type II, 125851 (3); Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3); Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3); Diabetes mellitus, permanent neonatal, 606176 (3)	
7.151	2	4	89	7p14.1	INHBA	P	Inhibin, beta-1	147290	REa			13(Inhba)
7.152	8	17	09	7p14.3	AVL9, KIAA0241	P	AVL9, S. cerevisiae, homolog of	612927	R, REc			
7.153	3	28	11	7p14.3	BMPER, CV2	P	BMP binding endothelial regulator	608699	REc		Diaphanospondylodysostosis, 608022 (3)	9(Bmper)
7.154	7	15	11	7p14.2	DPY19L1, KIAA0877	P	DPY19-like 1	613892	REc			7p14.3
7.155	9	30	09	7p14.3	LSM5	P	LSM5 protein	607285	R, REc			
7.156	2	19	10	7p14.3	PDE1C, HCAM3	P	Phosphodiesterase 1C	602987	REc			
7.157	4	26	10	7p14.3	TRIL, KIAA0644	P	TLR4 interactor with leucine-rich repeats	613356	REc			
7.158	12	17	12	7p14.3	SCRN1, SES1, KIAA0193	C	Secernin 1	614965	REc, R			
7.159	9	30	14	7p14.2	ANLN, FSFS8	P	Actin-binding protein anillin	616027	REc		Focal segmental glomerulosclerosis 8, 616032 (3)	
7.160	3	21	14	7p14.3	RP9, PAP1	C	RP9 gene (pim1-associated protein, mouse, homolog of)	607331	Fd, REc	mutation identified in 1 patient	?Retinitis pigmentosa 9, 180104 (3)	
7.161	7	18	12	7p14.1	CDK13, CDC2L5, CHED	P	Cyclin-dependent kinase 13	603309	REc			
7.162	6	13	12	7p14.1	GPR141, PGR13	P	G protein -coupled receptor 141	609045	REc			13(Gpr141)
7.163	3	14	13	7p14.1	NME8, TXNDC3, SPTRX2, CILD6	P	NME/NM23 family member 8	607421	R		Ciliary dyskinesia, primary, 6, 610852 (3)	
7.164	10	15	13	7p14.1	TRGC1	C	T-cell receptor gamma chain constant region 1	186970	REa, A, Ch			13(Tcrg)
7.165	10	15	13	7p14.1	TRGC2	P	T-cell receptor gamma chain constant region 2	615450	REc			
7.166	10	15	13	7p14.1	TRGV@	P	T-cell receptor gamma chain variable gene cluster	615454	REc			
7.167	10	15	13	7p14.1	TRGJ@	P	T-cell receptor gamma chain joining gene cluster	615455	REc			
7.168	9	30	09	7p14.1	VPS41	P	Vacuolar protein sorting 41, Yeast, homolog of	605485	R, REc	conflicting assignment 14q23		
7.169	1	7	95	7p14.3	ADCYAP1R1, PACAPR	C	Adenylate cyclase activating polypeptide-1 (pituitary) receptor type 1	102981	Psh, A			
7.170	10	26	99	7p14.3	AQP1, CHIP28, CO	C	Aquaporin-1 (channel-forming integral protein, 28kD)	107776	REa, A, Fd		[Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency] (3)	6(Aqp1)
7.171	7	24	15	7p14.1	C7orf10, GA3	P	Chromosome 7 open reading frame 10	609187	A		Glutaric aciduria III, 231690 (3)	
7.172	9	29	09	7p13	CAMK2B	P	Calcium/calmodulin-dependent protein kinase II-beta	607707	REc			
7.173	9	30	09	7p14.2-p14.1	ELMO1, CED12	P	Engulfment and cell motility gene 1	606420	REc			
7.174	12	29	06	7p14	HHT4	P	Telangiectasia, hereditary hemorrhagic, type 4	610655	Fd	between D7S2252 and D7S510	Telangiectasia, hereditary hemorrhagic, type 4 (2)	
7.175	6	2	15	7p14.1	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	C	M-phase specific PLK1 interacting protein	609188	A		Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	
7.176	2	28	08	7p14.1	MRPL32	P	Mitochondrial ribosomal protein L32	611839	R			
7.177	4	24	08	7p13	MRPS24	P	Mitochondrial ribosomal protein S24	611986	R, REc			
7.178	10	16	14	7p14.3	PTHB1, BBS9	C	Parathyroid hormone-responsive B1 gene	607968	REc, Fd		Bardet-Biedl syndrome 9, 615986 (3)	
7.179	10	1	07	7p14.2	SEPT7, CDC10	P	Septin 7	603151	REc			
7.180	3	26	95	7p14.1	AMPH	P	Amphiphysin	600418	Psh, A			13(Amph)
7.181	11	8	06	7p22.1-p21.3	C1GALT1	P	Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	610555	REc			
7.182	4	6	00	7p11.2	HPVC1, PE5L	P	Human papillomavirus E5 central sequence-like 1	600762	A			
7.183	9	21	09	7p13	OGDH	C	Oxoglutarate dehydrogenase, lipoamide (alpha-ketoglutarate dehydrogenase)	613022	REa, A		Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)	
7.184	12	7	04	7p14.1	POU6F2, WTSL, WT5	C	POU domain, class 6, transcription factor 2	609062	Ch, D, REc		{Wilms tumor susceptibility-5}, 601583 (3)	
7.185	1	7	02	7p14.1	SFRP4, FRPHE	L	Secreted frizzled-related protein 4	606570	H			13(Sfrp4)
7.186	1	28	08	7p14.1	STARD3NL, MENTHO	P	STARD3 N-terminal like	611759	REc			
7.187	10	13	94	7p14.2	AOAH	P	Acyloxyacyl hydrolase (neutrophil)	102593	A			
7.188	2	9	92	7p12.3	IGFBP1	C	Insulin-like growth factor-binding protein-1	146730	REa, A, REn			
7.189	2	9	92	7p12.3	IGFBP3	C	Insulin-like growth factor-binding protein-3	146732	REn	tail-to-tail 20kb from IGFBP1		
7.190	8	16	11	7p13	BLVRA	C	Biliverdin reductase A	109750	S, A		Hyperbiliverdinemia, 614156 (3)	2(Blvr)
7.191	2	10	04	7p13	C7orf22, CCM2, MGC4067	C	Malcavernin	607929	Fd, REc		Cerebral cavernous malformations-2, 603284 (3)	
7.192	8	21	12	7p13	COA1, C7orf44	P	Cytochrome c oxidase assembly factor 1, S. cerevisiae, homolog of	614769	REc			
7.193	8	29	13	7p13	DBNL, HIP55	P	Drebrin-like	610106	REc, R			
7.194	11	11	14	7p13	DDX56, NOH61	P	DEAD/H box 56	608023	R, REc			
7.195	8	5	11	7p14.1	GLI3, PAPA, PAPB	C	GLI-Kruppel family member GLI3 (oncogene GLI3)	165240	REa, A, Fd	amplified in glioblastoma	Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall syndrome, 146510 (3); Polydactyly, preaxial, type IV, 174700 (3); Polydactyly, postaxial, types A1 and B, 174200 (3); {Hypothalamic hamartomas, somatic}, 241800 (3)	13(Xt)
7.196	8	19	13	7p14-p13	HECW1, NEDL1, KIAA0322	P	HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 1	610384	REc, R			
7.197	9	8	11	7p13	MYL7, MYL2A, MLC2A, MYLC2A	P	Myosin, light chain 7, regulatory	613993	R, REc			11(Myl7)
7.198	7	2	14	7p13	MYO1G, HA2, HLA-HA2	P	Myosin IG	600642	A			
7.199	5	24	13	7p13	NUDCD3, KIAA1068, NUDCL	P	NUDC domain-containing protein 3	610296	REc, R			
7.200	5	31	05	7p13	NPC1L1	C	NPC1-like 1	608010	REa, A		[Ezetimibe, nonresponse to] (3)	
7.201	9	30	09	7p13	POLD2	P	Polymerase (DNA directed), delta 2, regulatory subunit, 50kD	600815	Psh, REc			
7.202	9	20	14	7p13	POLM	P	Polymerase, DNA, mu	606344	REc			
7.203	4	30	97	7p13	PPIA	C	Peptidylprolyl isomerase A (cyclophilin A)	123840	Psh, A			
7.204	6	9	06	7p14.1	PSMA2, PSC2, HC3	P	Proteasome (prosome, macropain) subunit, alpha type, 2	176842	REc	incorrectly assigned to 6q		
7.205	9	16	12	7p13	PURB	P	Purine-rich element-binding protein B	608887	REc			
7.206	2	23	08	7p12.3	SEPT13	P	Septin 13	611563	REc			
7.207	4	2	16	7p13	SNORA5C	P	Small nucleolar RNA, H/ACA box, 5C	611335	REc	in intron 3 of TBRG4		
7.208	10	2	12	7p13	STK17A, DRAK1	P	Serine/threonine protein kinase 17A	604726	REc			
7.209	4	6	15	7p13	TBRG4, KIAA0948, CPR2	P	Transforming growth factor-beta regulator 4	611325	A, REc			
7.210	2	19	10	7p13	URGCP, URG4	P	Upregulator of cell proliferation	610337	REc			
7.211	5	23	13	7p13	ZMIZ2, KIAA1886, ZIMP7	P	Zinc finger MIZ-domain containing 2	611196	REc			
7.212	8	17	09	7p13	PGAM2, PGAMM, GSD10	C	Phosphoglycerate mutase, muscle form	612931	REa, A		Glycogen storage disease X, 261670 (3)	
7.213	7	17	14	7p12.3	ADCY1, DFNB44	C	Adenylate cyclase-1, brain	103072	A, REa, Fd	mutation identified in 1 DFNB44 family	?Deafness, autosomal recessive 44, 610154 (3)	11(Adcy1, brl)
7.214	6	16	99	7p12.3	HUS1	P	Hydroxyurea-sensitive 1, S. pombe, homolog of	603760	A, R			
7.215	11	28	05	7p12.3	PKD1L1	P	Polycystin 1L1	609721	A			11(Pkd1l1)
7.216	2	15	01	7p13	RAMP3	C	Receptor activity-modifying protein 3	605155	R			11(Ramp3)
7.217	2	23	92	7p22.1	OCM	P	Oncomodulin	164795	REa			5(Ocm)
7.218	12	28	08	7p12.3	ABCA13	P	ATP-binding cassette, subfamily A, member 13	607807	REc, H			11(Abca13)
7.219	1	2	08	7p12.3	TNS3, TEM6	P	Tensin 3	606825	R, REc			
7.220	1	23	08	7p12.3	UPP1, UP	C	Uridine phosphorylase 1	191730	S, REc			
7.221	11	3	14	7p11.2	EGFR, NISBD2	C	Epidermal growth factor receptor	131550	S, Fd, D, REa	same as oncogene ERBB; mutation identified in 1 NISBD2 family	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3); Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3); {Nonsmall cell lung cancer, susceptibility to}, 211980 (3); ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3)	11(Erbb)
7.222	10	13	09	7p12.2	ALL2	P	Leukemia, acute lymphoblastic, susceptibility to, 2	613067	Fd	associated with rs11978267	{Leukemia, acute lymphoblastic, susceptibility to, 2} (2)	
7.223	6	13	07	7p12.2	VWC2, BRORIN	P	von Willebrand factor C domain-containing protein 2	611108	REc			
7.224	8	8	13	7p12.2	ZPBP, SP38	P	Zona pellucida-binding protein	608498	REc			
7.225	9	9	13	7p12.2	FIGNL1	P	Fidgetin-like protein 1	615383	REc			
7.226	6	7	12	7p12.1-q21	CMH21	P	Cardiomyopathy, familial hypertrophic, 21	614676	Fd	max lod at D7S669	Cardiomyopathy, hypertrophic, 21 (2)	
7.227	8	19	13	7p12.1	COBL, KIAA0633	P	Cordon-bleu, mouse, homolog of	610317	REc			11(Cobl)
7.228	3	12	15	7p14.3	FKBP9, FKBP60, FKBP63	P	FK506-binding protein 9	616257	A			
7.229	12	15	98	7p11.2	GBAS, NIPSNAP2	P	Glioblastoma amplified sequence	603004	R			
7.230	3	25	16	7p12.2	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	P	Ikaros family zinc finger 1	603023	REa, Ch	fused with BCL6 in DLBL	Immunodeficiency, common variable, 13, 616873 (3)	11(Ikaros)
7.231	1	7	02	7p12.1	GRB10, RSS	C	Growth factor receptor-bound protein-10	601523	REa, R, A			11(Grb1)
7.232	7	11	93	7p12-cen	TTIM1	C	T-cell tumor invasion and metastasis-1 (invasion-metastasis of neoplasms, chromosome 7 determined)	147830	S			
7.233	10	12	90	7p11.2	PHKG1	P	Phosphorylase kinase, gamma 1, muscle	172470	REa, A	presumed pseudogene on 11		5(Phkg)
7.234	8	8	13	7p11.2	CCT6A, CCT6, HTR3, TCP20	P	Chaperonin containing T-complex polypeptide 1, subunit 6A	104613	REc			
7.235	12	28	15	7p11.2	CHCHD2, PARK22	P	Coiled-coil-helix-coiled-coil-helix domain-containing protein 2	616244	REc		Parkinson disease 22, autosomal dominant, 616710 (3)	
7.236	7	22	09	7p11.2	LANCL2, TASP	P	LanC-like 2	612919	REc			
7.237	4	14	14	7p11.2	NYS3	P	Nystagmus 3, congenital, autosomal dominant	608345	Ch	translocation t(7;15)(p11.2;q11.2)	Nystagmus 3, congenital, autosomal dominant (2)	
7.238	3	24	14	7p11.2	PSPH, PSP, PSPHD	C	Phosphoserine phosphatase	172480	S, D		Phosphoserine phosphatase deficiency, 614023 (3)	5(Psph)
7.239	7	10	08	7p11.2	SEPT14	P	Septin 14	612140	Psh, REc			
7.240	5	27	09	7p11.2	SRS, RSS	C	Silver-Russell syndrome	180860	Ch	maternal uniparental disomy of chromosome 7	Silver-Russell syndrome (4)	
7.241	2	25	15	7p11.2	SUMF2	P	Sulfatase-modifying factor 2	607940	REc			
7.242	5	24	13	7p11.2	VOPP1, ECOP, GASP	P	Vesicular, overexpressed in cancer, prosurvival protein 1	611915	REc			
7.243	1	12	15	7p11.2	ZNF713	P	Zinc finger protein 713	616181	REc			
7.244	8	25	04	7p12.2-p12.1	DDC	C	DOPA decarboxylase (aromatic L-amino acid decarboxylase)	107930	REa, A		Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	
7.245	12	4	03	7q11.21	ASL	C	Argininosuccinate lyase	608310	S, REa, A		Argininosuccinic aciduria, 207900 (3)	5(Asl)
7.246	7	8	99	7q11.23	MDH2	C	Malate dehydrogenase, mitochondrial	154100	S			5(Mor1)
7.247	2	1	01	7p21.3	ARL4	L	ADP-ribosylation factor-like 4	604786	H			12(Arl4)
7.248	10	25	11	7q	MLSM7, DEL7q, C7DELq	P	Monosomy 7 of bone marrow	252270	Ch		Myelodysplasia and leukemia syndrome with monosomy 7 (4)	
7.249	8	11	91	7q	HRX	P	Hyperreflexia	145290	F	linked to KEL		
7.250	12	1	98	7q11.23	CLDN3, CPETR2	P	Claudin-3 (Clostridium perfringens enterotoxin receptor 2)	602910	REa, R			
7.251	7	22	15	7q11.21	SBDS, SDS	C	SBDS gene	607444	Fd, REc		Shwachman-Diamond syndrome, 260400 (3); {Aplastic anemia, susceptibility to}, 609135 (3)	
7.252	2	28	01	7q11.23	BAZ1B, WSTF, WBSCR9	P	Bromodomain adjacent to zinc finger domain, 1B	605681	REa			
7.253	4	23	08	7p11.2	MRPS17	C	Mitochondrial ribosomal protein S17	611980	R, REc	9 pseudogenes		
7.254	8	16	06	7p11-q21	HPC4	P	Prostate cancer, hereditary, 4	608658	Fd		{Prostate cancer, susceptibility to, 4}, 176807 (2)	
7.255	10	19	01	7q11.2	ANIB1	C	Aneurysm, intracranial berry, 1	105800	Fd	in or near ELN	Aneurysm, intracranial berry, 1 (2)	
7.256	2	28	08	7q22.1	ARMC10, SVH	P	Armadillo repeat-containing 10	611864	REc			
7.257	7	18	14	7q11.22	KIAA0442, MRD26	P	KIAA0442 gene	607270	A, Ch	translocation break at 7q11.2	Mental retardation, autosomal dominant 26, 615834 (3)	
7.258	7	16	09	7q11.23	CCL26, SCYA26	P	Chemokine, C-C motif, ligand 26	604697	A			
7.259	9	15	11	7q21.11	CD36, CHDS7, BDPLT10	C	CD36 antigen (collagen type I)	173510	A		[Macrothrombocytopenia] (1); Platelet glycoprotein IV deficiency, 608404 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3); {Coronary heart disease, susceptibility to, 7}, 610938 (3)	
7.260	9	12	06	7q11.23	ELN	C	Elastin	130160	REa, A, F, Fd		Supravalvar aortic stenosis, 185500 (3); Cutis laxa, AD, 123700 (3)	5(Eln)
7.261	7	8	10	7q11.2	EOE1, EE	P	Esophagitis, eosinophilic, 1	610247	Fd	associated with rs2302009	{Esophagitis, eosinophilic, 1} (2)	
7.262	2	1	01	7q11.21	ERV3	C	Endogenous retroviral sequence-3 (includes zinc finger protein H-plk)	131170	REa, R			
7.263	9	30	09	7q11.23	FGL2	P	Fibrinogen-like 2	605351	R, REc			
7.264	3	22	06	7q22.1	POLR2J2, RPB11	P	RNA polymerase II polypeptide J-related gene	609881	REc			
7.265	3	22	00	7q11.23	POMZP3	P	POM121/ZP3 fusion protein	600587	A			
7.266	1	27	11	7q11.23	POR	C	Cytochrome P450 oxidoreductase	124015	REa, A		Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3); Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	
7.267	3	23	14	7p11.2	PSPHP1, PSPHL, CO9	P	Phosphoserine phosphatase-like (pseudogene)	604239	TM			
7.268	6	16	99	7q11.23	STX1A, STX1	P	Syntaxin 1A, brain	186590	A, Psh			
7.269	6	6	00	7q11.21	ZNF107	P	Zinc finger protein-107	603989	A			
7.270	9	12	93	7q11.21	ZNF117	P	Zinc finger protein-117	194624	A			
7.271	2	20	03	7q21.2	CCM1, CAM, KRIT1	C	KREV interaction trapped 1	604214	Fd, A		Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3); Cavernous malformations of CNS and retina, 116860 (3)	
7.272	10	6	92	7q11.2-q21.3	EEC1	L	Ectrodactyly, ectodermal dysplasia, cleft lip/palate, 1	129900	Ch		?EEC syndrome-1 (2)	
7.273	8	20	12	7q11.21	KCTD7, EPM3, CLN14	P	Potassium channel tetramerization domain containing 7	611725	REc, Fd		Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	
7.274	12	28	08	7q11.21	RABGEF1, RABEX5	P	RAB guanine nucleotide exchange factor 1	609700	R, REc			
7.275	9	30	09	7q11.21	TPST1	P	Tyrosylprotein sulfotransferase 1	603125	REc			
7.276	5	26	13	7q11.21	TYW1	P	tRNA-wybutosine-synthesizing protein 1, S. cerevisiae, homolog of	611243	REc, R			
7.277	9	16	12	7q11.21	VKORC1L1	P	Vitamin K epoxide reductase complex, subunit 1-like 1	608838	REc			
7.278	2	1	11	7q11.21	ZNF92	P	Zinc finger protein-92	603974	REa, A, REc	sequence aligns with sequence on 19p13.1-p12		
7.279	2	2	01	7q11.21	ZNF138	P	Zinc finger protein-138	604080	A, REa			
7.280	4	6	13	7q11.22	WBSCR17, GALNTL3, GALNACT17	P	Williams-Beuren syndrome chromosome region 17	615137	REc			
7.281	4	17	01	7q11.23	BCL7B	P	B-cell CLL/lymphoma 7B	605846	REc			
7.282	8	29	02	7q11.23	CCL24, SCYA24, MPIF2	C	Chemokine, C-C motif, ligand 24	602495	Psh, REc, R			
7.283	10	4	05	7q11.23	CLDN4, CPETR1, CPER	P	Claudin 4	602909	Psh, H			5(Cldn4)
7.284	2	11	09	7q11.23	CLIP2, CYLN2, WBSCR4, WSCR4	P	CAP-GLY domain-containing linker protein 2	603432	A, H	?neurodevelopmental defect of Williams syndrome		5(Cyln2)
7.285	2	22	11	7q11.23	DEL7q11.23, C7DELq11.23	P	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	Ch	contiguous gene deletion syndrome	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)	
7.286	12	21	09	7q11.23	DTX2, KIAA1528	P	Deltex, Drosophila, homolog of, 2	613141	R, REc			
7.287	1	15	09	7q11.23	DUP7q11.23, C7DUPq11.23	P	Chromosome 7q11.23 duplication syndrome	609757	Ch		Chromosome 7q11.23 duplication syndrome (4)	
7.288	2	12	09	7q11.23	EIF4H, WBSCR1, WSCR1	P	Eukaryotic translation initiation factor 4H	603431	REc			
7.289	5	11	00	7q11.23	FKBP6	P	FK506-binding protein 6	604839	REc			
7.290	8	28	97	7q11.23	FZD9, FZD3	P	Frizzled, Drosophila, homolog of, 9	601766	REn			
7.291	1	9	14	7q11.23	GSAP, PION	P	Gamma-secretase-activating protein	613552	REc			
7.292	9	12	06	7q11.23	GTF2I, BAP135, WBS	P	General transcription factor II-I (BTK-associated protein, 135kD)	601679	D			
7.293	9	12	06	7q11.23	GTF2IRD1, GTF3, MUSTRD1, WBS	P	GTF21 repeat domain-containing protein 1	604318	REc			
7.294	2	28	03	7q11.23	HIP1	C	Huntingtin interacting protein-1	601767	A, R		{Prostate cancer, progression of}, 176807 (1)	5(Hip1)
7.295	6	8	07	7q11.23	HSPB1, HSP27, CMT2F, HMN2B	C	Heat-shock 27kD protein-1	602195	REa, H, REc, Fd		Neuropathy, distal hereditary motor, type IIB, 608634 (3); Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	5(Hsp105)
7.296	2	12	09	7q11.23	LAT2, WBSCR5, LAB, NTAL	P	Linker for activation of T cells family, member 2	605719	REc			5(Wbscr5)
7.297	9	3	96	7q11.23	LIMK1	C	LIM domain kinase 1	601329	REn, Ch, A			5(Limk1)
7.298	3	17	08	7q11.23	MLXIPL, WBSCR14, MONDOB, CHREBP	C	MLX interacting protein-like	605678	REn			
7.299	2	12	13	7q11.23	MIR590	P	Micro RNA 590	615070	REc			
7.300	10	12	90	7q11.23	NCF1	P	Neutrophil cytosolic factor-1, 47kD	608512	REa, A		Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)	
7.301	4	11	14	7q11.23	NSUN5, WBSCR20, WBSCR20A	P	NOP2/SUN domain family, member 5	615732	REc			
7.302	6	22	14	7q11.23	POM121, POM121A, KIAA0618	C	POM121 transmembrane nucleoporin	615753	R, REc			
7.303	6	22	14	7q11.23	POM121C, POM121-2	P	POM121 Transmembrane nucleoporin C	615754	REc			
7.304	12	5	13	7q11.23	PTPN12, PTPG1	P	Protein tyrosine phosphatase, nonreceptor-type, 12	600079	A		Colon cancer, somatic, 114500 (3)	5(Ptpn12)
7.305	3	6	95	7q11.23	RFC2	P	Replication factor C2, 40kD (activator 1, 40kD)	600404	Psh, A			
7.306	5	6	13	7q11.23	RHBDD2	P	Rhomboid domain-containing protein 2	615203	REc			
7.307	3	19	03	7q11.23	SRCRB4D	P	Protein with 4 group B scavenger receptor cysteine-rich domains	607639	REc, R			
7.308	12	17	15	7q11.23	STYXL1, MKSTYX, DUSP24	P	Serine/threonine/tyrosine-interacting protein-like 1	616695	REc			
7.309	4	17	01	7q11.23	TBL2	P	Transducin-beta-like 2	605842	H, R			5(Tbl2)
7.310	9	24	15	7q11.23	TMEM120A, TMPIT, NET29	P	Transmembrane protein 120A	616550	REc			
7.311	1	24	09	7q11.23	TRIM50, TRIM50A	P	Tripartite motif-containing protein 50	612548	REc, H			5(Trim50)
7.312	1	24	09	7q11.23	TRIM73, TRIM50B	P	Tripartite motif-containing protein 73	612549	REc			
7.313	1	24	09	7q11.23	TRIM74, TRIM50C	P	Tripartite motif-containing protein 74	612550	REc			
7.314	3	11	08	7q11.23	UPK3B, UPIIIB, P35	P	Uroplakin 3B	611887	REn			
7.315	6	9	06	7q11.23	VPS37D, WBSCR24	P	Vacuolar protein sorting 37, yeast, homolog of, D	610039	REc			
7.316	1	13	09	7q11.23	WBS, WMS, WS, DEL7q11, C7DELq11	C	Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome)	194050	Ch	contiguous gene syndrome	Williams-Beuren syndrome (4)	
7.317	4	10	14	7q11.23	WBSCR22, MERM1	P	Williams-Beuren syndrome critical region 22	615733	REc, H			5(Wbscr22)
7.318	1	24	09	7q11.23	WBSCR26	P	Williams-Beuren syndrome chromosome region 26	612545	REc, H			5(Wbscr26)
7.319	1	24	09	7q11.23	WBSCR27	P	Williams-Beuren syndrome chromosome region 27	612546	REc, H			5(Wbscr27)
7.320	1	24	09	7q11.23	WBSCR28	P	Williams-Beuren syndrome chromosome region 28	612547	REc, H			5(Wbscr28)
7.321	1	8	01	7q11.23	YWHAG	P	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform	605356	A, R			
7.322	9	25	02	7q11.23	ZP3, ZP3A, ZP3B	C	Zona pellucida glycoprotein-3 (sperm receptor)	182889	REa, A			5(Zp3)
7.323	2	2	16	7q11.23-q21.11	PHTF2	P	Putative homeodomain transcription factor 2	616785	REc			
7.324	6	23	15	7q21.11	PCLO, PCH3	C	Piccolo, mouse, homolog of	604918	R, REc, Fd	mutation identified in 1 PCHD3 family	?Pontocerebellar hypoplasia, type 3, 608027 (3)	
7.325	7	22	02	7q31.1	PPP1R3A, PPP1R3	P	Protein phosphatase 1, regulatory subunit 3A	600917	R		Insulin resistance, severe, digenic, 604367 (3)	
7.326	7	1	02	7q21.12	ADAM22	P	A disintegrin and metalloproteinase domain 22	603709	R			
7.327	10	11	01	7q21.11	AIP1, KIAA0705	P	Atrophin 1-interacting protein 1	606382	R			
7.328	10	12	14	7q11.23	APTR	P	Alu-mediated CDKN1A/p21 transcriptional regulator, noncoding	616048	REc			
7.329	1	2	08	7q21.3	CASD1, C7orf12	P	CAS1 domain-containing protein 1	611686	REc			
7.330	8	19	13	7q21.13	CLKDN12	P	Claudin 12	611232	REc			
7.331	2	18	09	7q22.1	EPO, MVCD2	C	Erythropoietin	133170	REa, A, REb, Fd	close to COL1A2; no recombination	{Microvascular complications of diabetes 2}, 612623 (3)	5(Epo)
7.332	1	12	99	7q21.13	FZD1	P	Frizzled, Drosophila, homolog of, 1	603408	A			
7.333	6	1	88	7q21.11	GNAI1	C	Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-1	139310	REa, A			5(Gnai1)
7.334	2	10	00	7q22.1	GNB2	C	Guanine nucleotide-binding protein, beta polypeptide-2	139390	REa, REn	30-70kb from EPO		5(Gnb2)
7.335	1	27	11	7q21	MAGI2IT, PR47	P	MAGI2 intronic transcript	608950	REc			
7.336	12	22	05	7q21.3	PEG10, KIAA1051	C	Paternally expressed gene 10	609810	R, REc			6(Peg10)
7.337	10	30	06	7q21.2	SAMD9, NFTC	C	Sterile alpha motif domain-containing protein 9	610456	REn		Tumoral calcinosis, familial, normophosphatemic, 610455 (3)	
7.338	9	9	03	7q21.3	SGCE, DYT11	C	Sarcoglycan, epsilon	604149	R, H, Fd	pseudogene on 2q21; maternally imprinted	Dystonia-11, myoclonic, 159900 (3)	6(Sgce)
7.339	1	31	00	7q21.13	STEAP	P	Six-transmembrane epithelial antigen of the prostate	604415	R			
7.340	1	2	03	7q21.13	STEAP2, STAMP1, IPCA1, PCANAP1	P	Six-transmembrane epithelial antigen of prostate 2	605094	REc			
7.341	8	22	07	7q21.12	STEAP4, STAMP2, TIARP	P	Six-transmembrane epithelial antigen of prostate 4	611098	REc			
7.342	2	17	09	7q21	STQTL11	P	Stature quantitative trait locus 11	612223	Fd	associated with rs2282978	{Stature QTL 11} (2)	
7.343	2	26	08	7q21.2	AKAP9, YOTIAO, AKAP450	P	A-kinase anchor protein 9	604001	REc	mutation identified in 1 LQT11 family	?Long QT syndrome-11, 611820 (3)	
7.344	3	15	10	7q22.1	ARPC1A, SOP2L	P	Actin-related protein 2/3 complex, subunit 1A	604220	REc			
7.345	3	15	10	7q22.1	ARPC1B, ARC41	P	Actin-related protein 2/3 complex, subunit 1B	604223	REc			
7.346	7	17	01	7q21.3	ASB4	P	Ankyrin repeat-containing SOCS box protein 4	605761	REc			6(Asb4)
7.347	8	5	97	7q21.11	CACNA2, CACNL2A	C	Calcium channel, voltage-dependent, L type, alpha 2/delta subunit	114204	Psh, Fd, A			
7.348	6	6	00	7q22.1	CPSF4, CPSF30, NEB1	P	Cleavage-polyadenylation specificity factor 4, 30kD	603052	R			
7.349	11	5	14	7q21.2	CDK6, PLSTIRE, MCPH12	C	Cyclin-dependent kinase 6	603368	R, REc, Psh	mutation identified in 1 MCPH12 family	?Microcephaly 12, primary, autosomal recessive, 616080 (3)	
7.350	5	2	16	7q21.2	ERVW1, ERVWE1, HERVW	P	Endogenous retroviral family W, member 1 (syncytin)	604659	REc			
7.351	8	5	97	7q21-q22	MHS3	P	Malignant hyperthermia susceptibility 3	154276	Fd	?mutation in CACNA2	{Malignant hyperthermia susceptibility 3} (2)	
7.352	10	28	15	7q21.2	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	C	Peroxisome biogenesis factor-1	602136	Ch, REc		Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3); Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3); Heimler syndrome 1, 234580 (3)	
7.353	8	9	99	7q21.3	TAC1, TAC2, NKNA	C	Tachykinin 1 (substance K; neurokinin A; neurokinin 2; neuromedin L; neuropeptide gamma; tachykinin 2)	162320	REa, A, H			6(Nkna)
7.354	9	28	96	7q22.1	ZNF36, KOX18	P	Zinc finger protein-36 (KOX 18)	601260	A, REc			
7.355	9	28	96	7q22.1	ZNF38, KOX25	P	Zinc finger protein-38 (KOX 25)	601261	A, REc			
7.356	12	24	13	7q21.3	ASNS, ASNSD	C	Asparagine synthetase	108370	S, REa, A	temperature sensitive G1 mutant	Asparagine synthetase deficiency, 615574 (3)	
7.357	12	7	12	7q21.12	ABCB4, PGY3, MDR3, ICP3	C	ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	RE	within 500kb of MDR1	Cholestasis, progressive familial intrahepatic 3, 602347 (3); Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3); Gallbladder disease 1, 600803 (3)	
7.358	5	4	12	7q21.12	ABCB1, PGY1, MDR1, IBD13, CLCs	C	ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)	171050	REa, A, REb		{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13}, 612244 (3)	5(Pgy1)
7.359	7	11	01	7q21.12	CROT, COT	P	Carnitine octanoyltransferase	606090	REc			
7.360	8	24	09	7q21.11	HGF, DFNB39	C	Hepatic growth factor	142409	REb, A, REa		Deafness, autosomal recessive 39, 608265 (3)	
7.361	6	4	89	7q21.12	SRI, SCN	P	Sorcin (class 4 gene)	182520	REa, H			
7.362	6	4	98	7q21.11-q21.12	GRM3	P	Glutamate receptor, metabotropic-3	601115	A			
7.363	1	30	01	7q22.1	SMURF1	P	SMAD ubiquitination regulatory factor 1	605568	REc			
7.364	7	17	14	7q21.11	GNAT3, GDCA	P	Guanine nucleotide-binding protein, alpha-transducing activity polypeptide 3	139395	REc			
7.365	8	21	91	7q11.21	GUSB, MPS7	C	Glucuronidase, beta-	611499	S, D, EM		Mucopolysaccharidosis VII, 253220 (3)	5(Gus)
7.366	6	11	13	7q21.11	SEMA3A, SEMAD, COLL1, HH16	P	Semaphorin 3A	603961	REc, R		{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	
7.367	4	21	15	7q21.11	SEMA3C	P	Semaphorin 3C	602645	REc			
7.368	4	21	15	7q21.11	SEMA3D	P	Semaphorin 3D	609907	R, REc			
7.369	8	8	13	7q21.12	DMTF1, DMP1	P	Cyclin D-binding MYB-like transcription factor 1	608491	REc			
7.370	1	13	16	7q21.11	SEMA3E, SEMAH, KIAA0331	P	Semaphorin 3E	608166	R, REc	mutation identified in 1 CHARGE patient	?CHARGE syndrome, 214800 (3)	
7.371	9	8	11	7q21.12	KIAA1324L, EIG121L	P	KIAA1324-like gene	614048	REc			
7.372	3	12	07	7q21.12	SLC25A40	P	Solute carrier family 25, member 40	610821	REc			5(Slc25a40)
7.373	6	23	15	7q21.12	TP53TG1	P	TP53 target gene 1	616403	REc			
7.374	4	17	13	7q21.13	CDK14, PFTK1, PFTAIRE1, KIAA0834	P	Cyclin-dependent kinase 14	610679	R			
7.375	4	18	07	7q21.13	GTPBP10, OBGH2	P	GTP-binding protein 10	610920	R, REc			
7.376	4	22	15	7q21.2	GATAD1, ODAG, CMD2B	P	GATA zinc finger domain-containing protein 1	614518	REc	mutation identified in 1 GATAD1 family	?Cardiomyopathy, dilated, 2B, 614672 (3)	
7.377	10	7	13	7q21.2	MTERF	P	Transcription termination factor, mitochondrial	602318	REc			
7.378	5	14	09	7q21.2	SAMD9L	P	Sterile alpha motif domain-containing 9-like	611170	REc			
7.379	3	5	03	7q21.2	CYP51A1, CYP51	P	Cytochrome P450, family 51, subfamily A, polypeptide 1 (lanosterol 14-alpha-demethylase)	601637	Psh, REc			
7.380	9	8	11	7q21.2	HEPACAM2, MIKI	P	Hepacam family member 2	614133	REc			
7.381	4	21	11	7q21.2-q21.3	SHFM1, SHFD1, SHSF1	C	Split hand/foot malformation (ectrodactyly) type 1	183600	Ch	contiguous gene deletion syndrome	Split hand/foot malformation 1 (4)	
7.382	7	20	15	7q21.2-q21.3	VPS50, CCDC132, KIAA1861	P	VPS50, EARP/GARPII complex subunit	616465	REc			
7.383	9	4	98	7q22.1	TRRAP	P	Transformation/transcription domain-associated protein	603015	R			
7.384	5	22	14	7q21.3	ACN9	P	Acn9, S. cerevisiae, homolog of	615773	REc			
7.385	11	22	99	7q21.12	ASK, DBF4	P	Activator of S-phase kinase	604281	A			5(Dbf4)
7.386	7	14	14	7q21.3	BET1	P	Bet1 golgi vesicular membrane-trafficking protein	605456	REc			
7.387	2	13	14	7q21.3	BRI3	P	Brain protein I3	615628	REc			
7.388	3	16	99	7q21.3	CALCR, CRT	C	Calcitonin receptor	114131	A, Psh	not deleted in Williams syndrome	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)	6(Calcr)
7.389	5	25	13	7q21.3	GNG11	P	Guanine nucleotide-binding protein, gamma 11	604390	REc			
7.390	6	16	99	7q21.3	GNGT1	P	Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 1	189970	Psh, REc			
7.391	3	30	12	7q21.3	MIR489	P	Micro RNA 489	614523	REc	in intron 4 of CALCR		
7.392	7	8	10	7q21.3	PON1, PON, ESA, MVCD5	C	Paraoxonase-1	168820	F, Fd, REc		{Coronary artery disease, susceptibility to} (3); {Coronary artery spasm 2, susceptibility to (3); {Organophosphate poisoning, sensitivity to} (3); {Microvascular complications of diabetes 5}, 612633 (3)	6(Pon1)
7.393	9	9	98	7q21.3	PON2	C	Paraoxonase-2	602447	REc		{Coronary artery disease, susceptibility to} (3)	
7.394	9	9	98	7q21.3	PON3	C	Paraoxonase-3	602720	REc			
7.395	10	20	04	7q21.3	PPP1R9A, NRBI, NRB1, KIAA1222	P	Protein phosphatase 1, regulatory subunit 9A (neurabin I)	602468	R, REc			
7.396	8	20	02	7q21.3	SLC25A13, CTLN2	P	Solute carrier family 25 (mitochondrial carrier, citrin), member 13	603859	Fd, LD		Citrullinemia, adult-onset type II, 603471 (3); Citrullinemia, type II, neonatal-onset, 605814 (3)	
7.397	8	31	12	7q21.3	TECPR1, KIAA1358	P	Tectonin beta-propeller repeat-containing 1	614781	R, REc			
7.398	1	7	95	7q22.1	PCOLCE	C	Procollagen C-endopeptidase enhancer	600270	REa, A			5(Pcolce)
7.399	4	13	10	7q22.1	PAI1, PLANH1, SERPINE1	C	Plasminogen activator inhibitor, type I	173360	REa, REb, Fd, A, D		Plasminogen activator inhibitor-1 deficiency, 613329 (3); {Transcription of plasminogen activator inhibitor, modulator of} (3)	
7.400	8	28	01	7q11.21	RCP	P	Calcitonin gene-related peptide receptor component protein	606121	REc			
7.401	3	5	08	7q21.3-q22.1	BAIAP2L1, IRTKS	P	BAI1-associated protein 2-like 1	611877	REc			
7.402	6	16	99	7q21.3	DNCI1	P	Dynein, cytoplasmic, intermediate chain 1	603772	REc			6(Dnci1)
7.403	9	23	97	7q21.3	DSS1	P	Deleted in split-hand/split-foot 1 region	601285	D	?gene mutant in SHFM1		
7.404	5	22	07	7q21.3	LMTK2, KPI2, BREK, KIAA1079	C	Lemur tyrosine kinase 2	610989	R, REc			
7.405	8	18	97	7q22.1	MCM7, MCM2	P	Minichromosome maintenance deficient, S. cerevisiae, homolog of, 7	600592	A			
7.406	9	20	95	7q22.1	NPTX2	P	Pentraxin II	600750	A			
7.407	11	4	98	7q21.3	PDK4	P	Pyruvate dehydrogenase kinase, isoenzyme 4	602527	REc			
7.408	8	28	92	7q22.1	ACHE, YT	C	Acetylcholinesterase (YT blood group)	100740	Psh, A, Fd, REb	blood group YT (112100) = epitope of ACHE	[Blood group, Yt system], 112100 (3)	5(Ache)
7.409	12	24	08	7q22.1	ACTL6B, BAF53B	P	Actin-like 6B	612458	REc			
7.410	1	31	01	7q22.1	APS	P	Adaptor protein containing PH and SH2 domains	605300	REc			
7.411	5	16	07	7q22	AUTS1	C	Autism, susceptibility to, 1	209850	Fd		{Autism susceptibility 1} (2)	
7.412	3	22	93	7q22.1	CUTL1, CDP	P	Cut, Drosophila, homolog of (CCAAT displacement protein)	116896	REa			
7.413	2	16	12	7q21.3	DLX5, SHFM1D	C	Distal-less homeo box-5	600028	REa, A, D	mutation identified in 1 family	?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3)	6(Dlx5)
7.414	1	8	95	7q21.3	DLX6	P	Distal-less homeo box-6	600030	REa, A			
7.415	9	30	09	7q22.1	EPHB4, HTK, MYK1	P	Ephrin receptor EphB4 (hepatoma transmembrane kinase)	600011	REa, REc			
7.416	9	30	09	7q22.1	DNAJC2, ZRF1, MPP11	P	DnaJ (Hsp40) homolog, subfamily C, member 2	605502	R, REc			
7.417	9	9	08	7q22.1	FBXO24, FBX24	P	F-box only protein 24	609097	REc			5(Fbxo24)
7.418	2	7	07	7q22.1	GAL3ST4	P	Galactose-3-O-sulfotransferase 4	608235	REc			
7.419	1	18	11	7q22	IBD11	P	Inflammatory bowel disease 11	191390	Fd	associated with MUC3A	{Inflammatory bowel disease 11} (2)	
7.420	3	14	14	7q22.3	KMT2E, MLL5	P	Lysine (K)-specific methyltransferase 2E	608444	REc			
7.421	10	13	09	7q22.1	MEPCE, BCDIN3	P	Methylphosphate capping enzyme	611478	A			
7.422	9	2	09	7q22.1	MIR93, MIRN9	P	Micro RNA 93	612984	REc			
7.423	9	3	09	7q22.1	MIR106B, MIRN106B	P	Micro RNA 106B	612983	REc			
7.424	1	18	11	7q22.1	MUC3A	P	Mucin 3A, intestinal	158371	REa, A			
7.425	2	12	01	7q22	MUC3B	P	Mucin 3B, intestinal	605633	A			
7.426	1	4	08	7q22.1	MUC12, MUC11	P	Mucin 12	604609	A			
7.427	11	5	08	7q22.1	MUC17	P	Mucin 17	608424	R			
7.428	4	15	04	7q22	MYH16	C	Myosin, heavy chain 16, skeletal muscle	608580	REc	inactivated in humans; expressed in masticatory muscles in nonhuman primates		
7.429	8	24	04	7q22	PAPA4	P	Polydactyly, postaxial, type A4	608562	Fd	highest lod with D7S1799	Polydactyly, postaxial, type A4 (2)	
7.430	9	20	00	7q22.3	PIK3CG	C	Phosphatidylinositol 3-kinase, catalytic, gamma	601232	A			
7.431	1	31	01	7q22.1	PILRA	C	Paired immunoglobulin-like receptor, alpha	605341	REc, R			
7.432	1	31	01	7q22.1	PILRB	P	Paired immunoglobulin-like receptor, beta	605342	REc, REn			
7.433	12	16	08	7q22.1	PLOD3, LH3	P	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3)	603066	REa, A	previously assigned to 7q36	Lysyl hydroxylase 3 deficiency, 612394 (3)	5(Plod3)
7.434	9	30	09	7q22.1	POP7, RPP20	P	Processing of precursor 7, S. cerevisiae, homolog of	606113	R, REc			
7.435	5	23	95	7q22.3	PRKAR2B	C	Protein kinase, cAMP-dependent, regulatory, type II, beta	176912	Fd, A, REc			
7.436	9	7	10	7q22.1	RASA4, CAPRI, GAPL, KIAA0538	P	Ras p21 protein activator 4	607943	REc			
7.437	6	23	15	7q22.1	RELN, RL, LIS2, ETL7	C	Reelin	600514	A, REc		Lissencephaly 2 (Norman-Roberts type), 257320 (3); {Epilepsy, familial temporal lobe, 7}, 616436 (3)	5(rl)
7.438	3	16	16	7q22.1	SLC12A9, CIP1, CCC6	P	Solute carrier family 12 (potassium/chloride transporter), member 9	616861	Psh			
7.439	2	23	12	7q22.1	SRRT, ARS2	P	Serrate RNA effector molecule, arabidopsis, homolog of	614469	REc			
7.440	4	8	16	7q22.1	STAG3, POF8	P	Stromalin 3	608489	Psh, R, H, REc		Premature ovarian failure 8, 615723 (3)	5(Stag3)
7.441	9	15	96	7q21.3	TFPI2	P	Tissue factor pathway inhibitor-2	600033	A			
7.442	5	3	00	7q22.1	TFR2, HFE3	P	Transferrin receptor 2	604720	R		Hemochromatosis, type 3, 604250 (3)	
7.443	11	20	98	7q22.1	TRIP6, OIP1	P	Thyroid hormone receptor interactor-6	602933	R			
7.444	3	5	98	7q22.1	VGF	P	VGF nerve growth factor inducible	602186	A			
7.445	6	19	98	7q22.1	ZAN	P	Zonadhesin	602372	A			5(Zan)
7.446	6	16	99	7q31.1	IFRD1	P	Interferon-related developmental regulator 1	603502	REc			
7.447	8	4	97	7q22.3	GPR22	P	G protein-coupled receptor-22	601910	A			
7.448	10	26	98	7q22.1	MPPB	P	Mitochondrial processing peptidase-beta	603131	REc			
7.449	10	19	99	7q22.1	POLR2J	P	Polymerase II, RNA, subunit J	604150	REc			
7.450	6	22	14	7q22.3-q31.1	SLC26A3, DRA, CLD	C	Solute carrier family 26 (sulfate transporter), member 3	126650	A, REc, Fd	5' and close to PDS	Diarrhea 1, secretory chloride, congenital, 214700 (3)	
7.451	9	14	89	7q22-q32	G7P1	P	Kinase-like protein	148750	REa, Fd			
7.452	11	4	04	7q22-q32	SCA18, SMNA	P	Spinal cerebellar ataxia 18	607458	Fd	between D7S2418 and D7S1804	Spinocerebellar ataxia 18 (2)	
7.453	9	9	08	7q33	CNOT4, NOT4	P	CCR4-NOT transcription complex, subunit 4	604911	REc			
7.454	7	20	12	7q22-qter	NM, NCR	C	Neutrophil migration, abnormal	162820	D		?Neutrophil chemotactic response, abnormal (2)	
7.455	7	18	14	7q22.1	AGFG2, HRBL, RABR	P	ADP-ribosylation factor GTPase-activating protein with FG repeats 2	604019	REc			
7.456	3	16	10	7q22.1	ALKBH4, ABH4	P	AlkB, E. coli, homolog of, 4	613302	REc			
7.457	1	14	13	7q22.1	AP1S1, CLAPS1, AP19, MEDNIK	P	Adaptor-related protein complex 1, sigma 1 subunit	603531	REa, REc		MEDNIK syndrome, 609313 (3)	
7.458	4	27	12	7q22.1	AP4M1, SPG50, CPSQ3	C	Adaptor-related protein complex 4, mu-1 subunit	602296	REc		Spastic paraplegia 50, autosomal recessive, 612936 (3)	
7.459	3	18	94	7q22.1	AZGP1, ZAG	C	Alpha-2-glycoprotein, zinc	194460	REa, A			
7.460	5	25	13	7q22.1	BUD31, G10	P	Bud31, S. cerevisiae, homolog of	603477	REc			
7.461	6	22	14	7q22.1	CLDN15	P	Claudin 15	615778	REc			
7.462	4	23	09	7q22.1	CNPY4, PRAT4B, MGC40499	P	Canopy 4, zebrafish, homolog of	610047	R, REc			
7.463	12	9	10	7q21.3	COL1A2	C	Collagen I, alpha-2 polypeptide	120160	S, REa, D, A	~17cM from CF	Ehlers-Danlos syndrome, type VIIB, 130060 (3); Osteogenesis imperfecta, type IV, 166220 (3); Osteogenesis imperfecta, type III, 259420 (3); Osteogenesis imperfecta, type II, 166210 (3); {Osteoporosis, postmenopausal}, 166710 (3); Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)	6(Cola2)
7.464	7	18	12	7q22.1	COPS6, CSN6	P	COP9 signalosome, subunit 6	614729	REc			
7.465	12	14	95	7q22.1	CYP3A4	C	Cytochrome P450, subfamily IIIA (nifedipine oxidase) polypeptide 4	124010	REa, D, Fd, A			6(Cyp3)
7.466	1	25	05	7q22.1	CYP3A5, P450PCN3	C	Cytochrome P450, subfamily IIIA, polypeptide 5	605325	REc, REn		{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)	
7.467	12	7	03	7q22.1	CYP3A7	P	Cytochrome P450, subfamily IIIA, polypeptide 7	605340	REn			
7.468	12	11	01	7q22.1	CYP3A43	P	Cytochrome P450, subfamily IIIa, polypeptide 43	606534	REc			
7.469	2	1	11	7q22.1	SH2B1, SH2B, KIAA1299	P	SH2B adaptor protein 1	608927	REc			7(Sh2b)
7.470	6	13	12	7q22.1	EBXL13, FBL13	P	F-box and leucine-rich repeat protein 13	609080	REc			5(Fbxl13)
7.471	8	18	08	7q22.1	GAEC1	P	Gene amplified in esophageal cancer 1	612130	REc			
7.472	6	10	08	7q22.1	GIGYF1	P	GRB10-interacting GYF protein 1	612064	REc, H			5(Gigyf1)
7.473	4	1	08	7q22.1	GJC3, CX30.2, CX31.3	P	Gap junction protein, gamma-3	611925	R, REc			
7.474	9	8	11	7q22.1	KPNA7	P	Karyopherin alpha 7	614107	REc			
7.475	12	28	08	7q22.2-q22.3	LHFPL3	P	LHFP-like protein 3	609719	R, REc			
7.476	4	17	13	7q22.1	LRWD1, ORCA	P	Leucine-rich repeats- and WD repeat domain-containing protein 1	615167	REc			5(Lrwd1)
7.477	3	23	09	7q22.1	MIR25, MIRN25	P	Micro RNA 25	612150	REc			
7.478	8	3	12	7q22.1	MOGAT3, MGAT3	P	Monoacylglycerol O-acyltransferase 3	610184	REc			
7.479	10	7	08	7q22.1	NAPEPLD	P	N-acyl phosphatidylethanolamine-hydrolyzing phospholipase D	612334	REc			
7.480	6	22	14	7q22.1	NAT16	P	N-acetyltransferase 16	615783	REc			
7.481	8	18	08	7q22.1	NFE4	P	Transcription factor NFE4	612133	REc			
7.482	12	10	13	7q22.1	NYPA1	P	Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1	615477	REc			
7.483	7	22	09	7q22.1	ORAI2, MEM142B, C7orf19	P	ORAI calcium release-activated calcium modulator 2	610929	REc			
7.484	2	18	98	7q22.1-q22.2	ORC5, ORC5L	P	Origin recognition complex, subunit 5, S. cerevisiae, homolog of	602331	REa, Psh, A, REc			
7.485	9	30	09	7q22.1	PDAP1, PAP1, PAP	P	PDGFA-associated protein 1	607075	R, REc			
7.486	11	11	14	7q22.1	PMS2P1, PMS2L1, PMS3	P	Postmeiotic segregation increased 2 pseudogene 1	605038	Psh, A, REc			
7.487	8	21	12	7q22.1	PTCD1, KIAA0632	c	Pentatricopeptide repeat domain 1	614774	R, REc			
7.488	6	9	15	7q22.1	SLC26A5, PRES, DFNB61	P	Solute carrier family 26, member 5	604943	REc	mutation identified in 1 DFNB61 family	?Deafness, autosomal recessive 61, 613865 (3)	
7.489	9	30	09	7q22.1	TAF6, TAF2E, TAFII80	P	TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD	602955	R, REc			
7.490	5	24	13	7q22.1	ZKSCAN5, ZFP95, KIAA1015	C	Zinc finger protein with KRAB and SCAN domains 5	611272	REc, R, A			5(Zkscan5)
7.491	11	2	04	7q22.1	TTC11, FIS1	P	Tetratricopeptide repeat domain 11	609003	R, REc			
7.492	10	13	09	7q22.1	UFSP1	P	UFM1-specific protease 1	611481	REc			
7.493	9	30	09	7q22.1	ZNF3	P	Zinc finger protein-3	194510	R, REc	?relation to ZNF4, ZNF5; previous assignment to Chr.5		
7.494	11	4	98	7q22.1	PSMC2, MSS1, S7	P	Proteasome 26S subunit, ATPase, 2	154365	A			
7.495	4	8	08	7q22.3	NAMPT, PBEF1, VF, PBEF	P	Nicotinamide phosphoribosyltransferase	608764	R, REc			
7.496	10	9	08	7q22.3	CBLL1, HAKAI, RNF188	P	Cas-Br-M murine ectopic retroviral transforming sequence like-1	606872	R, REc			
7.497	2	2	14	7q22.3	CDHR3	P	Cadherin-related family, member 3	615610	REc			
7.498	12	22	15	7q22.3	HBP1	P	HMG-box transcription factor 1	616714	REc			
7.499	5	29	12	7q22.3	MPVQTL6	P	Mean platelet volume quantitative trait locus 6	614646	Fd	associated with rs342293	Mean platelet volume QTL6 (2)	
7.500	3	12	15	7q22.3	PUS7, KIAA1897	P	Pseudouridylate synthase 7, putative	616261	REc			
7.501	7	19	12	7q22.3	RINT1	P	RAD50-interacting protein 1	610089	REc			
7.502	12	1	15	7q22.3	SYPL1, SYPL	P	Synaptophysin-like 1	616665	REc			
7.503	3	1	06	7q22.3-q31.1	CMD1Q	P	Cardiomyopathy, dilated, 1Q	609915	Fd	between D7S2545 and D7S2554	Cardiomyopathy, dilated, 1Q (2)	
7.504	11	19	13	7q31	AUTS9	P	Autism, susceptibility to, 9	611015	Fd	max lod near D7S530	{Autism, susceptibility to, 9} (2)	
7.505	1	18	11	7q22.3	COG5, GOLTC1, GTC90, CDG2I	P	Component of oligomeric golgi complex 5	606821	REc		Congenital disorder of glycosylation, type IIi, 613612 (3)	
7.506	12	20	05	7q31.31	CTTNBP2, CORTBP2, KIAA1758	P	Cortactin-binding protein 2	609772	REn			
7.507	5	20	99	7q31	DFNB14	P	Deafness, autosomal recessive 14	603678	Fd	?same as DFNB17	Deafness, autosomal recessive 14 (2)	
7.508	9	9	98	7q31	DFNB17	P	Deafness, autosomal recessive 17	603010	Fd		Deafness, autosomal recessive 17 (2)	
7.509	4	9	03	7q31.1	DOCK4, KIAA0716	P	Dedicator of cytokinesis 4	607679	REc			12(Dock4)
7.510	11	4	98	7q31.33	GPR37	P	G protein-coupled receptor-37	602583	REc			
7.511	9	15	00	7q31.1	GPR85, SREB2	P	G protein-coupled receptor-85	605188	R			
7.512	5	4	00	7q31.32	HYAL4	P	Hyaluronoglucosaminidase 4	604510	A, REc			
7.513	10	6	08	7q31.1	IMMP2L, IMP2	P	Inner mitochondrial membrane peptidase, subunit 2, S. cerevisiae, homolog of	605977	Ch			
7.514	1	27	03	7q31.31	ING3, P47ING3	P	Inhibitor of growth family, member 3	607493	REc			
7.515	11	27	00	7q31.31	KCND2, KIAA1044	C	Potassium voltage-gated channel, Shal-related subfamily, member 2	605410	R			
7.516	4	21	16	7q31.2	MET, DFNB97, OSFD	C	Oncogene MET	164860	REa, A, F	mutation identified in 1 DFNB97 family	Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3); Hepatocellular carcinoma, childhood type, somatic, 114550 (3); ?Deafness, autosomal recessive 97, 616705 (3); {Osteofibrous dysplasia, susceptibility to}, 607278 (3)	6(Met)
7.517	5	4	15	7q31.1	PNPLA8, MMLA	P	Patatin-like phospholipase domain-containing protein 8	612123	REc	mutation identified in 1 MMLA family	?Mitochondrial myopathy with lactic acidosis, 251950 (3)	
7.518	7	6	12	7q22.3	SLC26A4, PDS, DFNB4, EVA, TDH2B	C	Solute carrier family 26 (sulfate transporter), member 4	605646	Fd	some patients have digenic mutations with FOXI1	Pendred syndrome, 274600 (3); Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	
7.519	11	13	95	7q31.32	SPAM1	P	Sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)	600930	A			
7.520	3	23	06	7q33	STRA8	P	Stimulated by retinoic acid 8, mouse, homolog of	609987	REc			
7.521	11	26	01	7q31.1	FOXP2, SPCH1, TNRC10, CAGH44	C	Forkhead box P2	605317	Fd, Ch, REc		Speech-language disorder-1, 602081 (3)	
7.522	9	8	11	7q33	EXOC4, SEC8, KIAA1699	P	Exocyst complex component 4	608185	REc, R			
7.523	4	21	10	7q31.32	TAS2R16, T2R16	C	Taste receptor type 2, member 16	604867	REc		{Alcohol dependence}, 103780 (3)	6(T2r18)
7.524	6	10	94	7q31.2	WNT2, INT1L1	P	Wingless-type MMTV integration site family, member 2	147870	C	isolated by CMGT with MET		6(Irp, Wnt2)
7.525	12	4	90	7q36.1	ABP1	P	Amiloride-binding protein-1	104610	A			
7.526	3	20	08	7q32.1	CCDC136, NAG6, KIAA1793	P	Coiled-coil domain-containing protein 136	611902	REn			
7.527	3	7	13	7q31.1	DLD, LAD, PHE3, DLDD	C	Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex)	238331	REa		Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	12(Dld)
7.528	8	28	01	7q31.32	SLC13A1, NAS1	P	Solute carrier family 13 (sodium/sulfate symporters), member 1	606193	R			
7.529	10	7	98	7q32.1	SMOH, SMO	P	Smoothened, Drosophila, homolog of	601500	A		Basal cell carcinoma, somatic (3)	
7.530	4	16	11	7q33	BPGM	P	2,3-bisphosphoglycerate mutase	613896	A		Erythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3)	
7.531	4	10	14	7q31.2	CAV1, BSCL3, CGL3, PPH3, LCCNS	C	Caveolin-1	601047	REc	mutation identified in 1 CGL3 family; mutation identified in 1 LCCNS family	?Lipodystrophy, congenital generalized, type 3, 612526 (3); Pulmonary hypertension, primary, 3, 615343 (3); ?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	
7.532	3	29	99	7q31.2	CAV2	P	Caveolin-2	601048	REc			6(Cav2)
7.533	2	1	11	7q31.1	DNAJB9, MDG1	P	DnaJ, E. coli, homolog of, subfamily B, member 9 (microvascular endothelial differentiation gene-1)	602634	REc	previously assigned to chr.14 by FISH		
7.534	6	2	15	7q31.1	LAMB4	P	Laminin, beta-4	616380	REc			
7.535	3	29	12	7q31.1-q31.2	MDFIC, HIC	P	MYOD family inhibitor domain-containing protein	614511	REc			
7.536	11	7	01	7q31.2	ST7, TSG7, RAY1, FAM4A1	P	Suppressor of tumorigenicity 7 (breast)	600833	C, D			
7.537	3	29	10	7q31.31	TSPAN12, NET2, EVR5	P	Tetraspanin 12	613138	REc		Exudative vitreoretinopathy 5, 613310 (3)	6(Tspan12)
7.538	1	20	09	7q31.1	THAP5	P	THAP domain-containing protein 5	612534	REc			
7.539	1	29	01	7q31.1	ZNF277	P	Zinc finger protein-277	605465	REn			
7.540	1	21	97	7q31.1	NRCAM	P	Neuronal cell adhesion molecule	601581	A			
7.541	4	23	13	7q31.1	LAMB1, LIS5	C	Laminin, beta-1	150240	REa, A, Ch		Lissencephaly 5, 615191 (3)	1(Lamb1)
7.542	10	27	10	7q31.2	CFTR, ABCC7, CF, MRP7	C	Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421	F, Fd	distal and 5' to MET	Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, idiopathic}, 167800 (3); {Hypertrypsinemia, neonatal} (3); {Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	6(Cftr)
7.543	7	11	01	7q31.2	TES	P	Testin	606085	REc			6(Tes)
7.544	7	17	14	7q31.2	TFEC, TFECL	P	Transcription factor EC	604732	REc			
7.545	2	19	97	7q31.2	CAPZA2, CAPPA2	P	Capping protein (actin filament) muscle Z-line, alpha 2	601571	Psh, REn			6(Cappa2)
7.546	8	9	00	7q31.32	AASS	P	Alpha-aminoadipic semialdehyde synthase	605113	R		Hyperlysinemia, 238700 (3); Saccharopinuria, 268700 (1)	
7.547	1	30	07	7q31.31	ANKRD7	P	Ankyrin repeat domain-containing protein 7	610731	REc			
7.548	5	12	99	7q32.1	ARF5	P	ADP-ribosylation factor 5	103188	REc			
7.549	4	30	09	7q31.2	ASZ1, ALP1, ANKL1, GASZ	P	Ankyrin repeat, SAM, and basic leucine zipper domain-containing 1	605797	REc			
7.550	3	24	06	7q31.32	CADPS2, KIAA1591	P	Calcium-dependent activator protein for secretion 2	609978	A			
7.551	5	28	13	7q31.31	FAM3C	P	Family with sequence similarity 3, member C	608618	REc, R			
7.552	2	6	14	7q31.32	FEZF1, FEZ, ZNF312B, HH22	P	FEZ family zinc finger protein 1	613301	REc		Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	
7.553	11	25	14	7q31.32	LMOD2, CLMOD	P	Leiomodin 2	608006	REc			
7.554	6	22	14	7q32.1	FSCN3	P	Fascin actin-bundling protein 3, testicular	615800	A			
7.555	12	11	12	7q32.1	LEP, OB, LEPD	C	Leptin (murine obesity homolog)	164160	H, REa, REc, A	in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel	Obesity, morbid, due to leptin deficiency, 614962 (3)	6(ob)
7.556	1	23	01	7q32.1	P100, SND1	C	EBNA-2 coactivator p100	602181	REc, REa, A			
7.557	2	25	03	7q31.32	PTPRZ1, PTP18	P	Protein-tyrosine phosphatase, receptor-type, zeta-1, polypeptide	176891	REa, A		{H. pylori infection, susceptibility to}, 600263 (1)	
7.558	2	17	09	7q31.3	STQTL2	P	Stature quantitative trait locus 2	606256	Fd	max lod at D7S195	{Stature QTL 2} (2)	
7.559	2	25	15	7q31.32	WASL, NWASP	P	Wiskott-Aldrich syndrome gene-like	605056	REc			
7.560	7	19	12	7q31.31	WNT16	P	Wingless-type MMTV integration site family, member 16	606267	REc			
7.561	3	19	14	7q31.31	LSM8	P	LSM8, S. cerevisiae, homolog of, U6 small nuclear RNA associated	607288	REc			
7.562	3	31	11	7q32.1	IMPDH1, RP10, LCA11	C	Inosine-5'-monophosphate dehydrogenase, type I	146690	Psh, A, Fd	pseudogene on 16p13.13	Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11, 613837 (3)	
7.563	8	30	10	7q32.1	OPN1SW, BCP, CBT	C	Blue cone pigment (opsin 1, short-wave-sensitive)	613522	REa, A		Colorblindness, tritan, 190900 (3)	6(Bcp)
7.564	4	28	00	7q34	TAS2R3, T2R3	P	Taste receptor type 2, member 3	604868	REc			
7.565	4	28	00	7q34	TAS2R4, T2R4	P	Taste receptor type 2, member 4	604869	REc			6(T2R8)
7.566	1	31	01	7q34	TAS2R5, T2R5	P	Taste receptor type 2, member 5	605062	REc			
7.567	6	4	98	7q31.33	GRM8	P	Glutamate receptor, metabotropic-8	601116	A			
7.568	9	24	15	7q31.33	POT1, CMM10, GLM9	P	Protection of telomeres 1	606478	REc		{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3); {Glioma susceptibility 9}, 616568 (3)	
7.569	10	6	09	7q32	BCC6	P	Basal cell carcinoma, susceptibility to, 6	613063	Fd	associated with rs157935	{Basal cell carcinoma, susceptibility to, 6} (2)	
7.570	2	9	12	7q32.2	CEP41, TSGA14, JBTS15	P	Centrosomal protein, 41kD	610523	REc		Joubert syndrome 15, 614464 (3)	
7.571	5	26	13	7q32.2	COPG2IT1, CIT1	P	Coatomer protein complex, subunit gamma-2, intronic transcript 1	610581	REc			
7.572	3	20	03	7q32.2	CPA4, CPA3	P	Carboxypeptidase A4	607635	RE			
7.573	11	12	96	7q32.2	MEST, PEG1	C	Mesoderm specific transcript, mouse, homolog of	601029	A, H, REc	imprinted maternally		6(Mest)
7.574	1	13	99	7q32.1	CALU	P	Calumenin	603420				7(Calu)
7.575	4	19	01	7q32	CATR1	P	CATR tumorigenic conversion 1	600676	REc			
7.576	2	1	00	7q32.2	COPG2	P	Coatomer protein complex, subunit gamma-2	604355	REc			
7.577	4	19	01	7q32.2	CPA2	P	Carboxypeptidase A2, pancreatic	600688	REc			
7.578	7	1	11	7q32.1	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4	C	Filamin C (actin-binding protein-280)	102565	REa, R, H		Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065 (3)	6(Fln2)
7.579	9	24	08	7q32.1	IRF5, IBD14, SLEB10	C	Interferon regulatory factor 5	607218	REc		{Inflammatory bowel disease 14}, 612245 (3); {Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	
7.580	2	9	01	7q32.3	MKLN1	C	Muskelin 1	605623	REc, A			6(Mkln1)
7.581	5	8	97	7q31.32	NDUFA5, UQOR13	P	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (13kD, B13)	601677	REa, A			
7.582	4	1	96	7q32.2	NRF1	C	Nuclear respiratory factor 1	600879	Psh, A	earlier location = 7q31		
7.583	8	5	15	7q32.1	PAX4, MODY9, KPD	C	Paired box homeotic gene-4	167413	REa, A		Maturity-onset diabetes of the young, type IX, 612225 (3); Diabetes mellitus, type 2, 125853 (3); {Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3)	6(Pax4)
7.584	9	12	11	7q32	PBC4	P	Biliary cirrhosis, primary, 4	614220	Fd	associated with rs10488631	Biliary cirrhosis, primary, 4 (2)	
7.585	9	28	05	7q32	PPR3	P	Photoparoxysmal response 3	609573	Fd	max lod at D7S1804	Photoparoxysmal response 3 (2)	
7.586	4	19	01	7q32.2	UBE2H, UBCH2, UBC8	C	Ubiquitin-conjugating enzyme E2H (homologous to yeast UBC8)	601082	REa, REc			
7.587	1	23	09	7q33	AKR1D1, SRD5B1, CBAS2	P	Bile acid synthesis defect, congenital, 2	604741	REc		Bile acid synthesis defect, congenital, 2, 235555 (3)	
7.588	11	4	98	7q32.3	PODXL, PCLP	P	Podocalyxin-like	602632	A, Psh			
7.589	4	19	11	7q32-q33	SCA32	P	Spinocerebellar ataxia 32	613909	Fd	between rs3847110 and rs2241728	Spinocerebellar ataxia 32 (2)	
7.590	4	24	08	7q34	MRPS33	P	Mitochondrial ribosomal protein S33	611993	REc	4 pseudogenes		
7.591	8	14	15	7q33-q34	TRIM24, TIF1, TIF1A, PTC6	P	Tripartite motif-containing protein 24 (Transcriptional intermediary factor 1)	603406	A	fused with RET to form PTC6		
7.592	11	5	97	7q34-q35	EPHA1, EPHT1	C	eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence; oncogene EPH; ephrin receptor EphA1)	179610	REa, A			
7.593	7	13	89	7q34	PIP	P	Prolactin-inducible protein	176720	REa, A			
7.594	6	11	91	7q32.2	CPA1	C	Carboxypeptidase A	114850	REa, Fd	both CPA and TRY1 = serine proteases		6(Cpa)
7.595	8	26	16	7q32.1	AHCYL2	P	Adenosylhomocysteinase-like 2	616520	REc			
7.596	4	23	09	7q32.1	GCC1, GCC88	P	GRIP and coiled-coil domains-containing protein 1	607418	R			
7.597	2	25	15	7q32.1	LRRC4	P	Leucine-rich repeat-containing protein 4	610486	REc			
7.598	2	9	15	7q32.1	RBM28, ANES	C	RNA-binding motif protein 28	612074	R, REc, Fd	mutation identified in 1 ANES family	?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)	
7.599	7	15	14	7q32.1	TNPO3, TRNSR, LGMD1F	C	Transportin 3	610032	R, REc, Fd		Muscular dystrophy, limb-girdle, type 1F, 608423 (3)	
7.600	3	20	14	7q32.1	TSPAN33, PEN	P	Tetraspanin 33	610120	REc, A			
7.601	4	8	13	7q32.2	KLHDC10, SLIM	C	KELCH domain-containing protein 10	615152	R, REc			
7.602	6	26	11	7q32.2	LKF14, BTEB5	P	Kruppel-like factor 14	609393	REc			6(Klf14)
7.603	10	12	09	7q32.2	MIR96, MIRN96, DFNA50	P	Micro RNA 96	611606	REc		Deafness, autosomal dominant 50, 613074 (3)	6(Mirn96)
7.604	3	23	09	7q32.2	MIR182, MIRN182	P	Micro RNA 182	611607	REc, H			6(Mirn182)
7.605	3	23	09	7q32.2	MIR183, MIRN183	P	Micro RNA 183	611608	R, REc			
7.606	9	12	11	7q32.2-q36.1	HYSP3	P	Hypospadias 3, autosomal	146450	Fd	between D7S2519 and D7S2442.	Hypospadias 3, autosomal (2)	
7.607	7	1	05	7q32.1	KCP	P	Kielin/chordin-like protein	609344	REc			6(Kcp)
7.608	3	23	09	7q32.3	MIR29A, MIRN29A	C	Micro RNA 29A	610782	REc			
7.609	10	08	08	7q32.3	BMIQ1	P	Body mass index quantitative trait locus 1	606641	Fd	max lod at D7S1804	[Body mass index QTL1] (2)	
7.610	3	23	09	7q32.3	MIR29B1, MIRN29B1	C	Micro RNA 29B1	610783	REc			
7.611	9	30	09	7q32.3	PLXNA4	P	Plexin A4	604280	TM, REc			
7.612	2	2	01	7q33	DGKI	P	Diacylglycerol kinase, iota, 130-kD	604072	A			
7.613	2	21	11	7q32-q33	CHCHD3	P	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3	613748	REc			
7.614	5	29	12	7q33	AKR1B10, ARL1	P	Aldo-keto reductase family 1, member B10	604707	REc			
7.615	4	30	15	7q33	AKR1B15, AKR1B10L, AKR1R1B7	P	Aldo-keto reductase family 1, member B15	616336	REc			
7.616	1	5	93	7q33	CALD1, CDM	P	Caldesmon-1	114213	A			
7.617	9	21	11	7q33	CHDM	P	Chordoma	215400	Fd, Ch	associated with duplication of the T gene	{Chordoma, susceptibility to} (4)	
7.618	3	24	06	7q34	CLEC5A, CLECSF5, MDL1	P	C-type lectin domain family 5, member A	604987	A			
7.619	9	16	12	7q33	CREB3L2, BBF2H7	P	cAMP response element-binding protein 3-like 2	608834	REc			
7.620	9	11	12	7q34	KEL	C	Kell blood group	613883	Fd, REa, A		[Blood group, Kell], 110900 (3)	
7.621	8	26	15	7q33	LRGUK	P	Leucine-rich repeats- and guanylate kinase domain-containing protein	616478	REc			
7.622	4	23	09	7q33	LUZP6, MPD6	P	Leucine zipper protein 6	611050	REc			
7.623	4	7	16	7q33	NUP205, C7orf14, KIAA0225, NPHS13	P	Nucleoporin, 205kD	614352	R, REc	mutation identified in 1 NPHS13 family	?Nephrotic syndrome, type 13, 616893 (3)	
7.624	9	27	94	7q33	PTN, NEGF1	C	Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)	162095	REa, A			6(Ptn)
7.625	12	14	99	7q33	SLC13A4, SUT1	P	Solute carrier family 13 (sodium/sulfate symporters), member 4 (sulfate transporter 1)	604309	REc			
7.626	4	18	07	7q33	SLC35B4	P	Solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4	610923	REc			
7.627	5	23	16	7q33	WDR91, SORF1	P	WD repeat-containing protein 91	616303	REc			
7.628	7	16	02	7q34	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	C	ATPase, H+ transporting, lysosomal V0 subunit a isoform 4	605239	Fd		Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	
7.629	4	23	02	7q34	HIPK2	C	Homeodomain-interacting protein kinase 2	606868	A			
7.630	5	7	03	7q34	TRPV6, ECAC2, CAT1, CATL	P	Transient receptor potential cation channel, subfamily V, member 6	606680	A			
7.631	1	23	01	7q35	ARHGEF5, TIM	P	Rho guanine nucleotide exchange factor-5 (oncogene TIM)	600888	REa, A			
7.632	7	10	98	7q34	EPHB6, HEP	P	Ephrin receptor EPHB6	602757	A			
7.633	1	10	02	7q33	MTPN	P	Myotrophin	606484	A			
7.634	7	23	13	7q34	AGK, MULK, MTDPS10, CATC5, CTRCT38	P	Acylglycerol kinase	610345	REc		Sengers syndrome, 212350 (3); Cataract 38, autosomal recessive, 614691 (3)	
7.635	2	8	11	7q34	BRAF, NS7	C	Murine sarcoma viral (v-raf) oncogene homolog B1	164757	A, REa	pseudogene BRAF2 on Xq13 or 7q	Melanoma, malignant, somatic (3); Colorectal cancer, somatic (3); Adenocarcinoma of lung, somatic, 211980 (3); Nonsmall cell lung cancer, somatic (3); Cardiofaciocutaneous syndrome, 115150 (3); Noonan syndrome 7, 613706 (3); LEOPARD syndrome 3, 613707 (3)	10(Braf)
7.636	10	2	12	7q34	GSTK1	P	Glutathione S-transferase, kappa-1	602321	REc			
7.637	4	26	10	7q34	KIAA1549	C	KIAA1549 gene	613344	Psh, REc			
7.638	9	30	09	7q34	LUC7L2	P	Luc7, S. cerevisiae, homolog of, 2	613056	REc, H			6(Luc7l2)
7.639	4	1	03	7q34	MGAM, MGA	P	Maltase-glucoamylase	154360	REc	similar to EST GS1365		
7.640	12	17	08	7q34	PARP12, ZC3HDC1, FLJ22693	P	Poly(ADP-ribose) polymerase family, member 12	612481	REc			
7.641	1	18	96	7q34	SSBP1, SSBP	P	Single-stranded DNA-binding protein 1	600439	Psh, A			
7.642	1	2	08	7q34	SVOPL	P	SV2-related protein-like	611700	REc			6(Svopl)
7.643	9	21	11	7q34	TBXAS1, GHOSAL, CYP5, BDPLT14	C	Thromboxane A synthase 1, platelet	274180	A, Fd		Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase deficiency, 614158 (1)	6(Tbxas1)
7.644	6	26	11	7q34	TAS2R38, T2R61, PTC	C	Taste receptor, type 2, member 38	607751	Fd, REc		[Phenylthiocarbamide tasting], 171200 (3)	
7.645	6	27	11	7q34	TAS2R40, T2R40	P	Taste receptor, type 2, member 40	613964	REc			
7.646	8	26	15	7q34	TMEM139	P	Transmembrane protein 139	616524	REc			
7.647	2	13	12	7q35	TPK1, THMD5	P	Thiamine pyrophosphokinase	606370	A		Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	
7.648	10	15	13	7q34	TRBC1	C	T-cell receptor beta chain constant region 1	186930	REa, A			6(Tcrb)
7.649	10	15	13	7q34	TRBC2	P	T-cell receptor beta chain constant region 2	615445	REc			
7.650	10	15	13	7q34	TRBV@	P	T-cell receptor beta chain variable gene cluster	615446	REc			
7.651	10	15	13	7q34	TRBJ@	P	T-cell receptor beta chain joining gene cluster	615449	REc			
7.652	10	15	13	7q34	TRBD1	P	T-cell receptor beta chain diversity gene 1	615447	REn			
7.653	10	15	13	7q34	TRBD2	P	T-cell receptor beta chain diversity gene 2	615448	REc			
7.654	3	31	11	7q34	UBN2	P	Ubinuclein 2	613841	REc			
7.655	7	22	11	7q34	WEE2, WEE1B	P	Wee1, S. pombe, homolog of, 2	614084	REc			
7.656	11	30	06	7q34	ZC3HAV1, ZAP, FLJ13288, FLB6421	P	Zinc finger CCCH domain-containing antiviral protein 1	607312	REc			6(Zap)
7.657	9	30	98	7q34	ZYX	C	Zyxin	602002	Psh, A			
7.658	10	16	12	7q34-q36	DHMN1	P	Neuronopathy, distal hereditary motor, type I	182960	Fd	between D7S2513 and D7S637	Neuronopathy, distal hereditary motor, type I (2)	
7.659	10	15	98	7q34-q36	DFNB13	P	Deafness, autosomal recessive 13	603098	Fd		Deafness, autosomal recessive 13 (2)	
7.660	3	12	01	7q34-q36	OTSC2	P	Otosclerosis 2	605727	Fd		Otosclerosis 2 (2)	
7.661	1	22	08	7q36.1	ACCN3, ASIC3, TNAC1, DRASIC	P	Cation channel, amiloride-sensitive, neuronal 3	611741	R			
7.662	12	2	99	7q33	AKR1B1, ALDR1	P	Aldo-keto reductase family 1, member B1	103880	REa, A			
7.663	8	30	95	7q34	CLCN1	P	Chloride channel-1, skeletal muscle	118425	H, REa, Fd		Myotonia congenita, recessive, 255700 (3); Myotonia congenita, dominant, 160800 (3); Myotonia levior, recessive (3)	6(adr, Clc1)
7.664	8	19	98	7q34	CASP2, NEDD2, ICH1	C	Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2)	600639	R			
7.665	5	20	13	7q36.1	EZH2, EZH1, WVS	C	Enhancer of zeste, Drosophila, homolog of, 2	601573	REc, Psh, A	pseudogene on 21q22	Weaver syndrome, 277590 (3)	6(Ezh2)
7.666	10	6	08	7q36.1	FASTK, FAST	C	Fas-activated serine/threonine kinase	606965	R, REc			
7.667	2	4	15	7q35	NOBOX, POF5	C	Newborn ovary homeobox, mouse, homolog of	610934	REc		Premature ovarian failure 5, 611548 (3)	6(Nobox)
7.668	8	8	13	7q35	OR2F1, OLF3	P	Olfactory receptor, family 2, subfamily F, member 1	608497	REa, Psh			
7.669	7	1	11	7q34	PRSS1, TRY1	C	Protease, serine, 1 (trypsin 1)	276000	REa, Fd, REn, R	8 trypsinogen genes embedded in TCRB locus	Pancreatitis, hereditary, 167800 (3); Trypsinogen deficiency, 614044 (1)	6(Try1)
7.670	5	31	06	7q34	PRSS2, TRY2	C	Protease, serine, 2 (trypsin 2)	601564	REn, Fd		{Pancreatitis, chronic, protection against}, 167800 (3)	
7.671	6	26	11	7q35	TAS2R41, T2R59	C	Taste receptor, type 2, member 41	613965	REa, REc			
7.672	6	26	11	7q35	TAS2R60, T2R60	C	Taste receptor, type 2, member 60	613968	REa, REc			
7.673	1	4	16	7q35	TCAF1, FAM115A, KIAA0738	P	TRPM8 channel-associated factor 1	616251	R, REc			
7.674	1	4	16	7q35	TCAF2, FAM115C, FAM139A	P	TRPM8 channel-associated factor 2	616252	REc			
7.675	5	7	03	7q34	TRPV5, ECAC1, CAT2	P	Transient receptor potential cation channel, subfamily V, member 5	606679	R, A			
7.676	1	29	01	7q36.1	ABCB8, MABC1	C	ATP-binding cassette, subfamily B, member 8	605464	REc, REa			
7.677	2	19	10	7q35-q36	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	C	Contactin-associated protein-like 2	604569	REc		Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)	
7.678	8	11	91	7q33	CHRM2	C	Cholinergic receptor, muscarinic, 2	118493	A, REa, Fd			
7.679	1	23	90	7q35-q36	D7S437, MS3315	P	Minisatellite 33.15	157570	REa, A			
7.680	11	3	98	7q35-q36	GPDS1, PDS1	P	Glaucoma-related pigment dispersion syndrome-1	600510	Fd		Pigment dispersion syndrome (2)	
7.681	1	13	11	7q36.1	KCNH2, LQT2, HERG, SQT1	C	Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)	152427	Fd, REn, A		Long QT syndrome 2, 613688 (3); {Long QT syndrome 2, acquired, susceptibility to}, 613688 (3); Short QT syndrome 1, 609620 (3)	
7.682	11	28	94	7q36.1	SLC4A2, AE2, EPB3L1	P	Solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1)	109280	REa, A			5(Ae2)
7.683	1	5	09	7q35-q36	SLI4	P	Specific language impairment 4	612514	associated with rs1723629		{Specific language impairment 4} (2)	
7.684	6	16	99	7q36.1	SMARCD3, BAF60C	P	SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 3	601737	Psh, R			
7.685	12	24	08	7q36.1	ABCF2, HUSSY18	C	ATP-binding cassette, subfamily F, member 2	612510	Psh, R, REc			
7.686	6	14	01	7q36	ACRPS	P	Acropectoral syndrome	605967	Fd		Acropectoral syndrome (2)	
7.687	10	7	05	7q36	AD10	P	Alzheimer disease-10	609636	Fd	max lod with D7S798	Alzheimer disease-10, 104300 (2)	
7.688	6	12	12	7q36.1	ATP6V0E2	P	ATPase, H+ transporting, lysosomal, 9kD, V- subunit E2	611019	REc			
7.689	11	19	13	7q36	AUTS10	P	Autism, susceptibility to, 10	611016	Fd	max lod at D7S483	{Autism, susceptibility to, 10} (2)	
7.690	2	16	04	7q36.3	BLACE	P	B-cell acute lymphoblastic leukemia-expressed gene	608450	R			
7.691	5	24	13	7q36.3	C7orf13	P	Chromosome 7 open reading frame 13	610242	REc	overlaps RNF32 on the opposite strand		
7.692	5	4	15	7q36.1	CDK5, LIS7	P	Cyclin-dependent kinase 5	123831	A	mutation identified in 1 LIS7 family	?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3)	5(cdk5)
7.693	11	19	13	7q36.3	EN2	P	Engrailed-2	131310	REa, A			5(En2)
7.694	6	16	99	7q36.1	GBX1	P	Gastrulatin brain homeo box 1	603354	A			5(Gbx1)
7.695	11	5	97	7q36.3	INSIG1	P	Insulin-induced gene 1	602055	A			
7.696	3	14	14	7q36.1	KMT2C, MLL3, KIAA1506	P	Lysine (K)-specific methyltransferase 2C	606833	A			
7.697	11	6	14	7q36.3	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	C	Limb region 1, mouse, homolog of	605522	Fd, HZ, Fd		Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3); Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3); Hypoplastic or aplastic tibia with polydactyly, 188740 (3); Laurin-Sandrow syndrome, 135750 (3)	5(Lmbr1)
7.698	2	21	10	7q36.3	MNX1, HLXB9, HOXHB9, SCRA1	C	Motor neuron and pancreas homeobox 1	142994	Fd, REc		Currarino syndrome, 176450 (3)	
7.699	5	26	13	7q36.3	NOM1, C7orf3	P	Nucleolar protein with MIF4G domain 1	611269	REc			5(Nom1)
7.700	7	8	10	7q36.1	NOS3	C	Nitric oxide synthase 3, endothelial cell	163729	REa, A, Psh		{Coronary artery spasm 1, susceptibility to} (3); {Alzheimer disease, late-onset, susceptibility to}, 104300 (3); {Hypertension, susceptibility to}, 145500 (3); {Hypertension, pregnancy-induced}, 189800 (3); {Placental abruption} (3); {Ischemic stroke, susceptibility to}, 601367 (3)	5(Nos3)
7.701	10	11	05	7q36.2	PACIP1, PAXIP1L, PTIP	P	PAX transcription activation domain-interacting protein 1	608254	R, A		{Alzheimer disease, susceptibility to}, 104300 (3)	
7.702	1	22	09	7q36.1	PRKAG2, WPWS, CMH6	C	Protein kinase, AMP-activated, noncatalytic, gamma-2	602743	REc, R, Fd		Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, hypertrophic 6, 600858 (3); Glycogen storage disease of heart, lethal congenital, 261740 (3)	
7.703	3	23	06	7q36.3	PTPRN2, IAR, ICAAR	P	Protein-tyrosine phosphatase, receptor-type, N, polypeptide 2	601698	A, R			
7.704	9	10	09	7q36.1	RHEB, RHEB2	P	Ras homolog enriched in brain	601293	A			
7.705	5	24	13	7q36.3	RNF32	P	RING finger protein 32	610241	REc			
7.706	7	12	02	7q36.1	RNY1, Y1	P	RNA, Y1 small cytoplasmic	601821	REa, REc			
7.707	7	12	02	7q36.1	RNY3, Y3	P	RNA, Y3 small cytoplasmic	601822	REa, REc			
7.708	7	12	02	7q36.1	RNY4, Y4	P	RNA, Y4 small cytoplasmic	601823	REa, REc			
7.709	7	12	02	7q36.1	RNY5, Y5	P	RNA, Y5 small cytoplasmic	601824	REa, REc			
7.710	2	7	12	7q36.3	SHH, HPE3, HLP3, SMMCI, MCOPCB5	C	Sonic hedgehog	600725	Fd, Psh, Ch	separate from TPT1	Holoprosencephaly-3, 142945 (3); Single median maxillary central incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)	
7.711	2	12	16	7q36.1	AGAP3, CENTG3, CRAG	P	ARF GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 3	616813	REc			
7.712	8	6	13	7q36.1	ASB10, GLC1F	P	Ankyrin repeat- and SOCS box-containing protein 10	615054	REc, Fd		Glaucoma 1, open angle, F, 603383 (3)	
7.713	10	2	13	7q36.1	ATG9B, NOS3AS, APG9L2, SONE	P	Autophagy 9, S. cerevisiae, homolog of, B	612205	REc			
7.714	2	1	11	7q36.1	CHPF2, KIAA1402, CSGlcAT	P	Chondroitin polymerizing factor 2	608037	REc			
7.715	6	13	12	7q36.1	CUL1	P	Cullin 1	603134	REc			
7.716	4	6	13	7q36.1	GALNT11, GALNACT11	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11	615130	REc, H			5(Galnt11)
7.717	4	6	13	7q36.1	GALNTL5, GALNACT19	C	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5	615133	REc			
7.718	7	23	96	7q36.2	HTR5A	P	5-hydroxytryptamine (serotonin) receptor-5A	601305	Psh, REc			5(Htr5a)
7.719	1	27	11	7q36.1	GIMAP1, IMAP1	P	GTPase, IMAP family, member 1	608084	REc			
7.720	1	27	11	7q36.1	GIMAP2, IMAP2	P	GTPase, IMAP family, member 2	608085	REc			
7.721	1	27	11	7q36.1	GIMAP4, IMAP4, IAN1	P	GTPase, IMAP family, member 4	608087	REc			
7.722	1	27	11	7q36.1	GIMAP5, IAN4L1, IMAP3	P	GTPase, IMAP family, member 5	608086	REc			6
7.723	4	17	13	7q36.1	LOC100134040	P	LOC100134040 gene	615171	REc			
7.724	8	19	13	7q36.1	LR8	P	LR8 protein	610385	REc			
7.725	5	23	13	7q36.1	MIR671	P	Micro RNA 671	615245	REc			
7.726	6	24	13	7q36.1	NUB1	P	Negative regulator of ubiquitin-like proteins 1	607981	R, REc			
7.727	5	11	09	7q36.1	RARRES2, TIG2	P	Retinoic acid receptor responder 2	601973	REc			
7.728	8	19	13	7q36.1	TEM176A, HCA112, GS188	P	Transmembrane protein 176A	610334	R, REc			6(Gs188)
7.729	9	2	12	7q36.1	TMUB1, DULP, SB144, C7orf21	P	Transmembrane and ubiquitin-like domain-containing protein 1	614792	REc			
7.730	2	14	95	7q36.1	XRCC2	C	X-ray repair, complementing defective, repair in Chinese hamster cells-2	600375	REa, R, C			
7.731	5	31	13	7q36.1	ZBED6CL, C7orf29	P	ZBED6 C terminus-like protein	615252	REc			
7.732	3	17	06	7q36.1	ZNF212, ZNFC150, ZNF182	P	Zinc finger protein 212	602386	Psh			
7.733	7	20	12	7q36.1	ZNF282, HUB1	P	Zinc finger protein 282	603397	REc			
7.734	9	8	11	7q36.1	ZNF467, EZI, ZFP467	P	Zinc finger protein 467	614040	REc			
7.735	4	19	11	7q36.1	ZNF746, PARIS	P	Zinc finger protein 746	613914	REc			
7.736	4	14	15	7q36.2	DPP6, VF2, MRD33	P	Dipeptidylpeptidase VI	126141	Psh, REc		{Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3); Mental retardation, autosomal dominant 33, 616311 (3)	5(Dppx, Dpp6)
7.737	5	24	13	7q36.3	NCAPG2, CAPG2, MTB	P	Non-SMC condensin II complex subunit G2	608532	REc			
7.738	12	22	08	7q36.3	CNPY1	P	Canopy 1, zebrafish, homolog of	612493	REc			
7.739	4	25	12	7q36.3	DNAJB6, MRJ, DJ4, LGMD1E	P	DNAJ/HSP40 homolog, subfamily B, member 6	611332	REc, Fd	previously assigned to 11q25	Muscular dystrophy, limb-girdle, type 1E, 603511 (3)	
7.740	12	11	15	7q36.3	ESYT2, FAM62B	P	Extended synaptotagmin-like protein 2	616691	REc			
7.741	11	22	11	7q36.3	SCZD16, C16DUPq36.3, DUP7q36.3	P	Chromosome 7q36.3 duplication syndrome, 362kb	613959	Ch	362kb duplication that includes VIPR2	Schizophrenia 16 (4)	
7.742	1	30	12	7q36.3	UBE3C, HECTH2, KIAA0010, KIAA10	C	Ubiquitin protein ligase E3C	614454	Psh, REc			
7.743	11	22	11	7q36.3	VIPR2	P	Vasoactive intestinal peptide receptor 2	601970	A			12(Vipr2)
7.744	2	11	14	7q36.3	WDR60, SRTD8, SRPS6	P	WD repeat containing protein 60	615462	REc		Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	
7.745	11	19	11	Chr.7	AIS2, VAMAS3	P	Autoimmune disease, susceptibility to, 2	608391	Fd		{Autoimmune disease, susceptibility to, 2} (2)	
7.746	10	23	87	Chr.7	NHCP2	P	Nonhistone chromosomal protein-2	118880	S			
8.1	9	9	08	8p23.3	FBXO25, FBX25	P	F-box only protein 25	609098	REc			8(Fbxo25)
8.2	6	16	99	8p23.3	MYOM2	P	Myomesin 2	603509	Psh, A			
8.3	7	20	01	8p23.3-p22	DBA2	P	Diamond-Blackfan anemia 2	606129	Fd		Diamond-Blackfan anemia 2 (2)	
8.4	9	2	12	8p23.1	AGPAT5	P	1-acylglycerol-3-phosphate O-acyltransferase 5	614796	REc			
8.5	5	26	13	8p23.1	CLDN23	P	Claudin 23	609203	REc, REn			
8.6	9	9	08	8p23.1	DEFA1, DEF1, MRS	C	Defensin, alpha-1, myeloid-related sequence	125220	REa, A			8(Defcr)
8.7	9	9	08	8p23.1	DEFA5, DEF5	P	Defensin, alpha-5, Paneth cell-specific	600472	REa			
8.8	2	11	96	8p23.1	DEFA6, DEF6	P	Defensin, alpha-6, Paneth cell-specific	600471	REa			
8.9	9	9	08	8p23.1	DEFB1	P	Defensin, beta-1	602056	A			8(Defb1)
8.10	3	9	12	8p23.1	DEFB4A, DEFB4, DEFB2	C	Defensin, beta-4a (formerly defensin, beta-2)	602215	A, REc, Ch			
8.11	4	18	07	8p23.1	DEFB103A, DEFB3, HBD3, HBP3	C	Defensin, beta 103A	606611	REc, Ch			
8.12	12	29	05	8p23.1	DIH2	P	Hernia, congenital diaphragmatic 2	222400	Ch		Hernia, congenital diaphragmatic 2 (2)	
8.13	12	18	14	8p23.1	FAM86B1	P	Family with sequence similarity 86, member B1	616122	REc			
8.14	12	18	14	8p23.1	FAM86B2	P	Family with sequence similarity 86, member B2	616123	REc			
8.15	9	30	09	8p23.1	FAM90A3	P	Family with sequence similarity 90, member A3	613042	REc	copy 2		
8.16	9	30	09	8p23.1	FAM90A5	P	FAmily with sequence similarity 90, member A5	613043	REc	copy 5		
8.17	9	30	09	8p23.1	FAM90A7	P	Family with sequence similarity 90, member A7	613044	REc	copy 8		
8.18	9	30	09	8p23.1	FAM90A8	P	Family with sequence similarity 90, member A8	613045	REc	copy 15		
8.19	9	30	09	8p23.1	FAM90A9	P	Family with sequence similarity 90, member A9	613046	REc	copy 18		
8.20	9	30	09	8p23.1	FAM90A10	P	Family with sequence similarity 90, member A10	613047	REc	copy 19		
8.21	9	30	09	8p23.1	FAM90A12	P	Family with sequence similarity 90, member A12	613048	REc	copy 22		
8.22	9	30	09	8p23.1	FAM90A13	P	Family with sequence similarity 90, member A13	613049	REc	copy 4		
8.23	9	30	09	8p23.1	FAM90A14	P	Family with sequence similarity 90, member A14	613050	REc	copy 12		
8.24	9	30	09	8p23.1	FAM90A15	P	Family with sequence similarity 90, member A15	613051	REc	copy 1		
8.25	9	30	09	8p23.1	FAM90A18	P	Family with sequence similarity 90, member A18	613052	REc	copy 13		
8.26	9	30	09	8p23.1	FAM90A19	P	Family with sequence similarity 90, member A19	613053	REc	copy 17		
8.27	9	30	09	8p23.1	FAM90A20	P	Family with sequence similarity 90, member A20	613054	REc	copy 6		
8.28	11	26	01	8p23.1	MFHAS1, MASL1	P	Malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats-1	605352	REc		Malignant fibrous histiocytoma (2)	
8.29	3	23	09	8p23.1	MIR124-1, MIR124A	P	Micro RNA 124-1	609327	REc			
8.30	4	8	13	8p23.1	PRSS55, TSP1	P	Protease, serine, 55	615144	REc			
8.31	9	24	08	8p23.1	SLEB12	P	Systemic lupus erythematosus, susceptibility to, 12	612254	Fd	associated with rs13277113	{Systemic lupus erythematosus, susceptibility to, 12} (2)	
8.32	3	20	14	8p23.1	USP17L2, DUB3	P	Ubiquitin specific peptidase 17-like family member 2	610186	REc			
8.33	11	20	95	8p22	NAT1, AAC1	P	Arylamine N-acetyltransferase-1	108345	REa, A			8(Nat1)
8.34	8	29	08	8p22	NAT2, AAC2	C	Arylamine N-acetyltransferase-2	612182	REa, A, H	acetylation polymorphism	[Acetylation, slow], 243400 (3)	8(Nat2)
8.35	8	19	98	8p23.1	FDFT1, DGPT	P	Farnesyl-diphosphate farnesyltransferase 1 (squalene synthase)	184420	Psh, A			
8.36	9	11	14	8p23.1	GATA4, ASD2, VSD1, TACHD, TOF	C	GATA-binding protein-4	600576	REa, H, A	mutations identified in 1 TACHD family	Atrial septal defect 2, 607941 (3); Ventricular septal defect 1, 614429 (3); Atrioventricular septal defect 4, 614430 (3); ?Testicular anomalies with or without congenital heart disease, 615542 (3); Tetralogy of Fallot, 187500 (3)	14(Gata4)
8.37	8	20	02	8p23.1	ANGPT2, ANG2	C	Angiopoietin 2	601922	R, A	close to MCPH1		8(Angpt2)
8.38	9	17	14	8p23.3	ARHGEF10, KIAA0294, SNCV	C	Rho guanine nucleotide exchange factor 10	608136	REc	mutation identified in 1 SNCV family	?Slowed nerve conduction velocity, AD, 608236 (3)	
8.39	9	9	08	8p23.3	CLN8, EPMR	P	CLN8 gene	607837	Fd, H		Ceroid lipofuscinosis, neuronal, 8, 600143 (3); Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	8(mnd)
8.40	1	27	04	8p23.2	CSMD1, KIAA1890	P	Cub and Sushi multiple domains 1	608397	REc			
8.41	10	6	09	8p23.1	DEFA4, DEF4, HP4	P	Defensin, alpha-4, corticostatin	601157	REa, REc			
8.42	5	13	11	8p23.1	MCPH1	C	Microcephalin	607117	Fd, REc	genetic heterogeneity	Microcephaly 1, primary, autosomal recessive, 251200 (3)	8(Mcph1)
8.43	4	13	05	8p23	MYP10	P	Myopia 10	609259	Fd		Myopia 10 (2)	
8.44	12	27	01	8p23.1	PINX1	P	PIN2-interacting protein 1	606505	REc			
8.45	5	26	13	8p23.1	PPP1R3B, GL	P	Protein phosphatase 1, regulatory subunit 3B	610541	A			
8.46	1	27	11	8p23.1	RP1L1	C	RP1-like protein 1	608581	REc		Occult macular dystrophy, 613587 (3)	14(Rp1l1)
8.47	3	16	10	8p23	WS2C	P	Waardenburg syndrome, type 2C	606662	Ch		Waardenburg syndrome, type 2C (2)	
8.48	4	22	10	8p23.1	BLK, MODY11	P	BLK nonreceptor tyrosine kinase	191305	REa, A		Maturity-onset diabetes of the young, type 11, 613375 (3)	14(Blk)
8.49	8	29	08	8p23.1	FAM167A, C8orf13	P	Family with sequence similarity 167, member A	610085	REc			
8.50	10	15	97	8p23-p22	KWE	P	Keratolytic winter erythema	148370	Fd		Keratolytic winter erythema (2)	
8.51	9	5	02	8p23.1	MTMR9, MTMR8	P	Myotubularin-related protein 9	606260	REc			
8.52	12	27	01	8p23.1	SPAG11, HE2, EP2	P	Sperm-associated antigen 11	606560	REc			
8.53	4	17	13	8p23-p22	TDH	P	L-threonine dehydrogenase, pseudogene	615174	REc			
8.54	1	13	99	8p21.3	EGR3	P	Early growth response 3	602419	A			
8.55	9	11	12	8p23-p21	GEFSP6	P	Generalized epilepsy with febrile seizures plus, type 6	612279	Fd	between D8S1706 and D8S549	Epilepsy, generalized, with febrile seizures plus, type 6 (2)	
8.56	11	1	12	8p22	VPS37A, HCRP1, SPG53	P	Vacuolar protein sorting 37A	609927	REc		Spastic paraplegia 53, autosomal recessive, 614898 (3)	
8.57	10	18	11	8p22	ANIB11	P	Aneurysm, intracranial berry, 11	614252	Fd	max lod at D8S552	Aneurysm, intracranial berry, 11 (2)	
8.58	6	9	08	8p22	CHDS9	P	Coronary heart disease, susceptibility to, 9	612030	Fd	max lod at D8S1106	{Coronary heart disease, susceptibility to, 9} (2)	
8.59	7	12	92	8p23.1	CTSB, CPSB	C	Cathepsin B	116810	REa, A, Psh, D	13q14 by rat probe		8(Ctsb)
8.60	10	7	09	8p22	FGL1, HFREP1	P	Fibrinogen-like 1	605776	R, REc			
8.61	2	25	14	8p22	KIAA1456, TRM9L	P	KIAA1456 gene	615666	REc			
8.62	12	17	07	8p21.3	LPL, LIPD, HDLCQ11	C	Lipoprotein lipase	609708	REa, A, Fd		Lipoprotein lipase deficiency, 238600 (3); Combined hyperlipidemia, familial, 144250 (3); [High density lipoprotein cholesterol level QTL 11] (3)	8(Lpl)
8.63	12	11	01	8p21.3	LZTS1, F37, FEZ1	P	Leucine zipper, putative tumor suppressor 1	606551	Ch, LOH		Esophageal squamous cell carcinoma, 133239 (3)	
8.64	1	14	14	8p22	MICU3, EFHA2	P	Mitochondrial calcium uptake protein 3	610633	REc			
8.65	10	5	11	8p22	MSR1, SCARA1, SRA	C	Macrophage scavenger receptor	153622	REa, Fd, A	~11cM distal to LPL	Prostate cancer, hereditary, 176807 (3); Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
8.66	6	16	99	8p22	MTMR7	P	Myotubularin-related protein 7	603562	R, Psh			
8.67	6	19	01	8q22.2	POLR2K, RPB12	P	Polymerase II, RNA, subunit K	606033	R			
8.68	1	30	12	8p22	PSD3, HCA67, EFA6R	P	Pleckstrin and Sec7 domains-containing protein 3	614440	REc			
8.69	11	11	14	8p22	SGCZ, ZSG1	P	Sarcoglycan, zeta	608113	R, H			
8.70	12	17	12	8p21.3	SH2D4A, SH2A, PPP1R38	P	SH2 domain-containing protein 4A	614968	REc			
8.71	3	2	98	8p22	SLC7A2, ATRC2, HCAT2	P	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2	601872	A			
8.72	8	29	08	8p23.1	SOX7	P	SRY-box 7	612202	A, H			14(Sox7)
8.73	11	18	11	8p22	TUSC3, M33, D8S1992, MRT7, MRT22	C	Tumor suppressor candidate 3	601385	REn, Fd		Mental retardation, autosomal recessive 7, 611093 (3)	
8.74	7	20	12	8p22	ASAH1, AC, SMAPME	P	N-acylsphingosine amidohydrolase (acid ceramidase) 1	613468	REc		Farber lipogranulomatosis, 228000 (3); Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	
8.75	9	9	08	8p22	CNOT7, CAF1	P	CCR4-NOT transcription complex, subunit 7	604913	REc			
8.76	6	11	09	8p22-p21.3	DFNB71	P	Deafness, autosomal recessive 71	612789	Fd	max lod at D8S261	Deafness, autosomal recessive 71 (2)	
8.77	8	6	15	8p22	DLC1	P	Deleted in liver cancer 1	604258	A		Colorectal cancer, somatic, 114500 (3)	
8.78	4	10	14	8p22	FGF20, RHDA2	C	Fibroblast growth factor-20	605558	REc	mutation identified in 1 RHDA2 family	?Renal hypodysplasia/aplasia 2, 615721 (3)	
8.79	8	14	15	8p22	PCM1, PTC4	P	Pericentriolar material 1	600299	A, REn, Ch	fused with RET to form PTC4		
8.80	2	19	13	8p22	PDGFRL, PDGRL, PRLTS	P	Platelet-derived growth factor receptor-like	604584	REc		Hepatocellular cancer, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3)	
8.81	11	16	05	8p21.3	TNFRSF10B, DR5, TRAILR2	C	Tumor necrosis factor receptor superfamily, member 10B	603612	R, A		Squamous cell carcinoma, head and neck, 275355 (3)	
8.82	8	17	99	8p21.3	TNFRSF10C, DCR1, TRAILR3, TRID	P	Tumor necrosis factor receptor superfamily, member 10C	603613	R			
8.83	1	12	99	8p21.2	PTK2B, FAK2, PYK2	P	Protein tyrosine kinase-2, beta (focal adhesion kinase 2)	601212	Psh, A			
8.84	5	23	13	3p25.1	TPRXL	P	Tetrapeptide repeat homeobox-like	611167	REc			
8.85	11	4	93	8p11.21	FNTA	P	Farnesyltransferase, CAAX box, alpha	134635	REa, Psh, A	related FNTAL1 on 11, FNTAL2 on 13		8(Fnta)
8.86	7	3	06	8p22-q11	MPD3	P	Myopathy, distal 3	610099	Fd	possible locus on 12q13-q22	Myopathy, distal 3 (2)	
8.87	7	13	93	8p12	NRG1, HGL, HRGA, ARIA	C	Neuregulin 1 (heregulin, alpha, 45kD; ERBB2 p185-activator)	142445	Psh, A		{?Schizophrenia, susceptibility to}, 603013 (1)	7(Nrg1)
8.88	5	23	16	8p21.3	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	P	ATPase, H+ transporting, lysosomal, V1 subunit B, isoform 2	606939	R, REc		Zimmermann-Laband syndrome 2, 616455 (3); Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	
8.89	10	6	09	8p21.3	BIN3	P	Bridging integrator 3	606396	R, REc			
8.90	9	10	07	8p21.3	CHMP7	P	CHMP family, member 7	611130	REc			
8.91	10	28	15	8p21.3	CSGALNACT1	P	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	616615	REc			
8.92	7	26	10	8p21.3	DOK2, P56DOK	P	Docking protein 2	604997	REc			
8.93	1	13	16	8p21.3	ENTPD4, LYSAL1, LAP70, KIAA0392	P	Ectonucleoside triphosphate diphsophohydrolase 4	607577	R, REc			
8.94	6	11	13	8p21.3	FGF17, HH20	P	Fibroblast growth factor 17	603725	REc		Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3)	
8.95	3	24	14	8p21.3	INTS10, INT10	P	Integrator complex subunit 10	611353	R, REc			
8.96	12	4	03	8p21.3	LGI3	P	Leucine-rich gene, glioma-inactivated, 3	608302	R			14(Lgi3)
8.97	7	22	11	8p21.3	MIR320A, MIRN320A	P	Micro RNA 320A	614112	REc			
8.98	9	16	03	8p21.3	NPM2	P	Nucleophosmin/nucleoplasmin family, member 2	608073	REc			14(Npm2)
8.99	6	22	14	8p21.3	NUDT18, MTH3	P	Nucleoside diphosphate-linked moiety X motif 18	615791	REc			
8.100	12	19	08	8p21.3	PIWIL2, MILI	P	PIWI-like 2	610312	REc			14(Piwil2)
8.101	7	1	05	8p21.3	REEP4, C8orf20	P	Receptor expression-enhancing protein 4	609349	R, REc			
8.102	9	29	96	8p21.3	SLC18A1, VMAT1, VAT1, CGAT	P	Solute carrier family 18 (vesicular monoamine), member 1	193002	REa, A			19(Slc18a1)
8.103	5	6	13	8p23.1	SLC35G5, AMAC, AMAC1L2	P	Solute carrier family 35, member G5	615199	REc			
8.104	3	8	07	8p21.3	SORBS3, SCAM1, SH3D4	P	Sorbin and SH3 domains-containing 3	610795	REc			
8.105	8	3	12	8p21.3	XPO7, RANBP16, KIAA0745	P	Exportin 7	606140	R, REc			
8.106	2	4	02	8p21.3	LOXL2	P	Lysyl oxidase-like 2	606663	R, A			
8.107	4	21	16	8p21.2	DOCK5	P	Dedicator of cytokinesis 5	616904	REc			
8.108	3	22	06	8p21.2	EBF2	P	Early B-cell factor 2	609934	R, REc			
8.109	7	16	14	8p21.3	HR, AU, MUHH1, HYPT4	C	Hairless, mouse, homolog of	602302	H, R, Fd, LD		Alopecia universalis, 203655 (3); Atrichia with papular lesions, 209500 (3); Hypotrichosis 4, 146550 (3)	14(hr)
8.110	12	28	08	8p21.3	PDLIM2, MYSTIQUE	P	PDZ and LIM domain protein 2	609722	REc			
8.111	12	17	08	8p21.3	PEPB4, CORK1	P	Phosphatidylethanolamine-binding protein 4	612473	REc			
8.112	3	4	17	8p21.2	PNMA2, MA2, MM2	P	Paraneoplastic MA antigen 2	603970	REc			
8.113	5	6	03	8p21.3	RHOBTB2, DBC2, KIAA0717	C	Rho-related BTB domain-containing protein 2	607352	R, REc			
8.114	11	21	02	8p12	LEPROTL1	P	Leptin receptor overlapping transcript-like 1	607338	R			
8.115	5	7	09	8p21.1	ELP3, KAT9	P	Elongation protein 3, S. cerevisiae, homolog of	612722	REc			
8.116	12	28	05	8p21.1	ESCO2	C	Establishment of cohesion 1, S. cerevisiae, homolog of, 2	609353	REc, Fd		Roberts syndrome, 268300 (3); SC phocomelia syndrome, 269000 (3)	
8.117	11	20	95	8p21.3	EPB49, DMT	P	Erythrocyte membrane protein band 49 (dematin)	125305	REa, A			14(Epb4.9)
8.118	9	9	08	8p21.1	FBXO16, FBX16	P	F-box only protein 16	608519	REc	?8p12		14(Fbxo16)
8.119	10	23	87	8p12	GSR	C	Glutathione reductase	138300	S, D		Hemolytic anemia due to glutathione reductase deficiency (1)	8(Gr1)
8.120	8	4	97	8p21.1	GULOP, GULO	P	Gulonolactone (L-) oxidase pseudogene	240400	REb, A		Scurvy (3)	
8.121	3	23	14	8p21.1	INTS9, INT9, RC74	P	Integrator complex subunit 9	611352	REc			
8.122	8	19	13	8p21.1	PBK, TOPK	P	PDZ-binding kinase	611210	REc			
8.123	12	10	13	8p21.1	SCARA5	P	Scavenger receptor class A, member 5	611306	REc			
8.124	4	27	12	8p21.1-q13.3	SPG37	P	Spastic paraplegia 37	611945	Fd	max lod at D8S601	Spastic paraplegia 37, autosomal dominant (2)	
8.125	9	14	92	8p21.2	ADRA1C	P	Adrenergic, alpha-1C-, receptor	104221	REc, Fd	.03cM from NEFL		
8.126	10	11	12	8p21.3	BMP1, OI13	C	Bone morphogenetic protein-1	112264	H, REa, A	1kb 3' to SFTP2	Osteogenesis imperfecta, type XIII, 614856 (3)	14(Bmp1)
8.127	10	26	00	8p21.2	BNIP3L, NIX	P	BCL2/adenovirus E1B 19-kD protein-interacting protein 3-like	605368	A			
8.128	8	28	06	8p21.2	CHRNA2	C	Cholinergic receptor, nicotinic, alpha polypeptide-2	118502	REa		Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)	14(Acra2)
8.129	5	6	03	8p21.3	DBC1, KIAA1967	P	Deleted in breast cancer 1	607359	REc			
8.130	5	1	98	8p21.2	DPYSL2, DRP2, CRMP2	P	Dihydropyrimidinase-like 2	602463	TM			
8.131	5	7	01	8p21.1	EXTL3, EXTR1	C	Exostosin-like 3	605744	R, Psh, A, REc			
8.132	8	28	01	8p21.1	FZD3	C	Frizzled, Drosophila, homolog of, 3	606143	A			14(Fzd3)
8.133	7	15	99	8p21.3	GFRA2, GDNFRB	P	GDNF family receptor alpha-2	601956	A			14(Gdnfrb)
8.134	5	19	06	3p24-p21.2	TRICY1	P	Trichilemmal cyst 1	609649	Fd	max lod at D3S1277	Trichilemmal cyst 1 (2)	
8.135	7	17	14	8p21.2	NEFM, NEF3, NFM	P	Neurofilament protein, medium polypeptide	162250	REn			
8.136	5	28	03	8p21.2	NEFL, CMT2E, CMT1F	C	Neurofilament, light polypeptide	162280	REa, A, Fd		Charcot-Marie-Tooth disease, type 2E, 607684 (3); Charcot-Marie-Tooth disease, type 1F, 607734 (3)	14(Nfl)
8.137	7	18	14	8p21.2	NKX2-6, CSX2, CTHM	P	NK2, Drosophila, homolog of, 6	611770	R		Persistent truncus arteriosus, 217095 (3); Conotruncal heart malformations, 217095 (3)	
8.138	4	14	10	8p21.2	NKX3-1, NKX3A, BAPX2	P	NK3 homeo box 1	602041	A			
8.139	10	18	96	8p21.1	PNOC, PPNOC	P	Prepronociceptin	601459	REc			
8.140	9	5	02	8p21.1	SCARA3, MSLR1, CSR	P	Scavenger receptor class A, member 3	602728	REc			
8.141	12	15	98	8p21	SCZD6	C	Schizophrenia susceptibility locus, chromosome 8p-related	603013	Fd	?neuregulin 1	{Schizophrenia}, 181500 (2)	
8.142	5	21	07	8p21.3	SFTPC, SFTP2, SMDP2	C	Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C)	178620	REa, A, Fd		Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	14(Sftp2)
8.143	8	19	13	8p21.2	SLC25A37, MFRN, MFRN1	P	Solute carrier family 25 (mitochondrial iron carrier), member 37	610387	REc			14(Slc25a37)
8.144	8	17	99	8p21.3	TNFRSF10A, DR4, TRAILR1, APO2	P	Tumor necrosis factor receptor superfamily, member 10A	603611	R			
8.145	8	17	99	8p21.3	TNFRSF10D, DCR2, TRAILR4	P	Tumor necrosis factor receptor superfamily, member 10D	603614	R			
8.146	3	30	00	8p21.1	CLU, CLI, SGP2, TRPM2	C	Clusterin (complement lysis inhibitor, SP-40,40; sulfated glycoprotein 2; testosterone-repressed prostate message-2; apolipoprotein J)	185430	REa, REb, A, RE			14(Sgp2, Clu)
8.147	5	26	05	8p21.2-p21.1	EPHX2	P	Epoxide hydrolase 2, cytoplasmic	132811	A		{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3)	14(Ephx2)
8.148	5	11	16	8p12	GTF2E2, TTD6	P	General transcription factor IIE, polypeptide 2, beta subunit, 34kD	189964	REc		Trichothiodystrophy 6, nonphotosensitive, 616943 (3)	
8.149	11	19	14	8p21.2	GNRH1, LNRH, HH12	P	Gonadotropin-releasing hormone-1 (leutinizing-releasing hormone)	152760	REa, A	mutation identified in 1 HH12 family	?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3)	14(Gnrh)
8.150	1	7	99	8p21.2	STC1, STC	P	Stanniocalcin 1	601185	A			
8.151	10	29	02	8p21.2	ADAM7	P	A disintegrin and metalloproteinase domain 7	607310	REc			
8.152	10	29	02	8p21.2	ADAM28, MDCL	C	A disintegrin and metalloproteinase domain 28	606188	REc			
8.153	2	28	03	8p21.2	ADAMDEC1, DECYSIN	P	A disintegrin and metalloproteinase domain-like protein decysin 1	606393	REn			
8.154	6	19	98	8p11.23	EIF4EBP1, 4EBP1	P	Eukaryotic translation initiation factor-4E binding protein-1	602223	A			8(Eif4ebp1)
8.155	5	2	16	8p12	FUT10, FUCTX	P	Fucosyltransferase 10	616931	REc			
8.156	9	23	08	8p11.23	GPR124, TEM5, KIAA1531	P	G protein-coupled receptor 124	606823	R, REc			
8.157	8	18	08	8p11.21	IDO2, INDOL1	P	Indoleamine 2,3-dioxygenase 2	612129	REc			
8.158	7	20	12	8p12	KIF13B, GAKIN, KIAA0639	P	Kinesin family member 13B	607350	R			
8.159	4	15	08	8p12	MBOAT4, GOAT	P	Membrane-bound O-acetyltransferase domain-containing 4	611940	REc			
8.160	10	28	08	8p11.21	PLAT, TPA	C	Plasminogen activator, tissue type	173370	REa, A, REb		Thrombophilia, familial, due to decreased release of PLAT, 612348 (1); Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)	8(Plat)
8.161	12	1	06	8p11.23	PPAPDC1B, HTPAP	P	PPAP2 domain-containing protein 1B	610626	REc			
8.162	12	1	15	8p12	SNORD13	P	Small nucleolar RNA, C/D box, 13	616664	REc			
8.163	3	1	12	8p12	THPH9	L	Thrombophilia due to decreased release of tissue plasminogen activator	612348	LD		?Thrombophilia due to decreased release of tissue plasminogen (1)	
8.164	8	21	12	8p12	TMEM66, SARAF	P	Transmembrane protein 66	614768	REc			
8.165	11	22	13	8p12	TTI2, C8orf41, MRT39	P	TELO2-interacting protein 2	614426	REc		Mental retardation, autosomal recessive 39, 615541 (3)	
8.166	7	29	15	8p12	UNC5D, UNC5H4	P	Unc5. C. elegans, homolog of, D	616466	REc			
8.167	7	1	02	8p11.23	WHSC1L1, NSD3	P	Wolf-Hirschhorn syndrome candidate 1-like 1	607083	A, Ch	pseudogene on 17q21; fusion partner with NUP98 in AML	Leukemia, acute myeloid, 601626 (3)	
8.168	6	1	05	8p11.23	ADRB3	P	Adrenergic, beta-3-, receptor	109691	A		{Obesity, susceptibility to}, 601665 (3)	8(Adrb3)
8.169	7	13	93	8p12	PPP2CB	C	Protein phosphatase-2 (formerly 2A), catalytic subunit, beta isoform	176916	Psh, A, REc	pseudogene on 16		
8.170	8	12	03	8p12	RECQL2, RECQ3, WRN	C	DNA helicase, RecQ-like 2	604611	Fd, LD		Werner syndrome, 277700 (3)	8(wrn)
8.171	3	29	10	8p12	UBXN8, D8S2298E, REP8	P	UBX domain protein 8	602155	A			
8.172	10	22	99	8p11.21	SFRP1, FRP, SARP2	P	Secreted frizzled-related protein 1	604156	R, A			
8.173	9	10	09	8p12	DCTN6, WS3, P27	P	Dynactin 6	612963	A, Psh			
8.174	11	20	98	8p12	DUSP4, MKP2, HVH2	P	Dual-specificity phosphatase-4 (MAP kinase phosphatase-2)	602747	A			
8.175	9	9	08	8p11.21	IDO1, INDO, IDO	C	Indoleamine 2,3-dioxygenase	147435	Psh, REa, A			
8.176	1	20	09	8p12	RBPMS	P	RNA-binding protein gene with multiple splicing	601558	REc			
8.177	6	4	07	8p12-q22	AD12	P	Alzheimer disease 12	611073	Fd	max lod at D8S1119	{Alzheimer disease 12} (2)	
8.178	12	29	06	8p11.23	RAB11FIP1, RCP	P	RAB11 family-interacting protein 1	608737	REc			
8.179	8	19	13	8p11.22	TM2D2, BLP1	P	TM2 domain-containing protein 2	610081	R, REc			
8.180	10	15	09	8p11.22	ADAM9, MDC9, MCMP, CORD9	P	A disintegrin and metalloproteinase domain 9	602713	REc		Cone-rod dystrophy 9, 612775 (3)	
8.181	11	29	12	8p11.23	BAG4, SODD	P	Bcl2-associated athanogene 4	603884	REc			
8.182	10	6	09	8p11.23	BRF2, BRFU, TFIIIB50	P	BRF2 subunit of RNA polymerase III transcription initiation factor	607013	R, REc			
8.183	1	29	13	8p11.23	DDHD2, KIAA0725, SPG54	P	DDHD domain-containing protein 2	615003	REc		Spastic paraplegia 54, autosomal recessive, 615033 (3)	
8.184	1	16	07	8p11.22	HTRA4	P	HTRA serine peptidase 4	610700	REc			
8.185	5	6	13	8p11.23	KCNU1, SLO3	P	Potassium channel, subfamily U, member 1	615215	REc			
8.186	8	6	13	8p11.23	LSM1	P	LSM1 protein	607281	R, REc			
8.187	6	9	08	8p11.21	AGPAT6, LPAATZ	P	1-acylglycerol-3-phosphate O-acyltransferase 6	608143	REc			
8.188	5	5	10	8p11.21	CHRNA6	P	Cholinergic receptor, neuronal nicotinic, alpha polypeptide 6	606888	REc			
8.189	11	30	06	8p11.21	GINS4, SLD5	P	GINS complex subunit 4	610611	R, REc			
8.190	7	7	09	8p11.21	HOOK3, HK3	P	Hook, Drosophila, homolog of, 3	607825	REc			
8.191	12	27	13	8p11.21	SLC20A2, MLVAR, GLVR2, IBGC1	C	Solute carrier family 20, phosphate transporter, member 2 (murine leukemia virus, amphotropic, receptor for)	158378	S, REa		Basal ganglia calcification, idiopathic, 1, 213600 (3)	
8.192	5	14	09	8p11.21	THAP1, DYT6	P	THAP domain-containing protein 1	609520	REc		Dystonia 6, torsion, 602629 (3)	
8.193	2	20	07	8p11.21	NKX6-3, NKX6.3	P	NK6, Drosophila, homolog of	610772	REc			8(Nkx6-3)
8.194	11	16	05	8p11.22	ADAM2, FTNB, PH30, CRYN1, CRYN2	C	A disintegrin and metalloproteinase domain 2 (fertilin, beta)	601533	A, H			14(Ftnb)
8.195	11	17	15	8p11.21	ANK1, SPH1	C	Ankyrin-1, erythrocytic	612641	F, Ch, D, REa, A, Fd, REb		Spherocytosis, type 1, 182900 (3)	8(nb)
8.196	5	24	13	8p11.21	AP3M2, CLA20	P	Adaptor-related protein complex 3, mu-2 subunit	610469	A			
8.197	1	29	01	8p11.23	ASH2L, ASH2L2, ASH2L1	P	ASH2, Drosophila, homolog of	604782	REc			
8.198	5	7	03	8p11.21	C8orf4, TC1	P	Thyroid cancer 1	607702	A			
8.199	6	10	94	8p11.21	CHRNB3	C	Cholinergic receptor, nicotinic, beta polypeptide-3	118508	REa, A			
8.200	4	27	12	8p11.23	ERLIN2, SPFH2, C8orf2, SPG18	P	Endoplasmic reticulum lipid raft-associated protein 2	611605	REc		Spastic paraplegia 18, autosomal recessive, 611225 (3)	
8.201	1	7	14	8p11.21	IKBKB, NFKBIKB, IMD15	C	Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, beta	603258	A, R		Immunodeficiency 15, 615592 (3)	
8.202	3	8	95	8p11.21	POLB	C	Polymerase (DNA directed), beta	174760	REa, Fd, A			8(Polb)
8.203	5	4	00	8p11.23	PROSC	P	Proline synthetase cotranscribed, bacteria, homolog of	604436	REn			
8.204	5	29	12	8p11.21	RNF170, SNAX1	P	RING finger protein 170	614649	REc		Ataxia, sensory, 1, autosomal dominant, 608984 (3)	
8.205	2	12	96	8p11.23	STAR	P	Steroidogenic acute regulatory protein	600617	REa, A		Lipoid adrenal hyperplasia, 201710 (3)	
8.206	4	19	06	8p11.21	VDAC3	P	Voltage-dependent anion channel 3	610029	A, H			8(Vdac3)
8.207	11	20	95	8q11.21	CEBPD	C	CCAAT/enhancer-binding protein (C/EBP), delta	116898	A, REa	earlier mapped to 8q11		16(Cebpd)
8.208	3	3	03	8p11.21	DKK4	P	Dickkopf, Xenopus, homolog of, 4	605417	A			
8.209	4	8	16	8p11.23	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	C	Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350	REa, A	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3); Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3); Hartsfield syndrome, 615465 (3); Encephalocraniocutaneous lipomatosis, 613001 (3)	
8.210	9	10	15	8p11.2-p11.1	HGSNAT, TMEM76, MPS3C, RP73	C	Heparan-alpha-glucosaminide N-acetyltransferase	610453	Fd, REc		Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3); Retinitis pigmentosa 73, 616544 (3)	
8.211	3	23	15	8p11.21	KAT6A, MYST3, MOZ, ZNF220, MRD32	C	K(lysine) acetyltransferase 6A	601408	Ch		Mental retardation, autosomal dominant 32, 616268 (3)	
8.212	11	24	14	8p11.21	POMK, SGK196, MDDGA12, MDDGC12	P	Protein-O-mannose kinase	615247	REc	mutation in 1 MDDGC12 family has been reported	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3); ?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	
8.213	1	13	11	8p11	SCLL	P	Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma)	613523	Ch	translocation of FGFR1 (8p11) and various partners	Chromosome 8p11 myeloproliferative syndrome (4)	
8.214	1	31	01	8p11.22	TACC1	P	Transforming, acidic, coiled-coil-containing protein-1	605301	REc			
8.215	11	30	00	8p23.3	DLGAP2, DAP2	P	Discs large associated protein 2	605438	REc, R			
8.216	6	15	99	8q	CCAL1	P	Chondrocalcinosis 1	600668	Fd		Chondrocalcinosis with early-onset osteoarthritis (2)	
8.217	11	13	07	8q	HBFQTL4	C	Fetal hemoglobin quantitative trait locus 4	606789	Fd		Fetal hemoglobin quantitative trait locus 4 (2)	
8.218	10	23	87	8q	GPB	C	Glycerol phosphatase, beta-	109640	S			
8.219	10	20	99	8q21.11	RPL7	P	Ribosomal protein L7	604166	REa, R	pseudogene on chr.5		
8.220	10	20	99	8q24.3	RPL8	P	Ribosomal protein L8	604177	REa, R			
8.221	12	14	00	8q24.13	ZHX1	P	Zinc finger and homeodomain protein 1	604764	REa, R			
8.222	7	13	93	8q12.1	MOS	C	Oncogene MOS, Moloney murine sarcoma virus	190060	REa, A, REb			4(Mos)
8.223	8	31	15	8q11.21	PRKDC, HYRC1, DNPK1, IMD26	C	Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1)	600899	C, A		Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	16(scid)
8.224	8	18	14	8q11.22-q11.23	PXDNL, PMR1, VPO2	P	Peroxidasin, Drosopila, homolog-like	615904	REc			
8.225	2	20	03	8q11.23	RB1CC1, CC1, KIAA0203	C	RB1-inducible coiled-coil 1	606837	R		Breast cancer, somatic, 114480 (3)	
8.226	1	21	11	8q11.21	SNAI2, SLUG, WS2D	P	snail, Drosophila, homolog of, 2 (Neural crest transcription factor SLUG)	602150	Psh, R		Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)	16(Slug)
8.227	11	30	06	8q11.21	SNTG1, SYN4	P	Syntrophin, gamma-1	608714	REc, R	implicated in idiopathic scoliosis		
8.228	2	21	06	8q12.1	TGS1, NCOA6IP, PIMT	P	Trimethylguanosine synthase, S. cerevisiae, homolog of	606461	REc			
8.229	2	21	10	8q12.1	CA8, CALS, CARP, CAMRQ3	P	Carbonic anhydrase VIII	114815	REa, A		Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	4(Car)
8.230	10	7	02	8q24.3	CHARC1, CHARC15, YCL1	P	Chromatin accessibility complex, subunit 1	607268	REc			
8.231	11	19	98	8q12.1	CYP7A1, CYP7	P	Cytochrome P450, subfamily VII (cholesterol 7-alpha-monooxygenase), polypeptide 1	118455	REa, A			
8.232	1	21	04	8q12.1	RP1, ORP1	C	Oxygen-regulated photoreceptor protein-1 (retinitis pigmentosa-1)	603937	Fd, R, A		Retinitis pigmentosa 1, 180100 (3)	
8.233	2	25	15	8q11.1	BEYLA	P	BEYLA gene	609543	REc			
8.234	11	28	12	8q11.21	MCM4, NKGCD, NKCD	C	Minichromosome maintenance deficient, S. cerevisiae, homolog of, 4	602638	A, Fd		Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)	
8.235	3	18	94	8q11.23	OPRK1	C	Opiate receptor, kappa-1	165196	REa, A			
8.236	9	9	13	8q11.21	SPIDR, KIAA0146	P	Scaffolding protein involved in DNA repair	615384	REc			
8.237	6	13	12	8q11.21	UBE2V2, UEV2, DDVIT1, EDPF1, MMS2	P	Ubiquitin-conjugating enzyme E2 variant 2	603001	REc			
8.238	2	11	11	8q11.23	NPBWR1, GPR7	P	Neuropeptides B and W receptor 1	600730	A, REc	previously assigned to 10q11.2-q21.1 by FISH		
8.239	12	15	98	8q11.23	TCEA1, TF2S, GTF2S	P	Transcription elongation factor A, SII, 1	601425	REa, A	previously mapped to 3p22-p21.3		
8.240	2	26	08	8q11.23	MRPL15	P	Mitochondrial ribosomal protein L15	611828	R			
8.241	4	28	10	8q11.2-q13.2	GCCD3, FGD3, GCCD2	P	Glucocorticoid deficiency 3	609197	Fd	between D8S285 and D8S1718	Glucocorticoid deficiency 3 (2)	
8.242	4	1	03	8q11.1-q13.3	PAFC	L	Preauricular fistulae, congenital	128700	Fd	between D8S532 and D8S279	?Preauricular fistulae, congenital (2)	
8.243	7	23	07	8q12.1	CHCHD7	P	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7	611238	REn			
8.244	3	12	15	8q12	IS3	P	Scoliosis, isolated, susceptibility to, 3	608765	Fd		{Scoliosis, isolated, susceptibility to, 3} (2)	
8.245	12	11	15	8q12.1	PLAG1, SGPA, PSA	C	Pleomorphic adenoma gene 1	603026	REc, A	fused with CTNNB1 in SGPA	Adenomas, salivary gland pleomorphic, somatic, 181030 (3)	
8.246	4	10	90	8q21.13	IL7	P	Interleukin-7	146660	REa, A			
8.247	8	20	07	8q12-q13	MTBS2	P	Mycobacterium tuberculosis, susceptibility to, 2	611046	Fd	max lod at D8S1723	{Mycobacterium tuberculosis, susceptibility to, 2} (2)	
8.248	10	24	00	8q12.1	NSMAF, FAN	P	Neutral sphingomyelinase activation-associated factor	603043	A			
8.249	12	21	10	8q11.23	SOX17, VUR3	P	SRY-box 17	610928	REc		Vesicoureteral reflux 3, 613674 (3)	
8.250	2	18	09	8q12.1	ANIB10	P	Aneurysm, intracranial berry, 10	612587	Fd	associated with rs10958409	{Aneurysm, intracranial berry, 10} (2)	
8.251	7	15	14	8q12.3	ASPH, HAAH, FDLAB	C	Aspartate beta-hydroxylase (junctin; junctate)	600582	REc, A		Traboulsi syndrome, 601552 (3)	
8.252	3	12	14	8q12.2	CHD7, HH5	C	Chromodomain helicase DNA binding protein 7	608892	R, REc		CHARGE syndrome, 214800 (3); Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3)	
8.253	4	2	16	8q12.1	FAM110B, C8orf72	P	Family with sequence similarity 110, member B	611394	REc			
8.254	7	22	11	8q12.1	IMPAD1, GPAPP, IMPA3	P	Inositol monophosphatase domain-containing protein 1	614010	REc		Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	
8.255	2	28	03	8q12.1-q12.2	RAB2, RAB2A	P	Ras-associated protein RAB2	179509	REc			
8.256	11	2	04	8q12.1	RDHE2	P	Retinal dehydrogenase, epidermal, 2	608989	REc			
8.257	9	19	20	8q12.1	RPS20	C	Ribosomal protein S20	603682	REa, R, REc			
8.258	9	20	14	8q12.1	SDCBP, TACIP18, MDA9	P	Syndecan-binding protein	602217	REc			
8.259	3	22	13	8q12.1	TOX, KIAA0808	P	Thymus high mobility group box protein, mouse, homolog of	606863	R, REc			
8.260	6	2	15	8q12.1	UBXN2B, LOC137886, p37	P	UBX domain protein 2B	610686	REc			
8.261	5	11	16	8q12.2-q12.3	CLVS1, RLBP1L1, CRALBPL	P	Clavesin 1	611292	REc			
8.262	5	4	12	8q12.2-q21.2	DEL8q12q21, C8DELq12q21	P	Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome)	600257	Ch		Bor-Duane hydrocephalus contiguous gene syndrome (4)	
8.263	7	16	09	8q12.3	NKAIN3	P	Na+/K+ transporting ATPase-interacting 3	612872	REc			4(Nkain3)
8.264	2	22	13	8q12.2-q21.2	HDCPH1	L	Hydrocephalus, autosomal dominant	123155	Ch		?Hydrocephalus, autosomal dominant (2)	
8.265	7	18	06	8q12.3	GGH	P	Gamma-glutamyl hydrolase	601509	REc			
8.266	5	24	13	8q13.1	SGK3, SGKL, CISK	P	Serum/glucocorticoid-regulated kinase 3	607591	R			
8.267	8	31	99	8q13.2	ARFGEF1, ARFGEP1, BIG1, P200	P	ADP-ribosylation factor guanine nucleotide exchange factor 1	604141	R			
8.268	9	30	10	8q12.3	BHLHE22, BHLHB5, BETA3	P	Basic helix-loop-helix family, member E22	613483	A, H			3(Bhlhe22)
8.269	1	18	12	8q13.2	CPA6, CPAH, ETL5, FEB11	P	Carboxypeptidase A6	609562	REc		Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures, familial, 11, 614418 (3)	
8.270	9	3	09	8q13.1	CRH	C	Corticotropin releasing hormone	122560	REa, A			3(Crh)
8.271	10	29	10	8q13	DEL8q13, C8DELq13	P	Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome)	600383	REc	contiguous gene deletion of SULF1 and SLCO5A1	Mesomelia-synostoses syndrome (4)	
8.272	8	9	99	8q13	DURS1, DUS	C	Duane retraction syndrome 1	126800	Ch		Duane retraction syndrome 1 (2)	
8.273	9	2	08	8q13.1	SNHG6, U87HG	P	Small nucleolar RNA host gene 6	612215	R, REc			
8.274	6	29	98	8q21.11	TERF1, TRF1	P	Telomeric repeat binding factor 1	600951	A, Psh			17(Trf1)
8.275	9	2	08	8q13.1	SNORD87, U87	P	Small nucleolar RNA, C/D box, 87	612216	REc	within intron 2 of SNHG6		
8.276	1	31	13	8q21.11	TRPA1, ANKTM1, FEPS	P	Transient receptor potential cation channel, subfamily A, member 1 (ankyrin-like protein with transmembrane domains 1)	604775	A		Episodic pain syndrome, familial, 615040 (3)	
8.277	1	22	08	8q13.1	VCPIP1 VCIP135, KIAA1850	P	VCP/p47 complex-interacting protein 1	611745	R, REc			
8.278	8	9	05	8q13-q21	FEB1	P	Febrile seizures, familial, 1	121210	Fd		Febrile seizures, familial, 1 (2)	
8.279	2	18	96	8q22.1	GEM	P	GTP-binding protein overexpressed in skeletal muscle	600164	Fd			4(Gem)
8.280	5	14	01	8q21.11	STAU2	P	Staufen, Drosophila, homolog of, 2	605920	REc			
8.281	11	3	11	8q21.11	UBE2W, UBC16	P	Ubiquitin-conjugating enzyme 2W	614277	REc			
8.282	10	13	94	8q13.1	PDE7A, HCP1	P	Phosphodiesterase-7A	171885	REa			
8.283	3	25	15	8q13-q23	CMT2H	P	Charcot-Marie-Tooth disease, axonal, type 2H	607731	Fd	between D8S1807 and D8S548	Charcot-Marie-Tooth disease, axonal, type 2H (2)	
8.284	8	22	90	8q12.1	LYN	P	Yamaguchi sarcoma viral (v-yes-1) related oncogene homolog	165120	REa			4(Lyn)
8.285	8	21	07	8q13.1	ADHFE1, HOT, ADH8	C	Alcohol dehydrogenase, iron-containing, 1	611083	REc			
8.286	5	23	11	8q13.1	DNAJC5B	P	DNAJ/HSP40 homolog, subfamily C, member 5, beta	613945	REc			
8.287	2	5	13	8q13.1	TRIM55, RNF29, MURF2	P	Tripartite motif containing 55	606469	REc, R			
8.288	10	10	11	8q13.2	PREX2, DEPDC2	C	Phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 2	612139	REc			
8.289	12	11	95	8q12.3	TTPA, TTP1, AVED	C	Tocopherol, alpha, transfer protein	600415	Fd, LD, REc, A, REa		Ataxia with isolated vitamin E deficiency, 277460 (3)	
8.290	6	13	12	8q13.1	COPS5, JAB1, SGN5	P	COP9, subunit 5	604850	REc			
8.291	2	21	14	8q13.1-q13.2	CSPP1, CSPP, JBTS21	P	Centrosome spindle pole-associated protein 1	611654	REc		Joubert syndrome 21, 615636 (3)	
8.292	9	7	10	8q13.3	NCOA2, GRIP1, TIF2, SRC2	P	Nuclear receptor coactivator 2	601993	fused with MOZ in AML			
8.293	5	8	12	8q13.3	EYA1, BOR, BOS1, OFC1	C	Eyes absent, Drosophila, homolog of, 1	601653	REc, Fd, Ch	mutation identified in 1 OFC1 family	Branchiootorenal syndrome 1, with or without cataracts, 113650 (3); Anterior segment anomalies with or without cataract, 113650 (3); Branchiootic syndrome 1, 602588 (3); ?Otofaciocervical syndrome, 166780 (3)	
8.294	8	18	14	8q13.3	MSC, ABF1, MYOR	P	Musculin	603628	REc			
8.295	10	7	13	8q24.13	NDUFB9, UQOR22	P	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22kD, B22)	601445	REc	mutation identified in 1 family	?Mitochondrial complex I deficiency, 252010 (3)	
8.296	2	11	08	8q13.3	PRDM14, PFM11	P	PR domain-containing protein 14	611781	A			
8.297	8	27	15	8q13.3	SLCO5A1, OATPRP4, SLC21A15, OATPJ, OATP5A1	P	Solute carrier organic anion transporter family, member 5A1	613543	REc			
8.298	5	19	06	8q13.2-q13.3	SULF1, KIAA1077	C	Sulfatase 1	610012	REc			1(Sulf1)
8.299	11	27	13	8p21.3	POLR3D, BN51T, TSBN51	P	Polymerase III, RNA, subunit D	187280	REa, A			
8.300	12	9	15	8q21.11	JPH1, JP1, CMT2K	P	Junctophilin 1	605266	A	mutation identified in 1 CMT2K family	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3)	
8.301	9	18	08	8q21.3	CNGB3, ACHM3, ACHM1	C	Cyclic nucleotide-gated channel, beta-3	605080	REc, Fd		Achromatopsia-3, 262300 (3); Macular degeneration, juvenile, 248200 (3)	
8.302	11	10	06	8q21-q22	OPA6	P	Optic atrophy 6	258500	Fd	between D8S1702 and D8S1794	Optic atrophy 6 (2)	
8.303	12	14	06	8q24.3	CYP11B1, P450C11, FHI	C	Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))	610613	REa, A, Ch	chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3); Aldosteronism, glucocorticoid-remediable, 103900 (3)	
8.304	12	14	06	8q24.3	CYP11B2	C	Cytochrome P450, subfamily XIB, polypeptide 2	124080	REa		Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3); Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3); {Low renin hypertension, susceptibility to} (3); Aldosterone to renin ratio raised (3)	
8.305	6	19	98	8q21.13	FABP4	P	Fatty acid-binding protein-4, adipocyte	600434	A			
8.306	10	7	09	8q21.13	HNF4G	P	Hepatocyte nuclear factor 4-gamma	605966	Psh, REc			3(Hnf4g)
8.307	3	2	98	8q21.3	MMP16	C	Matrix metalloproteinase 16 (membrane-inserted)	602262	A			
8.308	1	7	16	8q21.3	NBN, NBS1	C	Nibrin	602667	Fd, M		Nijmegen breakage syndrome, 251260 (3); Aplastic anemia, 609135 (3); Leukemia, acute lymphoblastic, 613065 (3)	
8.309	5	25	13	8q21.13	TPD52, D52	P	Tumor protein D52	604068	A			
8.310	8	24	09	8q21.3	WWP1, TIUL1	P	WW domain-containing protein 1	602307	A			
8.311	10	25	12	8q21.13	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	C	Peroxisome biogenesis factor 2	170993	RE		Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3); Peroxisome biogenesis disorder 5B, 614867 (3)	3(Pxmp3)
8.312	4	24	08	8q21.13	MRPS28, MRPS35	P	Mitochondrial ribosomal protein S28	611990	R, REc			
8.313	10	23	87	8q21.1-qter	GLYB	P	Glycine auxotroph B, complementation of hamster	138480	S	gly(-)B		
8.314	9	21	11	8q21.11	DEL8q21.11, C8DELq21.11	P	Chromosome 8q21.11 deletion syndrome	614230	Ch	contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239	Chromosome 8q21.11 deletion syndrome (4)	
8.315	8	29	13	8q21.11	GDAP1, CMT4A, CMT2K, CMTRIA	C	Ganglioside-induced differentiation-associated protein 1	606598	Fd, REc		Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	
8.316	5	30	13	8q21.11	LY96, MD2	P	Lymphocyte antigen 96	605243	REc			
8.317	7	1	11	8q21.11	TMEM70, MC5DN2	P	Transmembrane protein 70	612418	REc		Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	
8.318	4	23	12	8q21.13	CHMP4C, SNF7-3	P	CHMP family, member 4C	610899	REc			
8.319	6	11	02	8q21.13	ZFHX4, ZFH4	P	Zinc finger homeobox 4	606940	H, Ch		?Ptosis, congenital, 178300 (2)	
8.320	10	6	09	8q21.13	FABP5, PAFABP, EFABP	P	Fatty acid-binding protein 5	605168	H, REc			3(Fabp5)
8.321	9	20	14	8q21.13	PI15, P25TI	P	Protease inhibitor 15	607076	REc			
8.322	12	10	12	8q21.13	SNX16	P	Sorting nexin 16	614903	REc			
8.323	5	4	12	8q21.13	STMN2, SCGN10, SCG10	P	Stathmin-like 2	600621	R, REc			
8.324	2	17	09	8q21.13	STQTL15	P	Stature quantitative trait locus 15	612578	Fd	associated with rs2220456	{Stature QTL 15} (2)	
8.325	6	9	98	8q21.13	IMPA1	P	Inositol(myo)-1(or 4)-monophosphatase-1	602064	Psh, REc			
8.326	11	4	15	8q22.1	TMEM67, MKS3, JBTS6, NPHP11	C	Transmembrane protein 67 (meckelin)	609884	Fd, REc		Meckel syndrome 3, 607361 (3); Joubert syndrome 6, 610688 (3); {Bardet-Biedl syndrome 14, modifier of}, 615991 (3); COACH syndrome, 216360 (3); Nephronophthisis 11, 613550 (3)	
8.327	8	18	14	8q21.2	E2F5	P	E2F transcription factor 5	600967	REc			
8.328	5	18	12	8q21.2	RALYL	P	RALY-like protein	614648	REc			
8.329	3	1	16	8q22.3	SLC25A32, MFT, RREI	P	Solute carrier family 25 (mitochondrial carrier, folate), member 32	610815	REc	mutation identified in 1 RREI patient	?Exercise intolerance, riboflavin-responsive, 616839 (3)	15(Slc25a32)
8.330	3	22	06	8q21.3	TMEM55A	P	Transmembrane protein 55A	609864	REc			
8.331	10	6	09	8q21.3	CPNE3, CPN3	P	Copine III	604207	R, REc			
8.332	4	25	12	8q12.3	CYP7B1, CBAS3, SPG5A	C	Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1	603711	R, Fd		Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic paraplegia 5A, autosomal recessive, 270800 (3)	
8.333	9	23	14	8q21.3	DECR1	P	2,4-dienoyl CoA reductase	222745	A			
8.334	3	4	08	8q21.3	FAM82B, RMD1	P	Family with sequence similarity 82, member B	611871	REc			
8.335	3	23	14	8q21.3	OSGIN2, C8orf1	P	Oxidative stress-induced growth inhibitor family member 2	604598	REc			
8.336	6	5	08	8q21.3	OTUD6B, DUBA5	P	OTU domain-containing protein 6B	612021	REc			
8.337	5	21	14	8q21.3	RIPK2, CARDIAK, RIP2, RICK	P	Receptor-interacting serine/threonine kinase 2	603455	REc			
8.338	12	5	13	8q22.1	RAD54B	P	RAD54, S. cerevisiae, homolog of, B	604289	A		Lymphoma, non-Hodgkin, somatic, 605027 (3); Colon cancer, somatic, 114500 (3)	
8.339	9	13	99	8q21.3	CALB1	P	Calbindin 1, 28kD	114050	REa, A			4(Calb)
8.340	10	4	93	8q21.13	PMP2	C	Peripheral myelin protein-2	170715	REb, A	not involved in CMT4A		
8.341	6	28	99	8q23.1	ANGPT1, ANG1	C	Angiopoietin-1	601667	A, R, H			15(Angpt1)
8.342	10	13	94	8q21.2	CA1	C	Carbonic anhydrase I	114800	REa, H, A			3(Car1)
8.343	10	3	07	8q21.2	CA2	C	Carbonic anhydrase II	611492	REa, H	CA1, CA2 linked in monkey and mouse	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)	3(Car2)
8.344	6	4	90	8q21.2	CA3	C	Carbonic anhydrase III	114750	REa, A			3(Car3)
8.345	4	14	10	8q22.3	DPYS, DHP	P	Dihydropyrimidinase	613326	A		Dihydropyrimidinuria, 222748 (3)	
8.346	9	30	14	8q22.3	GRHL2, TFCP2L3, DFNA28, ECTDS	P	Grainyhead-like 2	608576	REc		Deafness, autosomal dominant 28, 608641 (3); Ectodermal dysplasia/short stature syndrome, 616029 (3)	
8.347	6	30	05	8q22.2	HRSP12, PSP, UK114	P	Heat-responsive protein 12	602487	REc			
8.348	1	25	05	8q22	HTC1	L	Hypertrichosis universalis congenita, Ambras type	145701	Ch		?Hypertrichosis universalis congenita, Ambras type (2)	
8.349	11	20	98	8q22.2	KCNS2	P	Potassium voltage-gated channel, delayed-rectifier, subfamily S, member-2	602906	REc			
8.350	1	23	01	8q22.1-q22.2	MATN2	P	Matrilin 2	602108	A			
8.351	9	19	91	8q13.1	MYBL1	P	Avian myeloblastosis viral (v-myb) oncogene homolog like-1	159405	REa, A			
8.352	11	27	94	8q22.3	ODF1	P	Outer dense fiber of sperm tails 1	182878	REa, A			15(Odf1)
8.353	12	3	15	8q22.2	POP1	P	Processing of precursor 1, S. cerevisiae, homolog of	602486	A			
8.354	2	10	14	8q22.1	PTDSS1, PSS1, KIAA0024, LMHD	C	Phosphatidylserine synthase 1	612792	Psh, H, REc		Lenz-Majewski hyperostotic dwarfism, 151050 (3)	13(Pss1)
8.355	4	24	12	8q21.3	RUNX1T1, CBFA2T1, AML1T1, ETO	P	unt-related transcription factor 1, translocated to, 1, cyclin D-related	133435	Ch	fused with AML1 in t(8;21)		4(Cbfa2t1h)
8.356	1	28	01	8q22.1	TP53DINP1, P53DINP1	P	Tumor protein p53 inducible nuclear protein 1	606185	A			
8.357	5	4	00	8q22.3	PABPC1, PAB1, PABP1, PABP	P	Polyadenylate-binding protein, cytoplasmic, 1	604679	Psh			
8.358	11	11	13	8q22.2	SPAG1, CILD28	P	Sperm-associated antigen-1	603395	R		Ciliary dyskinesia, primary, 28, 615505 (3)	
8.359	5	19	06	8q22.3	TM7SF4, DCSTAMP, FIND	P	Transmembrane 7 superfamily, member 4	605933	A			
8.360	7	18	12	8q22.1	TSPYL5, KIAA1750	P	TSPY-like 5	614721	REc			
8.361	4	8	13	8q22.1	UQCRB, UQBP, QPC, MC3DN3	P	Ubiquinol-cytochrome c reductase binding protein	191330	REa		Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	
8.362	6	16	99	8q22.2	COX6C	P	Cytochrome c oxidase, subunit VIc	124090	A, R	pseudogene on 16p12		
8.363	10	3	07	8q23.1	EIF3E, EIF3S6, INT6	P	Eukaryotic translation initiation factor 3, subunit E (oncogene INT6)	602210	Psh, H			15(Int6)
8.364	9	9	09	8q22.1	MTDH, AEG1, LYRIC	C	Metadherin	610323	A, REc			15(Mtdh)
8.365	7	22	13	8q22.2	VPS13B, KIAA0532, COH1	C	Vacuolar protein sorting 13, yeast, homolog of, B	607817	Fd, REc		Cohen syndrome, 216550 (3)	
8.366	8	19	98	8q22.1	SDC2, HSPG1	P	Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated; fibroglycan)	142460	REa, A			
8.367	2	28	12	8q22.1	C8orf37, CORD16, RP64	P	Chromosome 8 open reading frame 37	614477	REc		Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500 (3)	
8.368	3	31	15	8q22.1	CCNE2	P	Cyclin E2	603775	REc			
8.369	11	4	98	8q22.1	CDH17, CDH16, HPT1	P	Cadherin-17, liver-intestine	603017	Psh, A			
8.370	4	28	14	8q22.1	DUP8q22.1, C8DUPq22.1	P	Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis)	151200	Ch	duplication of 0.9-1.2 Mb on 8q22.1	Leri pleonosteosis chromosome duplication syndrome (4)	
8.371	4	10	15	8q22.1	FSBP	P	Fibrinogen silencer-binding protein	616306	REc			
8.372	3	23	14	8q22.1	INTS8, INT8	P	Integrator complex subunit 8	611351	R, REc			
8.373	7	9	15	8q22.1	KIAA1429	P	KIAA1429 gene	616447	REc			
8.374	5	2	16	8q22.1	MTERF3, MTERFD1	P	Transcription termination factor 3, mitochondrial	616930	REc			
8.375	3	14	13	8q22.1	NDUFAF6, C8orf38	P	NADH dehydrogenase (ubiquinone) complex I, assembly factor 6	612392	REc		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
8.376	5	4	12	8q22.1	NMLFS, DEL8q22.1, C8DELq22.1	P	Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome)	608156	Ch		Nablus mask-like facial syndrome (4)	
8.377	4	15	11	8q22.1	DPY19L4	P	DPY19-like 4	613895	REc			
8.378	9	10	09	8q22.1	ESRP1, RMB35A	P	Epithelial splicing regulatory protein 1	612959	REc			
8.379	8	7	13	8q22.1	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	P	Growth/differentiation factor 6	601147	REc, Ch		Klippel-Feil syndrome 1, autosomal dominant, 118100 (3); Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3); Leber congenital amaurosis 17, 615360 (3)	
8.380	3	16	10	8q22.1	LAPTM4B	P	Lysosome-associated protein, transmembrane 4, beta	613296	REc	pseudogenes on 1q, 3q,3p, 4q, and 7q33-q35		
8.381	2	2	10	8q22.1	PDP1, PPM2C, PDP1, PDPC	P	Pyruvate dehydrogenase phosphatase catalytic subunit 1	605993	R, REc		Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	
8.382	5	6	13	8q22.1	PLEKHF2, EAPF, PHAFIN2	P	Pleckstrin homology domain-containing protein, family F, member 2	615208	REc			
8.383	5	13	13	8q22.3	KLF10, TIEG	P	Kruppel-like factor 10	601878	REc, H			1(Klf10)
8.384	6	17	02	8q22.3	NCALD	P	Neurocalcin, delta	606722	R			
8.385	2	25	14	8q22.2	RGS22	P	Regulator of G protein signaling 22	615650	REc			
8.386	11	11	14	8q22.2	STK3, MST2, KRS1	P	Serine/threonine protein kinase 3	605030	REc			
8.387	10	6	09	8q22.3	ATP6V1C1, ATP6C, ATP6D	P	ATPase, H+ transporting, lysosomal, 42-kD, V1 subunit C, isoform 1	603097	R, REc			
8.388	8	18	08	8q22.3	AZIN1, OAZIN	P	Antizyme inhibitor 1	607909	R, REc			
8.389	1	11	02	8q22.3	BAALC	P	Brain and acute leukemia gene, cytoplasmic	606602	REc			
8.390	10	5	11	8q22.3	CTHRC1	P	Collagen triple-helix repeat-containing protein 1	610635	R, REc		Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
8.391	2	4	15	8q22.3	DCAF13, WDSOF1	P	DDB1- and CUL4-associated factor 13	616196	REc			
8.392	9	9	08	8q22.2	FBXO43, EMI2, ERP1, FBX43	P	F-box only protein 43	609110	REc, H			15(Fbxo43)
8.393	1	8	06	8q22.3	KTWS, KTS	P	Klippel-Trenaunay-Weber syndrome	149000	Ch	translocation with 14q13	Klippel-Trenaunay-Weber syndrome (2)	
8.394	10	8	12	8q22.3	UBR5, EDD1, HYD, KIAA0896	P	Ubiquitin protein ligase E3 component n-recognin 5	608413	A			
8.395	3	24	10	8q22.3	YWHAZ	P	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide	601288	A	pseudogene on 2p25		
8.396	3	29	10	8q22.3	MMD2	P	Miyoshi muscular dystrophy 2	613318	Fd	max lod at D10S2325	Miyoshi muscular dystrophy 2 (2)	
8.397	8	25	11	8q22.3	FZD6, NDNC10	P	Frizzled, Drosophila, homolog of, 6	603409	A		Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3)	15(Mfz6)
8.398	3	22	07	8q23.2	KCNV1, KV8.1	P	Potassium channel, voltage-gated, subfamily V, member 1	608164	A			
8.399	12	7	07	8q23.1	ABRA, STARS	P	Actin-binding RHO-activating protein	609747	REc			
8.400	7	17	01	8q23.1	CML66	P	Immunogenic tumor antigen CML66	606109	A			
8.401	6	16	99	8q24.12	COL14A1, UND	P	Collagen, type XIV, alpha-1 (undulin)	120324	A			
8.402	8	20	08	8q23	CRCS6	P	Colorectal cancer, susceptibility to, 6	612231	Fd	associated with rs16892766	{Colorectal cancer, susceptibility to, 6} (2)	
8.403	4	19	01	8q23.2	EBAG9, RCAS1, EB9	P	Estrogen receptor-binding site-associated antigen 9	605772	A			
8.404	9	9	98	8q23	GLC1D	P	Glaucoma 1, open angle, D	602429	Fd		Glaucoma 1D, primary open angle (2)	
8.405	12	7	07	8q23.2	GOLSYN, SYBU, KIAA1472	C	Golgi-localized syntaphilin-related protein	611568	REc, H			15(Golsyn)
8.406	12	17	07	8q23	HDLCQ2	P	High density lipoprotein cholesterol level QTL 2	607053	Fd		[High density lipoprotein cholesterol level QTL 2] (2)	
8.407	5	4	09	8q23	LBMQTL1	P	Lean body mass quantitative trait locus 1	612729	Fd	associated with rs16892496 and rs7832552	[Lean body mass QTL 1] (2)	
8.408	10	24	12	8q23	MYMY3	P	Moyamoya disease 3	608796	Fd	max lod at D8S546	Moyamoya disease 3 (2)	
8.409	7	30	09	8q22.2	OSR2	P	Odd-skipped-related 2	611297	REc			
8.410	2	5	01	8q23.1	OXR1	P	Oxidation resistance 1	605609	REc	?pseudogene on chr.15		
8.411	9	2	09	8q23.1-q23.2	PKHD1L1	P	PKHD1-like 1	607843	REc			
8.412	7	18	14	8q22.3	RIMS2, KIAA0751, RIM2, OBOE	C	Regulating synaptic membrane exocytosis-2	606630	R, REc			
8.413	5	27	05	8q23.1	TRHR	C	Thyrotropin-releasing hormone receptor	188545	A, H, REa		Thyrotropin-releasing hormone resistance, generalized (3)	15(Trhr)
8.414	11	3	14	8q23.1	ZFPM2, FOG2, DIH3, SRXY9	C	Zinc finger protein, multitype 2 (friend of GATA2)	603693	R, REc		Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3); 46XY sex reversal 9, 616067 (3)	
8.415	1	10	02	8q23-q24	HT	P	Hashimoto thyroiditis	140300	Fd	?chr.12	Hashimoto thyroiditis (2)	
8.416	10	11	07	8q23-q24	MGS	P	Mungan syndrome	611376	Fd	between D8S1830 and D8S1799	Mungan syndrome (2)	
8.417	10	23	87	8q12.1	PENK	P	Proenkephalin	131330	REa, A			
8.418	1	8	95	8q24.12	SNT2B1, A1B, SNTB1	P	Syntrophin, beta 1 (dystrophin-associated protein A1, 59kD, basic basic component 1)	600026	REa, A			
8.419	4	18	07	8q24.22	ZFAT1, ZNF406, AITD3	P	Zinc finger gene in autoimmune thyroid disease 1	610931	REn		{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	
8.420	3	10	03	8q24.12	COLEC10, CLL1	P	Collectin 10	607620	A			
8.421	2	25	15	8q23.1	EMC2, KIAA0103	P	ER membrane protein complex subunit 2	607722	REa			
8.422	12	27	10	8q22.3	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	P	Ribonucleotide reductase M2 B, TP53 inducible	604712	A		Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3); Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	
8.423	10	15	09	8q23.1	RSPO2, CRISTIN2	P	R-spondin family, member 2	610575	REc			15(Rspo2)
8.424	4	26	11	8q23.1	TMEM74	P	Transmembrane protein 74	613935	REc			
8.425	1	27	04	8q23.3	CSMD3, KIAA1894	P	Cub and Sushi multiple domains 3	608399	REc			
8.426	12	24	08	8q24.3	ARC, KIAA0278	C	Activity-regulated cytoskeleton-associatec protein	612461	R, A			
8.427	6	10	98	8q24.3	BAI1	P	Brain-specific angiogenesis inhibitor-1	602682	A			
8.428	11	30	06	8q24.3	BOP1, KIAA0124	C	Block of proliferation 1	610596	Psh, REc			
8.429	12	29	06	8q24	BSZQTL3	P	Bone size quantitative trait locus 3	610649	Fd		[Bone size quantitative trait locus 3] (2)	
8.430	8	20	08	8q24	CRCS2	P	Colorectal cancer, susceptibility to, 2	611469	Fd	associated with rs7014346	{Colorectal cancer, susceptibility to, 2} (2)	
8.431	11	11	98	8q24	ECA1	P	Epilepsy, childhood absence, 1	600131	Fd		Epilepsy, childhood absence, 1 (2)	
8.432	10	28	10	8q24	EIG1	P	Epilespy, idiopathic generalized, susceptibility to 1	600669	Fd	?same as EBN2	{Epilepsy, idiopathic generalized, susceptibility to, 1} (2)	
8.433	5	11	16	8q24.3	AGO2, EIF2C2	P	Argonaute 2, RISC catalytic component	606229	R, REc			
8.434	6	16	99	8q24.3	GPAA1, GAA1	P	Glycophosphatidylinositol anchor attachment protein 1	603048	A, R			
8.435	8	10	99	8q24.22	HHLA1	P	Human endogenous retrovirus-H long terminal repeat-associating 1	604109	A, R			
8.436	8	9	07	8q24	HPC10	C	Prostate cancer, hereditary, 10	611100	Fd	strongest assoc. with rs1447295	{Prostate cancer, hereditary, 10} (2)	
8.437	2	22	92	8q24	HPV18I1	P	Human papillomavirus type 18 integration site-1	167959	A			
8.438	10	7	09	8q24.3	JRK, JH8	C	Jerky, mouse, homolog of	603210	R, A			15(Jrk)
8.439	3	9	98	8q24.22	KCNQ3, EBN2, BFNC2	C	Potassium voltage-gated channel, KQT-like subfamily, member 3	602232	Psh, R, Fd		Seizures, benign neonatal, type 2, 121201 (3)	
8.440	12	19	11	8q24	FAME1, BAFME1, MEBA	C	Epilepsy, myoclonic, adult familial, 1	601068	Fd		Epilepsy, myoclonic, familial adult, 1 (2)	
8.441	2	13	09	8q24.3	MAFA, RIPE3B1	P	v-MAF avian musculoaponeurotic fibrosarcoma oncogene homolog A	610303	REc			
8.442	8	10	99	8q24.22	OC90, PLA2L	P	Otoconin 90 (phospholipase A2-like)	601658	A, R	PLA2L = fusion between HHLA1 and OC90		
8.443	10	12	14	8q24.21	PCAT1	P	Prostate cancer-associated transcript 1, noncoding	616043	REc			
8.444	7	28	15	8q24.3	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	C	Plectin 1	601282	A, Psh, Fd	mutation identified in 1 EBSND family	Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3); Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle, type 2Q, 613723 (3); ?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	
8.445	10	15	13	8q24.21	PRNCR1, PCAT8	P	Prostate cancer-associated noncoding RNA 1	615452	REc			
8.446	10	23	87	8q24.21	PVT1	P	Oncogene PVT-1 (MYC activator)	165140	RE, Ch			
8.447	7	18	12	8q24.11	RAD21, SCC1, NXP1, KIAA0078, CDLS4	C	Rad21, S. pombe, homolog of	606462	REa, A		Cornelia de Lange syndrome 4, 614701 (3)	
8.448	3	26	07	8q24.3	SPATC1	P	Spermatogenesis- and centriole-associated 1 (speriolin)	610874	REc, H			15(Spatc1)
8.449	6	30	15	8q24.12	TNFRSF11B, OPG, OCIF, PDB5	C	Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin)	602643	R		Paget disease of bone 5, juvenile-onset, 239000 (3)	
8.450	7	13	93	8q24.3	ZNF7, KOX4	C	Zinc finger protein-7 (KOX4)	194531	A, REa			
8.451	9	28	96	8q24.3	ZNF16, KOX9	P	Zinc finger protein-16 (KOX 9)	601262	A, REc			
8.452	8	28	01	8q24.3	LY6D, E48	P	Lymphocyte antigen 6 complex, locus D	606204	REa, A	?pseudogene ono 15q22		
8.453	7	6	99	8q24.3	PTK2, FADK	P	PTK2 protein tyrosine kinase	600758	Psh, H			15(Fadk)
8.454	9	28	00	8q24.12	ENPP2, PDNP2	P	Ectonucleotide pyrophosphatase/phosphodiesterase 2	601060	A			
8.455	2	26	04	8q24.13	MTSS1, MIM, KIAA0429	C	Metastasis suppressor 1	608486	R, REc			
8.456	7	13	93	8q24.12	NOV	P	Nephroblastoma overexpressed gene	164958	REa, A	proximal to MYC		15(nov)
8.457	8	20	07	8q24.13	RNF139, TRC8, RCA1	P	RING finger protein 139	603046	Ch		Renal cell carcinoma, 144700 (3)	
8.458	8	16	99	8q24.13	SQLE	C	Squalene epoxidase	602019	R, Psh, A			
8.459	10	1	99	8q24.1	THM	L	Tibial hemimelia	275220	D		?Tibial hemimelia (2)	
8.460	10	16	98	8q24.13	ANX13, ISA	P	Annexin XIII	602573	A			
8.461	7	20	15	8q24.21-q24.22	ASAP1, DDEF1	P	Arf GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 1	605953	R			
8.462	10	13	09	8q24.21	GSDMC, MLZE	P	Gasermin C	608384	A			
8.463	9	23	08	8q24.3	KCNK9, TASK3	C	Potassium channel, subfamily K, member 9	605874	REc		Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)	
8.464	5	16	01	8q24.12	MTBP	P	Mouse double minute 2 homolog, binding protein of	605927	A			
8.465	3	29	99	8q24.22	WISP1	P	Wnt-1 inducible signaling pathway protein 1	603398	R			
8.466	10	3	07	8q23.3-q24.1	EIF3H, EIF3S3	P	Eukaryotic translation initiation factor 3, subunit H	603912	REc			
8.467	1	27	11	8q24.11	MED30, TRAP25, THRAP6	P	Mediator complex subunit 30	610237	A			
8.468	2	25	08	8q24.11	SLC30A8, ZNT8	P	Solute carrier family 30 (zinc transporter), member 8	611145	REc		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	15(Slc30a8)
8.469	1	27	04	8q24.11	EXT1	C	Exostosin 1	608177	Ch, Fd	distal to TRPS1	Exostoses, multiple, type 1, 133700 (3); Chondrosarcoma, 215300 (3)	15(Ext1)
8.470	12	14	10	8q24.11-q24.13	TRPS2, LGCR, LGS	C	Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome)	150230	Ch	contiguous gene syndrome involving TRPS1 and EXT1	Trichorhinophalangeal syndrome, type II (4)	
8.471	9	10	09	8q24.12	DEPDC6, DEPTOR	P	DEP domain-containing protein 6	612974	REc			
8.472	2	2	10	8q24.12	DSCC1, DCC1	P	Defective in sister chromatid cohesion 1, S. cerevisiae, homolog of	613203	REc			
8.473	6	19	98	8q24.13	HAS2	P	Hyaluronan synthase-2	601636	Psh, REc			15(Has2)
8.474	4	6	15	8q24.12	MRPL13, RPML13, L13A	P	Mitochondrial ribosomal protein L13	610200	R, REc			
8.475	1	14	14	8q24.12	TAF2, TAF2B, TAFII150, CIF150, MRT40	P	TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD	604912	REc		Mental retardation, autosomal recessive 40, 615599 (3)	
8.476	7	20	06	8q23.3	TRPS1	C	Zinc finger transcription factor TRPS1	604386	Ch, REc		Trichorhinophalangeal syndrome, type I, 190350 (3); Trichorhinophalangeal syndrome, type III, 190351 (3)	
8.477	12	9	91	8q24.21	MYC	C	Avian myelocytomatosis viral (v-myc) oncogene homolog	190080	REa, A	cen-5'-3'-ter	Burkitt lymphoma, 113970 (3)	15(Myc)
8.478	11	4	93	8q24.3	ZNF34, KOX32	P	Zinc finger protein-34 (KOX32)	194526	REa, A, D			
8.479	4	15	08	8q24.13	ATAD2, ANCCA	P	ATPase family, AAA domain-containing, member 2	611941	R, REc			
8.480	5	24	13	8q24.13	DERL1, DER1	P	DER1-like domain family, member 1	608813	REc			
8.481	9	9	08	8q24.13	FBXO32, MAFBX, FLJ32424, ATROGIN1	P	F-box only protein 32	606604	REc			15(Fbxo32)
8.482	12	1	11	8q24.13	HAS2AS1, HASNT	P	HAS2 antisense RNA 1	614353	REn			
8.483	11	24	15	8q24.13	KIAA0196, SPG8, RTSC1	C	KIAA0196 gene	610657	Fd, REc, R		Spastic paraplegia 8, autosomal dominant, 603563 (3); Ritscher-Schinzel syndrome 1, 220210 (3)	
8.484	10	28	15	8q24.13	TMEM65	P	Transmembrane protein 65	616609	REc			2(Tmem65)
8.485	6	11	12	8q24.13	TRIB1, TRB1, SKIP1, C8FW	P	Tribbles, Drosophila, homolog of, 1	609461	REc			
8.486	5	26	13	8q24.13	TRMT12, TRM12	P	tRNA methyltransferase 12, S. cerevisiae, homolog of	611244	R, REc			
8.487	12	17	12	8q24.13-q24.21	PPKP1B	P	Keratoderma, palmoplantar, punctate type IB	614936	Fd	between D8S1804 and D8S1720	Keratoderma, palmoplantar, punctate type IB (2)	
8.488	12	22	08	8q24.13-q24.22	ARHI1	P	Age-related hearing impairment 1	612448	Fd	between rs3765212 and rs4601326	{Age-related hearing impairment 1} (2)	
8.489	9	19	94	8q24.22	ADCY8, ADCY3	P	Adenylyl cyclase-8, brain	103070	A			
8.490	4	19	06	8q24.2-q24.3	COL22A1	P	Collagen, type XXII, alpha-1 polypeptide	610026	REc			15(Col22a1)
8.491	2	18	08	8q24.22	EFR3A, KIAA0143	P	EFR3, S. cerevisiae, homolog of, A	611798	Psh, REc, H			15(Efr3a)
8.492	2	28	07	8q24.23	KHDRBS3, TSTAR, SALP, SLM2, ETOILE	C	KH domain-containing, RNA-binding, signal transduction-associated protein 3	610421	REc			15(Khdrbs3)
8.493	4	8	98	8q24.3	PSCA	P	Prostate stem cell antigen	602470	A			
8.494	8	4	97	8q24.3	GPR20	P	G protein-coupled receptor-20	601908	A			
8.495	9	11	98	8q24.22	SLA	C	Src-like-adaptor	601099	REa, REn	in intron of TG		15(Slap)
8.496	9	29	09	8q24.22	TG, AITD3, TDH3	C	Thyroglobulin	188450	A, REa, REb	distal to MYC	Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	15(Tgn; cog)
8.497	9	30	09	8q24.21	CCD26, RAM	P	Coiled-coil domain-containing protein 26	613040	REc			
8.498	9	24	08	8q24.21	FAM84B, BCMP101	P	Family with sequence similarity 84, member B	609483	REc			
8.499	4	17	13	8q24.21	GLM7	P	Glioma susceptibility 7	613032	Fd	associated with rs55705857	{Glioma susceptibility 7} (2)	
8.500	4	29	14	8q24.21	POU5F1B, POU5F1P1, OCT4PG1	P	POU domain, class 5, transcription factor 1B	615739	REc			
8.501	11	29	12	8q24.22	LRRC6, LRTP, CILD19	P	Leucine-rich repeat-containing protein 6	614930	REc		Ciliary dyskinesia, primary, 19, 614935 (3)	
8.502	7	17	14	8q24.3	ARHGAP39, VILSE, KIAA1688	C	RHO GTPase-activating protein 39	615880	REc, R			
8.503	11	18	15	8q24.3	CYHR1, KIAA0496	P	Cysteine- and histidine-rich protein 1	616635	REc			
8.504	6	9	08	8q24.3	COMMD5, HCARG	P	COMM domain-containing protein 5	608216	REc			
8.505	10	15	13	8q24.3	CYC1, MC3DN6	C	Cytochrome c1	123980	REa, A		Mitochondrial complex III deficiency, nuclear type 6, 615453 (3)	
8.506	6	26	14	8q24.3	DGAT1, ARGP1, DIAR7	P	Diacylglycerol O-acyltransferase 1	604900	A, H, REc	mutation identified in 1 DIAR7 family	?Diarrhea 7, 615863 (3)	15(Dgat)
8.507	9	18	08	8q24.3	EEF1D, EF1D	P	Eukaryotic translation elongation factor 1, delta	130592	REc			
8.508	8	18	14	8q24.3	EPPK1	P	Epiplakin 1	607553	REc			
8.509	6	1	12	8q24.3	EXOSC4, RRP41	P	Exosome component 4	606491	REc			
8.510	4	1	08	8q24.3	FAM83H, AI3	P	Family with sequence similarity 83, member H	611927	Fd, REc		Amelogenesis imperfecta, type III, 130900 (3)	
8.511	3	30	99	8q24.3	FAST1	P	Forkhead activin signal transducer 1, Xenopus, homolog of	603621	A			
8.512	6	13	12	8q24.3	FBXL6, FBL6, FBL6A	P	F-box and leucine-rich repeat protein 6	609076	R, REc			15(FBXL6)
8.513	9	29	96	8q24.3	GLI4, HKR4	C	GLI-Kruppel family member GLI4 (oncogene HKR4)	165280	REa, A			
8.514	6	19	98	8q24.3	GML	P	Glycosylphosphatidylinositol-anchored molecule-like protein	602370	A			
8.515	8	22	14	8q24.3	GPIHBP1, HYPL1D	P	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	612757	REc		Hyperlipoproteinemia, type 1D, 615947 (3)	
8.516	5	19	16	8q24.3	KIFC2	P	Kinesin family member C2	615216	REc			
8.517	7	11	12	8q24.3	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	P	Solute carrier family 52, riboflavin transporter, member 2	607882	REc		Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	
8.518	6	17	99	8q24.3	GPT, GPT1, AAT1	C	Glutamic-pyruvate transaminase (alanine aminotransferase)	138200	S, EM, H, Fd, D, A			15(Gpt1)
8.519	3	14	96	8q24.3	GRINA, NMDARA1	C	Glutamate receptor, ionotropic, N-methyl	138251	REa, A, R			
8.520	9	9	08	8q24.3	HSF1	P	Heat-shock transcription factor 1	140580	R, REc			
8.521	1	7	99	8q24.3	LY6E, RIGE, SCA2	C	Lymphocyte antigen 6 complex, locus E (retinoic acid induced gene E)	601384	A			15(Ly6e)
8.522	8	17	99	8q24.3	LY6H	P	Lymphocyte antigen 6 complex, locus H	603625	A			
8.523	3	14	13	8q24.3	LY6K	P	Lymphocyte antigen 6 complex, locus K	615093	REc			
8.524	1	28	11	8q24.3	MAF1	P	Maf1, S. cerevisiae, homolog of	610210	R, REc			
8.525	1	31	11	8q24.3	MIR661, MIRN661	P	Micro RNA 661	613716	REc			
8.526	3	17	08	8q24.3	NAPRT1	P	Nicotinate phosphoribosyltransferase domain-containing 1	611552	REc			
8.527	10	2	03	8q24.22	NDRG1, HMSNL, CMT4D	P	N-myc downstream-regulated gene 1	605262	REc, Fd, LD		Charcot-Marie-Tooth disease, type 4D, 601455 (3)	
8.528	9	7	00	8q24.3	NFKBIL2, IKBR	P	Nuclear factor of kappa light chain gene enhancer in B cells inhibitor-like 2	604546	Psh, A			
8.529	12	27	13	8q24.3	NRBP2	P	Nuclear receptor-binding protein 2	615563	REc			
8.530	7	13	09	8q24.3	OFC12	P	Orofacial cleft 12	612858	Fd	associated with rs987525	Orofacial cleft 12 (2)	
8.531	3	30	12	8q24.3	OPLAH, OPLAHD	P	5-oxoprolinase (ATP-hydrolyzing)	614243	REc		5-oxoprolinase deficiency, 260005 (3)	
8.532	12	6	01	8q24.3	PTP4A3, PRL3	P	Protein-tyrosine phosphatase, type 4A, 3	606449	R			
8.533	1	7	14	8q24.3	PUF60, FIR, SIAHBP1, VRJS	P	Poly-U-binding splicing factor, 60kD	604819	REc		Verheij syndrome, 615583 (3)	
8.534	6	3	15	8q24.3	PYCRL, PYCR3	P	Pyrroline-5-carboxylate reductase-like	616408	REc			
8.535	5	22	14	8q24.3	RECQL4, RTS, RECQ4	P	DNA helicase, RecQ-like 4	603780	Ch, A		Rothmund-Thomson syndrome, 268400 (3); RAPADILINO syndrome, 266280 (3); Baller-Gerold syndrome, 218600 (3)	
8.536	8	18	14	8q24.3	RHPN1, ODF5	P	Rhophilin 1	601031	REc			
8.537	10	16	13	8q24.3	SCRIB, SCRB1, KIAA0147	P	Scribble, Drosophila, homolog of	607733	R, REc			
8.538	4	25	08	8q24.3	SCXA, SCX	P	Scleraxis, mouse, homolog of, A	609067	REc			
8.539	3	11	08	8q24.3	SHARPIN, SIPL1	P	SHANK-associated RH domain interactor	611885	REc			
8.540	6	24	02	8q24.3	SLC39A4, ZIP4	C	Solute carrier family 36 (zinc transporter), member 4	607059	REc, Fd		Acrodermatitis enteropathica, 201100 (3)	
8.541	10	15	01	8q24.3	TOP1MT	P	Topoisomerase I, mitochondrial	606387	A			
8.542	12	30	09	8q24.3	TRAPPC9, NIBP, KIAA1882, MRT13	P	Trafficking protein particle complex 9	611966	REc		Mental retardation, autosomal recessive 13, 613192 (3)	
8.543	11	20	98	8q24.3	TSTA3	P	Tissue-specific transplantation antigen-3	137020	A			
8.544	4	23	08	8q24.3	VPS28	P	Vacuolar protein sorting 28, yeast, homolog of	611952	R, REc			
8.545	8	23	01	8q24.3	SLURP1, MDM	C	Secreted LY6/uPAR-related protein 1	606119	Fd, R		Meleda disease, 248300 (3)	
8.546	11	19	11	Chr.8	AIS3, VAMAS4	P	Autoimmune disease, susceptibility to, 3	608392	Fd		{Autoimmune disease, susceptibility to, 3} (2)	
8.547	5	28	99	Chr.8	IFNB3	I	Interferon, beta-3, fibroblast	147860	S, REa	previously assigned to 2p23-qter		
8.548	5	22	03	8q21.11	KCNB2, KV2.2	P	Potassium channel, voltage-gated, shab-related subfamily, member 2	607738	R			
8.549	3	17	03	8q24.3	LYNX1	P	Lynx1, mouse, homolog of	606110	R			
8.550	1	30	01	8q11.23	LYPLA1	P	Lysophospholipase I	605599	R			
8.551	8	27	01	8q21.13	PAG	P	Phosphoprotein associated with glycosphingolipid-enriched microdomains	605767	R			
8.552	6	26	01	8q21.13	PKIA	P	Protein kinase, cAMP-dependent catalytic, inhibitor alpha	606059	R			
8.553	5	22	03	8p11.22	PLEKHA2, TAPP2	P	Pleckstrin homology domain-containing protein, family A, member 2	607773	R			
8.554	1	22	93	8p21.3	PPP3CC, CALNA3	P	Protein phosphatase-3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma)	114107	REa			
8.555	3	10	03	8q21.11	RDH10	P	Retinol dehydrogenase 10	607599	R			
8.556	7	13	92	8q22.2	RPL30	P	Ribosomal protein L30	180467	Psh			
8.557	6	21	01	8q24.3	SCRT1	P	Scratch, mouse, homolog of	605858	REc			
8.558	2	21	03	8q21.11	TCEB1	P	Transcription elongation factor B, polypeptide 1, 15kD (elongin C)	600788	R			
8.559	3	29	01	8p12	TEX15	P	Testis-expressed gene 15	605795	R			
8.560	8	27	02	8p23.1	TNKS	P	TRF1-interacting, ankyrin-related ADP-ribose polymerase (tankyrase)	603303	R			8(Tnks)
8.561	9	20	00	8q13.3	TRAM	P	Translocating chain-associating membrane protein	605190	R			
8.562	9	14	89	Chr.8	ZNF1	P	Zinc finger protein-1	194490	REa			8(Zfp2)
9.1	10	23	87	9p24.1	RLN1	P	Relaxin, H1	179730	REa			19(Rln1)
9.2	10	23	87	9p24.1	RLN2	P	Relaxin, H2	179740	REa			
9.3	8	21	07	9p24.3	CBWD1	P	Cobalamin synthetase W domain-containing protein 1	611078	REc			19(Cbwd)
9.4	8	29	11	9p24.3	DEL9p24.3, C9DELp24.3, SRXY4	C	Chromosome 9p24.3 deletion syndrome	154230	A, Ch		46XY sex reversal 4 (4)	
9.5	6	23	99	9p24.3	DMRT1, DMT1	C	Double sex and mab-3-related transcription factor-1	602424	A, Ch			
9.6	5	12	00	9p24.3	DMRT2	P	Double sex and mab-3-related transcription factor-2	604935	A			
9.7	8	3	12	9p24.3	DMRT3, DMRTA3	P	Doublesex-and mab3-related transcription factor 3	614754	REc			
9.8	5	4	12	9p24.3	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	C	KN motif- and ankyrin repeat domain-containing protein 1	607704	REc		Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	
9.9	11	22	10	9p24.3	WASH1, WASH	P	WAS protein family homolog 1	613632	REc	pseudogenes on 1p, 15q, 16p, Xq/Yq		
9.10	5	19	16	9p24.2	GLIS3, ZNF515, NDH	P	GLIS family zinc finger protein 3	610192	REc		Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	19(Glis3)
9.11	8	8	08	9p24-p23	PTPRD, PTPD, HPTP	C	Protein tyrosine phosphatase, receptor type, delta polypeptide	601598	H, REc			4(Ptprd)
9.12	3	31	10	9p24.2	KCNV2, KV11.1, RCD3B	P	Potassium channel, voltage-gated, subfamily V, member 2	607604	REc		Retinal cone dystrophy 3B, 610356 (3)	
9.13	3	23	06	9p24.2	KIAA0020, HLA-HA8	P	Minor histocompatibility antigen HA-8	609960	R, REc			
9.14	3	19	01	9p24.1	PDCD1L2, PDL2	P	Programmed cell death 1 ligand 2	605723	REc			19(Pdcd1l2)
9.15	5	25	13	9p24.2	RFX3	P	Regulatory factor X, 3	601337	REc			
9.16	7	1	13	9p24.1	AK3, AK3L1	P	Adenylate kinase 3	609290	REc, Psh			4(Ak3)
9.17	8	19	13	9p24.1	CDC37L1, HARC, FLJ20639	P	CDC37-like 1	610346	REc			
9.18	8	19	13	9p24.1	CIP150, KIAA1432	P	Connexin 43-interacting protein, 150kD	610354	R, REc			
9.19	4	1	08	9p24.1	IL33, C9orf26, NFEHEV	C	Interleukin 33	608678	REc, H			19(Il33)
9.20	7	20	12	9p24.1	KDM4C, JMJD2C, GASC1, KIAA0780	C	Lysine-specific demethylase 4C	605469	R, REc			
9.21	3	23	09	9p24.1	MIR101-2, MIRN101-2	P	Micro RNA 101-2	612512	REc	another locus, MIRN101-1, on 1p31		
9.22	10	1	95	9p23-p22	NFIB	C	Nuclear factor I/B	600728	A, Ch			4(Nfib)
9.23	12	17	07	9p24.1	PPAPDC2	P	PPAP2 domain-containing protein 2	611666	R, REc			
9.24	5	26	13	9p24.1	RCL1, RPCL1, RNAC	P	RNA terminal phosphate cyclase-like 1	611405	R, REc			
9.25	5	6	13	9p24.1	UHRF2, NIRF	P	Ubiquitin-like protein containing PDH and RING finger domains 2, E3 ubiquitin protein ligase	615211	REc			
9.26	3	4	10	9p24.1-p22.1	FECD7, FCD4	P	Corneal dystrophy, Fuchs endothelial, 7	613271	Fd	max lod at D9S256	Corneal dystrophy, Fuchs endothelial, 7 (2)	
9.27	8	4	15	9p24.3	DOCK8	P	Dedicator of cytokinesis 8	611432	REc		Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)	
9.28	4	23	09	9p24.1	ERMP1, KIAA1815, FXNA	P	Endoplasmic reticulum metallopeptidase 1	611156	R, REc			
9.29	5	24	13	9p24.2	SLC1A1, EAAC1, SCZD18, DCBXA	P	Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)	133550	REa, A	mutation identified in 1 SCZD18 family	{?Schizophrenia susceptibility 18}, 615232 (3); Dicarboxylic aminoaciduria, 222730 (3)	
9.30	11	6	95	9p24.1	INSL4	P	Insulin-like 4, placenta	600910	A			
9.31	11	1	01	9p24.1	INSL6	P	Insulin-like 6	606414	R			19(Insl6)
9.32	8	27	15	9p24.1	JAK2, THCYT3	P	Janus kinase 2 (a protein-tyrosine kinase)	147796	A		Polycythemia vera, somatic, 263300 (3); Thrombocythemia 3, 614521 (3); Myelofibrosis, somatic, 254450 (3); Erythrocytosis, somatic, 133100 (3); Leukemia, acute myeloid, somatic, 601626 (3); {Budd-Chiari syndrome, somatic}, 600800 (3)	19(Jak2)
9.33	11	30	15	9p24	MRD2	P	Mental retardation, autosomal dominant 2	614113	Ch	2 patients reported with genomic deletion or rearrangement including disruption of DOCK8	Mental retardation, autosomal dominant 2 (4)	
9.34	12	3	03	9p24.1	PDCD1LG1, B7H1	C	Programmed cell death 1 ligand 1	605402	REc			
9.35	2	21	10	9p24.2	VLDLR, CAMRQ1	C	Very low density lipoprotein receptor	192977	A, Psh		Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)	19(Vldlr)
9.36	5	3	13	9p23	MPDZ, MUPP1, HYC2	C	Multiple PDZ domain protein	603785	R, Psh		Hydrocephalus, nonsyndromic, autosomal recessive 2, 615219 (3)	
9.37	10	30	08	9p24-p22	RLS3	C	Restless legs syndrome, susceptibility to, 3	610438	Fd	associated with rs4626664 and rs1975197	{Restless legs syndrome 3} (2)	
9.38	5	4	12	9p24.3	SMARCA2, SNF2L2, NCBRS	P	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	600014	A		Nicolaides-Baraitser syndrome, 601358 (3)	19(Snf2l2)
9.39	12	30	14	9p23	LURAP1L, LRAP35B	P	Leucine-rich adaptor protein 1-like	616130	REc			
9.40	2	25	16	9p23	TYRP1, CAS2, GP75, SHEP11	C	Tyrosinase-related protein 1	115501	Psh, REa, A, Fd		Albinism, oculocutaneous, type III, 203290 (3); [Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	4(b;trp1)
9.41	9	6	11	9p23-p13.3	MRT16	P	Mental retardation, autosomal recessive 16	614208	Fd	between rs10738277 and rs12376565	Mental retardation, autosomal recessive 16 (2)	
9.42	9	5	01	9p23-p11	FRDA2	P	Friedreich ataxia 2	601992	Fd		Friedreich ataxia 2 (2)	
9.43	1	7	11	9p23-p21.2	DFNB83	P	Deafness, autosomal recessive 83	613685	Fd	between rs4742645 and rs1471364	Deafness, autosomal recessive 83 (2)	
9.44	2	20	12	9p22.3	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	P	FRAS1-related extracellular matrix protein 1	608944	REc, R		Bifid nose with or without anorectal and renal anomalies, 608980 (3); Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)	
9.45	10	2	12	9p22.3	SNAPC3, SNAP50	P	Small nuclear RNA-activating protein complex, polypeptide 3	602348	REc			
9.46	10	5	10	9p22.3	TTC39B	P	Tetratricopeptide repeat domain 39B	613574	REc			
9.47	4	27	12	9p22.3	ZDHHC21, DHHC21	P	Zinc finger DHHC domain-containing protein 21	614605	REc			
9.48	3	4	08	9p22.2	CNTLN, C9orf101, C9orf39	P	Centlein	611870	REc			
9.49	8	3	06	9p22.3	PSIP1, LEDGF	P	PC4- and SFRS1-interacting protein 1	603620	A			
9.50	12	15	10	9p22.1	ACER2	P	Alkaline ceramidase 2	613492	REc			
9.51	7	12	06	9p22.1	AD11	P	Alzheimer disease 11	609790	Fd	between D9S157 and D9S259	Alzheimer disease-11 (2)	
9.52	6	7	04	9p22.3-p22.2	BNC2	P	Basonuclin 2	608669	REc			4(Bnc2)
9.53	9	7	10	9p22.1	HAUS6, DGT6, FAM29A	P	HAUS, augmin-like complex, subunit 6	613433	REc			
9.54	1	21	01	9p22.1	PLIN2	P	Perilipin 2	103195	REc			4(Plin2)
9.55	8	29	08	9p22.1	RRAGA, RAGA, FIP1	P	Ras-related GTP-binding protein A	612194	R, REc			
9.56	4	10	15	9p22.1	SAXO1, FAM154A	P	Stabilizer of axonemal microtubules 1	616292	REc			
9.57	2	25	14	9p22.1	SCARNA8	P	Small Cajal body-specific RNA 8	615646	REc			
9.58	12	24	08	9p13.3	UBE2R2, UBC3B	P	Ubiquitin-conjugating enzyme E2R 2	612506	REc			
9.59	5	27	09	9p22.2-p22.1	ADAMTSL1	P	ADAMTS-like protein 1	609198	REc, H			4(Adamtsl1)
9.60	6	14	99	9p22.3	CER1	C	Cerebrus 1, Xenopus, homolog of	603777	R, H			4(Cer1)
9.61	5	4	01	9p24.1	GLDC, HYGN1, GCSP, GCE, NKH	C	Glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)	238300	Ch, A		Glycine encephalopathy, 605899 (3)	19(Gldc)
9.62	12	14	95	9p21.3	IFNA1, IFNA@	C	Interferon, alpha-1	147660	REa, A, RE	very close to IFF by Fd, LD; 15-30 genes	Interferon, alpha, deficiency (1)	4(Ifa)
9.63	12	14	95	9p21.3	IFNA2	P	Interferon, alpha-2	147562	D			
9.64	12	14	95	9p21.3	IFNA4	P	Interferon, alpha-4	147564	D			
9.65	12	14	95	9p21.3	IFNA5	P	Interferon, alpha-5	147565	D			
9.66	12	14	95	9p21.3	IFNA6	P	Interferon, alpha-6	147566	D			
9.67	12	14	95	9p21.3	IFNA7	P	Interferon, alpha-7	147567	D			
9.68	12	15	95	9p21.3	IFNA8	P	Interferon, alpha-8	147568	D			
9.69	12	15	95	9p21.3	IFNA10	P	Interferon, alpha-10	147577	D			
9.70	12	15	95	9p21.3	IFNA13	P	Interferon, alpha-13	147578	D			4(Ifna13)
9.71	12	15	95	9p21.3	IFNA14	P	Interferon, alpha-14	147579	D			
9.72	12	15	95	9p21.3	IFNA16	P	Interferon, alpha-16	147580	D			
9.73	12	15	95	9p21.3	IFNA17	P	Interferon, alpha-17	147583	D			
9.74	12	15	95	9p21.3	IFNA21	P	Interferon, alpha-21	147584	D			
9.75	7	13	93	9p21.3	MLLT3, AF9	P	Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 3	159558	Ch	fuses with ALL1		
9.76	5	4	00	9p22.2	SH3GL2, SH3P4	P	SH3 domain, GRB2-like, 2	604465	REa, A			
9.77	1	20	06	9p22.1	SLC24A2, NCKX2	P	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2	609838	REc			
9.78	1	6	11	9p22-p21	DFNA47, DFNB83	P	Deafness, autosomal dominant 47	608652	Fd	between D9S268 and D9S942; possibly allelic to DFNB83	Deafness, autosomal dominant 47 (2)	
9.79	11	7	89	9p22-p21	LALL	P	Lymphomatous acute lymphoblastic leukemia	247640	Ch		Leukemia, acute lymphoblastic (2)	
9.80	12	20	05	9p13.3	UBAP1, UBAP	P	Ubiquitin-associated protein 1	609787	REc			
9.81	12	23	05	9p21.2-p21.1	LRRN6C, LINGO2, LERN3	P	Leucine-rich repeat protein, neuronal, 6C	609793	REc			
9.82	2	20	11	9p21.1	ACO1, IREB1	C	Aconitase, soluble (iron-responsive element-binding protein-1)	100880	S, REc			4(Aco1)
9.83	7	23	13	9p21.2	IFNK	P	Interferon, kappa	615326	R			
9.84	7	11	12	9p21.2	IFT74, CCDC2, CMG1	P	Intraflagellar transport 74, Chlamydomonas, homolog of	608040	REc			
9.85	5	25	13	9p21.2	PLAA, PLAP	P	Phospholipase A2-activating protein	603873	REc			
9.86	4	10	15	9p21.1	DDX58, RIGI, SGMRT2	P	DEAD box polypeptide 58	609631	REc		Singleton-Merten syndrome 2, 616298 (3)	
9.87	12	30	14	9p21.1	MIR873	P	Micro RNA 873	616137	REc			
9.88	3	13	08	9p21	AAA3	P	Aneurysm, familial abdominal 3	611891	Fd	associated with rs10757278	{Aneurysm, familial abdominal 3} (2)	
9.89	3	13	08	9p21	ANIB6	P	Aneurysm, intracranial berry, 6	611892	Fd	associated with rs10757278	{Aneurysm, intracranial berry, 6} (2)	
9.90	10	6	09	9p21	BCC5	P	Basal cell carcinoma, susceptibility to, 5	613062	Fd	associated with rs2151280	{Basal cell carcinoma, susceptibility to, 5} (2)	
9.91	7	7	15	9p21.2	C9orf72, FTDALS1, FTDALS, ALSFTD	P	Chromosome 9 open reading frame 72	614260	REc		Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	
9.92	3	3	03	9p21.3	CDKN2A, MTS1, P16, MLM, CMM2	C	Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)	600160	RE, D, Fd		{Melanoma, cutaneous malignant, 2}, 155601 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple, (3)	4(Cdkn2a)
9.93	7	10	95	9p21.3	CDKN2B, MTS2, P15, INK4B	P	Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)	600431	A	tandem with MTS1		
9.94	12	21	09	9p21.3	CDKN2BAS, ANRIL	P	CDKN2B antisense RNA	613149	REc			
9.95	2	23	08	9p21	CHDS8	P	Coronary heart disease, susceptibility to, 8	611139	Fd	strongest linkage with dbSNP rs1333049	{Coronary heart disease, susceptibility to, 8} (2)	
9.96	2	24	97	9p21.3	ELAVL2, HELN1, HUB	C	Embryonic lethal, abnormal vision, Drosophila, homolog of, like-2 (Hu antigen B)	601673	Psh, A, H			4(Hub)
9.97	4	10	90	9p21.3	IFNB1	C	Interferon, beta-1, fibroblast	147640	REa, A, Fd, LD, RE	distal to IFL; ?9p23-p22; IFF duplicate in some		4(Ifb)
9.98	5	6	13	9p21.3	IFNE, INFE1, IFNT1	P	Interferon, epsilon	615223	REc			
9.99	5	6	97	9p21.3	IFNW1	P	Interferon, omega-1	147553	D	pseudogene IFNWP2; interspersed with IFNA		
9.100	6	16	08	9p21	MFT2, TEM	P	Trichoepithelioma, multiple familial, 2	612099	Fd	max lod at D9S171	Trichoepithelioma, multiple familial, 2 (2)	
9.101	9	10	12	9p21.3	DMRTA1, DMRT4	P	Doublesex- and MAB3-related transcription factor A1	614803	REc			4(Dmrta1))
9.102	5	4	12	9p21.3	FOCAD, KIAA1797	P	Focadhesin	614606	REc			
9.103	4	13	10	9p21.3	GLM5	P	Glioma susceptibility 5	613030	Fd	associated with rs4977756	{Glioma susceptibility 5} (2)	
9.104	5	6	13	9p21.3	KLHL9, KIAA1354	C	Kelch-like 9	611201	REc			4(Klhl9)
9.105	3	23	09	9p21.3	MIR31, MIRN31	P	Micro RNA 31	612155	REc			
9.106	6	2	15	9p21.3	MIR31HG, LOC554202	P	Micro RNA 31 host gene, noncoding	616356	REc			
9.107	8	18	14	9p21.3	PTPLAD2, HACD4	P	Protein tyrosine phosphatase-like A domain-containing protein 2	615941	REc			
9.108	5	4	12	9p21.3	MTAP, DMSMFH	C	Methylthioadenosine phosphorylase	156540	S, D, Fd		Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	
9.109	1	6	93	9p22.1	RPS6	C	Ribosomal protein S6	180460	Psh, A			
9.110	1	7	95	9p21.2	TEK, TIE2, VMCM	C	TEK tyrosine kinase, endothelial	600221	A, D, REc		Venous malformations, multiple cutaneous and mucosal, 600195 (3)	4(tek)
9.111	11	13	07	9p21.1	TOPORS, P53BP3, LUN, RP31	C	Topoisomerase I-binding arginine/serine-rich protein	609507	Fd, A, REc		Retinitis pigmentosa 31, 609923 (3)	
9.112	10	30	06	9p21.2	TUSC1, TSG9	P	Tumor suppressor candidate 1	610529	REc			4(Tusc1)
9.113	8	26	15	9p13.3	NPR2, ANPRB, AMDM, ECDM, SNSK	P	Natiuretic peptide receptor 2	108961	REa, A, Fd		Acromesomelic dysplasia, Maroteaux type, 602875 (3); Epiphyseal chondrodysplasia, Miura type, 615923 (3); Short stature with nonspecific skeletal abnormalities, 616255 (3)	
9.114	10	17	05	9p13.3	RMRP, RMRPR, CHH	C	Mitochondrial RNA-processing endoribonuclease	157660	REa, A, Fd, LD, REc		Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without hypotrichosis, 250460 (3); Anauxetic dysplasia, 607095 (3)	4(Rmrpn)
9.115	5	24	13	9p12	CNTNAP3, KIAA1714	P	Contactin-associated protein-like 3	610517	REc			
9.116	9	9	08	9p13.2	FBXO10, FBX10	P	F-box only protein 10	609092	REc			4(Fbxo10)
9.117	9	7	12	9p13.1	IGFBPL1, IGFBPRP4	P	Insulin-like growth factor binding protein-like 1	610413	REc, R			
9.118	8	21	07	9p13.3	RUSC2, KIAA0375, IPORIN	P	RUN and SH3 domain-containing 2	611053	REc			
9.119	12	4	03	9p13.3	STOML2	C	Stomatin-like protein 2	608292	REc, R			
9.120	6	27	08	9p13.1-q21.11	OTSC8	P	Otosclerosis 8	612096	Fd	between D9S970 and D9S1799	Otosclerosis 8 (2)	
9.121	6	1	12	9p21.1	APTX, AOA, AOA1	C	Aprataxin	606350	REc, Fd		Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	
9.122	2	1	11	9p13.3	CA9, MN	C	Carbonic anhydrase IX	603179	REc	previously assigned to 17q21.2		
9.123	4	10	14	9p13.3	CCIN	P	Calicin	603960	REc			
9.124	4	17	07	9p13.3	CHMP5	P	CHMP family, member 5	610900	REc			
9.125	1	13	11	9p13.3	CLTA	P	Clathrin, light polypeptide (Lca)	118960	REc	previously mapped to 12q23-q24		
9.126	2	6	13	9p13.3	DNAI1, CILD1, ICS, PCD	C	Dynein, axonemal, intermediate chain 1	604366	Psh, A, REc		Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	
9.127	3	23	14	9p13.3	DNAJB5, KIAA1045, HSC40	P	DNAJ/HSP40 homolog, subfamily B, member 5	611328	REc			
9.128	4	17	13	9p13.3	GBA2, KIAA1605, SPG46	P	Glucosidase, beta, acid 2	609471	REc		Spastic paraplegia 46, autosomal recessive, 614409 (3)	
9.129	2	21	13	9p13.3	GLIPR2, GAPR1, C9orf19	P	GLI pathogenesis-related 2	607141	REc			
9.130	12	10	15	9p13.3	GNE, GLCNE, IBM2, DMRV, NM	C	UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	603824	TM, R, Fd		Sialuria, 269921 (3); Nonaka myopathy, 605820 (3)	
9.131	2	21	11	9p13.3	KIF24	P	Kinesin family member 24	613747	REc			
9.132	10	15	13	9p13.3	MSMP, PSMP	P	Microseminoprotein, prostate-associated	612191	REc			4(Psmp)
9.133	11	11	14	9p13.3	NFX1	P	Nuclear transcription factor, X box-binding, protein 1	603255	REc, H			4(Nfx1)
9.134	8	27	15	9p13.3	PTENP1	P	Phosphatase and tensin homolog pseudogene 1 (functional)	613531	Psh, REc			
9.135	4	29	14	9p13.3	RGP1, KIAA0258	C	RGP1 retrograde golgi transport, S. cerevisiae, homolog of	615742	REc, R			
9.136	4	25	11	9p13.3	SPINK4, PEC60	P	Serine protease inhibitor, Kazal-type, 4	613929	REc			
9.137	4	8	16	9p13.3	TMEM8B, NGX6, NAG5	C	Transmembrane protein 8B	616888	REc			
9.138	6	13	12	9p13.2	EXOSC3, RRP40, PCH1B	P	Exosome component 3	606489	REc		Pontocerebellar hypoplasia, type 1B, 614678 (3)	
9.139	4	27	16	9p13.2	FRMPD1, FRMD2, KIAA0967	P	FERM and PDZ domains-containing protein 1	616919	REc			
9.140	1	12	15	9p13.2	TOMM5, TOM5	P	Translocase of outer mitochondrial membrane 5, yeast, homolog of	616169	REc			
9.141	10	13	15	9p13.2	ZBTB5, KIAA0354	C	Zinc finger- and BTB domain-containing protein 5	616590	REc, R			
9.142	8	2	13	9p13.3	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	C	Tropomyosin-2, beta	190990	REa, A, R, Fd		Arthrogryposis multiplex congenita, distal, type 1, 108120 (3); Arthrogryposis, distal, type 2B, 601680 (3); Nemaline myopathy 4, autosomal dominant, 609285 (3); CAP myopathy 2, 609285 (3)	
9.143	4	2	01	9p13.1	ALDH1B1, ALDH5	C	Aldehyde dehydrogenase 1 family, member B1	100670	REa, A			
9.144	2	28	03	9p13.3	AQP3	C	Aquaporin-3	600170	A	incorrectly mapped to chr.7	[Blood group GIL], 607457 (3)	
9.145	1	5	12	9p13.3	AQP7, GLYCQTL	C	Aquaporin-7	602974	A		[Glycerol quantitative trait locus], 614411 (3)	
9.146	7	11	02	9p21.1	B4GALT1, GGTB2, GT1, GTB, CDG2D	P	Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22)	137060	REa, A		Congenital disorder of glycosylation, type IId, 607091 (3)	4(Ggtb)
9.147	8	29	02	9p13.3	CCL19, SCYA19, ELC, MIP3B	P	Chemokine, C-C motif, ligand 19	602227	Psh, REa, R			
9.148	8	29	02	9p13.3	CCL21, SCYA21, SLC	C	Chemokine, C-C motif, ligand 21	602737	REa, R, REc			
9.149	8	29	02	9p13.3	CCL27, SCYA27, CCL27, ILC, CTACK	P	Chemokine, C-C motif, ligand 27	604833	REc			4(Scya27)
9.150	1	2	96	9p13.3	CNTFR	C	Ciliary neurotrophic factor receptor	118946	Psh, R, A			4(Cntfr)
9.151	12	4	02	9p13.3	DCTN3, DCTN22	P	Dynactin 3	607387	R			
9.152	6	10	02	9p13.3	GALT	C	Galactose-1-phosphate uridyltransferase	606999	S, D, F		Galactosemia, 230400 (3)	4(Galt)
9.153	8	25	11	9p13.3	IL11RA, CRSDA	C	Interleukin-11 receptor, alpha	600939	A		Craniosynostosis and dental anomalies, 614188 (3)	4(Il11ra, Etl2)
9.154	1	5	09	9p13.3	NOL6, NRAP	P	Nucleolar protein 6	611532	REc			
9.155	9	3	99	9p13.3	NUDT2, APAH1	P	Nudix-type motif 1 (AP4A hydrolase-1)	602852	A			
9.156	2	21	14	9p13.2	PAX5, BSAP, ALL3	C	Paired box homeotic gene-5 (B-cell lineage specific activator protein)	167414	REa, A, Fd, Ch		{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)	4(Pax5)
9.157	10	11	05	9p13	PEE3	P	Preeclampsia/eclampsia 3	609403	Fd		Preeclampsia/eclampsia 3 (2)	
9.158	8	20	12	9p13.3	PIGO, HPMRS2	P	Phosphatidylinositol glycan, class O	614730	REc		Hyperphosphatasia with mental retardation syndrome 2, 614749 (3)	
9.159	10	5	10	9p13.3	PRSS3, TRY3, T9	P	Protease, serine, 3	613578	REc			
9.160	12	14	10	9q21.2	PRUNE2, BMCC1, KIAA0367	C	PRUNE, Drosophila, homolog of, 2	610691	R, REc			
9.161	12	24	08	9p13.2	RNF38	P	Ring finger protein 38	612488	REc			
9.162	10	23	15	9p13.3	SIGMAR1, SRBP, ALS16, DSMA2	P	Sigma nonopioid intracellular receptor 1	601978	Psh, A	mutation identified in 1 ALS16 family and 1 DSMA2 family	?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3); ?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	
9.163	5	15	97	9p13.3	TESK1	P	Testis-specific protein kinase-1	601782	A			
9.164	7	13	11	9p13.3	XRCC9, FANCG	C	X-ray repair, complementing defective, in Chinese hamster, 9	602956	A, Fd, LD		Fanconi anemia, complementation group G, 614082 (3)	
9.165	9	20	00	9p13.3	RECK, ST15	P	Reversion-inducing cysteine-rich protein with kazal motifs (suppressor of tumorigenicity 15)	605227	REc			
9.166	2	20	02	9p13.3	SIT	P	SHP2-interacting transmembrane adaptor protein	604964	A			
9.167	3	19	01	9p13.3	SPAG8, SMP1	P	Sperm-associated antigen 8	605731	R, A			
9.168	12	17	15	9p13.3	VCP, IBMPFD1, ALS14, CMT2Y	C	Valosin-containing protein	601023	REa, A		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3); Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3); Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	4(Vcp)
9.169	11	13	96	9p13.3	BAG1	P	BCL2-associated athanogene	601497	REa, A			
9.170	6	8	95	9p13.1	SHB	P	SHB adaptor protein (a Src homology 2 protein)	600314	Psh, A			
9.171	11	6	00	9p12-q12	ACP	P	Cerebral palsy, ataxic, autosomal recessive	605388	Fd, HZ		Cerebral palsy, ataxic, autosomal recessive (2)	
9.172	2	18	96	9q21.11	PGM5	P	Phosphoglucomutase-5	600981	A			19(Pgm5)
9.173	8	26	15	9q21.11	FOXD4L4, FOXD4L2	P	Forkhead box D4-like 4	611085	REc			
9.174	3	24	06	9p13.3	HINT2	P	Histidine triad nucleotide-binding protein 2	609997	REc			
9.175	3	8	95	9p11	MROS	L	Melkersson-Rosenthal syndrome	155900	Ch		?Melkersson-Rosenthal syndrome (2)	
9.176	11	4	91	9p13.3	CD72, LYB2	P	CD72 antigen	107272	REa			4(Lyb2)
9.177	1	24	09	9p	DEL9p, C9DELp	P	Chromosome 9p deletion syndrome	158170	Ch		Chromosome 9p deletion syndrome (4)	
9.178	12	17	07	9p	HDLCQ1	P	High density lipoprotein cholesterol level QTL 1	606613	Fd		[High density lipoprotein cholesterol level QTL 1] (2)	
9.179	10	1	95	9p13.3	TLN1	P	Talin 1	186745	Psh			
9.180	11	22	99	9p13.2	GRHPR, GLXR	C	Glyoxylate reductase/hydroxypyruvate reductase	604296	R, Fd		Hyperoxaluria, primary, type II, 260000 (3)	
9.181	6	11	94	9q34.11	FPGS	C	Folylpolyglutamate synthetase	136510	S, H			2(Fpgs)
9.182	3	15	10	9q	HCHGQ2	P	Hematocrit/hemoglobin quantitative trait locus 2	609320	Fd		[Hematocrit/hemoglobin quantitative trait locus 2] (2)	
9.183	4	27	12	9q	SPG19	P	Spastic paraplegia-19	607152	Fd		Spastic paraplegia 19, autosomal dominant (2)	
9.184	1	25	91	9q21.13	ANXA1, LPC1	P	Annexin A1 (lipocortin I)	151690	REa, A			19(Lpc1)
9.185	1	29	01	9q22.32	BARX1	P	BarH-like homeo box gene 1	603260	R			
9.186	10	23	87	9q12	DNCM	P	Cytoplasmic membrane DNA	126330	A	in 9qh		
9.187	10	13	15	9q12	SPATA31A7, AEP1, FAM75A7, C9orf36	P	Spermatogenesis-associated protein 31, subfamily A, member 7	616584	REc			
9.188	7	17	14	9q21.11	TJP2, ZO2, PFIC4	P	Tight junction protein 2	607709	REc, Fd		Hypercholanemia, familial, 607748 (3); Cholestasis, progressive familial intrahepatic 4, 615878 (3)	
9.189	1	13	99	9q21.12	BTEB1, BTEB	P	Basic transcription element-binding protein 1	602902	Psh, A			
9.190	8	21	07	9q21.11	CBWD3	P	Cobalamin synthetase W domain-containing protein 3	611080	REc			
9.191	11	12	96	9q13	CMD1B, CMPD1, FDC	C	Cardiomyopathy, dilated-1B, autosomal dominant	600884	Fd		Cardiomyopathy, dilated 1B (2)	
9.192	8	21	07	9q21.11	FOXD4L3	P	Forkhead box D4-like 3	611086	REc			
9.193	11	30	06	9q21.11	FXN, FRDA, FARR, X25	C	Frataxin	606829	Fd		Friedreich ataxia, 229300 (3); Friedreich ataxia with retained reflexes, 229300 (3)	
9.194	4	10	02	9q21.13	GCNT1	C	Glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase)	600391	A, Psh, R			13(Gcnt1)
9.195	1	12	15	9q21.11	PRKACG, BDPLT19	P	Protein kinase, cAMP-dependent, catalytic, gamma	176893	REa, A	mutation identified in 1 BDPLT19 family	?Bleeding disorder, platelet-type, 19, 616176 (3)	
9.196	9	18	98	9q21.11	PIP5K1B, STM7, MSS4	P	Phosphatidylinositol-4-phosphate 5-kinase, type I, beta	602745	REn, REc			
9.197	2	13	98	9q13-q21	GSM1, GSP	P	Geniospasm 1	190100	Fd		Geniospasm (2)	
9.198	6	16	06	9q21.13	OSTF1, OSF, SH3P2	P	Osteoclast-stimulating factor 1	610180	REc	conflicting assignment to 12q24.1-q24.2 by FISH		
9.199	2	26	02	9q21.13	TMC1, DFNB7, DFNB11, DFNA36	C	Transmembrane channel-like protein 1	606706	Fd, REc		Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal dominant 36, 606705 (3)	19(Tmc1, dn, Bth)
9.200	4	26	01	9q21.13	TMEM2	P	Transmembrane protein 2	605835	REc			19(Tmem2)
9.201	5	7	03	9q21.12	X123	P	X123 gene	607710	REc			
9.202	1	16	07	9q21.13	ZFAND5, ZNF216	P	Zinc finger AN1 domain-containing protein 5	604761	REc			19(Znf216)
9.203	7	22	13	9q13-q22	CTRCT26, CAAR	P	Cataract 26, multiple types	605749	Fd		Cataract 26, multiple types (2)	
9.204	1	28	88	9q21.13	ALDH1A1	P	Aldehyde dehydrogenase-1 family, member A1, soluble	100640	REa, A			19(Ahd2)
9.205	1	3	00	9q21.2	GNA14	P	Guanine nucleotide-binding protein, alpha-14	604397	A, REc			
9.206	6	11	13	9q21.2	GNAQ, SWS, CMC1	P	Guanine nucleotide-binding protein (G protein), q	600998	REa, A	pseudogene on 2q	Sturge-Weber syndrome, somatic, mosaic, 185300 (3); Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)	
9.207	9	28	96	9q22.31	IARS	P	Isoleucine-tRNA synthetase	600709	Psh, A			
9.208	10	15	09	9q21	PVOP2	P	Pelvic organ prolapse, susceptibility to, 2	613088	Fd	between rs4077632 and rs10868525	{Pelvic organ prolapse, susceptibility to, 2} (2)	
9.209	2	29	04	9q21.2	VPS13A, CHAC	C	Vacuolar protein sorting 13A (chorein)	605978	Fd, LD		Choreoacanthocytosis, 200150 (3)	
9.210	10	20	92	9q22.33	COL15A1	P	Collagen XV, alpha-1 polypeptide	120325	REa, A			4(Col15a1)
9.211	3	22	93	9q21.33	CTSL	C	Cathepsin L	116880	REa, A, Psh	\'like\' sequence on 10q23-q24		13(Ctsl)
9.212	1	10	12	9q21-q22	ETL4, ETOLM	P	Epilepsy, familial temporal lobe, 4	611631	Fd	between GATA152H04 and D9S253	Epilepsy, familial temporal lobe, 4 (2)	
9.213	1	12	08	9q21.32	FRMD3, EPB41LO	P	FERM domain-containing 3	607619	REc			
9.214	1	29	01	9q21.2	PCA3, DD3	P	Prostate cancer antigen 3	604845	REa			
9.215	9	16	09	9q21.13	RFK	P	Riboflavin kinase	613010	REc			
9.216	11	1	10	9q21.11	DFNA51, C9DUPq21.11, DUP9q21.11	C	Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome)	613558	Ch	259kb duplication involving TJP2 and FAM189A2	Deafness, autosomal dominant 51 (4)	
9.217	10	2	13	9p24.3	FOXD4, FKHL9	P	Forkhead box D4	601092	A, REc			19(Foxd4)
9.218	7	20	09	9q21.12	MAMDC2	P	MAM domain-containing 2	612879	REc			
9.219	12	28	15	9q21.12	MIR204, MIRN204, RDICC	P	Micro RNA 204	610942	REc	mutation identified in 1 RDICC family	?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3)	
9.220	10	4	05	9q21.12	SMC5L1, SMC5, KIAA0594	P	Structural maintenance of chromosomes 5-like 1	609386	R, REc			
9.221	1	4	16	9q21.11	ZNF658	P	Zinc finger protein 658	616290	REc			
9.222	8	20	98	9q21.12	APBA1, X11, D9S411E, MINT1, LIN10	P	Amyloid beta A4 precursor protein-binding, family A, member 1	602414	RE, REc			
9.223	10	31	08	9q21.12-q21.13	TRPM3, MLSN2, LTRPC3, KIAA1616	P	Transient receptor potential cation channel, subfamily M, member 3	608961	REc			
9.224	9	24	15	9q21.13	CARNMT1, C9orf41, UPF0586	P	Carnosine N-methyltransferase 1	616552	REc			
9.225	9	9	13	9q21.13	GDA, CYPIN	P	Guanine deaminase	139260	REc			
9.226	6	26	00	9q21.32	UBQLN1, DA41	P	Ubiquilin 1 (Da41, rat, homolog of)	605046	A			
9.227	8	20	07	9q21.33	ISCA1, HBLD2, HISCA	P	Iron-sulfur cluster assembly 1, S. cerevisiae, homolog of	611006	REc			
9.228	5	1	97	9q21.13	PCSK5	C	Proprotein convertase subtilisin/kexin type 5	600488	REa, A, REc	?close to LPC1 on 9q		19(Pcsk5)
9.229	2	3	06	9q21.32	TLE1, ESG1	C	Transducin-like enhancer of split 1 (homolog of Drosophila E(spl))	600189	REa, A, REn, R	conflicting assignment to chr.19		
9.230	4	15	09	9q22.31	ASPN, PLAP1, OS3	C	Asporin	608135	REc		{Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc degeneration}, 603932 (3)	
9.231	3	13	06	9q21.3-q22	FHL1, HPLH1, HLH1	P	Hemophagocytic lymphohistiocytosis, familial, 1	267700	Fd		Hemophagocytic lymphohistiocytosis, familial, 1 (2)	
9.232	3	18	94	9q21.33	GAS1	C	Growth arrest-specific gene-1	139185	Psh, A			13(Gas1)
9.233	10	2	14	9q21.2	PSAT1, PSAT, EPIP, PSATD, NLS2	P	Phosphoserine aminotransferase 1	610936	REc	mutation identified in 1 PSATD family	?Phosphoserine aminotransferase deficiency, 610992 (3); Neu-Laxova syndrome 2, 616038 (3)	
9.234	3	23	14	9q21.32	C9orf64	P	Chromosome 9 open reading frame 64	611342	REc			
9.235	3	23	14	9q21.32	C9orf103	P	Chromosome 9 open reading frame 103	611343	REc			
9.236	4	2	16	9q21.32	GKAP1, GKAP42	P	G kinase-anchoring protein 1	611356	REc			
9.237	5	26	13	9q21.32	KIF27	C	Kinesin family member 27	611253	REc			
9.238	5	24	13	9q21.32	MIR7-1	P	Micro RNA 7-1	615239	REc			
9.239	2	23	14	9q21.32	RASEF	P	RAS and EF-hand domains-containing protein	611344	REc			
9.240	10	30	08	9q21.32	RMI2, BLAP75, C9orf76	P	RecQ-mediated genome instability 1, S. cerevisiae, homolog of	610404	REc			
9.241	10	13	15	9q21.32	HNRNPK, HNRPK, AUKS	C	Heterogeneous nuclear ribonucleoprotein K	600712	REa, A		Au-Kline syndrome, 616580 (3)	
9.242	4	6	11	9q21.33	AGTPBP1, NNA1, KIAA1035, CCP1	P	ATP/GTP-binging protein 1	606830	REc			
9.243	8	14	14	9q21.33	GOLM1, GOLPH2, GP73, C9orf155	P	Golgi membrane protein 1	606804	REc			
9.244	3	23	15	9q21.33	ZCCHC6, TUT7, KIAA1711	P	Zinc finger CCHC domain-containing protein 6	613467	REc			
9.245	4	30	15	9q22.33	ALG2, CDGII, CMSTA3, CMS14	C	Alg2, S. cerevisiae, homolog of	607905	REc	mutation identified in 1 CDGII patient	?Congenital disorder of glycosylation, type Ii, 607906 (3); Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	
9.246	9	2	08	9q31.1	CSMF	C	Chondrosarcoma, extraskeletal myxoid, fused to EWS in	600542	Ch, A	t(9;17)(q22;q11); t(9;22)(q22;q11-q12)	Chondrosarcoma, extraskeletal myxoid, 612237 (3)	
9.247	9	2	15	9q22.33	FOXE1, FKHL15, TITF2, TTF2, NMTC4	C	Forkhead box E1 (thyroid transcription factor-2)	602617	Psh, REc		Bamforth-Lazarus syndrome, 241850 (3); {Thyroid cancer, nonmedullary, 4}, 616534 (3)	4(Titf2)
9.248	10	5	10	9q22.33	GALNT12, CRCS1	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12	610290	REc		{Colorectal cancer, susceptibility to, 1}, 608812 (3)	
9.249	1	23	07	9q22.33	HEMGN, EDAG	P	Hemogen	610715	A			4(Hemgn)
9.250	11	17	94	9q22.32	HSD17B3, EDH17B3	P	Hydroxysteroid (17-beta) dehydrogenase 3	605573	A		Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	
9.251	8	25	04	9q22	JOAG2	P	Glaucoma, primary open angle, juvenile-onset, 2	608695	Fd	between D9S1803 and D9S196	Glaucoma, primary open angle, juvenile-onset, 2 (2)	
9.252	6	9	98	9q22.31	NINJ1	C	Ninjurin	602062	A			13(Ninj1)
9.253	2	2	01	9q22.31	PHF2	C	PHD finger protein-2	604351	REn, REc, R			
9.254	8	14	00	9q22.31	ROR2, BDB1, BDB, NTRKR2	C	Receptor tyrosine kinase-like orphan receptor 2	602337	Fd, R, REc, Ch		Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal recessive, 268310 (3)	13(Ror2)
9.255	12	3	98	9q21.13	RORB, RZRB	P	RAR-related orphan receptor B	601972	A			4(Rorb)
9.256	7	3	06	9q22	STQTL8	P	Stature quantitative trait locus 8	610114	Fd	between GATA81C04M and ATA18A07M	{Stature QTL 8} (2)	
9.257	1	7	95	9q22.2	SYK	P	Spleen tyrosine kinase	600085	A			13(Syk)
9.258	4	7	14	9q22.33	TGFBR1, ALK5, AAT5, LDS1, MSSE	C	Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)	190181	Psh, A		Loeys-Dietz syndrome 1, 609192 (3); {Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	4(Tgfbr1)
9.259	9	30	02	9q21.13	TRPM6, CHAK2, HOMG1	C	Transient receptor potential cation channel, subfamily M, member 6	607009	REc		Hypomagnesemia 1, intestinal, 602014 (3)	
9.260	4	8	08	9q31.1	ABCA1, ABC1, HDLDT1, TGD	C	ATP-binding cassette 1	600046	A, REc		Tangier disease, 205400 (3); HDL deficiency, type 2, 604091 (3); {Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)	
9.261	12	27	01	9q22.33	TRIM14, KIAA0129	P	Tripartite motif-containing protein 14	606556	REa, R			
9.262	10	15	98	9q31.1	ZNF189	P	Zinc finger protein-189	603132	A			
9.263	4	17	13	9q22.1	CDK20, CCRK, CDCH, P42	P	Cyclin-dependent kinase 20	610076	R, REc			
9.264	5	8	07	9q22.33	GPR51, GABBR2	C	G protein-coupled receptor 51	607340	R, A		{Nicotine dependence, susceptibility to}, 188890 (3); {Nicotine dependence, protection against}, 188890 (3)	
9.265	11	7	14	9q21.33	NTRK2, TRKB	C	Neurotrophic tyrosine kinase, receptor, type 2	600456	REa, A	mutation identified in 1 OBHD patient	?Obesity, hyperphagia, and developmental delay, 613886 (3)	
9.266	7	12	13	9q22.1	NXNL2, RDCVF2	P	Nucleoredoxin-like protein 2	615299	REc, H			13(Nxnl2)
9.267	11	11	14	9q22.1	SHC3, NSHC, RAI, SHCC	P	SHC transforming protein 3	605263	R, REc			
9.268	9	18	08	9q22.1	S1PR3, EDG3	P	Sphingosine-1-phosphate receptor 3	601965	A			
9.269	5	25	00	9q22.2	GADD45G, GRP17	C	Growth arrest- and DNA damage-inducible gene 45, gamma	604949	A, R			
9.270	10	11	00	9q22.31	NFIL3, NFIL3A, E4BP4	P	Nuclear factor, interleukin 3-regulated	605327	REc			
9.271	3	2	06	9q22.1	SPIN, SPIN1	P	Spindlin	609936	REc			
9.272	3	5	01	9q22.31	SPTLC1, LBC1, SPT1, HSN1, HSAN	P	Serine palmitoyltransferase, long-chain base subunit 1	605712	Fd		Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	
9.273	3	31	15	9q22.2	CKS2	P	CDC2-associated protein CKS2	116901	A, REc			
9.274	7	12	01	9q22.33	CTSL2, CTSV	C	Cathepsin L2	603308	A			
9.275	3	31	15	9q22.2	DIRAS2	P	DIRAS family, GTP-binding Ras-like protein 2	607863	R, REc			
9.276	11	9	05	9q22.2	SECISBP2, SBP2	C	Selenocysteine insertion sequence-binding protein 2	607693	REc		Thyroid hormone metabolism, abnormal, 609698 (3)	
9.277	3	22	07	9q21.32-q21.33	SLC28A3, CNT3	P	Solute carrier family (sodium-coupled nucleoside transporter), member 3	608269	A, REc			
9.278	11	13	07	9q22.32	FBP1	C	Fructose-bisphosphatase 1	611570	A, Fd, REc		Fructose-1,6-bisphosphatase deficiency, 229700 (3)	
9.279	4	30	09	9q31.1	ALDOB	C	Aldolase B, fructose-bisphosphatase	612724	REb, REa, A, D, REc		Fructose intolerance, 229600 (3)	4(Aldo2)
9.280	5	2	03	9q31.1	BAAT	C	Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase)	602938	REc, H		Hypercholanemia, familial, 607748 (3)	4(Baat)
9.281	7	12	13	9q22.31	BICD2, KIAA0699, SMALED2	P	Bicaudal D, Drosophila, homolog of, 2	609797	R, REc		Spinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3)	
9.282	10	20	99	9q22.33	CORO2A, WDR2, IR10	P	Coronin 2A	602159	REc			
9.283	6	14	99	9q22.31	ECM2	P	Extracellular matrix protein-2	603479	A			
9.284	4	19	11	9q22.32	FANCC, FACC	C	Fanconi anemia, complementation group C	613899	Fd, REc		Fanconi anemia, complementation group C, 227645 (3)	13(Facc)
9.285	5	4	00	9q22.31	OGN, OIF	C	Osteoglycin	602383	R, A			
9.286	3	1	07	9q22.32	PTCH1, NBCCS, BCNS, HPE7	C	Patched, Drosophila, homolog of	601309	R, Fd, D		Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly-7, 610828 (3)	13(Ptc)
9.287	2	3	05	9q22.32	SLC35D2, HFRC1, SQV7L	P	Solute carrier family 35, member D2	609182	REc			
9.288	3	22	06	9q22.33	TBC1D2, PARIS1	P	TBC1 domain family, member 2	609871	REc			
9.289	5	20	99	9q22.33	TMOD	C	Tropomodulin	190930	A, REc			4(Tmod)
9.290	5	26	05	9q22.31	WNK2, PRKWNK2	C	WNK lysine deficient protein kinase 2	606249	R, REc			
9.291	8	30	07	9q22.33	XPA, XPAC	C	XPA complementing gene	611153	S, A, M, REc		Xeroderma pigmentosum, group A, 278700 (3)	4(Xpa)
9.292	1	12	99	9q22.32	ZNF169	C	Zinc finger protein-169	603404	A, REn			
9.293	5	9	97	9q22.33	NCBP1	P	Nuclear cap binding protein 1, 80kD	600469	REa, REc	in 500kb of XPA		4(Ncbp)
9.294	8	9	12	9q22.31	AUH	P	AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase)	600529	R, REc		3-methylglutaconic aciduria, type I, 250950 (3)	
9.295	10	08	07	9q22.31	CENPP	P	Centromeric protein P	611505	R, REc			
9.296	9	24	08	9q22.31	FAM120A, C9orf10, KIAA0183	P	Family with sequence similarity 120, member A	612265	REc			
9.297	6	23	15	9q22.31	SUSD3	P	SUSHI domain-containing protein 3	616429	REc			
9.298	4	10	14	9q22.32	ERCC6L2, RAD26L, BMFS2	P	ERCC6-like 2	615667	REc		Bone marrow failure syndrome 2, 615715 (3)	
9.299	3	23	09	9q22.32	MIR189, MIRN24-1	P	Micro RNA 24-1	609705	REc			
9.300	3	23	09	9q22.32	MIR23B, MIRN23B	P	Micro RNA 23B	610723	REc			
9.301	3	23	09	9q22.32	MIR27B, MIRN27B	P	Micro RNA 27B	610636	REc			
9.302	3	23	09	9q22.32	MIRLET7A1, LET7A1, MIRNLET7A1	P	Micro RNA Let7a1	605386	REc			
9.303	3	23	09	9q22.32	MIRLET7D, LET7D, MIRNLET7D	P	Micro RNA Let7d	612145	REc			
9.304	3	23	09	9q22.32	MIRLET7F1, LET7F1, MIRNLET7F1	P	Micro RNA Let7f1	612146	REc			
9.305	8	20	08	9q22.31	NOL8, NOP132	P	Nucleolar protein 8	611534	REc			
9.306	8	19	13	9q22.32	ZNF367, AFF29	C	Zinc finger protein 367	610160	REc			
9.307	3	30	23	9q22.32-q22.33	CDC14B	P	Cell division cycle 14, S. cerevisiae, homolog B	603505	R, REc			
9.308	9	9	13	9q22.33	ANKS6, PKDR1, NPHP16	P	Ankyrin repeat and sterile alpha motif domains-containing protein 6	615370	REc		Nephronophthisis 16, 615382 (3)	
9.309	7	23	13	9q22.33	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	C	Tudor domain-containing protein 7	611258	REc, R, Ch		Cataract 36, 613887 (3)	
9.310	1	12	07	9q31.3	ACTL7A	C	Actin-like 7A	604303	REa, REn, H			4(Actl7a)
9.311	1	12	07	9q31.3	ACTL7B	C	Actin-like 7B	604304	REc, REn, H			4(Actl7b)
9.312	11	10	10	9q31.2	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	C	Fukutin	607440	Fd, LD		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy, dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	
9.313	3	20	06	9q31.2	FSD1NL, FSD1L, MIR1, CCDC10	P	FSD1 N-terminus-like protein	609829	REc			
9.314	2	2	11	9q31	HSCR5	P	Hirschsprung disease, susceptibility to, 5	600156	LD		{Hirschsprung disease, susceptibility to, 5} (2)	
9.315	4	5	01	9q31.3	IKBKAP, IKAP	C	Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein	603722	REc, Fd		Dysautonomia, familial, 223900 (3)	
9.316	8	12	03	9q31.1	INVS, INV, NPHP2, NPH2	C	Inversin	243305	REc, A, Fd		Nephronophthisis 2, infantile, 602088 (3)	
9.317	1	29	01	9q31.2	KLF4, EZF, GKLF	P	Kruppel-like factor 4	602253	R			4(Ezf)
9.318	12	20	05	9q31	PAND2	P	Panic disorder 2	607853	Fd	max lod at D9S271	Panic disorder 2 (2)	
9.319	12	19	01	9q34.11	SIAT7D, SIAT3C	C	Sialyltransferase 7D	606378	A, R, REc			
9.320	12	8	04	9q31.1	STX17	P	Syntaxin 17	604204	REc			
9.321	8	28	15	9q31.2	TAL2	P	T-cell acute lymphocytic leukemia-2	186855	REa, A, RE, Ch	33kb from breakpoint in t(7;9)	Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	4(Tal2)
9.322	6	14	99	9q31.1	TMEFF1, C9ORF2	P	Transmembrane protein with EGF-like and 2 follistatin-like domains 1	603421	A, REa			
9.323	5	9	95	9q31.3	TXN	C	Thioredoxin	187700	A, Psh	incorrectly assigned to 3		4(Txn)
9.324	8	10	98	9q31.3	UGCG, GCS	P	UDP-glucose ceramide glucosyltransferase	602874	A			4(Ugcg)
9.325	4	21	10	9q31.3	EPB41L4B, EHM2	P	Erythrocyte membrane protein band 4.1-like 4B	610340	REc			
9.326	6	29	05	9q31-q32	HNP1	P	Hypertensive nephropathy	608026	Fd		Hypertensive nephropathy (2)	
9.327	11	4	98	9q32	SLC31A1, COPT1, CTR1	P	Solute carrier family 31 (copper transporter), member 1	603085	REn			
9.328	12	13	00	9q32	SLC13A2, COPT2, CTR2	P	Solute carrier family 31 (copper transporter), member 2	603088	REn			
9.329	11	22	04	9q31.3	AKAP2, AKAPKL, KIAA0920, PALM2	P	A-kinase anchor protein 2	604582	R	multiple splice variants		
9.330	8	8	14	9q32	PRPF4, PRP4, HPRP4, RP70	P	Precursor mRNA-processing factor 4, S. cerevisiae, homolog of	607795	A		Retinitis pigmentosa 70, 615922 (3)	
9.331	3	5	98	9q32	RGS3	P	Regulator of G-protein signaling-3	602189	R			
9.332	12	17	07	9q32	SLC46A2, TSCOT	P	Solute carrier family 46, member 2	608956	H, REc			4(Slc46a2)
9.333	1	19	07	9q31-q34	SPDA2	P	Spondyloarthropathy, susceptibility to, 2	183840	Fd	max lod at D9S1776	{Spondyloarthropathy, susceptibility to, 2} (2)	
9.334	10	16	14	9q33.1	TRIM32, HT2A, LGMD2H, BBS11	C	Tripartite-motif-containing protein 32	602290	Fd, REc	mutation identified in 1 BBS11 family	Muscular dystrophy, limb-girdle, type 2H, 254110 (3); ?Bardet-Biedl syndrome 11, 615988 (3)	
9.335	11	30	12	9q31.1	CHDT3	P	Congenital heart defects, multiple types, 3	614954	Fd	max lod at D9S1690	Congenital heart defects, multiple types, 3 (2)	
9.336	3	24	09	9q31.1	CYLC2	P	Cylicin 2	604035	REc			
9.337	3	24	09	9q31.1	GRIN3A, NR3A	P	Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	606650	REc			
9.338	3	5	08	9q31.1	MRPL50	P	Mitochondrial ribosomal protein L50	611854	REc	pseudogenes on 2, 5, and 10		
9.339	9	16	12	9q31.1	NIPSNAP3A, TASSC	P	NIPSNAP, C. elegans, homolog of, 3A	608871	REc			
9.340	4	15	11	9q31.1	PPP3R2, PPP3RL, CBLP	C	Protein phosphatase 3, regulatory subunit B, beta	613821	R, REc			
9.341	4	21	14	9q31.1	RNF20, BRE1A	P	Ring finger protein 20	607699	REc			
9.342	12	23	15	9q31.1	TEX10	P	Testis-expressed gene 10	616717	REc			
9.343	10	7	13	9q31.1	TXNDC4, KIAA0573	C	Thioredoxin domain-containing protein 4	609170	R, REc			
9.344	1	12	07	9q31.3	CTNNAL1	C	Catenin, alpha-like, 1	604785	R, A, REn			
9.345	7	20	09	9q31.2	MENAQ3	P	Menarche, age at, QTL3	612883	Fd	associated with rs2090409	{Menarche, age at, QTL3} (2)	
9.346	7	18	14	9q31.2	RAD23B	P	RAD23 (Saccharomyces cerevisiae) homolog of, B	600062	A, RE, REc	previously 3p25.1		4(Rad23b)
9.347	4	24	09	9q31.1-q31.2	SLC44A1, CTL1, CDW92	P	Solute carrier family 44, member 1	606105	REc			
9.348	2	8	13	9q31.2	TMEM38B, TRICB, OI14	P	Transmembrane protein 38B	611236	REc		Osteogenesis imperfecta, type XIV, 615066 (3)	
9.349	9	22	08	9q31.2-q34.2	IS4	P	Scoliosis, idiopathic, susceptibility to, 4	612238	Fd	max lod at D9S2157	{Scoliosis, idiopathic, susceptibility to, 4} (2)	
9.350	3	23	14	9q31.3	FRRS1L, C9orf4, CG6	C	Ferric-chelate reductase 1-like	604574	REc, REa			
9.351	5	25	13	9q31.3	GNG10	P	Guanine nucleotide-binding protein, gamma 10	604389	REc			
9.352	12	17	15	9q31.3	KIAA0368, ECM29	P	KIAA0368 gene	616694	R, REc			
9.353	9	18	08	9q31.3	LPAR1, EDG2, LPA1, VZG1	P	Lysophosphatidic acid receptor 1	602282	R, REc			4(vzg1)
9.354	3	23	09	9q31.3	MIR32, MIRN32	P	Micro RNA 32	609355	REc			
9.355	4	10	14	9q31.3	PTGR1, LTB4DH	P	Prostaglandin reductase 1	601274	REc			
9.356	8	8	13	9q31.3	PTPN3, PTPH1	P	Protein-tyrosine phosphatase, nonreceptor-type, 3	176877	A, REc			
9.357	8	4	15	9q31.3	MUSK, CMS9, FADS	C	Receptor tyrosine kinase MuSK	601296	A		Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3); Fetal akinesia deformation sequence, 208150 (3)	4(Musk)
9.358	3	4	10	9q32	C9orf80, SOSSC	P	Sensor of single-stranded DNA complex, subunit C	613273	REc			
9.359	3	30	12	9q32	CDC26, APC12	P	Cell division cycle 26, S. cerevisiae, homolog of	614533	REc	pseudogene on 7q32.1		
9.360	8	12	14	9q32	COL27A1, KIAA1870, STLS	P	Collagen, type XXVII, alpha-1	608461	REc	mutation identified in 1 STLS family	?Steel syndrome, 615155 (3)	4(Col27a1)
9.361	4	17	00	9q33.1	DEC1	P	Deleted in esophageal cancer 1	604767	D		Esophageal squamous cell carcinoma, 133239 (1)	
9.362	4	30	09	9q32	IBD16	P	Inflammatory bowel disease 16, susceptibility to	612259	Fd		{Inflammatory bowel disease 16} (2)	
9.363	8	19	13	9q32	KIF12	P	Kinesin family member 12	611278	REc			
9.364	1	2	08	9q31.3	SVEP1, POLYDOM, SELOB	C	Sushi, von willebrand factor type A, EGF, and pentraxin domain-containing 1	611691	A, H, REc			4(Svep1)
9.365	9	26	08	9q32	TNFSF15, TL1, VEGI	C	Tumor necrosis factor ligand superfamily, member 15 (vascular endothelial growth inhibitor)	604052	R, A			
9.366	8	10	98	9q32	ZFP37	P	Zinc finger protein-37, mouse, homolog of	602951	REa, A	?candidate for Nager syndrome		4(Zfp37)
9.367	1	6	93	9q32	AMBP, ITIL, ITI, HCP	C	Alpha-1-microglobulin/bikunin precursor (inter-alpha-trypsin inhibitor, light chain; protein HC)	176870	REa, A, H			4(Intin4)
9.368	5	5	16	9q32-q33	ARMD10	C	Macular degeneration, age-related, 10	611488	Fd		Macular degeneration, age-related, 10 (2)	
9.369	10	6	09	9q32-q33	EIG3	P	Epilepsy, idiopathic generalized, susceptibility to 3	608762	Fd		{Epilepsy, idiopathic generalized, susceptibility to, 3} (2)	
9.370	5	5	16	9q33.1	TLR4	C	Toll-like receptor-4	603030	A			
9.371	12	24	08	9q33.2	MEGF9, EGFL5	P	Multiple epidermal growth factor-like domains 9	604268	R			
9.372	1	7	95	9q33.2	PTGS1, COX1, PGHS1, COX3, PCOX1	P	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)	176805	REa, A			
9.373	10	11	07	9q32	WHRN, CIP98, KIAA1526, DFNB31, USH2D	C	Whirlin	607928	Fd, REc		Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type 2D, 611383 (3)	4(Whrn)
9.374	1	8	01	9q33.2	MRFF, RRF	P	Ribosome-recycling factor, mitochondrial	604602	R			
9.375	3	29	10	9q33	ASRT8	P	Asthma-related traits, susceptibility to, 8	613207	Fd	associated with rs3789873	{Asthma-related traits, susceptibility to, 8} (2)	
9.376	1	30	01	9q33.2	CEP1, CEP110, FAN	P	Centrosomal protein 1	605496	R			2(Cep1)
9.377	5	5	10	9q33.2	DAB2IP, AIP1, KIAA1743	P	DAB2-interacting protein	609205	REc			
9.378	8	4	97	9q33.2	GPR21	P	G protein-coupled receptor-21	601909	A			
9.379	6	11	11	9q33.3	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	C	Nuclear receptor subfamily 5, group A, member 1	184757	A		46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964 (3); Adrenocortical insufficiency (3); Spermatogenic failure 8, 613957 (3)	2(Ftzf1)
9.380	10	7	02	9q32	POLE3, CHARAC17, YBL1	P	Polymerase, DNA, epsilon-3	607267	REc			
9.381	2	10	14	9q33.1	TNC, HXB, DFNA56	C	Tenascin C (hexabrachion)	187380	REa, A	proximal to ABL	Deafness, autosomal dominant 56, 615629 (3)	4(Hxb)
9.382	6	14	99	9q32-q33	TNFSF8, CD30L, CD30LG	P	Tumor necrosis factor ligand superfamily, member 8 (CD30 ligand)	603875	A			4(Cd30l)
9.383	8	20	98	9q33.3	GCNF	P	Germ cell nuclear factor	602778	A			
9.384	3	15	92	9q33.2	GGTA1, GLYT2	P	Glycoprotein, alpha-galactosyltransferase-1	104175	REa, A	processed pseudogene GGTA1P on 12q14-q15		
9.385	7	27	11	9q34.12	LAMC3, OCCM	P	Laminin, gamma-3	604349	REc, A		Cortical malformations, occipital, 614115 (3)	
9.386	6	11	94	9q33.3	PBX3	C	Pre-B-cell leukemia transcription factor-3	176312	A, H			2(Pbx3)
9.387	9	29	10	9q34.11	SPTAN1, NEAS, EIEE5	C	Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)	182810	REa, A		Epileptic encephalopathy, early infantile, 5, 613477 (3)	2(Spna2)
9.388	3	2	98	9q33.2	TRAF1	P	TNF receptor-associated factor 2	601711	A			
9.389	6	30	08	8q24	BMND10	P	Bone mineral density quantitative trait locus 10	612113	Fd	associated with rs6469804 and rs6993813	[Bone mineral density QTL 10] (2)	
9.390	7	12	99	9q33.3	LHX2, LH2	P	LIM/homeodomain protein LHX2	603759	REa, A			
9.391	7	13	09	9q33.1	ASTN2, KIAA0634	C	Astrotactin 2	612856	R, REc			
9.392	4	29	14	9q33.1	BRINP1, DBC1, DBCCR1	P	Bone morphogenetic protein/retinoic acid-inducible neural-specific protein 1	602865	REc			
9.393	1	8	07	9q33.1	DIPAS	P	DIPLA1, antisense	610689	REc			
9.394	7	13	93	9q33.1	PAPPA	P	Pregnancy-associated plasma protein A	176385	A			4(Pappa)
9.395	11	22	10	9q33.3	DENND1A, KIAA1608	C	DENN/MADD domain-containing protein 1A	613633	R, REc			
9.396	12	10	13	9q33.2	LHX6	P	LIM homeobox gene 6	608215	REc			
9.397	3	31	09	9q33.2	RAB14	P	Ras-associated protein	612673	REc			
9.398	7	17	14	9q33.2-q33.3	RABGAP1, GAPCENA, TBC1D11	P	RAB GTPase-activating protein 1	615882	REc			
9.399	6	15	99	9q33.2	NDUFA8	C	NADH-ubiquinone oxidoreductase 1 beta subcomplex, 8	603359	R, Psh			
9.400	2	25	15	9q33.3	ANGPTL2, ARP2	P	Angiopoietin-like 2	605001	REc			
9.401	4	25	05	9q33.2	CDK5RAP2, KIAA1633, MCPH3	C	CDK5 regulatory subunit-associated protein 2	608201	REc, Fd		Microcephaly 3, primary, autosomal recessive, 604804 (3)	
9.402	2	17	15	9q33.3	CRB2, FSGS9, VMCKD	P	Crumbs, Drosophila, homolog of	609720	REc		Focal segmental glomerulosclerosis 9, 616220 (3); Ventriculomegaly with cystic kidney disease, 219730 (3)	2(Crb2)
9.403	1	4	08	9q33.3	GAPVD1, RAP6, GAPEX5, KIAA1521	P	GTPase-activating protein and VPS9 domains 1	611714	REc			
9.404	5	25	13	9q33.3	GOLGA1	P	Golgi autoantigen, golgin subfamily A, 1	602502	REc			
9.405	5	26	13	9q33.3	MAPKAP1, SIN1, MIP1, JC310	P	Mitogen-activated protein kinase-associated protein 1	610558	REc, R			
9.406	5	11	09	9q33.3	MIR181A2, MIRN181A2	P	Micro RNA 181A2	612743	REc			
9.407	5	11	09	9q33.3	MIR181B2, MIRN181B2	P	Micro RNA 181B2	612745	REc			
9.408	8	1	14	9q33.3	OLFML2A	P	Olfactomedin-like 2A	615899	REc			
9.409	12	23	05	9q33.2	PHF19	P	PHD finger protein 19	609740	REc			
9.410	4	15	09	9q33.3	PPP6C	P	Protein phosphatase 6, catalytic subunit	612725	A, REc	highly related sequence on Xq22.3		
9.411	1	30	12	9q33.3	RALGPS1, RALGEF2, KIAA0351	C	Ral guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 1	614444	R, REc			
9.412	8	21	07	9q33.3	RPL12	P	Ribosomal protein L12	180475	REc			
9.413	1	2	08	9q33.3	ZBTB34, KIAA1993	P	Zinc finger- and BTB domain-containing protein 34	611692	REc			
9.414	1	19	12	9q33.3-q34.1	LRSAM1, TAL, RIFLE, CMT2P	P	Leucine-rich repeat- and sterile alpha motif-containing 1	610933	REc		Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)	
9.415	5	11	00	9q33.3	NEK6	P	Never-in-mitosis gene A-related kinase 6	604884	R			
9.416	10	29	99	9q34.3	ABCA2, ABC2	P	ATP-binding cassette 2	600047	A			
9.417	11	18	14	9q34.2	ABO	C	ABO glycosyltransferase	110300	F, Fc	linked to AK1	[Blood group, ABO system], 616093 (3)	
9.418	3	5	04	9q34.2	ADAMTS13, VWFCP, TTP	P	A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 13	604134	Fd, REc		Thrombotic thrombocytopenic purpura, familial, 274150 (3)	
9.419	5	19	09	9q32	ALAD, ALADH, PBGS	C	Aminolevulinate, delta-, dehydratase	125270	F, S, A, REa	linked to ABO; ORM-ALAD-AK-ABO	Porphyria, acute hepatic, 612740 (3); {Lead poisoning, susceptibility to}, 612740 (3)	4(Lv)
9.420	4	8	02	9q34.13	BARHL1	P	BARH-like 1	605211	R			2(Barh1)
9.421	3	28	15	9q34.3	CACNA1B, CACNL1A5, DYT23	C	Calcium channel, voltage-dependent, L type, alpha 1B subunit	601012	A	mutation identified in 1 DYT23 family	?Dystonia 23, 614860 (3)	
9.422	10	9	12	9q34.11	CIZ1, ZNF356, LSFR1, NP94	P	CDKN1A-interacting zinc finger protein 1	611420	R, A			
9.423	9	24	08	9q34.3	COBRA1, NELFB, KIAA1182	P	Cofactor of BRCA1	611180	R, REc			
9.424	6	13	12	9q33.2	FBXW2, FBW2, FWD2	P	F-box and WD40 domain protein 2	609071	A			2(Fbxw2)
9.425	11	7	08	9q34.13	MED27, CRSP8, CRAP34	P	Mediator complex subunit 27	605044	R			
9.426	11	16	10	9q34.2	DBH	C	Dopamine-beta-hydroxylase	609312	F, A	tightly linked to ABO	[Dopamine-beta-hydroxylase activity levels, plasma] (3); Dopamine beta-hydroxylase deficiency, 223360 (3)	2(Dbh)
9.427	5	8	15	9q34.11	DNM1, EIEE31	P	Dynamin-1	602377	A, REa		Epileptic encephalopathy, early infantile, 31, 616346 (3)	2(Dnm1)
9.428	10	21	15	9q34.11	DYT1, TOR1A	C	Torsin A	605204	Fd		Dystonia-1, torsion, 128100 (3); {Dystonia-1, modifier of} (3)	
9.429	9	28	00	9q34.3	ENTPD2, CD39L1	P	Ectonucleoside triphosphate diphosphohydrolase 2	602012	Psh, REc	same cosmid as ABC2		
9.430	1	13	16	9q34.3	ENTPD8	P	Ectonucleoside triphosphate diphosphohydrolase 8	616748	REc			
9.431	2	26	04	9q34.11	FNBP1, FBP17	P	Formin-binding protein 17	606191	Ch, REc	fused with MLL in chronic myeloid leukemia		
9.432	6	5	97	9q34.3	FCN1	C	Ficolin (collagen/fibrinogen domain-containing) 1	601252	A, Psh			
9.433	6	5	97	9q34.3	FCN2	P	Ficolin (collagen/fibrinogen domain-containing lectin) 2	601624	A			
9.434	3	3	03	9q34.11	FREQ, NCS1	P	Frequenin, Drosophila, homolog of	603315	REc			
9.435	7	17	01	9q34.2	GBGT1, FS	P	Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (Forssman synthetase)	606074	REc			
9.436	2	9	92	9q33.2	GSN	P	Gelsolin	137350	A, REa, RE	40kb proximal to ABL	Amyloidosis, Finnish type, 105120 (3)	2(Gsn)
9.437	8	5	97	9q33.3	HSPA5, GRP78	C	Heat-shock 70kD protein-5 (glucose-regulated protein, 78kD)	138120	REa, H, Psh, A			2(Grp78)
9.438	3	13	08	9q34.11	GLE1, GLE1L, LCCS, LCCS1	C	Gle1, RNA export mediator, S. cerevisiae, homolog of	603371	Fd, REc		Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	
9.439	5	9	12	9q34	KTCN6	P	Keratoconus 6	614623	Fd	max lod at 159cM	Keratoconus 6 (2)	
9.440	10	13	94	9q34.3	LCN1	C	Lipocalin 1 (protein migrating faster than albumin, tear prealbumin)	151675	A, Psh, Fd			2(Lcn1)
9.441	11	22	94	9q34.11	LCN2, NGAL	P	Lipocalin 2 (oncogene 24p3)	600181	REa			2(Lcn2)
9.442	5	23	05	9q34.3	LCN6	P	Lipocalin 6	609379	REc			
9.443	7	22	09	9q34.3	LCN8	P	Lipocalin 8	612902	REc, H			2(Lcn8)
9.444	7	22	09	9q34.3	LCN9	P	Lipocalin 9	612903	REc, H			2(Lcn9)
9.445	7	22	09	9q34.3	LCN10	P	Lipocalin 10	612904	REc, H			2(Lcn10)
9.446	7	22	09	9q34.3	LCN12	P	Lipocalin 12	612905	REc, H			2(Lcn12)
9.447	4	23	08	9q34.3	MRPS2	P	Mitochondrial ribosomal protein S2	611971	R, REc			
9.448	6	15	99	9q34.11	ODF2, ODF84	P	Outer dense fiber of sperm tails 2	602015	A			
9.449	2	28	00	9q34.3	OBP2A	P	Odorant-binding protein 2A	164320	REc			
9.450	2	28	00	9q34.2	OBP2B	P	Odorant-binding protein 2B	604606	REc			
9.451	9	4	91	9q34.3	PAEP, PP14	C	Progestagen-associated endometrial protein (placental protein 14)	173310	REa, A, H			2(Paep)
9.452	10	1	95	9q34.11	PPP2R4, PTPA	P	Protein phosphatase-2A, regulatory subunit B' (PR 53)	600756	A	proximal to ABL		
9.453	8	18	97	9q34.1-q34.2	RALGDS	P	ral guanine nucleotide dissociation stimulator	601619	R, REc			
9.454	5	24	13	9q33.2	RC3H2, MNAB	P	RING finger and CCCH-type zinc finger domains-containing protein 2	615231	REc			
9.455	9	28	05	9q34.2	REXO4, XPMC2H	P	RNA exonuclease 4, S. cerevisiae, homolog of	602930	REc			
9.456	12	3	96	9q34.2	RING3L, ORFX	P	RING3-like gene (open reading frame X)	601541	REn			
9.457	5	27	93	9q34.2	RPL7A, SURF3	C	Ribosomal protein L7a (surfeit-3)	185640	REa, A	in cluster with SURF1		2(Surf3)
9.458	3	23	15	9q34.13	SETX, SCAR1, AOA2, ALS4	C	Senataxin	608465	Fd, REc		Amyotrophic lateral sclerosis 4, juvenile, 602433 (3); Spinocerebellar ataxia, autosomal recessive 1, 606002 (3)	
9.459	1	4	96	9q34.11	SET	P	SET gene	600960	A	fused with CAIN in acute undifferentiated leukemia		
9.460	4	4	02	9q34.2	SLC2A6	P	Solute carrier family 2, member 6	606813	REc			
9.461	10	12	09	9q34.11	SLC27A4, FATP4, IPS	P	Solute carrier family 27 (fatty acid transporter), member 4	604194	R, REc		Ichthyosis prematurity syndrome, 608649 (3)	
9.462	2	14	06	9q34.3	SLC34A3, NPTIIC, HHRH	C	Solute carrier family 34 (sodium/phosphate cotransporter), member 3	609826	REc, Fd		Hypophosphatemic rickets with hypercalciuria, 241530 (3)	
9.463	9	10	07	9q33.3	STRBP, SPNR, p74	P	Spermatid perinuclear RNA-binding protein	611138	A, H			2(Spnr)
9.464	12	17	15	9q34.2	SURF1, CMT4K	C	Surfeit-1	185620	REa, A	distal to ABL, CAN	Leigh syndrome, due to COX IV deficiency, 256000 (3); Charcot-Marie-Tooth disease, type 4K, 616684 (3)	2(Surf)
9.465	5	27	93	9q34.2	SURF2	C	Surfeit-2	185630	REa, A			2(Surf2)
9.466	5	27	93	9q34.2	SURF4	C	Surfeit-4	185660	REa, A			2(Surf4)
9.467	5	27	93	9q34.2	SURF5	C	Surfeit-5	185641	H, A			2(Surf5)
9.468	8	25	03	9q34.11	TOR1B, DQ1	P	Torsin 1B	608050	REc	centromeric to TOR1A; pseudogene on chr.2		
9.469	11	12	02	9q34.13	TSC1, LAM	C	Hamartin (tuberous sclerosis 1 gene)	605284	F, Fd	linked to ABO, ABL	Tuberous sclerosis-1, 191100 (3); Lymphangioleiomyomatosis, 606690 (3); Focal cortical dysplasia, Taylor balloon cell type, 607341 (3)	
9.470	5	27	93	9q34.2	SURF6	C	Surfeit-6	185642	H, A			2(Surf6)
9.471	5	14	95	9q34.2	VAV2	P	Oncogene VAV2	600428	RE			
9.472	7	13	93	9q33.3	ZNF79	P	Zinc finger protein-79 (pT7)	194552	REa			
9.473	3	3	03	9q34.12	ABL1	C	Abelson murine leukemia viral (v-abl) oncogene homolog 1	189980	REa, Ch, A	fusion hybrid gene with BCR1 in CML	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)	2(Abl)
9.474	2	23	09	9q34.11	AK1	C	Adenylate kinase-1	103000	F, S, D, Fc	proximal to Ph1 break, 9q34.1; AK1 to ORM = 17cM	Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)	2(Ak1)
9.475	9	28	09	9q34.11	ASS1, ASS	C	Argininosuccinate synthetase 1	603470	S, D, REa, Fd	14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12	Citrullinemia, 215700 (3)	2(Ass1)
9.476	9	30	14	9q33.2	C5, C5D, ECLZB	C	Complement component-5	120900	REa, A		C5 deficiency, 609536 (3); [Eculizumab, poor response to], 615749 (3)	2(Hc)
9.477	11	5	98	9q34.11	CDK9, CDC2L4	P	Cyclin-dependent kinase-9	603251	Psh			
9.478	1	27	09	9q34.1	CLLS3	P	Leukemia, chronic lymphocytic, susceptibility to, 3	612557	Fd	associated with SNP -6531 upstream of DAPK1 promoter	{Leukemia, chronic lymphocytic, susceptibility to, 3} (2)	
9.479	11	22	94	9q34.11	CRAT, CAT1	P	Carnitine acetyltransferase	600184	REa		?Carnitine acetyltransferase deficiency (1)	
9.480	10	14	95	9q21.33	DAPK1	P	Death-associated protein kinase-1	600831	REa, A			
9.481	3	29	12	9q34.11	DOLPP1, LSFR2	P	Dolichyl pyrophosphate phosphatase 1	614516	R, A			
9.482	3	9	95	9q34.11	ENDOG	P	Endonuclease G	600440	Psh, A			
9.483	10	13	97	9q34.11	ENG, END, HHT1, ORW	C	Endoglin	131195	A, H, Fd		Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	2(Eng)
9.484	6	7	10	9q34.12	FIBCD1	P	Fibrinogene C domain-containing protein 1	613357	REc			
9.485	6	1	09	9q33.3	LMX1B, NPS1	C	LIM homeo box transcription factor 1, beta	602575	F, Fd, Ch		Nail-patella syndrome, 161200 (3)	2(Lmx1b)
9.486	8	27	15	9q34.13	NUP214, D9S46E, CAN, CAIN	C	Nucleoporin, 214kD	114350	Ch	fused with DEK in AML; fused with ABL1 in T-ALL	Leukemia, acute myeloid, somatic, 601626 (3); Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3)	2(D2H9S46E)
9.487	11	10	10	9q34.13	POMT1, MDDGA1, MDDGB1, MDDGC1	C	Protein O-mannosyltransferase 1	607423	R, REa, Fd		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	
9.488	7	29	15	9q34.12	PRDM12, HSAN8	P	PR domain-containing protein 12	616458	REc		Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3)	
9.489	2	6	01	9q34.11	PRRX2, PRX2	P	Paired-related homeo box gene 2	604675	A			
9.490	12	10	15	9q33.2	STOM, EPB72, BND7	C	Stomatin (erythrocyte membrane protein band 7.2)	133090	REa, Ch, A	proximal to ABL		2(Epb7.2)
9.491	8	29	08	9q34.11	STXBP1, UNC18, EIEE4	C	Syntaxin-binding protein 1	602926	A		Epileptic encephalopathy, early infantile, 4, 612164 (3)	
9.492	8	20	88	9q32	ORM1, AGP1	C	Orosomucoid-1 (alpha-1-acid glycoprotein-1)	138600	F, S, REa, Fc, A	linked to ABO, AK1, ALAD		4(Orm1)
9.493	8	20	88	9q32	ORM2	C	Orosomucoid-2	138610	RE, LD			4(Orm2)
9.494	1	31	13	9q34.11	ASB6	P	Ankyrin repeat- and SOCS box-containing protein 6	615051	REc			
9.495	12	29	06	9q34.11	C9orf90, NAIF1	P	Nuclear apoptosis-inducing factor 1	610673	REc			
9.496	12	29	06	9q34.11	CCBL1	C	Cysteine conjugate beta-lyase 1	600547	Psh, REc			
9.497	10	28	15	9q34.11	CERCAM	P	Cerebral endothelial cell adhesion molecule	616626	REc			
9.498	1	31	13	9q34.11	DPM2, CDG1U	P	Dolichyl-phosphate mannosyltransferase 2, regulatory subunit	603564	REc		Congenital disorder of glycosylation, type Iu, 615042 (3)	
9.499	8	26	15	9q34.11	GOLGA2, GM130	P	Golgi autoantigen, golgin subfamily A, 2	602580	REc			
9.500	9	2	12	9q34.11	MIR199B	P	Micro RNA 199B	614791	REc			
9.501	7	8	10	9q34.11	MIR2861, MIRN2861, BMND15	P	Micro RNA 2861	613405	REc		[Bone mineral density QTL 15], 613418 (3)	
9.502	7	17	14	9q34.11	NTMT1, METTL11A, NRMT, C9orf32	P	N-terminal X-Pro-Lys N-methyltransferase 1	613560	REc			
9.503	1	6	14	9q34.11	NUP188, KIAA1069	C	Nucleoporin, 188kD	615587	R, REc			
9.504	7	13	09	9q34.11	PIP5KL1, PIPKH	P	Phosphatidylinositol-4-phosphate-5-kinase-like 1	612865	REc			
9.505	2	22	07	9q34.11	TMEM15, DK1, SEC59, KIAA1094, CDG1M	P	Transmembrane protein 15	610746	R, REc		Congenital disorder of glycosylation, type Im, 610768 (3)	
9.506	2	7	07	9q34.11	PKN3	P	Protein kinase N3	610714	REc			
9.507	8	23	12	9q34.11	SH2D3C, NSP3	P	SH2 domain-containing protein 3C	604722	REc			
9.508	3	20	14	9q34.11	ST6GALNAC6, SIAT7F	P	ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	610135	REc, R			
9.509	8	26	15	9q34.11	SWI5, SAE3, C9orf119	P	SWi5 homologous recombination repair protein	616528	REc			
9.510	2	17	15	9q34.11	TBC1D13	P	TBC1 domain family, member 13	616218	REc			
9.511	7	17	14	9q34.11	TOR2A, TORP1	P	Torsin 2A	608052	REc			
9.512	1	29	07	9q34.11	TRUB2	P	TRUB pseudouridine synthase, E. coli, homolog of, 2	610727	REc			
9.513	3	31	09	9q34.11	URM1	P	Ubiquitin-related modifier 1, S. cerevisiae, homolog of	612693	REc			
9.514	4	8	13	9q34.11	USP20, VDU2	P	Ubiquitin-specific protease 20	615143	REc			
9.515	2	9	14	9q34.11	WDR34, SRTD11	P	WD repeat-containing protein 34	613363	REc		Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3)	
9.516	5	25	13	9q34.11-q34.12	FUBP3, FBP3	P	FAR upstream element-binding protein 3	603536	REc			
9.517	8	17	99	9q33.3	PSMB7	P	Proteasome subunit, beta-type, 7	604030	A			
9.518	6	1	12	9q34.12	EXOSC2, RRP4	P	Exosome component 2	602238	REc			
9.519	9	16	12	9q34.12	QRFP, P518, 26RFA	P	Pyroglutamylated FR-amide peptide precursor protein	609795	REc			
9.520	8	11	13	9q34.13	AK8	P	Adenylate kinase 8	615365	REc			
9.521	11	7	08	9q34.13	ALPQTL1	P	Alkaline phosphatase, plasma level of, QTL 1	171720	Fd	linkage with rs657152	{Alkaline phosphatase, plasma level of, QTL1} (2)	
9.522	3	28	15	9q34.11	COQ4, COQ10D7	P	Coenzyme Q4, S. cerevisiae, homolog of	612898	REc		Coenzyme Q10 deficiency, primary, 7, 616276 (3)	
9.523	8	27	15	9q34.13	DDX31, PPP1R25	P	DEAD box polypeptide 31	616533	REc			
9.524	3	29	07	9q34.11	FAM102A, EEIG1	P	Family with sequence similarity 102, member A	610891	REc			
9.525	9	8	11	9q34.11	FAM129B, MINERVA	P	Family with sequence similarity 129, member B	614045	REc			
9.526	2	2	14	9q34.13	GFI1B, BDPLT17	P	Growth factor-independent 1B	604383	REc		Bleeding disorder, platelet-type, 17, 187900 (3)	
9.527	3	28	16	9q34.11	LRRC8A, KIAA1437, AGM5	C	Leucine-rich repeat-containing 8A	608360	REc, R, Ch	mutation identified in 1 AGM5 patient	?Agammaglobulinemia 5, 613506 (3)	2(Lrrc8)
9.528	3	22	07	9q34.11	PTGES2, PGES2, GBF1	C	Prostaglandin E synthase 2	608152	REc, REn			
9.529	8	31	11	9q34.2	ADAMTSL2, KIAA0605, GPHYSD1	P	ADAMTS-like protein 2	612277	R, REc		Geleophysic dysplasia 1, 231050 (3)	
9.530	11	11	09	9q34.2	C9orf7, FLOWER	P	Flower, Drosophila, homolog of	613104	REc			
9.531	7	18	14	9q34.13	GTF3C5, TFIIIC63	P	General transcription factor 3C, polypeptide 5	604890	REc			
9.532	7	1	05	9q34.13	UCK1	P	Uridine/cytidine kinase 1	609328	REc			
9.533	1	31	13	9q34.2	SARDH, SARD, SAR	P	Sarcosine dehydrogenase	604455	H, REc		[Sarcosinemia], 268900 (3)	2(sar)
9.534	8	2	13	9q34.2	TMEM8C, MYOMAKER	P	Transmembrane protein 8C	615345	REc			
9.535	4	13	15	9q34.3	COL5A1, EDSC	C	Collagen V, alpha-1 polypeptide	120215	REa, A, Fd		Ehlers-Danlos syndrome, classic type, 130000 (3)	2(Col5a1)
9.536	6	11	94	9q34.3	PTGDS	C	Prostaglandin D2 synthase (21kD, brain)	176803	A, H	distal to ABL		2(Ptgds)
9.537	5	5	04	9q34.3	AGPAT2, LPAAB, BSCL, BSCL1	C	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta)	603100	A, Fd		Lipodystrophy, congenital generalized, type 1, 608594 (3)	
9.538	11	26	97	9q34.3	C8G	C	Complement component-8, gamma polypeptide	120930	REa, H, Fd			2(C8g)
9.539	3	29	12	9q34.3	C9orf116, PIERCE1	P	p53-induced expression in RB-null cells 1	614502	REc, H			2(Pierce1)
9.540	6	10	08	9q34.3	C9orf140, P42.3	P	Chromosome 9 open reading frame 140	612057	REc, H			2(P42.3)
9.541	3	24	11	9q34.3	CAMSAP1	P	Calmodulin-regulated spectrin-associated protein 1	613774	REc			
9.542	4	26	10	9q34.3	CARD9, CANDF2	P	Caspase recruitment domain-containing protein 9	607212	REc		Candidiasis, familial, 2, autosomal recessive, 212050 (3)	
9.543	8	17	14	9q34.3	CCDC183, KIAA1984	P	Coiled-coil domain-containing protein 183	615955	REc			
9.544	11	30	06	9q34.13	CEL, BSSL, CELL, MODY8	C	Carboxyl-ester lipase (bile-salt stimulated lipase)	114840	REa, A		Maturity-onset diabetes of the young, type VIII, 609812 (3)	
9.545	5	26	13	9q34.3	DPP7, QPP	P	Dipeptidyl peptidase VII	610537	R, REc			
9.546	11	12	09	9q34.3	EGFL7	P	Epidermal growth factor-like 7	608582	A, R			2(Egfl7)
9.547	2	16	10	9q34.3	EHMT1, EUHMTASE1, DEL9q34	C	Euchromatic histone methyltransferase 1	607001	REc, Ch		Kleefstra syndrome, 610253 (3)	
9.548	4	2	12	9q34.3	FAM69B	P	Family with sequence similarity 69, member B	614543	REc			
9.549	6	13	12	9q34.3	FBXW5, FBW5	P	F-box and WD40 domain protein 5	609072	REc			2(Fbxw5)
9.550	9	28	11	9q34.3	GRIN1, NMDAR1, MRD8	C	Glutamate receptor, ionotropic, N-methyl D-aspartate 1	138249	REb, A, Fd		Mental retardation, autosomal dominant 8, 614254 (3)	
9.551	1	20	11	9q34.3	GLT6D1, GT6M7, GLTDC1	P	Glycosyltransferase 6 domain-containing 1	613699	REc			
9.552	8	15	14	9q34.3	INPP5E, MORMS, JBTS1, CORS1	P	Inositol polyphosphate-5-phosphatase, 72kD	613037	REc		Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)	
9.553	1	9	13	9q34.3	KCNT1, KIAA1422, EIEE14, ENFL5	P	Potassium channel, subfamily T, member 1	608167	R, REc		Epileptic encephalopathy, early infantile, 14, 614959 (3); Epilepsy, nocturnal frontal lobe, 5, 615005 (3)	
9.554	10	2	09	9q34.3	LHX3, CPHD3	P	LIM/homeodomain protein LHX3	600577	H, A, REa	in mouse, close to Notch1; centromeric to ABL	Pituitary hormone deficiency, combined, 3, 221750 (3)	2(Lhx3)
9.555	12	15	10	9q34.3	LRRC26, CAPC	P	Leucine-rich repeat-containing protein 26	613505	REc			
9.556	9	1	11	9q34.3	MAN1B1, MRT15	P	Mannosidase, alpha, class 1B member 1	604346	REc		Mental retardation, autosomal recessive 15, 614202 (3)	
9.557	3	23	09	9q34.3	MIR126, MIRN126	P	Micro RNA 126	611767	REc			
9.558	3	5	08	9q34.3	MRPL41, MRPL27	P	Mitochondrial ribosomal protein L41	611846	R, REc			
9.559	6	22	14	9q34.3	NACC2, RBB	P	NACC family, member 2, BEN and BTB/POZ domains-containing	615786	REc			
9.560	3	14	13	9q34.3	NSMF, NELF, HH9	C	NMDA receptor synaptonuclear signaling and neuronal migration factor	608137	R, REc		Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	
9.561	9	30	14	9q34.3	NOTCH1, TAN1, AOS5, AOVD1	C	Notch, Drosophila, homolog of, 1, translocation-associated	190198	Ch, H, A		Aortic valve disease 1, 109730 (3); Adams-Oliver syndrome 5, 616028 (3)	2(Notch1)
9.562	5	26	13	9q34.3	NOXA1	P	NADPH oxidase activator 1	611255	REc			2(Noxa1)
9.563	7	17	01	9q34.3	NR1	P	NADPH-dependent FMN- and FAD-containing oxidoreductase	606073	A			
9.564	11	30	06	9q34.3	PARF, C9orf86	P	Partner of ARF	610615	R, REc			
9.565	4	14	15	9q34.3	PAXX, C9orf142	P	Paralog of XRCC4 and XLF	616315	REc			
9.566	7	3	06	9q34.3	PHPT1	P	Phosphohistidine phosphatase 1	610167	REc			
9.567	2	5	16	9q34.3	PMPCA, KIAA0123, SCAR2	P	Peptidase, mitochondrial processing, alpha	613036	REc		Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	
9.568	8	27	08	9q34.3	PNPLA7	P	Patatin-like phospholipase domain containing 7	612122	REc			
9.569	6	1	12	9q34.3	PPP1R26, KIAA0649	P	Protein phosphatase 1, regulatory subunit 26	614056	REc, R			
9.570	8	23	00	9q34.11	PTGES, PGES, PIG12, MGST1L1	P	Prostaglandin E synthase	605172	A			
9.571	7	13	09	9q34.3	QSOX2, SOXN	P	Quiescin Q6 sulfhydryl oxidase 2	612860	A			
9.572	3	14	07	9q34.13	RAPGEF1, GRF2, C3G	P	RAP guanine nucleotide exchange factor 1	600303	A			
9.573	5	19	94	9q34.2	RXRA	C	Retinoid X receptor, alpha	180245	Psh, A	distal to DBH		2(Rxra)
9.574	7	13	09	9q34.3	SEC16A, SEC16L, KIAA0310, p250	P	Sec16, S. Cerevisiae, homolog of, A	612854	R, REc			
9.575	10	2	12	9q34.3	SNAPC4, SNAP190	P	Small nuclear RNA-activating protein complex, polypeptide 4	602777	REc			
9.576	4	17	07	9q34.3	SSNA1, NA14	P	Sjogren syndrome nuclear autoantigen 1	610882	REc			
9.577	9	12	15	9q34.3	TMEM203	P	Transmembrane protein 203	616499	REc			
9.578	4	20	10	9q34.3	TPRN, C9orf75, DFNB79	P	Taperin	613354	REc, H, Fd		Deafness, autosomal recessive 79, 613307 (3)	2(Tprn)
9.579	8	19	14	9q34.3	TRAF2, TRAP	P	TNF receptor-associated factor 2	601895	REc			
9.580	3	14	13	9q34.3	TUBB4B, TUBB2C	P	Tubulin, beta-4B	602660	REc			
9.581	4	1	09	9q34.3	UBAC1, GBDR1	P	Ubiquitin-associated domain-containing protein 1	608129	Psh, REc			
9.582	2	18	10	9q34.3	WDR85	P	WD repeat-containing protein 85	613210	REc			
9.583	9	18	08	9q34.3	ZMYND19, MIZIP	P	Zinc finger MYND domain-containing protein 19	611424	REc, H			2(Zmynd19)
9.584	5	16	02	9q34.3	ANAPC2, APC2, KIAA1406	P	Anaphase-promoting complex, subunit 2	606946	R			
9.585	4	30	03	9q32	ATP6V1G1, ATP6G1	P	ATPase, H+ transporting, lysosomal, 13kD, V1 subunit G, isoform 1	607296	R			
9.586	1	24	01	9q31.1	CAPE	P	Chromosome-associated protein E	605576	R			
9.587	12	27	01	9q34.3	CLIC3	P	Chloride intracellular channel 3	606533	R			
9.588	2	28	03	9p13.3	CREB3, LZIP	P	cAMP response element-binding protein 3	606443	R			
9.589	7	15	02	9q22.32	FBP2	P	Fructose-1,6-bisphosphatase 2	603027	R			
9.590	3	5	98	9q34.3	FUT7	P	Fucosyltransferase 7 (alpha (1,3) fucosyltransferase)	602030	REa			
9.591	10	23	87	Chr.9	H142T	P	Temperature sensitivity complementation, H142	187290	S			
9.592	6	13	02	9p13.2	MELK, KIAA0175	P	Maternal embryonic leucine zipper kinase	607025	REa			4(Melk)
9.593	1	30	01	9p24.1	MLANA, MART1	P	Melan A	605513	R			
9.594	8	27	01	9q34.3	NPDC1, CAB1	P	Neural proliferation, differentiation, and control protein 1	605798	R			
9.595	12	23	02	9q22.33	NANS, SAS	P	N-acetylneuraminic acid synthase (sialic acid synthase)	605202	R			
9.596	12	14	01	9q34.3	OLFM1, AMY	P	Olfactomedin 1	605366	R			
9.597	5	4	00	9q33.2	PDCL	P	Phosducin-like	604421	REa, R			
9.598	5	4	00	9q33.2	PSMD5, S5B	P	Proeasome 26s subunit, non-ATPase, 5	604452	REa			
9.599	2	21	03	9q32	ROD1	P	Regulator of differentiation 1	607527	R			
9.600	11	15	00	9q33.3	SLC2A8, GLUT8	P	Solute carrier family 2, (facilitated glucose transporter) member 8	605245	R			
9.601	4	26	01	9p13.3	UNC13, MUNC13	P	UNC13, C. elegans, homolog of	605836	R			
10.1	3	6	94	10p15.1	CALML3	P	Calmodulin-like 3	114184	REa, Psh, A			
10.2	10	15	97	10p13	PHYH, PAHX	P	Phytanoyl-CoA hydroxylase	602026	LD, R		Refsum disease, 266500 (3)	
10.3	3	6	00	10pter-q11	ST12, PAC1	P	Suppression of tumorigenicity 12, prostate	601188	M		Prostate adenocarcinoma (2)	
10.4	8	29	07	10p15.3	DIP2C, KIAA0934	C	Disco-interacting protein 2, Drosophila, homolog of, C	611380	R, REc			
10.5	8	26	15	10p15.3	LARP4B, LARP5, KIAA0217	C	La ribonucleoprotein domain family, member 4B	616513	R, REc			
10.6	2	2	16	10p15.3	TUBB8, OOMD2	P	Tubulin, beta 8	616768	REc		Oocyte maturation defect 2, 616780 (3)	
10.7	2	9	92	10p15.2	PFKP	C	Phosphofructokinase, platelet type	171840	S, A, D			
10.8	1	31	13	10p15.1	ASB13	P	Ankyrin repeat- and SOCS box-containing protein 13	615055	REc			
10.9	8	26	09	10p14	ATP5C1, ATP5CL1, ATP5C	P	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide-1	108729	REa, REc			
10.10	9	9	08	10p15.1	FBXO18, FBH1, FBX18	P	F-box only protein 18	607222	REc			2(Fbxo18)
10.11	7	20	15	10p15.1	IL2RA, CD25, IL2R, IDDM10, IMD41	C	Interleukin-2 receptor, alpha	147730	REa, A, Fd, LD		Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	2(Il2ra)
10.12	2	23	09	10p15.1	MS2	P	Multiple sclerosis, susceptibility to, 2	612594	Fd	associated with rs12722489 and rs2104286	{Multiple sclerosis, susceptibility to, 2} (2)	
10.13	9	17	07	10p15.1	RBM17, SPF45	P	RNA binding motif protein 17	606935	REc			
10.14	7	9	09	10p13	TRDMT1, DMNT2	C	tRNA aspartic acid methyltransferase 1 (DNA methyltransferase 2)	602478	R, A			
10.15	3	6	98	10p15.3	ADARB2, RED2	P	Adenosine deaminase, RNA-specific, B2 (homolog of rat BLUE)	602065	REa			
10.16	8	3	11	10p14	GATA3, HDR, HDRS	C	GATA-binding protein-3	131320	A, Ch		Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	2(Gata3)
10.17	1	13	99	10p15.1	GDI2, RABGDIB	P	GDP dissociation inhibitor 2	600767	A	pseudogene on chr.7		
10.18	9	9	13	10p15.3	IDI1	P	Isopentenyl-diphosphate delta isomerase 1	604055	REc			13(Idi1)
10.19	9	9	13	10p15.3	IDI2, IPPI2	P	Isopentenyl-diphosphate delta isomerase 2	615389	REc			13(Idi2)
10.20	9	9	13	10p15.3	IDI2AS1	P	IDI2 antisense RNA 1, noncoding	615391	REc			
10.21	10	6	92	10p14	ITIH2	C	Inter-alpha (globulin) inhibitor, H2 polypeptide	146640	A, H			2(Intin2)
10.22	12	20	05	10p14	ITIH5	P	Inter-alpha-trypsin inhibitor, heavy chain 5	609783	REc			
10.23	10	7	05	10p15.2	KLF6, COPEB, BCD1, ZF9	C	Kruppel-like factor-6	602053	REa, A		Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic, 613659 (3)	
10.24	8	2	13	10p15	PFFE1	P	Plasmodium falciparum fever episodes QTL1	611384	Fd		{Plasmodium falciparum fever episodes QTL1} (2)	
10.25	9	27	95	10p15.1	PRKCQ	P	Protein kinase C, theta	600448	A			2(Pkcq)
10.26	8	18	99	10p15.1	AKR1C1, DDH1, DD1, HAKRC	P	Aldo-keto reductase family 1, member 1 (dihydrodiol dehydrogenase, type 1)	600449	Psh, A			
10.27	10	10	11	10p15.1	AKR1C2, DDH2, DD2, HAKRD, SRXY8	P	Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II)	600450	Psh, A		Obesity, hyperphagia, and developmental delay (3); 46XY sex reversal 8, 614279 (3)	
10.28	8	18	99	10p15.1	AKR1C3, HAKRB, DD3	P	Aldo-keto reductase family 1, member C3	603966	REa, A			
10.29	10	10	11	10p15.1	AKR1C4, CHDR, CDR, HAKRA, DD4	P	Aldo-keto reductase family 1, member C4 (chlordecone reductase)	600451	REa, A		{46XY sex reversal 8, modifier of}, 614279 (3)	
10.30	2	15	96	10p15.1	IL15RA	P	Interleukin-15 receptor, alpha	601070	A			2(Il15ra)
10.31	2	26	01	10p14	KIN, KIN17, BTCD	P	Antigenic determinant of recombination protein A, mouse, homolog of	601720	A			2(kin17)
10.32	7	26	10	10p13	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	C	Optineurin	602432	Fd		Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)	
10.33	1	31	01	10p15.1	PFKFB3, IPFK2	P	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	605319	A			
10.34	3	11	03	10p14	UPF2, RENT2	P	UPF2 regulator of nonsense transcripts, yeast, homolog of	605529	R			
10.35	8	20	08	10p14	CRCS5	P	Colorectal cancer, susceptibility to, 5	612230	Fd	associated with rs10795668	{Colorectal cancer, susceptibility to, 5} (2)	
10.36	11	21	14	10p14	DHTKD1, KIAA1630, AMOXAD, CMT2Q	P	Dehydrogenase E1 and transketolase domains-containing protein 1	614984	Psh, REc	mutation identified in 1 CMT2Q family	2-aminoadipic 2-oxoadipic aciduria, 204750 (3); ?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	
10.37	10	11	12	10p14	TAF3, TAFII140	P	TAF3 RNA polymerase II, TATA box-binding protein-associated factor, 140kD	606576	REc			
10.38	11	15	08	10p12.1	YME1L1, YME1L, PAMP	P	Mitochondrial escape 1-like 1	607472	REc			
10.39	9	9	13	10p14	SFMBT2, KIAA1617	P	SCM-like protein with 4 MBT domains 2	615392	REc			2(Sfmbt2)
10.40	11	6	14	10p15.3	ZMYND11, BS69, BRAM1, MRD30	P	Zinc finger MYND domain-containing protein 11	608668	A		Mental retardation, autosomal dominant 30, 616083 (3)	
10.41	9	2	96	10p14-p13	DGCR2, DGS2	C	DiGeorge syndrome chromosome region-2	601362	Ch		DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)	
10.42	3	2	98	10p12.33	STAM	P	Signal transducing adaptor molecule	601899	A			2(Stam)
10.43	1	6	00	10p14-p12	ARVD6	P	Arrhythmogenic right ventricular dysplasia 6	604401	Fd		Arrhythmogenic right ventricular dysplasia 6 (2)	
10.44	12	15	05	10p13	AD7	P	Alzheimer disease 7	606187	Fd	max LOD at D10S1423	Alzheimer disease-7 (2)	
10.45	5	26	13	10p13	ARMETL1, CDNF	P	Arginine-rich protein mutated in early stage tumors-like 1	611233	REc			
10.46	11	4	93	10p12.2	BMI1	P	Oncogene BMI-1	164831	A			
10.47	12	18	07	10p13	C10orf97, CARP	P	CARD-containing protein	611649	REc			
10.48	5	13	13	10p13	C1QL3, CTRP13, K100	P	Complement component 1, q subcomponent-like 3	615227	REc, H			1(C1ql3)
10.49	2	25	15	10p13	CAMK1D, CKLIK	P	Calcium/calmodulin-dependent protein kinase I-delta	607957	REc			
10.50	8	2	13	10p14	CELF2, CUGBP2, ETR3, BRUNOL3	P	CUGbp- and ELAV-like family, member 2	602538	REc			
10.51	2	17	16	10p13	FRMD4A, KIAA1294, CCAFCA	C	FERM domain-containing protein 4A	616305	R, REc	mutation identified in 1 CCAFCA family	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3)	
10.52	4	10	14	10p13	ITGA8, RHDA1	P	Integrin, alpha-8	604063	REc		Renal hypodysplasia/aplasia 1, 191830 (3)	
10.53	2	16	06	10p13	LPRS	C	Leprosy, paucibacillary type, susceptibility to	609888	Fd		{Leprosy, paucibacillary type, susceptibility to} (2)	
10.54	5	16	05	10p13	MCM10, CNA43	P	Minichromosome maintenance 10, S. cerevisiae, homolog of	609357	R, REc			
10.55	9	6	11	10p13	MEIG1	P	Meiosis-expressed gene 1, mouse, homolog of	614174	REc			
10.56	10	14	94	10p12.33	MRC1, MMR	P	Mannose receptor, C type 1	153618	Psh, A			2(Mrc1)
10.57	9	17	08	10p13	NMT2	P	N-myristoyltransferase 2	603801	REc			
10.58	8	26	09	10p13	PRPF18, PRP18	P	Prp18, S. cerevisiae, homolog of	604993	R, REc			
10.59	8	26	09	10p13	RPP38	P	Ribonuclease P, 38-kD subunit	606116	R, REc			
10.60	8	26	09	10p13	RSU1	P	Ras suppressor protein 1	179555	REa, REc			
10.61	3	24	11	10p13	SEPHS1, SPS1	P	Selenophosphate synthetase 1	600902	REc			
10.62	8	26	09	10p13	SUV39H2, FLJ23414	P	Suppressor of variegation 3-9, Drosophila, homolog of, 2	606503	R, REc			2(Suv39h2)
10.63	8	25	04	10p14	USP6NL, RNTRE	P	USP6 N-terminal-like	605405	Ch			
10.64	12	28	15	10p13	VIM, CTRCT30	C	Vimentin	193060	REa	mutation identified in 1 CTRCT30 patient	?Cataract 30, pulverulent, 116300 (3)	2(Vim)
10.65	1	12	09	10p12.31	NEBL	C	Nebulette	605491	R, A			
10.66	6	4	10	10p11.22	ARHGAP12	P	Rho GTPase-activating protein 12	610577	REc			
10.67	1	8	16	10p12.33	HACD1, PTPLA	P	3-hydroxyacyl-CoA dehydratase 1	610467	REc			
10.68	1	23	13	10p12.31	ARL5B, ARL8	P	ADP-ribosylation factor-like 5B	608909	REc			
10.69	8	19	13	10p12.31	DNAJC1, HTJ1	P	DNAJ/HSP40 homolog, subfamily C, member 1	611207	REc, R			
10.70	5	6	13	10p12.31	MIR1915	P	Micro RNA 1915	615202	REc			
10.71	4	6	15	10p12.33	ST8SIA6, SIAT8F	P	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	610139	REc			
10.72	3	22	06	10p12.1	ARHGAP21, KIAA1424	P	GTPase-activating protein, Rho, 21	609870	REc	pseudogene on chr.6		
10.73	3	3	10	10p12.31	EBLN1	P	Endogenous Borna-like N element-containing protein 1	613249	REc			
10.74	9	9	08	10p13	HSPA14, HSP70L1	P	Heat-shock 70kD protein 14	610369	REc			
10.75	11	30	06	10p12.31	PLXDC2, TEM7R	P	Plexin domain containing 2	606827	R			
10.76	7	19	06	10p12.1	BAMBI, NMA	P	BMP and activin membrane-bound inhibitor, xenopus, homolog of	604444	Psh, A			
10.77	8	18	14	10p12.2	PTF1A, PACA, PAGEN2	C	Pancreas transcription factor 1, alpha subunit	607194	REc, Fd		Pancreatic and cerebellar agenesis, 609069 (3); Pancreatic agenesis 2, 615935 (3)	
10.78	5	26	13	10p12.2	ARMC3	P	Armadillo repeat-containing protein 3	611226	REc			
10.79	12	22	15	10p12.2	COMMD3	P	COMM domain-containing protein 3	616700	REc			
10.80	6	5	08	10p12.2	OTUD1, DUBA7	P	OTU domain-containing protein 1	612022	REc			
10.81	9	12	08	10p12.2	PIP5K2A, PI5P4KA	P	Phosphatidylinositol-4-phosphate 5-kinase, type II, alpha	603140	R, REc			
10.82	10	28	15	10p12.1	ACBD5, KIAA1996	P	Acyl-CoA-binding domain-containing protein 5	616618	REc			
10.83	2	24	11	10p12.1	ANKRD26, KIAA1074, THC2	P	Ankyrin repeat domain-containing protein 26	610855	REc		Thrombocytopenia 2, 188000 (3)	6(Ankrd26)
10.84	10	15	13	10p12.1	ARMC4, CILD23	P	Armadillo repeat-containing protein 4	615408	REc		Ciliary dyskinesia, primary, 23, 615451 (3)	
10.85	2	21	03	10p13	CUBN, IFCR, MGA1	C	Cubilin (intrinsic factor-cobalamin receptor)	602997	A, R, REc		Megaloblastic anemia-1, Finnish type, 261100 (3)	
10.86	7	14	14	10p12.1	ENKUR, C10orf63	P	Enkurin, TRPC channel-interacting protein	611025	REc			2(4933434I06Rik)
10.87	4	19	12	10p12.1	GPR158, KIAA1136	P	G protein-coupled receptor 158	614573	REc			2(Gpr158)
10.88	2	9	15	10p12.1	MASTL, FLJ14813, GWL, THC2	P	Microtubule-associated serine/threonine kinase-like	608221	Fd, REc	mutation identified in 1 THC2 family	?Thrombocytopenia-2, 188000 (3)	
10.89	4	1	09	10p12.1	MKX, IFRX, IRXL1	P	Mohawk homeobox	601332	Psh, Fd			18(Mkx)
10.90	5	21	07	10p12.1	MPP7	P	Membrane protein, palmitoylated 7	610973	REc			
10.91	5	24	12	10p12.1	PDSS1, TPT, COQ1, COQ10D2	P	Prenyl diphosphate synthase, subunit 1	607429	R, REc		Coenzyme Q10 deficiency, primary, 2, 614651 (3)	
10.92	2	12	07	10p12.1	PRTFDC1	P	Phosphoribosyl transferase domain-containing protein 1	610751	R, REc			
10.93	2	14	08	10p12.1	PTCHD3	P	Patched domain-containing protein 3	611791	REc			
10.94	9	17	11	10p12.1	RAB18, WARBM3	P	Ras-associated protein RAB18	602207	H, REc		Warburg micro syndrome 3, 614222 (3)	18(Rab18)
10.95	5	26	13	10p12.1	THNSL1, TSH1	P	Threonine synthase-like 1	611260	REc			
10.96	3	6	94	10p11.21	CREM	P	cAMP-responsive element modulator	123812	A			18(Crem)
10.97	1	13	16	10p12.1	WAC, KIAA1844, DESSH	P	WW domain-containing adaptor with coiled-coil region	615049	REc		Desanto-Shinawi syndrome, 616708 (3)	
10.98	8	28	15	10p12.31	AF10	C	ALL1 fused gene from chromosome 10	602409	A, Ch	fuses with MLL and HEAB	Leukemia, acute myeloid, 601626 (3)	
10.99	3	5	08	10p12.33-p12.31	CACNB2	C	Calcium channel, voltage-dependent, beta 2 subunit	600003	A, REc		Brugada syndrome 4, 611876 (3)	
10.100	3	24	11	10p12.2	MSRB2, CBS1	P	Methionine sulfoxide reductase B2	613782	R			
10.101	5	25	00	10p11.22	NRP1, NRP, VEGF165R	P	Neuropilin 1	602069	REa, R			
10.102	5	4	00	10p13	PTER	P	Phosphotriesterase-related protein	604446	A			
10.103	3	19	01	10p12.2	SPAG6	P	Sperm-associated antigen 6	605730	A			
10.104	3	9	95	10p12.1	GAD2	C	Glutamate decarboxylase-2, pancreas	138275	A			2(Gad2)
10.105	5	12	09	10p11.23	LYZL2	P	Lysozyme-like 2	612748	REc			
10.106	12	16	10	10p11.23	MTPAP, PAPD1, SPAX4	P	Mitochondrial poly(A) polymerase	613669	REc		Ataxia, spastic, 4, 613672 (3)	
10.107	5	5	09	10p11.23-q21.1	DFNB33	P	Deafness, autosomal recessive 33	607239	Fd	prev. assignment to chr. 9 an error	Deafness, autosomal recessive 33 (2)	
10.108	4	15	08	10p11.22	EIG5	P	Epilepsy, idiopathic generalized, susceptibility to, 5	611934	Fd	max lod at D10S1426	{Epilepsy, idiopathic generalized, susceptibility to, 5} (2)	
10.109	9	23	13	10p11.22	KIF5B, KNS1, UKHC	P	Kinesin 1	602809	REc			18(Ukhc)
10.110	4	21	16	10p11.22	ZEB1AS1	P	ZEB1 antisense RNA 1, noncoding	616915	REc			
10.111	3	20	07	10p11.21	ANKRD30A	P	Ankyrin repeat domain-containing protein 30A	610856	REc			
10.112	4	1	08	10p11.21	GJD4, CX40.1	P	Gap junction protein, delta-4	611922	REc			
10.113	8	26	09	10p11.22-p11.21	PARD3, PAR3	P	Partitioning-defective protein 3, C. elegans, homolog of	606745	R, REc			
10.114	1	9	13	10p11.21-q21.1	USH1K	P	Usher syndrome, type IK	614990	Fd	max lod at D10S539	Usher syndrome, type IK (2)	
10.115	10	7	98	10p12.1	ABI1	P	ABL-interactor 1	603050	Ch			
10.116	5	19	09	10p11.21	CCNY, CFP1, CCNX, C10orf9	P	Cyclin Y	612786	REc			
10.117	8	28	01	10p11.21	FZD8	P	Frizzled, Drosophila, homolog of, 8	606146	A			18(Fzd8)
10.118	3	13	92	10p11.22	ITGB1, FNRB	C	Integrin, beta-1 (fibronectin receptor, beta polypeptide; antigen CD29 includes MDF2, MSK12)	135630	REb, REa, F, A, S	pseudogene FNRBL on 19p		
10.119	10	4	05	10p11.23	MAP3K8, COT, EST, TPL2	C	Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene)	191195	Psh, A, H		Lung cancer, somatic, 211980 (3)	18(Tpl2)
10.120	8	17	99	10p11.23	SVIL	P	Supervillin	604126	A			
10.121	2	25	10	10p11.22	ZEB1, TCF8, NIL2A, PPCD3, FECD6	C	Zinc finger E box-binding homeobox 1	189909	REa, A, Fd		Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	
10.122	5	12	09	10p11.21	CUL2	P	Cullin 2	603135	A			
10.123	8	20	92	10p11.21	ZNF25, KOX19	C	Zinc finger protein-25 (KOX 19)	194528	REa, A			
10.124	8	27	15	10p12.1	MYO3A, DFNB30	C	Myosin IIIA	606808	REa, R, Fd		Deafness, autosomal recessive 30, 607101 (3)	
10.125	11	11	14	10p11.1	ZNF37A, KOX21, ZNF37	P	Zinc finger protein 37A	616085	REc			
10.126	8	20	07	10p11.22	EPC1	P	Enhancer of polycomb, Drosophila, homolog of, 1	610999	R			
10.127	12	19	11	10p11.23	KIAA1462, JCAD	P	KIAA1462 gene	614398	REc			
10.128	2	21	03	10p	BULN	P	Bulimia nervosa, susceptibility to	607499	Fd	between D10S1430 and D10S1423	{Bulimia nervosa, susceptibility to} (2)	
10.129	9	14	05	10p13	DCLRE1C, ARTEMIS, SCIDA	C	DNA cross-link repair protein 1C	605988	Fd, REc		Severe combined immunodeficiency, Athabascan type, 602450 (3); Omenn syndrome, 603554 (3)	
10.130	10	8	08	10p	BMIQ8	C	Body mass index quantitative trait locus 8	603188	Fd		{Obesity, susceptibility to, BMIQ8} (2)	
10.131	10	30	03	10q	AITD4	P	Autoimmune thyroid disease, susceptibility to, 4	608176	Fd		{Autoimmune thyroid disease, susceptibility to, 4} (2)	
10.132	1	12	99	10q26.11	TIAL1, TIAR, TCBP	P	Tia1 cytotoxic granule-associated RNA-binding protein-like 1	603413	REc, R			
10.133	5	26	13	10q11.22-q11.23	ARHGAP22	P	Rho GTPase-activating protein 22	610585	REc			
10.134	5	19	16	10q11.23	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	C	Excision repair cross complementing rodent repair deficiency, complementation group 6	609413	A, M		Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to 5}, 613761 (3); UV-sensitive syndrome 1, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3); Premature ovarian failure 11, 616946 (3)	
10.135	8	18	98	10q22.1	TACR2, TAC2R, NKNAR	C	Tachykinin receptor 2 (substance K receptor; neurokinin 2 receptor)	162321	REa, A			
10.136	10	24	11	10q22.2	ADK	C	Adenosine kinase	102750	S, D, EM		Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)	14(Adk)
10.137	8	30	02	10q11.21	CXCL12, SDF1	P	Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1)	600835	A		{AIDS, resistance to}, 609423 (3)	
10.138	9	16	03	10q11.22	SYT15	P	Synaptotagmin 15	608081	REc			14(Syt15)
10.139	5	27	05	10q11.21	ALOX5	P	Arachidonate 5-lipoxygenase	152390	Psh		{Atherosclerosis, susceptibility to} (3); {Asthma, diminished response to antileukotriene treatment in}, 600807 (3)	
10.140	3	6	98	10q11.22	ANXA8	P	Annexin A8	602396	A			14(Anx8)
10.141	4	30	15	10q11.23	CHAT, CMS6	C	Choline acetyltransferase	118490	REa, A		Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3)	
10.142	1	29	01	10q21.1	DKK1	P	Dickkopf, Xenopus, homolog of, 1	605189	A			
10.143	3	23	06	10q11.22	MAPK8, PRKM8, JNK1, SAPK1	P	Mitogen-activated protein kinase 8	601158	R, REc			
10.144	4	23	08	10q11.22	MSMB, HPC13	C	Microseminoprotein, beta	157145	REa, A		{Prostate cancer, hereditary, 13}, 611928 (3)	
10.145	8	14	15	10q11.22	NCOA4, ELE1, PTC3	C	Nuclear receptor coactivator 4	601984	REn	fused with RET to form PTC3		
10.146	8	10	13	10q11.22	PTPN20A	P	Protein tyrosine phosphatase, nonreceptor-type, 20A	610630	Psh, A			
10.147	8	19	13	10q11.22	PTPN20B	P	Protein tyrosine phosphatase, nonreceptor-type, 20B	610631	Psh, A			
10.148	9	29	13	10q11.2-q21.1	PRKG1, PRKG1B, PRKGR1B, AAT8	P	Protein kinase, cGMP-dependent, regulatory, type I	176894	REa, A		Aortic aneurysm, familial thoracic 8, 615436 (3)	
10.149	6	4	13	10q11.22	RBP3, RP66	C	Retinol-binding protein-3, interstitial	180290	REa, A, Fd	1 family identified with mutation	?Retinitis pigmentosa 66, 615233 (3)	14(Rbp3)
10.150	5	19	16	10q11.21	RET, MEN2A, HSCR1	C	RET transforming sequence; oncogene RET	164761	A, REn, Fd, Ch, D		Multiple endocrine neoplasia IIA, 171400 (3); Medullary thyroid carcinoma, 155240 (3); Multiple endocrine neoplasia IIB, 162300 (3); Central hypoventilation syndrome, congenital, 209880 (3); Pheochromocytoma, 171300 (3); {Hirschsprung disease, susceptibility to, 1}, 142623 (3)	
10.151	12	7	07	10q11.23	SGMS1, SMS1, TMEM23, MOB	P	Sphingomyelin synthase 1	611573	REc			
10.152	12	17	95	10q11.23	SLC18A3, VACHT	P	Solute carrier family 18 (vesicular acetylcholine), member 3	600336	REn			
10.153	8	28	92	10q11.21	ZNF22, KOX15	C	Zinc finger protein-22 (KOX15)	194529	A, REa			
10.154	3	12	07	10p11.1	ZNF33A, NF11A, KOX2	C	Zinc finger protein-33a	194521	REa, A			
10.155	3	12	07	10q11.21	ZNF33B, ZNF11B, KOX2	C	Zinc finger protein-33b	194522	REa, A			
10.156	8	26	09	10q11.21	ZNF239, MOK2	P	Zinc finger protein-239	601069	R, REc	previously 19q13.2-q13.3		6(Mok2)
10.157	12	21	12	10q21.1	MBL2, MBL, MBP1, MBL2D, MBPD	C	Mannose-binding lectin 2, soluble (opsonic defect)	154545	REa, A, Fd	near MEN2A	{Chronic infections, due to MBL deficiency}, 614372 (3)	14(Mbl1)
10.158	1	30	09	10q11.2-q21	STHAG5	P	Tooth agenesis, selective, 5	610926	Fd	D10S604 and D10S568	Tooth agenesis, selective, 5 (2)	
10.159	12	5	07	10q21.1	UBE2D1, UBCH5A, UBCH5	C	Ubiquitin-conjugating enzyme E2D 1	602961	Psh, R			
10.160	2	18	98	10q11.22	PPYR1, NPY4R, PP1	P	Pancreatic polypeptide receptor-1	601790	REa, REc			14(Ppyr1)
10.161	8	5	14	10q11.21	BMS1, BMS1L, KIAA0187, ACC	P	Bms1, ribosome assembly protein, S. cerevisiae, homolog of	611448	REc	mutation identified in one ACC family	?Aplasia cutis congenita, nonsyndromic, 107600 (3)	
10.162	4	6	15	10q11.21	C10orf10, DEPP, FIG	P	Chromosome 10 open reading frame 10	611309	REc			
10.163	4	27	16	10q11.21	FXYD4, CHIF	P	FXYD domain-containing ion transport regulator 4	616926	REc			
10.164	6	7	10	10q11.21-q11.22	MARCH8	P	Membrane-associated RING-CH finger protein 8	613335	REc			
10.165	3	30	12	10q11.21	RASFEF1A	P	RASGEF domain family, member 1A	614531	REc			
10.166	5	26	13	10q11.21	RASSF4, AD037	P	Ras association domain family, member 4	610559	REc			
10.167	3	25	96	10q11.21	HNRPF	C	Heterogeneous nuclear ribonucleoprotein F	601037	A			
10.168	1	29	01	10q11.22	TIMM23	P	Translocase of inner mitochondrial membrane 23, Yeast, homolog of	605034	A			
10.169	10	28	15	10q11.21	CSGALNACT2	P	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	616616	REc			
10.170	11	22	10	10q11.22	FAM21C, VPEF, KIAA0592	P	Family with sequence similarity 21, member C	613631	R, REc			
10.171	3	29	10	10q11.22	FRMPD2	P	FERM and PDZ domains-containing protein 2	613323	REc			
10.172	11	11	13	10q11.22	GDF2, BMP9, HHT5	P	Growth differentiation factor 2 (bone morphogenetic protein 9)	605120	REc		Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	
10.173	5	26	13	10q11.22	GPRIN2, GRIN2	P	G protein-regulated inducer of neurite outgrowth 2	611240	REc			
10.174	3	29	10	10q11.23	WDFY4, KIAA1607	P	WD repeat- and FYVE domain-containing protein 4	613316	Psh, REc			
10.175	5	26	13	10q11.23	ASAH2	P	N-acylsphingosine amidohydrolase 2	611202	REc			
10.176	5	22	07	10q11.23	ASAH2C, ASAH2L	P	N-acylsphingosine amidohydrolase 2C	610987	REc			
10.177	8	26	09	10q11.23	DRGX, DRG11	P	Dorsal root ganglia homeobox	606701	REc			
10.178	2	20	01	10q11.23	PARG	P	Poly(ADP-ribose) glycohydrolase	603501	A			14(Parg)
10.179	9	28	11	10q11.23-q22.3	HYPT9	P	Hypotrichosis 9	614237	Fd	between D10S538 and D10S2327	Hypotrichosis 9 (2)	
10.180	10	13	09	10q21	ALL1	P	Leukemia, acute lymphocytic, susceptibility to, 1	613065	Fd	associated with rs10821936	{Leukemia, acute lymphocytic, susceptibility to, 1} (2)	
10.181	11	7	08	10q21	ALPQTL4	P	Alkaline phosphatase, plasma level of, QTL 4	612369	Fd	linkage with rs12355784	{Alkaline phosphatase, plasma level of, QTL4} (2)	
10.182	11	11	13	10q21.2	ANK3, MRT37	P	Ankyrin-3, node of Ranvier	600465	A	mutation identified in 1 family	?Mental retardation, autosomal recessive, 37, 615493 (3)	10(Ank3)
10.183	8	14	15	10q21.2	CCDC6, D10S170, H4, TST1	C	Coiled-coil domain-containing 6	601985	REn	fused with RET to form PTC1		
10.184	2	2	14	10q21.3	CTNNA3, ARVD13	P	Catenin, alpha-3	607667	A, Psh		Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3)	
10.185	7	9	06	10q22.1	DDX21	P	DEAD/H box 21	606357	R, REc			10(Ddx21)
10.186	9	24	08	10q21	IBD15	P	Inflammatory bowel disease 15	612255	Fd	association with rs10761659	{Inflammatory bowel disease 15} (2)	
10.187	3	20	06	10q21.1	IPMK	P	Inositol polyphosphate multikinase	609851	REc			
10.188	10	30	08	10q21	MAFD8	P	Major affective disorder 8	612357	Fd	associated with rs20994336	{Major affective disorder-8, susceptibility to} (2)	
10.189	2	28	03	10q22.1	NPFF1	P	Neuropeptide FF1	607448	R			
10.190	6	15	99	10q22.1	SGPL1, SPL	L	Sphingosine-1-phosphate lyase 1	603729	H			10(Spl)
10.191	9	18	08	10q21.1	TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6	P	Transcription factor A, mitochondrial	600438	Psh, A			10(Tfam)
10.192	3	18	08	10q22.1	CDH23, USH1D	C	Cadherin-23 (otocadherin)	605516	Fd, REc	between D10S529 and D10S573	Usher syndrome, type 1D, 601067 (3); Deafness, autosomal recessive 12, 601386 (3); Usher syndrome, type 1D/F digenic, 601067 (3)	10(Cdh23, v)
10.193	6	19	98	10q22.1	EIF4EBP2, 4EBP2	P	Eukaryotic translation initiation factor-4E binding protein-1	602224	A			10(Eif4ebp2)
10.194	3	18	08	10q21.1	PCDH15, DFNB23, USH1F	C	Protocadherin 15	605514	REc		Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive 23, 609533 (3); Usher syndrome, type 1D/F digenic, 601067 (3)	10(av)
10.195	9	29	96	10q22.2	PPP3CB, CALNB	C	Protein phosphatase-3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)	114106	REa			
10.196	7	7	09	10q22.1	UNC5B, UNC5H2	P	Unc5, C. elegans, homolog of, B	607870	R, REc			
10.197	2	2	16	10q21.1	ZWINT, SIP30	P	ZW10 interacting kinetochore protein	609177	REc			
10.198	1	11	07	10q22.1	SPOCK2, KIAA0275	C	SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 2	607988	R, REc			
10.199	5	14	95	10q23.31	HTR7	P	5-hydroxytryptamine (serotonin) receptor-7, adenylate cyclase-coupled	182137	REa, Fd			
10.200	6	14	10	10q21.2	CDK1, CDC2	C	Cyclin-dependent kinase 1	116940	REa, A			10(Cdc2a)
10.201	4	8	08	10q21.1	CISD1, MITONEET	P	CDGSH iron sulfur domain protein 1	611932	REc			
10.202	6	26	01	10q21.3	JDP1	P	J domain-containing protein 1	606060	REc			
10.203	5	4	09	10q21.1	MYP15	P	Myopia 15	612717	Fd	max lod at D10S1643	Myopia 15 (2)	
10.204	5	24	13	10q21.3	MYPN, CMD1DD, CMH22, RCM4	P	Myopalladin	608517	REc		Cardiomyopathy, dilated, 1KK, 615248 (3); Cardiomyopathy, hypertrophic, 22, 615248 (3); Cardiomyopathy, familial restrictive, 4, 615248 (3)	
10.205	8	29	08	10q21.3	PBLD, MAWBP, MAWDBP	P	Phenazine biosynthesis-like protein domain-containing protein	612189	Psh, R			
10.206	5	6	03	10q21.2	RHOBTB1, KIAA0740	P	Rho-related BTB domain-containing protein 1	607351	REc			
10.207	8	19	13	10q21.3	RUFY2, KIAA1537	P	RUN and FYVE domains-containing protein 2	610328	REc, R			
10.208	12	29	00	10q22.1	VPS26A, VPS26, HB58	P	Vacuolar protein sorting 26, yeast, homolog of, A	605506	R			
10.209	10	13	94	10q22.2	ANXA7, SNX	P	Annexin A7 (synexin)	186360	REa, A			14(Amx7)
10.210	4	25	03	10q21.3	EGR2, KROX20	P	KROX-20, Drosophila, homolog of (early growth response-2)	129010	D, REa, A, F		Neuropathy, congenital hypomyelinating, 1, 605253 (3); Charcot-Marie-Tooth disease, type 1D, 607678 (3); Dejerine-Sottas disease, 145900 (3)	10(Krox20; Egr2)
10.211	9	10	09	10q21.2	ARID5B, MRF2, DESRT	P	AT-rich interaction domain-containing protein 5B	608538	R, REc			
10.212		20	12	10q21.1	BICC1, BICC, CYSRD	P	Bicaudal C, Drosophila, homolog of, 1	614295	REc		{Renal dysplasia, cystic, susceptibility to}, 601331 (3)	
10.213	2	27	15	10q21.2	MRLN, LINC00948	P	Myoregulin	616246	REc, H			10(Mrln)
10.214	9	28	11	10q21.2	SLC16A9, MCT9	P	Solute carrier family 16 (monocarboxylic acid transporter), member 9	614242	REc			
10.215	5	31	05	10q21.2	ZNF365, UAN	C	Zinc finger protein 365	607818	Fd, REc		{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)	
10.216	12	20	12	10q21.3	ADO, C10orf22	P	2-aminoethanethiol dioxygenase	611392	REc			
10.217	2	12	09	10q21.3	CCAR1, CARP1	P	Cell division cycle and apoptosis regulator 1	612569	REc			
10.218	4	6	16	10q21.3	JMJD1C, TRIP8, KIAA1380	P	Jumonji domain-containing protein 1C	604503	REc			
10.219	3	26	07	10q21.3	LRRTM3	P	Leucine-rich repeat transmembrane protein 3	610869	REc, H			10(Lrrtm3)
10.220	1	9	13	10q21.3	MSE	P	Myelinating Schwann cell element	614996	REc, REn			
10.221	1	6	09	10q22.1	NEUROG3, NGN3, ATOH5	P	Neurogenin 3	604882	REc		Diarrhea 4, malabsorptive, congenital, 610370 (3)	
10.222	7	23	15	10q21.3	NRBF2, COPR	P	Nuclear receptor-binding factor 2	616477	REc			
10.223	7	1	05	10q22.1	OIT3, LZP	P	Oncoprotein-induced transcript 3, mouse, homolog of	609330	REc			10(Lzp)
10.224	3	24	06	10q22.1	PP	C	Inorganic pyrophosphatase	179030	S, D, R			10(Pyp)
10.225	7	1	05	10q21.3	REEP3, C10orf74	P	Receptor expression-enhancing protein 3	609348	R, REc			
10.226	9	9	08	10q21.3	SIRT1, SIR2L1	C	Sirtuin, S. cerevisiae, homolog 1	604479	REc			
10.227	8	25	14	10q21.3	ATOH7, PHPVAR, NCRNA	P	Atonal, Drosophila, homolog of, 7	609875	A, H, Fd		Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	10(Atoh7)
10.228	6	3	14	10q21.3	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	P	DNA replication helicase 2, yeast, homolog of	601810	A	mutation identified in 1 SCKL8 family	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3); ?Seckel syndrome 8, 615807 (3)	
10.229	4	16	14	10q21.3-q22.1	HCFP2	P	Facial paresis, hereditary congenital, 2	604185	Fd		Facial paresis, hereditary congenital, 2 (2)	
10.230	8	2	99	10q21.3	SLC25A16, D10S105E, GDA	P	Solute carrier family 25 (mitochondrial carrier), member 16 (Graves disease autoantigen)	139080	A			
10.231	4	10	90	10q22.1	P4HA1, P4HA	C	Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide 1	176710	REa, A, REn			
10.232	4	14	10	10q21.3-q22.3	HWE1	P	Epilepsy, hot water, 1	613339	Fd	max lod at D10S412	Epilepsy, hot water, 1 (2)	
10.233	3	6	98	10q22.2	CAMK2G, CAMKG	C	Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma	602123	REa, A	in intron of PCDH15		14(Camkg)
10.234	12	30	15	10q22.1	COL13A1, CMS19	C	Collagen XIII, alpha-1 polypeptide	120350	REa, A	~550kb proximal to P4HA	Myasthenic syndrome, congenital, 19, 616720 (3)	
10.235	8	25	11	10q24.2	GOLGA7B, C10orf132	P	Golgin A7 family, member B	614189	REc			
10.236	1	5	07	10q23.1-q23.2	GRID1, KIAA1220	P	Glutamate receptor, inotropic, delta 1	610659	R, H, REc			14(Grid1)
10.237	7	8	13	10q22.1	HK1, HKD, HMSNR	C	Hexokinase-1	142600	S, D, A, REa	10p11.2 conflicting assignment; ?2 loci on chr.10	Hemolytic anemia due to hexokinase deficiency, 235700 (3); Neuropathy, hereditary motor and sensory, Russe type, 605285 (3)	10(Hk1)
10.238	6	19	98	10q21.3	HNRPH3, 2H9	P	Heterogeneous nuclear ribonucleoprotein H3	602324	A			
10.239	4	19	12	10q22.2	KAT6B, MYST4, MORF, GTPTS	P	Lysine acetyltransferase 6B	605880	A		SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)	
10.240	9	18	08	10q22.3	MAT1A, MATA1, SAMS1	P	Methionine adenosyltransferase I, alpha	610550	A		Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3); Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	
10.241	6	13	07	10q22	MRT8	P	Mental retardation, autosomal recessive, 8	611094	Fd	between rs1599711 and rs942793	Mental retardation, autosomal recessive, 8 (2)	
10.242	11	16	98	10q22.2	NDST2	C	N-deacetylase/N-sulfotransferase 2	603268	A	in intron of PCDH15		
10.243	1	8	01	10q23.1	NRG3	P	Neuregulin 3	605533	REa			
10.244	1	30	15	10q22.1	PCBD1, DCOH	C	Pterin-4a-carbinolamine dehydratase 1	126090	REa, H, A		Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	10(Dcoh)
10.245	7	22	15	10q22.1	PRF1, HPLH2, FLH2	C	Perforin	170280	A	mistakenly assigned to chr.17	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3); Lymphoma, non-Hodgkin, 605027 (3); Aplastic anemia, 609135 (3)	10(Prf1)
10.246	5	9	07	10q22	SQTL1	P	Smoking as a quantitative trait locus 1	611003	Fd	near D10S1432	{Smoking as a quantitative trait locus 1} (2)	
10.247	5	28	09	10q21.3	TET1, CXXC6, LCX, KIAA1676	C	tet oncogene 1	607790	REc, A			
10.248	2	4	00	10q22.2	VDAC2	P	Voltage-dependent anion channel 2	193245	A			14(Vdac2)
10.249	12	5	01	10q23.32	BTAF1, TAFII170, TAF172, MOT1	P	BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kD (Mot1, S. cerevisiae, homolog of)	605191	A, R			
10.250	4	23	08	10q21.1	CSTF2T, KIAA0689	P	Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD, tau variant	611968	Psh, R			19(Cstf2t)
10.251	6	27	08	10q22-q23	MGR12	P	Migraine, with or without aura, susceptibility to, 12	611706	Fd	max lod at 100cM	{Migraine, with or without aura, susceptibility to, 12} (2)	
10.252	3	1	00	10q22.3	PPIF, CYP3	P	Peptidylprolyl-cis-trans-isomerase, mitochondrial	604486	Fd			
10.253	3	11	09	10q22.3	SFTPA2, SPA2, COLEC5	P	Surfactant, pulmonary-associated protein A2	178642	Psh	contiguous with SFTPA1	Pulmonary fibrosis, idiopathic, 178500 (3)	
10.254	12	29	06	10q22.3	RPS24, DBA3	C	Ribosomal protein S24	602412	R, Psh		Diamond-blackfan anemia 3, 610629 (3)	
10.255	7	1	11	10q23.31	ACTA2, ACTSA, AAT6, MYMY5	C	Actin, alpha-2, smooth muscle, aorta	102620	REa, A		Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)	
10.256	8	29	07	10q23.31	MPHOSPH1, MPP1	C	M-phase phosphoprotein 1	605498	R, REc			
10.257	1	14	13	10q23.2-q23.3	PAPSS2, ATPSK2, BCYM4	C	3'-phosphoadenosine 5'-phosphosulfate synthase 2	603005	REc, A		Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	19(Atpsk2, bm)
10.258	10	5	07	10q22-q24	ATFB1	P	Atrial fibrillation, familial, 1	608583	Fd		Atrial fibrillation, familial, 1 (2)	
10.259	11	11	14	10q22.1	ADAMTS14	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 14	607506	REc			
10.260	7	26	10	10q22.1	ANAPC16, MSAG, C10orf104	P	Anaphase-promoting complex, subunit 16	613427	REc			
10.261	3	25	16	10q22.1	ASCC1, p50, SMABF2	P	Activating signal cointegrator 1 complex, subunit 1	614215	REc	mutation identified in 1 SMABF2 family	Barrett esophagus/esophageal adenocarcinoma, 614266 (3); ?Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	
10.262	3	3	09	10q22.1	C10orf27	P	chromosome 10 open reading frame 27	612640	REc			
10.263	2	2	14	10q22.1	C10orf54, B7H5	P	Chromosome 10 open reading frame 54	615608	REc			
10.264	11	18	10	10q22.1	CHST3, C6ST, C6ST1, HSD	P	Carbohyrate sulfotransferase 3	603799	REc		Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	
10.265	8	19	13	10q22.1	DDX50, GUB	P	DEAD/H box 50	610373	REc			10(Ddx50)
10.266	5	29	12	10q22.1	KIAA1274, PALD	P	Paladin, mouse, homolog of	614656	REc, R			
10.267	7	1	05	10q22.1	KIAA1279	P	KIAA1279 gene	609367	R, REc		Goldberg-Shprintzen megacolon syndrome, 609460 (3)	
10.268	9	2	11	10q22.1	MCU, CCDC109A	P	Mitochondrial calcium uniporter	614197	REc			
10.269	3	5	14	10q22.1	MICU1, CBARA1, MPXPS	P	Mitochondrial calcium uptake protein 1	605084	REc		Myopathy with extrapyramidal signs, 615673 (3)	
10.270	1	5	07	10q22.2	MRPS16, COXPD2	C	Mitochondrial ribosomal protein S16	609204	R, REc		Combined oxidative phosphorylation deficiency 2, 610498 (3)	
10.271	1	30	01	10q22.2	MYOZ1	P	Myozenin 1 (calsarcin 2)	605603	R			
10.272	8	26	09	10q22.1	NODAL, HTX5	P	Nodal, mouse, homolog of	601265	R, REc		Heterotaxy, visceral, 5, 270100 (3)	10(nodal)
10.273	12	18	07	10q22.1	PLA2G12B, GXIIB	P	Phospholipase A2, group XIIB	611653	REc			
10.274	1	22	08	10q22.1	PSAP, SAP1	C	Prosaposin (sphingolipid activator protein-1)	176801	S, REa, A, D, Fd		Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3); Gaucher disease, atypical, 610539 (3); Combined SAP deficiency, 611721 (3); Krabbe disease, atypical, 611722 (3)	10(Psap)
10.275	5	22	03	10q22.1	SARA1, SAR1A	P	Sar1a, S. cerevisiae, homolog 1	607691	REc, R			
10.276	4	18	12	10q22.1	SLC29A3, ENT3, PHID, HCLAP	P	Solute carrier family 29 (nucleoside transporter), member 3	612373	R, REc		Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	
10.277	12	21	09	10q22.1	SRGN, PRG1, PRG	C	Serglycin	177040	REa, A			
10.278	10	11	05	10q22.1	STOX1, PEE4	P	Storkhead box 1	609397	REc, Fd		Preeclampsia/eclampsia 4, 609404 (3)	
10.279	1	31	01	10q22.1	SUPV3L1	P	Suv3-like 1	605122	A			
10.280	12	21	09	10q22.1	TSPAN15, NET7	P	Tetraspanin 15	613140	REn			
10.281	8	20	07	10q22.1	TYSND1	P	Trypsin domain-containing protein 1	611017	R, REc			
10.282	2	2	04	10q22.3	RAI17, KIAA1224, ZIMP10	P	Retinoic acid-induced gene 17	607159	REc			
10.283	3	3	10	10q22.2	VCL, CMD1W, CMH15	C	Vinculin	193065	REa, Fd, REb		Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, hypertrophic, 15, 613255 (3)	
10.284	4	27	12	10q22.1-q24.1	SPG27	P	Spastic paraplegia-27, autosomal recessive	609041	Fd	between D10S606 and D10S1758	Spastic paraplegia 27, autosomal recessive (2)	
10.285	5	24	13	10q22.2	AP3M1	P	Adaptor-related protein complex 3, mu-1 subunit	610366	R, REc			
10.286	1	27	04	10q22.1	DNAJB12, DJ10, FLJ0027	P	DNAJ, E. coli, homolog of, subfamily B, member 12	608376	R			
10.287	9	24	08	10q22.2	DNAJC9, JDD1, KIAA0974	P	DNAJ/HSP40 homolog, subfamily C, member 9	611206	R, REc			
10.288	12	21	09	10q22.2	DUSP13, TMDP, MDSP	P	Dual-specificity phosphatase 13	613191	REc			
10.289	7	13	15	10q22.2	ECD, SGT1	P	Ecdysoneless, Drosophila, homolog of	616464	REc			
10.290	8	21	12	10q22.2	MSS51, ZMYND17	P	MSS51 mitochondrial translational activator, S. cerevisiae, homolog of	614773	REc			
10.291	12	7	07	10q22.2	SAMD8, SMSR	P	Sterile alpha motif domain-containing 8	611575	REc			
10.292	3	13	15	10q22.2	SEC24C, KIAA0079	P	Sec24-related gene family, member C	607185	R, REc			
10.293	4	26	11	10q22.2	ZNF503, NOLZ1	P	Zinc finger protein 503	613902	REc			
10.294	1	27	04	10q22.3	SFTPA1, SFTP1	C	Surfactant, pulmonary-associated protein A1	178630	REa, A	contiguous with SFTPA2	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	14(Sftp1)
10.295	4	21	15	10q23.2	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	C	LIM domain binding 3	605906	R, Psh, Fd		Myopathy, myofibrillar, 4, 609452 (3); Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3); Cardiomyopathy, hypertrophic, 24, 601493 (3); Left ventricular noncompaction 3, 601493 (3)	
10.296	1	2	08	10q23.2	BMPR1A, ACVRLK3, ALK3	C	Bone morphogenetic protein receptor, type IA	601299	R, A		Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome, hereditary mixed, 2, 610069 (3); Juvenile polyposis syndrome, infantile form, 174900 (3)	
10.297	10	8	13	10q22.2-q22.3	C10orf11, OCA7	P	Chromosome 10 open reading frame 11	614537	REc		Albinism, oculocutaneous, type VII, 615179 (3)	
10.298	2	4	15	10q22.1	H2AFY2	P	H2A histone family, member Y2	616141	REc			
10.299	7	6	05	10q22.3	KCNMA1, SLO	C	Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)	600150	Psh, REc, Fd		Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)	
10.300	7	13	09	10q22.3	PLAC9	P	Placenta-specific gene 9	612857	REc, H			15(Plac9)
10.301	10	3	11	10q22.3	POLR3A, RPC1, RPC155, ADDH, HLD7	C	Polymerase III, RNA, subunit A	614258	REc		Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	
10.302	9	22	03	10q22.3	SCZD11	P	Schizophrenia susceptibility locus, chromosome 10q-related	608078	Fd	between D10S1677 and D10S1753	{Schizophrenia}, 181500 (2)	
10.303	12	11	03	10q22.3	SLEN1	P	Systemic lupus erythematosus with nephritis, susceptibility to, 1	607965	Fd		{Systemic lupus erythematosus with nephritis, susceptibility to, 1} (2)	
10.304	11	07	08	10q22.3	SS3	P	Sarcoidosis, susceptibility to, 3	612388	Fd	associated with rs2789679 and rs1049550	{Sarcoidosis, susceptibility to, 3} (2)	
10.305	1	26	99	10q22.3	ANXA11, ANX11	P	Annexin A11 (annexin XI)	602572	A			
10.306	3	28	15	10q23	DEL10q23, C10DELq23	P	Chromosome 10q22.3-q23.2 deletion syndrome	612242	DS		Chromosome 10q22.3-q23.2 deletion syndrome (4)	
10.307	3	9	00	10q23.31	CH25H	P	Cholesterol 25-hydroxylase	604551	A, R			
10.308	5	31	05	10q22.3	DLG5, PDLG, KIAA0583	C	Discs large, Drosophila, homolog of, 5	604090	R			
10.309	3	15	13	10q23.31	KLLN, CWS4	P	Killin	612105	REc		Cowden syndrome 4, 615107 (3)	
10.310	5	31	05	10q23.2	MINPP1, HIPER1	P	Multiple inositol polyphosphate phosphatase 1	605391	A, R, REc		Thyroid carcinoma, follicular, 188470 (3)	19(Minpp1)
10.311	7	9	06	10q23.31	PANK1	P	Pantothenate kinase 1	606160	REn			
10.312	1	26	07	10q23.33	PLCE1, KIAA1516, NPHS3	C	Phospholipase C, epsilon-1	608414	R, REc		Nephrotic syndrome, type 3, 610725 (3)	
10.313	8	26	09	10q24.32	POLL	P	Polymerase, DNA, lambda	606343	R, REc			
10.314	2	25	11	10q23.1	RGR, RP44	C	Retinal G protein coupled receptor	600342	A		Retinitis pigmentosa 44, 613769 (3)	
10.315	3	16	99	10q25.2	SMNR, SPF30	P	Survival motor neuron-related protein	603519	Psh, R			
10.316	10	28	08	10q23.31	STAMBPL1, KIAA1373	C	STAM-binding protein-like 1	612352	R, REc			19(Stambpl1)
10.317	5	22	03	10q24.2	CNNM1, ACDP1	P	Cyclin M1 (ancient conserved domain protein 1)	607802	R			
10.318	3	31	08	10q23-q24	CPROTQ	P	C-reactive protein QTL	611920	Fd	max lod at D10S1239	[C-reactive protein QTL] (2)	
10.319	6	15	99	10q23.33	CYP26A1	P	Cytochrome p450, subfamily XXVIA, polypeptide 1	602239	A			19(Cyp26a1)
10.320	10	23	87	10q24.1	DNTT, TDT	C	Terminal deoxynucleotidyltransferase	187410	REa, A, Ch			19(Tdt)
10.321	1	14	16	10q24.2	ENTPD7, LALP1	P	Ectonucleoside triphosphate diphosphohydrolase 7	616753	REc			
10.322	3	15	13	10q24.2	HPSE2, HPA2, UFS1	P	Heparanase 2	613469	R		Urofacial syndrome 1, 236730 (3)	
10.323	10	21	08	10q23-q24	IBD20	P	Inflammatory bowel disease 20	612288	Fd	associated with rs11190140	{Inflammatory bowel disease 20} (2)	
10.324	8	20	01	10q23.32	PPP1R3C, PPP1R5	P	Phosphatase 1, regulatory subunit 3C	602999	R			
10.325	3	6	02	10q24.1	TLL2, KIAA0932	P	Tolloid-like 2	606743	A			19(Tll2)
10.326	11	4	93	10q11.21	ZNF32, KOX30	P	Zinc finger protein-32 (KOX30)	194539	A			8(Zfp4)
10.327	2	9	92	10q23.33	IDE	C	Insulin-degrading enzyme	146680	REa, A			19(Ide)
10.328	10	8	12	10q23.1	CDHR1, PCDH21, PRCAD, CORD15, RP65	C	Cadherin-related family, member 1	609502	REc		Cone-rod dystrophy 15, 613660 (3); Retinitis pigmentosa 65, 613660 (3)	
10.329	4	8	13	10q23.1	DYDC1	P	DPY30 domain-containing protein 1	615154	REc			
10.330	6	11	02	10q24.2	HPS1	C	HPS gene 1	604982	LD, Fd		Hermansky-Pudlak syndrome 1, 203300 (3)	19(ep, ru)
10.331	11	24	14	10q23.1	LRIT1, PAL	C	Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 1	616103		REc, A		
10.332	8	10	10	10q24.1	BLNK, SLP65, AGM4	P	B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD)	604515	A		Agammaglobulinemia 4, 613502 (3)	
10.333	8	19	13	10q23.2	MIR346	P	Micro RNA 346	611190	REc			
10.334	4	10	15	10q23.2	OPN4	P	Opsin 4	606665	R, REc			
10.335	2	12	07	10q23.2	WAPAL, KIAA0261, FOE, WAPL	C	Wings apart-like protein, Drosophila, homolog of	610754	R, REc			
10.336	10	15	98	10q23.2	SNCG, BCSG1	C	Synuclein, gamma (breast cancer-specific gene 1)	602998	R, A			
10.337	12	3	98	10q24.31	NDUFB8	C	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (8kD, AGGG)	602140	R	previously assigned to 12q21		
10.338	4	23	04	10q24.32	ARL3, ARFL3	P	ADP-ribosylation factor-like 3	604695	REa, R			
10.339	11	30	06	10q23.32	CPEB3, KIAA0940	P	Cytoplasmic polyadenylation element-binding protein 3	610606	R, REc			
10.340	4	17	06	10q23.33	CYP2C8	P	Cytochrome P450, subfamily IIc, polypeptide 8	601129	REc		Rhabdomyolysis, cerivastatin-induced (3)	
10.341	1	15	13	10q23.33	CYP26C1, FFDD4	P	Cytochrome P450, subfamily XXVIC, polypeptide 1	608428	REc		Focal facial dermal dysplasia 4, 614974 (3)	
10.342	2	21	02	10q23.2	GLUD1	C	Glutamate dehydrogenase-1	138130	REa, A	pseudogene on Xq26-q28	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	14(Glud)
10.343	5	4	00	10q23.31	IFIT1, IFI56, G10P1, IFNAI1	C	Interferon-induced protein with tetratricopeptide repeats 1	147690	REa, A	10q25-q26 = conflicting site		
10.344	5	4	00	10q23.31	IFIT4	P	Interferon-induced protein with tetratricopeptide repeats 4	604650	A			
10.345	5	4	00	10q23.31	IFIT2, IFI54, G10P2	C	Interferon-induced protein with tetratricopeptide repeats 2	147040	A, REa			
10.346	6	7	10	10q23.32-q23.33	MARCH5	P	Membrane-associated RING-CH finger protein 5	610637	R, REc			
10.347	11	18	08	10q23.3	RCM2	P	Cardiomyopathy, familial restrictive, 2	609578	Fd	max lod at D10S1242	Cardiomyopathy, familial restrictive, 2 (2)	
10.348	8	19	98	10q22.3	SFTPD, SFTP4	C	Surfactant, pulmonary-associated protein D	178635	Psh			
10.349	4	27	09	10q23.31	SLC16A12, MCT12, CJMG	C	Solute carrier family 16 (monocarboylic acid transporter), member 12	611910	REc, Fd		Cataract, juvenile, with microcornea and glucosuria, 612018 (3)	
10.350	10	10	01	10q25.1	SORCS1	P	SORCS receptor 1	606283	REc			
10.351	10	10	01	10q25.1	SORCS3, KIAA1059	C	SORCS receptor 3	606285	R, REc			
10.352	2	8	08	10q23.33	C10orf4, FRA10AC1, FRA10A	P	Chromosome 10 open reading frame 4	608866	REc			
10.353	3	23	06	10q23.33	CEP55	P	Centrosomal protein, 55kD	610000	REc			
10.354	12	28	08	10q23.33	EXOC6, SEC15L1, SEC15L, SEC15	P	Exocyst complex component 6	609672	R, REc			
10.355	3	14	13	10q23.33	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	P	Free fatty acid receptor 4	609044	REc		{Obesity, susceptibility to}, 607514 (3)	
10.356	5	29	12	10q23.33	KIF11, KNSL1, MCLMR	P	Kinesin family member 11	148760	A, REc		Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	18(Kns)
10.357	9	9	09	10q23.31	RNLS, C10orf59	P	Renalase	609360	REc			
10.358	7	18	06	10q24.1	SORBS1, SH3D5, SH3P12, KIAA1296	C	Sorbin and SH3 domain containing 1	605264	R, REc, REn			
10.359	4	21	16	10q23.33	HELLS, LSH, ICF4	P	Helicase, lymphoid-specific	603946	A, H		Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	19(Hells)
10.360	10	28	14	10q23.31	ANKRD1, CARP	P	Ankyrin repeat domain-containing protein 1	609599	REc			
10.361	1	30	12	10q23.31	ATAD1, THORASE	P	ATPase family, AAA domain-containing, member 1	614452	REc			
10.362	9	9	09	10q23.31	IDDM24	P	Diabetes mellitus, insulin-dependent, 24	613006	Fd	associated with rs10509540	{Diabetes mellitus, insulin-dependent, 24} (2)	
10.363	12	30	14	10q23.31	IFIT5, RI58, ISG58	P	Interferon-induced protein with tetratricopeptide repeats 5	616135	REc			
10.364	12	15	10	10q23.31	LIPA, CESD	C	Lipase A, lysosomal acid, cholesterol esterase	613497	S, H	?close to GOT	Wolman disease, 278000 (3); Cholesteryl ester storage disease, 278000 (3)	19(Lip1)
10.365	4	26	11	10q23.31	LIPM, LIPL3	P	Lipase family, member M	613923	REc, H			19(Lipm)
10.366	1	18	13	10q23.31	LIPN, LIPL4, ARCI8, LI4	P	Lipase family, member N	613924	REc, H		Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	19(Lipn)
10.367	4	26	11	10q23.31	LIPK, LIPL2	P	Lipase family, member K	613922	REc, H			19(Lipk)
10.368	4	26	11	10q23.31	LIPJ, LIPL1	P	Lipase family, member J	613921	REc, H			19(Lipj)
10.369	12	21	09	10q23.31	MIR107, MIRN107	P	Micro RNA 107	613189	REc			
10.370	6	18	10	10q23.31	PTEN, MMAC1, GLM2, CWS1	C	Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728	REc, REa, A, Ch		Cowden syndrome 1, 158350 (3); Lhermitte-Duclos syndrome, 158350 (3); Bannayan-Riley-Ruvalcaba syndrome, 153480 (3); {Meningioma}, 607174 (3); {Glioma susceptibility 2}, 613028 (3); Macrocephaly/autism syndrome, 605309 (3); PTEN hamartoma tumor syndrome (3); VATER association with macrocephaly and ventriculomegaly, 276950 (3); {Prostate cancer, somatic}, 176807 (3); Malignant melanoma, somatic, 155600 (3); Endometrial carcinoma, somatic, 608089 (3); Squamous cell carcinoma, head and neck, somatic, 275355 (3)	19(Pten)
10.371	8	26	09	10q23.31	RPP30	P	Ribonuclease P, 30kD subunit	606115	R, REc			
10.372	1	30	07	10q24.2	ANKRD2, ARPP	P	Ankyrin repeat domain-containing protein 2	610734	R			
10.373	11	1	99	10q24.2	ABCC2, CMOAT	P	ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter)	601107	A		Dubin-Johnson syndrome, 237500 (3)	19(Cmoat)
10.374	1	8	01	10q24	AD6	C	Alzheimer disease 6	605526	Fd		Alzheimer disease 6, 104300 (2)	
10.375	2	23	08	10q24.32	AS3MT, CYT19	P	Arsenic (+3 oxidation state) methyltransferase	611806	REc			
10.376	7	29	15	10q24.31	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	C	T7 gene 4-like protein with intramitochondrial nucleoid localization	606075	Fd, REc	PEO digenic with POLG	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3); Perrault syndrome 5, 616138 (3)	
10.377	12	17	02	10q24.31	CHUK, IKBKA, NFKBIKA, IKKA, IKK1	C	Conserved helix-loop-helix ubiquitous kinase	600664	A, Psh		Cocoon syndrome, 613630 (3)	
10.378	4	25	13	10q24.2	COX15, CEMCOX2	C	Cytochrome c oxidase, subunit 15	603646	REc, Fd		Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3); Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 (3)	
10.379	7	3	06	10q24.2	CUTC	P	CutC copper transporter, E. coli, homolog of	610101	REc			
10.380	8	3	99	10q23.33	CYP2C9	C	Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9	601130	REn, H		Tolbutamide poor metabolizer (3); Warfarin sensitivity, 122700 (3)	7(War)
10.381	10	14	15	10q24.1	ENTPD1, CD39, SPG64	P	Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen)	601752	REc		Spastic paraplegia 64, autosomal recessive, 615683 (3)	
10.382	9	22	08	10q24.31	FAM178A, C10orf6	P	Family with sequence similarity 178, member A	610348	REc			
10.383	5	2	07	10q24.32	FBXW4, DAC, FBW4, FBWD4	C	F-box and WD repeat domain containing 4	608071	H, REc			19(Dac)
10.384	9	28	12	10q24.32	FGF8, HH6	C	Fibroblast growth factor-8	600483	H, REa, A, Fd		Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3)	19(Fgf8)
10.385	6	15	99	10q24.32	GBF1	P	Golgi-specific brefeldin-A resistance factor 1	603698	REa, A			
10.386	3	3	03	10q23.33	HHEX, PRHX, PRH	C	Hematopoietically expressed homeo box	604420	REc, A			
10.387	12	11	02	10q24.31	HIF1AN, FIH1	P	Hypoxia-inducible factor 1-alpha inhibitor	606615	REc			
10.388	1	10	12	10q23.33	LGI1, EPT, ETL1, ADLTE, ADPEAF	C	Leucine-rich gene, glioma-inactivated, 1	604619	Ch, Fd		Epilepsy, familial temporal lobe, 1, 600512 (3)	
10.389	10	26	99	10q24.32	LBX1, LBX1H	P	Lady bird late, Drosophila, homolog of, 1	604255	A			19(Lbx1)
10.390	2	28	03	10q24.2	LOXL4	P	Lysyl oxidate-like 4	607318	REc			
10.391	3	5	08	10q24.31	MRPL43	P	Mitochondrial ribosomal protein L43	611848	R, REc			
10.392	5	31	12	10q23.33	MYOF, FER1L3	C	Myoerlin	604603	REc, REn			
10.393	12	27	13	10q24.32	NFKB2, LYT10, CVID10	C	Nuclear factor of kappa light chain gene enhancer in B-cells 2 (p49/p100); oncogene Lyt-10	164012	REa, A, Ch		Immunodeficiency, common variable, 10, 615577 (3)	
10.394	2	16	07	10q23.33	NOC3L, FAD24	P	Nucleolar complex-associated 3, S. cerevisiae, homolog of	610769	REc			
10.395	3	20	08	10q25.2	PDCD4	P	Programmed cell death 4	608610	A			
10.396	11	3	09	10q23.33	PDE6C, PDEA2, COD4	P	Phosphodiesterase-6C, cGMP-specific, cone, alpha prime	600827	A		Cone dystrophy 4, 613093 (3)	
10.397	3	18	08	10q24.2	PI4K2A	P	Phosphatidylinositol 4-kinase type 2 alpha	609763	R, REc			
10.398	9	12	11	10q22.2	PLAU, URK, QPD, BDPLT5	C	Plasminogen activator, urokinase	191840	REa, A, Psh	proximal to HOX11	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3); Quebec platelet disorder, 601709 (3)	14(Plau)
10.399	2	18	98	10q24.32	PSD	P	Pleckstrin and Sec7 domain protein	602327	REn			
10.400	6	19	15	10q23.33	RBP4, RDCCAS, MCOPCB10	C	Retinol-binding protein-4, interstitial	180250	REa, A	just centromeric of CYP2C cluster	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3); Microphthalmia, isolated, with coloboma 10, 616428 (3)	19(Rbp4)
10.401	8	10	10	10q24	SHFM3, SHSF3, DUP10q24, C10DUPq24	P	Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome)	246560	Fd	contiguous gene duplication syndrome	Split-hand/foot malformation 3, gene duplication syndrome (4)	
10.402	1	12	06	10q24.2	SLC25A28, MRS4L, NPD016	P	Solute carrier family 25 (mitochondrial carrier), member 28	609767	Psh, REn			
10.403	5	4	09	10q24.31	TD1	P	TLX1 divergent gene	612734	REc			
10.404	7	17	02	10q24.31	TLX1, HOX11, TCL3	C	T-cell leukemia, homeobox 1	186770	Ch, RE, H	t(7;10) or t(10;4) in T-ALL		
10.405	12	10	13	10q24.33	USMG5, DAPIT	P	Upregulated during skeletal muscle growth 5, mouse, homolog of	615204	REc			19(Usmg5)
10.406	8	29	96	10q24.31	WNT8B	P	Wingless-type MMTV integration site family, member 8B	601396	Psh, A			
10.407	1	13	16	10q24.1	ZDHHC16, APH2	P	Zinc finger DHHC domain-containing protein 16	616750	REc			
10.408	8	18	99	10q24.32	BTRC, BTRCP	P	Beta-transducin repeat-containing protein	603482	R, A			
10.409	8	26	09	10q25.1	GSTO1	P	Glutathione S-transferase, omega-1	605482	REc, REn			
10.410	10	6	08	10q25.1	GSTO2	P	Glutathione S-transferase, omega-2	612314	REc			
10.411	2	4	99	10q24.32	LDB1, CLIM2, NLI	P	LIM domain-binding factor-1	603451	R, H			19(Ldb1)
10.412	3	9	00	10q24.31	PKD2L1, PKDL, PKD2L	C	Polycystin L	604532	A, R, REa			19(Pkdl)
10.413	7	14	14	10q24.32	SUFU, SUFUXL, SUFUH	C	Suppressor of fused	607035	A, R		Medulloblastoma, desmoplastic, 155255 (3); {Meningioma, familial, susceptibility to}, 607174 (3); Basal cell nevus syndrome, 109400 (3)	
10.414	12	4	01	10q24.33	TAF5, TAF2D, TAFII100	P	TAF5 RNA polymerase II, TATA box binding protein-associated factor, 100kD	601787	REa, A			
10.415	3	7	92	10q25.2	ADRA2A, ADRA2R	C	Adrenergic, alpha-2A-, receptor	104210	REa, A, Fd, RE			19(Adra2)
10.416	2	23	09	10q25.3	ADRB1, ADRB1R, RHR	C	Adrenergic, beta-1-, receptor	109630	REa, Fd, A	close linkage to ADRA2R	[Resting heart rate], 607276 (3); {Congestive heart failure and beta-blocker response, modifier of} (3)	19(Adrb1)
10.417	6	6	00	10q26.13	BUB3	P	Budding uninhibited by benzimidazoles 3, S. cerevisiae, homolog of	603719	R			
10.418	1	13	99	10q25.2	GPAM	L	Glycerol-3-phosphate acyltransferase	602395	H			19(Gpam)
10.419	1	10	02	10q24.32	NPM3	P	Nucleophosmin/nucleoplasmin family, member 3	606456	REc			19(Npm3)
10.420	11	20	98	10q25.3	NRAP	P	Nebulin-related anchoring protein	602873	R, H			19(Nrap)
10.421	5	29	12	10q26.11	GRK5, GPRK5	P	G protein-coupled receptor kinase 5	600870	REa			
10.422	12	7	07	10q24.1	ARHGAP19	P	RHO GTPase-activating protein 19	611587	REc			
10.423	6	1	12	10q24.1	EXOSC1, CSL4	P	Exosome component 1	606493	REc			
10.424	12	30	14	10q23.31	FAS, TNFRSF6, APT1, CD95, ALPS1A	C	Fas cell surface death receptor	134637	A		{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	19(Fas1)
10.425	8	27	01	10q24.1	FRAT2	P	Frequently rearranged in advanced T-cell lymphomas 2	605006	REc			
10.426	2	18	08	10q24.1	LCOR, MLR2, KIAA1795	C	Ligand-dependent nuclear receptor corepressor	607698	R, REc			
10.427	8	31	12	10q24.1	MMS19, MMS19L	P	MMS19 nucleotide excision repair, S. Cerevisiae, homolog of	614777	A, REc, R			
10.428	9	20	14	10q24.1	PIK3AP1, BCAP, FLJ35564	P	Phosphoinositide 3-kinase adaptor protein 1	607942	R, REc			
10.429	10	22	99	10q24.2	SFRP5, SARP3	P	Secreted frizzled-related protein 5	604158	A, R, Psh			
10.430	12	10	13	10q24.1	SLIT1, SLIL1, MEGF4	P	Slit, Drosophila, homolog of, 1	603742	Psh, REc			
10.431	9	10	12	10q24.1	TCTN3, TECT3, C10orf61, OFD4, JBTS18	P	Tectonic family, member 3	613847	REc		Orofaciodigital syndrome IV, 258860 (3); Joubert syndrome 18, 614815 (3)	
10.432	3	24	16	10q24.1	TM9SF3, SMBP	P	Transmembrane 9 superfamily, member 3	616872	REc			
10.433	6	1	15	10q24.1-q24.2	UBTD1	P	Ubiquitin domain-containing protein 1	616388	REc			
10.434	11	24	15	10q23.33	CYP2C, CYP2C19	C	Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)	124020	REa, A	4 genes in order: cen-C18-C19-C9-C8-tel	Mephenytoin poor metabolizer, 609535 (3); Omeprazole poor metabolizer, 609535 (3); Proguanil poor metabolizer, 609535 (3); Clopidogrel, impaired responsiveness to, 609535 (3)	19(P4502c)
10.435	8	31	99	10q24.32	MGEA5	P	Meningioma-expressed antigen 5	604039	Psh, A			
10.436	7	25	12	10q24.1-q25.1	CMTDIA	P	Charcot-Marie-Tooth disease, dominant intermediate A	606483	Fd		Charcot-Marie-Tooth disease, dominant intermediate A (2)	
10.437	1	18	12	10q24.2	GOT1, ASTQTL1	C	Glutamic-oxaloacetic transaminase-1, soluble (EC 2.6.1.1)	138180	S, D, H, A	10q26.1 = conflicting localization	Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	19(Got1)
10.438	3	10	03	10q24.2	CPN1, SCPN, CPN	C	Carboxypeptidase N, polypeptide 1, 50-kD	603103	Psh, R		Carboxypeptidase N deficiency, 212070 (3)	
10.439	5	26	13	10q24.2	DNMBP, TUBA, KIAA1010	P	Dynamin-binding protein	611282	R, REc			19(Dnmbp)
10.440	12	17	12	10q24.2	HOGA1, DHDPSL, HP3	P	4-hydroxy-2-oxoglutarate aldolase 1	613597	REc		Hyperoxaluria, primary, type III, 613616 (3)	
10.441	6	16	08	10q24.2	NKX2C, NK2.3, CSX3	P	NK2, Drosophila, homolog of, C	606727	REc			
10.442	4	27	12	10q24.2	ZFYVE27, SPG33	P	Zinc finger FYVE domain-containing protein 27	610243	REc		Spastic paraplegia 33, autosomal dominant, 610244 (3)	
10.443	2	3	99	10q25.1-q25.2	ADD3, ADDL	C	Adducin-3, gamma	601568	A, Ch	fusion with NUP98 in T-ALL		
10.444	10	7	08	10q24.33	PDCD11, ALG4, NFBP, KIAA0185	P	Programmed cell death 11	612333	A			
10.445	10	23	15	10q24.1	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	C	Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)	138250	S, A	GOT1 and GSAS in same pathway	Cutis laxa, autosomal recessive, type IIIA, 219150 (3); Spastic paraplegia 9A, autosomal dominant, 601162 (3); Spastic paraplegia 9B, autosomal recessive, 616586 (3); Cutis laxa, autosomal dominant 3, 616603 (3)	
10.446	9	24	15	10q25.1	COL17A1, BPAG2, ERED	C	Collagen XVII, alpha-1 polypeptide	113811	A, H		Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa, junctional, localisata variant, 226650 (3); Epithelial recurrent erosion dystrophy, 122400 (3)	19(Bpag2)
10.447	8	9	05	10q24.32	CYP17A1, CYP17, P450C17	C	Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)	609300	REa, H, A	at least 2 genes; distal to GOT1	17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase deficiency, isolated, 202110 (3)	19(Cyp17)
10.448	5	24	13	10q24.31	LZTS2, KIAA1813, LAPSER1	P	Leucine zipper, putative tumor suppressor 2	610454	REc			
10.449	10	14	15	10q24.32-q24.33	NT5C2, NT5B, PNT5, SPG45	P	5' nucleotidase, cytosolic II	600417	R, REc		Spastic paraplegia 45, autosomal recessive, 613162 (3)	
10.450	3	8	12	10q24.31	PDZD7	P	PDZ domain-containing 7	612971	REc		{Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3); Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3)	
10.451	3	30	12	10q24.31	SEC31B, SEC31L2	P	Sec31, yeast, homolog of, B	610258	REc			
10.452	7	10	02	10q24.32	TRIM8, RNF27, GERP	P	Tripartite motif-containing 8	606125	REc			
10.453	10	23	15	10q24.31	PAX2, PAPRS, FSGS7	C	Paired box homeotic gene-2	167409	REa, A		Papillorenal syndrome, 120330 (3); Glomerulosclerosis, focal segmental, 7, 616002 (3)	19(Pax2)
10.454	8	28	97	10q26.3	CYP2E, CYP2E1, P450C2E	C	Cytochrome P450, subfamily IIE, ethanol-inducible	124040	REa			7(Cyp2e)
10.455	12	28	08	10q24.31	BLOC1S2, BLOS2	P	Biogenesis of lysosome-related organelles complex 1, subunit 2	609768	R			
10.456	12	18	14	10q24.31	CWF19L1, C19L1, SCAR17	P	CWF19-like protein 1	616120	REc	mutation identified in 1 SCAR17 family	?Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	
10.457	5	23	16	10q24.31	ERLIN1, SPG62	P	Endoplasmic reticulum lipid raft-associated protein 1	611604	R, REc		Spastic paraplegia 62, 615681 (3)	
10.458	2	25	15	10q24.31	OLMALINC, LINC00263, OLMALINCAS	P	Oligodendrocyte maturation-associated long intergenic noncoding RNA	616240	REc	OLMALINCAS is on opposite strand overlapping exon 1 of OLMALINC		
10.459	8	26	09	10q24.31	SCD	P	Stearoyl-CoA desaturase	604031	REa, REc	pseudogene on chr.17		19(ab)
10.460	12	27	13	10q24.31	SFXN3	P	Sideroflexin 3	615571	REc			
10.461	4	2	16	10q24.31	SNORA12	P	Small nucleolar RNA, H/ACA box, 12	611330	REc	in intron 11 of CWF19L1		
10.462	8	31	12	10q24.32	ACTR1A, ARP1	P	Actin-related protein 1A	605143	REc			
10.463	10	23	15	10q24.32	BORCS7, C10orf32	P	BLOC1-related complex, subunit 7	616600	REc			
10.464	9	10	07	10q24.32	C10orf26, OPAL1	P	Chromosome 10 open reading frame 26	611129	R, REc			
10.465	8	6	11	10q24.32	CUEDC2	P	Cue domain-containing protein 2	614142	REc			
10.466	7	28	15	10q24.32	DPCD	P	Deleted in primary ciliary dyskinesia, mouse, homolog of	616467	REc, H			19(Dpcd)
10.467	2	23	08	10q24.32	ELOVL3, CIG30	P	Elongation of very long chain fatty acids-like 3	611815	REc			
10.468	5	24	13	10q24.32	FBXL15, JET	P	F-box and leucine-rich repeat protein 15	610287	REc			
10.469	1	29	03	10q24.32	HPS6, RU	P	HPS gene 6	607522	REc		Hermansky-Pudlak syndrome 6, 614075 (3)	19(ru)
10.470	5	26	13	10q24.32	MIR146B	P	Micro RNA 146B	610567	REc			
10.471	10	2	12	10q24.32	NOLC1, p130, NOPP140	P	Nucleolar and coiled-body phosphoprotein 1	602394	REc			
10.472	12	27	13	10q24.32	SFXN2	P	Sideroflexin 2	615570	REc			
10.473	11	14	12	10q24.32-q25.1	ECTD5	P	Ectodermal dysplasia 5, hair/nail type	614927	Fd	between D10S1239 and D10S1264	Ectodermal dysplasia 5, hair/nail type (2)	
10.474	9	8	08	10q24.33	CALHM1, FAM26C	P	Calcium homeostasis modulator 1	612234	REc	?Alzheimer disease, 605526		
10.475	9	8	08	10q24.33	CALHM2, FAM26B	P	Calcium homeostasis modulator 2	612235	REc			
10.476	6	17	15	10q24.32	CNNM2, ACDP2, HOMG6, HOMGSMR	C	Cyclin M2	607803	R, REc		Hypomagnesemia 6, renal, 613882 (3); Hypomagnesemia, seizures, and mental retardation, 616418 (3)	19(Cnnm2)
10.477	1	27	11	10q22.1	DDIT4, REDD1, RTP801	P	DNA damage-inducible transcript 4	607729	REc			
10.478	12	2	09	10q24.33	OBFC1, AAF44, STN1	P	Oligonucleotide/oligosaccharide-binding fold-containing protein 1	613128	REc			19(Obfc1)
10.479	12	28	08	10q24.33	PCGF6, RNF134, MBLR	P	Polycomb group ring finger 6	607816	R, REc			
10.480	9	24	15	10q24.3-q25.1	SLK, LOSK, KIAA0204	C	STE20-like protein kinase	616563	R, REc			
10.481	11	13	15	10q25.2	SMC3, CSPG6, HCAP, BAM, CDLS3	P	Structural maintenance of chromosomes 3	606062	R, H		Cornelia de Lange syndrome 3, 610759 (3)	19(Bam)
10.482	11	4	98	10q25.2	DUSP5, HVH3	P	Dual-specificity phosphatase-5	603069	A			
10.483	12	9	98	10q25	IDDM17	P	Insulin-dependent diabetes mellitus-17	603266	Fd		{Diabetes mellitus, insulin-dependent, 17} (2)	
10.484	2	18	98	10q25.3	LIMAB1	P	LIM actin-binding protein-1	602330	A, R			19(Limab1)
10.485	11	29	99	10q25.2	MXI1	C	MAX-interacting protein 1	600020	A, D		Neurofibrosarcoma (3); {Prostate cancer, susceptibility to}, 176807 (3)	19(Mxi1)
10.486	5	24	13	10q24.32	PITX3, CTPP4, CTRCT11	C	Paired-like homeodomain transcription factor-3	602669	R		Anterior segment mesenchymal dysgenesis, 107250 (3); Cataract 11, multiple types, 610623 (3); Cataract 11, syndromic, 610623 (3)	19(Pitx3)
10.487	10	12	09	10q25.2	SHOC2, SIAA0862, SOC2, SUR8	P	Suppressor of clear, C. elegans, homolog of	602775	A		Noonan-like syndrome with loose anagen hair, 607721 (3)	
10.488	9	29	96	10q25.3	SLC18A2, VAT2, SVMT	C	Solute carrier family 18 (vesicular monoamine), member 2	193001	REa, A			19(Slc18a2)
10.489	5	19	06	10q26.13	ACADSB, SBCAD	P	Acyl-Coenzyme A dehydrogenase, short/branched chain	600301	REa, A		2-methylbutyrylglycinuria, 610006 (3)	
10.490	12	2	05	10q25-q26	EIG4	P	Epilepsy, idiopathic generalized, susceptibility to 4	609750	Fd	between D16S397 and D16S3095	{Epilepsy, idiopathic generalized, susceptibility to 4} (2)	
10.491	9	1	15	10q25.3	HABP2, PHBP, HGFAL, FSAP, NMTC5	P	Hyaluronan-binding protein 2	603924	A	mutation identified in 1 NMTC5 family	{?Thyroid cancer, nonmedullary, 5}, 616535 (3); {Venous thromboembolism, susceptibility to}, 188050 (3)	
10.492	12	14	00	10q26.11	PRDX3, AOP1	P	Peroxiredoxin 3 (antioxidant protein 1)	604769	A			19(Aop1)
10.493	10	15	91	10q26.2	MKI67	P	Proliferation-related Ki-67 antigen	176741	S, REa, A			7(Mki67)
10.494	12	28	08	10q25.3	DCLRE1A, SNM1, SNM1A, KIAA0086	P	DNA cross-link repair protein 1A	609682	Psh, REc			
10.495	7	17	14	10q24.33	NEURL1, NEURL, NEUR1	P	Neuralized E3 ubiquitin protein ligase 1	603804	R, A			
10.496	8	26	15	10q25.1	SFR1, MEI5, C10orf78	P	SWI5-dependent homologous recombination repair protein 1	616527	REc			
10.497	9	18	08	10q25.2	ACSL5, FACL5, ACS5	P	Acyl-CoA synthetase long-chain family member 5	605677	REc			
10.498	7	1	97	10q25.3	CASP7, MCH3	P	Caspase 7, apoptosis-related cysteine protease	601761	R			
10.499	10	24	14	10q25.2	BBIP1, NCRNA00081, BBIP10, BBS18	P	BBSome interacting protein 1	613605	REc	mutation identified in 1 BBS18 family	?Bardet-Biedl syndrome 18, 615995 (3)	
10.500	12	21	09	10q25.2	RBM20	P	RNA-binding motif protein 20	613171	REc		Cardiomyopathy, dilated, 1DD, 613172 (3)	
10.501	11	10	14	10q25.2	VTI1A, VTI1RP2, MMDS3	P	VTI1, S. cerevisiae, homolog of, A	614316	REc			
10.502	1	27	04	10q26.3	DPYSL4, CRMP3, ULIP4	P	Dihydropyrimidinase-like 4	608407	A, H			7(Ulip4)
10.503	8	6	13	10q26.11	BAG3, MFM6	P	BCL2-associated athanogene 3	603883	REc		Myopathy, myofibrillar, 6, 612954 (3); Cardiomyopathy, dilated, 1HH, 613881 (3)	
10.504	3	20	97	10q26.13	HMX2	P	Homeo box (H6 family) 2	600647	REa			
10.505	5	14	02	10q26.2	UROS	P	Uroporphyrinogen III synthase	606938	REa, Psh		Porphyria, congenital erythropoietic, 263700 (3)	7(Uros)
10.506	12	18	08	10q25.3	AFAP1L2, XB130, KIAA1914	P	Actin filament-associated protein 1-like protein 2	612420	A, REc			
10.507	8	19	13	10q25.3	KIAA1598, SHOOTIN1	P	Kiaa1598 gene	611171	REc, R			
10.508	11	22	10	10q25.3	KCNK18, TRESK, TRIK, MGR13	P	Potassium channel, subfamily K, member 18	613655	REc, H		{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	19(Kcnk18)
10.509	6	5	89	10q24.1	PGAM1	P	Phosphoglycerate mutase A, nonmuscle form	172250	D, H			19(Pgam1)
10.510	3	18	12	10q25.3	PNLIPRP1, PLRP1	P	Pancreatic lipase-related protein 1	604422	REc			
10.511	8	23	10	10q25.3	PNLIPRP2, PLRP2	P	Pancreatic lipase-related protein 2	604423	REc			
10.512	7	3	06	10q25.2-q25.3	TCF7L2, TCF4	C	Transcription factor 7-like 2	602228	A, Fd		{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	
10.513	8	26	09	10q25.3	TDRD1	P	Tudor domain protein 1	605796	R, REc			
10.514	1	29	07	10q25.3	TRUB1, PUS4	P	TRUB pseudouridine synthase, E. coli, homolog of, 1	610726	REc			
10.515	10	11	05	10q25.1	XPNPEP1, SAMP, XPNPEPL	C	X-prolyl aminopeptidase P1	602443	A, REa			
10.516	11	5	95	10q26.11	GPR10	P	G protein-coupled receptor-10	600895	A			
10.517	10	29	09	10q26.13	DMBT1	P	Deleted in malignant brain tumors 1	601969	D			
10.518	9	21	11	10q25.3-q26.1	PDZD8	P	PDZ domain-containing protein 8	614235	REc			
10.519	3	11	08	10q26.2	BCCIP, TOK1	P	BRCA2- and CDKN1A-interacting protein	611883	A, REc			
10.520	2	3	16	10q26.13	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	P	HTRA serine peptidase 1	602194	A		{Macular degeneration, age-related, 7}, 610149 (3); {Macular degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3); Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	
10.521	2	25	16	10q26.13	PLEKHA1, TAPP1	C	Pleckstrin homology domain-containing protein, family A, member 1	607772	REc			
10.522	8	20	98	10q25.3-q26.3	ADORA2L1, ADORA2L	P	Adenosine A2 receptor-like 1	102777	A			
10.523	7	20	09	10q25.3	ATRNL1, KIAA0534, ALP	P	Attractin-like 1	612869	R, REc			
10.524	7	1	09	10q26.11	CASC2	P	Cancer susceptibility candidate 2	608598	REc	head-to-head orientation with RAB11FIP2		
10.525	9	7	10	10q26.13	CHST15, BRAG, KIAA0598	C	Carbohydrate sulfotransferase 15	608277	R, REa			
10.526	4	7	13	10q26	CORD17	P	Cone-rod dystrophy 17	615163	Fd	between D10S1757 and D10S1782	Cone-rod dystrophy 17 (2)	
10.527	11	16	08	10q26	DEL10q26, C10q26DEL	P	Chromosome 10q26 deletion syndrome	609625	Ch		Chromosome 10q26 deletion syndrome (4)	
10.528	4	30	09	10q26.2	DHX32, DDX32	P	DEAH (Asp-Glu-Ala-His) box polypeptide 32	607960	REc			
10.529	10	3	07	10q26.11	EIF3A, EIF3S10, P167	P	Eukaryotic translation initiation factor 3, subunit A	602039	REc, A			
10.530	9	1	05	10q26	ENDO1	P	Endometriosis, susceptibility to, 1	131200	Fd	max lod at D10S587	{Endometriosis, susceptibility to, 1} (2)	
10.531	2	19	04	10q26.13	FGFR2, BEK, CFD1, JWS, TK14, BBDS	C	Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943	A, Psh, Fd		Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600 (3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3); Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 613659 (3); Craniofacial-skeletal-dermatologic dysplasia, 101600 (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3); Scaphocephaly and Axenfeld-Rieger anomaly (3); LADD syndrome, 149730 (3); Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3); Bent bone dysplasia syndrome, 614592 (3)	7(Fgfr2)
10.532	6	29	98	10q25.3	GFRA1, GDNFRA, GDNFR	C	GDNF family receptor, alpha-1	601496	A, R			19(Gfra1)
10.533	9	12	93	10q26.3	MGMT	C	Methylguanine-DNA methyltransferase	156569	REa, A			
10.534	5	7	01	10q26.3	NKX6B, NKX6.2	P	NK homeo box, family 6, member B (Nkx6.2, mouse, homolog of)	605955	REc, R			7(Nkx6b)
10.535	4	20	10	10q26.13	OAT, GACR	C	Ornithine aminotransferase	613349	S, REa, A, Fd	pseudogene at Xp11.2	Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	7(Oat)
10.536	5	7	01	10q23.33	PDLIM1, CLP36, CLIM1	P	PDZ and LIM domain protein 1	605900	A, R, REa			
10.537	1	1	96	10q26.2	PTPRE	C	Protein tyrosine phosphatase, receptor type, epsilon	600926	A			7(Ptpre)
10.538	12	29	06	10q26.11	RAB11FIP2, KIAA0941	P	RAB11 family-interacting protein 2	608599	REc			
10.539	1	25	05	10q26	RRIS	P	Respiratory rhythmicity in sleep	609116	Fd		[Respiratory rhythmicity in sleep] (2)	
10.540	1	31	01	10q26.13	TACC2	P	Transforming, acidic, coiled-coil-containing protein 2	605302	REc			
10.541	8	17	99	10q26.3	UTF1	P	Undifferentiated embryonic cell transcription factor 1	604130	A			7(Utf1)
10.542	10	11	12	10q26.12	WDR11, DR11, KIAA1351, BRWD2, HH14	P	WD repeat-containing protein 11	606417	REc, Ch		Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	
10.543	4	15	02	10q26.11	EMX2	P	Empty spiracles, Drosophila, homolog of, 2	600035	REa, A	close to VAX1	Schizencephaly, 269160 (3)	19(Emx2)
10.544	5	23	14	10q26.3	JAKMIP3, C10orf39, NECC2, JAMIP3	P	Janus kinase and microtubule interacting protein 3	611198	REc			
10.545	3	20	03	10q26.11	EMX2OS	P	EMX2 opposite strand	607637	REc	non-coding RNA		19(Emx2os)
10.546	10	4	91	10q25.3	PNLIP, PNLIPD	P	Pancreatic lipase	246600	REa, A		Pancreatic lipase deficiency, 614338 (1)	
10.547	2	2	15	10q25.3	VAX1, MCOPS11	P	Ventral anterior homeo box 1	604294	H, REc	mutation identified in one MCOPS11 family	?Microphthalmia, syndromic 11, 614402 (3)	19(Vax1)
10.548	4	17	07	10q26.11	MCMBP, C10orf119	P	Minichromosome maintenance complex-binding protein	610909	R, REc			
10.549	9	23	13	10q26.11	NANOS1, NOS1, SPGF12	P	NANOS, Drosophila, homolog of, 1	608226	R, REc		Spermatogenic failure 12, 615413 (3)	
10.550	1	2	14	10q26.11	SFXN4, COXPD18	C	Sideroflexin 4	615564	REc		Combined oxidative phosphorylation deficiency 18, 615578 (3)	
10.551	1	16	07	10q25.3	HSPA12A, KIAA0417	P	Heat-shock 70kD protein 12A	610701	R, REc			19(Hspa12a)
10.552	4	23	08	10q26.13	CTBP2	P	C-terminal-binding protein 2	602619	REc			
10.553	11	20	15	10q26.13	CUZD1, ERG1, ITMAP1	P	Cub and zona pellucida-like domains 1	616644	REc			
10.554	4	23	09	10q26.13	FAM175B, ABRO1, KIAA0157	P	Family with sequence similarity 175, member B	611144	Psh, REc			
10.555	4	26	10	10q26.13	HMX3, NKX5.1	P	H6 family homeobox 3	613380	REc			7(Hmx3)
10.556	3	10	11	10q26.13	LOC387715, ARMD8	P	LOC387715 gene	611313	REc, Fd		{Macular degeneration, age-related, 8}, 613778 (3)	
10.557	1	20	16	10q26.2	MMP21, HTX7	P	Matrix metalloproteinase 21	608416	REc		Heterotaxy, visceral, 7, autosomal, 616749 (3)	
10.558	9	9	09	10q26.13	NSMCE4A, NSE4A	P	Non-SMC element 4, S. cerevisiae, homolog of, A	612987	REc			
10.559	4	6	15	10q26.13	PSTK, C10orf89	P	Phosphoseryl-tRNA kinase	611310	R, REc			
10.560	1	23	08	10q26.13	ZRANB1, TRABID	P	Zinc finger- and RAN-binding domain-containing protein 1	611749	R, REc			
10.561	6	3	98	10q26.2	DOCK1, DOCK180	P	Dedicator of cytokinesis-1	601403	A			
10.562	12	18	07	10q26.2	FANK1	P	Fibronectin type III and ankyrin repeat domains 1	611640	R, REc			
10.563	8	17	09	10q26.2	NPS	P	Neuropeptide S	609513	REc			
10.564	3	27	15	10q26.3	ECHS1, SCEH, ECHS1D	P	Enoyl-CoA hydratase, short-chain, 1, mitochondrial	602292	A		Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	
10.565	5	11	00	10q26.13	GPR26	P	G protein-coupled receptor 26	604847	A			
10.566	7	13	98	10q26.3	ADAM8, CD156	P	A disintegrin and metalloprotease domain 8	602267	A			7(Adam8)
10.567	12	11	98	10q26.2	ADAM12, MLTN	P	A disintegrin and metalloproteinase domain 12 (Meltrin-alpha, mouse, homolog of)	602714	A, R			
10.568	6	10	11	10q26.3	BNIP3, NIP3	P	BCL2/adenovirus E1B 19-kD protein-interacting protein 3	603293	REc			
10.569	6	27	14	10q26.3	CALY, DRD1IP	P	Calcyon neuron-specific vesicular protein	604647	REc			
10.570	1	2	03	10q26.3	EBF3, COE3	P	Early B-cell factor 3	607407	REc			
10.571	5	12	09	10q26.3	GLRX3, PICOT	P	Glutaredoxin 3	612754	REc			
10.572	9	23	08	10q26.3	GPR123, KIAA1828	P	G protein-coupled receptor 123	612302	REc			
10.573	1	20	98	10q26.3	INPP5A	P	Inositol polyphosphate-5-phosphatase, 40kD	600106	A			
10.574	2	25	15	10q26.3	KNDC1, RASGEF2, KIAA1768	P	Kinase noncatalytic C-lobe domain-containing protein 1	616237	R, REc			
10.575	7	18	14	10q26.3	PAOX, PAO	P	Polyamine oxidase	615853	REc			7(Paox)
10.576	9	8	11	10q26.3	PPP2R2D	P	Protein phosphatase 2, regulatory subunit B, delta	613992	REc			
10.577	12	20	05	10q26.3	PRAP1	P	Proline-rich acidic protein 1	609776	R, REc			
10.578	12	3	04	10q26.3	OMS	P	Otitis media susceptibility to	166760	Fd	also 19q, 3p	{Otitis media, susceptibility to} (2)	
10.579	12	1	06	10q26.3	SPRN, SHADOO, SHO	P	Shadow of prion protein	610447	REc			7(Sprn)
10.580	5	23	16	10q26.3	SYCE1, POF12, SPGF15	P	Synaptonemal complex central element protein 1	611486	REc	mutation identified in 1 POF12 and 1 SPGF15 family	?Premature ovarian failure 12, 616947 (3); ?Spermatogenic failure 15, 616950 (3)	
10.581	6	12	12	10q26.3	VENTX, VENTX2, HPX42B	P	VENT homeobox	607158	A			
11.1	1	27	04	11q14.1	ALG8, CDG1H	P	Alg8, S. cerevisiae, homolog of	608103	REc		Congenital disorder of glycosylation, type Ih, 608104 (3)	
11.2	12	11	01	11p15.2	RRAS2, TC21	P	Related Ras viral oncogene homolog 2	600098	R		Ovarian carcinoma (3)	
11.3	7	20	09	11p15.4	AMPD3	P	Adenosine monophosphate deaminase-3, isoform E	102772	REa		[AMP deaminase deficiency, erythrocytic], 612874 (3)	7(Ampd3)
11.4	5	4	12	11p13	CD44, MDU2, MDU3, MIC4, IN	P	CD44 antigen (homing function)	107269	S		[Blood group, Indian system], 609027 (3)	2(Ly24)
11.5	3	6	94	11pter-p11.2	TP250	P	T-cell activation antigen p250	186710	S			
11.6	5	12	08	11p15.5	AP2A2, KIAA0899	P	Adaptor-related protein complex 2, alpha-2 subunit	607242	R, REc			
11.7	8	4	97	11p15.5	ASCL2	P	Achaete-scute complex, Drosophila, homolog-like 2	601886	A			
11.8	9	23	13	11p15.5	BET1L, GS15	P	BET1-like protein	615417	REc			
11.9	5	23	13	11p15.5	BRSK2, SAD1, PEN11B	P	BR serine/threonine kinase 2	609236	A			
11.10	8	20	07	11p15.5	C11orf21	P	Chromosome 11 open reading frame 21	611033	REc			
11.11	11	4	93	11p15.4	CARS	P	Cysteinyl-tRNA synthetase	123859	REa, A			
11.12	7	20	06	11p15.5	CD151, PETA3, SFA1, MER2	C	CD151 antigen	602243	A, S, REa		Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3); [Blood group, Raph], 179620 (3)	
11.13	12	10	10	11p15.5	CDHR5, MUCDHL	P	Cadherin-related family, member 5	606839	REc			
11.14	7	20	12	11p15.4	CDKN1C, KIP2, BWS, IMAGE	C	Cyclin-dependent kinase inhibitor 1C (p57, Kip2)	600856	A, Ch, Fd	rare cause of BWS	Beckwith-Wiedemann syndrome, 130650 (3); IMAGE syndrome, 614732 (3)	7(Kip2)
11.15	12	19	11	11p15.5	CEND1, BM88	P	Cell cycle exit and neuronal differentiation 1	608213	REc, A			
11.16	3	14	14	11p15.5	CHID1, SICLP	P	Chitinase domain-containing protein 1	615692	REc			
11.17	11	28	01	11p15.4	CHRNA10	P	Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10	606372	A, R			
11.18	5	31	06	11p15.5	CTSD, CPSD, CLN10	C	Cathepsin D (lysosomal aspartyl protease)	116840	REa, A		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	
11.19	7	7	14	11p15.5	DEAF1, SPN, ZMYND5, MRD24	P	Deaf1, Drosophila, homolog of	602635	REc		Mental retardation, autosomal dominant 24, 615828 (3)	
11.20	11	16	10	11p15.5	DRD4	C	Dopamine receptor D4	126452	Fd	proximal to HRAS	Autonomic nervous system dysfunction (3); [Novelty seeking personality], 601696 (1); {Attention deficit-hyperactivity disorder}, 143465 (3)	
11.21	3	9	98	11p15.5	DUSP8, HVH8	P	Dual specificity phosphatase-8	602038	A	pseudogene on 10q11.2		7(Dusp8)
11.22	9	6	11	11p15.5	EFCAB4A, CRACR2B	P	EF-hand calcium-binding domain-containing protein 4A	614177	REc			
11.23	7	23	09	11p15.5	H19, D11S813E, ASM1, BWS, WT2	C	H19 gene	103280	REa, A, RE	same 200kb fragment as IGF2	Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome, 180860 (3); Wilms tumor 2, 194071 (3)	7(H19)
11.24	4	23	08	11p15.5	HCCA2	P	HCCA2 gene	611969	REc			
11.25	2	3	15	11p15.5	ICR1	P	H19-IGF2-imprinting control region	616186	REn		Beckwith-Wiedemann syndrome, 130650 (3)	
11.26	8	9	12	11p15.5	IFITM1, IFI17, LEU13	P	Interferon-induced transmembrane protein 1	604456	R, REc			
11.27	8	9	12	11p15.5	IFITM2	P	Interferon-induced transmembrane protein 1	605578	R, REc			
11.28	7	20	12	11p15.5	IFITM3	P	Interferon-induced transmembrane protein 3	605579	R, REc		{Influenza, severe, susceptibility to}, 614680 (3)	
11.29	9	21	12	11p15.5	IFITM5, OI5	P	Interferon-induced transmembrane protein 5	614757	REc		Osteogenesis imperfecta, type V, 610967 (3)	
11.30	5	13	15	11p15.5	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	P	Interferon regulatory factor 7	605047	REc	mutation identified in 1 family	?Immunodeficiency 39, 616345 (3)	
11.31	10	28	10	11p15.5-p15.4	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	C	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	Fd		Long QT syndrome 1, 192500 (3); Jervell and Lange-Nielsen syndrome, 220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome 2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	7(Kcnq1)
11.32	2	11	08	11p15.5	KIAA1542	P	KIAA1542 gene	611780	R, REc			
11.33	8	25	03	11p15.4	LCRB	C	Locus control region beta	152424	REc		Thalassemia, Hispanic gamma-delta-beta, 613985 (3)	
11.34	9	9	09	11p15.5	MIR210, MIRN210	P	Micro RNA 210	612982	REc			
11.35	3	31	09	11p15.4	MRGPRG, MRGG	P	MAS-related G protein-coupled receptor family, member G	607234	REc			
11.36	8	28	92	11p15.5	MUC2	C	Mucin 2, intestinal/tracheal	158370	REa			
11.37	6	13	95	11p15.5	MUC5AC, MUC5	C	Mucin 5, subtypes A and C, tracheobronchial/gastric	158373	REa, A			
11.38	2	28	13	11p15.4	HBB	C	Hemoglobin beta	141900	LD, AAS, F, Fd	pseudogene HBBP1 between HBG and HBD loci	Sickle cell anemia, 603903 (3); Thalassemias, beta-, 613985 (3); Erythremias, beta- (3); Methemoglobinemias, beta- (3); Heinz body anemias, beta-, 140700 (3); Thalassemia-beta, dominant inclusion-body, 603902 (3); Hereditary persistence of fetal hemoglobin, 141749 (3); Delta-beta thalassemia, 141749 (3); {Malaria, resistance to}, 611162 (3)	7(Hbb)
11.39	6	16	97	11p15.4	HBD	C	Hemoglobin delta	142000	AAS		Thalassemia, delta- (3); Thalassemia due to Hb Lepore (3)	
11.40	11	13	07	11p15.4	HBG1	C	Hemoglobin, gamma A	142200	RE		Fetal hemoglobin quantitative trait locus 1, 141749 (3)	
11.41	6	15	11	11p15.4	HBG2, TNCY	C	Hemoglobin, gamma G	142250	RE		Fetal hemoglobin quantitative trait locus 1, 141749 (3); Cyanosis, transient neonatal, 613977 (3)	
11.42	3	1	89	11p15.4	HBE1	C	Hemoglobin epsilon	142100	RE			
11.43	6	18	15	11p15.5	HRAS	C	Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020	S	pseudogene HRASP on X	{Bladder cancer, somatic}, 109800 (3); Costello syndrome, 218040 (3); {Thyroid carcinoma, follicular, somatic}, 188470 (3); Congenital myopathy with excess of muscle spindles, 218040 (3); {Nevus sebaceous or woolly hair nevus, somatic}, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); {Spitz nevus or nevus spilus, somatic}, 137550 (3)	7(Hras1)
11.44	7	28	15	11p15.5	IGF2, GRDF	C	Insulin-like growth factor-2, or somatomedin A	147470	REa, A, RE	mutation identified in 1 GRDF family	?Growth restriction, severe, with distinctive facies, 616489 (3)	7(Igf2)
11.45	7	8	13	11p15.5	IGF2AS, PEG8	P	Insulin-like growth factor II, antisense	610146	REc			
11.46	2	5	15	11p15.5	INS, MODY10, IDDM2	C	Insulin	176730	HS, A, REb, Fd, D	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	Hyperproinsulinemia, 616214 (3); Maturity-onset diabetes of the young, type 10, 613370 (3); Diabetes mellitus, permanent neonatal, 606176 (3); Diabetes mellitus, insulin-dependent, 2, 125852 (3)	6(Ins1); 7(Ins2)
11.47	2	28	03	11p15.5	IRDN, ILPR	P	Insulin-related DNA polymorphism (insulin-related VNTR)	147510	Fd			
11.48	5	22	07	11p15.4	KCNQ1DN	P	KCNQ1 downstream neighbor	610980	REc			
11.49	8	16	99	11p15.5	KCNQ1OT1, LIT1	C	KCNQ1-overlapping transcript 1	604115	REc		Beckwith-Wiedemann syndrome, 130650 (3)	7(Kcnq10t1)
11.50	12	19	90	11p15.5	KRTAP5-1, KRN1L	P	Keratin associated protein 5-1	148022	A			
11.51	3	23	93	11p15.5	LSP1	P	Lymphocyte-specific protein pp52	153432	A			
11.52	11	22	13	11p15.5	MIR675	P	Micro RNA 675	615509	REc			
11.53	3	7	06	11p15.5	NALP6, PYPAF5	P	NACHT domain-, leucine-rich repeat-, and PYD-containing protein 6	609650	REc			
11.54	6	9	98	11p15.4	NAP1L4, NAP2L, NAP2	P	Nucleosome assembly protein 1-like 4	601651	REc			
11.55	1	27	04	11p15.5	ODF3, SHIPPO1	P	Outer dense fiber of sperm tails 3	608356	REc			7(Odf3)
11.56	5	23	13	11p15.4	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	P	Post-GPI attachment to proteins 2	615187	A, R		Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	
11.57	10	28	04	11p15.4	PHLDA2, TSSC3, IPL, BRW1C	P	Pleckstrin homology-like domain, family A, member 2	602131	REn			7(Ipl)
11.58	11	11	14	11p15.5	PIDD1, LRDD	P	p53-induced death domain protein 1	605247	REc, H			
11.59	1	24	07	11p15.5	PNPLA2, TTS2, ATGL	P	Patatin-like phospholipase domain-containing protein 2	609059	R		Neutral lipid storage disease with myopathy, 610717 (3)	7(Pnpla2)
11.60	9	24	12	11p15.5	PSMD13, S11	P	Proteasome 26S subunit, non-ATPase, 13	603481	REc, R			
11.61	5	26	09	11p15.5	PTDSS2, PSS2	P	Phosphatidylserine synthase 2	612793	REc			
11.62	9	7	12	11p15.5	RASSF7, C11orf13, HRC1	P	RAS association domain family, member 7	143023	REn	29kb 5' to HRAS1; divergently transcribed		
11.63	12	10	12	11p15.5	RIC8A	P	Ric8, C. elegans, homolog of, A	609146	REc, R			
11.64	1	22	15	11p15.5	RNH1, RNH	C	Ribonuclease/angiogenin inhibitor 1	173320	REa, A			
11.65	12	22	98	11p15.5	RPL23L, L23MRP, MRPL23	P	Ribosomal protein L23-like (L23 mitochondrial-related protein)	600789	REn			
11.66	6	22	12	11p15.5	RPLP2	P	Ribosomal phosphoprotein, large, P2	180530	REc			
11.67	7	13	93	11p15.4	RRM1	C	Ribonucleotide reductase, M1 polypeptide	180410	S, REa, A			7(Rrm1)
11.68	2	25	15	11p15.5	SCGB1C1, RYD5	P	Secretoglobin, family 1C, member 1	610176	REc			
11.69	2	14	01	11p15.5	SCT	P	Secretin	182099	R			
11.70	1	30	01	11p15.5	SIGIRR	P	Single immunoglobulin domain-containing IL1R-related protein	605478	R			
11.71	5	4	00	11p15.5	SIRT3, SIR2L3	P	Sirtuin, S. cerevisiae, homolog 3	604481	REc			
11.72	2	3	00	11p15.4	SLC22A1LS, ORCTL2S, BWSCR1B	P	Solute carrier family 22, member 1-like-antisense	603240	REc			
11.73	6	23	11	11p15.4	SLC22A1L, BWSCR1A, IMPT1	P	Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)	602631	REn		Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210 (3); Lung cancer, somatic, 211980 (3)	
11.74	4	7	05	11p15.5	SLC25A22, GC1, EIEE3	P	Solute carrier family 25 (mitochondrial carrier, glutamate), member 22	609302	REc, Fd		Epileptic encephalopathy, early infantile, 3, 609304 (3)	
11.75	12	11	03	11p15.5	SLEN3	P	Systemic lupus erythematosus with nephritis, susceptibility to, 3	607967	Fd		{Systemic lupus erythematosus with nephritis, susceptibility to, 3} (2)	
11.76	7	17	14	11p15.4	STIM1, TAM1, IMD10, STRMK	P	Stromal interaction molecule 1	605921	REn		Immunodeficiency 10, 612783 (3); Myopathy, tubular aggregate, 1 160565 (3); Stormorken syndrome, 185070 (3)	
11.77	5	22	13	11p15.5	SYT8	P	Synaptotagmin 8	607719	REc			
11.78	1	20	09	11p15.5	TH, TYH	C	Tyrosine hydroxylase	191290	REa, A, Fd, RE	distal to HRAS1	Segawa syndrome, recessive, 605407 (3)	7(Th)
11.79	3	3	03	11p15.5	TNNI2, AMCD2B, DA2B, FSSV	C	Troponin I, fast-twitch skeletal muscle isoform	191043	R, Fd		Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	
11.80	8	11	03	11p15.5	TNNT3, AMCD2B, DA2B, FSSV	C	Troponin-T3, skeletal, fast	600692	REa, A, Fd		Arthyrgryposis, distal, type 2B, 601680 (3)	7(Tnnt3)
11.81	3	8	07	11p15.4	TRIM21, SSA1, RO52	P	Tripartite motif-containing protein 21	109092	A			
11.82	7	9	06	11p15.5	TOLLIP	P	Toll-interacting protein	606277	R, REc			
11.83	1	14	14	11p15.4	TPP1, CLN2, SCAR7	C	Tripeptidyl peptidase 1	607998	Fd, LD		Ceroid lipofuscinosis, neuronal, 2, 204500 (3); Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	
11.84	1	14	02	11p15.5	TRPM5, MTR1	P	Transient receptor potential cation channel, subfamily M, member 5 (MLSN1- and TRP-related gene 1)	604600	REc	maternal allele imprinted		7(Mtr1)
11.85	1	20	06	11p15.5	TSPAN4, TM4SF7, NAG2	P	Tetraspanin 4	602644	REc			
11.86	1	20	06	11p15.5	TSPAN32, PHEMX, TSSC6	P	Tetraspanin 32	603853	RE	not imprinted		
11.87	11	2	04	11p15.4	TSSC2	P	Tumor-suppressing subtransferable fragment candidate gene 2	608999	REc			
11.88	8	31	99	11p15.5	TSSC4	P	Tumor-suppressing subchromosomal transferable fragment cDNA 4	603852	RE	not imprinted		
11.89	3	9	98	11p15.4	ZNF195	P	Zinc finger protein-195	602187	REc			
11.90	12	4	02	11p15.4	FXC1, TIMM10B	P	Fracture callus 1, rat, homolog of	607388	A, R			
11.91	7	13	93	11p15.4	ARHG	P	ras homolog gene family, member G (rho G)	179505	A			
11.92	3	6	94	11p15.4	CCKBR, GASR	C	Cholecystokinin B receptor	118445	REa, A			7(Cckbr)
11.93	12	17	87	11p15.4	HPX	C	Hemopexin	142290	REa, A			
11.94	6	25	99	11p15.4	ILK, P59	P	Integrin-linked kinase	602366	A			
11.95	2	26	08	11p15.4	MRPL17	P	Mitochondrial ribosomal protein L17	611830	R			
11.96	2	20	97	11p15.5	MUC6	P	Mucin 6, gastric	158374	A	order: tel-HRAS-MUC6-MUC2-MUC5AC-MUC5B-IGF2-cen		
11.97	8	9	01	11p15.5	TALDO1	P	Transaldolase-1	602063	REa, A, R	pseudogene on chr.1	Transaldolase deficiency, 606003 (3)	
11.98	10	16	89	11p15.1	LDHC, LDH3	C	Lactate dehydrogenase C	150150	REa, A, REb	closely linked to LDHB in other species; in man syntenic with LDHA; ?close to LDHA		7(Ldh3)
11.99	7	15	99	11p15.4	ADM	C	Adrenomedullin	103275	REa			7(Adm)
11.100	10	2	12	11p15.4	ARFIP2, POR1	P	ADP-ribosylation factor-interacting protein 2	601638	REc			
11.101	4	13	15	11p15.4	BGLT3, LINC01083	P	Beta-globin locus transcript 3, noncoding	616308	REc			
11.102	3	20	09	11p15.4	CYB5R2	P	Cytochrome b5 reductase 2	608342	REc			
11.103	11	17	15	11p15.4	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	P	Dachsous, Drosophila, homolog of, 1	603057	REc		Van Maldergem syndrome 1, 601390 (3); Mitral valve prolapse 2, 607829 (3)	
11.104	10	3	07	11p15.4	EIF3F, EIF3S5	P	Eukaryotic translation initiation factor 3, subunit F	603914	REc			
11.105	12	8	14	11p15.4	GVINP1, VLIG1	P	GTPase, very large interferon-inducible, pseudogene 1	616121	REc			7(Gvin1)
11.106	8	17	09	11p15.1	LDHA, LDH1, GSD11	C	Lactate dehydrogenase A	150000	S, D, REb, C, A		Glycogen storage disease XI, 612933 (3)	7(Ldh1)
11.107	3	31	09	11p15.4	MRGPRE, MRGE	P	Mas-related G protein-coupled receptor family, member E	607232	REc			
11.108	4	30	91	11p15.1	MYOD1, MYF3	C	Myogenic factor-3	159970	REa, A	proximal to CALCA, HBB, BWS, PTH; ?11p14.3		7(Myod1)
11.109	4	17	13	11p15.4	NLRP1, NALP14, NOD5	P	NLR family, pyrin domain containing 1	609665	REc			
11.110	8	8	13	11p15.4	OR10A1	P	Olfactory receptor, family 10, subfamily A, member 1	608493	REc, A			
11.111	8	8	13	11p15.4	OR2D2	P	Olfactory receptor, family 2, subfamily D, member 2	608494	REc, A			
11.112	8	19	13	11p15.4	OR51E1, DGPCR, PSGR2	P	Olfactory receptor, family 51, subfamily E, member 1	611267	REn			
11.113	8	19	13	11p15.4	OR51E2, PSGR	P	Olfactory receptor, family 51, subfamily E, member 2	611268	REn			
11.114	5	7	03	11p15.4	OSBPL5, ORP5, KIAA1534	C	Oxysterol-binding protein-like protein 5	606733	R, REc			
11.115	12	10	12	11p15.4	RIC3	P	Resistance to inhibitors of cholinesterase 3, C. elegans, homolog of	610509	REc			
11.116	7	18	14	11p15.4	RRP8, NML, KIAA0409	P	Ribosomal RNA processing protein 8, homolog of	615818	R, REc			
11.117	4	19	12	11p15.4	SCUBE2	P	Signal peptide-, CUB domain-, and EGF-like domains-containing protein 2	611747	REc			
11.118	4	2	16	11p15.4	SNORA3B, SNORA45	P	Small nucleolar RNA, H/ACA box 3B	611333	REc			
11.119	8	17	10	11p15.4	SYT9	P	Synaptotagmin 9	613528	REc			
11.120	4	17	12	11p15.4	TRIM3, RNF22, BERP	P	Tripartite motif-containing 3	605493	R, REc			
11.121	4	23	08	11p15.4	TRIM66, TIF1D, KIAA0298	P	Tripartite motif-containing protein 66	612000	R, REc			
11.122	12	21	09	11p15.4	TRIM68, SS56, GC109	P	Tripartite motif-containing protein 68	613184	REc	incorrectly assigned to 2p24 by FISH		
11.123	2	3	15	11p15.4	TUB, RDOB	P	Tubby, mouse, homolog of	601197	REc, H	mutation identified in 1 RDOB family	?Retinal dystrophy and obesity, 616188 (3)	
11.124	6	26	00	11p15.4	ZNF214	P	Zinc finger protein-214	605015	REc			
11.125	6	26	00	11p15.4	ZNF215	P	Zinc finger protein-215	605016	REc			
11.126	2	25	15	11p15.4	MRVI1, IRAG	P	Murine retrovirus integration site 1, homolog of	604673	REc			
11.127	2	28	01	11p15.4	TRIM34, RNF21, IFP1	P	Tripartite motif-containing 34 (RING finger protein-21)	605684	A			
11.128	6	6	00	11p15.4	ZNF143, SBF	P	Zinc finger protein-143	603433	A			
11.129	3	31	03	11p15.4	SMPD1, NPD	C	Sphingomyelin phosphodiesterase-1, acid lysosomal	607608	REa, A		Niemann-Pick disease, type A, 257200 (3); Niemann-Pick disease, type B, 607616 (3)	7(Smpd1)
11.130	9	11	08	11p15.4	AKIP1, BCA3, C11orf17	P	Protein kinase A-interacting protein 1	609191	R, REc			7(Akip1)
11.131	4	6	13	11p15.4	GALNT18, GALNACT18, GALNTL4	P	UPD-N-acetyl-alpha-D-galactosamine:polypsptide N-acetylgalactosaminyltransferase 18	615136	REc			
11.132	10	28	08	11p15.3	MICAL2, KIAA0750	P	Microtubule-associated monooxygenase, calponin and LIM domains-containing 2	608881	R, REc			
11.133	10	28	08	11p15.3	MICALCL, EBITEIN1	P	MICAL C terminus-like protein	612355	REc			
11.134	12	2	09	11p15.4	NRIP3	P	Nuclear receptor-interacting protein 3	613125	REc			
11.135	5	16	05	11p15.4	SH2BP1, KIAA0155, p150	P	SH2 domain-binding protein 1	609366	Psh, REc			7(Sh2bl1)
11.136	4	3	03	11p15.4	STK33	P	Serine/threonine protein kinase 33	607670	REc, H			7(Stk33)
11.137	12	4	01	11p15.4	TAF10, TAF2H, TAF2A	C	TAF10 RNA polymerase II, TATA box-binding protein-associated factor, 30kD	600475	A			
11.138	2	23	12	11p15.3	USP47	P	Ubiquitin-specific protease 47	614460	REc			
11.139	5	29	13	11p15.4	ZBED5, BUSTER1	P	Zinc finger BED domain-containing protein 5	615251	REc			
11.140	10	7	02	11p15.2	SOX6	P	SRY-box 6	607257	A			7(Sox6)
11.141	7	20	06	11p15.3	PTH	C	Parathyroid hormone	168450	REa, REb, A, Fd	~9cM distal to CALC1; distal to MYOD	Hypoparathyroidism, autosomal dominant, 146200 (3); Hypoparathyroidism, autosomal recessive, 146200 (3)	7(Pth)
11.142	3	23	93	11p15.4	WEE1	P	wee1+, S. pombe, homolog of	193525	A			
11.143	8	21	91	11p15.1	TPH1, TPH	C	Tryptophan hydroxylase 1 (tryptophan-5-monooxygenase)	191060	REa, A			7(Tph)
11.144	8	12	14	11p15.3	BTBD10	P	BTB/POZ domain-containing protein 10	615933	REc			
11.145	10	15	10	11p15.2	COPB1, COPB	P	Coatomer protein complex, subunit beta 1	600959	REc			
11.146	7	20	04	11p15.2	CYP2R1	P	Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase)	608713	REc		Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)	
11.147	1	5	15	11p15.3	FAR1, MLSTD2, PFCRD	P	Fatty acyl CoA reductase 1	616107	REc		Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	7(Far1)
11.148	12	29	06	11p15.2	INSC	P	Inscuteable, Drosophila, homolog of	610668	REc			
11.149	7	18	12	11p15.3	RASSF10	P	Ras association domain family, member 10	614713	REc			
11.150	9	18	06	11p15.3	TEAD1, TCF13, REF1	C	TEA domain family member 1	189967	Psh, R		Sveinsson chorioretinal atrophy, 108985 (3)	
11.151	5	8	97	11p15.2	CALCA, CALC1	C	Calcitonin/calcitonin-related polypeptide, alpha	114130	REa, A, REb, D, Fd, REn	same 220kb fragment as CALCB		7(Calc)
11.152	3	23	93	11p15.2	CALCB, CALC2	C	Calcitonin-related polypeptide, beta	114160	A, REa, REb, D			
11.153	6	19	98	11p15.1	NELL1	P	Nel-like 1	602319	A			
11.154	2	18	96	11p15.1	PTPN5, STEP	P	Protein tyrosine phosphatase, nonreceptor-type, 5 (striatum-enriched)	176879	Psh, A			7(Ptpn5)
11.155	5	10	12	11p15.1	SLC6A5, GLYT2, HKPX3	C	Solute carrier family 6 (neurotransmitter transporter, glycine), member 5	604159	R		Hyperekplexia 3, 614618 (3)	
11.156	3	31	97	11p15.1	TSG101	P	Tumor susceptibility gene 101	601387	R, A		Breast cancer, somatic, 114480 (3)	
11.157	4	27	07	11p15.1	UEVLD, UEV3, ATTP	P	Ubiquitin E2 variant and lactate/malate dehydrogenase domains-containing protein	610985	REc			
11.158	7	14	98	11p14.3	GAS2	C	Growth arrest-specific 2	602835	R, A, H			7(Gas2)
11.159	8	31	06	11p15.1	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	C	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	A, REn, Fd, LD		Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3); Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2, 610374 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)	
11.160	1	31	11	11p15.1	B7H6	P	B7 homolog 6	613714	REc			
11.161	6	24	08	11p15.1	CSRP3, CRP3, CLP, CMD1M, CMH12	C	Cysteine- and glycine-rich protein 3	600824	A	mutation identified in 1 CMD1M family	?Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy, hypertrophic, 12, 612124 (3)	
11.162	8	11	15	11p15.3	DKK3, RIG	P	Dickkopf, Xenopus, homolog of, 3	605416	A			
11.163	6	9	08	11p15.1	E2F8	P	E2F transcription factor 8	612047	REc			7(E2f8)
11.164	6	1	04	11p15.1	HTATIP2, TIP30, CC3	P	HIV-1 TAT-interacting protein 2, 30kD	605628	R, REc			
11.165	4	22	15	11p15.1	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	C	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	A, REn, Fd, LD	4.5kb 3' of SUR	Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3); Diabetes, permanent neonatal, 606176 (3); Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3); {Diabetes mellitus, type 2, susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3); Maturity-onset diabetes of the young, type 13, 616329 (3)	
11.166	3	31	09	11p15.1	MRGPRX1, MRGX1	P	Mas-related G protein-coupled receptor family, member X1	607227	REc			
11.167	3	31	09	11p15.1	MRGPRX2, MRGX2	P	Mas-related G protein-coupled receptor family, member X2	607228	REc			
11.168	3	31	09	11p15.1	MRGPRX3, MRGX3	P	Mas-related G protein-coupled receptor family, member X3	607229	REc			
11.169	3	31	09	11p15.1	MRGPRX4, MRGX4	P	Mas-related G protein-coupled receptor family, member X4	607230	REc			
11.170	1	2	08	11p15.1	NAV2, RAINB1, KIAA1419	C	Neuron navigator 2	607026	R, REc			
11.171	3	31	15	11p15.1	PIK3C2A, CPK	P	Phosphatidylinositol 3-kinase, class 2, alpha	603601	REc			
11.172	3	31	09	11p15.2-p15.1	PLEKHA7	P	Pleckstrin homology domain-containing protein, family A, member 7	612686	REc			
11.173	1	13	99	11p15.2	PSMA1, PROS30	P	Proteasome subunit, alpha-type, 1	602854	A			
11.174	3	18	94	11p15.1	SAA1	C	Serum amyloid A1	104750	REa, H, A, Psh			7(Saa1)
11.175	3	18	94	11p15.1	SAA2	C	Serum amyloid A2	104751	REn, A, Fd, Psh	pseudogene = SAA3		
11.176	3	18	94	11p15.1	SAA4	C	Serum amyloid A4, constitutive	104752	REn, A, Psh			7(Saa4)
11.177	11	29	12	11p15.1	USH1C, DFNB18A	C	Harmonin (Usher syndrome 1C gene)	605242	Fd	Acadian and Samaritan variety	Usher syndrome, type 1C, 276904 (3); Deafness, autosomal recessive 18A, 602092 (3)	
11.178	7	15	09	11p15.1	ZDHHC13, HIP14L	P	Zinc finger DHHC domain-containing protein 13	612815	REc			
11.179	3	18	95	11p15.1	GTF2H1	C	General transcription factor IIH, polypeptide 1 (62kD subunit)	189972	A, REn	within 50kb of LDHA		
11.180	6	19	98	11p15.4	APBB1, FE65	P	Amyloid beta A4 precursor protein-binding, family B, member-1	602709	A			7(Apbb1)
11.181	8	20	98	11p15.3	ARNTL, BMAL1, TIC	P	Aryl hydrocarbon receptor nuclear translocator-like	602550	A			7(Arntl)
11.182	2	24	97	11p15.4	ART1	P	ADP-ribosyltransferase 1	601625	REa			7(Art1)
11.183	11	30	06	11p15.4	ART5	P	ADP-ribosyltransferase 5	610625	REc			7(Art5)
11.184	6	19	98	11p15.4	EIF4G2, DAP5	P	Eukaryotic translation initiation factor 4G-like 1	602325	A, H			7(Eif4G2)
11.185	1	9	13	11p15.5	EPS8L2, EPS8R2	P	EPS8-like protein 2	614988	REc			7(Eps8l2)
11.186	12	29	99	11p14.3	FANCF	P	Fanconi anemia, complementation group F	613897	REc		Fanconi anemia, complementation group F, 603467 (3)	
11.187	8	20	07	11p15	GINGF4, HGF4, GGF4	P	Fibromatosis, gingival, 4	611010	Fd	between D11S1984 and D11S1338	Fibromatosis, gingival, 4 (2)	
11.188	2	12	07	11p15	IH, HHP	P	Hemihyperplasia, isolated	235000	Fd	epigenetic or uniparental disomy	Hemihypertrophy (2)	
11.189	2	4	15	11p15.1	KCNC1, EPM7	C	Potassium voltage-gated channel, Shaw-related subfamily, member 1	176258	A, REn		Epilepsy, progressive myoclonic 7, 616187 (3)	7(Kcnc1)
11.190	4	17	97	11p15.4	LMO1, RBTN1, RHOM1	C	LIM domain only 1 (rhombotin 1)	186921	Ch, D		Leukemia, T-cell acute lymphoblastic (2)	7(Ttg1)
11.191	7	26	10	11p15	LVNC2	P	Left ventricular noncompaction 2	609470	Fd	max lod at D11S902	Left ventricular noncompaction 2 (2)	
11.192	1	8	01	11p15.4	MMP26	P	Matrix metalloproteinase 26 (matrilysin 2)	605470	REa, R			
11.193	7	22	11	11p15.5	MUC5B	P	Mucin 5, subtype B, tracheobronchial	600770	REa, A		{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	
11.194	2	5	16	11p15	NBLST7	P	Neuroblastoma, susceptiblity to, 7	616792	Fd	associated with rs2168101	{Neuroblastoma, susceptibility to, 7} (2)	
11.195	4	17	13	11p15.4	NLRP10, NALP10, PYNOD, NOD8	P	NLR family, pyrin domain containing 10	609662	REc			
11.196	2	4	00	11p15.4	NUP98	C	Nucleoporin, 98kD	601021	Ch, REc, Psh	fused with HOXA9, NSD1, NSD3, PMX1, HOXC13, DDX10, TOP1, HOXD11 in myeloid leukemia		
11.197	7	9	14	11p15.4	OR6A2, OR6A1	P	Olfactory receptor, family 6, subfamily A, member 2	608495	REc, A			
11.198	10	29	09	11p15.3	PARVA	P	Parvin, alpha	608120	REc			
11.199	3	9	98	11p15.2	PDE3B	P	Phosphodiesterase-3B, cGMP-inhibited	602047	A, Psh			
11.200	3	6	01	11p15.5	PKP3	P	Plakophilin-3	605561	A			
11.201	2	16	01	11p15.5	POLR2L, RPB10	P	Polymerase II, RNA, subunit L	601189	A			
11.202	9	24	08	11p15.4	RBMXL2, HNRNPGT, HNRPGT	C	RNA-binding motif protein, X chromosome, like 2	605444	A, R			
11.203	11	20	15	11p15.4	RNF141, ZNF230	P	RING finger protein 141	616641	REc			7(Rnf141)
11.204	2	20	01	11p15.4	RPL27A	C	Ribosomal protein L27a	603637	RE, R			7(Rpl27a)
11.205	11	16	05	11p15.4	SBF2, MTMR13, CMT4B2	C	SET binding factor 2 (myotubularin-related 13)	607697	Fd, REc		Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	
11.206	10	23	92	11p15.4	ST5, HTS1	P	Suppression of tumorigenicity-5	140750	S, REa, A			
11.207	5	23	00	11p15.4	SWAP70	P	Switch-associated protein 70	604762	A, H			7(Swap70)
11.208	2	26	04	11p15.4	TRIM5, RNF88	P	Tripartite motif-containing protein 5	608487	R			
11.209	2	19	03	11p15.4	TRIM6	P	Tripartite motif-containing protein 6	607564	R			
11.210	2	19	03	11p15.4	TRIM22, STAF50	C	Tripartite motif-containing protein 22	606559	A, R			
11.211	1	30	01	11p15.4	UBQLN3	P	Ubiquilin 3	605473	R			
11.212	1	20	09	11p15-p14	DEL11p15p14, C11DELp15p14	P	Chromosome 11p15-p14 deletion syndrome (homozygous)	606528	Ch	contiguous gene deletion syndrome	Chromosome 11p15-p14 deletion syndrome (4)	
11.213	1	12	07	11p15.1	NUCB2, NEFA	P	Nucleobindin 2	608020	REc			
11.214	1	9	01	11p13	ELF5, ESE2	P	E74-like factor 5 (epithelium-specific ETS factor 2)	605169	Psh, R			
11.215	1	29	03	11p15.1	HPS5, RU2, KIAA1017	P	HPS gene 5 (ruby-eye 2, mouse, homolog of)	607521	REc, H		Hermansky-Pudlak syndrome 5, 614074 (3)	7(ru2)
11.216	3	29	10	11p14.3	ANO5, TMEM16E, GDD1, LGMD2L	C	Anoctamin 5	608662	REn, H, Fd		Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy, limb-girdle, type 2L, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)	7(Tmem16e)
11.217	11	29	12	11p15.1	OTOG, OTGN, DFNB18B	P	Otogelin	604487	A		Deafness, autosomal recessive 18B, 614945 (3)	7(Otog)
11.218	2	19	03	11p14.3	SLC17A6, VGLUT2, DNPI	P	Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6	607563	A			
11.219	4	10	90	11p14.3-p12	ST2	P	Suppression of tumorigenicity-2	185440	Ch			
11.220	9	28	11	11p14.2	BBOX1, BBOX	C	Butyrobetaine-gamma, 2-oxoglutarate dioxygenase 1	603312	R, REc			
11.221	12	24	08	11p14.2	SLC5A12, SMCT2	P	Solute carrier family 5 (sodium/glucose cotransporter), member 12	612455	REc			
11.222	3	19	09	11p14.2-q12.3	DFNA59	P	Deafness, autosomal dominant 59	612642	Fd	between D22S929 and D11S480	Deafness, autosomal dominant 59 (2)	
11.223	10	6	08	11p14.1	CCDC34	P	Coiled-coil domain-containing protein 34	612324	REc			
11.224	10	6	08	11p14.1	DCDC5, KIAA1493	C	Doublecortin domain-containing protein 5	612321	REc, H			2(Dcdc5)
11.225	9	8	08	11p14.1	HSP90AA2, HSPCAL3	C	Heat-shock protein, 90kD, alpha, class A, member 2	140575	REa, A			
11.226	7	22	13	11p14.1	LGR4, GPR48, BNMD17	P	Leucine-rich repeat-containing G protein-coupled receptor 4	606666	REc, Psh, R	previously mapped to 5q34-q35.1	{Bone mineral density, low, susceptibility to}, 615311 (3)	
11.227	10	7	08	11p14.1	LIN7C, VELI3, MALS3	P	Lin7, C. elegans, homolog of, C	612332	REc			
11.228	3	23	09	11p14.1	MIR610, MIRN610	C	Micro RNA 610	612330	REc			
11.229	9	23	08	11p14.1	C11orf46	P	Chromosome 11 open reading frame 46	612295	REc			
11.230	9	23	08	11p13	LOC283267	P	LOC283267 gene	612296	REc			
11.231	4	20	10	11p14.1-p11.2	SPG41	L	Spastic paraplegia 41	613364	Fd	max lod 2.36; between D11S1324 and D11S1993	?Spastic paraplegia 41, autosomal dominant (2)	
11.232	1	28	13	11p14.3-p14.2	ANO3, TMEM16C, C11orf25, DYT24	P	Anoctamin 3	610110	REc		Dystonia 24, 615034 (3)	
11.233	8	27	15	11p14.1	BDNFAS, BDNFOS	P	BDNF antisense RNA	611468	REc			
11.234	8	19	13	11p14.1	KIF18A	P	Kinesin family member 18A	611271	REc			
11.235	8	1	13	11p15.1	SERGEF, DELGEF	P	Secretion-regulating guanine nucleotide exchange factor	606051	REc, Psh			
11.236	11	10	10	11p14	TST1	P	Tuberculin skin test reactivity, absence of	613636	Fd	at chr11:26.37M	[Tuberculin skin test reactivity, absence of] (2)	
11.237	1	27	04	11p14.3	LUZP2	P	Leucine zipper protein 2	608178	R			
11.238	3	16	10	11p14.1	MPPED2, C11orf8, D11S302E, 239FB	P	Metallophosphoesterase domain-containing protein 2	600911	REn			
11.239	12	22	08	11p13	APIP, CGI29, MMRP19	P	APAF1-interacting protein	612491	REc			
11.240	5	4	12	11p14.1	BDNF, BULN2, ANON2	C	Brain-derived neurotrophic factor	113505	A, REa, D	homeology with NRF3 on 12p; at p14 boundary	{Memory impairment, susceptibility to} (3); Central hypoventilation syndrome, congenital, 209880 (3); {Obsessive-compulsive disorder, protection against}, 164230 (3); {Bulimia nervosa, age of onset of weight loss in}, 607499 (3); {Anorexia nervosa, susceptibility to}, 610269 (3)	1(Bdnf)
11.241	4	21	16	11p13	DEL11p13, C11DELp13	P	Chromosome 11p13 deletion syndrome, distal	616902	Ch		Chromosome 11p13 deletion syndrome, distal, 616902 (4)	
11.242	12	14	10	11p13	DEL11p13, C11DELp13, WAGR	P	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (chromosome 11p13 deletion syndrome)	194072	Ch	deletion of WT1 and PAX6 genes	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)	
11.243	9	23	08	11p13	C11orf41, G2	P	Chromosome 11 open reading frame 41	612297	REc, REn			
11.244	11	19	13	11p13	CAPRIN1, M11S1, GPIAP1, GRIP137	P	Cell cycle associated protein 1	601178	REc			
11.245	9	21	11	11p13	CAT	C	Catalase	115500	S, D, Fd	cen-CAT-WT1-AN2-pter	Acatalasemia, 614097 (3)	2(Cas1)
11.246	10	7	08	11p13	CCDC73	P	Coiled-coil domain-containing protein 73	612328	REc			
11.247	9	23	08	11p13	CD59, MIC11	C	CD59 antigen (p18-20)	107271	REa, A, D	in mouse Ly-6 = multigene complex	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3)	15(Ly6)
11.248	9	23	08	11p13	COMM9	C	COMM domain-containing protein 9	612299	REc, REn			
11.249	5	25	13	11p13	CSTF3	P	Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kD	600367	REc			
11.250	8	29	03	11p13	DCDC1	P	Doublecortin domain-containing protein 1	608062	REc			
11.251	9	23	08	11p13	DEPDC7, TR2	P	DEP domain-containing protein 7	612294	REc, REn			
11.252	8	21	07	11p13	DPH4	P	DPH4, S. cerevisiae, homolog of	611072	R, REc			
11.253	3	9	10	11p13	ECT, BECTS	P	Centrotemporal epilepsy	117100	Fd	previously assigned to 15q14	Centrotemporal epilepsy (2)	
11.254	10	3	07	11p13	EIF3M, PCID1, B5, GA17	P	Eukaryotic translation initiation factor 3, subunit M	609641	REc			
11.255	4	10	14	11p13	ELP4, PAX6NEB, AN	P	Elongation protein 4, S. cerevisiae, homolog of	606985	REc	mutation identified in 1 AN patients	?Aniridia, 106210 (3)	
11.256	9	9	08	11p13	FBXO3, FBX3, FBA	P	F-box only protein 3	609089	REc			2(Fbxo3)
11.257	8	29	08	11p13	FJX1	P	Four-jointed box, Drosophila, homolog of, 1	612206	REc			
11.258	4	6	15	11p14.1	FSHB, HH24	C	Follicle-stimulating hormone, beta polypeptide	136530	D, REa	distal to AN2	Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3)	2(Fshb)
11.259	10	24	00	11p13	HIPK3, PKY, DYRK6	P	Homeodomain-interacting protein kinase-3	604424	A			
11.260	10	6	08	11p13	IMMP1L, IMP1	P	Inner mitochondrial membrane peptidase, subunit 1, S. cerevisiae, homolog of	612323	REc			
11.261	12	11	95	11p13	LMO2, RBTNL1, RHOM2, TTG2	P	LIM domain only 2 (rhombotin-like 1)	180385	REa, REc	3rd rhombotin gene not on 11	Leukemia, acute T-cell (2)	
11.262	4	13	05	11p13	MYP7	P	Myopia 7	609256	Fd		Myopia 7 (2)	
11.263	5	9	14	11p13	NAT10, ALP, KIAA1709	C	N-acetyltransferase 10	609221	REc, REn			
11.264	9	8	14	11p13	PAX6, AN2, MGDA, FVH1	C	Paired box homeotic gene-6	607108	Ch, Fd	mutation identified in 1 MGDA patient	Aniridia, 106210 (3); Peters anomaly, 604229 (3); Cataract with late-onset corneal dystrophy, 106210 (3); Keratitis, 148190 (3); Foveal hypoplasia 1, 136520 (3); ?Morning glory disc anomaly, 120430 (3); Optic nerve hypoplasia, 165550 (3); Coloboma, ocular, 120200 (3); Coloboma of optic nerve, 120430 (3); Gillespie syndrome, 206700 (3)	2(Sey)
11.265	7	20	04	11p13	PDX1	C	Pyruvate dehydrogenase complex, lipoyl-containing component X	608769	A, R, Psh, REc		Lacticacidemia due to PDX1 deficiency, 245349 (3)	
11.266	1	2	08	11p13	PRRG4, PRGP4, TMG4	P	Proline-rich gamma-carboxyglutamic acid protein 4	611690	REc			
11.267	6	9	08	11p12	RAG1	C	Recombination activating gene-1	179615	REa, D	assignment to 14 in error	Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	2(Rag1)
11.268	6	9	08	11p12	RAG2	C	Recombination activating gene-2	179616	REa, D	assignment to 14 in error	Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	2(Rag2)
11.269	7	13	98	11p13	RCN1	P	Reticulocalbin 1	602735	REc			2(Rcn1)
11.270	9	23	08	11p13	TRIM44	P	Tripartite motif-containing protein 44	612298	REc, REn			
11.271	8	16	11	11p13	WT1, NPHS4	C	Wilms tumor-1	607102	Ch	clumped: pter-FSHB-AN2-WT1-CAT	Wilms tumor, type 1, 194070 (3); Denys-Drash syndrome, 194080 (3); Nephrotic syndrome, type 4, 256370 (3); Frasier syndrome, 136680 (3); Meacham syndrome, 608978 (3); Mesothelioma, somatic, 156240 (3)	2(Wt1)
11.272	2	12	16	11p13	WT1AS, WIT1	P	WT1 antisense RNA	607899	REc			
11.273	3	13	06	11p13-p12	DFNB51	P	Deafness, autosomal recessive 51	609941	Fd	max lod at D11S4102	Deafness, autosomal recessive 51 (2)	
11.274	4	6	01	11p13-p12	EVR3	P	Exudative vitreoretinopathy 3	605750	Fd		Exudative vitreoretinopathy 3 (2)	
11.275	11	24	15	11p13-p12	PRR5L, PROTOR2, FLJ14213	P	Proline-rich protein 5-like	611728	R, REc			
11.276	2	24	97	11p11.2	PSMC3, TBP1	P	Proteasome (prosome, macropain) 26S subunit, ATPase, 3	186852	Psh, A			
11.277	1	29	96	11p13	SLC1A2, EAAT2	C	Solute carrier family 1 (glial high affinity glutamate transporter), member 2	600300	A, REa			2(Eaat2)
11.278	12	24	08	11p13-p12	WAGRO, DEL11p14p12	P	Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome	612469	Ch	contiguous gene deletion syndrome	WAGRO syndrome (4)	
11.279	7	20	09	11q14.3	FOLH1B, PSMAL, GCP3	C	Folate hydrolase 1B	609020	A, REc			
11.280	4	26	10	11p13-q12	CANDF3, CANDN1, FCNC	P	Candidiasis, familial, 3	607644	Fd	between D11S1312 and D11S4191	Candidiasis, familial, 3 (2)	
11.281	11	18	11	11p13-q14.1	MRT23	P	Mental retardation, autosomal recessive 23	614344	Fd	between rs604518 and rs10899421	Mental retardation, autosomal recessive 23 (2)	
11.282	12	23	05	11p12	API5, AAC11	P	Apoptosis inhibitor 5	609774	REc			
11.283	1	22	08	11p12	BMND8	P	Bone mineral density QTL 8	611739	Fd	between D11S1392 and D11S4102	{Osteoporosis}, 166710 (2)	
11.284	1	29	01	11p13	EHF, ESE3	P	ETS homologous factor	605439	REa, A			
11.285	9	12	08	11p12	LRRC4C, NGL1, KIAA1580	P	Leucine rich repeat containing 4C (netrin-G1 ligand)	608817	R, REc			
11.286	3	13	06	11p12	TRAF6	P	TNF receptor-associated factor 6	602355	REc, R			
11.287	3	15	92	11p11.2	CHRM4	C	Cholinergic receptor, muscarinic, 4	118495	A, REa, Fd			
11.288	4	30	15	11p11.2	LRP4, MEGF7, CLSS, SOST2, CMS17	P	Low density lipoprotein receptor-related protein 4	604270	R	mutation identified in 1 CMS17 family	Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2, 614305 (3); ?Myasthenic syndrome, congenital, 17, 616304 (3)	
11.289	3	1	00	11p11.2	MAPK8IP1, IB1	P	Mitogen-activated protein kinase 8-interacting protein 1	604641	R, A		{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
11.290	10	25	12	11p11.2	PEX16, PBD8A, PBD8B	P	Peroxisome biogenesis factor 16	603360	R, H		Peroxisome biogenesis disorder 8A, (Zellweger), 614876 (3); Peroxisome biogenesis disorder 8B, 614877 (3)	2(Pex16)
11.291	12	13	96	11p11.2	DDB2	P	Damage-specific DNA binding protein 2, 48kD	600811	A		Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	
11.292	12	29	15	11p11.2	EXT2, SSMS	C	Exostosin 2	608210	Fd, D	mutation identified in 1 SSMS family	Exostoses, multiple, type 2, 133701 (3); ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3)	2(Ext2)
11.293	4	17	07	11p12-p11	PSNP3	P	Supranuclear palsy, progressive, 3	610898	Fd		Supranuclear palsy, progressive, 3 (2)	
11.294	3	14	07	11p11.2	ARHGAP1, RHOGAP1, CDC42GAP	P	RHO GTPase-activating protein 1	602732	R, REc			
11.295	10	2	91	11q24.2	ACRV1	P	Acrosomal vesicle protein-1	102525	REa			
11.296	4	20	11	11p11.2	ACP2	C	Acid phosphatase 2, lysosomal	171650	S, REa		?Lysosomal acid phosphatase deficiency, 200950 (1)	2(Acp2)
11.297	11	19	13	11p11.2	ALX4, PFM2, FPP, FND2, CRS5	P	Aristaless-like 4, mouse, homolog of	605420	REc, Fd		Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3); {Craniosynostosis 5, susceptibility to}, 615529 (3)	
11.298	9	9	10	11p11.2	AMBRA1, KIAA1736	P	Activating molecule in beclin 1-regulated autophagy	611359	R, REc			
11.299	3	14	13	11p11.2	ATG13, KIAA0652, PARATARG8	C	Autophagy 13, S. cerevisiae, homolog of	615088	REc, R			
11.300	12	10	12	11p11.2	C1QTNF4, CTRP4	P	C1q- and tumor necrosis factor-related protein 4	614911	REc, R			
11.301	1	20	06	11p11.2	CD82, SAR2, KAI1, ST6	P	CD82 antigen	600623	M		{Prostate cancer, susceptibility to}, 176807 (2)	
11.302	2	23	08	11p11.2	CKAP5, CHTOG, MSPS, KIAA0097	P	Cytoskeleton-associated protein 5	611142	REa, REc			
11.303	2	11	15	11p11.2	CREB3L1, OASIS	P	cAMP response element-binding protein 3-like 1	616215	REc			
11.304	2	11	15	11p11.2	DGKZ	P	Diacylglycerol kinase, zeta, 104kD	601441	REc			
11.305	6	4	13	11p11.2	FNBP4, FBP30, KIAA1014	P	Formin-binding protein 4	615265	REc			
11.306	10	11	00	11p11.12	FOLH1, FOLH, PSM, PSMA	C	Folate hydrolase 1 (prostate-specific membrane antigen)	600934	A, REc	?pseudogene on 11q14		
11.307	11	15	05	11p11.2	GYLTL1B, LARGE2	P	Glycosyltransferase-like 1B	609709	REc			
11.308	3	7	13	11p11.2	HARBI1	C	Harbinger transposase-derived gene 1	615086	REc, Ch			
11.309	5	12	99	11p11.2	MADD, DENN	P	MAP kinase-activating death domain (differentially expressed in normal and neoplastic cells)	603584	A			
11.310	6	13	12	17p12-p11	NCOR1	P	Nuclear receptor corepressor 1	600849	REc			
11.311	9	14	94	11p11.2	MDK, NEGF2	C	Midkine (neurite growth-promoting factor 2)	162096	REa, A			2(Mdk)
11.312	6	22	14	11p11.2	NUP160, KIAA0197	P	Nucleoporin, 160kD	607614	Psh, REc			
11.313	9	9	13	11p11.2	MYBPC3, CMH4, CMD1MM, LVNC10	C	Myosin-binding protein C, cardiac	600958	A, Fd		Cardiomyopathy, hypertrophic, 4, 115197 (3); Cardiomyopathy, dilated, 1MM, 615396 (3); Left ventricular noncompaction 10, 615396 (3)	
11.314	2	23	15	11p11.2	OI16, C16DELp11.2, DEL16p11.2	P	Osteogenesis imperfecta, type XVI (chromosome 11p11.2 deletion syndrome, 91.3kb)	616229	Ch		Osteogenesis imperfecta, type XVI (4)	
11.315	9	28	10	11p11.2	PHF21A, BHC80, KIAA1696	P	PHD finger protein 21A	608325	R, REc			
11.316	5	19	15	11p11.2	PRDM11, PFM8	P	PR domain-containing protein 11	616347	REc			
11.317	5	13	10	11p11.2	PSS	C	Potocki-Shaffer syndrome	601224	Ch	contiguous gene syndrome caused by deletion of 11p11.2	Potocki-Shaffer syndrome (4)	
11.318	6	27	02	11p11.2	PTPRJ, DEP1	P	Protein tyrosine phosphatase, receptor type, J polypeptide	600925	H, A		Colon cancer, somatic, 114500 (3)	2(Ptprj)
11.319	7	18	14	11q12.2	DAK	P	Dihydroxyacetone kinase 2, S. cerevisiae, homolog of	615844	REc			
11.320	2	10	05	11p11.2	SLC35C1, FUCT1, CDG2C	C	Solute carrier family 35, member C1 (GDP-Fucose transporter 1)	605881	REc		Congenital disorder of glycosylation, type IIc, 266265 (3)	
11.321	10	29	08	11p11.2	SLC39A13	P	Solute carrier family 39 (zinc transporter), member 13	608735	REc		Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, 612350 (3)	
11.322	2	10	00	11p11.2	SPI1, SFPI1	P	Oncogene SPI1	165170	REa, A			
11.323	9	19	88	11p11.2	TYRL	P	Tyrosinase-like	191270	REa, A			
11.324	7	21	15	11p11.2	ZNF408, EVR6, RP72	P	Zinc finger protein 408	616454	REc	mutation identified in 1 EVR6 family	?Exudative vitreoretinopathy 6, 616468 (3); Retinitis pigmentosa 72, 616469 (3)	
11.325	12	4	08	11p11.2	ARFGAP2, ZNF289	P	ADP-ribosylation factor GTPase-activating protein 2	606908	R, REc			
11.326	9	3	04	11p11.2	CHST1, KSGAL6ST	C	Carbohydrate sulfotransferase-1	603797	A, R			
11.327	4	30	15	11p11.2	RAPSN, CMS1D, CMS11, FADS	P	Receptor-associated protein of the synapse, 43kD	601592	REa		Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3); Fetal akinesia deformation sequence, 208150 (3)	
11.328	3	8	07	11q12.1	SLC43A1, LAT3, POV1	P	Solute carrier family 43 (L-type amino acid transporter), member 1	603733	A			
11.329	11	30	06	11p11.2	ALKBH3, PCA1, DEPC1, ABH3	C	AlkB, E. coli, homolog of, 3	610603	REc			
11.330	10	5	11	11q11	OR4C46	P	Olfactory receptor, family 4, subfamily C, member 46	614273	REc			
11.331	7	20	01	11q14.3	RNF18	P	RING finger protein-18	606124	R			
11.332	12	17	12	11p11.2	NDUFS3	C	NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kD	603846	REa, R		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
11.333	1	31	12	11p11.2	ACCS, ACS, PHACS	P	1-aminocyclopropane-1-carboxylate synthase	608405	REc			
11.334	8	2	13	11p11.2	CELF1, CUGBP1, NAB50, BRUNOL2, CUGBP	P	CUGbp and ELAV-like family, member 1	601074	REc			
11.335	5	22	14	11p11	CLLS1	C	Leukemia, chronic lymphocytic, susceptibility to, 1	609630	Fd		{Leukemia, chronic lymphocytic, susceptibility to, 1} (2)	
11.336	12	27	01	11p11.2	PACSIN3	P	Protein kinase C and casein kinase substrate in neurons 3	606513	R			
11.337	5	4	12	11p11.2	F2, THPH1, RPRGL2	C	Coagulation factor II (thrombin)	176930	REa, A		Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3); Thrombophilia due to thrombin defect, 188050 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	2(Cf2)
11.338	12	15	10	11p15.5	CD81, TAPA1, CVID6	P	CD81 antigen (target of antiproliferative antibody-1)	186845	REa		Immunodeficiency, common variable, 6, 613496 (3)	7(Tapa1)
11.339	3	10	00	11p	HYPLIP2	P	Hyperlipidemia, combined, 2	604499	Fd		Hyperlipidemia, combined, 2 (2)	
11.340	12	15	98	11p	NNO1	P	Nanophthalmos 1	600165	Fd		Nanophthalmos-1 (2)	
11.341	8	9	99	11p15.1	RPS13	P	Ribosomal protein S13	180476	Psh, R			
11.342	4	4	02	11q12.1	PRG2, MBP	P	Proteoglycan 2	605601	R, A			
11.343	4	4	02	11q12.1	PRG3, MBPH	P	Proteoglycan 3	606814	A			
11.344	2	11	93	11q13.2	ADRBK1	C	Adrenergic, beta, receptor kinase-1	109635	REa			19(Adrbk1)
11.345	9	16	03	11q14.2	ME3	P	Malic enzyme 3	604626	R			
11.346	12	23	15	11q12.1	TMX2	P	Thioredoxin-related transmembrane protein 2	616715	REc			
11.347	9	4	98	11q12.1	CTNND1, CTNND	P	Catenin (cadherin-associated protein), delta 1	601045	A			2(Catns)
11.348	8	30	07	11q12.2	VWC1, URG11	C	von Willebrand factor C and EGF domain-containing protein	611115	R, REn			
11.349	9	12	91	11q12.1	TCN1, TC1	P	Transcobalamin I	189905	A			
11.350	1	24	09	11q12.1	C1NH, HAE1, HAE2, SERPING1	C	Complement component-1 inhibitor	606860	REa, A		Angioedema, hereditary, types I and II, 106100 (3); Complement component 4, partial deficiency of, 120790 (3)	2(C1nh)
11.351	5	24	13	11q12.2	CCDC86, CYCLON	P	Coiled-coil domain-containing protein 86	611293	REc			19(Ccdc86)
11.352	1	9	14	11q12.1	APLNR, AGTRL1, APJ	P	Apelin receptor	600052	Psh, A			
11.353	11	5	97	11q13.1	ESRRA, ESRL1	P	Estrogen-related receptor, alpha	601998	A			19(Estrra)
11.354	3	18	95	11q12.2	FEN1	P	Flap structure-specific endonuclease 1	600393	A, R			19(Fen1)
11.355	6	10	09	11q13.1	KIND3, URP2, MIG2B, FERMT3	C	Kindlin 3	607901	REc		Leukocyte adhesion deficiency, type III, 612840 (3)	
11.356	7	28	15	11q13.1	LTBP3, LTBP2, DASS	C	Latent transforming growth factor beta binding protein-3	602090	Psh, A, REc		Dental anomalies and short stature, 601216 (3)	19(Ltbp2)
11.357	4	30	09	11q12.1	MIR130A, MIRN130A	P	Micro RNA 130A	610175	REc			
11.358	1	2	08	11q13.1	NAALADL1, I100	P	N-acetylated alpha-linked acidic dipeptidase-like 1	602640	A			
11.359	7	14	98	11q12.1	P2RX3, P2X3	P	Purinergic receptor P2X, ligand-gated ion channel, 3	600843	A			2(P2rx3)
11.360	11	2	04	11q13.4	P4HA3	P	Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 3	608987	REc			
11.361	5	24	13	11q21	PIWIL4, HIWI2, MIWI2	P	PIWI-like 4	610315	REc			
11.362	4	11	11	11q12	SCA20, DUP11q12, C11DUPq12	P	Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb)	608687	Fd	contiguous gene duplication syndrome	Spinocerebellar ataxia 20 (4)	
11.363	5	15	14	11q12.2	SLC15A3, PHT2	P	Solute carrier family 15 (oligopeptide transporter), member 3	610408	REc			
11.364	2	2	01	11q12.1	SSRP1, FACT	P	Structure-specific recognition protein 1	604328	REa			
11.365	7	12	02	11q12.1	TNKS1BP1, TAB182, KIAA1741	P	Tankyrase 1-binding protein 1, 182kD	607104	REc			
11.366	2	1	01	11q12.1	UBE2L6, UBCH8	P	Ubiquitin-conjugating enzyme E2L 6	603890	A			
11.367	8	6	97	11q12.3	AHNAK	P	AHNAK nucleoprotein (desmoyokin)	103390	REa, A, REc			
11.368	5	5	16	11q12.3	B3GAT3, GLCATI, JDSCD	P	Beta-1,3-glucuronyltransferase 3	606374	A	pseudogene on chr.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	
11.369	8	29	02	11q13.1	CDC42EP2, CEP2, BORG1	P	CDC42 effector protein 2	606132	REc			
11.370	12	15	13	11q12.2	DDB1	P	Damage-specific DNA binding protein 1, 127kD	600045	A, H			19(Ddb1)
11.371	2	3	05	11q13.4	DHCR7, SLOS	C	Delta-7-dehydrocholesterol reductase	602858	R		Smith-Lemli-Opitz syndrome, 270400 (3)	
11.372	1	29	01	11q13.1	FLRT1	P	Fibronectin-like domain-containing leucine-rich transmembrane protein-1	604806	A			
11.373	11	19	13	11q12.3	FTH1, FTHL6, HFE5	C	Ferritin, heavy polypeptide 1	134770	REa, H, REn, R	mutation identified in 1 family	?Hemochromatosis, type 5, 615517 (3)	19(Fth)
11.374	2	16	16	11q13.2	KLC2, SPOAN	P	Kinesin, light chain 2	611729	REc, H, Fd		Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3)	19(Klc2)
11.375	5	21	07	11q13.1	MARK2, EMK1	P	MAP/microtubule affinity-regulating kinase 2	600526	A, REa, REn			19(Emk1)
11.376	11	29	01	11q12.1	MS4A3, HTM4, CD20L	P	Membrane-spanning 4-domains, subfamily A, member 3	606498	A			
11.377	12	27	01	11q12.2	MS4A4A, MS4A4	P	Membrane-spanning 4-domains, subfamily A, member 4A	606547	REc			
11.378	11	29	01	11q12.2	MS4A5, TETM4, CD20L2	P	Membrane-spanning 4-domains, subfamily A, member 5	606499	A, R			
11.379	12	27	01	11q12.2	MS4A6A, MS4A6	P	Membrane-spanning 4-domains, subfamily A, member 6A	606548	REc			
11.380	11	27	01	11q12.2	MS4A7, CFFM4	P	Membrane-spanning 4-domains, subfamily A, member 7	606502	REc			
11.381	12	27	01	11q12.2	MS4A8B	P	Membrane-spanning 4-domains, subfamily A, member 8B	606549	REc			
11.382	12	27	01	11q12.2	MS4A12	P	Membrane-spanning 4-domains, subfamily A, member 12	606550	REc			
11.383	12	21	03	11q12.3	NXF1, TAP, MEX67	C	Nuclear RNA export factor 1	602647	REc			
11.384	11	15	95	11q13.1	RELA, NFKB3	C	v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65))	164014	A, REa			
11.385	12	7	03	11q12.2	C11orf9, KIAA0954	P	Chromosome 11 open reading frame 9	608329	REc			
11.386	12	11	02	11q13.2	DPP3	P	Dipeptidyl peptidase III	606818	A			
11.387	5	27	09	11q12.2	FADS1	P	Fatty acid desaturase 1	606148	REc			
11.388	5	27	09	11q12.2	FADS2	P	Fatty acid desaturase 2	606149	REc			
11.389	5	27	09	11q12.2	FADS3	P	Fatty acid desaturase 3	606150	REc			
11.390	2	26	08	11q12.1	MRPL16	P	Mitochondrial ribosomal protein L16	611829	R			
11.391	1	27	04	11q12.2	MS4A4E	P	Membrane-spanning 4-domains, subfamily A, member 4E	608401	REc			
11.392	1	27	04	11q12.2	MS4A6E	P	Membrane-spanning 4-domains, subfamily A, member 6E	608402	REc			
11.393	1	27	04	11q12.2	MS4A10	P	Membrane-spanning 4-domains, subfamily A, member 10	608403	REc			
11.394	6	22	14	11q12.3	MTA2, MTA1L1	P	Metastasis-associated protein 2	603947	A			
11.395	7	20	09	11q12-q13.1	PURAQTL1	P	Polyunsaturated fatty acids plasma level QTL1	612795	Fd	associated with rs174537	[Polyunsaturated fatty acids plasma level QTL1] (2)	
11.396	3	6	01	11q14.1	RAB30	P	Ras-associated protein RAB30	605693	REa, REc			
11.397	5	22	14	11q12.1	CLP1, HEAB, PCH10	P	Cleavage and polyadenylation factor I subunit 1, yeast, homolog of	608757	REc, Psh, A, Ch		Pontocerebellar hypoplasia, type 10, 615803 (3)	
11.398	12	2	14	11q12.1	DTX4, RNF155, KIAA0937	P	Deltex, Drosoophila, homolog of, 4	616110	REc			
11.399	7	23	13	11q12.1	FAM111A, KIAA1895, KCS2, GCLEB	P	Family with sequence similarity 111, member A	615292	REc		Kenny-Caffey syndrome, type 2, 127000 (3); Gracile bone dysplasia, 602361 (3)	
11.400	3	26	14	11q12.1	FAM111B, POIKTMP	P	Family with sequence similarity 111, member B	615584	REc		Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3)	
11.401	8	21	12	11q12.1	GLYAT, ACGNAT, CAT	C	Glycine-N-acyltransferase	607424	R, REc			
11.402	8	21	12	11q12.1	GLYATL1	P	Glycine-N-acyltransferase-like 1	614761	REc			
11.403	8	21	12	11q12.1	GLYATL2	P	Glycine N-acyltransferase-like 2	614762	REc			
11.404	5	6	13	11q12.1	LRRC55	P	Leucine-rich repeat-containing protein 55	615213	REc			
11.405	11	7	08	11q12.1	MED19	P	Mediator complex subunit 19	612385	REc			
11.406	8	19	13	11q12.1	MPEG1, MPG1	P	Macrophage expressed gene 1	610390	R, REc			
11.407	2	19	10	11p11.2	MTCH2	P	Mitochondrial carrier homolog 2	613221	REc			
11.408	3	25	14	11q12.1	OR5AN1	P	Olfactory receptor, family 5, subfamily AN, member 1	615702	REc			
11.409	8	8	13	11q12.1	OR5F1	P	Olfactory receptor, family 5, subfamily F, member 1	608492	REc, A			
11.410	8	8	13	11q12.1	OR5I1, OLF1	P	Olfactory receptor, family 5, subfamily I, member 1	608496	REc, Psh			
11.411	5	7	03	11q12.1	OSBP	C	Oxysterol-binding protein	167040	REa, R			19(Osbp)
11.412	5	29	12	11q12.1	PATL1, PAT1B	P	Protein associated with topoisomerase II, S. cerevisiae, homolog of, 1	614660	REc			
11.413	5	24	13	11q12.1	RTN4RL2, NGRH1, NGR2	P	Reticulon 4 receptor-like 2	610462	REc			
11.414	2	25	15	11q12.1	SELH	P	Selenoprotein H	607914	REc			
11.415	12	14	10	11q12.1	SMTNL1, CHASM	P	Smoothelin-like 1	613664	REc			
11.416	1	21	11	11q12.1	STX3, STX3A	P	Syntaxin 3	600876	REc			
11.417	12	28	08	11q12.1	YPEL4	P	Yippee-like 4	609725	REc			2(Ypel4)
11.418	4	27	12	11q12.1	ZDHHC5, DHHC5, ZNF375, KIAA1748	P	Zinc finger DHHC domain-containing protein 5	614586	REc			
11.419	12	4	02	11q12.1	TIMM10, TIM10A, TIM10	P	Translocase of inner mitochondrial membrane 10, yeast, homolog of	602251	A, R			
11.420	10	23	87	11q12.1-q13.5	FNL2	P	Fibronectin-like-2	135610	S, A			
11.421	7	13	93	11q12.1	CNTF	C	Ciliary neurotrophic factor	118945	REa, A			19(Cntf)
11.422	9	8	11	11q12.2	DAGLA, KIAA0659	C	Diacylglycerol lipase, alpha	614015	REc, R			
11.423	2	23	09	11q12.2	PRPF19, PRP19, PSO4, NMP200	P	Precursor mRNA-processing factor 19, S. cerevisiae, homolog of	608330	R, REc			
11.424	7	23	15	11q12.2	PTGDR2, GPR44	P	Prostaglandin D2 receptor 2	604837	A			
11.425	2	9	12	11q12.2	TMEM138, JBTS16	P	Transmembrane protein 138	614459	REc		Joubert syndrome 16, 614465 (3)	
11.426	2	24	12	11q12.2	TMEM216, JBTS2, CORS2, MKS2	C	Transmembrane protein 216	613277	REc, Fd		Joubert syndrome 2, 608091 (3); Meckel syndrome 2, 603194 (3)	
11.427	6	9	06	11q12.2	VPS37C	P	Vacuolar protein sorting 37, yeast, homolog of, C	610038	R, REc			
11.428	2	11	16	11q12.2	ZP1, OOMD1	P	Zona pellucida glycoprotein 1	195000	REc		Oocyte maturation defect 1, 615774 (3)	
11.429	9	18	08	11q12.3	EEF1G, EF1G	P	Eukaryotic translation elongation factor 1, gamma	130593	REc			
11.430	4	7	11	11q12.3	HRASLS2	C	HRAS-like suppressor 2	613866	REc			
11.431	11	11	14	11q12.3	INCENP	P	Inner centromere protein	604411	R, REc			
11.432	3	23	14	11q12.3	INTS5, INT5, KIAA1698	P	Integrator complex subunit 5	611349	REc			
11.433	2	22	13	11q12.3	SCGB2A1, MGB2, LPNC	P	Secretoglobin, family 2A, member 1 (mammaglobin 2)	604398	A, REc			
11.434	2	22	13	11q12.3	SCGB1D1, LPNA	P	Secretoglobin, family 1D, member 1	615060	REc	previously mapped to 15q12-q13		
11.435	2	22	13	11q12.3	SCGB1D2, LPNB	P	Secretoglobin, family 1D, member 2	615061	REc	previously mapped to 10q23		
11.436	2	22	13	11q12.3	SCGB1D4, IIS	P	Secretoglobin, family 1D, member 4	615062	REc			
11.437	8	18	14	11q12.3	SLC22A9, OAT4, UST3	P	Solute carrier family 22 (organic anion/cation transporter), member 9	607579	REc			
11.438	8	18	14	11q12.3	SLC22A10, OAT5	P	Solute carrier family 22 (organic anion/cation transporter), member 10	607580	REc			
11.439	1	2	08	11q12.3	SLC22A24	P	Solute carrier family 22, member 24	611698	REc			19(Slc22a24)
11.440	1	21	11	11q12.3	STX5, STX5A	P	Syntaxin 5	603189	REc			
11.441	5	29	15	11q12.3	UBXN1, SAKS1	P	UBX domain protein 1	616378	REc			
11.442	12	1	14	11q12.3	UQCC3, C11orf83, MC3DN9	P	Ubiquinol-cytochrome C reductase complex assembly factor 3	616097	REc	mutation identified in 1 MC3DN9 patient	?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3)	
11.443	3	8	07	11q12.3	UST6	P	Organic anion transporter UST6	610792	REc			
11.444	3	23	02	11q12.3	MGB1, SCGB2A2	P	Mammaglobin 1 (secretoglobin, family 2A, member 2)	605562	A, R			
11.445	4	6	11	11q12.3-q13.1	PLA2G16, HRASLS3, HRSL3, HREV107	C	Phospholipase A2, group XVI	613867	REc			
11.446	10	16	14	11q12.3	SCGB1A1, UGB, CC10, CCSP, SCGB1A1	C	Secretoglobin, family 1A, member 1 (uteroglobin)	192020	REa, Fd, REc, A			
11.447	11	24	08	11q13.3	ANO1, TMEM16A, FLJ10261	P	Anoctamin 1, calcium activated chloride channel	610108	REc			7(Tmem16a)
11.448	8	26	98	11q13.1	ARL2	P	ADP=ribosylation factor-like 2	601175	REc			
11.449	12	11	95	11q13.4	ARRB1	C	Arrestin, beta 1	107940	A			
11.450	3	5	03	11q13.2	BBS1	C	BBS1 gene	209901	Fd		Bardet-Biedl syndrome 1, 209900 (3)	
11.451	8	18	14	11q12.3	BSCL2, SPG17, HMN5, PELD	C	Seipin	606158	Fd		Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver spastic paraplegia syndrome, 270685 (3); Neuropathy, distal hereditary motor, type VA, 600794 (3); Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	
11.452	3	29	07	11q13.2	C11orf24	P	Chromosome 11 open reading frame 24	610880	REc			
11.453	3	23	14	11q13.1	C11orf95	P	Chromosome 11 open reading frame 95	615699	REc			
11.454	5	6	16	11q13.1	CAPN1, SPG76	C	Calpain, large polypeptide L1	114220	REb		Spastic paraplegia 76, autosomal recessive, 616907 (3)	
11.455	4	20	10	11q13.2	CARNS1, ATPGD1, KIAA1394	P	Carnosine synthase 1	613368	REc			19(Carns1)
11.456	2	13	14	11q13.3	CCND1, PRAD1, BCL1	C	Cyclin D1	168461	REn, R, REa, A	pseudogene on 11q13	{Colorectal cancer, susceptibility to}, 114500 (3); {von Hippel-Lindau syndrome, modifier of}, 193300 (3); {Multiple myeloma, susceptibility to}, 254500 (3)	
11.457	5	25	00	11q13.2	CCS	P	Copper chaperone for superoxide dismutase	603864	A			9(Ccs)
11.458	6	8	89	11q12.2	CD5, LEU1	C	CD5 antigen (p56-62)	153340	REa, A			19(Ly1)
11.459	12	7	07	11q13.2	CD248, TEM1	P	CD248 antigen	606064	REa, REc			
11.460	9	8	11	11q13.1	CDC42BPG, MRCKG	P	CDC42-binding protein kinase, gamma	613991	REc			
11.461	1	8	97	11q13.1	CFL1	C	Cofilin 1 (non-muscle)	601442	REn, A, Psh, R			19(Cfl1)
11.462	8	6	97	11q12.3	CHRM1	P	Cholinergic receptor, muscarinic, 1	118510	REa, A, REn			
11.463	2	25	16	11q13.1	COX8A	C	Cytochrome c oxidase, subunit VIIIA	123870	A, R, REn	mutation identified in 1 COX4D patient	?Mitochondrial complex IV deficiency, 220110 (3)	
11.464	10	8	98	11q13.3	CPT1A	C	Carnitine palmitoyltransferase I, liver	600528	Psh, A		CPT deficiency, hepatic, type IA, 255120 (3)	
11.465	8	5	97	11q13.1	CST6	P	Cystatin-M	601891	A			
11.466	9	24	08	11q13.3	CTTN, EMS1	P	Cortactin	164765	RE	amplified in breast cancer and squamous cell cancer		
11.467	3	12	01	11q13.1	DANJC4, HSPF2	P	DnaJ, E. coli, homolog of, subfamily C, member 4 (heat-shock 40kD protein 2)	604189	REc			
11.468	12	18	08	11q13.1	DPF2, REQ, UBID4	C	D4, zinc, and double PHD fingers family, member 2	601671	A			6(Req)
11.469	1	30	12	11q13.1	EFEMP2, FBLN4, UPH1, ARCL1B	P	EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4)	604633	REc		Cutis laxa, autosomal recessive, type IB, 614437 (3)	
11.470	5	2	01	11q13.1	EHD1	C	EH domain-containing 1 protein	605888	REc, R			19(Ehd1)
11.471	9	12	93	11q13.1	FAU	C	Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived)	134690	A, REa, REc, R			19(Fau)
11.472	3	8	92	11q13.3	FGF4, HSTF1	C	Fibroblast growth factor-4 (heparin secretory transforming protein-1; Kaposi sarcoma oncogene)	164980	A, REa, RE	coamplified with FGF3 in melanoma		7(Hstf1)
11.473	1	22	07	11q13.3	FGF3, INT2	C	Fibroblast growth factor-3 (oncogene INT2)	164950	REa, A, RE	35kb 5' to HST1	Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	7(Int2)
11.474	12	28	93	11q13.1	FOSL1	P	FOS-like antigen-1	136515	REl			
11.475	2	7	07	11q13.1	GAL3ST3, GAL3ST2	P	Galactose-3-O-sulfotransferase 3	608234	REc			
11.476	5	31	05	11q12.1	GIF, IF	C	Gastric intrinsic factor	609342	REa, H		Intrinsic factor deficiency, 261000 (3)	19(Gif)
11.477	7	6	99	11q13.2	GSTP1, GST3	C	Glutathione S-transferase pi	134660	S, A, REa, R, Fd	formerly called GST1		19(Gst3)
11.478	3	15	04	11q14.1	HBXAP, RSF1	C	Hepatitis B virus X-associated protein	608522	A, REc			
11.479	4	23	08	11q13	HPC14	P	Prostate cancer, hereditary, 14	611958	Fd	associated with rs7931342	{Prostate cancer, hereditary, 14} (2)	
11.480	12	9	98	11q13	IDDM4	C	Insulin-dependent diabetes mellitus-4	600319	Fd		{Diabetes mellitus, insulin-dependent, 4} (2)	
11.481	12	8	09	11q13.1	KAT5, HTATIP, TIP60, ESA1, PLIP	P	K(lysine) acetyltransferase 5	601409	R, REc			
11.482	3	7	01	11q13.1	KCNK4, TRAAK	P	Potassium channel, subfamily K, member 4	605720	R			
11.483	6	6	00	11q13.1	KCNK7	P	Potassium channel, subfamily K, member 7	603940	R			
11.484	4	18	05	11q12.3	LGALS12	P	Lectin, galactoside-binding, soluble, 12	606096	REc			
11.485	9	20	99	11q13.1	MAP4K2, RAB8IP, GCK	P	Mitogen-activating protein kinase kinase kinase kinase 2 (RAB8-interacting protein; germinal center kinase)	603166	REc			
11.486	2	9	11	11q13.1	MEN1	C	Menin	613733	Fd, D	linked distal to PYGM	Multiple endocrine neoplasia 1, 131100 (3); Carcinoid tumor of lung (3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Angiofibroma, somatic (3); Adrenal adenoma, somatic (3)	19(Men1)
11.487	2	22	11	11q13.4	MIR326, MIRN326	P	Micro RNA 326	613755	REc			
11.488	4	29	02	11q13.1	MRPL49, NOF1	P	Mitochondrial ribosomal protein L49	606866	REc			19(Mrpl49)
11.489	9	27	01	11q12.1	MS4A2, FCER1B	C	Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for, beta polypeptide)	147138	Fd, REn		{Atopy, susceptibility to}, 147050 (3)	
11.490	12	15	10	11q12.2	MS4A1, CD20, CVID5	C	Membrane-spanning 4-domains, subfamily A, member 1	112210	REa, A, R		Immunodeficiency, common variable, 5, 613495 (3)	19(Ly44)
11.491	1	7	02	11q13.1	MUS81	P	Mus81, S. cerevisiae, homolog of	606591	A, REc			
11.492	12	17	12	11q13.2	NDUFS8	C	NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kD (NADH-coenzyme Q reductase)	602141	A, REc, R	previously assigned to 3q28	Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
11.493	12	14	11	11q13.2	NDUFV1, UQOR1	P	NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kD	161015	REa, A		Mitochondrial complex I deficiency, 252010 (3)	
11.494	8	29	08	11q13.2	NPAS4, NXF	P	Neuronal PAS domain protein 4	608554	REc			
11.495	6	6	00	11q13.1	NRXN2	P	Neurexin 2	600566	REc			
11.496	8	28	15	11q13.4	NUMA1	C	Nuclear mitotic apparatus protein-1	164009	A, Ch	fused with RARA in APL	Leukemia, acute promyelocytic, somatic, 612376 (3)	
11.497	12	7	07	11q13.3	ORAOV1, TAOS1	P	Oral cancer overexpressed gene 1	607224	REc, H			7(Oraov1)
11.498	5	4	12	11q13	OTDD, DEL11q13, C11DELq13	P	Otodental dysplasia (chromosome 11q13 deletion syndrome)	166750	Ch	between rs9666584 and rs41408348	Otodental dysplasia chromsome deletion syndrome (4)	
11.499	7	15	99	11q13.1	OVOL1	P	Ovo, Drosophila, homolog-like, 1	602313	H, Psh, A			19(Ovol1)
11.500	10	23	87	11q13	PGA3	C	Pepsinogen A3	169710	REa, RE, A			
11.501	10	23	87	11q12.2	PGA4	C	Pepsinogen A4	169720	REa, RE, A			
11.502	10	23	87	11q12.2	PGA5	C	Pepsinogen A5	169730	REa, A	pter-5'HRAS--5'INS--cen		
11.503	1	7	95	11q13.1	PLCB3	C	Phospholipase C, beta 3 (phosphatidylinositol-specific)	600230	REn, Ch	within 900kb of MEN1		19(Plcb3)
11.504	10	13	09	11q13.2	POLD4, POLDS, P12	P	Polymerase, DNA-directed, delta 4	611525	R, REc			
11.505	12	18	08	11q13.2	RBM14, PSP2, COAA, SIP	P	RNA-binding motif protein 14	612409	REc			
11.506	12	29	15	11q13.1	SCYL1, NTKL, SCAR21	P	SCY1-like 1	607982	REc		Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	
11.507	1	26	12	11q13.2	UNC93B1, IIAE1	C	UNC93, C. elegans, homolog of, B1	608204	A		{Herpes simplex encephalitis, susceptibility to, 1}, 610551 (3)	
11.508	7	17	01	11q13.1	PPP1R14B, PLCB3N, PNG	P	Protein phosphatase 1, regulatory subunit 14B	601140	REc			
11.509	8	20	98	11q13.2	PPP1CA, PPP1A	C	Protein phosphatase-1, catalytic subunit, alpha isoform	176875	REa, A, R			7(Ppp1a)
11.510	10	19	97	11q13.1	PPP2R5B	C	Protein phosphatase-2, regulatory subunit B (B56), beta isoform	601644	A, REc			
11.511	1	7	02	11q13.1	PRDX5, AOEB166	P	Peroxiredoxin 5	606583	R			
11.512	3	9	04	11q13.1	PYGM	C	Phosphorylase, glycogen, muscle	608455	REb, Fd, REn		McArdle disease, 232600 (3)	19(Pygm)
11.513	7	17	14	11q13.1	RASGRP2, CDC25L	P	Ras guanyl nucleotide-releasing protein 2	605577	REc	mutation identified in 1 BDPLT18 family	?Bleeding disorder, platelet-type, 18, 615888 (3)	
11.514	6	25	99	11q13.2	RBM4. LARK	P	RNA-binding motif protein-4 (lark, Drosophila, homolog of)	602571	A, R			
11.515	12	18	13	11q13.2	RCE1	P	Ras converting CAAX endopeptidase 1	605385	R, REc			
11.516	2	25	15	11q12.3	RNU22	P	RNA, U22 small nucleolar	603223	A, R			
11.517	2	25	15	11q12.3	RNU25	P	RNA, U25 small nucleolar	603224	A, R			
11.518	11	11	14	11q12.3	RNU26	P	RNA, U26 small nucleolar	603225	A, R			
11.519	11	11	14	11q12.3	RNU27	P	RNA, U27 small nucleolar	603226	A, R			
11.520	11	11	14	11q12.3	RNU28	P	RNA, U28 small nucleolar	603227	A, R			
11.521	11	11	14	11q12.3	RNU29	P	RNA, U29 small nucleolar	603228	A, R			
11.522	11	1	14	11q12.3	RNU30	P	RNA, U30 small nucleolar	603229	A, R			
11.523	11	11	14	11q12.3	RNU31	P	RNA, U31 small nucleolar	603230	A, R			
11.524	7	12	13	11q12.3	ROM1, ROSP1, RP7	P	Rod outer segment membrane protein-1	180721	REa, A	digenic RP with RDS	Retinitis pigmentosa 7, digenic, 608133 (3)	19(Rosp1)
11.525	10	22	99	11q13.1	RTN3, NSPL2	C	Reticulon 3	604249	REa, R, REc	pseudogene on chr.4		
11.526	3	29	07	11q13.2	SAPS3, PP6R3, C11orf23, KIAA1558	C	SAPS domain family, member 3	610879	Psh, REc			
11.527	9	17	92	11q13	SEA	C	Oncogene SEA (S13 avian erythroblastosis)	165110	REa, A, R			19(Sea)
11.528	1	28	01	11q13.1	SF1, ZNF162, D11S636, ZFM1	P	Splicing factor 1 (zinc finger protein-162)	601516	REf, REa, A			
11.529	5	30	00	11q12.3	SLC3A2, MDU1, NACAE	C	Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2	158070	S, H	prob. 11q13		19(Mdu1)
11.530	7	12	02	11q13.1	SLC22A11, OAT4	P	Solute carrier family 22 (organic anion/cation transporter), member 11	607097	REc			
11.531	7	12	02	11q13.1	SLC22A12, OAT4L, URAT1	P	Solute carrier family 22 (urate transporter), member 12	607096	REc		Hypouricemia, renal, 220150 (3)	
11.532	3	9	98	11q13.2	SLC29A2, HNP36, DER12	P	Solute carrier family 29 (nucleoside transporters), member 2 (hydrophobic nucleolar protein, 36kD)	602110	A			19(Hnp36)
11.533	7	2	02	11q13	SMAR	P	Spinal muscular atrophy, chronic distal, autosomal recessive	607088	Fd	no mutations found in IGHMBP2	Spinal muscular atrophy, chronic distal, autosomal recessive (2)	
11.534	5	25	01	11q13.1	SNX15	P	Sorting nexin 15	605964	REc			
11.535	9	9	13	11q13.2	SPTBN2, SCA5, SCAR14	C	Spectrin, beta, nonerythrocytic, 2	604985	R, H, Fd		Spinocerebellar ataxia 5, 600224 (3); Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	19(Spnb3)
11.536	12	9	91	11q13	ST3	C	Suppression of tumorigenicity-3 (tumor-suppressor gene, HELA cell type)	191181	S, D		Cervical carcinoma (2)	
11.537	1	31	01	11q13.1	STIP1, HOP	P	Stress-induced phosphoprotein 1	605063	R			
11.538	4	17	07	11q13.2	SUV420H1, CGI85	P	Suppressor of variegation 4-20, Drosophila, homolog of, 1	610881	REc			
11.539	6	6	00	11q12.2	SYT7	P	Synaptotagmin 7	604146	REc			
11.540	12	7	05	11q13.1	SYVN1, HRD1, KIAA1810	P	Synovial apoptosis inhibitor 1	608046	R, REc			
11.541	1	13	99	11q13.1	TM7SF2, ANG1	P	Transmembrane 7 superfamily, member 2	603414	REc			
11.542	3	14	07	11q13.1	TRPT1	P	Transfer RNA phosphotransferase 1	610470	REc			
11.543	10	08	08	11q13.4	UCP2, BMIQ4	P	Uncoupling protein-2	601693	REc, Fd, REn		{Obesity, susceptibility to, BMIQ4}, 607447 (3)	7(Ucp2)
11.544	5	31	05	11q13.4	UCP3	C	Uncoupling protein-3	602044	REn, R, Psh		{Obesity, severe, and type II diabetes}, 601665 (3)	
11.545	11	5	98	11q12.3	UHG, U22HG	P	U22 host gene	603222	A, R			
11.546	6	25	99	11q13.5	UVRAG	P	UV radiation resistance-associated gene	602493	A, Psh			
11.547	10	5	15	11q12.3	BEST1, VMD2, ARB, RP50	C	Bestrophin 1	607854	Fd, Psh		Macular dystrophy, vitelliform, 2, 153700 (3); Bestrophinopathy, autosomal recessive, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)	
11.548	1	27	97	11q13.1	VEGFB, VRF	P	Vascular endothelial growth factor B	601398	REc, Psh			
11.549	7	7	14	11q22.1	YAP1, COB1	P	Yes-associated protein 1, 65kD	606608	A, REa		Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3); Coloboma, ocular, 120433 (3)	
11.550	10	2	07	11q13.2	YIF1A, YIF1	P	Yip1-interacting factor, S. cerevisiae, homolog of, A	611484	R, REc			
11.551	2	22	11	11q13.1	ZNHIT2, C11orf5, FON	P	Zinc finger HIT domain containing protein 2	604575	REc			
11.552	2	6	08	11q13.2	ACTN3	P	Actinin, alpha-3	102574	REa, A		[Alpha-actinin-3 deficiency] (3); [Sprinting performance] (3)	19(Actn3)
11.553	11	23	09	11q13.4	KCNE3, HOKPP, HYPP	P	Potassium voltage-gated channel, ISK-related subfamily, member 3	604433	R		Brugada syndrome 6, 613119 (3)	
11.554	6	25	99	11q13.5-q14.1	PAK1	P	p21/CDC42/RAC1-activated kinase 1	602590	REc			
11.555	3	25	03	11q13.4	PLEKHB1, PHR1, KPL1	P	Pleckstrin homology domain-containing protein, family B, member 1	607651	A, R, H			7(Tyr)
11.556	10	23	87	11q13-q22	ESA4	C	Esterase-A4	133220	S			9(Es17)
11.557	10	23	87	11q12.3	GANAB	P	Neutral alpha-glucosidase AB	104160	S			
11.558	9	18	12	11q13.1	AP5B1, DKFZp761E198	P	Adaptor-related protein complex 5, beta-1 subunit	614367	REc			
11.559	2	17	15	11q13.1	ATG2A, KIAA0404	P	Autophagy 2, S. cerevisiae, homolog of, A	616225	R, REc			
11.560	2	13	14	11q13.1	ATL3, HSN1F	P	Atlastin 3	609369	REc		Neuropathy, hereditary sensory, type IF, 615632 (3)	
11.561	11	16	09	11q13.1	BAD, BCL2L8	P	BCL1 antagonist of cell death	603167	REc			
11.562	7	1	11	11q13.1	BANF1, BAF, NGPS	P	Barrier to autointegration factor 1	603811	R		Nestor-Guillermo progeria syndrome, 614008 (3)	
11.563	1	15	13	11q13.1	BATF2, SARI	P	Basic leucine zipper transcription factor, ATF-like 2	614983	REc			
11.564	10	26	12	11q13.2	CABP2, DFNB93	C	Calcium-binding protein 2	607314	A, REn		Deafness, autosomal recessive 93, 614899 (3)	
11.565	6	21	15	11q13.2	CABP4, CRSD, CSNB2B	P	Calcium-binding protein 4	608965	REc		Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	
11.566	11	3	11	11q13.1	CATSPER1, CATSPER, SPGF7	P	Cation channel, sperm-associated, 1	606389	REc		Spermatogenic failure 7, 612997 (3)	
11.567	6	22	14	11q13.1	DIPA	P	Delta antigen-interacting protein A	605360	R, REc			
11.568	8	30	11	11q13.1	CCDC88B, GIPIE	P	Coiled-coil domain-containing protein 88B	611205	REc			
11.569	4	5	11	11q13.1	CDCA5, SORORIN	P	Cell division cycle-associated protein 5 (sororin)	609374	R, REc			
11.570	8	19	13	11q13.2	CTSF, CLN13	P	Cathepsin F	603539	A, REa		Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3)	
11.571	2	12	99	11q13.1	CTSW	P	Cathepsin W	602364	A			
11.572	9	20	14	11q13.1	DRAP1	P	DR1-associated protein 1	602289	REc			
11.573	12	18	14	11q13.1	FAM89B, MTVR, LRAP25	P	Family with sequence similarity 89, member B	616128	REc			19(Fam89b)
11.574	11	16	06	11q13.3	FGF19	P	Fibroblast growth factor 19	603891	REc			7(Fgf15)
11.575	12	5	03	11q13.1	FIBP	P	Fibroblast growth factor, acidic, intracellular binding protein	608296	A			
11.576	7	15	09	11q13.2	LRFN4, SALM3	P	Leucine-rich repeat and fibronectin type III domain-containing protein 4	612810	REc, H			19(Lrfn4)
11.577	2	25	15	11q13.1	MACROD1, LRP16	P	Macro domain-containing 1	610400	R, REc			
11.578	5	19	09	11q13.1	MALAT1, PRO1073	C	Metastasis-associated lung adenocarcinoma transcript 1	607924	Ch, REc	fused with TFEB in renal tumors		
11.579	3	23	09	11q13.1	MIR192, MIRN192	P	Micro RNA 192	610939	REc			
11.580	3	23	09	11q13.1	MIR194-2, MIRN194-2	P	Micro RNA 194-2	610941	REc			
11.581	3	1	01	11q13.3	MYEOV	P	Myeloma overexpressed gene	605625	A			
11.582	5	19	09	11q13.1	NCRNA00084, NEAT1, TNCRNA	C	Noncoding RNA 84	612769	REc, H			19(Ncrna00084)
11.583	6	5	08	11q13.1	OTUB1, OTU1, OTB1	P	OTU domain-containing ubiquitin aldehyde-binding protein 1	608337	REc			
11.584	1	14	13	11q13.1-q13.2	PACS1, MRD17	P	Phosphofurin acidic cluster sorting protein 1	607492	REc		Mental retardation, autosomal dominant 17, 615009 (3)	
11.585	10	15	97	11q12.3	POLR2G	P	Polymerase (RNA) II (DNA directed) polypeptide G	602013	R, REc			
11.586	2	4	09	11q13.2	RAB1B	P	Ras-associated protein RAB1B	612565	REc			
11.587	10	12	14	11q13.1	RCOR2	P	Rest corepressor 2	616019	REc			
11.588	5	25	13	11q13.1	RPS6KA4, RSKB, MSK2	P	Ribosomal protein S6 kinase, 90kD, 4	603606	REc			
11.589	9	17	09	11q12.2	SDHAF2, SDH5, PGL2	P	Succinate dehydrogenase complex assembly factor 2	613019	REc, Fd		Paragangliomas 2, 601650 (3)	
11.590	1	2	08	11q13.1	SLC22A20, OAT6	P	Solute carrier family 22, member 20	611696	REc			19(Slc22a20)
11.591	3	12	07	11q13.1	SLC25A45	P	Solute carrier family 25, member 45	610825	REc			19(Slc25a45)
11.592	9	8	11	11q13.1	SPDYC, RINGOC	P	Speedy, xenopus, homolog of, C	614030	REc			
11.593	3	8	07	11q13.2	TBC1D10C, CARABIN	P	TBC1 domain family, member 10C	610831	REc			
11.594	4	29	14	11q13.1	VPS51, ANG2	P	Vacuolar protein sorting 51, S. cerevisiae, homolog of	615738	REc			
11.595	9	13	01	11q13.2	BRMS1	P	Breast cancer metastasis suppressor 1	606259	A			
11.596	6	25	99	11q13.2	RAD9A, RAD9	P	RAD9, S. pombe, homolog of	603761	A, RE			
11.597	2	27	03	11q12.3	SLC22A6, OAT1, PAHT	C	Solute carrier family 22 (organic anion transporter), member 6	607582	REa, R, A			
11.598	12	13	00	11q13.2	TBX10	P	T-box 10	604648	A, REc			19(Tbx10)
11.599	3	23	93	11q13.1	FKBP2	P	FK506-binding protein-2, 13kD	186946	A			
11.600	1	8	95	11q13.1	MAP3K11, MLK3, PTK1, SPRK	P	Mitogen-activated protein kinase kinase kinase 11	600050	A			
11.601	1	5	12	11q13.2	ACY3, HCBP1	P	Aminoacylase 3	614413	REc			19(Acy3)
11.602	4	6	13	11q13.2	ANKRD13D	P	Ankyrin repeat domain-containing protein 13D	615126	REc			
11.603	7	1	13	11q13.2	B3GNT1, IGNT, IGAT, MDDGA13	P	Beta-1,3-N-acetylglucosaminyltransferase 1	605517	R, REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	
11.604	12	1	14	11q13.2	C11orf80	C	Chromosome 11 open reading frame 80	616109	A, REc			
11.605	5	24	13	11q13.2	CNIH2, CNIL	P	Cornichon, Drosophila, homolog of, 2	611288	REc			
11.606	7	22	11	11q13.2	CHKA, CHK	P	Choline kinase, alpha	118491	REc			
11.607	1	24	06	11q13.2	CORO1B	P	Coronin 1B	609849	REc			19(Coro1b)
11.608	3	31	09	11q13.3	MRGPRD, MRGD	P	Mas-related G protein-coupled receptor family, member D	607231	REc			
11.609	3	31	09	11q13.3	MRGPRF, MRGF, RTA	P	Mas-related G protein-coupled receptor family, member F	607233	REc			
11.610	2	28	08	11q13.3	MRPL21	P	Mitochondrial ribosomal protein L21	611834	REc			
11.611	3	5	08	11q13.4	MRPL48	P	Mitochondrial ribosomal protein L48	611853	REc	pseudogene on 6		
11.612	12	5	03	11q13.4	NADSYN1	P	NAD synthetase 1	608285	R, REc			
11.613	9	2	12	11q13.2	PELI3	P	Pellino, Drosophila, homolog of, 3	609827	REc			
11.614	10	15	07	11q13.1	RNASEH2C, AYP1, FLJ20974, AGS3	P	Ribonuclease H2, subunit C	610330	REc, Fd		Aicardi-Goutieres syndrome 3, 610329 (3)	
11.615	4	3	12	11q13.2	SSH3	P	Slingshot, Drosophila, homolog of, 3	606780	R			
11.616	6	7	10	11q13.2	SYT12, SRG1	P	Synaptotagmin 12	606436	REc			
11.617	9	24	08	11q13.3	TPCN2, TPC2, SHEP10	C	Two-pore segment channel 2	612163	REc		[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	
11.618	2	2	01	11q13.3	MTL5, TESMIN	P	Metallothionein-like 5, testis-specific	604374	A			19(Mtl5)
11.619	1	5	15	11q13.3	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	P	Immunoglobulin mu binding protein 2	600502	A		Neuronopathy, distal hereditary motor, type VI, 604320 (3); Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	19(Ighmbp2)
11.620	4	1	08	11q13.2	AIP, XAP2, ARA9	P	Aryl hydrocarbon receptor-interacting protein	605555	REa, A		Pituitary adenoma, growth hormone-secreting, 102200 (3); Pituitary adenoma, prolactin-secreting, 600634 (3); Pituitary adenoma, ACTH-secreting, 219090 (3)	
11.621	11	10	14	11q13.2	CLCF1, BSF3, CLC, CISS2	C	Cardiotrophin-like cytokine	607672	A, R		Cold-induced sweating syndrome 2, 610313 (3)	
11.622	8	3	12	11q13.4	DNAJB13, TSARG6	P	DNAJ/HSP40 homolog, subfamily B, member 13	610263	REc			
11.623	3	10	11	11q13.3	FADD	C	FAS-associating protein with death domain	602457	REa, A		Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations, 613759 (3)	
11.624	2	26	08	11q13.2	MRPL11	P	Mitochondrial ribosomal protein L11	611826	R			
11.625	8	21	07	11q13.3	PPFIA1, LIP1	P	Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha-1	611054	R, REc			
11.626	8	28	97	11q13.2	PTPRCAP, LPAP	P	Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein	601577	A			
11.627	10	17	05	11q13.1	SIPA1, SPA1	C	Signal-induced proliferation-associated gene-1	602180	A, REc, H			19(Spa1)
11.628	12	23	05	11q13.4	XRRA1	P	X-ray radiation resistance-associated 1	609788	REc			
11.629	11	24	08	11q13.4	LRTOMT, LRTOMT1, LRTOMT2, DFNB63	P	Leucine-rich transmembrane O-methyltransferase	612414	REc, REn		Deafness, autosomal recessive 63, 611451 (3)	7(Lrrc51, Tomt)
11.630	3	20	03	11q13.4	PHOX2A, ARIX, CFEOM2	C	Paired-like (astraless) homeobox 2a	602753	REa, A, Fd		Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	7(Arix)
11.631	9	7	10	11q13.3-q13.4	SHANK2, CORTBP1, AUTS17	P	SH3 and multiple ankyrin repeat domains 2	603290	R, REc		{Autism susceptibility 17}, 613436 (3)	
11.632	3	23	93	11q13.3-q13.4	ZNF126	P	Zinc finger protein-126 (HZF-2)	194633	A			
11.633	10	12	09	11q13.4	FOLR1	C	Folate receptor-1, adult	136430	REa, A, Fd, REn	telomeric of FGF3	Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)	
11.634	10	20	92	11q13.4	FOLR2	P	Folate receptor-2 (fetal)	136425	A, REn	23kb from FOLR1		
11.635	7	13	15	11q13.2	GAL, GALN, GLNN, ETL8	P	Galanin	137035	Psh, A	mutation identified in 1 ETL8 family	?Epilepsy, familial temporal lobe, 8, 616461 (3)	19(Glnn)
11.636	3	18	95	11q13.4	RNU15A	P	RNA, U15a small nucleolar	600455	Psh, A, REn	processed from intron of RPS3		
11.637	3	18	95	11q13.4	RPS3	P	Ribosomal protein S3	600454	Psh, A, REn			
11.638	7	13	12	11q13.4	ANAPC15, APC15	P	Anaphase-promoting complex, subunit 15	614717	REc			
11.639	8	22	14	11q13.4	C2CD3, OFD14	P	C2 calcium-dependent domain-containing protein 3	615944	REc	mutation identified in 1 OFD14 patient and 1 OFD14 fetus	?Orofaciodigital syndrome XIV, 615948 (3)	
11.640	2	23	14	11q13.4	CENTD2, ARAP1, KIAA0782	P	Centaurin, delta-2	606646	R, REc			
11.641	1	12	07	11q13.4	CHCHD8, E2IG2	P	Coiled-coil-helix-coiled-coil-helix domain containing 8	608016	REc, R			
11.642	12	2	09	11q13.4	CHRDL2, CHL2, BNF1	P	Chordin-like 2	613127	REc, H			7(Chrdl2)
11.643	3	23	15	11q13.4	CLPB, SKD3, MEGCANN, MGCA7	P	Caseinolytic peptidase B	616254	REc		3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	
11.644	12	18	14	11q13.4	FAM86C1	P	Family with sequence similarity 86, member C1	616124	REc			
11.645	4	22	15	11q13.4	RAM168A, TCRP1, KIAA0280	C	Family with sequence similarity 168, member A	616316	Psh, REc			
11.646	8	22	13	11q13.4	IL18BP	P	Interleukin 18-binding protein	604113	REc			
11.647	2	5	15	11q13.4	LAMTOR1, C11orf59, PDRO	P	Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 1	613510	REc			
11.648	7	26	11	11q13.2	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	C	Low density lipoprotein receptor-related protein-5	603506	H, A, R		Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710 (3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)	19(Lrp5)
11.649	3	7	13	11q13.4	MIR139, MIR139-3p	P	Micro RNA 139	615017	REc			
11.650	5	25	13	11q13.4	PDE2A	P	Phosphodiesterase 2A	602658	REc			
11.651	2	18	08	11q13.4	PGM2L1	P	Phosphoglucomutase 2-like 1	611610	R, REc			
11.652	9	10	07	11q13.4	PPME1	P	Protein phosphatase methylesterase 1	611117	R, REc			
11.653	10	12	90	11q13.4	RAB6A, RAB6	P	Oncogene RAB6	179513	A, REc	previously assigned to 2q14-q21		
11.654	9	18	08	11q13.4	RELT, TNFRSF19L	P	Receptor expressed in lymphoid tissues	611211	R, REc			
11.655	4	20	04	11q13.5	EMSY, C11orf30	P	EMSY gene	608574	A, R, REn	100kb from GARP		
11.656	3	3	03	11q14.1	GAB2	C	GRB2-associated binding protein 2	606203	R, A			7(Gab2)
11.657	2	19	10	11q13.4-q13.5	GDPD5, GDE2, PP1665	P	Glycerophosphodiester phosphodiesterase domain-containing protein 3	609632	REc			
11.658	8	25	04	11q13.2	PC	C	Pyruvate carboxylase	608786	REa, H, A		Pyruvate carboxylase deficiency, 266150 (3)	19(Pc)
11.659	6	26	00	11q13.2	TCIRG1, TIRC7, OC116, OPTB1	C	T-cell immune regulator 1	604592	A, Fd, H		Osteopetrosis, autosomal recessive 1, 259700 (3)	19(oc)
11.660	1	9	94	11p14.1	KCNA4, KCNA8	C	Potassium voltage-gated channel, shaker-related subfamily, member 4	176266	REa, A, H	other map to 11p		2(Kcna4)
11.661	3	23	93	11q13.5	OMP	P	Olfactory marker protein	164340	REa, A			7(Omp)
11.662	10	12	09	11q13.5	ATOD7	P	Dermatitis, atopic, 7	613064	Fd	associated with rs7927894	{Dermatitis, atopic, susceptibility to, 7} (2)	
11.663	2	18	16	11q13.5	DGAT2	P	Diacylglycerol O-acyltransferase 2	606983	R, REc			
11.664	10	4	91	11q13.4	KRTAP5-9, KRN1	C	Keratin associated protein 5-9	148021	A, R			
11.665	6	21	12	11q13.5	LRRC32, GARP, D11S833E	C	Leucine rich repeat containing 32	137207	A, REn			7(Garp)
11.666	8	3	12	11q13.5	MOGAT2, MGAT2	P	Monoacylglycerol O-acyltransferase 2	610270	REc			
11.667	11	26	97	11q13.5	MYO7A, USH1B, DFNB2, DFNA11	C	Myosin VIIA	276903	Fd		Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2, 600060 (3); Deafness, autosomal dominant 11, 601317 (3)	7(sh1, Myo7a)
11.668	3	9	00	11q13.4	NEU3, SIAL3	P	Neuraminidase 3 (membrane sialidase; sialidase 3)	604617	A			
11.669	7	15	99	11q13.4	P2RY2, P2Y2, P2U	C	Purinergic receptor P2Y, G-protein coupled, 2	600041	Psh, A			
11.670	7	15	99	11q13.4	P2RY6, P2Y6	P	Pyrimidinergic receptor P2Y, G protein-coupled, 6	602451	Psh, A			
11.671	7	14	14	11q13.5	PRKRIR	P	PRKR inhibitor, repressor of	607374	REc			
11.672	8	20	15	11q13.5	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	P	Serpin peptidase inhibitor, clade H, member 1	600943	A	mutation identified in 1 OI10 patient	{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3); ?Osteogenesis imperfecta, type X, 613848 (3)	
11.673	6	9	98	11q14.1	THRSP	C	Thyroid hormone responsive SPOT14, rat, homolog of	601926	A			
11.674	1	12	07	11q13.5	TSKU, E2IG4, TSK	P	Tsukushin	608015	REc			
11.675	6	25	99	11q13.5	WNT11	P	Wingless-type MMTV integration site family, member 11	603699	A, Psh			
11.676	3	9	98	11q14.1	CLNS1A, CLNS1B	P	Chloride channel, nucleotide-sensitive, 1A	602158	A	CLNS1B on 6p12.1-q13 = pseudogene?		
11.677	11	21	02	11q14.2	RAB38	C	Ras-family, member RAB38	606281	R, H, REc			7(Rab38, cht)
11.678	3	1	06	11q14.1	AQP11, AQPX1	P	Aquaporin 11	609914	REc			
11.679	7	22	13	11q13.5	B3GNT6	P	Beta-1,3-N-acetylglucosaminyltransferase 6	615315	REc			
11.680	2	21	14	11q13.5	CAPN5, HTRA3, VRNI	C	Calpain 5	602537	R, Fd		Vitreoretinopathy, neovascular inflammatory, 193235 (3)	
11.681	4	17	07	11q14	GCRG224	P	Gastric cancer-related gene 224	610888	REc			
11.682	8	27	15	11q14.2	PICALM, CALM, CLTH, LAP	P	Phosphatidylinositol-binding clathrin assembly protein	603025	Ch	fuses with AF10 in t(10;11)	Leukemia, acute myeloid, somatic, 601626 (3)	
11.683	6	9	98	11q14.1	PRCP, PCP	P	Prolylcarboxypeptidase (angiotensinase C)	176785	Psh, REc, R			
11.684	10	28	02	11q14	SLEH1	P	Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1	607279	Fd		{Systemic lupus erythematosus with hemolytic anemia} (2)	
11.685	7	20	09	11q14.1	SYTL2, SLP2, SLP2A, EXO4, KIAA1597	P	Synaptotagmin-like 2	612880	R, REc			
11.686	12	14	98	11q14-q21	SCZD2	L	Schizophrenia susceptibility locus, chromosome 11-related	603342	Ch		{?Schizophrenia}, 181500 (2)	
11.687	8	25	14	11q14.2	FZD4, EVR1	C	Frizzled, Drosophila, homolog of, 4	604579	A, Fd		Exudative vitreoretinopathy 1, 133780 (3); Retinopathy of prematurity, 133780 (3)	
11.688	10	8	13	11q14.3	TYR, SHEP3, CMM8, OCA1A, ATN	C	Tyrosinase	606933	REa, A, H, F		Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg syndrome/albinism, digenic, 103470 (3); Albinism, oculocutaneous, type IB, 606952 (3); [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3); [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	7(Tyr)
11.689	5	15	08	11q14-q22	IHPS3	P	Pyloric stenosis, infantile hypertrophic, 3	612017	Fd	max lod at rs541821	Pyloric stenosis, infantile hypertrophic, 3 (2)	
11.690	3	23	14	11q14.1	INTS4, INT4	P	Integrator complex subunit 4	611348	REc			
11.691	2	25	15	11q14.1	NARS2, COXPD24	P	Asparaginyl-tRNA synthetase 2	612803	REc		Combined oxidative phosphorylation deficiency 24, 616239 (3)	
11.692	5	25	13	11q14.1	NDUFC2	P	NADH-ubiquinone oxidoreductase 1, subunit C2	603845	REc			
11.693	9	16	12	11q14.1	PCF11, KIAA0824	P	PCF11, yeast, homolog of	608876	REc			
11.694	1	13	16	11q14.1	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	P	Teneurin transmembrane protein 4	610084	REc, R, H		Tremor, hereditary essential, 5, 616736 (3)	7(Odz4)
11.695	11	19	13	11q14.1	TMEM126B	P	Transmembrane protein 126B	615533	REc			
11.696	12	21	12	11q14.2	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	C	Cathepsin C	602365	A, REc, Fd		Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010 (3); Periodontitis 1, juvenile, 170650 (3)	7(Ctsc)
11.697	9	2	09	11q14.1	TMEM126A, OPA7	P	Transmembrane protein 126A	612988	REc		Optic atrophy 7, 612989 (3)	
11.698	4	1	16	11q14.2	C11orf73, HIKESHI, HLD13	P	Hikeshi	614908	REc		Leukodystrophy, hypomyelinating, 13, 616881 (3)	
11.699	5	19	15	11q14.2	TMEM135, PMP52	P	Transmembrane protein 135	616360	REc			
11.700	4	19	12	11q14.2-q14.3	GRM5, MGLUR5	P	Glutamate receptor, metabotropic, 5	604102	REc			7(Grm5)
11.701	7	12	02	11q14.3	NOX4, RENOX	C	NADPH oxidase 4	605261	REc, A			
11.702	6	8	01	11q14.2	EED, WAIT1	P	Embryonic ectoderm development protein, mouse, homolog of	605984	A			
11.703	8	3	12	11q13.2	RHOD, ARHD, RHOHP1	P	Ras homolog gene family, member D	605781	R			
11.704	3	24	11	11q21	SLC36A4, PAT4	P	Solute carrier family 36, member 4	613760	REc			
11.705	1	18	11	11q14.3	UBTFL1, HMGPI	P	Upstream binding transcription factor (RNA polymerase I)-like 1	613696	REc			
11.706	12	17	08	11q14.3	FAT3	C	FAT tumor suppressor, Drosophila, homolog of, 3	612483	R, REc			
11.707	1	2	08	11q14.3	NAALAD2	P	N-acetylated alpha-linked acidic dipeptidase 2	611636	A			
11.708	5	29	12	11q21	AMOTL1, JEAP	P	Angiomotin-like 1	614657	REc			
11.709	7	14	14	11q21	C11orf54, PTOD012	P	Chromosome 11 open reading frame 54	615810	REc			
11.710	9	21	11	11q21	C11orf75, FN5	C	FN5, pufferfish, homolog of	609477	R, Psh			
11.711	7	28	11	11q21	CEP57, PIG8, TSP57, KIAA0092, MVA2	P	Centrosomal protein 57kD	607951	REc		Mosaic variegated aneuploidy syndrome 2, 614114 (3)	
11.712	6	25	99	11q14.1	DLG2	P	Discs large, Drosophila, homolog of, 2 (channel-associated protein of synapses, 110kD)	603583	R, REc			
11.713	4	22	05	11q21	GPR83, GIR, GPR72	P	G protein-coupled receptor 83	605569	R			9(Gpr83)
11.714	4	29	14	11q21	FOLR4	C	Folate receptor 4	615737	REc			9(Folr4)
11.715	5	19	94	11q21	FUT4, FCT3A, CD15	C	Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)	104230	S, REa, R			9(Fut4)
11.716	12	28	08	11q21	JMJD2D	P	Jumonji domain-containing protein 2D	609766	REc, REn			
11.717	11	3	98	11q21	JRKL, HHMJG	P	Jerky, mouse, homolog-like	603211	A			
11.718	9	29	15	11q21	KDM4E, JMJD2E	P	Lysine-specific demethylase 4E	616581	REc			
11.719	3	3	03	11q21	MAML2, MAM3	P	Mastermind-like 2	607537	Ch	t(11;19)	Mucoepidermoid salivary gland carcinoma (3)	
11.720	12	21	10	11q21	MED17, CRSP6, CRSP77, TRAP80, DRIP80	P	Mediator complex subunit 17	603810	R, REc		Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	
11.721	12	29	99	11q21	MRE11A, MRE11, ATLD	P	Meiotic recombination 11, S. cerevisiae, homolog A of	600814	REa, A	like gene on 7q11.2-q11.3	Ataxia-telangiectasia-like disorder, 604391 (3)	
11.722	8	8	13	11q21	PANX1, PX1	P	Pannexin 1	608420	REc, R			
11.723	5	13	03	11q21	SEST3	P	Sestrin 3	607768	A			10(Sest3)
11.724	7	16	09	11q21	TAF1D, RAFI41, JOSD3	P	TATA box-binding protein-associated factor 1D	612823	REc			
11.725	2	21	10	11q21-q22	FGQTL3	P	Fasting plasma glucose level QTL 3	613233	Fd	associated with rs10830963	[Fasting plasma glucose level QTL 3] (2)	
11.726	8	18	98	11q22.3	GUCY1A2, GUC1A2	P	Guanylate cyclase 1, soluble, alpha 2	601244	A			
11.727	9	29	96	11q22.2	MMP7	C	Matrix metalloproteinase 7 (matrilysin, uterine)	178990	H, REa, Psh, A			
11.728	11	15	94	11q22.2	MMP8, CLG1	P	Matrix metalloproteinase 8 (neutrophil collagenase)	120355	A			
11.729	3	30	12	11q14.3	MTNR1B	P	Melatonin receptor 1B	600804	REa		{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	
11.730	9	9	13	11q21	MIR1260B	P	Micro RNA 1260B	615372	REc			
11.731	7	6	05	11q22.1	TRPC6, TRP6, FSGS2	C	Transient receptor potential channel-6	603652	A, Fd		Glomerulosclerosis, focal segmental, 2, 603965 (3)	
11.732	10	17	02	11q22.1	CNTN5, NB2	P	Contactin 5	607219	A			
11.733	4	1	03	11q22.1	ANGPTL5	P	Angiopoietin-like 5	607666	REc			
11.734	3	21	14	11q22.3	CARD16, COP1	P	Caspase recruitment domain-containing protein 16	615680	REn			
11.735	10	27	92	11q22.3	FDX1, ADX	C	Ferredoxin-1 (adrenodoxin)	103260	REa, A	pseudogene on 20q11-q12		
11.736	8	1	05	11q22.3	INCA	P	Inhibitory caspase recruitment domain protein	609490	REc			
11.737	5	28	03	11q21	MTMR2, CMT4B1	C	Myotubularin-related protein 2	603557	A, R, Psh		Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	
11.738	10	21	02	11q22.1	PGR	C	Progesterone receptor	607311	REa, A, REb	11q13 = earlier regionalization	?Progesterone resistance, 264080 (2)	9(Pgr)
11.739	12	19	11	11q21	SRSF8, SFRS2B, SRp46	P	Splicing factor, arginine/serine-rich, 8	603269	A			
11.740	9	22	98	11q22.2	API2, HAIP1	P	Apoptosis inhibitor-2	601721	A	fused with MALT1 in MALT lymphoma		
11.741	7	6	99	11q22.2	API1, HIAP2	P	Apoptosis inhibitor-1	601712	A			
11.742	11	4	98	11q24.2	CHEK1, CHK1	P	Checkpoint kinase 1, S. pombe, homolog of	603078	R			
11.743	2	17	09	11q24.1	CRTAM	P	Cytotoxic and regulatory T-cell molecule	612597	REc, H			9(Crtam)
11.744	1	7	99	11q22.3	CUL5, VACM1	P	Cullin-5 (vasopressin-activated calcium-mobilizing receptor-1)	601741	REc			
11.745	4	30	96	11q22.3	DDX10	P	DEAD/H box-10 (RNA helicase)	601235	REa, Ch	400kb telomeric to ATM; pseudogene on 9q21-q22; fused with NUP98 in AML		
11.746	3	1	94	11q22.3	GRIA4, GLUR4	P	Glutamate receptor, ionotropic, AMPA 4	138246	Psh, A			9(Glur4)
11.747	3	9	98	11q23.1	HSPB2	P	Heat-shock 27kD protein-2	602179	REc			
11.748	6	24	08	11q22.2	MMP1, CLG	C	Matrix metalloproteinase 1 (interstitial collagenase)	120353	REn		COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)	
11.749	5	28	98	11q22.3	SLN	P	Sarcolipin	602203	Psh, R			
11.750	10	15	98	11q23.1	PPP2R1B	P	Protein phosphatase 2, structural/regulatory subunit A, beta	603113	REc, R		Lung cancer, 211980 (3)	
11.751	6	27	08	11q23.3	TECTA, DFNA8, DFNA12, DFNB21	C	Tectorin, alpha	602574	Psh, REc		Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal recessive 21, 603629 (3)	
11.752	4	24	90	11q22-qter	ANC	L	Anal canal carcinoma	105580	Ch	3p22 also deleted	?Anal canal carcinoma (2)	
11.753	8	12	14	11q22.1	ARHGAP42, GRAF3	C	Rho GTPase-activating protein 42	615936	REc			
11.754	6	1	12	11q22.1	KIAA1377	P	KIAA1377 gene	614634	R, REc			
11.755	7	9	06	11q22.2	TMEM123, PORIMIN	P	Transmembrane protein 123	606356	REc			
11.756	8	20	98	11q22.3	CASP1, IL1BC	C	Caspase 1, apoptosis-related cysteine protease (interleukin-1, beta convertase)	147678	REa, A			9(Ilb1bc)
11.757	3	16	99	11q22.3	CASP4	P	Caspase 4, apoptosis-related cysteine protease	602664	REc			
11.758	3	16	99	11q22.3	CASP5	P	Caspase 5, apoptosis-related cysteine protease	602665	REc			
11.759	6	25	99	11q23.1	IL18, IGIF	P	Interleukin-18	600953	R, Psh			
11.760	5	19	97	11q22.2	MMP12	P	Matrix metalloproteinase 12 (macrophage elastase)	601046	A			
11.761	3	16	10	11q22.3	ALKBH8, ABH8	P	AlkB, E. coli, homolog of, 8	613306	REc			
11.762	1	27	16	11q22.3	ATM, ATA, AT1	C	Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)	607585	Fd, C, M		Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin, somatic (3); {Breast cancer, susceptibility to}, 114480 (3); Lymphoma, mantle cell, somatic (3); T-cell prolymphocytic leukemia, somatic (3)	9(Atm)
11.763	3	21	14	11q22.3	CARD18, ICEBERG	P	Caspase recruitment domain-containing protein 18	605354	REc			
11.764	5	31	05	11q22.3	CASP12, CASP12P1	P	Caspase 12, apoptosis-related cysteine protease	608633	REc		{Sepsis, susceptibility to} (3)	
11.765	8	26	15	11q22.3	DCUN1D5, SCCRO5	P	DCN1 domain-containing protein 5	616522	REc, Ch			
11.766	2	11	14	11q22.3	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	P	Dynein, cytoplasmic-2, heavy chain-1	603297	Psh, R, REc	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	
11.767	12	10	13	11q22.3	ELMOD1	P	ELMO/CED12 domain-containing protein 1	615456	REc			
11.768	1	24	13	11q22.3	EXPH5, SLAC2B, KIAA0624	P	Exophilin 5	612878	R, REc		Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3)	
11.769	1	7	95	11q23.3	GRIK4	P	Glutamate receptor, ionotropic, kainate 4	600282	REa, A			9(Grik4)
11.770	10	12	09	11q22.2	MMP13, CLG3, MANDP1	C	Matrix metalloproteinase 13 (collagenase 3)	600108	A, REn, Fd		Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3); Metaphyseal anadysplasia 1, 602111 (3)	
11.771	1	12	99	11q22.3	NPAT, E14	P	Nuclear protein, ataxia-telangiectasia locus	601448	REn, REc			
11.772	12	28	08	11q22.3	PDGFD, SCDGFB, IEGF	P	Platelet-derived growth factor D	609673	REc, R			
11.773	1	9	13	11q22.3	ZC3H12C, MCPIP3	P	Zinc finger CCCH domain-containing protein 12C	615001	REc			
11.774	7	13	94	11q22.2	MMP10, STMY2	P	Matrix metalloproteinase 10 (stromelysin 2)	185260	A			
11.775	8	4	09	11q22.2	MMP20, AI2A2	P	Matrix metalloproteinase-20 (enamelysin)	604629	A		Amelogenesis imperfecta, type IIA2, 612529 (3)	
11.776	10	29	03	11q22.3	ACAT1	C	Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase)	607809	A	cluster: cen-STMY2-CLG-STMY1-ter	Alpha-methylacetoacetic aciduria, 203750 (3)	
11.777	1	22	08	11q23.1	BCDO2, BCO2	P	Beta-carotene dioxygenase 2	611740	R, REc			
11.778	8	6	13	11q23.1	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	C	Crystallin, alpha B	123590	REa, A, Ch		Myopathy, myofibrillar, 2, 608810 (3); Cataract 16, multiple types, 613763 (3); Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3); Cardiomyopathy, dilated, 1II, 615184 (3)	
11.779	4	15	09	11q23.1	PTS	P	6-pyruvoyltetrahydropterin synthase	612719	A		Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)	
11.780	5	19	16	11q23.1	ALG9, DIBD1, CDG1L, GIKANIS	C	Alg9, yeast, homolog of	606941	REc, Ch		Congenital disorder of glycosylation, type Il, 608776 (3); Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	
11.781	12	20	05	11q23.3	AMICA1, JAML	P	Adhesion molecule, interacts with CXADR antigen 1	609770	REc			
11.782	7	21	06	11q23.3	APOA1	C	Apolipoprotein A-I	107680	REa, RE, Fd, F, D		ApoA-I and apoC-III deficiency, combined (3); Hypoalphalipoproteinemia, 604091 (3); Corneal clouding, autosomal recessive (3); Amyloidosis, 3 or more types, 105200 (3)	9(Apoa1)
11.783	11	24	14	11q23.3	APOC3, HALP2	C	Apolipoprotein C-III	107720	REa, RE, F	2.6kb 3' to APOA1	Apolipoprotein C-III deficiency, 614028 (3)	
11.784	3	15	91	11q23.3	APOA4	C	Apolipoprotein A-IV	107690	F, RE	12 kb 3' to APOA1		9(Apoa4)
11.785	11	14	05	11q23.3	APOA5	C	Apolipoprotein A-V	606368	REc	proximal to APOA1, APOC3, APOA4	{Hypertriglyceridemia, susceptibility to}, 145750 (3); Hyperchylomicronemia, late-onset, 144650 (3)	
11.786	5	18	05	11q23	BMND5	P	Bone mineral density QTL 5	609354	Fd	between D11S901 and D11S925	[Bone mineral density QTL 5] (2)	
11.787	11	13	94	11q23	BRCATA	P	Breast cancer, 11;22 translocation associated	600048	Ch	associated with t(11;22)(q23;q11)	Breast cancer, 11:22 translocation associated (1)	
11.788	2	27	01	11q23.1	BTG4, PC3B	P	B-cell translocation gene 4	605673	R			
11.789	2	5	14	11q23.3	CD3D, T3D, IMD19	C	CD3D antigen, delta polypeptide (TiT3 complex)	186790	REa, A, RE	3 CD3 genes in 50kb	Immunodeficiency 19, 615617 (3)	9(T3d)
11.790	2	10	14	11q23.3	CD3E, IMD18	P	CD3E antigen, epsilon polypeptide (TiT3 complex)	186830	REa, A, RE		Immunodeficiency 18, 615615 (3); Immunodeficiency 18, SCID variant, 615615 (3)	9(T3e)
11.791	2	2	14	11q23.3	CD3G, IMD17	C	CD3G antigen, gamma polypeptide (TiT3 complex)	186740	RE, REa, A		Immunodeficiency 17, CD3 gamma deficient, 615607 (3)	9(T3g)
11.792	3	23	14	11q23.1	COLCA1	P	Colorectal cancer-associated gene 1	615693	REc			
11.793	3	23	14	11q23.1	COLCA2	P	Colorectal cancer-associated gene 2	615694	REc	opposite strand from COLCA1		
11.794	8	20	08	11q23	CRCS7	P	Colorectal cancer, susceptibility to, 7	612232	Fd	associated with rs3802842	{Colorectal cancer, susceptibility to, 7} (2)	
11.795	2	11	08	11q23.3	DSCAML1, KIAA1132	C	Down syndrome cell adhesion molecule-like 1	611782	R, A, H			9(Dscaml1)
11.796	8	3	12	11q24.2	EI24, PIG8, EPG4	P	Etoposide-induced 1.4 mRNA	605170	A			9(Ei24)
11.797	11	1	00	11q23.3	FXYD2, ATP1G1, HOMG2	C	FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide)	601814	REc, Fd		Hypomagnesemia 2, renal, 154020 (3)	
11.798	11	21	00	11q23	GTS	L	Gilles de la Tourette syndrome	137580	Fd	several loci suspected (e.g., 17q25)	Tourette syndrome (2)	
11.799	3	7	13	11q13.4	INPPL1, OPSMD	P	Inositol polyphosphate phosphatase-like 1	600829	Psh		Opsismodysplasia, 258480 (3)	
11.800	7	20	06	11q23	JBS	C	Jacobsen syndrome	147791	Ch	contiguous gene deletion syndrome	Jacobsen syndrome (4)	
11.801	3	14	14	11q23.3	KMT2A, MLL, HRX, HTRX1, WDSTS	C	Lysine (K)-specific methyltransferase 2E	159555	Ch, RE	fuses with ENL, AF4, AF9, GMPS	Wiedemann-Steiner syndrome, 605130 (3); Leukemia, myeloid/lymphoid or mixed-lineage (2)	9(All1)
11.802	5	4	12	11q23.3	MFRP, MCOP5, NNO2	P	Membrane-type frizzled-related protein	606227	REc		Microphthalmia, isolated 5, 611040 (3); Nanophthalmos 2, 609549 (3)	
11.803	3	31	03	11q22.2	MMP3, STMY1, CHDS6	C	Matrix metalloproteinase 3 (stromelysin 1, progelatinase)	185250	REa, A		{Coronary heart disease, susceptibility to, 6}, 614466 (3)	
11.804	6	7	10	11q23	NAFLD2	P	Fatty liver disease, nonalcoholic, susceptibility to, 2	613387	Fd	associated with rs2854116, rs2854117	{Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)	
11.805	10	2	98	11q23.3	PAFAH1B2	C	Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit	602508	R, REc, A			
11.806	1	5	07	11q23.3	PDZD3, IKEPP	P	PDZ domain-containing 3	607146	REc			
11.807	1	31	01	11q12.3	RARRES3, TIG3	P	Retinoic acid receptor responder 3	605092	REc			
11.808	8	22	07	11q22.3	RDX, DFNB24	C	Radixin	179410	REa, Psh, A		Deafness, autosomal recessive 24, 611022 (3)	
11.809	7	20	01	11q23.3	RNF26	P	RING finger protein-26	606130	REc			
11.810	9	9	13	11q23.3	SCN2B, ATFB14	C	Sodium channel, voltage-gated, type II, beta polypeptide	601327	H, A, REc, R		Atrial fibrillation, familial, 14, 615378 (3)	9(Scn2b)
11.811	7	30	14	11q23.3	SCN4B, LQT10, ATFB17	P	Sodium channel, voltage-gated, type IV, beta subunit	608256	REc		Long QT syndrome-10, 611819 (3); Atrial fibrillation, familial, 17, 611819 (3)	
11.812	7	31	15	11q23.1	SDHD, PGL1, CWS3	C	Succinate dehydrogenase complex, subunit D, integral membrane protein	602690	A		Paragangliomas 1, with or without deafness, 168000 (3); Pheochromocytoma, 171300 (3); Carcinoid tumors, intestinal, 114900 (3); Merkel cell carcinoma, somatic (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden syndrome 3, 615106 (3); Mitochondrial complex II deficiency, 252011 (3)	
11.813	5	19	09	11q23.3	SLC37A4, G6PT1	C	Solute carrier family 37 (glucose-6-phosphate transporter), member 4	602671	Fd, Psh, R		Glycogen storage disease Ib, 232220 (3); Glycogen storage disease Ic, 232240 (3)	
11.814	6	20	94	11q23	TCPT	L	Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome)	188025	Ch	contiguous gene deletion of 11q23	?Thrombocytopenia, Paris-Trousseau type (4)	
11.815	6	9	06	11q23.3	TMPRSS13, MSPL, MSPS	P	Transmembrane protein, serine 13	610050	R, REc			
11.816	7	10	08	11q23.3	TREH	P	Trehalase	275360	H, REc		Trehalase deficiency, 612119 (1)	9(Treh)
11.817	12	31	99	11q23	TSG11	P	Tumor suppressor gene on chromosome 11	603040	D		{Nonsmall cell lung cancer} (2)	
11.818	2	7	07	11q23.2	USP28, KIAA1515	C	Ubiquitin-specific protease 28	610748	R, REc			
11.819	7	20	12	11q24.2	VWA5A, LOH11CR2A, BCSC1	C	von Willebrand factor A domain-containing protein 5A	602929	REc			
11.820	2	23	09	11q23-q24	ADIPQTL4	P	Adiponectin, serum level of, quantitative trait locus locus 4	612629	Fd	between D11S925 and D11S968	{Adiponectin, serum level of, QTL4} (2)	
11.821	3	29	16	11q24.2	SRPRA, SRPR, DP	C	Signal recognition particle receptor, alpha subunit	182180	REa, A, Psh			
11.822	12	19	11	11q24.2	TIRAP, BACTS1	P	TIR domain-containing adaptor protein	606252	R		{Pneumococcal disease, invasive, protection against}, 610799 (3); {Bacteremia, protection against}, 614382 (3); {Malaria, protection against}, 611162 (3); {Tuberculosis, protection against}, 607948 (3)	
11.823	5	31	05	11q24.2	ROBO3, RBIG1, RIG1, HGPPS	C	Roundabout, Drosophila, homolog of, 3	608630	Fd, R, REc		Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)	
11.824	2	25	15	11q23.1	DIXDC1, CCD1, KIAA1735	P	DIX domain-containing protein 1	610493	REc			
11.825	1	23	09	11q23.1	DLAT, PDCE2	P	Dihydrolipoamide S-acetyltransferase	608770	A		Pyruvate dehydrogenase E2 deficiency, 245348 (3)	
11.826	10	20	15	11q23.2	DRD2	C	Dopamine receptor D2	126450	Fd, REa, Ch	11q22-q23 junction; 150kb 5' to NCAM; centromeric to APOA1; telomeric to STMY1		
11.827	10	23	87	11q23.1	EBVM1	P	Epstein-Barr virus modification site-1	132860	V			
11.828	3	9	00	11q23.2	HTR3B	P	5-hydroxytryptamine receptor 3B	604654	REc			
11.829	3	23	14	11q23.1	MIR34B	P	Micro RNA 34B	611374	REc			
11.830	4	2	16	11q23.1	MIR34C	P	Micro RNA 34C	611375	REc			
11.831	8	20	98	11q23.2	NCAM1, MSK39	C	Neural cell adhesion molecule 1	116930	A, Fd	defective in "staggerer" in mice		9(Ncam)
11.832	10	4	05	11q23.2	NNMT	C	Nicotinamide N-methyltransferase	600008	A		Homocysteine plasma level (2)	
11.833	4	23	96	11q23.1	POU2AF1, OBF1	P	POU domain, class 2, associating factor 1	601206	REa, A			
11.834	8	21	12	11q23.1	SIK2, KIAA0781	P	Salt-inducible kinase 2	608973	R, REc			
11.835	12	4	08	11q23.2	ZBTB16, ZNF145, PLZF	C	Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger)	176797	Ch, A	fused with RARA in APL of t(11;17) type	Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	9(lu)
11.836	12	9	95	11q23.2	HTR3	P	5-hydroxytryptamine (serotonin) receptor-3	182139	REa, A			
11.837	12	18	08	11q23.2	RBM7	P	RNA-binding motif protein 7	612413	REc			
11.838	9	28	05	11q23.2	REXO2, RFN	P	RNA exonuclease 2, S. cerevisiae, homolog of	607149	REc			
11.839	3	23	93	11q24.3	ZNF123	P	Zinc finger protein-123 (HZF-1)	194630	A			
11.840	3	23	93	11q23.1-q23.2	ZNF125	P	Zinc finger protein-125 (HZF-3)	194632	A			
11.841	11	15	06	11q23.2	ANKK1	C	Ankyrin repeat and kinase domain containing 1	608774	REc, REn		Dopamine receptor D2, reduced brain density of (3)	
11.842	5	14	09	11q23.1	C11orf34, PLET1	P	Chromosome 11 open reading frame 34	611904	REc, H			9(Plet1)
11.843	5	28	99	11q23.3	TAGLN, SMCC, SM22	P	Transgelin	600818	Psh, R			9(Tagln)
11.844	2	28	01	11q23.3	IGSF4	P	Immunoglobulin superfamily, member 4	605686	REc			
11.845	1	30	07	11q23.2	TTC12, TPARM	P	Tetratricopeptide repeat domain 12	610732	REc			
11.846	2	2	16	11q23.2	ZW10	P	Zeste-white 10, Drosophila, homolog of	603954	R			
11.847	3	2	98	11q23.3	H2AX	P	H2AX histone	601772	A			
11.848	3	8	07	11q24.1	SORL1, LR11, SORLA	C	Sortilin-related receptor, L(DLR class) A repeats-containing	602005	A		{Alzheimer disease, pathogenesis, association with}, 104300 (3)	
11.849	5	22	03	11q23.3	ABCG4, WHITE2	P	ATP-binding cassette, subfamily G, member 4	607784	REc, H			9(Abcg4)
11.850	12	11	95	11q23.3	ARCN1	P	Archain 1	600820	Ch	60kb telomeric to MLL		
11.851	6	25	15	11q23.3	ARHGEF12, LARG, KIAA0382	P	Rho guanine nucleotide exchange factor 12, leukemia-associated	604763	A, R	fused with MLL in AML		
11.852	2	20	01	11q23.3	BACE1, BACE	C	Beta-site amyloid beta A4 precursor protein-cleaving enzyme (secretase, beta; memapsin 2)	604252	REc, R			
11.853	10	3	11	11q23.3	BACE1AS	P	BACE1 antisense RNA	614263	REc			
11.854	11	2	04	11q23.3	BCL9L	P	B-cell CLL/lymphoma 9-like	609004	REc			
11.855	5	31	05	11q23.3	C1QTNF5, CTRP5, LORD	C	C1q- and tumor necrosis factor-related protein 5	608752	REn, REc		Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	
11.856	5	19	16	11q23.3	CBL, CBL2, NSLL	C	Cas-Br-M ecotropic retroviral transforming sequence (Oncogene CBL2)	165360	REa, Ch	mutation identified in 1 JMML family	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3); ?Juvenile myelomonocytic leukemia, 607785 (3)	9(Cbl2)
11.857	10	4	12	11q23.3	CEP164, KIAA1052	P	Centrosomal protein, 164kD	614848	R, REc		Nephronophthisis 15, 614845 (3)	
11.858	9	9	08	11q23.3	CXCR5, BLR1	P	Chemokine, CXC motif, receptor 5	601613	REc			
11.859	3	4	96	11q23.3	DDX6, HLR2	P	DEAD/H box-6 (RNA helicase, 54kD)	600326	Ch, REn			9(Ddx6)
11.860	4	30	15	11q23.3	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	C	Dolichyl-phosphate N-acetylglucosamine phosphotransferase	191350	R, REa, A		Congenital disorder of glycosylation, type Ij, 608093 (3); Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	17(Dpagt2)
11.861	1	13	93	11q24.3	ETS1	C	Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1	164720	REa, A, Ch	shown by HSR; 19cM distal to THY1; Ewing sarcoma breakpoint region-2 splices to EWSR1		9(Ets1, Fli1)
11.862	4	29	14	11q23.3	FOXR1, FOXN5	P	Forkhead box R1	615755	REc			
11.863	7	18	12	11q23.3	HDLCQ14, HYLAP	P	High density lipoprotein cholesterol level quantitative trait locus 14	605201	Fd		High density lipoprotein cholesterol level QTL14 (2)	
11.864	1	13	06	11q23.3	HMBS, PBGD, UPS	C	Hydroxymethylbilane synthase	609806	S, D, Fd, REn		Porphyria, acute intermittent, 176000 (3); Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	9(Ups)
11.865	1	12	11	11q23.3	IL10RA, IL10R, IBD28	C	Interleukin-10 receptor, alpha	146933	REa, A		Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	
11.866	5	24	13	11q23.3	LRRC35, EL	P	Leucine-rich repeat-containing protein 35	610451	REc, R			
11.867	6	18	12	11q23.3	MCAM, MUC18, CD146	P	Melanoma adhesion molecule	155735	R, REc			
11.868	1	2	08	11q23.3	MPZL3	P	Myelin protein zero-like 3	611707	REc			9(Mpzl3)
11.869	5	23	16	11q23.3	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	C	Nectin 1	600644	A		Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3); Orofacial cleft 7, 225060 (3)	
11.870	4	23	08	11q23.3	NLRX1, NOD9, CLR11.3	P	NLR family member X1	611947	REc			
11.871	8	3	12	11q23.3	PCSK7, PC8, PC7, LPC	P	Proprotein convertase, subtilisin/kexin-type, 7	604872	REc			
11.872	7	16	09	11q23.3	PHLDB1, LL5A, KIAA0638	C	Pleckstrin homology-like domain, family B, member 1	612834	R, REc			
11.873	12	4	02	11q23.3	POU2F3, OCT11	P	POU domain, class 2, transcription factor 3	607394	A			9(Oct11)
11.874	3	18	94	11q23.3	RPS25	P	Ribosomal protein S25	180465	A			
11.875	11	1	02	11q23.3-q24.1	SC5DL, ERG3	C	Sterol C5-desaturase-like	602286	A		Lathosterolosis, 607330 (3)	
11.876	8	1	14	11q24.1	SCN3B, SCNB3, BRGDA7, ATFB16	P	Sodium channel, voltage-gated, type III, beta subunit	608214	R		Brugada syndrome 7, 613120 (3); Atrial fibrillation, familial, 16, 613120 (3)	
11.877	8	21	12	11q23.3	SIK3, KIAA0999	C	Salt-inducible kinase 3	614776	REc, R			
11.878	1	7	14	11q24.2	STT3A, ITM1, TMC	C	STT3A, subunit of the oligosaccharyltransferase complex (catalytic)	601134	REa, H, A, REc	mutation identified in 1 family	?Congenital disorder of glycosylation, type Iw, 615596 (3)	9(Itm1)
11.879	7	4	95	11q23.3	THY1	C	Thy-1 T-cell antigen	188230	REa, H, A, Fd, REn			9(Thy1)
11.880	4	26	11	11q23.3	TMEM25	P	Transmembrane protein 25	613934	REc			9(Tmem25)
11.881	12	17	01	11q23.3	TMPRSS4	P	Transmembrane protease, serine 4	606565	R			
11.882	3	3	03	11q23.2	TMPRSS5	P	Transmembrane protease, serine 5	606751	REc			
11.883	5	21	07	11q23.3	TRAPPC4	P	Trafficking protein particle complex, subunit 4 (synbindin)	610971	R, REc			
11.884	3	17	08	11q23.3	UPK2, UP2, UPII	P	Uroplakin 2	611558	REc			
11.885	1	12	16	11q23.3	VPS11, HLD12	P	Vacuolar protein sorting 11, yeast, homolog of	608549	REc		Leukodystrophy, hypomyelinating, 12, 616683 (3)	
11.886	6	25	99	11q24.1	ZNF202	P	Zinc finger protein-202	603430	D			
11.887	12	21	15	11q23.3	ZPR1, ZNF259	P	ZPR1 zinc finger protein	603901	REc			
11.888	7	12	02	11q23.3-q24	AAT1, FAA1	P	Aortic aneurysm, familial thoracic 1	607086	Fd		Aortic aneurysm, familial thoracic 1 (2)	
11.889	10	4	95	11q24.1	HSPA8, HSP73	P	Heat-shock 70kD protein-8 (HSP73)	600816	REa, A			
11.890	10	24	00	11q24.3	APLP2	C	Amyloid beta (A4) precursor-like protein-2	104776	REa, A			9(Aplp2)
11.891	11	6	94	11q24.3	FLI1	C	Friend leukemia virus integration 1	193067	REa, Ch, A	fused with EWS in Ewing sarcoma; within 200-400kb of ETS1		
11.892	4	3	03	11q24.2	GRTH	P	Gonadotropin-regulated testicular RNA helicase	607663	A, H			9(Grth)
11.893	5	23	11	11q24.2	HEPACAM, MLC2A, MLC2B	P	Hepatocyte cell adhesion molecule	611642	REc		Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3); Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	
11.894	8	23	04	11q24.3	KCNJ1, ROMK1	C	Potassium inwardly-rectifying channel, subfamily J, member 1	600359	A		Bartter syndrome, type 2, 241200 (3)	
11.895	6	11	11	11q24.3	KCNJ5, GIRK4, KATP1, LQT13	P	Potassium inwardly-rectifying channel, subfamily J, member 5	600734	Psh, R, REc		Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type III, 613677 (3)	9(Girk4)
11.896	4	21	01	11q24	MGR9	P	Migraine with aura, susceptibility to, 9	609670	Fd	max lod at GATA64D03	{Migraine with aura, susceptibility to, 9} (2)	
11.897	1	2	08	11q23.3	MPZL2, EVA1, EVA	P	Myelin protein zero-like 2	604873	REc			9(Eva)
11.898	10	7	05	11q24	NEDE	P	Nephropathy, progressive, with deafness	609469	Fd	max lod at D11S4464	Nephropathy, progressive, with deafness (2)	
11.899	6	19	98	11q24.2	NRGN	P	Neurogranin	602350	REc			9(Nrgn)
11.900	4	18	02	11q24.2	PATE	P	Prostate- and testis-expressed gene	606861	REc			
11.901	1	26	12	11q24.2	SIAE, AIS6	P	Sialic acid acetylesterase	610079	R		{Autoimmune disease, susceptibility to, 6}, 613551 (3)	
11.902	6	22	14	11q24.3	TP53AIP1, P53AIP1	P	Tumor protein p53-regulated apoptosis-inducing protein 1	605426	A			
11.903	7	10	08	11q24-q25	ANIB7	P	Aneurysm, intracranial berry, 7	612161	Fd	between rs618176 and rs1940033	Aneurysm, intracranial berry, 7 (2)	
11.904	10	21	92	11q24.3	NFRKB	P	Nuclear factor related to kappa B-binding protein	164013	REa, A	most telomeric 11q marker		
11.905	10	2	09	11q24.2	PKNOX2, PREP2	P	PBX/Knotted 1 homeobox 2	613066	A			
11.906	4	10	14	11q24.3	ST14, MTSP1, ARCI11	C	Suppression of tumorigenicity 14	606797	A		Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	
11.907	9	24	08	11q24.1	BLID, BRCC@	C	BH3-like motif-containing cell death inducer	608853	REc, REn	distal to SORL1		
11.908	8	21	07	11q24.1	BSX1	P	Brain-specific homeobox, mouse, homolog of	611074	REc, H			9(Bsx)
11.909	1	27	09	11q24.1	CLLS5	P	Leukemia, chronic lymphocytic susceptibility to, 5	612559	Fd	associated with rs735665	{Leukemia, chronic lymphocytic susceptibility to, 5} (2)	
11.910	5	24	13	11q24.1	CLMP, ASAM, ACAM, CSBS	P	Coxsackievirus- and adenovirus receptor-like membrane protein	611693	REc		Congenital short bowel syndrome, 615237 (3)	9(Clmp)
11.911	12	21	09	11q24.1	MIR100, MIRN100	P	Micro RNA 100	613186	REc, REn			
11.912	9	20	14	11q24.1	MIR100HG, AGD1	P	MIR100-LET7A2 cluster host gene, noncoding	615965	REc			
11.913	3	23	09	11q24.1	MIR125B1, MIRN125B1	P	Micro RNA 125B-1	610104	REc			
11.914	3	23	09	11q24.1	MIRLET7A2, LET7A2, MIRNLET7A2	P	Micro RNA let7a2	612142	REc			
11.915	7	14	14	11q24.3	SENCR, lncRNA9	P	Smooth muscle- and endothelial cell-enriched migration/differentiation-associated long noncoding RNA	615815	REc			
11.916	7	10	08	11q24.1	UBASH3B, STS1, KIAA1959, P70	P	Ubiquitin-associated and SH3 domain-containing protein B	609201	R, REc			
11.917	9	21	11	11q24.2	CDON, CDO, HPE11	C	Cell adhesion molecule-related/downregulated by oncogenes	608707	R, REc		Holoprosencephaly 11, 614226 (3)	
11.918	7	13	15	11q24.2	DCPS, HINT5, DCS1, ARS	P	Decapping enzyme, scavenger	610534	REc		Al-Raqad syndrome, 616459 (3)	
11.919	10	10	11	11q24.2	ESAM	P	Endothelial cell adhesion molecule	614281	REc			
11.920	10	13	15	11q24.2	FAM118B	P	Family with sequence similarity 118, member B	616587	REc			
11.921	11	16	11	11q24.2	FEZ1	P	Fasciculation and elongation protein zeta 1	604825	R, REc			
11.922	10	25	11	11q24.2	FOXRED1	P	FAD-dependent oxidoreductase domain-containing protein 1	613622	REc		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
11.923	12	18	07	11q24.2	HEPN1	P	Cancer susceptibility gene HEPN1	611641	REc			
11.924	1	10	07	11q24.2	HYLS1, FLJ32915	C	HYLS1 gene	610693	Fd, REc		Hydrolethalus syndrome, 236680 (3)	
11.925	2	17	09	11q24.2	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4	P	Kin of IRRE-like 3	607761	R		Mental retardation, autosomal dominant 4, 612581 (3)	
11.926	11	2	14	11q24.2	PANX3, PX3	P	Pannexin 3	608422	R, REc			
11.927	3	28	15	11q24.2	PUS3	P	Pseudouridylate synthase 3	616283	REc			
11.928	2	21	03	11q24.2	ROBO4	P	Roundabout, Drosophila, homolog of, 4	607528	REc			
11.929	7	14	14	11q24.2	ST3GAL4, SIAT4C, SIAT4, CGS23, NANTA3	C	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	104240	S, Psh, REc			
11.930	11	30	06	11q24.2	TBRG1, NIAM	P	Transforming growth factor-beta regulator 1	610614	R, REc			
11.931	11	11	14	11q24.3	ADAMTS15	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 15	607509	REc			
11.932	12	10	12	11q24.3	ARHGAP32, RICS, GRIT, p200RHOGAP, p250GAP	P	Rho GTPase activating protein 32	608541	REc, R			
11.933	8	30	07	11q25	ACAD8	P	Acyl-CoA dehydrogenase family, member 8	604773	REc		Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)	
11.934	1	31	01	11q24.3	ADAMTS8, METH2	P	A disintegrin-like and metalloproteinase with thrombospondin type-1 motif, 8	605175	R, H			9(Adamts8)
11.935	4	17	07	11q25	B3GAT1, GLCATP, CD57, HNK1	P	Beta-1,3-glucuronyltransferase 1	151290	A, S			
11.936	1	29	01	11q24.3	BARX2	P	BarH-like homeo box gene 2	604823	A			
11.937	4	19	12	11q25	HJCD, HCLAP	P	Histiocytosis with joint contractures and sensorineural deafness	602782	Fd		Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	
11.938	2	24	11	11q25	IGSF9B, KIAA1030	P	Immunoglobulin superfamily, member 9B	613773	R, REc			
11.939	2	11	11	11q25	JAM3	P	Junctional adhesion molecule 3	606871	REc		Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)	
11.940	5	24	13	11q25	NCAPD3, CAPD3, KIAA0056	P	Non-SMC condensin II complex subunit D3	609276	REc, R			
11.941	1	11	07	11q25	NTM, HNT	P	Neurotrimin	607938	REc			9(Ntm)
11.942	2	11	09	11q25	OPCML	C	Opioid-binding protein/cell adhesion molecule-like	600632	REa, H, REc		{Ovarian cancer, somatic}, 167000 (3)	9(Obcam)
11.943	12	23	05	11q25	SPATA19	P	Spermatogenesis-associated protein 19	609805	REc			
11.944	2	8	11	11q25	THYN1, HSPC144, THY28	P	Thymocyte nuclear protein 1	613739	R, REc			
11.945	4	19	06	11q25	VPS26B	P	Vacuolar protein sorting 26, yeast, homolog of, B	610027	REc			9(Vps26b)
11.946	10	20	99	11q25-qter	DFNB20	P	Deafness, autosomal recessive 20	604060	Fd		Deafness, autosomal recessive 20 (2)	
11.947	4	2	01	11q13.2	ALDH3B1, ALDH7	P	Aldehyde dehydrogenase 3 family, member B1	600466	R			
11.948	7	9	01	Chr.11	AOCH	P	Acromegaloid features, overgrowth, cleft palate, and hernia	606049	Ch	pericentric inversion (46,XY,inv(11)(p15.3;q23.3))	Acromegaloid features, overgrowth, cleft palate, and hernia (2)	
11.949	4	2	01	11q13.2	ALDH3B2, ALDH8	P	Aldehyde dehydrogenase 3 family, member B2	601917	R			
11.950	7	3	88	11q12.2	CD6, TP120	P	CD6 antigen	186720	S			
11.951	4	28	99	11p11.2	CRY2	P	Cryptochrome 2	603732	R			2(Cry2)
11.952	2	20	01	11q13.2	FBXL11, FBL11	P	F-box and leucine-rich repeat protein-11	605657	R			
11.953	2	21	02	11q23.3	FXYD6	P	FXYD domain-containing ion transport regulator 6	606683	R			
11.954	7	15	02	11q23.3	HYOU1	P	Hypoxia-upregulated 1	601746	R			
11.955	3	11	03	11p15.4	IPO7, RANBP7	P	Importin 7	605586	R			
11.956	11	5	00	11q12.1	LPXN	P	Leupaxin	605390	R			
11.957	2	28	01	11p15.4	LYVE1	P	Lymphatic vessel endothelial hyaluronan receptor 1	605702	R			
11.958	7	12	02	11q23.3	MIZF	P	MBD2-interaction zinc finger protein	607099	R			
11.959	5	7	01	11q13.1	SART1, HOMS1	P	Squamous cell carcinoma antigen recognized by T cells 1	605941	R			
11.960	2	5	01	11q13.1	SF3B2, SF3B145, SAP145	P	Splicing factor 3B, subunit 2	605591	R			
11.961	1	29	01	11q13.4	SLC21A9, OATPB	P	Solute carrier family 21 (organic anion transporter), member 9	604988	R			
11.962	2	27	03	11q12.3	SLC22A8, OAT3	P	Solute carrier family 22 (organic anion transporter), member 8	607581	R			
11.963	1	29	01	11p15.2	SPON1	P	F-spondin, Rat, homolog of	604989	R			
11.964	5	7	03	11p11.2	SYT13, KIAA1427	P	Synaptotagmin 13	607716	R			
11.965	3	29	01	11q23.1	TEX12	P	Testis-expressed gene 12	605791	R			
11.966	6	6	00	11q23.3	UBE4A, UFD2, E4	P	Ubiquitination factor E4A	603753	REa			
12.1	1	24	06	12p13.33	DCP1B, DCP1	P	Decapping enzyme 1, S. cerevisiae, homolog of	609843	REc, R			
12.2	6	13	12	12p13.33	FBXL14, FBL14	P	F-box and leucine-rich repeat protein 14	609081	REc			6(Fbxl14)
12.3	11	7	14	12p13.32	C12orf4	P	Chromosome 12 open reading frame 4	616082	REc			
12.4	12	18	14	12p13.33	RHNO1, RHINO, C12orf32	P	Rad9-, Rad1-, and Hus1-interacting nuclear orphan 1	614085	REc			
12.5	4	10	12	12p13.33	FKBP4, FKBP52	P	FK506-binding protein 4	600611	REc			
12.6	6	30	08	12p13.33	IQSEC3, KIAA1110	P	IQ motif- and SEC7 domain-containing protein 3	612118	R, REc			
12.7	4	8	13	12p13.32	DYRK4	P	Dual-specificity tyrosine phosphorylation-regulated kinase 4	609181	REc			
12.8	9	6	11	12p13.32	EFCAB4B, CRACR2A	P	EF-hand calcium-binding domain-containing protein 4B	614178	REc			
12.9	2	22	92	12p13.31	LAG3	P	Lymphocyte activation gene-3	153337	A			
12.10	12	21	09	12p13.33-p13.32	TSPAN9, NET5	P	Tetraspanin 9	613137	REc			
12.11	12	1	11	12p13.31	ACSM4	P	Acyl-CoA synthetase medium-chain family, member 4	614360	REc			
12.12	1	4	12	12p13.33	ADIPOR2, FLJ21432	P	Adiponectin receptor 2	607946	REc			6(Adipor2)
12.13	2	17	09	12p13.31	ATN1, DRPLA, HRS, NOD	C	Atrophin 1	607462	Fd, D, A		Dentatorubro-pallidoluysian atrophy, 125370 (3)	6(Drpla)
12.14	12	1	06	12p13.31	A2ML1	P	Alpha-2-macroglobulin-like 1	610627	REc			
12.15	11	2	04	12p13.31	C1RL, CLSPA, C1RLP	P	Complement component C1r-like protein	608974	REc			
12.16	11	11	14	12p13.31	C3AR1, C3AR	P	Complement component 3a receptor 1	605246	REc			
12.17	5	23	11	12p13.31	CD4	C	CD4 antigen (p55)	186940	REa, A	CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens	OKT4 epitope deficiency, 613949 (3)	6(Ly4)
12.18	1	13	09	12p13.31	CLEC2A	C	C-type lectin domain family 2, member A	612087	REc			
12.19	9	24	08	12p13.2	CLEC9A, DNGR1	P	C-type lectin domain family 9, member A	612252	REc			
12.20	2	12	14	12p13.31	CLECL1, DCAL1	P	C-type lectin-like 1	607467	REc			
12.21	9	22	14	12p13.31	COPS7A, CSN7	P	COP9 signalosome, subunit 7A	616009	REc			
12.22	1	27	04	12p13.31	DPPA3	P	Developmental pluripotency-associated gene 3	608408	REc, H			6(Dppa3)
12.23	9	30	09	12p13.31	FAM90A1	P	Family with sequence similarity 90, member A1	613041	REc	other family members on chr. 8		
12.24	2	25	15	12p13.31	IFFO1	P	Intermediate filament family orphan 1	610495	REc			
12.25	3	15	04	12p13.31	ING4	C	Inhibitor of growth-4	608524	R, REc, D			
12.26	3	23	14	12p13.31	KLRG1, MAFA, MAFAL	P	Killer cell lectin-like receptor, subfamily G, member 1	604874	Psh, REc			6(Klrg1)
12.27	3	23	09	12p13.31	MIR141, MIRN141	P	Micro RNA 141	612093	REc			
12.28	3	23	09	12p13.31	MIR200C, MIRN200C	P	Micro RNA 200C	612092	REc			
12.29	6	13	12	12p13.31	NANOG	P	Homeobox transcription factor NANOG	607937	REc, H			6(Nanog)
12.30	3	7	14	12p13.31	NCAPD2, CNAP1, KIAA0159	P	Non-SMC condensin I complex subunit D2	615638	Psh, REc			
12.31	7	7	14	12p13.31	NECAP1, EIEE21	P	NECAP endocytosis-associated protein 1	611623	REc	mutation identified in 1 EIEE21 family	?Epileptic encephalopathy, early infantile, 21, 615833 (3)	
12.32	9	23	13	12p13.31	PHC1, EDR1, HPH1, RAE28, MCPH11	P	Polyhomeotic-like 1	602978	REc	mutations identified in 1 family	?Microcephaly 11, primary, autosomal recessive, 615414 (3)	
12.33	11	3	14	12p13.31	PIANP, PANP, LEDA1	P	PILR-alpha-associated neural protein	616065	REc			
12.34	1	22	08	12p13.31	PLEKHG6, MYOGEF	P	Pleckstrin homology domain-containing protein, family G, member 6	611743	REc			
12.35	7	8	11	12p13.31	PTMS	P	Parathymosin	168440	REc	previously assigned to 17q12-q22		
12.36	2	28	08	12p13.31	RBP5, CRBP3	P	Retinol-binding protein 5	611866	REc			
12.37	7	1	11	12p13.31	RIMKLB, NAAGS	P	Ribosomal modification protein RimK-like family, member B	614054	R, REc			
12.38	3	7	13	12p13.31	SCARNA10	P	Small cajal body-specific RNA 10	615639	REc, REn	in intron 4 of NCAPD2		
12.39	2	25	14	12p13.31	SCARNA12	P	Small Cajal body-specific RNA 12	615642	REc			
12.40	12	18	07	12p13.31	SPSB2, SSB2	P	SPRY domain- and SOCS box-containing 2	611658	REc			
12.41	6	27	14	12p13.31	VAMP1, SYB1, SPAX1	C	Vesicle-associated membrane protein-1 (synaptobrevin-1)	185880	REa, Fd		Spastic ataxia 1, autosomal dominant, 108600 (3)	6(Syb1)
12.42	10	5	10	12p13.31	CLEC6A, CLEC4N	P	C-type lectin domain family 6, member A	613579	REc			
12.43	10	23	87	12p13.31	GAPDH, GAPD	C	Glyceraldehyde-3-phosphate dehydrogenase	138400	S, D, R	pseudogene on Xp21-q11		6(Gapd)
12.44	9	2	08	12p13.33	B4GALNT3	P	Beta-1,4-N-acetylgalactosaminyltransferase 3	612220	REc			
12.45	3	5	08	12p13.33	CACNA1C, CACNL1A1, CCHL1A1, TS	C	Calcium channel, voltage-dependent, L type, alpha 1C subunit	114205	Psh, Fd, REa, A		Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)	
12.46	10	11	06	12p13.33	CACNA2D4, RCD4	C	Calcium channel, voltage-dependent, alpha-2/delta subunit 4	608171	REc		Retinal cone dystrophy 4, 610478 (3)	
12.47	1	23	01	12p13.31	CD163	C	CD163 antigen (hemoglobin scavenger receptor)	605545	A, REa, R			
12.48	9	30	09	12p13.31	CD164L1, CD163B, M160	P	CD164 antigen-like 1	606079	A, R			
12.49	5	20	05	12p13.32	FGF23, ADHR, HPDR2, PHPTC	C	Fibroblast growth factor 23	605380	Fd, REc		Hypophosphatemic rickets, autosomal dominant, 193100 (3); Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	6(Fgf23)
12.50	1	27	04	12p13.32	GALNT8	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8	606250	REc			
12.51	1	2	03	12p13.1	GPRC5D	P	G protein-coupled receptor, family C, group 5, member D	607437	REc			
12.52	10	30	08	12p13.3	MAFD9	P	Major affective disorder 9	612372	Fd	associated with rs1006737	{Major affective disorder-9, susceptibility to} (2)	
12.53	12	23	15	12p13.32	PARP11, ARTD11	P	Poly(ADP-ribose) polymerase family, member 11	616706	REc			
12.54	12	23	15	12p13.31	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	C	Peroxisome biogenesis factor 5	600414	REa, A, R		Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3); Peroxisome biogenesis disorder 2B, 202370 (3); Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	
12.55	4	6	15	12p13.32	PRMT8, HRMT1L3, HRMT1L4	C	Protein arginine methyltransferase 8	610086	REc, H			6(Prmt8)
12.56	11	28	94	12p13.31	SLC2A3, GLUT3	P	Solute carrier family 2 (facilitated glucose transporter), member 3	138170	A	pseudogene SLC2A3P on 5q34		
12.57	8	20	07	12p13.31	SLC2A14, GLUT14	P	Solute carrier family 2 (facilitated glucose transporter), member 14	611039	REc			
12.58	3	14	13	12p13.33	SLC6A13, GAT2, GAT3	P	Solute carrier family 6 (neurotransmitter transporter, GABA), member 13	615097	REc			
12.59	7	2	02	12p13.31	TAPBPR	P	TAP-binding protein-related protein	607081	REc			
12.60	2	20	07	12p13.32	TIGAR, C12orf5	P	TP53-induced glycolysis and apoptosis regulator	610775	REc			
12.61	10	4	10	12p13.31	VWF, F8VWF	C	Coagulation factor VIII VWF (von Willebrand factor)	613160	A, REa, REb, Fd	pseudogene on chr. 22	von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3); von Willebrand disease, type 1, 193400 (3); von Willibrand disease, type 3, 277480 (3)	6(Vwf)
12.62	11	4	04	12p13.33	WNT5B	C	Wingless-type MMTV integration site family, member 5B	606361	REc			
12.63	10	15	98	12p13.33	TEAD4, TCF13L1, RTEF1	P	TEA domain family, member 4	601714	A			6(Tcf13l1)
12.64	7	1	11	12p13.31	A2M , A2MD	C	Alpha-2-macroglobulin	103950	REa, A	cluster of genes	Alpha-2-macroglobulin deficiency, 614036 (1); {Alzheimer disease, susceptibility to}, 104300 (3)	6(A2m)
12.65	3	5	08	12p13.31	MRPL51, MRP64	P	Mitochondrial ribosomal protein L51	611855	R, REc			
12.66	12	28	15	12p13.2	LRP6, ADCAD2, STHAG7	C	Low density lipoprotein receptor-related protein 6	603507	A, R		{Coronary artery disease, autosomal dominant, 2}, 610947 (3); Tooth agenesis, selective, 7, 616724 (3)	6(Lrp6)
12.67	12	24	08	12p13.1	APOLD1, VERGE	P	Apolipoprotein L domain-containing 1	612456	REc			
12.68	10	23	15	12p13.2	BORCS5, LOH12CR1, MYRLYSIN	P	BLOC1-related complex, subunit 5	616598	REc			
12.69	3	27	90	12p13.2	PRB1	P	Proline-rich protein BstNI, subfamily-1	180989	F, RE			
12.70	3	27	90	12p13.2	PRB2	C	Proline-rich protein BstNI, subfamily-2 (parotid size variant)	168810	F, RE	Ps allele		
12.71	3	27	90	12p13.2	PRB3	C	Proline-rich protein BstNI, subfamily-3 (parotid salivary glycoprotein)	168840	LD, F, RE	G1 allele		
12.72	3	27	90	12p13.2	PRB4	C	Proline-rich protein BstNI, subfamily-4	180990	F, RE	Po, CON1, CON2 alleles		
12.73	4	10	90	12p13.2	PRH1	C	Proline-rich protein HaeIII, subfamily-1	168730	F, LD, RE	Pa, Db, PIF alleles		
12.74	3	27	90	12p13.2	PRH2	C	Proline-rich protein HaeIII, subfamily-2	168790	F, LD, RE	Pr allele		
12.75	1	28	88	12p13.2	PCS	P	Parotid proline-rich salivary protein Pc	168710	F	linked to PRB2		
12.76	8	27	15	12p13.2	STYK1, NOK	P	Serine/threonine/tyrosine kinase 1	611433	REc			
12.77	6	11	11	12p13.2	TAS2R20, T2R56	C	Taste receptor, type 2, member 20	613962	Psh, REc			
12.78	6	27	11	12p13.2	TAS2R30, T2R30, T2R47	P	Taste receptor, type 2, member 30	613963	REc	previously assigned to chr.1		
12.79	6	26	11	12p13.2	TAS2R45, T2R45	P	Taste receptor, type 2, member 45	613967	REc			
12.80	3	23	09	12p13.2	TAS2R43, T2R52	P	Taste receptor, type 2, member 43	612668	REc			
12.81	1	24	12	12p13.2	TAS2R31, TAS2R44, T2R53	P	Taste receptor, type 2, member 31	612669	REc			
12.82	9	15	09	12p13.2	TAS2R46, T2R46, T2R54	P	Taste receptor, type 2, member 46	612774	REc			
12.83	11	4	08	12p13.2	TAS2R50, T2R50, TAS2R51, T2R51	P	Taste receptor, type 2, member 50	609627	Psh, REc			
12.84	9	7	12	12p13.31	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	C	Tumor necrosis factor receptor superfamily, member 1A	191190	REa, A, Psh		Periodic fever, familial, 142680 (3); {Multiple sclerosis, susceptibility to, 5}, 614810 (3)	6(Tnfr2)
12.85	11	12	07	12p13.32	RAD51AP1, PIR51	P	Rad51-associated protein 1	603070	A			6(Pir51)
12.86	2	15	02	12p13.31	CLEC4C, CLECSF11, DLEC, BDCA2	P	C-type lectin domain family 4, member C	606677	REc			
12.87	9	8	11	12p13.2	CLEC7A, CLECSF12, DECTIN1, CANDF4	C	C-type lectin domain family 7, member A	606264	A, REc	in natural killer gene complex	Candidiasis, familial, 4, autosomal recessive, 613108 (3); {Aspergillosis, susceptibility to}, 614079 (3)	
12.88	1	13	99	12p13.1	GPR19	C	G protein-coupled receptor-19	602927	A, REn			
12.89	1	13	99	12p13.2	KLRC1, NKG2, NKG2A	C	Killer cell lectin-like receptor, subfamily C, member 1	161555	REa, A	family of at least 3 genes on 12		6(Klrc1)
12.90	1	13	99	12p13.2	KLRC2, NKG2C	P	Killer cell lectin-like receptor, subfamily C, member 2	602891	REc			
12.91	1	13	99	12p13.2	KLRC3, NKG2E	P	Killer cell lectin-like receptor, subfamily C, member 3	602892	REc			
12.92	9	3	98	12p13.2	KLRC4, NKG2F, D12S2489E	P	Killer cell lectin-like receptor, subfamily C, member 4	602893	REc			
12.93	1	13	99	12p13.2	KLRD1, CD94	P	Killer cell lectin-like receptor, subfamily D, member 1	602894	REc			
12.94	1	29	01	12p13.31	KLRF1	P	Killer cell lectin-like receptor, subfamily F, member 1	605029	REc			
12.95	2	26	08	12p13.2	KLRK1, NKG2D	P	Kill cell lectin-like receptor, subfamily K, member 1	611817	REc			
12.96	7	18	06	12p13.2-p11.23	DFNB62	P	Deafness, autosomal recessive 62	610143	Fd	between D12S358 and D12S1042	Deafness, autosomal recessive 62 (2)	
12.97	1	6	97	12p13.2-q24.1	IBD2	C	Inflammatory bowel disease 2	601458	Fd, LD	mainly ulcerative colitis	{Inflammatory bowel disease 2} (2)	
12.98	1	7	95	12p13.31	APOBEC1, BEDP	C	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1	600130	A			
12.99	11	22	10	12p13.1	ATF7IP, AM, MCAF, MCAF1	P	Activating transcription factor 7-interacting protein	613644	REc			
12.100	1	22	99	12p13.2	CSDA, DBPA	P	Cold-shock domain protein A	603437	A			
12.101	10	7	13	12p13.1	DDX47	P	DEAD box polypeptide 47	615428	REc			
12.102	1	20	11	12p13.31	GDF3, KFS3, MCOPCB6, MCOP7	P	Growth differentiation factor 3	606522	R		Klippel-Feil syndrome 3, autosomal dominant, 613702 (3); Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)	
12.103	10	12	14	12p13.1	GNAI2P1, GNAI2L, GNAI2A	C	Guanine nucleotide-binding protein (G protein), alpha-inhibiting, polypeptide 2 pseudogene 1	139180	REa, A			
12.104	2	8	13	12p12.3	HIST4H4	P	Histone gene cluster 4, H4 histone	615069	REc			
12.105	1	8	15	12p13.31	MFAP5, MAGP2, AAT9	P	Microfibril-associated protein 5	601103	A		Aortic aneurysm, familial thoracic 9, 616166 (3)	
12.106	11	25	14	12p12.3	MGP	C	Matrix Gla protein	154870	REa, R, Fd, LD		Keutel syndrome, 245150 (3)	6(Mglap)
12.107	4	17	12	12p13.1	GPRC5A, RAI3, RAIG1	P	G protein-coupled receptor, family C, group 5, member A	604138	R, REc			
12.108	9	19	00	12p13.31	AICDA, AID, HIGM2	C	Activation-induced cytidine deaminase	605257	A, Fd		Immunodeficiency with hyper-IgM, type 2, 605258 (3)	
12.109	11	24	08	12p13.31	ANO2, TMEM16B, C12orf3	P	Anoctamin 2	610109	REc			
12.110	4	2	90	12p13.31	C1R	C	Complement component-1, r subcomponent	613785	REa, Fd, RE, A		C1r/C1s deficiency, combined, 216950 (1)	
12.111	3	24	11	12p13.31	C1S	C	Complement component-1, s subcomponent	120580	REa, Fd, RE, A		C1s deficiency, 613783 (3)	
12.112	4	23	13	12p13.31	C12orf57, C10, TEMTYS	C	Chromosome 12 open reading frame 57	615140	REc, H		Temtamy syndrome, 218340 (3)	6(C12orf57)
12.113	8	22	14	12p13.32	CCND2, MPPH3	C	Cyclin D2	123833	REa, A		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3)	
12.114	6	5	89	12p13.31	CD9, MIC3	C	CD9 antigen (p24)	143030	S, REa, A			
12.115	5	22	07	12p13.1	CDKN1B, KIP1, CDKN4, MEN4	C	Cyclin-dependent kinase inhibitor 1B (p27, Kip1)	600778	Psh, A, REc, REn		Multiple endocrine neoplasia, type IV, 610755 (3)	7(Cdkn1b)
12.116	12	3	98	12p13.31	CHD4	P	Chromodomain helicase DNA-binding protein-4	603277	A			
12.117	3	26	02	12p13.2	CLEC1A, CLEC1	P	C-type lectin domain family 1, member A	606782	REa			
12.118	3	26	02	12p13.3-p13.2	CLEC2B, CLEC2	P	C-type lectin domain family 1, member B	606783	REa			
12.119	3	23	06	12p13.31	CLEC4D, CLECSF8, CLEC6	P	C-type lectin domain family 4, member D	609964	REc			
12.120	3	24	06	12p13.31	CLEC2D, LLT1	P	C-type lectin domain family 2, member D	605659	REc			
12.121	3	23	06	12p13.31	CLEC4E, MINCLE	P	C-type lectin domain family 4, member E	609962	REc			6(Clec4e)
12.122	1	31	01	12p13.31	CLEC4A, CLECSF6, DCIR, DDB27	P	C-type lectin domain family 4, member A	605306	REa, R			
12.123	6	27	08	12p13.31	CLEC12A, MICL	P	C-type lectin domain family 12, member A	612088	REc, H			6(Clec12a)
12.124	3	23	13	12p13.31	CLSTN3, KIAA0726	C	Calsyntenin 3	611324	R, REc			
12.125	6	25	99	12p13.1	CREBL2	P	Cyclic AMP response element-binding protein-like 2	603476	D, A			
12.126	5	13	98	12p13.31	DDX12, CHLR2	P	DEAD/H box-12	601151	Psh, A			
12.127	1	11	07	12p13	EDS8	P	Ehlers-Danlos syndrome, type VIII	130080	Fd	prob. genetic heterogeneity	Ehlers-Danlos syndrome, type VIII (2)	
12.128	8	24	09	12p13.31	EMG1, NEP1, C2F, BWCNS	P	Essential for mitotic growth 1, S. cerevisiae, homolog of	611531	REc, Fd		Bowen-Conradi syndrome, 211180 (3)	
12.129	8	11	91	12p13.31	ENO2	C	Enolase-2, gamma, neuronal	131360	S, D, A, REa			
12.130	2	13	15	12p13.2	ETV6, TEL, THC5	C	ETS variant gene-6 (TEL oncogene)	600618	RE, Fd, D	fused to PDGFRB or AML1 in leukemia	Leukemia, acute myeloid, somatic, 601626 (3); Thrombocytopenia 5, 616216 (3)	
12.131	3	18	94	12p13.32	FGF6	C	Fibroblast growth factor-6	134921	A, Ch, Psh			
12.132	11	9	98	12p13.33	FOXM1, FKHL16, HFH11	C	Forkhead box M1	602341	Psh, R, A			
12.133	3	17	98	12p13.31	GNB3	C	Guanine nucleotide-binding protein, beta polypeptide-3	139130	REa, A		{Hypertension, essential, susceptibility to}, 145500 (3)	6(Gnb3)
12.134	2	11	96	12p13.32	KCNA1, AEMK, EA1	C	Potassium voltage-gated channel, shaker-related subfamily, member 1	176260	REa, Fd, A, H	close to VWF	Episodic ataxia/myokymia syndrome, 160120 (3)	6(Kcna1)
12.135	9	8	08	12p13.32	KCNA5, ATFB7	C	Potassium voltage-gated channel, shaker-related subfamily, member 5	176267	REa, Fd, H		Atrial fibrillation, familial, 7, 612240 (3)	6(Kcna5)
12.136	3	17	94	12p13.32	KCNA6	L	Potassium voltage-gated channel, shaker-related subfamily, member 6	176257	REa			6(Kcna6)
12.137	4	19	16	12p13.31	P3H3, LEPREL2	P	Prolyl 3-hydroxylase 3	610342	REc			
12.138	8	21	98	12p12.3	LMO3, RBTNL2, RHOM3	P	LIM domain only 3 (rhombotin-like 2)	180386	A, Ch	expressed mainly in brain		
12.139	4	24	08	12p13.31	LPAR5, GPR92, GPR93, LPA5	C	Lysophosphatidic acid receptor 5	606926	REc			
12.140	8	21	98	12p13.31	LTBR, TNFCR	L	Lymphotoxin-beta receptor (tumor necrosis factor C receptor)	600979	H	tightly linked to TNFR1 in mouse		6(Tnfcr)
12.141	12	4	95	12p13.31	M6PR	C	Mannose-6-phosphate receptor, cation-dependent	154540	REa, Psh, A			6(Mprd)
12.142	4	23	08	12p13.31	MBOAT5, LPCAT3, NESSY	P	Membrane-bound O-acyltransferase domain-containing 5	611950	REc			
12.143	8	29	96	12p13.31	MLF2	P	Myeloid leukemia factor-2	601401	A, REc			
12.144	4	29	03	12p13.33	NINJ2	P	Nerve injury-induced protein 2	607297	REc			
12.145	10	15	94	12p13.31	NOL1	P	Nucleolar protein 1, 120kD	164031	Psh, A			
12.146	6	21	91	12p13.31	NTF3	C	Neurotrophin-3	162660	A, REa			6(Ntf3)
12.147	10	25	12	12p12.3	PDE6H, RCD3, ACHM6	C	Phosphodiesterase 6H, cGMP-specific, cone, gamma	601190	A		Retinal cone dystrophy 3, 610024 (3); Achromatopsia 6, 610024 (3)	
12.148	1	17	07	12p13.31	PHB2, REA	P	Prohibitin 2	610704	R, REc			
12.149	12	30	14	Xp21.1	PRRG1, PRGP1	P	Proline-rich gamma-carboxyglutamic acid protein 1	300935	REc			
12.150	1	6	93	12p13.31	PTPN6	P	Protein tyrosine phosphatase, nonreceptor-type, 6	176883	A			6(Hcph)
12.151	10	8	09	12p13.31	SCNN1A, BESC2	C	Sodium channel, nonvoltage-gated 1, alpha	600228	REa, Psh, A, Fd		Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 2, 613021 (3)	6(Scnn1)
12.152	10	2	98	12p13.33	SLC6A12	P	Solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12	603080	A			
12.153	6	11	11	12p13.2	TAS2R19, T2R19, T2R48	P	Taste receptor, type 2, member 19	613961	REc			
12.154	6	26	11	12p13.2	TAS2R42, T2R42, T2R55	P	Taste receptor, type 2, member 42	613966	REc			
12.155	3	27	13	12p13.31	TNFRSF7, CD27, S152. LPFS2	P	Tumor necrosis factor receptor superfamily, member 7 (CD27 antigen)	186711	Psh, A		Lymphoproliferative syndrome 2, 615122 (3)	
12.156	11	13	13	12p13.31	TPI1, TPID	C	Triosephosphate isomerase-1	190450	S, D, R, REa		Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3)	6(Tpi1)
12.157	4	5	00	12p13.2	TRB1, T2R14	P	Taste receptor, family B, member 1	604790	REc			
12.158	4	5	00	12p13.2	TRB2, T2R10	P	Taste receptor, family B, member 2	604791	REc			
12.159	4	5	00	12p13.2	TRB3, T2R13	P	Taste receptor, family B, member 3	604792	REc			
12.160	4	5	00	12p13.2	TRB4, T2R7	P	Taste receptor, family B, member 4	604793	REc			
12.161	4	5	00	12p13.2	TRB5, T2R8	P	Taste receptor, family B, member 5	604794	REc			
12.162	4	5	00	12p13.2	TRB6, T2R9	P	Taste receptor, family B, member 6	604795	REc			
12.163	12	14	00	12p13.33	TULP3	P	Tubby-like protein 3	604730	R			6(Tulp3)
12.164	2	5	99	12p13.31	USP5, ISOT	P	Ubiquitin-specific protease-5 (ubiquitin isopeptidase T)	601447	REn			
12.165	2	27	12	12p13.33	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	C	WNK lysine deficient protein kinase 1	605232	Fd, REc		Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	
12.166	6	8	89	12p13.31	PZP	P	Pregnancy zone protein	176420	REa, A			
12.167	3	18	95	12p13.33	RAD52	P	RAD52, yeast, homolog of	600392	Psh, A			
12.168	10	24	14	12p12.3	ART4, DO, DOK1	C	ADP-ribosyltransferase-4 (Dombrock blood group)	110600	A, Psh		[Blood group, Dombrock], 616060 (3)	
12.169	3	1	94	12p13.31	CD69	C	CD69 antigen (p60, early T-cell activation antigen)	107273	REa, A			
12.170	3	24	06	12p13.31	CLEC2B, CLECSF2, AICL	P	C-type lectin domain family 2, member B	603242	REc			
12.171	11	3	99	12p13.2	KLRA1, LY49L	P	Killer cell lectin-like receptor, subfamily A, member 1	604274	H, REc	?functional		6(Ly49)
12.172	1	13	99	12p13.31	KLRB1, NKRP1A	P	Killer cell lectin-like receptor, subfamily B, member 1	602890	Psh, A, REc			
12.173	11	29	11	12p13.2	OLR1, LOX1	C	Low density lipoprotein, oxidized, receptor 1	602601	A, REn		{Myocardial infarction, susceptibility to}, 608446 (3)	
12.174	9	6	11	12p12.3	PTPRO, GLEPP1, NPHS6	P	Protein tyrosine phosphatase, receptor type, O	600579	A		Nephrotic syndrome, type 6, 614196 (3)	
12.175	6	21	94	12q13.3	ATP5B, ATPSB	C	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	102910	REa, REb			
12.176	7	14	98	12p12.3	ARHGDIB, GDID4, D4	P	Rho GDP dissociation inhibitor (GDI) beta	602843	A			
12.177	10	20	99	12p13.1	EMP1, TMP	C	Epithelial membrane protein-1	602333	REa, A, R			6(Emp1)
12.178	9	2	14	12p12.3	EPS8, DFNB102	P	Epidermal growth factor receptor pathway substrate-8	600206	REa, A	mutation identified in 1 DFNB102 family	?Deafness, autosomal recessive 102, 615974 (3)	
12.179	2	28	03	12p13.2	GABARAPL1, GEC1	P	GABA-A receptor-associated protein-like protein 1	607420	R, REc			
12.180	9	16	03	12p12.3	PLCZ1	P	Phospholipase C, zeta-1	608075	REc			
12.181	7	18	14	12p11.23	STK38L, NDR2, KIAA0965	P	Serine/threonine protein kinase 38-like protein	615836	R, REc			6(Stk38l)
12.182	5	18	10	12p12.3	STRAP, UNRIP, MAWD	P	Serine/threonine kinase receptor-associated protein	605986	R, REc	previously assigned to 12q		
12.183	4	25	93	12p12.1	IAPP	C	Islet amyloid polypeptide (diabetes-associated peptide; amylin)	147940	REa, A			
12.184	4	23	13	12p12.1	GYS2	C	Glycogen synthase-2, liver	138571	A, Fd		Glycogen storage disease 0, liver, 240600 (3)	
12.185	6	23	15	12p12.2	PDE3A, HTNB	C	Phosphodiesterase 3A, cGMP-inhibited	123805	REc, Fd		Hypertension and brachydactyly syndrome, 112410 (3)	
12.186	1	18	12	12p12.2	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	P	Solute carrier organic anion transporter family, member 1B3	605495	REc	HBLRR digenic with SLCO1B1	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
12.187	6	21	04	12p12.2-p12.1	HYT4	P	Hypertension, essential, susceptibility to, 4	608742	Fd		{Hypertension, essential, susceptibility to, 4}, 145500 (2)	
12.188	9	4	15	12p12.1	LDHB, LDHBD	C	Lactate dehydrogenase B	150100	S, D, Fd		[Lactate dehydrogenase-B deficiency], 614128 (3)	6(Ldh2)
12.189	7	6	12	12p12.1	ABCC9, SUR2, CMD1O, ATFB12, CANTU	P	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	A		Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation, familial, 12, 614050 (3); Hypertrichotic osteochondrodysplasia, 239850 (3)	
12.190	4	19	16	12p12.1	CASC1, LAS1, PPP1R54	C	Cancer susceptibility candidate 1	616906	REc, H			6(Casc1)
12.191	4	19	06	12p12.1	CMAS	P	Cytidine monophosphate N-acetylneuraminic acid synthetase	603316	REn			
12.192	3	7	13	12p12.1	GOLT1B, GOT1B, GCT2	P	Golgi transport 1B	615078	REc			
12.193	6	20	13	12p12.1	KRAS, KRAS2, RASK2, NS, CFC2, RALD	C	Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog	190070	REa, A, Fd	pseudogene KRAS1P on 6p12-p11	Lung cancer, somatic, 211980 (3); Bladder cancer, somatic, 109800 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, somatic, 137215 (3); Leukemia, acute myeloid, 601626 (3); Noonan syndrome 3, 609942 (3); Cardiofaciocutaneous syndrome 2, 615278 (3); Breast cancer, somatic, 114480 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	6(Kras2)
12.194	4	29	14	12p12.1	LRMP, JAW1	P	Lymphoid-restricted membrane protein	602003	REc			
12.195	9	7	12	12p12.1	RASSF8, C12orf2	P	RAS association domain family, member 8	608231	REc			
12.196	2	12	16	12p12.1	SOX5, LAMSHF	P	SRY-box 5	604975	A, H	some LAMSHF patients have 12p12 deletions	Lamb-Shaffer syndrome, 616803 (3)	6(Sox5)
12.197	8	24	09	12p12.1	BHLHE41, BHLHB3, DEC2, SHARP1	P	Basic helix-loop-helix domain-containing protein, member E41	606200	A		[Short sleeper], 612975 (3)	6(Dec2)
12.198	3	20	06	12p12.1	ETNK1, EKI1	P	Ethanolamine kinase 1	609858	REc			12(Etnk1)
12.199	3	22	06	12p12.1	DADR	P	DAD1-related gene	609860	A			
12.200	4	27	10	12p11.22	PTHLH, BDE2	P	Parathyroid hormone-like hormone	168470	REa, A		Humoral hypercalcemia of malignancy (1); Brachydactyly, type E2, 613382 (3)	6(Pthlh)
12.201	3	14	96	12p12.1	SIAT8	C	Sialyltransferase-8 (alpha-N-acetylneuraminate: alpha-2,8-sialyltransferase, GD3 synthase)	601123	Psh, A			6(Siat8)
12.202	7	6	00	12q13.13	TARBP2	P	TAR RNA-binding protein 2	605053	Psh	pseudogene on 8q22-qter		15(Tarbp2)
12.203	9	15	98	12p12.1	BCAT1, BCT1	C	Branched chain aminotransferase-1, cytosolic	113520	S, H		?Hyperleucinemia-isoleucinemia or hypervalinemia (1)	6(Bcat1)
12.204	8	30	01	12p13.2	BCLG	P	Apoptosis regulator BCLG	606126	REc			
12.205	6	10	04	12p12.3	CAPZA3, CAPPA3	P	Capping protein, actin, alpha-3	608722	REc			6(Capza3)
12.206	6	27	12	12p13.2	DUSP16, MKP7, KIAA1700	P	Dual-specificity phosphatase 16	607175	REc			
12.207	12	26	14	12p13.1	GRIN2B, NMDAR2B, MRD6, EIEE27	P	Glutamate receptor, ionotropic, N-methyl D-aspartate 2B	138252	A, REa		Mental retardation, autosomal dominant 6, 613970 (3); Epileptic encephalopathy, early infantile, 27, 616139 (3)	6(Nmdar2b)
12.208	5	29	12	12p12.3	GUCY2C, GUC2C, DIAR6, MECIL	P	Guanylate cyclase 2C (heat stable enterotoxin receptor)	601330	A		Diarrhea 6, 614616 (3); Meconium ileus, 614665 (3)	6(Gucy2c)
12.209	8	25	09	12p12.3	PEPP2, KIAA1686	P	Phosphatidylinositol 3-phosphate-binding PH domain protein 2	607770	R, REc			
12.210	11	2	04	12p12.3	PIK3C2G	P	Phosphatidylinositol 3-kinase, class 2, gamma	609001	A, H			6(Pik3c2g)
12.211	3	23	09	12p12.3	RERG	P	Ras-like and estrogen-regulated growth inhibitor	612664	REc			
12.212	7	7	14	12p12.3	SKP1P2, SKP1B	P	S-phase kinase-associated protein 1 pseudogene 2 (p19B)	601435	A			
12.213	1	13	99	12p12.1	SLC21A3, OATP	C	Solute carrier family 21 (organic anion transporter), member 3	602883	Psh, A			
12.214	1	18	12	12p12.1	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	P	Solute carrier organic anion transporter family, member 1B1	604843	R, REn	HBLRR digenic with SLCO1B3	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
12.215	6	7	10	12p12.2	SLCO1C1, OATPF, OATP14, SLC21A14	P	Solute carrier organic anion transporter family, member 1C1	613389	REc			
12.216	3	14	06	12p13.31	ZNF384, CIZ, CAGH1, NMP4	P	Zinc finger protein 384	609951	REc, H			6(Znf384)
12.217	5	22	14	12p12.1	RECQL, RECQL1	P	RecQ helicase-like (DNA helicase, RecQ-like 1)	600537	Psh, A			
12.218	11	19	13	12p11.21	CAPRIN2, C1QDC1, EEG1, KIAA1873	P	Caprin family, member 2	610375	REc			
12.219	1	1	12	12p11.21	DNM1L, DRP1, DVLP, DYMPLE, EMPF	P	Dynamin 1-like	603850	R, REc		Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)	
12.220	12	30	14	12p11.21	H3F3C	P	H3 histone, family 3C	616134	REc, A			
12.221	6	4	13	12p11.21	METTL20, C12orf72	P	Methyltransferase-like 20	615256	REc			
12.222	9	17	10	12p11.21	YARS2, TYRRS, MLASA2	P	Tyrosyl-tRNA synthetase 2	610957	R, REc		Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	
12.223	3	29	12	12p11.23	ARNTL2, BMAL2, CLIF	P	Aryl hydrocarbon receptor nuclear translocator-like protein 2	614517	A, REc			
12.224	3	7	13	12p11.23	ASUN, MAT89BB, GCT1	P	Asunder, spermatogenesis regulator	615079	REc			
12.225	1	8	15	12p11.22	FAR2, MLSTD1	P	Fatty acyl CoA reductase 2	616156	REc			12(Far2)
12.226	2	5	15	12p12.1	KCNJ8	P	Potassium inwardly-rectifying channel, subfamily J, member 8	600935	A			
12.227	7	22	09	12p11.23	MED21, SURB7, SRB7	P	Mediator complex subunit 21	603800	REc			
12.228	6	2	98	12p11.23-q13.12	AD5	P	Alzheimer disease, familial, type 5	602096	Fd		Alzheimer disease-5, 104300 (2)	
12.229	9	22	08	12p11.22	ERGIC2, CDA14, PTX1	P	Endoplasmic reticulum-golgi intermediate compartment protein 2	612236	Psh, REc			
12.230	3	15	07	12p11.22	REP15	P	Rab15 effector protein	610848	R, REc			
12.231	7	18	14	12p11.22	TMTC1	P	Transmembrane and tetratricopeptide repeat domains-containing protein 1	615855	REc			
12.232	7	2	07	12p11.21	FGD4, FRABIN, CMT4H	C	FYVE, RhoGEF, and PH domain-containing protein 4	611104	R, Fd		Charcot-Marie-Tooth disease, type 4H, 609311 (3)	
12.233	1	26	97	12p12.1	SSPN, KRAG	P	Sarcospan (Kirsten-ras associated gene)	601599	A			
12.234	5	28	98	12p11.21	BICD1	P	Bicaudal-D, Drosophila, homolog of, 1	602204	REc	second homolog on 9q		
12.235	1	18	13	12p11.2-q13.1	ARCI7	P	Ichthyosis, congenital, autosomal recessive 7	615022	Fd	between D12S345 and D12S390	Ichthyosis, congenital, autosomal recessive 7, 615022 (3)	
12.236	2	17	09	12p11.2-q14	STQTL3	P	Stature quantitative trait locus 3	606257	Fd	max lod at D12S398 and D12S10990	{Stature QTL 3} (2)	
12.237	2	5	14	12p11.1	ALG10, KCR1	P	Alg10, S. cerevisiae, homolog of	603313	REc		{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3)	
12.238	6	14	10	12p11.21	DDX11, CHLR1, KRG2	P	DEAD/H box-11 (CHL1-related helicase gene-1)	601150	Psh, A		Warsaw breakage syndrome, 613398 (3)	
12.239	1	24	13	12p11.21	FAM60A	P	Family with sequence similarity 60, member A	615027	REc			
12.240	4	3	15	12p11.23	ITPR2, ANHD	P	Inositol 1,4,5-triphosphate receptor, type 2	600144	A	mutation has been identified in 1 ANHD family	?Anhidrosis, isolated, with normal sweat glands, 106190 (3)	
12.241	7	9	09	12p13.33	KDM5A, JARID1A, RBP2, RBBP2	P	Lysine(K)-specific demethylase 5A	180202	Psh, A			
12.242	12	30	04	12p11.21	PKP2, ARVD9	C	Plakophilin-2	602861	A, Psh	pseudogene on 12p13	Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	
12.243	9	9	13	12p11-q13	VUR7	P	Vesicoureteral reflux 7	615390	Fd	max lod at D12S1048	Vesicoureteral reflux 7 (2)	
12.244	1	28	88	12p	KAR	L	Aromatic alpha-keto acid reductase	107920	S	?same as MDH1		
12.245	2	23	12	12p13.32	NDUFA9	P	NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 9	603834	REc		Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
12.246	5	7	03	12q21.2	OSBPL8, ORP8, KIAA1451	C	Oxysterol-binding protein-like protein 8	606736	R, REc			
12.247	5	4	12	12p	PKS	P	Pallister-Killian syndrome	601803	Ch		Pallister-Killian syndrome (4)	
12.248	5	15	95	12q21.2	SYT1	C	Synaptotagmin-1	185605	REa, H			10(Syt1)
12.249	6	2	99	12q23.1	FXR, RIP14	L	Farnesoid X-activated receptor	603826	H			10(Fxr)
12.250	7	8	10	12q	IHPS1, IHPS	P	Pyloric stenosis, infantile hypertrophic 1	179010	Fd		Pyloric stenosis, infantile hypertrophic 1 (2)	
12.251	6	25	99	12q24.13	RPL6	P	Ribosomal protein L6	603703	Psh, R			
12.252	3	29	10	12q13.2	RPS26, DBA10	P	Ribosomal protein S26	603701	Psh, R		Diamond-Blackfan anemia 10, 613309 (3)	
12.253	5	22	03	12q13.13	SMUG1	P	Single-strand-selective monofunctional uracil-DNA glycosylase 1	607753	REc			
12.254	1	2	08	12q12	ADAMTS20	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 20	611681	REc			
12.255	10	29	99	12q12	ABCD2, ALDR, ALDL1	P	ATP-binding cassette, subfamily D, member 2	601081	A, Psh			15(Aldl1)
12.256	7	7	14	12q12	CNTN1, MYPCN	P	Contactin 1	600016	A	mutation identified in 1 MYPCN family	?Myopathy, congenital, Compton-North, 612540 (3)	
12.257	1	31	01	12p11.23	TM7SF3	P	Transmembrane 7 superfamily, member 3	605181	A, R			
12.258	1	25	93	12q13.13	ITGA5, FNRA, VLA5A	C	Integrin, alpha-5 (fibronectin receptor, alpha subunit; very late activation protein-5, alpha subunit)	135620	REa, A			15(Itga5)
12.259	6	7	95	12q13.13	KRT2, KRT2A, KRT2E	P	Keratin 2	600194	Fd		Ichthyosis bullosa of Siemens, 146800 (3)	
12.260	3	3	09	12q13.11-q13.12	CCNT1, CCNT	P	Cyclin T1	143055	R, REc			
12.261	12	11	97	12q13.13	ACVRL1, ACVRLK1, ALK1, HHT2	C	Activin A receptor, type II-like kinase 1	601284	REc		Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	
12.262	1	13	99	12q13.12	ACCN2	P	Cation channel, amiloride-sensitive, neuronal, 2	602866	A			
12.263	9	15	11	12q12	ANO6, TMEM16F, SCTS, BDPLT7	P	Anoctamin 6	608663	REc		Scott syndrome, 262890 (3)	15(Tmem16f)
12.264	2	25	15	12q12	ARID2, BAF200, KIAA1557	P	AT-rich interaction domain-containing protein 2	609539	REc			
12.265	3	29	10	12q12	GXYLT1, GLT8D3	P	Glucoside xylosyltransferase 1	613321	REc			
12.266	3	8	07	12q12	IRAK4, REN64, IPD1	P	Interleukin 1 receptor-associated kinase 4	606883	REc		IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)	
12.267	2	17	10	12q12	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	C	Kinesin family member 21A	608283	Fd, REc		Fibrosis of extraocular muscles, congenital, 1, 135700 (3); Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	15(Kif21a)
12.268	4	10	15	12q12	LRRK2, PARK8	C	Leucine-rich repeat kinase 2 (dardarin)	609007	Fd, REc		{Parkinson disease 8}, 607060 (3)	
12.269	7	31	08	12q12	MUC19	P	Mucin 19, oligomeric	612170	REc			15(Muc19)
12.270	12	28	08	12q12	PDZRN4	P	PDZ domain-containing ring finger protein 4	609730	REc			
12.271	7	9	06	12q13.13	PFDN5, MM1	P	Prefoldin 5	604899	R			
12.272	3	22	07	12q12	PPHLN1	P	Periphilin 1	608150	REc			
12.273	12	24	08	12q12	PRICKLE1, RILP, EPM1B	C	Prickle-like 1	608500	REc		Epilepsy, progressive myoclonic 1B, 612437 (3)	15(Prickle1)
12.274	8	20	07	12q12	SLC2A13, HMIT	P	Solute carrier family 2 (facilitated glucose transporter), member 13	611036	R, REc			
12.275	4	19	07	12q12	TWF1, PTK9	P	Twinfilin, Drosophila, homolog of, 1	610932	R, REc			
12.276	8	18	14	12q12	YAF2	P	YY1-associated factor 2	607534	REc			
12.277	2	12	07	12q12	ZCRB1, MADP1	P	Zinc finger CCHC domain- and RNA-binding motif-containing protein 1	610750	REc	possible pseudogenes on chr16, X, and 6		
12.278	3	31	15	12q13.12	ADCY6, LCCS8	C	Adenylate cyclase-6	600294	A, REa	mutation identified in 1 LCCS8 family	?Lethal congenital contracture syndrome 8, 616287 (3)	15(Adcy6)
12.279	10	1	95	12q13.2	CD63, MLA1	P	CD63 antigen (melanoma 1 antigen)	155740	REa, A			10(Cd63)
12.280	2	21	12	12q13.12	GPD1, HTGTI	C	Glycerol-3-phosphate dehydrogenase, soluble	138420	S, R		Hypertriglyceridemia, transient infantile, 614480 (3)	15(Gdc1)
12.281	5	27	05	12q13.12	PRPH	P	Peripherin	170710	A		{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	15(Prph)
12.282	6	25	99	12q13.3	TIMELESS, TIM, TIM1	P	Timeless, Drosophila, homolog of	603887	A, R, H			10(Tim)
12.283	5	6	13	12q13.12	WNT1, INT1, OI15, BMND16	C	Wingless-type MMTV integration site family, member 1 (oncogene INT1)	164820	REa, A		Osteogenesis imperfecta, type XV, 615220 (3); {Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	15(Int1, Wnt1)
12.284	2	1	11	12q12	SCAF11, SFRS2IP, SIP1, CASP11, SRRP129	P	SR-related C-terminal domain-associated factor 11	603668	REc	previously assigned to 21q22.3		
12.285	4	30	04	12q12-q13.3	CMT2G	P	Charcot-Marie-Tooth disease, axonal, type 2G	608591	Fd	between D12S1663 and D12S1644	Charcot-Marie-Tooth disease, axonal, type 2G (2)	
12.286	12	13	95	12q13.13	KRT7	P	Keratin 7	148059	REa, A			
12.287	12	17	07	12q13.12	TUBA1A, TUBA3, LIS3	P	Tubulin, alpha-1A	602529	REc		Lissencephaly 3, 611603 (3)	
12.288	11	16	05	12q13.11	VDR	P	Vitamin D (1,25-dihydroxyvitamin D3) receptor	601769	REa, A		Rickets, vitamin D-resistant, type IIA, 277440 (3); ?Osteoporosis, involutional, 166710 (1)	
12.289	2	28	07	12q12-q21	RLS1	P	Restless legs syndrome, susceptibility to, 1	102300	Fd	between D12S1044 and D12S78	{Restless legs syndrome 1} (2)	
12.290	11	1	00	12q13.13	AAAS, AAA	C	Aladin	605378	Fd, REc		Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	
12.291	4	26	01	12q13.13	ACVR1B, ACVRLK4, ALK4	C	Activin A receptor, type IB	601300	REa, A		Pancreatic cancer, somatic (3)	
12.292	8	21	98	12q13.13	AMHR2, AMHR	P	Anti-Mullerian hormone receptor, type II	600956	A		Persistent Mullerian duct syndrome, type II, 261550 (3)	15(Amhr)
12.293	11	16	05	12q13.12	AQP2	C	Aquaporin-2 (collecting duct)	107777	A		Diabetes insipidus, nephrogenic, 125800 (3)	
12.294	11	5	97	12q13.12	AQP6, AQP2L	C	Aquaporin-6, kidney specific	601383	Psh, A			
12.295	10	7	13	12q13.12	AQP5, PPKB	P	Aquaporin-5	600442	A, Fd		Palmoplantar keratoderma, Bothnian type, 600231 (3)	15(Aqp2)
12.296	5	6	98	12q13.12	ARF3	C	ADP-ribosylation factor-3	103190	REc, A			
12.297	1	31	13	12q13.11	ASB8	P	Ankyrin repeat- and SOCS box-containing protein 8	615053	R, REc			
12.298	2	1	01	12q13.12	ATF1, TREB36	C	Activating transcription factor 1	123803	A, Ch	fused with EWS in soft tissue clear cell sarcoma, with FUS in angiomatoid fibrous histiocytoma		
12.299	10	6	09	12q13	BCC4	P	Basal cell carcinoma, susceptibility to, 4	613061	Fd	associated with rs11170164	{Basal cell carcinoma, susceptibility to, 4} (2)	
12.300	5	13	13	12q13.12	C1QL4, CTRP11	P	Complement component 1, q subcomponent-like 4	615229	REc			5(C1ql4)
12.301	7	17	13	12q13.13	C12orf10, MYG1	P	Chromosome 12 open reading frame 10	611366	REc			
12.302	10	19	97	12q13.12	CACNB3	P	Calcium channel, voltage-dependent, beta 3 subunit	601958	A			
12.303	5	19	94	12q13.2	CDK2	P	Cyclin-dependent kinase 2	116953	A			
12.304	9	2	12	12q13.13	CELA1, ELA1	C	Chymotrypsin-like elastase family, member 1	130120	REa, A, REc	on proximal 12p		15(Ela1)
12.305	1	12	15	12q13	CMTS	P	Chronic mountain sickness, susceptibility to	616182	Fd		{Chronic mountain sickness, susceptibility to} (2)	
12.306	8	23	07	12q13.2	ERBB3, LCCS2	C	Transformation gene ERBB-3	190151	A		Lethal congenital contractural syndrome 2, 607598 (3)	
12.307	3	10	09	12q13.13	ESPL1, ESP1	P	Extra spindle poles-like 1	604143	REc	prev. mapping to chr.8		
12.308	7	20	04	12q13.12	FAIM2, LFG, NMP35	C	FAS apoptotic inhibitory molecule 2	604306	Psh, A, REc			
12.309	5	26	13	12q13.12	FKBP11, FKBP19	P	FK506-binding protein 11	610571	REc			
12.310	3	31	15	12q13.12	FMNL3, FRL2	P	Formin-like 3	616288	REc			
12.311	1	27	04	12q13.13	GALNT6, GalNAcT6	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6	605148	A			
12.312	5	19	09	12q13.3	GLS2, GA	P	Glutaminase, liver	606365	R, REc			
12.313	3	30	12	12q14.3	HELB, HDHB	P	Helicase, DNA, B	614539	REc			
12.314	2	4	02	12q13.3	HSE	P	3-alpha-hydroxysteroid epimerase	606623	A			
12.315	2	26	93	12q13.13	HOXC4, HOX3E	C	Homeo box-C4	142974	RE			
12.316	2	26	93	12q13.13	HOXC5, HOX3D	C	Homeo box-C5	142973	RE			15(Hox6.2)
12.317	2	26	93	12q13.13	HOXC6, HOX3C	C	Homeo box-C6	142972	RE			15(Hox6.1)
12.318	2	26	93	12q13.13	HOXC8, HOX3A	C	Homeo box-C8	142970	RE			15(Hox3.1)
12.319	2	26	93	12q13.13	HOXC9, HOX3B	C	Homeo box-C9	142971	RE			15(Hox3.2)
12.320	2	26	93	12q13.13	HOXC12, HOX3F	C	Homeo box-C12	142975	RE			
12.321	11	19	12	12q13.13	HOXC13, HOX3G, ECTD9	C	Homeo box-C13	142976	RE	fused with NUP98 in AML	Ectodermal dysplasia 9, hair/nail type, 614931 (3)	
12.322	12	9	91	12q13	HPV18I2	C	Human papillomavirus type 18 integration site-2	167960	REa, A	on 8 near MYC in HeLa		
12.323	8	29	08	12q13.11	HRG1	P	Heme-responsive gene 1	612187	REc			
12.324	9	10	07	12q13.2	IKZF4, ZNFN1A4, EOS, KIAA1782	P	Ikaros family zinc finger 4	606239	R, REc			
12.325	2	2	10	12q13.2	ITGA7	P	Integrin, alpha-7	600536	A		Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)	
12.326	8	27	01	12q13.12	KCNH3, BEC1	C	Potassium voltage-gated channel, subfamily H (eag-related), member 3	604527	REc			
12.327	4	27	12	12q13.3	KIF5A, NKHC, SPG10	C	Kinesin family member 5A	602821	A, REc, Fd		Spastic paraplegia 10, autosomal dominant, 604187 (3)	2(Nkhc)
12.328	2	3	12	12q13.13	KRT1, EPPK, NEPPK, EHK	C	Keratin 1	139350	H, REa, A	close to Hox-3 in mouse; class II keratin	Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3); Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)	15(Krt2)
12.329	10	27	97	12q13.13	KRT3	C	Keratin 3	148043	A, Fd, R		Meesmann corneal dystrophy, 122100 (3)	
12.330	5	22	14	12q13.13	KRT4, CYK4, WSN1	C	Keratin 4	123940	REa, A	a class II keratin; probably in cluster with other keratin genes	White sponge nevus 1, 193900 (3)	
12.331	11	1	13	12q13.13	KRT5, DDD1	C	Keratin 5	148040	A, Fd		Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3); Epidermolysis bullosa simplex-MP, 131960 (3); Dowling-Degos disease 1, 179850 (3); Epidermylysis bullosa simplex-MCR, 609352 (3); Epidermolysis bullosa simplex, recessive 1, 601001 (3)	
12.332	4	10	14	12q13.13	KRT6A, PC3	P	Keratin 6A	148041	REa, A		Pachyonychia congenita 3, 615726 (3)	
12.333	4	10	14	12q13.13	KRT6B, PC4	P	Keratin 6B	148042	REa		Pachyonychia congenita 4, 615728 (3)	
12.334	11	5	13	12q13.13	KRT8	P	Keratin 8	148060	Psh		Cirrhosis, cryptogenic, 215600 (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
12.335	12	5	13	12q13.13	KRT18	C	Keratin 18	148070	REn, A	contiguous to KRT8, type II heteromer partner	Cirrhosis, cryptogenic, 215600 (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
12.336	7	17	14	12q13.13	KRT71, K6IRS1, KRT6IRS1, HYPT13	P	Keratin 71	608245	REc	mutation identified in 1 HYPT13 family	?Hypotrichosis 13, 615896 (3)	
12.337	3	22	07	12q13.13	KRT72, K6IRS2, KRT6IRS2	P	Keratin 72	608246	REc, REn			
12.338	3	22	07	12q13.13	KRT73, K6IRS3, KRT6IRS3	P	Keratin 73	608247	REc, REn			
12.339	2	17	15	12q13.13	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	P	Keratin 74	608248	REc, Fd	mutation identified in 1 HYPT3 family and ECTD7 family	Woolly hair, autosomal dominant, 194300 (3); ?Hypotrichosis 3, 613981 (3); ?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	
12.340	10	9	08	12q13.13	KRT75, K6HF, PFB	P	Keratin 75	609025	REc		{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	
12.341	3	7	08	12q13.13	KRT81, KRTHB1, HB1	P	Keratin 81	602153	A, Fd		Monilethrix, 158000 (3)	
12.342	7	2	14	12q13.13	KRT83, KRTHB3, HB3	P	Keratin 83	602765	REc	mutation identified in 1 MNLTX patient	?Monilethrix, 158000 (3)	
12.343	12	17	12	12q13.13	KRT85, KRTHB5, HB5, ECTD4	P	Keratin 85	602767	REc		Ectodermal dysplasia 4, hair/nail type, 602032 (3)	
12.344	3	7	08	12q13.13	KRT86, KRTHB6, HB6	C	Keratin 86	601928	A, Fd		Monilethrix, 158000 (3)	
12.345	12	18	02	12q13.2	LACRT	P	Lacritin	607360	A			
12.346	10	23	87	12q13.11	LALBA	P	Lactalbumin, alpha	149750	REa, A			
12.347	10	12	10	12q13.12	LIMA1, EPLIN, SREBP3	P	LIM domain and actin-binding protein 1	608364	REc			
12.348	2	2	01	12q14.1	METTL1	P	Methyltransferase-like 1	604466	R			
12.349	8	6	13	12q13.3	MIP, AQP0, CTRCT15	C	Major intrinsic protein of lens fiber	154050	REa, A	slightly distal to AQP2	Cataract 15, multiple types, 615274 (3)	10(Mip)
12.350	3	23	09	12q13.13	MIR196A2, MIRN196A2	P	Micro RNA 196A2	609687	REc			
12.351	1	2	08	12q13.2	NEUROD4, MATH3	P	Neurogenic differentiation 4	611635	R, REc			10(Neurod4)
12.352	10	15	94	12q13.13	NFE2	C	Nuclear factor, erythroid-derived 2, 45kD	601490	A, H			15(Nfe2)
12.353	9	15	99	12q13.13	MAP3K12, ZPK	P	Mitogen-activated protein kinase kinase kinase 12	600447	REa, A			
12.354	9	7	90	12q13.13	NR4A1, HMR, NP10, GFRP1	P	Nuclear receptor subfamily 4, group A, member 1	139139	A			15(np10)
12.355	3	17	16	12q13.12	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	P	Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2	600523	A		Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	15(Nramp2, mk)
12.356	12	28	08	12q13.3-q14.1	OS9	C	Amplified in osteosarcoma 9	609677	REc, Psh, A			
12.357	6	4	98	12q13.2	PA2G4	P	Proliferation-associated 2G4, 38kD	602145	A	family of genes on 7 chromosomes		
12.358	9	28	98	12q13.2	PDE1B1, PDES1B, PDE1B	C	Phosphodiesterase-1B	171891	Psh, REc			15(Pde1b)
12.359	11	5	97	12q13.3	PRIM1	P	Primase, polypeptide-1, 49kD	176635	Psh, A, REc, H			10(Prim1)
12.360	8	18	99	12q13.2	RAB5B	P	Ras-associated protein RAB5B	179514	A			
12.361	8	11	91	12q13.13	RARG	C	Retinoic acid receptor, gamma polypeptide	180190	A, REa			15(Rarg)
12.362	9	8	11	12q13.2	SARNP, CIP29, HCC1, HSPC316	P	SAP domain-containing ribonucleoprotein	610049	REc	fused with MLL in AML		
12.363	4	22	15	12q13.13	SCN8A, CIAT, EIEE13	P	Sodium channel, voltage gated, type VIII, alpha polypeptide	600702	REa, A	mutation identified in 1 CIAT family	?Cognitive impairment with or without cerebellar ataxia, 614306 (3); Epileptic encephalopathy, early infantile, 13, 614558 (3)	2(med, Scn8a)
12.364	7	13	93	12q13.3	SHMT2, GLYA	C	Serine hydroxymethyltransferase	138450	S, R, A	glycine A auxotroph		
12.365	8	18	99	12q14.1	SLC16A7, MCT2	P	Solute carrier family 16 (monocarboxylic acid transporters), member 7	603654	REa, A			
12.366	8	29	03	12q13.11	SLC38A4, NAT3, ATA3	C	Solute carrier family 38 (amino acid transporter), member 4	608065	REc, Psh, A			
12.367	9	9	03	12q13.13	SOAT2, ACACT2	P	Sterol O-acyltransferase 2	601311	REc			
12.368	9	10	14	12q13	SPDT	P	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	Fd		Spondyloepiphyseal dysplasia tarda, autosomal dominant (2)	
12.369	6	10	98	12q13.3	STAT6	C	Signal transducer and activator of transcription-6, interleukin-4 induced	601512	A, H, REc			10(Stat6)
12.370	4	24	96	12q13.12-q13.13	TFCP2	C	Transcription factor CP2, alpha globin	189889	REa, H, A			
12.371	8	24	09	12q13.12	WNT10B, SHFM6	P	Wingless-type MMTV integration site family, member 10B	601906	A		Split-hand/foot malformation 6, 225300 (3)	
12.372	12	17	15	12q13-q14	DFNA48	P	Deafness, autosomal dominant 48	607841	Fd		Deafness, autosomal dominant 48 (2)	
12.373	10	18	96	12q13.2	GCN5L1	P	GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1	601444	A			
12.374	3	11	03	12p11.21	IPO8, RANBP8	P	Importin 8	605600	R			
12.375	5	28	99	12q13-q14	PABPL2	P	Poly(A)-binding protein-like 2	604681	A	?pseudogenes on 3q and 13q		
12.376	6	2	99	12q13.2	RDH5	P	Retinol dehydrogenase-5	601617	REa, A		Fundus albipunctatus, 136880 (3)	
12.377	8	31	98	12q13.2	SILV, D12S53E, PMEL17	P	Silver, mouse, homolog of	155550	REa			10(si)
12.378	6	25	99	12q13.2	SMARCC2, BAF170	P	SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2	601734	Psh, R			
12.379	6	25	99	12q13.12	SMARCD1, BAF60A	P	SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1	601735	Psh, R			
12.380	1	5	07	12q14.1	TSFM, COXPD3	C	Ts translation elongation factor, mitochondrial	604723	REa, A		Combined oxidative phosphorylation deficiency 3, 610505 (3)	
12.381	1	20	06	12q14.1	TSPAN31, SAS	P	Tetraspanin 31	181035	REa, A			
12.382	12	17	15	12q13.3	MYO1A	C	Myosin IA	601478	A			10(Myo1a)
12.383	6	2	98	12q15	YEATS4, GAS41	P	YEATS domain-containing protein 4	602116	REc			
12.384	9	30	95	12q13-q21	ENUR2	P	Enuresis, nocturnal, 2	600808	Fd		Enuresis, nocturnal, 2 (2)	
12.385	9	28	12	12q13.3	TAC3, NKNB, HH10	P	Tachykinin 3 (neuromedin K, neurokinin B)	162330	REa, A		Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	
12.386	3	18	94	12q24.33	ZNF10, KOX1	C	Zinc finger protein-10 (KOX 1)	194538	REa	same 300kb fragment as ZNF26		
12.387	12	21	03	12q13.2	DCD	C	Dermcidin	606634	R			
12.388	11	30	06	12q13.12	DDN, KIAA0749	P	Dendrin	610588	R, REc			
12.389	8	14	09	12q13.12	DHH, SRXY7, GDXYM	C	Desert hedgehog	605423	A		46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3); 46XY sex reversal 7, 233420 (3)	
12.390	2	21	14	12q13.11	ENDOU, PP11	P	Endonuclease polyU-specific	606720	REc			
12.391	4	25	93	12q13.1-q13.2	HEM1	P	Hematopoietic protein-1	141180	REb, A			
12.392	11	5	13	12q13.13	HNRNPA1, IBMPFD3, ALS20	P	Heterogeneous nuclear ribonucleoprotein A1	164017	A	mutation identified in 1 family with IBMPFD3	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3); Amyotrophic lateral sclerosis 20, 615426 (3)	
12.393	1	27	97	12q13.3	INHBC	P	Inhibin, beta C	601233	A			10(Inhbc)
12.394	1	13	99	12q13.12	PRKAG1	P	Protein kinase, AMP-activated, noncatalytic, gamma-1	602742	A			
12.395	7	10	08	12q13.11	SENP1	P	Sentrin-specific protease family, member 1	612157	REc			
12.396	11	4	93	12q13.13	SP1	C	Sp1 transcription factor	189906	REa, A			15(Sp1)
12.397	10	12	10	12q13.3	DDIT3, GADD153, CHOP10	C	DNA-damage-inducible transcript-3	126337	REa, A, Ch	fused with FUS in myxoid liposarcoma	Myxoid liposarcoma, 613488 (1)	
12.398	8	26	03	12q13.2	DRIP78, HDJ3	P	Dopamine receptor-interacting protein, 78kD	606092	REc			
12.399	4	17	06	12q14.1	CYP27B1, VDD1, PDDR	C	Cytochrome P450, subfamily XXVIIB, polypeptide 1	609506	A, Fd		Vitamin D-dependent rickets, type I, 264700 (3)	
12.400	8	25	94	12q13.3	LRP1, A2MR	C	Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor)	107770	A			15(A2mr)
12.401	3	12	14	12q13.11	AMIGO2, ALI1	C	Adhesion molecule with Ig-like domain 2	615690	REc, H			15(Amigo2)
12.402	9	30	13	12q13.11	ANP32D, PP32R2	P	Acidic leucine-rich nuclear phosphoprotein 32 family, member D	606878	REc			
12.403	9	30	14	12q13.3	ARHGEF25, GEFT	P	Rho guanine nucleotide exchange factor 25	610215	REc			
12.404	12	10	13	12q13.11	KANSL2, NSL2, C12orf41	P	KAT8 regulatory NSL complex, subunit 2	615488	REc			15(Kansl2)
12.405	10	13	09	12q13.11	RPAP3	P	RNA polymerase II-associated protein 3	611477	REc			
12.406	3	12	04	12q13.11	SLC38A1	P	Solute carrier family 38 (amino acid transporter), member 1	608490	REc, R			
12.407	3	15	14	12q13.11	SLC38A2, ATA2, KIAA1382	P	Solute carrier family 38, member 2	605180	REc			
12.408	4	8	16	12q13.11	SNORA2C, SNORA34, ACA34, MIR1291	P	Small nucleolar RNA, H/ACA box, 34	615487	REc, REn	MIR1291 in intron of SNORA34	Small nucleolar RNA, H/ACA box, 2C, 615487 (3)	
12.409	5	16	11	12q13.11	ZNF641	P	Zinc finger protein 641	613906	REc			
12.410	6	19	98	12q12	NELL2	P	Nel-like 2	602320	A			
12.411	10	13	15	12q13.11	COL2A1	C	Collagen II, alpha-1 polypeptide	120140	REa, A		Stickler syndrome, type I, 108300 (3); Kniest dysplasia, 156550 (3); Achondrogenesis, type II or hypochondrogenesis, 200610 (3); SED congenita, 183900 (3); SMED Strudwick type, 184250 (3); Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3); Spondyloperipheral dysplasia, 271700 (3); Osteoarthritis with mild chondrodysplasia, 604864 (3); Vitreoretinopathy with phalangeal epiphyseal dysplasia (3); Platyspondylic skeletal dysplasia, Torrance type, 151210 (3); Otospondylomegaepiphyseal dysplasia, 215150 (3); Avascular necrosis of the femoral head, 608805 (3); Legg-Calve-Perthes disease, 150600 (3); Stickler sydrome, type I, nonsyndromic ocular, 609508 (3); Czech dysplasia, 609162 (3); Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3)	15(Col2a1, seds)
12.412	11	19	11	12q13.11-q15	MRT25	P	Mental retardation, autosomal recessive 25	614346	Fd	between rs4760658 and rs1882033	Mental retardation, autosomal recessive 25 (2)	
12.413	11	11	13	12q13.12	CCDC65, CILD27	P	Coiled-coil domain-containing protein 65	611088	REc		Ciliary dyskinesia, primary, 27, 615504 (3)	
12.414	8	2	13	12q13.12	CERS5, LASS5, TRH4	P	Ceramide synthase 5	615335	REc			
12.415	9	8	14	12q13.12	COX14, C12orf62	P	Cytochrome c oxidase assembly protein COX14	614478	REc, H	mutation identified in 1 Cox4 deficient family	?Mitochondrial complex IV deficiency, 220110 (3)	15(C12orf62)
12.416	8	27	08	12q13.12	DDX23, PRP28	P	Dead box polypeptide 23	612172	REc			
12.417	8	29	07	12q13.12	DIP2B, KIAA1463	P	Disco-interacting protein 2, Drosophila, homolog of, B	611379	A, REc		Mental retardation, FRA12A type, 136630 (3)	
12.418	3	14	14	12q13.12	KMT2D, MLL2, ALR, KABUK1	P	Lysine (K)-specific methyltransferase 2D	602113	Psh, R		Kabuki syndrome 1, 147920 (3)	
12.419	3	28	06	12q13.12	LMBR1L, LIMR, KIAA1174	P	Limb region 1 homolog-like	610007	R, REc			
12.420	2	25	15	12q13.12	MCRS1, MSP58, MCRS2	P	Microspherule protein 1 (microspherule protein 2, included)	609504	R, REc			
12.421	3	14	13	12q13.12	NCKAP5L, KIAA1602	P	NCK-associated protein 5-like	615104	REc			
12.422	5	13	13	12q13.12	RCGAP1, MGCRACGAP, CYK4	P	GTPase-activating protein, Rac, 1	604980	R, REc			
12.423	6	13	12	12q13.12	RND1, RHO6	P	Rho family GTPase 1	609038	REc, A			
12.424	6	22	14	12q13.12	TMBIM6, TEGT	P	Transmembrane BAX inhibitor motif-containing protein 6	600748	REa, A			15(Tegt)
12.425	3	9	98	12q13.13	PCBP2	P	Poly(rC)-binding protein-2	601210	A			
12.426	3	14	13	12q13.13	ATG101, C12orf44	P	Autophay-related protein 101	615089	REc			
12.427	5	7	01	12q13.13	BIN2	P	Bridging integrator 2	605936	A, REc	previously mapped to 4q22.1		
12.428	11	11	14	12q13.13	CBX5, HP1	P	Chromobox homolog 5	604478	R, REc			
12.429	12	10	13	12q13.13	COPZ1, COPZ	P	Coatomer protein complex, subunit zeta-1	615472	REc			
12.430	9	28	15	12q13.13	CSAD, CSD, PCAP	P	Cysteine sulfinic acid decarboxylase	616569	REc			
12.431	5	25	13	12q13.13	EIF4B	P	Eukaryotic translation initiation factor 4B	603928	REc			
12.432	3	8	04	12q13.2	GDF11, BMP11	P	Growth/differentiation factor 11	603936	R, REc			
12.433	11	28	01	12q13.13	GPR84	P	G protein-coupled receptor 84	606383	REc			15(Gpr84)
12.434	6	5	08	12q13.13	GRASP, TAMALIN	P	GRP1-associated scaffold protein	612027	R, REc			
12.435	12	4	08	12q13.13	HOTAIR	P	Hox transcript antisense RNA	611400	R, REc			
12.436	7	12	92	12q13.13	ITGB7	C	Integrin, beta-7	147559	REa, A			15(Itgb7)
12.437	4	11	14	12q13.13	KRT6C, PPKNEFD	P	Keratin 6C	612315	REc		Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3)	
12.438	12	2	15	12q13.13	KRT76, K76, KRT2P	P	Keratin 76, type II	616671	REc			
12.439	2	25	08	12q13.13	KRT77, K1B	P	Keratin 77	611158	REc			
12.440	2	25	08	12q13.13	KRT78, K5B	P	Keratin 78	611159	REc			
12.441	3	7	08	12q13.13	KRT79,  KRT6L, K6L	P	Keratin 79	611160	REc			
12.442	2	28	08	12q13.13	KRT80, KB20	P	Keratin 80	611161	REc			
12.443	11	13	13	12q13.13	KRT82, KRTHB2, HB2	P	Keratin 82	601078	REc			
12.444	11	13	13	12q13.13	KRT84, KRTHB4, HB4	P	Keratin 84	602766	REc			
12.445	5	13	11	12q13.13	MIR148B, MIRN148B	P	Micro RNA 148B	613787	REc			
12.446	7	20	09	12q13.2	MYL6B, MLC1SA	P	Myosin, light chain 6B, alkali, smooth muscle and nonmuscle, slow	609930	R, REc			
12.447	5	24	13	12q13.13	PRR13, TXR1	P	Proline-rich protein 13	610459	REc			
12.448	2	11	15	12q13.13	SP7, OSX, OI12	P	Transcription factor Sp7	606633	A, H	mutation identified in 1 OI12 patient	?Osteogenesis imperfecta, type XII, 613849 (3)	15(Sp7)
12.449	3	3	16	12q13.13	TNS2, TENC1, C1TEN, KIAA1075	P	Tensin 2	607717	R, REc			
12.450	10	27	08	12q13.13	ZNF385A, ZNF385, RZF, HZF	P	Zinc finger protein 385A	609124	REc			
12.451	12	1	15	12q13.2	ESYT1, MBC2, FAM62A	P	Extended synaptotagmin-like protein 1	616670	REc			
12.452	2	6	09	12q13.3	IL23A, SGRF, P19, IL23P19	C	Interleukin 23, p19 subunit	605580	R, REc			
12.453	2	25	09	12q14.1	LIRG3, LIG3	C	Leucine-rich repeats- and immunoglobulin-like domains-containing protein 3	608870	A, H			10(Lrig3)
12.454	3	1	06	12q13.2	MYL6	P	Myosin light chain 6, alkali, smooth muscle and nonmuscle	609931	R, REc			
12.455	4	7	10	12q13.2	ORMDL2	P	ORM1-like protein 2	610074	REc	pseudogene on 8q22.1		
12.456	3	3	10	12q13.2	PPP1R1A, IPP1, I1	P	Protein phosphatase 1, regulatory subunit 1A	613246	REc			
12.457	3	29	10	12q13.2	RPL41, HG12	P	Ribosomal protein L41	613315	REc			
12.458	3	20	07	12q13.2	SBEM	P	Small breast epithelial mucin	610857	REc			
12.459	12	17	07	12q13.12	SPATS2, SPATA10, P59SCR, SCR59	P	Spermatogenesis-associated serine-rich protein 2	611667	REc			
12.460	12	1	15	12q13.3	STAT2, IMD44	P	Signal transducer and activator of transcription 2	600556	R, REc		Immunodeficiency 44, 616636 (3)	
12.461	3	7	14	12q13.2	TESPA1, KIAA0748	P	Thymocyte-expressed positive selection-associated protein 1	615664	REc			
12.462	11	23	09	12q13.3	CS	C	Citrate synthase, mitochondrial	118950	S, D, REc			10(Cs)
12.463	7	17	91	12q13.3	GLI	C	Glioma-associated oncogene homolog (zinc finger protein)	165220	REa, A			10(Gli)
12.464	12	19	11	12q13.3	AAA4	P	Aortic aneurysm, familial abdominal, 4	614375	Fd	associated with rs1466535	Aortic aneurysm, familial abdominal, 4 (2)	
12.465	12	3	13	12q13.3	APOF, LTIP	P	Apolipoprotein F	107760	REc, Psh			
12.466	2	25	16	12q13.3	B4GALNT1, GALGT, GALNACT, SPG26	P	Beta-1,4-N-acetylgalactosaminyltransferase 1	601873	A, Fd		Spastic paraplegia 26, autosomal recessive, 609195 (3)	
12.467	12	17	15	12q13.3	DCTN2, DCTN50	P	Dynactin 2	607376	R, REc			
12.468	10	15	98	12q13.2	DGKA, DAGK1	C	Diacylglycerol kinase, alpha, 80kD	125855	REa, A, H			10(Dagk1)
12.469	12	21	09	12q13.3	DTX3	P	Deltex, Drosophila, homolog of, 3	613142	REc			
12.470	6	9	08	12q13.3	INHBE	P	Inhibin, beta E	612031	REc			
12.471	6	19	15	12q13.3	MARS, MTRNS, METRS, ILLD, CMT2U	P	Methioninyl-tRNA synthetase	156560	S, REc		Interstitial lung and liver disease, 615486 (3); Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	
12.472	2	12	21	12q13.3	MIR616	P	Micro RNA 616	614489	REc			
12.473	1	13	16	12q13.3	NEMP1, TMEM194A	P	Nuclear envelope integral membrane protein 1	616496	REc			
12.474	11	3	14	12q13.3	NXPH4, NPH4	P	Neuroexophilin 4	604637	REc			
12.475	6	26	08	12q13.3	OBFC2B, SSB1	P	Oligonucleotide/oligosaccharide-binding fold-containing protein 2B	612104	REc			
12.476	3	12	07	12q13.11	PFKM, GSD7	C	Phosphofructokinase, muscle type	610681	Psh, A, Fd	incorrectly assigned to chr.1	Glycogen storage disease VII, 232800 (3)	15(Pfk4)
12.477	3	1	11	12q13.3	PTGES3, P23, CPGES	P	Prostaglandin E synthase 3	607061	R, REc			
12.478	9	20	14	12q13.3	RBMS2, SCR3	P	RNA-binding motif protein, single strand interacting, 2	602387	REc			
12.479	12	20	05	12q13.3	SDRO	P	Orphan short-chain dehydrogenase/reductase	609769	REc			10(Sdro)
12.480	8	22	14	12q13.3	SLC39A5, MYP24	P	Solute carrier family 39 (zinc transporter), member 5	608730	REc		Myopia 24, autosomal dominant, 615946 (3)	
12.481	11	19	13	12q13.3	STAC3, NAM	P	SH3 and cystein-rich domains 3	615521	REc		Native American myopathy, 255995 (3)	
12.482	6	19	98	12q13.3	NAB2	P	NGFIA-binding protein-2	602381	A			10(Nab2)
12.483	6	7	10	12q14.1	AVIL	P	Advillin	613397	A, H			10(Avil)
12.484	5	12	11	12q14.1	CDK4, CMM3	C	Cyclin-dependent kinase 4	123829	A		{Melanoma, cutaneous malignant, 3}, 609048 (3)	
12.485	11	5	13	12q13.3	ARHGAP9	P	Rho GTPase-activating protein 9	610576	REc			
12.486	2	3	05	12q15	DYRK2	C	Dual-specificity tyrosine phosphorylation-regulated kinase 2	603496	REc			
12.487	5	6	13	12q14	GLC1P	P	Glaucoma 1, open angle, P	177700	Ch	caused by 300kb duplication	Glaucoma 1, open angle, P (4)	
12.488	3	27	03	12q14.3	GNS, G6S	P	N-acetylglucosamine-6-sulfatase	607664	A, REa		Mucopolysaccharidosis type IIID, 252940 (3)	
12.489	2	22	10	12q15	IFNG, IFG, IFI	C	Interferon, gamma	147570	REa, A	3 introns; none in IFF, IFL	{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic anemia}, 609135 (3); {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3);{Hepatitis C virus, response to therapy of}, 609532 (3)	10(Ifg)
12.490	5	31	05	12q14.3	LEMD3, MAN1	C	LEM domain-containing 3	607844	R, Fd		Osteopoikilosis, 166700 (3); Buschke-Ollendorff syndrome, 166700 (3); Melorheostosis with osteopoikilosis, 155950 (3)	
12.491	9	24	15	12q13.2	MMP19, MMP18, CODA	P	Matrix metalloproteinase-19	601807	A, Fd	triplication in upstream regulatory region	Cavitary optic disc anomalies, 611543 (3)	
12.492	12	1	11	12q14	PRO2268	P	PRO2268 gene	614354	REc			
12.493	9	15	89	12q15	RAP1B	P	RAS-related protein RAP1B	179530	A			
12.494	8	5	97	12q14.2	AVPR1A	P	Arginine vasopressin receptor-1A	600821	Psh, A			
12.495	3	22	06	12q21.2	ZDHHC17, HIP14	P	Zinc finger DHHC domain-containing protein 17	607799	A			
12.496	2	11	16	12q14.1	AGAP2, CENTG1, PIKE	P	ARF-GAP with GTP-binding protein-like, ankyrin repeat, and pleckstrin homology domains 2	605476	REc			
12.497	6	7	10	12q14.1	MARCH9	P	Membrane-associated RING-CH finger protein 9	613336	REc			
12.498	6	4	13	12q14.1	METTL21B, FAM119B	P	Methyltransferase-like 21B	615258	REc			
12.499	10	6	09	12q14.1	MIR26A2, MIRN26A2	P	Micro RNA 26A2	613057	REc			
12.500	3	23	09	12q14.1	MIRLET7I, LET7I, MIRNLET7I	P	Micro RNA Let7i	612148	REc			
12.501	2	17	16	12q14.1	MON2, KIAA1040	P	Mon2, S. cerevisiae, homolog of	616822	REc			
12.502	9	30	02	12q14.2	RASSF3	P	Ras association domain family protein 3	607019	REc			
12.503	10	2	12	12q14.1	USP15	P	Ubiquitin-specific protease 15	604731	REc			
12.504	9	30	14	12q14.1-q14.2	PPM1H, KIAA1157	P	Protein phosphatase, magnesium/manganese-dependent, 1H	616016	REc			
12.505	9	20	00	12q15	KCNMB4	P	Potassium large conductance calcium-activated channel, subfamily M, beta member 4	605223	REc			
12.506	1	20	06	12q21.1	TSPAN8, TM4SF3	P	Tetraspanin 8	600769	REc			
12.507	8	23	09	12q14.2	AUTS13	P	Autism, susceptibility to, 13	610908	Fd	linkage with rs1445442	{Autism susceptibility 13} (2)	
12.508	6	11	11	12q14.2	DPY19L2, SPGF9	P	DPY19-like 2	613893	REc	pseudogene on 7p14.3	Spermatogenic failure 9, 613958 (3)	9(Dpy19l2)
12.509	9	1	15	12q14.2	SRGAP1, KIAA1304, NMTC2	P	Slit-robo GTPase-activating protein, rho, 1	606523	R, REc		{Thyroid cancer, nonmedullary, 2}, 188470 (3)	
12.510	7	9	15	12q14.2	TBK1, NAK, FTDALS4	P	TANK-binding kinase 1	604834	REc		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3)	
12.511	1	31	13	12q14.2	TMEM5, MDDGA10	P	Transmembrane protein 5	605862	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3)	
12.512	9	8	06	12q15	BEST3, VMD2L3	P	Bestrophin 3	607337	A			
12.513	8	16	13	12q14.3	GRIP1	P	Glutamate receptor-interacting protein 1	604597	REc		Fraser syndrome, 219000 (3)	
12.514	2	25	16	12q14.3	HMGA2, HMGIC, BABL	C	High-mobility group AT-hook 2	600698	A, Psh, Ch, RE, Fd	fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas	Leiomyoma, uterine, somatic, 150699 (1)	10(pg, Hmgic)
12.515	5	31	07	12q14.3	IRAK3, IRAKM, ASRT5	C	Interleukin 1 receptor-associated kinase 3	604459	REc		{Asthma susceptibility 5}, 611064 (3)	
12.516	2	1	11	12q14.3	MSRB3, DFNB74	P	Methionine sulfoxide reductase B3	613719	REc		Deafness, autosomal recessive 74, 613718 (3)	
12.517	2	17	09	12q14.3	STQTL9	P	Stature quantitative trait locus 9	611547	Fd	associated with rs1042725	{Stature QTL 9} (2)	
12.518	3	7	13	12q14.3	TBC1D30, KIAA0984	P	TBC1 domain family, member 30	615077	REc			
12.519	3	25	16	12q14.3	TMBIM4, GAAP	P	Transmembrane BAX inhibitor motif-containing protein 4	616874	REc			
12.520	6	13	12	12q14-q15	CAND1, TIP120A, TIP120, KIAA0829	P	Cullin-associated neddylation-dissociated protein 1	607727	A, REc			
12.521	12	19	11	12q15	MDM2, ACTFS	C	Mouse double minute 2, homolog of (p53-binding protein)	164785	REa, A		{Accelerated tumor formation, susceptibility to}, 614401 (3)	10(Mdm2)
12.522	4	30	03	12q21.1-q21.2	CAPS2	P	Calcyphosine 2	607724	REc			
12.523	9	9	08	12q15	CNOT2, NOT2	P	CCR4-NOT transcription complex, subunit 2	604909	REc			
12.524	4	23	09	12q13.3	CNPY4, TMEM4, MSAP	P	Canopy 2, zebrafish, homolog of	605861	R, REc			
12.525	2	18	96	12q15	CPM	P	Carboxypeptidase M	114860	Psh, REc, A			
12.526	4	8	16	12q15	FRS2, FRS1A, SNT1	P	Fibroblast growth factor receptor substrate 2	607743	REc			
12.527	3	3	09	12q15	IBD26	P	Inflammatory bowel disease 26	612639	Fd	associated with rs1558744	{Inflammatory bowel disease 26} (2)	
12.528	10	17	00	12q15	IL22, IL21, ILTIF	P	Interleukin 22	605330	R			
12.529	11	26	01	12q15	IL26, AK155	P	Interleukin 26	605679	REc			
12.530	3	15	07	12q15	LRRC10, HRLRRP	P	Leucine-rich repeat-containing protein 10	610846	R, REc			
12.531	1	9	09	12q15	LYZ	P	Lysozyme	153450	REa, REc		Amyloidosis, renal, 105200 (3)	
12.532	3	15	11	12q15	MDM1	P	Mouse double minute 1 homolog	613813	REc			10(Mdm1)
12.533	1	11	16	12q15	NUP107, NUP84, NPHS11	P	Nucleoporin, 107kD	607617	R		Nephrotic syndrome, type 11, 616730 (3)	
12.534	7	17	14	12q15	PTPRR, PCPTP1	P	Protein-tyrosine phosphatase, receptor type, R	602853	REc			
12.535	4	25	93	12q15	PTPRB	P	Protein tyrosine phosphatase, receptor type, beta polypeptide	176882	A			
12.536	2	16	02	12q21.1	TRHDE	P	Thyrotropin-releasing hormone-degrading ectoenzyme	606950	A			
12.537	1	31	01	12q21.2	PHLDA1, TDAG51	C	Pleckstrin homology-like domain, family A, member 1	605335	R			
12.538	8	30	01	12q21.2-q21.3	PPP1R12A, MYPT1	P	Protein phosphatase 1, regulatory subunit 12A (myosin phosphatase target subunit 1)	602021	A, R			
12.539	2	4	02	12q21.1	GPR49, LGR5	C	G protein-coupled receptor-49	606667	R, A			
12.540	12	24	13	12q21.1	ATXN7L3B	P	Ataxin 7-like 3B	615579	REc			
12.541	4	10	14	12q21.33	EPYC, DSPG3	P	Epiphycan	601657	A, REc			
12.542	2	23	09	12q21.2	GLIPR1, GLIPR, RTVP1	P	Glioma pathogenesis-related protein 1	602692	REc			10(Glipr1)
12.543	8	19	13	12q21.2	GLIPR1L1	P	GLIPR1-like protein 1	610395	REc			10(Glipr1l1)
12.544	8	19	13	12q21.2	GLIPR1L2	P	GLIPR1-like protein 2	610394	REc			10(Glipr1l2)
12.545	12	4	02	12q21.31-q21.32	GNTIVH	P	UDP-N-acetylglucosamine:alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV	607385	A			
12.546	10	27	97	12q21.31	MYF5	P	Myogenic factor-5	159990	REa, A, RE			
12.547	12	30	11	12q21.31	MYF6, CNM3	C	Myogenic factor-6	159991	REa, A, RE, REc	6.5kb upstream from MYF5; both prob. 12q15, by H	Myopathy, centronuclear, 3, 614408 (3)	10(Myf6)
12.548	5	2	16	12q23.3	MTERF2, MTERFD3	P	Transcription termination factor 2, mitochondrial	616929	REc			
12.549	8	28	97	12q21.31	NTS	C	Neurotensin	162650	REa, A			
12.550	12	15	98	12q21.2	PAWR, PAR4	C	PRKC, apoptosis, WT1, regulator	601936	A, Psh, R			
12.551	10	23	87	12q21	PEPB	C	Peptidase B	169900	S			10(Pep2)
12.552	1	27	11	12q23.1	RMST, NCRMS, NCRNA00054	P	Rhabdomyosarcoma 2-associated transcript	607045	REc			
12.553	4	12	92	12q21.33	ATP2B1, PMCA1	P	ATPase, Ca++ transporting, plasma membrane, 1	108731	REa, A			
12.554	5	5	09	12q21-q23	DUH2	P	Dyschromatosis universalis hereditaria 2	612715	Fd	between rs1921045 and rs2373584	Dyschromatosis universalis hereditaria 2 (2)	
12.555	11	12	98	12q21-q23	MYP3	P	Myopia, high grade, 3, autosomal dominant	603221	Fd		Myopia-3 (2)	
12.556	11	24	98	12q21.2	CSRP2, LMO5	C	Cysteine and glycine-rich protein-2 (LIM domain only 5, smooth muscle)	601871	A, R	pseudogene on 3q21.1		
12.557	2	6	08	12q21.2	NAV3, POMFIl1, KIAA0938	P	Neuron navigator 3	611629	R, REc			
12.558	12	18	08	12q21.1	RAB21, KIAA0118	P	RAB-associated protein RAB21	612398	R, REc			
12.559	3	23	09	12q21.1	TBC1D15	P	TBC1 domain family, member 15	612662	REc			
12.560	1	20	09	12q21.1	THAP2	P	THAP domain-containing protein 2	612531	REc			
12.561	9	8	09	12q21.1	TPH2, NTPH, ADHD7	P	Tryptophan hydroxylase 2	607478	REc		{Unipolar depression, susceptibility to}, 608516 (3); {Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	
12.562	4	24	08	12p11.22	MRPS35, MRPS28	P	Mitochondrial ribosomal protein S35	611995	REc	3 pseudogenes		
12.563	10	16	14	12q21.2	BBS10, C12orf58, FLJ23560	C	BBS10 gene	610148	REc, Fd		Bardet-Biedl syndrome 10, 615987 (3)	
12.564	6	11	09	12q21.2	KRR1	P	KRR1, yeast, homolog of	612817	REc			
12.565	5	19	06	12q21.2	NAP1L1, NAP1L	P	Nucleosome assembly protein 1-like 1	164060	R, REc			
12.566	12	17	12	12q21.31	PTPRQ, PTPGMC1, DFNB84A	P	Protein-tyrosine phosphatase, receptor-type, Q	603317	A, REc		Deafness, autosomal recessive 84A, 613391 (3)	10(Ptpgmc1)
12.567	10	11	49	12q21.32	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	C	Centrosomal protein, 290kD	610142	R, REc, Fd	mutation identified in 1 BBS14 family	Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3); Leber congenital amaurosis 10, 611755 (3); Meckel syndrome 4, 611134 (3); ?Bardet-Biedl syndrome 14, 615991 (3)	
12.568	3	11	09	12q21.33	DCN, CSCD	C	Decorin	125255	REa, A	conflicting assignments to 12q23 and 12q13.2	Corneal dystrophy, congenital stromal, 610048 (3)	10(Dcn)
12.569	6	9	08	12q21.2	E2F7	P	E2F transcription factor 7	612046	REc			10(E2f7)
12.570	5	19	14	12q21.31	ALX1, CART1, FND3	P	Aristaless-like homeobox 1 (cartilage homeoprotein 1)	601527	REa, REc	mutation identified in 1 FND3 patient	?Frontonasal dysplasia 3, 613456 (3)	
12.571	6	25	99	12q21.33	GALNT4, GalNAcT4	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4	603565	A, Fd			
12.572	5	27	97	12q21.33	LUM, LDC	C	Lumican	600616	A, Psh			10(Ldc)
12.573	4	26	12	12q21.31	SLC6A15, SBAT1	P	Solute carrier family 6 (neurotransmitter transporter), member 15	607971	R, REc			
12.574	12	1	11	12q21.31	ACSS3	P	Acyl-CoA synthetase short-chain family, member 3	614356	REc			
12.575	12	29	06	12q24.31	MLXIP, MONDOA, KIAA0867	C	MLX-interacting protein	608090	R, A			
12.576	11	20	12	12q21.31	OTOGL, C12orf64, DFNB84B	P	Otogelin-like protein	614925	REc		Deafness, autosomal recessive 84B, 614944 (3)	
12.577	7	18	12	12q21.31	RASSF9, PAMCI, PCIP1	P	Ras association domain family, member 9	610383	REc			
12.578	7	18	14	12q21.31	TMTC2	P	Transmembrane and tetratricopeptide repeat domains-containing protein 2	615856	REc			
12.579	6	11	13	12q21.33	DUSP6, MKP3, PYST1, HH19	P	Dual-specificity phosphatase-6	602748	Psh, A, REc		Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	
12.580	9	24	14	12q21.33	POC1B, PIX1, CORD20	P	POC1 centriolar protein, Chlamydomonas, homolog of, B	614784	REc		Cone-rod dystrophy 20, 615973 (3)	
12.581	3	29	12	12q22	CRADD, RAIDD, MRT34	P	Caspase and RIP adaptor with death domain	603454	R		Mental retardation, autosomal recessive 34, 614499 (3)	10(Raidd)
12.582	3	17	94	12q21.33	BTG1	P	B-cell translocation gene 1, anti-proliferative	109580	Ch			
12.583	6	27	14	12q22	CEP83, CCDC41, NPHP18	P	Centrosomal protein, 83kD	615847	REc		Nephronophthisis 18, 615862 (3)	
12.584	7	10	13	12q22	EEA1	P	Early endosome antigen 1	605070	REc, R			
12.585	8	27	15	12q22	FGD6, ZFYVE24	P	FYVE, RhoGEF, and ph domain-containing protein 6	613520	REc			
12.586	3	6	01	12q21.33	KERA, CNA2	C	Keratocan	603288	H, Fd, LD, A		Cornea plana congenita, recessive, 217300 (3)	10(Kera)
12.587	12	29	15	12q21.32	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA	C	KIT ligand (mast cell growth factor; steel, mouse, homolog of)	184745	REa, A	associated with dbSNP rs12821256	[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3); Hyperpigmentation with or without hypopigmentation, 145250 (3); Deafness, congenital, unilateral or asymmetric, 616697 (3)	10(Sl; Scf)
12.588	10	1	95	12q23.1	LTA4H	P	Leukotriene A4 hydrolase	151570	A			
12.589	8	3	12	12q22	METAP2, p67	P	Methionine aminopeptidase 2	601870	REc			
12.590	1	12	95	12q22	MGCT	C	Male germ cell tumor	273300	D, Ch		Male germ cell tumor (2)	
12.591	12	19	11	12q22	MIR492	P	Micro RNA 492	614384	REc	within KRT19		
12.592	3	5	08	12q22	MRPL42, MRPL31, MRPS32	P	Mitochondrial ribosomal protein L42	611847	R, REc			
12.593	3	30	12	12q22	NDUFA12	P	NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 12	614530	REc		Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 (3)	
12.594	3	18	95	12q23.1	NEDD1	P	Neural precursor cell expressed, developmentally down-regulated 1	600372	A			
12.595	2	12	09	12q23.2	SPIC	P	SPIC transcription factor	612568	REc			
12.596	4	16	14	12q23.1	TMPO, LAP2, CMD1T	P	Thymopoietin	188380	A	mutation identified in 1 family with CMD1T	?Cardiomyopathy, dilated, 1T, 613740 (3)	10(Tmpo)
12.597	8	18	14	12q22	UBE2N, UBCHBEN; UBC13	P	Ubiquitin-conjugating enzyme E2N	603679	REc			
12.598	1	13	06	12q23.2	ASCL1, ASH1	C	Achaete-scute complex, Drosophila, homolog-like 1	100790	REa, A	distal to PAH and proximal to TRA1	Central hypoventilation syndrome, congenital, 209880 (3); Haddad syndrome, 209880 (3)	
12.599	12	17	07	12q24.13	DDX54, DP97	P	Dead/H Box 54	611665	REc			
12.600	8	9	05	12q23.1	HAL, HSTD	C	Histidine ammonia-lyase (histidase)	609457	REa, A		[Histidinemia], 235800 (3)	10(Hstd)
12.601	9	18	06	12q22	NTN4	P	Netrin 4	610401	A			
12.602	1	11	07	12q23.1-q23.2	SLC5A8, AIT, SMCT	C	Solute carrier family (iodide transporter), member 8	608044	REc			
12.603	8	21	07	12q23.3	NT5DC3, TU12B1TY, GNN	P	5' nucleotidase domain-containing protein 3	611076	A, REc			10(Nt5dc3)
12.604	6	7	04	12q22-q23.2	MDD1	P	Major depressive disorder	608520	Fd	max lod with D12S1706	Major depressive disorder 1, 608516 (2)	
12.605	1	10	12	12q22-q23.3	ETL2, FTLE	P	Epilepsy, familial temporal lobe	608096	Fd	max lod at D12S1706	Epilepsy, familial temporal lobe, 2 (2)	
12.606	8	25	04	12q23.2	IGF1	C	Insulin-like growth factor-1, or somatomedin C	147440	REa, A, Fd		Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)	10(Igf1)
12.607	4	30	02	12q24.31	ACADS, SCAD	C	Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain	606885	REa, A		Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	5(Bcd1)
12.608	10	24	00	12q23.1	APAF1	P	Apoptotic protease activating factor 1	602233	A			
12.609	1	12	11	12q23.2	C12orf48, AROM, PARPBP	P	Chromosome 12 open reading frame 48	613687	REc			
12.610	4	6	15	12q23.3	CHST11, C4ST1	P	Carbohydrate sulfotransferase 11	610128	R			
12.611	1	7	95	12q23.1	ELK3, SAP2, ERP	P	ELK3, ETS-domain protein (SRF accessory protein 2)	600247	REa			6(Scnn1)
12.612	2	7	06	12q23.1	IKIP	P	I-kappa-B kinase-interacting protein	609861	REc			
12.613	9	24	08	12q23.1	SLC17A8, VGLUT3, DFNA25	C	Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3)	607557	REc, Fd		Deafness, autosomal dominant 25, 605583 (3)	
12.614	2	19	07	12q23.1	SLC25A3, PHC	C	Solute carrier family 25 (mitochondrial carrier), member 3	600370	REa, A		Mitochondrial phosphate carrier deficiency, 610773 (3)	
12.615	2	12	16	12q23.2	SYCP3, SCP3, COR1, SPGF4, RPRGL4	P	Synaptonemal complex protein 3	604759	REc		Spermatogenic failure 4, 270960 (3); Pregnancy loss, recurrent, 4, 270960 (3)	
12.616	11	24	08	12q23.1	TMEM16D, FLJ34272	P	Transmembrane protein 16D	610111	REc			
12.617	5	22	07	12q22	USP44	P	Ubiquitin-specific protease 44	610993	R, REc			
12.618	3	18	94	12q23.2	PMCH	C	Pro-melanin-concentrating hormone	176795	REa, A			
12.619	8	16	99	12q24.13	RASAL1, RASAL	P	Ras protein activator-like 1	604118	R			
12.620	4	27	12	12q23-q24	SPG36	P	Spastic paraplegia-36	613096	Fd	between D12S360 and D12S354	Spastic paraplegia 36, autosomal dominant (2)	
12.621	12	22	08	12q24.11	USP30	P	Ubiquitin-specific protease 30	612492	REc			
12.622	2	25	03	12q24.11	ATP2A2, ATP2B, DAR	C	ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2	108740	REa, A, Fd		Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)	11(Atpb2)
12.623	3	2	98	12q23.3	CRY1, PHLL1	P	Cryptochrome 1 (photolyase-like)	601933	A			10(Cry1)
12.624	9	2	09	12q23.3	EID3, NSMCE4B, NSE4B	P	E1A-like inhibitor of differentiation 3	612986	REc			10(Eid3)
12.625	1	27	97	12q13.3	NACA	P	Nascent-polypeptide-associated complex alpha polypeptide	601234	A, REa			
12.626	4	10	96	12q24.31	PLA2G1B, PLA2A, PLA2, PPLA2	C	Phospholipase A2, group IB, pancreas	172410	REa, Fd			
12.627	4	19	01	12q23.3	PRDM4, PFM1	P	PR domain-containing protein 4	605780	REc, Psh			
12.628	12	4	03	12q24.31	RNF34, RFI	P	Ring finger protein 34	608299	A			
12.629	2	20	98	12q23.3	TXNRD1, TXNR	P	Thioredoxin reductase-1	601112	A			
12.630	6	15	12	12q24.11	UNG, DGU, HIGM5	C	Uracil-DNA glycosylase	191525	REa, R		Immunodeficiency with hyper IgM, type 5, 608106 (3)	
12.631	6	16	10	12q24.11	MYL2, CMH10	C	Myosin, light polypeptide-2, regulatory, cardiac, slow	160781	A, REa		Cardiomyopathy, hypertrophic, 10, 608758 (3)	
12.632	12	28	08	12q23.1	ANKS1B, EB1	P	Ankyrin repeat and sterile alpha motif domain-containing protein 1B	607815	R, REc			
12.633	7	18	14	12q23.1	CDK17, PCTK2, PCTAIRE2	P	Cyclin-dependent kinase 17	603440	REc			
12.634	5	25	13	12q23.1	SNRPF	P	Small nuclear ribonucleoprotein polypeptide F	603541	REc			
12.635	5	19	15	12q23.1	SCYL2, CVAK104, KIAA1360	P	SCY1-like protein 2	616365	REc			
12.636	7	20	12	12q23.2	ARL1	P	ADP-ribosylation factor-like 1	603425	REc			
12.637	1	11	16	12q23.2	CHPT1, CPT, CPT1	P	Choline phosphotransferase 1	616747	REc			
12.638	4	20	10	12q23.2	DRAM1	P	Damage-regulated autophagy modulator 1	610776	R, REc			
12.639	1	9	13	12q23.2	HELLPAR, lncHELLP	P	HELLP syndrome-associated long noncoding RNA	614985	REc			
12.640	12	12	12	12q23.2	MYBPC1, LCCS4	P	Myosin-binding protein C, slow type	160794	REa, REc		Arthrogryposis, distal, type 1B, 614335 (3); Lethal congenital contracture syndrome 4, 614915 (3)	
12.641	4	14	05	12q23.2	NUP37, p37	P	Nucleoporin, 37kD	609264	REc			
12.642	7	16	09	12q23.2	UTP20, DRIM	P	UTP20, S. cerevisiae, homolog of	612822	A			
12.643	4	6	15	12q23.3	ALDH1L2	P	Aldehyde dehydrogenase 1 family, member L2	613584	REc			
12.644	11	30	06	12q24.11	ALKBH2, ABH2	P	AlkB, E. coli, homolog of, 2	610602	REc			
12.645	3	13	08	12q23.2	GNPTAB, GNPTA	C	N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits	607840	F, S, D, REc	conflicting assignment to 4q	Mucolipidosis III alpha/beta, 252600 (3); Mucolipidosis II alpha/beta, 252500 (3)	
12.646	9	7	04	12q23.3	HCFC2, HCF2	P	Host cell factor C2	607926	R, REc			
12.647	9	8	08	12q23.3	HSP90B1, TRA1, GRP94, GP96	C	Heat-shock protein, 90kD, beta, 1	191175	REa, A, REc			10(Tra1)
12.648	6	27	14	12q23.3	KIAA1033, SWIP, MRT43	C	Strumpellin and WASH-interacting protein	615748	REc, Psh	mutation identified in 1 MRT43 family	?Mental retardation, autosomal recessive 43, 615817 (3)	
12.649	8	29	13	12q23.3	NFYB	P	Transcription factor NF-Y, B subunit	189904	REa, A, REc			10(Nfyb)
12.650	5	29	12	12q23.3	NUAK1, ARK5,  KIAA0537	P	NUAK family, SNF1-like kinase, 1	608130	REc, R			
12.651	12	19	11	12q23.3	POLR3B, RPC2, C128, HLD8	P	Polymerase III, RNA, subunit B	614366	REc		Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	
12.652	12	10	12	12q23.3	RIC8B	P	Ric8, C. elegans, homolog of, B	609147	REc			
12.653	2	27	07	12q23.3	SLC41A2	P	Solute carrier family 41, member 2	610802	REc			10(Slc41a2)
12.654	1	29	01	12q24.31	ABCB9	P	ATP-binding cassette, subfamily B, member 9	605453	REc			
12.655	4	14	15	12q24.12	ATXN2, ATX2, SCA2, ASL13	C	Ataxin-2	601517	Fd		Spinocerebellar ataxia 2, 183090 (3); {Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3); {Parkinson disease, late-onset, susceptibility to}, 168600 (3)	
12.656	3	9	09	12q24.12	BRAP, BRAP2, IMP	P	BRCA1-associated protein	604986	REc			
12.657	5	28	08	12q24	CELIAC13	P	Celiac disease, susceptibility to, 13	612011	Fd	associated with rs3184504	{Celiac disease, susceptibility to, 13} (2)	
12.658	2	10	04	12q24	CIMT	P	Carotid intimal medial thickness	608447	Fd	161cM from pter; near SCARB1	Carotid intimal medial thickness (2)	
12.659	1	2	03	12q24.11	DAO, DAMOX	C	D-amino-acid oxidase	124050	REa, Fd, LD	tightly linked to SCA2	{Schizophrenia}, 181500 (2)	
12.660	1	19	01	12q24.13	DTX1	P	Deltex, Drosophila, homolog of, 1	602582	R, A			
12.661	6	8	07	12q24.23	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	C	Heat-shock 22-kD protein 8	608014	REc, Fd		Neuropathy, distal hereditary motor, type IIA, 158590 (3); Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	
12.662	2	5	16	12q24.21	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	P	Mediator complex subunit 13-like	608771	A, REc		Transposition of the great arteries, dextro-looped 1, 608808 (3); Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	5(Med13l)
12.663	2	20	03	12q24.11	MMAB	P	MMAB gene	607568	Fd		Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)	
12.664	11	7	15	12q24.11	MVK, MVLK, POROK3	C	Mevalonate kinase	251170	REa, A		Mevalonic aciduria, 610377 (3); Hyper-IgD syndrome, 260920 (3); Porokeratosis 3, multiple types, 175900 (3)	
12.665	2	1	00	12q24.31	NCOR2, SMRT	P	Nuclear receptor corepressor 2	600848	A			
12.666	6	8	15	12q24.31	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	P	ORAI calcium release-activated calcium modulator 1	610277	Fd, REc		Immunodeficiency 9, 612782 (3); Myopathy, tubular aggregate, 2, 615883 (3)	
12.667	1	27	09	12q24.31	P2RX7, P2X7	P	Purinergic receptor P2X, ligand-gated ion channel, 7	602566	A, R			
12.668	8	17	12	12q24	PDA1	P	Patent ductus arteriosus	607411	Fd		{Patent ductus arteriosus, susceptibility to} (2)	
12.669	6	25	99	12q24.23	PXN	P	Paxillin	602505	A			
12.670	12	30	03	12q24.11	RAD9B	P	RAD9, S. pombe, homolog of, A	608368	REc			5(Rad9b)
12.671	10	1	95	12q24.11	SELPLG, PSGL1	P	Selectin P ligand	600738	REa, A			5(Selpl)
12.672	7	12	11	12q24.12	SH2B3, LNK	C	SH2B adaptor protein 3	605093	R, Fd		Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3); Erythrocytosis, somatic, 133100 (3)	
12.673	1	20	06	12q24.13	SLC24A6, NCKX6	P	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 6	609841	REc			5(Slc24a6)
12.674	2	16	04	12q24	SLEB4	P	Systemic lupus erythematosus, susceptibility to, 4	608437	Fd		{Systemic lupus erythematosus, susceptibility to, 4} (2)	
12.675	11	2	05	12q24.31	HPD	C	4-hydroxyphenylpyruvate dioxygenase	609695	REa, A		Tyrosinemia, type III, 276710 (3); Hawkinsinuria, 140350 (3)	
12.676	6	9	98	12q24.11	ACACB, ACCB, ACC2	P	Acetyl-Coenzyme A carboxylase, beta	601557	A			
12.677	2	25	14	12q24.12	ACAD10	P	Acyl-CoA dehydrogenase family, member 10	611181	REc			
12.678	2	20	07	12q23.3	APPL2, FLJ10659	P	Adaptor protein, phosphotyrosine interaction, PH domain, and leucine zipper-containing protein 2	606231	Ch, REc			
12.679	8	21	98	12q24.31	BCL7A, BCL7	P	B-cell CLL/lymphoma-7A	601406	Ch		B-cell non-Hodgkin lymphoma, high-grade (3)	
12.680	3	16	99	12q23.3	CMKLR1	P	Chemokine-like receptor 1	602351	A			
12.681	1	31	01	12q24.11	CORO1C	P	Coronin 1C	605269	A			
12.682	6	30	05	12q24.11	FOXN4	P	Forkhead box N4	609429	R, REc			
12.683	4	13	10	12q23.3	ISCU, HML	C	Iron-sulfur cluster scaffold, E. coli, homolog of	611911	R, REc, Fd		Myopathy with lactic acidosis, hereditary, 255125 (3)	
12.684	3	24	09	12q23.2	PAH, PKU1	C	Phenylalanine hydroxylase	612349	REa, A, Fd	close to IGF1	Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild], 261600 (3)	10(Pah)
12.685	12	28	08	12q24.11	PPTC7, TAPP2C	P	PTC7 protein phosphatase, S. cerevisiae, homolog of	609668	R, REc			
12.686	1	13	99	12q24.23	PRKAB1	P	Protein kinase, AMP-activated, noncatalytic, beta-1	602740	A			
12.687	8	27	15	12q24.13	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	C	Protein tyrosine phosphatase, nonreceptor-type, 11	176876	A, Fd		Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3); Leukemia, juvenile myelomonocytic, somatic, 607785 (3); Metachondromatosis, 156250 (3)	
12.688	7	10	08	12q24.13	RPH3A, KIAA0985	P	Rabphilin 3A	612159	R, REc			
12.689	10	16	14	12q23.3	SART3, P100, KIAA0156, TIP110	C	Squamous cell carcinoma antigen recognized by T cells 3	611684	Fd, Psh, REc, H			5(Sart3)
12.690	5	2	07	12q24.1	STUT2	P	Stuttering, familial persistent, 2	609261	Fd	max lod with PAH	Stuttering, familial persistent, 2 (2)	
12.691	1	2	08	12q24.11	SVOP	P	SV2-related protein	611699	REc			5(Svop)
12.692	8	4	97	12q24.21	TBX3	C	T-box 3	601621	REc, A		Ulnar-mammary syndrome, 181450 (3)	5(Tbx3)
12.693	2	19	97	12q24.21	TBX5	C	T-box 5	601620	Fd, REc, Ch		Holt-Oram syndrome, 142900 (3)	5(Tbx5)
12.694	3	23	09	12q24.11	TCHP	P	Trichoplein	612654	R, REc			
12.695	6	2	98	12q23.3	TDG	P	Thymine-DNA glycosylase	601423	A			10(Tdg)
12.696	8	25	11	12q24.11	TECT1, JBTS13	P	Tectonic family, member 1	609863	REc, R		Joubert syndrome 13, 614173 (3)	5(Tect1)
12.697	5	19	06	12q24.13	TPCN1, TPC1, KIAA1169	P	Two-pore segment channel 1	609666	R, REc			
12.698	7	18	12	12q24.11	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	C	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	REc, Fd		Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3); Digital arthropathy-brachydactyly, familial, 606835 (3)	5(Vroac)
12.699	8	16	94	12q24.11	PPP1CC	C	Protein phosphatase-1, catalytic subunit, gamma isoform	176914	REa, A			10(Ppp1cc)
12.700	11	13	12	12q24.1-q24.2	POROK2, PPPD1	P	Porokeratosis 2, palmar, plantar, and disseminated	175850	Fd	between D12S1613 and D12S1341	Porokeratosis 2, palmar, plantar, and disseminated (2)	
12.701	2	8	01	12q24.23	STK21, CRIK, CIT	P	Serine/threonine protein kinase-21	605629	REc			
12.702	12	10	98	12q24.31	MSI1	C	Musashi, Drosophila, homolog of, 1	603328	A, Psh, REc			
12.703	8	18	14	12q24.11	ANAPC7, APC7	P	Anaphase-promoting complex, subunit 7	606949	REc			
12.704	4	5	13	12q24.11	ANKRD13A	P	Ankyrin repeat domain-containing protein 13A	615123	REc			
12.705	11	11	14	12q24.11	ARPC3, ARC21	P	Actin-related protein 2/3 compelx, subunit 3	604225	REc			
12.706	11	1	13	12q24.11	GLTP	P	Glycolipid transfer protein	608949	REc			
12.707	1	3	12	12q24.11	HVCN1, HV1, VSOP	P	Hydrogen voltage-gated channel 1	611227	REc			
12.708	7	26	10	12q24.11	KCTD10	P	Potassium channel tetramerization domain-containing 10	613421	REc			
12.709	6	1	12	12q24.11	MYO1H	P	Myosin IH	614636	REc			
12.710	4	3	12	12q24.11	SSH1, KIAA1298	P	Slingshot, Drosophila, homolog of, 1	606778	R			
12.711	4	10	15	12q24.11	UBE3B, BPIDS, KOS	P	Ubiquitin-protein ligase E3B	608047	REc		Kaufman oculocerebrofacial syndrome, 244450 (3)	5(Ube3b)
12.712	9	30	11	12q24.12	FAM109A, SES1, IPIP27A	P	Family with sequence similarity 109, member A	614239	REc			
12.713	7	8	10	12q24.12-q24.13	MAPKAPK5, PRAK	C	Mitogen-activated protein kinase-activated protein kinase 5	606723	R, REc			
12.714	12	5	13	12q24.11	IFT81, DV1, CDV1R	P	Intraflagellar transport 81, Chlamydomonas, homolog of	605489	H, REc			5(Cdv1, Cdv1r)
12.715	5	12	09	12q24.13	MDM20, C12orf30	P	Mitochondrial distribution and morphology 20, yeast, homolog of	612755	REc			
12.716	5	25	13	12q24.13	SDS, SDH	P	Serine dehydratase	182128	REc			
12.717	12	29	09	12q24.13	TRAFD1, FLN29	P	TRAF-type zinc finger domain-containing 1	613197	REc			
12.718	6	30	15	12q24.13-q24.21	RBM19, KIAA0682	C	RNA-binding motif protein 19	616444	R, REc			
12.719	7	8	10	12q24.12	ALDH2	C	Aldehyde dehydrogenase 2 family, mitochondrial	100650	REa, A, H		Alcohol sensitivity, acute, 610251 (3); {Hangover, susceptibility to}, 610251 (3); {Sublingual nitroglycerin, susceptibility to poor response to} (3); {Esophageal cancer, alcohol-related, susceptibility to} (3)	4(Aldh2)
12.720	1	9	13	12q24.31	CAMKK2, KIAA0787, CAMKKB	P	Calcium/calmodulin-dependent protein kinase kinase 2, beta	615002	REc			
12.721	10	9	14	12q24.31	COX6A1, CMTRID	P	Cytochrome c oxidase, subunit VIa, polypeptide-1	602072	REc	pseudogenes on chr.7 and chr.6	Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3)	
12.722	2	21	06	12q24.31	DYNLL1, DNCL1, DLC1, PIN	P	Dynein, light chain, LC8-type 1	601562	A, REc, REn	possible pseudogene on 14q24		
12.723	2	9	01	12q24.23	GCN1L1	P	General control of amino acid synthesis 1, yeast, homolog-like 1	605614	R, REa			
12.724	3	29	12	12q24.31	HNF1A, TCF1, MODY3, IDDM20	C	HNF1 homeobox B	142410	A, Fd		MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes mellitus, insulin-dependent, 20, 612520 (3)	5(Tcf1)
12.725	8	8	13	12q24.22	HRK, DP5	P	Harakiri	603447	REc			
12.726	1	31	07	12q24.22-q24.23	KSR2	P	Kinase suppressor of RAS 2	610737	REc			
12.727	12	11	02	12q24.2	NIDDM2	P	Diabetes mellitus, noninsulin-dependent, 2	601407	Fd	no mutations found in HNF1A	Diabetes mellitus, noninsulin-dependent, 2 (2)	
12.728	3	16	06	12q24.13	OAS1, OIAS	C	2',5'-oligoadenylate synthetase-1	164350	REa, A, REc		{Viral infection, susceptibility to} (3); {Diabetes mellitus, type 1, susceptibility to}, 222100 (3)	
12.729	6	24	99	12q24.13	OAS2	P	2',5'-oligoadenylate synthetase-2	603350	A, REc			
12.730	6	24	99	12q24.13	OAS3	P	2',5'-oligoadenylate synthetase-3	603351	A, REc			
12.731	11	16	98	12q24.31	OASL, TRIP14	P	2',5'-oligoadenylate synthetase-like	603281	REc			
12.732	12	7	07	12q24.22	TESC, TSC	P	Tescalcin, mouse, homolog of	611585	R, REc, H			5(Tesc)
12.733	9	9	08	12q24.22	FBXO21, FBX21, KIAA0875	C	F-box only protein 21	609095	REc			5(Fbxo21)
12.734	9	9	08	12q24.22	FBXW8, FBW8, FBXW6, FBW6, FBXO29, FBX29	P	F-box and WD40 domain protein 8	609073	REc			5(Fbxw8)
12.735	9	8	08	12q24.23	PEBP1, PBP, RKIP	C	Phosphatidylethanolamine-binding protein 1	604591	R, REc			
12.736	10	26	15	12q24.23	RAB35	P	Ras-associated protein Rab35	604199	REc			
12.737	11	11	09	12q24.23	SRRM4, KIAA1853, NSR100	P	Serine/arginine repetitive matrix protein 4	613103	R, REc			
12.738	12	22	15	12q24.23	TAOK3, JIK, DPK	P	TAO kinase 3	616711	REc			
12.739	6	25	99	12q24.2-q24.3	ALFN1, HALF1	P	Activation of liver function 1	603416	A			
12.740	7	23	13	12q24.2-q24.3	CTRCT37, CCA5	P	Cataract 37	614422	Fd	between D12S1718 and D12S1723	Cataract 37, autosomal dominant (2)	
12.741	5	19	09	12q24.31	HIP1R, HIP12	P	Huntingtin-interacting protein 1-related protein	605613	A			
12.742	11	16	98	12q24.31	PSMD9	P	Proteasome 26S subunit, non-ATPase, 9	603146	A			
12.743	7	8	10	12q24.22	NOS1	C	Nitric oxide synthase 1, neuronal	163731	REa, A			5(Nos1)
12.744	3	18	95	12q24.23	RFC5	P	Replication factor C5, 36.5kD (activator 1, 36.5kD)	600407	Psh, A			
12.745	1	30	12	12q24.31	ATP6V0A2, WSS, ARCL2A	C	ATPase, H+ transporting, lysosomal, V0 subunit A2	611716	R, REc, Fd		Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin syndrome, 278250 (3)	
12.746	6	15	15	12q24.31	CLIP1, RSN, CYLN1, CLIP170	P	CAP-GLY domain containing linker protein 1	179838	A			
12.747	10	19	97	12q24.33	MUC8	P	Mucin 8, tracheobronchial	601932	REa, A			
12.748	4	27	13	12q24.33	POLE1, CRCS12, FILS	P	Polymerase (DNA directed), epsilon-1	174762	REa, A		{Colorectal cancer, susceptibility to, 12}, 615083 (3); FILS syndrome, 615139 (3)	5(Pole)
12.749	6	1	09	12q24.33	RAN, ARA24	P	Ras-related nuclear protein	601179	REc			
12.750	5	26	13	12q24.33	TMEM132D, KIAA1944, MOLT	P	Transmembrane protein 132D	611257	REc			
12.751	2	9	92	12q24.31	UBC	P	Ubiquitin C	191340	REa, A			
12.752	6	25	99	12q24.33	ULK1, UNC51	P	UNC51-like kinase 1	603168	Psh, R, A			
12.753	3	24	04	12q24.33	ZNF268	P	Zinc finger protein 268	604753	REc			
12.754	2	28	01	12q13.3	BAZ2A	P	Bromodomain adjacent to zinc finger domain, 2A	605682	REa, R			
12.755	12	6	11	12q24.31	AACS, ACSF1	P	Acetoacetyl-CoA synthetase	614364	REc			
12.756	10	23	14	12q24.31	ARL6IP4	P	ADP-ribosylation-like factor 6 interacting protein 4	607668	R, REc			
12.757	4	26	10	12q24.31	B3GNT4	P	Beta-1,3-N-acetylglucosaminyltransferase 4	605864	REc			
12.758	2	13	14	12q24.31	BRI3BP	C	BRI3-binding protein	615627	REc			
12.759	12	5	13	12q24.31	C12orf65, COXPD7, SPG55	P	Chromosome 12 open reading frame 65	613541	REc		Combined oxidative phosphorylation deficiency 7, 613559 (3); Spastic paraplegia 55, autosomal recessive, 615035 (3)	
12.760	9	29	10	12q24.31	CCDC62, ERAP75	P	Coiled-coil domain-containing protein 62	613481	REc			
12.761	5	19	15	12q24.31	COQ5	P	Coq5, S. cerevisiae, homolog of	616359	REc			
12.762	12	10	15	12q24.31	EIF2B1, EIF2BA	P	Eukaryotic translation initiation factor 2B, subunit 1	606686	R, REc		Leukoencephalopathy with vanishing white matter, 603896 (3)	
12.763	3	25	14	12q24.31	DENR, DRP	P	Density-regulated protein	604550	REc			
12.764	2	5	15	12q24.31	NRAV, DYNLL1AS1	P	Negative regulator of antiviral response, noncoding	616207	REc	overlaps intron 1 of DYNLL1 in antisense orientation		
12.765	8	18	14	12q24.31	FAM101A, CFM2	P	Family with sequence similarity 101, member A	615927	REc			
12.766	8	25	11	12q24.31	SMAC, DIABLO, DFNA64	P	Second mitochondria-derived activator of caspase	605219	REc		Deafness, autosomal dominant 64, 614152 (3)	
12.767	2	21	06	12q24.31	DNAH10	P	Dynein, axonemal, heavy chain 10	605884	A, R, REc	previously assigned to 13q14		
12.768	6	26	01	12q24.31	CDK2AP1, DOC1	P	CDK-associated protein 1 (deleted in oral cancer-1)	602198	A			
12.769	7	14	14	12q24.31	HCAR1, GPR81, TAGPCR	C	Hydroxycarboxylic acid receptor 1	606923	REc			
12.770	7	14	14	12q24.31	HCAR2, GPR109A, HM74A	P	Hydroxycarboxylic acid receptor 2	609163	REc			
12.771	7	14	14	12q24.31	HCAR3, GPR109B, HM74, PUMAG	P	Hydroxycarboxylic acid receptor 3	606039	REn			
12.772	2	25	15	12q24.31	IL31	P	Interleukin 31	609509	REc			
12.773	5	6	15	12q24.31	KDM2B, FBXL10, FBL10, CXXC2, JHDM1B	P	Lysine-specific demethylase 2B	609078	REc			
12.774	2	1	11	12q24.31	KNTC1, ROD, KIAA0166	P	Kinetochore-associated protein 1	607363	REc	previously assigned to chr.17		
12.775	3	15	11	12q24.31	MLEC, KIAA0152	P	Malectin	613802	REc			
12.776	3	11	09	12q24.31	MPVQTL1	P	Mean platelet volume quantitative trait locus 1	612573	Fd	associated with rs7961894	[Mean platelet volume QTL1] (2)	
12.777	3	23	06	12q24.31	POP5, HSPC004	P	Processing of precursor 5, S. cerevisiae, homolog of	609992	R			
12.778	7	22	11	12q24.31	RILPL1, RLP1, GOSPEL	P	RAB-interacting lysosomal protein-like 1	614092	REc, H			5(Rilpl1)
12.779	7	22	11	12q24.31	RILPL2, RLP2	P	RAB-interacting lysosomal protein-like 2	614093	REc			
12.780	9	22	14	12q24.31	RNF10, KIAA0262	C	RING finger protein 10	615998	R, REc, H			5(Rnf10)
12.781	10	5	11	12q24.31	SBNO1	P	Strawberry notch, Drosophila, homolog of, 1	614274	REc			
12.782	1	31	11	12q24.31	SCARB1, CD36L1, CLA1, HDLQTL6	C	Scavenger receptor class B, member 1 (CD36 antigen-like 1)	601040	Psh, REc		[High density lipoprotein cholesterol level QTL6], 610762 (3)	
12.783	8	21	07	12q24.31	SETD1B, SET1B, KIAA1076	P	SET domain-containing protein 1B	611055	R, REc			
12.784	3	31	15	12q24.23-q24.31	SIRT4, SIR2L4	P	Sirtuin, S. cerevisiae, homolog 4	604482	REc			
12.785	3	22	07	12q24.31	SPPL3, IMP2	P	Signal peptide peptidase-like 3	608240	R, REc			
12.786	12	19	11	12q24.31	SRSF9, SFRS9, SRp30c	P	Splicing factor, serine/arginine-rich, 9	601943	REc			
12.787	11	23	15	12q24.31	TCTN2, TECT2, MKS8, JBTS24	P	Tectonic family, member 2	613846	REc	mutation identified in 1 MKS8 family	?Meckel syndrome 8, 613885 (3); Joubert syndrome 24, 616654 (3)	
12.788	2	2	14	12q24.31	THRIL, LINC1992, BRI3BPAS1	P	TNF- and HNRNPL-related immunoregulatory long noncoding RNA	615622	REc			
12.789	9	24	15	12q24.31	TMEM120B	P	Transmembrane protein 120B	616551	REc			
12.790	12	17	12	12q24.31	TRIAP1, HSPC132	P	TP53-regulated inhibitor of apoptosis 1	614943	REc			
12.791	5	19	06	12q24.31	VPS33A	P	Vacuolar protein sorting 33, yeast, homolog of, A	610034	R, REc			
12.792	6	1	15	12q24.31	ZCCHC8	P	Zinc finger CCHC domain-containing protein 8	616381	REc			
12.793	6	9	06	12q24.31	VPS37B	P	Vacuolar protein sorting 37, yeast, homolog of, B	610037	R, REc			
12.794	6	8	01	12q24.13	LHX5	P	LIM homeo box protein 5	605992	A			
12.795	7	14	98	12q24.31	P2RX4, P2X4	P	Purinergic receptor P2X, ligand-gated ion channel, 4	600846	A			
12.796	6	22	14	12q24.33	SLC15A4, PHT1, PTR4	P	Solute carrier family 15 (oligopeptide transporter), member 4	615806	REc			
12.797	6	19	00	12q24.33	ZNF140	P	Zinc finger protein-140	604082	A			
12.798	12	9	15	12q24.33	ANKLE2, LEM4, KIAA0692, MCPH16	P	Ankyrin repeat- and LEM domain-containing protein 2	616062	R, REc	mutation identified in 1 MCPH16 family	?Microcephaly 16, primary, autosomal recessive, 616681 (3)	
12.799	5	25	09	12q24.33	CHFR	P	Checkpoint protein with FHA and ring-finger domains	605209	REc			
12.800	2	21	02	12q24.33	EP400, TNRC12, KIAA1498,	P	p400 SWI2/SNF2-related protein	606265	R			
12.801	4	6	13	12q24.33	GALNT9, GALNACT9	P	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9	606251		REc		
12.802	11	22	10	12q24.33	GPR133, PGR25	P	G protein-coupled receptor 133	613639	REc			
12.803	9	30	09	12q24.33	STX2, EPIM, STX2C, STX2B, STX2A	P	Epimorphin (syntaxin 2)	132350	A, REc			5(Epim)
12.804	8	30	01	12q24.33	FZD10	P	Frizzled, Drosophila, homolog of, 10	606147	A			
12.805	5	12	99	12q24.33	MMP17	C	Matrix metalloproteinase 17	602285	A, Psh, R			5(Mmp17)
12.806	7	15	09	12q24.33	NOC4L, NOC4	P	Nucleolar complex-associated protein 4, S. cerevisiae, homolog of	612819	REc			
12.807	11	25	13	12q24.33	P2RX2, P2X2, DFNA41	C	Purinergic receptor P2X, ligand-gated ion channel, 2	600844	REc, Fd		Deafness, autosomal dominant 41, 608224 (3)	
12.808	11	29	12	12q24.33	PGAM5	P	Phosphogycerate mutase family, member 5	614939	REc			
12.809	3	17	16	12q24.33	PUS1, MLASA1	P	Pseudourine synthase 1	608109	R, REc		Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3)	
12.810	2	19	08	12q24.33	RIMBP2, KIAA0318	P	RIMS-binding protein 2	611602	R, REc			
12.811	4	29	14	12q24.33	SFSWAP, SFRS8, SWAP	P	Splicing factor, suppressor-of-white-apricot family	601945	REc			
12.812	6	7	91	12q24.33	ZNF26	P	Zinc finger protein-26 (KOX20)	194537	REa, A			
12.813	5	16	02	12q24.31	ANAPC5, APC5	P	Anaphase-promoting complex, subunit 5	606948	R			
12.814	11	28	01	12q13.13	ATF7	P	Activating transcription factor 7	606371	R			
12.815	11	5	98	12q13.13	ATP5G2	P	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 2	603193	REn			
12.816	12	11	02	12q24.13	C12orf8, ERP28, ERP29	P	Endoplasmic reticulum lumenal protein 28	602287	R			
12.817	1	31	01	12q15	CCT2, CCTB	P	Chaperonin containing T-complex polypeptide 1, subunit 2	605139	R			
12.818	2	6	01	12q15	CPSF6, CFIM	P	Cleavage and polyadenylation specific factor 6, 68kD subunit	604979	R			
12.819	8	21	98	12p12.3	MGST1, GST12	P	Microsomal glutathione S-transferase 1	138330	RE, REa	pseudogene at 12q13-q14		
12.820	7	17	01	12q13.11	EPAC	P	cAMP-regulated guanine nucleotide exchange factor I	606057	R			
12.821	5	12	03	12q24.33	GOLGA3	P	Golgi autoantigen, golgin subfamily A, 3	602581	R			
12.822	12	11	01	12q13.11	HDAC7A, HDAC7	P	Histone deacetylase 7A	606542	R			
12.823	8	27	01	12p13.1	HEBP1, HBP	P	Heme-binding protein 1	605826	R			
12.824	1	19	01	12q13.13	HOXC10	P	Homeo box-C10	605560	REc			15(Hoxc10)
12.825	1	19	01	12q13.13	HOXC11	P	Homeo box-C11	605559	REc			15(Hoxc11)
12.826	1	25	93	12q13.13	IGFBP6	P	Insulin-like growth factor-binding protein-6	146735	Psh			
12.827	11	1	02	12q21.1	KCNC2	P	Potassium voltage-gated channel, Shaw-related subfamily, member 2	176256	R	previously on 19q13.3-q13.4		10(Kcnc2)
12.828	1	30	01	12q24.31	MPHOSPH9, MPP9	P	M-phase phosphoprotein 9	605501	R			
12.829	1	23	01	12q24.33	PIWIL1	P	Piwi, Drosophila, homolog of	605571	R			
12.830	1	28	02	12p13.2	PROL4, LPRP	P	Proline rich 4, lacrimal	605359	R			
12.831	4	15	02	12q24.23	RPLP0	P	Ribosomal phosphoprotein, large, P0	180510	R			
12.832	1	29	01	12q13.13	SLC4A8, NBC3	P	Solute carrier family 4 (sodium bicarbonate cotransporter), member 8	605024	R			
12.833	5	9	02	12q13.2	SUOX	P	Sulfite oxidase	606887	R		Sulfite oxidase deficiency, 272300 (3)	
12.834	4	16	93	Chr.12	TUBAL1	P	Tubulin, alpha-like-1	191120	REa			
12.835	10	28	99	12q22	VESPR	P	Virus-encoded semaphorin protein receptor	604259	R			
12.836	4	3	02	12q14.3	WIF1	P	WNT inhibitory factor 1	605186	R			
13.1	9	2	11	13pter-q12.13	FECD2, FCD1	P	Corneal dystrophy, Fuchs endothelial, 2	610158	Fd	max lod at D13S1304	Corneal dystrophy, Fuchs endothelial, 2 (2)	
13.2	4	26	90	13p12	RNR1	C	Ribosomal RNA-1	180450	A			
13.3	2	28	03	13q12.11	IL17D	P	Interleukin 17D	607587	REc	?associated with Hodgkin lymphoma		
13.4	2	20	07	13q	CLQTL1, CLF	P	Cholesterol level quantitative trait locus 1	604595	Fd		[Cholesterol level QTL 1] (2)	
13.5	7	25	13	13q12.11	GJA3, CX46, CZP3, CAE3, CTRCT14	C	Gap junction protein, alpha-3, 46kD (connexin 46)	121015	REa, A, Fd		Cataract 14, multiple types, 601885 (3)	14(Gja3)
13.6	4	19	06	13q12.12	PARP4, ADPRTL1, VPARP, KIAA0177	P	Poly(ADP-ribose) polymerase 4	607519	REc			
13.7	6	15	99	13q12.11	TUBA2	P	Tubulin, alpha 2	602528	REc			
13.8	11	21	14	13q12.11	FGF9, SYNS3	P	Fibroblast growth factor-9 (glia-activating factor)	600921	A	mutation identified in 1 SYNS3 family	?Multiple synostoses syndrome 3, 612961 (3)	
13.9	3	6	09	13q12.11	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	C	Gap junction protein, beta-2, 26kD (connexin 26)	121011	REa, A, Fd		Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)	14(Gjb2)
13.10	5	11	00	13q12.11	LATS2	P	Large tumor suppressor, Drosophila, homolog of, 2	604861	A			14(Lats2)
13.11	1	6	09	13q12.3	ALOX5AP, FLAP	C	Arachidonate 5-lipoxygenase-activating protein	603700	R, A, REc		{Stroke, susceptibility to}, 601367 (3)	
13.12	7	2	13	13q12.13	ATP8A2, ATPIB, CAMRQ4	C	ATPase, class I, type 8A, member 2	605870	A		?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3)	
13.13	10	26	98	13q12.13	CDK8	P	Cyclin-dependent kinase 8	603184	REc			
13.14	1	2	91	13q12.3	FLT1	C	fms-related tyrosine kinase-1 (vascular endothelial growth factor/vascular permeability factor receptor)	165070	REa, A	150kb from FLT3		
13.15	8	27	15	13q12.2	FLT3	C	fms-related tyrosine kinase-3	136351	A, Psh, REn		Leukemia, acute myeloid, reduced survival in, somatic, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3); Leukemia, acute lymphoblastic, somatic, 613065 (3)	5(Flt3)
13.16	12	17	12	13q12.11	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	C	Gap junction protein, beta-6 (connexin-30)	604418	Fd, H		Deafness, autosomal dominant 3B, 612643 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3); Ectodermal dysplasia 2, Clouston type, 129500 (3)	
13.17	10	1	95	13q12.13	GPR12	P	G protein-coupled receptor-12	600752	A			
13.18	8	28	02	13q12.3	HMGB1, HMG1	P	High-mobility group box 1 (high-mobility group (nonhistone chromosomal) protein 1)	163905	A			5(Hmg1)
13.19	12	17	07	13q13.1	KL, KLOTHO	P	Klotho	604824	A, REc		{Coronary artery disease, susceptibility to} (3); Tumoral calcinosis, hyperphosphatemic, 211900 (3)	
13.20	5	7	03	13q13.3-q14.1	LHFP	P	Lipoma HMGIC fusion partner	606710	REc			
13.21	1	6	09	13q12	MCI2	P	Myocardial infarction, susceptibility to, 2	608557	Fd	defined by 4-SNP haplotype HapA	{Myocardial infarction, susceptibility to, 2} (2)	
13.22	6	18	98	13q12.12	MIPEP	P	Mitochondrial intermediate peptidase	602241	A			
13.23	6	15	99	13q12.13	MTMR6	C	Myotubularin-related protein 6	603561	R, REc, Psh			
13.24	2	1	00	13q12.12	SACS, ARSACS	P	Sacsin	604490	LD, Fd		Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	1(Sacs)
13.25	10	13	97	13q12.12	SGCG, LGMD2C, DMDA1, SCG3	C	Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein)	608896	Fd, LD, A		Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	
13.26	1	31	01	13q12.13	WASF3, WAVE3, SCAR3	P	Wiskott-Aldrich syndrome protein family, member 3	605068	A			
13.27	12	14	00	13q12.3	UBL3	P	Ubiquitin-like 3	604711	REa, R			5(Ubl3)
13.28	10	12	09	13q12-q14	ATOD5	P	Dermatitis, atopic, 5	605844	Fd	max lod at D13S218	{Dermatitis, atopic, susceptibility to, 5} (2)	
13.29	8	2	13	13q13.3	MADH9, SMAD9, MADH6, PPH2	P	Mothers against decapentaplegic, Drosophila, homolog of, 9	603295	R, A		Pulmonary hypertension, primary, 2, 615342 (3)	
13.30	5	1	08	13q14.11	RGC32	P	Response gene to complement 32	610077	Psh, R			
13.31	3	29	99	13q14.13	TPT1, HRF	P	Tumor protein, translationally-controlled 1	600763	Psh, R			
13.32	8	3	14	13q12.11	IFT88, D13S1056E, TG737	C	Intraflagellar transport 88, Chlamydomonas, homolog of	600595	A			14(TgN737Rpw)
13.33	8	12	14	13q12.2	IPF1, MODY4, PAGEN1	P	Insulin promoter factor 1, homeodomain transcription factor	600733	Psh, A		Pancreatic agenesis 1, 260370 (3); MODY, type IV, 606392 (3); {Diabetes mellitus, type II, susceptibility to}, 125853 (3)	5(Ipf1)
13.34	10	26	15	13q12.13	NUP58, NUPL1, KIAA0410	P	Nucleoporin 58kDa	607615	R, REc			
13.35	7	27	09	13q12.12	RNF17	P	RING finger protein-17	605793	R, REc			
13.36	11	8	00	13q12.12	ATP12A, ATP1AL1	C	ATPase, H+/K+ transporting, nongastric, alpha polypeptide	182360	REa, Fd			
13.37	9	23	08	13q12.11	ADHD6	P	Attention deficit-hyperactivity disorder, susceptibility to, 6	612312	Fd	max lod at rs1974047	{Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)	
13.38	2	22	10	13q12.11	CFEOM3C, FEOM4	L	Fibrosis of extraocular muscles, congenital, 3C	609384	Ch		Fibrosis of extraocular muscles, congenital, 3C (2)	
13.39	2	7	06	13q12.11	CRYL1	C	Crystallin, lambda-1	609877	R, REc, H			14(Cryl1)
13.40	1	14	14	13q12.11	MICU2, EFHA1	P	Mitochondrial calcium uptake protein 2	610632	REc			
13.41	2	6	08	13q12.11	MPHOSPH8, TWA3	P	M-phase phosphoprotein 8	611626	REc			
13.42	4	24	08	13q12.11	MRP63	C	Mitochondrial ribosomal protein 63	611997	R, REc	10 pseudogenes		
13.43	12	18	08	13q12.11	PSPC1, PSP1	P	Paraspeckle component 1	612408	REc			
13.44	10	17	02	13q12.13	RNF6	C	RING finger protein-6	604242	A, REn		Esophageal carcinoma, somatic, 133239 (3)	
13.45	8	3	12	13q12.11	SAP18	P	Sin3-associated polypeptide, 18kD	602949	REc			
13.46	7	14	14	13q12.11	TPTE2, TPIP	P	Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	606791	REc			
13.47	6	30	15	13q12.11	ZMYM2, ZNF198, RAMP, FIM	C	Zinc finger, MYM-type 2	602221	REc, R, Ch			
13.48	6	30	15	13q12.11	ZMYM5, ZNF237, ZNF198L1	P	Zinc finger, MYM-type 5	616443	A, R, REc			
13.49	8	30	01	13q12.12	TAJ, TROY	P	Toxicity and JNK inducer	606122	REc			14(Troy)
13.50	11	19	11	13q12.12	C1QTNF9A, CTRP9, C1QTNF9	P	C1q- and tumor necrosis factor-related protein 9A	614285	REc			14(C1qtnf9a)
13.51	8	5	11	13q12.12	C1QTNF9B, CTRP9B	P	C1q- and tumor necrosis factor-related protein 9B	614148	REc			
13.52	8	25	11	13q12.12	MYP20	P	Myopia 20, autosomal dominant	614166	Fd	associated with rs9318086	Myopia 20, autosomal dominant (2)	
13.53	3	29	10	13q12.12	SPATA13, ASEF2	P	Spermatogenesis-associated protein 13	613324	REc			
13.54	5	29	12	13q12.13	FAM123A, AMER2	P	Family with sequence similarity 123, member A (APC membrane recruitment protein 2)	614659	REc			
13.55	4	25	05	13q12.12-q12.13	CENPJ, CPAP, MCPH6, SCKL4	C	Centromeric protein J	609279	Fd, REc	mutation identified in 1 SCKL4 family	Microcephaly 6, primary, autosomal recessive, 608393 (3); ?Seckel syndrome 4, 613676 (3)	
13.56	9	3	15	13q12.2	GSX1, GSH1	P	GS homeobox 1	616542	REc			5(Gsx1)
13.57	12	28	08	13q12.2	LNX2, PDZRN1	P	Ligand of numb protein X2	609733	REc			
13.58	1	31	11	13q12.2	POLR1D, RPA16, RPAC2, TCS2	P	Polymerase I, RNA, subunit D	613715	REc		Treacher Collins syndrome 2, 613717 (3)	
13.59	12	18	08	13q12.2	RASL11A	P	RAS-like, family 11, member A	612403	REc			
13.60	7	17	14	13q12.2	RPL21, HYPT12	C	Ribosomal protein L21	603636	REa, R, REc		Hypotrichosis 12, 615885 (3)	
13.61	6	22	14	13q12.2	URAD	P	Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase	615804	REc			
13.62	4	17	00	13q12.2-q13	MBS, MBS1	L	Moebius syndrome	157900	Ch		?Moebius syndrome (2)	
13.63	10	16	00	13q13.1	AS3	P	Androgen-induced prostate proliferative shutoff-associated protein	605333	REc			
13.64	2	19	16	13q12.3	B3GLCT, B3GALTL, B3GTL	P	Beta 3-glucosyltransferase	610308	REc		Peters-plus syndrome, 261540 (3)	
13.65	11	16	15	13q13.1	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	C	BRCA2 gene	600185	Fd		{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia, complementation group D1, 605724 (3); {Prostate cancer}, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3); {Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pancreatic cancer 2}, 613347 (3)	5(Brca2)
13.66	8	21	98	13q12.2	CDX2, CDX3	C	Caudal type homeo box transcription factor 2	600297	A, Psh			5(Cdx2)
13.67	1	16	07	13q12.3	HSPH1, HSP105, KIAA0201	P	Heat-shock 105/110kD protein 1	610703	R, REc			
13.68	8	21	12	13q12.3	KATNAL1	P	Katanin p60 subunit A-like 1	614764	REc			
13.69	5	3	10	13q12.3	POMP, UMP1	P	Proteasome maturation protein	613386	REc		Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3)	
13.70	8	21	98	13q12.3	SLC7A1, ATRC1	C	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1	104615	Fd, A, REa	distal to ATP1AL1		5(Rec1)
13.71	1	20	16	13q12.3	SLC46A3	P	Solute carrier family 46, member 3	616764	REc			
13.72	7	26	02	13q13.3	SPG20	P	Spartin	607111	REc		Troyer syndrome, 275900 (3)	
13.73	3	22	06	13q13.1-q13.2	STARD13, DLC2	P	Start domain-containing protein 13	609866	REc			
13.74	6	6	00	13q13.3	CCNA1	P	Cyclin A1	604036	R			
13.75	3	20	95	13q13.2	RFC3	P	Replication factor C3, 38kD (activator 1, 38kD)	600405	Psh, A			
13.76	12	17	95	13q12.2	GTF3A, TFIIIA	P	General transcription factor IIIA	600860	A			
13.77	12	21	09	13q13.3	DCLK1, DCAMKL1, CLICK1, CL1, KIAA0369	C	Doublecortin-like kinase 1	604742	R, A			3(Dclk1)
13.78	10	18	96	13q13.3	MAB21L1	P	mab-21 (C. elegans)-like 1	601280	REa, Fd, R			
13.79	12	7	03	13q13.3	STOML3, SRO	P	Stomatin-like protein 3	608327	REc			
13.80	7	4	95	13q13-q14.3	ENUR1	P	Enuresis, nocturnal, 1	600631	Fd		Enuresis, nocturnal, 1 (2)	
13.81	11	11	14	13q13.3	EXOSC8, OIP2, RRP43, PCH1C	P	Exosome component 8	606019	R, REc		Pontocerebellar hypoplasia, type 1C, 616081 (3)	
13.82	9	14	12	13q13.1	FRY, C13orf14	P	Furry, Drosophila, homolog of	614818	REc			
13.83	6	27	08	13q13.1	HPRHP	P	Hypophosphatemic rickets and hyperparathyroidism	612089	Ch	?due to altered KLOTHO expression	Hypophosphatemic rickets and hyperparathyroidism (2)	
13.84	8	5	15	13q13.1	LGR8, GREAT	P	Leucine-rich repeat-containing G protein-coupled receptor 8	606655	REc			
13.85	6	22	14	13q13.1	N4BP2L2, PFAAP5	P	NEDD4-binding protein 2-like 2	615788	REc			
13.86	3	3	03	13q13.3	TRPC4, TRP4	P	Transient receptor potential cation channel, subfamily C, member 4	603651	A			
13.87	3	14	06	13q13.3	NBEA	C	Neurobeachin	604889	REc, R, REa, Ch	site of FRA13A		3(Nbea)
13.88	3	25	14	13q13.3	ALG5	P	Alg5, S. cerevisiae, homolog of	604565	REc			
13.89	8	14	13	13q14.11	COG6, COD2, KIAA1134, CDG2L, SHNS	P	Component of oligomeric golgi complex 6	606977	R, REc		Congenital disorder of glycosylation, type IIl, 614576 (3); Shaheen syndrome, 615328 (3)	
13.90	2	28	03	13q14.11	EPSTI1	P	Epithelial stromal interaction 1	607441	REc, REa			
13.91	7	26	10	13q13.3	FAM48A, P38IP, C13orf19	P	Family with sequence similarity 48, member A	613417	A, R			
13.92	5	26	05	13q13.3	FREM2	P	FRAS1-related extracellular matrix protein 2	608945	REc		Fraser syndrome, 219000 (3)	3(my)
13.93	6	9	09	13q13.3	IBD27	P	Inflammatory bowel disease 27	612796	Fd		{Inflammatory bowel disease 27} (2)	
13.94	4	24	08	13q14.11	MRPS31	P	Mitochondrial ribosomal protein S31	611992	REc	4 pseudogenes		
13.95	11	3	14	13q13.3	SOHLH2	P	Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 2	616066	REc			3(Sohlh2)
13.96	2	11	13	13q13.3-q21	PAPA5	P	Polydactyly, postaxial, type A5	263450	Fd	between D13S1288 and D13S632	Polydactyly, postaxial, type A5 (2)	
13.97	3	23	09	13q13.3	POSTN, OSF2, PN	P	Periostin	608777	R, REc			
13.98	5	24	13	13q13.3	UFM1	P	Ubiquitin-fold modifier 1	610553	REc			
13.99	10	8	08	13q14	BMIQ2	P	Body mass index quantitative trait locus 2	606643	Fd	max lod at D13S257	[Body mass index QTL2] (2)	
13.100	6	30	08	13q14	BMND9	P	Bone mineral density quantitative trait locus 9	612110	Fd	associated with rs9594759	[Bone mineral density QTL 9] (2)	
13.101	12	7	07	13q14.3	CKAP2, TMAP, LB1	P	Cytoskeleton-associated protein 2	611569	A			
13.102	10	28	08	13q14.2	CLLD6, C13orf1	P	Chronic lymphocytic leukemia deletion region gene 6	607866	REc			
13.103	8	29	02	13q14.2	CYSLTR2, CYSLT2	P	Cysteinyl leukotriene receptor 2	605666	R			
13.104	10	28	08	13q14	CLLS2, D13S25, DBM	P	Leukemia, chronic lymphocytic, susceptibility to, 2	109543	D	>530kb telomeric to RB1	{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)	
13.105	5	6	11	13q14	DEL13q14, C13DELq14	P	Chromosome 13q14 deletion syndrome	613884	Ch		Chromosome 13q14 deletion syndrome (4)	
13.106	4	19	01	13q14.2-q14.3	DLEU1, LEU1	P	Deleted in lymphocytic leukemia 1	605765	REc			
13.107	4	19	01	13q14.2	DLEU2, LEU2, BCMSUN	P	Deleted in lymphocytic leukemia 2	605766	REc			
13.108	10	24	00	13q14	GER	P	Gastroesophageal reflux	109350	Fd		Gastroesophageal reflux (2)	
13.109	11	11	14	13q14.2	ITM2B, BRI, ABRI, FBD, RDGCA	P	Integral membrane protein 2B (BRI gene)	603904	A	mutation identified in 1 RDGCA family	Dementia, familial British, 176500 (3); Dementia, familial Danish, 117300 (3); ?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	
13.110	12	18	08	13q14.1-q14.2	LRCH1, KIAA1016	C	Leucine-rich repeats and calponin homology domain-containing 1	610368	R, REc			
13.111	2	1	01	13q14.12	NUFIP1, NUFIP	P	Nuclear fragile X mental retardation protein-interacting protein 1	604354	REa, A	pseudogene on 6q12		
13.112	7	26	10	13q14.2	RCBTB1, CLLD7, GLP	P	RCC! domain- and BTB domain-containing protein 1	607867	REc		[Beta-glycopyranoside tasting] (3); {Alcohol dependence, susceptibility to}, 103780 (3)	
13.113	11	2	98	13q13.3	RFXAP	P	Regulatory factor X-associated protein	601861	R		Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	
13.114	12	4	96	13q14	RIEG2, RGS2	C	Rieger syndrome, type 2	601499	Fd, Ch		Rieger syndrome, type 2 (2)	
13.115	10	28	08	13q14.2	SETDB2, CLLD8	P	SET domain protein, bifurcated, 2	607865	REc			
13.116	6	4	99	13q14.11	SLC25A15, ORNT1, HHH	C	Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1)	603861	D, Ch, REc	with deficiency of factors VII and X in 3 unrelated cases	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	
13.117	4	27	12	13q14	SPG24	P	Spastic paraplegia 24, autosomal recessive	607584	Fd		Spastic paraplegia 24, autosomal recessive (2)	
13.118	2	19	07	13q14.11	TSC22D1, TSC22	P	TSC22 domain family, member 1	607715	A			
13.119	12	7	07	13q14.11	TNFSF11, OPGL, TRANCE, OPTB2	P	Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand)	602642	R, H		Osteopetrosis, autosomal recessive 2, 259710 (3)	14(Trance)
13.120	10	23	87	13q14	XRS	L	X-ray sensitivity	194370	Ch			
13.121	7	19	12	13q14.3	CTAGE3	P	Cutaneous T-cell lymphoma-associated antigen 3	608857	REc			
13.122	5	31	06	13q14.2	HTR2A	C	5-hydroxytryptamine (serotonin) receptor-2A	182135	REa, A, Fd		{Schizophrenia, susceptibility to}, 181500 (3); {Obsessive-compulsive disorder, susceptibility to}, 164230 (3); {Seasonal affective disorder, susceptibility to}, 608516 (3); {Alcohol dependence, susceptibility to}, 103780 (3); {Anorexia nervosa, susceptibility to}, 606788 (3); {Major depressive disorder, response to citalopram therapy in}, 608516 (3)	14(Htr2)
13.123	3	11	03	13q14.3	LECT1, CHM1	P	Leukocyte cell derived chemotaxin 1 (chondromodulin)	605147	A			
13.124	3	23	09	13q14.2	MLNR, GPR38	P	Motilin receptor	602885	A			
13.125	8	2	13	13q14.11	DNAJC15, MCJ	P	DNAJ/HSP40 homolog, subfamily C, member 15	615339	A, REc			
13.126	8	28	02	13q14.11	FOXO1A, FKHR	P	Forkhead box O1A (forkhead in rhabdomyosarcoma)	136533	Ch	chimeric with PAX3 in t(2;13); fuses with PAX3	Rhabdomyosarcoma, alveolar, 268220 (3)	
13.127	5	22	03	13q14.2	PHF11, NYREN34	P	PHD finger protein 11	607796	REc		[IgE levels QTL], 147050 (3); {Asthma}, 600807 (3)	
13.128	1	6	09	13q14.3	RNASEH2B, DLEU8, FLJ11712, AGS2	P	Ribonuclease H2, subunit B	610326	REc, Fd		Aicardi-Goutieres syndrome 2, 610181 (3)	
13.129	6	16	97	13q14.2	RB1	C	Retinoblastoma-1	614041	Ch, F, Fd		Retinoblastoma, 180200 (3); Osteosarcoma, somatic, 259500 (3); Bladder cancer, somatic, 109800 (3); Small cell cancer of the lung, somatic, 182280 (3); Retinoblastoma, trilateral, 180200 (3)	14(Rb1)
13.130	10	23	87	13q14.13	LCP1	C	Lymphocyte cytosolic protein-1 (plasmin)	153430	F, D			
13.131	1	8	01	13q14.11	MTRF1	P	Translational release factor, mitochondrial, 1	604601	R			
13.132	12	10	13	13q14.11	AKAP11, AKAP220	P	A-kinase anchor protein 11	604696	REc, R			
13.133	2	11	15	13q14.11	DGKH	P	Diacylglycerol kinase, eta, 130kD	604071	REc			
13.134	9	23	13	13q14.11	LACC1, C13orf31	P	Laccase (multicopper reductase) domain-containing protein 1	613409	REc			
13.135	7	6	10	13q14.11	CCDC122	P	Coiled-coil domain-containing protein 122	613408	REc			
13.136	8	5	99	13q14.13	CPB2, CPU, TAFI	C	Carboxypeptidase B2, plasma (carboxypeptidase U)	603101	Psh			
13.137	8	8	13	13q14.11	ELF1	P	E74-like factor 1	189973	A, REc			
13.138	4	4	07	13q14.11	ENOX1, CNOX	P	ECTO-NOX disulfide-thiol exchanger 1	610914	REc			
13.139	10	23	87	13q14.2	ESD	C	Esterase D; S-formylglutathione hydrolase	133280	S, F, D	proximal to RB1, WND		14(Es10)
13.140	7	8	10	13q14.11	LPRS6	P	Leprosy, susceptibility to, 6	613407	Fd	associated with rs9533634 and rs3764147	{Leprosy, susceptibility to, 6} (2)	
13.141	3	8	07	13q14.13	SLC25A30, KMCP1	P	Solute carrier family 25 (mitochondrial carrier, kidney), member 30	610793	REc			
13.142	3	31	15	13q14.11	WBP4, FBP21	P	WW domain-containing binding protein 4	604981	REc			
13.143	7	27	09	13q14.13	COG3, SEC34	P	Component of oligomeric golgi complex 3	606975	REc			
13.144	2	2	14	13q14.13	SIAH3	P	SIAH E3 ubiquitin protein ligase family, member 3	615609	REc			
13.145	5	25	13	13q14.12-q14.13	GTF2F2, TF2F2, RAP30	P	General transcription factor IIF, polypeptide 2, 30kD	189969	REc			
13.146	11	3	11	13q14.2	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	C	Lysophosphatidic acid receptor 6	609239	REc, Fd	in intron 17 of RB gene	Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	
13.147	7	13	15	13q14.13	ZC3H13, KIAA0853	C	Zinc finger CCCH domain-containing protein 13	616453	R, REc			
13.148	8	1	08	13q14.2	CAB39L	P	Calcium-binding protein 39-like protein	612175	REc			
13.149	6	22	14	13q14.2	FNDC3A, KIAA0970, HUGO	P	Fibronectin type III domain-containing protein 3A	615794	REc			
13.150	3	23	06	13q14.2	MED4, DRIP36, HSPC126	P	Mediator of RNA polymerase II transcription, subunit 4, S. cerevisiae, homolog of	605718	REc			
13.151	7	17	02	13q14.3	NEK3	P	Never in mitosis gene A-related kinase 3	604044	REa, R			
13.152	4	19	16	13q14.2	NUDT15, MTH2, NUDT15D	P	Nucleoside diphosphate-linked moiety X motif 15	615792	REc		{Thiopurines, poor metabolism of, 2}, 616903 (3)	
13.153	6	2	15	13q14.2	SUCLA2, MTDPS5	C	Succinate-CoA ligase, ADP-forming, beta subunit	603921	REc		Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3)	
13.154	8	15	03	13q14.2-q14.1	AUTS3	P	Autism, susceptibility to, 3	608049	Ch		{Autism susceptibility 3} (2)	
13.155	12	14	10	13q14.3	ALG11, KIAA1266, CDG1P	P	Alg11, S. cerevisiae, homolog of	613666	R, REc		Congenital disorder of glycosylation, type Ip, 613661 (3)	
13.156	1	29	09	13q14.2	ARL11, ARLTS1	P	ADP-riposylation factor-like 11	609351	REc			
13.157	12	30	14	13q14.3	DHRS12, SDR40C1	P	Short-chain dehydrogenase reductase family, member 12	616163	REc			
13.158	6	15	99	13q14.3	GUCY1B2	C	Guanylate cyclase 1, soluble, beta-2	603695	A, Fd			
13.159	3	23	14	13q14.3	INTS6, DDX26, DICE1	P	Integrator complex subunit 6	604331	Ch, REc			
13.160	2	25	15	13q14.2	KCNRG, DLTET	P	Potassium channel regulator	607947	REc, H			14(Kcnrg)
13.161	8	5	97	13q14.2	KPNA3	P	Karyopherin (importin) alpha-3	601892	A			
13.162	3	23	09	13q14.2	MIR15A, MIRN15A	P	Micro RNA 15A	609703	REc			
13.163	3	23	09	13q14.2	MIR16-1, MIRN16-1	P	Micro RNA 16-1	609704	REc			
13.164	1	13	16	13q14.3	NEK5	P	Never in mitosis gene A-related kinase 5	616731	REc			
13.165	7	1	11	13q14.3	OLFM4, GC1, GW112	P	Olfactomedin 4	614061	A, R			
13.166	6	15	99	13q14.3	PCDH8	P	Protocadherin 8	603580	REc, H			14(Pcdh8)
13.167	1	27	11	13q14.2	RCBTB2, CHC1L	P	RCC1 domain- and BTB domain-containing protein 2	603524	REc			
13.168	7	22	09	13q14.3	STQTL20	P	Stature quantitative trait locus 20	612894	Fd	associated with rs3118914	{Stature QTL 20} (2)	
13.169	7	20	12	13q14.3	SUGT1, SGT1	P	Suppressor of G2 allele of Skp1, S. Cerevisiae, homolog of	604098	REc			
13.170	2	16	16	13q14.3	THSD1, TMTSP	P	Thrombospondin type 1 domain-containing protein 1	616821	REc			
13.171	8	20	07	13q14.2	TRIM13, RFP2, LEU5	C	Tripartite motif-containing protein 13	605661	REc, H			14(Trim13)
13.172	4	17	07	13q14.3	VPS36, EAP45	P	Vacuolar protein sorting 36, S. cerevisiae, homolog of	610903	R, REc			
13.173	5	24	13	13q14.3	WDFY2	P	WD repeat- and FYVE domain-containing protein 2	610418	REc, R			
13.174	4	30	02	13q14.3	ATP7B, WND	C	ATPase, Cu++ transporting, beta polypeptide	606882	F, Fd		Wilson disease, 277900 (3)	8(Atp7b)
13.175	3	15	10	13q21	ATXN8	P	Ataxin 8	613289	REc	CAG repeat results in polyglutamine expansion protein	Spinocerebellar ataxia 8, 608768 (3)	
13.176	3	9	10	13q21.33	ATXN8OS, SCA8, KLHL1AS	C	Ataxin 8 opposite strand	603680	REc	due to CTG repeat in untranslated DNA	Spinocerebellar ataxia 8, 608768 (3)	
13.177	10	13	00	13q21.33	KLHL1	P	Kelch-like 1	605332	REc			
13.178	6	4	02	13q21	BRCA3, BRCAX	L	Breast cancer, type 3	605365	Fd		?Breast cancer, type 3 (2)	
13.179	5	26	13	13q22.3	KCTD12, PFET1, KIAA1778, C13orf2	P	Potassium channel tetramerization domain-containing protein 12	610521	REc, A			14(Kctd12)
13.180	11	7	05	13q21	SLI3	P	Specific language impairment QTL, 3	607134	Fd	max with D13S1317	Specific language impairment QTL, 3 (2)	
13.181	2	3	03	13q21.33	DIS3, KIAA1008	P	Dis3, S. pombe, homolog of	607533	REc			
13.182	2	3	03	13q21.3-q22.1	PIBF1	P	Progesterone-induced blocking factor 1	607532	REc			
13.183	9	9	08	13q22.2	LMO7, FBXO20, FBX20, KIAA0858	C	LIM domain only 7	604362	REa, REc			14(Lmo7)
13.184	10	27	97	13q21-q32	PAPA2	P	Postaxial polydactyly, type A2	602085	Fd		Postaxial polydactyly, type A2 (2)	
13.185	6	15	99	13q21.32	PCDH9	P	Protocadherin 9	603581	A, D, H			14(Pcdh9)
13.186	1	29	08	13q21.1	PCDH17, PCDH68	P	Protocadherin 17	611760	R, REc			
13.187	2	28	97	13q31.1	POU4F1, BRN3A	C	POU domain, class 4, transcription factor 1	601632	Psh, REc			
13.188	4	19	12	13q21.2	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	P	Diaphanous, Drosophila, homolog of, 3	614567	Fd, REc		Auditory neuropathy, autosomal dominant, 1, 609129 (3)	
13.189	1	30	12	13q21.2	PCDH20, PCDH13	P	Protocadherin 20	614449	REc			
13.190	1	1	12	13q21.2	TDRD3	P	Tudor domain-containing protein 3	614392	REc			
13.191	9	9	10	13q21.33	C13orf37, MOZART1	P	Mitotic spindle-organizing protein associated with a ring of gamma-tubulin	613448	REc			
13.192	3	11	09	13q22.2	COMMD6	P	COMM domain-containing protein 6	612377	REc, H			14(Commd6)
13.193	5	21	99	13q21.33	DACH	P	Dachshund, Drosophila, homolog of	603803	R, A			13(Dach)
13.194	2	2	14	13q22	DDH1	P	Developmental dysplasia of the hip 1	142700	Fd		Developmental dysplasia of the hip 1 (2)	
13.195	3	16	10	13q22.3	EDNRB, HSCR2, ABCDS, WS4A	C	Endothelin receptor type B	131244	REa, Ch, LD	?piebald lethal in mouse	{Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)	
13.196	2	15	01	13q22.3	FBXL3A, FBL3A, FBL3	P	F-box and leucine-rich repeat protein 3A	605653	A			14(Fbxl3)
13.197	2	3	03	13q22.1	KLF12, AP2REP	P	Kruppel-like factor 12	607531	A			
13.198	8	19	13	13q22.3	MYCBP2, PAM, KIAA0916	P	Myc-binding protein 2	610392	REc			
13.199	8	10	99	13q22.3	SCEL	P	Sciellin	604112	A			
13.200	10	15	01	13q22.3	TNFRSF11B, OPG, OCIF	P	Tumor necrosis factor receptor superfamily, member 11B	602543	A			
13.201	3	11	09	13q22.2	UCHL3	P	Ubiquitin carboxyl-terminal esterase L3	603090	REc, H			14(Uchl3)
13.202	12	20	04	13q22-q32	PAND1	P	Panic disorder syndrome 1	167870	?locus on 22		Panic disorder syndrome 1 (2)	
13.203	5	26	13	13q21.33	BORA, C13orf34	P	Aurora borealis	610510	REc			
13.204	6	9	06	13q31.1	NDFIP2, N4WBP5A, KIAA1165	C	NEDD4 family-interacting protein 2	610041	R, REc			
13.205	12	30	14	13q22.2	TBC1D4, AS160, KIAA0603, NIDDM5	P	TPC1 domain family, member 4	612465	REc, R		{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	
13.206	7	18	14	13q22.3	CLN5	C	CLN5 gene	608102	Fd, REc		Ceroid lipofuscinosis, neuronal, 5, 256731 (3)	
13.207	8	6	13	13q22.3	IRG1	P	Immunoresponsive gene 1, mouse, homolog of	615275	REc			
13.208	4	6	15	13q22.3	SLAIN1	P	SLAIN motif family, member 1	610491	REc			14(Slain1)
13.209	11	30	06	13q34	ADPRHL1, ARH2	P	ADP-ribosylhydrolase-like 1	610620	REc			
13.210	5	19	15	13q32.1	GPR180, ITR	P	G protein-coupled receptor 180	607787	A			
13.211	8	5	15	13q31.1	SLITRK1, KIAA1910, TTM	P	SLIT- and NTRK-like family, member 1	609678	REc, H	mutation identified in 1 TTM patient	Tourette syndrome, 137580 (3); ?Trichotillomania, 613229 (3)	17(Slitrk1)
13.212	12	28	08	13q31.2	SLITRK5, KIAA0918	C	SLIT- and NTRK-like family, member 5	609680	R, REc, H			14(Slitrk5)
13.213	11	22	13	13q31.1	SLITRK6, DFNMYP	P	SLIT- and NTRK-like family, member 6	609681	REc, H		Deafness and myopia, 221200 (3)	14(Slitrk6)
13.214	8	21	98	13q32.1	DCT, TYRP2	P	Dopachrome tautomerase (dopachrome delta-isomerase; tyrosinase-related protein 2)	191275	A			14(Tyrp2)
13.215	1	29	01	13q32.1	SOX21	P	SRY-box 21	604974	Psh, A			
13.216	7	27	09	13q32.2	STK24, MST3, MST3B	P	Serine/threonine protein kinase 24	604984	REc			
13.217	4	16	14	13q31-q33	NYS4	P	Nystagmus 4, congenital, autosomal dominant	193003	Fd		Nystagmus 4, congenital, autosomal dominant (2)	
13.218	8	18	14	13q31.1	RNF219, C13orf7	P	Ring finger protein 219	615906	REc			
13.219	2	17	16	13q31.1	SPRY2, IGAN3	C	Sprouty, Drosophila, homolog of, 2	602466	R, REc	mutation identified in 1 IGAN3 family	{?IgA nephropathy, susceptibility to, 3}, 616818 (3)	
13.220	5	13	13	13q31.1	LNCR13Q1	P	Long noncoding RNA on 13q (TCONS_00021856)	615230	REc			
13.221	3	23	09	13q31.3	MIR17, MIR91, MIRN17	P	Micro RNA 17	609416	A, REc	within C13orf25; sequence encodes 2 micro RNAs		
13.222	11	3	11	13q31.3	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	P	Micro RNA 17 host gene	609415	A, REc		Feingold syndrome 2, 614326 (3)	
13.223	3	23	09	13q31.3	MIR18A, MIRN18A	P	Micro RNA 18A	609417	A, REc	within C13orf25		
13.224	3	23	09	13q31.3	MIR19A, MIRN19A	P	Micro RNA 19A	609418	A, REc	within C13orf25		
13.225	3	23	09	13q31.3	MIR19B1, MIRN19B1	P	Micro RNA 19B1	609419	A, REc	within C13orf25		
13.226	3	23	09	13q31.3	MIR20A, MIRN20A	P	Micro RNA 20A	609420	A, REc	within C13orf25		
13.227	9	7	10	13q31.3	MIR92A1, MIR92-1, MIRN92-1	P	Micro RNA 92A1	609422	A, REc	within C13orf25		
13.228	9	28	05	13q31.3	PPR2	P	Photoparoxysmal response 2	609572	Fd	max lod at D13S1230	Photoparoxysmal response 2 (2)	
13.229	3	8	07	13q31.3-q32.1	MMVP3	P	Mitral valve prolapse, myxomatous 3	610840	Fd	max lod at D13S132	Mitral valve prolapse, myxomatous 3 (2)	
13.230	9	1	00	13q32.1	ABCC4, MRP4, MOATB	C	ATP-binding cassette, subfamily C, member 4	605250	R, A			
13.231	12	23	05	13q32.3	CLYBL, CLB	P	Citrate lyase beta-like	609686	R, REc			
13.232	2	4	15	13q32.1	DNAJC3, PRKRI, P58, ACPHD	P	DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58)	601184	A	mutation identified in 1 ACPHD family	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	
13.233	6	15	99	13q31.3	GPC5	P	Glypican 5	602446	A			
13.234	10	15	09	13q31.3-q32.1	GPC6, OMIMD1	P	Glypican 6	604404	R, A		Omodysplasia 1, 258315 (3)	
13.235	6	18	98	13q32.3	GPR18	P	G protein-coupled receptor-18	602042	A			14(Gpr18)
13.236	6	1	12	13q32	KTCN7	P	Keratoconus 7	614629	Fd	max lod at D13S159	Keratoconus 7 (2)	
13.237	5	19	15	13q32	MCOR, C13DELq32, DEL13q32	C	Microcoria, congential (chromosome 13q32 deletion syndrome)	156600	Fd, Ch	35-80kb deletion encompassing TGDS and GPR180	Microcoria, congenital (4)	
13.238	6	21	01	13q32.3	PCCA	C	Propionyl Coenzyme A carboxylase, alpha polypeptide	232000	REa, D, A, Fd		Propionicacidemia, 606054 (3)	14(Pcca)
13.239	12	15	98	13q32	SCZD7	P	Schizophrenia susceptibility locus, chromosome 13q-related	603176	Fd		{Schizophrenia}, 181500 (2)	
13.240	2	21	06	13q32	SLEB5	P	Systemic lupus erythematosus, susceptibility to, 5	609903	Fd	max lod at D13S892	{Systemic lupus erythematosus, susceptibility to, 5} (2)	
13.241	10	7	05	13q32.3	ZIC2, HPE5	P	ZIC family member 2	603073	Ch		Holoprosencephaly-5, 609637 (3)	
13.242	6	30	05	13q32.1	HS6ST3	P	Heparan sulfate 6-O-sulfotransferase 3	609401	REc			
13.243	2	17	09	13q32-q33	STQTL4	P	Stature quantitative trait locus 4	606258	Fd	max lod at D13S779 and D13S797	{Stature QTL 4} (2)	
13.244	9	15	93	13q33.1	TPP2	C	Tripeptidyl peptidase II	190470	REa, A			1(Tpp2)
13.245	8	4	99	13q33.3	TNFSF13B, BLYS, BAFF	P	Tumor necrosis factor ligand superfamily, member 13B	603969	TM			
13.246	10	27	08	13q32.1	GPR80	P	G protein-coupled receptor 80	606922	REc			
13.247	2	13	15	13q32.1	TGDS, SDR2E1, CATMANS	P	TDP-glucose 4,6-dehydratase	616146	REc		Catel-Manzke syndrome, 616145 (3)	
13.248	8	27	09	13q32.1	UGGT2, HUGT2	P	UDP-glucose glycoprotein glucosyltransferase 2	605898	REc			
13.249	12	10	13	13q32.2	FARP1, CDEP	P	FERM, ARHGEF, and pleckstrin domain-containing protein 1	602654	REc			
13.250	4	26	10	13q32.3	A2LD1, GGACT	P	AIG1-like domain-containing protein 1	613378	REc			
13.251	9	29	10	13q32.3	GPR183, EBI2	P	G protein-coupled receptor 183	605741	R			
13.252	7	18	14	13q32.3	TM9SF2	P	Transmembrane 9 superfamily, member 2	604678	REc			
13.253	7	27	09	13q32.3	ZIZ1, KIAA1058	P	Zizimin 1	607325	R, REc			
13.254	9	28	15	13q33.1	ERCC5, XPG, COFS3	C	Excision-repair, complementing defective, in Chinese hamster, number 5	133530	S, A		Xeroderma pigmentosum, group G, 278780 (3); Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3); Cerebrooculofacioskeletal syndrome 3, 616570 (3)	1(Ercc5)
13.255	11	5	97	13q33.3	EFNB2, EPLG5, LERK5, HTKL	P	eph-related receptor tyrosine kinase ligand 5 (ephrin-B2)	600527	A			8(Lerk5)
13.256	10	21	99	13q33.1	ITGBL1, TIED	P	Integrin, beta-like 1	604234	A			
13.257	2	18	08	13q33.1	KDELC1, EP58	P	KDEL motif-containing 1	611613	REc			
13.258	3	16	10	13q33.1	SLC10A2, NTCP2, PBAM	C	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2	601295	REa, A		Bile acid malabsorption, primary, 613291 (3)	8(Slc10a2)
13.259	8	21	98	13q32.2-q32.3	SLC15A1, HPECT1	P	Solute carrier family 15 (oligopeptide transporter), member 1	600544	REa, A			
13.260	6	4	13	13q33.1	METTL21C, C13orf39	P	Methyltransferase-like 21C	615259	REc			
13.261	2	11	16	13q32.3-q33.1	NALCN, IHPRF1, CLIFAHDD	P	Sodium leak channel, nonselective	611549	R, REc		Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3); Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	
13.262	4	22	10	13q33.1-q34	OFC9	P	Orofacial cleft 9	610361	Fd	associated with rs1830756	Orofacial cleft 9 (2)	
13.263	11	3	11	13q33.2	VUR5	P	Vesicoureteral reflux 5	614318	Fd	nearest marker rs4476030	Vesicoureteral reflux 5 (2)	
13.264	9	8	11	13q33.3	ARGLU1	P	Arginine- and glutamate-rich protein 1	614046	REc			
13.265	11	13	13	13q33.3	MYO16, MYAP3, KIAA0865	P	Myosin XVI	615479	REc, R			
13.266	7	17	14	13q33.3	LIG4, LIG4S	P	Ligase IV, DNA, ATP-dependent	601837	A		LIG4 syndrome, 606593 (3); {Multiple myeloma, resistance to}, 254500 (3)	
13.267	7	27	09	13q34	ARHGEF7, PIXB, COOL1	P	Rho guanine nucleotide exchange factor 7 (PAK-interacting exchange factor, beta)	605477	R, REc			
13.268	1	23	93	13q34	ATP4B	P	ATPase, H+, K+ transporting, beta	137217	A			
13.269	7	27	09	13q34	ATP11A, ATPIS, ATPIH	C	ATPase, class VI, type 11A	605868	REc			
13.270	8	18	14	13q34	CARKD	P	Carbohydrate kinase domain-containing protein	615910	REc			
13.271	12	3	15	13q34	CARS2, COXPD27	P	Cysteinyl-tRNA synthetase 2	612800	R, REc		Combined oxidative phosphorylation deficiency 27, 616672 (3)	
13.272	8	8	13	13q34	CDC16, APC6	P	Cell division cycle 16, S. cerevisiae, homolog of	603461	REc			
13.273	9	29	15	13q34	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40	P	Chromosome alignment-maintaining phosphoprotein 1	616327	REc		Mental retardation, autosomal dominant 40, 616579 (3)	
13.274	4	30	15	13q34	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	C	Collagen IV, alpha-1 polypeptide	120130	REa, A, REb, RE, Fd	mutation identified in 1 RATOR family	Porencephaly 1, 175780 (3); Brain small vessel disease with or without ocular anomalies, 607595 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3); {Hemorrhage, intracerebral, susceptibility to}, 614519 (3); ?Retinal arteries, tortuosity of, 180000 (3)	8(Col4a1)
13.275	3	18	13	13q34	COL4A2, POREN2, ICH	C	Collagen IV, alpha-2 polypeptide	120090	REa, A, RE, Fd		Porencephaly 2, 614483 (3); {Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	8(Col4a2)
13.276	10	29	09	13q34	CUL4A	P	Cullin 4A	603137	Psh, A			
13.277	5	19	09	13q33.2	DAOA, G72	P	D-amino acid oxidase activator	607408	Fd		{Schizophrenia}, 181500 (2)	
13.278	1	27	11	13q33.2	DAOAAS, G30	P	DAOA antisense RAN	607415	REn			
13.279	9	15	11	13q34	DFNA33	P	Deafness, autosomal dominant 33	614211	Fd	maximum lod at D13S285	Deafness, autosomal dominant 33 (2)	
13.280	4	15	11	13q34	F7	C	Coagulation factor VII	613878	D		Factor VII deficiency, 227500 (3); {Myocardial infarction, decreased susceptibility to}, 608446 (3)	
13.281	10	23	87	13q34	F10	C	Coagulation factor X	613872	D, A, REa		Factor X deficiency, 227600 (3)	8(Cf10)
13.282	8	9	05	13q33.1	FGF14, FHF4, SCA27	C	Fibroblast growth factor-14	601515	REa, H, Fd		Spinocerebellar ataxia 27, 609307 (3)	14(Fhf4)
13.283	2	15	96	13q34	GAS6, AXLLG, AXSF	P	Growth arrest-specific 6	600441	A			8(Gas6)
13.284	4	2	07	13q34	GRK1, RHOK, RK	P	G protein-dependent receptor kinase 1 (rhodopsin kinase)	180381	REa, A		Oguchi disease-2, 613411 (3)	
13.285	11	16	05	13q34	ING1	C	Inhibitor of growth 1	601566	A, R		Squamous cell carcinoma, head and neck, somatic, 275355 (3)	
13.286	2	5	01	13q34	IRS2	P	Insulin receptor substrate 2	600797	R, REc		{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
13.287	2	9	92	13q34	LAMP1	C	Lysosome-associated membrane protein-1	153330	A, REa			8(Lamp1)
13.288	9	26	11	13q34	MCF2L, OST, KIAA0362	P	MCF2-like protein	609499	R, REc			
13.289	1	31	11	13q34	PCID2	P	PCI domain-containing protein 2	613713	REc			
13.290	4	10	15	13q34	PROZ, PZ	P	Protein Z	176895	REc		[Protein Z deficiency], 614024 (3)	
13.291	7	17	91	13q32.1	RAP2A	P	RAP2, member of RAS oncogene family (K-rev)	179540	A			
13.292	7	27	09	13q34	RASA3	P	Ras p21 protein activator 3	605182	R, REc			
13.293	6	9	98	13q34	SOX1	P	SRY (sex determining region Y)-box 1	602148	A			
13.294	11	1	99	13q34	TFDP1, DP1, DRTF1	P	Transcription factor Dp-1	189902	A	pseudogene on 1q32.3		
13.295	2	1	11	13q34	UPF3A, RENT3A	P	UPF3 regulator of nonsense transcripts, yeast, homolog of, A	605530	REc			
14.1	4	26	90	14p12	RNR2	C	Ribosomal RNA-2	180451	A			
14.2	2	17	09	14p11.2-q13	ADIPQTL3, CAQ14	P	Adiponectin, serum level of, quantitative trait locus 3	606771	Fd	between D14S608 and D14S599	{Adiponectin, serum level of, QTL3} (2)	
14.3	1	31	01	14q12	ADAP6, ADAP100	C	A-kinase anchor protein 6	604691	R, REc			
14.4	8	14	15	14q32.12	GOLGA5, RFG5	P	Golgi autoantigen, golgin subfamily A, 5	606918	REc	fused with RET to form PTC5		
14.5	4	21	98	14q23.2-q23.3	ESR2	P	Estrogen receptor-2 (ER beta)	601663	REa, R			
14.6	6	2	98	14q21.1	MGEA, MEA6	P	Meningioma-expressed antigen 6	602132	A	?pseudogenes on other chromosomes		
14.7	5	29	98	14q12	NOVA1	L	Neurooncological ventral antigen 1	602157	H			12(Nova1)
14.8	8	18	14	14q21.3	RPS29, DBA13	P	Ribosomal protein S29	603633	R,		Diamond-Blackfan anemia 13, 615909 (3)	
14.9	1	9	95	14q32.2	YY1	P	YY1 transcription factor	600013	REa, H			12(Yy1)
14.10	3	30	11	14q11.2	RPGRIP1, LCA6, CORD13	C	Retinitis pigmentosa GTPase regulator-interacting protein	605446	R, REa		Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13, 608194 (3)	
14.11	9	2	09	14q11.2	TRNAP1, TRP1	C	tRNA proline-1	189930	REa, A, Fd			
14.12	6	26	00	14q11.2	ZNF219	P	Zinc finger protein-219	605036	REc			
14.13	5	6	09	14q11.2	DAD1	P	Defender against cell death 1	600243	A			14(Dad1)
14.14	2	21	02	14q11-q12	IBD4	P	Inflammatory bowel disease 4	606675	Fd		{Inflammatory bowel disease 4} (2)	
14.15	10	7	13	14q11.2	MMP14, WNCHRS	P	Matrix metalloproteinase 14 (membrane-inserted)	600754	A	mutation identified in 1 family	?Winchester syndrome, 277950 (3)	
14.16	3	28	15	14q11.2	TRL-AAG2-1, TRNAL1, TRL1	C	tRNA leucine (AAG) 2-1	189932	REa, A, Fd			
14.17	9	2	09	14q11.2	TRNAP2, TRP2	C	tRNA proline-2	189931	REa, A, Fd			
14.18	9	2	09	14q11.2	TRNAT2, TRT2	C	tRNA threonine-2	189933	REa, A, Fd			
14.19	4	27	12	14q22.1	ATL1, SPG3A, HSN1D	C	Atlastin GTPase 1	606439	REc, Fd		Spastic paraplegia 3A, autosomal dominant, 182600 (3); Neuropathy, hereditary sensory, type ID, 613708 (3)	
14.20	1	21	07	14q12	GMPR2	C	Guanosine monophosphate reductase 2	610781	REc			
14.21	9	29	10	14q11-q22	DEL14q11q22, C14DELq11q22	P	Chromosome 14q11-q22 deletion syndrome	613457	Ch	contiguous gene syndrome	Chromosome 14q11-q22 deletion syndrome (4)	
14.22	7	11	95	14q24.1	PIGH	L	Phosphatidylinositol glycan, class H	600154	H			12(Pigh)
14.23	1	27	04	14q11.2	C14orf18, HEI10	P	Human enhancer of invasion 10	608249	REc			
14.24	12	17	08	14q11.2	METTL3, IME4	P	Methyltransferase-like 3	612472	R, REc			
14.25	3	7	05	14q11-q12	NRL, D14S46E, RP27	C	Neural retina leucine zipper	162080	REa, A, Fd		Retinitis pigmentosa 27, 613750 (3); Retinal degeneration, autosomal recessive, clumped pigment type (3)	14(Nrl)
14.26	1	14	03	14q11.2	RAB2B	P	Ras-associated protein RAB2B	607466	REc			
14.27	9	8	14	14q11.2	SALL2, HSAL2, COLB	P	Sal-like 2	602219	A	mutation identified in 1 COLB family	?Coloboma, ocular, autosomal recessive, 216820 (3)	
14.28	4	30	12	14q11.2	ACIN1, KIAA0670	P	Acinus	604562	R, REc			
14.29	5	16	95	14q12	ADCY4	C	Adenylate cyclase-4	600292	REa			14(Adcy4)
14.30	12	18	08	14q11.2	ANG, RNASE5, ALS9	C	Angiogenin	105850	A, REa, Fd, REn	proximal to TCRA/TCRD	Amyotrophic lateral sclerosis 9, 611895 (3)	14(Ang)
14.31	5	27	05	14q11.2	CEBPE, CRP1	P	CCAAT/enhancer-binding protein (C/EBP), epsilon	600749	H, A		Specific granule deficiency, 245480 (3)	14(Cebpe)
14.32	1	24	13	14q11.2	CHD8, DUPLIN, KIAA1564, AUTS18	P	Chromodomain helicase DNA-binding protein 8	610528	R, REc		{Autism, susceptibility to, 18}, 615032 (3)	
14.33	1	21	00	14q12	CMA1	P	Chymase-1, mast cell	118938	REa, REn			
14.34	12	5	11	14q11.2	CMTM5, CKLFSF5	P	CKLF-like marvel transmembrane domain-containing 5	607888	REc			14(Cklfsf5)
14.35	2	28	01	14q11.2	CPNE6	C	Copine VI	605688	R, REc			
14.36	4	25	93	14q12	CTSG	C	Cathepsin G	116830	A, REn			
14.37	3	29	10	14q12	DCAF11, WDR23	P	DDB1- and CUL4-associated factor 11	613317	REc			
14.38	5	6	13	14q11.2	DHRS2, HEP27	P	Short-chain dehydrogenase/reductase family, member 2	615194	A, REc			
14.39	2	23	08	14q11.2	DHRS4, NRDR	P	Short-chain dehydrogenase/reductase family, member 4	611596	REc			
14.40	4	27	16	14q11.2	DHRS4AS1, DHRS4AS1, AS1DHRS4, C14orf67	P	DDHRS4 antisense RNA 1, noncoding	616925	REc			
14.41	5	6	13	14q11.2	DHRS4L1	P	Short-chain dehydrogenase/reductase family, member 4-like 1	615195	REc			
14.42	5	6	13	14q11.2	DHRS4L2	P	Short-chain dehydrogenase/reductase family, member 4-like 2	615196	REc			
14.43	12	7	07	14q11.2	FAM12A, HE3A	P	Family with sequence similarity 12, member A	611580	R, REc			
14.44	12	7	07	14q11.2	FAM12B, HE3B	P	Family with sequence similarity 12, member B	611582	REc			
14.45	8	21	98	14q12	GZMB, CTLA1, CSPB	C	Granzyme B (cytotoxic T-lymphocyte-associated serine esterase-1; cathepsin G-like 1)	123910	A, REa, RE			14(Ctla1)
14.46	8	20	98	14q12	GZMH, CTSGL2	C	Granzyme H (cathepsin G-like 2)	116831	A, REn			
14.47	9	7	10	14q11.2	HAUS4, C14orf94	P	HAUS augmin-like complex, subunit 4	613431	REc			
14.48	6	1	12	14q11.2	HNRNPC, HNRPC	P	Heterogeneous nuclear ribonucleoprotein C	164020	R, REc			
14.49	11	11	14	14q11.2	HOMEZ, KIAA1443	P	Homeodomain leucine zipper-containing factor	608119	REc, H			14(Homez)
14.50	2	2	07	14q11.2	IL25, IL17E	P	Interleukin 25	605658	REc			
14.51	6	22	99	14q12	ISGF3, ISGF3G	P	Interferon-stimulated gene transcription factor 3, gamma, 48kD	147574	RE			
14.52	3	1	06	14q11.2	LRP10, LRP9	P	Low density lipoprotein receptor-related protein 10	609921	R, H			14(Lrp10)
14.53	7	18	12	14q11.2	LRRC16B	P	Leucine-rich repeat-containing protein 16B	614716	REc			
14.54	11	24	14	14q11.2	METTL17, METT11D1	P	Methyltransferase-like 17	616091	REc			
14.55	11	24	14	14q11.2	MHRT	P	Myosin heavy chain-associated RNA transcript, noncoding	616096	REc, H			14(Mhrt)
14.56	1	27	11	14q11.2	MIR208B, MIRN208B	P	Micro RNA 208B	613613	REc			14(Mir208b)
14.57	3	5	08	14q11.2	MRPL52	P	Mitochondrial ribosomal protein L52	611856	R, REc			
14.58	9	19	00	14q11.2	NDRG2	P	N-myc downstream-regulated gene 2	605272	R			
14.59	2	20	07	14q11.2	NGDN, NGD	P	Neuroguidin	610777	R, REc			
14.60	7	13	09	14q11.2	NRCLP5	P	Narcolepsy 5	612851	Fd	associated with rs1154155, rs12587781, rs1263646	{Narcolepsy 5} (2)	
14.61	2	15	96	14q11.2	OXA1L	P	Oxidase (cytochrome c) assembly 1-like	601066	A			
14.62	4	19	06	14q11.2	PARP2, ADPRTL2, ADPRT2	C	Poly(ADP-ribose) polymerase 2	607725	R, A			14(Adprtl2)
14.63	6	19	98	14q11.2	PSMB5, LMPX	P	Proteasome subunit, beta type, 5	600306	REn			
14.64	9	10	07	14q11.2	PSMB11	P	Proteasome subunit, beta-type, 11	611137	REc			
14.65	6	19	98	14q12	PSME1, IFI5111	P	Proteasome activator subunit-1	600654	A			
14.66	6	19	98	14q12	PSME2	P	Proteasome activator subunit-2	602161	A			
14.67	3	2	98	14q12	RABGGTA	P	Rab geranylgeranyltransferase, alpha subunit	601905	REa, A			
14.68	8	27	01	14q12	RIPK3, RIP3	P	Receptor-interacting serine/threonine kinase 3	605817	A			
14.69	12	18	08	14q11.2	RNASE1, RNS1	P	Ribonuclease, RNase A family, 1 (pancreatic)	180440	H, REn			14(Rib1)
14.70	12	18	08	14q11.2	RNASE2, RNS2, EDN	C	Ribonuclease, RNase A family, 2, liver (eosinophil-derived neurotoxin)	131410	REa, A, REn			
14.71	12	18	08	14q11.2	RNASE3, RNS3, ECP	C	Ribonuclease, RNase A family, 3 (eosinophil cationic protein)	131398	REa, A, REn			
14.72	12	18	08	14q11.2	RNASE4, RNS4	C	Ribonuclease, RNase A family, 4	601030	Psh, REn			
14.73	12	18	08	14q11.2	RNASE6	C	Ribonuclease, RNase A family, k6	601981	Psh, REn			
14.74	12	24	08	14q11.2	RNASE7	P	Ribonuclease A family 7	612484	REc			
14.75	12	18	08	14q11.2	RNASE8	P	Ribonuclease A family, 8	612485	REn			
14.76	9	8	11	14q11.2	RNAE9	P	Ribonuclease A family, 9	614014	REc			
14.77	12	24	08	14q12	RNF31, ZIBRA	P	Ring finger protein 31	612487	REc			
14.78	9	23	13	14q11.2	RPPH1, H1RNA	P	Ribonuclease P, RNA component H1	608513	REc			
14.79	12	8	00	14q11.2	RSCIS	P	Radiation sensitivity/chromosome instability syndrome, autosomal dominant	605463	Ch		Radiation sensitivity/chromosome instability syndrome, autosomal dominant (1)	
14.80	3	10	99	14q11.2	SLC7A7, LPI	C	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7	603593	A, Fd, LD		Lysinuric protein intolerance, 222700 (3)	
14.81	10	22	99	14q11.2	SLC7A8, LAT2	P	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8	604235	R			
14.82	10	13	09	14q11.2	SLC22A17, NGALR, BOIT, BOCT, NGALR2, NGALR3	P	Solute carrier family 22, organic cation transporter, member 17	611461	R, REc			
14.83	2	26	03	14q13.3	SLC25A21, ODC	C	Solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21	607571	A			
14.84	7	31	08	14q11.2	SLC39A2, ZIP2	P	Solute carrier family 39 (zinc transporter), member 2	612166	R, REc			
14.85	4	25	06	14q11.2	SOLO, FLJ10357	P	SOLO gene	610018	REc			
14.86	2	25	15	14q11.2	SUPT16H, SPT16	P	Suppressor of ty 16, S. cerevisiae, homolog of	605012	REc			
14.87	10	15	13	14q11.2	TRAC, TRCA, TRA, IMD7	C	T-cell receptor alpha	186880	H, REa, A, REn	cen--V-C--ter	Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	14(Tcra)
14.88	10	15	13	14q11.2	TRDC	C	T-cell receptor delta chain constant region	186810	RE, Ch, REc	in midst of TCRA		14(Tcrd)
14.89	10	15	13	14q11.2	TRDD@	P	T-cell receptor delta chain diversity gene cluster	615460	REc			
14.90	10	15	13	14q11.2	TRDV@	P	T-cell receptor delta chain variable gene cluster	615459	REc			
14.91	10	15	13	14q11.2	TRDJ@	P	T-cell receptor delta chain joining gene cluster	615461	REc			
14.92	5	28	98	14q11.2	TEP1, TP1	P	Telomerase-associated protein-1	601686	A, H			14(Tep1)
14.93	1	18	13	14q12	TGM1, ICR2, ARCI1	C	Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase)	190195	REa, A, Fd		Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	
14.94	2	18	08	14q11.2	THTPA	P	Thiamine triphosphatase	611612	REc			
14.95	6	8	11	14q11.2	TOX4, LCP1, KIAA0737	C	TOX high mobility group box family member 4	614032	R, REc			
14.96	10	15	13	14q11.2	TRAJ@	C	T-cell receptor alpha chain joining gene cluster	615443	REc, Ch			
14.97	10	15	13	14q11.2	TRAV@	C	T-cell receptor alpha chain variable gene cluster	615442	REn, Ch			
14.98	1	22	07	14q12	TSSK4, TSSK5	P	Testis-specific serine/threonine kinase 4	610711	REc			
14.99	3	3	98	14q11.2	BCL2L2, BCLW	P	BCL2-like 2	601931	A			
14.100	3	16	06	14q11.2-q12	DFNA53	P	Deafness, autosomal dominant 53	609965	Fd	max lod at D14S1280	Deafness, autosomal dominant 53 (2)	
14.101	3	16	06	14q11.2	EFS	P	Embryonal FYN-associated substrate	609906	A			
14.102	10	15	98	14q12	LTB4R, CMKRL1, P2RY7, BLTR,	P	Leukotriene b4 receptor (purinergic receptor P2Y, G protein-coupled, 7; chemokine receptor-like 1)	601531	A			
14.103	8	27	01	14q12	LTB4R2, BLTR2, BLT2	P	Leukotriene B4 receptor 2	605773	REc			
14.104	12	20	11	14q11.2-q12	MRT9, MRT26	P	Mental retardation, autosomal recessive, 9/26	611095	Fd	between rs1998463 and rs243286	Mental retardation, autosomal recessive, 9/26 (2)	
14.105	5	24	13	14q11.2-q12	PAURT1	P	Preauricular tag, isolated, autosomal dominant, 1	610420	Fd	between D14S990 and D14S264	Preauricular tag, isolated, autosomal dominant, 1 (2)	
14.106	7	11	11	14q11-q12	PCK2, PEPCK2	P	Phosphoenolpyruvate carboxykinase 2, mitochondrial	614095	A		PEPCK deficiency, mitochondrial, 261650 (1)	
14.107	7	3	06	14q11.2	OSGEP, FLJ20411	P	O-sialoglycoprotein endopeptidase	610107	REc			
14.108	10	29	03	14q12	REC8L1, REC8	P	Rec8, S. pombe, homolog of	608193	A			
14.109	1	30	12	14q11.2-q13	HHPP	P	Hyperhidrosis palmaris et plantaris	144110	Fd	between D14S283 and D14S264	Hyperhidrosis palmaris et plantaris (2)	
14.110	11	16	05	14q11.2	PABPN1, PABP2, PAB2	C	Poly(A)-binding protein, nuclear 1	602279	REc, Fd		Oculopharyngeal muscular dystrophy, 164300 (3)	
14.111	7	19	06	14q11.2-q12	SPD3	P	Synpolydactyly 3	610234	Fd	max lod at D14S264	Synpolydactyly 3 (2)	
14.112	4	27	12	14q12	AP4S1, CPSQ6, SPG52	P	Adaptor-related protein complex 4, sigma-1 subunit	607243	R, REc		Spastic paraplegia 52, autosomal recessive, 614067 (3)	
14.113	6	24	94	14q11.2	APEX, APE	C	APEX nuclease (multifunctional DNA repair enzyme)	107748	Psh, A			14(Apex)
14.114	3	14	07	14q12	ARHGAP5, RHOGAP5	P	RHO GTPase-activating protein 5	602680	R, REc			
14.115	9	9	09	14q12	CBLN3	P	Precerebellin 3	612978	REc			14(Cbln3)
14.116	8	2	13	14q13.1	CFL2, NEM7	C	Cofilin 2, muscle	601443	Psh, REc		Nemaline myopathy 7, autosomal recessive, 610687 (3)	
14.117	3	29	07	14q12	CHMP4A, SNF7	P	CHMP family, member 4A	610051	R, REc			
14.118	12	3	96	14q12	DFNB5	P	Deafness, autosomal recessive 5	600792	Fd		Deafness, autosomal recessive 5 (2)	
14.119	6	9	08	14q12	FIT1	P	Fat-inducing transcript 1	612028	R, REc			
14.120	5	24	13	14q12	G2E3, KIAA1333	P	G2/M phase-specific E3 ubiquitin ligase	611299	REc			
14.121	2	25	14	14q12	GPR33	P	G protein-coupled receptor 33	610118	REc, A			
14.122	1	27	11	14q11.2	MIR208A, MIRN208A, MIR208, MIRN208	P	Micro RNA 208A	611116	REc			
14.123	7	22	11	14q11.2	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	C	Myosin, heavy polypeptide-6, cardiac muscle, alpha	160710	REa, RE, D, A, Fd		Cardiomyopathy, hypertrophic, 14, 613251 (3); Atrial septal defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)	14(Myhca)
14.124	6	9	15	14q11.2	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	C	Myosin, heavy polypeptide-7, cardiac muscle, beta	160760	REa, RE, D, A	5'-B-4.5kb-A-3'	Cardiomyopathy, hypertrophic, 1, 192600 (3); Cardiomyopathy, dilated, 1S, 613426 (3); Myopathy, myosin storage, autosomal dominant, 608358 (3); Liang distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3); Left ventricular noncompaction 5, 613426 (3); Myopathy, myosin storage, autosomal recessive, 255160 (3)	
14.125	6	13	12	14q12	NEDD8	P	Neural precursor cel expressed, developmentally downregulated 8	603171	REc			
14.126	1	27	11	14q12	NUBPL, IND1	P	Nucleotide-binding protein-like protein	613621	REc		Mitochondrial complex I deficiency, 252010 (3)	
14.127	8	17	10	14q12	PRKD1, PRKCM, PKD	C	Protein kinase D1	605435	REa, R, REc	also assigned to chr.21		
14.128	12	30	14	14q12	SDR39U1	P	Short-chain dehydrogenase/reductase family 39U, member 1	616162	REc			
14.129	8	21	12	14q12	STRN3, SG2NA	P	Striatin, calmodulin-binding protein 3	614766	REc, A			
14.130	11	18	11	14q12	STXBP6, AMISYN, HSPC156	P	Syntaxin-binding protein 6	607958	R, REc			
14.131	12	24	11	14q12	TINF2, TIN2, DKCA3	P	TRF1-interacting nuclear factor 2	604319	REc		Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz syndrome, 268130 (3)	
14.132	5	29	13	1p34.3	ZMYM6, ZNF258	P	Zinc finger, MYM-type 6	613567	A			
14.133	2	28	01	14q13.1-q13.2	BAZ1A	P	Bromodomain adjacent to zinc finger domain, 1A	605680	REa, R			
14.134	2	5	09	14q12	COCH, DFNA9	C	Cochlin	603196	Fd, A		Deafness, autosomal dominant 9, 601369 (3)	12(Coch5B2)
14.135	2	11	08	14q13.3	NKX2-8, NKX2H, NKX2.8	P	NK2 homeobox 8	603245	REn, H			12(Nkx2-9)
14.136	4	24	09	14q13.3	PAX9, STHAG3	P	Paired box gene 9	167416	REa, A		Tooth agenesis, selective, 3, 604625 (3)	
14.137	4	27	12	14q12-q21	SPG32	P	Spastic paraplegia-32	611252	Fd	between D14S264 and D14S978	Spastic paraplegia 32, autosomal recessive (2)	
14.138	10	27	97	14q12-q22	ARVD3	P	Arrhythmogenic right ventricular dysplasia 3	602086	Fd	?distinct from ARVD1	Arrhythmogenic right ventricular dysplasia 3 (2)	
14.139	1	2	03	14q21.1	FOXA1, HNF3A	C	Forkhead box A1 (hepatocyte nuclear factor-3, alpha)	602294	A, D			12(Hnf3a)
14.140	7	22	11	14q12	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	C	Forkhead box G1B	164874	REa, A		Rett syndrome, congenital variant, 613454 (3)	
14.141	3	1	07	14q13	HPE8	P	Holoprosencephaly 8	609408	Fd	between D14S49 and D14S1014	Holoprosencephaly-8 (2)	
14.142	3	14	06	14q13.2	KIAA0391	P	KIAA0391 gene	609947	R, REc			
14.143	11	6	14	14q13.3-q21.1	MIPOL1	P	MIPOL1 gene	606850	Ch			
14.144	7	10	08	14q13.2	NFKBIA, IKBA	C	Nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha	164008	A		Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 (3)	12(ikba)
14.145	9	1	15	14q13.3	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	P	NK2 homeobox 1	600635	A		{Thyroid cancer, monmedullary, 1}, 188550 (3); Chorea, hereditary benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	
14.146	3	24	06	14q13.1	NPAS3, MOP6	P	Neuronal PAS domain protein 3	609430	REc, H			12(Npas3)
14.147	11	2	11	14q13.2	PSMA6, PROS27, P27K	P	Proteasome subunit, alpha-type, 6	602855	A		{Myocardial infarcation, susceptibility to}, 608446 (3)	
14.148	4	25	93	14q21.1	SSTR1	C	Somatostatin receptor-1	182451	REa			12(Sstr1)
14.149	5	23	00	14q21.3	POLE2, DPE2	P	Polymerase, DNA, epsilon-2	602670	REa, A			
14.150	8	25	04	14q13-q21	RLS2	C	Restless legs syndrome, susceptibility to, 2	608831	Fd	max lod at D14S288	{Restless legs syndrome 2} (2)	
14.151	9	11	02	14q22.1	WW45, SAV	P	WW domain-containing protein, 45kD	607203	R			
14.152	4	27	12	14q13.1	EGLN3, PHD3, HIFP4H3	P	Egl9, C. elegans, homolog of, 3	606426	REc			
14.153	12	17	09	14q11.2	PNP, NP	C	Purine nucleoside phosphorylase	164050	S, D	centromeric to TCRA	Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	14(Np1,2)
14.154	12	10	12	14q13.1	SNX6	C	Sorting nexin 6	606098	R, REc			
14.155	9	8	11	14q13.2	INSM2, IA6	P	Insulinoma-associated 2	614027	REc			
14.156	9	10	12	14q13.1	SPTSSA, C14orf147, SSSPTA	P	Serine palmitoyltransferase, small subunit, A	613540	REc			
14.157	8	19	14	14q13.2	PPP2RC2, G5PR	P	Protein phosphatase 2, regulatory subunit B-double prime, gamma	615902	REc			
14.158	7	9	06	14q13.2	SRP54	P	Signal recognition particle, 54kD	604857	R			
14.159	6	22	10	14q13.2	RALGAPA1, GARNL1, TULIP1, GRIPE, KIAA0884	C	Ral GTPase activating protein, alpha subunit 1 (catalytic)	608884	Psh, A	pseudogene on 9q31.1		12(Garnl1)
14.160	2	4	09	14q21.1	FBXO33, FBX33, BMND12	C	F-box only protein 33	609103	REc			12(Fbxo33)
14.161	6	30	05	14q13.3	MBIP	P	MAP3K12-binding inhibitory protein	609431	R, REc			
14.162	9	14	12	14q13.3	PTCSC3	P	PTCSC3 gene	614821	REc			
14.163	2	1	11	14q13.3-q21.1	HPV6AI1	P	Human papillomavirus type 6A integration site 1	604461	REc	previously assigned to 10q24		
14.164	5	28	02	14q22.1	GNG2	P	Guanine nucleotide-binding protein, gamma-2	606981	Psh, A			14(Gng2)
14.165	9	10	07	14q21.3	MDGA2	P	MAM domain-containing glycosylphosphatidylinositol anchor 2	611128	REc, H			12(Mdga2)
14.166	4	16	10	14q21.3	MGAT2, CDGS2, CDG2A	P	Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase	602616	A		Congenital disorder of glycosylation, type IIa, 212066 (3)	
14.167	9	2	12	14q22.3	PELI2	P	Pellino, Drosophila, homolog of, 2	614798	REc			
14.168	9	24	15	14q21.3	SOS2, NS9	P	Son of sevenless, Drosophila, homolog of, 2	601247	A		Noonan syndrome 9, 616559 (3)	12(Sos2)
14.169	12	4	02	14q23.1	TIMM9, TIM9	C	Translocase of inner mitochondrial membrane 9, yeast, homolog of	607384	REc, A, R			
14.170	10	15	97	14q22.3	LGALS3, MAC2, GALBP	P	Lectin, galactose-binding, soluble, 3	153619	A	assigned earlier to 1p13		
14.171	9	4	98	14q23.1	RTN1, NSP	P	Reticulon 1 (neuroendocrine-specific protein)	600865	A			
14.172	6	15	99	14q23.2	HIF1A, MOP1	P	Hypoxia-inductible factor 1, alpha subunit	603348	A,			12(Hif1a)
14.173	12	27	01	14q22.1	TRIM9, SPRING, KIAA0282	P	Tripartite motif-containing protein 9	606555	R			
14.174	3	3	16	14q21.1	CLEC14A	P	C-type lectin domain family 14, member A	616845	REc			
14.175	9	30	15	14q21.1	GEMIN2, SIP1	P	GEM-associated protein 2	602595	A			
14.176	11	1	06	14q21.1	SEC23A, CLSD	C	Sec23, S. cerevisiae, homolog of, A	610511	R, Fd		Craniolenticulosutural dysplasia, 607812 (3)	
14.177	2	25	14	14q21.1	TRAPPC6B, TPC6	P	Trafficking protein particle complex, subunit 6B	610397	REc, R			12(Trappc6b)
14.178	3	10	11	14q21.2	FKBP3, FKBP25	P	FK506-binding protein 3	186947	REc			
14.179	7	15	09	14q21.1	LRFN5, SALM5	P	Leucine-rich repeat and fibronectin type III domain-containing protein 5	612811	REc, H			12(Lrfn5)
14.180	12	10	12	14q21.2	PRPF39	P	Precursor mRNA-processing factor 39, S. cerevisiae, homolog of	614907	REc			
14.181	3	3	03	14q21.2-q22.3	MGR4, MGOA	P	Migraine without aura, susceptibility to, 4	607501	Fd	between D14S976 and D14S978	{Migraine without aura, susceptibility to, 4} (2)	
14.182	9	16	12	14q21.3	ARF6	P	ADP-ribosylation factor 6	600464	REc			
14.183	5	25	13	14q21.3	CDKL1, KKIALRE, p42	P	Cyclin-dependent kinase-like 1	603441	REc			
14.184	9	7	12	14q12	DHRS1	P	Short-chain dehydrogenase/reductase family, member 1	610410	REc			
14.185	6	22	15	14q21.2	FANCM, KIAA1596	P	FANCM gene	609644	REc			
14.186	2	11	08	14q21.2	FSCB, C14orf155	P	Fibrous sheath cabyr-binding protein	611779	REc			12(Fscb)
14.187	5	26	13	14q21.3	KLHDC1	P	KELCH domain-containing protein 1	611281	REc			
14.188	5	26	13	14q21.3	KLHDC2, HCLP1	P	KELCH domain-containing protein 2	611280	REc			
14.189	1	7	09	14q21.3	KTU, C14orf104, CILD10	P	Kintoun, Medaka, homolog of	612517	REc		Ciliary dyskinesia, primary, 10, 612518 (3)	
14.190	6	4	13	14q21.3	METTL21D, C14orf138	P	Methyltransferase-like 21D	615260	REc			
14.191	9	14	95	14q22.2	CDKN3	P	Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)	123832	A			
14.192	4	1	96	14q22.3	KTN1, CG1	C	Kinectin	600381	REa, A			
14.193	8	21	07	14q22.1	PTGER2	C	Prostaglandin E receptor 2, EP2 subtype, 53kD	176804	A		{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	15(Ptgerep2)
14.194	1	27	04	14q21.3	SDCCAG1	P	Serologically defined colon cancer antigen 1	608378	A			
14.195	7	22	13	14q22-q23	CTRCT32, CTAA1, CAP, CTPP5	P	Cataract 32, multiple types	115650	Ch, Fd	between D14S980 and D14S1069	Cataract 32, multiple types (2)	
14.196	3	8	07	14q23.1	PRKCH, PKCL, PRKCL	C	Protein kinase C, eta	605437	A, REc		{Cerebral infarction, susceptibility to}, 601367 (3)	
14.197	1	29	01	14q24.2	ZNFN2A1, DFCP1	P	Zinc finger protein, subfamily 2A, 1	605471	REc			
14.198	12	19	01	14q24.1	ZFP36L1, BRF1, ERF1	P	Zinc finger protein 36, C3H type-like 1 (butyrate response factor 1; EGF-response factor 1)	601064	A			
14.199	3	20	07	14q22.1	C14orf166, CGI99	P	Chromosome 14 open reading frame 166	610858	R, REc			
14.200	1	29	13	14q22.1	DDHD1, PAPLA1, KIAA1705, SPG28	C	DDHD domain-containing protein 1	614603	REc, Fd		Spastic paraplegia 28, autosomal recessive, 609340 (3)	
14.201	10	7	13	14q22.1	ERO1L, ERO1LA	P	Endoplasmic reticulum oxidoreduction 1-like	615435	A, H, REc			14(Ero1l)
14.202	4	30	09	14q22.2	GCRRF1, CGR19	P	Cell growth regulator with ring finger domain 1	606138	R, REc			
14.203	8	26	15	14q22.1	GNPNAT1, GNA1	P	Glucosamine-phosphate N-acetyltransferase 1	616510	REc			
14.204	3	31	08	14q22.1	FERMT2, PLEKHC1, MIG2, UNC112, KIND2	C	Fermitin family, Drosophila, homolog of, 2	607746	R, REc			
14.205	4	2	12	14q22.1	FRMD6, WILLIN, C14orf31	P	FERM domain-containing protein 6	614555	REc			
14.206	10	7	05	14q21.3	L2HGDH, C14orf160, L2HGA	C	L-2-hydroxyglutarate dehydrogenase	609584	REc		L-2-hydroxyglutaric aciduria, 236792 (3)	
14.207	10	11	12	14q22.1	NIN, KIAA1565, SCKL7	P	Ninein	608684	REc		Seckel syndrome 7, 614851 (3)	
14.208	8	27	08	14q21.3	RN7SL1, 7SL, 7L1A	P	RNA, 7SL, cytoplasmic 1	612177	REc			
14.209	8	27	08	14q21.3	RN7SL2, 7L1C	P	RNA, 7SL, cytoplasmic 2	612179	REc			
14.210	8	27	08	14q21.3	RN7SL3	P	RNA, 7SL, cytoplasmic 3	612180	REc			
14.211	2	1	11	14q22.1	PSMC6	P	Proteasome 26S subunit, ATPase, 6	602708	REc	previously assigned to 12q15 by FISH		
14.212	12	9	04	14q22.1	PTGDR, AS1, ASRT1	C	Prostaglandin D2 receptor	604687	Fd, REc		{Asthma, susceptibility to, 1}, 607277 (3)	
14.213	6	23	98	14q22.1	PYGL	C	Phosphorylase, glycogen, liver	613741	REb, Fd, REc		Glycogen storage disease VI, 232700 (3)	12(Pygl)
14.214	7	16	09	14q23.2	SGPP1, SPPASE1	P	Sphingosine-1-phosphate phosphatase 1	612826	REc			
14.215	7	14	14	14q22.1	STYX	P	Serine/threonine/tyrosine-interacting protein	615814	REc			
14.216	10	27	06	14q22.1	TXNDC1, TMX	P	Thioredoxin domain-containing 1	610527	REc			
14.217	2	4	15	14q22.1	TXNDC16, KIAA1344	P	Thioredoxin domain-containing protein 16	616179	REc			
14.218	5	4	09	14q22.2	GCH1, DYT5, HPABH4B	P	GTP cyclohydrolase 1	600225	Psh, A		Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3); Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	
14.219	6	3	14	14q22.1-q22.3	FRIASS, DEL14q22, C14DELq22	P	Frias syndrome	609640	Ch	deletion spans 4.1 Mb on 14q22.1-q22.3	Frias syndrome (4)	
14.220	3	7	11	14q22.1-q24.2	MYP18	P	Myopia 18	255500	Fd	between D14S984 and D14S999	Myopia 18 (2)	
14.221	3	7	14	14q22.2	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	C	Bone morphogenetic protein-4	112262	H, REa, A, Ch, REc		Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625 (3)	14(Bmp2b1)
14.222	5	25	13	14q22.2	CNIH, TGAM77	P	Cornichon, Drosophila, homolog of	611287	REc			
14.223	2	23	09	14q22.2	CRCS8	P	Colorectal cancer, susceptibility to, 8	612589	Fd	associated with rs4444235	{Colorectal cancer, susceptibility to, 8} (2)	
14.224	9	9	08	14q22.3	FBXO34, FBX34	P	F-box only protein 34	609104	REc			14(Fbxo34)
14.225	2	7	07	14q22.2	SAMD4A, SMAUG1, KIAA1053	P	Sterile alpha motif domain-containing 4A	610747	REc			14(Samd4a)
14.226	11	11	14	14q22.2-q22.3	WDHD1, AND1	P	WD repeat and HMG-box DNA binding protein 1	608126	R, REc			
14.227	9	18	12	14q22.3	AP5M1, MUDENG, MUD, C14orf108	P	Adaptor-related protein complex 5, mu-1 subunit	614368	REc			
14.228	8	27	15	14q22.3	ATG14, ATG14L, KIAA0831, BARKOR	P	Autophagy 14, S. cerevisiae, homolog of	613515	R, REc			
14.229	9	10	09	14q23.1	DACT1, DPR1, DAPPER1, FRODO	P	Dapper, antagonisty of beta-catenin, 1	607861	REc			
14.230	9	8	11	14q22.3	EXOC5, SEC10L1	P	Exocyst complex component 5	604469	REc			
14.231	5	8	15	14q22.3	OTX2, MCOPS5, CPHD6	C	Orthodenticle, Drosophila, homolog of, 2	600037	A, REa		Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone deficiency, combined, 6, 613986 (3); Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	
14.232	4	30	15	14q22.3	SOCS4, SOCS7	P	Suppressor of cytokine signaling 4	616337	REc			
14.233	7	10	08	14q23	ANIB8	P	Aneurysm, intracranial berry, 8	612162	Fd	associated with rs767603	Aneurysm, intracranial berry, 8 (2)	
14.234	10	6	09	14q23	EIG2	P	Epilepsy, idiopathic generalized, susceptibility to, 2	606972	Fd		{Epilepsy, idiopathic generalized, susceptibility to, 2} (2)	
14.235	3	30	99	14q23.3	FUT8	C	Fucosyltransferase 8	602589	REc, A			
14.236	8	14	11	14q23.3	MAX	P	MAX protein	154950	A	interacts with MYC	{Pheochromocytoma, susceptibility to}, 171300 (3)	12 (Myn)
14.237	6	15	99	14q23.1	MNAT1, MAT1	P	Menage a trois 1	602659	A,			
14.238	12	9	97	14q23.1	PSMA3	P	Proteasome (prosome, macropain) subunit, alpha type, 3	176843	Fd			
14.239	8	1	06	14q23.1	SIX1, BOS3, DFNA23	C	Sine oculis homeo box, Drosophila, homolog of, 1	601205	REa, A		Brachiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23, 605192 (3)	
14.240	10	4	01	14q23.1	SIX4	P	Sine oculis homeo box, Drosophila, homolog of, 4	606342	A			
14.241	4	10	15	14q23.1	SIX6, ODRMD	C	Sine oculis homeo box, Drosophila, homolog of, 6	606326	A, R, D		Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3)	
14.242	11	20	13	14q23.2	SYNE2, NUANCE, KIAA1011, EDMD5	P	Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2)	608442	A		Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	
14.243	11	4	93	14q23.3	FNTB	P	Farnesyltransferase, CAAX box, beta	134636	REa, Psh, A	related FNTBL1 on 9		
14.244	1	4	12	14q23.3	ZBTB25, ZNF46, KUP	P	Zinc finger and BTB domain containing 25	194541	A			
14.245	12	28	08	14q23.1	ARID4A, RBP1, RBBP1	P	AT-rich interactive domain-containing protein 4A	180201	R, REc			
14.246	4	30	12	14q23.1	DAAM1, KIAA0666	P	Dishevelled-associated activator of morphogenesis 1	606626	R, REc			
14.247	7	16	09	14q23.1	DHRS7, RETSDR4	P	Short-chain dehydrogenase/reductase family, member 7	612833	REc			
14.248	2	25	15	14q23.1	GPR135	C	G protein-coupled receptor 135	607970	R, REc			12(Gpr135)
14.249	5	23	13	14q23.1	JKAMP, C24orf100, JAMP	P	JNK1/MAPK8-associated membrane protein	611176	REc			
14.250	9	21	15	14q23.1	KIAA0586, TALPID3, JBTS23, SRTD14	P	KIAA0586 gene	610178	REc, R		Joubert syndrome 23, 616490 (3); Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	
14.251	9	10	12	14q23.1	L3HYPDH, C14orf149	P	L-3-hydroxyproline dehydratase, trans	614811	REc			
14.252	10	12	14	14q23.1	PPM1A, PP2CA	P	Protein phosphatase, magnesium/manganese-dependent, 1A	606108	REc			
14.253	10	7	05	14q23.2	PPP2R5E	P	Protein phosphatase-2, regulatory subunit B (B56), epsilon isoform	601647	REc	incorrectly assigned to 7p12-p11.2 by FISH		
14.254	8	26	15	14q23.1	SLC38A6, SNAT6	P	Solute carrier family 38 (amino acid transporter), member 6	616518	REc			
14.255	5	2	07	14q23.2	SYT16, STREP14	P	Synaptotagmin 16	610950	REc			
14.256	8	20	07	14q23.1	TMEM30B, CDC50B	P	Transmembrane protein 30B	611029	REc			
14.257	9	4	15	14q23.1	TRMT5, TRM5, KIAA1393, COXPD26	C	tRNA methyltransferase 5, S. cerevisiae, homolog of	611023	R, REc		Combined oxidative phosphorylation deficiency 26, 616539 (3)	
14.258	3	30	12	14q23.2	HIF1AAS1	P	HIF1A antisense RNA 1	614528	REc			
14.259	3	30	12	14q23.2	HIF1AAS2	P	HIF1A antisense RNA 2	614529	REc			
14.260	4	30	12	14q23.2	KCNH5	P	Potassium voltage-gated channel, subfamily H, member 5	605716	REc			
14.261	4	30	12	14q23.2	RHOJ, ARHJ, TCL	P	Ras homolog gene family, member J	607653	REc			
14.262	10	2	12	14q23.2	SNAPC1, SNAP43	P	Small nuclear RNA-activating protein compelx, polypeptide 1	600591	REc			
14.263	2	28	06	14q23.2	TELM	P	Telomere length, mean leukocyte	609113	Fd	suggestive QTL on 12, 10q, 3p	[Telomere length, mean leukocyte] (2)	
14.264	2	25	15	14q23.3	AKAP5, AKAP79	P	A-kinase anchor protein 5	604688	REc			
14.265	7	22	13	14q23.3	MPP5, PALS1	P	Membrane protein, palmitoylated 5	606958	R, REc			12(Pals1)
14.266	7	17	14	14q23.3-q24.1	PLEK2	P	Pleckstrin 2	608007	REc			
14.267	12	1	14	14q24.1	RDH11, PSDR1, RALR1, RDJCSS	C	Retinol dehydrogenase 11	607849	R, REn	mutation identified in 1 RDJCSS family	?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	12(Rdh11)
14.268	9	23	04	14q24.1	RDH12, LCA13	C	Retinol dehydrogenase 12	608830	Fd, REn	near RDH11	Leber congenital amaurosis 13, 612712 (3)	
14.269	11	18	15	14q23.3	SPTB, SPH2, EL3, HS2	C	Spectrin, beta, erythrocytic	182870	REb, F, H, REa, A, RE		Elliptocytosis-3 (3); Spherocytosis, type 2, 616649 (3); Anemia, neonatal hemolytic, fatal and near-fatal (3)	12(Sptb1)
14.270	9	28	15	14q23.3	ZBTB1	P	Zinc finger- and BTB domain-containing protein 1	616578	REc			12(Zbtb1)
14.271	8	25	11	14q24.1	RAD51L1	P	RAD51. S. cerevisiae, homolog of, like 1	602948	REc, A, R	fused with HMGA2 in uterine leiomyoma		
14.272	11	30	06	14q24.3	ALKBH1, ALKB	P	AlkB, E. coli, homolog of, 1	605345	A			
14.273	12	17	08	14q24.3	BATF, BATF1, SFA2	P	Basic leucine zipper transcription factor, ATF-like	612476	A			
14.274	3	9	00	14q24.3	C14orf1	P	Chromosome 14 open reading frame 1	604576	R			
14.275	10	29	03	14q24.3	EIF2B2	P	Eukaryotic translation initiation factor 2B, subunit 2	606454	R, Fd		Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
14.276	9	28	00	14q24.3	ENTPD5, CD39L4	P	Ectonucleoside triphosphate diphosphohydrolase 5	603162	R,			12(Cd39l4)
14.277	11	4	13	14q23.3	GPHN, GPH, KIAA1385, GEPH, MOCODC	C	Gephyrin	603930	REc, Ch		Molybdenum cofactor deficiency C, 615501 (3)	
14.278	9	14	12	14q24.3	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	P	Latent transforming growth factor beta binding protein-2	602091	RE, A		Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3); Weill-Marchesani syndrome 3, recessive, 614819 (3)	
14.279	8	25	06	14q23.3	MTHFD, MTHFC	C	5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methylenetetrahydrofolate cyclohydrolase	172460	S, REa, A	trifunctional protein	{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3); {Abruptio placentae, susceptibility to} (3)	
14.280	9	28	00	14q24.3	NGB	P	Neuroglobin	605304	R			
14.281	7	14	15	14q24.3	TGFB3, ARVD1, RNHF, LDS5	C	Transforming growth factor, beta-3	190230	REa, A		Arrhythmogenic right ventricular dysplasia 1, 107970 (3); Loeys-Dietz syndrome 5, 615582 (3)	12(Tgfb3)
14.282	5	10	04	14q24.3	ZADH1	P	Zinc-binding alcohol dehydrogenase domain-containing protein 1	608642	REc			
14.283	3	12	15	14q32.11	CALM1, PHKD, CPVT4, LQT14	C	Calmodulin-1 (phosphorylase kinase, delta)	114180	REa, Psh, A		Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3); Long QT syndrome 14, 616247 (3)	
14.284	3	14	96	14q24.3	PGF, PLGF	P	Placental growth factor, vascular endothelial growth factor-related protein	601121	A			12(Plgf)
14.285	1	29	01	14q31.3	FLRT2	C	Fibronectin-like domain-containing leucine-rich transmembrane protein-2	604807	R, REc			
14.286	5	3	13	14q24.1	ACTN1, BDPLT15	P	Actinin, alpha-1	102575	REa, A, REc		Bleeding disorder, platelet-type, 15, 615193 (3)	12(Actn1)
14.287	6	6	00	14q24.2	ADAM20	P	A disintegrin and metalloproteinase domain 20	603712	R			
14.288	6	6	00	14q24.2	ADAM21	P	A disintegrin and metalloproteinase domain 21	603713	R			
14.289	6	29	07	14q24.1	ERH	P	Enhancer of rudimentary, Drosophila, homolog of	601191	REc	possible pseudogene on 7q34		
14.290	5	9	16	14q24.1	EXD2, EXDL2	P	Exonuclease 3'-to-5' domain-containing protein 2	616940	REc			
14.291	4	6	13	14q24.1	GALNT16, GALNACT16, GALNTL1, KIAA1130	C	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16	615132	R, REc			
14.292	4	9	96	14q23.3	GPX2	C	Glutathione peroxidase-2, gastrointestinal	138319	REa, A			
14.293	10	15	94	14q23.3	HSPA2	C	Heat-shock 70kD protein-2	140560	REa, A			12(Hspa2)
14.294	10	4	02	14q24.1	SLC10A1, NTCP1	C	Solute carrier family 10 (sodium/bile acid cotransporter family), member 1	182396	REa, REc			12(Slc10a1)
14.295	2	21	11	14q24.2	SMOC1, OAS	P	SPARC-related modular calcium-binding 1	608488	REc		Microphthalmia with limb anomalies, 206920 (3)	
14.296	1	15	16	14q24.1	SUSD6, DRAGO, KIAA0247	C	SUSHI domain-containing protein 6	616761	R, REc			
14.297	9	23	13	14q24.1	VTI1B, VTI1, VTI1L	P	Vti1, S. cerevisiae, homolog of, B	603207	REc			
14.298	4	27	12	14q24.1	ZFYVE26, KIAA0321, SPG15	C	Zinc finger FYVE domain-containing protein 26	612012	R, REc, Fd		Spastic paraplegia 15, autosomal recessive, 270700 (3)	
14.299	9	9	10	14q24.1	DCAF5, WDR22, BCRP2, D14S1461E	P	DDB1- and CUL4-associated factor 5	603812	REc			
14.300	6	15	99	14q24.1	ARG2	P	Arginase II	107830	A, R, Psh			
14.301	11	21	02	14q32.11	KCNK13, THIK1	P	Potassium channel, subfamily K, member 13	607367	REc			
14.302	5	19	15	14q24.2	DCAF4, WDR21, WDR21A	P	DDB1- and CUL4-associated factor 4	616372	REc			
14.303	12	22	08	14q24.2	RBM25, RED120	P	RNA-binding motif protein 25	612427	REc			
14.304	12	19	11	14q24.1	SRSF5, SFRS5, SRp40	P	Splicing factor, serine/arginine-rich, 5	600914	R, REc			
14.305	6	30	05	14q24.2	SYNJ2BP, OMP25, ARIP2	P	Synaptojanin 2-binding protein	609411	R, REc			
14.306	2	25	15	14q24.2	TTC9, KIAA0227	P	Tetratricopeptide repeat domain-containing protein 9	610488	Psh, REc			
14.307	10	17	12	14q24.3	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	C	ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like)	603214	Psh, A		Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	
14.308	10	25	11	14q24.3	ACOT1	P	Acyl-CoA thioesterase 1	614313	REc			12(Acot1)
14.309	3	17	06	14q24.3	ACOT2, PTE2, MTE1	P	Acyl-CoA thioesterase 2	609972	REc, R			12(Acot2)
14.310	10	28	11	14q24.3	ACOT4	P	Acyl-CoA thioesterase 4	614314	REc	?pseudogene on 19q13.12		12(Acot4)
14.311	10	5	11	14q24.3	ACOT6	P	Acyl-CoA thioesterase 6	614267	REc, H			12(Acot6)
14.312	5	25	00	14q24.3	ACYP1, ACYPE	P	Acylphosphatase, erythrocyte	600875	A, REa			
14.313	8	8	13	14q24.3	AHSA1, AHA1	P	Activator of heat-shock 90kD protein ATPase 1	608466	REc, R			
14.314	8	3	11	14q24.3	ALDH6A1, MMSDH	P	Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase)	603178	REc		Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	
14.315	9	9	13	14q24.3	AREL1, KIAA0317	P	Apoptosis-resistant E3 ubiquitin protein ligase 1	615380	REc			
14.316	1	9	08	14q24.3	C14orf4, EAP1	P	Enhanced at puberty 1	611720	R, REc			
14.317	3	31	08	14q24.3	C14orf169, NO66, MAPJD	P	Myc-associated protein with JMJC domain	611919	R, REc			
14.318	7	17	06	14q24.3	CHX10, HOX10, MCOP2, MCOPCB3	C	C. elegans ceh-10 homeo domain-containing homolog	142993	REa, A		Microphthalmia with coloboma 3, 610092 (3); Microphthalmia, isolated 2, 610093 (3)	12(Hox10)
14.319	5	24	12	14q24.3	COQ6, CGI10, COQ10D6	P	Coq6, S. cerevisiae, homolog of	614647	REc		Coenzyme Q10 deficiency, primary, 6, 614650 (3)	
14.320	11	9	05	14q31.1	DIO2, TXDI2, D2	P	Deiodinase, iodothyronine, type II	601413	R, A			
14.321	10	15	94	14q24.3	DLST	C	Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)	126063	A			
14.322	6	8	11	14q24.3	DNAL1, C14orf168, CILD16	P	Dynein, axonemal, light chain 1	610062	REc		Ciliary dyskinesia, primary, 16, 614017 (3)	12(Dnal1)
14.323	2	7	08	14q24.3	ESRRB, ESRL2, DFNB35	C	Estrogen-related receptor beta	602167	A, Fd		Deafness, autosomal recessive 35, 608565 (3)	12(Estrrb)
14.324	4	20	10	14q24.3	FLVCR2, C14orf58, CCT, PVHH, EPV	P	Feline leukemia virus subgroup C receptor 2	610865	REc		Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)	12(Flvcr2)
14.325	6	5	92	14q24.3	FOS	C	FBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS)	164810	REa, A			12(Fos)
14.326	10	14	09	14q24.3	GLC3C	P	Glaucoma 3, primary congenital, C	613085	Fd	between D14S61 and D14S1000	Glaucoma 3, primary congenital, C (2)	
14.327	6	15	99	14q24.3	GSTZ1, MAAI	P	Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase)	603758	A, R		Tyrosinemia, type Ib (1)	
14.328	8	3	11	14q24.3	IFT43, C14orf179, CED3	P	Intraflagellar transport 43, Chlamydomonas, homolog of	614068	REc		Cranioectodermal dysplasia 3, 614099 (3)	
14.329	5	19	15	14q24.3	ISCA2, MMDS4	P	Iron-sulfur cluster assembly 2, S. cerevisiae, homolog of	615317	REc		Multiple mitochondrial dysfunctions syndrome 4, 616370 (3)	
14.330	3	31	09	14q24.3	ISM2, THSD3, TAIL1	P	Isthmin 2, zebrafish, homolog of	612684	REc			
14.331	7	24	13	14q24.3	JDP2	P	JUN dimerization protein 2	608657	REc			
14.332	5	9	12	14q24.3	KTCN8	P	Keratoconus 8	614628	Fd	between rs1074501 and rs755212	Keratoconus 8 (2)	
14.333	10	28	08	14q24.3	MUSTQTL1	P	Muscle strength quantitative trait locus 1	612083	Fd		Muscle strength quantitative trait locus 1 (2)	
14.334	3	31	03	14q24.3	NPC2, HE1	C	Epididymal secretory protein HE1	601015	REc, R		Niemann-pick disease, type C2, 607625 (3)	
14.335	6	22	14	14q24.3	MLH3, HNPCC7	C	Mismatch repair gene MLH3	604395	A		Colorectal cancer, somatic, 114500 (3); Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3); {Endometrial cancer, susceptibility to}, 608089 (3)	12(Mlh3)
14.336	12	23	05	14q24.3	NEK9, NERCC1	P	Never in mitosis gene A-related kinase 9	609798	REc			
14.337	6	15	99	14q24.2-q24.3	NUMB, S171	P	Numb, Drosophila, homolog of	603728	REn			
14.338	3	7	14	14q24.3	PNMA1, MA1	P	Paraneoplastic MA antigen 1	604010	REc			
14.339	11	10	10	14q24.3	POMT2, MDDGA2, MDDGB2, MDDGC2	C	Putative protein O-mannosyltransferase 2	607439	REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	
14.340	3	14	13	14q24.3	PROX2	P	Prospero-related homeobox 2	615094	REc, H			12(Prox2)
14.341	2	14	11	14q24.2	PSEN1, AD3	C	Presenilin 1	104311	Fd		Alzheimer disease, type 3, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3); Dementia, frontotemporal, 600274 (3); Pick disease, 172700 (3); Cardiomyopathy, dilated, 1U, 613694 (3); Acne inversa, familial, 3, 613737 (3)	
14.342	8	18	99	14q24.2	RGS6	P	Regulator of G protein signaling 6	603894	REa, R			
14.343	6	13	12	14q24.3	SKIIP, SKIP, SNW1, BX42	P	SKI-interacting protein	603055	REc			
14.344	12	21	09	14q24.3	SLIRP, C14orf156	P	SRA stem loop-interacting RNA-binding protein	610211	REc			
14.345	11	19	11	14q24.3	SYNDIG1L, TMEM90A, CAPUCIN	P	Synapse differentiation-induced gene 1-like	609999	REc			12(Capucin)
14.346	7	15	14	14q24.3	TTLL5, STAMP, KIAA0998, CORD19	P	Tubulin tyrosine ligase-like family, member 5	612268	REc		Cone-rod dystrophy 19, 615860 (3)	
14.347	5	23	06	14q24.3	TMED10, TMP21	P	Transmembrane p24 trafficking protein 10	605406	Fd			
14.348	3	14	13	14q24.3	VIPAS39, VIPAR, SPE39, C14orf133	P	VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog	613401	REc		Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	
14.349	5	6	98	14q22.3	UBE2L1, UBCL, UBC4	P	Ubiquitin-conjugating enzyme E2L 1	600012	Psh, A			
14.350	5	19	09	14q31.3-q32.1	FOXN3, CHES1	P	Forkhead box N3	602628	Fd			
14.351	12	9	98	14q24.3-q31	IDDM11	P	Insulin-dependent diabetes mellitus-11	601208	Fd		{Diabetes mellitus, insulin-dependent, 11} (2)	
14.352	12	17	95	14q24.2	MAP3K9, MLK1	P	Mitogen-activated protein kinase kinase kinase 9	600136	REa, A			
14.353	11	17	10	14q24.3	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	P	Serine palmitoyltransferase, long-chain base subunit 2	605713	REc, R		Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	12(Sptlc2)
14.354	11	5	08	14q24.2	DPF3, CERD4	P	D4, zinc and double PHD fingers, family 3	601672	A			
14.355	10	4	02	14q24.3-q31.1	NRXN3	C	Neurexin 3	600567	REc			
14.356	11	1	13	14q32.13	DICER1, HERNA, KIAA0928, MNG1, RMSE2	P	Dicer, Drosophila, homolog of, 1	606241	REa, R		Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3); Rhabdomyosarcoma, embryonal, 2, 180295 (3)	
14.357	5	1	02	14q31.3	GALC	C	Galactosylceraminidase	606890	REa, A, H, Fd		Krabbe disease, 245200 (3)	12(tw)
14.358	10	14	09	14q31	GRD1	P	Graves disease, susceptibility to, 1	275000	Fd	associated with rs2268458	{Graves disease, susceptibility to, 1} (2)	
14.359	9	2	96	14q32.11	GPR68, OGR1	P	G protein-coupled receptor 68	601404	Psh, A			
14.360	8	25	11	14q31	HPPD	P	Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	Fd		Hypertelorism, preauricular sinus, punctal pits, and deafness (2)	
14.361	4	24	01	14q31.3	KCNK10, TREK2	P	Potassium channel, subfamily K, member 10	605873	REc			
14.362	2	18	98	14q31.1	SEL1L	C	Suppressor of lin 12 (sel-1), C. elegans, homolog of	602329	Psh, A, R			
14.363	2	21	06	14q31.1	TSHR, CHNG1	C	Thyroid-stimulating hormone receptor	603372	REa, Fd, A, R		Hypothyroidism, congenital, nongoitrous, 1 275200 (3); Thyroid adenoma, hyperfunctioning, somatic (3); Hyperthyroidism, nonautoimmune, 609152 (3); Thyroid carcinoma with thyrotoxicosis (3); Hyperthyroidism, familial gestational, 603373 (3)	12(Tshr)
14.364	10	24	00	14q32.11	RPS6KA5, MSK1	P	Ribosomal protein S6 kinase, 90kD, 5	603607	R			
14.365	12	11	02	14q32.11	TDP1	C	Tyrosyl-DNA phosphodiesterase 1	607198	REc, Fd		Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)	
14.366	2	21	10	14q32.12	TRIP11, TRIP230, CEV14, ACG1A	C	Thyroid hormone receptor interactor 11	604505	REa, A		Achondrogenesis, type IA, 200600 (3)	
14.367	3	9	00	14q31.3	GPR65, TDAG8	P	G protein-coupled receptor 65	604620	A			
14.368	4	16	10	14q32.13	SERPINA4, KST, PI4	P	Serpin peptidase inhibitor, clade A, member 4	147935	REa, A	in cluster with related AAT, AACT, CBG, PCI		
14.369	10	2	12	14q31.1	GTF2A1, TF2A1	P	General transcription factor IIA, alpha/beta subunits	600520	REc			
14.370	8	8	13	14q31.1	STON2, STN2, STNB	P	Stonin 2	608467	REc, R			
14.371	6	19	12	14q31.3	PTPN21, PTPD1	P	Protein-tyrosine phosphatase, nonreceptor-type, 21	603271	REc			
14.372	1	3	13	14q31.3	SPATA7, HSD3, LCA3	C	Spermatogenesis-associated protein 7	609868	REc		Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)	
14.373	3	15	10	14q31.3	ZC3H14, SUT2	P	Zinc finger CCCH domain-containing protein 14	613279	REc			
14.374	2	21	03	14q32.32	AMN	C	Amnionless, mouse, homolog of	605799	REc, Fd		Megaloblastic anemia-1, Norwegian type, 261100 (3)	12(Amn)
14.375	6	15	99	14q32.2	CCNK	P	Cyclin K	603544	A			
14.376	12	4	03	14q32	CHDS4	P	Coronary heart disease, susceptibility to, 4	608318	Fd	highest LOD with D14S1426	{Coronary heart disease, susceptibility to, 4} (2)	
14.377	12	24	89	14q32.12	CHGA	C	Chromogranin A, parathyroid secretory protein-1	118910	REa, A			12(Chga)
14.378	11	19	13	14q32.33	CKB, CKBB, BCK	C	Creatine kinase, brain type	123280	S, REa, Fd	distal to PI and AACT; closely linked to AKT1 and IGH; proximal to IGH		
14.379	10	23	87	14q32	CKBE	P	Creatine kinase, ectopic expression	123270	F	linked to IGH, PI; ?same locus as CKBB	[Creatine kinase, brain type, ectopic expression of] (2)	
14.380	8	30	01	14q32.12	DDX24	P	DEAD/H box 24	606181	R			
14.381	5	25	00	14q32.31	DIO3, TXDI3	P	Deiodinase, iodothyronine, type 3	601038	A			12(Dio3)
14.382	3	15	04	14q32.31	DIO3OS	P	Deiodinase, iodothyronine, type 3, opposite strand	608523	REc			12(Dio3os)
14.383	5	2	01	14q32.2	DLK1, PREF1, FA1	P	Delta, Drosophila, homolog-like 1	176290	A			
14.384	10	21	15	14q32	DUP14q32, C14DUPq32	P	Chromosome 14q32 duplication syndrome, 700kB	616604	Ch	heterozygous germline duplication of 700kb	{Myeloproliferative neoplasms, familial, susceptibility to} (4)	
14.385	10	28	14	14q32.31	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	C	Dynein, cytoplasmic-1, heavy chain-1	600112	REa, H, REc, Fd		Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3); Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	14(Dnecl)
14.386	2	15	02	14q32.2	EML1, EMAPL, EMAP	P	Echinoderm microtubule associated protein like 1	602033	REn, REc			
14.387	9	7	04	14q32	GEVQ1	P	Gene expression, variation in, quantitative trait locus on chromosome 14	608875	Fd		{Gene expression, variation in, QTL} (2)	
14.388	3	20	16	14q32.13	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	C	Glutaredoxin 5	609588	REc, H		Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3); Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	
14.389	1	28	02	14q32	HFM	P	Hemifacial microsomia	164210	Fd		Hemifacial microsomia (2)	
14.390	12	17	95	14q32.12	IFI27	P	Interferon, alpha-inducible protein-27	600009	A			
14.391	2	4	02	14q32.33	JAG2	P	Jagged 2	602570	A			12(Jag2)
14.392	1	4	16	14q32	KAOGS	P	Kagami-Ogata syndrome	608149	Ch	uniparental isodisomy of imprinted region of chromosome 14	Kagami-Ogata syndrome (4)	
14.393	7	25	06	14q32	MCOP1	P	Microphthalmia, isolated 1	251600	Fd		Microphthalmia, isolated 1 (2)	
14.394	11	22	10	14q32.2-q32.3	MEG8	P	Maternally expressed gene 8	613648	REc			
14.395	11	22	10	14q32.31	MIR380, MIRN380	P	Micro RNA 380	613654	REc, H			12(Mir380)
14.396	8	27	01	14q32.31	RAGE, MOK	P	Renal tumor antigen	605762	REc			
14.397	3	6	14	14q32.13	SERPINA9, GCET1, CENTERIN	P	Serpin peptidase inhibitor, clade A, member 9	615677	REc			
14.398	3	24	14	14q32.31	SNORD114-1	P	Small nucleolar RNA, C/D box, 114-1	613651	REc			
14.399	2	17	15	14q32	TEMPS	P	Temple syndrome (maternal uniparental disomy chromosome 14)	616222	Ch		Temple syndrome (4)	
14.400	4	10	14	14q32.2	TUNAR, TUNA, LINC00617	P	TCL1 upstream neural differentiation-associated RNA	615719	REc			
14.401	11	20	98	14q32.32	TNFAIP2	P	Tumor necrosis factor, alpha-induced protein-2	603300	Psh, A			
14.402	9	20	14	14q32.12	SLC24A4, NCKX4, SHEP6, AI2A5	C	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4	609840	REc		[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3); [Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3); Amelogenesis imperfecta, type IIA5, 615887 (3)	
14.403	2	22	13	14q32.2	SLC25A29, CACL, ORNT3	P	Solute carrier family 25 (carnitine/acylcarnitine translocase), member 29	615064	REc			
14.404	11	22	10	14q32.2	SNORD112	P	Small nucleolar, C/D box, 112	613649	REc	located in an intron of MEG8		
14.405	11	22	10	14q32.31	SNORD113-1	P	Small nucleolar RNA, C/D box, 113-1	613650	REc			
14.406	11	3	09	14q32.2	VRK1, PCH1A	P	Vaccinia-related kinase-1	602168	R		Pontocerebellar hypoplasia type 1A, 607596 (3)	
14.407	12	14	01	14q32.2	BCL11B, CTIP2	P	C-cell CLL/lymphoma 11B	606558	REc			
14.408	9	8	06	14q32.12	BTBD7, FUP1	P	BTB/POX domain-containing protein 7	610386	R, REc			
14.409	10	4	07	14q32.13	CBG, SERPINA6	C	Corticosteroid-binding globulin	122500	A, REn		Corticosteroid-binding globulin deficiency, 611489 (3)	
14.410	3	5	03	14q32.2	CYP46A1, CYP46	P	Cytochrome P450, family 46, subfamily A, polypeptide 1 (cholesterol 24-hydroxylase)	604087	A, R			
14.411	12	22	15	14q32.12	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	C	Fibulin 5	604580	A		Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa, autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3); Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	
14.412	4	10	14	14q32.13	GSC, SAMS	P	Goosecoid	138890	REa, A		Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3)	12(Gsc)
14.413	1	23	02	14q32.12	LGMN, PRSC1	P	Legumain (protease, cysteine, 1)	602620	A			
14.414	12	5	13	14q32.1	SERPINA2P, PIL, ATR, ARGS	P	Serpin peptidase inhibitor, clade A, member 2, pseudogene	107410	REn	?pseudogene		
14.415	8	17	10	14q32.13	SERPINA1, PI, AAT	C	Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)	107400	F, S, A, D, EM, Fd		Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due to AAT deficiency, 613490 (3); Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)	12(Aat)
14.416	1	8	00	14q32.13	SERPINA3, AACT, ACT	C	Alpha-1-antichymotrypsin	107280	REa, A, Fd, REn	220kb from PI	Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular disease, occlusive (3)	
14.417	4	16	10	14q32.13	SERPNA5, PCI	C	Serpin peptidase inhibitor, clade A, member 5 (protein C inhibitor)	601841	Psh, REn			
14.418	6	17	15	14q32.13	SERPINA10, ZPI	P	Serine (or cysteine) proteinase inhibitor, clade A, member 10 (protein Z-dependent protease inhibitor precursor)	605271	REc			
14.419	12	21	98	14q32.13	TCL1A, TCL1	C	T-cell lymphoma/leukemia 1A	186960	Ch, RE		Leukemia/lymphoma, T-cell (2)	
14.420	12	13	00	14q32.13	TCL1B, TML1	P	T-cell lymphoma/leukemia 1B	603769	Psh		Leukemia/lymphoma, T-cell (2)	
14.421	9	9	08	14q32.13	TCL6, TNG1, TNG2	P	T-cell leukemia/lymphoma 6	604412	REc			
14.422	10	16	14	14q31.3	TTC8, BBS8, RP51	P	Tetratricopeptide repeat domain 8	608132	REc	mutation identified in 1 RP51 family	Bardet-Biedl syndrome 8, 615985 (3); ?Retinitis pigmentosa 51, 613464 (3)	
14.423	2	11	96	14q32.2	BDKRB1	P	Bradykinin receptor B1	600337	A			
14.424	2	11	96	14q32.2	BDKRB2	C	Bradykinin receptor B2	113503	Psh, A			
14.425	3	16	01	14q32.2	PAPOLA, PAP	P	Poly(A) polymerase	605553	A, R			
14.426	10	12	14	14q32.11-q32.12	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	P	Coiled-coil domain-containing protein 88C	611204	REc, R	mutation identified in 1 SCA40 family	Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3); ?Spinocerebellar ataxia 40, 616053 (3)	
14.427	2	1	11	14q32.11	PSMC1, S4	P	Proteasome 26S subunit, ATPase, 1	602706	REc	previously assigned to 19p13.3 by FISH		12(Psmc1)
14.428	4	30	12	14q32.12	ASB2	P	Ankyrin repeat-containing SOCS box protein 2	605759	R, REc			12(Asb2)
14.429	2	7	14	14q32.12	ATXN3, MJD, SCA3	C	Ataxin-3 (josephin)	607047	Fd, REc		Machado-Joseph disease, 109150 (3)	
14.430	3	28	11	14q32.12	CATSPERB, C14orf161	P	Cation channel, sperm-associated, beta	611169	REc			
14.431	3	10	16	14q32.12	COX8C	P	Cytochrome c oxidase, subunit 8c	616855	REc			12(Cox8c)
14.432	4	2	16	14q32.12	IFI27L2, FAM14A, ISG12B	P	Interferon alpha inducible protein 27 like 2	611319	REc			
14.433	8	18	14	14q32.12	ITPK1, ITRPK1	P	Inositol 1,3,4-trisphosphate 5/6-kinase	601838	REc			
14.434	3	7	14	14q32.12	MOAP1, MAP1, PNMA4	P	Modulator of apoptosis 1	609485	REc			
14.435	5	25	13	14q32.12	NDUFB1	P	NADH-ubiquinone oxidoreductase 1 beta subcomplex, 1	603837	REc			
14.436	6	5	08	14q32.12	OTUB2, OTU2, OTB2, C14orf137	P	OTU domain-containing ubiquitin aldehyde-binding protein 2	608338	REc			
14.437	3	31	11	14q32.12	PRIMA1, PRIMA	P	Proline-rich membrane anchor 1	613851	REc			
14.438	2	6	16	14q32.12	PPP4R3A, SMEK1, PP4R3A, KIAA2010	P	Protein phosphatase 4, regulatory subunit 3, alpha	610351	REc, R			
14.439	4	15	11	14q32.12	UBR7	P	Ubiquitin protein ligase E3 component N-recognin 7	613816	REc			
14.440	3	30	16	14q32.12	UNC79	P	Unc79, C. elegans, homolog of	616884	REc			12(Unc79)
14.441	9	10	07	14q32.13	CLMN, KIAA1188	P	Calmin	611121	R, REc			
14.442	2	5	16	14q32.12-q32.13	PPP4R4, PP4R4, KIAA1622	P	Protein phosphatase 4, regulatory subunit 4	616790	REc			
14.443	11	13	07	14q32.13	SYNE3, C14orf49	P	Spectrin repeat-containing nuclear envelope protein 3 (nesprin 3)	610861	REc			12(C14orf49)
14.444	11	19	11	14q32.13-q32.2	MRT32	P	Mental retardation, autosomal recessive 32	614339	Fd	between rs763357 and rs1956859	Mental retardation, autosomal recessive 32 (2)	
14.445	8	19	13	14q32.2	AK7	P	Adenylate kinase 7	615364	REc			
14.446	2	17	15	14q32.2	ATG2B	P	Autophagy 2, S. cerevisiae, homolog of, B	616226	REc			
14.447	7	18	14	14q32.2	DEGS2, DES2	P	Delta(4)-desaturase, sphingolipid, 2	610862	R, REc			
14.448	4	21	16	14q32.2	EVL	P	ENAH/VASP-like protein	616912	REc			
14.449	10	20	15	14q32.2	GSKIP, C14orf129	P	GSK3B-interacting protein	616605	REc			
14.450	9	8	08	14q32.31	HSP90AA1, HSPCA, HSPC1, HSP90A, HSP89A, HSPCAL4, LAP2	C	Heat-shock protein, 90kD, alpha, class A, member 1	140571	REa			
14.451	3	17	08	14q32.2	RTL1, PEG11	P	Retrotransposon-like gene 1	611896	REn, H			12(Rtl1)
14.452	3	7	14	14q32.2	SETD3	P	SET domain-containing protein 3	615671	REc			
14.453	3	15	13	14q32.33	AKT1, CWS6	C	Murine thymoma viral (v-akt) oncogene homolog-1	164730	REa, A	proximal to IGH	Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Ovarian cancer, somatic, 167000 (3); {Schizophrenia, susceptibility to}, 181500 (2); Proteus syndrome, somatic, 176920 (3); Cowden syndrome 6, 615109 (3)	12(Akt)
14.454	7	1	11	14q32.32	CDC42BPB, MRCKB	P	CDC42-bindingn protein kinase, beta	614062	R, A			
14.455	6	15	99	14q32.33	CRIP2, CRP2	C	Cysteine-rich intestinal protein 2	601183	A, REa			
14.456	5	25	10	14q32.32	EIF5	P	Eukaryotic translation initiation factor 5	601710	REc			
14.457	2	7	05	14q32.33	GPR132, G2A	P	G protein-coupled receptor-132	606167	A			
14.458	3	9	07	14q32.33	KLC1, KNS2, KNS2A	C	Kinesin, light chain 1	600025	REa, A			
14.459	6	10	98	14q32.32-q32.33	MARK3	P	MAP/microtubule affinity-regulating kinase-3	602678	A			
14.460	1	12	05	14q32.2	MEG3, GTL2	C	Maternally expressed gene 3	605636	REc, REn	100kb from DLK1		
14.461	5	22	03	14q32.33	MTA1	P	Metastasis-associated gene 1	603526	A			12(Mta1)
14.462	5	12	11	14q32.33	XRCC3, CMM6	P	X-ray-repair, complementing defective, repair in Chinese hamster cells-3	600675	REa, A		{Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer, susceptibility to}, 114480 (3)	
14.463	4	20	10	14q32.31	CINP	P	CDK2-interacting protein	613362	REc			
14.464	10	10	14	14q32.2	HDMCP, C14orf68	P	Hepatocellular carcinoma-downregulated mitochondrial carrier protein	609911	REc, H			12(Hdmcp)
14.465	3	23	09	14q32.2	MIR127, MIRN127	P	Micro RNA 127	611709	R			
14.466	3	23	09	14q32.31	MIR134	P	Micro RNA 134	610164	REc			
14.467	3	23	09	14q32.2	MIR136, MIRN136	P	Micro RNA 136	611710	R			
14.468	6	22	14	14q32.31	MIR376C, MIR368	P	Micro RNA 368C	610983	REc			
14.469	7	1	11	14q32.31	MIR369, MIR369-3, MIRN369-3	P	Micro RNA 369	611794	REc			
14.470	1	24	09	14q32.31	MIR370, MIRN370	P	Micro RNA 370	612553	REc			
14.471	3	23	09	14q32.31	MIR376A-1, MIRN376A-1	P	Micro RNA 376A-1	610959	R			
14.472	3	23	09	14q32.31	MIR376A-2, MIRN376A-2	P	Micro RNA 376A-2	610960	R			
14.473	3	23	09	14q32.31	MIR376B, MIRN376B	P	Micro RNA 376b	610961	R			
14.474	5	19	15	14q32.31	MIR379	P	Micro RNA 379	616358	REc			12(Mir379)
14.475	7	1	11	14q32.31	MIR409, MIRN409	P	Micro RNA 409	614057	REc			
14.476	1	29	13	14q32.31	MIR410	P	Micro RNA 410	615036	REc			
14.477	3	23	09	14q32.2	MIR431, MIRN431	P	Micro RNA 431	611708	R			
14.478	3	23	09	14q32.2	MIR433, MIRN433	P	Micro RNA 433	611711	R			
14.479	9	9	13	14q32.31	MIR485	P	Micro RNA 485	615385	REc			
14.480	1	29	13	14q32.31	MIR487B	P	Micro RNA 487B	615037	REc			
14.481	10	12	14	14q32.31	MIR494	P	Micro RNA 494	616036	REc			
14.482	4	8	13	14q32.31	MIR551A	P	Micro RNA 495	615149	REc			
14.483	5	19	15	14q32.31	MIR656	P	Micro RNA 656	616376	REc			
14.484	6	4	97	14q32.31	PPP2R5C	P	Protein phosphatase-2, regulatory subunit B (B56), gamma isoform	601645	A	pseudogene on 3p21		
14.485	1	29	13	14q32.31	TECPR2, KIAA0329, SPG49	P	Tectonin beta-propeller repeat-containing protein 2	615000	REc, R		Spastic paraplegia 49, autosomal recessive, 615031 (3)	
14.486	9	26	96	14q32.2	WARS	C	Tryptophanyl-tRNA synthetase	191050	S, A, Fd			
14.487	8	31	15	14q32.32	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	P	TNF receptor-associated factor 3	601896	REc	mutation identified in 1 IIAE5 patient	{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	
14.488	12	22	08	14q32.33	ADSL1	P	Adenylosuccinate synthase-like 1	612498	REc			
14.489	10	12	14	14q32.33	APOPT1, APOP	P	Apoptogenic protein 1, mitochondrial	616003	REc		Mitochondrial complex IV deficiency, 220110 (3)	12(Apopt1)
14.490	2	3	15	14q32.33	BRF1, TAF3C, GTF3B, TF3B90, CFDS	P	BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C)	604902	R, REc		Cerebellofaciodental syndrome, 616202 (3)	
14.491	9	24	08	14q32.33	CDCA4, HEPP	P	Cell division cycle-associated protein 4	612270	REc			
14.492	11	15	05	14q32.33	CRIP1, CRIP	P	Cysteine-rich intestinal protein 1	123875	Psh, R, H	previously assigned to 7q11.23		12(Crip)
14.493	3	9	00	14q32.33	C14orf2, MP68	P	MP68, rat, homolog of	604573	R			
14.494	4	8	08	14q32.33	IGHD@	C	Immunoglobulin heavy chain diversity gene cluster	146910	RE, REa, A	many genes		
14.495	10	23	87	14q32.33	IGHA1	C	Constant region of heavy chain of IgA1	146900	REa, A	Fused with IRTA1 in multiple myeloma		
14.496	10	23	87	14q32.33	IGHA2	C	Constant region of heavy chain of IgA2	147000	REa, A			
14.497	4	30	91	14q32.33	IGHD	C	Constant region of heavy chain of IgD	147170	REa, A, Fd			
14.498	4	8	08	14q32.33	IGHD3-3, DXP4	P	Immunoglobulin heavy chain diversity gene 3-3	611937	REn			
14.499	10	23	87	14q32.33	IGHE	C	Constant region of heavy chain of IgE	147180	REa, A	pseudogene IGHEP1 nearby; IGHEP2 on chr.9		
14.500	10	23	87	14q32.33	IGHG1	C	Constant region of heavy chain of IgG1	147100	REa, A			
14.501	4	8	98	14q32.33	IGHG2	C	Constant region of heavy chain of IgG2	147110	REa, A	5'-G2-17kb-G4-3'; closeness of IGG3 and IGG1 known from Lepore-like myeloma protein	IgG2 deficiency, selective (3)	
14.502	4	30	91	14q32.33	IGHG3	C	Constant region of heavy chain of IgG3	147120	REa, A, Fd			
14.503	10	23	87	14q32.33	IGHG4	C	Constant region of heavy chain of IgG4	147130	REa, A			
14.504	4	15	08	14q32.33	IGHJ@	C	Immunoglobulin heavy chain joining gene cluster	147010	RE, REa, A	more than 4 genes		
14.505	8	10	10	14q32.33	IGHM, MU, AGM1	C	Constant region of heavy chain of IgM	147020	REa, A		Agammaglobulinemia 1, 601495 (3)	
14.506	9	15	89	14q32.33	IGHR	L	Immunoglobulin heavy chain regulator	144120	F		?Hyperimmunoglobulin G1 syndrome (2)	
14.507	4	15	08	14q32.33	IGHV@	C	Immunoglobin heavy polypeptide, variable gene cluster	147070	REa, RE, A	~250 genes; orientation: cen-PI-D14S1-IGH-IGHV--qter; 3' centromeric, 5' telomeric; IgM telomeric to IgG		
14.508	2	21	10	14q32.33	KIF26A, KIAA1236	P	Kinesin family member 26A	613231	R, REc			
14.509	4	15	08	14q32.33	IGHV3-23, IGHV323, DP47, VH26	P	Immunoglobulin heavy chain variable gene 3-23	611939	REn			
14.510	1	30	12	14q32.33	INF2, FSGS5, C14orf173, CMTDIE	P	Inverted formin 2	610982	REc		Glomerulosclerosis, focal segmental, 5, 613237 (3); Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	
14.511	10	28	15	14q32.33	KIAA0125, FAM30A, C14orf110	P	KIAA0125 gene, noncoding	616623	Psh, REc			
14.512	3	23	09	14q32.33	MIR203, MIRN203	P	Micro RNA 203	611899	REc			
14.513	5	24	13	14q32.33	PACS2, KIAA0602	C	Phosphofurin acidic cluster sorting protein 2	610423	R, REc			
14.514	2	25	15	14q32.33	ZBTB42, ZNF925, LCCS6	P	Zinc finger- and BTB domain-containing protein 42	613915	REc	mutation identified in 1 LCCS6 family	?Lethal congenital contracture syndrome 6, 616248 (3)	
14.515	12	15	10	14q32.33	ZFYVE21, ZF21	P	Zinc finger FYVE domain-containing protein 21	613504	REc			
14.516	10	23	87	Chr.14	LCH	C	Lentil agglutinin-binding	151020	S			
14.517	5	12	00	14q22.1	MAP4K5, MAPKKKK5	P	Mitogen-activated protein kinase kinase kinase kinase-5	604923	R			
14.518	9	3	02	14q12	NFATC4	P	Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4	602699	R			
14.519	11	21	02	14q22.1	NID2	P	Nidogen 2	605399	H			14(Nid2)
14.520	1	27	04	Chr.14	PHOBS	P	Phobia, specific	608251	Fd		Phobia, specific (2)	
14.521	9	20	00	14q21.1	PNN, DRS	P	Pinin	603154	R			
14.522	10	21	15	Chr.14	RC14S	P	Ring chromosome 14 syndrome	616606	Ch		Ring chromosome 14 syndrome (4)	
14.523	4	4	03	14q32.31-q32.32	RCOR, COREST, KIAA0071	P	REST corepressor	607675	R			
14.524	1	28	02	14q21.3	RPL36AL, RPL36A	P	Ribosomal protein L36a-like	180469	Psh			
15.1	4	26	90	15p12	RNR3	C	Ribosomal RNA-3	180452	A			
15.2	9	28	00	15q25.2	AP3B2, NAPTB	L	Adaptor-related protein complex 3, beta 2 subunit	602166	H			7(Naptb)
15.3	11	16	98	15q13.1	APBA2	P	Amyloid beta A4 precursor protein-binding, family A, member 2	602712	R			7(Apba2)
15.4	2	1	00	15q	HYT2	P	Hypertension, essential, susceptibility to, 2	604329	Fd		{Hypertension, essential, susceptibility to, 2}, 145500 (2)	
15.5	5	24	01	15q	LCS1, CHLS	P	Cholestasis-lymphedema syndrome	214900	Fd, HZ		Cholestasis-lymphedema syndrome (2)	
15.6	1	13	99	15q21.3	NEDD4	P	Neural precursor cell expressed, developmentally downregulated-4	602278	H, A			
15.7	10	20	99	15q22.31	RPL4	P	Ribosomal protein L4	180479	REa, R			
15.8	1	13	09	15q25.2	RPS17, RPS17L1, RPS17L2, DBA4	P	Ribosomal protein S17	180472	Psh, R	previously on chr.11; pseudogenes on 5q33-qter and 17q	Diamond-Blackfan anemia 4, 612527 (3)	
15.9	5	16	07	15q11	AUTS4	P	Autism, susceptibility to, 4	608636	Ch		{Autism susceptibility 4} (2)	
15.10	11	15	08	15q11.2	CYFIP1, KIAA0068	P	Cytoplasmic FMRP interacting protein 1	606322	R, REc			
15.11	7	17	91	15q11-q12	IGHDY2	P	Immunoglobulin heavy chain diversity region-2	146990	A	?functional		
15.12	10	23	87	15q11-q12	MIC7	P	Attached cell antigen 28.3.7	108990	S			
15.13	6	5	03	15q12	ATP10A, ATP10C, ATPVC	C	ATPase, class V, type 10A	605855	R, REc, D			
15.14	4	4	06	15q11-q13	CELIAC5, GSES	P	Celiac disease, susceptibility to, 5	607202	Fd	in homogeneous Finnish population	{Celiac disease, susceptibility to, 5} (2)	
15.15	11	28	05	15q11-q13	GLC1I	P	Glaucoma 1, open angle, I	609745	Fd	max lod at GABRB3	Glaucoma 1, open angle, I (2)	
15.16	11	8	96	15q11.2	IPW	P	Imprinted in Prader-Willi syndrome	601491	REc			
15.17	1	25	93	15q24.2	MAN2C1, MANA	C	Mannosidase, alpha, class 2C, member 1	154580	S, D			
15.18	8	1	13	15q11.2	MKRN3, ZFP127, ZNF127, CPPB2	P	Makorin 3	603856	REc	expressed only from paternal allele	Precocious puberty, central, 2, 615346 (3)	7(Znf127)
15.19	11	3	99	15q11-q13	MRKN3AS, ZNF127AS	P	MKRN3 antisense RNA	603857	REc			
15.20	4	5	00	15q11.2	NDN	C	Necdin	602117	A, Psh, REc		Prader-Willi syndrome, 176270 (3)	7(Ndn)
15.21	11	13	94	15q11.2	D15S227E, PAR1	P	Prader-Willi/Angelman region-1	600161	REn	paternally imprinted		
15.22	11	13	94	15q11.2	D15S226E, PAR5	P	Prader-Willi/Angelman syndrome-5	600162	REn	paternally imprinted		
15.23	2	20	97	15q11.2	UBE3A, ANCR	C	Ubiquitin protein ligase E3A	601623	Ch, D, REc	same location as PWS	Angelman syndrome, 105830 (3)	
15.24	6	6	12	15q13.3	SCG5, SGNE1	P	Secretogranin V (7B2 protein )	173120	A			2(Sgne1)
15.25	5	3	10	15q11-q21.1	RCHTS	L	Roifman-Chitayat syndrome	613328	Fd	?1p36.23-p33	?Roifman-Chitayat syndrome (2)	
15.26	10	29	91	15q11-q22	MIC12	P	Antigen identified by monoclonal antibody 30.2A8	107254	S	in myoblasts, but not myotubes		
15.27	7	5	92	15q11-qter	HCVS	P	Human coronavirus sensitivity	122460	S			
15.28	5	2	01	15q15.1	EHD4	P	EH domain-containing 4	605892	R			
15.29	4	27	12	15q11.2	NIPA1, SPG6	C	Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 1	608145	Fd, REc		Spastic paraplegia 6, autosomal dominant, 600363 (3)	7(Nipa1)
15.30	3	7	14	15q11.2	DEL15q11.2, C15DELq11.2	P	Chromosome 15q11.2 deletion syndrome	615656	Ch	deleted region spans 300-500kb beteen BP1 and BP2	Chromosome 15q11.2 deletion syndrome (4)	
15.31	4	7	15	15q11.2	MAGEL2, NDNL1, SHFYNG	P	MAGE-like 2	605283	REc		Schaaf-Yang syndrome, 615547 (3)	7(Magel2)
15.32	7	21	14	15q11.2	NBEAP1, BCL8	P	Neurobeachin pseudogene 1	601889	REc, A			
15.33	4	25	06	15q11.2	NIPA2	C	Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 2	608146	REc, H			7(Nipa2)
15.34	5	26	13	15q11.2	PWRN1	P	Prader-Willi region noncoding RNA 1	611215	REc			
15.35	5	26	13	15q11.2	PWRN2	P	Prader-Willi region noncoding RNA 2	611217	REc			
15.36	3	23	15	15q11.2	SNHG14, LNCAT, UBE3AATS	P	Small nucleolar RNA host gene 14	616259	REc, H			7(Snhg14)
15.37	3	16	10	15q11.2	SNORD115-1, RNHBII52	C	Small nucleolar RNA, C/D box, 115-1	609837	REn, REc			
15.38	3	16	10	15q11.2	SNORD116-1, PWCR1	P	Small nucleolar RNA, C/D box, 116-1	605436	REc			
15.39	11	21	03	15q11.2	TUBGCP5, GCP5, KIAA1899	C	Tubulin-gamma complex-associated protein 5	608147	REc, H			7(Gcp5)
15.40	9	10	14	15q12	GABRB3, ECA5	C	Gamma-aminobutyric acid (GABA) A receptor, beta-3	137192	A, H, D, REn		{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3)	7(Gabrb3)
15.41	1	9	95	15q12	GABRA5	C	Gamma-aminobutyric acid (GABA) A receptor, alpha-5	137142	A, REa, REb, D, REn	100kb from GABRB3		7(Gabra5)
15.42	1	9	95	15q12	GABRG3	P	Gamma-aminobutyric acid (GABA) A receptor, gamma-3	600233	REn	cen--G3--A5--B3		
15.43	4	18	05	15q11.2-q12	MGR7	P	Migraine with aura, susceptibility to, 7	609179	Fd	between D15S113 and D15S1019	{Migraine with aura, susceptibility to, 7} (2)	
15.44	1	17	08	15q12-q13	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	C	Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)	611409	D, REa, Fd	?hypopigmentation in PWS and AS	Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	7(p)
15.45	8	21	07	15q12	HPC7	P	Prostate cancer, hereditary, 7	610321	Fd		{Prostate cancer, hereditary, 7} (2)	
15.46	12	14	10	15q13.3	KLF13, RFLAT1, FKLF2	P	Kruppel-like factor 13	605328	REc			
15.47	6	15	12	15q11.2	NPAP1, C15orf2	P	Nuclear pore associated protein 1	610922	REc			
15.48	4	5	00	15q11.2	SNRPN	P	Small nuclear ribonucleoprotein polypeptide N	182279	REa, D		Prader-Willi syndrome, 176270 (3)	7(Snrpn)
15.49	7	25	06	15q12-q15	MCOPCB2	P	Microphthalmia, isolated, with coloboma 2	605738	Fd		Microphthalmia with coloboma 2 (2)	
15.50	2	3	16	15q15.1	MAPKBP1, JNKBP1	P	Mitogen-activated protein kinase-binding protein 1	616786	REc			
15.51	2	11	14	15q13	SRTD1, ATD1	P	Short-rib thoracic dysplasia 1 with or without polydactyly	208500	Fd		Short-rib thoracic dysplasia 1 with or without polydactyly (2)	
15.52	9	22	09	15q13	SCZD13	P	Schizophrenia 13	613025	Ch	associated with deletion at 15q13.3	{Schizophrenia, susceptibility to, 13} (2)	
15.53	2	18	96	15q13.1	TJP1	P	Tight junction protein 1 (zona occludens 1)	601009	A			7(Tjp1)
15.54	8	21	98	15q13.3	FMN, LD	C	Formin (limb deformity)	136535	REa, A, Fd, Psh			2(ld)
15.55	10	7	02	15q14	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	C	Solute carrier family 12 (potassium/chloride transporters), member 6	604878	A, R, REa, Fd		Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	
15.56	1	31	13	15q13.3	TRPM1, MLSN1, CSNB1C	P	Transient receptor potential cation channel, subfamily M, member 1 (melastatin)	603576	R		Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	7(Mlsn1)
15.57	10	23	87	15q13-q15	B2MR	C	Beta-2-microglobulin regulator	109710	D			
15.58	6	15	12	15q13.3	GREM1, CKTSF1B1	P	Gremlin 1 homolog, cystine knot superfamily	603054	Psh, R			
15.59	11	13	94	15q15.3	MAP1A, MAP1L	P	Microtubule-associated protein 1A	600178	Psh			
15.60	11	19	13	15q13.1	HERC2, SHEP1, MRT38	C	HECT domain and RCC1-like domain 2	605837	Psh, R, REc	mutations in intron 4	[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3); Mental retardation, autosomal recessive 38, 615516 (3)	
15.61	1	27	04	15q13.1	NDNL2, MAGEG1	P	Necdin-like gene 2	608243	REc, H			7(Ndnl2)
15.62	5	11	04	15q13.1-q15.1	CILD4	P	Ciliary dyskinesia, primary, 4	608646	Fd	between D15S1012 and D15S1048	Ciliary dyskinesia, primary, 4 (2)	
15.63	11	30	06	15q13.3	ARHGAP11A, KIAA0013	P	RHO GTPase-activating protein 11A	610589	Psh, REc			
15.64	4	10	15	15q13.2	ARHGAP11B, FAM7B1	P	RHO GTPase-activating protein 11B	616310	REc			
15.65	9	16	09	15q14	SPRED1, NFLS	C	Sprouty-related EVH1 domain-containing protein 1	609291	REc		Legius syndrome, 611431 (3)	2(Spred1)
15.66	9	14	12	15q13.3	FAN1, MTMR15, KIAA1018, KMIN	P	FANCD2/FANCI-associated nuclease 1	613534	REc		Interstitial nephritis, karyomegalic, 614817 (3)	
15.67	7	11	11	15q15.1	CHP	P	Calcineurin B homologous protein	606988	R, REc			
15.68	9	22	09	15q13.3	DEL15q13.3, MICRODEL15q13.3	P	Chromosome 15q13.3 microdeletion syndrome	612001	Ch		Chromosome 15q13.3 microdeletion syndrome (4)	
15.69	2	22	11	15q13.3	MIR211, MIRN211	P	Micro RNA 211	613753	REc			
15.70	10	18	11	15q15.1	NDUFAF1, CIA30, CGI65	P	NADH-ubiquinone oxidoreductase 1 alpha subcomplex, assembly factor 1	606934	REc		Mitochondrial complex I deficiency, 252010 (3)	
15.71	6	5	08	15q13.3	OTUD7A, OTUD7, C16orf15, CEZANNE2	P	OTU domain-containing protein 7A	612024	REc			
15.72	6	16	10	15q14	ACTC1, CMD1R, CMH11, ASD5, LVNC4	C	Actin, alpha, cardiac muscle	102540	REa, Fd, A		Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)	2(Actc1)
15.73	6	9	08	15q14	AGPAT7, AYTL3	P	1-acylglycerol-3-phosphate O-acyltransferase 7	612039	REc			
15.74	5	26	13	15q14	AQR, IBP160, KIAA0560	P	Aquarius, mouse, homolog of	610548	R, REc			2(Aqr)
15.75	7	9	06	15q15.1	BMF	P	BCL2-modifying factor	606266	REn			
15.76	2	13	14	15q14	C15orf41	P	Chromosome 15 open reading fram 41	615626	REc		Dyserythropoietic anemia, congenital, type Ib, 615631 (3)	
15.77	5	8	97	15q13.3	CHRNA7	C	Cholinergic receptor, nicotinic, alpha polypeptide-7	118511	A		Schizophrenia, neurophysiologic defect in (2)	7(Acra7)
15.78	11	22	13	15q15.1	CHST14, D4ST1, ATCS, EDSMC1	b	Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	608429	REc		Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	
15.79	9	22	09	15q14	EIG7, EJM2	P	Epilepsy, idiopathic generalized, susceptibility to, 7	604827	Fd	?role of CHRNA7	{Epilepsy, idiopathic generalized, susceptibility to, 7} (2); Epilepsy, juvenile myoclonic (2)	
15.80	2	25	15	15q14	EMC4, TMEM85, PIG17	P	ER membrane protein complex subunit 4	616245	REc			
15.81	1	12	15	15q14	FAM98B	P	Family with sequence similarity 98, member B	616142	REc			
15.82	6	22	14	15q14	FSIP1, HSD10	P	Fibrous sheath-interacting protein 1	615795	REc			
15.83	12	27	07	15q14	GJD2, GJA9, CX36	P	Gap junction protein, delta-2 (connexin 36)	607058	A, H			2(Gja9)
15.84	1	12	15	15q14	GOLGA8A, KIAA0855	C	Golgin A8 family, member A	616180	R, REc			
15.85	10	5	04	15q14	GOLGA8B, KIAA0855	P	Golgi autoantigen, golgin subfamily A, 8B	609619	R, REc			
15.86	2	25	15	15q14	KATNBL1, C15orf29	P	Katanin, p80 subunit, B-like 1	616235	REc			
15.87	8	29	08	15q14-q15	GPR176	P	G protein-coupled receptor 176	612183	R, REc			
15.88	4	7	16	15q14	DEL15q14, C15DELq14	P	Chromosome 15q14 deletion syndrome	616898	Ch		Chromosome 15q14 deletion syndrome (4)	
15.89	3	31	03	15q15.1	IVD	P	Isovaleryl Coenzyme A dehydrogenase	607036	REa		Isovaleric acidemia, 243500 (3)	
15.90	12	28	11	15q14	NOLA3, NOP10, DKCB1	C	Nucleolar protein family A, member 3	606471	R, Fd		Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	
15.91	11	4	93	15q13-q14	RYR3	C	Ryanodine receptor-3	180903	A, Psh			2(Ryr3)
15.92	10	16	92	15q15.1	ITPKA	P	Inositol 1,4,5-trisphosphate 3-kinase A	147521	A			
15.93	7	15	99	15q14	MEIS2, MRG1	P	Meis1, mouse, homolog of, 2	601740	Psh			2(Mrg1)
15.94	4	17	13	15q21.1	BLOC1S6, BLOS6, PLDN, PA, HPS9	P	Biogenesis of lysosome-related organelles complex 1, subunit 6	604310	R		Hermansky-pudlak syndrome 9, 614171 (3)	2(Pa)
15.95	2	19	13	15q15.1	BUB1B, BUBR1, MVA1	C	Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of, beta	602860	A		Colorectal cancer, somatic, 114500 (3); Mosaic variegated aneuploidy syndrome 1, 257300 (3); [Premature chromatid separation trait], 176430 (3)	
15.96	2	13	14	15q15.2	CDAN1, CDA1, CDAN1A	C	Codanin 1	607465	Fd, LD		Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	
15.97	7	26	10	15q15.3	CKMT1A	P	Creatine kinase, mitochondrial 1A	613415	REc	telomeric to CKMT1B		
15.98	1	9	95	15q15.3	CKMT1B, CKMT1	C	Creatine kinase, mitochondrial 1B	123290	REa, A	centromeric to CKMT1A		2(Ckmt1)
15.99	5	19	09	15q21.1	DUOXA1	P	Dual oxidase maturation factor 1	612771	REc	tail-to-tail with DUOXA2		
15.100	9	29	09	15q21.1	DUOXA2, TDH5	P	Dual oxidase maturation factor 2	612772	REc	head-to-head with DUOX2	Thyroid dyshormonogenesis 5, 274900 (3)	
15.101	11	18	15	15q15.2	EPB42, SPH5	C	Erythrocyte surface protein band 4.2	177070	A		Spherocytosis, type 5, 612690 (3)	2(Epb4.2)
15.102	4	13	98	15q15.3	GRP58	P	Glucose regulated protein, 58kD	602046	A			2(Grp58)
15.103	10	24	14	15q15.1	MGA, KIAA0518	C	MAX dimerization protein MGA	616061	R, REc			2(Mga)
15.104	7	13	09	15q15.1	PLA2G4D	P	Phospholipase A2, Group IVD	612864	REc			
15.105	6	10	02	15q15.1	PLCB2	P	Phospholipase C, beta-2	604114	REa, A		Platelet PLC beta-2 deficiency (1)	
15.106	8	9	99	15q14	RASGRP1	P	Ras guanyl nucleotide releasing protein-1	603962	A			2(Rasgrp1)
15.107	8	3	12	15q15	SCZD10	P	Schizophrenia 10	605419	Fd	between D15S1042 and D15S659	{Schizophrenia 10} (2)	
15.108	8	30	01	15q21.1	SLC28A2, CNT2, SPNT1	C	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2	606208	R, A			2(Slc28a2)
15.109	6	1	12	15q15.2	STARD9, KIAA1300	C	START domain-containing protein 9	614642	R, REc			
15.110	11	8	01	15q15.3	STRC, DFNB16	C	Stereocilin	606440	REc, Fd		Deafness, autosomal recessive 16, 603720 (3)	
15.111	6	5	90	15q14	THBS1	P	Thrombospondin 1	188060	REa, A			2(Thbs1)
15.112	5	4	15	15q15.3	TUBGCP4, GCP4, MCCRP3	P	Tubulin-gamma complex-associated protein 4	609610	R, REc		Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	
15.113	1	12	95	15q15.3	MFAP1	C	Microfibrillar-associated protein-1	600215	REa, A, REc			
15.114	9	20	00	15q15.3	TP53BP1, 53BP1	P	Tumor protein p53-binding protein-1	605230	A			
15.115	6	19	98	15q21.1	DUT	P	dUTP pyrophosphatase	601266	A			
15.116	5	29	98	15q21.2	FGF7	C	Fibroblast growth factor-7 (keratinocyte growth factor)	148180	A, H			2(Fgf7)
15.117	8	23	04	15q21.1	SLC12A1, NKCC2	C	Solute carrier family 12 (sodium/potassium/chloride transporters), member 1	600839	H, Fd, LD		Bartter syndrome, type 1, 601678 (3)	2(Slc12a1)
15.118	12	7	05	15q15.2	UBR1, JBS	C	Ubiquitin-protein ligase E3-alpha	605981	H, REc, Fd		Johanson-Blizzard syndrome, 243800 (3)	2(Ubr1)
15.119	4	15	11	15q15.1	BAHD1, KIAA0945	P	BROMO-adjacent homology domain-containing protein 1	613880	R, REc			
15.120	3	3	16	15q15.1	DNAJC17	P	DNAJ/HSP40 homolog, subfamily C, member 17	616844	REc			2(Dnajc17)
15.121	10	7	14	15q15.1	KNSTRN, C15orf23, SKAP	P	Kinetochore-localized astrin/SPAG5 binding protein	614718	REc			
15.122	10	25	12	15q15.1	CASC5, AF15Q14, KIAA1570, D40, MCPH4	C	Cancer susceptibility candidate 5	609173	A, REc		Microcephaly 4, primary, autosomal recessive, 604321 (3)	
15.123	4	27	12	15q15.1	CHAC1	P	ChaC, E. coli, homolog of, 1	614587	REc			
15.124	2	13	14	15q15.1	EIF2AK4, GCN2, KIAA1338, PVOD2	P	Eukaryotic translation initiation factor 2-alpha kinase 4	609280	REc		Pulmonary venoocclusive disease 2, 234810 (3)	
15.125	9	23	08	15q15.1	FAM82A2, FAM82C, RMD3, PTPIP51	P	Family with sequence similarity 82, member A2	611873	REc			
15.126	5	25	13	15q15.1	GCHFR, GFRP	P	GTP cyclohydrolase I feedback regulatory protein	602437	REc			
15.127	7	9	15	15q15.1	INO80, INOC1	P	INO80 complex subunit	610169	REc			
15.128	7	15	09	15q15.1	NUSAP1, ANKT, NUSAP	P	Nucleolar and spindle-associated protein 1	612818	REc			
15.129	5	10	11	15q15.1	PAK6	P	p21-activated kinase 6	608110	R, REc			
15.130	3	3	10	15q15.1	PPP1R14D, GBPI1	P	Protein phosphatase 1, regulatory subunit 14D	613256	REc			
15.131	3	29	12	15q15.1	RAD51A, RECA, MRMV2	C	RAD51, S. cerevisiae, homolog of, A (E. coli RecA homolog)	179617	REa, A		{Breast cancer, susceptibility to}, 114480 (3); Mirror movements 2, 614508 (3)	2(Rad51)
15.132	10	13	09	15q15.1	RPAP1, KIAA1403	P	RNA polymerase II-associated protein 1	611475	R, REc			
15.133	9	2	10	15q15.1	RTF1, KIAA0252	C	RTF1, S. cerevisiae, homolog of	611633	R			
15.134	11	19	15	15q15.1	VPS18	P	Vacuolar protein sorting 18, yeast, homolog of	608551	REc			
15.135	8	29	08	15q15.1	VPS39, VAM6, TLP, KIAA0770	P	Vacuolar protein sorting 39, yeast, homolog of	612188	R, REc			
15.136	1	2	03	15q15.1	GANC	C	Neutral alpha-glucosidase C	104180	S, REc			
15.137	4	9	15	15q15.3	CATSPER2	C	Cation channel, sperm-associated, 2	607249	A, REc, H	in region with tandem duplication containing a CATSPER2 pseudogene		2(Catsper2)
15.138	11	2	95	15q15.1	CAPN3, CANP3	C	Calpain, large polypeptide L3	114240	REb, Fd, A, REn, H		Muscular dystrophy, limb-girdle, type 2A, 253600 (3)	2(Canp3)
15.139	1	9	95	15q15.1	LTK, TYK1	C	Leukocyte tyrosine kinase	151520	REa, Psh			2(Ltk)
15.140	6	14	95	15q15.1	TYRO3	C	TYRO3 protein tyrosine kinase	600341	REa, Psh, REn			2(Tyro3)
15.141	9	7	10	15q15.2	HAUS2, CEP27	P	HAUS augmin-like complex, subunit 2	613429	REc			
15.142	11	10	14	15q15.2	TGM5, TGX, PSS2	C	Transglutaminase 5	603805	A, Fd		Peeling skin syndrome 2, 609796 (3)	
15.143	3	26	02	15q15.2-q15.3	TGM7, TGMZ	P	Transglutaminase 7	606776	Psh, R			2(Tgm7)
15.144	1	2	08	15q15.2	TTBK2, SCA11	C	Tau tubulin kinase 2	611695	Fd, REc		Spinocerebellar ataxia 11, 604432 (3)	
15.145	1	15	09	15q15.3	DEL15q15.3, C15DELq15.3	P	Chromosome 15q15.3 deletion syndrome	611102	Ch		Deafness and male infertility (4)	
15.146	1	11	07	15q21.1	DUOX1, THOX1	C	Dual oxidase 1 (thyroid oxidase 1)	606758	A, R, H			2(Duox1)
15.147	9	29	09	15q21.1	DUOX2, THOX2, TDH6	C	Dual oxidase 2 (thyroid oxidase 2)	606759	A, R, H		Thryoid dyshormonogenesis 6, 607200 (3)	2(Duox2)
15.148	10	3	07	15q21.1	EIF3J, EIF3S1	P	Eukaryotic translation initiation factor 3, subunit J	603910	REc			
15.149	2	10	06	15q15.3	ELL3	P	Elongation factor, RNA polymerase II, 3	609885	R, REc			
15.150	4	13	15	15q15.3	FRMD5	P	FERM domain-containing protein 5	616309	REc			
15.151	6	7	10	15q15.3	FRTS1, FRTS, RFS	P	Fanconi renotubular syndrome	134600	Fd		Fanconi renotubular syndrome 1 (2)	
15.152	5	19	09	15q15.3	HYPK	P	Huntingtin-interacting protein K	612784	REc			
15.153	5	26	13	15q15.3	LCMT2, TYW4, KIAA0547	P	Leucine carboxyl methyltransferase 2	611246	REc			
15.154	10	30	06	15q21.2	LEO1, RDL	P	LEO1 RNA polymerase II associated factor, S. cerevisiae, homolog of	610507	REc			
15.155	9	3	15	15q15.3	PPIP5K1, HISPPD2A, IPS1, KIAA0377	C	Diphosphoinositol pentakisphophate kinase 1	610979	R, REc			
15.156	3	25	14	15q15.3	SERF2, H4F5REL	P	Small EDRK-rich factor 2	605054	REc			
15.157	4	2	12	15q15.3	SERINC4	P	Serine incorporator 4	614550	REc			
15.158	8	31	99	15q21.1	SORD, SORD1	C	Sorbitol dehydrogenase	182500	S, H, A, REa, Psh		?Cataract, congenital (2)	2(Sdh1)
15.159	11	12	03	15q21.2	SPPL2A, IMP3	P	Signal peptide peptidase-like 2A	608238	REc			
15.160	6	15	12	15q15.3-q22.1	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	P	Polyposis syndrome, mixed, hereditary 1	601228	Fd	duplication of 40kb of 15q resulting in overexpression of GREM1	Polyposis syndrome, mixed hereditary 1 (4); {Colorectal cancer, susceptibility to, 4} (4)	
15.161	6	13	02	15q21.2	BCL2L10	C	BCL2-like 10	606910	REc, R			9(Bcl2l10)
15.162	3	20	95	15q21	CDAN3, CDA3	P	Congenital dyserythropoietic anemia, type III	105600	Fd		Dyserythropoietic anemia, congenital, type III (2)	
15.163	11	10	13	15q21.3	DYX1C1, DYXC1, DYX1, CILD25	C	Dyslexia susceptibility 1 candidate 1	608706	Fd, REc	not confirmed by some studies	{Dyslexia, susceptibility to, 1}, 127700 (3); Ciliary dyskinesia, primary, 25, 615482 (3)	
15.164	6	20	13	15q22.31	MAP2K1, PRKMK1, MKK1, MEK1, CFC3	C	Mitogen-activated protein kinase kinase 1	176872	R, REa, A	pseudogene on 8p21	Cardiofaciocutaneous syndrome 3, 615279 (3)	9(Mek1)
15.165	4	28	10	15q21.2	MYO5A, MYH12, GS1	C	Myosin Va	160777	REa, A, Fd		Griscelli syndrome, type 1, 214450 (3)	9(d, Myh12)
15.166	4	19	06	15q21.2	MYO5C	P	Myosin Vc	610022	REc			
15.167	6	25	08	15q22.31	OSTB	P	Organic solute transporter, beta	612085	REc			9(Ostb)
15.168	3	17	03	15q21.3	RAB27A, RAM, GS2	P	Ras-associated protein RAB27A	603868	A, REc		Griscelli syndrome, type 2, 607624 (3)	9(ash, Rab27a)
15.169	5	29	01	15q15.1	SPTBN5, BSPECV	P	Spectrin, beta, non-erythrocytic 5	605916	REc			
15.170	7	22	13	15q21.3	TCF12, HTF4, CRS3	C	Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4)	600480	REa, A, REc		Craniosynostosis 3, 615314 (3)	
15.171	5	2	06	15q21.2	TRPM7, LTRPC7, CHAK, ALSPDC	P	Transcient receptor potential cation channel, subfamily M, member 7	605692	REc		{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	
15.172	10	29	03	15q22.31	ACP33, MAST, SPG21	C	Acidic cluster protein, 33kD, (maspardin)	608181	REc, Fd		Mast syndrome, 248900 (3)	
15.173	3	19	91	15q22.2	ANXA2, ANX2L4, LPC2D, LIP2	C	Annexin A2 (lipocortin I)	151740	REa, Psh	pseudogenes ANX2P1 on 4q21-q31; ANX2P2 on 9p13; ANX2P3 on 10q24-q22		
15.174	11	17	15	15q21.1	B2M, IMD43	C	Beta-2-microglobulin	109700	S, D, H	mutation identified in 1 FVA family	Immunodeficiency 43, 241600 (3); ?Amyloidosis, familial visceral, 105200 (3)	2(B2m)
15.175	7	22	13	15q21-q22	CTRCT25, CCSSO	P	Cataract 25	605728	Fd		Cataract 25 (2)	
15.176	2	21	14	15q21.2	HDC	C	Histidine decarboxylase	142704	REa, Psh, A		{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3)	2(Hdc)
15.177	8	2	11	15q22.2	MYO1E, MYO1C, FSGS6	P	Myosin IE	601479	A		Glomerulosclerosis, focal segmental, 6, 614131 (3)	9(Myo1e)
15.178	8	16	99	15q21.3	PIGB	P	Phosphatidylinositol glycan, class B	604122	A			
15.179	11	3	09	15q22.31	PPIB, CYPB, OI9	P	Peptidyl-prolyl isomerase B	123841	REc		Osteogenesis imperfecta, type IX, 259440 (3)	
15.180	2	18	96	15q22.2	RORA	P	RAR-related orphan receptor A	600825	A			9(Rora)
15.181	9	25	12	15q22.31	SMAD6, MADH6, AOVD2	P	Mothers against decapentaplegic, Drosophila, homolog of, 6	602931	Psh, REc		Aortic valve disease 2, 614823 (3)	
15.182	4	17	01	15q15.1-q15.2	SNAP23	P	Synaptosomal-associated protein, 23kD	602534	A			
15.183	1	5	12	15q23	CLN6, CLN4A	C	CLN6 gene	606725	Fd, LD		Ceroid lipofuscinosis, neuronal, 6, 601780 (3); Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)	9(nclf, Cln6)
15.184	1	4	13	15q21.1	CEP152, KIAA0912, MCPH9, SCKL5	P	Centrosomal protein, 152kD	613529	R, REc		Microcephaly 9, primary, autosomal recessive, 614852 (3); Seckel syndrome 5, 613823 (3)	
15.185	9	20	10	15q21.2	CYP19A1, CYP19, ARO	C	Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens)	107910	REa, A, H	close to CYP11 in mouse	Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300 (3)	9(Cyp19)
15.186	10	15	15	15q15.1	DLL4, AOS6	P	Delta-like 4	605185	R		Adams-Oliver syndrome 6, 616589 (3)	2(Dll4)
15.187	4	27	16	15q21.1	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	C	Fibrillin-1	134797	A, Fd		Marfan syndrome, 154700 (3); Marfan lipodystrophy syndrome, 616914 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending, and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)	2(Fbn1)
15.188	4	19	16	15q21.1	GATM, AGAT, CCDS3	C	L-arginine:glycine amidinotransferase	602360	Psh, R, H, REc		Cerebral creatine deficiency syndrome 3, 612718 (3)	2(Gatn)
15.189	4	2	16	15q21.1	HMGN2P46, C15orf21	P	High mobility group nucleosomal binding domain 2 pseudogene 46	611314	REc			
15.190	1	27	04	15q21.1	NMES1	P	Normal mucosa of esophagus-specific gene 1	608409	R			
15.191	4	29	14	15q21.1	SECISBP2L, SBP2L, KIAA0256	P	Selenocysteine insertion sequence-binding protein 2-like	615756	R, REc			
15.192	4	21	15	15q21.1	SEMA6D, KIAA1479	P	Semaphorin 6D	609295	REc			
15.193	8	8	13	15q21.1	SLC24A5, NCKX5, SHEP4, OCA6	P	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5	609802	REc, R		[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3); Albinism, oculocutaneous, type VI, 113750 (3)	
15.194	9	12	01	15q21.1	SLC30A4, ZNT4	C	Solute carrier family 30 (zinc transporter), member 4	602095	A, REc, H			2(lm, Slc30a4)
15.195	12	1	15	15q21.1	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	C	Spastascin	610844	Fd, R		Spastic paraplegia 11, autosomal recessive, 604360 (3); Amyotrophic lateral sclerosis 5, juvenile, 602099 (3); Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	
15.196	9	30	14	15q21.1	TRIM69, TRIF, RNF36	P	Tripartite motif-containing protein 69	616017	REc, H			2(Trim69)
15.197	5	7	01	15q21.1	CRI1, C15orf3, EID1	P	CREBBP/EP300 inhibitory protein 1	605894	R			
15.198	10	20	99	15q21.3	ONECUT1, HNF6A, HNF6	P	One cut domain, family member 1 (hepatocyte nuclear factor 6-alpha)	604164	A			
15.199	4	17	01	15q21.2	TMOD2	P	Tropomodulin 2, neuronal	602928	R			9(Tmod2)
15.200	4	17	01	15q21.2	TMOD3	C	Tropomodulin 3	605112	R, REc			9(Tmod3)
15.201	3	16	16	15q21.2	AP4E1, SPG51, CPSQ4, STUT1	P	Adaptor-related protein complex 4, epsilon-1 subunit	607244	REc		Spastic paraplegia 51, autosomal recessive, 613744 (3); Stuttering, familial persistent, 1, 184450 (3)	
15.202	12	4	14	15q21.2	DMXL2, RC3, KIAA0856, PEPNS	P	DMX-like 2	612186	R, REc	mutation identified in 1 PEPNS family	?Polyendocrine-polyneuropathy syndrome, 616113 (3)	
15.203	10	2	06	15q21.2	GLDN, CRGL2	P	Gliomedin	608603	REc			
15.204	8	28	02	15q21.2	SLC27A2, FACVL1, VLACS	P	Solute carrier family 27 (fatty acid transporter), member 2 (fatty acid CoA ligase, very long-chain 1)	603247	A			
15.205	7	11	03	15q21.2	GABPB, BABPB2, GABPB1, E4TF1B, NRF2B1	C	GA-binding protein transcription factor, beta subunit	600610	A			
15.206	6	30	15	15q21.2	TNFAIP8L3, TIPE3	P	Tumor necrosis factor-alpha-induced protein 8-like 3	616438	REc			
15.207	1	29	01	15q21.1	TRIP15, SGN2, COPS2	P	Thyroid hormone receptor interactor-15	604508	REc			2(Cops2)
15.208	9	16	12	15q21.2	USP8, HUMORF8	P	Ubiquitin-specific protease 8	603158	REc			
15.209	1	11	07	15q21.3	CGNL1, FLJ14957, KIAA1749	C	Cingulin-like 1	607856	REc, REn			
15.210	1	9	14	15q21.3	ADAM10, MADM, RAK, AD18	P	A disintegrin and metalloprotease domain 10	602192	R, REc		Reticulate acropigmentation of Kitamura, 615537 (3); {Alzheimer disease 18, susceptibility to}, 615590 (3)	
15.211	6	10	14	15q21.3	ALDH1A2, RALDH2	P	Aldehyde dehydrogenase 1 family, member A2 (retinaldehyde dehydrogenase 2)	603687	R, REc			
15.212	4	21	10	15q22.2	C2CD4B, NLF2	P	C2 calcium-dependent domain containing 4B	610344	REc			
15.213	4	2	16	15q21.3	CCPG1, KIAA1254, CPR8	P	Cell cycle progression 1	611326	R, REc			
15.214	4	10	02	15q22.2	GCNT3	C	Glucosaminyl (N-acetyl) transferase 3, mucin-type	606836	Psh, R, A			
15.215	7	1	11	15q21.3	LIPC, HL, LIPH, HDLCQ12	C	Lipase, hepatic	151670	REa, A		[High density lipoprotein cholesterol level QTL 12], 612797 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)	9(Hl)
15.216	2	16	07	15q21.3	MNS1, FLJ11222	P	Meiosis-specific nuclear structural protein 1	610766	REc			
15.217	3	6	07	15q22.2	NARG2	C	NMDA receptor-regulated 2	610835	REc, H	pseudogenes on chr.4 and chr.3		9(narg2)
15.218	4	21	10	15q22.2	C2CD4A, NLF1	P	C2 calcium-dependent domain containing 4A	610343	REc			
15.219	3	4	10	15q21.3	PRTG	P	Protogenin, chicken, homolog of	613261	REc, H			9(Prtg)
15.220	3	23	09	15q21.3	RFX7, RFXDC2	P	Regulatory factor X, 7	612660	REc			
15.221	3	4	10	15q21.3	RSL24D1, RLP24	P	Ribosomal protein L24 domain-containing protein 1	613262	REc			
15.222	2	18	08	15q21.2	SCG3	P	Secretogranin III	611796	REc			
15.223	4	19	12	15q21.3	UNC13C	P	Unc13, C. elegans, homolog of, C	614568	REc			
15.224	9	18	12	15q21.3	GUP, GCOM1, MYOZAP	P	GRINL1A complex locus upstream gene	614071	REc			
15.225	7	11	14	15q21.3	WDR72, AI2A3	P	WD repeat-containing protein 72	613214	REc		Amelogenesis imperfecta, type IIA3, 613211 (3)	
15.226	1	30	01	15q22.31	RAB11A	P	Ras family, member RAB11A	605570	R, A			
15.227	3	17	06	15q21.3	AQP9	P	Aquaporin 9	602914	R, REc			
15.228	12	21	10	15q22.2	CA12	P	Carbonic anhydrase XII	603263	A		Hyperchlorhidrosis, isolated, 143860 (3)	
15.229	5	26	05	15q22.31	CILP	P	Cartilage intermediate layer protein	603489	A		{Lumbar disc disease, susceptibility to}, 603932 (3)	
15.230	12	11	02	15q22.31	DPP8	P	Dipeptidyl peptidase 8	606819	A			
15.231	4	21	10	15q24.1	GOLGA6, GLP	P	Golgi autoantigen, golgin subfamily A, 6	610288	REc, A			
15.232	4	18	02	15q23	PIAS1, DDXBP1, GBP	P	protein inhibitor of activated STAT, 1	603566	A			
15.233	11	17	15	15q23	PKM, PKM2, PK3, PKM2, THBP1	C	Pyruvate kinase, muscle	179050	S, D, A			9(Pk3)
15.234	9	23	97	15q24.1	PML, MYL	C	Promyelocytic leukemia, inducer of	102578	Ch, RE	fused with RARA in APL	Leukemia, acute promyelocytic, PML/RARA type (3)	9(Pml)
15.235	10	11	10	15q23	SPESP1	P	Sperm equatorial segment protein 1	609399	REc			
15.236	1	31	13	15q22.31	SLC24A1, NCKX1, CSNB1D	P	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1	603617	A, R		Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	
15.237	12	17	95	15q15.1	SRP14	P	Signal recognition particle 14kD (homologous Alu RNA-binding protein)	600708	REa			
15.238	12	7	03	15q24.1	STOML1, STORP	P	Stomatin-like protein 1	608326	A, REc			
15.239	2	11	96	15q23	TLE3, ESG	C	Transducin-like enhancer of split 3, homolog of Drosophila a E(spl)	600190	REa, Psh, A			
15.240	5	11	00	15q23	MYO9A	P	Myosin IXa	604875	R			
15.241	3	3	09	15q22-q23	USH1H	P	Usher syndrome, type 1H	612632	Fd	max lod at D15S980	Usher syndrome, type 1H (2)	
15.242	3	14	14	15q22-q24	GLC1N	P	Glaucoma 1, open angle, N	611274	Fd	max lod at D15S125	Glaucoma 1, open angle, N (2)	
15.243	5	26	98	15q24.1	MPI, PMI1, CDG1B	C	Mannosephosphate isomerase (phosphomannose isomerase 1)	154550	S		Congenital disorder of glycosylation, type Ib, 602579 (3)	9(Mpi1)
15.244	1	9	95	15q25.2	NMB	C	Neuromedin B	162340	REa, Psh			
15.245	6	13	12	15q22.31	FBXL22, FBL22	P	F-box and leucine-rich repeat protein 22	609088	REc			9(Fbxl22)
15.246	2	16	04	15q22.2	LACTB	P	Lactamase, beta	608440	R, REc			9(Lactb)
15.247	1	11	07	15q22.31	PAF, OEATC1, KIAA0101	C	PCNA-associated factor, 15kD	610696	Psh, REc			
15.248	9	18	12	15q21.3	POLR2M, GDOWN, GRINL1A	P	Polymerase II, RNA, subunit M	606485	A			9(Grinl1a)
15.249	9	9	13	15q22.2	TPM1, CMH3, CMD1Y , LVNC9	C	Tropomyosin 1, alpha	191010	Fd, R		Cardiomyopathy, hypertrophic, 3, 115196 (3); Cardiomyopathy, dilated, 1Y, 611878 (3); Left ventricular noncompaction 9, 611878 (3)	9(Tpm1)
15.250	3	20	16	15q22.2	VPS13C, KIAA1421, PARK23	P	Vacuolar protein sorting 13, yeast, homolog of, C	608879	REc		Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	
15.251	7	19	12	15q22.1-q22.2	RNF111	P	Ring finger protein 111	605840	REc			
15.252	7	9	06	15q22.31	CSNK1G1	P	Casein kinase I, gamma-1	606274	A			
15.253	6	10	09	15q22.2	APH1B	P	Anterior pharynx defective 1, C. elegans, homolog of, B	607630	R, REc			
15.254	6	22	12	15q22.2	BNIP2, NIP2	P	BCL2/adenovirus E1B 19kD protein-interacting protein 2	603292	REc			
15.255	11	11	14	15q22.2	CCNB2	P	Cyclin B2	602755	REc			
15.256	10	2	12	15q22.2	GTF2A2, TF2A2	P	General transcription factor IIA, gamma subunit	600519	REc	pseudogenes on chr. 1, 8, 9		
15.257	9	30	14	15q22.2	MIR190A	P	Micro RNA 190A	615845	REc			
15.258	4	6	15	15q22.2	RAB8B	P	Ras-associated protein RAB8B	613532	REc			
15.259	6	10	08	15q22.2	RPS27L	P	Ribosomal protein S27-like	612055	REc			
15.260	7	18	14	15q22.2	TLN2, KIAA0320	C	Talin 2	607349	R, REc			
15.261	8	26	15	5q22.2	YTHDC2, CAHL	P	YTH domain-containing protein 2	616530	REc			
15.262	8	1	12	15q24.1	SEMA7A, SEMAL, SEMAK1, CDW108, JMH	C	Semaphorin 7A	607961	A		[Blood group, John-Milton-Hagen system], 614745 (3)	9(Sema7a)
15.263	4	18	05	15q22.31	SNX1, SNX1A	P	Sorting nexin 1	601272	R, REc			
15.264	1	24	07	15q22.31	TIPIN	P	Timeless-interacting protein	610716	REc, H			9(Tipin)
15.265	4	18	05	15q22.31	USP3	P	Ubiquitin-specific protease 3	604728	A			
15.266	3	21	06	15q22.31	ZWILCH	P	Zwilch, Drosophila, homolog of	609984	R, REc			
15.267	2	15	02	15q23	ANP32A, PHAP1	P	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A	600832	A			
15.268	10	16	14	15q24.1	BBS4	C	BBS4 gene	600374	Fd, LD, REc		Bardet-Biedl syndrome 4, 615982 (3)	
15.269	7	31	97	15q24.1	NEO1, NGN	C	Neogenin, chicken, homolog of, 1	601907	A			
15.270	10	20	99	15q22.31	PUNC	C	Putative neuronal cell adhesion molecule	604184	A, REa, H			9(Punc)
15.271	12	23	05	15q24.1	UBL7	P	Ubiquitin-like 7	609748	REc			
15.272	2	2	14	15q22.31	CLPX	C	Caseinolytic mitochondrial matrix peptidase chaperone subunit	615611	R, REa, REc			
15.273	9	28	15	15q22.31	DAPK2, DRP1	P	Death-associated protein kinase 2	616567	REc			
15.274	5	25	13	15q22.31	DENND4A	P	DENN/MADD domain containing 4A	600382	REc			
15.275	8	25	11	15q22.31	DIS3L, DIS3L1, KIAA1955	P	Dis3 mitotic control, S. cerevisiae, homolog-like	614183	REc			
15.276	2	12	16	15q22.31	IGDCC4, NOPE, KIAA1628	P	Immunoglobulin superfamily, DCC subclass, member 4	616810	REc, H			9(Nope)
15.277	1	7	09	15q23	IQCH, NYDSP5	P	IQ motif-containing protein H	612523	REc			
15.278	8	2	13	15q22.31	KBTBD13, NEM6	P	Kelch repeat and BTB/POZ domains-containing protein 13	613727	REc		Nemaline myopathy 6, autosomal dominant, 609273 (3)	
15.279	12	24	08	15q22.31	MEGF11, KIAA1781	P	Multiple epidermal growth factor-like domains 11	612454	REc			
15.280	12	15	12	15q22.31	MTFMT, COXPD15	P	Mitochondrial methionyl-tRNA formyltransferase	611766	R, REc		Combined oxidative phosphorylation deficiency 15, 614947 (3)	
15.281	5	25	13	15q22.31	OAZ2	P	Ornithine decarboxylase antizyme 2	604152	REc			
15.282	3	22	07	15q22.31	PDCD7	P	Programmed cell death 7	608138	R, REc			
15.283	5	21	07	15q22.31	PIF1, PIF	P	Pif1, S. cerevisiae, homolog of	610953	REc			
15.284	8	18	14	15q22.31	PTPLAD1, BIND1, HACD3	P	Protein tyrosine phosphatase-like A domain-containing protein 1	615940	REc			
15.285	6	24	08	15q22.31	RNU5A, RNU5	P	RNA, U5A small nuclear	180691	REc			
15.286	9	6	12	15q22.33	SMAD3, MADH3, LDS3	P	Mothers against decapentaplegic, Drosophila, homolog of, 3	603109	REa, REc		Loeys-Dietz syndrome 3, 613795 (3)	
15.287	10	2	12	15q22.31	SNAPC5, SNAP19	P	Small nuclear RNA-activating protein complex, polypeptide 5	605979	REc			
15.288	3	25	16	15q22.31	TRIP4, ASC1, SMABF1	P	Thyroid hormone receptor interactor 4	604501	REc		Spinal muscular atrophy with congenital bone fractures 1, 616866 (3)	
15.289	2	17	09	15q22.32	STQTL16	P	Stature quantitative trait locus 16	612579	Fd	associated with rs8038652	{Stature QTL 16} (2)	
15.290	12	12	12	15q23	AAGAB, p34, PPKP1A, PPKP1, KPPP1	P	Alpha- and gamma-adaptin-binding protein	614888	REc, Fd		Keratoderma, palmoplantar, punctate type IA, 148600 (3)	
15.291	10	13	09	15q23	CORO2B, CLIPINC	P	Coronin 2B	605002	R, REc			
15.292	6	1	15	15q23	DRAIC	P	Downregulated RNA in androgen-independent cells, noncoding	616387	REc			
15.293	7	29	15	15q23	EWSAT1, LINC00277	P	Ewing sarcoma-associated transcript 1, noncoding	616492	REc			
15.294	9	9	08	15q24.2	FBXO22, FBX22	P	F-box only protein 22	609096	REc			9(Fbxo22)
15.295	8	27	15	15q23	FEM1B, KIAA0396	C	Fem1, C. elegans, homolog of, B	613539	R, REc			9(Fem1b)
15.296	8	18	08	15q23	GLCE, HSEPI, KIAA0836	P	Glucuronic acid epimerase	612134	R, REc			
15.297	4	6	00	15q23	ITGA11	C	Integrin, alpha-11	604789	A, REa			
15.298	3	2	06	15q23	KIF23, KNSL5, MKLP1	P	Kinesin family member 23	605064	R, REc			
15.299	3	23	14	15q23	LARP6, ACHN	P	La ribonucleoprotein domain family, member 6	611300	REc			
15.300	6	10	09	15q23	LBXCOR1, CORL1	P	LBX1 corepressor 1, mouse, homolog of	611273	REc			
15.301	6	10	09	15q23	MAP2K5, PRKMK5, MEK5, MAPKK5	P	Mitogen-activated protein kinase kinase 5	602520	REc			
15.302	1	24	13	15q23	NOX5	C	NADPH oxidase 5	606572	REc			
15.303	7	9	07	15q23	NR2E3, PNR, ESCS, RP37	C	Nuclear receptor subfamily 2, group E, member 3	604485	A, R	near BBS4	Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37, 611131 (3)	9(rd7)
15.304	4	19	12	15q23	PAQR5, MPRG	P	Progestin and ADIPOQ receptor family, member 5	607781	REc			
15.305	3	23	15	15q23	PCAT29	P	Prostate cancer-associated transcript 29, noncoding	616273	REc			
15.306	6	10	98	15q24.3	RCN2, ERC55	C	Reticulocalbin 2, EF-hand calcium binding domain (endoplasmic reticulum calcium-binding protein, 55kD)	602584	R, A			
15.307	6	24	08	15q23	RNU6-1, RNU6A, RNU6	P	RNA, U6 small nuclear 1	180692	REc			
15.308	2	25	11	15q24.2	SCAMP5	P	Secretory carrier membrane protein 5	613766	REc			
15.309	6	13	12	15q23	SENP8, NEDP1, DEN1	P	Sentrin-specific protease family, member 8	608659	REc			
15.310	1	20	09	15q23	THAP10	P	THAP domain-containing protein 10	612538	REc			
15.311	2	21	12	15q23	THSD4, ADAMTSL6	P	Thrombospondin type-1 domain-containing 4	614476	REc			9(Thsd4)
15.312	10	13	09	15q24.2	UBE2Q2, LOC92912	P	Ubiquitin-conjugating enzyme E2Q 2	612501	REc			
15.313	12	1	11	15q25.1	ACSBG1, BG, BG1, KIAA0631	C	Acyl-CoA synthetase, bubble gum family, member 1	614362	R, REc			
15.314	3	23	09	15q24.1	CD276, B7H3	P	CD276 molecule	605715	REc			9(B7h3)
15.315	5	7	02	15q23	HEXA, TSD	C	Hexosaminidase A, alpha polypeptide	606869	S, D, A	on 15q+ in APL	Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms, 272800 (3); [Hex A pseudodeficiency], 272800 (3)	9(Hexa)
15.316	6	9	98	15q24.1	ISLR	P	Immunoglobulin superfamily containing leucine-rich repeat	602059	A			
15.317	8	14	92	15q24.1	CSK	P	c-src tyrosine kinase	124095	A			
15.318	8	25	03	15q24.2-q24.3	ETFA, GA2, MADD	C	Electron transfer flavoprotein, alpha polypeptide	608053	REa, A		Glutaric acidemia IIA, 231680 (3)	13(Etfa)
15.319	4	30	91	15q25.1	FAH	C	Fumarylacetoacetase	613871	A, REa		Tyrosinemia, type I, 276700 (3)	
15.320	10	29	09	15q23-q26.3	GLM4	P	Glioma susceptibility 4	607248	Fd	max lod at D15S130	{Glioma susceptibility 4} (2)	
15.321	12	29	09	15q26.3	ADAMTS17	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 17	607511	REc		Weill-Marchesani-like syndrome, 613195 (3)	
15.322	12	24	08	15q24.1	ARID3B, DRIL2, BDP	P	AT-rich interactive domain-containing protein 3B	612457	REc			
15.323	3	1	01	15q24.1	ARIH1, ARI, UBCH7BP	C	Ariadne, Drosophila, homolog of, 1	605624	R, A			
15.324	8	12	14	15q25.1	ARNT2, WEDAS	C	Aryl hydrocarbon receptor nuclear translocator 2	606036	R	mutation identified in 1 WEDAS family	?Webb-Dattani syndrome, 615926 (3)	
15.325	8	2	13	15q23	CELF6, BRUNOL6	P	CUGbp- and ELAV-like family, member 6	612681	REc			
15.326	8	4	97	15q25.1	CRABP1, RBP5	C	Cellular retinoic acid-binding protein-1	180230	REa, Ch, A	distal to APL breakpoint		9(Rbp5)
15.327	7	5	92	15q25.1	CHRNB4	C	Cholinergic receptor, neuronal nicotinic, beta polypeptide-4	118509	REa, H, A, REn			9(Acrb4)
15.328	10	17	12	15q25.1	CIB2, KIP2	C	Calcium- and integrin-binding protein 2	605564	R, A		Deafness, autosomal recessive 48, 609439 (3); Usher syndrome, type IJ, 614869 (3)	
15.329	6	15	99	15q24.1	CLK3	C	CDC-like kinase 3	602990	Psh, A			
15.330	9	7	10	15q24	DEL15q24, CHR15DELq24	P	Chromosome 15q24 deletion syndrome	613406	Ch	contiguous gene deletion syndrome	Chromosome 15q24 deletion syndrome (4)	
15.331	11	11	98	15q24	ENFL2	P	Epilepsy, nocturnal frontal lobe, type 2	603204	Fd	some ENFL not on 20q or 15q	Epilepsy, nocturnal frontal lobe, type 2 (2)	
15.332	1	8	01	15q24.3	HMG20A	C	High mobility group protein 20A	605534	REc, A, R			
15.333	9	2	09	15q24.2	IMP3, MRPS4, BRMS2	P	Imp3, S. cerevisiae, homolog of	612980	REc			
15.334	1	27	04	15q25.1	KIAA1199	P	KIAA1199 gene	608366	REc			
15.335	12	23	05	15q24.3	LRRN6A, LERN1, LINGO1	P	Leucine-rich repeat protein, neuronal, 6A	609791	REc, A			
15.336	6	6	03	15q25.1	MORF4L1, MRG15	P	Mortality factor 4-like 1	607303	A			
15.337	6	11	98	15q24	MRST	P	Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685	Fd		Mental retardation, severe, with spasticity and tapetoretinal degeneration (2)	
15.338	2	18	08	15q24.3	SCAPER, KIAA1454	C	S-phase cyclin A-associated protein in the endoplasmic reticulum	611611	R, REc			
15.339	8	9	99	15q25.2	SH3GL3	P	SH3-domain GRB2-like 3	603362	Psh, A			
15.340	5	22	03	15q24.2	SIN3A	P	Sin3, yeast, homolog of, A	607776	A			
15.341	1	6	09	15q23	UACA, NUCLING	P	Uveal autoantigen with coiled-coil domains and ankyrin repeats	612516	REc			
15.342	6	13	02	15q25.3	AKAP13, HT31, LBC, BRX	C	A-kinase anchor protein 13	604686	A			
15.343	12	3	08	15q24-q25	CILD8	P	Ciliary dyskinesia, primary, 8	612274	Fd	max lod at D15S154	Ciliary dyskinesia, primary, 8 (2)	
15.344	1	9	94	15q25.1	CTSH	P	Cathepsin H	116820	REa, A			9(Ctsh)
15.345	12	2	09	15q24.1	HCN4, SSS2	P	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4	605206	A		Sick sinus syndrome 2, 163800 (3); Brugada syndrome 8, 613123 (3)	
15.346	3	5	08	15q25.3	MRPL46	P	Mitochondrial ribosomal protein L46	611851	R, REc			
15.347	5	3	04	15q24.3	PSTPIP1, PSTPIP, CD2BP1, PAPAS	C	Proline-serine-threonine phosphatase-interacting protein 1	606347	R, Fd		Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	
15.348	12	27	01	15q25.2	TM6SF1	P	Transmembrane 6 superfamily, member 1	606562	REc			
15.349	2	26	08	15q24.1	ADPGK	P	ADP-dependent glucokinase	611861	R, REc			9(Adpgk)
15.350	4	28	10	15q24.1	CYP1A1, CYP1	C	Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 1	108330	S, REa, H	head-to-head with CYP1A2		9(Cyp1a1)
15.351	4	28	10	15q24.1	CYP1A2	C	Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 2	124060	REa, H, REc	23.3kb from CYP1A1		9(Cyp1a2)
15.352	10	7	13	15q24.1	CYP11A1, P450SCC	C	Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme)	118485	REa, H, A, Fd		Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	9(Cyp11a)
15.353	7	13	15	15q24.1	EDC3, YJDC, MRT50	P	Enhancer of mRNA decapping 3, S. cerevisiae, homolog of	609842	REc	mutation identified in 1 MRT50 family	?Mental retardation, autosomal recessive 50, 616460 (3)	
15.354	9	6	11	15q24.1	ISLR2, LINX, KIAA1464	C	Immunoglobulin superfamily containing leucine-rich repeat 2	614179	REc, Psh			
15.355	2	9	16	15q24.1	LOXL1, LOXL	C	Lysyl oxidase-like 1	153456	A, H, REc		{Exfoliation syndrome, susceptibility to}, 177650 (3)	9(Loxl1)
15.356	2	9	16	15q24.1	LOXL1AS1	P	LOXL1 antisense RNA 1	616800	REc			
15.357	1	29	13	15q24.1	NPTN, SDFR1, GP55, NP55, GP65, NP65	C	Neuroplastin	612820	R, REc			
15.358	4	17	13	15q24.1	NPTNIT1	P	NPTN intronic transcript 1, noncoding	615176	REc			
15.359	4	17	07	15q24.2	NRG4, HRG4	P	Neuregulin 4	610894	R, REc			
15.360	11	30	12	15q24.1	STRA6, MCOPS9, MCOPCB8	P	Stimulated by retinoic acid 6, mouse, homolog of	610745	REc, R		Microphthalmia, syndromic 9, 601186 (3); Microphthalmia, isolated, with coloboma 8, 601186 (3)	
15.361	9	29	10	15q24.1	ULK3	P	UNC51-like kinase 3	613472	REc			
15.362	12	22	15	15q24.2	COMMD4	P	COMM domain-containing protein 4	616701	REc			
15.363	4	27	12	15q24.2	CSPG4, MCSPG, MSK16, NG2	P	Chondroitin sulfate proteoglycan	601172	REa, REc			
15.364	9	16	12	15q24.2	NEIL1, NEI1, FPG1	P	Endonuclease VIII-like 1	608844	REc			
15.365	3	20	06	15q24.2	PPCDC	P	Phosphopantothenoylcysteine decarboxylase	609854	REc			
15.366	5	25	13	15q24.2	PTPN9	P	Protein-tyrosine phosphatase, nonreceptor-type, 9	600768	REc			
15.367	6	9	98	15q25.1	BCL2A1	P	BCL2-related protein A1	601056	REa, A			9(Bcl2a1)
15.368	12	21	15	15q25.2	HOMER2, HOMER2B, HOMER2A, DFNA68	P	Homer, homolog 2 (Drosophila)	604799	R, REc	mutation identified in 1 DFNA68 family	?Deafness, autosomal dominant 68, 616707 (3)	
15.369	9	26	11	15q24.3	PEAK1, KIAA2002	P	Pseudopodium-enriched atypical kinase 1	614248	REc			
15.370	12	2	09	15q24.3	TSPAN3	P	Tetraspanin 3	613134	REc			
15.371	6	14	99	15q24.2	COX5A	P	Cytochrome C oxidase, subunit Va	603773	A, R	pseudogene on 14q22		
15.372	10	26	11	15q25	DEL15q25, C15DELq25	P	Chromosome 15q25 deletion syndrome	614294	Ch	chr15:82,889,423-83,552,890, NCBI36	Chromosome 15q25 deletion syndrome (4)	
15.373	11	20	15	15q25.2	HRP3, HDGFRP3	P	Hepatoma-derived growth factor-related protein 3	616643	A			
15.374	6	2	98	15q26.1	MAN2A2, MANA2X	P	Manosidase, alpha-, type II, isozyme X	600988	A			
15.375	6	14	99	15q26.1	MFGE8	P	Milk fat globule-EGF factor 8	602281	A			
15.376	4	23	08	15q25.3	MRPS11	P	Mitochondrial ribosomal protein S11	611977	R, REc			
15.377	10	19	97	15q25.3	NTRK3, TRKC	C	Neurotrophic tyrosine kinase, receptor, type 3	191316	Psh, A			
15.378	3	25	16	15q26.1	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	P	Polymerase (DNA directed), gamma	174763	A	PEO also digenic with C10orf2	Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3); Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	7(Polg)
15.379	11	6	00	15q26.1	RHCG, RHGK	P	Rhesus blood group-associated kidney homolog	605381	A			
15.380	12	16	93	15q26.1	ANPEP, PEPN, CD13	C	Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150)	151530	REa, A			
15.381	11	13	01	15q25-q26	DFNA30	P	Deafness, autosomal dominant 30	606451	Fd		Deafness, autosomal dominant 30 (2)	
15.382	8	21	07	15q26.1	FANCI, KIAA1794	P	FANCI gene	611360	REc		Fanconi anemia, complementation group I, 609053 (3)	
15.383	12	23	02	15q26.1	FURIN, PACE, FUR, PCSK3	C	Furin (paired basic amino acid cleaving enzyme)	136950	RE	less than 1.1kb 5' to FES		7(Fur, Pcsk3)
15.384	4	30	09	15q26.3	IGF1R	C	Insulin-like growth factor-1 receptor	147370	REa, A, D		Insulin-like growth factor I, resistance to, 270450 (3)	7(Igf1r)
15.385	8	30	01	15q25.3	SLC28A1, CNT1	P	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1	606207	A			
15.386	5	12	08	15q26.1	UNC45A, SMAP1, GCUNC45	P	UNC45, C. elegans, homolog of, A	611219	REc, R, H			7(Unc45a)
15.387	3	22	13	15q25.1	ADAMTS7	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 7	605009	REa, REc			
15.388	12	7	12	15q25.1	AGPHD1	P	Aminoglycoside phosphotransferase domain-containing protein 1	614681	REc			
15.389	6	7	04	15q25.2	BNC1	C	Basonuclin	601930	Psh, REc			
15.390	5	28	09	15q25.1	CHRNA3, LNCR2, PAOD2	C	Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3	118503	REa, H, A, REn		{Lung cancer susceptibility 2}, 612052 (3)	9(Acra3)
15.391	4	27	12	15q25.1	CHRNA5, LNCR2	C	Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5	118505	REa, H, Fd, A		{Lung cancer susceptibility 2}, 612052 (3); {Nicotine dependence, susceptibility to}, 612052 (3)	9(Acra5)
15.392	10	16	09	15q25.1	IREB2	P	Iron-responsive element-binding protein-2	147582	REa, REc			
15.393	12	10	13	15q25.1	MESDC1	P	Mesoderm development candidate 1	615466	R, REc, H			7(Mesdc1)
15.394	5	4	12	15q25.1	MIR184, MIRN184, KTCNCT, EDICT	P	Micro RNA 184	613146	REc		EDICT syndrome, 614303 (3)	9(Mir184)
15.395	5	25	13	15q25.1	MTHFS	P	5,10-methenyltetrahydrofolate synthetase	604197	REc			
15.396	12	17	07	15q25.1	PSMA4, PSC9, HC9	P	Proteasome subunit, alpha-type, 4	176846	R, REc			
15.397	1	16	07	15q25.1	ZFAND6, ZA20D3, AWP1	P	Zinc finger AN1 domain-containing protein 6	610183	REc			
15.398	4	9	96	15q25.1	IDH3A	P	Isocitrate dehydrogenase 3 (NAD+) alpha	601149	A			
15.399	11	11	12	15q25.1-q26.1	POROK4, DSAP2	P	Porokeratosis 4, disseminated superficial actinic	607728	Fd	between D15S1023 and D15S1030	Porokeratosis 4, disseminated superficial actinic (2)	
15.400	5	27	09	15q25.2	ADAMTSL3, KIAA1233	P	ADAMTS-like protein 3	609199	REc, H			7(Adamtsl3)
15.401	5	25	13	15q25.2	CPEB1	P	Cytoplasmic polyadenylation element-binding protein 1	607342	REc			
15.402	4	2	12	15q25.2	FAM103A1, RAM	P	Family with sequence similarity 103, member A1	614547	REc			
15.403	8	20	07	15q25.2	MEX3B, RKHD3	P	Mex-3, C. elegans, homolog of, B	611008	REc			
15.404	5	24	13	15q25.2	SCAND2	P	SCAN domain-containing 2	610417	REc, A			
15.405	3	31	09	15q25.2	SCARNA15, ACA45	P	Small cajal body-specific RNA 15	612675	REc			
15.406	2	4	15	15q25.2	WDR73, HSPC264, GAMOS	P	WD repeat-containing protein 73	616144	REc		Galloway-Mowat syndrome, 251300 (3)	
15.407	4	21	16	15q25.2	WHAMM, WHAMM, KIAA1971	P	Was protein homolog associated with actin, golgi membranes, and microtubules	612393	REc			
15.408	11	19	13	15q25.3	AGBL1, CCP4, FECD8	C	ATP/GTP-binding protein-like 1	615496	REc, REn		Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	
15.409	5	23	14	15q26.1	DET1	P	De-etiolated 1, Arabidopsis, homolog of	608727	REc			
15.410	9	1	15	15q25.3	ZNF592, KIAA0211	P	Zinc finger protein 592	613624	Fd, REc			
15.411	2	21	06	15q25.3-q26.1	CHNG3, RTSH	P	Hypothyroidism, congenital, nongoitrous, 3	609893	Fd	max lod at D15S655	Hypothyroidism, congenital, nongoitrous, 3 (2)	
15.412	12	18	01	15q26.1	CIB, KIP	P	Calcium- and integrin-binding protein (kinase-interacting protein)	602293	Psh, R, A			
15.413	5	21	07	15q25.3	PDE8A	P	Phosphodiesterase 8A	602972	REc			
15.414	6	7	04	15q25.3-q26.2	MDD2	P	Major depressive disorder 2	608691	Fd		Major depressive disorder 2, 608516 (2)	
15.415	3	15	13	15q26.3	ALDH1A3, ALDH6, MCOP8	P	Aldehyde dehydrogenase 1 family, member A3	600463	A		Microphthalmia, isolated 8, 615113 (3)	
15.416	8	19	13	15q26.1	CHD2, EEOC	P	Chromodomain helicase DNA binding protein-2	602119	R		Epileptic encephalopathy, childhood-onset, 615369 (3)	
15.417	12	4	90	15q14	CHRM5	P	Cholinergic receptor, muscarinic, 5	118496	A, REa			
15.418	12	9	98	15q26	IDDM3	C	Insulin-dependent diabetes mellitus-3	600318	Fd		{Diabetes mellitus, insulin-dependent, 3} (2)	
15.419	2	6	01	15q26.1	IQGAP1, SAR1	C	RASGAP-like with IQ motifs (sar1, S. pombe, homolog of)	603379	REa, REc	amplified in gastric cancer		
15.420	2	7	01	15q26.1	ISG20, HEM45	P	Interferon-stimulated gene, 20kD	604533	A			
15.421	3	23	14	15q26.3	LINS1, WINS1, FLJ10583, MRT27	P	Lines, Drosophila, homolog of, 1	610350	REc, Fd		Mental retardation, autosomal recessive 27, 614340 (3)	
15.422	12	3	03	15q26.3	MEF2A, ADCAD1	C	MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	600660	A, REa		{Coronary artery disease, autosomal dominant, 1}, 608320 (3)	7(Mef2a)
15.423	4	25	93	15q26.3	PCSK6, PACE4, SPC4	C	Proprotein convertase subtilisin/kexin type 6	167405	REa, A			7(Pcsk6)
15.424	4	16	11	15q26.1	PLIN1, PLIN, FPLD4	C	Perilipin 1	170290	A, H		Lipodystrophy, familial partial, type 4, 613877 (3)	7(Plin)
15.425	4	2	09	15q26.1	RLBP1	P	Retinaldehyde-binding protein-1, cellular	180090	REa, A		Fundus albipunctatus, 136880 (3); Retinitis punctata albescens, 136880 (3); Newfoundland rod-cone dystrophy, 607476 (3); Bothnia retinal dystrophy, 607475 (3)	7(Rlbp1)
15.426	12	4	08	15q26.1	SLCO3A1, OATPD, OATP3A1	C	Solute carrier organic anion transporter family, member 3A1	612435	R, REn			
15.427	6	28	02	15q25.1	STARD5	P	Start domain-containing protein 5	607050	REc			
15.428	7	13	98	15q26.1	STX	P	Sialyltransferase X	602546	A			
15.429	12	26	14	15q26	VVS	P	Syncope, familial vasovagal	609289	Fd		Syncope, familial vasovagal (2)	
15.430	3	19	09	15q26-qter	DEL15q26qter, C15DELq26qter	P	Chromosome 15q26-qter deletion syndrome	612626	Ch	contiguous gene deletion syndrome	Chromosome 15q26-qter deletion syndrome (4)	
15.431	10	25	12	15q26-qter	LVSKS	P	Levy-Shanske syndrome (tetrasomy 15q26)	614846	Ch		Levy-Shanske syndrome (4)	
15.432	8	29	08	15q26.1	ABHD2, LABH2	P	Abhydrolase domain-containing 2	612196	REc			16(Abhd2)
15.433	7	6	10	15q26.1	ACAN, AGC1, CSPG1, MSK16, SEDK	C	Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)	155760	S, A, Fd		Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3); Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)	7(Agc1)
15.434	11	27	13	15q26.1	C15orf38, ARPIN	P	Chromosome 15 open reading frame 38	615543	REc			
15.435	3	16	10	15q26.1	C15orf42, TRESLIN	P	Treslin	613298	REc			
15.436	10	27	08	15q26.1	CRTC3, TORC3	P	CREB-regulated transcription coactivator 3	608986	R, REc			
15.437	12	29	05	15q26.1	DIH1, HCD	P	Hernia, congenital diaphragmatic 1	142340	Ch		Hernia, congenital diaphragmatic 1 (2)	
15.438	7	13	93	15q26.1	FES	C	Oncogene FES, feline sarcoma virus	190030	S, A			7(Fes)
15.439	12	14	10	15q26.1	IDH2, IDPM, D2HGA2	C	Isocitrate dehydrogenase, mitochondrial	147650	S, A		D-2-hydroxyglutaric aciduria 2, 613657 (3)	7(Idh2)
15.440	6	16	06	15q26.1	ISG20L1, AEN	P	Interferon-stimulated exonuclease gene 20kD-like 1	610177	R, REc			
15.441	11	3	99	15q25.1	IL16, LCF	P	Interleukin 16	603035	Psh, A			7(Il16)
15.442	1	21	16	15q26.1	KIF7, HLS2, ACLS, JBTS12, AGBK	P	Kinesin family member 7	611254	REc	mutation identified in 1 HLS2 family and 1 AGBK family	?Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome, 200990 (3); Joubert syndrome 12, 200990 (3); ?Al-Gazali-Bakalinova syndrome, 607131 (3)	
15.443	10	13	15	15q26.1	MESP1	P	Mesoderm posterior bHLH transcription factor 1	608689	REc			
15.444	6	4	04	15q26.1	MESP2, SCDO2	P	Mesoderm posterior bHLH transcription factor 2	605195	REc		Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)	
15.445	3	23	09	15q26.1	MIR9-3, MIRN9-3	P	Micro RNA 9-3	611188	REc			
15.446	12	23	15	15q26.1	NGRN	P	Neurite outgrowth-associated protein	616718	REc			
15.447	10	25	12	15q26.1	PEX11A	P	Peroxisome biogenesis factor 11A	603866	R, REc			
15.448	5	29	10	15q26.1	PRC1	P	Protein regulating cytokinesis 1	603484	REc			
15.449	8	12	03	15q26.1	RECQL3, RECQ2, BLM, BS	C	DNA helicase, RecQ-like 3	604610	M, LD		Bloom syndrome, 210900 (3)	
15.450	2	28	03	15q26.1	RGMA, RGMA	P	RGM domain family, member A (repulsive guidance molecule)	607362	REc			4(Ephb2)
15.451	5	24	13	15q26.1	SV2B, KIAA0735	P	Synaptic vesicle glycoprotein 2B	185861	REc, R			
15.452	7	8	10	15q26.1	VPS33B	P	Vacuolar protein sorting 33, yeast, homolog of, B	608552	R		Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)	
15.453	5	22	14	15q26.2	NR2F2, TFCOUP2, ARP1, CHTD4	P	Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2)	107773	REa, A		Congenital heart defects, multiple types, 4, 615779 (3)	7(Tcfcoup2)
15.454	4	8	98	15q26.1-qter	OTSC1, OTS	P	Otosclerosis 1	166800	Fd		Otosclerosis 1 (2)	
15.455	4	7	15	15q26.2	MCTP2	C	Multiple C2 domains-containing transmembrane protein 2	616297	REc			
15.456	5	3	11	15q26.2	SPATA8, SRG8	P	Spermatogenesis-associated protein 8	613948	REc			
15.457	1	31	13	15q26.3	ASB7	P	Ankyrin repeat- and SOCS box-containing protein 7	615052	REc			
15.458	7	9	13	15q26.3	CERS3, LASS3, ARCI9	C	Ceramide synthase 3	615276	REc, Fd		Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	
15.459	2	24	11	15q26.3	CHSY1, KIAA0990, TPBS	P	Carbohydrate synthase 1	608183	REc, R		Temtamy preaxial brachydactyly syndrome, 605282 (3)	
15.460	4	27	07	15q26.3	LRRK1	P	Leucine-rich repeat kinase 1	610986	REc			
15.461	11	9	05	15q26.3	SEPS1, SELS, VIMP, ADO15	P	Selenoprotein S	607918	REc			
15.462	8	22	07	15q26.3	SNRPA1	C	Small nuclear ribonucleoprotein polypeptide A'	603521	R, Psh, A			7(Snrpa1)
15.463	4	19	06	15q26.3	TM2D3, BLP2	P	TM2 domain-containing protein 3	610014	R, REc			
15.464	1	30	01	15q21.2	ARPP19, ARPP16	P	cAMP-regulated phosphoprotein, 19kD	605487	R			
15.465	1	31	01	15q14	AVEN	P	Cell death regulator AVEN	605265	REc			
15.466	7	12	02	15q15.2	CCNDBP1, GCIP	P	Cyclin D-type-binding protein 1	607089	R			
15.467	4	26	90	Chr.15	COL1AR	P	Collagen I, alpha, receptor	120340	S			
15.468	3	3	03	15q15.1	DISPB, KIAA1742	P	Dispatched, Drosophila, homolog of, B	607503	R			
15.469	7	11	01	15q26.3	DMN	P	Desmuslin	606087	R			
15.470	1	24	93	15q21.1-q21.2	GALK2, GK2	P	Galactokinase-2	137028	Psh			
15.471	4	19	02	15q21.2	GNB5	P	Guanine nucleotide-binding protein, beta-5	604447	R			
15.472	5	22	03	15q25.1	MESDC2, MESD, BOCA, KIAA0081	P	Mesoderm development candidate gene 2	607783	Psh, H			7(Mesdc2)
15.473	7	11	01	15q15.1	PLA2G4B	P	Phospholipase A2, group IVB	606088	REc			
15.474	4	15	02	15q23	RPLP1	P	Ribosomal phosphoprotein, Large, P1	180520	R			
15.475	5	13	02	15q24.1	SCAMP2	P	Secretory carrier membrane protein 2	606912	R			
16.1	10	26	99	16p13.3	SYNGR3	P	Synaptogyrin 3	603927	A			
16.2	8	3	11	16p13.3	HBA1, HBH	C	Hemoglobin alpha-1	141800	HS	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Thalassemias, alpha-, 604131 (3); Methemoglobinemias, alpha- (3); Erythremias, alpha- (3); Heinz body anemias, alpha-, 140700 (3); Hemoglobin H disease, nondeletional, 613978 (3)	11(Hba)
16.3	8	30	11	16p13.3	HBA2, HBH	C	Hemoglobin alpha-2	141850	HS		Thalassemia, alpha-, 604131 (3); Heinz body anemia, 140700 (3); Erythrocytosis (3); Hypochromic microcytic anemia (3); Hemoglobin H disease, nondeletional, 613978 (3)	11(Hba)
16.4	1	12	89	16p13.3	HBQ1	P	Hemoglobin theta-1	142240	RE			
16.5	7	17	91	16p13.3	HBZ	P	Hemoglobin, zeta	142310	RE			
16.6	6	11	93	16pter-p13.3	HBHR, ATR1	C	Alpha-thalassemia/mental retardation syndrome, type 1	141750	Fd, RE, D	contiguous gene syndrome involving deletion of HBA1 and HBA2	Alpha-thalassemia/mental retardation syndrome, type 1 (4)	
16.7	10	15	95	16p13.3	MPG, MDG	P	N-methylpurine DNA glycosylase	156565	REa, REn	75kb upstream of HBZ		11(Mpg)
16.8	2	28	03	16pter-p13	CHDS1	P	Coronary heart disease, susceptibility to, 1	607339	Fd		{Coronary heart disease, susceptibility to} (2)	
16.9	1	26	97	16p13.3	ZNF75A	P	Zinc finger protein-75A	601473	REa			
16.10	12	21	09	16p13.2	ABAT, GABAT	P	4-aminobutyrate aminotransferase	137150	R		GABA-transaminase deficiency, 613163 (3)	
16.11	5	21	07	16p13.3	ABCA3, ABC3, SMDP3	P	ATP-binding cassette-3	601615	REc		Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	
16.12	11	20	98	16p13.3	ADCY9	P	Adenylate cyclase-9	603302	A			16(Adcy9)
16.13	8	24	04	16p13.3	ALG1, HMAT1, HMT1, CDG1K	P	Alg1, yeast, homolog of (beta-1,4 mannosyltransferase)	605907	REc		Congenital disorder of glycosylation, type Ik, 608540 (3)	
16.14	1	8	15	16p13.3	AXIN1, AXIN	P	Axis inhibitor 1	603816	REc	hypermethylation of AXIN1 promoter seen in 1 CDUP patient	Hepatocellular carcinoma, somatic, 114550 (3); ?Caudal duplication anomaly, 607864 (3)	
16.15	7	18	02	16p13.3	ATP6V0C, ATP6L, ATP6C	P	ATPase, H+ transporting, lysosomal, 16kD, V0 subunit c	108745	REc			
16.16	10	26	99	16p13.3	BAIAP3, BAP3	C	BAI1-associated protein 3	604009	A, R			
16.17	8	5	11	16p13.3	C1QTNF8, CTRP8	P	C1q- and tumor necrosis factor-related protein 8	614147	REc			
16.18	10	30	06	16p13.3	C16orf5	P	Chromosome 16 open reading frame 5	610503	A, Psh			
16.19	10	6	09	16p13.3	CACNA1H, EIG6, ECA6	P	Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	R, A		{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3); {Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)	17(Cacna1h)
16.20	8	29	08	16p13.3	CASKIN1, KIAA1306	P	CASK-interacting protein 1	612184	R, REc			
16.21	9	14	12	16p13.3	CCDC78, C16orf25, CNM4	P	Coiled-coil domain-containing protein 78	614666	REc		Myopathy, centronuclear, 4, 614807 (3)	
16.22	1	12	95	16p13.3	CCNF, FBX1	P	Cyclin F	600227	REn			17(Ccnf)
16.23	8	30	07	16p13.3	CEMP1, CP23	P	Cementum protein 1	611113	R, REc			
16.24	11	9	95	16p13.3	CGTHBA	P	Conserved gene telomeric to alpha globin cluster	600928	REn			
16.25	2	2	10	16p13.3	CHTF18, CHL12, CTF18	P	Chromosome transmission fidelity factor 18, S. cerevisiae, homolog of	613201	REc			
16.26	6	22	14	16p13.3	CLDN6	P	Claudin 6	615798	REc			
16.27	6	22	14	16p13.3	CLDN9	P	Claudin 9	615799	REc			
16.28	10	13	09	16p13.3	CORO7, POD1, CRN7	P	Coronin 7	611668	REc			
16.29	12	4	95	16p13.3	CREBBP, CBP, RSTS	C	CREB binding protein	600140	A, Ch	fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML	Rubinstein-Taybi syndrome, 180849 (3)	
16.30	7	18	14	16p13.3	DECR2, PDCR	P	2,4-dienoyl-CoA reductase 2, peroxisomal	615839	REc			
16.31	1	27	04	16p13.3	DNAJA3, TID1	P	DNAJ, E. coli, homolog of, subfamily A, member 3	608382	REc			
16.32	5	26	05	16p13.3	DNASE1, DNL1	P	Deoxyribonuclease I	125505	Psh		{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
16.33	9	9	10	16p13.3	DUP16p13.3, C16DUPq13.3	P	Chromosome 16p13.3 duplication syndrome	613458	Ch	contiguous gene duplication syndrome	Chromosome 16p13.3 duplication syndrome (4)	
16.34	9	10	98	16p13.3	E4F1, E4F	C	E4F transcription factor 1	603022	REc, Psh, A			17(E4fl)
16.35	7	18	14	16p13.3	ECI1, DCI	P	Enoyl-CoA delta isomerase 1	600305	Psh, A			
16.36	12	18	14	16p13.3	EEF2KMT, FAM86A	P	Eukaryotic elongation factor 2 lysine methyltransferase	615263	REc			
16.37	4	17	07	16p13.3	EME2	P	Essential meiotic endonuclease 1, S. pombe, homolog of, 2	610886	REc			
16.38	4	22	15	16p13.3	FAHD1, FLJ36880	P	Fumarylacetoacetate hydrolase domain-containing protein 1	616320	REc			
16.39	6	13	12	16p13.3	FBXL16, FBL16, C16orf22	P	F-box and leucine-rich repeat protein 16	609082	REc			17(Fbxl16)
16.40	11	13	07	16p13.3	GLIS2, NPHP7	C	GLIS family zinc finger protein 2	608539	REc		Nephronophthisis 7, 611498 (3)	16(Glis2)
16.41	4	29	03	16p13.3	GNG13	P	Guanine nucleotide-binding protein, gamma-13	607298	REc			
16.42	10	10	05	16p13.3	HBM	P	Hemoglobin mu	609639	REc	?functional		
16.43	5	23	94	16p13.3	HMOX2	P	Heme oxygenase, decycling, 2	141251	Psh, A			
16.44	2	11	14	16p13.3	IFT140, KIAA0590, SRTD9, MZSDS	P	Intraflagellar transport 140, Chlamydomonas, homolog of	614620	REc		Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3)	
16.45	9	20	14	16p13.3	IGFALS, ALS, ACLSD	P	Insulin-like growth factor-binding protein, acid-labile subunit	601489	REc		Acid-labile subunit, deficiency of, 615961 (3)	
16.46	5	2	05	16p13.3	IL32, NK4	P	Interleukin 32	606001	REc			
16.47	5	26	13	16p13.3	KCTD5	P	Potassium channel tetramerization domain-containing protein 5	611285	REc, R			
16.48	2	21	06	16p13.3	KREMEN2, KRM2	P	Kringle domain-containing transmembrane protein 2	609899	REc			
16.49	1	29	08	16p13.3	LMF1, TMEM112	P	Lipase maturation factor 1	611761	REc, H		Lipase deficiency, combined, 246650 (3)	17(Lmf1)
16.50	5	22	03	16p13.3	LUC7L	P	Luc7, S. cerevisiae, homolog of	607782	REc			17(Luc7l)
16.51	7	14	14	16p13.3	MAPK8IP3, SYD2, JSAP1, JIP3	P	Mitogen-activated protein kinase 8-interacting protein 3	605431	REc			
16.52	7	26	06	16p13.3	MCOPCT1	P	Microphthalmia with cataract 1	156850	Ch	proximal to HBA1	Microphthalmia with cataract 1 (2)	
16.53	8	20	07	16p13.3	METRN	P	Meteorin	610998	REc			17(Metrn)
16.54	2	12	03	16p13.3	MGRN1, KIAA0544	C	Mahogunin, ring finger 1	607559	R			16(Mgrn1)
16.55	3	23	09	16p13.3	MIR1225, MIRN1225	P	Micro RNA 1225	611621	REc			
16.56	8	8	13	16p13.3	MMP25, MMP20A	P	Matrix metalloproteinase 25	608482	REc, R			
16.57	3	11	08	16p13.3	MRPL28, MAAT1	P	Mitochondrial ribosomal protein L28	604853	R, REc			
16.58	3	31	11	16p13.3	MLST8, GBL, LST8, WAT1, POP3	P	MTOR-associated protein LST8	612190	REc			
16.59	9	24	11	16p13.3	NAA60, NAT15	P	N-alpha-acetyltransferase 60, NatF catalytic subunit	614246	REc			
16.60	3	2	10	16p13.3	NAGPA, UCE	P	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	607985	R, REc			
16.61	9	10	07	16p13.3	NARFL, IOP1	P	Nuclear prelamin A recognition factor-like	611118	REc			
16.62	6	15	99	16p13.3	NDUFB10	P	NADH-ubiquinone oxidoreductase 1 beta subcomplex, 10	603843	R			
16.63	3	7	14	16p13.3	NLRC3	P	NLR family, Caspase recruitment domain-containing 3	615648	REc			
16.64	6	18	97	16p13.3	NME4	P	Non-metastatic cells 4, protein expressed in	601818	REa, A			
16.65	12	29	06	16p13.3	NP60	P	Nuclear protein, 60kD	610660	REc			
16.66	2	25	15	16p13.3	NPW, PPNPW, PPL8	P	Neuropeptide W	607997	REc			
16.67	6	19	98	16p13.3	NTN2L	P	Netrin-2, chicken, homolog of, like	602349	REf			
16.68	2	22	07	16p13.3	NUBP2, CFD1	C	Nucleotide-binding protein 2	610779	R, H			17(Nubp2)
16.69	3	28	15	16p13.3	PAM16, MAGMAS, SMDMDM	P	Presequence translocase-associated motor 16, S. cerevisiae, homolog of	614336	REc		Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	
16.70	4	19	12	16p13.3	PAQR4	P	Progestin and ADIPOQ receptor family, member 4	614578	REc			
16.71	8	22	07	16p13.3	PDIA2, PDIP	P	Protein disulfide isomerase, family A, member 2	608012	Psh, A			
16.72	1	31	01	16p13.3	PDPK1, PDK1	P	3-phosphoinositide-dependent protein kinase 1	605213	REc			
16.73	10	12	90	16p13.3	PGP	C	Phosphoglycolate phosphatase	172280	S, F, Fd	no recombination with PKD1		
16.74	9	21	11	16p13.3	PKDTS	C	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	RE, Ch	contiguous gene syndrome caused by deletion of TSC2 and PKD1	Polycystic kidney disease, infantile severe, with tuberous sclerosis (4)	
16.75	8	8	13	16p13.3	PKMYT1, MYT1	P	Protein kinase, membrane-associated tyrosine/threonine, 1	602474	REc			
16.76	8	22	90	16p13.13	PRM1	C	Sperm protamine P1	182880	REa, A	16q21 = conflicting localization		16(Prm1)
16.77	8	22	90	16p13.13	PRM2	C	Sperm protamine P2	182890	H, RE	in same 4.8kb fragment as PRM2		16(Prm2)
16.78	3	22	07	16p13.3	PRSS21, ESP1	C	Protease, serine, 21 (testisin)	608159	A, R			
16.79	7	1	05	16p13.3	PRSS22	P	Protease, serine, 22	609343	REc			17(Prss22)
16.80	4	14	11	16p13.3	PRSS33, EOS	P	Protease, serine, 33	613797	REc			
16.81	9	7	10	16p13.3	PTX4	P	Pentraxin 4, long	613442	REc			17(Ptx4)
16.82	12	29	06	16p13.3	RAB11FIP3, EFERIN, KIAA0665	P	RAB11 family-interacting protein 3	608738	R, REc			
16.83	12	8	00	16p13.3	RAB26	P	RAS-associated protein RAB26	605455	Psh, R			
16.84	1	1	12	16p13.3	RHBDF1, IRHOM1, DIST1	C	Rhomboid 5, Drosophila, homolog of, 1	614403	REc, REn, H			11(Rhbdf1)
16.85	6	24	10	16p13.3	RHBDL, RRP	C	Rhomboid, Drosophila, homolog of	603264	REc			
16.86	4	15	11	16p13.3	RHOT2, MIRO2, ARHT2	P	Ras homolog gene family, member T2	613889	REc			17(Rhot2)
16.87	5	8	12	16p13.3	ROGDI, KTZS	P	Rogdi, Drosophila, homolog of	614574	REc		Kohlschutter-Tonz syndrome, 226750 (3)	
16.88	8	20	99	16p13.3	RS11	P	Regulator of G protein signaling 11	603895	REc			
16.89	8	20	99	16p13.3	RPS2	P	Ribosomal protein S2	603624	REa			
16.90	12	29	06	16p13.3	DEL16p13.3, RSTSS	P	Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome)	610543	Ch	contiguous gene deletion syndrome	Chromosome 16p13.3 deletion syndrome (4)	
16.91	9	18	12	16p13.3	SEPT12, SPGF10	P	Septin 12	611562	REc		Spermatogenic failure 10, 614822 (3)	
16.92	6	24	10	16p13.3	SEPX1, SELX	P	Selenoprotein X, 1	606216	R, REc			
16.93	1	7	02	16p13.3	SLC9A3R2, SIP1, NHERF2	P	Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 2	606553	REc			
16.94	5	23	11	16p13.3	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	P	Slx4, S. cerevisiae, homolog of	613278	REc		Fanconi anemia, complementation group P, 613951 (3)	
16.95	11	10	98	16p13.3	SOLH	P	Small optic lobes, Drosophila, homolog of	603267	A	conflicting localization to Xq24		
16.96	4	11	01	16p13.3	SOX8	P	SRY-box 8	605923	REc			
16.97	12	18	07	16p13.3	SPSB3, SSB3	P	SPRY domain- and SOCS box-containing 3	611659	REc			
16.98	1	29	01	16p13.3	SRL	P	Sarcalumenin	604992	REc			
16.99	12	5	08	16p13.3	SSTR5	C	Somatostatin receptor-5	182455	REa, A		Somatostatin analog, resistance to (3)	17(Sstr5)
16.100	5	22	14	16p13.3	STUB1, CHIP, SCAR16	P	STIP1 homologous and U box-containing protein 1	607207	R, REc		Spinocerebellar ataxia, autosomal recessive 16, 615768 (3)	
16.101	10	15	14	16p13.3	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	P	TBC1 domain family, member 24	613577	REc, Fd		Myoclonic epilepsy, infantile, familial, 605021 (3); Epileptic encephalopathy, early infantile, 16, 615338 (3); DOOR syndrome, 220500 (3); Deafness , autosomal recessive 86, 614617 (3); Deafness, autosomal dominant 65, 616044 (3)	
16.102	5	14	01	16p13.3	TBL3	P	Transducin-beta-like 3	605915	REa, R			
16.103	7	22	09	16p13.3	TELO2, TEL2, CLK2, KIAA0683, HCLK2	P	Telomere maintenance 2, S. cerevisiae, homolog of	611140	R			
16.104	2	25	16	16p13.3	THOC6, FSAP35, BBIS	P	THO complex subunit 6	615403	REc, Fd		Beaulieu-Boycott-Innes syndrome, 613680 (3)	
16.105	12	7	07	16p13.2	TMEM114	P	Transmembrane protein 114	611579	REc			
16.106	7	14	14	16p13.3	TMEM204, C16orf30, CLP24	C	Transmembrane protein 204	611002	REc			
16.107	12	23	02	16p13.3	TNFRSF12A, FN14, TWEAKR	P	Tumor necrosis factor receptor superfamily, member 12A	605914	A			17(Fn14)
16.108	4	25	93	16p13.13	TNP2	C	Transition protein-2 (during histone to protamine replacement)	190232	REn, A	in 13kb segment with PRM1 and PRM2		16(Tnp2)
16.109	3	23	05	16p13.3	TPSAB1, TPS1	C	Tryptase, alpha/beta-1	191080	REa, REn, A			
16.110	3	23	05	16p13.3	TPSB2, TPS2	C	Tryptase, beta 2	191081	REa, REn, A			
16.111	3	23	05	16p13.3	TPSD1, MCP7L1	C	Tryptase, delta-1	609272	A, REc			
16.112	7	1	05	16p13.3	TPSG1, TMT	P	Tryptase, gamma-1	609341	Psh, REc			17(Tpsg1)
16.113	2	26	10	16p13.3	TRAF7, RFWD1	P	TNF receptor-associated factor 7	606692	R, REc			
16.114	9	8	08	16p13.3	TRAP1, HSP75, HSP90L	C	Tumor necrosis factor receptor-associated protein 1	606219	REc			
16.115	2	14	02	16p13.3	TSC2, LAM	C	Tuberin (tuberous sclerosis 2 gene)	191092	Fd, Ch, D, REn	distal to PKD1	Tuberous sclerosis-2, 613254 (3); Lymphangioleiomyomatosis, somatic, 606690 (3)	17(Tsc2)
16.116	2	24	97	16p13.3	UBE2I	C	Ubiquitin-conjugating enzyme E2I (homologous to yeast UBC9)	601661	A			
16.117	12	20	05	16p13.3	UBN1	P	Ubinuclein 1	609771	REc			16(Ubn1)
16.118	2	3	99	16p13.2	USP7, HAUSP	P	Ubiquitin-specific protease-7, herpes virus-associated	602519	REc	previously reported to map to 3p21		
16.119	8	19	04	16p13.3	VASN	P	Vasorin	608843	REc			
16.120	3	29	07	16p13.3	WFIKKN1, WFIKKN	P	WAP, follistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 1	608021	REc			
16.121	6	15	99	16p13.3	ZNF174	P	Zinc finger protein-174	603900	REa, A			
16.122	6	18	99	16p13.3	ZNF205, ZNF210	P	Zinc finger protein-205	603436	REc			
16.123	1	27	04	16p13.3	ZNF213, CR53	P	Zinc finger protein 213	608387	REn, REc			
16.124	5	25	13	16p13.3	ZNF263	P	Zinc finger protein 263	604191	REc			
16.125	7	20	12	16p13.3	ZNF597	P	Zinc finger protein 597	614685	REc			
16.126	9	15	98	16q21	CSNK2A2	C	Casein kinase-2, alpha-prime polypeptide	115442	REa, A			8(Csnk2a2)
16.127	6	15	15	16p13.3	NTHL1, OCTS3, FAP3	P	Endonuclease III, E. coli, homolog of	602656	A		Familial adenomatous polyposis 3, 616415 (3)	
16.128	4	16	10	16p13.2	PMM2, CDG1A	C	Phosphomannomutase 2	601785	REa, REc, Fd, R		Congenital disorder of glycosylation, type Ia, 212065 (3)	
16.129	10	13	15	16p13.12	ERCC4, XPF, FANCQ, XFEPS	C	Excision-repair, complementing defective, in Chinese hamster, number 4	133520	S, A	mutation identified in 1 XFEPS patient	Xeroderma pigmentosum, group F, 278760 (3); ?XFE progeroid syndrome, 610965 (3); Fanconi anemia, complementation group Q, 615272 (3); Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	
16.130	10	12	09	16p13.3	GFER, ERV1, ALR	P	Growth factor, erv1, S. cerevisiae, homolog of (augmenter of liver regeneration)	600924	REn		Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)	17(Gfer)
16.131	12	7	98	16p13.3	PKD1	C	Polycystin-1	601313	F, Fd, REn		Polycystic kidney disease, adult type I, 173900 (3)	17(Pkd1)
16.132	5	28	03	16p13.13	LITAF, CMT1C	C	LPS-induced TNFA factor	603795	A, Fd		Charcot-Marie-Tooth disease, type 1C, 601098 (3)	
16.133	3	30	16	16p13.2	CARHSP1, CRHSP24	P	Calcium-regulated heat-stable protein 1	616885	REc			
16.134	3	25	16	16p13.2	DEL16p13.2, C16DELp13.2	P	Chromosome 16p13.2 deletion syndrome	616863	Ch		Chromosome 16p13.2 deletion syndrome (4)	
16.135	6	27	14	16p13.13	EMP2, NPHS10	P	Epithelial membrane protein 2	602334	REa, R, REc		Nephrotic syndrome, type 10, 615861 (3)	16(Emp2)
16.136	6	4	13	16p13.2	METTL22, C16orf68	P	Methyltransferase-like 22	615261	REc			
16.137	1	2	03	16p13.13	SOCS1, SSI1, CIS1, CISH1	P	Suppressor of cytokine signaling 1	603597	REc			
16.138	11	22	10	16p13.2-p13.1	ATF7IP2, MCAF2	P	Activating transcription factor 7-interacting protein 2	613645	REc			
16.139	2	21	11	16p13.13	BCAR4	P	Breast cancer antiestrogen resistance 4	613746	REc			
16.140	12	22	08	16p13.13	C16orf75, RMI2, BLAP18	P	BLM-associated protein, 18kD	612426	REc			
16.141	9	15	10	16p13.13	CLEC16A, KIAA0350	P	C-type lectin domain family 16, member A	611303	REc, R			
16.142	4	27	12	16p13.11	KIAA0430, LKAP, MARF1	P	KIAA0430 gene	614593	R, REc			
16.143	2	28	06	16p13.11	MYH11, AAT4, FAA4	C	Myosin, heavy polypeptide-11, smooth muscle	160745	REa, A, Ch, Fd	fused with CBFB by inversion in acute myelomonocytic leukemia	Aortic aneurysm, familial thoracic 4, 132900 (3)	16(Myh11)
16.144	1	15	14	16p13.12	CPPED1	P	Calcineurin-like phosphoesterase domain-containing protein 1	615603	REc			
16.145	7	20	12	16p13.12	MIR193B	P	Micro RNA 193B	614734	REc			16(Mir193b)
16.146	7	20	12	16p13.12	MIR365A	P	Micro RNA 365A	614735	REc			16(Mir365a)
16.147	3	20	14	16p13.12	MKL2, MRTFB	P	MKL1/myocardin-like 2	609463	REc			
16.148	6	1	15	16p13.12	PARN, DAN, DKCB6, PFBMFT4	P	Polyadenylate-specific ribonuclease	604212	R, REc		Dyskeratosis congenita, autosomal recessive 6, 616353 (3); Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	
16.149	4	26	10	16p13.12	SHISA9, CKAMP44	P	Shisa, Xenopus, homolog of, 9	613346	REc			16(Shisa9)
16.150	6	10	08	16p12.3	ACSM3, SAH	P	Acyl-CoA synthetase medium-chain family member 3	145505	REa, A		{?Hypertension, essential} (1)	
16.151	9	24	13	16p13.11	NOMO1	P	Nodal modulator 1	609157	REc			
16.152	9	24	13	16p13.11	NOMO3	P	Nodal modulator 3	609159	REc			
16.153	8	19	13	16p13.11	NTAN1	P	N-terminal asparagine amidase	615367	REc			
16.154	9	28	11	16p13.11	PDXDC1, KIAA0251	P	Pyridoxal-dependent decarboxylase domain-containing protein 1	614244	REc			
16.155	5	12	15	16p12.2	CRYM, DFNA40	P	Crystallin, mu	123740	Psh		Deafness, autosomal dominant 40, 616357 (3)	
16.156	11	1	99	16p13.11	ABCC1, MRP1, MRP	C	ATP-binding cassette, subfamily C, member 1 (multidrug resistance-associated protein 1)	158343	A			
16.157	2	24	12	16p13.11	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	C	ATP-binding cassette, subfamily C, member 6	603234	A, Fd, LD		Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum, forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)	
16.158	8	17	92	16p13.13	GSPT1	P	G1 to S phase transition-1	139259	REa, A			
16.159	2	25	16	16p13.11	NDE1, NUDE, LIS4, MHAC	P	Nude, A. nidulans, homolog of, 1	609449	R, REc, Fd	mutation identified in 1 MHAC family	Lissencephaly 4 (with microcephaly), 614019 (3); ?Microhydranencephaly, 605013 (3)	
16.160	11	2	01	16p13.11	NPIP	P	Nuclear pore complex-interacting protein	606406	A			
16.161	2	22	07	16p13.13	NUBP1, NBP	P	Nucleotide-binding protein 1	600280	R, H			16(Nubp1)
16.162	12	18	98	16p13.13	TNFRSF17, BCMA	P	Tumor necrosis factor receptor superfamily, member 17 (B-cell maturation factor)	109545	Ch			
16.163	5	22	14	16p12.3	XYLT1, XT1, DBQD2	P	Xylosyltransferase 1	608124	R		{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3); Desbuquois dysplasia 2, 615777 (3)	
16.164	11	2	01	16p12.1	CACNG3	C	Calcium channel, voltage-dependent, gamma-3 subunit	606403	REc			
16.165	8	21	91	16p12.2	CDR2	P	Cerebellar degeneration-related antigen-2, 62kD	117340	REa, A			7(Cdr2)
16.166	1	13	16	16p12.3	COQ7, CLK1, COQ10D8	C	COQ7, S. cerevisiae, homolog of	601683	Psh, A, R	mutation identified in 1 COQ10D8 patient	?Coenzyme Q10 deficiency, primary, 8, 616733 (3)	
16.167	6	18	99	16p13.12	PLA2G10, SPLA2, GXSPLA2	P	Phospholipase A2, group X	603603	A			
16.168	12	30	09	16p11.2	TAOK2, TAO2, KIAA0881, PSK, PSK1	C	Tao kinase 2	613199	R, REc			
16.169	11	19	12	16p12.2	EARS2, KIAA1970, COXPD12	P	Glutamyl-tRNA synthetase 2	612799	REc		Combined oxidative phosphorylation deficiency 12, 614924 (3)	
16.170	1	31	01	16p11.2	MVP, LRP	P	Major vault protein, rat, homolog of	605088	A			
16.171	9	22	04	16p13	ADHD1	C	Attention deficit-hyperactivity disorder, susceptibility to, 1	608903	Fd	max lod at D16S3114	{Attention deficit-hyperactivity disorder}, 143465 (2)	
16.172	10	08	08	16p13	BMIQ5	P	Body mass index quantitative trait locus 5	608558	Fd	near D16S404 and D16S764	[Body mass index QTL5] (2)	
16.173	11	19	13	16p13.2	GRIN2A, NMDAR2A, FESD, LKS	P	Glutamate receptor, ionotropic, N-methyl D-aspartate 2A	138253	A		Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	
16.174	2	8	16	16p13.3	CLUAP1, QILIN, FAP22, KIAA0643	C	Clusterin-associated protein 1	616787	R, REc			
16.175	10	3	07	16p13.3	CLCN7, CLC7, OPTA2, OPTB4	C	Chloride channel-7	602727	A		Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis, autosomal dominant 2, 166600 (3)	
16.176	7	1	11	16p13.3	HAGH, GLO2	C	Hydroxyacyl glutathione hydrolase; glyoxalase II	138760	S		[Glyoxalase II deficiency], 614033 (1)	
16.177	8	30	01	16p12.2	IGSF6, DORA	P	Immunoglobulin superfamily, member 6	606222	R			7(Igsf6)
16.178	1	24	09	16p13.3	MEFV, MEF, FMF	C	Pyrin (marenostrin)	608107	Fd, LD	between D16S80 and D16S283	Familial Mediterranean fever, AR, 249100 (3); Familial Mediterranean fever, AD, 134610 (3)	16(Mefv)
16.179	7	22	09	16p13.13	MHC2TA, C2TA	P	MHC class II transactivator	600005	A, R		Bare lymphocyte syndrome, type II, complementation group A, 209920 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
16.180	5	26	13	16p13.3	NOXO1	P	NADPH oxidase organizer 1	611256	REc			17(Noxo1)
16.181	11	5	98	16p13.3	OR1F1, OLFMF	P	Olfactory receptor, family 1, subfamily F, member 1	603232	REn			
16.182	8	10	98	16p13.3	PPL	P	Periplakin	602871	R, H			16(Ppl)
16.183	9	8	11	16p13.3	RBFOX1, 2BP1, FOX1, HRNBP1	C	RNA-binding protein FOX1, C. elegans, homolog of, 1	605104	Ch, A, REc			
16.184	7	17	14	16p13.13	RSL1D1, CSIG, PBK1	P	Ribosomal L1 domain-containing protein 1	615874	REc			
16.185	9	15	98	16p13.13	SNN	C	Stannin	603032	Psh, H			16(Snn)
16.186	8	24	09	16p13.3	TIGD7, SANCHO	P	Tigger transposable element-derived gene 7	612969	REc			
16.187	11	5	98	16p13.3	ZNF200	P	Zinc finger protein-200	603231	REn			
16.188	7	19	06	16p13-p12	IHPS2	P	Pyloric stenosis, infantile hypertrophic, 2	610260	Fd		Pyloric stenosis, infantile hypertrophic, 2 (2)	
16.189	10	12	09	16p12.2	SCNN1B, BESC1	C	Sodium channel, nonvoltage-gated 1, beta	600760	REa, Fd, A, REc		Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	7(Scnn1b)
16.190	10	12	09	16p12.2	SCNN1G, PHA1, BESC3	C	Sodium channel, nonvoltage-gated 1, gamma	600761	Fd, REn, A, REc	same 400kb fragment as SCNN1B	Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	7(Scnn1g)
16.191	10	15	95	16p13.3	TFAP4	L	Transcription factor AP-4 (activating enhancer-binding protein 4)	600743	H			16(Tfp4)
16.192	12	1	11	16p12.3	ACSM1, MACS1	C	Acyl-CoA synthetase medium-chain family, member 1	614357	REc			
16.193	12	1	11	16p12.3	ACSM2A	P	Acyl-CoA synthetase medium-chain family, member 2A	614358	REc			
16.194	5	29	12	15q21.1	PATL2, PAT1A	P	Protein associated with topoisomerase II, S. Cerevisiae, homolog of	614661	REc			
16.195	12	1	11	16p12.3	ACSM2B, HXMA	P	Acyl-CoA synthetase medium-chain family, member 2B	614359	REc			
16.196	12	1	11	16p12.3	ACSM5	P	Acyl-CoA synthetase medium-chain family, member 5	614361	REc			
16.197	4	8	13	16p12.3	CCP110, CP110, KIAA0419	P	Centrosomal coiled-coil protein, 110kD	609544	R, REc			
16.198	1	8	15	16p12.3	DCUN1D3, SCCRO3	P	DCN1 domain-containing protein 3	616167	REc			
16.199	2	1	11	16p12.3	GP2	P	Glycoprotein 2, zymogen granule membrane	602977	REc	previously assigned to chr.9		
16.200	7	11	12	16p12.3	LYRM1	P	LYR motif-containing protein 1	614709	REc			
16.201	9	24	13	16p12.3	NOMO2	P	Nodal modulator 2	609158	REc			
16.202	4	6	15	16p12.3	TMEM159	P	Transmembrane protein 159	611304	REc			
16.203	12	1	15	16p12.3	THUMPD1	P	THUMP domain-containing protein 1	616662	REc			
16.204	11	3	09	16p12.3	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	C	Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)	191845	REa, Fd		Hyperuricemic nephropathy, familial juvenile 1, 162000 (3); Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	7(Umod)
16.205	5	7	01	16p12.3	GPRC5B, RAIG2	C	G protein-coupled receptor, family C, group 5, member B	605948	REc			
16.206	4	21	10	16p12.1	LCMT1	P	Leucine carboxyl methyltransferase 1	610286	R, REc			
16.207	6	15	99	16p12.2	NDUFAB1	P	NADH-ubiquinone oxidoreductase 1, alpha/beta subcomplex, 1	603836	R			
16.208	5	12	98	16p12.3-p12.1	RP22	P	Retinitis pigmentosa-22	602594	Fd		Retinitis pigmentosa 22 (2)	
16.209	3	9	10	16p12.2	ANKS4B, HARP, FLJ38819	P	Ankyrin repeat and sterile alpha motif domain-containing protein 4B	609901	REc, H			7(Harp)
16.210	3	14	07	16p12.1	ARHGAP17, RICH1	P	RHO GTPase-activating protein 17	608293	R, REc			
16.211	9	10	09	16p12.2	DCTN5, p25	P	Dynactin 5	612962	REc			
16.212	12	10	13	16p12.2	ERN2	P	Endoplasmic reticulum-to-nucleus signaling 2	604034	R, H, REc			7(Ern2)
16.213	6	18	02	16p12.2	OTOA, DFNB22	P	Otoancorin	607038	REc, Fd		Deafness, autosomal recessive 22, 607039 (3)	
16.214	11	1	10	16p12.2-p11.2	DEL16p12.1p11.2, C16DELp12.1p11.2	P	Chromsome 16p12.2-p11.2 deletion syndrome	613604	Ch	17.1-8.7 Mb contiguous gene deletion syndrome	Chromosome 16p12.2-p11.2 deletion syndrome (4)	
16.215	9	25	12	16p12.2-q12.1	MRT10, MRT20	P	611096	611096	Fd	between rs724466 and rs3901517, rs7197568 and rs71972227	Mental retardation, autosomal recessive 10/20 (2)	
16.216	1	5	12	16p12.1	CLN3, BTS	C	Battenin	607042	F, Fd		Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	7(Cln3)
16.217	7	17	14	16p12.1	GTF3C1	P	General transcription factor 3C, polypeptide 1	603246	REc			
16.218	3	31	08	16p12.1	JMJD5	P	Jumonji domain-containing protein 5	611917	REc			
16.219	2	3	16	16p12.1	KATNIP, KIAA0556	P	Katanin-interacting protein	616650	R, REc	mutation identified in 1 JBTS26 family	?Joubert syndrome 26, 616784 (3)	
16.220	3	23	14	16p11.2	PYDC1, POP1, PYC1, ASC2	P	Pyrin domain-containing protein 1	615700	REc			
16.221	5	24	13	16p12.1	SLC5A11, KST1, SGLT6, SMIT2	P	Solute carrier family 5 (sodium/glucose cotransporter), member 11	610238	REc, A			
16.222	1	27	04	16p12.1	XPO6, EXP6, KIAA0370	P	Exportin 6	608411	R, REc			
16.223	3	20	06	16p12.1	IL4R, IL4RA	P	Interleukin-4 receptor	147781	A, REa		{Atopy, susceptibility to}, 147050 (3); {AIDS, slow progression to}, 609423 (3)	7(Il4r)
16.224	1	11	07	16p12.1-p11.2	MMVP1, MVP, PMV	P	Mitral valve prolapse, myxomatous 1	157700	Fd		Mitral valve prolapse, myxomatous 1 (2)	
16.225	1	9	09	16p11.2	PHKG2, GSD9C	P	Phosphorylase kinase, gamma 2 (testis/liver)	172471	REa		Glycogen storage disease IXc, 613027 (3); Cirrhosis due to liver phosphorylase kinase deficiency (3)	
16.226	5	27	97	16p11.2	SULT1A1, STP1, STP, PST	P	Sulfotransferase family 1A, phenol-preferring, member 1	171150	Psh			7(Stp)
16.227	8	18	99	16p11.2	SULT1A2, STP2	C	Sulfotransferase family 1A, phenol-preferring, member 2	601292	Psh, REn	45kb from STP1		7(Stp)
16.228	10	8	96	16p11.2	ATP2A1, SERCA1	C	ATPase, Ca++ transporting, fast-twitch, 1	108730	REa, A		Brody myopathy, 601003 (3)	7(Atp2a1)
16.229	5	4	12	16p12	DEL16p12.1, C16DELp12.1	P	Chromosome 16p12.1 deletion syndrome, 520kb	136570	Ch	between 21.85-22.37 Mb	Chromosome 16p12.1 deletion syndrome, 520kb (4)	
16.230	4	27	01	16p12.3	DNAH3, DNAHC3B	P	Dynein, axonemal, heavy chain 3	603334	A, R			
16.231	6	6	00	16p12.2	HS3ST2, 30ST2	P	Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 2	604056	REc			7(30st2)
16.232	10	5	07	16p12	MAFD4, BPAD	P	Major affective disorder 4	611247	Fd	max lod at D16S769	Major affective disorder 4 (2)	
16.233	4	22	10	16p12.2	PALB2, FANCN, PNCA3	P	Partner and localizer of BRCA2	610355	REc		Fanconi anemia, complementation group N, 610832 (3); {Breast cancer, susceptibility to}, 114480 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)	
16.234	9	14	05	16p13.11	RRN3, TIFIA	P	RRN3, S. cerevisiae, homolog of	605121	REc			
16.235	6	27	02	16p12.3	SMG1, LIP, KIAA0421	P	SMG1, C. elegans, homolog of	607032	R, A			
16.236	1	31	07	16p12.1	TNRC6A, GW182, KIAA1460	C	Trinucleotide repeat-containing gene 6A	610739	R, REc			
16.237	3	8	13	16p12.2	UQCRC2, MC3DN5	P	Ubiquinol-cytochrome c reductase core protein II	191329	A		Mitochondrial complex III deficiency, nuclear type 5, 615160 (3)	
16.238	7	19	10	16p12.3-p12.2	ZP2	P	Zona pellucida glycoprotein 2	182888	REc			
16.239	5	2	01	16p12.1	AQP8	P	Aquaporin 8	603750	REa, A, H			7(Aqp8)
16.240	3	7	14	16p12.3	ARL6IP1, KIAA0069, SPG61	P	ADP-ribosylation factor-like 6 interacting protein 1	607669	A	mutation identified in 1 family	?Spastic paraplegia 61, autosomal recessive, 615685 (3)	7(Arl6ip)
16.241	6	24	05	16p12-p11.2	EPRPDC	P	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	Fd	between D16S3133 and D16S3131	Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp (2)	
16.242	2	17	09	16p12.3	GDE1, MIR16	P	Glycerophosphodiester phosphodiesterase 1	605943	REc			
16.243	2	15	12	16p11.2	HSD3B7, CBAS1	C	3-beta-hydroxy-delta-5-C27-steroid oxidoreductase	607764	R		Bile acid synthesis defect, congenital, 1, 607765 (3)	
16.244	4	10	02	16p11.2	PYCARD, TMS1, ASC	P	PYD and CARD domain-containing protein (target of methylation-induced silencing 1)	606838	A, R			
16.245	8	4	98	16p12.1	RBBP6	P	Retinoblastoma-binding protein-6	600938	A			
16.246	1	13	99	16p11.2	PPP4C, PP4, PPX	P	Protein phosphatase 4, catalytic subunit	602035	A			
16.247	3	20	16	16q12.1	CNEP1R1, NEP1R1, TMEM188	P	C-terminal domain nuclear envelope phosphatase 1 regulatory subunit 1	616869	REc			
16.248	8	24	09	16p11.2	ALDOA, GSD12	C	Aldolase A, fructose-bisphosphatase	103850	REa, REb, A, REc	pseudogenes on 3 and 10	Glycogen storage disease XII, 611881 (3)	
16.249	6	3	14	16p12.1	APOBR, APOB48R	C	Apolipoprotein B receptor	605220	A, REc			
16.250	8	22	14	16p11.2	ARMC5, AIMAH2	P	Armadillo repeat-containing protein 5	615549	REc		ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3)	
16.251	11	12	12	16p11.2	BCKDK, BDK, BCKDKD	P	Branched-chain alpha-keto acid dehydrogenase kinase	614901	REc		Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)	
16.252	4	26	10	16p11.2	CCDC101, STAF36	P	Coiled-coil domain-containing protein 101	613374	REc			
16.253	12	15	10	16p11.2	CD19, CVID3	P	CD19 antigen	107265	Psh, A		Immunodeficiency, common variable, 3, 613493 (3)	
16.254	11	11	14	16p11.2	CD2BP2	P	CD2 antigen-binding protein 2	604470	REc			
16.255	9	12	13	16p11.2	CORO1A, TACO, CLIPINA, IMD8	P	Coronin 1A	605000	REc		Immunodeficiency 8, 615401 (3)	
16.256	12	6	11	16p11.2	BMIQ16, DEL16p.11.2, C16DELp11.2	P	Chromosome 16p11.2 deletion syndrome, 220kb	613444	Ch		Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass index QTL16] (4)	
16.257	7	18	14	16p11.2	DCTPP1	P	dCTP pyrophosphatase 1	615840	REc			
16.258	6	7	12	16p11.2	DEL16p11.2, C16DELp11.2, AUTS14A	P	Chromosome 16p11.2 deletion syndrome, 593kb	611913	Ch		Chromosome 16p11.2 deletion syndrome, 593kb (4); {Autism susceptibility 14A} (2)	
16.259	6	7	12	16p11.2	DUP16p11.2, C16DUPp11.2, AUTS14B	P	Chromosome 16p11.2 duplication syndrome	614671	Ch		Chromosome 16p11.2 duplication syndrome (4); {Autism, susceptibility to, 14B} (2)	
16.260	1	12	07	16p11.2	DOC2A	P	Double C2-like domain-containing protein, alpha	604567	R, REc			
16.261	10	3	07	16p11.2	EIF3C, EIF3S8	P	Eukaryotic translation initiation factor 3, subunit C	603916	REc			
16.262	1	25	05	16p11.2	ERAF, EDRF, AHSP	P	Erythroid-associated factor (alpha-hemoglobin stabilizing protein)	605821	REc			
16.263	4	17	13	16p11.2	FAM57B	P	Family with sequence similarity 57, member B	615175	REc			
16.264	1	11	16	16p11.2	FBRS, FBS1	P	Fibrosin	608601	REc			
16.265	7	1	11	16p11.2	FBXL19, FBL19	P	F-box and leucine-rich repeat protein 19	609085	REc			
16.266	7	8	15	16p11.2	FUS, TLS, ALS6, ETM4	C	Fusion, derived from 12-16 translocation, malignant liposarcoma	137070	Ch, RE, REc	fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3); Tremor, hereditary essential, 4, 614782 (3)	
16.267	4	22	15	16p11.2	GDPD3, GDE7	P	Glycerophosphodiester phosphodiesterase domain-containing protein 3	616318	REc			
16.268	7	20	12	16p11.2	HIRIP3	P	HIRA-interacting protein 3	603365	REc			
16.269	6	6	00	16p12.1	HS3ST4, 30ST4	P	Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4	604059	REc			7(30st4)
16.270	3	31	98	16p11.2	ITGAD, CD11D	P	Integrin, alpha D	602453	A			
16.271	6	11	92	16p11.2	ITGAL, CD11A, LFA1A	C	Integrin, alpha-L (antigen CD11A (p180), lymphocyte function-associated antigen-1, alpha polypeptide)	153370	S, REa, A			7(Ly15)
16.272	9	24	08	16p11.2	ITGAM, CR3A, CD11B, MAC1A, SLEB6	C	Integrin, alpha-M (complement component receptor-3, alpha; antigen CD11B (p170); macrophage antigen, alpha polypeptide)	120980	RE, A	?in same restriction fragment as LFA1A	{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	
16.273	1	9	94	16p11.2	ITGAX, CD11C	P	Integrin, alpha-X (antigen CD11C (p150), alpha polypeptide)	151510	REa, A			
16.274	8	29	13	16p11.2	KAT8, MYST1, MOF	P	K(lysine) acetyltransferase 8	609912	REc			
16.275	10	1	04	16p11.2	KCTD13, POLDIP1, FKSG86	P	Potassium channel tetramerization domain-containing 13	608947	A			
16.276	1	25	12	16p11.2	KIF22, KNSL4, KID, OBP, SEMDJL2	C	Kinesin family member 22	603213	REc, A		Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	
16.277	3	3	03	16p11.2	LAT	P	Linker for activation of T cells	602354	A			
16.278	5	19	97	16p11.2	MAPK3, PRKM3, ERK1	P	Mitogen-activated protein kinase 3	601795	REa, A			7(Prkm3)
16.279	10	26	98	16p11.2	MAZ, ZF87, PUR1	C	MYC-associated zinc finger protein	600999	A			
16.280	3	30	12	16p11.2	NFATC2IP, NIP45	P	NFATC2-interacting protein	614525	REc			
16.281	9	10	12	16p11.2	NUPR1, COM1, p8	P	Nuclear protein, transcriptional regulator, 1	614812	Psh			
16.282	7	22	09	16p11.2	ORAI3, TMEM142C	P	ORAI calcium release-activated calcium modulator 3	610930	REc			
16.283	7	14	14	16p11.2	PAGR1, C16orf53, PA1	P	PAXIP1-associated glutamate-rich protein 1	612033	REc			
16.284	8	13	91	16p12.2-p12.1	PRKCB1, PKCB	P	Protein kinase C, beta 1 polypeptide	176970	REa, A			
16.285	11	21	12	16p11.2	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	P	Proline-rich transmembrane protein 2	614386	Fd, REc		Episodic kinesigenic dyskinesia 1, 128200 (3); Seizures, benign familial infantile, 2, 605751 (3); Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	
16.286	5	26	13	16p11.2	PRSS53, POL3S	P	Protease, serine, 53	610561	REc			
16.287	4	1	96	16p11.2	PRSS8	P	Protease, serine, 8 (prostasin)	600823	A			
16.288	5	26	13	16p11.2	PRSS36	P	Protease, serine, 36	610560	REc			
16.289	7	9	06	16p11.2	QPRT	P	Quinolinate phosphoribosyltransferase	606248	R			
16.290	10	2	13	16p11.2	RABEP2	P	RAB GTPase-binding effector protein 2	611869	REc			
16.291	4	21	14	16p11.2	RNF40, BRE1B, RBP95, KIAA0661	P	Ring finger protein 40	607700	REc			
16.292	2	15	12	16p11.2	SRCAP, SWR1, KIAA0309, FLHS	P	SNF2-related CBP activator protein	611421	R, REc		Floating-Harbor syndrome, 136140 (3)	
16.293	2	1	11	16p11.2	SEPHS2, SPS2	P	Selenophosphate synthetase 2	606218	REc			7(Sps2)
16.294	7	22	09	16p11.2	SEPT1, DIFF6	P	Septin 1	612897	REc			
16.295	8	21	07	16p11.2	SETD1A, SET1A, SET1, KIAA0339	P	SET domain-containing protein 1A	611052	R, REc			
16.296	12	1	15	16p11.2	SEZ6L2, BSRPA	P	SEZ6-like protein 2	616667	REc			
16.297	6	3	14	16p11.2	SH2B1, SH2B, KIAA1299	P	SH2B adaptor protein 1	608937	REc, R			7(Sh2b)
16.298	12	10	02	16p11.2	SLC5A2, SGLT2	P	Solute carrier family 5 (sodium/glucose cotransporter), member 2	182381	REa		Renal glucosuria, 233100 (3)	
16.299	7	14	14	16p11.2	SLX1A, GIYD1	P	SLX1 structure-specific endonuclease subunit, S. cerevisiae, homolog of, A	615822	REc			
16.300	7	14	14	16p11.2	SLX1B, GIYD2	P	SLX1 structure-specific endonuclease subunit, S. cerevisiae, homolog of, B	615823	REc			
16.301	10	12	90	16p11.2	SPN, LSN, CD43	C	Sialophorin (leukosialin)	182160	REa, A			7(Ly48)
16.302	2	17	09	16p11.2	SPNS1, SPIN1	P	Spinster, Drosophila, homolog of, 1	612583	REc			
16.303	1	21	11	16p11.2	STX4, STX4A	P	Syntaxin 4	186591	REc			
16.304	8	18	99	16p11.2	SULT1A3, STM	C	Sulfotransferase family 1A, phenol-preferring, member 3	600641	REa, Psh			
16.305	7	14	14	16p11.2	SULT1A4	P	Sulfotransferase family 1A, cytosolic, phenol-preferring, member 4	615819	REc			
16.306	1	12	15	16p11.2	STX1B, GEFSP9	P	Syntaxin 1B	601485	A		Generalized epilepsy with febrile seizures plus, type 9, 616172 (3)	
16.307	1	27	11	16p11.2	TBC1D10B	P	TBC1 domain family, member 10B	613620	REc			
16.308	9	24	15	16p11.2	TBX6, SCDO5	C	T-box 6	602427	A, H, R		Spondylocostal dysostosis 5, 122600 (3)	7(Tbx6)
16.309	4	23	09	16p11.2	TGFB1I1, ARA55, HIC5	P	Transforming growth factor, beta-1-induced 1	602353	Psh, A			
16.310	3	9	10	16p11.2	TRIM72, MG53	P	Tripartite motif-containing protein 72	613288	REc			
16.311	1	5	07	16p11.2	TUFM, EFTU, COXPD4	C	Tu translation elongation factor, mitochondrial	602389	Psh, A	pseudogene on chr.17	Combined oxidative phosphorylation deficiency 4, 610678 (3)	
16.312	4	21	04	16p11.2	VKORC1, VKOR, VKCFD2, FLJ00289	C	Vitamin K epoxide reductase complex, subunit 1	608547	REn, REc, Fd, H		Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3); Warfarin resistance, 122700 (3)	
16.313	12	28	08	16p11.2	YPEL3	P	Yippee-like 3	609724	REc			7(Ypel3)
16.314	1	31	01	16p11.2	CTF1, CT1	P	Cardiotrophin 1	600435	A, R			
16.315	7	21	14	16p11	INV16p11	P	Chromosome 16p11 inversion (0.45Mb)	615835	Ch			
16.316	11	5	04	16p11.2	ATXN2L, A2D	P	Ataxin 2-like	607931	A	pseudogene at 7p21		
16.317	4	17	01	16p11.2	BCL7C	P	B-cell CLL/lymphoma 7C	605847	A			
16.318	5	3	13	16p12.1	IL21R	C	Interleukin 21 receptor	605383	R, REc, Ch	fusion partner with BCL6	[IgE, elevated level of], 147050 (3); Immunodeficiency, primary, autosomal recessive, IL21R-related, 615207 (3)	
16.319	3	22	07	16p12.1-p11.2	IL27, IL30	P	Interleukin 27	608273	REc			
16.320	7	7	04	16p12.2	COG7, CDG2E	C	Component of oligomeric golgi complex 7	606978	REc		Congenital disorder of glycosylation, type IIe, 608779 (3)	
16.321	3	13	08	16p13.3	GNPTAG	C	N-acetylglucosamine-1-phosphotransferase, gamma subunit	607838	REc		Mucolipidosis III gamma, 252605 (3)	
16.322	1	31	02	16p	IBD8	P	Inflammatory bowel disease 8	606668	Fd		{Inflammatory bowel disease 8} (2)	
16.323	8	20	99	16p12.3	RPS15A	P	Ribosomal protein S15a	603674	REa, R			
16.324	8	30	02	16q21	CX3CL1, SCYD1, NTT, NTN	C	Chemokine, C-X3-C motif, ligand 1 (fractalkine; neurotactin)	601880	R, Psh, REc			8(Ntt)
16.325	1	22	07	16q	PSORS8	P	Psoriasis susceptibility 8	610707	Fd	proximal to D16S3034	{Psoriasis susceptibility 8} (2)	
16.326	2	27	02	16q	SLI1	P	Specific language impairment QTL, 1	606711	Fd		Specific language impairment QTL, 1 (2)	
16.327	9	2	96	16q	WT3	P	Wilms tumor-3	194090	D	loss of heterozygosity	Wilms tumor, type 3 (2)	
16.328	7	23	03	16q12.1	NEOT2	P	Neuropilin and tolloid like 2	607974	REc			
16.329	2	12	07	16q11-q22	AA2	P	Alopecia areata 2	610753	Fd	max lod at D16S415	Alopecia areata 2 (2)	
16.330	12	9	05	16q11.1-q22	DUPC1	P	Dupuytren contracture 1	126900	Fd	max lod at D16S415	Dupuytren contracture 1 (2)	
16.331	12	21	09	16p11.2	BOLA2	P	BolA, E. coli, homolog of, 2	613182	REc			
16.332	7	10	08	16q11.2	MYLK3, MLCK	P	Myosin light chain kinase 3	612147	REc, H			8(Mylk3)
16.333	8	20	07	16q11.2	SHCBP1, PAL	P	SHC SH2 domain-binding protein 1	611027	R, REc			
16.334	7	12	12	16q12.2	IRX5, HMMS	P	Iroquois homeo box protein 5	606195	A		Hamamy syndrome, 611174 (3)	
16.335	7	8	03	16q12.2	IRX6, IRX7	P	Iroquois homeo box protein 6	606196	A			
16.336	3	31	15	16q12.1	NKD1	P	Naked cuticle, Drosophila, homolog of, 1	607851	REc			
16.337	1	12	11	16q12.1	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	C	Nucleotide-binding oligomerization domain protein 2	605956	REc, Fd		{Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580 (3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)	
16.338	3	15	11	16q11.2	ORC6, ORC6L	P	Origin recognition complex, subunit 6, S. cerevisiae, homolog of	607213	REc		Meier-Gorlin syndrome 3, 613803 (3)	
16.339	5	28	98	16q12.1	SIAH1	C	Seven in absentia, Drosophila, homolog of, 1	602212	A			
16.340	4	10	15	16q11.2	VPS35, MEM3, PARK17	P	Vacuolar protein sorting 35, yeast, homolog of	601501	REc		{Parkinson disease 17}, 614203 (3)	
16.341	10	25	12	16q12.1	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	P	Zinc finger protein 423	604557	R		Nephronophthisis 14, 614844 (3); Joubert syndrome 19, 614844 (3)	8(Zfp423)
16.342	3	21	95	16q12.1	ADCY7	P	Adenylate cyclase-7	600385	Psh, REc			
16.343	6	17	08	16q12.1	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	P	CYLD gene	605018	Fd, REc	behaves as tumor suppressor	Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome, 605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)	
16.344	2	10	00	16q12.1	PHKB	C	Phosphorylase kinase, beta polypeptide	172490	REa, A		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	
16.345	1	27	11	16q12.1	ABCC11, MRP8, EWWD, WW	C	ATP-binding cassette, subfamily C, member 11	607040	R, REc, Fd		[Earwax, wet/dry], 117800 (3); [Axillary odor, variation in], 117800 (3); [Colostrum secretion, variation in], 117800 (3)	
16.346	6	28	02	16q12.1	ABCC12, MRP9	P	ATP-binding cassette, subfamily C, member 12	607041	R, REc			
16.347	9	9	09	16q12.1	CLN1	P	Precerebellin 1	600432	REc			8(Cbln1)
16.348	11	4	08	16q11.2	DNAJA2, DJ3, CPR3	P	DNAJ/HSP40 homolog, subfamily A, member 2	611322	R, REc			
16.349	3	28	15	16q11.2	GPT2, ALT2, MRT49	P	Glutamate pyruvate transaminase 2	138210	REc	mutation identified in 1 MRT49 family	?Mental retardation, autosomal recessive 49, 616281 (3)	
16.350	12	17	12	16q12.1	HEATR3, SYO1	P	HEAT repeat-containing protein 3	614951	REc			
16.351	2	23	08	16q12.1	ITFG1, TIP	P	Integrin-alpha FG-gap repeat-containing protein 1	611803	R, REc			
16.352	6	29	04	16q12.1	SALL1, HSAL1, TBS	P	Sal-like 1	602218	Ch, A		Townes-Brocks syndrome, 107480 (3); Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	8(Sall1)
16.353	2	25	10	16q12.1	SNX20, SLIC1	P	Sorting nexin 20	613281	REc			
16.354	4	24	09	16q12.1	STHAG2, HYD2	P	Tooth agenesis, selective, 2	602639	Fd		Tooth agenesis, selective, 2 (2)	
16.355	6	7	12	16q12.1-q23.1	STUT4	P	Stuttering, familial persistent, 4	614668	Fd	max lod at D16S3043	Stuttering, familial persistent, 4 (2)	
16.356	5	21	07	16q12.2	AKTIP, FTS, FT1	P	AKT_interacting protein	608483	REc			
16.357	5	2	16	16q12.2	CHD9, CREMM, PRIC320, KIAA0308	P	Chromodomain helicase DNA-binding protein 9	616936	R			
16.358	2	13	14	16q12.2	CRNDE	P	Colorectal neoplasia differentially expressed gene, noncoding	615624	REc			
16.359	11	13	15	16q12.2	FTO, GDFD, BMIQ14	P	Fat mass- and obesity-associated gene	610966	REc		Growth retardation, developmental delay, facial dysmorphism, 612938 (3); {Obesity, susceptibility to, BMIQ14}, 612460 (3)	
16.360	9	2	09	16q12.2	IRX3, IRXB1	P	Iroquois homeobox protein 3	612985	R, REc			
16.361	6	9	08	16q12.2	LPCAT1, AYTL1	P	Lysophosphatidylcholine acyltransferase 2	612040	R, REc			
16.362	7	8	10	16q12.2	RPGRIP1L, KIAA1005, JBTS7, MKS5	C	RPGRIP1-like	610937	R, REc		Joubert syndrome 7, 611560 (3); Meckel syndrome 5, 611561 (3); COACH syndrome, 216360 (3)	
16.363	3	22	00	16q12.2	SLC6A2, NAT1, NET1	C	Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive	163970	REa, A, Fd		Orthostatic intolerance, 604715 (3)	8(Slc6a2)
16.364	5	23	94	16q12.2	RBL2	P	Retinoblastoma-like 2	180203	A			
16.365	9	16	03	16q13	HERPUD1, MIF1, HERP, KIAA0025	P	Homocysteine- and endoplasmic reticulum stress-inducible protein, ubiquitin-like domain-containing, 1	608070	REa, REc			
16.366	9	29	13	16q13	ARL2BP, BART	P	ADP ribosylation factor-like 2-binding protein	615407	REc		Retinitis pigmentosa with or without situs inversus, 615434 (3)	
16.367	2	26	10	16q21	C16orf57, PN	P	Chromosome 16 open reading frame 57	613276	REc		Poikiloderma with neutropenia, 604173 (3)	
16.368	8	29	02	16q21	CCL17, SCYA17, TARC	P	Chemokine, C-C motif, ligand 17	601520	R, Psh, REc			
16.369	8	29	02	16q21	CCL22, SCYA22	C	Chemokine, C-C motif, ligand 22	602957	R, Psh, REc			
16.370	7	10	09	16q21	CNGB1, CNCG3L, CNCG2, RP45	P	Cyclic nucleotide gated channel, beta 1	600724	Psh, A		Retinitis pigmentosa 45, 613767 (3)	
16.371	5	25	13	16q13	CPNE2, CPN2	P	Copine II	604206	REc			
16.372	5	24	12	16q21	COQ9, C16orf49, COQ10D5	P	Coq9, S. cerevisiae, homolog of	612837	REc		Coenzyme Q10 deficiency, primary, 5, 614654 (3)	
16.373	12	11	03	16q21	DOK4	P	Docking protein 4	608333	REc			
16.374	11	1	13	16q13	GNAO1, EIEE17	P	Guanine nucleotide-binding protein (G protein), alpha-activating activity	139311	REa, H	close to MT1 in mouse	Epileptic encephalopathy, early infantile, 17, 615473 (3)	8(Gnao1)
16.375	4	24	14	16q21	GPR56, TM7XN1, BFPP, BPPR	C	G protein-coupled receptor 56	604110	A, R, REc, Fd		Polymicrogyria, bilateral frontoparietal, 606854 (3); Polymicrogyria, bilateral perisylvian, 615752 (3)	8(Gpr56)
16.376	6	7	10	16q13	MIR138-2, MIRN138-2	P	Micro RNA 138-2	613395	REc			
16.377	11	1	13	16q12.2	MMP2, CLG4A, MONA	C	Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase)	120360	REa, A, Ch	near MT1,2	Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	8(Mmp2)
16.378	2	23	92	16q13	MT1A	C	Metallothionein 1A (functional)	156350	REa, A, REn	proximal to FRA16B		8(Mt1)
16.379	2	23	92	16q13	MT1B	C	Metallothionein 1B (functional)	156349	REn			
16.380	2	23	92	16q13	MT1E	C	Metallothionein 1E (functional)	156351	REn			
16.381	2	23	92	16q13	MT1F	C	Metallothionein 1F (functional)	156352	REn			
16.382	2	23	92	16q13	MT1G	C	Metallothionein 1G	156353	REn			
16.383	2	23	92	16q13	MT1H	C	Metallothionein 1H	156354	REn			
16.384	2	23	92	16q13	MT1I	C	Metallothionein 1I	156355	REn			
16.385	2	23	92	16q13	MT1J	C	Metallothionein 1J	156356	REn			
16.386	2	23	92	16q13	MT1K	C	Metallothionein 1K	156357	REn			
16.387	2	23	92	16q13	MT1L	C	Metallothionein 1L	156358	REn			
16.388	2	23	92	16q13	MT1X	C	Metallothionein 1X	156359	REn			
16.389	2	23	92	16q13	MT2A, MT2	C	Metallothionein 2A	156360	REa, A, REn	pseudogene MT2P1 on 4cen-q21		8(Mt2)
16.390	12	16	93	16q13	MT3, GIFB	C	Metallothionein 3 (growth inhibitory factor (neurotrophic))	139255	REa			
16.391	11	22	09	16p13.3	NME3, NM23H3	P	Nonmetastatic cells 3, protein expressed in	601817	Psh, A			
16.392	4	7	16	16q13	NUP93, NIC96, KIAA0095, NPHS12	P	Nucleoporin, 93kD	614351	R, REc		Nephrotic syndrome, type 12, 616892 (3)	
16.393	7	18	14	16q13	OGFOD1	P	2-oxoglutarate- and iron-dependent oxygenase domain-containing protein 1	615857	REc			
16.394	5	15	96	16q13	SLC12A3, NCCT, TSC	C	Solute carrier family 12 (sodium/potassium/chloride transporters), member 3	600968	Fd, A		Gitelman syndrome, 263800 (3)	
16.395	8	29	02	16q13	PLLP, PMLP, TM4SF11	P	Plasma membrane proteolipid (plasmolipin)	600340	R, A			
16.396	12	28	15	16q13	RSPRY1, KIAA1972, SEMDFA	P	RING finger- and SPRY domain-containing protein 11	616585	REc		Spondylopeimetaphyseal dsyplasia, Faden-Alkuraya type, 616723 (3)	
16.397	8	3	12	16q21	TEPP	P	Testis-prostate-placenta-expressed protein	610264	REc			
16.398	3	20	01	16q13-q21	ANMA	P	Anisomastia	605746	Ch		Anisomastia (2)	
16.399	2	7	01	16q21	KIFC3	P	Kinesin family member C3	604535	REa, R			
16.400	1	13	99	16q21	MMP15	C	Matrix metalloproteinase 15	602261	A			
16.401	4	24	08	16p13.3	MRPS34, MRPS12	P	Mitochondrial ribosomal protein S34	611994	REc			
16.402	5	23	94	16q21	POLR2C	P	Polymerase (RNA) II (DNA directed) polypeptide C, 33kD	180663	A			
16.403	9	23	08	16q12.2	CES1, SES1	C	Carboxylesterase 1 (monocyte/macrophage serine esterase 1)	114835	REa		Carboxylesterase 1 deficiency (3)	8(Ces1)
16.404	8	20	07	16q13-q22.1	EKD2	P	Episodic kinesigenic dyskinesia 2	611031	Fd	max lod at D16S503	Episodic kinesigenic dyskinesia 2 (2)	
16.405	11	5	98	16q13	AMFR, GP78	P	Autocrine motility factor receptor	603243	A			
16.406	9	24	15	16q13	BBS2, RP74	C	Bardet-Biedl syndrome 2	606151	Fd, REc		Bardet-Biedl syndrome 2, 615981 (3); Retinitis pigmentosa 74, 616562 (3)	
16.407	2	18	10	16q21	BEAN, SCA31	P	Brain-expressed, associated with NEDD4	612051	REc		Spinocerebellar ataxia 31, 117210 (3)	
16.408	11	4	14	16q21	CCDC113	P	Coiled-coil domain-containing protein 113	616070	REc			
16.409	2	12	07	16q22.1	CES3, ES31	P	Carboxylesterase 3	605279	REc			
16.410	9	6	11	16q13	CETP, HDLCQ10	C	Cholesteryl ester transfer protein, plasma	118470	REa, A		Hyperalphalipoproteinemia, 143470 (3); [High density lipoprotein cholesterol level QTL 10], 143470 (3)	
16.411	11	17	14	16q21	CIAPIN1	P	Cytokine-induced apoptosis inhibitor 1 (anamorsin)	608943	REc			
16.412	9	9	08	16q21	CNOT1, NOT1	P	CCR4-NOT transcription complex, subunit 1	604917	REc			
16.413	9	30	11	16q21	SLC38A7, SNAT7	P	Solute carrier family 38 (amino acid transporter), member 7	614236	REc			
16.414	11	30	06	16q21	GINS3, PSF3	P	GINS complex subunit 3	610610	R, REc			
16.415	4	26	90	16q21	GOT2	C	Glutamic-oxaloacetic transaminase-2, mitochondrial (EC 2.6.1.1)	138150	S, F, H	?pseudogenes on 12 and 1		8(Got2)
16.416	2	13	15	16q21	KATNB1, LIS6	P	Katanin, p80 subunit, B1	602703	REc		Lissencephaly 6, with microcephaly, 616212 (3)	
16.417	6	30	15	16q21	SETD6	P	SET domain-containing protein 6	616424	REc			
16.418	10	11	01	16q22.1	WWP2	P	WW domain-containing protein 2	602308	R			
16.419	4	30	09	16q22.2	DHX38, DDX38, PRP16	P	DEAH (Asp-Glu-Ala-His) box polypeptide 38 (PRP6, S. cerevisiae, homolog of)	605584	R			
16.420	11	20	15	16q21-q22	OPA8	P	Optic atrophy 8	616648	Fd	max lod at D16S752	Optic atroph 8 (2)	
16.421	1	13	99	16q21	CDH8	P	Cadherin-8	603008	Psh			
16.422	1	13	99	16q21	CDH11, CAD11	P	Cadherin-11 (OB-cadherin, osteoblast)	600023	H, Psh			8(cad11)
16.423	5	6	13	16q22.1	HSF4, CTM, CTRCT5	C	Heat-shock transcription factor 4	602438	A, Fd		Cataract 5, multiple types, 116800 (3)	
16.424	2	24	12	16q21	NDRG4, SMAP8, KIAA1180	P	NMYC downstream-regulated gene 4	614463	REc			
16.425	3	23	09	16q23.2	BCMO1, BCDO, BCO1	P	Beta-carotene 15,15-prime-dioxygenase	605748	Psh, R		Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	
16.426	10	27	89	16q22.1	CA7	P	Carbonic anhydrase VII	114770	REa, A			
16.427	11	29	12	16q22.1	NOL3, NOP, MYC, ARC, FCM	P	Nucleolar protein 3	605235	R		Myoclonus, familial cortical, 614937 (3)	
16.428	4	30	15	16q22.1	AARS, CMT2N, EIEE29	C	Alanyl-tRNA synthetase	601065	A, R		Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3); Epileptic encephalopathy, early infantile, 29, 616339 (3)	
16.429	4	20	04	16q22.1	AGRP, ART, AGRT	P	Agouti-related transcript, mouse, homolog of	602311	A		{Obesity, late-onset}, 601665 (3); {Leanness, inherited} (3)	
16.430	8	29	01	16q22	ANBC	P	Aneurysmal bone cysts	606179	Ch	t(16:17); ?defect at 17p13	Aneurysmal bone cysts (2)	
16.431	9	30	09	16q22	ATFB8	P	Atrial fibrillation, familial, 8	613055	Fd	associated with rs7193343	Atrial fibrillation, familial, 8 (2)	
16.432	6	13	02	16q22.1	ATP6V0D1	C	ATPase, H=transporting lysosomal, 38kD, V0 subunit D, isoform 1	607028	R, REc			
16.433	3	27	12	16q22	C16DELq22, DEL16q22	P	Chromosome 16q22 deletion syndrome	614541	Ch		Chromosome 16q22 deletion syndrome (4)	
16.434	3	27	12	16q22.1	CBFB, PEBP2B	C	Core-binding factor, beta subunit	121360	Ch	inv(16)(p13;q22); fuses to MYH11	Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)	
16.435	9	28	00	16q23.1	CHST5	P	Carbohydrate sulfotransferase-5 (GlcNAc-6-O-sulfotransferase, intestinal)	604817	REc, R			
16.436	9	28	00	16q23.1	CHST6, MCDC1	P	Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal)	605294	Fd, REc, R		Macular corneal dystrophy, 217800 (3)	
16.437	9	18	00	16q22.1	CIRH1A, NAIC, TEX292, KIAA1988	C	Cirhin	607456	Fd, HZ		Cirrhosis, North American Indian childhood type, 604901 (3)	
16.438	12	5	11	16q21	CMTM1, CKLFSF1	P	CKLF-like marvel transmembrane domain-containing 1	607884	REc			8(Cklfsf1)
16.439	12	5	11	16q21	CMTM2, CKLFSF2	P	CKLF-like marvel transmembrane domain-containing 2	607885	REc			8(Cklfsf2a/b)
16.440	12	5	11	16q22.1	CMTM3, CKLFSF3	P	CKLF-like marvel transmembrane domain-containing 3	607886	REc			8(Cklfsf3)
16.441	12	5	11	16q21-q22	CMTM4, CKLFSF4	P	CKLF-like marvel transmembrane domain-containing 4	607887	REc			8(Cklfsf4)
16.442	5	26	13	16q23.1	CNTNAP4, CASPR4, KIAA1763	C	Contactin-associated protein-like 4	610518	R, REc			
16.443	5	28	10	16q22.2	DHODH, URA1, POADS	P	Dihydroorotate dehydrogenase	126064	A		Miller syndrome, 263750 (3)	
16.444	4	29	02	16q22.1	FHOD1, FHOS	P	Formin homology 2 domain-containing 1	606881	R			
16.445	9	24	11	16q22.1	HSD11B2, HSD11K, AME	C	Hydroxysteroid (11-beta) dehydrogenase 2	614232	A		Apparent mineralocorticoid excess, 218030 (3)	
16.446	4	16	09	16q22.1	NAE1, APPBP1	P	NEDD8 activating enzyme E1 subunit 1	603385	A			
16.447	3	20	07	16q22.1	RLTPR	P	RGD-, leucine-rich repeat-, tropomodulin domain-, and proline-rich domain-containing protein	610859	REc			
16.448	9	26	96	16q22.1	RRAD	P	Ras-related associated with diabetes	179503	Fd, A			
16.449	12	21	10	16q21	TK2, MTDPS2	C	Thymidine kinase, mitochondrial	188250	S, REc		Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)	
16.450	6	18	99	16q22.1	TRADD	L	TNRF1-associated death domain protein	603500	H			8(Tradd)
16.451	3	24	06	16q22.1	VPS4A, VPS4	C	Vacuolar protein sorting 4, yeast, homolog of, A	609982	A, REc, H			8(Vps4a)
16.452	2	9	92	16q22.2	ZNF19, KOX12	P	Zinc finger protein-19 (KOX12)	194525	A	?16q23, 19q13		8(Zfp1)
16.453	11	4	93	16q22.2	ZNF23, KOX16	P	Zinc finger protein-32 (KOX16)	194527	A			8(Zfp4)
16.454	10	15	95	16q23.1	GLG1	P	Golgi apparatus protein 1	600753	A			8(Glg1)
16.455	6	8	15	16q23.2	MAF, CCA4, CTRCT21, AYGRP	P	v-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog	177075	A		Cataract 21, multiple types, 610202 (3); Ayme-Gripp syndrome, 601088 (3)	
16.456	11	7	01	16q22.1	SNTB2, SNT2B2, SNTL	C	Syntrophin, beta-2	600027	REa, Psh, A			8(Sntb2)
16.457	3	8	91	16q24.1	COX4I1, COX4	P	Cytochrome c oxidase, subunit IV, isoform 1	123864	REa			
16.458	9	24	15	16q22.1	ACD, PTOP, PIP1, TINT1	P	Acd, mouse, homolog of	609377	R, REc	mutation has been identified in 1 DKCA7 and 1 DKCB7 family	?Dyskeratosis congenita, autosomal dominant 6, 616553 (3); ?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	8(Acd)
16.459	6	28	94	16q22.2	CALB2	P	Calbindin 2, 29kD (calretinin)	114051	REa			
16.460	1	26	12	16q22.1	CDH1, UVO, LCAM, ECAD	C	Cadherin-1 (E-cadherin; uvomorulin)	192090	REa, D, Ch	near LCAT	Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma, somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3); {Prostate cancer, susceptibility to}, 176807 (3)	8(Um)
16.461	1	23	09	16q22.1	CDH3, CDHP, PCAD, HJMD	C	Cadherin-3 (P-cadherin)	114021	H, Psh, Fd	in mouse tightly linked to ECAD	Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	8(Pcad)
16.462	1	13	99	16q21	CDH5	P	Cadherin-5	601120	H, Psh			8(Cdh5)
16.463	1	13	05	16q22.1	CDH16	C	Cadherin-16	603118	A, R			8(Cdh16)
16.464	10	8	07	16q22.1	CENPT	P	Centromere protein T	611510	R, REc			
16.465	11	11	14	16q22.1	CES2	P	Carboxylesterase 2	605278	R, REc			
16.466	10	3	11	16q22.1	CHTF8, CTF8	P	Chromosome transmission fidelity factor 8, S. cerevisiae, homolog of	613202	REc			
16.467	9	28	15	16q22.1	CLEC18A	P	C-type lecting domain family 18, member A	616571	REc			
16.468	9	28	15	16q22.1	CLEC18C	P	C-type lectin domain family 18, member C	616573	REc			
16.469	10	12	10	16q22.1	COG4, COD1, CDG2J	P	Component of oligomeric golgi complex 4	606976	R		Congenital disorder of glycosylation, type IIj, 613489 (3)	
16.470	7	10	07	16q22.1	COG8, DOR1, CDG2H	C	Component of oligomeric golgi complex 8	606979	R, REc		Congenital disorder of glycosylation, type IIh, 611182 (3)	
16.471	2	23	09	16q22.1	CRCS9	P	Colorectal cancer, susceptibility to, 9	612590	Fd	associated with rs9929218	{Colorectal cancer, susceptibility to, 9} (2)	
16.472	11	5	13	16q22.1	CTCF, MRD21	P	CCCTC-binding factor	604167	A		Mental retardation, autosomal dominant 21, 615502 (3)	
16.473	11	4	93	16q22.1	CTRL	P	Chymotrypsin-like protease	118888	REn			
16.474	4	23	08	16q22.1	CYB5B, CYPB5M	P	Cytochrome b5, type B (outer mitochondrial membrane)	611964	REc			
16.475	3	10	03	16q22.1	DDX28, MDDX28	P	DEAD/H box 28	607618	REc			
16.476	3	1	06	16q22.1	DPEP2, MBD2	P	Dipeptidase 2	609925	R, REc			
16.477	3	1	06	16q22.1	DPEP3, MBD3	P	Dipeptidase 3	609926	REc			
16.478	12	28	08	16q22.1	DUS2L, DUS2	P	Dihydrouridine synthase 2-like	609707	R, REc			
16.479	10	2	95	16q22.1	E2F4	P	E2F transcription factor 4, p107/p130-binding	600659	A			
16.480	10	2	12	16q22.1	EDC4, RCD8, GE1, HEDL5	P	Enhancer of mRNA decapping 4	606030	REc, R			
16.481	9	10	09	16q22.1	ESRP2, RBM35B	P	Epithelial splicing regulatory protein 2	612960	REc			
16.482	9	8	11	16q22.1	EXOC3L1, EXOC3L	P	Exocyst complex component 3-like 1	614117	REc			8(Exoc3l1)
16.483	6	1	12	16q22.1	EXOSC6, MTR3	P	Exosome component 6	606490	REc			
16.484	8	31	12	16q22.1	FAM96B, MIP18	P	Family with sequence similarity 96, member B	614778	REc			
16.485	6	13	12	16q22.1	FBXL8, FBL8	P	F-box and leucine-rich repeat protein 8	609077	REc			
16.486	6	18	99	16q22.1	HAS3	P	Hyaluronan synthase 3	602428	Psh, REc			8(Has3)
16.487	7	22	11	16q22.2	HP	C	Haptoglobin	140100	Fc	just distal to fra16q22.1	[Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)	8(Hp)
16.488	1	12	89	16q22.2	HPR	C	Haptoglobin-related locus	140210	REa	2.2kb 3' to HP; multiple tandem genes in blacks		
16.489	5	25	13	16q13	NLRC5	P	NLR family, caspase recruitment domain-containing 5	613537	REc			
16.490	6	25	08	16q22.1	IL34, C16orf77	P	Interleukin 34	612081	REc			
16.491	5	29	02	16q22.1	LCAT	C	Lecithin-cholesterol acyltransferase	606967	F, LD, A, REa	very close to HP	Norum disease, 245900 (3); Fish-eye disease, 136120 (3)	8(Lcat)
16.492	5	16	05	16q22.1	LYPLA3, LLPL, ACS, LPLA2	P	Lysophospholipase 3	609362	R, REc			
16.493	11	4	93	16q22.1	MECL1, LMP10, PSMB10	P	Proteosome subunit MECL1	176847	REn	3.1kb from LCAT		8(Psmb10)
16.494	3	23	09	16q22.1	MIR140, MIRN140	P	Micro RNA 140	611894	REc			
16.495	1	20	11	16q22.1	MIR328, MIRN328	P	Micro RNA 328	613701	REc			
16.496	5	23	16	16q22.1	MTSS1L, ABBA1	P	Metastasis suppressor 1-like protein	616951	REc			
16.497	5	25	13	16q22.1	NFAT5, KIAA0827, NFATL1, TONEBP	P	Nuclear factor of activated T cells 5	604708	REc			
16.498	9	24	08	16q22.1	NQO1, DIA4, NMOR1	C	NAD(P)H dehydrogenase, quinone 1 (diaphorase-4)	125860	S, REa, Ch		{Benzene toxicity, susceptibility to} (3); {Leukemia, post-chemotherapy, susceptibility to} (3); {Breast cancer, poor survival after chemotherapy for} (3)	8(Nmor1)
16.499	12	10	13	16q22.1	PDP2, KIAA1348	P	Pyruvate dehydrogenase phosphatase catalytic subunit 2	615499	R, REc			
16.500	11	3	09	16q22.1	PLEKHG4	P	Pleckstrin homology domain containing, family G (puratrophin 1)	609526	REc			
16.501	4	25	12	16q22.1	PRMT7, KIAA1933	P	Protein arginine N-methyltransferase 7	610087	REc			
16.502	10	27	93	16q22.1	PSKH1	P	Putative serine kinase H1	177015	REn			
16.503	9	8	11	16q22.1	RANBP10, KIAA1464	P	Ran-binding protein 10	614031	REc			
16.504	10	13	97	16q22.1	SCA4	C	Spinocerebellar ataxia 4	600223	Fd		Spinocerebellar ataxia 4 (2)	
16.505	6	5	12	16q22.1	SF3B3, SF3B130, SAP130	P	Splicing factor 3B, subunit 3	605592	R, REc			
16.506	6	27	95	16q22.1	SLC9A5, NHE5	P	Solute carrier family 9 (sodium/hydrogen exchanger), member 5	600477	REa, A, Fd			
16.507	8	17	99	16q22.1	SLC12A4, KCC1	P	Solute carrier family 12 (potassium/chloride transporters), member 4	604119	REn			
16.508	6	22	99	16q22.1	TERF2, TRF2	P	Telomeric repeat-binding factor-2	602027	Psh, R			8(Terf2)
16.509	9	30	13	16q22.1	THAP11, RONIN	P	THAP domain-containing protein 11	609119	REc			
16.510	9	24	08	16q22.1-q22.2	VAC14, TAX1BP2, TRX	P	Vac14, S. cerevisiae, homolog of	604632	R, REc			
16.511	6	30	05	16q22.1	ZFP90, NK10, KIAA1954	P	Zinc finger protein 90, mouse, homolog of	609451	REc, H			8(Zfp90)
16.512	5	21	07	16q24.3	TRAPPC2L	P	Trafficking protein particle complex 2-like	610970	REc			
16.513	9	17	09	16q22.2	TAT	C	Tyrosine aminotransferase, soluble	613018	REa, A, H, D		Tyrosinemia, type II, 276600 (3)	8(Tat)
16.514	12	7	07	16q22.1-q23.1	OTSC4	P	Otosclerosis 4	611571	Fd	between D16S3107 and D16S3097	{Otosclerosis 4} (2)	
16.515	12	7	04	16q22.2	PKD1L3	P	Polycystin 1-like 3	607895	REc			8(Pkd1l3)
16.516	10	24	11	16q22.2	ATXN1L, BOAT1	P	Ataxin 1-like (brother of ataxin 1)	614301	REc			
16.517	2	4	15	16q22.2	CMTR2, MTR2, FTSJD1	P	CAP methyltransferase 2	616190	REc			
16.518	10	25	12	16q22.2	HYDIN, HYDIN1, CILD5	C	Hydin, mouse, homolog of	610812	REc, H, Fd	duplicated copy on 1q21.1	Ciliary dyskinesia, primary, 5, 608647 (3)	8(Hydin)
16.519	6	23	15	16q22.2	IST1, KIAA0174	P	Increased sodium tolerance 1, yeast, homolog of	616434	R, REc			
16.520	7	22	11	16q22.2	MARVELD3	P	Marvel domain-containing protein 3	614094	REc			
16.521	6	18	01	16q23.1	ADAT1	P	Adenosine deaminase, tRNA-specific, 1	604230	R			
16.522	1	27	04	16q23.1	CFDP1, CP27, BCNT	C	Craniofacial development protein 1	608108	REc, Psh, A			
16.523	10	7	14	16q23.1	KARS, CMTRIB, DFNB89	C	Lysyl-tRNA synthetase	601421	Psh, A, R	mutation identified in 1 CMTRIB patient	?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3); Deafness, autosomal recessive 89, 613916 (3)	
16.524	9	24	15	16q23.1	CLEC18B	P	C-type lectin domain family 18, member B	616572	REc			
16.525	2	2	14	16q22.3	HCCAT5, HTA	P	Hepatocellular carcinoma-associated transcript 5	615613	REc			
16.526	8	21	07	16q22.2	PHLPPL, PHLPP2	P	PH domain and leucine-rich repeat protein phosphatase-like	611066	REc			
16.527	9	20	04	16q22.3-q23.1	KTCN2	P	Keratoconus 2	608932	Fd		Keratoconus 2 (2)	
16.528	2	28	03	16q23.1	GABARAPL2	P	GABA-A receptor-associated protein-like protein 2	607452	R			
16.529	1	22	15	16q22.2-q22.3	ZFHX3, ATBF1	C	Zinc finger homeobox 3	104155	A, D		{Prostate cancer, susceptibility to, somatic}, 176807 (3)	8(Atbf1)
16.530	11	11	13	16q23.1	ADAMTS18, MMCAT	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 18	607512	REc		Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3)	
16.531	9	18	00	16q22.2	AP1G1, ADTG, CLAPG1	P	Adaptor-related protein complex 1, gamma 1 subunit (adaptin, gamma)	603533	A, Psh			
16.532	5	4	09	16q23	BMND13	P	Bone mineral density quantitative trait locus 13	612727	Fd	associated with rs16945612	[Bone mineral density QTL 13] (2)	
16.533	11	3	14	16q21	CKLF, HSPC224	P	Chemokine-like factor	616074	R, REc			
16.534	8	27	15	16q23.1	CLEC3A, CLECSF1	P	C-type lectin domain family 3, member A	613588	A			
16.535	5	23	11	16q23.1	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	P	Fatty acid 2-hydroxylase	611026	R, REc		Spastic paraplegia 35, autosomal recessive, 612319 (3)	8(Fa2h)
16.536	2	2	11	16q23	HSCR8	P	Hirschsprung disease, susceptibility to, 8	608462	LD		{Hirschsprung disease, susceptibility to, 8} (2)	
16.537	8	24	98	16q23.1	PSMD7, MOV34	P	Proteasome 25S subunit, non-ATPase, 7 (Moloney leukemia virus-34 proviral integration homolog)	157970	REa, A			8(Mov34)
16.538	5	25	00	16q23.1	BCAR1, CRKAS, CAS	P	Breast cancer antiestrogen resistance 1	602941	A, Psh			
16.539	4	8	13	16q23.1	MLKL	P	Mixed lineage kinase domain-like protein	615153	REc			
16.540	6	7	10	16q23.1	MON1B, SRG1, KIAA0872	P	Mon1, S. cerevisiae, homolog of, B	608954	REc			
16.541	8	8	11	16q23.1	RFWD3	P	RING finger and WD repeat domains-containing protein 3	614151	REc			
16.542	6	24	10	16q23.1	TERF2IP, RAP1	P	Telomeric repeat binding factor 2, interacting protein	605061	R, REc			
16.543	7	21	14	16q23.1	TMEM231, JBTS20, MKS11	P	Transmembrane protein 231	614949	REc		Joubert syndrome 20, 614970 (3); Meckel syndrome 11, 615397 (3)	
16.544	6	10	08	16q23.1	ZNRF1, NIN283	P	Zinc finger and ring finger protein 1	612060	REc			
16.545	7	20	12	16q23.2	ATMIN, ASCIZ, KIAA0431	C	ATM interactor	614693	R, REc			
16.546	10	8	07	16q23.2	CENPN	P	Centromere protein N	611509	REc			
16.547	3	13	15	16q23.2	MAFTRR, lincMAF4	P	MAF transcriptional regulator FNA, noncoding	616264	REc			
16.548	3	31	15	16q23.2	PKD1L2, PC1L2, KIAA1879	P	Polycystin 1-like 2	607894	REc, REn			8(Pkd1l2)
16.549	6	21	91	16q23.1	CTRB1	C	Chymotrypsinogen B1	118890	REa, H, D, Fd, Ch	HP-7cM-TAT-9cM-CTRB		8(Ctrb)
16.550	3	31	11	16q23.3	ADIPQTL5	P	Adiponectin, serum level of, quantitative trait locus 5	613836	Fd	associated with rs3865188	{Adiponectin, serum level of, QTL5] (2)	
16.551	2	21	06	16q23.2	DYNLRB2, DNCL2B	P	Dynein, light chain, roadblock-type 2	607168	REc			
16.552	3	25	14	16q23.3	HSBP1	P	Heat-shock factor-binding protein 1	604553	REc			
16.553	3	23	14	16q23.3	OSGIN1, OKL38	P	Oxidative stress-induced growth inhibitor 1	607975	REc			
16.554	12	30	14	16q23.3	SDR42E1	P	Short-chain dehydrogenase/reductase family 42E, member 1	616164	REc			
16.555	4	10	14	16q23.3	SLC38A8, FVH2	P	Solute carrier family 38 (amino acid transporter), member 8	615585	REc		Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3)	
16.556	2	25	16	16q23.1-q23.2	WWOX, FOR, SCAR12, EIEE28	C	WW domain-containing oxidoreductase	605131	REc, H, Ch, Fd		Esophageal squamous cell carcinoma, somatic, 133239 (3); Spinocrebellar ataxia, autosomal recessive 12, 614322 (3); Epileptic encephalopathy, early infantile, 28, 616211 (3)	8(Wox1, Fra8E1)
16.557	9	10	98	16q24.3	AFG3L1, AFG3	P	ATPase family gene 3, yeast, homolog of	603020	A, R			
16.558	10	30	07	16q24.2	BANP, SMAR1	P	BTG3-associated nuclear protein	611564	A			8(Banp)
16.559	6	15	99	16q24.3	CBFA2T3, MTGR2, MTG16	C	Core-binding factor, alpha subunit 2, translocated to, 3	603870	R, A			
16.560	6	18	99	16q24.3	CDK10, PISSLRE	P	Cyclin-dependent kinase 10	603464	RE			
16.561	2	13	09	16q23.2-q23.3	CMIP, KIAA1694, TCMIP	C	C-MAF-inducing protein	610112	R, REc			
16.562	7	9	90	16q24.2	CYBA	C	Cytochrome b-245, alpha polypeptide	608508	REa, A		Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3)	
16.563	8	18	09	16q24.1	FOXF1, FKHL5, ACDMPV	P	Forkhead box F1	601089	A		Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	8(Foxf1)
16.564	8	29	01	16q23.2	GCSH, NKH	P	Glycine cleavage system H protein	238330	A		Glycine encephalopathy, 605899 (3)	
16.565	4	5	00	16q24.2	IL17C	P	Interleukin 17C	604628	R			
16.566	4	4	01	16q23.3-q24.1	MBTPS1, S1P	C	Membrane-bound transcription factor protease, site 1	603355	REa, A, R			
16.567	3	26	02	16q23.3	MLYCD, MCD	P	Malonyl-CoA decarboxylase	606761	R, Psh		Malonyl-CoA decarboxylase deficiency, 248360 (3)	
16.568	9	3	10	16q24	STQTL22	P	Stature quantitative trait locus 22	613547	Fd	linked to rs299956 and rs2076962	{Stature QTL 22} (2)	
16.569	2	1	01	16q24.1	TAF1C, TAFI110, SL1	C	TATA box-binding protein-associated factor 1C	604905	R, A			
16.570	4	21	10	16q24.1	USP10, KIAA0190	P	Ubiquitin-specific protein 10	609818	R, REc			
16.571	6	11	08	16q24.2	ZNF469, KIAA1858, BCS1	C	Zinc finger protein 469	612078	Fd, R, REc		Brittle cornea syndrome 1, 229200 (3)	
16.572	10	13	09	16q24.1	ATP2C2, SPCA2, KIAA0703	P	ATPase, Ca(2+)-transporting, type 2C, member 2	613082	R, REc			
16.573	2	1	11	16q24.1	COTL1, CLP	P	Coactosin-like protein 1	606748	R, Psh, REc	pseudogenes on 15, 17, and Y		
16.574	12	4	08	16q24.1	CRISPLD2	P	Cysteine-rich secretory protein, LCCL domain-containing, 2	612434	REc			
16.575	2	25	15	16q24.1	EMC8, NOC4	P	ER membrane protein complex subunit 8	604886	REc			
16.576	1	15	13	16q24.1	FOXF1AS1, TCONS_00024240	P	FOXF1 antisense RNA 1, noncoding	614975	REc	partial overlap with FOXF1 promoter		
16.577	5	4	09	16q24.1	FOXL1, FKHL11, FREAC7, FKH6	P	Forkhead box L1	603252	REc			8(Foxl1)
16.578	11	2	00	16q23.2	GAN, GAN1	C	Gigaxonin	605379	Fd, LD, REc		Giant axonal neuropathy-1, 256850 (3)	
16.579	11	30	06	16q24.1	GINS2, PSF2	P	GINS complex subunit 2	610609	R, REc			
16.580	3	30	16	16q24.1	GSE1, KIAA0182	C	GSE1 coiled-coil protein	616886	REc			
16.581	4	23	03	16q24.1	HDLC3	P	High density lipoprotein cholesterol, low serum, 3	607687	Fd		{High density lipoprotein cholesterol, low serum, 3} (2)	
16.582	9	8	14	16q24.1	IRF8, ICSBP1, IMD32A, IMD32B	P	Interferon regulatory factor 8	601565	REc		Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3); Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 614894 (3)	
16.583	3	10	03	16q24.1	KCNG4, KV6.3, KV6.4	P	Potassium channel, voltage-gated, subfamily G, member 4	607603	REc			
16.584	12	17	07	16q24.1	KIAA0513	P	KIAA0513 gene	611675	R, REc			
16.585	12	30	09	16q24.1	LRRC50, ODA7, CILD13	P	Leucine-rich repeat-containing protein 50	613190	REc		Ciliary dyskinesia, primary, 13, 613193 (3)	
16.586	2	16	16	16q24.1	MTHFSD	P	Methenyltetrahydrofolate synthetase domain-containing protein	616820	REc			
16.587	10	25	12	16q23.3	PLCG2, FCAS3, APLAID	P	Phospholipase C, gamma 2 (phosphatidylyinositol-specific)	600220	Psh		Familial cold autoinflammatory syndrome 3, 614468 (3); Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	8(Plcg2)
16.588	1	14	13	16q24.1	TCONS00024492	P	Long noncoding RNA TCONS_00024492	614978	REc			
16.589	8	14	14	16q24.1	LINC01081, TCONS00024764	P	Long intergenic non-protein coding RNA 1081	614977	REc			
16.590	4	27	12	16q24.1	ZDHHC7, DHHC7	P	Zinc finger DHHC domain-containing protein 7	614604	REc			
16.591	7	11	95	16q23.3	HSD17B2, EDH17B2	C	Hydroxysteroid (17-beta) dehydrogenase 2	109685	A, Fd			
16.592	3	15	13	16q24.2	MAP1LC3B, LC3B	P	Microtubule-associated protein 1, light chain 3, beta	609604	R, REc			
16.593	1	13	99	16q23.3	CDH13, CDHH	P	Cadherin-13 (H-cadherin, heart)	601364	A			
16.594	10	1	11	16q24.3	ACSF3	P	Acyl-CoA synthetase family member 3	614245	REc		Combined malonic and methylmalonic aciduria, 614265 (3)	
16.595	9	21	11	16q24.3	ANKRD11, ANCO1, KBGS	P	Ankyrin repeat domain-containing protein 11	611192	REc		KBG syndrome, 148050 (3)	
16.596	9	21	12	16q24.3	APRT, APRTD	C	Adenine phosphoribosyltransferase	102600	S, D, REn	telomeric to GALNS, transcribed in same cen-tel direction	Adenine phosphoribosyltransferase deficiency, 614723 (3)	8(Aprt)
16.597	1	8	01	16q24.3	C16orf3, EID1	P	E1A-like inhibitor of differentiation 1	605179	REc			
16.598	4	29	14	16q24.2	CA5A, CA5AD	C	Carbonic anhydrase VA (mitochondrial)	114761	Psh, A	pseudogene on 16p	Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3)	8(Car5)
16.599	2	17	09	16q24.3	CDH15, CDH14, CDH3, MRD3	P	Cadherin-15, M-cadherin (myotubule)	114019	REa, Psh	tightly linked to Aprt in mouse	Mental retardation, autosomal dominant 3, 612580 (3)	8(Cdh3)
16.600	3	15	11	16q24.3	CDT1	C	Chromatin licensing and DNA replication factor 1	605525	REc		Meier-Gorlin syndrome 4, 613804 (3)	
16.601	12	15	12	16q24.3	CHMP1A, PCOLN3, PRSM1, PCH8	P	CHMP family, member 1A	164010	Psh, REa		Pontocerebellar hypoplasia, type 8, 614961 (3)	
16.602	2	28	01	16q24.3	CPNE7	P	Copine VII	605689	D			
16.603	4	25	93	16q24.3	DPEP1, RDP, MDP, MBD1	C	Dipeptidase 1	179780	A, REa, Fd			
16.604	1	27	03	16q24.3	FANCA, FACA, FA1, FA, FAA	C	Fanconi anemia, complementation group A	607139	Fd, LD	linkage heterogeneity	Fanconi anemia, complementation group A, 227650 (3)	8(Fanca)
16.605	9	22	14	16q24.2	FBXO31, FBX31, FBXO14, FBX14, MRT45	P	F-box only protein 31	609102	REc	mutation identified in 1 MRT45 family	?Mental retardation, autosomal recessive 45, 615979 (3)	8(Fbxo31)
16.606	6	27	08	16q24.1	FOXC2, FKHL14, MFH1	C	Forkhead box C2	602402	A, Fd, Ch		Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	8(Mfh1)
16.607	9	18	08	16q24.3	GALNS, MPS4A	C	Galactosamine (N-acetyl)-6-sulfate sulfatase	612222	A, Psh, REn	centromeric to APRT	Mucopolysaccharidosis IVA, 253000 (3)	
16.608	1	11	16	16q24.3	GAS8, GAS11, CILD33	P	Growth arrest-specific 8	605178	REc		Ciliary dyskinesia, primary, 33, 616726 (3)	
16.609	1	24	09	16q24.3	IHPS5	P	Pyloric stenosis, infantile hypertrophic, 5	612525	Fd	between rs7197068 and rs750740	Pyloric stenosis, infantile hypertrophic, 5 (2)	
16.610	11	13	01	16q24.2	JPH3, JP3, HDL2	C	Junctophilin 3	605268	A		Huntington disease-like 2, 606438 (3)	
16.611	11	30	11	16q24.3	MC1R, SHEP2, CMM5	C	Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555	A		[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3); [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3); [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {UV-induced skin damage}, 266300 (3); {Albinism, oculocutaneous, type II, modifier of}, 203200 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3)	8(Mc1r)
16.612	11	18	15	16q24.2	MVD, MPD, POROK7	P	Mevalonate pyrophosphate decarboxylase	603236	REc, Fd		Porokeratosis 7, multiple types, 614714 (3)	
16.613	4	27	12	16q24.3	PGN, SPG7, CMAR, CAR	P	Paraplegin	602783	Fd, REc		Spastic paraplegia 7, autosomal recessive, 607259 (3)	
16.614	3	3	16	16q24.3	PIEZO1, FAM38A, MIB, DHS, LMPH3	P	PIEZO1 ion channel	611184	REc		Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3); Lymphedema, hereditary, III, 616843 (3)	
16.615	4	10	11	16q24.3	RPL13, BBC1, D16S44E	P	Ribosomal protein L13	113703	REc			
16.616	2	19	99	16q24.2	SLC7A5, D16S469E, MPE16	P	Solute carrier family 7, member 5	600182	REa			
16.617	5	5	09	16q24.2	SNAI3, SNAIL3, SMUC, ZFP293	P	SNAIL, Drosophila, homolog of, 3	612741	REc			
16.618	9	23	13	16q24.3	SPATA33, C16orf55	P	Spermatogenesis-associated protein 33	615409	REc			
16.619	10	7	08	16q24.3	TCF25, NULP1, KIAA1049	C	Transcription factor 25	612326	R, REc			
16.620	9	23	13	16q24.3	TUBB3, TUBB4, CFEOM3A, CDCBM1	P	Tubulin, beta-3	602661	REc		Fibrosis of extraocular muscles, congenital, 3A, 600638 (3); Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	
16.621	6	22	14	16q24.3	URAHP, URAH	P	Urate (hydroxyiso-) hydrolase, pseudogene	615805	REc			
16.622	10	13	00	16q24.1	WFDC1, PS20	C	WAP four-disulfide core domain-1, mouse, homolog of	605322	A			
16.623	2	16	04	16q24.3	ZFP276	P	Zinc finger protein 276	608460	REn			
16.624	2	28	03	16q24.2	ZFPM1, FOG, FOG1	P	Zinc finger protein, multitype 1 (friend of GATA1)	601950	REc			
16.625	2	6	01	16q13	CPSF5, CFIM25	P	Cleavage and polyadenylation specificity factor 5	604978	R			
16.626	8	27	01	16q22.1	DDX19, DBP5	P	DEAD/H box 19	605812	R			
16.627	9	30	02	16p12.2	EEF2K	P	Elongation factor 2 kinase	606968	R			
16.628	11	2	01	16q22.1	ELMO3	P	Engulfment and cell motility gene 3	606422	REc			
16.629	10	23	87	Chr.16	ESB3	P	Esterase-B3	133290	S			8(Es6)
16.630	6	14	95	Chr.16	GRLL1	P	Glucocorticoid receptor-like 1	138060	REb			
16.631	8	21	91	Chr.16	IFNR	P	Interferon production regulator	147573	REa, S			
16.632	1	27	03	16q23.1	LDHD	P	D-lactate dehydrogenase	607490	R			
16.633	10	23	87	Chr.16	LIPB	P	Lipase B, lysosomal acid	247980	S			
16.634	1	30	01	16q23.3	MPHOSPH6, MPP	P	M-phase phosphoprotein 6	605500	R			
16.635	7	11	01	16p13.3	MSLN	P	Mesothelin	601051	R			
16.636	8	30	01	16q13	MT4, MTIV	P	Metallothionein 4	606206	A			8(Mt4)
16.637	9	3	02	16q22.1	NFATC3	P	Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 3	602698	R			
16.638	10	23	87	Chr.16	NHCP1	P	Nonhistone chromosomal protein-1	118870	S			
16.639	2	15	01	16q22.1	SLC7A6	P	Solute carrier family 7 (y+L-type amino acid transporter), member 6	605641	R			
16.640	9	25	01	16p13.3	SRRM2, SRM300, KIAA0324	C	Serine/arginine repetitive matrix 2 (ser/arg-rich splicing factor-related nuclear matrix protein, 300kD)	606032	R, REc			
16.641	9	2	09	1p36.13	TRNAG1, TRG1	P	tRNA glycine-1	189911	REa			
16.642	7	17	91	Chr.16	VDI, DIPI	P	Vesicular stomatitis virus defective interfering particle repressor	125260	S			
16.643	2	25	02	16p11.2	ZNF267, HZF2	P	Zinc finger protein-167	604752	R			
17.1	8	15	03	17p13.2	ASPA	C	Aspartoacylase (aminoacylase-2)	608034	A		Canavan disease, 271900 (3)	
17.2	9	10	14	17p13.2	ENO3, GSD13	C	Enolase-3, beta, muscle	131370	REa, A	mutation identified in 1 GSD13 patient	?Glycogen storage disease XIII, 612932 (3)	
17.3	1	24	09	17p13.2	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	C	Glycoprotein Ib, platelet, alpha polypeptide	606672	A		Bernard-Soulier syndrome, type A1 (recessive), 231200 (3); {Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand disease, platelet-type, 177820 (3)	
17.4	12	21	09	17p13.3	PLI, SERPINF2	P	Alpha-2-plasmin inhibitor	613168	Psh		Alpha-2-plasmin inhibitor deficiency, 262850 (3)	
17.5	10	12	90	17p13.2	ZFP3	P	Zinc finger protein-3	194480	REa	probably in cluster with ZNF29 proximal to TP53		11(Zfp3)
17.6	3	26	95	17p13.3	ABR	C	Active BCR-related gene	600365	A			
17.7	5	12	99	17p13.2	ALOX15	P	Arachidonate 15-lipoxygenase	152392	Psh			11(Alox15)
17.8	8	12	98	17p13.2	ATP2A3, SERCA3	P	ATPase, Ca(2+)-transporting, ubiquitous	601929	A			
17.9	1	23	96	17p13.3	BCPR	P	Breast cancer-related regulator of TP53	113721	D		Breast cancer (1)	
17.10	1	8	15	17p13.3	BHLHA9, BHLHF42, MSSD	P	Basic helix-loop-helix family, member A9	615416	REc		Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3)	
17.11	7	15	99	17p13.2	C1QBP, HABP1	C	Complement component C1q binding protein (hyaluronic acid-binding protein 1)	601269	A, Psh			
17.12	2	3	15	17p13.3	CLUH, CLU1, KIAA0664	P	Clustered mitochondria, D. discoideum, homolog of	616184	R, REc			
17.13	11	4	93	17p13.3	CRK	P	Avian sarcoma virus CT10 (v-crk) oncogene homolog	164762	A			
17.14	1	12	07	17p13.3	DOC2B	P	Double C2-like domain-containing protein, beta	604568	REc			
17.15	4	21	16	17p13.3	DPH1, DPH2L1, OVCA1, DEDSSH	P	DPH1, S. cerevisiae, homolog of (ovarian cancer gene 1)	603527	REf		Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3)	
17.16	5	13	10	17p13.3	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	P	Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome)	247200	Ch		Miller-Dieker lissencephaly syndrome (4)	
17.17	2	19	10	17p13.3	DUP17p13.3, C17DUPp13.3	P	Chromosome 17p13.3 duplication syndrome	613215	Ch	includes LIS1 and/or YWHAE	Chromosome 17p13.3 duplication syndrome (4)	
17.18	2	6	08	17p13.3	FAM57A, CT120	P	Family with sequence similarity 57, member A	611627	REc			
17.19	8	18	14	17p13.3	FAM101B, CFM1	P	Family with sequence similarity 101, member B	615928	REc			
17.20	6	16	99	17p13.1	GLP2R	P	Glucagon-like peptide 2 receptor	603659	A			
17.21	6	4	99	17p13.3	HIC1	C	Hypermethylated in cancer	603825	A, H			11(Hic1)
17.22	3	23	09	17p13.3	MIR22, MIRN22	P	Micro RNA 22	612077	REc			
17.23	3	23	09	17p13.3	MIR132, MIRN132	P	Micro RNA 132	610016	REc			
17.24	7	16	10	17p13.3	MIR212, MIRN212	P	Micro RNA 212	613487	REc			
17.25	9	18	98	17p13.3	MNT, ROX	P	MAX-binding protein	603039	REc			11(Mnt)
17.26	5	11	00	17p13.2	MYBBP1A, P160	P	MYB-binding protein 1A	604885	A, R			11(Mybbp1a)
17.27	7	22	09	17p13.3	NXN	P	Nucleoredoxin	612895	REc			11(Nxn)
17.28	8	24	98	17p13.3	OR1D2, OLFR1	C	Olfactory receptor, family 1, subfamily D, member 2	164342	A, Fd, REa	cluster of 16 genes in 350kb		
17.29	3	31	15	17p13.3	OVCA2	P	Ovarian cancer-associated gene 2	607896	REc			
17.30	8	6	15	17p13.2	P2RX1, P2X1	P	Purinergic receptor P2X, ligand-gated ion channel, 1	600845	A, H		Bleeding disorder due to P2RX1 defect, somatic, 609821 (3)	11(P2rx1)
17.31	1	3	03	17p13.3	PAFAH1B1, LIS1	C	Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit	601545	Ch, RE, D		Lissencephaly 1, 607432 (3); Subcortical laminar heterotopia, 607432 (3)	
17.32	12	22	15	17p13.2	PELP1, MNAR	C	Proline-, glutamic acid-, and leucine-rich protein 1	609455	REc			
17.33	9	10	12	17p13.2	PFN1, ALS18	P	Profilin-1	176610	REa, A, D		Amyotrophic lateral sclerosis 18, 614808 (3)	11(Pfn1)
17.34	9	7	10	17p13.3	PITPNA, PITPN	P	Phosphotidylinositol transfer protein, alpha	600174	Psh, A			11(Pitpn)
17.35	3	31	15	17p13.3	RILP	P	RAB-interacting lysosomal protein	607848	R, REc			11(Rilp)
17.36	2	28	03	17p13.3	PRPF8, PRPC8, RP13	C	Precursor mRNA-processing factor 8, S. cerevisiae, homolog of	607300	Fd, REc		Retinitis pigmentosa 13, 600059 (3)	
17.37	2	17	09	17p13.3	RNMTL1, HC90	P	RNA methyltransferase-like 1	612600	REc			
17.38	4	11	94	17p13.3	RPA1	P	Replication protein A1, 70kD	179835	Psh, R, A			
17.39	7	14	00	17p13.3	RPH3AL, NOC2	P	Rabphilin 3A-like	604881	REc			
17.40	5	24	13	17p13.3	RTN4RL1, NGRH2, NGR3	P	Reticulon 4 receptor-like 1	610461	REc			
17.41	3	13	08	17p13.3	SCARF1, SREC, KIAA0149	P	Scavenger receptor class F, member 1	607873	R, REc			
17.42	2	2	12	17p13.3	SERPINF1, PEDF, OI6	C	Serpin peptidase inhibitor, clade F, member 1	172860	REa, A, Psh	same region as RP13	Osteogenesis imperfecta, type VI, 613982 (3)	
17.43	9	24	11	17p13.3	SGSM2, KIAA0397	P	Small G protein signaling modulator 2	611418	REc, R			
17.44	10	20	99	17p13.2	SLC25A11, SLC20A4, OGC	P	Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11	604165	A			
17.45	3	8	07	17p13.3	SLC43A2, LAT4	P	Solute carrier family 43 (L-type amino acid transporter, member 2	610791	REc			
17.46	5	21	07	17p13.3	SMG6, EST1A, KIAA0732	P	SMG6, C. elegans, homolog of	610963	REc			
17.47	12	27	01	17p13.3	SRR	P	Serine racemase	606477	R			
17.48	9	16	13	17p13.3	TIMM22, TIM22	P	Translocase of inner mitochondrial membrane 22, yeast, homolog of	607251	R, REc			
17.49	1	8	01	17p13.2	TM4SF5	P	Transmembrane 4 superfamily, member 5	604657	REa, R			
17.50	12	14	98	17p13.1	TNFSF12, TWEAK, APO3L, DR3LG	C	Tumor necrosis factor ligand superfamily, member 12	602695	R			
17.51	5	24	13	17p13.3	TSR1, KIAA1401	P	TSR1, 20S r RNA accumulation, S. cerevisiae, homolog of	611214	REc, R			
17.52	9	2	08	17p13.3	TUSC5, LOST1	P	Tumor suppressor candidate 5	612211	REc			
17.53	6	22	14	17p13.3	VPS53, HCCS1, PCH2E	P	Vacuolar protein sorting 53, S. cerevisiae, homolog of	615850	REc		Pontocerebellar hypoplasia, type 2E, 615851 (3)	
17.54	6	4	12	17p13.3	WDR81, CAMRQ2	P	WD repeat-containing protein 81	614218	REc		Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3)	11(Wdr81)
17.55	5	13	10	17p13.3	YWHAE, MDCR, MDS	C	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon isoform	605066	A, R, Ch, D			11(Ywhae)
17.56	12	18	14	17p13.3-p13.1	SHFLD3, DUP17p13.3, C17DUPp13.3	P	Split-hand/foot malformation with long bone deficiency 3	612576	Fd	max lod at or near D17S1533; contiguous gene duplication syndrome	Split-hand/foot malformation with long bone deficiency 3 (4)	
17.57	2	25	15	17p13.2	ANKFY1, ANKHZN, KIAA1255	C	Ankyrin repeats- and FYVE domain-containing protein 1	607927	R, A, REc			
17.58	10	8	07	17p13.2	CAMTA2, KIAA0909	P	Calmodulin-binding transcription activator 2	611508	R, REc			
17.59	5	24	13	17p13.2	DERL2	P	DER1-like domain family, member 2	610304	REc			
17.60	1	1	12	17p13.2	DHX33	P	DEAH box polypeptide 33	614405	REc			
17.61	9	9	08	17p13.1	FBXO39, FBX39	P	F-box protein 39	609106	REc			11(Fbxo39)
17.62	10	9	08	17p13.2	GGT6	P	Gamma-glutamyltransferase 6	612341	REc			
17.63	1	12	11	17p13.1	HES7, SCDO4	P	Hairy/enhancer of split, Drosophila, homolog of, 7	608059	H, REc		Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	11(Hes7)
17.64	1	24	06	17p13.1	KCTD11, REn	C	Potassium channel tetramerization domain-containing protein 11	609848	REc, H			11(Kcntd11)
17.65	2	2	14	17p13.2	KIF1C, LTXS1, KIAA0706, SPAX2	P	Kinesin family member 1C	603060	REc		Spastic ataxia 2, autosomal recessive, 611302 (3)	
17.66	11	7	08	17p13.2	MED11	P	Mediator complex subunit 11	612383	REc			
17.67	2	2	16	17p13.2	MIS12	P	Mis12, S. pombe, homolog of	609178	R, REc			
17.68	10	28	15	17p13.2	NCBP3, C17orf85	P	Nuclear cap-binding protein 3	616624	REc			
17.69	5	24	13	17p13.2	RNF167, RING105	P	RING finger protein 167	610431	R, REc			
17.70	1	1	12	17p13.2	SCIMP, C17orf87	P	SLP adaptor- and CSK-interacting membrane protein	614406	REc			
17.71	4	29	14	17p13.1	SLC16A11, MCT11	P	Solute carrier family 16, member 11	615765	REc			
17.72	1	31	13	17p13.2	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	P	Solute carrier family 52, riboflavin transporter, member 1	607883	REc, R		Riboflavin deficiency, 615026 (3)	
17.73	8	19	13	17p13.2	SPAG7	P	Sperm-associated antigen 7	610056	REc			
17.74	2	17	09	17p13.2	SPNS2	P	Spinster, Drosophila, homolog of, 2	612584	REc			
17.75	1	2	08	17p13.2	SPNS3	P	Spinster, Drosophila, homolog of, 3	611701	REc			11(Spns3)
17.76	4	20	11	17p13.2	UBE2G	C	Ubiquitin-conjugating enzyme E2G (UBC7, C. elegans, homolog of)	601569	R, REc	possible pseudogene on 1q42		
17.77	5	7	03	17p13.1	XAF1	P	XIAP-associated factor 1	606717	A			
17.78	7	7	14	17p13.2	ZMYND15, SPGF14	P	Zinc finger MYND-containing protein 15	614312	REc, H	mutation identified in 1 SPGF14 family	?Spermatogenic failure 14, 615842 (3)	11(Zmynd15)
17.79	7	9	15	17p13.2	ZNF232, ZSCAN11	P	Zinc finger protein 232	616463	Psh, REc			
17.80	11	19	11	17p13.2-p13.1	MRT33	P	Mental retardation, autosomal recessive 33	614341	Fd	between rs1367950 and rs1826925	Mental retardation, autosomal recessive 33 (2)	
17.81	4	3	09	17p13.2	AIPL1, LCA4	C	Arylhydrocarbon-interacting receptor protein-like 1	604392	Fd, REc, A, R	LCA1 due to GUCY2D mutation also on 17p13.1	Leber congenital amaurosis 4, 604393 (3); Retinitis pigmentosa, juvenile, 604393 (3); Cone-rod dystrophy, 604393 (3)	
17.82	1	25	93	17p13.1	ALOX12	C	Arachidonate 12-lipoxygenase	152391	Psh	pseudogene also on chr.17		
17.83	1	18	13	17p13.1	ALOX12B, ARCI2	C	Archidonate 12-lipoxygenase, R type	603741	A, REc		Ichthyosis, congenital, autosomal recessive 2, 242100 (3)	
17.84	5	25	13	17p13.1	ALOX15B	P	Arachidonate 15-lipoxygenase, second type	603697	REc			
17.85	1	18	13	17p13.1	ALOXE3, ARCI3	P	Arachidonate lipoxygenase 3	607206	Fd		Ichthyosis, congenital, autosomal recessive 3, 606545 (3)	
17.86	3	9	04	17p13.1	ARGEF15, KIAA0915	P	Rho guanine nucleotide exchange factor 15	608504	R, REc			
17.87	11	2	04	17p13.1	BCL6B, BAZF	P	B-cell lymphoma 6B	608992	A			
17.88	10	23	15	17p13.1	BORCS6, C17orf59, LYSPERSIN	P	BLOC1-related complex, subunit 6	616599	REc			
17.89	6	3	14	17p13.1	CNTROB, LIP8	P	Centrosomal BRCA2-interacting protein	611425	REc			
17.90	5	8	12	17p13.1	CTC1, CRMCC, C17orf68, AAF132	P	Conserved telomere maintenance component 1	613129	REc		Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	11(Aaf132)
17.91	10	4	12	17p13.1	CTDNEP1, DULLARD	P	C-terminal domain nuclear envelope phosphatase 1	610684	REc			
17.92	9	9	10	17p13.1	CLEC10A, CLECSF14, MGL, HML, CD301	P	C-type lectin domain family 10, member A	605999	REc			
17.93	3	24	11	17p13.1	DEL17p13.1, C17DELp13.1	P	Chromosome 17p13.1 deletion syndrome	613776	Ch	contiguous gene deletion syndrome	Chromosome 17p13.1 deletion syndrome (4)	
17.94	12	30	14	17p13.1	DHRS7C, SDR32C2	P	Short-chain dehydrogenase reductase family, member 7C	616161	REc			
17.95	6	24	02	17p13.1	DLG4, PSD95, SAP90	P	Discs large, Drosophila, homolog of, 4	602887	R			
17.96	3	7	13	17p13.1	ELP5, DERP6, C17orf81	P	Elongator acetyltransferase complex, subunit 5	615019	REc			
17.97	10	17	00	17p13.1	FXR2	P	Fragile X mental retardation, autosomal homolog-2	605339	REc			
17.98	4	14	10	17p13.1	GABARAP	P	GABA-A receptor-associated protein	605125	REc			
17.99	4	3	09	17p13.1	GUCY2D, GUC2D, LCA1, CORD6, RCD2	C	Guanylate cyclase 2D, membrane, retina-specific	600179	Psh, A, Fd	LCA4 due to Aipl1 mutation also on 17p13.1	Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6, 601777 (3)	
17.100	6	6	00	17p13.1	KCNAB3, KCNA3B	P	Potassium voltage-gated channel, shaker-related subfamily, beta member 3	604111	Psh, REn			
17.101	12	19	11	17p13.1	KDM6B, JMJD3, KIAA0346	P	Lysine-specific demethylase 6B	611577	REc			
17.102	6	30	05	17p13.2	MINK1, MINK	P	Misshapen/nik-related kinase 1	609426	REc			
17.103	3	23	09	17p13.1	MIR195, MIRN195	P	Micro RNA 195	610718	REc			
17.104	3	7	14	17p13.1	MIR497	P	Micro RNA 497	615672	REc			
17.105	1	24	93	17p13.1	MYH1	C	Myosin, heavy polypeptide-1, skeletal muscle, adult	160730	REa, C	cluster = 6 genes in 500kb		11(Myh)
17.106	3	19	15	17p13.1	MYH2, MYPOP	C	Myosin, heavy polypeptide-2, skeletal muscle, adult	160740	REa, C		Proximal myopathy and ophthalmoplegia, 605637 (3)	
17.107	7	10	15	17p13.1	MYH3, DA2A, DA2B, DA8	C	Myosin, heavy polypeptide-3, skeletal muscle, embryonic	160720	REa		Arthrogryposis, distal, type 2A, 193700 (3); Arthrogryposis, distal, type 2B, 601680 (3); Arthrogryposis, distal, type 8, 178110 (3)	
17.108	10	4	93	17p13.1	MYH4	P	Myosin, heavy polypeptide-4, skeletal muscle	160742	REa, REn			
17.109	2	24	15	17p13.1	MYH8, DA7	C	Myosin, heavy polypeptide-8, skeletal muscle, perinatal	160741	REa, REn, Fd		Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly syndrome, 158300 (3)	
17.110	7	17	14	17p13.1	NEURL4, KIAA1787	P	Neuralized E3 ubiquitin protein ligase 4	615865	REc			
17.111	10	2	12	17p13.1	NTN1, NTN1L	P	Netrin 1, mouse, homolog of	601614	A, REc			
17.112	7	3	06	17p13.1	ODF4, OPPO1	P	Outer dense fiber of sperm tails 4	610097	REc, H			11(Odf4)
17.113	5	3	13	17p13.1	PIK3R5, p101	P	Phosphatidylinositol 3-kinase, regulatory subunit 5	611317	R, REc		Ataxia-oculomotor apraxia 3, 615217 (3)	
17.114	6	24	08	17p12	PIRT	P	Phosphoinositide-interacting regulator of transient receptor potential channels	612068	REc			
17.115	8	29	08	17p13.2-p13.1	PITPNM3, NIR1, CORD5	C	Phosphatidylinositol transfer protein, membrane-associated, 3	608921	R, A, Fd		Cone-rod dystrophy 5, 600977 (3)	
17.116	5	24	00	17p13.2	PLD2	P	Phospholipase D2	602384	A			11(Pld2)
17.117	3	10	03	17p13.1	PLSCR3	P	Phospholipid scramblase 3	607611	REc			
17.118	4	27	93	17p13.1	POLR2A, RPOL2	C	Polymerase (RNA) II (DNA directed) polypeptide A, 220kD	180660	REa, A, C			11(Rpo21)
17.119	2	25	15	17p13.1	RANGRF, MOG1	P	RAN guanine nucleotide release factor	607954	REc			
17.120	5	10	93	17p13.1	RCV1	C	Recoverin	179618	REa, A			11(Rcvrn)
17.121	10	13	09	17p13.1	SAT2, SSAT2	P	Spermidine/spermine N(1)-acetyltransferase 2	611463	REc			
17.122	7	9	09	17p13.1	SENP3	P	Sentrin-specific protease family, member 3	612844	REc			
17.123	3	12	07	17p13.1	SLC25A35	P	Solute carrier family 25, member 35	610818	REc			11(Slc25a35)
17.124	12	1	15	17p13.1	SNORD118	P	Small nucleolar RNA, C/D box, 118	616663	REc			
17.125	3	15	13	17p13.1	SPEM1, C17orf83	P	Spermatid maturation protein 1	615116	REc			
17.126	5	25	00	17p13.1	STK12, ARK2, AIK2, AIM1	P	Serine/threonine protein kinase 12	604970	A, R, H			11(Stk12)
17.127	11	2	04	17p13.1	TEKT1	P	Tektin 1	609002	REc			
17.128	1	13	15	17p13.1	TMEM107	P	Transmembrane protein 107	616183	REc			11(Tmem107)
17.129	11	11	14	17p13.1	TNFSF13, APRIL, TALL2	P	Tumor necrosis factor ligand superfamily, member 13	604472	REn			
17.130	9	16	03	17p13.1	TNK1	P	Tyrosine kinase, nonreceptor, 1	608076	Psh, A			
17.131	1	14	13	17p13.1	TP53, P53, LFS1 , BCC7	C	Tumor protein p53	191170	REa, A, D		Colorectal cancer, 114500 (3); Li-Fraumeni syndrome, 151623 (3); Hepatocellular carcinoma, 114550 (3); Osteosarcoma, 259500 (3); Choroid plexus papilloma, 260500 (3); Nasopharyngeal carcinoma, 607107 (3); Pancreatic cancer, 260350 (3); Adrenal cortical carcinoma, 202300 (3); Breast cancer, 114480 (3); {Basal cell carcinoma 7}, 614740 (3); {Glioma susceptibility 1}, 137800 (3)	11(Trp53)
17.132	4	26	11	17p13.1	TMEM102, CBAP	P	Transmembrane protein 102	613936	REc			
17.133	9	2	09	17p13.1	TRNAG2, TRG2	P	tRNA glycine-2	610407	A, Psh	at least 8 copies in this region		
17.134	10	24	14	17p13.1	TRNAK1, TRK1, TRK-TTT3-4	C	Transfer RNA lysine (TTT) 3-4	189918	REa, A			
17.135	9	2	09	17p13.1	TRNAL2, TRL2	C	tRNA leucine-2	189920	REa, A			
17.136	9	2	09	17p13.1	TRNAR1, TRR1	P	tRNA arginine-1	610406	A, Psh			
17.137	9	2	09	17p13.1	TRNAQ1, TRQ1	C	tRNA glutamine-1	189919	REa, A			
17.138	12	23	05	17p13.1	WDR16, WDRPUH	P	WD repeat-containing protein 16	609804	REc			
17.139	8	27	15	17p13.1	YBX2, MSY2, CSDA3, DBPC	P	Y box-binding protein 2	611447	Psh, REc			
17.140	9	22	08	17p13.1	ZBTB4, KIAA1538	P	Zinc finger and BTB domain-containing 4	612308	R, REc			
17.141	2	10	05	17p13.1	MPDU1, SL15, CDGIF	C	Mannose-P-dolichol utilization defect 1	604041	R		Congenital disorder of glycosylation, type If, 609180 (3)	
17.142	6	25	99	17p13.1	MYH13	P	Myosin, heavy polypeptide 13, skeletal muscle	603487	R, REc			11(Myh13)
17.143	3	16	99	17p13.1	EFNB3, EPLG8, LERK8, EFL6	P	Ephrin B3	602297	Psh			
17.144	9	12	95	17p11.2	NOS2B	P	Nitric oxide synthase 2B	600719	Psh			
17.145	9	12	95	17q11.2	NOS2C	P	Nitric oxide synthase 2C	600720	Psh			
17.146	9	26	05	17p13.1	ACADVL, VLCAD	C	Acyl-Coenzyme A dehydrogenase, very long chain	609575	REa, H		VLCAD deficiency, 201475 (3)	11(Acadvl)
17.147	11	27	94	17p13.2	ARRB2	P	Arrestin, beta 2	107941	A			
17.148	6	7	04	17p13	ASPG2	P	Asperger syndrome, susceptibility to, 2	608631	Ch	breakpoints between CHRNE and GP1BA	{Asperger syndrome susceptibility 2} (2)	
17.149	7	6	00	17p13.2	CARKL	P	Carbohydrate kinase-like	605060	REn			
17.150	12	15	98	17p13.1	CD68	P	Macrophage antigen CD68 (macrosialin)	153634	A			11(Cd68)
17.151	5	29	98	17p13.1	CHD3	P	Chromodomain helicase DNA binding protein-3	602120	R			
17.152	7	22	13	17p13	CTRCT24, CTAA2	P	Cataract 24, anterior polar	601202	Fd		Cataract 24, anterior polar (2)	
17.153	2	28	03	17p13.2	CTNS	C	Cystinosin	606272	Fd, REc	?3 allelic forms	Cystinosis, nephropathic, 219800 (3); Cystinosis, ocular nonnephropathic, 219750 (3); Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3); Cystinosis, atypical nephropathic, 219800 (3)	
17.154	11	27	00	17p13.2	CXCL16	P	CXC chemokine ligand-16	605398	Psh			11(Cxcl16)
17.155	2	21	06	17p13.1	DNAH2, DNAHC2	P	Dynein, axonemal, heavy chain-2	603333	REa, REc			11(Dnach2)
17.156	12	15	98	17p13.1	EIF4A1, DDX2A	P	Eukaryotic translation initiation factor 4A, isoform 1	602641	A			11(Eif4a1)
17.157	8	1	14	17p13.2	ITGAE, CD103	P	Integrin, alpha-E	604682	RE			11(Itgae1)
17.158	1	24	93	17p13.1	MYH10	P	Myosin, heavy polypeptide-10, non-muscle	160776	REa, A			
17.159	12	27	01	17p13.3	MYO1C	P	Myosin IC	606538	Psh, R			
17.160	5	13	13	17p13.2	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	C	NLR family, pyrin domain containing 1	606636	R, Fd	1 CIDED family identified with mutation	{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3); ?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	
17.161	12	2	14	17p13	NDNC7	P	Nail disorder, nonsyndromic congenital, 7 (onychodysplasia, isolated congenital)	605779	Fd		Nail disorder, nonsyndromic congenital, 7 (2)	
17.162	5	20	99	17p13.2	NUP88	P	Nucleoporin, 88-kD	602552	A			
17.163	7	22	09	17p13.1	PHF23	P	PHD finger protein 23	612910	REc, A			
17.164	3	4	08	17p13.2	RABEP1, RABPT5	P	RAB GTPase-binding effector protein 1	603616	Ch	fused to PDGFRB in CMML		
17.165	10	16	14	17p13.1	SLC2A4, GLUT4	P	Solute carrier family 2 (facilitated glucose transporter), member 4	138190	REa, A			
17.166	8	29	02	17p13.1	SOX15, SOX20	P	SRY (sex-determining region Y)-box 15	601297	A			
17.167	12	15	10	17p13	SXGQTL1	P	Sex hormone-binding globulin circulating level quantitative trait locus 1	613498	Fd	associated with rs1799941	[Sex hormone-binding globulin circulating level QTL 1] (2)	
17.168	7	28	15	17p13.2	TAX1BP3, TIP1	P	TAX1-binding protein 3	616484	REc			
17.169	5	21	07	17p13.1	TRAPPC1, MUM2, BET5	P	Trafficking protein particle complex, subunit 1	610969	R			
17.170	3	23	02	17p13.2	TRPV1, VR1	P	Transient receptor potential cation channel, subfamily V, member 1 (vanilloid receptor 1; capsaicin receptor)	602076	REc			11(Vr1)
17.171	6	3	15	17p13.2	TRPV3, OLMS, FNEPPK2	P	Transient receptor potential cation channel, subfamily V, member 3	607066	REc	mutation identified in 1 FNEPPK2 family	Olmsted syndrome, 614594 (3); ?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3)	11(Trpv3)
17.172	5	22	03	17p13.2	USP6, TRE2	C	Ubiquitin-specific protease 6	604334	A, REc			
17.173	7	1	11	17p13.1	WRAP53, TCAB1, WDR79, DKCB3	P	WD repeat-containing protein antisense to TP53	612661	REc		Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	
17.174	11	11	91	17p13.1	ASGR1	P	Asialoglycoprotein receptor-1	108360	H, REa			11(Asgr1)
17.175	4	30	15	17p13.2	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	C	Cholinergic receptor, nicotinic, epsilon polypeptide	100725	Psh, REc		Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3); Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3); Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	
17.176	12	17	95	17p13.1	EIF5A	P	Eukaryotic translation initiation factor-5A	600187	A			
17.177	8	20	15	17p13.1	SCO1, SCOD1	P	SCO1 cytochrome c oxidase assembly protein	603644	REc, Fd		Mitochondrial complex IV deficiency, 220110 (3)	
17.178	6	21	91	17p13.1	SHBG, ABP	P	Sex hormone-binding globulin (androgen binding protein)	182205	A			11(Shbg)
17.179	8	11	14	17p13.1	SLC13A5, NACT, EIEE25	C	Solute carrier family 13 (sodium-dependent citrate transporter), member 5	608305	R, REc		Epileptic encephalopathy, early infantile, 25, 615905 (3)	
17.180	10	4	93	17p12	ZNF18, KOX11	C	Zinc finger protein-18 (KOX11)	194524	REa, A			
17.181	10	12	90	17p12	ZNF29	P	Zinc finger protein-29 (KOX26)	194535	REa, A	proximal to TP53		11(Zfp2)
17.182	1	22	01	17p12	AOMS2	P	Abdominal obesity-metabolic syndrome QTL2	605572	Fd	second QTL on 3q27	Abdominal obesity-metabolic syndrome (2)	
17.183	4	26	01	17p12	DNAH9, DNAH17L, DNEL1	C	Dynein, axonemal, heavy chain 9	603330	A			
17.184	12	17	07	17p11.2	FBXW10	P	F-box and WD40 domain protein 10	611679	REc			11(Fbxw10)
17.185	11	2	98	17p13.1	PER, RIGUI	P	Period, Drosophila, homolog of	602260	A			11(Per)
17.186	6	6	00	17p13.1	STX8	P	Syntaxin 8	604203	REa, A			
17.187	3	31	09	17p12	TEKT3	P	Tektin 3	612683	REc			
17.188	6	23	15	17p12	TTC19, MC3DN2	P	Tetratricopeptide repeat domain 19	613814	REc		Mitochondrial complex III deficiency, nuclear type 2, 615157 (3)	
17.189	1	24	01	17p13.1	VAMP2, SYB2	C	Vesicle-associated membrane protein-2 (synaptobrevin-2)	185881	REa, A			11(Syb2)
17.190	3	30	12	17p12	ZSWIM7, SWS1	P	Zinc finger SWIM domain-containing protein 7	614535	REc			
17.191	3	26	95	17p12	ADORA2B	P	Adenosine A2b receptor	600446	A, Psh	incorrectly put on 10		
17.192	7	14	00	17p12	COX10	C	Cytochrome c oxidase, subunit X	602125	REc		Mitochondrial complex IV deficiency, 220110 (3); Leigh syndrome due to mitochondrial COX4 deficiency, 256000 (3)	
17.193	6	6	00	17p12	HS3ST3A1, 30ST3A1	P	Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3A1	604057	REc			11(30st3a1)
17.194	6	6	00	17p12	HS3ST3B1, 30ST3B1	P	Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3B1	604058	REc			11(30st3B)
17.195	12	20	96	17p11.2	LLGL1, DLG4	C	Lethal giant larvae, Drosophila, homolog of, 1	600966	REa, A			
17.196	5	4	12	17p11.2	PIGL, CHIME	P	Phosphatidylinositol glycan, class L	605947	R		CHIME syndrome, 280000 (3)	
17.197	6	25	99	17p11.2	PRPSAP2, PAP41	P	Phosphoribosylpyrophosphate synthetase-associated protein 2	603762	A			
17.198	1	27	97	17p11.2	TOP3A	P	Topoisomerase (DNA) III, alpha	601243	REa, A			
17.199	11	23	15	17p12-p11.2	YUHAL	C	Yuan-Harel-Lupski syndrome	616652	Ch	contiguous gene duplication syndrome	Yuan-Harel-Lupski syndrome (4)	
17.200	1	29	08	17p11.2	UBB	C	Ubiquitin B	191339	A, REc		Cleft palate, isolated, 119540 (2)	
17.201	4	30	15	17p13.1	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	C	Cholinergic receptor, nicotinic, beta polypeptide-1, muscle	100710	H, REa, A	mutation identified in 1 CMS2C family	Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3); ?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	11(Acrb)
17.202	6	7	10	17p12-q11.2	DFNB85	P	Deafness, autosomal recessive 85	613392	Fd	between rs230884 and rs12603885	Deafness, autosomal recessive 85 (2)	
17.203	11	14	12	17p12-q21.2	ECTD6	P	Ectodermal dysplasia 6, hair/nail type	614928	Fd	between D17S839 and D17S1299	Ectodermal dysplasia 6, hair/nail type (2)	
17.204	3	27	95	17p11.2	ALDH3A1, ALDH3	C	Aldehyde dehydrogenase 3 family, member A1	100660	S, A			11(Ahd4)
17.205	8	9	05	17p11.2	ALDH3A2, ALDH10, SLS, FALDH	C	Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase)	609523	Fd, LD		Sjogren-Larsson syndrome, 270200 (3)	
17.206	3	16	10	17p11.2	ALKBH5, ABH5	P	AlkB, E. coli, homolog of, 5	613303	REc			
17.207	7	1	11	17p11.2	ATPAF2, ATP12, MC5DN1	P	ATP synthase, mitochondrial F1 complex, assembly factor 2	608918	REc		Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	11(Atpaf2)
17.208	4	24	15	17p11.2	B9D1, MKSR1, MKS9	P	B9 domain-containing protein 1	614144	REc	mutation identified in 1 MKS9 patient	?Meckel syndrome 9, 614209 (3)	
17.209	4	23	10	17p11.2	CENPV, P30	P	Centromere protein V	608139	R, REc			
17.210	1	8	01	17p11.2	COPS3, SGN3	P	COP9 signalosome, subunit 3	604665	REa, REc			
17.211	12	30	14	17p11.2	DHRS7B, SDR32C1	P	Short-chain dehydrogenase reductase family, member 7B	616160	REc			
17.212	3	6	01	17p11.2	DRG2	C	Developmentally regulated GTP-binding protein 2	602986	A, REa			
17.213	3	7	05	17p11.2	FLCN, BHD	C	Folliculin	607273	Fd, REc		Birt-Hogg-Dube syndrome, 135150 (3); Pneumothorax, primary spontaneous, 173600 (3); Renal carcinoma, chromophobe, somatic, 144700 (3); Colorectal cancer, somatic, 114500 (3)	
17.214	5	13	97	17p11.2	FLII	P	Flightless-I, Drosophila, homolog of	600362	A, REa			
17.215	2	2	04	17q11.2	GIT1	P	G protein-coupled receptor kinase-interacting protein 1	608434	REc, R			
17.216	11	21	02	17p11.2	IS2, AIS2	P	Scoliosis, idiopathic 2	607354	Fd	between D17S947 and D17S798	Scoliosis, idiopathic 2 (2)	
17.217	2	21	10	17p11.2	KCNJ18, KIR2.6, TTPP2	P	Potassium channel, inwardly rectifying, subfamily J, member 18	613236	REc		{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	
17.218	6	25	99	17p11.2	MAPK7, PRKM7, ERK5	P	Mitogen-activated protein kinase 7 (extracellular signal-regulated kinase 5)	602521	Psh			
17.219	3	22	06	17p11.2	MED9, MED25, FLJ10193	P	Mediator of RNA polymerase II transcription, subunit 9, S. cerevisiae, homolog of	609878	R, REc			
17.220	12	10	13	17p11.2	MEIF2, SMCR7, MID49	P	Mitochondrial elongation factor 2	615498	REc			
17.221	4	9	96	17p11.2	MFAP4	P	Microfibrillar-associated protein-4	600596	D			
17.222	10	12	10	17p11.2	MIR33B, MIRN33B	P	Micro RNA 33B	613486	REc			
17.223	8	17	09	17p11.2	MPRIP, MRIP, KIAA0864, RIP3, P116RIP	P	Myosin phosphatase Rho-interacting protein	612935	R, REc			
17.224	3	16	04	17p12	MYOCD	P	Myocardin	606127	REc			
17.225	5	28	98	17p11.2	MYO15A, DFNB3	C	Myosin XVA	602666	Fd, REc		Deafness, autosomal recessive 3, 600316 (3)	11(sh2, Myo15)
17.226	6	21	01	17p11.2	NT5M, DNT2	P	Deoxyribonucleotidase, mitochondrial (5' nucleotidase, mitochondrial)	605292	REc, REn			
17.227	9	13	12	17p11.2	PEMT, PEMPT	P	Phosphatidylethanolamine N-methyltransferase	602391	REc			
17.228	5	4	12	17p12	PMP22, CMT1A, CMT1E, DSS	C	Peripheral myelin protein-22	601097	Fd, D, A		Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3); Roussy-Levy syndrome, 180800 (3); Neuropathy, inflammatory demyelinating, 139393 (3)	11(Tr)
17.229	12	17	12	17p11.2	PLD6, ZUC	P	Phospholipase D family, member 6	614960	REc			
17.230	8	1	14	17p11.2	PRG4, FLJ36000	P	p53-responsive gene 4	605160	REc			
17.231	4	17	07	17p11.2	PTLS	P	Potocki-Lupski syndrome	610883	Ch, REc	contiguous gene syndrome	Potocki-Lupski syndrome (4)	
17.232	3	25	03	17p11.2	RAI1, SMCR, SMS	C	Retinoic acid-induced gene 1	607642	REc, Ch		Smith-Magenis syndrome, 182290 (3)	
17.233	2	9	04	17p11.2	RASD1, DEXRAS1	P	Ras protein, dexamethasone-induced, 1	605550	REc, R			
17.234	9	22	93	17p11.2	RNU3	P	RNA, U3 small nuclear	180710	D	deleted in Smith-Magenis syndrome		
17.235	7	8	96	17p12	SERK1, PRKMK4, MAPKK4, JNKK1	P	SAPK/ERK kinase-1	601335	Psh, A			11(Serk1)
17.236	7	13	93	17p11.2	SHMT1	C	Serine hydroxymethyltransferase (soluble)	182144	A, D	?role in Smith-Magenis syndrome		
17.237	7	9	09	17p11.2	SLC47A1, MATE1, FLJ10847	P	Solute carrier family 47, member 1	609832	REc			11(Mate1)
17.238	7	9	09	17p11.2	SLC47A2, MATE2, FLJ31196, MATE2K	P	Solute carrier family 47, member 2	609833	REc			11(Mate2)
17.239	9	8	11	17p11.2	SPECC1, HCMOGT1, NSP	P	Sperm antigen with calponin homology and coiled-coil domains 1	608793	A			
17.240	1	10	96	17p11.2	SREBF1	P	Sterol regulatory element binding transcription factor 1	184756	REa, A			
17.241	12	15	10	17p11.2	TNFRSF13B, TACI, CVID2	P	Tumor necrosis factor receptor superfamily, member 13B	604907	REc		Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common variable, 2, 240500 (3)	
17.242	11	19	13	17p11.2	TOM1L2	P	TOM1-like 2	615519	REc			
17.243	2	25	15	17p12	TRIM16, EBBP	P	Tripartite motif-containing protein 16	609505	REa, A			
17.244	3	14	13	17p11.2	ULK2, KIAA0623, UNC51.2	C	UNC51-like kinase 2	608650	REc, R			11(Ulk2)
17.245	6	30	08	17p11.2	USP22, KIAA1064	P	Ubiquitin-specific protease 22	612116	R, REc			
17.246	3	10	00	17p11.2-p11.2	VWSM	P	Van der Woude syndrome modifier	604547	Fd			
17.247	5	13	97	17p11.2	ZNF179, BFP	P	Zinc finger protein-179	601237	A	proximal to LLGS		11(Bfp)
17.248	5	3	04	17p11.2	KCNJ12, KCNJN1	C	Potassium inwardly-rectifying channel, subfamily J, member 12	602323	A			
17.249	4	2	09	17p11.2	AKAP10	P	A-kinase anchor protein 10	604694	R		{Cardiac conduction defect, susceptibility to}, 115080 (3)	
17.250	1	1	12	17q11.2	IFT20	P	Intraflagellar transport 20, chlamydomonas, homolog of	614394	REc			
17.251	11	4	98	17q11.2	CPD	P	Carboxypeptidase D	603102	Psh			11(Cpd)
17.252	10	8	99	17q11.2	SLC13A2, NADC1	C	Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2	604148	REa, A, R			
17.253	9	30	04	17p11	ADHD2	P	Attention deficit-hyperactivity disorder, susceptibility to, 2	608904	Fd		{Attention deficit-hyperactivity disorder}, 143465 (2)	
17.254	10	15	13	17p12	ELAC2, HPC2, COXPD17	C	elaC, E. coli, homolog 2	605367	Fd, R	at ~365cR	{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3); Combined oxidative phosphorylation deficiency 17, 615440 (3)	
17.255	1	2	91	17p13.1	ASGR2	L	Asialoglycoprotein receptor-2	108361	H			11(Asgr2)
17.256	4	12	92	17p13.1	ATP1B2, AMOG	P	ATPase, Na+K+ transporting, beta-2 polypeptide	182331	H, REa			11(Atp1b2)
17.257	1	26	97	17p	CACD1	P	Choroidal dystrophy, central areolar 1	215500	Fd		Choroidal dystrophy, central areolar 1 (2)	
17.258	10	14	98	17p13.1	GAS7	P	Growth arrest-specific 7	603127	REc, H			11(gas7)
17.259	11	4	13	17p13.1	RPL26, DBA11	P	Ribosomal protein L26	603704	Psh, R	mutation identified in 1 family	?Diamond-Blackfan anemia 11, 614900 (3)	
17.260	2	20	03	17q11.2	NOS2A, NOS2	C	Nitric oxide synthase 2A, inducible, hepatocytes	163730	REa, A, Psh, H	?cluster of 3 NOS2 genes	{Hypertension, susceptibility to}, 145500 (2); {Malaria, resistance to}, 611162 (3)	11(Nos2)
17.261	9	15	89	17q11.2	ALDOC	C	Aldolase C, fructose-bisphosphatase	103870	REb, REa, A			
17.262	8	4	99	17q	HYT1	P	Hypertension, essential, susceptibility to, 1	603918	Fd	~18cM distal to ACE	{Hypertension, essential, susceptibility to, 1}, 145500 (2)	
17.263	10	20	99	17q25.1	RPL38	P	Ribosomal protein L38	604182	REa, R			
17.264	5	16	07	17q11	AUTS6	P	Autism, susceptibility to, 6	609378	Fd	max lod at D17S1800	{Autism susceptibility 6} (2)	
17.265	1	11	02	17q11	ERVE1, HERVE1	P	Endogenous retroviral sequence E, 1	606601	REc			
17.266	8	20	99	17q11.2	GOSR1, GOS28, GS28	P	Golgi snap receptor complex member 1	604026	R, A			
17.267	3	3	03	17q11.2	PPY2	P	Pancreatic polypeptide 2	606638	REa			
17.268	3	3	03	17q11.2	PYY2	P	Peptide YY, 2	606637	Psh, REa			
17.269	10	18	11	17q12	RAD51L3, RAD51D, BROVCA4	P	RAD51, S. cerevisiae, homolog of, D	602954	R, H		{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	11(Rad51d)
17.270	9	1	11	17q11.2	RNF135, MMFD	P	Ring finger protein 135	611358	REc		Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)	
17.271	8	20	99	17q12	RPL23	P	Ribosomal protein L23	603662	REa, R			
17.272	3	26	95	17q12	RPL19	C	Ribosomal protein L19	180466	REa, A			
17.273	2	18	98	17q11.2	RPL23A	P	Ribosomal protein L23a	602326	A			
17.274	4	30	03	17q11.2	SARM, KIAA0524	C	Sterile alpha and heat/armadillo motifs-containing protein	607732	R, REc			
17.275	3	25	15	17q12	UNC45B, SMUNC45, CTRCT43	P	UNC45, C. elegans, homolog of, B	611220	REc, Fd	mutation identified in 1 CTRCT43 family	?Cataract 43, 616279 (3)	
17.276	8	7	92	17q11.2	VTN, VNT	P	Vitronectin (serum spreading factor, somatomedin B, complement S-protein)	193190	A			
17.277	8	24	98	17q11.2	FLOT2, M17S1, ECS1, ESA1	C	Flotillin 2 (epidermal surface antigen 1)	131560	Fd, REa, A, REn	~180kb centromeric to NF1		11(Esa1)
17.278	2	11	08	17q11.2	FOXN1, WHN	P	Forkhead box N1 (winged helix nude)	600838	R		T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)	
17.279	12	27	01	17q11.2	MYO1D, KIAA0727	P	Myosin ID	606539	R, H			11(Myo1d)
17.280	6	28	02	17q12	STARD3, MLN64	P	Start domain-containing protein 3	607048	REa, A			
17.281	4	2	01	17q21.2	DANJC7, TTC2, TPR2	P	DnaJ, E. coli, homolog of, subfamily C, member 7 (tetratricopeptide repeat domain 2)	601964	REa			
17.282	5	8	96	17q23.3	CYB561	P	Cytochrome b-561	600019	REa			
17.283	8	1	08	17q25.1	ITGB4	C	Integrin, beta-4	147557	REa		Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa of hands and feet, 131800 (3)	
17.284	9	29	13	17q11.2	NEK8, JCK, NPHP9, RHPD2	P	Never in mitosis gene A-related kinase 8	609799	REc	mutations identified in 1 family each with RHPD2 and NPHP9	?Nephronophthisis 9, 613824 (3); ?Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	
17.285	4	18	07	17q11.2	RAB34, RAH	P	Ras-associated protein 34	610917	REc			
17.286	5	5	09	17q11.2	SLC46A1, HCP1, PCFT	P	Solute carrier family 46 (folate transporter), member 1	611672	REc		Folate malabsorption, hereditary, 229050 (3)	11(Slc46a1)
17.287	3	24	14	17q11.1	WSB1, SWIP1	P	WD repeat- and SOCS box-containing protein 1	610091	R, REc			
17.288	12	5	01	17q12	TAF15, TAF2N, RBP56	C	TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD	601574	REa, A, Psh	fusion gene with CSMF	Chondrosarcoma, extraskeletal myxoid, 612237 (1)	
17.289	5	23	13	17q11.2	CRYBA1, CRYB1, CTRCT10	C	Crystallin, beta A1	123610	REa, A, Fd	centromeric to NF1	Cataract 10, multiple types, 600881 (3)	11(Cryba1)
17.290	1	26	12	17q11.2	SLC6A4, HTT, OCD1	C	Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	182138	REa, A, Fd		{Anxiety-related personality traits}, 607834 (3); {Obsessive-compulsive disorder}, 164230 (3)	11(Htt)
17.291	7	17	14	17q11.2	ADAP2, CENTA2	P	ArfGAP with dual PH domains 2	608635	REc			
17.292	4	6	13	17q11.2	ANKRD13B	P	Ankyrin repeat domain-containing protein 13B	615124	REc			
17.293	1	12	12	17q11.2	ATAD5, C17orf41, FRAG1, FLJ12735	P	ATPase family, AAA domain containing 5	609534	A			11(Atad5)
17.294	8	24	98	17q11.2	BLMH, BMH	P	Bleomycin hydrolase	602403	REc		{Alzheimer disease, susceptibility to}, 104300 (3)	
17.295	2	5	07	17q11.2	CCL3L1, SCYA3L1, LD78	C	Chemokine, C-C motif, ligand 3-like 1	601395	REn	varies in copy number 1-10	{HIV/AIDS, susceptibility to}, 609423 (3)	
17.296	8	29	02	17q12	CCL8, SCYA8	P	Chemokine, C-C motif, ligand 8	602283	REc			
17.297	8	29	02	17q12	CCL13, SCYA13, NCC1	P	Chemokine, C-C motif, ligand 13	601391	REn			
17.298	8	29	02	17q12	CCL14, SCYA14, NCC2	P	Chemokine, C-C motif, ligand 14	601392	REn			
17.299	5	27	97	17q12	CCL15, SCYA15, NCC3, LKN1	C	Chemokine, C-C motif, ligand 15	601393	REn			
17.300	8	29	02	17q12	CCL16, SCYA16, NCC4	P	Chemokine, C-C motif, ligand 16	601394	REn			
17.301	8	29	02	17q12	CCL18, SCYA18, PARC, AMAC1, DCCK1	C	Chemokine, C-C motif, ligand 18	603757	REc	in 47kb, CCL18-CCL3-CCL4		
17.302	10	11	12	17q11.2	CRLF3, CYTOR4, CRLM9, CREME9	P	Cytokine receptor-like factor 3	614853	REc			
17.303	1	21	11	17q11.2	DEL17q11.2, C17DELq11.2	P	Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome)	613675	Ch		Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)	
17.304	12	30	14	17q11.2	DHRS13, SDR7C5	P	Short-chain dehydrogenase reductase family, member 13	616157	REc			
17.305	3	6	92	17q11.2	EVI2A, EVI2, EVDA	C	Ecotropic viral integration site 2A	158380	Fd, REa, RE	within the NF1 gene		11(Evi2)
17.306	3	4	92	17q11.2	EVI2B, EVDB	C	Ecotropic viral integration site 2B	158381	REn	within the NF1 gene		
17.307	6	22	14	17q11.2	JJAZ1, KIAA0160	C	JJAZ1 gene	606245	Ch, REn			
17.308	5	1	03	17q21.2	KRT24, FLJ20261	P	Keratin 24	607742	REc			
17.309	1	31	07	17q11.2	KSR, KSR1	P	Kinase suppressor of RAS	601132	REc			
17.310	4	18	05	17q11.2	LGALS9	P	Lectin, galactoside-binding, soluble, 9	601879	REc			
17.311	9	24	15	17q11.2	LRRC37B	P	Leucine-rich repeat-containing protein 37B	616558	A, REc			
17.312	5	12	09	17q12	LYZL6	P	Lysozyme-like 6	612751	REc			
17.313	3	23	09	17q11.2	MIR144, MIRN144	P	Micro RNA 144	612070	REc			
17.314	7	20	12	17q11.2	MIR193A	P	Micro RNA 193A	614733	REc			11(Mir193a)
17.315	3	23	09	17q11.2	MIR451, MIRN451	P	Micro RNA 451	612071	REc			
17.316	8	8	13	17q12	MMP28	C	Matrix metalloproteinase 28	608417	REc, Psh			
17.317	3	11	09	17q11.2	MPVQTL3	P	Mean platelet volume quantitative trait locus 3	612575	Fd	associated with rs2138852	[Mean platelet volume QTL3] (2)	
17.318	3	16	10	17q11.2	MYO18A, SPR210	P	Myosin XVIIIA	610067	REc			
17.319	8	20	14	17q11.2	NF1, VRNF, WSS, NFNS	C	Neurofibromin (neurofibromatosis, type I)	613113	Fd, EM, Ch, F		Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile myelomonocytic, 607785 (3); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan syndrome, 601321 (3); Watson syndrome, 193520 (3)	
17.320	5	18	99	17q21.1	NR1D1, THRAL, EAR1	P	Nuclear receptor 1, subfamily D, member 1 (thyroid hormone receptor, alpha-1-like)	602408	REn			
17.321	1	12	15	17q11.2	NSRP1, NSRP70, CCDC55	P	Nuclear speckle splicing regulatory protein 1	616173	REc			11(Nsrp1)
17.322	6	2	08	17q11.2	NUFIP2, KIAA1321, PIG1	P	Nuclear fragile X mental retardation protein-interacting protein 2	609356	R, REc			
17.323	8	13	91	17q11.2	OMG, OMGP	C	Oligodendrocyte-myelin glycoprotein	164345	REa, A	within the NF1 gene		
17.324	8	3	12	17q11.2	PIGS	P	Phosphatidylinositol glycan, class S	610271	REc, R			
17.325	9	9	08	17q11.2	POLDIP2, PDIP38	P	Polymerase delta-interacting protein 2	611519	R, REc			
17.326	6	23	99	17p11.2	PRKMK3, MAPKK3, MEK3	P	Protein kinase, mitogen-activated, kinase-3	602315	R			
17.327	9	25	12	17q11.2	PSMD11, S9	P	Proteasome 26S subunit, non-ATPase, 11	604449	REc			
17.328	4	23	08	17q11.2	RAB11FIP4, KIAA1821	P	RAB11 family-interacting protein 4	611999	REc			
17.329	7	22	09	17q12	RDM1	P	RAD52 motif-containing protein 1	612896	REc			
17.330	4	15	11	17q11.2	RHOT1, MIRO1, ARHT1	P	Ras homolog gene family, member T1	613888	REc			
17.331	8	6	98	17q11.2	SDF2	P	Stromal cell-derived factor-2	602934	A			
17.332	5	22	07	17q11.2	SEBOX, OG9	P	Skin-, embryo-, brain-, and oocyte-specific homeobox	610975	REc, H			11(Sebox)
17.333	12	1	15	17q11.2	SEZ6, BSRPC	P	Seizure-related 6, mouse, homolog of	616666	REc			
17.334	12	27	13	17q11.2	SPAG5, MAP126, ASTRIN	P	Sperm-associated antigen 5	615562	REc			
17.335	4	3	12	17q11.2	SSH2, KIAA1725	P	Slingshot, Drosophila, homolog of, 2	606779	R, REc			
17.336	8	27	15	17q21.2	STAT5B	P	Signal transducer and activator of transcription 5B	604260	A, Ch	fused with RARA in PML	Leukemia, acute promyelocytic, somatic, 102578 (3); Growth hormone insensitivity with immunodeficiency, 245590 (3)	
17.337	7	8	96	17q11.2	SUPT6H	P	Suppressor of Ty, S.cerevisiae, 6 homolog of	601333	Psh, A			11(Supt6h)
17.338	12	7	09	17q11.2	TAOK1, PSK2, TAO1, MARKK	P	TAO kinase 1	610266	REc			
17.339	6	19	15	17q11.2	TEFM, C17orf42	P	Transcription elongation factor, mitochondrial	616422	REc			
17.340	1	27	12	17q21.1	THRA, ERBA1, THRA1, CHNG6	C	Thyroid hormone receptor, alpha (oncogene ERBA1)	190120	REa, Ch		Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	11(Erba)
17.341	4	19	06	17q11.2	TIAF1, MYO18A, MYSPDZ, MAJN, SPR210, KIAA0216	P	TGFB1-induced antiapoptotic factor 1	609517	R, Psh, REc			
17.342	7	22	09	17q11.2	TMEM97, MAC30	C	Transmembrane protein 97	612912	Psh, REa, Ch			
17.343	3	10	16	17q11.2	TMEM98, NNO4	P	Transmembrane protein 98	615949	REc		Nanophthalmos 4, 615972 (3)	
17.344	2	29	16	17q11.2	TMEM199, VMA12, VPH2, C17orf32, CDG2P	P	Transmembrane protein 199	616815	REc		Congenital disorder of glycosylation, type IIp, 616829 (3)	
17.345	11	19	13	17q11.2	UNC119, HRG4, IMD13	C	Unc119, C. elegans, homolog of (human retinal gene 4)	604011	REa, A	mutation identified in 1 IMD13 family and CORD family	?Cone-rod dystrophy (3); ?Immunodeficiency 13, 615518 (3)	
17.346	6	18	99	17q11.2	ZNF207	P	Zinc finger protein-207	603428	A, REc	mapped by FISH to 6p21.3		
17.347	2	16	04	17q12	AATF, CHE1	P	Apoptosis-antagonizing transcription factor	608463	A			11(Aatf)
17.348	7	13	98	17q11-q12	ACCN1, BNC1, MDEG	P	Amiloride-sensitive cation channel 1, neuronal (degenerin)	601784	A			
17.349	9	18	00	17q12	AP2B1, CLAPB1, ADTB2	P	Adaptor-related protein complex 2, beta 1 subunit	601025	REa			
17.350	10	11	06	17q12	CCL2, SCYA2, MCP1, MCAF	C	Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)	158105	REa, A		{HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility to}, 182940 (3); {Coronary artery disease, modifier of} (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
17.351	10	7	02	17q12	CCL5, SCYA5, D17S136E, TCP228	P	Chemokine, C-C motif, ligand 5	187011	REa, A		{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid progression of} (3)	
17.352	8	29	02	17q12	CCL7, SCYA7, MCP3	P	Chemokine, C-C motif, ligand 5	158106	A	close to ERBB2		
17.353	7	8	89	17q21.1	CSF3, GCSF	C	Colony-stimulating factor-3 (granulocyte)	138970	A, REa, REb, RE			11(Csfq)
17.354	10	15	97	17q12	LIG3	C	Ligase III, DNA, ATP-dependent	600940	Psh, A			
17.355	10	15	94	17q11.2-q24	MHS2	P	Malignant hyperthermia susceptibility 2	154275	Fd	?due to mutation in SCN4A	{Malignant hyperthermia susceptibility 2} (2)	
17.356	11	30	06	17q12	ARHGAP23, KIAA1501	C	RHO GTPase-activating protein 23	610590	R, REc			11(Arhgap23)
17.357	2	19	08	17q12	C17orf37, RDX12	P	Chromosome 17 open reading frame 37	611802	REc			
17.358	7	18	06	17q12	CCL3, SCYA3, MIP1A	C	Chemokine, C-C motif, ligand 3	182283	REa, REn	in 47kb, CCL18-CCL3-CCL4	{HIV infection, resistance to}, 609423 (2)	11(Mip1a)
17.359	2	2	04	17q12	CCL4, SCYA4, ACT2, MIP1B, AT744.1	C	Chemokine, C-C motif, ligand 4	182284	REa, A, REn			(Mip1b)
17.360	3	8	07	17q12	CCL4L, SCYA4L, LAG1	C	Chemokine, C-C motif, ligand 4-like	603782	Psh, REn			
17.361	3	8	07	17q12	CCL4L2	P	Chemokine, CC motif, ligand 4-like 2	610757	REc			
17.362	4	29	14	17q12	CCL23, SCYA23	P	Chemokine, C-C motif, ligand 23	602494	REn, REc			
17.363	1	30	07	17q12	CCT6B, CCTZ2	P	Cahperonin containing T-complex polypeptide 1, subunit 6B	610730	R, REc			
17.364	4	8	08	17q12	CISD3, MINER2	P	CDGSH iron sulfur domain protein 3	611933	R, REc			
17.365	3	30	12	17q12	DEL17q12, C17DELq12	P	Chromosome 17q12 deletion syndrome	614527	Ch		Chromosome 17q12 deletion syndrome (4)	
17.366	12	30	14	17q12	DHRS11, SDR24C1	P	Short-chain dehydrogenase reductase family, member 11	616159	REc			
17.367	3	30	12	17q12	DUP17q12, C17DUPq12	P	Chromosome 17q12 duplication syndrome	614526	Ch		Chromosome 17q12 duplication syndrome (4)	
17.368	8	1	05	17q12	FBXO47	P	F-box only protein 47	609498	REc			
17.369	4	2	16	17q12	GAS2L2, GAR17	P	Growth arrest-specific 2-like 2	611398	REc			
17.370	1	31	13	17q12	GPR179, GPR158L, GPR158L1, CSNB1E	P	G protein-coupled receptor 179	614515	REc		Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	11(Gpr179)
17.371	4	23	08	17q12	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	C	HNF1 homeobox B (transcription factor 2)	189907	REa		Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)	11(Hnf2)
17.372	1	21	09	17q12	HPC11	P	Prostate cancer, hereditary, 11	611955	Fd	associated with rs4430796 and rs7501939	{Prostate cancer, hereditary, 11} (2)	
17.373	2	25	98	17q21.2	KRT12	C	Keratin 12	601687	R, Fd, A		Meesmann corneal dystrophy, 122100 (3)	
17.374	12	2	10	17q12	LHX1, LIM1	P	LIM/homeodomain protein LHX1	601999	REc, A	previously mapped to 11p13-p12 by FISH		11(Lhx1)
17.375	2	1	11	17q12	MED1, PPARBP, PBP, TRAP220	C	Mediator complex subunit 1 (peroxisome proliferator-activated receptor-binding protein)	604311	A			
17.376	4	7	97	17q12	NEUROD2	P	Neurogenic differentiation 2	601725	A			11(Neurod2)
17.377	9	12	11	17q12	PBC5	P	Biliary cirrhosis, primary, 5	614221	Fd	associated with rs9303277	Biliary cirrhosis, primary, 5 (2)	
17.378	4	10	14	17q12	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	P	Post-GPI attachment to proteins 3	611801	REc		Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	
17.379	10	25	12	17q12	PEX12, PBD3A	P	Peroxisome biogenesis factor 12	601758	H, REc		Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3); Peroxisome biogenesis disorder 3B, 266510 (3)	11(Pex12)
17.380	10	12	14	17q12	PIGW, HPMRS5	P	Phosphatidylinositol glycan, class W	610275	REc	mutation identified in 1 HPMRS5 patient	?Hyperphosphatasia with mental retardation syndrome 5, 616025 (3)	
17.381	2	25	15	17q12	PIP5K2B, PIP5P4KB, PIP4K2B	P	Phosphatidylinositol 4-phosphate 5-kinase, type II, beta	603261	R, REc			
17.382	10	24	14	17q12	PNMT, PENT	C	Phenylethanolamine N-methyltransferase	171190	REa, Fd, REc			
17.383	2	24	98	17q12	PSMB3	P	Proteasome subunit, beta type, 3	602176	A, REc	previously assigned to 2q35		
17.384	8	18	08	17q12	RASL10B, RRP17	P	Ras-like, family 10, member B	612128	REc			
17.385	11	28	05	17q12	RFFL	P	Ring finger and FYVE-like domain containing 1 (rififylin)	609735	R, REc			11(Rffl)
17.386	10	13	04	17q12	RNF110, ZNF144, MEL18	P	Ring finger protein 110 (zinc finger protein-144)	600346	A, H, REc	previously assigned to 12q22		10(Mel18)
17.387	12	17	12	17q12	SLFN5	P	Schlafen family, member 5	614952	REc			
17.388	11	30	12	17q12	SLFN11	P	Schlafen family, member 11	614953	REc			
17.389	12	17	12	17q12	SLFN12	P	Schlafen family, member 12	614955	REc			
17.390	12	17	12	17q12	SLFN12L	P	Schlafen family, member 12-like	614956	REc			
17.391	12	17	12	17q12	SLFN13	P	Schlafen family, member 13	614957	REc			
17.392	4	21	16	17q12	SLFN14, BDPLT20	P	Schlafen family, member 14	614958	REc		Bleeding disorder, platelet-type, 20, 616913 (3)	
17.393	2	22	07	17q12	SNIP, KIAA1684	P	SNAP25-interacting protein	610786	REc			
17.394	5	12	09	17q11.2	SPACA3, LYZL3, SLLP1, LYC3, ALLP17	C	Sperm acrosome-associated 3	612749	REc			
17.395	5	12	03	17q12	TBC1D3, PRC17, TBC1D3A	P	TBC1D3 gene	607741	REc			
17.396	10	27	08	17q12	TBC1D3B, PRC17	C	TBC1 domain family, member 3B	610144	REc			
17.397	3	12	07	17q12	TBC1D3C	P	TBC1 domain family, member 3C	610806	REc			
17.398	4	21	15	17q12	TCAP, LGMD2G, CMH25	C	Telethonin	604488	Fd, REc		Muscular dystrophy, limb-girdle, type 2G, 601954 (3); Cardiomyopathy, hypertrophic, 25, 607487 (3)	
17.399	1	12	17	17q12	TMEM132E	P	Transmembrane protein 132E	616178	REc			
17.400	12	2	10	17q12	ZNHIT3, TRIP3	P	Zinc finger HIT domain-containing protein 3	604500	REc			
17.401	10	5	10	17q21.31	ARL4D, ARF4L	P	ADP-ribosylation factor-like 4D	600732	REc, Psh			
17.402	2	21	14	17q21.2	COASY, NBIA6	P	Coenzyme A synthase	609855	REc		Neurodegeneration with brain iron accumulation 6, 615643 (3)	
17.403	3	4	94	17q21.2	IGFBP4	P	Insulin-like growth factor-binding protein-4	146733	A			
17.404	9	27	13	17q21.2	KRT9, EPPK	C	Keratin 9	607606	Fd, REa		Palmoplantar keratoderma, epidermolytic, 144200 (3)	
17.405	10	7	13	17q21.2	KRT14	C	Keratin 14	148066	REa		Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, recessive 1, 601001 (3); Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3); Dermatopathia pigmentosa reticularis, 125595 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	
17.406	4	10	14	17q21.2	KRT16, FNEPPK, PC1	C	Keratin 16	148067	REa, Fd	probably 17q21-q22	Pachyonychia congenita 1, 167200 (3); Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	
17.407	4	10	14	17q21.2	KRT17, PC2, PCHC1	C	Keratin 17	148069	REn, Fd	~5' to KRT16; probably 17q21-q22	Pachyonychia congenita 2, 167210 (3); Steatocystoma multiplex, 184500 (3)	
17.408	3	22	07	17q21.2	KRT20, CD20, KRT21	P	Keratin 20	608218	REn			
17.409	9	12	08	17q21.2	KRTAP1-1, KAP1.1, KAP1.7, KAP1.6	P	Keratin-associated protein 1-1	608819	REc			
17.410	9	12	08	17q21.2	KRTAP1-3, KAP1.3, KAP1.2, KAP1.9	P	Keratin-associated protein 1-3	608820	REc			
17.411	9	12	08	17q21.2	KRTAP1-4, KAP1.4	P	Keratin-associated protein 1-4	608821	REc			
17.412	9	12	08	17q21.2	KRTAP-15, KAP1.5	P	Keratin-associated protein 1-5	608822	REc			
17.413	2	18	08	17q21.2	TNS4, CTEN	P	Tensin 4	608385	REc			
17.414	3	12	07	17q12	TBC1D3D	P	TBC1 domain family, member 3D	610807	REc			
17.415	3	12	07	17q12	TBC1D3E	P	TBC1 domain family, member 3E	610808	REc			
17.416	3	12	07	17q12	TBC1D3F	P	TBC1 domain family, member 3F	610809	REc			
17.417	3	12	07	17q12	TBC1D3G	P	TBC1 domain family, member 3G	610810	REc			
17.418	3	12	07	17q12	TBC1D3H	P	TBC1 domain family, member 3H	610811	REc			
17.419	3	7	08	17q21.2	KRT31, KRTHA1, HA1	P	Keratin 31	601077	REc			
17.420	3	8	08	17q21.2	KRT32, KRTHA2, HA2	P	Keratin 32	602760	A			
17.421	3	8	08	17q21.2	KRT33A, KRTHA3A, HA3I	P	Keratin 33A	602761	REc			
17.422	3	8	08	17q21.2	KRT33B, KRTHA3A, HA3II	P	Keratin 33B	602762	REc			
17.423	3	7	08	17q21.2	KRT34, KRTHA4, HA4	P	Keratin 34	602763	REc			
17.424	3	7	08	17q21.2	KRT35, KRTHA5	P	Keratin 35	602764	REn			
17.425	3	7	08	17q21.2	KRT36, KRTHA6, HA6	P	Keratin 36	604540	REc			
17.426	3	7	08	17q21.2	KRT37, KRTHA7, HA7	P	Keratin 37	604541	REc			
17.427	3	7	08	17q21.2	KRT38,  KRTHA8, HA8	P	Keratin 38	604542	REc			
17.428	5	27	97	17q21.31	MPP2, DLG2	P	Membrane protein, palmitoylated-2 (MAGUK p55 subfamily member 2)	600723	RE			
17.429	5	27	97	17q21.31	MPP3, DLG3	P	Membrane protein, palmitoylated-3 (MAGUK p55 subfamily member 3)	601114	REc, A			
17.430	3	3	94	17q21.31	PPY	C	Pancreatic polypeptide	167780	REa, Fd, H, REn	in rat, close to GH		?11(Ppy)
17.431	1	31	01	17q21.31	PSME3, PA28G	P	Proteasome activator subunit 3	605129	REc, A			14(Psme3)
17.432	4	29	14	17q21.31	SOST, VBCH, CDD, SOST1	C	Sclerostin	605740	Fd, REc		Sclerosteosis 1, 269500 (3); Van Buchem disease, 239100 (3); Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	
17.433	4	26	10	17q12	TADA2L, TADA2A, ADA2A	P	Transcriptional adaptor 2A	602276	A			
17.434	9	2	96	17q12-q21	WT4	C	Wilms tumor-4	601363	Fd		Wilms tumor, type 4 (2)	
17.435	7	27	07	17q21.1	ZPBP2, ZPBPL	P	Zona pellucida-binding protein 2	608499	REc			
17.436	9	24	08	17q12	GGNBP2, DIF3, LCRG1, LZK1	P	Gametogenetin-binding protein 2	612275	REc			
17.437	2	14	01	17q21.2	RAMP2	C	Receptor activity-modifying protein 2	605154	R			11(Ramp2)
17.438	9	9	08	17q21.2	CCR7, CMKBR7, EBI1	P	Chemokine (C-C) receptor 7 (Epstein-Barr virus induced gene 1)	600242	REa, A			
17.439	2	16	04	17q21.1	MLN51, CASC3	P	MLN51 gene	606504	A			
17.440	7	12	13	17q21.33	SGCA, ADL, DAG2, LGMD2D, DMDA2	C	Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin)	600119	Psh, A		Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	
17.441	10	15	95	17q21.31	CRHR1, CRHR	P	Corticotropin releasing hormone receptor 1	122561	Psh			
17.442	4	11	94	17q21.32	CDC27	P	Cell division cycle 27	116946	Psh, H	between ERBB2 and PRKCA		11(Cdc27)
17.443	5	23	11	17q12	ACACA, ACAC, ACC1, ACACAD	C	Acetyl-Coenzyme A carboxylase, alpha	200350	A	proximal to q21.33; others put at 17q12	Acetyl-CoA carboxylase deficiency, 613933 (1)	
17.444	3	16	99	17q21.31	AOC2, RAO	P	Amine oxidase, copper-containing, 2	602268	A			
17.445	6	25	99	17q21.31	AOC3, HPAO, VAP1	P	Amine oxidase, copper-containing 3	603735	TM			
17.446	11	20	06	17q21.31	ARHGAP27, CAMGAP1	P	RHO GTPase-activating protein 27	610591	REc			
17.447	2	29	08	17q21	ASRT6	P	Asthma-related traits, susceptibility to, 6	611403	Fd	strongly associated with rs7216389	{Asthma-related traits, susceptibility to, 6} (2)	
17.448	1	8	08	17q21.2	ATP6V0A1, ATP6N1A, VPP1	C	ATPase, H+ transporting, lysosomal, V0 subunit A1	192130	REa, REn			11(Atp6n1)
17.449	4	30	09	17q21	AUTS7	P	Autism, susceptibility to, 7	610676	Fd	max lod at D17S2180	{Autism susceptibility 7} (2)	
17.450	1	4	00	17q21.31	BECN1	P	Beclin 1	604378	REc, A			
17.451	11	3	11	17q21.31	BRCA1, PSCP, BROVCA1, PNCA4	C	Breast cancer-1 gene	113705	Fd, REc		{Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer, susceptibility to, 4}, 614320 (3)	11(Brca1)
17.452	11	20	13	17q12	CDK12, CRKRS, CRK7, KIAA0904	C	Cyclin-dependent kinase 12	615514	REc, R			11(Cdk12)
17.453	12	7	07	17q21.31	C1QL1, CRF, C1QRF	P	Complement component 1, q subcomponent-like 1	611586	A			
17.454	7	13	93	17q21.2	CNP, CNP1	C	2', 3' cyclic nucleotide 3' phosphohydrolase	123830	REa, A, Psh, Fd, REb	flanked by THRA1 and NGFR		11(Cnp)
17.455	3	27	15	17q21.2	CNTNAP1, CASPR, P190	P	Contactin-associated protein 1	602346	REc		Lethal congenital contracture syndrome 7, 616286 (3)	
17.456	9	14	95	17q21.31	ETV4	P	ETS variant gene-4 (E1A enhancer-binding protein, E1AF)	600711	REa, REc, A			
17.457	12	17	07	17q21.31	DBF4B, DRF1, ASKL1	P	DBF4, S. cerevisiae, homolog of, B	611661	REc			
17.458	1	14	97	17q21.31	DUSP3, VHR	C	Dual specificity phosphatase-3 (vaccinia virus phosphatase VH1-related)	600183	REn, RE			
17.459	2	24	97	17p13.1	FGF11, FHF3	P	Fibroblast growth factor-11	601514	REa, REl			11(Fhf3)
17.460	12	22	00	17q21.31	FMNL, C17orf1B	P	Formin-like	604656	A, R			
17.461	3	27	95	17q21.31	G6PC, G6PT	C	Glucose-6-phosphatase, catalytic	613742	REa, REn		Glycogen storage disease Ia, 232200 (3)	
17.462	6	7	11	17q21.31	G6PC3, UGRP, SCN4	P	Glucose-6-phosphatase, catalytic, 3	611045	REc		Neutropenia, severe congenital 4, autosomal recessive, 612541 (3); Dursun syndrome, 612541 (3)	
17.463	3	3	94	17q21.2	GAS, GAST	C	Gastrin	137250	REa			11(Gast)
17.464	1	8	01	17q21.31	GFAP, ALXDRD	C	Glial fibrillary acidic protein	137780	REa, A		Alexander disease, 203450 (3)	11(Gfap)
17.465	1	13	11	17q21.32	GNGT2	P	Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 2	139391	A			
17.466	7	1	11	17q21.32	GOSR2, GS27, EPM6	P	Golgi snap receptor complex member 2	604027	R, A		Epilepsy, progressive myoclonic 6, 614018 (3)	
17.467	10	13	09	17q21.1	GSDMA, GSDM1, GSDM	C	Gasdermin A	611218	REc, H			11(Gsdma1-3)
17.468	10	1	09	17q21.1	GSDMB, GSDML	P	Gasdermin B	611221	REc			
17.469	7	27	15	17q21.2	HCRT, OX, NRCLP1	P	Hypocretin	602358	R	mutation identified in 1 NRCLP1 patient	?Narcolepsy 1, 161400 (3)	
17.470	7	25	14	17q21.31	HDAC5	C	Histone deacetylase 5	605315	R, A			
17.471	1	8	97	17q21.31	IFI35	C	Interferon-induced protein-35	600735	REc			
17.472	8	10	07	17q12-q21	IKZF3, ZNFN1A3, AIOLOS	P	Ikaros family zinc finger 3	606221	A			
17.473	11	13	07	17q21.2	JUP, DP3, PDGB, ARVD12	C	Junction plakoglobin	173325	REa, Fd	incorrectly mapped to 7; close to BRCA1	Naxos disease, 601214 (3); Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	11(Jup, Pkgb)
17.474	5	12	09	17q21.2	KAT2A, GCN5L2, GCN5	C	K(lysine) acetyltransferase 2A	602301	A			11(Gcn5l2)
17.475	1	24	01	17q21.32	KPNB1	P	Karyopherin beta-1	602738	A			11(Kpnb1)
17.476	3	21	03	17q12	LASP1, MLN50	C	LIM and SH3 protein 1	602920	Ch, H	fused to MLL in AML		11(Lasp1)
17.477	9	14	00	17q21.31	MAP3K14, NIK, HSNIK	P	Mitogen-activated protein kinase kinase kinase-14	604655	A, R			
17.478	2	22	13	17q21.31	MEOX1, MOX1, KFS2	C	Mesenchyme homeo box 1 (Mox1, mouse, homolog of)	600147	RE		Klippel-Feil syndrome 2, 214300 (3)	
17.479	4	6	15	17q21.32	MIR10A	P	Micro RNA 10A	610173	REc			
17.480	3	2	98	17q12	MLLT6, AF17	P	Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 6	600328	Ch			
17.481	1	20	06	17q21.33	MYCBPAP, AMAP1	P	MYCBP-associated protein	609835	REc			
17.482	7	29	15	17q21.2	NAGLU, MPS3B, CMT2V	C	N-acetylglucosaminidase, alpha-	609701	REn	mutation identified in 1 CMT2V family	Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3); ?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3)	
17.483	3	26	02	17q21.32	NPEPPS, PSA, MP100	P	Aminopeptidase, puromycin-sensitive	606793	A			11(Psa)
17.484	3	29	10	17q21.33	PHB	C	Prohibitin	176705	REa, A		{Breast cancer, susceptibility to}, 114480 (3)	
17.485	4	13	10	17q21.2	PTRF, CAVIN, CGL4	P	RNA polymerase I and transcript release factor	603198	REc, H		Lipodystrophy, congenital generalized, type 4, 613327 (3)	11(Ptrf)
17.486	5	5	15	17q21.31	PYY	P	Peptide YY	600781	A	10kb from PPY		
17.487	8	3	12	17q21.31	RND2, ARHN, RHO7	P	Ras homolog gene family, member N (GTP-binding protein Rho7)	601555	REn			
17.488	9	20	14	17q21.2	STAT3, APRF, HIES, ADMIO	P	Signal transducer and activator of transcription-3 (acute-phase response factor)	102582	A		Hyper-IgE recurrent infection syndrome, 147060 (3); Autoimmune disease, multisystem, infantile-onset, 615952 (3)	11(Stat3)
17.489	1	8	01	17q21.33	TOB1, TOB	P	Transducer of ERBB2, 1	605523	REc			
17.490	9	23	13	17q21.2	TUBG1, CDCBM4	P	Tubulin, gamma 1	191135	R		Cortical dysplasia, complex, with other brain malformations 4, 615412 (3)	
17.491	4	4	01	17q21.2	TUBG2	P	Tubulin, gamma 2	605785	R	pseudogene on chr. 7		
17.492	3	9	00	17q21.31	VAT1	P	Vesicle amine transport protein 1	604631	REn			
17.493	2	17	15	17q21.31-q21.32	WNT3, INT4, TETAMS	C	Wingless-type MMTV integration site family, member 3	165330	REa, S, A, H	mutation identified in 1 TETAMS family	?Tetra-amelia syndrome, 273395 (3)	11(Wnt4)
17.494	8	10	98	17q21.32	WNT15	C	Wingless-type MMTV integration site family, member 15	602864	REa, H, R			11(Wnt15)
17.495	4	29	97	17q12	CACNB1, CACNLB1, CCHLB1	P	Calcium channel, voltage-dependent, beta 1 subunit	114207	REa			
17.496	11	28	01	17q12	GRB7	P	Growth factor receptor-bound protein 7	601522	REc			11(Grb7)
17.497	7	26	12	17q21.32	HOXB1, HOX2I, HCFP3	C	Homeo box-B1	142968	RE		Facial paresis, hereditary congenital, 3, 614744 (3)	11(Hox2.9)
17.498	1	20	95	17q21.32	HOXB2, HOX2H	C	Homeo box-B2	142967	RE			11(Hox2.8)
17.499	1	20	95	17q21.32	HOXB3, HOX2G	C	Homeo box-B3	142966	RE			11(Hox2.7)
17.500	1	20	95	17q21.32	HOXB4, HOX2F	C	Homeo box-B4	142965	RE			11(Hox2.6)
17.501	1	20	95	17q21.32	HOXB5, HOX2A	C	Homeo box-B5	142960	REa, A, H, Fd, RE			11(Hox2.2)
17.502	1	20	95	17q21.32	HOXB6, HOX2B	C	Homeo box-B6	142961	RE			11(Hox2.2)
17.503	1	20	95	17q21.32	HOXB7, HOX2C	C	Homeo box-B7	142962	RE			11(Hox2.3)
17.504	1	20	95	17q21.32	HOXB8, HOX2D	C	Homeo box-B8	142963	RE			11(Hox2.4)
17.505	1	20	95	17q21.32	HOXB9, HOX2E	C	Homeo box-B9	142964	RE			11(Hox2.5)
17.506	8	20	07	17q21-q22	HPC9	P	Prostate cancer, hereditary, 9	610997	Fd	max LOD at D17S1820	{Prostate cancer, hereditary, 9} (2)	
17.507	12	21	10	17q21.2	KRT10, EHK, BCIE, BIE	C	Keratin 10	148080	REa, A, REn	in cluster of class I keratins	Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)	
17.508	10	4	91	17q21.2	KRT15	C	Keratin 15	148030	H, REa, A, REn	tightly linked to Hox-2 in mouse		11(Krt1)
17.509	6	9	98	17q21.2	KRT19	P	Keratin 19	148020	REa	probably 17q21-q22		
17.510	3	23	09	17q21.32	MIR196A1, MIRN196A1	P	Micro RNA 196A1	608632	REc			
17.511	2	19	04	17q21-q22	MYP5	P	Myopia 5	608474	Fd	between D17S787 and D17S1811	Myopia 5 (2)	
17.512	6	6	89	17q21.33	NGFR, TNFRSF16	C	Nerve growth factor receptor	162010	REa, A, S, Fd, C	distal to APL breakpoint, q21; < 0.5mb from HOX2		11(Ngfr)
17.513	8	15	97	17q21.31	NSF	P	N-ethylmaleimide-sensitive factor	601633	Psh, A			11(Nsf)
17.514	8	18	08	17q21.31	RNU2-1, RNU2	C	RNA, U2 small nuclear, 1	180690	REa, A, C			
17.515	7	17	01	17q22	PCTP	P	Phosphatidylcholine transfer protein	606055	R			11(Pctp)
17.516	3	10	00	17q21-q22	PTLAH, FPAH	P	Patella aplasia or hypoplasia	168860	Fd		Patella aplasia or hypoplasia (2)	
17.517	10	15	95	17q21.31	SHCL1	P	SHC (Src homology 2 domain-containing) transforming protein-like 1	600739	A			
17.518	12	9	15	17q21.31	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	C	Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270	REa, RE, Fd, A		Ovalocytosis, SA type, 166900 (3); Spherocytosis, type 4, 612653 (3); [Malaria, resistance to], 611162 (3); Renal tubular acidosis, distal, AD, 179800 (3); Renal tubular acidosis, distal, AR, 611590 (3); [Blood group, Diego], 110500 (3); [Blood group, Waldner], 112010 (3); [Blood group, Wright], 112050 (3); [Blood group, Froese], 601551 (3); [Blood group, Swann], 601550 (3); Cryohydrocytosis, 185020 (3)	
17.519	2	2	16	17q23.2	TBX4, ICPPS	P	T-box 4	601719	REc		Ischiocoxopodopatellar syndrome, 147891 (3)	
17.520	5	26	05	17q21.2	TOP2A, TOP2	C	Topoisomerase (DNA) II, alpha, 170kD	126430	REa, A		DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	11(Top2a)
17.521	2	27	12	17q21.2	WNK4, PRKWNK4, PHA2B	C	WNK lysine deficient protein kinase 4	601844	Fd, REc		Pseudohypoaldosteronism, type IIB, 614491 (3)	
17.522	2	25	98	1p34.2	HTLVR	C	Receptor for HTLV-1 and HTLV-2	143090	REa			
17.523	6	28	94	17q21.2	ACLY	C	ATP citrate lyase	108728	H, REa, R			?11(Atpcl)
17.524	12	22	08	17q12	DDX52, ROK1, HUSSY19	P	DEAD box polypeptide 52	612500	R			
17.525	5	27	05	17q12	ERBB2, NGL, NEU, HER2	C	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	REa, A, R, Fd		Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic, 137800 (3); Gastric cancer, somatic, 613659 (3); Ovarian cancer, somatic, (3)	
17.526	7	1	97	17q21.31	FZD2	P	Frizzled, Drosophila, homolog of, 2	600667	A			11(Fzd2)
17.527	12	28	07	17q21.2	GJD3, GJC1, CX31.9	P	Gap junction protein, delta-3 (31.9kD)	607425	REc			
17.528	8	8	14	17q21.31	MAPT, MTBT1, DDPAC, MSTD	C	Microtubule-associated protein tau	157140	REb, A, R, Fd	see 6p21	Dementia, frontotemporal, with or without parkinsonism, 600274 (3); Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease, susceptibility to}, 168600 (3)	11(Mapt)
17.529	2	1	11	17q21.1	MED24, TRAP100, KIAA0130	P	Mediator complex subunit 24	607000	R, REc			
17.530	3	17	08	17q21.2	MLX, TCFL4	P	MAX-like protein X	602976	REc			
17.531	2	25	14	17q21.1	MSL1	P	Male-specific lethal 1, Drosophila, homolog of	614801	REc			
17.532	8	23	94	17q21.31	NBR1, M17S2	C	Neighbor of BRCA1 gene 1 (membrane component, chromosome 17, surface marker 2)	166945	A, REn			
17.533	11	11	14	17q21.2	NKIRAS2, KBRAS2	P	NFKB inhibitor-interacting Ras-like protein 2	604497	REc			
17.534	11	5	08	17q21.1	ORMDL3	P	ORM1-like protein 3	610075	REc			
17.535	11	30	06	17q12	PLXDC1, TEM7	P	Plexin domain containing 1	606826	R			
17.536	10	30	08	17q21.2	RARA	C	Retinoic acid receptor, alpha polypeptide	180240	A, Ch	fused with MYL in APL	Leukemia, acute promyelocytic, 612376 (1)	11(Rara)
17.537	7	17	02	17q21.31	STH	P	Saitohin	607067	REn	in intron 9 of TAU		
17.538	8	20	07	17q12	CCL11, SCYA11	C	Chemokine, C-C motif, ligand 11	601156	REa, A		{HIV1, resistance to}, 609423 (3); {Asthma, susceptibility to}, 600807 (3)	
17.539	3	18	10	17q21.31	RPL27	P	Ribosomal protein L27	607526	REa, R			
17.540	5	8	97	17q21.2	EZH1	P	Enhancer of zeste, Drosophila, homolog of, 1	601674	REn			11(Ezh1)
17.541	8	10	06	17q21.32	B4GALGT2, GALGT2, SD	P	Beta-1,4-N-acetyl-galactosaminyl transferase 2	111730	REc			11(B4galnt2)
17.542	7	28	15	17q21.2	CCR10, GPR2	P	Chemokine (C-C) receptor 10	600240	A, REc			11(Gpr2)
17.543	3	15	11	17q21.2	CDC6, CDC18L	P	Cell division cycle 6, S. cerevisiae, homolog of	602627	REc		Meier-Gorlin syndrome 5, 613805 (3)	
17.544	4	30	09	17q21.2	DHX58, LGP2, D11LGP2	P	DEAH (Asp-Glu-Ala-His) box polypeptide 58	608588	REc			11(Lgp2)
17.545	8	12	15	17q21.2	FAM134C	P	Family with sequence similarity 134, member C	616498	REc			
17.546	6	13	12	17q12	FBXL20, FBL20, FBL2, SCR	p	F-box and leucine-rich repeat protein 20	609086	REc			11(Fbxl20)
17.547	2	13	15	17q21.2	FKBP10, FKBP65, OI11, BRKS1	P	FK506-binding protein 10	607063	R, REc, Fd, LD		Osteogenesis imperfecta, type XI, 610968 (3); Bruck syndrome 1, 259450 (3)	
17.548	3	9	00	17q21.32	HOXB13	P	Homeo box B13	604607	A			11(Hoxb13)
17.549	5	8	13	17q21.2	HSD17B1, EDH17B2	C	Estradiol 17-beta-dehydrogenase-1	109684	A, REa			
17.550	9	11	14	17q21.2	HSPB9	P	Heat-shock 27kD protein 9	608344	REc			
17.551	1	14	09	17q21.2	IBD22	P	Inflammatory bowel disease 22	612380	Fd	associated with rs744166	{Inflammatory bowel disease 22} (2)	
17.552	3	1	13	17q21.2	KLHL10, SPGF11	P	Kelch-like 10	608778	REc, H		Spermatogenic failure 11, 615081 (3)	11(Klhl10)
17.553	5	22	14	17q21.2	KRT13, WSN2	P	Keratin 13	148065	Psh, A, REn	in same PFGE fragment as KRT10, KRT15	White sponge nevus 2, 615785 (3)	
17.554	11	13	13	17q21.2	KRT23	P	Keratin 23	606194	REc			
17.555	1	15	16	17q21.2	KRT25, K25, KRT24IRS1, ARWH3	P	Keratin 25, type I	616646	REc, H		Woolly hair, autosomal recessive 3, 616760 (3)	11(Krt25)
17.556	12	4	15	17q21.2	KRT26, K25, K25B, K25IRS2	P	Keratin 26, type I	616675	REc, H			11(Krt26)
17.557	12	9	15	17q21.2	KRT28, K25D, K25IRS4	P	Keratin 28, type I	616677	REc			
17.558	12	4	15	17q21.2	KRT27, KRT25C, K25IRS3	P	Keratin 27, type I	616676	REc			11(Krt27)
17.559	12	9	15	17q21.2	KRT39	P	Keratin 38, type I	616678	REc, H			11(Krt39)
17.560	12	9	15	17q21.2	KRT40, KA36	P	Keratin 40, type I	616679	REc, H			11(Krt40)
17.561	5	7	03	17q21.32	OSBPL7, ORP7	C	Oxysterol-binding protein-like protein 7	606735	REc			
17.562	11	3	11	17q21.2	PSMC3IP, TBPIP, GT198, HOP2, ODG3	C	PSMC3-interacting protein	608665	REc, R		Ovarian dysgenesis 3, 614324 (3)	
17.563	10	26	99	17q21.2	RAB5C, RABL	C	Ras-associated protein RAB5c	604037	REc, A			
17.564	5	11	16	17q21.2	SMARCE1, BAF57, CSS5	P	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1	603111	REc		{Meningioma, familial, susceptibility to}, 607174 (3); Coffin-Siris syndrome 5, 616938 (3)	
17.565	12	23	05	17q21.2	WIRE, WICH	P	WASP-interacting protein-related protein	609692	R, REc			
17.566	10	30	08	17q21.2	HAP1, HLP, HAP2	C	Huntingtin-associated protein 1 (neuroan 1)	600947	H, A			11(Hap1)
17.567	12	11	98	17q21.31	ADAM11, MDC	P	A disintegrin and metalloproteinase domain 11	155120	REc			
17.568	4	17	07	17q21.33	EME1	P	Essential meiotic endonuclease 1, S. pombe, homolog of, 1	610885	REc			11(Eme1)
17.569	11	19	98	17q21.3	ERDA1	P	Expanded repeat domain, CAG/CTG, 1	603279	A	no apparent pathology		
17.570	4	27	12	17q21.32	HOXBAS5, PRAC2	P	HOXB cluster antisense RNA 5	610787	REc			
17.571	12	4	03	17q21.32	IGF2BP1, IMP1, CRDBP, ZBP1	P	Insulin-like growth factor 2 mRNA-binding protein 1	608288	A			11(Crdbp)
17.572	3	15	10	17q21.33	LUC7L3, CROP, LUC7A	P	Luc7, S. cerevisiae, homolog of, 3	609434	R, REc			
17.573	2	26	08	17q21.32	MRPL10, MRPL8	P	Mitochondrial ribosomal protein L10	611825	R			
17.574	11	28	01	17q21.32	NESH	P	NESH protein	606363	Psh, R			
17.575	5	17	95	17q21.32	NFE2L1, NRF1	C	Nuclear factor, erythroid-derived 2-like 1	163260	A			11(Nfe2l1)
17.576	3	17	98	17q21.33	NME1, NM23	C	Non-metastatic cells 1, protein (NM23A) expressed in	156490	A, Fd, REa		Neuroblastoma, 256700 (3)	
17.577	5	27	93	17q21.33	NME2	C	Non-metastatic cells 2, protein (NM23) expressed in	156491	REa, A, REn			
17.578	10	3	07	17q21.31	PLEKHM1, AP162, KIAA0356, OPTB6	P	Pleckstrin homology domain-containing protein, family M, member 1	611466	R, REc		Osteopetrosis, autosomal recessive 6, 611497 (3)	
17.579	2	21	07	17q21.32	PRAC1	P	Prostate, rectum, and colon gene	609819	REc			
17.580	3	19	08	17q21.31	RUNDC3A, RPIP8	P	RUN domain contain 3A	605448	REc			
17.581	7	19	12	17q21.33	RAC4, PPTC, HK1	P	Tachykinin 4	607833	REc			
17.582	12	17	12	17q21.32	SCRN2, SES2	P	Secernin 2	614966	REc			
17.583	4	17	06	17q21.32	TBX21, TBET	P	T-box 21	604895	REc, H		{Asthma, aspirin-induced, susceptibility to}, 208550 (3); Asthma and nasal polyps, 208550 (3)	11(Tbx21)
17.584	6	25	99	17q21.31	UBTF, UBF	P	Upstream binding transcription factor, RNA polymerase I	600673	A, R			
17.585	4	17	07	17q21.2	VPS25, FAP20	P	Vacuolar protein sorting 25, S. cerevisiae, homolog of	610907	REc			
17.586	4	17	07	17q21.33	WFIKKN2, WFIKKNRP	P	WAP, fillistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 2	610895	REc			
17.587	3	7	14	17q21.3-q22	DDD3	P	Dowling-Degos disease 3	615674	Fd	max lod at D17S1529	Dowling-Degos disease 3 (2)	
17.588	7	11	14	17q21.33	DLX3, TDO, AI4	C	Distal-less homeo box-3	600525	REa, A, Fd		Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta, type IV, 104510 (3)	
17.589	2	4	16	17q21.33	DLX4, DLX7, DLX8, OFC15	P	Distal-less homeo box-4	601911	A	mutation identified in 1 OFC15 family	?Orofacial cleft 15, 616788 (3)	
17.590	3	20	94	17q21.32	GIP	C	Gastric inhibitory polypeptide	137240	REa, A			11(Gip)
17.591	2	28	08	17q21.33	MRPL27	P	Mitochondrial ribosomal protein L27	611837	R			
17.592	12	19	11	17q22	SRSF1, SFRS1, ASF, SF2, SRp30a	P	Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)	600812	REa, A			11(Sfrs1)
17.593	8	6	15	17q21.33	XYLT2, XT2, SOS	P	Xylosyltransferase 2	608125	R		{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3); Spondyloocular syndrome, 605822 (3)	
17.594	2	16	10	17q21.31	AARSD1	P	Alanyl-tRNA synthetase domain-containing 1	613212	REc			
17.595	1	31	13	17q21.31	ASB16	P	Ankyrin repeat- and SOCS box-containing protein 16	615056	REc			
17.596	6	13	12	17q21.31	CCDC103, SMH, PR46B, CILD17	P	Coiled-coil domain-containing protein 103	614677	REc		Ciliary dyskinesia, primary, 17, 614679 (3)	
17.597	5	24	13	17q21.31	CD300LG, TREM4, CLM9	P	CD300 antigen-like family, member G	610520	REc			
17.598	8	21	12	17q21.2	COA3, CCDC56	P	Cytochrome c oxidase assembly factor 3	614775	REc			
17.599	1	27	11	17q21.31	DUP17q21.31, C17DUPq21.31	P	Chromosome 17q21.31 duplication syndrome	613533	Ch	contiguous gene duplication syndrome	Chromosome 17q21.31 duplication syndrome (4)	
17.600	10	29	03	17q21.32	CDK5RAP3	P	CDK5 regulatory subunit-associated protein 3	608202	REc			
17.601	4	30	09	17q21.31	DHX8, DDX8, HRH1	P	DEAH (Asp-Glu-Ala-His) box polypeptide 8	600396	REc			
17.602	3	7	13	17q21.31	EFTUD2, KIAA0031, MFDGA	P	Elongation factor Tu GTP-binding domain-containing 2	603892	REa		Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	
17.603	12	19	11	17q21.31	GPATCH8, KIAA0553	C	G-patch domain-containing protein 8	614396	R, REc			16(Gpatch8)
17.604	12	5	03	17q21.31	IMP5	P	Intramembrane protease 5	608284	REc			
17.605	10	4	12	17q21.31	KANSL1, KIAA1267, MSL1V1, KDVS	P	KAT8 regulatory NSL complex subunit 1	612452	R, REc		Koolen-De Vries syndrome, 610443 (3)	
17.606	4	19	12	17q21.31	KIF18B	P	Kinesin family member 18B	614570	REc			
17.607	2	14	08	17q21.31	LSM12	P	LSM12, S. cerevisiae, homolog of	611793	REc			
17.608	5	2	16	17q21.31	MEIOC, C17orf104	P	Meiosis-specific protein with coiled-coil domain	616934	REc			11(Meioc)
17.609	3	5	08	17q12	MRPL45	P	Mitochondrial ribosomal protein L45	611850	REc	pseudogenes on 2 and 17		
17.610	12	21	03	17q21.31	NAGS	C	N-acetylglutamate synthase	608300	REc		N-acetylglutamate synthase deficiency, 237310 (3)	11(Nags)
17.611	9	17	08	17q21.31	NMT1, NMT	P	N-myristoyltransferase 1	160993	REc			
17.612	7	22	13	17q21.31	SLC25A39, CGI69	C	Solute carrier family 25, member 39	610820	REc, R			11(Slc25a39)
17.613	4	13	15	17q21.33	COL1A1, OI1, OI2, OI3, OI4, EDSC	C	Collagen I, alpha-1 polypeptide	120150	C, M, A, REa	fused with PDGFB in DFPB	Osteogenesis imperfecta, type I, 166200 (3); Osteogenesis imperfecta, type II, 166210 (3); Osteogenesis imperfecta, type III, 259420 (3); Osteogenesis imperfecta, type IV, 166220 (3); Ehlers-Danlos syndrome, classic, 130000 (3); Ehlers-Danlos syndrome, type VIIA, 130060 (3); Caffey disease, 114000 (3); {Bone mineral density variation QTL, osteoporosis}, 166710 (3)	11(Col1a1)
17.614	4	17	13	17q21.31-q22	MRT35	P	Mental retardation, autosomal recessive 35	615162	Fd	between rs4792947 and rs11079258	Mental retardation, autosomal recessive 35, 615162 (3)	
17.615	9	24	15	17q21.31	LRRC37A	P	Leucine-rich repeat-containing protein 37A	616555	A, REc			
17.616	9	24	15	17q21.31	LRRC37A2	P	Leucine-rich repeat-containing protein 37A2	616556	A, REc			
17.617	11	19	13	17q21.32	COPZ2	P	Coatomer protein complex, subunit zeta-2	615526	REc			
17.618	7	18	12	17q21.31	GRN, CLN11	C	Granulin	138945	REa, REc, REn		Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3); Aphasia, primary progressive, 607485 (3); Ceroid lipofuscinosis, neuronal, 11, 614706 (3)	
17.619	3	23	14	17q21.31	HEXIM2	P	Hexamethylene bis acetamide-inducible protein 2	615695	REc			
17.620	5	6	13	17q21.31	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	C	Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)	607759	A, REb, REa, RE, F, LD	3' to GP3A; BAK platelet antigen	Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal alloimmune, BAK antigen related (3); Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	
17.621	5	6	13	17q21.32	ITGB3, GP3A, GT, BDPLT2, BDPLT16	C	Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)	173470	REa, REb, A, RE, F, LD	in same 260kb fragment as GP2B; PL(A) platelet antigen	Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal alloimmune (3); {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3); Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	
17.622	3	23	15	17q21.33	KAT7, MYST2, HBO1	P	K(lysine) acetyltransferase 7	609880	R, REc			
17.623	5	15	11	17q21.32	MIR152, MIRN152	P	Micro RNA 152	613788	REc			
17.624	7	3	06	17q21.32	PNPO	P	Pyridoxamine 5'-phosphate oxidase	603287	REc, H		Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)	11(Pnpo)
17.625	1	30	12	17q21.32	SKAP1, SCAP1, SKAP55	P	SRC kinase-associated phosphoprotein 1, 55kD	604969	R, REc			
17.626	4	17	07	17q21.32	SNF8, VPS22, EAP30	P	SNF8, S. cerevisiae, homolog of	610904	R, REc			
17.627	12	10	12	17q21.32	SNX11	P	Sorting nexin 11	614906	REc			
17.628	3	18	13	17q21.32	TBKBP1, PROSAPIP2, KIAA0775	P	TBK1-binding protein 1	608476	REc			
17.629	3	15	07	17q21.32	TTLL6	P	Tubulin tyrosine ligase-like family, member 6	610849	REc			
17.630	4	2	16	17q21.32	UBE2Z, USE1	P	Ubiquitin-conjugating enzyme E2Z	611362	REc			
17.631	5	23	13	17q21.32-q21.33	ZNF652, KIAA0924	P	Zinc finger protein 652	613907	R, REc			
17.632	6	10	08	17q21.33	ACSF2, FLJ20920	P	Acyl-CoA synthetase family member 2	610465	R, REc			
17.633	6	25	99	17q21.33	CHAD	P	Chondroadherin	602178	Psh, A			
17.634	1	27	04	17q21.33	HILS1	P	Spermatid-specific linker histone H1-like protein	608101	REc			11(Hils1)
17.635	12	21	12	17q21.33	ITGA3, CD49C, GAPB3, ILNEB	P	Integrin, alpha-3	605025	REc		Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	
17.636	10	11	12	17q21.33	LRRC59, p34	P	Leucine-rich repeat-containing protein 59	614854	REc			
17.637	11	3	14	17q21.33	NXPH3, NPH3	P	Neuroexophilin 3	604636	REc			
17.638	9	9	13	17q21.33	PDK2	P	Pyruvate dehydrogenase kinase, isoenzyme 2	602525	REc			
17.639	3	8	07	17q21.33	SLC35B1, UGTREL1	P	Solute carrier family 35, member B1	610790	R, REc			
17.640	4	18	02	17q21.33	SPAG9, SYD1, KIAA0516	P	Sperm-associated antigen 9	605430	R, REc			
17.641	5	16	11	17q21.33	SPATA20, SSP411	P	Spermatogenesis-associated protein 20	613939	REc			
17.642	12	19	12	17q21.33	SPOP	P	Speckle-type POZ protein	602650	REc, R			
17.643	7	15	09	17q21.33	UTP18	P	UTP18, S. cerevisiae, homolog of	612816	REc			
17.644	7	18	14	17q21-q22	CA10, CARPX	P	Carbonic anhydrase X	604642	REc			
17.645	2	28	01	17q21.33	ABCC3, CMOAT2, MRP3, MLP2	C	ATP-binding cassette, sub-family C, member 3	604323	R, A			
17.646	2	22	92	17q22	BCL5	P	B-cell CLL/lymphoma-5	151441	REa, A			
17.647	10	11	05	17q23.2	BRIP1, BACH1, FANCJ	C	BRCA1-associated C-terminal helicase 1	605882	REc, Fd	?or 17q23	Breast cancer, early-onset, 114480 (3); Fanconi anemia, complementation group J, 609054 (3)	
17.648	12	21	09	17q22	C17orf71, SMG8	P	Chromosome 17 open reading frame 71	613175	REc			
17.649	2	11	16	17q21.33	CACNA1G, SCA42	P	Calcium channel, voltage-dependent, T type, alpha-1G subunit	604065	A, R, H		Spinocerebellar ataxia 42, 616795 (3)	11(Cacna1g)
17.650	8	20	99	17q22	COX11	P	Cytochrome c oxidase, subunit 11	603648	REa	pseudogene on 6p23-p22		
17.651	7	23	15	17q22	DGKE, NPHS7, AHUS7	P	Diacylglycerol kinase, epsilon, 64-kD	601440	A, R		Nephrotic syndrome, type 7, 615008 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3)	
17.652	8	21	00	17q22	HLF	P	Hepatic leukemia factor	142385	Ch, R			
17.653	4	8	13	17q22	KIF2B	P	Kinesin family member 2B	615142	REc			
17.654	3	7	14	17q22	MIR142	P	Micro RNA 142	615657	REc			
17.655	3	23	14	17q22	MIR301A, MIR301	P	Micro RNA 301A	615675	REc			
17.656	4	19	12	17q22	MMD, MMD1, PAQR11	P	Monocyte-to-macrophage differentiation-associated protein	604467	REc			
17.657	2	21	14	17q22	MSI2	P	Musashi, Drosophila, homolog of, 2	607897	A, REc			11(Msi2)
17.658	10	23	15	17q22	NOG, SYM1, SYNS1A	C	Noggin, mouse, homolog of	602991	A, R, Fd		Symphalangism, proximal, 1A, 185800 (3); Multiple synostoses syndrome 1, 186500 (3); Tarsal-carpal coalition syndrome, 186570 (3); Stapes ankylosis with broad thumb and toes, 184460 (3); Brachydactyly, type B2, 611377 (3)	
17.659	11	30	06	17q25.1	PRCD, RP36	P	PRCD, Dog, homolog of	610598	REc		Retinitis pigmentosa 36, 610599 (3)	
17.660	7	8	10	17q22	RAD51C, FANCO, BROVCA3	P	RAD51, S. cerevisiae, homolog of, C	602774	REc		Fanconi anemia, complementation group O, 613390 (3); {Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	
17.661	8	18	14	17q22	PRR11	P	Proline-rich protein 11	615920	REc			
17.662	12	2	15	17q22	SKA2, FAM33A	P	Spindle- and kinetochore-associated complex, subunit 2	616674	REc			
17.663	2	25	15	17q22	STXBP4, SYNIP	P	Syntaxin-binding protein 4	610415	REc			
17.664	2	23	12	17q22	TEX14	C	Testis-expressed gene 14	605792	R, REc, H			11(Tex14)
17.665	4	30	15	17q22	TMEM100	P	Transmembrane protein 100	616334	REc			
17.666	7	11	12	17q22	TOM1L1	P	TOM1-like 1	604701	REc			
17.667	5	12	03	17q23.1-q23.2	USP32, USP10	P	Ubiquitin-specific protease 32	607740	REc			
17.668	9	24	08	17q22	VEZF1, ZNF161	P	Vascular endothelial zinc finger 1	606747	R			
17.669	9	30	02	17q23.2	APPBP2, PAT1	C	Amyloid beta precursor protein-binding protein 2	605324	R, REc			
17.670	1	12	95	17q22	COIL, CLN80	P	Coilin p80	600272	A			
17.671	2	1	11	17q23.2	MED13, THRAP1, TRAP240	P	Mediator complex subunit 13	603808	REa, REc			
17.672	4	24	08	17q22	MRPS23	P	Mitochondrial ribosomal protein S23	611985	R, REc			
17.673	9	30	02	17q23.2	PPM1D, WIP1	P	Protein phosphatase, magnesium-dependent, 1, delta isoform	605100	A, REc	amplified in breast cancer	Breast cancer, 114480 (3)	
17.674	3	22	93	17q11.2	TNFAIP1	P	Tumor necrosis factor, alpha-induced protein-1 (endothelial)	191161	A			
17.675	11	26	01	17q22	TRIM37, MUL, KIAA0898	C	Tripartite motif-containing 37	605073	Fd, Ld, REn		Mulibrey nanism, 253250 (3)	
17.676	3	17	98	17q24.2	PRKCA, PKCA	C	Protein kinase C, alpha polypeptide	176960	REa, A, Fd	cen-COL1A1-PKCA-GH1	Pituitary tumor, invasive (3)	11(Pkca)
17.677	3	26	02	17q25.1	CMRF35, CMRF35A	P	CMRF35 antigen	606786	Psh, A			
17.678	7	18	91	17q23.3	CSH1, CSA, PL	C	Chorionic somatomammotropin hormone-1	150200	REa, A		[Placental lactogen deficiency] (1)	13(Pl1)
17.679	7	18	91	17q23.3	CSH2, CSB	C	Chorionic somatomammotropin B	118820	REa, A			13(Pl2)
17.680	6	25	99	17q23.3	CSHL1, CSL	P	Chorionic somatomammotropin hormone-like 1	603515	A			
17.681	7	14	09	17q23.3	GH1, GHN, IGHD1B	C	Growth hormone-1	139250	REa, A, Fd	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	Growth hormone deficiency, isolated, type IA, 262400 (3); Growth hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome, 262650 (3)	11(Gh)
17.682	9	16	88	17q23.3	GH2, GHV	C	Growth hormone-2	139240	REa, A			
17.683	2	21	14	17q23.3	TACO1, CCDC44	P	Translational activator of mitochondrially encoded cytochrome c oxidase subunit I	612958	REc		Mitochondrial complex IV deficiency, 220110 (3)	
17.684	2	17	04	17q25.1	FOXJ1, FKHL13, HFH4	P	Forkhead box J1	602291	REc			
17.685	11	5	98	17q25.1	CDK3	P	Cyclin-dependent kinase 3	123828	Psh	distal to BRCA1		
17.686	3	29	12	17q23.3	ACE, DCP1, ACE1, MVCD3, ICH	C	Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180	A, H, Fd		{Myocardial infarction, susceptibility to} (3); {Alzheimer disease, susceptibility to}, 104300 (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3); {SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)	
17.687	5	19	06	17q23	BSZQTL	P	Bone size quantitative trait locus 1	609656	Fd		{Bone size QTL} (2)	
17.688	7	20	04	17q23.1	CA4, RP17	C	Carbonic anhydrase IV	114760	REa, A, Fd		Retinitis pigmentosa 17, 600852 (3)	
17.689	8	3	10	17q23.3	CD79B, IGB, B29, AGM6	P	CD79B antigen	147245	A		Agammaglobulinemia 6, 612692 (3)	
17.690	1	27	04	17q23.1	CLTC	C	Clathrin, heavy polypeptide (Hc)	118955	REc, Ch	fusion gene with TFE3 in renal adenocarcinoma		
17.691	5	22	14	17q23.1	LNCDC, LOC615638	P	Long noncoding RNA, dendritic cell	615772	REc			
17.692	10	16	14	17q22	MKS1, MKS, BBS13	C	MKS1 gene	609883	Fd, REc	frequent in Finland	Meckel syndrome 1, 249000 (3); Bardet-Biedl syndrome 13, 615990 (3)	
17.693	9	15	96	17q23.3	PECAM1	P	Platelet/endothelial cell adhesion molecule (CD31 antigen)	173445	Psh, A			6(Pecam1)
17.694	7	1	05	17q22	SEPT4, PNUTL2	C	Septin 4	603696	A, REc			11(Sept4)
17.695	2	19	97	17q23.2	TBX2	C	T-box 2	600747	A, H			11(Tbx2)
17.696	3	4	02	17q24.2	KPNA2, RCH1, QIP2	P	Karyopherin alpha-2	600685	REc			
17.697	7	17	06	17q23.3	POLG2, POLGB, PEOA4	P	Polymerase, DNA, gamma-2	604983	REc		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	
17.698	8	14	15	17q24.2	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	C	Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830	S, M, REa, RE, Fd	fused with RET to form PTC2	Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic, (3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)	11(Tse1)
17.699	1	27	04	17q24.1	RGS9, PERRS	C	Regulator of G protein signaling 9	604067	R, A		Bradyopsia, 608415 (3)	
17.700	6	25	99	17q23.3	SMARCD2, BAF60B	P	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2	601736	Psh, R			
17.701	3	4	96	17q23.3	DDX5, HLR1, G17P1	C	DEAD/H box-5 (RNA helicase, 68kD)	180630	REa, REn	near BRCA1		
17.702	10	4	91	17q23.3	ICAM2	P	Intercellular adhesion molecule-2	146630	REa, C			
17.703	3	5	08	17q25.1	MRPL38	P	Mitochondrial ribosomal protein L38	611844	R, REc			
17.704	4	23	08	17q25.1	MRPS7	P	Mitochondrial ribosomal protein S7	611974	R, REc			
17.705	5	1	02	17q25.1	NT5C, UMPH2, DNT1	C	5', 3' nucleotidase, cytosolic	191720	REa			11(Umph2)
17.706	1	24	11	17q24.2	APOH	C	Apolipoprotein H (beta-2-glycoprotein I)	138700	Fd, REa			11(Apoh)
17.707	10	23	87	17q23-qter	PEPE	C	Peptidase E	170200	S			
17.708	8	18	15	17q22	EPX, EPXD	P	Eosinophil peroxidase	131399	REa, A		[Eosinophil peroxidase deficiency], 261500 (3)	
17.709	3	9	01	17q22	LPO	P	Lactoperoxidase	150205	REn			
17.710	5	5	09	17q23.1	MIR21, MIRN21	P	Micro RNA 21	611020	REc			
17.711	8	30	07	17q22	MPO	C	Myeloperoxidase	606989	REa, A, F, Ch, C, REc	translocated in t(15;17)(q22;q11.2)	Myeloperoxidase deficiency, 254600 (3); {Alzheimer disease, susceptibility to}, 104300 (3); {Lung cancer, protection against, in smokers} (3)	11(Mpo)
17.712	3	13	15	17q23.1	PTRH2, BIT1, IMNEPD	P	Peptidyl-tRNA hydrolase 2	608625	R, REc		Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	
17.713	4	17	13	17q23.1	RNFT1	P	RING finger protein, transmembrane 1	615172	REc			11(Rnft1)
17.714	10	15	09	17q23.1	RPS6KB1, S6K1	P	Ribosomal protein S6 kinase, 70kD	608938	R, REc			
17.715	3	23	95	17q22	TRIM25, ZNF147, EFP	C	Tripartite motif-containing 25	600453	A, REc	300kb from MPO		11(Efp)
17.716	2	5	13	17q23.1	VMP1, TMEM49, EPG3	P	Vacuole membrane protein 1	611753	R, REc			
17.717	4	20	10	17q23.1-q23.2	DEL17q23.1q23.2, C17DELq23.1q23.2	P	Chromosome 17q23.1-q23.2 deletion syndrome	613355	Ch		Chromosome 17q23.1-q23.2 deletion syndrome (4)	
17.718	11	1	10	17q23.1-q23.2	DUP17q23.1q23.2, C17DUPq23.1q23.2	P	Chromosome 17q23.1-q23.2 duplication syndrome	613618	Ch	2.2 Mb contiguous gene duplication syndrome	Chromosome 17q23.1-q23.2 duplication syndrome (4)	
17.719	9	12	12	17q24.3	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	C	Potassium channel, inwardly rectifying, subfamily J, member 2	600681	R, REc		Andersen syndrome, 170390 (3); Short QT syndrome 3, 609622 (3); Atrial fibrillation, familial, 9, 613980 (3)	11(Irk1)
17.720	4	30	15	17q23.3	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	C	Sodium channel, voltage-gated, type IV, alpha polypeptide	603967	REa, Fd	21.5kb from GH1	Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, congenital, 16, 614198 (3); Hypokalemic periodic paralysis, type 2, 613345 (3)	
17.721	4	1	09	17q22	BZRAP1, PRAX1, RIMBP1, KIAA0612	C	Benzodiazapine receptor (peripheral)-associated protein 1	610764	R, A, REc, H			11(Bzrap1)
17.722	2	21	06	17q22	DYNLL2, DLC2	P	Dynein, light chain, LC8-type 2	608942	REc			
17.723	4	14	15	17q22	GDPD1, GDE4	P	Glycerophosphodiester phosphodiesterase domain-containing protein 1	616317	REc			
17.724	3	23	14	17q23.2	INTS2, INT2, KIAA1287	P	Integrator complex subunit 2	611346	REc			
17.725	6	7	10	17q23.2	MARCH10	P	Membrane-associated RING-CH finger protein 10	613337	REc			
17.726	9	24	08	17q23.2	MRC2, ENDO180, UPARAP, CD280	P	Mannose receptor, C-type, 2	612264	R, REc			
17.727	12	17	08	17q22	RNF43, RNF124	P	Ring finger protein 43	612482	REc			
17.728	8	8	13	17q23.2	TLK2	P	Tousled-like kinase 2	608439	A, REc			
17.729	12	29	08	17q22	YPEL2	P	Yippee-like 2	609723	REc			11(Ypel2)
17.730	8	24	09	17q23.2-q25.1	BMIQ15	P	Body mass index quantitative trait locus 15	612967	Fd	associated with rs228883 and rs1005651	[Body mass index QTL 15] (2)	
17.731	4	20	10	17q23.3	DDX42, RHELP	P	DEAD (Asp-Glu-Ala-Asp) box polypeptide 42	613369	REc			
17.732	4	30	09	17q23.1	DHX40, DDX40	P	DEAH (Asp-Glu-Ala-His) box polypeptide 40	607570	REc			
17.733	12	10	13	17q23.3	ERN1, IRE1, IRE1A	P	Endoplasmic reticulum-to-nucleus signaling 1	604033	REc			
17.734	3	14	13	17q23.3	KCNH6, HERG2	P	Potassium channel, voltage-gated, subfamily H, member 6	608168	REc			
17.735	6	26	14	17q23.3	MAP3K3, MEKK3, MAPKKK3	P	Mitogen-activated kinase kinase kinase 3	602539	REc			
17.736	5	19	09	17q23.3	STRADA, STRAD, LYK5	C	STE20-related kinase adaptor alpha	608626	REc		Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	
17.737	1	31	13	17q23.2-q23.3	TANC2, KIAA1636	P	Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 2	615047	REc			
17.738	5	12	09	17q23.3	TCAM1	P	Testicular cell adhesion molecule 1	612756	REc			11(Tcam1)
17.739	4	21	14	17q23.3-q24.1	SMURF2	P	SMAD-specific E3 ubiquitin protein ligase 2	605532	REc			
17.740	2	19	13	17q24.1	AXIN2, ODCRCS	C	Axis inhibitor 2 (conductin, mouse, homolog of)	604025	R, A		Oligodontia-colorectal cancer syndrome, 608615 (3); Colorectal cancer, somatic, 114500 (3)	
17.741	11	3	14	17q24.2	BPTF, FALZ, FAC1, NURF301	P	Bromodomain PHD finger transcription factor	601819	A			
17.742	4	29	97	17q24.2	CACNG1, CACNLG	C	Calcium channel, voltage-dependent, gamma-1 subunit	114209	A			
17.743	11	28	01	17q24.2	CACNG5	P	Calcium channel, voltage-dependent, gamma-5 subunit	606405	REc			
17.744	5	13	13	17q24	CTRCT7, CCA1	P	Cataract 7	115660	Fd		Cataract 7 (2)	
17.745	5	6	03	17q25.1	CMRF35H, CMRF35H9	P	CMRF35H antigen	606790	Psh, A			
17.746	11	29	99	17q25.1	GALK1	C	Galactokinase-1	604313	S, Ch, R, C, A		Galactokinase deficiency with cataracts, 230200 (3)	11(Glk)
17.747	6	23	15	17q24	SRXY10	C	46,XY sex reversal 10	616425	Ch	deletion of 32.5kb XYSR regulatory region upstream of SOX9	46XY sex reversal 10 (4)	
17.748	2	3	03	17q25.1	SSTR2	C	Somatostatin receptor-2	182452	REa			11(Sstr2)
17.749	12	12	00	17q25.1	CDC42EP4, BORG4	P	CDC42 effector protein 4 (binder of Rho GTPases 4)	605468	A			11(Borg4)
17.750	10	27	92	17q25.1	FDXR, ADXR	C	Ferredoxin reductase (adrenodoxin reductase)	103270	REa, A			
17.751	10	20	99	17q25.1	GRB2	C	Growth factor receptor-bound protein 2	108355	A, REa			11(Grb2)
17.752	10	22	96	17q25.1	PRPSAP1	P	Phosphoribosyl pyrophosphate synthetase-associated protein-1	601249	Psh, A			
17.753	2	24	97	17q23.3	PSMC5, TRIP1	P	Proteasome (prosome, macropain) 26S subunit, ATPase, 5	601681	Psh, A			
17.754	4	23	03	17q25.1	SANS, USH1G	C	Scaffold protein containing ankyrin repeats and SAM domain	607696	Fd	?allelic to DFNA20	Usher syndrome, type 1G, 606943 (3)	
17.755	5	22	07	17q25.1	TRIM47, GOA	P	Tripartite motif-containing protein 47	611041	A			
17.756	9	24	15	17q24.1	LRRC37A3	P	Leucine-rich repeat-containing protein 37A3	616557	A, REc			
17.757	12	23	08	17q24.3	ABCA5, KIAA1888	C	ATP-binding cassette, subfamily A, member 5	612503	Psh, R, REc			
17.758	12	22	08	17q24.2-q24.3	ABCA6	P	ATP-binding cassette, subfamily A, member 6	612504	REc			
17.759	12	22	08	17q24.2	ABCA8, KIAA0822	C	ATP-binding cassette, subfamily A, member 8	612505	R, REc			
17.760	12	24	08	17q24.2	ABCA9	P	ATP-binding cassette, subfamily A, member 9	612507	REc			
17.761	12	24	08	17q24.3	ABCA10	P	ATP-binding cassette, subfamily A, member 10	612508	REc			
17.762	4	17	13	17q24.2	AMZ2	P	Archaelysin family metallopeptidase 2	615169	REc			
17.763	5	19	06	17q24.2	ARSG, KIAA1001	C	Arylsulfatase G	610008	REc			
17.764	7	14	14	17q24.2	FAM20A, AIGFS, AI1G	P	Family with sequence similarity 20, member A	611062	R, REc		Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	
17.765	8	19	13	17q24.2	NOL11	P	Nucleolar protein 11	615366	REc			
17.766	7	14	14	17q24.2	PITPNC1, RDGBB	P	Phosphatidylinositol transfer protein, cytoplasmic, 1	605134	REc			
17.767	11	11	14	17q24.2	PSMD12, P55	P	Proteasome 26S subunit, non-ATPase, 12	604450	REc			
17.768	8	24	09	17q24.2-q24.3	HTGH, DEL17q24	P	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome)	135400	Ch		Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (4)	
17.769	3	11	08	17q24.1	GNA13	P	Guanine nucleotide-binding protein, alpha-13	604406	R, REc			
17.770	11	19	10	17q24.3	MAP2K6, PRKMK6, MKK6, MEK6, MAPKK6	P	Mitogen-activated protein kinase kinase 6	601254	REc			
17.771	4	26	11	17q24.3-q25.1	SRXX2, DUP17q24.3	P	46XX sex reversal 2	278850	Ch	duplication or triplication of 68kb XXSR regulatory region upstream of SOX9	46XX sex reversal 2 (4)	
17.772	5	19	09	17q24.3-q25.1	PRBNS	P	Pierre Robin syndrome	261800	Fd	between D17S795 and D17S929	Pierre Robin syndrome (2)	
17.773	8	7	15	17q24.3-q25.1	SLC39A11, ZIP11, C17orf26	P	Solute carrier family 39 (zinc transporter), member 11	616508	REc			
17.774	5	24	13	17q25.3	C1QTNF1, GIP	P	C1q- and tumor necrosis factor-related protein 1	610365	REc			
17.775	6	23	15	17q24.3	SOX9, CMD1, SRA1	C	SRY (sex-determining region Y)-box 9	608160	Ch, REn		Campomelic dysplasia with autosomal sex reversal, 114290 (3); Acampomelic campomelic dysplasia, 114290 (3); Campomelic dysplasia, 114290 (3)	11(Ts, Sox9)
17.776	12	30	15	17q25.1	AANAT, SNAT	P	Arylalkylamine N-acetyltransferase	600950	Psh, A			11(Nat4)
17.777	4	6	00	17q25.3	API4	P	Apoptosis inhibitor 4	603352	A			
17.778	6	7	06	17q25.3	ASPSCR1, RCC17, ASPL, ASPS	P	Alveolar soft-part sarcoma chromosome region, candidate 1	606236	Ch	t(X;17)(p11.2;q25)	Alveolar soft-part sarcoma, 606243 (3)	
17.779	2	26	02	17q25.3	BAIAP2, IRSP53	P	BAI1-associated protein 2	605475	A			
17.780	1	22	16	17q25.3	CBX2, M33, SRXY5	P	Chromobox homolog 2, Drosophila polycomb class	602770	A	mutation identified in 1 SRXY5 patient	?46XY sex reversal 5, 613080 (3)	
17.781	2	11	98	17q25	CDR3	L	Cerebellar degeneration-related autoantigen-3	602197	H			11(Cdr3)
17.782	5	13	13	17q25.3	CSNK1D, ASPS, FASPS2	C	Casein kinase-1, delta	600864	A, Psh		Advanced sleep-phase syndrome, familial, 2, 615224 (3)	
17.783	10	1	10	17q25.1	CYGB, HGB, STAP	P	Cytoglobin	608759	REc			
17.784	9	30	09	17q25.3	CYTH1, D17S811E, SEC7	P	Cytohesin 1	182115	Psh, A			
17.785	8	19	13	17q25.3	DNAH17, DNEL2	P	Dynein, axonemal, heavy chain 17	610063	A, R			
17.786	12	3	08	17q25.1	DNAI2, CILD9	C	Dynein, axonemal, intermediate chain 2	605483	Psh, A		Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	
17.787	12	30	15	17q25	DSPS	P	Delayed sleep phase syndrome, susceptibliity to	614163	Fd	associated with rs28936679 in AANAT	{Delayed sleep phase syndrome, susceptibility to} (2)	
17.788	1	5	11	17q25	EPR1	P	Effector cell protease receptor 1	603411	A			
17.789	4	14	10	17q25.3	TMC8, EVER2, EV2	C	Transmembrane channel-like 8	605829	Fd, REc	previously mapped to 2p24-p21	Epidermodysplasia verruciformis, 226400 (3)	
17.790	1	21	97	17q25.1	EVPL	P	Envoplakin	601590	REa, A			
17.791	1	12	95	17q25.3	FASN	P	Fatty acid synthase	600212	A			
17.792	12	18	07	17q25.3	FN3KRP	P	Fructosamine 3-kinase-related protein	611683	REc			
17.793	1	18	12	17q25.3	FOXK2, ILF1	P	Forkhead box K2 (interleukin enhancer-binding factor 1)	147685	REa, A			
17.794	6	25	03	17q25.3	FSCN2, RFSN, RP30	P	Fascin, sea urchin, homolog of, 2	607643	A, REc	within 200kb of ACTG1	Retinitis pigmentosa 30, 607921 (3)	
17.795	3	17	98	17q25.3	GCGR	P	Glucagon receptor	138033	A, Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
17.796	6	20	94	17q25.1	GRIN2C, NMDAR2C	P	Glutamate receptor, ionotropic, N-methyl D-aspartate 2C	138254	A			
17.797	2	16	96	17q25.1	H3F3B	P	H3 histone, family 3B (H3.3B)	601058	A			
17.798	2	7	01	17q25.3	HGS, HRS	C	Human growth factor-regulated tyrosine kinase substrate	604375	REa, A			
17.799	11	12	07	17q25.1	JMJD6, PSR	P	Jumonji domain containing 6 (phosphatidylserine receptor)	604914	REc			
17.800	5	29	01	17q24.3	KCNJ16, KIR5.1	P	Potassium channel, inwardly rectifying, subfamily J, member 16	605722	R			
17.801	7	12	95	17q25.3	LGALS3BP	P	Lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein)	600626	A			11(Lgals3bp)
17.802	8	20	99	17q25.3	MAFG	C	v-maf avian musculoaponeurotic fibrosarcoma oncogene family, protein G	602020	A			
17.803	4	7	15	17q25.3	P4HB, PROHB, CLCRP1	C	Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide	176790	S, REa, A, C		Cole-Carpenter syndrome 1, 112240 (3)	
17.804	10	7	10	17q25.3	PDE6G, PDEG, RP57	C	Phosphodiesterase-6G, cGMP-specific, rod, gamma	180073	REa, A, Fd		Retinitis pigmentosa 57, 613582 (3)	11(Pdeg)
17.805	11	11	10	17q25.1	NUP85, PCNT1, PCNT	P	Nucleoporin 85kD	170285	REc			
17.806	5	22	14	17q25.1	RECQL5, RECQ5	P	DNA helicase, RecQ-like 5	603781	A			
17.807	10	20	99	17q25.3	RFNG	P	Radical fringe	602578	REa			11(Rfng)
17.808	2	25	11	17q25.3	RNF213, ALO17, KIAA1618, MYMY2	P	Ring finger protein 213	613768	Psh, REc, Fd		{Moyamoya disease 2, susceptibility to}, 607151 (3)	
17.809	7	20	06	17q25.3	SEPT9, MSF, MSF1, NAPB	C	Septin 9	604061	Ch, REa, Fd		Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1); Amyotrophy, hereditary neuralgic, 162100 (3)	
17.810	4	6	15	17q25.3	SLC26A11	P	Solute carrier family 26 (sulfate transporter), member 11	610117	REc, H			11(Slc26a11)
17.811	12	7	11	17q25.1	SRSF2, SFRS2, SC35	P	Serine/arginine-rich splicing factor 2	600813	H, REc			11(Sfrs2)
17.812	9	22	04	17q25.3	TBCD	C	Tubulin-specific chaperone D	604649	REc			
17.813	9	22	93	17q25.3	TIMP2	P	Tissue inhibitor of metalloproteinase-2	188825	H, REa, A			11(Timp2)
17.814	4	14	10	17q25.3	TMC6, EVER1, EV1	C	Transmembrane channel-like 6	605828	Fd, REc		Epidermodysplasia verruciformis, 226400 (3)	
17.815	12	4	02	17q25.3	SYNGR2	C	Synaptogyrin 2	603926	A, REc	pseudogene on 15q11; near EV1, EV2, TK1		
17.816	5	28	02	17q25.1	WBP2	P	WW domain-binding protein 2	606962	A			
17.817	6	25	99	17q25.3	MRPL12, RPML12	P	Ribosomal protein, mitochondrial, L12	602375	A			
17.818	4	20	11	17q25.1	ACOX1, ACOX, SCOX	C	Acyl-Coenzyme A oxidase 1, palmitoyl	609751	A, Psh		Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	
17.819	4	6	01	17q25.1	C17orf28, DMC1	P	Downregulated in multiple cancers-1	605752	REc			
17.820	12	2	09	17q25.1	C17orf106, TEN1	P	Chromosome 17 open reading frame 106	613130	REc			
17.821	9	24	15	17q25.1	CD300H	P	CD300H antigen	616560	REc			
17.822	4	10	15	17q25.1	CD300LD, CD300D	P	CD300 antigen-like family, member D	616301	REc			
17.823	1	22	07	17q25.1	CD300LB, TREM5, IREM3	P	CD300 antigen-like family, member B	610705	REc			11(Cd300lb)
17.824	8	29	08	17q25.1	CASKIN2, KIAA1139	P	CASK-interacting protein 2	612185	R, REc			
17.825	12	23	05	17q25.1	CD300E, CD300LE, IREM2, CLM2	P	CD300E antigen	609801	REc			
17.826	12	23	05	17q25.1	CD300LF, IGSF13, IREM1, CLM1	C	CD300 antigen-like family, member F	609807	REc			
17.827	1	14	11	17q25.1	COG1, LDLB, KIAA1381, CDG2G	C	Component of oligomeric golgi complex 1	606973	R, REc		Congenital disorder of glycosylation, type IIg, 611209 (3)	
17.828	9	14	05	17q25.1	EXOC1, EX070, KIAA1067	P	Exocyst complex component 7	608163	R, REc			
17.829	2	12	16	17q25.1	FGF1, ALB	P	FAS-binding factor 1	616807	REc			
17.830	6	13	12	17q25.1	GPR142, PGR2	P	G protein-coupled receptor 142	609046	REc			11(Gpr142)
17.831	3	10	11	17q25.1	ICT1, DS1	P	Immature colon carcinoma transcript 1	603000	REc			
17.832	7	26	10	17q25.1	KCTD2, KIAA0176	P	Potassium channel tetramerization domain-containing 2	613422	R, REc			
17.833	8	22	14	17q25.1	METTL23, C17orf95, MRT44	P	Methyltransferase-like 23	615262	REc		Mental retardation, autosomal recessive 44, 615942 (3)	
17.834	12	2	14	17q25.1-q25.3	NDNC9	P	Nail disorder, nonsyndromic congenital, 9 (anonychia-onycholysis)	614149	Fd	max lod at D17S1301	Nail disorder, nonsyndromic congenital, 9 (2)	
17.835	6	24	08	17q25.1	MIF4GD, SLIP1	P	MIF4G domain-containing protein	612072	REc			
17.836	3	14	06	17q25.1	RAB37	P	Pas-associated protein RAB37	609956	R, REc			
17.837	4	19	12	17q25.1	RHBDF2, IRHOM2, TOC	P	Rhomboid 5, Drosophila, homolog of, 2	614404	REc		Tylosis with esophageal cancer, 148500 (3)	
17.838	10	22	10	17q25.1	SAP30BP, HTRP, HCNGP, HTRG	P	SAP30-binding protein	610218	R, REc			
17.839	10	18	15	17q25.1	SDK2, KIAA1514	P	Sidekick, Drosophila, homolog of, 2	607217	REc			
17.840	9	23	08	17q25.1	SLC9A3R1, EBP50, NHERF1, NPHLOP2	C	Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1	604990	R, REc		Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	
17.841	4	6	01	17q25.1	SRP68	C	Signal recognition particle, 68kD	604858	R, A			
17.842	8	19	13	17q25.1	ST6GALNAC1, SIAT7A, STYI	P	ST6 alpha-N-aetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	610138	REc			
17.843	3	20	14	17q25.1	ST6GALNAC2, SIAT7B, SAITL1	P	ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha2-,6-sialyltransferase 2	610137	REc, Psh			
17.844	2	13	15	17q25.1	TSEN54, SEN54, PCH2A, PCH4, PCH5	P	tRNA splicing endonuclease 54, S. cerevisiae, homolog of	608755	REc	mutation identified in 1 PCH5 patient	Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar hypoplasia type 4, 225753 (3); ?Pontocerebellar hypoplasia type 5, 610204 (3)	
17.845	9	16	12	17q25.1	TTYH2	P	Tweety, Drosophila, homolog of, 2	608855	REc			
17.846	9	3	04	17q25.1	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	C	UNC13, C. elegans, homolog of, D	608897	Fd, REc		Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	
17.847	5	19	15	17q25.1	UNK, UNKEMPT, ZC3H5, KIAA1753	P	Unkempt family zinc finger protein	616375	REc			
17.848	5	20	99	17q25.3	NPTX1, NP1	P	Pentraxin I, neuronal	602367	A			11(Nptx1)
17.849	1	6	97	17q25.2-q25.3	SEC14L	P	SEC14, S. cerevisiae, like	601504	A			
17.850	5	7	01	17q25.1	GPRC5C, RAIG3	P	G protein-coupled receptor, family C, group 5, member C	605949	REc			
17.851	7	12	02	17q25.1	SPHK1	P	Sphingosine kinase	603730	REc			
17.852	1	2	91	17q25.3	CD7	C	CD7 antigen (p41)	186820	S, A			11(Cd7)
17.853	4	11	02	17q25.3	GAA	C	Glucosidase, acid alpha-	606800	S, A, D, C	distal to TK1	Glycogen storage disease II, 232300 (3)	
17.854	6	25	99	17q25.3	SECTM1, K12	P	Secreted and transmembrane 1	602602	REn			
17.855	3	8	96	17q25.3	TK1	C	Thymidine kinase-1	188300	S, Ch, R, C, Fd, A			11(Tk1)
17.856	10	31	00	17q25.3	AATK, AATYK	C	Apoptosis-associated tyrosine kinase	605276	REa, A			
17.857	4	19	12	17q25.3	ACTG1, DFNA20, DFNA26, BRWS2	C	Actin, gamma-1	102560	REa, A, Fd		Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter syndrome 2, 614583 (3)	
17.858	5	2	16	17q25.3	ALYREF, THOC4, ALY, BEF	P	ALY/REF export factor	604171	REc			
17.859	3	30	12	17q25.3	ANAPC11, APC11	P	Anaphase-promoting complex subunit 11	614534	REc			
17.860	8	1	14	17q25.3	ARHGDIA, GDIA1, NPHS8	P	Rho GDP dissociation inhibitor (GDI) alpha	601925	A, REa		Nephrotic syndrome, type 8, 615244 (3)	
17.861	10	12	09	17q25.3	ATOD4	P	Dermatitis, atopic, 4	605805	Fd	maximum lod at D17S1290	{Dermatitis, atopic, susceptibility to, 4} (2)	
17.862	2	1	11	17q25.3	AZI1, ZA1, KIAA1118	P	5-azacytidine-induced gene 1, mouse, homolog of	613479	R, REc			
17.863	8	2	13	17q25.3	B3GNTL1	P	Beat-1,3-N-acetylglucosaminyltransferase-like 1	615337	REc			
17.864	3	23	14	17q25.3	C17orf70, FAAP100	P	Chromosome 17 open reading frame 70	611301	REc			
17.865	10	21	15	17q25.3	CANT1, SCAN1, DBQD1	P	Calcium-activated nucleotidase 1	613165	REc		Desbuquois dysplasia 1, 251450 (3)	
17.866	12	1	14	17q25.3	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	C	Caspase recruitment domain-containing protein 14	607211	Fd, REc		Psoriasis 2, 602723 (3); Pityriasis rubra pilaris, 173200 (3)	
17.867	11	11	14	17q25.3	CBX4, PC2	P	Chromobox homolog 4, Drosophila polycomb class	603079	REc			
17.868	3	15	11	17q25.3	CCDC40, KIAA1640	P	Coiled-coil domain-containing protein 40	613799	REc		Ciliary dyskinesia, primary, 15, 613808 (3)	
17.869	10	5	11	17q25.3	CCDC137	P	Coiled-coil domain-containing protein 137	614271	REc			
17.870	4	17	07	17q25.3	CHMP6	P	CHMP family, member 6	610901	R, REc			
17.871	4	7	14	17q25.3	DCXR, P34H, PNTSU	P	Dicarbonyl/L-xylulose reductase	608347	R, REc		[Pentosuria], 260800 (3)	
17.872	3	11	14	17q25.3	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	P	DEAD/H Box 48	608546	REc		Robin sequence with cleft mandible and limb anomalies, 268305 (3)	
17.873	8	26	15	17q25.3	FAM195B, MCRIP1	P	Family with sequence similarity 194, member B	616514	REc			
17.874	8	8	13	17q25.3	FN3K	P	Fructosamine 3-kinase	608425	REc, A			
17.875	6	25	99	17q25.1	GALR2, GALNR2	P	Galanin receptor 2	603691	A			
17.876	10	7	02	17q25.3	GPR14, UTR2, UTR	P	G protein-coupled receptor-14 (urotensin II receptor)	600896	A			
17.877	2	12	07	17q25.3	GPS1	P	G protein pathway suppressor 1	601934	R, REc			
17.878	3	10	15	17q25.3	IS5	P	Scoliosis, idiopathic, susceptibility to, 5	612239	Fd	between D17S1806 and 17qter	{Scoliosis, idiopathic, susceptibility to, 5} (2)	
17.879	4	19	07	17q25.1	LGICZ1, ZAC, L2	C	Ligand-gated ion channel, zinc-activated, 1	610935	REc, REn			
17.880	2	25	15	17q25.3	METRNL	P	Meteorin-like protein	616241	REc			
17.881	12	4	08	17q25.2	MGAT5B	P	Alpha-1,6-mannosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase isozyme B	612441	REc			
17.882	7	1	11	17q25.3	MIR338, MIRN338	P	Micro RNA 338	614059	REc			
17.883	3	18	08	17q25.3	NAGLUEB, FLJ21865	P	N-acetylglucosaminidase, endo-beta	611898	R, REc			
17.884	1	24	06	17q25.3	NOTUM	P	Notum, Drosophila, homolog of	609847	REc			
17.885	2	25	15	17q25.3	NPB, PPL7	P	Neuropeptide B	607996	REc			
17.886	6	13	14	17q25.1	OTOP2	P	Otopetrin 2	607827	REc, H			11(Otop2)
17.887	6	13	14	17q25.1	OTOP3	P	Otopetrin 3	607828	REc, H			11(Otop3)
17.888	12	17	12	17q25.3	PGS1	P	Phosphatidylglycerophosphate synthase 1	614942	REc			
17.889	1	31	12	17q25.3	PYCR1, PRO3, ARCL2B, ARCL3B	P	Pyroline-5-carboxylate reductase-1	179035	REa		Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	
17.890	2	1	01	17q25.3	RAC3	C	Ras-related C3 botulinum toxin substrate-3 (rho family, small GTP-binding protein Rac3)	602050	Psh, A			
17.891	12	2	09	17q25.3	RPTOR, RAPTOR, KIAA1303	P	Regulatory-associated protein of MTOR	607130	REc			
17.892	2	2	11	17q25.3	SGSH, MPS3A, SFMD	C	N-sulfoglucosamine sulfohydrolase (sulfamidase)	605270	A		Mucopolysaccharidisis type IIIA (Sanfilippo A), 252900 (3)	11(Sgsh)
17.893	8	17	10	17q25.3	SIRT7, SIR2L7	C	Sirtuin 7 (Sir2, S. cerevisiae, homolog of, 7)	606212	REc			
17.894	3	26	02	17q25.3	SLC25A10, DIC	P	Solute carrier family 25 (mitochondrial carrier), member 10 (dicarboxylate ion carrier)	606794	A			
17.895	2	13	12	17q25.1	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	C	Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19	606521	A, Fd, REc		Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	
17.896	8	26	15	17q25.3	SLC38A10	P	Solute carrier family 38 (amino acid transporter), member 10	616525	REc			
17.897	10	8	09	17q25.3	SOCS3, SSI3, CIS3	C	Suppressor of cytokine signaling 3	604176	REc			
17.898	4	6	13	17q25.3	STRA13, CENPX, FAAP10, MHF2, D9	P	Stimulated by retinoic acid 13	615128	REc			
17.899	11	15	15	17q25.3	TBC1D16	P	TBC1 domain family, member 16	616637	REc			
17.900	2	13	14	17q25.3	TEX19	P	Testis-expressed gene 19	615647	REc			
17.901	1	31	07	17q25.3	TNRC6C, KIAA1582	P	Trinucleotide repeat-containing gene 6C	610741	R, REc			
17.902	1	27	09	17q25.3	USP36, KIAA1453	P	Ubiquitin-specific protease 36	612543	REa, REc			
17.903	7	9	06	17q25.3	ZNF750, FLJ13841	C	Zinc finger protein 750	610226	REc, Fd		Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)	
17.904	1	7	02	17q25.3	NPL4, KIAA1499	P	Npl4, S. cerevisiae, homolog of	606590	Psh, A			
17.905	5	26	98	17q22	AKAP1, AKAP149, SAKAP84	P	A-kinase anchor protein 1, 149kD	602449	TM			
17.906	4	30	03	17q12	AP1GBP1, SYNG	P	Adaptor-related protein complex 1 gamma subunit-binding protein 1	607291	R			
17.907	11	5	98	17q21.32	ATP5G1	P	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 1	603192	REc			
17.908	8	29	02	17q12	CCL1, SCYA1	P	Chemokine, C-C motif, ligand 1	182281	REa			
17.909	5	22	03	17p13.1	CENTB1, KIAA0050, ACAP1	P	Centaurin, beta-1	607763	Psh			
17.910	11	1	02	17q21.31	CLP1, HIS1	P	Cardiac lineage protein 1	607328	R			
17.911	12	11	02	17q12	DUSP14, MKP6	P	Dual-specificity phosphatase 14	606618	R			
17.912	10	7	02	17p11.2	EPN2, KIAA1065	P	Epsin 2	607263	R			
17.913	10	7	02	17q21.33	EPN3	P	Epsin 3	607264	REc			
17.914	4	10	90	Chr.17	G6PDL	P	Glucose-6-phosphate dehydrogenase-like	138110	REa, REb			
17.915	12	19	01	17q25.1	GGA3, KIAA0154	P	Golgi associated, gamma adaptin ear containing, ARF binding protein 3	606006	R			
17.916	2	20	02	17q24.2	HELZ, KIAA0054, HUMORF5	P	Helicase with zinc finger domain	606699	R			
17.917	6	25	99	17q22	MTMR4	P	Myotubularin-related protein 4	603559	R, REc			
17.918	4	10	90	17q21.32	MYL4	C	Myosin, light polypeptide-4, alkali; atrial, embryonic	160770	REa			11(Myla)
17.919	12	27	01	17p13.1	NLGN2, KIAA1366	P	Neuroligin 2	606479	R			
17.920	2	3	03	17p13.1	NUDEL	P	Nude-like protein (endooligopeptidase A)	607538	R			
17.921	3	20	15	Chr.17	ODS1	P	Opioid dependence, susceptibility to, 1	610064	Fd		{Opioid dependence, susceptibility to, 1} (2)	
17.922	6	2	98	17p13.1	PFAS, FGARAT	P	phosphoribosylformylglycinamidine synthase (FGAR amidotransferase)	602133	REa, A			
17.923	6	13	03	17p13.3	SKIP	P	Skeletal muscle- and kidney-enriched inositol phosphatase	607875	R			
17.924	3	23	02	17p11.2	TRPV2, VRL1	P	Transient receptor potential cation channel, subfamily V, member 2	606676	R			
17.925	11	21	02	17q23.1	TUBD1, TUBD	P	Tubulin, delta-1	607344	REc			
18.1	8	26	09	18p11.32	CETN1, CEN1	P	Centrin-1	603187	REa, REc			
18.2	6	14	94	18pter-p11.21	ERV1	C	Oncogene ERV1; endogenous retrovirus-1	131150	REa, A			
18.3	3	10	03	18p11.32	COLEC12, SRCL, CLP1	P	Collectin 12	607621	REc			
18.4	12	15	10	18p11.32	ENOSF1, RTS	P	Enolase superfamily member 1	607427	REn			
18.5	1	9	13	18p11.32	SMCHD1, KIAA0650	P	Structural maintenance of chromosomes flexible hinge domain-containing protein 1	614982	REc		Fascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3)	17(Smchd1)
18.6	10	20	92	18p11.32	TYMS, TS, TMS	C	Thymidylate synthase	188350	S, A	<50 kb from YES1		
18.7	8	26	09	18p11.32	THOC1, HPR1	P	THO complex 1 (nuclear matrix protein p84)	606930	R, REc			
18.8	3	14	06	18p11.32-p11.31	DFNB46	P	Deafness, neurosensory, autosomal recessive 46	609647	Fd	between D18S59 and D18S391	Deafness, autosomal recessive 46 (2)	
18.9	11	30	06	18p11.31	ARHGAP28, KIAA1314	P	RHO GTPase-activating protein 28	610592	R, REc			
18.10	6	19	15	18p11.31	C18orf42	P	Chromosome 18 open reading frame 42	616427	REc			
18.11	7	14	14	18p11.31	DLGAP1, DAP1, DLGAP1A, DLGAP1B	P	Discs large-associated protein 1	605445	REc			
18.12	9	20	14	18p11.31	LAMA1, PTBHS	P	Laminin, alpha-1	150320	A		Poretti-Boltshauser syndrome, 615960 (3)	17(Lama)
18.13	7	20	09	18p11.31	MYL12B, MRLC2	P	Myosin, light chain 12B, regulatory	609211	R, REc			
18.14	12	4	12	18p11.31	MYOM1, SKELEMIN	C	Myomesin 1	603508	Psh, A, REc			
18.15	11	12	98	18p11.31	MYP2	P	Myopia, high grade, autosomal dominant 1	160700	Fd		Myopia-2 (2)	
18.16	11	16	10	18p11.22	NDUFV2	C	NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kD	600532	REa, A	pseudogene on 19q13.3-qter	Mitochondrial complex I deficiency, 252010 (3)	
18.17	11	13	12	18p11.3	POROK6, DSAP4	P	Porokeratosis 6	612353	Fd	between telomere and D18S391	Porokeratosis 6, multiple types (2)	
18.18	4	3	01	18p11.31	EPB41L3, DAL1	P	Erythrocyte membrane protein band 4.1-like 3	605331	REc			
18.19	11	18	11	18p11.3	MRT19	P	Mental retardation, autosomal recessive 19	614343	Fd	between rs4606805 and rs1787846	Mental retardation, autosomal recessive 19 (2)	
18.20	3	6	01	18p11.22	RAB31	P	Ras-associated protein RAB31	605694	REa, REc			
18.21	5	4	10	18p11.31	TGIF, HPE4	C	TG-interacting factor	602630	Ch, A		Holoprosencephaly-4, 142946 (3)	
18.22	4	25	93	18p11.32	YES1	C	Oncogene YES-1	164880	REa, REn, A	<50 kb from TYMS		
18.23	2	12	07	18p11.3-p11.2	AA1	P	Alopecia areata 1	104000	Fd	max lod at D18S967	Alopecia areata 1 (2)	
18.24	7	13	93	18p11.21	PTPN2, PTPT	C	Protein tyrosine phosphatase, nonreceptor-type, 2	176887	REc, A			18(Ptpt)
18.25	9	27	02	18p11.22	TWSG1, TSG	P	Twisted gastrulation, Drosophila, homolog of	605049	R			17(Tsg)
18.26	12	18	08	18p11.23	PSORS10	P	Psoriasis susceptibility 10	612410	Fd	between D18S63 and D18S967	{Psoriasis susceptibility 10} (2)	
18.27	6	18	99	18p11.21	RNMT, MET	P	RNA guanine-7-methyltransferase	603514	A, R			
18.28	1	28	05	18p11.23-q12.2	ANIC	P	Anosmia, isolated congenital	107200	Fd	max lod at D18S1108	Anosmia, isolated congenital (2)	
18.29	11	30	06	18p11.22	ANKRD12, ANCO1, KIAA0874	P	Ankyrin repeat domain-containing protein 12	610616	R, REc			
18.30	12	30	14	18p11.22	GACAT2, MTCL1AS1	P	Gastric cancer-associated transcript 2, noncoding	616131	REc			
18.31	4	29	14	18p11.22	MTCL1, KIAA0802	C	Microtubult crosslinking factor 1	615766	REc, R			
18.32	4	29	14	18p11.22	NAPG	P	N-ethylmaleimide-sensitive factor attachment protein, gamma	603216	REc			
18.33	6	22	14	18p11.22-p11.21	PIEZO2, FAM38B, DA5, DA3, MWKS	P	PIEZO-type mechanosensitive ion channel component 2	613629	REc	mutation identified in 1 MWKS patient	Arthrogryposis, distal, type 5, 108145 (3); Arthrogryposis, distal, type 3, 114300 (3); ?Marden-Walker syndrome, 248700 (3)	
18.34	8	26	09	18p11.22	PPP4R1, PP4R1	P	Protein phosphatase 4, regulatory subunit 1	604908	R, REc			
18.35	7	20	15	18p11.22	RAB12	P	Ras-associated protein RAB12	616448	REc			
18.36	8	26	09	18p11.22	VAPA, VAP33	P	Vesicle-associated membrane protein-associated protein A	605703	R, REc			
18.37	9	28	15	18p11.21	ANKRD30B	P	Ankyrin repeat domain-containing protein 30B	616565	REc			
18.38	6	19	15	18p11.21	CEP192, PPP1R62, KIAA1569	C	Centrosomal protein, 192kD	616426	Psh, REc			
18.39	2	14	12	18p11.21	CIDEA	P	Cell death-inducing DFFA-like effector A	604440	REc			
18.40	6	4	13	18p11.21	GNAL, DYT25	C	Guanine nucleotide-binding protein, alpha-subunit, olfactory type	139312	REc		Dystonia 25, 615073 (3)	18(Gnal)
18.41	9	11	15	18p11.21	PRELID3A, SLMO1, C18orf43	P	PRELI domain-containing protein 3A	616545	REc			
18.42	10	28	08	18p11.21	PSMG2, TNFSF5IP1, HCCA3, CLAST3, PAC2	P	Proteasome (prosome, macropain) assembly chaperone 1	609702	R, REc			
18.43	4	14	05	18p11.21	SEH1L, SEH1, SEC13L	P	Seh1-like protein	609263	REc			
18.44	3	14	13	18p11.21	TUBB6	P	Tubulin, beta-6	615103	REc			
18.45	6	18	99	18p11.31	ZFP161, ZF5	P	Zinc finger protein-161	602126	Psh			17(Zfp161)
18.46	12	19	01	18p11.21	C18orf1	P	Chromosome 18 open reading frame 1	606571	REc			
18.47	9	30	02	18p11.2	DYX6, DYXQTL18	P	Dyslexia, susceptibility to, 6	606616	Fd		{Dyslexia, susceptibility to, 6} (2)	
18.48	8	9	05	18p11.2	FEB6	P	Febrile seizures, familial, 6	609253	Fd	max lod at D18S1158	Febrile seizures, familial, 6 (2)	
18.49	5	16	01	18p11.21	IMPA2	P	Myo-inositol monophosphatase 2	605922	REc			
18.50	12	4	02	18p11.21	MC2R	C	Melanocortin-2 receptor (ACTH receptor)	607397	A, Psh		Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)	18(Mc2r)
18.51	5	17	95	18p11.21	MC5R	P	Melanocortin-5 receptor	600042	A			
18.52	3	20	08	18p11.21	MPPE1	P	Metallophosphoesterase 1	611900	REc			
18.53	11	4	93	18p11.23	PTPRM, PTPRL1, RPTPM	C	Protein tyrosine phosphatase, receptor type, mu polypeptide	176888	REa, A			
18.54	7	13	93	18p11.32	ADCYAP1	P	Adenylate cyclase activating polypeptide-1 (pituitary)	102980	A			
18.55	3	29	12	18p11.21	AFG3L2, SCA28, SPAX5	C	ATPase family gene 3-like 2	604581	R, Fd		Spinocerebellar ataxia 28, 610246 (3); Ataxia, spastic, 5, autosomal recessive, 614487 (3)	
18.56	7	16	14	18p11.22	APCDD1, HHS, HYPT1, HTS	P	Adenomatosis polyposis coli down-regulated 1	607479	REc		Hypotrichosis 1, 605389 (3)	
18.57	3	29	07	18p11.21	CHMP1B, C10orf2	P	CHMP family, member 1B	606486	REc			
18.58	1	16	03	18p11	DYT15	P	Dystonia-15, myoclonic	607488	Fd		Dystonia-15, myoclonic (2)	
18.59	10	28	08	18p11	IBD21	P	Inflammatory bowel disease 21	612354	Fd	associated with rs2542151	{Inflammatory bowel disease 21} (2)	
18.60	8	27	01	18p11.22	RALBP1, RLIP76	P	RALA-binding protein 1	605801	A			
18.61	1	24	09	18p	DEL18p, C18DELp	P	Chromosome 18p deletion syndrome	146390	Ch		Chromosome 18p deletion syndrome (4)	
18.62	5	26	98	18p	DYT7	P	Dystonia-7 (torsion dystonia, adult-onset, focal)	602124	Fd		Dystonia-7, torsion (2)	
18.63	1	15	09	18p11.31	LPIN2	P	Lipin 2	605519	REc		Majeed syndrome, 609628 (3)	17(Lpin2)
18.64	5	6	08	18p	MAFD1, BPAD, MD1	L	Major affective disorder 1	125480	Fd	?also 18q	{Major affective disorder 1} (2)	
18.65	12	15	98	18p	SCZD8	P	Schizophrenia susceptibility locus, chromosome 18-related	603206	Fd		{Schizophrenia}, 181500 (2)	
18.66	10	18	11	18p	TET18P	P	Tetrasomy 18p	614290	Ch		Tetrasomy 18p (4)	
18.67	2	28	03	18p11.32	USP14, TGT	C	Ubiquitin-specific protease 14	607274	R, REc			18(Usp14, ax)
18.68	11	16	08	18q	DEL18q	C	Chromosome 18q deletion syndrome	601808	DS		Chromosome 18q deletion syndrome (4)	
18.69	11	12	98	18q	OHDS	P	Orthostatic hypotensive disorder of Streeten	143850	Fd		Orthostatic hypotensive disorder of Streeten (2)	
18.70	8	20	99	18q21.1	RPL17	P	Ribosomal protein L17	603661	REa, R			
18.71	10	26	99	18q12.1	B4GALT6	P	Beta-1,4-galactosyltransferase 6	604017	TM			
18.72	3	13	03	18q11.2	NPC1, NPC	C	NPC1 gene	607623	Ch, H, Fd, M	some families not linked to 18; type D prob. allelic	Niemann-Pick disease, type C1, 257220 (3); Niemann-Pick disease, type D, 257220 (3)	18(spm)
18.73	5	7	03	18q11.2	OSBPL1A, ORP1	P	Oxysterol-binding protein-like protein 1A	606730	R, REc			
18.74	4	5	11	18q12.3	SLC14A1, JK, UTE, UT1	C	Solute carrier family 14 (urea transporter), member 1 (Kidd blood group)	613868	Fd, EM, A	previous suggestion of chr.7 or chr.2	[Blood group, Kidd], 111000 (3)	
18.75	8	29	08	18q11.2	ABHD3, LABH3	P	Abhydrolase domain-containing 3	612197	R, REc			
18.76	1	28	09	18q11.1	ROCK1	P	RHO-associated coiled-coil-containing protein kinase 1	601702	R, REc			
18.77	2	24	12	18q11.2	GATA6, AVSD5, ASD9, AVSD5, PACHD	P	GATA-binding protein-6	601656	A		Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9, 614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)	
18.78	8	11	98	18q12.1	CDH2, NCAD	C	Cadherin 2 (cadherin, neuronal type; N-cadherin)	114020	REa, A			18(Ncad)
18.79	3	14	15	18q11.2	CHST9, GalNAc4ST2	P	Carbohydrate sulfotransferase 9	610191	REc			
18.80	12	28	08	18q11.2	ESCO1, ECO1, CTF, ESO1, EFO1, KIAA1911	P	Establishment of cohesion 1, S. cerevisiae, homolog of, 1	609674	REc			
18.81	5	6	03	18q11.2	HRH4, HH4R	C	Histamine receptor H4	606792	REc, R			
18.82	7	22	13	18q11.2	KCTD1, SENS	P	Potassium channel tetramerization domain-containing 1	613420	REc		Scalp-ear-nipple syndrome, 181270 (3)	
18.83	10	15	03	18q11.2	LAMA3, LOCS	P	Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epilegrin)	600805	A		Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, generalized atrophic benign, 226650 (3); Laryngoonychocutaneous syndrome, 245660 (3)	
18.84	3	1	13	18q11.2	MIB1, MIB, DIP1, KIAA1323, LVNC7	P	Mindbomb, Drosophila, homolog of, 1	608677	REc, R		Left ventricular noncompaction 7, 615092 (3)	
18.85	5	24	13	18q11.2	MIR1-2	P	Micro RNA 1-2	610252	REc			
18.86	5	24	13	18q11.2	MIR133A1	P	Micro RNA 133A1	610254	REc			
18.87	2	21	12	18q11.2	RBBP8, RIM, SCKL2, JWDS	P	Retinoblastoma-binding protein 8	604124	A		Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3); Jawad syndrome, 251255 (3)	
18.88	8	18	14	18q11.2	SNRPD1	P	Small nuclear ribonucleoprotein polypeptide D1	601063	REc			
18.89	6	26	01	18q11.2	SS18, SSXT, SYT	C	Synovial sarcoma translocation, chromosome 18	600192	Ch, RE	5' SYST/3' SSRC in t(X;18)	Sarcoma, synovial (1)	
18.90	6	18	99	18q11.2	SUDD	P	sudD, Aspergillus nidulans, homolog of	603579	A, REc, Psh			
18.91	7	7	14	18q11.2	TAF4B, TAF2C2, TAFII105, SPGF13	P	TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD	601689	R, REc	mutation identified in 1 SPGF13 family	?Spermatogenic failure 13, 615841 (3)	
18.92	11	1	13	18q11.2	TMEM241, C18orf45	P	Transmembrane protein 241	615430	REc			
18.93	5	22	07	18q11.2	ZNF521, EHZF, EVI3	P	Zinc finger protein 521	610974	REc			
18.94	12	13	96	18q11.2	AQP4, MIWC	P	Aquaporin-4	600308	A, Psh			18(Aqp4)
18.95	7	23	13	18q11.2	IMPACT	P	Impact RWD domain protein	615319	REc, H			18(Impact)
18.96	2	26	10	18q12.1	TTR, PALB	C	Transthyretin (prealbumin)	176300	REa, A		Amyloidosis, hereditary, transthyretin-related, 105210 (3); [Dystransthyretinemic hyperthyroxinemia], 145680 (3); Carpal tunnel syndrome, familial, 115430 (3)	18(Palb)
18.97	5	23	11	18q11.2-q12.2	APMR3	P	Alopecia-mental retardation syndrome 3	613930	Fd	between D18S866 and D18S811	Alopecia-mental retardation syndrome 3 (2)	
18.98	8	2	13	18q12.2	CELF4, BRUNOL4	P	CUGbp- and ELAV-like family, member 4	612679	REc			
18.99	7	16	14	18q12.1	DSG4, LAH, HYPT6	P	Desmoglein 4	607892	REn		Hypotrichosis 6, 607903 (3)	
18.100	9	21	11	18q21.1	IER3IP1, MEDS	P	Immediate-early response 3-interacting protein 1	609382	REc		Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	
18.101	1	8	16	18q12.1-q12.2	MAPRE2, EB2, RP1, CSCSC2	C	Microtubule-associated protein, RP/EB family, member 2	605789	R, A		Symmetric circumferential skin creases, congenital, 2, 616734 (3)	
18.102	7	18	12	18q12.2	RPRD1A, P15RS, FLJ10656	P	Regulation of nuclear pre-mRNA domain-containing protein 1A	610347	REc			
18.103	10	1	90	18q12.2	ZNF24	P	Zinc finger protein-24 (KOX17)	194534	REa, A			
18.104	10	4	05	18q12.2	ZNF396	P	Zinc finger protein-396	609600	REc			
18.105	10	4	05	18q12.2	ZNF397	P	Zinc finger protein-397	609601	REc			
18.106	5	1	02	18q12.2	ZNFEB, ZNF271	P	Epstein-Barr virus-induced zinc finger protein	604754	REc			
18.107	10	12	14	18q21.1	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	C	ATP synthase, H+ transporting (ATPase, mitochondrial)	164360	S, REa, A	pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family	?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3); ?Combined oxidative phosphorylation deficiency 22, 616045 (3)	
18.108	10	13	09	18q21.1	LOXHD1, DFNB77	P	Lipoxygenase homology domains-containing 1	613072	REc		Deafness, autosomal recessive 77, 613079 (3)	
18.109	5	29	97	18q21.1-q21.2	MAPK4, PRKM4, ERK3	P	Mitogen-activated protein kinase 4	176949	REa, A			
18.110	3	4	05	18q21.1	DYM, FLJ90130, DMC, SMC	C	Dymeclin	607461	REc, Fd		Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia, 607326 (3)	
18.111	11	10	13	18q12.1	ASXL3, KIAA1713, BRPS	P	Additional sex combs-like 3	615115	REc		Bainbridge-Ropers syndrome, 615485 (3)	
18.112	8	25	09	18q12.1	DSC1	P	Desmocollin-1	125643	REa, REc			
18.113	6	4	12	18q12.1	DSC2, DSC3, ARVD11	C	Desmocollin-2	125645	REa, Psh, H, REn, A		Arrhythmogenic right ventricular dysplasia 11, 610476 (3); Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	18(Dsc2)
18.114	10	04	14	18q12.1	DSC3, DSC4	C	Desmocollin-3	600271	A, Psh	mutation identified in 1 HYPTSV family	?Hypotrichosis and recurrent skin vesicles, 613102 (3)	
18.115	2	12	99	18q12.2	GALNT1	C	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1	602273	A			
18.116	2	24	11	18q12.1	KLHL14, PRINTOR, KIAA1384	P	Kelch-like 14	613772	REc			
18.117	5	22	14	18q12.1	NOL4, NOLP	P	Nucleolar protein 4	603577	REc			
18.118	3	12	15	18q12.1	RNF125, TRAC1, TNORS	P	RING finger protein 125	610432	REc		Tenorio syndrome, 616260 (3)	
18.119	4	22	15	18q12.1	RNF138, NARF	P	RING finger protein 138	616319	REc			
18.120	12	30	14	18q12.1	SLC25A52, MCART2	P	Solute carrier family 25, member 52	616153	REc			
18.121	9	8	11	18q12.1	TRAPPC8, KIAA1012	P	Trafficking protein particle complex, subunit 8	614136	R, REc			
18.122	11	22	13	18q12.1	DSG1, PPKS1, SPPK1, EPKHE	C	Desmoglein-1	125670	REa, A, REn	pemphigus foliaceous antigen	Keratosis palmoplantaris striata I, AD, 148700 (3); Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	18(Dsg1)
18.123	7	17	09	18q12.1	DSG2, ARVD10, ARVC10, CMD1BB	C	Desmoglein-2	125671	Psh, REn		Arrhythmogenic right ventricular dysplasia 10, 610193 (3); Cardiomyopathy, dilated, 1BB, 612877 (3)	
18.124	5	26	94	18q12.1	DSG3	C	Desmoglein-3 (pemphigus vulgaris antigen)	169615	Psh, A, REn			18(Dsg3)
18.125	6	16	10	18q12.1	DTNA, D18S892E, DRP3, LVNC1	P	Dystobrevin, alpha (dystrophin-related protein 3)	601239	A		Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	
18.126	9	22	98	18q12.3	SLC14A2, UT2, UTR	P	Solute carrier family 14 (urea transporter), member 2	601611	A			
18.127	8	18	08	18q11.2	CABYR, FSP2	P	Calcium-binding tyrosine phosphorylation-regulated protein	612135	REc			18(Cabyr)
18.128	10	15	14	18q12.2	ELP2, STATIP1	P	Elongator acetyltransferase complex, subunit 2	616054	REc			
18.129	12	28	08	18q12.2	FHOD3, FHOS2, KIAA1695	P	Formin homology-2 domain-containing protein 3	609691	REc			
18.130	7	28	15	18q12.2	KIAA1328, HINDERIN	P	Hinderin	616480	REc			
18.131	3	31	09	18q12.2	MIR187, MIRN187	P	Micro RNA 187	612698	REc			
18.132	3	4	10	18q12.2	MOCOS, MCS	P	Molybdenum cofactor sulfurase	613274	REc			
18.133	3	27	95	18q12.1	MEP1B	P	Meprin A, beta	600389	REa			8(Mep1b)
18.134	9	28	00	18q12.2-q12.3	OPA4	P	Optic atrophy 4	605293	Fd		Optic atrophy 4 (2)	
18.135	10	4	12	18q12.3	RIT2, RIN, ROC2	P	Ric-like protein without CAAX motif 2	609592	REc, R			
18.136	2	14	01	18q12.3	SYT4	P	Synaptotagmin-4	600103	A			18(Syt4)
18.137	11	3	11	18q12.3	VUR6	P	Vesicoureteral reflux 6	614319	Fd	closest marker rs1054986	Vesicoureteral reflux 6 (2)	
18.138	3	1	13	18q12.3-q21.1	EPG5, KIAA1632, HEEW1, VICIS	C	Ectopic P-granules autophagy protein 5, C. elegans, homolog of	615068	REc, Psh		Vici syndrome, 242840 (3)	
18.139	12	7	12	18q21.31	ATP8B1, FIC1, BRIC, PFIC1, ICP1	P	ATPase, class I, type 8B, member 1	602397	Fd, LD		Cholestasis, progressive familial intrahepatic 1, 211600 (3); Cholestasis, benign recurrent intrahepatic, 243300 (3); Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	
18.140	12	2	05	18q21	ALS3	P	Amyotrophic lateral sclerosis 3	606640	Fd		Amyotrophic lateral sclerosis 3 (2)	
18.141	10	10	14	18q21.2	C18orf54, LAS2	P	Chromosome 18 open reading frame 54	613258	REc			18(C18orf54)
18.142	9	16	03	18q21.2	ELAC1, D29	P	Elac, E. coli, homolog of, 1	608079	REc			
18.143	10	23	87	18q21.32	GRP	C	Gastrin-releasing peptide	137260	REa, A	mammalian equivalent of bombesin		18(Grp)
18.144	12	9	98	18q21	IDDM6	P	Insulin-dependent diabetes mellitus-6	601941	Fd, LD		{Diabetes mellitus, insulin-dependent, 6} (2)	
18.145	8	24	98	18q21.1	MADH2, JV18, SMAD2	P	Mothers against decapentaplegic, Drosophila, homolog of, 2	601366	REn			
18.146	4	30	14	18q21.32	MALT1, MLT, IMD12	P	Mucosa-associated lymphoid tissue lymphoma translocation gene 1	604860	Ch	fused with API2 in MALT lymphoma	Immunodeficiency 12, 615468 (3)	
18.147	2	3	14	18q21.2	MBD2	P	Methyl-CpG-binding domain protein 2	603547	Psh, A			18(Mbd2)
18.148	3	20	15	18q21.2	ME2	C	Malic enzyme, mitochondrial	154270	REc	10cM distal to F13A; previously mapped to chr.6		7(Mod2)
18.149	3	23	09	18q21.31	MIR122A, MIRN122A	P	Micro RNA 122A	609582	REc			
18.150	8	27	08	18q21.2	MRO, B29	P	Maestro	608080	REc			
18.151	1	24	09	18q21.1	MYO5B, KIAA1119	C	Myosin VB	606540	REc, H		Microvillus inclusion disease, 251850 (3)	18(Myo5b)
18.152	2	20	03	18q21.31	NEDD4L, KIAA0439, RSP5	C	Ubiquitin protein ligase NEDD4-like	606384	R			
18.153	4	25	93	18q21	SSAV1	C	Simian sarcoma-associated virus-1/Gibbon ape leukemia virus	182090	REa, A			
18.154	9	10	07	18q22.1	DSEL, C18orf4, NCAG1	P	Dermatan sulfate epimerase-like	611125	REc			
18.155	6	28	02	18q21.2	STARD6	P	Start domain-containing protein 6	607051	REc			
18.156	10	13	15	18q21.1	ZBTB7C, APM1	P	Zinc finger- and BTB domain-containing protein 7C	616591	A			
18.157	7	19	12	18q21.1	ACAA2	P	Acetyl-CoA acyltransferase 2	604770	REc			
18.158	8	31	12	18q21.1	CCDC11, HTX6	P	Coiled-coil domain-containing protein 11	614759	REc		Heterotaxy, visceral, 6, autosomal recessive, 614779 (3)	
18.159	6	1	10	18q21.1	HAUS1, CCDC5, HEIC	P	HAUS augmin-like complex, subunit 1	608775	REc	pseudogenes on 5, 8, and X		
18.160	7	6	12	18q21.1	KATNAL2	P	Katanin, p60 subunit, A-like protein 2	614697	REc			
18.161	12	21	09	18q21.1	KIAA0427, CTIF	P	KIAA0427 gene	613178	R			
18.162	12	17	07	18q21.1	LIPG, EL, EDL	P	Lipase, endothelial	603684	REc			
18.163	12	5	13	18q21.2	MADH4, DPC4, SMAD4, JIP, MYHRS	C	Mothers against decapentaplegic, Drosophila, homolog of, 4	600993	D, R		Pancreatic cancer, somatic, 260350 (3); Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3); Polyposis, juvenile intestinal, 174900 (3)	
18.164	7	6	99	18q21.1	MBD1, PCM1	P	Methyl=CpG binding domain protein 1 (protein containing methyl-CpG binding domain 1)	156535	R			18(Mbd1)
18.165	10	24	00	18q21.2	POLI, RAD30B	P	Polymerase, DNA, iota	605252	REc, A			18(Rad30b)
18.166	10	12	14	18q21.1	PSTPIP2, MAYP	P	Proline/serine/threonine phosphatase-interacting protein 2	616046	REc			
18.167	2	25	14	18q21.1	SCARNA17	P	Small Cajal body-specific RNA 17	615645	REc			
18.168	11	3	14	18q12.3	SETBP1, KIAA0437, SEB, MRD29	P	SET-binding protein 1	611060	R, A, ch	fused with NUP98 in ALL	Schinzel-Giedion midface retraction syndrome, 269150 (3); Mental retardation, autosomal dominant 29, 616078 (3)	
18.169	8	26	09	18q21.1	SIAT8E	P	Sialyltransferase 8E	607162	R, REc			
18.170	12	2	15	18q21.1	SKA1, C18orf24	P	Spindle- and kinetochore-associated complex, subunit 1	616673	REc			
18.171	8	20	08	18q21.1	SMAD7, MADH7, CRCS3	C	Mothers against decapentaplegic, Drosophila, homolog of, 7	602932	REa, A		{Colorectal cancer, susceptibility to, 3}, 612229 (3)	
18.172	4	30	15	18q22.2	SOCS6, SSI4, STAT4, CIS4	P	Suppressor of cytokine signaling 6	605118	R, REc			
18.173	5	25	00	18q21.31	ONECUT2, OC2	P	One cut domain, family member 2	604894	R			
18.174	7	13	95	18q21.1-q21.3	CORD1, CRD1	P	Cone rod dystrophy 1, autosomal dominant	600624	Ch		Cone-rod retinal dystrophy-1 (2)	
18.175	8	26	09	18q21.31	NARS, ASNRS	P	Asparaginyl-tRNA synthetase	108410	REa, S, REc			
18.176	4	21	16	18q21.2	CCDC68	P	Coiled-coil domain-containing protein 68	616909	REc			
18.177	12	4	08	18q21.2	HYT8	P	Hypertension, essential, susceptibility to, 8	611014	Fd	associated with rs1941958 and rs1893379	{Hypertension, essential, susceptibility to, 8} (2)	
18.178	4	17	13	18q21.31	LINC-ROR	P	Long intergenic noncoding RNA, regulator of reprogramming	615173	REc			
18.179	12	4	08	18q21.2	MEX3C, RKHD2	P	Mex-3, C. elegans, homolog of, C	611005	REc			
18.180	7	29	15	18q21.2	TCF4, SEF2, ITF2, PTHS, FECD3	C	Transcription factor-4 (immunoglobulin transcription factor-2)	602272	Fd, R, Ch		Pitt-Hopkins syndrome, 610954 (3); Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	
18.181	10	10	05	18q21.33	BCL2	C	B-cell CLL/lymphoma-2	151430	Ch, RE, REn	most frequent hematologic malignancy t(14;18)(q32;q21)	Leukemia/lymphoma, B-cell, 2 (3)	1(Bcl2)
18.182	5	27	97	18q21.3	CNSN	P	Carnosinemia (carnosinase)	212200	Ch		Carnosinemia (2)	
18.183	5	6	13	18q21.2	DCC, MRMV1	C	Deleted in colorectal carcinoma	120470	D, RE		Mirror movements 1, 157600 (3); Colorectal cancer, somatic, 114500 (3); Esophageal carcinoma, somatic 133239 (3)	18(Dcc)
18.184	8	26	11	18q21.31	FECH, FCE	C	Ferrochelatase	612386	A, REb		Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)	
18.185	3	23	95	18q21.33	FVT1	P	Follicular lymphoma, variant translocation 1	136440	RE	~10kb 5' to BCL2	Lymphoma/leukemia, B-cell, variant (1)	
18.186	6	25	08	18q22.1	HMSD	P	Minor histocompatibility antigen, serpin domain-containing	612086	REc			
18.187	5	17	95	18q21.33	PI5, SERPINB5	P	Protease inhibitor 5 (maspin)	154790	REn, Psh	in cluster of serpins		
18.188	11	5	97	18q22.1	PI8, CAP2, SERPINB8	P	Protease inhibitor 8, ovalbumin type	601697	Psh, REn			
18.189	3	14	08	18q21.32	RAX, RX, MCOP3	C	Retina and anterior neural fold homeobox gene	601881	REc		Microphthalmia, isolated 3, 611038 (3)	
18.190	6	7	10	18q21.3-q22.1	SERPINB2, PAI2, PLANH2	C	Serpin peptidase inhibitor, clade B (ovalbumin), member 2 (Plasminogen activator inhibitor, type II (arginine-serpin))	173390	REa, A, REn	600kb telomeric to BCL2		
18.191	3	23	14	18q21.33	SERPINB11	P	Serpin peptidase inhibitor, clade B (ovalbumin), member 11	615682	REc, H			1(Serpinb11)
18.192	2	25	14	18q21.33	SERPINB12	P	Serpin peptidase inhibitor, clade (ovalbumin), member 12	615662	REc			
18.193	11	27	00	18q21.33	SERPINB13, PI13, HURPIN	P	Protease inhibitor 13	604445	REc			
18.194	4	11	11	18q21.33	SERPINB3, SCCA1	C	Serpin peptidase inhibitor, clade B (ovalbumin), member 3 (squamous cell carcinoma antigen 1)	600517	REn, Psh, A			
18.195	3	21	02	18q21.33	SERPINB4, SCCA2	P	Serpin peptidase inhibitor, clade B (ovalbumin), member 4 (squamous cell carcinoma antigen 2)	600518	REn			
18.196	1	7	14	18q21.33	SERPINB7, MEGSIN, PPKN	P	Serpin peptidase inhibitor, clade B (ovalbumin), member 7	603357	REc		Palmoplantar keratoderma, Nagashima type, 615598 (3)	
18.197	11	5	97	18q22.1	SERPINB10, PI10	P	Protease inhibitor 10, ovalbumin type (bomapin)	602058	Psh, REn			
18.198	3	24	06	18q21.33	VPS4B, SKD1	C	Vacuolar protein sorting 4, yeast, homolog of, B	609983	R, A, REc, H			1(Vps4b)
18.199	9	29	10	18q21.31	WDR7, TRAG, KIAA0541	C	WD repeat-containing protein 7	613473	R, A, H, REc			18(Wdr7)
18.200	6	16	98	18q21.32	LMAN1, ERGIC53, F5F8D, MCFD1	C	Lectin, mannose-binding, 1	601567	A, Fd		Combined factor V and VIII deficiency, 227300 (3)	
18.201	7	20	12	18q21.31	TXNL1, TXNL	P	Thioredoxin-like 1	603049	REc			
18.202	9	30	14	18q21.32	CCBE1, KIAA1983, HKLLS1	P	Collagen and calcium-binding EGF domain-containing protein 1	612753	REc		Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	
18.203	3	31	15	18q21.32	PMAIP1, APR, NOXA	P	Phorbol-12-myristate-13-acetate-induced protein 1	604959	REc			
18.204	3	8	12	18q21.33	PHLPP1, SCOP, KIAA0606	P	PH domain and leucine-rich repeat protein phosphatase	609396	REc			
18.205	7	22	11	18q21.33	PIGN, MCAHS1	P	Phosphatidylinositol glycan, class N	606097	R, REc		Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	
18.206	8	26	15	18q21.33	RNF152	P	Ring finger protein 152	616512	REc			
18.207	1	20	09	18q22	DUP18pDEL18q, DUP18qDEL18p	P	Chromosome 18 pericentric inversion	609334	Ch		Chromosome 18 pericentric inversion (4)	
18.208	11	19	98	18q21.32	MC4R	C	Melanocortin-4 receptor	155541	A, R		Obesity, autosomal dominant, 601665 (3)	
18.209	4	1	01	18q22.1	CDH7	P	Cadherin-7	605806	Psh, A			
18.210	4	2	01	18q22.1	CDH19, CDH7	P	Cadherin 19	603016	Psh, A			
18.211	4	2	01	18q21.33	CDH20	P	Cadherin 20	605807	Psh, A			
18.212	7	23	03	18q22.3	NETO1, BCTL1	P	Neuropilin and tolloid like 1	607973	REc			
18.213	1	8	01	18q23	ZNF236	P	Zinc finger protein-236	604760	REa, A			
18.214	10	23	87	18q23	MBP	C	Myelin basic protein	159430	REa, A	defective in "shiverer," neurologic mutant in mouse		18(Mbp, shi)
18.215	11	24	14	18q22.1	TMX3, TXNDC10, KIAA1830	P	Thioredoxin-related transmembrane protein 3	616102	REc			
18.216	6	30	15	18q21.33	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	C	Tumor necrosis factor receptor superfamily, member 11A	603499	R, RE, Fd		Osteolysis, familial expansile, 174810 (3); {Paget disease of bone 2, early-onset}, 602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)	
18.217	11	14	12	18q22.1-q22.3	ECTD8	P	Ectodermal dysplasia 8, hair/tooth/nail type	602401	Fd	between D18S857 and D18S815	Ectodermal dysplasia 8, hair/tooth/nail type (2)	
18.218	3	29	16	18q22.2	RTTN, MSSP	P	Rotatin	610436	REc		Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3)	18(Rttn)
18.219	1	30	12	18q23	ATP9B	P	ATPase, class II, type 9B	614446	REc			
18.220	1	24	13	18q22.3	CBLN2	P	Cerebellin 2 precursor	600433	H, REc			18(Cbln1)
18.221	5	18	10	18q22.3	CNDP1, CN1	P	Carnosine dipeptidase 1	609064	R, REc			
18.222	1	31	01	18q22.2	DNAM1, CD226	P	DNAX accessory molecule 1	605397	A			
18.223	4	2	12	18q22.3	FAM69C	P	Family with sequence similarity 69, member C	614544	REc			
18.224	9	9	08	18q22.3	FBXO15, FBX15	P	F-box only protein 15	609093	REc			18(Fbxo15)
18.225	4	17	13	18q22.3	TIMM21, TIM21	P	Translocase of inner mitochondrial membrane 21, yeast, homolog of	615180	REc			
18.226	1	30	12	18q22.3	TSHZ1, TSH1, CAA	P	Teashirt zinc finger homeobox 1	614427	REc, Ch		Aural atresia, congenital, 607842 (3)	
18.227	7	17	14	18q22.3	ZNF407	P	Zinc finger protein 407	615894	REc			
18.228	5	31	05	18q23	CTDP1, FCP1, CCFDN	P	C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1	604927	Fd, REc		Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	
18.229	2	21	10	18q22.3	CYB5A, MCB5	C	Cytochrome b5	613218	Psh, REa, A	pseudogenes on X, 14q, 20p	Methemoglobinemia, type IV, 250790 (3)	
18.230	12	18	98	18q23	GALR1, GALNR1, GALNR	C	Galanin receptor 1	600377	A, H, REc			18(Galnr)
18.231	5	17	95	18q23	NFATC1	P	Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1	600489	REa, R			18(Nfatc)
18.232	11	2	04	18q23	PARD6G	P	partitioning-defective protein 6, C. elegans, homolog of	608976	R, REc			
18.233	10	23	87	18q22.3	PEPA	C	Peptidase A	169800	S, D			18(Pep1)
18.234	7	22	09	18q23	SALL3	P	Sal-like 3	605079	A			
18.235	1	8	15	18q23	TXNL4A, DIM1, BMKS	P	Thioredoxin-like 4A	611595	R, REc		Burn-McKeown syndrome, 608572 (3)	
18.236	3	15	13	18q23	ZNF516, KIAA0222	C	Zinc finger protein 516	615114	REc, R			
19.1	9	20	11	19pter-p13.1	FPH1, MUH, HPP	P	Hyperpigmentation, familial progressive, 1	614233	Fd		Hyperpigmentation, familial progressive, 1 (2)	
19.2	10	23	87	19pter-q13	CXB3S	P	Coxsackie virus B3 sensitivity	120050	S			
19.3	11	1	13	19p13.3	EEF2, EF2, SCA26	C	Eukaryotic translation elongation factor-2	130610	S	mutation identified in 1 family	?Spinocerebellar ataxia 26, 609306 (3)	
19.4	4	27	16	19p13.3	ABCA7, ABCX, AD9	P	ATP-binding cassette, subfamily A, member 7	605414	REc		{Alzheimer disease 9, susceptibility to}, 608907 (3)	
19.5	12	15	10	19p13.3	ACER1	P	Alkaline ceraminidase 1	613491	REc			
19.6	12	6	11	19p13.3	ACSBG2, BGR	P	Acyl-CoA synthetase, bubblegum family, member 2	614363	REc			
19.7	8	1	13	19p13.3	ADAT3, TAD3, MRT36	P	Adenosine deaminase, tRNA-specific, 3	615302	REc		Mental retardation, autosomal recessive 36, 615286 (3)	
19.8	2	12	16	19p13.3-p13.2	ADGRE1, EMR1	P	Adhesion G protein-coupled receptor E1	600493	REa, A			17(Emr1)
19.9	2	12	16	19p13.2	ADGRE4P, EMR4, GPR127, EMR4P, FIRE	P	Adhesion G protein-coupled receptor E4, pseudogene	612305	REc			
19.10	6	30	15	19p13.12	ADGRL1, LPHN1, CIRL1, CL1, LEC2, KIAA0821	P	Adhesion G protein-coupled receptor L1	616416	R, REc			
19.11	8	9	99	19p13.3	AES	C	Amino-terminal enhancer of split	600188	REa, A			
19.12	3	16	10	19p13.3	ALKBH7, ABH7	P	AlkB, E. coli, homolog of, 7	613305	REc			
19.13	7	10	14	19p13.2	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	P	Angiopoietin-like 4	605910	R		Plasma triglyceride level QTL, low, 615881 (3)	
19.14	5	24	13	19p13.3	AP3D1	P	Adaptor-related protein complex 3, delta-1 subunit	607246	REc, H			10(Ap3d1)
19.15	5	25	13	19p13.3	APBA3, X11L2, MINT3	P	Amyloid beta A4 precursor protein-binding, family A, member 3	604262	REc			
19.16	6	9	08	19p13.3	APC2, APCL	C	APC2 gene	612034	A, H			10(Apc2)
19.17	11	22	10	19p13.3	DENND1C	P	DENN/MADD domain-containing protein 1C	613634	REc			
19.18	9	3	02	19p13.3	IS1, AIS	P	Adolescent idiopathic scoliosis	181800	Fd		Scoliosis, idiopathic 1 (2)	
19.19	10	26	03	19p13.3	ATCAY, CLAC, KIAA1872	C	Caytaxin	608179	REc, Fd, H		Ataxia, cerebellar, Cayman type, 601238 (3)	10(ji)
19.20	7	17	14	19p13.3	ATP5D	P	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	603150	REc			
19.21	5	2	01	19p13.3	ATP8B3, ATPIK	P	ATPase, class I, type 8B, member 3	605866	REc			
19.22	10	26	92	19p13.3	AZU1, CAP37	P	Azurocidin-1 (cationic antimicrobial protein-37)	162815	A, REn	5\(rm-AZU1-8kb-PR3-3kb-ELAN-3'		
19.23	3	13	01	19p13.3	BSG	P	Basigin (blood group OK)	109480	A		[Blood group, OK], 111380 (3)	10(Bsg)
19.24	4	21	10	19p13.3	C2CD4C, NLF3, KIAA1957	P	C2 calcium-dependent domain containing 4C	610336	REc			
19.25	8	20	07	19p13.3	C19orf6	P	Membralin	611011	REc			10(Orf61)
19.26	11	20	03	19p13.3	C19orf10, SF20, IL25	P	Stroma-derived growth factor 20	606746	REc			17(Il25)
19.27	11	23	15	19p13.3	C19orf70, MIC13, QIL1	P	Chromosome 19 open reading frame 70	616658	REc			
19.28	3	8	91	19p13.3	CAPS	P	Calcyphosine	114212	A			
19.29	12	5	11	19p13.2	CD209, CDSIGN	C	CD209 antigen	604672	R		{Dengue fever, protection against}, 614371 (3); {HIV type 1, susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
19.30	6	14	94	19p13.3	CDC34	P	Cell division cycle 34	116948	A			
19.31	4	26	11	19p13.3	CFD, ADN	C	Complement factor D	134350	REc		Complement factor D deficiency, 613912 (3)	
19.32	5	28	98	19p13.3	CIRBP	P	Cold-inducible RNA-binding protein	602649	A			
19.33	3	13	15	19p13.2	CLEC4G, LSECTIN	P	C-type lectin domain family 4, member G	616256	REc			
19.34	2	28	06	19p13.2	CLEC4M, CD209L, LSIGN, DCSIGNR	P	C-type lectin domain family 4, member M	605872	R		SARS infection, protection against (2)	
19.35	12	15	14	19p13.3	CLPP, PRLTS3, DFNB81	C	ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of	601119	REa, REc, Fd		Perrault syndrome 3, 614129 (3)	
19.36	2	1	11	19p13.3	CNN2	P	Calonin 2	602373	REc	previously assigned to 21q11.1		
19.37	11	28	05	19p13.3	CRB3	P	Crumbs, Drosophila, homolog of, 3	609737	R, REc			
19.38	4	23	08	19p13.3	CREB3L3, CREBH	P	cAMP responsive element-binding protein 3-like 3	611998	REc			
19.39	5	28	98	19p13.3	CSNK1G2	P	Casein kinase 1, gamma-2	602214	Psh, A			
19.40	3	31	15	19p13.3	DIRAS1, RIG	P	DIRAS family, GTP-binding Ras-like protein 1	607862	REc			
19.41	5	26	13	19p13.3	DOHH, HLRC1	P	Deoxyhypusine hydroxylase	611262	REc			
19.42	11	22	02	19p13.3	DOT1L, DOT1, KIAA1814	C	Dot1, yeast, homolog of	607375	R, REc			
19.43	11	10	98	19p13.3	DRIL1	P	Dead ringer, Drosophila, homolog-like 1	603265	A, REc			
19.44	8	27	01	19p13.3	EBI3	P	Epstein-Barr virus-induced gene 3	605816	A			
19.45	2	28	03	19p13.3	EFNA2, EPLG6, LERK6	C	Ephrin A2	602756	Psh, A			
19.46	6	7	11	19p13.3	ELANE, ELA2, SCN1	C	Elastase, neutrophil-expressed	130130	A, Fd, REc		Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	10(Ela2)
19.47	4	25	93	19p13.2	FCER2, FCE2, CD23, CLEC4J	C	Fc fragment of IgE, low affinity II, receptor for (CD23A)	151445	REa, A			
19.48	1	5	00	19p13.3	FEB2	P	Febrile seizures, familial, 2	602477	Fd		Febrile seizures, familial, 2 (2)	
19.49	8	27	15	19p13.3	FEM1A	P	Fem1, C. elegans, homolog of, A	613538	REc			17(Fem1a)
19.50	4	26	01	19p13.3	FGF22	P	Fibroblast growth factor 22	605831	REc			
19.51	3	18	07	19p13.3	FSD1, GLFND	C	Fibronectin type 3 and SPRY domains-containing protein 1	609828	REc			
19.52	9	17	03	19p13.3	FUT3, LE	C	Fucosyltransferase 3	111100	F, Psh, REn, Fd	cen-FUT5-23kb-FUT3-14kb-FUT6-ter	[Blood group, Lewis] (3)	
19.53	5	17	95	19p13.3	FUT5	P	Fucosyltransferase 5 (alpha (1,3) fucosyltransferase)	136835	A, REn	cen-FUT5-FUT3-FUT6-ter		
19.54	3	31	11	19p13.3	FUT6	P	Fucosyltransferase 6 (alpha (1,3) fucosyltransferase)	136836	Psh, REn	in cluster with FUT3, FUT5	Fucosyltransferase 6 deficiency, 613852 (3)	
19.55	5	25	00	19p13.3	GADD45B, MYD118	P	Growth arrest- and DNA damage-inducible gene 45, beta	604948	R			
19.56	7	18	13	19p13.3	GAMT, CCDS2	P	Guanidinoacetate methyltransferase	601240	Psh, R		Cerebral creatine deficiency syndrome 2, 612736 (3)	10(Gamt)
19.57	7	26	11	19p13.3	GIPC3, DFNB15, DFNB72, DFNB95	P	GAIP C-terminus-interacting protein 3	608792	REc		Deafness, autosomal recessive 15, 601869 (3)	
19.58	1	11	16	19p13.3	GPX4, SMDS	C	Glutathione peroxidase-4 (phospholipid hydroperoxidase)	138322	REa, A		Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3)	
19.59	11	22	94	19p13.3	GTF2F1, RAP74	P	General transcription factor IIF, polypeptide 1 (74kD subunit)	189968	A			
19.60	6	9	95	19p13.3	GZMM	P	Granzyme M (lymphocyte met-ase 1)	600311	H			10(Gzmm)
19.61	3	30	99	19p13.3	HCDH, FZR	P	CDH1/HCT1, S. cerevisiae, homolog of	603619	REc			
19.62	8	9	00	19p13.3	HCN2, BCNG2	P	Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2	602781	REc			
19.63	3	23	09	19p13.3	HMHA1, HLA-HA1, KIAA0223	C	Minor histocompatibility antigen HA-1	601155	R, REc			
19.64	1	8	01	19p13.3	HMG20B, BRAF35	P	High mobility group protein 20B	605535	REc			
19.65	11	3	06	19q13.32	IGFL1	P	IGF-like family member 1	610544	REc			7(Igfl1)
19.66	11	3	06	19q13.32	IGFL2	P	IGF-like family member 2	610545	REc			7(Igfl2)
19.67	11	3	06	19q13.32	IGFL3	P	IGF-like family member 3	610546	REc			7(Igfl3)
19.68	11	3	06	19q13.32	IGFL4	P	IGF-like family member 4	610547	REc			7(Igfl4)
19.69	7	20	12	19p13.3	KDM4B, JMJD2B, KIAA0876	C	Lysine-specific demethylase 4B	609765	R, REc			
19.70	7	19	12	19p13.3	JSRP1, JP45	P	Junctional sarcoplasmic reticulum protein 1	608743	REc			
19.71	4	20	06	19p13.3	KHSRP, KSRP, FUBP2, FBP2	P	KH-type splicing regulatory protein	603445	R, H			17(Khsrp)
19.72	8	24	09	19p13.3	KIR2DL5A, KIR2DL5	P	Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A	605305	REc			
19.73	8	1	13	19p13.3	KISS1R, GPR54, HH8, CPPB1	C	KISS1 receptor	604161	REc, Fd	mutation identified in 1 CPPB1 patient	Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3); ?Precocious puberty, central, 1, 176400 (3)	
19.74	9	24	15	19p13.3	LMNB2, LMN2, EPM9	P	Lamin B2	150341	A	mutation identified in 1 EPM9 family	{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3); ?Epilepsy, progressive myoclonic, 9, 616540 (3)	
19.75	7	11	11	19p13.3	LPPR3, LPR3, PRG2	P	Lipid phosphate phosphatase-related 3	610391	REc			
19.76	12	10	13	19p13.3	LRG1, LRG	P	Leucine-rich alpha-2-glycoprotein 1	611289	REc			11(Lrg1)
19.77	12	23	05	19p13.3	LRRN6B, LINGO3, LERN2	P	Leucine-rich repeat protein, neuronal, 6B	609792	R, REc			
19.78	8	24	09	19p13.3	LSM7	P	LSM7 protein	607287	R, REc			
19.79	9	21	11	19p13.2	ICAM4, CD242, LW	C	Intracellular adhesion molecule 4	614088	F, Fd, A, REc	close to C3, LU	[Blood group, Landsteiner-Wiener], 111250 (3)	
19.80	3	3	98	19p13.3	MACAM1	C	Mucosal addressin cell adhesion molecule-1	102670	Psh, A			
19.81	6	20	13	19p13.3	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	P	Mitogen-activated protein kinase kinase 2	601263	A, REc	previously assigned to 7q32	Cardiofaciocutaneous syndrome 4, 615280 (3)	10(Mek2)
19.82	7	1	98	19p13.3	MATK, HYL, CTK	P	Megakaryocyte-associated tyrosine kinase	600038	A, REa, H			10(Matk)
19.83	7	8	99	19p13.3	MBD3	P	Methyl-CpG-binding domain protein 3	603573	REc			10(Mbd3)
19.84	6	19	97	19p13.3	MDRV	P	Muscular dystrophy with rimmed vacuoles	601846	Fd		Muscular dystrophy with rimmed vacuoles (2)	
19.85	2	25	15	19p13.2	MCEMP1	P	Mast cell-expressed membrane protein 1	609565	REc			
19.86	8	20	07	19p13.3	MEX3D, RKHD1, TINO, KIAA2031	P	Mex-3, C. elegans, homolog of, D	611009	REc			
19.87	8	24	09	19p13.3	MIDN	P	Midnolin, mouse, homolog of	606700	REc			
19.88	5	11	09	19p13.12	MIR181C, MIRN181C	P	Micro RNA 181C	612746	REc			
19.89	5	6	13	19p13.3	MIR1909	P	Micro RNA 1909	615201	REc			
19.90	6	26	13	19p13.3	MISP, C19orf21	P	Mitotic spindle-positioning protein	615289	REc			
19.91	5	28	02	19p13.3	MKNK2, MNK2, GPRK7	P	Mitogen-activated protein kinase-interacting serine/threonine kinase-2	605069	REc			
19.92	1	12	95	19p13.3	MLLT1, ENL	C	Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 1	159556	Ch	fuses with ALL1		
19.93	3	11	08	19p13.3	MRPL54	P	Mitochondrial ribosomal protein L54	611858	R, REc			
19.94	4	30	09	19p13.3	NDUFA11	P	NADH-dehydrogenase 1 alpha subcomplex, 11	612638	REc		Mitochondrial complex I deficiency, 252010 (3)	
19.95	10	15	95	19p13.3	NFIC	P	Nuclear factor I/C (CCAAT-binding transcription factor)	600729	A	order: cen-NFIX-NFIC-tel		10(Nfic)
19.96	9	2	12	19p13.13	NFIX, NF1A, SOTOS2, MRSHSS	C	Nuclear factor I/X (CCAAT-binding transcription factor)	164005	A		Sotos syndrome 2, 614753 (3); Marshall-Smith syndrome, 602535 (3)	8(Nfix)
19.97	1	2	08	19p13.3	NRTN, NTN	P	Neurturin	602018	A			17(Nrtn)
19.98	8	28	97	19p13.3	OAZ1	P	Ornithine decarboxylase antizyme 1	601579	A			
19.99	11	11	14	19p13.3	PALM, KIAA0270	P	Paralemmin	608134	R, H, REc			10(Palm)
19.100	8	24	09	19p13.3	PCSK4	P	Proprotein convertase subtilisin/kexin type 4	600487	REa, REc			10(Pcsk4)
19.101	2	27	03	19p13.2	PEX11G	P	Peroxisome biogenesis factor 11G	607583	REc			
19.102	2	9	16	19p13.3	PIAS4, PIASY	P	Protein inhibitor of activated STAT4	605989	REc			
19.103	8	23	07	19p13.3	PIP5K1C, LCCS3	P	Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma	606102	R,		Lethal congenital contractural syndrome 3, 611369 (3)	
19.104	1	21	10	19p13.3	PLIN3, M6PRBP1, TIP47	P	Perilipin 3	602702	REc			
19.105	3	3	10	19p13.3	PLIN4, KIAA1881	P	Perilipin 4	613247	R, REc			
19.106	3	3	10	19p13.3	PLIN5, LSDP5	P	Perilipin 5	613248	REc			17(Plin5)
19.107	3	19	15	19p13.2	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	C	Patatin-like phospholipase domain-containing protein 6	603197	REc, A, Fd	mutation identified in 1 LMNS family	Spastic paraplegia 39, autosomal recessive, 612020 (3); Boucher-Neuhauser syndrome, 215470 (3); ?Laurence-Moon syndrome, 245800 (3); Oliver-McFarlane syndrome, 275400 (3)	8(Nte)
19.108	5	27	94	19p13.3	POLR2E	P	Polymerase (RNA) II (DNA directed) polypeptide E, 25kD	180664	A			
19.109	8	3	97	19p13.3	POLRMT, APOLMT	P	Polymerase (RNA) mitochondrial (DNA directed)	601778	Psh			
19.110	1	24	93	19p13.3	PRTN3, AGP7	C	Proteinase-3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen)	177020	A, REn, Psh			10(Prtn3)
19.111	7	24	13	19p13.3	ONECUT3, OC3	P	One cut homeobox 3	611294	REc, R			10(Onecut3)
19.112	7	8	99	19p13.3	PSPN	P	Persephin	602921	Psh, R			
19.113	1	28	01	19p13.3	PTBP1, PTB, HNRNPI	P	Polypyrimidine tract-binding protein 1	600693	REc	pseudogene on chr. 14		
19.114	8	28	97	19p13.3	PTPRS	P	Protein tyrosine phosphatase, receptor type, sigma	601576	A, REc			17(Ptprs)
19.115	12	15	98	19p13.3	RANBP3	P	RAN-binding protein-3	603327	REc			
19.116	10	23	15	19p13.3	RAX2, RAXL1, QRX, CORD11, ARMD6	C	Retina and anterior neural fold homeobox 2	610362	R	mutation identified in 1 ARMD6 patient	?Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy 11, 610381 (3)	
19.117	7	1	05	19p13.3	REEP6, DP1L1, TB2L1, C19orf32	P	Receptor expression-enhancing protein 6	609346	R, REc, H			10(Dp1L1)
19.118	10	4	05	19p13.3	REXO1, REX1, ELOABP1, TCEB3BP1	P	RNA exonuclease 1, S. cerevisiae, homolog of	609614	R, REc			
19.119	4	18	02	19p13.12	RLN3, H3, RXN3	P	Relaxin 3	606855	REc			8(Rln3)
19.120	4	17	13	19p13.3	RNF126	P	RING finger protein 126	615177	REc			
19.121	9	18	08	19p13.3	S1PR4, EDG6, S1P4	P	Sphingosine-1-phosphate receptor 4	603751	Psh			
19.122	8	29	03	19p13.3	SAFB2, KIAA0138	P	Scaffold attachment factor B2	608066	REc			
19.123	4	29	14	19p13.3	SBNO2, KIAA0963	P	Strawberry notch, Drosophila, homolog of, 2	615729	R, REc			
19.124	9	16	12	19p13.3	SEMA6B	P	Semaphorin 6B	608873	REc			
19.125	3	24	11	19p13.3	SCAMP4	P	Secretory carrier membrane protein 4	613764	REc			
19.126	7	7	13	19p13.3	SHC2, SHCB, SCK	P	SHC transforming protein 2	605217	REc			
19.127	2	25	15	19p13.3	SHD	P	SH2 domain-containing protein D	610481	REc, R			
19.128	3	1	01	19p13.3	SH3GL1, EEN	C	SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene)	601768	A, R, REa		Leukemia, acute myeloid, 601626 (1)	
19.129	8	30	01	19p13.3	SIRT6, SIR2L6	P	Sirtuin 6 (Sir2, S. cerevisiae, homolog of, 6)	606211	REc			
19.130	3	12	07	19p13.3	SLC25A41	P	Solute carrier family 25, member 41	610822	REc			17(Slc25a41)
19.131	10	13	09	19p13.3	SLC39A3, ZIP3	P	Solute carrier family 39, zinc transporter, member 3	612168	R, REc			
19.132	3	22	07	19p13.3	SNPPL2B, IMP4, KIAA1532	P	Signal peptide peptidase-like 2B	608239	R, REc			
19.133	3	31	15	19p13.3	STAP2, BKS	P	Signal-transducing adaptor protein 2	607881	REc			
19.134	4	12	13	19p13.3	STK11, PJS, LKB1	C	Serine/threonine protein kinase-11	602216	Fd, D, REc		Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant, somatic (3); Pancreatic cancer, 260350 (3); Testicular tumor, somatic, 273300 (3)	10(Stk11)
19.135	9	15	11	19p13.3	TBXA2R, BDPLT13	C	Thromboxane A2 receptor	188070	Psh, Fd, A, H		{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)	10(Tbxa2r)
19.136	5	11	16	19p13.3	TCF3, E2A, AGM8	C	Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47)	147141	REa, A		Agammaglobulinemia 8, autosomal dominant, 616941 (3)	
19.137	2	25	15	19p13.3	THEG	P	Testicular haploid expressed gene, mouse, homolog of	609503	REc			
19.138	12	11	98	19p13.3	THOP1	C	Thimet oligopeptidase-1	601117	REa, A, REc			
19.139	8	31	15	19p13.3	TICAM1, TRIF, IIAE6	P	TIR domain-containing adaptor molecule 1	607601	REc		{Herpes simplex encephalitic, susceptibility to, 6}, 614850 (3)	
19.140	12	4	02	19p13.3	TIMM13	C	Translocase of inner mitochondrial membrane 13, yeast, homolog of	607383	R			
19.141	5	23	13	19p13.3	TINCR	P	Terminal differentiation-induced noncoding RNA	615241	REc			17(Tincr)
19.142	3	31	09	19p13.3	TJP3, ZO3	P	Tight junction protein 3	612689	REc			
19.143	2	11	96	19p13.3	TLE2, ESG2	P	Transducin-like enhancer of split 2 (homolog of Drosophila E(spl))	601041	A			
19.144	2	12	16	19p13.3	TLE6, GRG6, PREMBL	P	Transducin-like enhancer of split 6	612399	REc		Preimplantation embryonic lethality, 616814 (3)	
19.145	7	13	12	19p13.3	TMIGD2, IGPR1	P	Transmembrane and immunoglobulin domains-containing protein 2 `	614715	REc			
19.146	2	25	15	19p13.3	TMPRSS9	P	Transmembrane protease, serine 9	610477	REc, H			10(Tmprss9)
19.147	8	30	01	19p13.3	TNFSF9	P	Tumor necrosis factor ligand superfamily, member 9	606182	A			
19.148	1	18	02	19p13.3	TNFSF14, HVEML	P	Tumor necrosis factor ligand superfamily, member 14	604520	REc, A			
19.149	4	6	15	19p13.3	TRIP10, CIP4	P	Thyroid hormone receptor interactor 10	604504	R			
19.150	12	17	07	19p13.13	TRMT1, TRM1	P	tRNA methyltransferase 1, S. cerevisiae, homolog of	611669	REc			
19.151	7	22	13	19p13.3	TRNAG3	P	Transfer RNA glycine 3	615303	REc			
19.152	7	22	13	19p13.3	TRNAV32	P	Transfer RNA valine 32	615304	REc			
19.153	10	30	14	19p13.3	TUBB4A, DYT4, HLD6	P	Tubulin, beta-4A	602662	REc		Dystonia 4, torsion, autosomal dominant, 128101 (3); Leukodystrophy, hypomyelinating, 6, 612438 (3)	
19.154	10	27	08	19p13.3	UHRF1, ICBP90, NP95	P	Ubiquitin-like protein containing PHD and RING finger domains 1	607990	A			
19.155	10	9	09	19p13.11	UNC13A, KIAA1032	P	UNC13, C. elegans, homolog of, A	609894	R, REc			
19.156	11	15	05	19p13.3	UQCR	P	Ubiquinol-cytochrome c reductase, 6.4kD subunit	609711	R, REc			
19.157	8		13	19p13.3	ZBTB7A, FBI1, LRF	P	Zinc finger and BTB domain containing 7A	605878	A			
19.158	6	10	08	19p13.3	ZNRF4, SPERIZIN	P	Zinc finger and ring finger protein 4	612063	Psh, H			17(Znrf4)
19.159	11	2	04	19p13.2	ADAMTS10, WMS1	C	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 10	608990	Fd, REc		Weill-Marchesani syndrome 1, recessive, 277600 (3)	
19.160	12	13	95	19p13.3	AMH, MIF	P	Anti-Mullerian hormone	600957	REa, A		Persistent Mullerian duct syndrome, type I, 261550 (3)	10(Amh)
19.161	3	15	92	19p13.3-p13.2	ATHS, ALP	P	Atherosclerosis susceptibility (lipoprotein associated)	108725	Fd	closely linked to LDLR; may be LDLR	{Atherosclerosis, susceptibility to} (2)	
19.162	3	10	11	19p13.3	C3, ARMD9, AHUS5	C	Complement component-3	120700	F, S, A, REa	LE ~7cM in males vs. C3 RFLP	C3 deficiency, 613779 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3); {Macular degeneration, age-related, 9}, 611378 (3)	17(C3)
19.163	7	2	13	19p13.2	DNMT1, MCMT, HSN1E, ADCADN	C	DNA methyltransferase 1	126375	REa, A		Neuropathy, hereditary sensory, type IE, 614116 (3); Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	
19.164	3	23	93	19p13.2	EPOR	C	Erythropoietin receptor	133171	A, REa, H, Fd		[Erythrocytosis, familial, 1], 133100 (3)	9(Epor)
19.165	4	5	00	19p13.2	ICAM1	C	Intercellular adhesion molecule-1	147840	REa, H, A	close to Ldlr in mouse	{Malaria, cerebral, susceptibility to}, 611162 (3)	9(Icam1)
19.166	6	13	95	19p13.2	ICAM3, CDW50	P	Intercellular adhesion molecule-3	146631	A, Psh			
19.167	9	7	00	19p13.2	MCOLN1, ML4	C	Mucolipin 1	605248	Fd, REn		Mucolipidosis IV, 252650 (3)	
19.168	11	12	96	19p13.2	MYO1F	P	Myosin IF	601480	A			17(Myo1f)
19.169	5	15	00	19p13.2	HNRPM, HNRPM4, NAGR1	P	Heterogeneous nuclear ribonucleoprotein M	160994	A			
19.170	8	21	92	19p13.3	RFX2	P	Regulatory factor (trans-acting) 2 (influences HLA class II expression)	142765	A			
19.171	8	24	98	19p13.3	SAFB, HET	P	Scaffold attachment factor B	602895	REa, A			
19.172	3	29	00	19p13.3	SF3A2, SAP62, PRP11	P	Splicing factor 3a, subunit 2, 66kD	600796	REn			10(Sap62)
19.173	5	4	12	19p13.2	STXBP2, UNC18B, FHL5	P	Syntaxin binding protein 2	601717	A		Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	8(Stxbp2)
19.174	7	6	00	19p13.2	TIMM44	P	Translocase of inner mitochondrial membrane 44, yeast, homolog of	605058	A			
19.175	8	24	98	19p13.3	VAV1, VAV	C	Oncogene VAV1	164875	REa, A, RE	close to INSR		
19.176	9	28	96	19p13.11	ZNF14, KOX6	P	Zinc finger protein-14 (KOX 6)	194556	REc, A			
19.177	9	28	96	19p13.2	ZNF20, KOX13	P	Zinc finger protein-14 (KOX 6)	194557	REc, A			
19.178	6	11	11	19p13.2	ACP5, SPENCDI	C	Acid phosphatase 5, tartrate resistant	171640	REa, H, Psh	incorrectly assigned to 15 by A	Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	9(Acp5)
19.179	7	1	05	19p13.2	ANGPTL6, AGF	P	Angiopoietin-like 6	609336	REc			
19.180	2	20	15	19p13.2	ANGPTL8, C19orf80, LIPASIN	P	Angiopoietin-like protein 8	616223	REc	within intron of DOCK6		9(C19orf80)
19.181	2	28	03	19p13.2	AP1M2, MU1B	C	Adaptor-related protein complex 1, mu-2 subunit	607309	A, H			9(Ap1m2)
19.182	6	23	15	19p13.2	SRHGEF18, KIAA0521	P	Rho guanine nucleotide exchange factor 18	616432	R, REc			
19.183	3	23	14	19p13.2	ATG4D, APG4D, AUTL4	P	Autophagy 4, S. cerevisiae, homolog of, D	611340	REc			
19.184	6	8	95	19p13.11	BST2	P	Bone marrow stromal cell antigen	600534	A			
19.185	2	12	16	19p13.2	C19orf66, RYDEN	P	Chromosome 19 openreading frame 66	616808	REc			
19.186	2	10	14	19p13.13	CALR, SSA	P	Sicca syndrome antigen A (autoantigen Ro; calreticulin)	109091	REa	distal to C3, near LDLR	Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3)	8(Calr)
19.187	7	7	13	19p13.2	CARM1, PRMT4	P	Coactivator-associated arginine methyltransferase 1	603934	REc			
19.188	8	2	13	19p13.2	CERS4, LASS4, TRH1	P	Ceramide synthase 4	615334	REc			
19.189	10	9	14	19p13.2	CCDC151, CILD30	P	Coiled-coil domain-containing protein 151	615956	REc		Ciliary dyskinesia, primary, 30, 616037 (3)	
19.190	8	29	02	19p13.2	CCL25, SCYA25, TECK	C	Chemokine, C-C motif, ligand 25	602565	Psh, R, A			8(Teck)
19.191	11	22	10	19p13.2	CD320, 8D6, 8D6A, TCBLR	P	CD320 molecule	606475	R, REc		Methylmalonic aciduria due to transcobalamin receptor defect, 613646 (3)	17(Cd320)
19.192	11	11	14	19p13.2	CDC37	P	Cell division cycle 37, S. cerevisiae, homolog of	605065	REc			
19.193	3	16	99	19p13.2	CNN1, SMCC	C	Calponin 1	600806	A, R, Psh			9(Cnn1)
19.194	8	9	01	19p13.2	COL5A3	P	Collagen, type V, alpha-3 polypeptide	120216	R			9(Col5a3)
19.195	9	22	08	19p13.2	CTXN1, CTXN	P	Cortexin 1	600135	REc			8(Ctxn)
19.196	9	30	99	19p13.12	CYP4F3, LTB4H	P	Cytochrome P450, subfamily IVF, polypeptide 3	601270	A			
19.197	3	12	01	19p13.12	DNAJB1, HSPF1	P	DnaJ, E. coli, homolog of, subfamily B, member 1 (heat-shock 40kD protein 1)	604572	A			
19.198	8	19	13	19p13.2	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	C	Dynamin-2	602378	H, REc, Fd	1 LCCS5 family identified with mutation	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3); Myopathy, centronuclear, 160150 (3); Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3); Lethal congenital contracture syndrome 5, 615368 (3)	9(Dnm2)
19.199	9	12	11	19p13.2	DOCK6, KIAA1395, AOS2	P	Dedicator of cytokinesis 6	614194	REc, R		Adams-Oliver syndrome 2, 614219 (3)	
19.200	10	3	07	19p13.2	EIF3G, EIF3S4	P	Eukaryotic translation initiation factor 3, subunit G	603913	REc			
19.201	2	8	99	19p13.2	ELAVL1, HUR	P	Embryonic lethal, abnormal vision, Drosophila, homolog-like 1	603466	A			
19.202	7	8	99	19p13.2	ELAVL3, HUC, PLE21	P	Embryonic lethal, abnormal vision, Drosophila, homolog-like 3	603458	A, H, R	centromeric to ELAVL1		9(HuC)
19.203	6	13	12	19p13.2	FBXL12, FBL12	P	F-box and leucine-rich repeat protein 12	609079	REc, REa			9(Fbxl12)
19.204	6	13	12	19p13.13	FBXW9, FBW9	P	F-box and WD40 domain protein 9	609074	REc			9(Fbxw9)
19.205	4	27	12	19p13.2	FDX1L, FDX2	P	Ferredoxin 1-like protein	614585	REc			
19.206	8	25	04	19p13.13	GCDH	C	Glutaryl-Coenzyme A dehydrogenase	608801	REa, A		Glutaricaciduria, type I, 231670 (3)	8(Gcdh)
19.207	3	14	13	19p13.13	MRI1, MRDI	P	Methylthioribose-1-phosphate isomerase, S. cerevisiae, homolog of	615105	REc			
19.208	4	10	14	19p13.2	PET100, C19orf79	P	PET100, S. cerevisiae, homolog of	614770	REc		Mitochondrial complex IV deficiency, 220110 (3)	
19.209	10	2	12	19p13.13	PRDX2, PRX2, TDPX1, PTX1, NKEFB	P	Peroxiredoxin 2	600538	REc	prev. mapped to chr.13		
19.210	7	8	02	19p13.2	RAD3D, GOV	P	Ras family, member RAB3D	604350	A			
19.211	5	25	00	19p13.2	ICAM5, TLCN, TLN	C	Intercellular adhesion molecule 5 (telencephalin)	601852	A			
19.212	9	14	12	19p13.11	INSL3	P	Insulin-like 3, Leydig cell	146738	A		Cryptorchidism, 219050 (3)	
19.213	12	29	06	19p13.2	INSR, HHF5	C	Insulin receptor	147670	REa, A, REb	1 gene for alpha and beta subunits	Leprechaunism, 246200 (3); Rabson-Mendenhall syndrome, 262190 (3); Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	8(Insr)
19.214	4	25	93	19p13.13	JUNB	C	jun B proto-oncogene	165161	A			8(Junb)
19.215	11	19	14	19p13.2	KANK2, ANKRD25, KIAA1518, PPKWH	P	KN motif- and ankyrin repeat domain-containing protein 2	614610	REc		Palmoplantar keratoderma and woolly hair, 616099 (3)	
19.216	5	4	12	19p13.2	KANK3	P	KN motif- and ankyrin repeat domain-containing protein 3	614611	REc			
19.217	1	16	07	19p13.2	KEAP1, KIAA0132	P	Kelch-like ECH-associated protein 1	606016	REa, REc			
19.218	2	24	12	19p13.2	LDLR, FHC, FH, LDLCQ2	C	Low density lipoprotein receptor	606945	F, REa, A	~20cM distal to C3	Hypercholesterolemia, familial, 143890 (3); LDL cholesterol level QTL2, 143890 (3)	9(Ldlr)
19.219	2	13	15	19p13.3	LONP1, PRSS15, LON, CODASS	P	lon peptidase 1, mitochondrial	605490	A		CODAS syndrome, 600373 (3)	
19.220	7	22	09	19p13.2	LRRC8E	P	Leucine-rich repeat-containing protein 8E	612891	REc			8(Lrrc8e)
19.221	6	26	14	19p13.2	MAP2K7, PRKMK7, MKK7, JNKK2, MAPKK7	P	Mitogen-activated protein kinase kinase 7	603014	REc			
19.222	6	7	10	19p13.2	MARCH2	P	Membrane-associated RING-CH finger protein 2	613332	REc			
19.223	9	24	08	19p13.13	MAST1, SAST, KIAA0973	P	Microtubule-associated serine/threonine kinase 1	612256	R, REc			
19.224	2	25	15	19p13.2	MBD3L1	P	Methyl-CpG binding domain protein 3-like 1	607963	R, REc			9(Mbd3l1)
19.225	2	25	15	19p13.2	MBD3L2	P	Methyl-CpG binding domain protein 3-like 2	607964	R, REc			9(Mbd3l2)
19.226	3	23	09	19p13.2	MIR199A1, MIRN199A1	P	Micro RNA 199A1	610719	REc			
19.227	2	26	08	19p13.2	MRPL4	P	Mitochondrial ribosomal protein L4	611823	R			
19.228	8	3	12	19p13.2	MUC16, CA125	P	Mucin 16	606154	REc			
19.229	12	3	98	19p13.2	NDUFA7	C	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (14.5kD, B14.5a)	602139	R	previously assigned to 20p13		
19.230	3	23	09	19p13.2	NEZHA, KIAA1543	P	Nezha	612685	REc			
19.231	9	12	11	19p13.2	NRCLP6	P	Narcolepsy 6	614223	Fd	associated with rs2305795	Narcolepsy 6 (2)	
19.232	8	20	08	19p13.2	OR7D4, OR19B	P	Olfactory receptor, family 7, subfamily D, member 4	611538	REc			
19.233	4	20	11	19p13.2	PCOS1, PCO1, PCO	P	Polycystic ovary syndrome 1	184700	Fd	max lod at D19S884	Polycystic ovary syndrome 1 (2)	
19.234	8	21	98	19p13.2	PDE4A, DPDE2	C	Phosphodiesterase-4A, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E2)	600126	REa, A, REc			9(Pde4a)
19.235	5	25	00	19p13.11	PGLS	P	6-phosphogluconolactonase	604951	R			
19.236	3	25	03	19p13.11	PLVAP, PV1	P	Plasmalemma vesicle-associated protein	607647	REc, R, H			8(Plvap)
19.237	10	4	05	19p13.2	QTRT1, TGT	P	Queuine tRNA-ribosyltransferase 1	609615	REc			
19.238	8	18	14	19p13.2	RAB11B	P	Ras-associated protein RAB11B	604198	REc			
19.239	1	12	95	19p13.13	RAD23A, HHR23A	P	RAD23, S. cerevisiae, homolog of, A	600061	A			8(Rad23a)
19.240	3	14	06	19p13.2	RAVER1, KIAA1978	P	Raver1, mouse, homolog of	609950	R, REc			
19.241	9	22	04	19p13.2	RETN, RSTN, FIZZ3	C	Resistin	605565	REc		{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3); {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	
19.242	1	11	16	19p13.2	RGL3	P	Ral guanine nucleotide dissociation stimulator-like 3	616743	REc			
19.243	3	29	15	19p13.2	RPS28, DBA15	P	Ribosomal protein S28	603685	REa, R		Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3)	
19.244	3	16	16	19p13.2	S1PR2, EDG5, DFNB68	P	Sphingosine-1-phosphate receptor 2	605111	REc, Fd		Deafness, autosomal recessive 68, 610419 (3)	
19.245	9	18	08	19p13.2	S1PR5, EDG8	P	Sphingosine-1-phosphate receptor 5	605146	REc			
19.246	1	27	04	19p13.2	SITPEC, ECSIT	P	Signaling intermediate in toll pathway, evolutionarily conserved	608388	R, REc			
19.247	4	29	16	19p13.2	SMARCA4, BRG1, RTPS2, MRD16, CSS4	P	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4	603254	REc		{Rhabdoid tumor predisposition syndrome 2}, 613325 (3); Coffin-Siris syndrome 4, 614609 (3)	
19.248	10	2	12	19p13.2	SNAPC2, SNAP45	P	Small nuclear RNA-activating protein complex, polypeptide 2	605076	REc			
19.249	7	14	14	19p13.2	SPC24, SPBC24	P	SPC24, NDC80 kinetochore complex component	609394	REc			
19.250	3	31	15	19p13.13	STX10, SYN10	P	Syntaxin 10	603765	REc			
19.251	3	30	12	19p13.2	SWSAP1, ZSWIM7AP1, C19orf39	P	SWIM-type zinc finger domain-containing protein 7-associated protein 1	614536	REc			
19.252	3	29	99	19p13.2	TCO	P	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	Fd		Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)	
19.253	5	23	06	19p13.2	TMED1, IL1RL1LG	P	Transmembrane p24 trafficking protein 1 (interleukin-1 receptor-like 1 ligand)	605395	A			
19.254	2	24	11	19p13.2	TMEM205	P	Transmembrane protein 205	613771	REc			
19.255	9	12	14	19p13.2	TYK2, IMD35	C	Tyrosine kinase 2	176941	REa, A		Immunodeficiency 35, 611521 (3)	
19.256	4	16	02	19p13.2	UBL5, HUB1	P	Ubiquitin-like 5	606849	REc	pseudogene on 17p11.2		
19.257	3	15	07	19p13.2	XAB2	P	XPA-binding protein 2	610850	REc			
19.258	2	20	02	19p13.2	ZK1	P	Zinc finger protein ZK1	606697	A, R			
19.259	1	13	11	19p13.2	ZNF44, KOX7	P	Zinc finger protein-44 (KOX7)	194542	REc	previously assigned to 16p11		
19.260	1	13	11	19p13.2	ZNF69	P	Zinc finger protein-69 (Cos5)	194543	REc	previously assigned to 22q11.2		
19.261	8	24	09	19p13.2	ZNF266, HZF1	P	Zinc finger protein-266	604751	R, REc			
19.262	9	24	08	19p13.2	ZNF627	P	Zinc finger protein 627	612248	REc			
19.263	4	2	16	19p13.2	ZNF653, ZIP67	P	Zinc finger protein 653	611371	REc			
19.264	9	20	14	19p13.2	ZNF699, FLJ38144	P	Zinc finger protein 699	609571	REc			
19.265	12	16	11	19p13.2	ZGLP1, GLP1	P	Zinc finger GATA-like protein 1	611639	REc			
19.266	6	13	12	19p13.13	DAND5, CER2, CERL2, DANTE, COCO	P	DAN domain family, member 5	609068	REc			8(Crl2)
19.267	3	2	11	19p13.11	UPF1, RENT1, HUPF1	P	Upf1, yeast, homolog of	601430	REa			9(Rent1)
19.268	9	8	06	19p13.13	BEST2, VMD2L1	P	Bestrophin 2	607335	A			
19.269	6	19	00	19p13.2	ZNF136	P	Zinc finger protein-136	604078	A			
19.270	8	25	04	19p13.11	GDF15, PLAB, PDF, MIC1	P	Growth/differentiation factor-15 (bone morphogenetic protein, placental)	605312	A			
19.271	4	25	93	19p13.13	LYL1	C	Lymphoblastic leukemia derived sequence-1	151440	Ch, A		Leukemia, T-cell acute lymphoblastoid (2)	8(Lyl1)
19.272	6	9	08	19p13.11	NDUFA13, GRIM19	P	NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 13	609435	A		{Thyroid carcinoma, Hurthle cell}, 607464 (3)	
19.273	2	3	16	19p13.12	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	C	Notch, Drosophila, homolog of, 3	600276	REa, A, Fd	mutation identified in 1 IMF2 family	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3); ?Myofibromatosis, infantile 2, 615293 (3); Lateral meningocele syndrome, 130720 (3)	17(Notch3)
19.274	2	28	03	19p13.2-p13.1	PAPA3	P	Polydactyly, postaxial, type A3	607324	Fd	between D19S1165 and D19S929	Polydactyly, postaxial, type A3 (2)	
19.275	2	21	03	19p13.2	PRKCSH, G19P1, PCLD	C	Protein kinase C substrate 80K-H	177060	REb, Fd		Polycystic liver disease, 174050 (3)	
19.276	11	26	09	19p13.11	LRRC25, MAPA	P	Leucine rich repeat containing 25	607518	REc, R			
19.277	9	29	09	19p13.11	SLC5A5, NIS, TDH1	P	Solute carrier family 5 (sodium iodide symporter), member-5	601843	A		Thyroid dyshormonogenesis 1, 274400 (3)	
19.278	3	14	06	19p13.11	RAB8A, MEL	C	Ras-associated protein RAB8A (oncogene MEL)	165040	REa, Fd			
19.279	10	27	93	19p13.2-q13.3	LPSA, D19S381E	P	Oncogene liposarcoma (DNA segment, single copy, expressed, probes MC15, MC6)	164953	A		Liposarcoma (1)	
19.280	5	29	97	19p13.13	DNASE2, DNL	P	Deoxyribonuclease II, lysosomal	126350	S			
19.281	2	3	05	19p13.12	ASF1B	P	Anti-silencing function 1, S. cerevisiae, homolog of, B	609190	REc			
19.282	11	17	10	19p13.13	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	P	Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome)	613638	Ch	contiguous gene syndrome	Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13 duplication syndrome (4)	
19.283	6	15	15	19p13.13	GADD45GIP1, PRG6, CRIF1	P	Growth arrest- and DNA damage-inducible DABB45G-interacting protein	605162	R, REc			
19.284	7	7	09	19p13.13	HOOK2, HK2	P	Hook, Drosophila, homolog of, 2	607824	REc			
19.285	8	24	09	19p13.12	MIR23A, MIRN23A	P	Micro RNA 23a	607962	REc			
19.286	9	16	13	19p13.12	NANOS3, NOS3	P	Nanos, Drosophila, homolog of, 3	608229	REc			
19.287	10	15	07	19p13.13	RNASEH2A, RNHIA, AGS4	C	Ribonuclease H2, large subunit	606034	R, REc		Aicardi-Goutieres syndrome 4, 610333 (3)	
19.288	5	27	09	19p13.13	SYCE2, CESC1	P	Synaptonemal complex central element protein 2	611487	REc			
19.289	4	19	06	19p13.13	TNPO2, TRN2, KPNB2B	P	Transportin 2	603002	R			
19.290	3	8	16	19p13.13	WDR83, MORG1	P	WD repeat-containing protien 83	616850	REc			
19.291	2	12	14	19p13.13	KLF1, EKLF, INLU, HBFQTL6, CDAN4	P	Kruppel-like factor 1, erythroid	600599	A		Blood group--Lutheran inhibitor, 111150 (3); [Hereditary persistence of fetal hemoglobin], 613566 (3); Dyserythropoietic anemia, congenital, type IV, 613673 (3)	
19.292	2	25	15	19p13.12	AKAP8, AKAP95	P	A-kinase anchor protein 8	604692	REa, REc			
19.293	8	24	09	19p13.11	AP1M1, AP47, CLAPM2	P	Adaptor-related protein complex 1, mu 1 subunit	603535	REa			
19.294	7	21	15	19p13.11	CALR3, CRT2, CMH19	P	Calreticulin 3	611414	REc	mutation identified in 1 CMH19 patient	?Cardiomyopathy, hypertrophic, 19, 613875 (3)	
19.295	5	2	06	19p13.12	CC2D1A, MRT3	P	Coiled-coil and C2 domain-containing 1A	610055	REc, Fd		Mental retardation, autosomal recessive 3, 608443 (3)	
19.296	2	29	16	19p13.12	CLEC17A	P	C-type lectin domain family 17, member A	616838	REc			
19.297	11	11	14	19p13.12	CYP4F2	P	Cytochrome P450, family 4, subfamily F, polypeptide 2	604426	REc			
19.298	1	18	13	19p13.12	CYP4F22, ARCI5, LI3	C	Cytochrome P450, family 4, subfamily F, polypeptide 22	611495	REc		Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	
19.299	4	2	12	19p13.11	FAM32A, OTAG12	P	Family with sequence similarity 32, member A	614554	REc			8(Fam32a)
19.300	3	23	09	19p13.12	MIR24-2, MIRN24-2	P	Micro RNA 24-2	610724	REc			
19.301	3	23	09	19p13.12	MIR27, MIRN27A	P	Micro RNA 27A	612153	REc			
19.302	10	29	03	19p13.12	PGRPL	P	Peptidoglycan recognition protein, long	608199	REc			
19.303	8	24	15	19p13.12	RASAL3	P	Ras protein activator-like 3	616561	REc			
19.304	8	18	14	19p13.12	SLC1A6, EAAT4	P	Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6	600637	REc			
19.305	6	2	11	19p13.12	TECR, GPSN2, TER, SC2, MRT14	P	Trans-2,3-enoyl-CoA reductase	610057	R, REc		Mental retardation, autosomal recessive 14, 614020 (3)	
19.306	2	25	15	19p13.12	AKAP8L, HA95, NAKAP, HAP95	P	A-kinase anchor protein 8-like protein	609475	REa			
19.307	9	23	96	19p13.13	DHPS	C	Deoxyhypusine synthase	600944	REa, A			
19.308	6	15	99	19p13.12	NDUFB7	P	NADH-ubiquinone oxidoreductase 1 beta subcomplex, 7	603842	R			
19.309	1	8	01	19p12	ZNF254, ZNF91L	P	Zinc finger protein-254	604768	R			
19.310	3	24	06	19p13.11	BCNP1	P	B-cell novel protein 1	609967	R, REc			
19.311	10	23	15	19p13.11	BORCS8, MEF2BNB	P	BLOC1-related complex, subunit 8	616601	REc			
19.312	5	12	09	19p13.11	C10orf62, MERIT40, NBA1	P	Chromosome 19 open reading frame 62	612766	REc			
19.313	10	14	10	19p13.11	CILP2	P	Cartilage intermediate layer protein 2	612419	REc			
19.314	8	24	09	19p13.11	COPE	P	Cotamer protein complex, subunit epsilon	606942	R, REc			
19.315	9	16	12	19p13.11	CPAMD8, KIAA1283	P	Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8	608841	REc			
19.316	2	23	16	19p13.11	EPS15L1, EPS15R	P	EPS15-like protein 1	616826	REc			
19.317	9	7	10	19p13.11	FCHO1	P	FCH domain-only protein 1	613437	REc			
19.318	2	5	15	19p13.11	GTPBP3, MSS1, COXPD23	P	GTP-binding protein 3	608536	REc		Combined oxidative phosphorylation deficiency 23, 616198 (3)	
19.319	9	7	10	19p13.11	HAUS8, DGT4, HICE1	P	HAUS augmin-like complex, subunit 8	613434	REc			
19.320	7	9	06	19p13.11	HOMER3	P	Homer, homolog 3 (Drosophila)	604800	R, REc			
19.321	6	22	10	19p13.11	IFI30, GILT	P	Interferon-gamma-inducible protein 30	604664	REc			
19.322	4	17	13	19p13.11	KXD1, C10orf50	P	KXDL motif-containing protein 1	615178	REc			
19.323	8	24	09	19p13.11	LSM4	P	LSM4 protein	607284	R, REc			
19.324	4	10	14	19p13.11	MAP1S, BPY2IP1, VCY2IP1, C19ORF5	P	Microtubule-associated protein 1S	607573	R, REc			
19.325	9	24	08	19p13.11	MAST3, KIAA0561	P	Microtubule-associated serine/threonine kinase 3	612258	R, REc			
19.326	3	28	12	19p13.11	MAU2, SCC4, KIAA0892	P	MAU2 chromatid cohesion factor, C. elegans, homolog of	614560	REc			
19.327	8	24	09	19p13.11	MED26, CRSP7, CRSP70	P	Mediator complex subunit 26	605043	R, REc			
19.328	12	30	14	19p13.11	MPV17L2	P	MPV17-like protein 2	616133	REc			
19.329	7	12	13	19p13.11	NXNL1, RDCVF, TXNL6, LOC115861	P	Nucleoredoxin-like protein 1	608791	REc, H			8(Nxnl1)
19.330	1	4	16	19p13.11	NWD1	P	NACHT domain- and WD repeat-containing protein 1	616250	REc			
19.331	11	11	14	19p13.11	PBX4	P	Pre-B-cell leukemia transcription factor 4	608127	REc, A, H			8(Pbx4)
19.332	1	10	07	19p13.11	PGPEP1, PCP, PGP	P	Pyroglutamyl peptidase I	610694	REc			
19.333	1	11	07	19p13.11	SF4	P	Splicing factor 4	607992	REc			
19.334	8	24	09	19p13.11	SIN3B, KIAA0700	P	Sin3, yeast, homolog of, B	607777	R, REc			
19.335	3	12	07	19p13.11	SLC25A42	P	Solute carrier family 25, member 42	610823	REc			8(Slc25a42)
19.336	1	11	07	19p13.11	SRFS14, KIAA0365	C	Splicing factor, arginine/serine-rich, 14	607993	R, REc			
19.337	11	6	00	19p13.12	TCCR, WSX1	P	T-cell cytokine receptor	605350	Psh, R			
19.338	11	24	08	19p13.11	TMEM16H, KIAA1623	C	Transmembrane protein 16H	610216	R, REc			
19.339	4	6	15	19p13.11	TMEM38A, TRICA	P	Transmembrane protein 38A	611235	REc			
19.340	1	23	07	19p13.11	TSSK6, SSTK, TSSK4	C	Testis-specific serine/threonine kinase 6	610712	REc			8(Tssk6)
19.341	2	11	16	19p13.12	ADGRE2, EMR2, VBU	P	Adhesion G protein-coupled receptor E2	606100	REc		Vibratory urticaria, 125630 (3)	
19.342	2	23	16	19p13.12	ADGRE5, CD97	P	Adhesion G protein-coupled receptor E5	601211	REa			
19.343	5	15	08	19p13.12	BRD4, CAP, HUNK1	P	Bromodomain-containing protein 4	608749	REc, A, H	fused with NUT		17(Brd4)
19.344	4	17	01	19p13.12	CASP14	P	Caspase 14, apoptosis-related cysteine protease	605848	REc			
19.345	7	4	95	19p13.11	COMP, EDM1, MED, PSACH	P	Cartilage oligomeric matrix protein	600310	REa, A, Fd		Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple, 1, 132400 (3)	
19.346	8	20	08	19p13.12	CYP4F8	P	Cytochrome P450, family 4, subfamily F, polypeptide 8	611545	REc			
19.347	10	13	09	19p13.12	CYP4F11	P	Cytochrome P450, family 4, subfamily F, polypeptide 11	611517	R, REc			
19.348	12	3	07	19p13.12	CYP4F12	P	Cytochrome P450, family 4, subfamily F, polypeptide 12	611485	REc			
19.349	4	23	96	19p13.11	ELL	C	ELL gene (11-19 lysine-rich leukemia gene)	600284	Ch, RE			
19.350	10	6	15	19p13.12	EMR3	P	EGF-like module-containing, mucin-like hormone receptor 3	606101	REc			
19.351	9	8	14	19p13.11	IL12RB1, IMD30	P	Interleukin-12 receptor, beta-1	601604	A		Immunodeficiency 30, 614891 (3)	
19.352	4	19	01	19p13.12	ILVBL, AHAS	P	IlvB-like (acetolactate synthase, bacterial, homolog of)	605770	REc			
19.353	12	17	07	19p13.11	ISYNA1, IPS	P	Myoinositol 1-phosphate synthase A1	611670	REc	pseudogene on 4p15		
19.354	5	4	12	19p13.11	JAK3, JAKL	P	Janus kinase 3 (Janus kinase, leukocyte)	600173	A, Psh		SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	
19.355	5	7	03	19p13.11	KLF2, LKLF	C	Kruppel-like factor 2	602016	R, REa, A			
19.356	3	5	08	19p13.11	MRPL34	P	Mitochondrial ribosomal protein L34	611840	R, REc			
19.357	12	7	05	19p13.11	MYO9B, MYR5, CELIAC4	P	Myosin IXB	602129	A, REc		{Celiac disease, susceptibility to, 4}, 609753 (3)	
19.358	8	24	09	19p13.11	NR2F6, ERBAL2, EAR2	P	Nuclear receptor subfamily 2, group F, member 6	132880	REb, REc			
19.359	12	14	99	19p13.11	PDE4C, DPDE1	C	Phosphodiesterase-4C, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E1)	600128	REa, A	between JUND (proximal) and RAB3A (distal)		8(Pde4c)
19.360	6	27	14	19p13.12	PRKACA	P	Protein kinase, cAMP-dependent, catalytic, alpha	601639	A		Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3)	
19.361	6	13	95	19p13.12	PTGER1	P	Prostaglandin E receptor 1, EP1 subtype, 42kD	176802	A			
19.362	10	15	97	19p13.12	RFX1	C	Regulatory factor (trans-acting) 1 (influences HLA class II expression)	600006	A			
19.363	1	28	02	19p13.12	RGS19IP1, C19orf3, GIPC,	C	Regulator of G-protein signaling 19 interacting protein 1	605072	R, A			
19.364	1	8	01	19p13.11	SLC27A1, FATP, FATP1	P	Solute carrier family 27, member 1	600691	A			
19.365	4	24	09	19p13.2	SLC44A2, CTL2	P	Solute carrier family 44, member 2	606106	REc			
19.366	12	4	02	19p13.11	SSBP4	P	Single-stranded DNA-binding protein 4	607391	REc			
19.367	9	29	96	19p13.12-p13.11	TPM4	P	Tropomyosin 4	600317	Psh, A			
19.368	2	23	08	19p13.11	USHBP1, MCC2	P	USH1C-binding protein 1	611810	R, REc			
19.369	2	23	08	19p13.12	ZNF333, KIAA1806	P	Zinc finger protein 333	611811	REc			
19.370	4	25	93	19p13.11	JUND	C	jun D proto-oncogene	165162	A			8(Jund)
19.371	4	25	93	19p13.11	RAB3A	C	RAS-associated protein RAB3A	179490	REb, A			
19.372	6	19	00	19p12	ZNF43	P	Zinc finger protein-43	603972	A			
19.373	3	20	94	19p13.11	UBA52	P	Ubiquitin A-52 residue ribosomal protein fusion product 1	191321	REa, A			
19.374	6	19	00	19p12	ZNF90	P	Zinc finger protein-90	603973	A			
19.375	6	19	00	19p12	ZNF91	P	Zinc finger protein-91	603971	A			
19.376	8	10	99	19p12	ZNF85	P	Zinc finger protein-85	603899	Psh, A			
19.377	6	19	00	19p12	ZNF93	P	Zinc finger protein-93	603975	A			
19.378	6	19	00	19p13.1-p12	ZNF94	P	Zinc finger protein-94	603976	REc			
19.379	6	6	00	19p12	ZNF100	P	Zinc finger protein-100	603982	A			
19.380	6	6	00	19p13.11	ZNF101	P	Zinc finger protein-101	603983	A			
19.381	6	6	00	19p13.1-p12	ZNF103	P	Zinc finger protein-103	603985	A			
19.382	6	6	00	19p13.1-p12	ZNF105	P	Zinc finger protein-105	603987	A			
19.383	6	6	00	19p13.1-p12	ZNF106	P	Zinc finger protein-106	603988	A			
19.384	6	6	00	19p13.1-p12	ZNF109	P	Zinc finger protein-109	603991	A			
19.385	6	6	00	19p13.1-p12	ZNF110	P	Zinc finger protein-110	603992	A			
19.386	6	6	00	19p13.1-p12	ZNF111	P	Zinc finger protein-111	603993	A			
19.387	6	6	00	19q13.31	ZNF112	P	Zinc finger protein-112	603994	A			
19.388	6	19	00	19p13.1-p12	ZNF113	P	Zinc finger protein-113	603995	A	?13q21		
19.389	6	19	00	19p13.1-p12	ZNF118	P	Zinc finger protein-118	603997	A	?13q21		
19.390	6	6	00	19p13.1-p12	ZNF119	P	Zinc finger protein-119	603998	A			
19.391	6	6	00	19p13.1-p12	ZNF120	P	Zinc finger protein-120	603999	A			
19.392	6	6	00	19p13.1-p12	ZNF122	P	Zinc finger protein-122	604000	A			
19.393	9	9	09	19p12	ZNF208, ZNF95	P	Zinc finger protein-208	603977	A			
19.394	9	2	09	19p12	ZNF737, ZNF102	P	Zinc finger protein-737	603984	A			
19.395	10	15	97	19p13.13	CACNA1A, CACNL1A4, SCA6	C	Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011	A, Fd		Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type 2, 108500 (3); Spinocerebellar ataxia 6, 183086 (3); Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)	8(tg, Cacl1a4)
19.396	11	9	95	19p13.2	CDKN2D	P	Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)	600927	A	possible tumor suppressor		
19.397	8	2	13	19p13.3	CELF5, BRUNOL5	P	CUGbp- and ELAV-like family, member 5	612680	REc			
19.398	10	27	08	19p13.11	CRTC1, MECT1, KIAA0616, FLJ14027	P	CREB-regulated transcription coactivator 1	607536	Ch	t(11;19)	Mucoepidermoid salivary gland carcinoma (3)	
19.399	10	17	00	19p13.3	FSTL3, FLRG	P	Follistatin-like 3	605343	REa, A			
19.400	8	13	13	19p13.3	GNA11, HHC2, HYPOC2	C	Guanine nucleotide-binding protein, Gq class, GNA11	139313	A, Fd		Hypocalciuric hypercalcemia, type II, 145981 (3); Hypocalcemia, autosomal dominant 2, 615361 (3)	10(Gna11)
19.401	9	27	95	19p13.3	GNA15, GNA16	P	Guanine nucleotide-binding protein (G protein) alpha 15 (Gq class)	139314	REa, A			10(Gna15)
19.402	2	21	02	19p13	IBD6	P	Inflammatory bowel disease 6	606674	Fd		{Inflammatory bowel disease 6} (2)	
19.403	5	6	03	19p13.2	ILF3, NF90, DRBP76, MPHOSPH4, NFAR	P	Interleukin enhancer-binding factor 3	603182	A			
19.404	10	24	03	19p13	MGR5	P	Migraine with or without aura, susceptibility to, 5	607508	Fd		{Migraine with or without aura, susceptibility to, 5} (2)	
19.405	6	15	99	19p13.3	NDUFS7, PSST	P	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kD (NADH-coenzyme Q reductase)	601825	A		Leigh syndrome, 256000 (3)	
19.406	5	22	03	19p13.2	P2RY11	P	Purinergic receptor P2Y, G protein-coupled, 11	602697	REc	fuses with PPAN		
19.407	3	9	98	19p13.2	PIN1, DOD	P	Peptidyl-prolyl cis/trans isomerase, NIMA-interacting	601052	Psh, A			
19.408	7	18	14	19p13	PPNAD4	P	Pigmented nodular adrenocortical disease, primary, 4	615830	Ch	duplication of 294kb to 2.7Mb on 19p13	Pigmented nodular adrenocortical disease, primary, 4 (4)	
19.409	5	22	03	19p13.2	PPAN, SSF1	P	Peter pan, Drosophila, homolog of	607793	REc	fuses with P2RY11		
19.410	11	21	00	19p13	PSORS6	P	Psoriasis susceptibility 6	605364	Fd		{Psoriasis susceptibility 6} (2)	
19.411	8	25	05	19p13.13	RTBDN	P	Retbindin	609553	REc			
19.412	4	15	04	19p13.2	RDH8, PRRDH	P	Retinol dehydrogenase 8	608575	REc			
19.413	6	28	99	19p13.3	SGTA, SGT	P	Small glutamine-rich tetratricopeptide repeat-containing protein, alpha	603419	A			
19.414	12	11	98	19p13.3	TNFSF7, CD70, CD27L	P	Tumor necrosis factor ligand superfamily, member 7 (CD70 antigen)	602840	A			
19.415	6	4	13	19p13.3	UBXN6, UBXD1	P	UBX domain protein 6	611946	REc			
19.416	9	9	10	19p13.2	ZNF177	P	Zinc finger protein 177	601276	REc			
19.417	9	30	02	19p13.11	ZNF253	P	Zinc finger protein 253	606954	A			
19.418	4	6	11	19p13.2	ZNF317, KIAA1588	P	Zinc finger protein 317	613864	REc			
19.419	5	27	93	19q13.33	CD37	P	Leukocyte surface antigen CD37	151523	REa			
19.420	2	24	15	19p13.11	CERS1, LASS1, UOG1, EPM8	P	Ceramide synthase 1	606919	A	mutation identified in 1 EPM8 family	?Epilepsy, progressive myoclonic, 8, 616230 (3)	
19.421	11	10	14	19p13.11	CRLF1, CISS1	C	Cytokine-like factor 1	604237	TM, REc, Fd, Ch		Cold-induced sweating syndrome 1, 272430 (3)	
19.422	11	2	98	19p13.11	CSPG3, NCAN	P	Chondroitin sulfate proteoglycan 3 (neurocan)	600826	REc			
19.423	2	3	99	19p13.11	F2RL3, PAR4	P	Coagulation factor II, thrombin, receptor-like 3 (protease-activated receptor-4)	602779	A			
19.424	1	24	04	19p13.11	FKBP8, FKBP38	P	FK506-binding protein 8	604840	R, REc	pseudogene on 1q32		
19.425	9	19	13	19p13.11	GDF1, DTGA3, DORV, RAI	P	Growth/differentiation factor 1	602880	REc		Double-outlet right ventricle, 217095 (3); Tetralogy of Fallot, 187500 (3); Transposition of great arteries, dextro-looped 3, 613854 (3); Right atrial isomerism, 208530 (3)	
19.426	9	18	08	19p13.11	LPAR2, EDG4	P	Lysophosphatidic acid receptor 2	605110	REc			8(Edg4)
19.427	11	8	95	19p13.11	MEF2B	P	MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B)	600661	REn			?8(Mef2b)
19.428	11	30	06	19p13.12	PKN1, PRKCL1, PRK1, PAK1	C	Protein kinase N1	601032	R, A			8(Prkcl1)
19.429	11	2	98	19p13.11	RFXANK	P	Regulatory factor X, ankyrin repeat-containing	603200	REc		MHC class II deficiency, complementation group B, 209920 (3)	
19.430	12	27	01	19p13.11	TM6SF2, KIAA1926	P	Transmembrane 6 superfamily, member 2	606563	REc			
19.431	8	24	09	19p12	ZNF98	P	Zinc finger protein-98	603980	REc			
19.432	8	24	09	19p12	ZNF99	P	Zinc finger protein-99	603981	REc			
19.433	11	20	12	19p12	ZNF257	P	Zinc finger protein 257	606957	A			
19.434	11	1	05	19p13.11	GMIP	P	GEM-interacting protein	609694	REc			
19.435	11	30	94	19p	EXT3	P	Exostoses, multiple, 3	600209	Fd		Exostoses, multiple, type 3 (2)	
19.436	10	20	99	19p13.11	RPL18A	P	Ribosomal protein L18a	604178	REa, R			
19.437	2	7	01	19p13.3	RPS15, RIG	P	Ribosomal protein S15	180535	REa, R			
19.438	6	20	01	19p13.11	TMEM3, B3GNT3	P	Transmembrane protein 3 (beta-1,3-N-acetylglucosaminyltransferase 3)	605863	REc			
19.439	7	13	93	19p13.3	ZNF77	P	Zinc finger protein-77 (pT1)	194551	REa			
19.440	4	25	93	19p13.2	ZNF121, D19S204	P	Zinc finger protein-121 (clone ZHC32)	194628	REa, Fd			
19.441	8	9	05	19p13.13	MAN2B1, MANB	C	Mannosidase, alpha, class 2B, member 1	609458	S, Psh, REa		Mannosidosis, alpha-, types I and II, 248500 (3)	8(Man2b1)
19.442	2	21	10	19q13.11	PEPD	C	Peptidase D (prolidase)	613230	S, F, H, Fd	closely linked to APOC2	Prolidase deficiency, 170100 (3)	7(Pep4)
19.443	2	2	90	19q13.43	A1BG	P	Glycoprotein, alpha-1B	138670	F	order: C3-SE-LU-A1BG		
19.444	4	8	11	19q	BFIS1, BFIC1	P	Benign familial infantile seizures	601764	Fd		Seizures, benign familial infantile, 1 (2)	
19.445	3	29	07	19q13.43	CHMP2A, VPS2A, VPS2, BC2	P	CHMP family, member 2A	610893	R			
19.446	2	28	03	19q	HPCQTL19	P	Prostate cancer aggressiveness quantitative trait locus on chromosome 19	607592	Fd	D19S902	{Prostate cancer aggressiveness QTL}, 176807 (2)	
19.447	8	27	01	19q13.32	PUMA	P	p53-upregulated modulator of apoptosis	605854	R			
19.448	10	20	99	19q13.33	RPL18	P	Ribosomal protein L18	604179	REa, R			
19.449	7	13	92	19q13.33	RPS11	P	Ribosomal protein S11	180471	Psh			
19.450	2	7	01	19q13.2	RPS16	P	Ribosomal protein S16	603675	REa, R			
19.451	2	7	01	19q13.2	SIRT2, SIR2L, SIR2L2	P	Sirtuin, S. cerevisiae, homolog 2	604480	REc			
19.452	2	27	02	19q	SLI2	P	Specific language impairment QTL, 2	606712	Fd		Specific language impairment QTL, 2 (2)	
19.453	5	17	95	19q13.33	SYT3	P	Synaptotagmin-3	600327	REa, H			7(Syt3)
19.454	3	9	11	19q13.2	CXCL17, VCC1, DMC	P	Chemokine (C-X-C motif) ligand 17	611387	REc			
19.455	5	6	13	19q12	PLEKHF1, LAPF, PHAFIN1	P	Pleckstrin homolog domain-containing protein, family F, member 1	615200	REc			7(Plekhf1)
19.456	3	19	93	19q13.11	HPN	P	Hepsin	142440	REa			
19.457	11	20	13	19q12	C19orf12, NBIA4, SPG43	P	Chromosome 19 open reading frame 12	614297	REc	mutation identified in 1 SPG43 family	Neurodegeneration with brain iron accumulation 4, 614298 (3); ?Spastic paraplegia 43, autosomal recessive, 615043 (3)	
19.458	1	25	11	19q12	HSCR7	P	Hirschsprung disease, susceptibility to, 7	606875	Fd		{Hirschsprung disease, susceptibility to, 7} (2)	
19.459	1	14	13	19q13.2	MEGF8, EGFL4, CRPT2	P	Multiple epidermal growth factor-like domains 8	604267	R		Carpenter syndrome 2, 614976 (3)	
19.460	4	29	02	19q12	NNX3, RMP	P	NNX3 protein	603494	REc, A			
19.461	5	27	94	19q13.12	POLR2I	P	Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kD	180662	A			
19.462	8	24	09	19q12	RPP29, POP4	P	Ribonuclease P, 29kD subunit	606114	R, REc			
19.463	3	15	10	19q13.11	UBA2, SAE2	P	Ubiquitin-like modifier-activating enzyme 2	613295	REc			
19.464	7	4	95	19q12	UQCRFS1	P	Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	191327	REa, A, RE			
19.465	6	3	14	19q13.2	DYRK1B, MIRK, AOMS3	C	Dual-specificity tyrosine phosphorylation-regulated kinase 1B	604556	R, REc		Abdominal obesity-metabolic syndrome 3, 615812 (3)	
19.466	10	12	14	19q13.2	ATP1A3, DYT12, RDP, AHC2, CAPOS	C	ATPase, Na+K+ transporting, alpha-3 polypeptide	182350	REa, H, Fd		Dystonia-12, 128235 (3); Alternating hemiplegia of childhood 2, 614820 (3); CAPOS syndrome, 601338 (3)	7(Atpla3)
19.467	6	28	99	19q13.11	LRP3	P	Low density lipoprotein receptor related protein 3	603159	Psh, A			
19.468	7	9	09	19q13.12	SDHAF1	P	Succinate dehydrogenase complex assembly factor 1	612848	REc, Fd		Mitochondrial complex II deficiency, 252011 (3)	
19.469	9	30	09	19q13	AAA1, AAA	P	Aortic aneurysm, familial abdominal 1	100070	Fd	near D19S416	Aortic aneurysm, familial abdominal 1 (2)	
19.470	3	1	00	19q13.2	ACTN4, FSGS1, FSGS	C	Actinin, alpha-4	604638	Fd, REc		Glomerulosclerosis, focal segmental, 1, 603278 (3)	7(Actn4)
19.471	11	28	01	19q13.33	ACPT	P	Acid phosphatase, testicular	606362	REc			
19.472	8	24	04	19q13	ANIB2	P	Aneurysm, intracranial berry, 2	608542	Fd	between D19S245 and D19S246	Aneurysm, intracranial berry, 2 (2)	
19.473	9	15	98	19q13.33	BCAT2, BCT2	C	Branched chain aminotransferase-2, mitochondrial	113530	S, H		?Hypervalinemia or hyperleucine-isoleucinemia (1)	7(Bcat2)
19.474	6	5	90	19q13.32	BCL3	C	B-cell CLL/lymphoma-3	109560	Ch, S, H		Leukemia/lymphoma, B-cell, 3 (2)	7(Bcl3)
19.475	2	3	06	19q13.32	BLOC1S3, BLOS3, HPS8	P	Biogenesis of lysosome-related organelles complex 1, subunit 3	609762	R, Fd		Hermansky-Pudlak syndrome 8, 614077 (3)	7(rp)
19.476	8	18	04	19q13.2	CAPN12	P	Calpain 12	608839	REc			7(Capn12)
19.477	7	23	13	19q13	CTRCT35, CATCN1	P	Cataract 35	609376	Fd	max lod at D19S416	Cataract 35, congenital nuclear (2)	
19.478	10	25	90	19q13.32	CKM, CKMM	C	Creatine kinase, muscle type	123310	REa, A			7(Ckmm)
19.479	6	19	15	19q13.12	CLIP3, CLIPR59	P	CAP-GLY domain-containing linker protein 3, 607382 (3)	607382	R			
19.480	1	31	08	19q13.2	CNFN	P	Cornifelin	611764	REc, H			7(Cnfn)
19.481	9	30	09	19q13.33	CYTH2, PSCD2, ARNO, PSCD2L	P	Cytohesin 2	602488	R			
19.482	3	30	00	19q13.2	DLL3, SCDO1	C	Delta, Drosophila, homolog of	602768	Fd, REc		Spondylocostal dysostosis 1, autosomal recessive, 277300 (3)	7(Dll3)
19.483	4	1	08	19q13	EA7	P	Episodic ataxia, type 7	611907	Fd	between rs1366444 and rs952108	Episodic ataxia, type 7 (2)	
19.484	9	12	95	19q13.2	ECH1	P	Enoyl Coenzyme A hydratase 1, peroxisomal	600696	REc, REa			
19.485	12	7	04	19q13.42	EPN1	P	Epsin 1	607262	REc			
19.486	6	30	05	19q13.33	FGF21	P	Fibroblast growth factor 21	609436	REc			
19.487	7	18	12	19q13.33	FUZ, NTD	P	Fuzzy, Drosophila, homolog of	610622	REc		Neural tube defects, 182940 (3)	
19.488	10	19	10	19q13.12	HAMP, LEAP1, HEPC, HFE2B	C	Hepcidin antimicrobial peptide	606464	REc, Fd	digenic form with HAMP and HFE mutations	Hemochromatosis, type 2B, 613313 (3)	7(Hepc1)
19.489	10	18	00	19q13.33	HRMT1L2, PRMT1, IR1B4	P	Heterogeneous nuclear ribonucleoprotein methyltransferase 1-like 2	602950	REa, A			7(Prmt1)
19.490	3	7	06	19q13.43	NALP5, MATER	P	NACHT domain-, leucine-rich repeat-, and PYD-containing protein 5	609658	REc			
19.491	9	1	95	19q13	OFC3	P	Orofacial cleft-3	600757	Fd	?role of BCL3	Orofacial cleft-3 (2)	7(Cebpa)
19.492	10	29	03	19q13.32	PGRP, PGRPS	P	Peptidoglycan recognition protein	604963	REc			
19.493	8	11	91	19q13.31	PLAUR, URKR	P	Plasminogen activator, urokinase, receptor	173391	REa, Fd			
19.494	9	27	01	19q13.33	SLC17A7, BNPI, VGLUT1	P	Solute carrier family 17, (sodium-dependent inorganic phosphate cotransporter), member 7	605208	A			
19.495	8	1	12	19q13	UAQTL5	P	Uric acid concentration, serum, quantitative trait locus 5	614746	Fd	associated with rs150414818	[Uric acid concentration, serum, QTL5] (2)	
19.496	10	16	95	19q13.12	USF2	L	Upstream transcription factor 2, c-fos interacting	600390	H			7(Usf2)
19.497	9	30	02	19q13.43	ZNF256	P	Zinc finger protein 256	606956	A			
19.498	12	27	13	19q13.2	ADCK4, NPHS9	P	AARF domain-containing kinase 4	615567	REc		Nephrotic syndrome, type 9, 615573 (3)	
19.499	12	2	92	19q13.12	ATP4A, ATP6A	P	ATPase, H+, K+ transporting, alpha	137216	A			7(Atp4a)
19.500	9	7	10	19q13.2	CATSPERG	P	Cation channel, sperm-associated, gamma	613452	REc			
19.501	3	31	15	19q12	CCNE1	C	Cyclin E1	123837	A, REc			7(Ccne)
19.502	7	13	93	19q13.12	CD22	P	CD22 antigen	107266	A			
19.503	12	30	14	19q13.11	CEBPA, CEBP	C	CCAAT/enhancer-binding protein (C/EBP), alpha	116897	REa, A	germline mutation identified in 1 AML family	?Leukemia, acute myeloid, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3)	
19.504	3	15	15	19q13.11	CHST8, GALNAC4ST1, PSS3	P	Carbohydrate sulfotransferase 8	610190	REc	mutation has been identified in 1 PSS3 family	?Peeling skin syndrome 3, 616265 (3)	
19.505	11	4	93	19q13.2	CLC	C	Charcot-Leyden crystal protein	153310	REa, A, RE			
19.506	11	5	15	19q13.12	COX6B1	P	Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous)	124089	A		Mitochondrial complex IV deficiency, 220110 (3)	
19.507	8	3	99	19q13.12	DAP10	P	DNAX-activation protein 10	604089	REn			
19.508	7	22	13	19q13.2	ERF, PE2, CRS4	C	ETS2 repressor factor	611888	Psh, A, H		Craniosynostosis 4, 600775 (3)	7(Erf)
19.509	5	16	05	19q13.12	ETV2, ETSRP71	P	ETS variant gene 2	609358	R, REc			
19.510	5	8	15	19q13.12	FFAR1, GPR40	P	Free fatty acid receptor 1	603820	REn			
19.511	5	8	15	19q13.12	FFAR3, GPR41	P	Free fatty acid receptor 3	603821	REn			
19.512	5	8	15	19q13.12	FFAR2, GPR43	P	Free fatty acid receptor 2	603823	REn			
19.513	5	23	00	19q13.12	FXYD1, PLM	P	FXYD domain-containing ion transport regulator 1 (phospholemman)	602359	A			
19.514	1	25	05	19q13.12	GAPDHS, GAPD2	P	Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic	609169	REc	9.5 Mbp prox. to APOE		
19.515	9	9	10	19q13.11	GPI	C	Glucose phosphate isomerase; neuroleukin	172400	S, D, A		Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)	7(Gpi1)
19.516	5	21	99	19q13.12	GPR42	P	G protein-coupled receptor-42	603822	REn			
19.517	5	2	01	19q13.2	KCNK6, TWIK2, TOSS	P	Potassium channel, subfamily K, member 6	603939	R			
19.518	3	14	14	19q13.12	KMT2B, MLL4, KIAA0304	C	Lysine (K)-specific methyltransferase 2B	606834	R, REc, A			
19.519	4	18	05	19q13.2	LGALS13, GAL13, PP13	P	Lectin, galactoside-binding, soluble, 13	608717	REc, R			
19.520	12	9	15	19q13.12	MAG, GMA, SPG75	C	Myelin-associated glycoprotein	159460	REa, REb, A		Spastic paraplegia 75, autosomal recessive, 616680 (3)	7(Mag)
19.521	5	22	03	19q13.12	KIRREL2, NEPH3, NLG1, FILTRIN	P	Kin or IRRE-like 2 (nephrin-like 3)	607762	REc			
19.522	2	9	00	19q13.2	NFKBIB, IKBB, TRIP9	P	Nuclear factor of kappa light chain gene enhancer in B cells inhibitor, beta	604495	A			
19.523	10	25	10	19q13.12	NPHS1, NPHN	P	Nephrin	602716	Fd, REn		Nephrotic syndrome, type 1, 256300 (3)	
19.524	6	30	15	19q13.12	OVOL3	P	ovo-like 3	616442	REc			
19.525	10	2	98	19q13.2	PAFAH1B3	P	Platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit	603074	R, A			
19.526	9	10	98	19q13.2	MRPS12, RPSM12	C	Ribosomal protein, mitochondrial, S12	603021	REa, R			
19.527	1	21	16	19q13.2	PLEKHG2, CLG, LDAMD	P	Pleckstrin homology domain-containing protein, family G, member 2	611893	REc		Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	
19.528	3	22	07	19q13.2	PPP1R14A, CPI17	C	Protein phosphatase 1, regulatory subunit 14A	608153	R, REn			
19.529	2	8	11	19q13.12	PSENEN, PEN2	P	Presenilin enhancer 2, C. elegans, homolog of	607632	R		Acne inversa, familial, 2, 613736 (3)	
19.530	2	28	03	19q13.2	RASGRP4	P	Ras guanyl nucleotide-releasing protein 4	607320	REc			
19.531	7	12	13	19q13.2	RYR1, MHS, CCO	C	Ryanodine receptor-1, skeletal	180901	A, Fd, H		{Malignant hyperthermia susceptibility 1}, 145600 (3); Central core disease, 117000 (3); Minicore myopathy with external ophthalmoplegia, 255320 (3); Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3); King-Denborough syndrome, 145600 (3)	7(Ryr)
19.532	3	24	06	19q13.12	SBSN	P	Suprabasin	609969	REc, H			7(Sbsn)
19.533	6		12	19q13.33	SCGF, LSLCL	C	Stem cell growth factor	604713	A, REc, H			7(Scgf)
19.534	9	9	13	19q13.11	SCN1B, GEFSP1, BRGDA5, ATFB13	C	Sodium channel, voltage-gated, type I, beta polypeptide	600235	A, Fd		Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3); Brugada syndrome 5, 612838 (3); Cardiac conduction defect, nonspecific, 612838 (3); Atrial fibrillation, familial, 13, 615377 (3)	
19.535	8	18	08	19q13.2	SERTAD3, RBT1	P	SERTA domain-containing 3	612125	REc			
19.536	3	8	16	19q13.1-q13.2	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	C	SIPA1-like protein 3	616655	R, REc	mutation identified in 1 CTRCT45 family	?Cataract 45, 616851 (3)	
19.537	4	21	10	19q13.11	SLC7A9, CSNU3	C	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9	604144	Fd, REc		Cystinuria, 220100 (3)	
19.538	2	12	99	19q13.2	SNRPA	P	Small nuclear ribonucleoprotein polypeptide A	182285	REa			
19.539	4	1	09	19q13.2	SPINT2, HAI2, DIAR3	P	Serine protease inhibitor, Kunitz-type, 2 (hepatocyte growth factor activator inhibitor 2; bikunin, placental)	605124	Psh		Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	
19.540	12	23	05	19q13.2	TGFB1, DPD1, CED	C	Transforming growth factor, beta-1	190180	REa, A, Fd		Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung disease, modifier of}, 219700 (3)	7(Tgfb1)
19.541	7	15	99	19q13.33	TULP2	P	Tubby-like protein-2	602309	R			
19.542	12	11	02	19q13.12	TYROBP, PLOSL, DAP12	C	TYRO protein tyrosine kinase-binding protein	604142	REc, Fd, Ld		Nasu-Hakola disease, 221770 (3)	
19.543	3	17	08	19q13.12	UPK1A, UPIA	P	Uroplakin 1A	611557	REc			
19.544	1	17	07	19q13.12	ZBTB32, FAXF, TZFP, ROG	P	Zinc finger- and BTB domain-containing protein 32	605859	REc			
19.545	8	19	91	19q13.2	ZFP36, TTP	P	Zfp36, mouse, homolog of	190700	REa, A, H			7(Zfp36)
19.546	1	6	97	19q13.12	ZNF146, OZF	P	Zinc finger protein-146	601505	A			
19.547	11	14	11	19q13.2	AKT2, HIHGHH	P	Murine thymoma viral (v-akt) homolog-2	164731	A		Diabetes mellitus, type II, 125853 (3); Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	7(Akt2)
19.548	9	22	93	19q13.2	AXL	C	AXL transforming sequence (a receptor tyrosine kinase)	109135	A			
19.549	1	29	04	19q13.2	BCKDHA, MSUD1	C	Branched chain keto acid dehydrogenase E1, alpha polypeptide	608348	REa, REb, A		Maple syrup urine disease, type Ia, 248600 (3)	
19.550	2	9	15	19q13.2	LIPE, LHS, FPLD6	C	Lipase, hormone-sensitive	151750	REa, A		Lipodystrophy, familial partial, type 6, 615980 (3)	7(Lipe)
19.551	1	31	13	19q13.2	LTBP4, LTBP4S, LTBP4L, ARCL1C	P	Latent transforming growth factor-beta-binding protein 4	604710	A		Cutis laxa, autosomal recessive, type IC, 613177 (3)	
19.552	9	24	08	19q13.31	LYPD3	P	LY6/PLAUR domain-containing protein 3	609484	A			
19.553	4	6	00	19q13.2	MAP3K10, MLK2, MST	P	Mitogen-activated protein kinase kinase kinase 10	600137	A			
19.554	7	30	14	19q13.2	PRX, CMT4F	P	Periaxin	605725	A, REc		Dejerine-Sottas disease, 145900 (3); Charcot-Marie-Tooth disease, type 4F, 614895 (3)	
19.555	6	28	99	19q13.2	SUPT5H, SPT5	P	Suppressor of Ty 5, S. cerevisiae, homolog of	602102	Psh, R, H			7(Supt5h)
19.556	1	12	07	19q13.2	MAP4K1, HPK1	P	Mitogen-activated protein kinase kinase kinase kinase 1	601983	R, REc			
19.557	9	30	09	19q13.11	DEL19q13.11, C19DELq13.11	P	Chromosome 19q13.11 deletion syndrome	613026	Ch	contiguous gene syndrome	Chromosome 19q13.11 deletion syndrome (4)	
19.558	10	23	87	19q13.1-qter	E11S	C	Echo 11 sensitivity	129150	S			
19.559	4	17	07	19q13.11	C19orf40, FAAP24	P	Chromosome 19 open reading frame 40 (Fanconi anemia-associated protein, 24kD	610884	REc			
19.560	11	1	13	19q13.11	CEP89, CCDC123, CEP123, FLJ14640	P	Centrosomal protein, 89kD	615470	REc			
19.561	1	9	14	19q13.11	CEBPG, GPE1BP	P	CCAAT/enhancer-binding protein, gamma	138972	REc			
19.562	4	15	11	19q13.11	DPY19L3	P	DPY19-like 3	613894	REc			
19.563	1	9	13	19p13.11	GATAD2A	P	GATA zinc finger domain-containing protein 2A	614997	REc			
19.564	5	24	13	19q13.11	KCTD15	P	Potassium channel tetramerization domain-containing protein 15	615240	REc			
19.565	12	4	03	19q13.12	LGI4	P	Leucine-rich gene, glioma-inactivated, 4	608303	REc			7(Lgi4)
19.566	4	13	15	19q13.11	LSM14A, RAP55	P	LSM14A protein	610677	REc			
19.567	3	7	14	19q13.11	PDCD2L, MGC13096	P	Programmed cell death 2-like protein	615661	REc			
19.568	3	25	14	19q13.11	PDCD5, TFAR19	P	Programmed cell death 5	604583	REc			
19.569	2	7	07	19q13.11	RGS9BP, R9AP, RGS9, PERRS	P	Regulator of G protein signaling 9-binding protein	607814	R		Bradyopsia, 608415 (3)	
19.570	2	22	13	19q13.11	SCGB2B2	P	Secretoglobin, family 2B, member 2	615063	REc			
19.571	2	25	15	19q13.11	SLC7A10, ASC1	P	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 10	607959	A, REc			
19.572	7	27	11	19q12	TSHZ3, KIAA1474	P	Teashirt zinc finger homeobox 3	614119	Psh, REc			
19.573	9	29	96	19q13.12	CKAP1	P	Cytoskeleton-associated protein 1	601303	A			
19.574	6	28	99	19q13.2	PSMC4, TBP7, S6	P	Proteasome 26S subunit, ATPase, 4	602707	A			
19.575	3	16	10	19q13.12	ALKBH6, ABH6	P	AlkB, E. coli, homolog of, 6	613304	REc			
19.576	12	10	12	19q13.12	ARHGAP33, TCGAP	P	Rho GTPase-activating protein 33	614902	REc			
19.577	8	24	09	19q13.12	CAPNS1, CAPN4	P	Calpain, small polypeptide	114170	REb, REc			
19.578	3	26	07	19q13.12	COX7A1, COX7AM	C	Cytochrome c oxidase, subunit VIIa, polypeptide-1, muscle	123995	REa, R, REc			
19.579	8	24	09	19q13.12	FXYD3, PLML, MAT8	P	FXYD domain-containing ion transport regulator 3	604996	R, REc			
19.580	3	26	07	19q13.12	FXYD5	C	FXYD domain-containing ion transport regulator 5	606669	R, REc			
19.581	8	24	09	19q13.12	FXYD7	P	FXYD domain-containing ion transport regulator 7	606684	R, REc			
19.582	9	7	10	19q13.12	HAUS5, DGT5, KIAA0841	P	HAUS augmin-like complex, subunit 5	613432	R, REc			
19.583	8	24	09	19q13.12	HKR1	P	GLI-Kruppel family member HKR1 (oncogene HKR1)	165250	REa, REc			
19.584	8	5	11	19q13.12	IGFLR1, TMEM149	P	IGF-like family receptor 1	614143	REc			
19.585	9	30	15	19q13.12	LSR	P	Lipolysis-stimulated lipoprotein receptor	616582	REc			
19.586	6	1	15	19q13.12	PRODH2, HYPDH	P	Proline dehydrogenase (oxidase) 2	616377	REc			
19.587	2	21	10	19q13.12	RBM42	P	RNA-binding motif protein 42	613232	REc			
19.588	11	22	13	19q13.12	SYNE4, NESP4, C19orf46, DFNB76	P	Spectrin repeat-containing nuclear envelope protein 4	615535	REc		Deafness, autosomal recessive 76, 615540 (3)	
19.589	1	20	09	19q13.12	THAP8	P	THAP domain-containing protein 8	612536	REc			
19.590	6	8	11	19q13.12	WDR62, C19orf14, MCPH2	C	WD repeat-containing protein 62	613583	REc, Fd		Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	
19.591	9	2	12	19q13.11	WTIP	P	WT1-interacting protein	614790	REc			
19.592	2	21	11	19q13.12	ZNF260, PEX1	P	Zinc finger protein 260	613749	REc, H			7(Zfp260)
19.593	10	5	11	19q13.12	ZNF565	P	Zinc finger protein 565	614275	REc			
19.594	5	16	11	19q13.12	ZNF569	P	Zinc finger protein 569	613904	REc			
19.595	3	29	00	19q13.2	ARHGEF1, LBCL2	P	Rho guanine nucleotide exchange factor, 115-kD	601855	R			
19.596	1	10	07	19q13.12	HSPB6, HSP20	P	Heat-shock 27kD protein 6	610695	REc			
19.597	2	11	13	19q13.2	IFNL1, IL29	P	Interferon, lambda 1	607403	REc			
19.598	2	11	13	19q13.2	IFNL2, IL28A	P	Interferon, lambda 2	607401	REc			
19.599	2	11	13	19q13.2	IFNL3, IL28B	P	Interferon, lambda 3	607402	REc		{Hepatitis C virus infection, response to therapy of}, 609532 (3)	
19.600	3	14	13	19q13.2	IFNL4	P	Interferon, lambda-4	615090	REc			
19.601	1	26	12	19q13.12	ZNF382, KS1	P	Zinc finger protein 382	609516	REc			
19.602	7	11	11	19q13.2	SELV	P	Selenoprotein V	607919	REc			
19.603	10	11	07	19q13.2	SPRED3	P	Sprouty-related EVH1 domain-containing protein 3	609293	REc			7(Spred3)
19.604	8	30	01	19q13.2	SPTBN4, QV	C	Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of)	606214	R, A			7(Spnb4)
19.605	5	13	11	19q13.12	ZNF540	P	Zinc finger protein 540	613903	REc			
19.606	1	1	96	19q13.2	BLVRB, BVRB, FLR	P	Biliverdin reductase B	600941	A			
19.607	12	18	08	19q13.2	DPF1, NEUD4	C	D4, zinc, and double PHD fingers family, member 1	601670	REa, REc			
19.608	2	1	00	19q13.2	NUMBL, NUMBR, NBL	P	Numb, Drosophila, homolog-like	604018	Fd			
19.609	11	16	98	19q13.33	GRIN2D, NMDAR2D	P	Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D	602717	R			
19.610	3	26	07	19q13.12	APLP1, APLP	C	Amyloid beta (A4) precursor-like protein-1	104775	REa			
19.611	10	16	95	19q13.32	APOC4	P	Apolipoprotein C-IV	600745	REn	555bp upstream of APOC2		
19.612	5	18	09	19q13.32	APOE, AD2, LPG, LDLCQ5	C	Apolipoprotein E	107741	F, REa, LD, A, Fd	possible 2nd locus for AD2 on chr.19	Hyperlipoproteinemia, type III (3); {Myocardial infarction susceptibility} (3); Sea-blue histiocyte disease, 269600 (3); Alzheimer disease-2, 104310 (3); {?Macular degeneration, age-related}, 603075 (3); Lipoprotein glomerulopathy, 611771 (3)	7(Apoe)
19.613	4	25	93	19q13.32	APOC1	C	Apolipoprotein C-I	107710	REa, RE, A			
19.614	10	29	03	19q13.32	APOC2	C	Apolipoprotein C-II	608083	REa, F, LD, A, Fd		Hyperlipoproteinemia, type Ib, 207750 (3)	
19.615	9	2	11	19q13.2	B9D2, MKS10	P	B9 domain-containing protein 2	611951	REc		Meckel syndrome 10, 614175 (3)	7(B9d2)
19.616	8	7	13	19q13.2	B3GNT8, BGALT15, B3GALT7	P	Beta-1,3-galactosyltransferase 8	615357	REc			7(B3gnt8)
19.617	2	16	04	19q13.32	CBLC	C	CAS-BR-M murine ecotropic retroviral transforming sequence C	608453	Psh, R, A			
19.618	1	6	00	19q13.2	CEACAM1, BGP	C	Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)	109770	H, REn	in CEA cluster		7(Bgp1)
19.619	1	6	00	19q13.2	CEACAM5, CEA	C	Carcinoembryonic antigen-related cell adhesion molecule 5	114890	REa, A, REc	proximal to PSG cluster in 1.1-1.2Mb segment		
19.620	1	6	00	19q13.2	CEACAM6, NCA	C	Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific crossreacting antigen)	163980	REa, A, REn	in CEA cluster		
19.621	5	22	14	19q13.2	CEACAM8, CD66B, CGM6	P	Carcinoembryonic antigen-related cell adhesion molecule 8	615747	REc			
19.622	6	25	08	19q13.2	CIC, KIAA0306	P	Capicua, Drosophila, homolog of	612082	REc			
19.623	12	20	05	19q13.2	CRI2, EID2	P	CREBBP/EP300 inhibitory protein 2	609773	REc, R			7(Cri2)
19.624	8	26	03	19q13.2	CYP2A7	P	Cytochrome P450, subfamily IIA, polypeptide 7	608054	REc			
19.625	8	26	03	19q13.2	CYP2A13	P	Cytochrome P450, subfamily IIA, polypeptide 13	608055	REc			
19.626	1	5	09	19q13.2	CYP2S1	P	Cytochrome P450, family 2, subfamily S, polypeptide 1	611529	REc			
19.627	9	10	12	19q13.2	DMRTC2	P	Doublesex- and MAB3-related transcription factor C2	614806	REc			
19.628	8	24	09	19q13.2	EGLN2, PHD1, HIFPH1	P	Egl9, C. elegans, homolog of, 2	606424	R, REc			
19.629	6	1	12	19q13.2	EXOSC5, RRP46	P	Exosome component 5	606492	REc			
19.630	9	29	10	19q13.2	FBL	P	Fibrillarin	134795	REc			
19.631	9	9	08	19q13.2	FBXO17, FBX17, FBX26, FBG4	C	F-box only protein 17	609094	REc			7(Fbxo17)
19.632	9	9	08	19q13.2	FBXO27, FBX27, FBG5	C	F-box only protein 27	609099	REc			7(Fbxo27)
19.633	8	1	14	19q13.2	NCCRP1, FBXO50	P	Nonspecific cytotoxic cell receptor protein 1, zebrafish, homolog of	615901	REc			
19.634	2	4	00	19q13.2	GMFG	P	Glia maturation factor, gamma	604104	REn			
19.635	11	11	14	19q13.2	HNRNPL, HNRPL	P	Heterogeneous nuclear riboprotein 1	603083	REc			
19.636	8	24	09	19q13.2	HNRNPUL1, HNRPUL1, E1BAP5	P	Heterogeneous nuclear ribonucleoprotein U-like 1	605800	R, REc			
19.637	7	15	09	19q13.2	LRFN1, SALM2, KIAA1484	P	Leucine-rich repeat and fibronectin type III domain-containing protein 1	612807	REc			
19.638	7	15	09	19q13.12	LRFN3, SALM4	P	Leucine-rich repeat and fibronectin type III domain-containing protein 3	612809	REc, H			7(Lrfn3)
19.639	12	20	01	19q13.32	MARK4, KIAA1860, MARKL1	P	Map/microtubule affinity-regulating kinase-4	606495	REc			
19.640	7	22	09	19q13.2	MED29, IXL	P	Mediator complex subunit 29	612914	REc			
19.641	10	4	02	19q13.31	NB1, PRV1, CD177, HNA2A	P	Neutrophil-specific antigen 1	162860	REc			
19.642	3	31	16	19q13.2	PLD3, HUK4	P	Phospholipase D family, member 3	615698	REc			
19.643	8	24	09	19q13.2	POU2F2, OTF2, OCT2	P	POU domain, class 2, transcription factor 2	164176	REa, REc			7(Otf2)
19.644	1	6	00	19q13.2	PSG10, PSG12	P	Pregnancy-specific beta-1-glycoprotein-10	176399	A			
19.645	1	6	00	19q13.31	PSG11, PSG13, PSG14	P	Pregnancy-specific beta-1-glycoprotein-11	176401	A			
19.646	8	29	03	19q13.32	PVRL2, HVEB, PVRR2, PRR2	C	Poliovirus receptor-like 2	600798	REc, A			
19.647	8	2	10	19q13.2	CD79A, IGA	P	CD79A antigen (immunoglobulin-associated alpha)	112205	Psh		Agammaglobulinemia 3, 613501 (3)	
19.648	5	8	07	19q13.2	CYP2A6, CYP2A3, CYP2A, P450C2A	C	Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6	122720	REa, A, Fd, REn		Coumarin resistance, 122700 (3); {Nicotine addiction, protection from}, 188890 (3); {Lung cancer, resistance to}, 211980 (3)	7(Cyp2a)
19.649	4	2	12	19q13.2	CYP2B6, CYP2B, EFVM	C	Cytochrome P450, family 2, subfamily B, polypeptide 6	123930	REa, REn, Fd, Psh	same NotI fragment as CYP2A	Efavirenz, poor metabolism of, 614546 (3); {Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	7(Cyp2b)
19.650	4	25	93	19q13.2	CYP2F1	C	Cytochrome P450, subfamily IIF, polypeptide 1	124070	Fd, REa, A, REn	CYP2A, CYP2B, CYP2F1 in 240kb		7(Cyp2f1)
19.651	10	3	07	19q13.2	EIF3K, PLAC24, EIF3S12	P	Eukaryotic translation initiation factor 3, subunit K	609596	REc			
19.652	3	24	06	19q13.2	GGN	P	Gametogenetin, mouse, homolog of	609966	R, REc			7(Ggn)
19.653	1	12	95	19q13.2	GRIK5	P	Glutamate receptor, ionotropic, kainate 5	600283	REa, A			7(Grik5)
19.654	3	24	06	19q13.32	HIF3A, IPAS	C	Hypoxia-inducible factor 3, alpha subunit	609976	REc			
19.655	1	4	08	19q13.2	HIPK4	P	Homeodomain-interacting protein kinase 4	611712	REc			
19.656	12	28	08	19q13.31	IGSF4C, TSLL2, NECL4, SYNCAM4	P	Immunoglobulin superfamily, member 4C	609744	A, H			7(Igsf4c)
19.657	2	11	08	19q13.2	ITPKC	C	Inositol 1,4,5-trisphosphate 3-kinase C	606476	R, REc, Fd		{Kawasaki disease, susceptibility to}, 611775 (3)	
19.658	12	11	15	19q13.31	KCNN4, KCA4, SK4, DHS2	P	Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	602754	A		Dehydrated hereditary stomatocytosis 2, 616689 (3)	
19.659	4	18	05	19q13.2	LGALS4	P	Lectin, galactoside-binding, soluble, 4	602518	REc			
19.660	4	18	05	19q13.2	LGALS7	P	Lectin, galactoside-binding, soluble, 7 (galectin 7)	600615	REa, REc			
19.661	1	8	01	19q13.42	LILRA1, LIR6	P	Leukocyte immunoglobulin-like receptor, subfamily A, member 1	604810	R			
19.662	1	8	01	19q13.42	LILRB5, LIR8	P	Leukocyte immunoglobulin-like receptor, subfamily B, member 5	604814	R			
19.663	7	16	09	19q13.32	LU, AU, BCAM	C	B-cell adhesion molecule	612773	F, H	linked to SE	[Blood group, Lutheran system], 111200 (3); [Blood group, Auberger system], 111200 (3); [Blood group, Lutheran null], 247420 (3)	7(lu)
19.664	10	30	06	19q13.2	PAF1, PD2	P	PAF1 RNA polymerase II-associated factor, S. cerevisiae, homolog of	610506	Psh, REc			
19.665	8	24	09	19q13.2	PAK4	P	p21-activated kinase 4	605451	R, REc			
19.666	7	11	11	19q13.2	PAPL, FLJ16165	P	Purple acid phosphatase, long form	610490	REc			
19.667	10	7	02	19q13.2	PPL13	P	Placental protein 13-like protein	607260	REc			
19.668	8	20	07	19q13.33	PPP1R15A, GADD34	P	Protein phosphatase 1, regulatory subunit 15A	611048	A, REc			
19.669	8	24	09	19q13.2	PRA1	P	Prenylated RAB acceptor 1	604925	R, REc			
19.670	7	11	11	19q13.31	PRG1	P	p53-responsive gene 1	605157	REc			
19.671	3	1	01	19q13.2	PSG1, PSBG1, B1G1, SP1	C	Pregnancy-specific beta-1-glycoprotein-1	176390	REa, REc	distal to CEA		
19.672	4	25	93	19q13.31	PSG2, PSBG2	C	Pregnancy-specific beta-1-glycoprotein-2	176391	RE, A			
19.673	6	13	95	19q13.2	PSG3	P	Pregnancy-specific beta-1-glycoprotein-3	176392	A			
19.674	3	1	01	19q13.31	PSG4	C	Pregnancy-specific beta-1-glycoprotein-4	176393	REa, REc			
19.675	3	1	01	19q13.31	PSG5	C	Pregnancy-specific beta-1-glycoprotein-5	176394	REa, REc			
19.676	3	1	01	19q13.31	PSG6	C	Pregnancy-specific beta-1-glycoprotein-6	176395	REa, REc			
19.677	3	1	01	19q13.31	PSG7	C	Pregnancy-specific beta-1-glycoprotein-7	176396	REa, REc			
19.678	3	1	01	19q13.2	PSG8	C	Pregnancy-specific beta-1-glycoprotein-8	176397	REa, REc			
19.679	1	6	00	19q13.31	PSG9, PSG11	P	Pregnancy-specific beta-1-glycoprotein-9	176398	A			
19.680	8	9	99	19q13.2	RPS19, DBA, DBA1	C	Ribosomal protein S19	603474	Ch, Fd, D, REc		Diamond-Blackfan anemia 1, 105650 (3)	
19.681	3	31	11	19q13.2	SARS2	P	Seryl-tRNA synthetase 2	612804	REc		Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)	
19.682	8	24	09	19q13.33	SPHK2	P	Sphingosine kinase 2	607092	R, REc			
19.683	1	11	07	19q13.2	TEC	P	Transient erythroblastopenia of childhood	227050	Fd		Transient erythroblastopenia of childhood (2)	
19.684	7	14	14	19q13.2	TIMM50, TIM50	P	Translocase of inner mitochondrial membrane 50, yeast, homolog of	607381	REc			
19.685	8	29	03	19q13.32	TOMM40, TOM40, PEREC1	P	Translocase of outer mitochondrial membrane 40, yeast, homolog of	608061	REc			
19.686	7	7	14	19q13.12	U2AF1L4, U2AF1RS3	P	U2 small nuclear RNA auxillary factor 1-like 4	601080	A			
19.687	4	25	93	19q13.31	XRCC1	C	X-ray-repair, complementing defective, repair in Chinese hamster cells-1	194360	S, A			7(Xrcc1)
19.688	8	7	00	19q13.31	ZFP93, ANF270, HZF6	P	Zinc finger protein 93, mouse, homolog of	604749	REc			7(Zfp93)
19.689	2	7	07	19q13.31	ZNF45, ZNF13, KOX5	P	Zinc finger protein-45	194554	REc, A			
19.690	3	6	02	19q13.31	ZNF180	P	Zinc finger protein-180	606740	A			
19.691	3	6	02	19q13.11	ZNF181	P	Zinc finger protein-181	606741	A			
19.692	12	19	11	19q13.2	ZNF526, KIAA1951	P	Zinc finger protein 526	614387	REc			
19.693	2	12	13	19q13.32	AP2S1, CLAPS2, AP17, HHC3	C	Adaptor-related protein complex 2, sigma 1 subunit	602242	A		Hypocalciuric hypercalcemia, familial, type III, 600740 (3)	
19.694	3	2	00	19q13.33	CA11, CARP2	P	Carbonic anhydrase XI	604644	A			
19.695	7	13	93	19q13.32	CALM3	C	Calmodulin-3	114183	REa, Psh, A			
19.696	4	27	12	19q13.32	CD3EAP, ASE1, PAF49	P	CD3-epsilon-associated protein	107325	REc			
19.697	11	3	00	19q13.32	DMPK, DM, DMK	C	Dystrophia myotonica-protein kinase	605377	F, Fd	distal to APOLP2; distal to CKM	Myotonic dystrophy 1, 160900 (3)	7(Dm15)
19.698	2	20	07	19q13.32	ERCC1, UV20, COFS4	C	Excision repair cross complementing rodent repair deficiency, complementation group-1	126380	S, RE, Fd, A	distal to CKM	Cerebrooculofacioskeletal syndrome 4, 610758 (3)	
19.699	6	2	15	19q13.32	ERCC2, EM9, XPD, COFS2, TTD1	C	Excision repair cross complementing rodent repair deficiency, complementation group-2	126340	S, RE, M	< 250kb from ERCC1	Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy 1, photosensitive, 601675 (3); Cerebrooculofacioskeletal syndrome 2, 610756 (3)	7(Ercc2)
19.700	2	15	96	19q13.32	GPR4	P	G protein-coupled receptor-4	600551	A			
19.701	1	12	06	19q13.32	KLC3, KLC2L	P	Kinesin, light chain, 3	601334	REn			
19.702	4	25	93	19q13.33	LIG1	C	Ligase I, DNA, ATP-dependent	126391	REa, A		DNA ligase I deficiency (3)	7(Lig1)
19.703	6	13	07	19q13.2-q13.3	MRT11	P	Mental retardation, autosomal recessive, 11	611097	Fd	between rs2109075 and rs8101149	Mental retardation, autosomal recessive, 11 (2)	
19.704	6	28	99	19q13.32	NPAS1, MOP5	P	Neuronal PAS domain protein 1	603346	Psh, R, H			7(Npas1)
19.705	9	9	11	19q13.32	OPA3, MGA3	C	OPA3 gene	606580	Fd, REc		3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophy 3 with cataract, 165300 (3)	
19.706	5	2	11	19q13.31	PVR, PVS	C	Polio virus receptor	173850	S, A, REa			9(Pvs)
19.707	9	10	09	19q13.2	RAB4B	P	Ras-associated protein RAB4B	612945	R			
19.708	10	27	10	19q13.32	TRNAU1, TRSP	C	Transfer RNA selenocysteine 1 (anticodon UCA)	165060	REa, A, Fd	pseudogene on 22		7(Trsp)
19.709	3	31	97	19q13.32	VASP	P	Vasodilator-stimulated phosphoprotein	601703	A			
19.710	4	17	14	19q13.32	CCDC8, 3M3	P	Coiled-coil domain-containing protein 8	614145	REc		3-M syndrome 3, 614205 (3)	
19.711	6	19	00	19q13.31	ZNF155	P	Zinc finger protein-155	604086	A			
19.712	6	4	99	19q13.2-q13.4	CFM1	P	Cystic fibrosis modifier-1	603855	Fd		{Meconium ileus in cystic fibrosis, susceptibility to} (2)	7(Cfm1)
19.713	9	18	02	19q13.32	FOXA3, HNF3G	P	Forkhead box A3 (hepatocyte nuclear factor-3, gamma)	602295	A			7(Hnf3g)
19.714	3	19	01	19q13.32	GRLF1, P190A	P	Glucocorticoid receptor DNA-binding factor 1	605277	REa, A, R			
19.715	9	15	96	19q13.33	NUCB1	P	Nucleobindin 1	601323	Psh, A			
19.716	8	22	14	19p13.11	PIK3R2, MPPH1	P	Phosphatidylinositol 3-kinase, regulatory subunit 2	603157	A		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3)	
19.717	4	25	93	19q13.43	ZNF42, MZF1	P	Zinc finger protein-42 (myeloid-specific retinoic acid responsive)	194550	A, REb			
19.718	2	7	07	19q13.31	ZNF224, ZNF255, BMZF2, KOX22, ZNF27	P	Zinc finger protein-224	194555	REc, A			
19.719	9	18	00	19q13.33	AP2A1, CLAPA1, ADTAA	P	Adaptor-related protein complex 2, alpha 1 subunit	601026	REc	match to PAC AC006942		
19.720	6	3	02	19p13.13	ASNA1, ARSA1	P	arsA arsenite transporter, ATP-binding, E. coli, homolog of, 1	601913	Psh			8(Asna1)
19.721	8	24	09	19q13.33	ATF5, ATFX	P	Activating transcription factor 5	606398	R, REc			
19.722	3	12	07	19q13.33	BCL2L12	P	BCL2-like 12	610837	REc			
19.723	12	10	08	19q13.33	CARD8, TUCAN, KIAA0955, NDPP1	P	Caspase recruitment domain-containing protein 8	609051	REc			
19.724	2	8	13	19q13.33	CCDC114, CILD20	P	Coiled-coil domain-containing protein 114	615038	REc		Ciliary dyskinesia, primary, 20, 615067 (3)	
19.725	7	18	14	19q13.32	CLPTM1	P	Cleft lip and palate-associated transmembrane protein 1	604783	REc			
19.726	9	9	11	19q13.33	CRX, CORD2, CRD, LCA7	C	Cone-rod homeo box-containing gene	602225	Fd		Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital amaurosis 7, 613829 (3)	
19.727	8	30	07	19q13.32	DACT3	C	Dapper, antagonist of beta-catenin, 3	611112	R, REn			7(Dact3)
19.728	2	15	96	19q13.33	DBP	C	D site of albumin promoter binding protein	124097	REa, A, REc			7(Dbp)
19.729	3	20	06	19q13.32	DMWD, DMRN9	P	Dystrophia myotonica WD repeat-containing protein	609857	REc			
19.730	5	2	01	19q13.33	EHD2	C	EH domain-containing 2	605890	REc			
19.731	10	20	99	19q13.33	EMP3	P	Epithelial membrane protein 3	602335	A, REa, R			7(Emp3)
19.732	8	25	03	19q13.41	ETFB, MADD	C	Electron transfer flavoprotein, beta polypeptide	130410	REa, A		Glutaric acidemia IIB, 231680 (3)	7(Etfb)
19.733	9	9	08	19q13.32	FBXO46, FBX46	P	F-box only protein 46	609117	R, REc			7(Fbxo46)
19.734	9	23	96	19q13.33	FCGRT	P	Fc fragment of IgG, receptor, transporter, alpha	601437	A			
19.735	11	10	10	19q13.32	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	C	Fukutin-related protein	606596	R		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	
19.736	6	11	92	19q13.32	FOSB	P	Oncogene FOS-B	164772	REn			7(Fosb)
19.737	1	14	16	19q13.33	FUT1, H, HH	C	Fucosyltransferase-1 (Bombay phenotype)	211100	F, Fd	SE tightly linked	[Bombay phenotype], 616754 (3)	
19.738	1	24	09	19q13.33	FUT2, SE, B12QTL1	C	Fucosyltransferase-2 (secretor)	182100	F, Fd	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	{Norwalk virus infection, resistance to} (3); [Bombay phenotype] (3); {Vitamin B12 plasma level QTL1}, 612542 (3)	
19.739	7	8	10	19q13.32	GIPR, PGQTL2	C	Gastric inhibitory polypeptide receptor	137241	A, Fd		[Plasma glucose, 2-hour, QTL 2] (2)	
19.740	2	28	01	19q13.33	GLTSCR1	P	Glioma tumor suppressor candidate region gene 1	605690	D			
19.741	2	28	01	19q13.33	GLTSCR2	P	Glioma tumor suppressor candidate region gene 2	605691	D			
19.742	11	5	98	19q13.33	GPR32	P	G protein-coupled receptor-32	603195	A			
19.743	11	30	06	19q13.33	GRWD1, GRWD, KIAA1942	P	Glutamate-rich WD repeat-containing protein 1	610597	REc			
19.744	11	13	07	19q13.33	GYS1, GYS	C	Glycogen synthase	138570	REa, A		Glycogen storage disease 0, muscle, 611556 (3)	
19.745	1	25	91	19q13.33	HRC	P	Histidine-rich calcium-binding protein	142705	REa, A, H			
19.746	9	5	02	19q13.33	KCNA7	C	Potassium voltage-gated channel, shaker-related subfamily, member 7	176268	REa, A			7(Kcna7)
19.747	7	7	15	19q13.33	MED25, PTOV2, ARC92, CMT2B2, BVSYS	P	Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of	610197	Fd, REc	mutation identified in 1 CMT2B2 family	?Charcot-Marie-Tooth disease, type 2B2, 605589 (3); Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	
19.748	2	24	04	19q13.32-q13.33	NAPA, SNAPA	P	N-ethylmaleimide-sensitive factor attachment protein, alpha	603215	H, REc			7(hyh)
19.749	3	3	98	19q13.32	NOVA3, ANOVA	P	Neurooncological ventral antigen 3	601991	REf			
19.750	5	17	95	19q13.33	NR1H2, UNR	P	Nuclear receptor subfamily 1, group H, member 2 (ubiquitously-expressed nuclear receptor)	600380	A			
19.751	10	3	09	19q13.33	NTF4 , NTF5, NT5, NT4, GLC1O	C	Neurotrophin-4 (neurotrophin-4/5)	162662	REa, A	3 genes, ? functional, also on 19	Glaucoma 1, open angle, 1O, 613100 (3)	7(Ntf5)
19.752	8	24	09	19q13.33	PLA2G4C	P	Phospholipase A2, group IVC	603602	REc			
19.753	4	10	96	19q13.32	PPP5C, PP5	P	Protein phosphatase-5, catalytic subunit	600658	Psh, A			
19.754	8	24	09	19q13.32	PRKD2, PKD2	P	Protein kinase D2	607074	R, REc			
19.755	6	13	95	19q13.32	PTGIR	P	Prostaglandin I2 (prostacyclin) receptor (IP)	600022	A, REa			7(Ptgir)
19.756	2	28	03	19q13.32	RSHL1	P	Radial spokehead-like 1	607548	REc			
19.757	3	29	12	19q13.32	RTN2, NSPL1, SPG12	P	Reticulon-2	603183	REc		Spastic paraplegia 12, autosomal dominant, 604805 (3)	
19.758	2	20	01	19q13.33	RUVBL2, TIP48, ECP51	C	RUVB, E. coli, homolog-like 2 (TATA box-binding protein-interacting protein)	604788	REn, R			7(Ruvbl2)
19.759	5	30	03	19q13.33	SEPW1	P	Selenoprotein W, 1	603235	REc			
19.760	10	20	99	19q13.41	SIGLEC5, CD33L2, OBBP2	C	Sialic acid-binding Ig-like lectin 5	604200	A, REa, R			
19.761	2	7	01	19q13.41	SIGLEC6, CD33L, CD33L1, OBBP1	P	Sialic acid-binding immunoglobulin-like lectin 6	604405	A			
19.762	2	1	00	19q13.41	SIGLEC7, AIRM1	P	Sialic acid-binding immunoglobulin-like lectin 7	604410	REa, REn			
19.763	4	17	07	19q13.32	SIX5, DMAHP, BOR2	P	Sine oculis homeo box, Drosophila, homolog of, 5	600963	REn		Branchiootorenal syndrome 2, 610896 (3)	
19.764	7	9	90	19q13.33	SNRP70, U1RNP, RNPU1Z, RPU1	C	Small nuclear ribonucleoprotein 70kD polypeptide (RNP antigen)	180740	REa, A			
19.765	6	4	99	19q13.32	SLC1A5, RDRC, M7V1, M7VS1	C	Solute carrier family 1 (neutral amino acid transporter), member 5 (receptor for RD114/simian type D retroviruses)	109190	A, Fd, R			
19.766	2	25	98	19q13.32	SPK	P	Symplekin	602388	REc			
19.767	8	18	99	19q13.33	SULT2A1, STD	C	Sulfotransferase family 2A, dehydroepiandrosterone-preferring, member 1 (DHEA sulfotransferase)	125263	A, Psh, Fd			
19.768	8	17	99	19q13.33	SULT2B1	P	Sulfotransferase family 2B, member 1	604125	A, Psh			
19.769	1	5	04	19q13.33	SYNGR4	P	Synaptogyrin 4	608373	REc			
19.770	6	28	99	19q13.33	TEAD2, TEF4	P	TEA domain family member 2	601729	A, R			
19.771	11	16	98	19p13.3	ZIPK	P	ZIP kinase	603289	Psh, R, A			
19.772	6	22	14	19q13.33	BAX	C	BCL2-associated X protein	600040	REa, A, REc		Colorectal cancer, somatic, 114500 (3); T-cell acute lymphoblastic leukemia, somatic, 613065 (3)	7(Bax)
19.773	8	24	09	19q13.32	C5R1, C5AR	P	Complement component-5 receptor-2 (C5a ligand)	113995	REa, REc			
19.774	4	25	93	19q13.41	CD33	C	CD33 antigen (gp67)	159590	REa, A			
19.775	8	24	09	19q13.41	FPR2, FPRL1, FPRH1, LXA4R, HM63	P	Formyl peptide receptor 2	136538	REa, REc			
19.776	8	24	09	19q13.41	FPR3, FPRL2, FPRH2	P	Formyl peptide receptor 3	136539	REa, REc			
19.777	1	15	14	19q13.33	FTL, NBIA3, LFTD	C	Ferritin, light chain	134790	S, A, REa, REb		Hyperferritinemia-cataract syndrome, 600886 (3); Neurodegeneration with brain iron accumulation 3, 606159 (3); L-ferritin deficiency, dominant and recessive, 615604 (3)	7(Ftl1)
19.778	6	28	99	19q13.41	HAS1	C	Hyaluronan synthase 1	601463	Psh, REc, A			17(Has1)
19.779	12	28	08	19q13.33	IL4I1, FIG1	P	Interleukin 4-induced gene 1	609742	REn			
19.780	8	11	91	19q13.42	IL11	P	Interleukin-11	147681	A			
19.781	9	2	15	19q13.33	IRF3, IIAE7	P	Interferon regulatory factor 3	603734	Fd	mutation identified in one IIAE7 patient	{?Herpes simplex encephalitis, susceptibility to, 7}, 616532 (3)	
19.782	5	2	06	19q13.33	KCNC3, SCA13	C	Potassium voltage-gated channel, Shaw-related subfamily, member 3	176264	REa, A, Fd		Spinocerebellar ataxia 13, 605259 (3)	10(Kcnc3)
19.783	9	9	13	19q13.33	POLD1, CRCS10, MDPL	C	Polymerase (DNA directed), delta 1, catalytic subunit	174761	Psh, REa, A		{Colorectal cancer, susceptibility to, 10}, 612591 (3); Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	7(Pold1)
19.784	3	3	10	19q13.42	PPP1R12C, MBS85	P	Protein phosphatase 1, regulatory subunit 12C	613245	REc			
19.785	8	19	13	19q13.33	PTOV1, ACID2	P	Prostate tumor overexpressed gene 1	610195	A			
19.786	8	27	02	19q13.33	SIGLEC11	P	Sialic acid-binding immunoglobulin-like lectin 11	607157	REc	pseudogene 8kb upstream		
19.787	5	6	03	19q13.33	SPIB	P	SPIB transcription factor	606802	A			
19.788	10	15	94	19q13.41	ZNF83	P	Zinc finger protein-83	194558	A			
19.789	6	19	00	19q13.41	ZNF137	P	Zinc finger protein-137	604079	A			
19.790	3	27	95	19q13.41-q13.42	ZNF160	P	Zinc finger protein-160	600398	A			
19.791	11	6	01	19q13.41	ZNF320	P	Zinc finger protein 320	606427	REc			
19.792	6	20	01	19q13.42	ZNF331, ZNF463	P	Zinc finger protein-331	606043	A			
19.793	8	24	09	19q13.33	RRAS	P	Oncogene RRAS	165090	REa, REc			7(Rras)
19.794	5	2	16	19q13.31	C19orf61, SMG9, HBMS	P	Chromosome 19 open reading frame 61	613176	REc		Heart and brain malformation syndrome, 616920 (3)	
19.795	12	26	14	19q13.31-q13.32	CEACAM16, CEAL2, DFNA4B	P	Carcinoembryonic antigen-related cell adhesion molecule 16	614591	REc	mutation identified in 1 DFNA4B family	?Deafness, autosomal dominant 4B, 614614 (3)	
19.796	3	23	09	19q13.31	TEX101, SGRG, TES101RP	P	Testis-expressed gene 101	612665	R, REc			
19.797	9	2	08	19q13.33	BSPH1	P	Bovine seminal plasma protein-like 1	612213	REc			7(Bsph1)
19.798	10	23	87	19q13.33	CGB	C	Chorionic gonadotropin, beta polypeptide	118860	REa, H, A	at least 5 genes		7(Cgb)
19.799	10	17	13	19q13.32	DHX34, KIAA0134	C	DEAH box polypeptide 34	615475	REc, R			
19.800	2	10	04	19q13.31	ETHE1, HSCO, D83198	P	ETHE1 gene	608451	REc		Ethylmalonic encephalopathy, 602473 (3)	
19.801	4	27	16	19q13.32	EXOC3L2, XTP7	C	Exocyst complex component 3-like 2	616927	REc			7(Exoc3l2)
19.802	8	24	09	19q13.32	GEMIN7	P	GEM-associated protein 7	607419	R, REc			
19.803	7	23	13	19q13.32	IRF2BP1	P	Interferon regulatory factor 2-binding protein 1	615331	REc			
19.804	3	27	15	19q13.33	LHB, HH23	C	Luteinizing hormone, beta polypeptide	152780	RE	beta chains of FSH, TSH on 11p, 1p, respectively	Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3)	7(Lhb)
19.805	9	23	13	19q13.32	NANOS2, NOS2	P	Nanos, Drosophila, homolog of, 2	608228	REc			
19.806	2	24	15	19q13.32	PPP1R13L, RAI, IASPP, NKIP1	P	Protein phosphatase 1, regulatory subunit 13-like	607463	REc			7(Ppp1r13l)
19.807	3	18	08	19q13.32	RELB, IREL	P	v-rel avian reticuloendotheliosis viral oncogene homolog B	604758	REc			
19.808	3	15	10	19q13.32	SAE1, SUA1, AOS1	P	SUMO1-activating enzyme, subunit 1	613294	REc			
19.809	2	1	11	19q13.32	SLC8A2, NCX2	P	Solute carrier family 8, member 2 (sodium-calcium exchanger 2)	601901	REc			7(Slc8a2)
19.810	11	11	14	19q13.32	SNRPD2	P	Small nuclear ribonucleoprotein polypeptide D2	601061	REc			
19.811	8	21	12	19q13.32	STRN4, ZIN	P	Striatin, calmodulin-binding protein 4	614767	REc, A			
19.812	8	19	13	19q13.33	TPRX1	P	Tetrapeptide repeat homeobox 1	611166	REc			
19.813	8	19	13	19q13.32	TRAPPC6A	P	Trafficking protein particle complex, subunit 6A	610396	R, REc			7(Trappc6a)
19.814	6	7	10	19q13.33	TRPM4, PFHB1B	P	Transient receptor potential cation channel, subfamily M, member 4	606936	REc		Progressive familial heart block, type IB, 604559 (3)	
19.815	2	21	10	19q13.32	ZNF296, ZFP296, ZNF342	C	Zinc finger protein 296	613226	REc, R, H			7(Znf296)
19.816	1	8	97	19q13.2	MIA	P	Melanoma inhibitory activity	601340	A			
19.817	6	7	10	19q13.33	ALDH16A1	P	Aldehyde dehydrogenase 16 family, member A1	613358	REc			
19.818	3	31	09	19q13.41	ATPBD3	P	ATP-binding domain protein 3	612694	REc			
19.819	9	10	14	19q13.33	CABP5, CABP3	P	Calcium-binding protein 5	607315	A			
19.820	9	16	12	19q13.33	CGB1	P	Chorionic gonadotropin, beta polypeptide 1	608823	REc			
19.821	9	16	12	19q13.33	CGB7, CGB6	P	Chorionic gonadotropin, beta polypeptide 7	608826	REc			
19.822	3	28	15	19q13.33	CPT1C, SPG73	P	Carnitine palmitoyltransferase IC	608846	REc	mutation identified in 1 SPG73 family	?Spastic paraplegia 73, autosomal dominant, 616282 (3)	
19.823	8	24	09	19q13.33	DKKL1, SGY1, SGY	P	Dickkopf-like 1	605418	REc			
19.824	6	13	12	19q13.33	ELSPBP1	P	Epididymal sperm binding protein 1	607443	REc			
19.825	2	25	15	19q13.33	EMC10, C19orf63, HSS1, HSM1	P	ER membrane protein complex subunit 10	614545	REc			
19.826	7	16	09	19q13.33	HSD17B14, DHRS10, RETSDR3	P	17-beta-hydroxysteroid dehydrogenase XIV	612832	REc			
19.827	4	10	14	19q13.33	IZUMO1, MGC34799	P	Izumo sperm-egg fusion protein 1	609278	REc			
19.828	7	23	13	19q13.33	JOSD2	P	Josephin domain-containing protein 2	615324	REc			
19.829	11	11	14	19q13.33	KDELR1, ERD2, HDEL	P	KDEL endoplasmic reticulum protein retention receptor 1	131235	REc			
19.830	10	7	08	19q13.33	LIN7B, VELI2, MALS2	P	Lin7, C. elegans, homolog of, B	612331	REc			
19.831	8	19	13	19q13.33	MAMSTR, MASTR	P	MEF2-activating SAP transcriptional regulator	610349	REc			
19.832	6	10	09	19q13.41	MIR125A, MIRN125A	P	Micro RNA 125A	611191	REc			
19.833	5	19	09	19q13.33	MIR150, MIRN150	P	Micro RNA 150	611114	REc			
19.834	8	24	09	19q13.33	MYBPC2, MYBPCF	P	Myosin-binding protein C, fast type	160793	REa, REc			
19.835	12	26	14	19q13.33	MYH14, KIAA2034, DFNA4A, PNMHH	C	Myosin, heavy chain 14, nonmuscle	608568	REc, Fd	mutation identified in 1 PNMHH family	Deafness, autosomal dominant 4A, 600652 (3); ?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	7(Myh14)
19.836	2	19	04	19q13.33	NAPA, NAP1, SNAPA	P	Napsin A	605631	REc			
19.837	1	15	16	19q13.33	NOSIP	P	Nitric oxide synthase-interacting protein	616759	REc			
19.838	8	21	07	19q13.33	NUP62, SNDI, IBSN	C	Nucleoporin, 62-kD	605815	R		Striatonigral degeneration, infantile, 271930 (3)	
19.839	10	13	09	19q13.33	PIH1D1, NOP17	P	PIH1 domain-containing protein 1	611480	R, REc			
19.840	8	24	09	19q13.33	PLEKHA4, PEPP1	P	Pleckstrin homology domain-containing protein, family A, member 4	607769	REc			
19.841	8	24	09	19q13.33	PPFIA3, LPNA3	P	Protein tyrosine phosphatase, receptor type, f polypeptide (liprin-alpha-3)	603144	R, REc			
19.842	11	17	15	19q13.33	PRR12, KIAA1205	P	Proline-rich protein 12	616633	R, REc			
19.843	11	11	14	19q13.33	PRRG2, PRGP2	P	Proline-rich gamma-carboxyglutamic acid protein 2	604429	REc			
19.844	10	4	05	19q13.33	RASIP1, RAIN	P	Ras-interacting protein 1	609623	REc			
19.845	5	15	12	19q13.33	SHANK1, SSTRIP	P	SH3 and multiple ankyrin repeat domains 1	604999	REc			
19.846	5	24	13	19q13.33	SLC6A16, NT5	P	Solute carrier family 6 (neurotransmitter transporter), member 16	607972	REc, R			
19.847	3	2	06	19q13.33	SPACA4, SAMP14	P	Sperm acrosome-associated protein 4	609932	REc			7(Spaca4)
19.848	11	23	15	19q13.33	TBC1D17	P	TBC1 domain family, member 17	616659	REc			
19.849	1	27	04	19q13.33	TIP39	P	Tuberoinfundibular peptide of 39 amino acids	608386	REc			
19.850	8	24	09	19q13.33	ZNF114	P	Zinc finger protein-114	603996	REc			
19.851	3	23	06	19q13.42	MYADM	P	Myeloid-associated differentiation marker	609959	R			
19.852	2	15	01	19q13.41	SIGLEC8, SAF2, SIGLEC8L	P	Sialic acid-binding immunoglobulin-like lectin 8	605639	A			
19.853	7	17	01	19q13.42	BB1, LENG4	P	Breast and bladder cancer overexpressed gene 1	606048	REc			
19.854	7	7	09	19q13.42	BRSK1, KIAA1811	P	BR serine/threonine kinase 1	609235	REc			
19.855	5	1	02	19q13.42	CACNG6	P	Calcium channel, voltage-dependent, gamma-6 subunit	606898	REc			
19.856	5	1	02	19q13.42	CACNG7	P	Calcium channel, voltage-dependent, gamma-7 subunit	606899	REc			
19.857	5	1	02	19q13.42	CACNG8	P	Calcium channel, voltage-dependent, gamma-8 subunit	606900	REc			
19.858	9	9	08	19q13.42	CNOT3, NOT3	P	CCR4-NOT transcription complex, subunit 3	604910	REc			
19.859	5	9	12	19q13.42	DNAAF3, PF22, DAB1, CILD2	P	Dynein, axonemal, assembly factor 3	614566	REc		Ciliary dyskinesia, primary, 2, 606763 (3)	
19.860	1	9	13	19q13.42	EPS8L1, EPS8R1	P	EPS8-like protein 1	614987	REc			7(Eps8l1)
19.861	7	12	92	19q13.42	FCAR	P	Fc fragment of IgA, receptor for	147045	REa, A			
19.862	8	24	09	19q13.41	FPR1	C	Formyl peptide receptor-1	136537	REa			
19.863	8	19	13	19q13.43	GALP, ALARIN	P	Galanin-like peptide (GALP precursor protein)	611178	REc			
19.864	9	15	11	19q13.42	GP6, GPIV, BDPLT11	C	Glycoprotein VI, platelet	605546	Fd, R, REc		Bleeding disorder, platelet-type, 11, 614201 (3)	7(Gp6)
19.865	3	14	06	19q13.32	GPF77, C5L2	C	G protein-coupled receptor 77	609949	REc, REn			
19.866	4	23	08	19q13.4	HPC15	P	Prostate cancer, hereditary, 15	611959	Fd	associated with rs2735839	{Prostate cancer, hereditary, 15} (2)	
19.867	6	18	04	19q13.42	ILT11, CD85F, LIR9	P	Immunoglobulin-like transcript 11	606047	REn			
19.868	5	12	00	19q13.42	KIR2DL1, NKAT1	P	Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1	604936	REa, REc			
19.869	4	23	03	19q13.42	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	P	Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1	604946	REa, REc		{AIDS, delayed/rapid progression to}, 609423 (3)	
19.870	5	12	00	19q13.42	KIR2DL3, NKAT2	P	Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3	604938	REa, REc			
19.871	5	12	00	19q13.42	KIR2DL4, KIR103AS	P	Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4	604945	REa, REc			
19.872	5	12	00	19q13.4	KIR2DS1	P	Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1	604952	REc			
19.873	5	12	00	19q13.42	KIR2DS4, NKAT8	P	Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4	604955	REa, REc			
19.874	5	12	00	19q13.42	KIR3DL2, NKAT4	P	Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2	604947	REc			
19.875	8	24	09	19q13.4	KIR2DL2, NKAT6	P	Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2	604937	REa, REc			
19.876	4	29	14	19q13.4	KIR2DL5B	P	Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B	615727	REc, Psh			
19.877	8	24	09	19q13.4	KIR2DS2, NKAT5	P	Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2	604953	R, REc			
19.878	8	24	09	19q13.4	KIR2DS3, NKAT7	P	Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3	604954	R, REc			
19.879	3	31	15	19q13.4	KIR2DS5, NKAT9, CD158G	P	Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5	604956	REc			
19.880	8	19	13	19q13.42	KIR3KL3, KIRC1, KIR3DL7, KIR44	P	Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3	610095	REc			
19.881	9	20	14	19q13.33	KLK1, KLKR	C	Kallikrein 1	147910	REa, A, Fd	~10cM distal to APOC2	[Kallikrein, decreased urinary activity of], 615953 (3)	7(Kal)
19.882	11	30	06	19q13.33	KLK2	C	Kallikrein-related peptidase 2	147960	REa, RE	12kb from APS		
19.883	11	30	06	19q13.42	KIR3DP1, CD158C, KIRX, KIR48, KIR2DS6	P	Killer cell immunoglobulin-like receptor, three domains, pseudogene	610604	REc	functional in some individuals		
19.884	5	12	99	19q13.33	KLK3, APS, PSA	C	Kallikrein-related peptidase 3	176820	REa, RE, A	probably with cluster KLK1, KLK2		7(Aps)
19.885	8	4	09	19q13.41	KLK4, EMSP1, PRSS17, AI2A1	C	Kallikrein-related peptidase 4	603767	Psh, A		Amelogenesis imperfecta, type IIA1, 204700 (3)	
19.886	2	15	01	19q13.41	KLK5, SCTE, KLKL2	C	Kallikrein-related peptidase 5	605643	REc, REn			
19.887	2	15	01	19q13.41	KLK8, TADG14, PRSS19	P	Kallikrein-related peptidase 8	605644	REn			
19.888	11	30	06	19q13.41	KLK11, PRSS20, TLSP	C	Kallikrein-related peptidase 11	604434	REn			
19.889	11	30	06	19q13.41	KLK12, KLKL5	C	Kallikrein-related peptidase 12	605539	REn			
19.890	11	30	06	19q13.41	KLK13, KLKL4	C	Kallikrein-related peptidase 13	605505	REc			
19.891	11	30	06	19q13.41	KLK6, PRSS9, ZYME	C	Kallikrein-related peptidase 6	602652	Psh, A			
19.892	11	30	06	19q13.41	KLK9, KLKL3	C	Kallikrein-related peptidase 9	605504	REc, REn			
19.893	11	30	06	19q13.41	KLK14	C	Kallikrein-related peptidase 14	606135	REc			
19.894	11	30	06	19q13.41	KLK10, PRSSL1, NES1	C	Kallikrein-related peptidase 10	602673	A, REn			
19.895	11	30	06	19q13.33	KLK15	C	Kallikrein-related peptidase 15	610601	REc			
19.896	2	21	14	19q13.32	KPTN, 2E4, MRT41	P	Kaptin	615620	REc		Mental retardation, autosomal recessive 41, 615637 (3)	
19.897	12	15	98	19q13.42	LAIR1	P	Leukocyte-associated immunoglobulin-like receptor 1	602992	A			
19.898	8	21	00	19q13.42	LILRA2, LIR7, ILT1	C	Leukocyte immunoglobulin-like receptor, subfamily A, member 2	604812	R			
19.899	8	21	00	19q13.42	LILRB1, LIR1, ILT2, MIR7, CD85	C	Leukocyte immunoglobulin-like receptor, subfamily B, member 1	604811	R			
19.900	8	21	00	19q13.42	LILRB2, LIR2, ILT4, MIR10	C	Leukocyte immunoglobulin-like receptor, subfamily B, member 2	604815	R, A			
19.901	8	21	00	19q13.42	LILRB3, LIR3, ILT5, HL9	C	Leukocyte immunoglobulin-like receptor, subfamily B, member 3	604820	R			
19.902	8	21	00	19q13.42	LILRB4, LIR5, ILT3, HM18	C	Leukocyte immunoglobulin-like receptor, subfamily B, member 4	604821	R, A			
19.903	8	21	00	19q13.4	LILRA3, LIR4, ILT6, HM43	C	Leukocyte immunoglobulin-like receptor, subfamily A, member 3	604818	R			
19.904	8	6	13	19q13.41	LIM2, MP19, CTRCT19	C	Lens intrinsic protein 2, 19kD	154045	REc, REa, A	same cosmid as ETFB	Cataract 19, multiple types, 615277 (3)	7(Lim2)
19.905	7	7	09	19q13.4	MENOQ2	P	Menopause, natural, age at, QTL2	612884	Fd	associated with rs1172822, rs2384687, rs1551562, rs897798	{Menopause, natural, age at, QTL2} (2)	
19.906	5	16	05	19q13.42	NALP2, PAN1, PYPAF2	P	NACHT-, leucine-rich repeat-, and PYD-containing 2	609364	REc			
19.907	3	7	06	19q13.43	NALP4, PAN2, PYPAF4	C	NACHT domain-, leucine-rich repeat-c and PYD-containing protein 4	609645	REc			
19.908	11	14	14	19q13.42	NALP7, NOD12, PYPAF3, HYDM	C	NACHT domain-, leucine-rich repeat-, and PYD-containing protein 7	609661	Fd, REc		Hydatidiform mole, recurrent, 1, 231090 (3)	
19.909	3	7	06	19q13.43	NALP8, NOD16, PAN4	P	NACHT domain-, leucine-rich repeat-, and PYD-containing protein 8	609659	REc			
19.910	4	17	13	19q13.42	NLRP12, NALP12, PYPAF7, RNO, FCAS2	C	NLR family, pyrin domain containing 12	609648	REc		Familial cold autoinflammatory syndrome 2, 611762 (3)	
19.911	3	7	06	19q13.42	NALP9, NOD6	P	NACHT domain-, leucine-rich repeat-, and PYD-containing protein 9	609663	REc			
19.912	3	7	06	19q13.42-q13.43	NALP11, PYPAF7, NOD17	P	NACHT domain-, leucine-rich repeat-, and PYD-containing protein 11	609664	REc			
19.913	3	7	06	19q13.43	NALP13, NOD14	P	NACHT domain-, leucine-rich repeat-, and PYD-containing protein 13	609660	REc			
19.914	4	18	02	19q13.42	OSCAR	P	Osteoclast-associated receptor	606862	REc			7(Oscar)
19.915	8	5	97	19q13.43	PEG3	P	Paternally expressed gene 3	601483	REc			7(Peg3)
19.916	3	23	15	19q13.33	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	C	Polynucleotide kinase 3' phosphatase	605610	A		Microcephaly, seizures, and developmental delay, 613402 (3); Ataxia-oculomotor apraxia 4, 616267 (3)	
19.917	5	13	15	19q13.41	PPP2R1A, MRD36	P	Protein phosphatase 2, structural/regulatory subunit A, alpha	605983	REc		Mental retardation, autosomal dominant 36, 616362 (3)	
19.918	4	23	03	19q13.42	PRKCG, PKCC, PKCG, SCA14	C	Protein kinase C, gamma polypeptide	176980	REa, A, Fd		Spinocerebellar ataxia 14, 605361 (3)	7(Pkcc)
19.919	10	30	01	19q13.42	PRPF31, PRP31, RP11	P	Precursor RNA-processing factor 31, S. cerevisiae, homolog of	606419	REc		Retinitis pigmentosa 11, 600138 (3)	
19.920	4	15	98	19q13.42	PTPRH	P	Protein tyrosine phosphatase, receptor type, H	602510	A			
19.921	2	17	09	19q13.42	RFPL4A, RNF210	P	Ret finger protein-like 4A	612601	REc			7(Rfpl4a)
19.922	11	15	08	19q13.42	TSEN34, PCH2C, LENG5, SEN34	P	tRNA splicing endonuclease 34, S. cerevisiae, homolog of	608754	REc, Fd		Pontocerebellar hypoplasia type 2C, 612390 (3)	
19.923	6	19	00	19q13.43	ZNF132	P	Zinc finger protein-132	604074	A			
19.924	6	28	99	19q13.42	RPL28	P	Ribosomal protein L28	603638	RE, R			
19.925	6	28	99	19q13.43	RPS5	P	Ribosomal protein S5	603630	RE, R			
19.926	6	28	99	19q13.42	RPS9	P	Ribosomal protein S9	603631	RE, R			
19.927	2	15	01	19q13.41	SIGLEC9	P	Sialic acid-binding immunoglobulin-like lectin 9	605640	REc			
19.928	6	8	09	19q13.41	SIGLEC10	C	Sialic acid-binding immunoglobulin-like lectin 10	606091	REc			
19.929	9	21	11	19q13.41	SIGLEC12, SIGLECL1, S2V, SLG	P	Sialic acid-binding immunoglobulin-like lectin 12	606094	REc			
19.930	2	11	16	19q13.42	TARM1	P	T cell-interacting activating receptor on myeloid cells 1	616802	REc			
19.931	2	20	08	19q13.42	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	C	Troponin-I, cardiac	191044	REa, R	mutation identified in 1 CMD2A family	Cardiomyopathy, hypertrophic, 7, 613690 (3); Cardiomyopathy, familial restrictive, 1, 115210 (3); ?Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)	7(Tnni3)
19.932	8	2	13	19q13.42	TNNT1, ANM, NEM5	C	Troponin-T1, skeletal, slow	191041	REa, Psh, A		Nemaline myopathy 5, Amish type, 605355 (3)	
19.933	4	4	01	19q13.42	TTYH1	P	Tweety, Drosophila, homolog of, 1	605784	A, R			
19.934	3	14	03	19q13.43	VN1R1, V1RL1	P	Vomeronasal 1 receptor 1	605234	R			
19.935	2	12	16	19q13.42	VSTM1, SIRL1	P	V-SET and transmembrane domains-containing protein 1	616804	REc			
19.936	9	2	10	19q13.43	ZNF71	P	Zinc finger protein-71 (Cos26)	194545	REc	previously assigned to 22q11.2		
19.937	6	19	00	19q13.43	ZNF134	P	Zinc finger protein-134	604076	A			
19.938	6	19	00	19q13.43	ZNF135	P	Zinc finger protein-135	604077				
19.939	6	19	00	19q13.43	ZNF154	P	Zinc finger protein-154	604085	A			
19.940	10	4	99	19q13.41	ZNF175, OTK18	P	Zinc finger protein-175	601139	A			
19.941	8	24	09	19q13.43	ZNF264	P	Zinc finger protein-264	604668	R, REc			
19.942	5	10	04	19q13.43	ZNF272, HZF8, ZNF460	P	Zinc finger protein-272	604755	REc			
19.943	8	24	09	19q13.43	ZNF274	P	Zinc finger protein-274	605467	R, REa, REc			
19.944	5	10	04	19q13.12	ZNF461, GIOT1	P	Zinc finger protein-461	608640	REc			
19.945	12	29	06	19q13.42	ZNF628, ZEC	P	Zinc finger protein 628	610671	REc			
19.946	8	20	07	19q13.43	ZNF667, MIPU1	P	Zinc finger protein 667	611024	REc			
19.947	6	12	97	19q13.43	ZNFC25	P	Zinc finger protein-C2H2-25	601856	Psh, REc			
19.948	2	11	16	19q13.43	ZFP28	P	Zinc finger protine 28	616798	REc			
19.949	4	20	11	19q13.4-qter	AAVS1	P	Adeno-associated virus integration site-1	102699	REa, A			
19.950	11	25	13	19q13.41	LKL7, PRSS6, SCCE	P	Kallikrein-related peptidase 7	604438	REc			
19.951	8	19	13	19q13.41	MIRLET7E, LET7E	P	Micro RNA Let7e	611250	REc			
19.952	3	29	12	19q13.41	MIR99B	P	Micro RNA 99B	614510	REc			
19.953	4	6	15	19q13.42	MIR371A	P	Micro RNA 371A	612043	REc			
19.954	3	23	09	19q13.42	MIR372, MIRN372	P	Micro RNA 372	612044	REc			
19.955	3	23	09	19q13.42	MIR373, MIRN373	P	Micro RNA 373	611954	REc			
19.956	3	1	16	19q13.41	ZNF468	P	Zinc finger protein 468	616841	REc			
19.957	5	16	11	19q13.41	ZNF480	P	Zinc finger protein 480	613910	REc			
19.958	12	26	13	19q13.41	ZNF528, KIAA1827	P	Zinc finger protein 528	615580	REc			
19.959	3	20	08	19q13.41	ZNF649	P	Zinc finger protein 649	611903	R, REc			
19.960	9	29	10	19q13.42	CCDC106	P	Coiled-coil domain-containing protein 106	613478	REc			
19.961	7	14	14	19q13.42	CDC42EP5, CEP5, BORG3	P	CDC42 effector protein 5	609171	REc			
19.962	8	19	13	19q13.42	DPRX	P	Divergent-paired related homeobox	611165	REc	many pseudogenes		
19.963	7	14	14	19q13.42	FIZ1, FLJ14768	P	FLT3-interacting zinc finger protein 1	609133	REc			
19.964	8	17	09	19q13.42	HSPBP1	P	Heat-shock 70kD protein-binding protein 1	612939	REc			
19.965	8	17	09	19q13.42	ISOC2	P	Isochorismatase domain-containing 2	612928	REc			
19.966	9	28	15	19q13.42	LENG8, KIAA1932	P	Leukocyte receptor cluster gene 8	616575	R, REc			
19.967	12	30	14	19q13.42	LIAR2, CD306	P	Leukocyte-associated immunoglobulin-like receptor 2	602993	REc			
19.968	11	11	14	19q13.42	LILRA4, ILT7	P	Leukocyte immunoglobulin-like receptor, subfamily A, member 4	607517	R, REc			
19.969	9	24	11	19q13.42	MIR519D, MIRN519D	P	Micro RNA 519D	614247	REc			
19.970	8	18	14	19q13.42	MIR520C	P	Micro RNA 520C	615908	REc			
19.971	3	25	15	19q13.42	MIR520G	P	Micro RNA 520G	616272	REc			
19.972	9	2	12	19q13.42	MIR520H	P	Micro RNA 520H	614755	REc			
19.973	8	24	09	19q13.42	NCR1, LY94, NKP46	P	Natural cytotoxicity triggering receptor 1 (lymphocyte antigen 94, mouse, homolog of)	604530	REa, REc			
19.974	5	25	13	19q13.42	NDUFA3	P	NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 3	603832	REc			
19.975	3	29	07	19q13.42	SAPS1, PP6R1, KIAA1115	P	SAPS domain family, member 1	610875	R, REc			
19.976	12	29	09	19q13.42	SUV420H2	P	Suppressor of variegation 4-20, Drosophila, homolog of, 2	613198	REc			
19.977	2	1	11	19q13.42	SYT5	P	Synaptotagmin-5	600782	REc			7(Syt5)
19.978	7	18	14	19q13.42	U2AF2, U2AF65	P	U2 small nuclear RNA auxiliary factor 2	191318	REc			
19.979	3	1	07	19q13.42	UBE2S, EPF5, E2EPF	P	Ubiquitin-conjugating enzyme E2S	610309	REc, R			
19.980	8	19	13	19q13.43	DUXA	P	Double homeobox A	611168	REc	many pseudogenes		
19.981	8	24	09	19q13.43	SLC27A5, FATP5, VLACSR, VLCSH2	P	Solute carrier family 27 (fatty acid transporter), member 5	603314	R, REc			
19.982	11	3	11	19q13.43	STK13, AIE2, SPGF5	C	Serine/threonine kinase 13, aurora/Ipl1-like	603495	RE, A, R		Spermatogenic failure 5, 243060 (3)	
19.983	6	13	12	19q13.43	UBE2M, UBC12	P	Ubiquitin-conjugating enzyme E2M	603173	REc			
19.984	1	13	11	19q13.43	ZNF8	P	Zinc finger protein-8	194532	REc	previously assigned to 20q13		
19.985	3	28	11	19q13.43	ZNF304	P	Zinc finger protein 304	613840	REc			
19.986	8	24	09	19q13.43	ZNF444, EZF2	P	Zinc finger protein 444	607874	R, REc			
19.987	3	8	16	19q13.43	ZNF543	P	Zinc finger protein 543	616847	REc			
19.988	1	7	14	19q13.43	ZNF582	P	Zinc finger protein 582	615600	REc			
19.989	5	16	11	19q13.43	ZNF606, ZNF328, KIAA1852	P	Zinc finger protein 606	613905	REc			
19.990	7	26	10	19q13.43	ZSCAN4, ZNF494	P	Zinc finger- and SCAN domain-containing protein 4	613419	REc, H			7(Zscan4)
19.991	8	24	09	19q13.43	ZSCAN22, HKR2	P	Zinc finger- and SCAN domain-containing protein 22	165260	REa			
19.992	6	19	00	Chr.19	ZNF97	P	Zinc finger protein-97	603979	REc			
20.1	8	23	01	20q11.22	NFS1, NIFS	P	Nitrogen fixation gene 1	603485	R			
20.2	5	13	93	20p12.3	CHGB, SCG1	C	Chromogranin B (secretogranin B)	118920	REa, A, H			2(Scg1)
20.3	10	28	99	20p13	PRND, DPL	P	Prion gene complex, downstream (doppel)	604263	REc			2(Prnd)
20.4	11	27	13	20p13	PRNP, PRIP, KURU, CJD	C	Prion protein (p27-30)	176640	REa, REb, A	pter-PRNP-SCG1-BMP2A-PAX1-cen	Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease, 137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3); {Kuru, susceptibility to}, 245300 (3); Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	2(Prnp)
20.5	10	8	08	20pter-p11.2	BMIQ6	P	Body mass index quantitative trait locus 6	608559	Fd	near D20S482 and D20S851	[Body mass index QTL6] (2)	
20.6	9	3	02	20p13	ADAM33	P	A disintegrin and metalloproteinase domain 33	607114	REc			
20.7	8	26	09	20p13	ADRA1D, ADRA1A	C	Adrenergic, alpha-1D-, receptor	104219	A	incorrectly assigned to 5q		11(Adra1a)
20.8	4	23	04	20p13	ALS7	P	Amyotrophic lateral sclerosis 7	608031	Fd	max lod at D20S103	Amyotrophic lateral sclerosis 7 (2)	
20.9	6	28	99	20p13	ANGPT4, ANG4	P	Angiopoietin 4	603705	A	no ANGT3 in human		2(Angpt3)
20.10	9	18	12	20p13	AP5S1, C20orf29	P	Adaptor-related protein complex 5, sigma-1 subunit	614824	REc			
20.11	8	14	00	20p13	ATRN, MGCA	P	Attractin (mahogany, mouse, homolog of)	603130	REc			2(Atrn)
20.12	4	25	93	20p13	AVP, AVRP, VP	C	Arginine vasopressin (neurophysin II, antidiuretic hormone)	192340	REa, RE, Fd	distal 20p	Diabetes insipidus, neurohypophyseal, 125700 (3)	2(Avp)
20.13	12	29	06	20p13	C20orf28, CLAMP, SPEF1	P	Sperm flagellar protein 1	610674	REc			2(Spef1)
20.14	8	5	11	20p13	C20orf194	P	Chromosome 20 open reading frame 194	614146	REc			
20.15	11	4	93	20p13	CDC25B	C	Cell division cycle 25B	116949	REa, A, Psh			
20.16	6	15	99	20p12.3	CDS2	C	CDP-diacylglycerol synthase 2	603549	R, A, H			2(Cds2)
20.17	1	12	95	20p13	CENPB	C	Centromeric protein B	117140	REa, A			
20.18	10	23	92	20p13	CSNK2A1, CK2A1	C	Casein kinase-2, alpha-1 polypeptide	115440	REa, A	pseudogene on 11p15		
20.19	2	3	15	20p13	DDRGK1, UFBP1, C20orf116	P	DDRGK domain-containing protein 1	616177	REc			
20.20	3	22	06	20p13	EBF4, KIAA1442	P	Early B-cell factor 4	609935	R, REc			
20.21	3	23	14	20p13	FAM110A, C20orf55	P	Family with sequence similarity 110, member A	611393	REc			
20.22	10	5	11	20p13	FASTKD5	P	Fast kinase domain-containing protein 5	614272	REc			
20.23	4	25	93	20p13	FKBP1A, FKBP12	C	FK506-binding protein-1A, 12kD	186945	Psh, A			
20.24	2	18	98	20p13	GNRH2	P	Gonadotropin-releasing hormone-2	602352	A			
20.25	1	16	07	20p13	HSPA12B	P	Heat-shock 70kD protein 12B	610702	REc			2(Hspa12b)
20.26	5	4	12	20p13	IDH3B, RP46	P	Isocitrate dehydrogenase 3, beta subunit	604526	R, A		Retinitis pigmentosa 46, 612572 (3)	
20.27	7	17	03	20p12.3	KIND1, URP1, C20orf42	C	Kindlin 1	607900	REc, Fd		Kindler syndrome, 173650 (3)	
20.28	10	12	09	20p13	MAVS, VISA, IPS1, MAVS, CARDIF, KIAA1271	P	Mitochondrial antiviral signaling protein	609676	R, REc			
20.29	12	21	09	20p13	MIR103-2, MIRN103-2	P	Micro RNA 103-2	613188	REc			
20.30	8	9	11	20p13	MIR1292, MIRN1292	P	Micro RNA 1292	614155	REc			
20.31	4	24	08	20p13	MRPS26, MRPS13	P	Mitochondrial ribosomal protein S26	611988	R, REc			
20.32	9	6	11	20p13	NOP56, SCA36	P	Nop56, S. cerevisiae, homolog of	614154	REc		Spinocerebellar ataxia 36, 614153 (3)	
20.33	12	29	06	20p13	NRSN2	P	Neurensin 2	610666	REc			
20.34	4	25	93	20p13	OXT	C	Oxytocin-neurophysin I	167050	RE, Fd, A	12kb from ARVP		2(Oxt)
20.35	12	21	10	20p13	PDYN, SCA23	C	Prodynorphin	131340	REa, A, Fd		Spinocerebellar ataxia 23, 610245 (3)	
20.36	9	28	12	20p12.3	PROKR2, PKR2, GPR73L1, HH3	P	Prokineticin receptor 2	607123	REc		Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	
20.37	7	11	11	20p13	PROSAPIP1, KIAA0552	P	Proline-rich synapse-associated protein-interacting protein 1	610484	R, REc			
20.38	8	17	92	20p13	PTPRA, PTPA, PTPRL2, LRP	C	Protein tyrosine phosphatase, receptor type, alpha polypeptide	176884	REa, A			2(Ptpa)
20.39	2	4	15	20p13	RBCK1, HOIL1, PGBM1, PBMEI	P	RANBP-type and C3HC4-type zinc finger-containing 1	610924	R, REc		Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	
20.40	8	8	08	20p13	RLS5	P	Restless legs syndrome, susceptibility to, 5	611242	Fd	max lod at D20S849	{Restless legs syndrome 5} (2)	
20.41	6	25	07	20p13	RSPO4, CRISTIN4	P	R-spondin family, member 4	610573	REc		Anonychia congenita, 206800 (3)	2(Rspo4)
20.42	2	15	06	20p13	SIRPG, SIRPB2	P	Signal regulatory protein, gamma	605466	Psh, R			
20.43	1	28	16	20p13	SIGLEC1, SN, CD169	P	Sialic acid-binding immunoglobulin-like lectin 1 (sialoadhesin)	600751	REa, A			2(Sn)
20.44	3	12	15	20p13	SNRPB, CCMS	P	Small nuclear ribonucleoprotein polypeptides B and B1	182282	REc		Cerebrocostomandibular syndrome, 117650 (3)	
20.45	8	29	02	20p13	SOX12, SOX22	P	SRY (sex-determining region Y)-box 12	601947	A			
20.46	7	13	98	20p13	SHPS1	P	SHP substrate-1	602461	A			2(Shps1)
20.47	1	20	06	20p11.23	SLC24A3, NCKX3	P	Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3	609839	REc			
20.48	7	11	12	20p13	SLC52A3, C20orf54, RFT2, BVVLS1	P	Solute carrier family 52, riboflavin transporter, member 3	613350	REc		Brown-Vialetto-Van Laere syndrome 1, 211530 (3); Fazio-Londe disease, 211500 (3)	
20.49	7	18	14	20p13	SMOX, SMO, PAO1, C20orf16, PAOH	P	Spermine oxidase	615854	REc			
20.50	12	7	07	20p13	SNPH	P	Syntaphilin	604942	R, REc			
20.51	5	16	05	20p13	STK35, CLIK1	P	Serine/threonine kinase 35	609370	REn			
20.52	2	25	14	20p13	TBC1D20, C20orf140, WARBM4	P	TBC1 domain family, member 20	611663	REc		Warburg micro syndrome 4, 615663 (3)	
20.53	2	18	96	20p13	TCF15	P	Transcription factor-15 (basic helix-loop-helix)	601010	A			2(Meso1)
20.54	2	26	02	20p13	TMC2	P	Transmembrane channel-like protein 2	606707	REc			
20.55	3	31	15	20p13	TRIB3, NIPK, SINK, C20orf97, SKIP3	P	Tribbles, Drosophila, homolog of, 3	607898	R, REc			
20.56	11	19	15	20p13	VPS16	P	Vacuolar protein sorting 18, yeast, homolog of	608550	REc			
20.57	10	5	10	20p12.3	CRLS1, GCD10, C20orf155	P	Cardiolipin synthase 1	608188	REc			
20.58	3	19	15	20p12.3	MCM8, POF10	C	Minichromosome maintenance complement component 8	608187	REc	mutation identified in 1 POF10 family	?Premature ovarian failure 10, 612885 (3)	
20.59	3	9	10	20p13	PANK2, NBIA1, PKAN, HARP	P	Pantothenate kinase 2	606157	LD, Fd		Neurodegeneration with brain iron accumulation 1, 234200 (3); HARP syndrome, 607236 (3)	
20.60	7	22	11	20p13	TGM6, TG6, TGY, SCA35	P	Transglutaminase 6	613900	REc		Spinocerebellar ataxia 35, 613908 (3)	2(Tgm6)
20.61	12	24	08	20p13	RNF24, G1L	P	Ring finger protein 24	612489	REc			
20.62	3	30	16	20p13	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	C	Solute carrier family 4 (sodium borate cotransporter), member 11	610206	REc, Fd		Corneal endothelial dystrophy, autosomal recessive, 217700 (3); Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	
20.63	8	26	09	20p13	SLC23A2, SVCT2	C	Solute carrier family 23 (nucleobase transporters), member 2 (sodium-dependent vitamin C transporter 2)	603791	R, REc			
20.64	1	22	08	20p12.3	BMND7	P	Bone mineral density QTL 7	611738	Fd	most significant association with haplotype C	{Osteoporosis}, 166710 (2)	
20.65	2	23	09	20p12.3	CRCS11	P	Colorectal cancer, susceptibility to, 11	612592	Fd	associated with rs961253	{Colorectal cancer, susceptibility to, 11} (2)	
20.66	7	27	11	20p12.3	GPCPD1, GDE5, KIAA1434	P	Glycerophosphocholine phosphodiesterase GDE1, S. cerevisiae, homolog of	614124	REc			
20.67	1	21	16	20p12.3	TMX4	P	Thioredoxin-related transmembrane protein 4	616766	REc			
20.68	9	10	07	20p12.1	SPTLC3, SPTLC2L	P	Serine palmitoyltransferase, long-chain base subunit 3	611120	REc			
20.69	12	27	13	20p12.2	BTBD3, KIAA0952	P	BTB/POZ domain-containing protein 3	615566	REc			
20.70	6	1	12	20p12.2	LAMP5, BADLAMP	P	Lysosome-associated membrane protein 5	614641	REc			
20.71	9	20	14	20p12.2	SLX4IP, C20orf94	P	SLX4-interacting protein	615958	REc			
20.72	9	11	08	20p12.1	DSTN, ADF	P	Destrin	609114	R, REc			
20.73	6	22	14	20p12.1	ISM1, ISM	P	Isthmin 1, angiogenesis inhibitor	615793	REc			2(Ism1)
20.74	12	17	12	20p12.1	NDUFAF5, C20orf7	P	NADH dehydrongenase (ubiquinone) complex I, assembly factor T	612360	REc		Mitochondrial complex 1 deficiency, 252010 (3)	
20.75	10	18	11	20p12.1	SEL1L2	P	Suppressor of Lin12-like 2	614289	REc			
20.76	5	25	13	20p12.1	SNRPB2	P	Small nuclear ribonucleoprotein polypeptide B-double prime	603520	REc			
20.77	3	22	07	20p12.1	TASP1, C20orf13	P	Threonine aspartase 1	608270	REc			
20.78	7	23	13	20p12.1	BFSP1, CP115, CTRCT33	P	Beaded filament structural protein-1 (filensin)	603307	A		Cataract 33, 611391 (3)	
20.79	10	10	11	20p12.3	BMP2, BMP2A, BDA2	C	Bone morphogenetic protein-2	112261	H, REa, A		{HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly, type A2, 112600 (3)	2(Bmp2a)
20.80	8	29	05	20p12	GLC1K, JOAG3	P	Glaucoma 1K, primary open angle, juvenile-onset	608696	Fd	between D20S189 and D20S104	Glaucoma 1K, primary open angle, juvenile-onset (2)	
20.81	2	1	01	20p12.3	HAO1, GOX1	C	Hydroxyacid oxidase 1	605023	R, REc			
20.82	8	26	15	20p12.2	JAG1, AGS, AHD	C	Jagged 1	601920	Ch, D, Fd, A, REc	mutation identified in 1 DFNCDPE family	Alagille syndrome, 118450 (3); Tetralogy of Fallot, 187500 (3); ?Deafness, congenital heart defects, and posterior embryotoxon (3)	
20.83	2	23	08	20p12.1	MACROD2, C2orf133	P	Macro domain-containing 2	611567	REc			
20.84	10	16	14	20p12.2	MKKS, HMCS, KMS, MKS, BBS6	C	McKusick-Kaufman syndrome gene	604896	Fd		McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6, 605231 (3)	
20.85	8	5	14	20p12.3	PCNA, ATLD2	C	Proliferating cell nuclear antigen	176740	REa, A	pseudogenes on X and 6; mutation identified in one ATLD2 family	?Ataxia-telangiectasia-like disorder, 615919 (3)	
20.86	2	11	11	20p12.3	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12	C	Phospholipase C, beta-1	607120	A, Psh		Epileptic encephalopathy, early infantile, 12, 613722 (3)	
20.87	6	4	12	20p12.3-p12.2	PLCB4, ARCND2	P	Phospholipase C, beta 4	600810	Psh, A		Auriculocondylar syndrome 2, 614669 (3)	
20.88	5	31	06	20p12	SLEB7	P	Systemic lupus erythematosus, susceptibility to, 7	610065	Fd		{Systemic lupus erythematosus, susceptibility to, 7} (2)	
20.89	8	27	01	20p11.21	NXT1, MTR2	P	NTF2-related export protein 1	605811	REc			
20.90	5	19	98	20p12.1	RRBP1, ES130	P	Ribosome binding protein-1	601418	A			
20.91	1	9	13	20p11.23	LINC00237	P	Long intergenic noncoding RNA 237	614992	A			
20.92	5	22	14	20p11.23	KIZ, KIZUNA, C20orf19, RP69	P	Kizuna centrosomal protein	615757	REc		Retinitis pigmentosa 69, 615780 (3)	
20.93	2	21	13	20p11.23	MGME1, C20orf72, MTDPS11	P	Mitochondrial genome maintenance exonuclease 1	615076	REc		Mitochondrial DNA depletion syndrome 11, 615084 (3)	
20.94	3	30	16	20p11.23	OVOL2, ZNF339, PPCD1	P	ovo-like 2	616441	RE, H, REc		Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	2(Ovol2)
20.95	8	21	12	20p11.23	PET117	P	PET117, S. cerevisiae, homolog of	614771	REc			
20.96	12	1	11	20p11.21	ACSS1, ACECS1	P	Acyl-CoA synthetase short-chain family, member 1	614355	REc			
20.97	12	18	08	20p11.22	AGA3	P	Alopecia, androgenetic, 3	612421	Fd	associated with rs1160312	Alopecia, androgenetic, 3 (2)	
20.98	10	12	09	20p11.23	RIN2, MACS	P	RAS and RAB interactor 2	610222	R, REc		Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	
20.99	5	21	07	20p11.23	CRNKL1, CRN	C	Crooked neck pre-mRNA splicing factor-like 1	610952	REc, A			
20.100	4	15	98	20p11.21	CST1	P	Cystatin SN	123855	A			
20.101	4	15	98	20p11.21	CST2	C	Cystatin SA	123856	REa, A			
20.102	4	23	08	20p11.21	CST3, ARMD11	C	Cystatin C	604312	REa, A	proximal to 20p11.2	Cerebral amyloid angiopathy, 105150 (3); Macular degeneration, age-related, 11, 611953 (3)	2(Cst3)
20.103	4	15	98	20p11.21	CST4	P	Cystatin S	123857	A			
20.104	1	27	11	20p11.21	ABHD12, PHARC	P	Abhydrolase domain-containing protein 12	613599	REc, Fd		Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	
20.105	8	8	13	20p11.21	C1QR1, CD93, C1QR	P	Complement component 1, q subcomponent, receptor 1	120577	REc			
20.106	3	31	97	20p11.21	CST5	P	Cystatin D	123858	A			
20.107	11	11	14	20p11.21	CST7, CMAP	P	Cystatin 7	603253	A, H			2(Cst7)
20.108	11	28	05	20p11.21	CST11, CST8L	P	Cystatin 11	609731	REc			
20.109	11	30	06	20p11.21	GINS1, PSF1, KIAA0186	P	GINS complex subunit 1	610608	R, REc			
20.110	3	31	11	20p11.21	GZF1, ZNF336	P	GDNF-inducible zinc finger protein 1	613842	REc			2(Gzf1)
20.111	8	19	13	20p11.21	NAPB, SNAPB	P	N-ethylmaleimide-sensitive factor attachment protein, beta	611270	REc, R			
20.112	10	25	11	20p11.21	SYNDIG1, TMEM90B	P	Synapse differentiation-induced gene 1	614311	REc			
20.113	7	17	14	20p11.21	APMAP, C20orf3, BSCV	P	Adipocyte plasma membrane-associated protein	615884	REc			
20.114	9	4	15	20p11.21	CST9, CLM	P	Cystatin 9	616543	REc			
20.115	9	2	15	20p11.21	CST9L	P	Cystatin 9-like	616536	R			
20.116	8	9	99	20p11.23	INSM1, IA1	P	Insulinoma-associated 1	600010	A			
20.117	3	6	07	20p11.23	NAT5, NAT3	P	N-acetyltransferase 5	610833	REc, R			
20.118	12	5	13	20p11.22	PAX1, OFC2	C	Paired box homeotic gene-1	167411	A, Psh, REa	mutation identified in 1 family	?Otofaciocervical syndrome 2, 615560 (3)	2(Pax1)
20.119	5	14	95	20p11.21	SSTR4	P	Somatostatin receptor-4	182454	A, Psh			2(Sstr4)
20.120	9	29	96	20p12.1	PCSK2, NEC2, PC2	C	Proprotein convertase subtilisin/kexin type 2	162151	A, R			2(Nec2)
20.121	2	20	01	20p11.23	RBBP9, BOG	P	Retinoma-binding protein 9	602908	A			2(Rbbp9)
20.122	3	11	16	20p11.23	SEC23B, CDAN2, HEMPAS, CWS7	P	Sec23, S. cerevisiae, homolog of, B	610512	R, REc, Fd		Dyserythropoietic anemia, congenital, type II, 224100 (3); Cowden syndrome 7, 616858 (3)	
20.123	4	30	15	20p12.2	SNAP25, CMS18	P	Synaptosomal-associated protein, 25kD	600322	R	mutation identified in 1 CMS18 patient	?Myasthenic syndrome, congenital, 18, 616330 (3)	2(Snap)
20.124	3	1	12	20p11.21	THBD, THRM, AHUS6, THPH12	C	Thrombomodulin	188040	REb, A, R		Thrombophilia due to thrombomodulin defect, 614486 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	2(Thbd)
20.125	3	30	16	20p11.21	VSX1, RINX, KTCN1, CAASDS	C	Visual system homeo box gene 1, zebrafish, homolog of	605020	R, Fd	mutation identified in 1 CAASDS family	Keratoconus 1, 148300 (3); ?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	
20.126	6	19	00	20p11.23	ZNF133	P	Zinc finger protein-133	604075	A			
20.127	4	24	96	20p11.21	PYGB	C	Phosphorylase, glycogen, brain	138550	REa, REb, A			2(Pygb)
20.128	8	18	04	20p11.22	XRN2	P	Exoribonuclease 2	608851	R			
20.129	11	25	08	20p11.2-q13.12	DYT17	P	Dystonia-17, primary torsion	612406	Fd	between D20S472 and D20S911	Dystonia-17, primary torsion (2)	
20.130	10	9	08	20p11.21	GGTLC1, GGTL6, GGTLA4	P	Gamma-glutamyltransferase, light chain 1	612338	REc			
20.131	5	22	07	20p11.23	DTD1, C20orf88	P	D-tyrosyl-tRNA deacylase 1, S. cerevisiae, homolog of	610996	REc			
20.132	6	11	13	20p12.1	FLRT3, HH21	P	Fibronectin-like domain-containing leucine-rich transmembrane protein-3	604808	REc		Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3)	
20.133	9	18	02	20p11.21	FOXA2, HNF3B	C	Forkhead box A2 (hepatic nuclear factor-3, beta)	600288	H, A			2(Hnf3b)
20.134	2	16	07	20p11.21	NANP, HDHD4	P	N-acetylneuraminic acid phosphatase	610763	REc			
20.135	2	11	08	20p11.22	NKX2-2, NKX2B	P	NK2, homeobox 2	604612	A			
20.136	2	11	08	20p11.22	NKX2-4, NKX2D	P	NK2 homeobox 4	607808	R, H			2(Nkx2d)
20.137	7	11	01	20p12.1	OTOR	C	Otoraplin	606067	A, REc			2(Otor)
20.138	8	26	09	20p11.23	SNX5	P	Sorting nexin 5	605937	R, REc			
20.139	11	20	15	20p13	ITPA, EIEE35	C	Inosine triphosphatase-A	147520	S		[Inosine triphosphatase deficiency], 613850 (3); Epileptic encephalopathy, early infantile, 35, 616647 (3)	2(Itp)
20.140	4	10	97	20q11.22	MAP1ALC3, MAP1BLC3	P	Microtubule-associated proteins 1A and 1B, light chain 3	601242	REa			
20.141	2	21	11	20q11.22	AHCY, SAHH	C	S-adenosylhomocysteine hydrolase	180960	S, F	~13cM from ADA	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	
20.142	7	26	02	20p	AD8	P	Alzheimer disease 8	607116	Fd	?related to CST3	Alzheimer disease 8, 104300 (2)	
20.143	10	12	09	20p	ATOD3	P	Dermatitis, atopic, 3	605804	Fd	max lod at D20S115	{Dermatitis, atopic, susceptibility to, 3} (2)	
20.144	12	11	02	20p13	P47	P	p47, rat, homolog of	606610	REc			
20.145	1	8	01	20q12	LPIN3	P	Lipin 3	605520	REc			2(Lpin3)
20.146	4	30	15	20q13.33	OSBPL2, ORP2, KIAA0772, DNFA67	C	Oxysterol-binding protein-like protein 2	606731	R, REc		Deafness, autosomal dominant 67, 616340 (3)	
20.147	6	26	01	20q13.12	PKIG	P	Protein kinase, cAMP-dependent catalytic, inhibitor gamma	604932	R			
20.148	6	1	12	20q11.21	BPIFA1, PLUNC, SPLUNC1	P	BPI fold-containing protein, family A, member 1	607412	H, REc			2(Plunc)
20.149	6	1	12	20q11.21	BPIFB2, BPIL1	P	BPI fold-containing protein, family B, member 2	614108	Psh, R, REc			
20.150	6	1	12	20q11.21	BPIFB6, BPIL3	P	BPI fold-containing protein, family B, member 6	614110	Psh, R, REc			
20.151	3	25	03	20q11.21	DEFB118, C20orf63, ESC42	P	Defensin, beta, 118	607650	REc			
20.152	1	15	96	20q11.21	ID1	P	Inhibitor of DNA binding 1, dominant negative	600349	REa, A			
20.153	12	19	01	20q11.22	NCOA6, ASC2, RAP250, NRC, PRIP	P	Nuclear receptor coactivator 6	605299	R, A			
20.154	3	8	07	20q11.21	PDRG1, PDRG, C20orf126	P	P53 and DNA damage-regulated 1	610789	REc			2(Pdrg1)
20.155	10	23	87	20q11.21	HCK	P	Hemopoietic cell kinase	142370	REb, A			
20.156	7	18	06	20q11-q13	HYT5	P	Hypertension, essential, susceptibility to, 5	610261	Fd		{Hypertension, essential, susceptibility to, 5}, 145500 (2)	
20.157	1	19	07	20q11-q13	SCAR6, CLA3	P	Spinocerebellar ataxia, autosomal recessive 6	608029	Fd	between D20S471 and D20S119	Spinocerebellar ataxia, autosomal recessive 6 (2)	
20.158	11	5	14	20q11.21	DEFB119, DEFB120, DEFB20	P	Defensin, beta, 119	615997	REc, H			2(Defb19)
20.159	11	5	14	20q11.21	DEFB121, DEFB21	P	Defensin, beta, 121	616075	REc, H			2(Defb21)
20.160	11	5	14	20q11.21	DEFB122, DEFB22	P	Defensin, beta, 122, pseudogene	616077	REc			2(Defb22)
20.161	11	4	15	20q11.21	DEFB123, DEFB23	P	Defensin, beta, 123	616076	REc, H			2(Defb23)
20.162	7	20	12	20q11.21	FOXS1, FKHL18, FREAC10	P	Forkhead box S1	602939	REa, A			
20.163	8	27	01	20q11.21	MAPRE1, EB1	C	Microtubule-associated protein, RP/EB family, member 1	603108	A, REc			
20.164	5	26	13	20q11.22-q11.23	PHF20, GLEA2, HCA58	P	PHD finger protein 20	610335	REc, Psh			
20.165	11	30	11	20q11.22	ASIP, AGTIL, SHEP9	C	Agouti, mouse, signaling protein	600201	Psh, A		[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3); [Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	2(a)
20.166	5	11	01	20q11.21	C20orf1, P100	P	Proliferation-associated nuclear protein, 100kD	605917	A			
20.167	4	4	05	20q11.21-q11.22	CBFA2T2, MTGR1, EHT	P	Core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (ETO homolog on chromosome 20)	603672	Psh, A			
20.168	8	26	09	20q11.21	CDK5RAP1	P	CDK5 regulatory subunit-associated protein 1	608200	R, REc			
20.169	12	28	08	20q11.22	CEP2, CEP250, CNAP1	P	Centrosomal protein 2	609689	R			
20.170	9	24	08	20q11.2	CMM7	P	Melanoma, cutaneous malignant, susceptibility to, 7	612263	Fd	between rs910873 and rs1885120	{Melanoma, cutaneous malignant, 7} (2)	
20.171	11	29	99	20q11.21	DNMT3B, ICF1	C	DNA methyltransferase 3B	602900	A, Fd		Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	
20.172	7	1	98	20q11.22	E2F1	P	E2F transcription factor-1	189971	A			
20.173	10	3	07	20q11.22	EIF6, EIF3A, ITGB4BP	P	Eurkaryotic translation initiation factor 6	602912	A			
20.174	9	28	00	20p11.21	ENTPD6, CD39L2	P	Ectonucleoside triphosphate diphosphohydrolase 6	603160	R, Psh			
20.175	8	20	15	20q11.22	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	C	Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146	H, Fd	mutation identified in 1 AMDHT family	?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3); Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Du Pan syndrome, 228900 (3); Brachydactyly, type A2, 112600 (3); Symphalangism, proximal, 1B, 615298 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis-5}, 612400 (3); Brachydactyly, type A1, C, 615072 (3)	2(bp)
20.176	10	9	08	20q11.22	GGT7, GGTL3, GGTL5, GGT4	P	Gamma-glutamyltransferase 7	612342	REc			
20.177	8	24	98	20q11.23	GHRH, GHRF	C	Growth hormone releasing hormone (somatocrinin)	139190	REa, REb, Ch, Fd, A		?Isolated growth hormone deficiency due to defect in GHRF (1); Gigantism due to GHRF hypersecretion (1)	
20.178	7	1	05	20q11.22	GSS, GSHS	P	Glutathione synthetase	601002	REa, A		Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3); Glutathione synthetase deficiency, 266130 (3)	
20.179	5	11	00	20q11.22	MMP25	P	Matrix metalloproteinase 24	604871	A			
20.180	11	27	00	20q11.22	PROCR, EPCR, CCCA, CCD41	P	Protein C receptor	600646	R, A			2(Procr)
20.181	5	27	94	20q11.23	RBL1, CP107	P	Retinoblastoma-like 1 (p107)	116957	A			2(Rbl1)
20.182	1	4	16	20q11.23	SAMHD1, AGS5, DCIP, CHBL2	P	SAM domain- and HD domain-containing protein 1	606754	REc	mutation identified in 1 CHBL2 family	Aicardi-Goutieres syndrome 5, 612952 (3); ?Chilblain lupus 2, 614415 (3)	
20.183	9	21	15	20q11.21	SNTA1, SNT1, TACIP1, LQT12	C	Syntrophin, alpha-1	601017	REa, Psh, A		Long QT syndrome 12, 612955 (3)	2(Snta1)
20.184	5	16	11	20q11.21	SUN5, TSARG4, SPAG4L	P	Sad1 and Unc84 domain-containing protein 5	613942	REc			
20.185	12	8	98	20q11.22	SPAG4	P	Sperm-associated antigen-4	603038	A			
20.186	12	2	09	20q11.23	BLCAP, BC10	P	Bladder cancer-associated protein	613110	REc			
20.187	8	20	08	20q11.23	CTNNBL1, NAP	P	Catenin, beta-like, 1	611537	REc			2(Ctnnbl1)
20.188	3	5	14	20q11.23	EPB41L1, MRD11	P	Erythrocyte membrane protein band 4.1-like 1	602879	R, Psh	mutation identified in 1 patient	?Mental retardation, autosomal dominant 11, 614257 (3)	
20.189	3	31	09	20q11.2-q12	MLRL, MTS	P	Myeloid leukemia-related locus (myeloid tumor suppressor)	601308	Ch			
20.190	10	15	98	20q11.23	NNAT	P	Neuronatin	603106	Psh, A			2(Nnat)
20.191	2	28	03	20q11.23	TGIF2	P	Transforming growth factor-beta-induced factor 2	607294	A			
20.192	1	12	95	20q11.23	TGM2	C	Transglutaminase-2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)	190196	A, Psh			
20.193	4	19	12	20q12	MAFB, KRML, MCTO	P	v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein B	608968	REc		Multicentric carpotarsal osteolysis syndrome, 166300 (3)	
20.194	10	12	09	20q13.12	MMP9, CLG4B, MANDP2	C	Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase)	120361	REa, Fd, H, A		Metaphyseal anadysplasia 2, 613073 (3)	2(Clg4b)
20.195	11	4	14	20q13.12	ZNF335, NIF1, NIF2, MCPH10	P	Zinc finger protein 335	610827	REc	mutation identified in 1 MCPH10 family	?Microcephaly 10, primary, autosomal recessive, 615095 (3)	
20.196	10	12	14	20q11.21	ABALON, INXS	P	Apoptotic BCL2L1-antisense long noncoding RNA	616018	REc			
20.197	10	25	11	20q11.21	ASXL1, KIAA0978, BOPS, MDS	P	Additional sex combs-like 1	612990	A, REc		Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome, somatic, 614286 (3)	
20.198	3	17	03	20q11.21	BASE	P	Breast cancer- and salivary gland-expressed gene	607627	REc			
20.199	3	1	10	20q11.21	BCL2L1, BCLX, BCLXL, BCLXS	P	BCL2-like 1	600039	REc			
20.200	4	10	14	20q11.21	BPIFBP3, RYA3	P	BPI fold-containing protein, family B, member 3	615717	REc			2(Bpifbp3)
20.201	4	10	14	20q11.21	BPIFB4, RY2G5	P	BPI fold-containing protein, family B, member 4	615718	REc			2(Bpifb4)
20.202	12	22	15	20q11.21	COMMD7	P	COMM domain-containing protein 7	616703	REc			
20.203	5	4	09	20q11.21	COX4I2	P	Cytochrome c oxidase, subunit IV, isoform 2	607976	REc		Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)	
20.204	7	23	13	20q11.22	CHMP4B, SNF7, CTPP3, CTRCT31	C	CHMP family, member 4B	610897	REc, Fd		Cataract 31, multiple types, 605387 (3)	
20.205	1	29	16	20q11.21	DUSP15, VHY	C	Dual-specificity phosphatase 15	616776	REn, REc			
20.206	8	26	09	20q11.21	HM13, SPP	P	Minor histocompatibility 13 (signal peptide peptidase)	607106	R, REc			
20.207	8	26	09	20q11.21	KIF3B, KIAA0359	P	Kinesin family member 3B	603754	R, REc			
20.208	8	3	12	20q11.21	PLAGL2	P	Pleomorphic adenoma gene-like 2	604866	REc			
20.209	7	23	13	20q11.21	POFUT1, OFUCT1, KIAA0180, DDD2	P	Protein O-fucosyltransferase 1	607491	REc		Dowling-Degos disease 2, 615327 (3)	
20.210	8	19	13	20q11.21	REM1, GES	P	Ras (Rad and Gem)-like GTP-binding 1	610388	REc, R			
20.211	9	19	00	20q11.23	NDRG3	P	N-myc downstream-regulated gene 3	605273	REc, R			
20.212	5	13	08	20q11.22	ACSS2, ACS	P	Acetyl-CoA synthetase short-chain family member 2	605832	R, REc			
20.213	5	25	13	20q11.22	CPNE1, CPN1	P	Copine I	604205	REc			
20.214	5	24	13	20q11.22	EDEM2	P	Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2	610302	REc			
20.215	1	27	11	20q11.22	MIR499, MIRN499	P	Micro RNA 499	613614	REc			2(Mir499)
20.216	3	1	06	20q11.22	MYH7B, MYH14, KIAA1512	C	Myosin, heavy chain 7B, cardiac muscle, beta	609928	R, REc			
20.217	12	17	08	20q11.22	NECAB3, EFCBP3, NIP1, APBA2BP, XB51, STIP3	P	N-terminal EF-hand calcium-binding protein 3	612478	REc			
20.218	4	27	16	20q11.22	PIGU, CDC91L1	C	Phosphatidylinositol glycan anchor biosynthesis class U protein	608528	REc, REn			
20.219	6	2	15	20q11.22	PXMP4, PMP24	P	Peroxisomal membrane protein 4	616397	REc			
20.220	10	2	12	20q11.22	RBM39, CAPER, RNPC2	P	RNA binding motif protein 39	604739	REc, R			
20.221	2	17	09	20q11.22	STQTL14	P	Stature quantitative trait locus 14	612228	Fd	associated with rs6060373	{Stature QTL 14} (2)	
20.222	2	17	09	20q11.22	UQCC, CBP3, BFZB, C20orf44	P	Ubiquinol-cytochrome C reductase complex chaperone	611797	REc			
20.223	9	20	14	20q11.22	ITCH, AIP4, NAPP1, ADMFD	P	Itchy, mouse, homolog of	606409	A, R		Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	2(Itch)
20.224	2	25	10	20q11.23	PPP1R16B, TIMAP, KIAA0823	P	Protein phosphatase 1, regulatory subunit 16B	613275	REc			
20.225	2	13	13	20q11.23	ADIG, SMAF1	P	Adipogenin	611396	REc			2(Smaf1)
20.226	2	4	15	20q11.23	DLGAP4, SAPAP4, KIAA0964	P	Discs LARGE-associated protein 4	616191	REc	noncoding RNAs transcribed from intron 1 are expressed in all tissues		
20.227	2	2	16	20q11.23	DSN1, C20orf172	P	DSN1 homolog, MIS12 kinetochore complex component	609175	REc			
20.228	2	21	06	20q11.23	MYL9, MLC2	P	Myosin light chain 9, regulatory	609905	R, REc			
20.229	7	18	12	20q11.23	RPRD1B, CREPT	P	Regulation of nuclear pre-mRNA domain-containing protein 1B	614694	REc			
20.230	5	24	13	20q11.23	SCAND1, RAZ1, SDP1	P	SCAN domain-containing 1	610416	REc			
20.231	8	26	09	20q11.23	SLA2, SLAP2	P	SRC-like adaptor 2	606577	R, REc			
20.232	2	2	04	20q11.22	TRPC4AP, TRUSS	P	TRPC4-associated protein	608430	R, REc			2(Trpc4ap)
20.233	1	18	12	20q11.23	TTI1, KIAA0406	P	TELO2-interacting protein 1	614425	R, REc			
20.234	9	2	15	20q11.23	VSTM2L, C20orf102	P	V-SET and transmembrane domains-containing protein 2-like	616537	REc			
20.235	12	3	14	20q12	CHD6, CHD5, RIGB	P	Chromodomain helicase DNA-binding protein 6	616114	REc			
20.236	4	25	93	20q11.23	BPI	P	Bactericidal/permeability-increasing protein	109195	REa, A			
20.237	4	25	93	20q11.23	LBP	P	Lipopolysaccharide-binding protein	151990	REa, A			
20.238	9	18	08	20q13.12	DBNDD2, HSMNP1	P	Dysbindin domain-containing 2	611453	A			
20.239	4	11	11	20q13.12	JPH2, JP2, CMH17	P	Junctophilin 2	605267	A		Cardiomyopathy, hypertrophic, 17, 613873 (3)	
20.240	11	12	10	20q13.12	L3MBTL, L3MBTL1, KIAA0681	C	L3MBT-like	608802	Psh, R			
20.241	2	1	00	20q13.12	NCOA3, AIB1, TNRC14	P	Nuclear receptor coactivator 3 (amplified in breast cancer-1)	601937	Pcm			
20.242	5	14	95	20p13	TGM3	P	Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase)	600238	Psh, A			
20.243	11	21	02	20q13.12	KCNK15, TASK5	C	Potassium channel, subfamily K, member 15	607368	REc			
20.244	5	27	94	20q13.12	PI3	P	Protease inhibitor 3, skin derived (SKALP)	182257	REa, A			
20.245	12	19	96	20q13.12	SDC4	P	Syndecan 4 (amphiglycan, ryudocan)	600017	A, H			2(Sdc4)
20.246	10	4	05	20q12	ZHX3, KIAA0395	P	Zinc finger and homeodomain protein-3	609598	R, REc			
20.247	5	5	16	20q11.23	SRC, ASV, SRC1, THC6	C	Protooncogene SRC, Rous sarcoma	190090	REa, A, REb	?20q11.2	Colon cancer, advanced, somatic, 114500 (3); Thrombocytopenia 6, 616937 (3)	2(Src)
20.248	3	29	99	20q13.12	WISP2	P	Wnt-1 inducible signaling pathway protein 2	603399	R			
20.249	10	13	14	20q13.12	HNF4A, TCF14, MODY1, FRTS4	C	Hepatocyte nuclear factor 4, alpha (transcription factor-14)	600281	Fd, A		MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	2(Hnf4a)
20.250	3	1	00	20q12-q13.1	NIDDM3	P	Noninsulin-dependent diabetes mellitus 3	603694	Fd		{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	
20.251	7	12	94	20q12	PLCG1, PLC1	C	Phospholipase C, gamma 1 (formerly subtype 148)	172420	REa, A, Fd			
20.252	12	17	07	20q13.12	PLTP, HDLCQ9	C	Phospholipid transfer protein	172425	REa, A		[High density lipoprotein cholesterol level QTL 9] (3)	2(Pltp)
20.253	12	11	13	20q12-q13	PTPRT, KIAA0283	P	Protein-tyrosine phosphatase, receptor-type, T	608712	REc, H			2(Ptprt)
20.254	12	10	91	20q11.23	RPN2	C	Ribophorin II	180490	REa, A			2(Rpn2)
20.255	7	13	93	20q13.12	SEMG1, SEMG	C	Semenogelin	182140	A, REn			
20.256	7	13	93	20q13.12	SEMG2	P	Semenogelin II	182141	REn			
20.257	12	22	15	20q13.12	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	C	Solute carrier family 12, (potassium-chloride transporter) member 5	606726	R, A		Epileptic encephalopathy, early infantile, 34, 616645 (3); {Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	5(Slc12a5)
20.258	10	24	01	20q13.12	SLC13A3, NADC3	P	Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3	606411	A			
20.259	5	16	11	20q13.12	SPINT3	P	Serin protease inhibitor, Kunitz-type, 3	613941	REc			
20.260	5	26	05	20q12	TOP1	C	Topoisomerase (DNA) I	126420	REa, A	pseudogenes on chr.1 and 22	DNA topoisomerase I, camptothecin-resistant (3)	2(Top1)
20.261	3	22	06	20q13.12	WFDC12, WAP2, SWAM2	C	Wap 4-disulfide core domain 12	609872	REc			
20.262	5	28	09	20q11.22	DYNLRB1, DNCL2A, DNLC2A	C	Dynein, light chain, roadblock type, 1	607167	R			
20.263	6	1	98	20q13.12	TNNC2	C	Troponin C2, fast	191039	Psh, R			
20.264	5	6	11	20q12-q13.12	PSMNSW	P	Parasomnia, sleepwalking type	613938	Fd	between 55.6 and 61.4 cM	Parasomnia, sleepwalking type (2)	
20.265	7	1	11	20q13.12	CD40, TNFRSF5	C	CD40 antigen	109535	A, D		Immunodeficiency with hyper-IgM, type 3, 606843 (3)	2(Cd40)
20.266	1	12	05	20q13.12	WFDC5, PRG5, WAP1	C	WAP 4-disulfide core domain 5	605161	REc			
20.267	9	30	10	20q13.33	BHLHE23, BHLHB4	P	Basic helix-loop-helix family, member E23	609331	A, REa, H			2(Bhlhb4)
20.268	6	3	98	20q13.13	CSE1L, CAS	P	Chromosome segregation-1, yeast, homolog of, like	601342	A			
20.269	9	10	09	20q13.32	CTSZ	C	Cathepsin Z	603169	A, REc			
20.270	6	3	15	20q13.33	EEF1A2, EIEE33, MRD38	P	Eukaryotic translation elongation factor-1, alpha-2	602959	H, A		Mental retardation, autosomal dominant 38, 616393 (3); Epileptic encephalopathy, early infantile, 33, 616409 (3)	2(wst, Eef1a2)
20.271	8	26	09	20q13.12	ELMO2, CED12	P	Engulfment and cell motility gene 2	606421	REc			
20.272	9	7	04	20q13	GEVQ2	P	Gene expression, variation in, quantitative trait locus on chromosome 20	608878	Fd		{Gene expression, variation in, QTL} (2)	
20.273	8	15	06	20q13	HPC3	P	Prostate cancer, hereditary, 3	608656	Fd		{Prostate cancer, susceptibility to, 3}, 176807 (2)	
20.274	2	12	09	20q13	IBD24	P	Inflammatory bowel disease 24	612566	Fd	associated with rs2315008 and rs4809330	{Inflammatory bowel disease 24} (2)	
20.275	5	21	99	20q13.13	KCNG1, KH2	P	Potassium voltage-gated channel, subfamily G, member 1	603788	A			
20.276	6	15	99	20q13.33	NTSR1	P	Neurotensin receptor	162651	A			2(Ntsr1)
20.277	3	7	13	20q13.31	PMEPA1, TMEPAI	P	Prostate transmembrane protein, androgen-induced	606564	REc			
20.278	8	24	09	20q13	PSORS12	P	Psoriasis susceptibility 12	612950	Fd	associated with rs495337	{Psoriasis susceptibility 12} (2)	
20.279	12	24	08	20q13.13	RNF114, ZNF313	P	Ring finger protein 114	612451	REc			
20.280	5	31	06	20q13	SLEB8	P	Systemic lupus erythematosus, susceptibility to, 8	610066	Fd		{Systemic lupus erythematosus, susceptibility to, 8} (2)	
20.281	8	20	01	20q13.32	TH1L, TH1	P	TH1, Drosophila, homolog of	605297	REn			
20.282	1	12	99	20q13.33	TNFRSF6B, DCR3	P	Tumor necrosis factor receptor superfamily, member 6b (decoy receptor 3)	603361	R, Fd			
20.283	3	17	06	20q13.12	ACOT8, PTE1	P	Acyl-CoA thioesterase 8	608123	R, REc			2(Acot8)
20.284	3	1	06	20q13.12	CDH22	P	Cadherin 22	609920	R, REc			
20.285	9	12	92	20q13.13	CEBPB, TCF5	C	CCAAT/enhancer-binding protein (C/EBP), beta (transcription factor-5)	189965	REa, A			2(Cebpb)
20.286	11	23	09	20q13.12	CTSA, PPGB, GSL, NGBE, GLB2	C	Cathepsin A (protective protein for beta-galactosidase)	613111	S, A, Fd		Galactosialidosis, 256540 (3)	2(Ppgb)
20.287	2	3	97	20q13.12	EYA2	C	Eyes absent, Drosophila, homolog of, 2	601654	A, R			2(Eya2)
20.288	9	23	96	20q13.12	MYBL2, BMYB	P	v-myb avian myeloblastosis viral oncogene homolog-like 2	601415	A			2(Mybl2)
20.289	2	19	15	20q13.12	NCOA5, CIA	P	Nuclear receptor coactivator 5	616825	REc			
20.290	5	2	06	20q13.12	SLC2A10, GLUT10, ATS	C	Solute carrier family 2 (facilitated glucose transporter), member 10	606145	REc, Fd		Arterial tortuosity syndrome, 208050 (3)	
20.291	10	22	99	20q13.13	SNAI1	P	Snail 1, Drosophila, homolog of	604238	A, R	pseudogene on 2q34		
20.292	3	31	15	20q13.13	STAU1, STAU	P	Staufen, Drosophila, homolog of, 1	601716	A, REa			
20.293	9	28	96	20q13.12	YWHAB	P	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide	601289	A			
20.294	11	29	99	20q13.13	B4GALT5	C	Beta-1,4-galactosyltransferase 5	604016	Psh, TM	previously mapped to chr.11		
20.295	2	7	01	20q13.12	MATN4	P	Matrilin 4	603897	A			
20.296	1	7	09	20q13.13	PTPN1, PTP1B	C	Protein tyrosine phosphatase, nonreceptor-type, 1	176885	REa, A, H	20pter-q12 by REa	{Insulin resistance, susceptibility to}, 125853 (3)	2(Ptpn1)
20.297	8	26	09	20q13.13	SPATA2, KIAA0757	P	Spermatogenesis-associated protein 2	607662	R, REc			
20.298	8	26	09	20q13.31	BMP7	C	Bone morphogenetic protein-7 (osteogenic protein-1)	112267	REa, H			2(Bmp7)
20.299	11	21	06	20q13.12	SERINC3, TDE1	P	Serine incorporator 3	607165	A			
20.300	5	31	05	20q13.12	ADA	C	Adenosine deaminase	608958	S, D, REa, F, A, Fd		Severe combined immunodeficiency due to ADA deficiency, 102700 (3); Adenosine deaminase deficiency, partial, 102700 (3)	2(Ada)
20.301	10	14	09	20q13.11	GRD2	C	Graves disease, susceptibility to, 2	603388	Fd		{Graves disease, susceptibility to, 2} (2)	
20.302	12	19	11	20q13.11	SRSF6, SFRS6, SRp55	P	Splicing factor, serine/arginine-rich, 6	601944	R, REc			
20.303	12	20	02	20q13.13	PTGIS, CYP8A1, PGIS, CYP8	P	Prostaglandin 12 synthase	601699	A		Hypertension, essential, 145500 (3)	
20.304	4	2	16	20q13.12	DNTTIP1, TDIF1, C20orf167	P	Deoxynucleotidyltransferase, terminal, interacting protein 1	611388	REc			
20.305	6	9	08	20q13.12	FIT2, C20orf142	P	Fat-inducing transcript 2	612029	R, REc			
20.306	7	20	12	20q13.12	KCNS1, KV9.1	P	Potassium channel, voltage-gated, delayed-rectifier, subfamily S, member 1	602905	REc			
20.307	1	21	16	20q13.12	PIGT, NDAP, PNH2, MCAHS3	P	Phosphatidylinositol glycan, class T	610272	REc, R	mutation identified in 1 PNH2 family	?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	
20.308	11	24	14	20q13.12	RBPJL, RBPL, SUHL	P	RBPJ-like protein	616104	A, REc			
20.309	8	8	13	20q13.12	SLPI, HUSI	P	Secretory leukocyte protease inhibitor	107285	REc			2(Slpi)
20.310	5	19	06	20q13.12	SULF2, KIAA1247	P	Sulfatase 2	610013	REc			2(Sulf2)
20.311	9	9	09	20q13.12	SYS1	P	Sys1 golgi-localized integral membrane protein, S. cerevisiae, homolog of	612979	REc			
20.312	10	12	14	20q13.12	TOMM34, TOM34	P	Translocase of outer mitochondrial membrane 34, yeast, homolog of	616049	REc			
20.313	8	19	13	20q13.12	TOX2, GCX1, C20orf100	P	TOX high mobility group box family member 2	611163	REc			
20.314	10	31	08	20q13.12	UBE2C, UBCH10	P	Ubiquitin-conjugating enzyme E2C	605574	R, REc			
20.315	4	10	14	20q13.12	ZMYND8, PRKCBP1	C	Zinc finger MYND domain-containing protein 8	615713	REc, R			
20.316	7	17	14	20q13.13	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	P	Activity-dependent neuroprotector homeobox	611386	REc, A		Helsmoortel-van der Aa syndrome, 615873 (3)	
20.317	8	17	09	20q13.13	ARFGEF2, BIG2, PVNH2	C	ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited	605371	REa, Fd		Periventricular heterotopia with microcephaly, 608097 (3)	
20.318	11	15	08	20q13.13	BCAS4	P	Breast carcinoma amplified sequence 4	607471	REc			
20.319	10	28	15	20q13.13	DDX27, RHLP	P	DEAD box polypeptide 27	616621	REc			
20.320	8	25	04	20q13.13	DPM1, MPDS, CDGIE	P	Dolichyl-phosphate mannosyltransferase 1, catalytic subunit	603503	REc, Fd		Congenital disorder of glycosylation, type Ie, 608799 (3)	
20.321	11	2	04	20q13.13	PARD6B	P	Partitioning-defective protein 6, C. elegans, homolog of, beta	608975	R, REc			
20.322	5	13	02	20q13.13	PREX1, KIAA1415	P	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1	606905	REc			
20.323	5	4	09	20q13.13	SLC9A8, NHE8, KIAA0939	P	Solute carrier family 9 (sodium/hydrogen exchanger), member 8	612730	REc			
20.324	4	17	07	20q13.2	SALL4, HSAL4	C	sal-like 4	607343	REc, Fd		Duane-radial ray syndrome, 607323 (3); IVIC syndrome, 147750 (3)	
20.325	10	15	98	20q13.2	BCAS1, NABC1	P	Breast carcinoma amplified sequence	602968	REc			
20.326	1	24	13	20q13.2	CBLN4	P	Precerebellin 4	615029	REc			
20.327	5	25	13	20q13.2-q13.3	CSTF1	P	Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kD	600369	REc			
20.328	2	28	03	20q13.31	CTCFL, BORIS	P	CCCTC-binding factor-like protein	607022	A			
20.329	12	13	03	20q13.2	DOK5	P	Docking protein 5	608334	REc			
20.330	3	2	10	20q13.32	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	C	GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320	REa, H, A, Fd		Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome, somatic, mosaic 174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Acromegaly, somatic, 102200 (3); Pseudopseudohypoparathyroidism, 612463 (3); ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	2(Gnas)
20.331	4	27	12	20q13.32	GNASAS1, GNASAS, SANG, NESPAS	P	GNAS antisense RNA 1	610540	REc		Pseudohypoparathyroidism, type IB, 603233 (3)	
20.332	10	24	14	20q13.13	KCNB1, EIEE26	P	Potassium voltage-gated channel, Shab-related subfamily, member 1	600397	A, Fd		Epileptic encephalopathy, early infantile, 26, 616056 (3)	2(Kcnb1)
20.333	7	22	09	20q13.2	MC3R, BMIQ9	C	Melanocortin-3 receptor	155540	A		{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3); {Mycobacterium tuberculosis, protection against}, 607948 (3)	2(Mc3r)
20.334	7	9	06	20q13.2	PFDN4, C1	P	Prefoldin 4	604898	R			
20.335	8	26	09	20q13.12	SGK2	P	Serum/glucocorticoid-regulated kinase 2	607589	R, REc			
20.336	6	13	12	20q13.12	SPINLW1, EPPIN, WAP7	C	Serine protease inhibitor-like protein with Kunitz and WAP domains 1	609031	REc			2(Spinlw1)
20.337	10	17	12	20q13.12	STK4, MST1, KRS2, TIIAC	C	Serine/threonine protein kinase 4	604965	R, REc		T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	
20.338	1	26	97	20q13.31	TFAP2C	P	Transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma)	601602	A			2(Tfap2c)
20.339	4	6	15	20q13.13	TMEM189, KUA	P	Transmembrane protein 189	610994	REc			
20.340	7	27	11	20q13.2	TSHZ2	P	Teashirt zinc finger homeobox 2	614118	REc			
20.341	11	4	98	20q13.13	UBE2V1, UEV1	P	Ubiquitin-conjugating enzyme E2 variant 1	602995	A			
20.342	5	5	99	20q13.2	ZNF217	C	Zinc finger protein-217	602967	REn			
20.343	4	17	06	20q13.2	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	C	Aurora kinase A	603072	H, REc		{Colon cancer, susceptibility to}, 114500 (3)	
20.344	7	19	04	20q13.33	CHRNA4, ENFL1	C	Cholinergic receptor, nicotinic, alpha polypeptide-4	118504	REa, REn, A		Epilepsy, nocturnal frontal lobe, 1, 600513 (3); {Nicotine addiction, susceptibility to}, 188890 (3)	2(Acra4)
20.345	9	8	11	20q13.2	CYP24A1, CYP24, HCAI	C	Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase)	126065	A, REa		Hypercalcemia, infantile, 143880 (3)	2(Cyp24)
20.346	7	19	06	20q13.2-q13.3	DFNB65	P	Deafness, autosomal recessive 65	610248	Fd	max lod at D20S840	Deafness, autosomal recessive 65 (2)	
20.347	1	25	11	20q13.32	EDN3, WS4B, HSCR4	C	Endothelin-3	131242	REa, A		Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation syndrome, congenital, 209880 (3); {Hirschsprung disease, susceptibility to, 4}, 613712 (3)	2(Edn3)
20.348	3	15	92	20q13.2-q13.3	EEGV1, EEGL	P	Electro-encephalographic variant pattern-1	130180	Fd			
20.349	10	3	07	20q13.33	GATA5	P	GATA-binding protein 5	611496	REc, H			2(Gata5)
20.350	10	19	97	20q13.33	LAMA5	P	Laminin, alpha-5	601033	A			2(Lama5)
20.351	2	14	97	20q13.2	NFATC2, NFATP	P	Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 2	600490	REa, A			2(Nfatp)
20.352	7	14	00	20q13.31	SPO11	P	Spo11, S. cerevisiae, homolog of	605114	A			2(Spo11)
20.353	6	15	99	20q13.33	TPD52L2	P	Tumor protein D52-like 2	603747	A			
20.354	10	7	14	20q13.32	ATP5E, MC5DN3	P	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	606153	R	pseudogene on 4q25; mutation identified in 1 MC5DN3 patient	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	
20.355	3	19	01	20q13.33	BIRC7, MLIAP, KIAP, LIVIN	C	Baculoviral IAP repeat-containing protein 7	605737	R, A			
20.356	7	1	02	20q13.33	CDH4	P	Cadherin 4	603006	R			
20.357	6	3	02	20q13.33	COL9A3, EDM3, IDD	C	Collagen IX, alpha-3 polypeptide	120270	Fd, A, R		Epiphyseal dysplasia, multiple, 3, 600969 (3); Epiphyseal dysplasia, multiple, with myopathy (3); {Intervertebral disc disease, susceptibility to}, 603932 (3)	
20.358	9	14	95	20q13.33	GPR8	P	G protein-coupled receptor-8	600731	A	related sequence on 14		
20.359	2	11	11	20q13.33	KCNQ2, EBN1, EIEE7, BFNS1	C	Potassium voltage-gated channel, KQT-like subfamily, member 2	602235	REc, Fd		Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3); Epileptic encephalopathy, early infantile, 7, 613720 (3)	
20.360	12	23	05	20q13.33	LIME1, LIME	P	LCK-interacting transmembrane adaptor 1	609809	REc, R			
20.361	8	26	09	20q13.32	MIR296, MIRN296	P	Micro RNA 296	610945	REc			
20.362	12	17	01	20q11.21	MYLK2, MLCK	P	Myosin light chain kinase 2	606566	REc		Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3)	
20.363	11	1	09	20q13.33	MYT1, PLPB1	P	Myelin transcription factor 1	600379	REc, H			2(Myt1)
20.364	8	23	01	20q13.33	PPP1R3D, PPP1R6	P	Protein phosphatase 1, regulatory subunit 3D	603326	R			
20.365	7	11	11	20q13.33	PRIC285, PDIP1, KIAA1769	P	Peroxisomal proliferator-activated receptor alpha-interacting cofactor complex, 285kD subunit	611265	R, REc			
20.366	3	14	13	20q13.33	PTK6, BRK	P	Protein-tyrosine kinase 6	602004	A			
20.367	9	10	09	20q13.32	RAB22A	P	Ras-associated protein RAB22A	612966	R			
20.368	11	11	14	20q13.33	RGS19, GAIP	P	Regulator of G protein signaling 19	605071	REc, H			2(Rgs19)
20.369	2	23	08	20q13.12	RIMS4	P	Protein regulating synaptic membrane exocytosis 4	611601	REc			2(Rims4)
20.370	2	7	01	20q13.33	RPS21	P	Ribosomal protein S21	180477	REa, R			
20.371	6	1	15	20q13.33	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	C	Regulator of telomere elongation helicase 1	608833	REc, H		Dyskeratosis congenita, autosomal recessive 5, 615190 (3); Dyskeratosis congenita, autosomal dominant 4, 615190 (3); Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	2(Rtel)
20.372	11	3	14	20q13.33	SLC17A9, C20orf59, POROK8	P	Solute carrier family 17, member 9	612107	REc		Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	
20.373	1	11	07	20q13.33	SS18L1, KIAA0693, CREST	C	SS18-like gene 1	606472	R, A			
20.374	1	27	04	20q13.33	STMN3, SCLIP	P	Stathmin-like 3	608362	REc			
20.375	5	2	06	20q13.32	VAPB, VAPC, ALS8	C	Vesicle-associated membrane protein-associated protein B	605704	R, Fd		Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	
20.376	12	22	08	20q13.31	RBM38, RNPC1	P	RNA-binding motif protein 38	612428	REc			
20.377	8	25	11	20q13.31	PCK1	C	Phosphoenolpyruvate carboxykinase-1 (soluble)	614168	REa, A, Fd		?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)	2(Pck1)
20.378	12	2	09	20q13.32	TUBB1	P	Tubulin, beta-1	612901	REc		Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)	
20.379	8	23	02	20q13.31	ZBP1, C20ORF183, DLM1	P	Z-DNA binding protein 1 (tumor stroma and activated macrophage protein DLM1)	606750	REc			
20.380	4	20	11	20q13.31-q13.33	MTBS3	P	Mycobacterium tuberculosis, susceptibility to, 3	612929	Fd	associated with rs3827103	{Mycobacterium tuberculosis, susceptibility to, 3} (2)	
20.381	12	10	12	20q13.32	MIR298	P	Micro RNA 298	614914	REc			
20.382	7	16	12	20q13.32-q13.33	PHACTR3, SCAPININ	P	Phosphatase and actin regulator 3	608725	REc			
20.383	12	10	08	20q13.32	STX16, SYN16	P	Syntaxin 16	603666	REn, REc		Pseudohypoparathyroidism, type IB, 603233 (3)	
20.384	1	27	04	20q13.33	ARFGAP1	P	ADP-ribosylation factor GTPase-activating protein 1	608377	REc			
20.385	2	24	12	20q13.33	ARFRP1, ARP	P	ADP-ribosylation factor-related protein 1	604699	REc			
20.386	2	18	08	20q13.33	C20orf11, TWA1	P	Chromosome 20 open reading frame 11	611625	R, REc			
20.387	11	4	05	20q13.33	DATF1, DIO1	P	Death-associated transcription factor 1	604140	REc			
20.388	1	5	12	20q13.33	DNAJC5, DNAJC5A, CSP, CLN4B	P	DNAJ/HSP40 homolog, subfamily C, member 5	611203	REc		Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	
20.389	4	13	10	20q13.33	GLM6	P	Glioma susceptibility 6	613031	Fd	associated with rs6010620	{Glioma susceptibility 6} (2)	
20.390	8	26	09	20q13.33	GMEB2, KIAA1269	P	Glucocorticoid modulatory element-binding protein 2	607451	R, REc			
20.391	4	18	07	20q13.33	GTPBP5, OBGH1	P	GTP-binding protein 5	610919	R, REc			
20.392	1	6	09	20q13.33	HAR1A, HAR1F	P	Highly accelerated region gene 1A	610556	REc			
20.393	1	6	09	20q13.33	HAR1B, HAR1R	P	Highly accelerated region gene 1B	610557	REc			
20.394	3	25	14	20q13.33	HRH3, GPCR97	P	Histamine receptor H3	604525	REc			
20.395	5	24	13	20q13.33	MIR1-1	P	Micro RNA 1-1	609326	REc			
20.396	5	24	13	20q13.33	MIR133A2	P	Micro RNA 133A2	610255	REc			2(Mir133a2)
20.397	8	18	15	20q13.33	MRGBP, C20orf20	P	MRG/MORF4L-binding protein	611157	R, REc			
20.398	7	16	09	20q13.33	NKAIN4	P	Na+/K+ transporting ATPase-interacting 4	612873	REc			2(Nkain4)
20.399	5	20	11	20q13.33	PRPF6, PRP6, ANT1, TOM, C20orf14	P	Precursor mRNA-processing factor 6, S. cerevisiae, homolog of	613979	REc		Retinitis pigmentosa 60, 613983 (3)	
20.400	8	26	09	20q13.33	PSMA7	P	Proteasome subunit, alpha-type, 7	606607	R, REc			
20.401	12	4	08	20q13.33	SLCO4A1, OATPE, OATP4A1	P	Solute carrier organic anion transporter family, member 4A1	612436	R, REc			
20.402	6	2	15	20q13.33	SOX18, HLTS, HLTRS	C	SOX18, mouse, homolog of	601618	REa, R		Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3); Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	2(Sox18, ragged)
20.403	2	7	01	20q13.33	SYCP2, SCP2	P	Synaptonemal complex protein 2	604105	A			
20.404	8	26	09	20q13.33	TAF4, TAF2C1, TAFII130, TAF2C	P	TAF4 RNA polymerase II, TATA box-binding protein-associated factor, 135kD	601796	R, REc			
20.405	3	26	07	20q13.33	UCKL1, UCK1L, URKL1	P	Uridine/cytidine kinase-like 1	610866	REc			
20.406	8	26	15	20q13.33	YTHDF1	P	YTH N6-methyladenosine RNA-binding protein 1	616529	REc			
20.407	7	20	12	20q13.33	ZBTB46, BZEL	P	Zinc finger- and BTB domain-containing protein 46	614639	REc			
20.408	10	23	87	Chr.20	HTL, LEUT, HLT	P	Leucine transport, high	151310	S			
21.1	8	24	09	21p13-q11	AUTS12	P	Autism, susceptibility to, 12	610838	Fd	max lod at D21S1437	{Autism susceptibility 12} (2)	
21.2	4	26	90	21p12	RNR4	C	Ribosomal RNA-4	180453	A			
21.3	2	27	01	21p11.2	TPTE	P	Transmembrane phosphatase with tensin homology	604336	REc, A			
21.4	12	21	98	21q11.2-q21.1	NRIP1, RIP140	C	Nuclear receptor interacting protein 1 (receptor interacting protein 140)	602490	A, REc			
21.5	3	5	96	21q11.2	STCH	P	Stress 70 protein chaperone, microsome-associated, p60	601100	A			
21.6	9	16	12	21q11.2	ABCC13	P	ATP-binding cassette, subfamily C, member 13	608835	REc			
21.7	10	27	99	21q21.1	CXADR, CAR	P	Coxsackie virus and adenovirus receptor	602621	Psh, A	pseudogenes on chr.15 and chr.18		
21.8	3	31	05	21q11.2	LIPI, LPDL, PRED5	P	Lipase I	609252	REc		{Hypertriglyceridemia, susceptibility to}, 145750 (3)	16(Lipi)
21.9	12	15	04	21q11.2	NRCLP3	P	Narcolepsy 3	609039	Fd	max lod at D21S1245	Narcolepsy 3 (2)	
21.10	6	7	10	21q11.2	POTED, ANKRD21, POTE	P	POTE ankyrin domain family, member D	607549	REc, A			
21.11	7	24	03	21q11.2	SAMSN1, HACS1	P	SAM domain, SH3 domain, and nuclear localization signals 1	607978	REc			
21.12	3	26	96	21q11.2	TAM, MST	P	Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)	159595	Ch		Leukemia, transient, of Down syndrome (2)	
21.13	3	5	08	21q21.3	MRPL39, MRPL5	P	Mitochondrial ribosomal protein L39	611845	R, REc			
21.14	2	27	01	21q21.1	BTG3, ANA, TOB5	P	B-cell translocation gene 3	605674	A			
21.15	4	17	12	21q21.3	APP, AAA, CVAP, AD1	C	Amyloid beta (A4) precursor protein	104760	REa, A, Fd, RE	proximal to SOD; very distal q21 or boundary with q22	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)	16(App)
21.16	4	1	15	21q21.1	CHODL	P	Chondrolectin	607247	A			
21.17	11	6	00	21q21.1	NCAM2	P	Cell adhesion molecule, neural, 2	602040	Psh			
21.18	1	28	02	21q21.1	PRSS7, ENTK	C	Protease, serine, 7 (enterokinase)	606635	A		Enterokinase deficiency, 226200 (3)	
21.19	6	13	07	21q21.3	TAK1L, C21orf7	P	TAK1-like	611110	REc			
21.20	5	29	98	21q21	USH1E	P	Usher syndrome-1E, autosomal recessive, severe	602097	Fd		Usher syndrome, type 1E (2)	
21.21	2	1	01	21q21.3	ADAMTS5, ADAMTS11	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 5 (aggrecanase 2)	605007	REa, R			16(Adamts5)
21.22	10	17	95	21q21.3	GABPA, E4TF1A	C	GA-binding protein transcription factor, alpha subunit, 60kD	600609	A, REn, Psh, REc			
21.23	9	20	14	21q21.1	MIR99AHG, MONC, LINC00478	P	MIR99A-LET7C cluster host gene, noncoding	615964	REc			
21.24	3	23	09	21q21.1	MIR125B2, MIRN125B2	P	Micro RNA 125B-2	610105	REc			
21.25	3	23	09	21q21.1	MIRLET7C, MIRNLET7C, LET7C	P	Micro RNA Let7c	612144	REc			
21.26	1	29	01	21q21.3	ADAMTS1, METH1	P	A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 1	605174	REc			
21.27	4	29	02	21q21.3	JAM2, VEJAM	P	Junctional adhesion molecule 2	606870	REc			
21.28	2	1	11	21q21.3	ATP5J, ATP5	P	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6	603152	REc			9(Atp5j)
21.29	10	12	14	21q21.3	CYYR1	C	Cysteine/tyrosine-rich protein 1	616020	R, REc, H			16(Cyyr1)
21.30	10	12	14	21q21.3	CYYR1AS1, CYYR1-AS1	P	CYRR1 antisense RNA 1	616021	REc			
21.31	3	23	09	21q21.3	MIR155, BIC, MIRN155	C	Micro RNA 155	609337	REc			
21.32	4	2	12	21q21.3	N6AMT1	P	N6 adenine-specific DNA methyltransferase 1, putative	614553	REc			
21.33	12	10	13	21q21.3	USP16, UBPM	P	Ubiquitin-specific protease 16	604735	REc			
21.34	4	24	08	21q22.11	MRPS6	P	Mitochondrial ribosomal protein S6	611973	R, REc			
21.35	5	28	13	21q22.3	FAM3B	P	Family with sequence similarity 3, member B	608617	REc			16(Fam3b)
21.36	8	20	08	21q22	FEB7	P	Febrile seizures, familial, 7	611515	Fd	max lod at D21S1910	Febrile seizures, familial, 7 (2)	
21.37	3	1	94	21q21.3	GRIK1, GLUR5	C	Glutamate receptor, ionotropic, kainate 1	138245	REc, REa, A, Fd			16(Glur5)
21.38	12	27	01	21q22.11	HUNK	L	Hormonally upregulated NEU-associated kinase	606532	H			16(Hunk)
21.39	9	28	11	21q22.3	RRP1B, KIAA0179, NNP1L	P	Ribosomal RNA-processing protein 1, S. cerevisiae, homolog of, B	610654	Psh, REc			
21.40	3	27	95	21q22.11	SLC5A3	P	Solute carrier family 5 (inositol transporter), member 3	600444	A	?role in Down syndrome		
21.41	6	24	05	21q22	TUKLS	P	Tukel syndrome	609428	Fd	max lod at D21S1259	Tukel syndrome (2)	
21.42	11	28	01	21q21.3	BACH1	P	BTB and CNC homology 1	602751	REc			
21.43	1	12	11	21q22.11	CRFB4, IBD25	C	Cytokine receptor, family II, member 4	123889	Fd, REn	35kb distal to IFNAR; D21S58	{Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	16(Crfb4)
21.44	6	18	99	21q22.11	CRYZL1	P	Crystallin, zeta-like 1	603920	A			
21.45	11	29	11	21q22.13	DYRK1A, MNBH, MNB, MRD7	C	Dual specificity tyrosine-(Y)-phosphorylation regulated kinase-1A (\'minibrain\', Drosophila, homolog of)	600855	REn, H, REc	?triplicate state responsible for mental defect in Down syndrome	Mental retardation, autosomal dominant 7, 614104 (3)	16(mmb)
21.46	6	3	94	21q22.11	GART, PRGS, PGFT	C	Phosphoribosylglycinamide formyltransferase (phosphoribosylglycinamide synthetase; phosphoribosylaminoimidazole synthetase)	138440	S, H, REa	multifunctional protein: Ade(-)C, Ade(-)G, GART		16(Prgs)
21.47	2	20	03	21q22.13	HLCS, HCS	C	Holocarboxylase synthetase	609018	Psh, A		Holocarboxylase synthetase deficiency, 253270 (3)	16(Hlcs)
21.48	8	24	98	21q22.11	IFNAR1	C	Interferon, alpha, beta and omega, receptor 1	107450	S, D, A, REn			16(Ifrc)
21.49	12	2	15	21q22.11	IFNAR2, IMD45	C	Interferon, alpha, beta, and omega, receptor 2	602376	REa, REc	mutation identified in 1 IMD45 family	{Hepatitis B virus, susceptibility to}, 610424 (3); ?Immunodeficiency 45, 616669 (3)	
21.50	1	14	11	21q22.11	KCNE2, MIRP1, LQT6, ATFB4	C	Potassium voltage-gated channel, Isk-related family, member 2	603796	RE		Long QT syndrome 6, 613693 (3); Atrial fibrillation, familial, 4, 611493 (3)	
21.51	3	30	15	21q22.13	KCNJ6, GIRK2, KCNJ7, KPLBS	P	Potassium inwardly-rectifying channel, subfamily J, member 6	600877	A		Keppen-Lubinsky syndrome, 614098 (3)	16(Kcnj6)
21.52	2	10	05	21q22.11	MRAP, FALP, C21orf61, GCCD2, FGD2	C	Melanocortin 2 receptor accessory protein	609196	REc, Fd		Glucocorticoid deficiency 2, 607398 (3)	
21.53	9	20	14	21q22.11	OLIG1	P	Oligodendrocyte linease transcription factor 1	606385	REc			
21.54	9	21	12	21q22.11	SOD1, ALS1	C	Superoxide dismutase-1, soluble	147450	S, D, Fd	mid q22.1	Amyotrophic lateral sclerosis 1, 105400 (3)	16(Sod1)
21.55	1	27	04	21q22.11	TCP10L	P	T-complex protein 10-like	608365	REc			
21.56	2	15	96	21q22.11	TIAM1	P	T-cell lymphoma invasion and metastasis 1	600687	REc, H			16(Tiam1)
21.57	9	16	12	21q22.11	URB1, NPA1, C21orf108, KIAA0539	P	URB1 ribosome biogenesis 1 homolog (S. cerevisiae)	608865	REc, R			
21.58	12	13	95	21q22.11	ATP5O	P	ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein)	600828	REa, A			
21.59	9	8	14	21q22.11	IFNGR2, IFNGT1, IFGR2, IMD28	C	Interferon gamma receptor-2 (interferon gamma transducer 1)	147569	S, A		Immunodeficiency 28, mycobacteriosis, 614889 (3)	16(Ifgr2)
21.60	11	19	98	21q22.11	ITSN1, SH3D1A, SH3P17	P	Intersectin 1 (SH3 domain protein-1A)	602442	REc			
21.61	1	14	11	21q22.12	KCNE1, JLNS, LQT5, JLNS2	C	Potassium voltage-gated channel, Isk-related subfamily, member 1	176261	REa, A, Psh, Fd		Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome 5, 613695 (3)	
21.62	12	29	06	21q22.13	PIGP, DSCR5	P	Phosphatidylinositol glycan, class P	605938	REc	expressed in tongue		16(Dscr5)
21.63	9	24	08	21q22.12	RCAN1, DSCR1, MCIP1, CSP1	C	Regulator of calcineurin 1	602917	REc			16(Rcan1)
21.64	8	29	96	21q22.11	SON	P	SON DNA-binding protein	182465	Psh			
21.65	11	11	13	21q22.11	C21ORF59, CILD26	P	Chromosome 21 open reading frame 59	615494	REc		Ciliary dyskinesia, primary, 26, 615500 (3)	
21.66	5	26	13	21q22.11	CLDN8	P	Claudin 8	611231	REc			
21.67	12	21	09	21q22.11	KRTAP11-1, HACL1	P	Keratin-associated protein 11-1	600064	REc, H			16(Krtap11-1)
21.68	11	13	13	21q22.11	KRTAP13-1	P	Keratin-associated protein 13-1	608718	REc			
21.69	9	29	10	21q21.3	LTN1, RNF160, KIAA0714	P	Listerin E3 ubiquitin protein ligase 1	613083	R, REc			16(Rnf160)
21.70	3	11	08	21q22.11	OLIG2, PRKCBP2	P	Oligodendrocyte lineage transcription factor 2	606386	R, REc			
21.71	9	30	14	21q22.11	SCAF4, KIAA1172	P	SR-related C-terminal domain-associated factor 4	616023	R, REc			
21.72	8	24	98	21q22.12	CBR1	C	Carbonyl reductase 1	114830	REa, Fd, A			16(Cbr1)
21.73	7	22	13	21q22.12	CLIC6, CLIC1L	P	Chloride intracellular channel 6	615321	REc			
21.74	11	24	14	21q22.12	MIR802	P	Micro RNA 802	616090	REc			
21.75	3	24	14	21q22.12	MORC3, NXP2	P	MORC family CW-type zinc finger 3	610078	Psh, REc			
21.76	10	11	05	21q22.13	MAFD3, BPEO	P	Major affective disorder 3	609633	Fd	max lod at D21S1252	{Major affective disorder 3, early onset} (2)	
21.77	3	22	06	21q22.13-qter	BMND6	P	Bone mineral density QTL 6	609876	Fd	max lod at D21S1446	[Bone mineral density QTL 6] (2)	
21.78	9	12	96	21q22.12-q22.13	CAF1A	P	Chromatin assembly factor I, p60 subunit	601245	REn, Psh			
21.79	2	6	01	21q22.12	CBR3	P	Carbonyl reductase 3	603608	REc			
21.80	8	25	09	21q22.12	DOPEY2, 21orf5, KIAA0933	P	Dopey family member 2	604803	REc			
21.81	5	11	00	21q22.13	DSCR4, DSCRB	P	Down syndrome critical region gene 4	604829	REc			
21.82	3	22	06	21q22.13	DSCR6, RIPPLY3	P	Down syndrome critical region gene 6	609892	REc			
21.83	6	7	10	21q22.13	DSCR8, MMA1	P	Down syndrome critical region gene 8	613396	REc			
21.84	12	29	06	21q22.2	JAM4	P	Junctional adhesion molecule 4	610638	R, REc			
21.85	3	20	98	21q22.1-q22.2	KCNJ15	P	Potassium inwardly-rectifying channel, subfamily J, member 15	602106	REf			
21.86	7	31	97	21q22.13	SIM2	P	Single-minded, Drosophila, homolog of, 2	600892	REc			
21.87	11	22	13	21q22.11	SYNJ1, PARK20	P	Synaptojanin 1	604297	A		Parkinson disease 20, early-onset, 615530 (3)	16(Synj1)
21.88	1	13	99	21q22.13	TTC3, TPRD	P	Tetratricopeptide repeat domain 3	602259	REc			
21.89	1	15	08	21q22.2	C21orf24	P	Chromosome 21 open reading frame 24	611723	REc			
21.90	4	17	98	21q22.2	DSCAM	P	Down syndrome cell adhesion molecule	602523	REc			
21.91	3	28	90	21q22.3	S100B	C	S100 calcium-binding protein, beta (neural)	176990	REa, A			10(S100b)
21.92	10	29	99	21q22.3	ABCG1, ABC8, WHITE1	P	ATP-binding cassette, subfamily G, member 1 (white, Drosophila, homolog of)	603076	A			17(Abc8)
21.93	2	25	98	21q22.3	ADARB1, RED1	C	Adenosine deaminase, RNA-specific, B1 (RED1, rat, homolog of)	601218	Psh, REc			
21.94	9	2	12	21q22.3	AGPAT3, LPAAT3	C	1-acylglycerol-3-phosphate O-acyltransferase 3	614794	REc			
21.95	3	11	09	21q22.3	AIRE, APECED, APS1	C	Autoimmune regulator	607358	Fd		Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	
21.96	5	23	00	21q22.2	B3GALT5, GLCT5	P	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5	604066	REc			
21.97	2	20	01	21q22.2-q22.3	BACE2, ALP56, DRAP	C	Beta-site amyloid beta A4 precursor protein-cleaving enzyme 2 (Down syndrome region aspartic protease)	605668	REc, A			
21.98	11	5	98	21q22.3	C21orf2	P	Chromosome 21 open reading frame 2	603191	REn			
21.99	12	19	08	21q22.3	C21orf56	P	Chromosome 21 open reading frame 56	612412	REc			
21.100	6	7	10	21q22.3	CBS	C	Cystathionine beta-synthase	613381	S, D, A, Fd	subtelomeric	Homocystinuria, B6-responsive and nonresponsive types, 236200 (3); Thrombosis, hyperhomocysteinemic, 236200 (3)	17(Cbs)
21.101	7	1	11	21q22.13	CLDN14, DFNB29	C	Claudin 14	605608	REc, Fd		Deafness, autosomal recessive 29, 614035 (3)	
21.102	7	20	15	21q22.3	COL6A1, BTHLM1, UCHMD1	C	Collagen VI, alpha-1 polypeptide	120220	REa, A, REn, Fd		Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3)	10(Col6a1)
21.103	7	20	15	21q22.3	COL6A2, BTHLM1, UCMD1	C	Collagen VI, alpha-2 polypeptide	120240	REa, A, REn, Fd	mutation identified in 1 MYSCL family	Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3); ?Myosclerosis, congenital, 255600 (3)	10(Col6a2)
21.104	5	28	08	21q22.3	COL18A1, KNO1	C	Collagen XVIII, alpha-1 polypeptide	120328	A, Fd		Knobloch syndrome, type 1, 267750 (3)	10(Col18a1)
21.105	5	24	13	21q22.3	CRYAA, CRYA1, CTRCT9	C	Crystallin, alpha A	123580	REa, A, RE, Fd		Cataract 9, multiple types, 604219 (3)	17(Crya1)
21.106	12	7	11	21q22.3	CSTB, STFB, EPM1, PME, EPM1A, ULD	P	Cystatin B (stefin B)	601145	REn		Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	
21.107	9	16	96	21q22.3	DCR, DSCR	C	Down syndrome chromosome region	190685	Ch	many genes are involved in this phenotype	Down syndrome (4)	
21.108	8	29	07	21q22.3	DIP2, KIAA0184	C	Disco-interacting protein 2, Drosophila, homolog of	607711	REc	previously mapped to Chr.2		10(Dip2)
21.109	1	7	02	21q22.3	DNMT3L	P	DNA methyltransferase 3-like protein	606588	REc			
21.110	2	1	01	21q22.13	DSCR3, DSCRA	P	Down syndrome critical region gene 3	605298	REn			
21.111	10	15	94	21q22.2	ERG	C	Erythroblastosis virus E26, avian, (v-ets) oncogene related	165080	REa, Fd, A	fused with EWS in Ewing sarcoma, with FUS in leukemia		
21.112	7	6	99	21q22.3	ES1, HES1, GT335, C21orf33	C	ES1, zebrafish, protein, homolog of	601659	REc			
21.113	3	18	91	21q22.2	ETS2	C	Oncogene ETS-2	164740	REa, A, Fd	proximal q22.3		16(Ets2)
21.114	8	22	03	21q22.3	FTCD	C	Formiminotransferase cyclodeminase	606806	R		Glutamate formiminotransferase deficiency, 229100 (3)	10(Ftcd)
21.115	8	28	02	21q22.2	HMGN1, HMG14	C	High-mobility group nucleosomal binding protein 1	163920	REa, Fd, A			
21.116	4	9	96	21q22.3	HPE1	P	Holoprosencephaly-1, alobar	236100	Ch, REa		Holoprosencephaly-1 (2)	
21.117	10	19	97	21q22.3	HRMT1L1, PRMT2	P	HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1	601961	REa, REc			
21.118	2	6	01	21q22.3	HSF2BP	P	Heat-shock transcription factor 2-binding protein	604554	REc			
21.119	8	25	09	21q22.3	ICOSLG, B7H2, GL50, B7RP1	P	Inducible T-cell co-stimulator ligand	605717	R, REc			
21.120	12	26	13	21q22.3	MCM3AP, MAP80, GANP	C	Minichromosome maintenance 3-associated protein, 80-kD	603294	R, A			
21.121	2	6	01	21q22.3	PDXK, PNK, PKH	P	Pyridoxal kinase	179020	REc			
21.122	5	24	13	21q22.3	POFUT2, C21Orf80, KIAA0958	C	Protein O-fucosyltransferase 2	610249	R, REc			
21.123	1	23	96	21q22.3	ITGB2, CD18, LCAMB, LAD	C	Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1; macrophage antigen, beta polypeptide)	600065	S, A, Fd	common subunit for CR3, LFA1, and P150,95	Leukocyte adhesion deficiency, 116920 (3)	7(Ly15)
21.124	8	7	15	21q22.3	LSS, OSC, CTRCT44	P	Lanosterol synthase	600909	REa, REc		Cataract 44, 616509 (3)	
21.125	3	18	91	21q22.3	MX1, MX, IFI78	C	Myxovirus (influenza) resistance-1 (interferon induced protein p78)	147150	REa, D, Fd			16(Mx1)
21.126	8	25	09	21q22.3	MX2	P	Myxovirus (influenza) resistance-2	147890	REa, REc			16(Mx2)
21.127	1	27	11	21q22.3	NCRNA00163, NLC1A	P	Noncoding RNA 163	610259	Fd, REc			
21.128	8	20	98	21q22.3	NDUFV3	C	NADH-ubiquinone oxidoreductase flavoprotein 3, 10kD	602184	A, REc			
21.129	3	16	05	21q22.3	PCBP3	P	Poly(rC)-binding protein 3	608502	REc			10(Pcbp3)
21.130	11	11	10	21q22.3	PCNT, PCNT2, KEN, SCKL4, MOPD2	C	Pericentrin	605925	Psh, A, Fd		Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	
21.131	8	15	97	21q22.2	PCP4	C	Purkinje cell protein 4	601629	REc, Psh, A			16(Pcp4)
21.132	6	18	99	21q22.3	PDE9A, HSPDE9A2	P	Phosphodiesterase 9A	602973	Psh, REc			
21.133	3	18	91	21q22.3	PFKL	C	Phosphofructokinase, liver type	171860	S, D, Fd		Hemolytic anemia due to phosphofructokinase deficiency (1)	17(Pfkl)
21.134	6	18	99	21q22.3	PKNOX1	P	PBX/knotted 1 homeo box 1	602100	Psh, Fd, A			17(Pknox1)
21.135	2	24	11	21q22.2	PLAC4	P	Placenta-specific gene 4	613770	REc			
21.136	9	24	08	21q22.2	PSMG1, DSCR2, C21LRP	P	Proteasome (prosome, macropain) assembly chaperone 1	605296	REn			
21.137	8	8	00	21q22.3	PTTG1IP, C21orf1, C21orf3, PBF	P	Pituitary tumor-transforming gene 1 protein-interacting protein	603784	A, TM			
21.138	1	26	97	21q22.3	PWP2H, PWP2	P	PWP2 periodic tryptophan protein, yeast, homolog of	601475	RE			
21.139	12	29	15	21q22.3	RIPK4, NKRD3, DIK, PPS2	P	Receptor-interacting serine-threonine kinase 4	605706	REc		Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3)	
21.140	11	1	13	21q22.3	RSPH1, TSGA2, TSA2, CILD24	P	Radial spoke head 1, Chlamydomonas, homolog of	609314	R		Ciliary dyskinesia, primary, 24, 615481 (3)	17(Tsa2)
21.141	8	23	09	21q22.12	RUNX1, CBFA2, AML1	C	Runt-related transcription factor 1 (aml1 oncogene)	151385	Ch, Fd		Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	
21.142	1	19	98	21q22.2	SH3GBR	P	SH3 domain binding glutamic acid-rich protein	602230	REc			
21.143	10	17	95	21q22.3	SLC19A1, FOLT	P	Solute carrier family 19 (folate transporter), member 1	600424	REa, A			
21.144	9	16	03	21q22.3	SLC37A1, G3PP	P	Solute carrier family 37 (glycerol-3-phosphate transporter), member 1	608094	REc			
21.145	4	30	15	21q22.3	SIK1, SNF1LK, MSK, EIEE30	P	Salt-inducible kinase 1	605705	REc		Epileptic encephalopathy, early infantile, 30, 616341 (3)	
21.146	8	25	04	21q22.3	SUMO3, SMT3H1	P	Small ubiquitin-like modifier 3	602231	REc			
21.147	10	15	96	21q22.3	TFF1, BCEI	C	Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in)	113710	REa, A, Fd			
21.148	8	24	98	21q22.3	TFF2, SML1	C	Trefoil factor 2 (spasmolytic protein-1)	182590	A, REn, REa	within 230kb of BCEI		
21.149	4	9	96	21q22.3	TFF3, ITF	C	Trefoil factor 3 (intestinal)	600633	Psh, A, REn			17(Tff3)
21.150	2	25	98	21q22.3	TMEM1, EHOC1	C	Transmembrane protein 1	602103	REc	near PWP2H		
21.151	6	9	98	21q22.3	TMPRSS2	P	Transmembrane protease, serine 2	602060	Psh, REc			
21.152	1	9	13	21q22.3	TMPRSS3, ECHOS1, DFNB8, DFNB10	C	Transmembrane protease, serine 3	605511	Fd, REc		Deafness, autosomal recessive 8/10, 601072 (3)	
21.153	6	18	99	21q22.3	TRPM2, TRPC7, KNP3	P	Transient receptor potential cation channel, subfamily M, member 2	603749	REf			
21.154	10	25	12	21q22.3	TSPEAR, C21orf29, DFNB98	P	Thrombospondin-type laminin G domain and EAR repeats	612920	REc, Fd		Deafness, autosomal recessive 98, 614861 (3)	
21.155	9	28	96	21q22.3	U2AF1	P	U2(RNU2) small nuclear RNA auxillary factor 1	191317	A, REa			
21.156	10	26	98	21q22.3	UBE2G2, UBC7	C	Ubiquitin-conjugating enzyme E2G 2	603124	Psh			
21.157	3	16	01	21q22.3	UBASH3A	P	Ubiquitin-associated and SH3 domain-containing protein A	605736	REc			
21.158	4	6	11	21q22.3	UMODL1	P	Uromodulin-like 1	613859	REc			
21.159	5	25	01	21q22.3	WDR4	P	WD repeat-containing protein 4	605924	REf			
21.160	5	5	99	21q22.2	WRB, CHD5	P	Tryptophan-rich basic protein	602915	REc, REn			
21.161	8	26	15	21q22.3	ZBTB21, ZNF295, KIAA1277	P	Zinc finger- and BTB domain-containing protein 21	616485	REc			
21.162	10	23	87	Chr.21	BAS	L	Beta-adrenergic stimulation, response to	109670	D			
21.163	10	23	87	Chr.21	HTOR	L	5-hydroxytryptamine oxygenase regulator	143460	D			
22.1	4	26	90	22p12	RNR5	C	Ribosomal RNA-5	180454	A			
22.2	8	20	92	22p	ZNF72	P	Zinc finger protein-72 (Cos8)	194546	REa			
22.3	8	20	92	22p	ZNF73	P	Zinc finger protein-73 (Cos12)	194547	REa			
22.4	3	13	07	22q12.2	UCRC	P	Ubiquinol-cytochrome C reductase complex, 7.2kD subunit	610843	R, REc			
22.5	10	20	99	22q13.1	RPL3	P	Ribosomal protein L3	604163	REa, R			
22.6	10	30	03	22q11	ACF	P	Asymmetric crying facies (Cayler cardiofacial syndrome)	125520	Fd		Cayler cardiofacial syndrome (2)	
22.7	11	27	94	22q12.1	ADRBK2, BARK2, GRK3	P	Adrenergic, beta, receptor kinase-2	109636	A			
22.8	6	29	99	22q11.21	ARVCF	P	Armadillo repeat gene deleted in VCFS	602269	A, REc	?role in VCFS		
22.9	10	23	87	22q11	CECR, CES	C	Cat eye syndrome	115470	Ch, A, D	partial tetrasomy of 22q11	Cat eye syndrome (4)	
22.10	10	26	98	22q11.21	CRKL	P	v-crk avian sarcoma virus CT10 oncogene homolog-like	602007	A			
22.11	8	24	98	22q11.21	DGCR6	P	DiGeorge syndrome critical region 6	601279	REn			
22.12	12	2	08	22q11.21	DGCR6L	P	DiGeorge syndrome critical region gene 6-like	609459	REc, REn			
22.13	8	15	96	22q11.21	DVL, DVL1	P	Dishevelled, Drosophila, homolog-like	601225	Ch, REc			
22.14	3	1	12	22q11.21	HCF2, HC2, SERPIND1, THPH10	C	Heparin cofactor II	142360	REb, REa	proximal to BCR	Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	
22.15	8	24	98	22q11.21	HIRA, TUPLE1	C	Histone cell cycle regulation defective, S. cerevisiae, homolog of, A (Tup-like enhancer of split 1)	600237	A	?role in CATCH22		16(Tuple1)
22.16	4	5	05	22q13.2	NAGA	C	Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)	104170	S, Ch	proximal to Ph1 break	Schindler disease, type I, 609241 (3); Kanzaki disease, 609242 (3); Schindler disease, type III, 609241 (3)	
22.17	9	16	03	22q11.21	P2RXL1, P2XM, P2X6	P	Purinergic receptor P2X-like 1	608077	A			
22.18	5	31	05	22q11.21	RTN4R, NOGOR	P	NOGO receptor (reticulon 4 receptor)	605566	REc		{Schizophrenia, susceptibility to}, 181500 (3)	
22.19	3	15	11	22q11.21	SCARF2, SREC2, VDEGS	P	Scavenger receptor class F, member 2	613619	REc		Van den Ende-Gupta syndrome, 600920 (3)	16(Scarf2)
22.20	5	6	13	22q11.21	SLC25A1, SLC20A3, CTP, D2L2AD	C	Solute carrier family 25 (mitochondrial citrate transporter), member 1	190315	REc, Psh, A		Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	
22.21	4	29	16	22q11.23	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	C	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	601607	Ch, REc		Rhabdoid tumors, somatic, 609322 (3); {Rhabdoid predisposition syndrome 1}, 609322 (3); Coffin-Siris syndrome 3, 614608 (3); {Schwannomatosis-1, susceptibility to}, 162091 (3)	
22.22	6	29	99	22q11.22	TOP3B	P	Topoisomerase, DNA, III, beta	603582	REc			
22.23	12	29	09	22q11.21	TUBA8, TUBAL2	P	Tubulin, alpha 8	605742	R		Polymicrogyria with optic nerve hypoplasia, 613180 (3)	
22.24	2	1	01	22q11.23	VPREB3	P	Pre-B-lymphocyte gene 3	605017	A			10(Vpreb3)
22.25	11	21	03	22q12.1	HSC20, HSCB, JAC1	P	HSC20, E. coli, homolog of	608142	REc			
22.26	2	9	92	22q11-q12	LRE1, L1.2	C	Line-1.2 retrotransposable element	151626	REa, A			
22.27	9	17	09	22q13.2	XRCC6, G22P1, TLAA, Ku70	C	X-ray repair, complementing defecting, in chinese hamster, 6	152690	REa, F	tight linkage to CYP2D		15(Ku70)
22.28	6	7	10	22q11.1	POTEH, POTE22, ACTBL1	P	POTE ankyrin domain family, member H	608913	REc, A			
22.29	12	17	07	22q11.1	XKR3, XTES, XRG3	P	X Kell blood group precursor-related family, member 3	611674	REc			
22.30	5	24	90	22q11.1-q11.2	GGT1, GTG	C	Gamma-glutamyltransferase-1	231950	A, S, F, RE	minor peak, q13.1	Glutathioninuria (1)	
22.31	9	24	15	22q11.21	LZTR1, SWNTS2, NS10	P	Leucine-zipper-like regulator-1	600574	RE		{Schwannomatosis-2, susceptibility to}, 615670 (3); Noonan syndrome 10, 616564 (3)	
22.32	12	7	98	22q11.21	GGT2	P	Gamma-glutamyltransferase-2	137181	REn		[Gamma-glutamyltransferase, familial high serum] (2)	
22.33	8	28	97	22q11.23	ADORA2A	C	Adenosine A2a receptor	102776	REa, REl, Psh, A	incorrectly assigned to 11q		
22.34	7	18	02	22q11.21	ATP6V1E1, ATP6E	C	ATPase, H+ transporting, lysosomal, 31kD, V1 subunit E isoform 1	108746	REa, REc			6(Atp6e)
22.35	12	3	98	22q11.21	BID	P	BH3-interacting domain death agonist	601997	Psh, D			6(Bid)
22.36	4	14	10	22q11.23	CABIN1, CAIN	P	Calcineurin-binding protein 1	604251	REc			
22.37	11	16	08	22q11.2	DEL22q11.2, C22DELq11.2	P	Chromosome 22q11.2 deletion syndrome, distal	611867	Ch		Chromosome 22q11.2 deletion syndrome, distal (4)	
22.38	1	20	09	22q11.2	DUP22q11.2	P	Chromosome 22q11.2 microduplication syndrome	608363	Ch	contiguous gene microduplication syndrome	Chromosome 22q11.2 microduplication syndrome (4)	
22.39	1	20	11	22q11.2	DER22t8-22	P	Supernumerary der(22)t(8;22) syndrome	613700	Ch		Supernumerary der(22)t(8-22) syndrome (4)	
22.40	1	20	11	22q11.2	DER22t11-22	P	Emanuel syndrome (supernumerary der(22)t(11;22) syndrome)	609029	Ch		Emanuel syndrome (4)	
22.41	6	16	99	22q11.21	CDC45L, CDC45L2	C	Cell division cycle 45, S. Cerevisiae, homolog-like	603465	D, A, REc			
22.42	8	14	14	22q11.1	CECR1, PAN, SNEDS	P	Cat eye syndrome chromosome region, candidate 1	607575	REc	mutation identified in 1 SNEDS family	Polyarteritis nodosa, childhood-onset, 615688 (3); ?Sneddon syndrome, 182410 (3)	
22.43	2	26	03	22q11.1-q11.2	CECR2, KIAA1740	P	Cat eye syndrome chromosome region, candidate 2	607576	REc			6(Cecr2)
22.44	2	3	99	22q11.21	CLDN5, TMVCF, AWAL	P	Claudin-5 (transmembrane protein deleted in velocardiofacial syndrome)	602101	REc			16(Tmvcf)
22.45	12	19	05	22q11.21	COMT	C	Catechol-O-methyltransferase	116790	S, D, A, REn		{Schizophrenia, susceptibility to}, 181500 (3); {Panic disorder, susceptibility to}, 167870 (3)	16(Comt)
22.46	5	12	99	22q11.21	CLTCL1, CLTD	P	Clathrin, heavy polypeptide-like 1	601273	RE			11(Cltd)
22.47	8	3	99	22q11.23	DDT	P	D-dopachrome tautomerase	602750	Fd, A			10(Ddt)
22.48	2	18	98	22q11.21	DGCR2, IDD	P	DiGeorge critical region gene 2 (integral membrane protein deleted in DiGeorge syndrome)	600594	Ch			16(Idd)
22.49	5	2	07	22q11.21	DGCR8	P	DiGeorge syndrome critical region gene 8	609030	REc, Ch			16(Dgcr8)
22.50	4	21	97	22q11.21	DGSI	P	DiGeorge syndrome critical region gene DGSI	601755	REc			16(Dgsi)
22.51	8	25	09	22q12.2	EIF4ENIF1	P	Eukaryotic translation initiation factor 4E nuclear import factor 1	607445	R, REc			
22.52	10	9	08	22q11.23	GGT1, GGT	P	Gamma-glutamyltransferase 1	612346	REc			
22.53	10	9	08	22q11.23	GGT5	P	Gamma-glutamyltransferase 5	137168	REc			
22.54	10	9	08	22q11.22	GGTLC2, GGTL4	P	Gamma-glutamyltransferase, light chain 2	612339	REc			
22.55	10	9	08	22q11.21	GGTLC3	P	Gamma-glutamyltransferase, light chain 3	612340	REc			
22.56	9	13	92	22q11.22-q11.23	GNAZ	C	Guanine nucleotide-binding protein (G protein), alpha z polypeptide	139160	REa, A			10(Gnaz)
22.57	2	21	07	22q11.21	GNB1L, WDR14	P	Guanine nucleotide-binding protein, beta-1-like	610778	REc			16(Gnb1l)
22.58	9	21	11	22q11.21	GP1BB, BS, BDPLT1	C	Glycoprotein Ib, platelet, beta polypeptide	138720	REa, D		Bernard-Soulier syndrome, type B, 231200 (3); Giant platelet disorder, isolated, 231200 (3)	16(Gp1bb)
22.59	5	4	00	22q11.2	GSTT1	P	Glutathione S-transferase, theta-1	600436	A			
22.60	3	27	95	22q11.23	GSTT2	P	Glutathione S-transferase theta-2	600437	REa, A			
22.61	5	7	03	22q11.21	HIC2, HRG22, KIAA1020	P	Hypermethylated in cancer 2	607712	REc			
22.62	4	15	08	22q11.2	IGLV@	C	Immunoglobulin lambda light chain variable gene cluster	147240	REa, A	many genes		
22.63	4	15	08	22q11.2	IGLJ@	C	Immunoglobulin lambda light chain joining gene cluster	147230	REa, A	nine J-C duplexes		
22.64	12	7	98	22q11.22	IGLC1, IGLC	C	Constant region of lambda light chains	147220	REa, A	several genes		16(Igl1)
22.65	9	13	99	22q11.22	MAPK1, PRKM1, ERK2	C	Mitogen-activated protein kinase 1	176948	REa, A, H			16(Prkm1)
22.66	1	27	11	22q11.21	MED15, PCQAP, TIG1, ARC105	P	Mediator complex subunit 15	607372	Ch			16(Pcqap)
22.67	3	30	04	22q11.23	MIF	C	Macrophage migration inhibitory factor	153620	REa, A	previously assigned to chr.19	{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)	10(Mif)
22.68	7	13	94	22q11.23	MMP11, STMY3	P	Matrix metalloproteinase 11 (stromelysin 3)	185261	REa, A			
22.69	9	15	11	22q12.3	MYH9, MHA, FTNS, DFNA17, BDPLT6	C	Myosin, heavy polypeptide-9, nonmuscle	160775	REa, A		May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3); Sebastian syndrome, 605249 (3); Deafness, autosomal dominant 17, 603622 (3); Epstein syndrome, 153650 (3); Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	
22.70	5	24	13	22q11.23	PIWIL3	P	PIWI-like 3	610314	REc			
22.71	5	31	05	22q11.21	PRODH, PRODH2, SCZD4	C	Proline dehydrogenase (proline oxidase)	606810	D, A		Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility to, 4}, 600850 (3)	
22.72	2	20	01	22q11.23	RAB36	P	Ras family, member 36	605662	REc			
22.73	9	2	08	22q11.23	RGL4, RGR	P	Ral guanine nucleotide dissociation stimulator-like 4	612214	REc			
22.74	3	30	16	22q11.22-q11.23	RSPH14, RTDR1	P	Radial spoke head 14, Chlamydomonas, homolog of	605663	REc			
22.75	2	28	03	22q11.21	SDF2L1	P	Stromal cell-derived factor 2-like 1	607551	REc			
22.76	11	1	05	22q11.21	SEPT5, PNUTL1, CDCREL	C	Septin 5	602724	REn, Ch	just 5' of GP1BB		
22.77	8	19	13	22q11.23	SLC2A11, GLUT11	P	Solute carrier family 2 (facilitated glucose transporter), member 11	610367	REc			
22.78	5	12	99	22q11.21	SLC7A4, CAT4	P	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 4	603752	A, REc			
22.79	4	7	05	22q11.21	SLC25A18, GC2	P	Solute carrier family 25 (mitochondrial carrier, glutamate), member 18	609303	REc			
22.80	9	19	05	22q11.21	SNAP29, CEDNIK	P	Synaptosomal-associated protein, 29kD	604202	R, REc		Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	
22.81	3	25	16	22q11.21	TANGO2, C22orf25, MECRCN	P	Transport and golgi organization 2, Drosophila, homolog of	616830	REc		Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	
22.82	4	21	97	22q11.21	UFD1L	C	Ubiquitin fusion degradation 1-like	601754	REc, D, A	?role in CATCH22		
22.83	2	8	13	22q11.21	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	C	T-box 1	602054	REa, D, Ch		Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome, 188400 (3); Velocardiofacial syndrome, 192430 (3); Tetralogy of Fallot, 187500 (3)	16(Tbx1)
22.84	3	4	02	22q11.21	TXNRD2, TRXR2, SELZ	P	Thioredoxin reductase 2	606448	REc			16(Txnrd2)
22.85	12	21	09	22q11.23	UPB1, BUP1	P	Beta-ureidopropionase	606673	A		Beta-ureidopropionase deficiency, 613161 (3)	
22.86	6	27	02	22q11.21	USP18, UBP43, ISG43	P	Ubiquitin-specific protease 18	607057	A			6(Usp18)
22.87	12	13	00	22q11.22	VPREB1, IGI, VPREB	P	Pre-B lymphocyte gene 1	605141	REa			
22.88	9	16	03	22q11.21-q11.22	YPEL1	C	Yippee-like 1	608082	A, REc	pseudogene on 9p24.3		16(Ypel1)
22.89	8	20	92	22q11.23	ZNF70	P	Zinc finger protein-70 (Cos17)	194544	REa			
22.90	8	20	92	22q11.21	ZNF74	P	Zinc finger protein-74 (Cos52)	194548	REa			
22.91	8	6	13	22q12.1	CRYBB1, CATCN3, CTRCT17	P	Crystallin, beta B1	600929	REc		Cataract 17, multiple types, 611544 (3)	5(Crybb1)
22.92	5	3	13	22q11.23	CRYBB2, CRYB2, CTRCT3, CCA2	C	Crystallin, beta-B2	123620	REa, A	2nd CRYB2 gene in same region	Cataract 3, multiple types, 601547 (3)	5(Crybb2)
22.93	8	6	13	22q11.23	CRYBB3, CRYB3, CATCN2, CTRCT22	C	Crystallin, beta-B3	123630	RE		Cataract 22, autosomal recessive, 609741 (3)	5(Crybb3)
22.94	2	11	02	22q12.1	HPS4	P	HPS gene 4	606682	REc		Hermansky-Pudlak syndrome 4, 614073 (3)	5(le)
22.95	2	9	92	22q12.3	IL2RB	C	Interleukin-2 receptor, beta polypeptide	146710	REa, A, Fd, H			15(Il2rb)
22.96	10	23	87	22q12.3	MB	C	Myoglobin	160000	REa, Fd			
22.97	7	22	13	22q12.1	CRYBA4, CTRCT23	C	Crystallin, beta polypeptide A4	123631	REa, Fd		Cataract 23, 610425 (3)	
22.98	2	7	01	22q11.21	UBE2L3, UBCH7	P	Ubiquitin-conjugating enzyme E2L 3	603721	REa, A	pseudogenes on 12q12 and 19q13.1-q13.2		
22.99	8	25	09	22q12.2	INPP5J, PIB5PA, PIPP	P	Inositol polyphosphate-5-phosphatase J	606481	R, REc			
22.100	12	18	07	22q12.2	PLA2G3, SPLA2III	P	Phospholipase A2, group III	611651	REc			
22.101	6	29	99	22q12.3	MPST	P	Mercaptopyruvate sulfurtransferase	602496	REc			
22.102	7	8	10	22q12.2	TCN2, TC2	C	Transcobalamin II	613441	F, S, D	linked to P1	Transcobalamin II deficiency, 275350 (3)	11(Tcn2)
22.103	6	29	99	22q12.3	TST, RDS	P	Thiosulfate sulfurtransferase (Rhodanese)	180370	REc			
22.104	8	27	15	22q11.23	BCR, CML, PHL, ALL	C	Breakpoint cluster region	151410	Ch, RE	Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML	Leukemia, chronic myeloid, somatic, 608232 (3); Leukemia, acute lymphocytic, somatic, 613065 (3)	10(Bcr)
22.105	5	24	13	22q11.21	GSC2, GSCL	C	Goosecoid homeobox 2	601845	REc			
22.106	8	10	10	22q11.23	IGLL1, IGO, IGL5, VPREB2, AGM2	C	Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide)	146770	REa, Ch	between BCR2 and BCR4; distal to IGLC	Agammaglobulinemia 2, 613500 (3)	
22.107	10	28	08	22q11.21	MICAL3, KIAA1364	P	Microtubule-associated monooxygenase, calponin and LIM domains-containing 3	608882	R, REc			
22.108	12	27	13	22q11.21	MIR185	P	Micro RNA 185	615576	REc	within first intron of C22orf25		
22.109	2	5	15	22q11.21	MIR648	P	Micro RNA 648	616205	REc	in intron 1 of MICAL3		
22.110	8	3	12	22q11.21	MRPL40, NLVCF, MRPL22	P	Mitochondrial ribosomal protein L40	605089	REc			16(Nlvcf)
22.111	10	25	12	22q11.21	PEX26, PBD7A, PBD7B	C	Peroxisome biogenesis factor 26	608666	REc		Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3); Peroxisome biogenesis disorder 7B, 614873 (3)	
22.112	9	2	15	22q11.21	PI4KA, PIK4CA, PMGYCHA	P	Phosphatidylinositol 4-kinase, catalytic, alpha	600286	REc		Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	
22.113	2	28	03	22q11.21	PPIL2, CYP60	P	Peptidyl-prolyl isomerase-like 2	607588	R			
22.114	8	8	13	22q11.21	RANBP1, HTF9A	P	RAN-binding protein 1	601180	REc			
22.115	4	1	09	22q11.21	RIMBP3, RIMBP3A, KIAA1666	C	RIMS-binding protein 3	612699	REc, H			16(Rimbp3)
22.116	4	1	09	22q11.21	RIMBP3B	P	RIMS-binding protein 3B	612700	REc, H			16(Rimbp3)
22.117	4	1	09	22q11.21	RIMBP3C	P	RIMS-binding protein 3C	612701	REc, H			16(Rimbp3)
22.118	4	23	09	22q11.21	TRMT2A, HTF9C	P	tRNA methyltransferase 2, S. cerevisiae, homolog of, A	611151	REc			
22.119	1	22	07	22q11.21	TSSK2, STK22B	P	Testis-specific serine/threonine kinase 2	610710	REc			16(Tssk2)
22.120	3	22	06	22q11.21	ZDHHC8, ZNF378, KIAA1292	P	Zinc finger DHHC domain-containing protein 8	608784	R, REc			
22.121	1	21	11	22q11.21	MIR130B, MIRN130B	P	Micro RNA 130B	613682	REc			
22.122	11	21	03	22q11.21-q12.1	DFNB40	P	Deafness, autosomal recessive 40	608264	Fd		Deafness, autosomal recessive 40 (2)	
22.123	9	9	13	22q11.22	MIR650	P	Micro RNA 650	615379	REc			
22.124	8	25	09	22q11.22	PRAME, MAPE, OIP4	P	Preferentially expressed antigen in melanoma	606021	R, REc			
22.125	6	22	15	22q11.1	IL17RA, IL17R, CANDF5	P	Interleukin 17 receptor A	605461	R	mutation identified in 1 CANDF5 family	?Candidiasis, familial, 5, autosomal recessive, 613953 (3)	6(Il17r)
22.126	2	5	15	22q11.23	CHCHD10, FTDALS2, SMAJ, IMMD	P	Coiled-coil-helix-coiled-coil-helix domain-containing protein 10	615903	REc	mutation identified in 1 IMMD family	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3); ?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3); Spinal muscular atrophy, Jokela type, 615048 (3)	
22.127	5	24	13	22q11.23	DERL3	P	DER1-like domain family, member 3	610305	REc, R			
22.128	6	30	15	20q11.23	SLC32A1, VGAT, VIAAT	P	Solute carrier family 32 (GABA vesicular transporter), member 1	616440	REc			
22.129	3	16	15	22q11.23	SPECC1L, KIAA0376, OBLFC1, GBBB2	P	Sperm antigen with calponin homology and coiled-coil domains 1-like	614140	R, REc	mutation identified in 1 OBLFC1 patient	?Facial clefting, oblique, 1, 600251 (3); Opitz GBBB syndrome, type II, 145410 (3)	
22.130	7	18	14	22q11.23	SUSD2	P	Sushi domain-containing protein 2	615825	REc			
22.131	9	18	00	22q12.2	AP1B1, ADTB1, BAM22, CLAPB2	P	Adaptor-related protein complex 1, beta 1 subunit (adaptin, beta)	600157	D			
22.132	11	23	09	22q12	BRV2	P	Vertigo, benign recurrent, 2	613106	Fd		Vertigo, benign recurrent, 2 (2)	
22.133	9	2	08	22q12.2	EWSR1, EWS	C	Ewing sarcoma breakpoint region-1	133450	Ch	t(11;22)(q24;q12); t(21;22)(q22;q12)	Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)	
22.134	7	11	07	22q12.2	GAS2L1, GAR22	P	Growth arrest-specific 2 like 1	602128	REc			
22.135	1	28	13	22q12.3	HMOX1, HMOX1D	C	Heme oxygenase, decycling, 1	141250	Psh, A		Heme oxygenase-1 deficiency, 614034 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)	
22.136	2	14	13	22q12	KAZA1	P	Kala-azar (visceral leishmaniasis), susceptibility to, 1	608207	Fd		{Kala-azar, susceptibility to, 1} (2)	
22.137	6	16	99	22q13.1	MFNG	C	Manic fringe	602577	REa, R, A			15(Mfng)
22.138	6	29	99	22q12.2	MTMR3	C	Myotubularin-related protein 3	603558	R, Psh, A, REc			
22.139	11	5	98	22q12.2	NIPSNAP1	P	4-nitrophenylphosphatase domain and nonneuronal SNAP25-like 1	603249	REn			
22.140	5	7	03	22q12.2	OSBP2, ORP4, KIAA1664	P	Oxysterol-binding protein 2	606729	REc			
22.141	5	19	09	22q12.2	PISD, PSD, PSSC	P	Phosphatidylserine decarboxylase	612770	REc			
22.142	8	18	08	22q12.2	RASL10A, RRP22	P	Ras-like, family 10, member A	602220	REc			
22.143	7	16	09	22q12.2	SEC14L3, TAP2	C	Sec14-like 3	612824	REc			
22.144	7	16	09	22q12.2	SEC14L4, TAP3	P	Sec14-like 4	612825	REc			
22.145	5	9	07	22q12	SQTL2	P	Smoking as a quantitative trait locus 2	611004	Fd	max lod at D22S315	{Smoking as a quantitative trait locus 2} (2)	
22.146	5	5	09	22q12.2	THOC5, FMIP	P	THO complex 5	612733	REc, REn			
22.147	10	30	08	22q12.1	XBP1, XBP2	C	X-box-binding protein-1	194355	REa	pseudogene on chr.5	{Major affective disorder-7, susceptibility to}, 612371 (3)	
22.148	9	28	96	22q12.3	YWHAH, YWHA1	C	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide 22	113508	REb, A			
22.149	4	4	05	22q12.2	ZNF278, PATZ, MAZR	P	Zinc finger protein-278	605165	REc, R			
22.150	5	8	03	22q13.1	CBY, C22orf2, HS508I15A	P	Chibby	607757	R			
22.151	6	22	05	22q12-q13	CDAGS	P	Craniosynostosis, anal anomalies, and porokeratosis syndrome	603116	Fd		CDAGS syndrome (2)	
22.152	10	22	95	22q13.1	CSNK1E	P	Casein kinase-1, epsilon	600863	A			
22.153	3	31	09	22q12.3	FBXO7, FBX7, FBX, PKPS, PARK15	C	F-box only protein 7	605648	REc		Parkinson disease 15, autosomal recessive, 260300 (3)	10(Fbxo7)
22.154	2	28	03	22q13.1	GCAT, KBL	P	Glycine C-acetyltransferase	607422	REc			
22.155	3	15	10	22q12-q13	HCHGQ3	P	Hematocrit/hemoglobin quantitative trait locus 3	613284	Fd	associated with rs855791	[Hematocrit/hemoglobin quantitative trait locus 3] (2)	
22.156	6	8	01	22q12.2	RFPL1	P	RET finger protein-like 1	605968	REc			
22.157	7	2	01	22q12.2	RFPL1S	P	Ret finger protein-like 1, antisense	605972	REc			
22.158	6	8	01	22q12.3	RFPL2	P	RET finger protein-like 2	605969	REc			
22.159	6	8	01	22q12.3	RFPL3	P	RET finger protein-like 3	605970	REc			
22.160	7	2	01	22q12.3	RFPL3S	P	Ret finger protein-like 3, antisense	605971	REc			
22.161	5	10	11	22q13.1	SUN2, UNC84B, KIAA0668	C	SAD1 and UNC84 domain-containing protein 2	613569	REc, R			
22.162	5	30	08	22q12.3	TMPRSS6, IRIDA	C	Transmembrane protease, serine 6 (matriptase 2)	609862	REn, Fd		Iron-refractory iron deficiency anemia, 206200 (3)	
22.163	6	19	02	22q13.1	TOMM22, TOM22	P	Translocase of outer mitochondrial membrane 22, yeast, homolog of	607046	REc			
22.164	1	2	03	22q13.1	GTPBP1, GP1	P	GTP-binding protein 1	602245	R, REc			15(Gtpbp1)
22.165	4	25	93	22q13.1	LGALS1	C	Lectin, galactose-binding, soluble, 1	150570	A			15(Lgals1)
22.166	3	15	05	22q13.31	PPARA, PPAR	P	Peroxisome proliferator-activated receptor-alpha	170998	REa, Fd		{Hyperapobetalipoproteinemia, susceptibility to} (3)	
22.167	3	18	91	22q12.3	PVALB	C	Parvalbumin	168890	REa, D, H	?role in DiGeorge syndrome		15(Pva)
22.168	11	2	04	22q13.1	APOBEC3F	P	Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3F	608993	REc, A			
22.169	5	22	03	22q13.1	APOBEC3G, MDS019, CEM15, FLJ12740	P	Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G	607113	A, REc			
22.170	2	1	01	22q13.1	GRAP2, GRID	P	GRB2-related adaptor protein 2	604518	REc			
22.171	8	27	01	22q12.2	PES1, PES	P	Pescadillo, zebrafish, homolog of, 1	605819	REc			11(Pes1)
22.172	8	4	09	22q12.1	CHEK2, RAD53, CHK2, CDS1, LFS2	P	Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of)	604373	REc		Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3); {Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility to} (3)	
22.173	2	21	06	22q12.1	KREMEM1, KRM1	P	Kringle domain-containing transmembrane protein 1	609898	R, REc			
22.174	11	2	11	22q12.1	MIAT, C22orf35	P	MIAT gene	611082	REc		{Myocardial infarction, susceptibility to}, 608446 (3)	
22.175	9	21	15	22q12.1	MYO18B, KFS4	P	Myosin XVIIIB	607295	REc		Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3)	
22.176	8	25	09	22q12.1	PITPNB	P	Phosphatidylinositol transfer protein, beta	606876	R, REc			
22.177	9	30	02	22q12.1	SEZ6L	P	Seizure-related 6-like	607021	Ch, REc			
22.178	1	27	11	22q12.1	SRRD	P	SRR1 domain-containing protein	602254	REc			
22.179	5	11	09	22q12.1	TFIP11, TIP39, NTR1	P	Tuftelin-interacting protein 11	612747	REc			5(Tfip11)
22.180	10	14	98	22q12.1	TPST2	P	Tyrosylprotein phosphotransferase 2	603126	REc			
22.181	3	14	13	22q12.1	TTC28, TPRBK, KIAA1043	P	Tetratricopeptide repeat domain-containing protein 28	615098	REc			
22.182	6	10	08	22q12.1	ZNRF3, KIAA1133	P	Zinc finger and ring finger protein 3	612062	REc			
22.183	11	21	02	22q12.1-q12.2	ITS	P	Insulinoma tumor suppressor gene locus	606960	LOH		Insulinoma (1)	
22.184	9	28	93	22q12.2	LIF, HILDA	C	Leukemia inhibitory factor (cholinergic differentiation factor)	159540	REa, A, RE	distal to ES		11(Lif)
22.185	9	28	93	22q12.2	OSM	C	Oncostatin M	165095	REa, REn	10kb from LIF		
22.186	1	22	07	22q12.1-q13.1	OPA5	P	Optic atrophy 5	610708	Fd	between D22S1148 and D22S283	Optic atrophy 5 (2)	
22.187	1	12	95	22q12.3	TIMP3, SFD	C	Tissue inhibitor of metalloproteinase-3	188826	REa, A, Fd		Sorsby fundus dystrophy, 136900 (3)	
22.188	3	3	03	22q12.2	SEC14L2, TAP, KIAA1186	C	Sec14-like 2	607558	R, REc			
22.189	4	25	06	22q12.2	TBC1D10A, EPI64	P	TBC1 domain family, member 10A	610020	REc			
22.190	9	8	11	22q12.2	ASCC2, p100	P	Activating signal cointegrator 1 complex, subunit 2	614216	REc			
22.191	2	7	07	22q12.2	GAL3ST1, CST	P	Galactose-3-O-sulfotransferase 1	602300	R, REc			
22.192	5	25	13	22q12.2	LIMK2	P	LIM domain kinase 2	601988	REc			
22.193	12	17	15	22q12.2	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z	C	MORC family CW-type zinc finger protein 2	616661	R, REc		Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	
22.194	5	24	13	22q12.2	MTFP1	P	Mitochondrial fission process 1	610235	REc			
22.195	4	27	16	22q12.2	NEFH, CMT2CC	C	Neurofilament, heavy polypeptide	162230	A, RE, D	mutation identified in 1 family with ALS susceptibility	?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3)	11(Nfh)
22.196	1	29	03	22q12.2	NF2	C	Merlin	607379	RE, F, Ch, D, Fd	loss of heterozygosity	Neurofibromatosis, type 2, 101000 (3); Meningioma, NF2-related, somatic, 607174 (3); Schwannomatosis, 162091 (3)	11(Nf2)
22.197	8	25	09	22q12.2	SF3A1, SF3A120, SAP114, PRP21	P	Splicing factor 3A, subunit 1	605595	REa, REc			
22.198	5	12	09	22q12.2	SFI1, KIAA0542	P	SFI1, yeast, homolog of	612765	R, REc			
22.199	4	13	07	22q12.2	SELM, SEPM	P	Selenoprotein M	610918	REc			
22.200	1	15	13	22q12.2	TUG1	P	Taurine-upregulated gene 1, noncoding	614971	REc			
22.201	6	4	13	22q12.2-q12.3	DEPDC5, KIAA0645, FFEVF	C	DEP domain-containing protein 5	614191	Psh, REc, Fd		Epilepsy, familial focal, with variable foci, 604364 (3)	
22.202	12	5	11	22q12.3	CSF2RB, SMDP5	P	Colony-stimulating factor-2 receptor, beta, low-affinity	138981	Psh, A		Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	
22.203	6	29	99	22q13.1	GALR3	P	Galanin receptor 3	603692	REc, A			
22.204	4	27	00	22q13.1	MAFF	P	v-MAF avian musculoaponeurotic fibrosarcoma oncogene family, protein F	604877	REc			
22.205	10	25	10	22q12.3	APOL1, FSGS4	C	Apolipoprotein L1	603743	R, REc		{Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3); {End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)	
22.206	12	11	02	22q12.3	APOL2	C	Apolipoprotein L2	607252	R, REc		{Schizophrenia}, 181500 (1)	
22.207	12	11	02	22q12.3	APOL3	C	Apolipoprotein L3	607253	R, REc			
22.208	12	11	02	22q12.3	APOL4	C	Apolipoprotein L4	607254	R, REc		{Schizophrenia}, 181500 (1)	
22.209	12	11	02	22q12.3	APOL5	C	Apolipoprotein L5	607255	R, REc			
22.210	12	11	02	22q12.3	APOL6	C	Apolipoprotein L6	607256	R, REc			
22.211	12	10	12	22q12.3	C1QTNF6, CTFP6	P	C1q- and tumor necrosis factor-related protein 6	614910	REc			
22.212	3	24	11	22q12.3	FOXRED2, ERFAD	P	FAD-dependent oxidoreductase domain-containing protein 2	613777	REc			
22.213	2	29	08	22q12.3	HPC6	P	Prostate cancer, hereditary, 6	609558	Fd	between D22S1265 and D22S277	{Prostate cancer, susceptibility to}, 176807 (2)	
22.214	7	17	14	22q12.3	IFT27, RABL4, BBS19	P	Intraflagellar transport 27, Chlamydomonas, homolog of	615870	REc	mutation identified in 1 BBS19 family	?Bardet-Biedl syndrome 19, 615996 (3)	
22.215	6	2	08	22q12.3	ISX, RAXLX	P	Intesting-specific homeobox	612019	REc			
22.216	6	1	16	22q12.3	KCTD17	P	Potassium channel tetramerization domain-containing protein 17	616386	REc		Dystonia 26, myoclonic, 616398 (3)	
22.217	6	10	09	22q12.3	RASD2, RHES, TEM2	P	RASD family, member 2	612842	REc			
22.218	7	17	14	22q12.3	RTCB, C22orf28, HSPC117	P	RNA 2-prime, 3-prime cyclic phosphate and 5-prime-OH ligase	613901	REc			
22.219	5	28	99	22q12.2	SMTN	P	Smoothelin	602127	A, R			11(Smtn)
22.220	8	20	98	22q12.3	SYN3	P	Synapsin III	602705	REn	?relation to schizophrenia		
22.221	2	12	16	22q12.3	TXN2, TRX2, MTRX, COXPD29	P	Thioredoxin 2	609063	REc	mutation identified in 1 COXPD29 patient	?Combined oxidative phosphorylation deficiency 29, 616811 (3)	
22.222	9	30	09	22q13.1	CYTH4, PSCD4, CYT4	P	Cytohesin 4	606514	REc			
22.223	11	10	10	22q12.3	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	C	Acetylglucosaminyltransferase-like protein	603590	D, REc		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	8(Large)
22.224	1	20	11	22q12.3-q13.1	MDNS	P	Mammary-digital-nail syndrome	613689	Fd	max lod at D22S277, D22S1142, D22S683, D22S283	Mammary-digital-nail syndrome (2)	
22.225	11	11	13	22q13.1	PDGFB, SIS, IBGC5	C	Platelet-derived growth factor, beta polypeptide (oncogene SIS)	190040	REa, Fd	fused with COL1A1 in DFSP	Meningioma, SIS-related, 607174 (3); Dermatofibrosarcoma protuberans, 607907 (3); Basal ganglia calcification, idiopathic, 5, 615483 (3)	15(Pdgfb)
22.226	3	22	06	22q13.1	PICK1, PRKCABP	P	Protein interacting with C kinase 1	605926	REc			
22.227	10	27	03	22q13.1	RAC2	C	Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP-binding protein Rac2)	602049	A		Neutrophil immunodeficiency syndrome, 608203 (3)	
22.228	2	25	15	22q13.1	SLC16A8, MCT3	P	Solute carrier family 16 (monocarboxylic acid transporter), member 8	610409	REc, R			
22.229	3	16	99	22q12.1	MN1, MGCR	P	Meningioma chromosome region	156100	Fd, Ch	fused with TEL in AML	Meningioma, 607174 (3)	
22.230	8	23	02	22q13.1	APOBEC3A, PHRBN	P	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (phorbolin 1)	607109	A, REc			
22.231	8	23	02	22q13.1	APOBEC3B, PHRBNL	P	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B	607110	A, REc			
22.232	5	22	03	22q13.1	APOBEC3C	P	Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3C	607750	REn, A			
22.233	8	30	07	22q13.31	ATXN10, SCA10	C	Ataxin 10	611150	Fd	ATTCTn repeat in intron 9	Spinocerebellar ataxia 10, 603516 (3)	
22.234	6	1	12	22q12.3	BPIFC, BPIL2	P	BPI fold-containing protein, family C	614109	Psh, R, REc			
22.235	2	22	00	22q13.33	BRL	P	BR140-like gene	604589	A			
22.236	5	24	13	22q13.31	CERK, KIAA1646	P	Ceramide kinase	610307	REc			
22.237	7	22	11	22q13.33	CHKB, CHKL, CKEKB, EKB, MDCMC	P	Choline kinase, beta	612395	REc		Muscular dystrophy, congenital, megaconial type, 602541 (3)	
22.238	10	13	09	22q13.33	CPT1B	P	Carnitine palmitoyltransferase I, muscle	601987	A, REn			
22.239	11	20	13	22q13	DUP22q13, C22DUPq13	P	Chromosome 22q13 duplication syndrome	615538	Ch		Chromosome 22q13 duplication syndrome, 615538 (4)	
22.240	2	19	13	22q13.2	EP300, RSTS2	P	E1A-binding protein, 300kD	602700	A		Rubinstein-Taybi syndrome 2, 613684 (3); Colorectal cancer, somatic, 114500 (3)	
22.241	5	26	13	22q13.33	IL17REL	P	Interleukin 17 receptor E-like	613414	REc			
22.242	5	22	03	22q13.33	MAPK8IP2, JIP2, IB2	P	Mitogen-activated protein kinase 8-interacting protein 2	607755	REc			
22.243	3	26	07	22q13	MENAQ1	P	Menarche, age at, QTL 1	610873	Fd	max lod at UT7136	{Menarche, age at, QTL} (2)	
22.244	3	23	09	22q13.31	MIRLET7B, LET7B, MIRNLET7B	P	Micro RNA Let7B	611249	R, REn			
22.245	6	28	01	22q13.1-q13.2	MKL1, AMKL, MAL	P	Megakaryoblastic leukemia 1 gene	606078	Ch	fusion with RBM15	Megakaryoblastic leukemia, acute (3)	
22.246	6	7	10	22q13	NAFLD1	P	Fatty liver disease, nonalcoholic, susceptibility to, 1	613282	Fd	associated with rs738409	{Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)	
22.247	12	4	08	22q13	NRCLP4	P	Narcolepsy 4	612417	Fd	associated with rs5770917	{Narcolepsy 4} (2)	
22.248	11	2	14	22q13.33	PANX2, PX2	P	Pannexin 2	608421	REc			
22.249	3	9	10	22q13.31	PNPLA3, ADPN	P	Patatin-like phospholipase domain-containing protein 3	609567	REc			
22.250	8	21	07	22q13.1	RNU86	P	RNA, U86 small nucleolar	611069	REc			
22.251	8	26	15	22q13.33	SCO2, CEMCOX1, MYP6	C	SCO2 cytochrome c oxidase assembly protein	604272	REc, Fd		Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3); Myopia 6, 608908 (3)	
22.252	1	22	08	22q13.2	SCUBE1	P	Signal peptide-, CUB domain-, and EGF-like domains-containing protein 1	611746	REc, H			15(Scube1)
22.253	3	26	02	22q13.2	SLC25A17, PMP34	P	Solute carrier family 25 (mitochondrial carrier), member 17 (peroxisomal membrane protein, 34kD)	606795	REc			
22.254	8	21	07	22q13.1	SNORD43, RNU43	P	Small nucleolar RNA, C/D box, 43	611068	REc			
22.255	8	21	07	22q13.1	SNORD83A, RNU83A	P	Small nucleolar RNA, C/D box, 83A	611070	REc			
22.256	8	21	07	22q13.1	SNORD83B, RNU83B	P	Small nucleolar RNA, C/D box, 83B	611071	REc			
22.257	3	16	10	22q13.1	SOX10, WS4, WS4C, PCWH	C	SRY (sex-determining region Y)-box-10	602229	REn	megacolon and spotting in mice	Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)	15(Sox10, Dom)
22.258	1	10	96	22q13.2	SREBF2	P	Sterol regulatory element binding transcription factor 2	600481	REa, A			
22.259	3	3	03	22q13.2	ST13, P48, HOP	P	Suppression of tumorigenicity 13	606796	A			
22.260	2	7	01	22q13.1	SYNGR1	P	Synaptogyrin 1	603925	REc			
22.261	11	17	94	22q13.2	TEF	P	Thyrotroph embryonic factor	188595	A			15(Tef)
22.262	10	28	11	22q13.31	TRMU, MTO2	P	tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase	610230	REc		{Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure, transient infantile, 613070 (3)	15(Trmu)
22.263	6	9	98	22q13.31	WNT7B	P	Wingless-type MMTV integration site family, member-7B	601967	A			
22.264	11	8	03	22q13.1	ADSL	C	Adenylosuccinate lyase	608222	S, REa, A	ade(-)I; bifunctional	Adenylosuccinase deficiency, 103050 (3)	15(Adsl)
22.265	4	29	10	22q13.1	ANKRD54, LIAR	P	Ankyrin repeat domain-containing protein 54	613383	REc, H			15(Ankrd54)
22.266	5	22	07	22q13.1	APOBEC3H, ARP10	C	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H	610976	REc, REn			
22.267	2	10	09	22q13.1	ATF4, CREB2, TAXREB67	P	Activating transcription factor 4	604064	R, REc			
22.268	3	22	07	22q13.1	CACNA1I, KIAA1120	C	Calcium channel, voltage-dependent, T type, alpha-1I subunit	608230	REc			
22.269	10	3	11	22q12.3	CACNG2, MRD10	C	Calcium channel, voltage-dependent, gamma-2 subunit (stargazin)	602911	REc		Mental retardation, autosomal dominant 10, 614256 (3)	15(Cacng2)
22.270	8	25	09	22q13.1	CARD10, CARMA3, BIMP1	P	Caspase recruitment domain-containing protein 10	607209	R, REc			
22.271	2	16	04	22q13.1	CBX7	P	Chromobox homolog 7	608457	R, REc			
22.272	8	25	09	22q13.1	CDC42EP1, MSE55, BORG5, CEP1	P	CDC42 effector protein 1	606084	R, REc			
22.273	1	20	09	22q13.2	CYP2D6, CPD6, P450DB1	C	Cytochrome P450, subfamily IID, polypeptide 6	124030	F, Fd, Psh, A		{Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902 (3)	15(Cyp2d)
22.274	11	11	14	22q13.1	DMC1, LIM15	P	Disrupted meiotic cDNA 1, yeast, homolog of	602721	REc			
22.275	11	3	14	22q13.1	DNAL4, MRMV3	P	Dynein, axonemal, light chain 4	610565	REc	mutation identified in 1 MRMV3 family	?Mirror movements 3, 616059 (3)	15(Dnal4)
22.276	2	19	04	22q13.1	DDX17, RH70, P72	P	DEAD/H box-17	608469	R, REc			
22.277	10	3	07	22q12.3	EIF3D, EIF3S7	P	Eukaryotic translation initiation factor 3, subunit D	603915	REc			
22.278	8	25	98	22q13.1	H1F0, H1FV	P	H1 histone family, member 0	142708	Psh, A			
22.279	5	18	95	22q13.1	KCNJ4, HIR	P	Potassium inwardly-rectifying channel, subfamily J, member 4	600504	Psh, A			
22.280	2	21	03	22q12.3	HMGXB4, HMG2L1	P	HMG box domain-containing 4	604702	REc			
22.281	7	23	13	22q13.1	JOSD1, KIAA0063	P	Josephin domain-containing protein 1	615323	REc, Psh			
22.282	4	18	05	22q13.1	LGALS2	P	Lectin, galactoside-binding, soluble, 2	150571	A, REc		{Myocardial infarction, susceptibility to}, 608446 (3)	
22.283	6	29	99	22q12.3	MCM5, CDC46	P	Minichromosome maintenance, S. cerevisiae, homolog of, 5	602696	A			
22.284	12	10	13	22q13.1	MEIF1, SMCR7L, MID51	P	Mitochondrial elongation factor 1	615497	REc			
22.285	3	9	00	22q13.1	MGAT3, GNT3	P	Beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase	604621	A			
22.286	8	27	15	22q13.1	MIR659	P	Micro RNA 659	613556	REc			
22.287	9	8	11	22q12.3	NCF4, P40PHOX	P	Neutrophil cytosolic factor-4	601488	Psh, A		Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)	
22.288	12	3	98	22q13.2	NDUFA6	C	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6	602138	R	previously assigned to 21q22		
22.289	3	9	10	22q13.1	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	C	Phospholipase A2, group VI	603604	REc, Fd		Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration with brain iron accumulation 2B, 610217 (3); Parkinson disease 14, autosomal recessive, 612953 (3)	
22.290	5	19	97	22q13.2	PMM1	P	Phosphomannomutase 1	601786	REa, A			
22.291	2	7	01	22q13.1	POLR2F	P	Polymerase II, RNA, subunit F	604414	REc			
22.292	7	10	08	22q12.3	RBM9, FOX2, RTA	C	RNA-binding motif protein 9	612149	R, REc			
22.293	6	30	06	22q13.1	RPS19BP1, S19BP, MGC52010	P	Ribosomal protein S19 binding protein 1	610225	REc, H			15(Rps19bp1)
22.294	5	24	13	22q13.1	SGSM3, RUTBC3, MAP, RUSC3	P	Small G protein signaling modulator 3	610440	R, REc			
22.295	4	16	02	22q12.3	SLC5A1, SGLT1	C	Solute carrier family 5 (sodium/glucose transporter), member 1	182380	REa		Glucose/galactose malabsorption, 606824 (3)	
22.296	4	25	93	22q13.1	SSTR3	C	Somatostatin receptor-3	182453	REa			15(Sstr3)
22.297	1	11	16	22q13.1	TAB1, MAP3K7IP1	P	Tak1 (MAP3K7) binding protein 1	602615	R, REc			
22.298	1	31	07	22q13.1	TNRC6B, KIAA1093	P	Trinucleotide repeat-containing gene 6B	610740	R, REc			
22.299	11	19	13	22q12.3	TOM1	P	Target of MYB1, chicken, homolog of	604700	REn			8(Tom1)
22.300	1	11	06	22q13.1	TRIOBP, KIAA1662	P	Trio- and F-actin-binding protein	609761	REc, Fd		Deafness, autosomal recessive 28, 609823 (3)	
22.301	3	15	07	22q13.2	TTLL1, KIAA0173	P	tubulin tyrosine ligase-like protein 1	608955	REc			
22.302	12	15	10	22q13.2	TNFRSF13C, BAFFR, CVID4	P	Tumor necrosis factor receptor superfamily, member 13C	606269	REc		Immunodeficiency, common variable, 4, 613494 (3)	15(Baffr)
22.303	12	4	02	22q13.2	TOB2, KIAA1663	P	Transducer of erbb2, 2	607396	A			
22.304	2	8	13	22q13.2	A4GALT, P1PK	P	Alpha 1,4-galactosyltransferase	607922	REc		[Blood group, P1Pk system, p phenotype], 111400 (3); [Blood group, P1Pk system, P(2) phenotype], 111400 (3); NOR polyagglutination syndrome, 111400 (3)	
22.305	11	10	15	22q13.2	ACO2, ICRD, OPA9	C	Aconitase, mitochondrial	100850	S, Ch, REc	distal to Ph1 break; mutation identified in 1 OPA9 family	Infantile cerebellar-retinal degeneration, 614559 (3); ?Optic atrophy 9, 616289 (3)	
22.306	12	4	08	22q13.2	ARFGAP3	P	ADP-ribosylation factor GTPase-activating protein 3	612439	R, REc			
22.307	2	25	15	22q13.2	CHADL	P	Chondroadherin-like	616236	REc			
22.308	7	20	12	22q13.2	DESI1, PPPDE2	P	Desumoylating isopeptidase 1	614637	REc			
22.309	3	23	14	22q13.2	DNAJB7, DJ5, HSC3	P	DNAJ/HSP40 homolog, subfamily B, member 7	611336	REc			
22.310	9	30	11	22q13.2	FAM109B, SES2, IPIP27B	P	Family with sequence similarity 109, member B	614240	REc			
22.311	3	23	09	22q13.2	MIR33A, MIRN33A	P	Micro RNA 33A	612156	REc			
22.312	1	29	07	22q13.2	NFAM1, CNAIP	P	NFAT activating protein with ITAM motif 1	608740	REc			
22.313	2	1	11	22q13.2	NHP2L1	P	Non-histone chromosome protein 2, S. cerevisiae, like 1	601304	REc	previously assigned to 12q24.3 by FISH		
22.314	12	10	13	22q13.2	PACSIN2	P	Protein kinase C and casein kinase substrate in neurons 2	604960	REc			
22.315	10	13	09	22q13.2	POLDIP3, SKAR, PDIP46	P	Polymerase delta-interacting protein 3	611520	R, REc			
22.316	3	30	12	22q13.2	RBX1, ROC1	P	RING-box 1	603814	REc			
22.317	12	7	03	22q13.2	SEPT3, SEP3	C	Septin 3	608314	REc			
22.318	9	9	13	22q13.2	SERHL	P	Serine hydrolase-like	607979	REc			
22.319	1	7	14	22q13.2	SMDT1, EMRE, C22orf32	P	Single-pass membrane protein with aspartate-rich tail 1	615588	REc			
22.320	5	22	07	22q13.2	WBP2NL, PAWP	P	WWBP2 N-terminal-like protein	610981	REc			
22.321	1	27	04	22q13.31	SULT4A1, BRSTL1	P	Sulfotransferase family 4A, member 1	608359	R, REc			
22.322	3	9	04	22q13.2	BIK, NBK	P	Bcl2-interacting killer	603392	A			
22.323	3	10	00	22q13.31	CELSR1	P	Cadherin EGF LAG seven-pass G-type receptor 1	604523	A			15(Celsr1)
22.324	7	15	14	22q13.31	FBLN1	C	Fibulin 1	135820	A		Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4)	15(Fbln1)
22.325	2	28	08	22q13.2	L3MBTL2, L3MBT	P	L3MBT-like 2	611865	REc			15(L3mbtl2)
22.326	6	29	99	22q13.33	MAPK12, SAPK3, ERK3	P	Mitogen-activated protein kinase 12 (Stress-activated protein kinase-3)	602399	A			
22.327	6	7	10	22q13.2	MCHR1, GPR24, SLC1	C	Melanin-concentrating hormone receptor 1	601751	A, R			
22.328	1	9	01	22q13.31	NUP50, NPAP60L, NPAP60	C	Nucleoporin, 50 kD	604646	H, REc			15(Npap60)
22.329	5	4	00	22q13.31	PKDREJ	P	Polycystic kidney disease and sea urchin REJ homolog-like	604670	R			
22.330	11	27	00	22q13.33	RABL2B	C	RAB-like 2B	605413	REc			
22.331	3	28	12	22q13.33	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	C	SH3 and multiple ankyrin repeat domains 3	606230	A		Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15}, 613950 (3)	
22.332	11	4	98	22q13.2	TCF20, SPBP, AR1	P	Transcription factor 20	603107	A, Psh			
22.333	6	30	05	22q13.31	ARHGAP8, BPGAP1	C	GTPase-activating protein, RHO, 8	609405	REc, H			15(Arhgap8)
22.334	8	25	09	22q13.1	GGA1	P	Golgi associated, gamma adaptin ear containing, ARF binding protein 1	606004	R, REc			
22.335	1	20	11	22q13.31	GRAMD4, KIAA0767, DIP	P	Gram domain-containing protein 4	613691	REc			
22.336	2	24	12	22q13.2	MCAT	P	Malonyl CoA:ACP acyltransferase, mitochondrial	614479	REc			
22.337	3	23	09	22q13.31	MIRLET7A3, LET7A3, MIRNLET7A3	P	Micro RNA let7a3	612143	REc			
22.338	3	16	10	22q13.2	MPPED1, C22orf1, 239AB	P	Metallophosphoesterase domain-containing protein 1	602112	REc			
22.339	12	29	06	22q13.2	PANE1, C22orf18	P	Proliferation-associated nuclear element 1	610152	REc			
22.340	10	29	09	22q13.31	PARVB	P	Parvin, beta	608121	REc			
22.341	10	29	09	22q13.31	PARVG	P	Parvin, gamma	608122	REc			
22.342	1	4	16	22q13.31	PHF21B, PHF4, BHC80L	P	PHD finger protein 21B	616727	REc			
22.343	2	23	08	22q13.31	PNPLA5, GS2L	P	Patatin-like phospholipase domain-containing 5	611589	R, REc			
22.344	6	30	05	22q13.31	PRR5, PP610	C	Proline-rich protein 5	609406	REc, H			15(Prr5)
22.345	6	10	08	22q13.31	SAMM50, SAM50	P	Sorting and assembly machinery component 50, S. cerevisiae, homolog of	612058	R, REc			
22.346	3	29	16	22q13.31	TBC1D22A, C22orf4	P	TBC1 domain family, member 22A	616879	REc			
22.347	7	9	10	22q13.2	TSPO, BZRP, PBR, PBS, BPBS	C	Translocator protein, 18kD (benzodiazepine receptor, peripheral type)	109610	A			15(Bzrp)
22.348	4	14	12	22q13.31	UPK3A, UPK3, UPIII	C	Uroplakin 3A	611559	REc			
22.349	11	22	99	22q13.33	PLXNB2, MM1	P	Plexin B2	604293	REc, R			
22.350	9	8	10	22q13.2	XPNPEP3, APP3, NPHPL1	C	X-prolyl aminopeptidase 3	613553	REc		Nephronophthisis-like nephropathy 1, 613159 (3)	
22.351	2	27	03	22q13.33	ARSA	C	Arylsulfatase A	607574	S, D		Metachromatic leukodystrophy, 250100 (3)	15(As2)
22.352	2	21	10	22q13.2	CYB5R3, DIA1, B5R	C	Cytochrome b5 reductase 3	613213	S, REa		Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II, 250800 (3)	15(Dia1)
22.353	12	21	10	22q13.33	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	C	Thymidine phosphorylase	131222	REa, A, Fd		Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	
22.354	4	20	11	22q13.33	ACR	C	Acrosin	102480	REa, Ch, REc		?Male infertility due to acrosin deficiency (2)	15(Acr)
22.355	2	19	07	22q13.33	ALG12, CDG1G	C	Dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6- mannosyltransferase	607144	R, Ch		Congenital disorder of glycosylation, type Ig, 607143 (3)	
22.356	2	19	07	22q13.33	MLC1, LVM, VL	C	MLC1 gene	605908	Fd, REc, Ch		Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	
22.357	5	24	13	22q13.33	NCAPH2, CAPH2	P	Non-SMC condensin II complex subunit H2	611230	REc, R			15(Ncaph2)
22.358	8	25	09	22q13.33	MOV10L1	P	Mov10-like 1	605794	R, REc			
22.359	5	26	13	22q13.33	PIM3	P	Oncogene PIM3	610580	REc, R			
22.360	3	29	07	22q13.33	SAPS2, PP6R2, KIAA0685	P	SAPS domain family, member 2	610877	R, REc			
22.361	7	1	13	22q13.33	SBF1, MTMR5, CMT4B3	P	SET-binding factor 1 (myotubularin-related protein 5)	603560	RE, R, REc		Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	
22.362	7	11	11	22q13.33	SELO	P	Selenoprotein O	607917	REc			
22.363	6	22	14	22q13.33	SYCE3	P	Synaptonemal complex central element protein 3	615775	REc			
22.364	1	12	15	22q13.33	TUBGCP6, GCP6, KIAA1669, MCCRP1	P	Tubulin-gamma complex-associated protein 6	610053	REc		Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	
22.365	1	24	09	22q13.33	ZBED4, KIAA0637	P	Zinc finger BED domain-containing protein 4	612552	R, REc			
22.366	6	16	89	Chr.22	MSK41	P	Antigen MSK41 identified by monoclonal antibody E3	107260	S			
23.1	7	9	90	Xpter-p22.32	ARSC2	L	Arylsulfatase C, f form	301780	D	probably close to STS = ARSC1, or s form		
23.2	4	25	93	Xp22.33	ASMT, HIOMT	P	Acetylserotonin methyltransferase	300015	REa, Fd	pseudoautosomal		
23.3	12	3	98	Xp22.33	ASMTLX, ASTML	P	Acetylserotonin methyltransferase-like	300162	REc			
23.4	2	14	03	Xp22.33	CD99, MIC2, MIC2X	C	CD99 antigen (MIC2 (monoclonal antibody 12E7))	313470	S, A, D	distal to STS		
23.5	4	30	98	Xp22.33	SHOX, GCFX, SS, PHOG	C	Short stature homeo box	312865	Fd, D, REc	pseudoautosomal; ?gene causing short stature in Turner syndrome	Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
23.6	12	31	99	Xpter-p22.32	HDPA	P	Hodgkin disease, susceptibility, pseudoautosomal	300221	Fd		{Hodgkin disease susceptibility, pseudoautosomal} (2)	
23.7	10	23	87	Xpter-p22.32	XG	C	Xg blood group	314700	F, D	nonlyonizing; spans pseudoautosomal boundary; XGPY on Yq11.21	[Blood group, XG system] (3)	
23.8	8	30	11	Xp22.33	GTPBP6, PGPL	P	GTP-binding protein 6	300124	Psh, A, REc			
23.9	4	6	15	Xp22.33	MXRA5	P	Matrix remodeling-associated protein 5	300938	REc			
23.10	1	21	11	Xp22.32-p22.31	NLGN4, KIAA1260, AUTSX2, ASPGX2	P	Neuroligin 4	300427	R		{Autism susceptibility, X-linked 2}, 300495 (3); {Asperger syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)	
23.11	5	28	13	Xp22.33	PPP2R3B, PR48	P	Protein phosphatase 2, regulatory subunit B-double prime, beta	300339	REc			
23.12	10	23	00	Xp22.33	VSPA	P	Visuospatial/perceptual abilities	313000	D		Turner syndrome-associated neurocognitive phenotype (2); [Visuospatial/perceptual abilities] (2)	
23.13	1	6	09	Xp22.33	ZBED1, ALTE, KIAA0785, TRAMP	P	Zinc finger BED domain-containing protein 1	300178	REc			
23.14	9	14	12	Xp22.33	XG, PBDX	P	XG glycoprotein	300879	REc			
23.15	2	16	04	Xp22.31	FAM9A	P	Family with sequence similarity 9, member A	300477	REc	pseudogene on Xq28, Yp11.31, 1p36.12, 8p11.1		
23.16	12	19	11	Xp22.33	AKAP17A, SFRS17A, DXYS155E, XE7	P	A kinase (PRKA) anchor protein 17A	312095	REn	nonlyonizing		
23.17	12	5	11	Xp22.33	CSF2RA, SMDP4	C	Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage	306250	A	order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen	Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	19(Csf2ra)
23.18	2	16	04	Xp22.31	FAM9B	P	Family with sequence similarity 9, member B	300478	REc			
23.19	11	7	08	Xp22.31	HDHD1A, DXF68S1E, GS1	P	Haloacid dehalogenase-like hydrolase domain-containing 1A	306480	REn	escapes X-inactivation; 100kb telomeric to STS		
23.20	3	6	00	Xp22.33	SLC25A6, ANT3	C	Solute carrier family 25 (mitochondrial carrier), member 6 (adenine nucleotide translocator-3, liver)	300151	Pcm, REc, REn	1st intron ~1.3Mb from Xqter; nonlyonized		
23.21	4	30	09	Xp22.31	STS, ARSC1, ARSC, SSDD, XLI	C	Steroid sulfatase, microsomal (arylsulfatase C, isozyme S)	300747	F, S, D	nonlyonizing	Ichthyosis, X-linked, 308100 (3)	X,Y(Sts)
23.22	10	12	90	Xp22.32	XGR	P	XG/MIC2 regulator	314705	F	?between XG and MIC2		
23.23	11	30	06	Xp22.2	ASB11	P	Ankyrin repeat- and SOCS box-containing protein 11	300626	REc			
23.24	7	9	09	Xp22.2	FAAP95, FAAP90, FLJ34064, FANCB	C	Fanconi anemia-associated polypeptide, 95kD	300515	REn		Fanconi anemia, complementation group B, 300514 (3)	
23.25	2	16	04	Xp22.2	FAM9C	P	Family with sequence similarity 9, member C	300479	REc			
23.26	11	23	98	Xp22.2	FIGF, VEGFD	P	c-fos induced growth factor (vascular endothelial growth factor D)	300091	Psh			
23.27	2	18	98	Xp22.2	ARHGAP6	P	Rho GTPase-activating protein-6	300118	REc			
23.28	3	28	03	Xp22.33	ARSE, CDPX1, CDPXR	C	Arylsulfatase E	300180	D, Fd	CDPX1 in contiguous gene syndrome with STS	Chondrodysplasia punctata, X-linked recessive, 302950 (3)	
23.29	2	14	97	Xp22.33	ARSD	P	Arylsulfatase D	300002	REn			
23.30	2	14	97	Xp22.33	ARSF	C	Arylsulfatase F	300003	REn, REc			
23.31	5	19	06	Xp22.33	ARSH	P	Arylsulfatase H	300586	REc			
23.32	1	12	95	Xp22.2	CLCN4	P	Chloride channel-4	302910	RE			
23.33	8	30	01	Xp22.33	CRLF2, CRL2	P	Cytokine receptor-like factor 2	300357	A	pseudoautosomal		
23.34	10	23	97	Xp22.31	DXS1283E	P	GS2 gene	300102	REn			
23.35	10	19	99	Xp22.3	EMWX	P	Episodic muscle weakness, X-linked	300211	Fd		Episodic muscle weakness, X-linked (2)	
23.36	6	7	10	Xp22.2	GPR143, OA1, NYS6	C	G protein-coupled receptor 143	300808	F, Fd	linked to XG	Ocular albinism, type I, Nettleship-Falls type, 300500 (3); Nystagmus 6, congenital, X-linked, 300814 (3)	X(Oa1)
23.37	2	7	01	Xp22.33	GYG2, GN2	P	Glycogenin 2	300198	A			
23.38	10	4	93	Xp22.33	IL3RA	C	Interleukin-3 receptor, alpha subunit	308385	REa, A, REn	same 190kb segment as CSF2RA		14(Il3ra)
23.39	9	28	12	Xp22.31	KAL1, KMS, ADMLX, HH1	C	Kallmann syndrome-1 sequence (anosmin-1)	300836	F, Fd, D, REa, REn	with ichthyosis in probable microdeletion syndrome	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	
23.40	9	10	09	Xp22.3	LECD	P	Corneal dystrophy, Lisch epithelial	300778	Fd	max lod between DXYS233 and DXYS228X	Corneal dystrophy, Lisch epithelial (2)	
23.41	7	18	06	Xp22.2	MSL3L1	P	Male-specific lethal 3-like 1	300609	REc			
23.42	3	26	03	Xp22.3	MRX2	P	Mental retardation, X-linked, 2	300428	Fd		Mental retardation, X-linked 2 (2)	
23.43	5	12	99	Xp22.3	MRX49	C	Mental retardation, X-linked-49	300114	Fd, Ch		Mental retardation, X-linked 49 (2)	
23.44	12	16	93	Xp22.3	OASD	P	Ocular albinism and sensorineural deafness	300650	Fd	?allelic to OA1	Ocular albinism with sensorineural deafness (2)	
23.45	7	28	11	Xp22.33	P2RY8, P2Y8	P	Pyrimidinergic receptor P2Y, G protein-coupled, 8	300525	REc			
23.46	8	5	97	Xp22.33	PRKX	P	Protein kinase, X-linked	300083	REc			
23.47	4	18	07	Xp22.2	SHROOM2, APXL	P	Shroom family member 2	300103	REn			X(Apxl)
23.48	5	24	02	Xp22.3-p22.2	TBL1X, TBL1	P	Transducin-beta-like 1, X-linked	300196	A			X(Tbl1)
23.49	4	14	05	Xp22.31	VCX, VCXB1, VCX10R	C	Variably charged, X chromosome	300229	REc			
23.50	4	14	05	Xp22.31	VCX2, VCX2R, VCXB	P	Variably charged, X chromosome, 2	300532	R			
23.51	4	14	05	Xp22.31	VCX3A, VCX8R, VCXA	P	Variably charged, X chromosome, 3A	300533	R			
23.52	11	5	14	Xp22.2	OFD1, CXorf5, SGBS2, JBTS10, RP23	C	OFD1 protein	300170	Fd, REc	mutation identified in 1 RP23 family	Orofaciodigital syndrome I, 311200 (3); Simpson-Golabi-Behmel syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3); ?Retinitis pigmentosa 23, 300424 (3)	
23.53	12	4	90	Xp22.2	PRPS2	C	Phosphoribosyl pyrophosphate synthetase-2	311860	REa, A	between STS and ZFX		
23.54	6	24	10	Xp22.2	TLR7	P	Toll-like receptor 7	300365	REc	centromeric to TLR8		
23.55	6	24	10	Xp22.2	TLR8	P	Toll-like receptor 8	300366	REc	16kb telomeric to TLR7		
23.56	7	11	14	Xp22.2	AMELX, AMG, AIH1, AMGX, AI1E	C	Amelogenin	300391	REa, A, Fd	also Y	Amelogenesis imperfecta, type 1E, 301200 (3)	X(Amel)
23.57	9	28	93	Xp22.2	GRPR	C	Gastrin-releasing peptide receptor	305670	Psh			
23.58	3	30	12	Xp22.1-p21.3	POLA1	C	Polymerase, DNA, alpha-1	312040	S	proximal to ZFX	?N syndrome, 310465 (1)	X(Pola)
23.59	1	31	13	Xp22.2	ASB9	P	Ankyrin repeat- and SOCS box-containing protein 9	300890	REc			
23.60	4	29	14	Xp22.2	ATXN3L	P	Ataxin 3-like	300920	REc			
23.61	10	23	97	Xp22.2	BMX	P	BMX non-receptor tyrosine kinase	300101	A			
23.62	1	10	92	Xp22.2	CMTX2	P	Charcot-Marie-Tooth disease, X-linked recessive, 2	302801	Fd		Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)	
23.63	10	13	15	Xp22.2	FRMPD4, PRESO, KIAA0316	P	FERM and PDZ domains-containing protein 4	300838	R, REc			
23.64	9	29	15	Xp22.2	GEMIN8, FAM51A1	P	GEM-associated protein 8	300962	REc			
23.65	11	13	07	Xp22.2	HBFQTL3, FCP1, FCPX, FCP	P	Fetal hemoglobin quantitative trait locus 3	305435	F, Fd		Fetal hemoglobin quantitative trait locus 3 (2)	
23.66	9	28	96	Xp22.2	GPM6B, M6B	P	Glycoprotein M6B	300051	A			
23.67	5	26	13	Xp22.2	INE2	P	Inactivation escape 2	300165	A			
23.68	3	25	15	Xp22.2	MRX73	P	Mental retardation, X-linked 73	300355	Fd	between DXS8019 and DXS365	Mental retardation, X-linked 73 (2)	
23.69	9	20	14	Xp22.2	PIR	P	Pirin	300931	REc			
23.70	12	5	00	Xp22.2	RAB9	P	RAS-associated protein RAB9	300284	R			
23.71	1	13	11	Xp22.2	RBBP7	P	Retinoblastoma-binding protein 7	300825	REc			
23.72	5	27	93	Xp22.11	ZFX	C	Zinc finger protein, X-linked	314980	Ch, REa, Fd	nonlyonizing		X(Zfx)
23.73	12	3	98	Xp22.11	EIF2S3, EIF2G	P	Eukaryotic translation initiation factor 2, subunit 3	300161	A, H			
23.74	11	3	14	Xp22.12	PDHA1, PHE1A, PDHAD	C	Pyruvate dehydrogenase, E1-alpha polypeptide-1	300502	REa, A, Fd		Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	X(Pdha1)
23.75	2	1	11	Xp22.11	PHEX, HYP, HPDR1, LXHR	C	Phosphate regulating endopeptidase homolog, X-linked	300550	Fd		Hypophosphatemic rickets, X-linked dominant, 307800 (3)	X(Phex, Gy)
23.76	10	1	09	Xp22.13	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	C	Phosphorylase kinase, liver, alpha-2 subunit	300798	Fd, REa, A		Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage disease, type IXa2, 306000 (3)	
23.77	6	9	98	Xp22.13	PPEF1	P	Protein phosphatase, EF hand calcium-binding domain 1	300109	REc			
23.78	7	1	11	Xp22.12	RPS6KA3, RSK2, MRX19	C	Ribosomal protein S6 kinase, 90kD, polypeptide 3	300075	Fd, RE		Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked 19, 300844 (3)	
23.79	3	31	11	Xp22.13	RS1, XLRS1	C	Retinoschisin	300839	F, Fd	25cM from XG	Retinoschisis, 312700 (3)	
23.80	2	7	01	Xp22.13	SCML1	P	Sex comb on midleg, Drosophila, homolog-like 1	300227	REn			
23.81	3	14	07	Xp22.2	TRAPPC2, SEDL, SEDT	C	Trafficking protein particle complex 2 (sedlin)	300202	Fd		Spondyloepiphyseal dysplasia tarda, 313400 (3)	
23.82	5	28	13	Xp22.12	YY2, ZNF631	P	Transcription factor YY2	300570	REc			
23.83	10	24	11	Xp21.3	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	C	Aristaless-related homeobox, X-linked	300382	REc, Fd		Epileptic encephalopathy, early infantile, 1, 308350 (3); Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510 (3); Hydranencephaly with abnormal genitalia, 300215 (3)	
23.84	7	23	13	Xp22.2-p22.1	NHS, CXN, CTRCT40	C	NHS gene	300457	Fd, REc		Nance-Horan syndrome, 302350 (3); Cataract 40, X-linked, 302200 (3)	?X(Xcat)
23.85	10	15	98	Xp22.13-p21.1	MEHMO	P	MEHMO syndrome (Mental retardation, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity)	300148	Fd		MEHMO syndrome (2)	
23.86	8	29	08	Xp22.12	CNKSR2, CNK2, KIAA0902	P	connector enhancer of KSR 2	300724	R, REc	conflicting assignment to chr.1		
23.87	12	15	10	Xp22.12	MAP3K15, ASK3	P	Mitogen-activated protein kinase kinase kinase 15	300820	REc			
23.88	4	29	14	Xp22.12	MBTPS2, S2P, IFAP, KFSDX, OLMSX	P	Membrane-bound transcription factor protease, site 2	300294	A, REc	mutation identified in 1 OLMSX family	IFAP syndrome with or without BRESHECK syndrome, 308205 (3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3); ?Olmsted syndrome, X-linked, 300918 (3)	
23.89	10	23	11	Xp22.11	ACOT9, MTACT48	P	Acyl-CoA thioesterase 9	300862	REc			X(Acot9)
23.90	4	2	15	Xp22.11	PCYT1B	P	Phosphate cytidylyltransferase 1, choline, beta isoform	300948	REc			
23.91	8	19	13	Xp22.11	PDK3, CMTX6	P	Pyruvate dehydrogenase kinase, isoenzyme 3	300906	REc	1 family identified with mutation	?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3)	
23.92	8	18	14	Xp22.11	PRDX4, AOE372	P	Peroxiredoxin 4	300927	REc			
23.93	10	13	15	Xp22.11	PTCHD1, AUTSX4	P	Patched domain-containing protein 1	300828	REc		{Autism, susceptibility to, X-linked 4}, 300830 (3)	
23.94	12	17	08	Xp22.11	APOO, MYO25, FAM121B	P	Apolipoprotein O	300753	REc			
23.95	5	28	13	Xp22.2	CXorf15, FIAT	P	Chromosome X open reading frame 15	300677	REc			
23.96	3	9	00	Xp22.2	CA5B	P	Carbonic anhydrase VB, mitochondrial	300230	A			X(Car5b)
23.97	6	3	14	Xp22.2	PIGA, PNH1, MCAHS2	P	Phosphatidylinositol glycan, class A	311770	A	pseudogene on chr.12	Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	X(Piga)
23.98	10	13	15	Xp22.11	SAT1, SSAT	C	Spermidine/spermine N1-acetyltransferase 1	313020	Psh, A, D			
23.99	7	1	11	Xp22.12	SMPX, DFNX4	C	Small muscle protein, X-linked	300226	A, R, REc, Fd		Deafness, X-linked 4, 300066 (3)	
23.100	5	6	04	Xp22.11	SMS, SRS, MRSR	C	Spermine synthase	300105	REn, Fd		Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	X(Sms)
23.101	4	10	97	Xp22.2	ZRSR2, U2AF1RS2	P	Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 2	300028	A			X(U2af1rs2)
23.102	3	13	06	Xp21.3-p21.2	IL1RAPL1, IL1R8, MRX21, MRX34	C	Il-1 receptor accessory protein-like 1	300206	F, Fd, D, REc		Mental retardation, X-linked 21/34, 300143 (3)	
23.103	12	11	02	Xp22.12	SH3KBP1, CIN85	P	SH3-domain kinase-binding protein 1	300374	A			
23.104	10	12	90	Xp22.2	GLRA2	P	Glycine receptor, alpha-2 polypeptide	305990	REa, Fd			X(Glra2)
23.105	6	17	04	Xp11.23	ZNF81, MRX45	C	Zinc finger protein-81 (HFZ20)	314998	REa		Mental retardation, X-linked 45, 300498 (3)	
23.106	2	2	14	Xp11.3	ZNF41	P	Zinc finger protein-41	314995	REa			
23.107	5	16	01	Xp22.2	ACE2, ACEH	P	Angiotensin I converting enzyme 2	300335	REc			
23.108	12	18	89	Xp22	AGMX2, XLA2, IMD6	P	Agammaglobulinemia, X-linked 2 (with growth hormone deficiency)	300310	Fd		Agammaglobulinemia, X-linked 2 (2)	X(Xid)
23.109	10	8	88	Xp22	AIC	C	Aicardi syndrome	304050	X/A, Ch	?in p22.31 with FDH as contiguous gene syndrome	Aicardi syndrome (2)	
23.110	5	29	12	Xp22	ANIB5	P	Aneurysm, intracranial berry, 5	300870	Fd		Aneurysm, intracranial berry, 5 (2)	
23.111	7	17	14	Xp22.2	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	C	Adaptor-related protein complex 1, sigma-2 subunit	300629	REc, Fd		Mental retardation, X-linked syndromic 5, 304340 (3)	
23.112	7	14	15	Xp22.13	CDKL5, STK9, ISSX, EIEE2	C	Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9)	300203	Fd, Ch		Epileptic encephalopathy, early infantile, 2, 300672 (3)	X(Stk9)
23.113	5	7	03	Xp22.2	CTPS2	P	Cytidine 5-prime triphosphate synthetase 2	300380	REc			
23.114	2	1	01	Xp22.2	EGFL6	P	Epidermal growth factor-like 6	300239	REa, REc			
23.115	5	13	15	Xp22.2	HCCS, MCOPS7, LSDMCA1	C	Holocytochrome c synthase (cytochrome c heme-lyase)	300056	REc		Linear skin defects with multiple congenital anomalies 1, 309801 (3)	
23.116	12	30	03	Xp21.3	MAGEB5	P	Melanoma antigen, family B, 5	300466	REc			
23.117	12	30	03	Xp21.3	MAGEB6	P	Melanoma antigen, family B, 6	300467	REc			
23.118	3	16	12	Xp22.2	MID1, OGS1, BBBG1, FXY, OSX	C	Midline-1	300552	Fd, Ch	type II defect on chr.22	Opitz GBBB syndrome, type I, 300000 (3)	X(Mid1)
23.119	10	18	00	Xp22	MNG2	P	Multinodular goiter-2	300273	Fd		Goiter, multinodular, 2 (2)	
23.120	11	29	99	Xp22.13	RAI2	P	Retinoic acid-induced 2	300217	REc			
23.121	2	7	01	Xp22.13	SCML2	P	Sex comb on midleg, Drosophila, homolog-like 2	300208	A			
23.122	12	29	06	Xp22.2	TMEM27, NX17	P	Transmembrane protein 27 (collectrin)	300631	REc			
23.123	11	13	94	Xp22-p21	PDR	P	Pigment disorder, reticulate	301220	Fd	between DXS1052 and DXS1061	Pigment disorder, reticulate (2)	
23.124	2	7	06	Xp22.13	GPR64, HE6	P	G protein-coupled receptor 64	300572	A, H			X(Gpr64)
23.125	3	19	09	Xp21.2	MAGEB1, MAGEL1, DAM10	P	Melanoma antigen, family B, 1	300097	RE			X(Smage1/2)
23.126	3	19	09	Xp21.2	MAGEB2, DAM6	P	Melanoma antigen, family B, 2	300098	REc			
23.127	10	26	98	Xp21.2	MAGEB3	P	Melanoma antigen, family B, 3	300152	REc			
23.128	10	26	98	Xp21.2	MAGEB4	P	Melanoma antigen, family B, 4	300153	REc			
23.129	3	19	09	Xp21.3	MAGEB10	P	Melanoma antigen, family B, 10	300761	REc			
23.130	3	19	09	Xp21.1	MAGEB16	P	Melanoma antigen, family B, 16	300762	REc			
23.131	3	19	09	Xp22.2	MAGEB17	P	Melanoma antigen, family B, 17	300763	REc			
23.132	3	26	07	Xp21.3	MENOQ1	P	Menopause, natural, age at, QTL 1	300488	Fd		{Menopause, natural, age at, QTL1} (2)	
23.133	2	28	03	Xq21.31	TGIF2LX, TGIFLX	P	Transforming growth factor-beta-induced factor 2-like, X-linked	300411	REc			
23.134	8	29	11	Xp21.2	DAX1, AHC, AHX, NR0B1, SRXY2	C	DSS-AHC critical region on the X chromosome, gene 1	300473	D, Fd	distal to GK	Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism, 300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)	X(Ahch)
23.135	2	24	04	Xp21.2	GK	C	Glycerol kinase	300474	D, Fd	2Mb distal to DMD; pseudogene on 4q32	Glycerol kinase deficiency, 307030 (3)	X(Gyk)
23.136	1	25	93	Xp21.3-p21.2	RP6	L	Retinitis pigmentosa-6, X-linked recessive	312612	Fd		?Retinitis pigmentosa, X-linked recessive, 6 (2)	
23.137	3	18	08	Xp21.2	DFNX3, DFN4	C	Deafness, X-linked 3	300030	Fd	?same as DMD	Deafness, X-linked 3 (2)	
23.138	3	14	02	Xp21.2-p21.1	DMD, BMD, CMD3B	C	Dystrophin	300377	X/A, Fd, D	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy, 300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)	X(Dmd)
23.139	3	23	14	Xp21.2	FTHL17	P	Ferritin heavy polypeptide-like 17	300308	R, REc			
23.140	1	11	16	Xp21.2	TAB3	P	Tak1 (MAP3K7) binding protein 3	300480	REc			
23.141	5	23	11	Xp21.1	XK, MCLDS	C	Kell blood group precursor	314850	F, D	~500kb distal to CGD	McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	
23.142	2	5	99	Xp11.3	USP11, UHX1	C	Ubiquitin-specific protease-11 (ubiquitin carboxyl-terminal hydrolase)	300050	REa, REc			
23.143	8	25	98	Xp21.2-q21.1	XS, LUXS	L	Lutheran suppressor, X-linked	309050	Fd			
23.144	9	8	14	Xp21.1-p11.4	CYBB, CGD, AMCBX2, IMD34	C	Cytochrome b-245, beta polypeptide	300481	F, D	proximal to DMD	Chronic granulomatous disease, X-linked, 306400 (3); Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	X(Cybb)
23.145	12	4	03	Xp11.4	OTC	C	Ornithine transcarbamylase	300461	L, REa, A, D	proximal to DMD, CGD	Ornithine transcarbamylase deficiency, 311250 (3)	X(spf; Otc)
23.146	12	31	99	Xp11.4	SRPX, ETX1	C	Sushi-repeat-containing protein, X chromosome	300187	Fd, D	probably between OTC and CGD		
23.147	10	5	11	Xp21.1-p11.23	MRXS17	P	Mental retardation, X-linked, syndromic 17	300858	Fd	between rs2748314 and rs5906782	Mental retardation, X-linked, syndromic 17 (2)	
23.148	9	9	10	Xp21	DELXp21, CXDELp21	P	Chromosome Xp21 deletion syndrome	300679	Ch	contiguous gene deletion syndrome	Chromosome Xp21 deletion syndrome (4)	
23.149	3	6	01	Xp11.4	TCTE1L	P	T complex-associated testis-expressed 1-like	300302	REc			
23.150	11	19	13	Xp11.4	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	C	ATPase, H+ transporting, lysosomal, accessory protein 2	300556	REc, Fd	mutation identified in 1 MRXSH family and 1 XPDS family	?Mental retardation, X-linked, syndromic, Hedera type, 300423 (3); ?Parkinsonism with spasticity, X-linked, 300911 (3)	
23.151	3	30	04	Xp11.4	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	C	BCL6 corepressor	300485	R, REc, Fd		Microphthalmia, syndromic 2, 300166 (3)	
23.152	3	28	12	Xp11.4	CASK, MICPCH, FGS4, CMG, MRXSNA	C	Calcium/calmodulin-dependent serine protein kinase	300172	R, Fd		Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)	
23.153	1	31	13	Xp11.4	NYX, CSNB1A, NBM1	C	Nyctalopin	300278	Fd, REc		Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	
23.154	9	18	00	Xp11.4	GPR34	P	G protein-coupled receptor 34	300241	A, REc			
23.155	10	29	08	Xp11.4	GPR82	P	G protein-coupled receptor 82	300748	REc			
23.156	9	28	15	Xp11.4	MID1IP1, MIG12	P	MID1-interacting protein 1	300961	REc			
23.157	8	25	14	Xp11.3	NDP, ND, EVR2	C	Norrin	300658	Fd, D		Norrie disease, 310600 (3); Exudative vitreoretinopathy 2, X-linked, 305390 (3)	X(Ndp)
23.158	6	7	10	Xp11.4	NYS5	P	Nystagmus 5, congenital, X-linked	300589	Fd	max lod at DXS993	Nystagmus 5, congenital, X-linked (2)	
23.159	3	5	13	Xp11.4	RPGR, RP3, CRD, RP15, COD1, CORDX1	C	Retinitis pigmentosa GTPase regulator	312610	D, Fd		Retinitis pigmentosa 3, 300029 (3); Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3); Cone-rod dystrophy, X-linked, 1, 304020 (3)	
23.160	2	28	08	Xp21.1	TMEM47, BCMP1	P	Transmembrane protein 47	300698	R			
23.161	3	1	16	Xp11.4	USP9X, DFFRX, MRX99, MRXS99F	P	Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)	300072	REa, REc		Mental retardation, X-linked 99, 300919 (3); Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	
23.162	3	25	02	Xp11.23	PFC, PFD	C	Properdin P factor, complement	300383	Fd, REa, A		Properdin deficiency, X-linked, 312060 (3)	X(Pfc)
23.163	9	9	11	Xp11.4-p11.21	OPA2	P	Optic atrophy, X-linked	311050	Fd		Optic atrophy 2, X-linked (2)	
23.164	3	21	94	Xp11.3	ARAF1, RAFA1, PKS2	C	Oncogene ARAF1	311010	REa, A, Fd			X(Araf)
23.165	8	10	99	Xp11.4	MED14, CRSP2, CXorf4, TRAP170, EXLM1	P	Mediator complex subunit 14	300182	A			
23.166	8	24	04	Xp11.3-p11.2	SYN1	C	Synapsin I	313440	A, Fd, REn	5kb from PFC	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)	X(Syn1)
23.167	12	7	12	Xp11.4-q21.1	MRX78	P	Mental retardation, X-linked 78	300551	Fd	max lod with DXS8054 and DXS1003	Mental retardation, X-linked 78 (2)	
23.168	2	28	06	Xp11.3	CHST7, C6ST2	C	Carbohydrate sulfotransferase 7	300375	REc			
23.169	9	24	15	Xp11.3	CXorf36, DIA1R	P	Chromosome X open reading frame 36	300959	REc			
23.170	2	18	09	Xp11.3	DELXp11.3, CXDELp11.3	P	Chromosome Xp11.3 deletion syndrome (X-linked mental retardation with retinitis pigmentosa)	300578	Ch		Chromosome Xp11.3 deletion syndrome (4)	
23.171	5	28	13	Xp11.3	DUSP21, LMWDSP21	P	Dual-specificity phosphatase 21	300678	REc			
23.172	9	9	10	Xp11.3	EFHC2	P	EF-hand domain (C-terminal)-containing protein 2	300817	REc			
23.173	7	20	12	Xp11.3	FUNDC1	P	FUN14 domain-containing protein 1	300871	REc			
23.174	3	23	09	Xp11.3	MIR221, MIRN221	P	Micro RNA 221	300568	REc	near MIRN222		
23.175	3	23	09	Xp11.3	MIR222, MIRN222	P	Micro RNA 222	300569	REc	near MIRN221		
23.176	2	2	14	Xp11.3	MRX89	P	Mental retardation, X-linked 89	300848	Ch	t(X;7)(p11.3;q11.21)	Mental retardation, X-linked 89 (2)	
23.177	1	24	14	Xp11.3	MRX92	P	Mental retardation, X-linked 92	300851	Fd	previously associated with ZNF674	Mental retardation, X-linked 92 (2)	
23.178	5	19	15	Xp11.3	NDUFB11, LSDMCA3	P	NADH-dehydrogenase 1 beta subcomplex, 11	300403	R, REc		Linear skin defects with multiple congenital anomalies 3, 300952 (3)	
23.179	6	27	02	Xp11.23	PCSK1N, PROSAAS	P	Proprotein convertase, subtilisin/kexin-type, 1, inhibitor of	300399	R			
23.180	2	28	06	Xp11.3	SLC9A7, NHE7	C	Solute carrier family 9 (sodium/hydrogen exchanger), member 7	300368	R			
23.181	8	16	99	Xp11.23	ZNF21	C	Zinc finger protein-12	314993	REc			
23.182	3	23	06	Xp11.3	ZNF673, FLJ20344	C	Zinc finger protein 673	300585	REc			
23.183	4	17	13	Xp11.3	CDK16, PCTK1, PCTAIRE1	C	Cyclin-dependent kinase 16	311550	A, REn			
23.184	9	4	15	Xp11.4	DDX3X, DDX3, DBX, MRX102	P	DEAD/H box-3, X-linked	300160	A		Mental retardation, X-linked 102, 300958 (3)	
23.185	12	18	07	Xp11.23	TBC1D25, OATL1	C	TBC1 domain family, member 25	311240	REa, A, Fd			
23.186	8	21	91	Xp11.3	TIMP1, TIMP, EPA	C	Erythroid-potentiating activity (tissue inhibitor of metalloproteinases)	305370	REa, A	in intron of SYN1		X(Timp)
23.187	6	29	99	Xp11.3-p11.21	MRX50	P	Mental retardation, X-linked nonspecific, type 50	300115	Fd		Mental retardation, X-linked 50 (2)	
23.188	2	25	08	Xp11.3-q12	AGSPX	P	Angioma serptiginosum, X-linked	300652	Fd	between DXS8026 and DXS106	Angio serpiginosum (2)	
23.189	9	22	96	Xp11.3-q13.3	MRX14	P	Mental retardation, X-linked-14	300062	Fd		Mental retardation, X-linked 14 (2)	
23.190	11	9	11	Xp11.3-q22	MRXS7	P	Mental retardation, X-linked, syndromic 7	300218	Fd		Mental retardation, X-linked syndromic 7 (2)	
23.191	9	30	04	Xp11.3-q22.3	MRX84	P	Mental retardation, X-linked 84	300505	Fd	29 other MRX loci in same region	Mental retardation, X-linked 84 (2)	
23.192	1	31	13	Xp11.23	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	C	Calcium channel, voltage-dependent, alpha-1F subunit	300110	REn, Fd		Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)	
23.193	11	24	15	Xp11.23	CCDC22, RTSC2	P	Coiled-coil domain-containing protein 22	300859	REc		Ritscher-Schinzel syndrome 2, 300963 (3)	
23.194	3	27	15	Xp11.23	CCDC120	P	Coiled-coil domain-containing protein 120	300947	REc			
23.195	2	1	07	Xp11.23	FTSJ1, JM23, SPB1, MRX44, MRX9	C	FTSJ homolog 1	300499	REc		Mental retardation, X-linked 9, 309549 (3)	
23.196	9	2	08	Xp11.23	GAGE1	C	G antigen 1	300594	Psh, A, REc			
23.197	9	2	08	Xp11.23	GAGE2A	P	G antigen 2A	300720	REc			
23.198	9	2	08	Xp11.23	GAGE2B	P	G antigen 2B	300726	REc			
23.199	9	2	08	Xp11.23	GAGE2C, GAGE2	C	G antigen 2C	300595	Psh, A, REc			
23.200	9	2	08	Xp11.23	GAGE2D	P	G antigen 2D	300735	REc			
23.201	9	2	08	Xp11.23	GAGE2E	P	G antigen 2E	300736	REc			
23.202	5	28	13	Xp11.23	GAGE3	P	G antigen 3	300596	REc			
23.203	5	28	13	Xp11.23	GAGE4	P	G antigen 4	300597	REc			
23.204	6	1	12	Xp11.23	GAGE5	P	G antigen 5	300598	REc			
23.205	6	1	12	Xp11.23	GAGE6	P	G antigen 6	300599	REc			
23.206	3	13	08	Xp11.23	GAGE7	P	G antigen 7	300601	REc			
23.207	9	2	08	Xp11.23	GAGE7B	C	G antigen 7B	300637	Psh, A, REc			
23.208	9	2	08	Xp11.23	GAGE10	P	G antigen 10	300737	REc			
23.209	9	2	08	Xp11.23	GAGE12C	P	G antigen 12C	300727	REc			
23.210	9	2	08	Xp11.23	GAGE12D	P	G antigen 12D	300728	REc			
23.211	9	2	08	Xp11.23	GAGE12E	P	G antigen 12E	300729	REc			
23.212	9	2	08	Xp11.23	GAGE12F	P	G antigen 12F	300730	REc			
23.213	9	2	08	Xp11.23	GAGE12G	P	G antigen 12G	300731	REc			
23.214	9	2	08	Xp11.23	GAGE12H	P	G antigen 12H	300732	REc			
23.215	9	2	08	Xp11.23	GAGE12J	P	G antigen 12J	300733	REc			
23.216	9	2	08	Xp11.23	GAGE13	P	G antigen 13	300734	REc			
23.217	7	20	12	Xp11.23	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	C	GATA-binding protein-1 (globin transcription factor-1)	305371	REa, A		Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	X(Gf1)
23.218	2	17	15	Xp11.23	GRIPAP1, GRASP1, KIAA1167	C	GRIP1-associated protein 1	300408	R, REc			
23.219	2	17	15	Xp11.23	HDAC6, CPBHM	C	Histone deacetylase 6	300272	R, A	mutation identified in 1 CPBHM family	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3)	
23.220	5	26	13	Xp11.3	INE1	P	Inactivation escape 1	300164	A			
23.221	6	1	12	Xp11.23	KCND1	P	Potassium voltage-gated channel, SHAL-related subfamily, member 1	300281	R, REc			
23.222	2	7	01	Xp11.22	MAGED1	P	Melanoma antigen, family D, 1	300224	R			
23.223	12	16	93	Xp11.3	MAOA	C	Monoamine oxidase A	309850	Fd, REa, D, A, REn	NDP, MAOA, MAOB closely linked	Brunner syndrome, 300615 (3)	X(Maoa)
23.224	4	10	90	Xp11.3	MAOB	C	Monoamine oxidase B	309860	REa, D, A, REn			X(Maob)
23.225	4	17	13	Xp11.23	MIR502	P	Micro RNA 502	300893	REc			
23.226	3	13	08	Xp11.22	NUDT10, DIPP3A, APS2	P	Nucleoside diphosphate-linked moiety X motif 10	300527	REc			
23.227	3	13	08	Xp11.22	NUDT11, DIPP3B, APS1	P	Nucleoside diphosphate-linked moiety X motif 11	300528	REc			
23.228	6	5	08	Xp11.23	OTUD5, DUBA	P	OTU domain-containing protein 5	300713	REc			
23.229	9	4	08	Xp11.23	GAGEB1, PAGE1	C	P antigen family, member 1	300288	REc, Psh			
23.230	9	4	08	Xp11.23	PAGE4, GAGEC1	P	P antigen family, member 4	300287	REa, R			
23.231	5	26	13	Xp11.3	PHF16, JADE3, KIAA0215	P	PHD finger protein 16	300618	REc			X(Phf16)
23.232	8	31	07	Xp11.23	PORCN, PORC, DHOF, FODH	C	Porcupine, Drosophila, homolog of	300651	REc		Focal dermal hypoplasia, 305600 (3)	
23.233	4	6	11	Xp11.23	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	C	Polyglutamine-binding protein 1	300463	REc, R, Fd		Renpenning syndrome, 309500 (3)	
23.234	3	31	11	Xp11.23	PRAF2, JM4	P	PRA1 domain family, member 2	300840	REc			
23.235	11	1	13	Xp11.23	PRICKLE3, LMO6	P	Prickle, Drosophila, homolog of, 3	300111	REc			
23.236	2	19	96	Xp11.23	RBM3	P	RNA binding motif protein 3	300027	REc, REn			
23.237	7	8	10	Xp11.3	RBM10, DXS8237E, KIAA0122, TARPS	P	RNA-binding motif protein 10	300080	REc		TARP syndrome, 311900 (3)	
23.238	6	18	10	Xp11.3	RP2	C	Retinitis pigmentosa-2, X-linked recessive	300757	Fd		Retinitis pigmentosa 2, 312600 (3)	
23.239	8	22	07	Xp11.23	SLC38A5, SN2	P	Solute carrier family 38 (amino acid transporter), member 5	300649	REc			
23.240	3	13	08	Xp11.23	SPACA5, LOC389852	P	Sperm acrosome associated 5	300593	REc			
23.241	5	28	13	Xp11.23	SSX1, SSRC	C	Synovial sarcoma, X breakpoint 1	312820	Ch, RE, A, REc	fused with SYT in synovial sarcoma	?Sarcoma, synovial, 300813 (3)	
23.242	5	28	13	Xp11.23	SSX3	P	Synovial sarcoma, X breakpoint 3	300325	Psh, REc			
23.243	5	28	13	Xp11.23	SSX4	P	Synovial sarcoma, X breakpoint 4	300326	Ch, RE, REc			
23.244	5	28	13	Xp11.23	SSX6	P	Synovial sarcoma, X breakpoint 6	300541	REc			
23.245	5	26	13	Xp11.23	SSX9	P	Sarcoma, synovial, X breakpoint 9	300544	REc			
23.246	5	28	13	Xp11.23	SSX5	P	Synovial sarcoma, X breakpoint 5	300327	REc			
23.247	2	1	01	Xp11.23	SUV39H1	P	Suppressor of variegation 3-9, Drosophila, homolog of, 1	300254	REc			
23.248	2	24	12	Xp11.3	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	C	Ubiquitin-like modifier-activating enzyme 1	314370	A, S, Ch, REa, Fd	escapes inactivation	Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	
23.249	6	1	12	Xp11.23	UXT	P	Ubiquitously expressed transcript	300234	REc			
23.250	11	2	04	Xp11.23	WDR13	P	WD repeat-containing protein 13	300512	A, REc			
23.251	4	17	13	Xp11.23	WDR45, WIPI4, NBIA5	P	WD repeat-containing protein 45	300526	REc	?pseudogene on 4q31.3	Neurodegeneration with brain iron accululation 5, 300894 (3)	
23.252	10	12	10	Xp11.23	ZNF630	P	Zinc finger protein 630	300819	REc			
23.253	10	12	09	Xp11.23-p11.22	DUPXp11.23p11.22, CXDUPp11.23p11.22	P	Chromosome Xp11.23-p11.22 duplication syndrome	300801	Ch		Chromosome Xp11.23-p11.22 duplication syndrome (4)	
23.254	9	24	15	Xp11.23	EBP, CDPX2, CPXD, CPX, MEND	P	Emopamil-binding protein	300205	Fd, R, H		Chondrodysplasia punctata, X-linked dominant, 302960 (3); MEND syndrome, 300960 (3)	X(Bpa)
23.255	9	30	99	Xp11.23	PLP2	P	Proteolipid protein 2	300112	REc			
23.256	8	6	13	Xp11.23	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	P	Solute carrier family 35 (UDP-galactose transporter), member 2	314375	A		Congenital disorder of glycosylation, type IIm, 300896 (3)	
23.257	10	8	09	Xp11.23	SYP, MRXSYP	P	Synaptophysin	313475	RE, REa, F, Fd		Mental retardation, X-linked 96, 300802 (3)	X(Syp)
23.258	6	13	02	Xp11.23	WAS, IMD2, THC1, SCNX	C	Wiskott-Aldrich syndrome	300392	Fd, X/A	t(18;X)(q11.2;p11.2); distal to TIMP	Wiskott-Aldrich syndrome, 301000 (3); Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia, X-linked, intermittent, 313900 (3)	X(Wasp, ?sf)
23.259	2	28	03	Xp11.22	GSPT2, GST2, ERF3B	P	G1- to S-phase transition 2	300418	R			
23.260	9	26	11	Xp11.21	UBQLN2, PLIC2, CHAP1, ALS15	C	Ubiquilin 2	300264	R		Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	
23.261	1	27	04	Xp11.23	FOXP3, IPEX, AIID, XPID, PIDX	C	Forkhead box P3 (scurfin)	300292	Fd, REc		Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)	X(sf, Foxp3)
23.262	3	22	07	Xp11.22	CCNB3	P	Cyclin B3	300456	A, REc			
23.263	8	31	07	Xp11.23	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	C	Chloride channel-5	300008	RE		Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3); Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	X(Clcn5)
23.264	3	9	11	Xp11.22	DGKK	P	Diacylglycerol kinase, kappa, 142kD	300837	REc			
23.265	8	22	14	Xp11.22	DUPXp11.22, MRX17, MRX31	P	Xp11.22 microduplication syndrome	300705	Ch	minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10	Xp11.22 microduplication syndrome (4)	
23.266	7	18	12	Xp11.22	GNL3L	P	Guanine nucleotide binding protein-like 3-like protein	300873	REc			
23.267	2	2	14	Xp11.22	GPR173, SREB3	P	G protein-coupled receptor 173	300253	R, REc			
23.268	4	23	08	Xp11.22	HPCX2	P	Prostate cancer, hereditary, X-linked 2	300704	Fd	associated with rs5945572	{Prostate cancer, hereditary, X-linked 2} (2)	
23.269	9	12	11	Xp11.22	HYSP4	P	Hypospadias 4, X-linked, susceptibility to	300856	Fd	associated with rs1934179 and rs7063116	{Hypospadias 4, X-linked, susceptibility to} (2)	
23.270	5	11	16	Xp11.22	IQSEC2, KIAA0522, MRX1, MRX78	P	IQ motif- and Sec7 domain-containing protein 2	300522	R, REc, H		Mental retardation, X-linked 1/78, 309530 (3)	X(Iqsec2)
23.271	12	21	09	Xp11.22	MIR98, MIRN98	P	Micro RNA 98	300810	REc			
23.272	3	23	09	Xp11.22	MIRLET7F2, LET7F2, MIRNLET7F2	P	Micro RNA Let7f2	300721	REc			
23.273	5	28	13	Xp11.22	SSX2	P	Sarcoma, synovial, X breakpoint 2	300192	Ch, RE		?Sarcoma, synovial, 300813 (3)	
23.274	5	29	13	Xp11.22	SSX7	P	Sarcoma, synovial, X breakpoint 7	300542	REc			
23.275	5	28	13	Xp11.22	SSX8	P	Sarcoma, synovial, X breakpoint 8	300543	REc			
23.276	9	20	11	Xp11.23	TFE3, RCCX1	P	Transcription factor for IgH enhancer	314310	REa, Fd	fuses with PRCC in RCCP	Renal cell carcinoma, papillary, 1, 300854 (3)	X(Tfe3)
23.277	3	25	15	Xp11.22	TSR2, WGG1, DBA14	P	TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of	300945	REc	mutation identified in 1 DBA14 family	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3)	
23.278	9	22	08	Xp11.22	XAGE1A	P	X antigen family, member 1A	300742	REc			
23.279	9	22	08	Xp11.22	XAGE1B	P	X antigen family, member 1B	300743	REc			
23.280	9	22	08	Xp11.22	XAGE1C	P	X antigen family, member 1C	300744	REc			
23.281	9	22	08	Xp11.22	XAGE1E	P	X antigen family, member 1E	300745	REc			
23.282	5	26	13	Xp11.22	XAGE2, GAGED3	P	X antigen family, member 2	300416	REc			
23.283	9	8	08	Xp11.22	XAGE3, PLAC6	P	X antigen family, member 3	300740	REc			
23.284	2	20	07	Xp11.22	DXS423E, SMC1, CDLS2	P	Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8)	300040	REn	escapes lyonization	Cornelia de Lange syndrome 2, 300590 (3)	X(Sb1.8)
23.285	10	24	11	Xp11.22	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	C	Lysine-specific demethylase 5C (Jumonji, AT-rich interactive domain 1C)	314690	REa, REn, A	escapes inactivation	Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	X(Smcx)
23.286	6	10	98	Xp11.21	TRO	P	Trophinin	300132	A			
23.287	3	17	16	Xp11.21	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	C	Aminolevulinate, delta-, synthase-2	301300	Ch, REa, A, Fd		Anemia, sideroblastic, 1, 300751 (3); Protoporphyria, erythropoietic, X-linked, 300752 (3)	X(Alas)
23.288	5	12	09	Xp11.21	APEX2, APE2, XTH2, APEXL2	P	APEX nuclease (apurinic/apyrimidinic endonuclease) 2	300773	REc			
23.289	5	26	13	Xp11.21	DSF34	P	DXF34 gene	300621	REc			X(Dxf34)
23.290	10	27	11	Xp11.22	FGD1, FGDY, AAS, MRXS16	C	FYVE, RhoGEF, and PH domain-containing protein 1	300546	X/A, Fd		Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked syndromic 16, 305400 (3)	X(Fgdy)
23.291	4	10	15	Xp11.21	FOXR2, FOXN6	P	Forkhead box R2	300949	REc, H			X(Foxn6)
23.292	5	28	13	Xp11.21	MAGEH1, MAGEH	P	Melanoma antigen, family H, 1	300548	REc			
23.293	9	4	08	Xp11.21	PAGE2, GAGEC2	P	P antigen family, member 2	300738	REc			
23.294	9	4	08	Xp11.21	PAGE3, GAGEC1	P	P antigen family, member 3	300739	REc			
23.295	4	27	00	Xp11.21	PFKFB1, PFRX	P	Fructose-2,6-bisphosphatase	311790	REa, A, REc	?Xq27-q25; ?Xcen-q13		
23.296	8	29	08	Xp11.21	RRAGB, RAGB	P	Ras-related GTP-binding protein B	300725	R, REc			
23.297	5	26	13	Xp11.21	SNORA11	P	Small nucleolar RNA, H/ACA box, 11	300662	REc	in intron 1 of MAGED2		
23.298	5	26	13	Xp11.21	SPIN2	P	Spindlin family, member 2	300517	REc			
23.299	1	8	01	Xp11.21	ZXDA	P	Zinc finger-encoding gene, X-linked, duplicated, A	300235	REa, REc			
23.300	1	8	01	Xp11.21	ZXDB	P	Zinc finger-encoding gene, X-linked, duplicated, B	300236	REa, REc			
23.301	8	25	04	Xp11.21-q22.3	MRX52	P	Mental retardation, X-linked 52	300504	Fd	max lod at DXS559	Mental retardation, X-linked 52 (2)	
23.302	10	1	99	Xp11.22	AKAP4, AKAP82, HI, FSC1	P	A-kinase anchor protein 4, 82kD	300185	A			
23.303	8	31	06	Xp11.22	BMP15, GDF9B, ODG2, POF4	P	Bone morphogenetic protein 15	300247	A		Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4, 300510 (3)	X(Bmp15)
23.304	9	22	08	Xp11.22	FAM120C, CXorf17	P	Family with sequence similarity 120, member C	300741	REc			
23.305	8	22	14	Xp11.22	HSD17B10, HADH2, ERAB, MRXS10	C	17-beta-hydroxysteroid dehydrogenase X	300256	REc, Fd	mutation identified in 1 MRXS10 family	17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3); ?Mental retardation, X-linked syndromic 10, 300220 (3)	
23.306	9	12	92	Xp11.23	ELK1	C	ELK1, member of ETS oncogene family	311040	REa, A	distal to OATL1		X(Elk1)
23.307	7	2	03	Xp11.23	HRAS2, HRASP	P	v-Ha-ras harvey rat sarcoma viral oncogene homolog 2	300437	REc			
23.308	6	5	08	Xp11.22	HUWE1, UREB1, KIAA0312, LASU1	P	HECT, UBA, and WWE domains-containing protein 1	300697	REc, R		Mental retardation, X-linked syndromic, Turner type, 300706 (3)	X(Huwe1)
23.309	1	26	12	Xp11.3	KDM6A, UTX, KABUK2	P	Lysine (K)-specific demethylase 6A	300128	REa, A	UTY also in mouse and man; escapes inactivation	Kabuki syndrome 2, 300867 (3)	X(Utx)
23.310	5	19	16	Xp11.21	MAGED2, MAGED, BARTS5	C	Melanoma antigen, family D, 2	300470	REc, A		Bartter syndrome, type 5, antenatal, transient, 300971 (3)	
23.311	4	17	06	Xp11.22	PHF8, ZNF422, KIAA1111, MRXSSD	C	PHD finger protein 8	300560	Fd, REc		Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	
23.312	11	13	14	Xp11.22	SHROOM4, KIAA1202, SDSX	C	Shroom family member 4	300579	Fd, Ch, REc	mutation identified in 1 SDSX family	?Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	
23.313	7	6	00	Xp11.23	TIMM17B, TIM17B	P	Translocase of inner mitochondrial membrane 17, yeast, homolog of, B	300249	A			
23.314	9	2	08	Xp11.22	TSPYL2, CDA1, DENTT, CINAP	P	TSPY-like 2	300564	R, REc			
23.315	5	26	05	Xp11.22	WNK3, PRKWNK3, KIAA1566	C	WNK lysine deficient protein kinase 3	300358	R, REc			
23.316	2	15	96	Xp11.3	ZNF157	C	Zinc finger protein-157 (HZF22)	300024	REc			
23.317	10	22	99	Xp11.3	RGN, SMP30	P	Regucalcin	300212	Psh			
23.318	5	12	03	Xp11.2-q12	MRX81	P	Mental retardation, X-linked 81	300433	Fd	between DXS1039 and DXS1216	Mental retardation, X-linked 81 (2)	
23.319	3	13	08	Xp11.21	FAAH2	P	Fatty acid amide hydrolase 2	300654	REc			
23.320	10	14	09	Xp11	GRDX, GD3	P	Graves disease, susceptibility to, X-linked	300351	Fd		{Graves disease, susceptibility to, X-linked} (2)	
23.321	6	29	98	Xp11	IDDMX	P	Diabetes mellitus, insulin-dependent, X-linked, susceptibility to	300136	Fd	only with DR3	{Diabetes mellitus, insulin-dependent, X-linked} (2)	
23.322	12	28	05	Xp11	LOAS	P	Leber optic atrophy, susceptibility to	308905	Fd		{Leber optic atrophy, susceptibility to} (2)	
23.323	3	11	08	Xp11.22	MAGED4, MAGEE1, KIAA1859	P	Melanoma antigen, family D, 4	300702	R			
23.324	3	19	09	Xp11.22	MAGED4B	P	Melanoma antigen, family D, 4B	300765	REc			
23.325	2	17	06	Xp11	MRXS12	L	Mental retardation, X-linked, syndromic 12	309545	Fd		?Mental retardation, X-linked, syndromic 12 (2)	
23.326	5	26	13	Xp11.22	SPANXN5	P	SPANX family, member N5	300668	REc			
23.327	1	24	14	Xp11.3	ZNF674	P	Zinc finger protein 674	300573	REc			
23.328	4	16	96	Xp11-q21	MRX20	P	Mental retardation, X-linked-20	300047	Fd		Mental retardation, X-linked 20 (2)	
23.329	1	10	93	Xp11-q21	PRS, MRXS2	P	Prieto syndrome (mental retardation, X-linked, syndromic 2, with dysmorphism and cerebral atrophy)	309610	Fd		Prieto syndrome (2)	
23.330	12	1	94	Xp22.2	CALB3, CABP9K	P	Calbindin 3 (vitamin D-dependent calcium-binding protein)	302020	REa			
23.331	6	22	94	Xq13.1	ARR3	P	Arrestin 3, retinal	301770	REa			
23.332	8	5	97	Xq	CGF1	P	Cognitive function-1, social	300082	Ch	imprinted locus	[Social cognition] (2)	
23.333	3	28	90	Xq	DXS435E, A11	P	A-11 gene	300010	REc			
23.334	11	29	11	Xq	MGR2	P	Migraine, familial typical, susceptibility to, 2	300125	Fd		{Migraine, familial typical, susceptibility to, 2} (2)	
23.335	8	15	13	Xq	MTBSX	P	Mycobacterium tuberculosis, susceptibility to, X-linked	300259	Fd		{Mycobacerium tuberculosis, susceptibility, X-linked} (2)	
23.336	11	8	03	Xp11.4	TSPAN7, TM4SF2, MXS1, A15, MRX58	C	Tetraspanin 7	300096	REa, Ch, A		Mental retardation, X-linked 58, 300210 (3)	
23.337	5	15	08	Xq11-q12	AGA2	P	Alopecia, androgenetic, 2	300710	Fd	associated with rs6152	Alopecia, androgenetic, 2 (2)	
23.338	2	23	09	Xq12	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	C	Androgen receptor (dihydrotestosterone receptor)	313700	S, Fd, REa, A		Androgen insensitivity, 300068 (3); Spinal and bulbar muscular atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to}, 176807 (3); Hypospadias 1, X-linked, 300633 (3)	X(Tfm)
23.339	8	9	99	Xq12	HEPH	P	Hephaestin	300167	R, H, Psh, REc			X(Heph)
23.340	9	23	13	Xq11.2	AMER1, FAM123B, WTX, OSCS	C	APC membrane recruitment protein 1	300647	REc		Osteopathia striata with cranial sclerosis, 300373 (3)	
23.341	1	31	13	Xq11.2	ASB12	P	Ankyrin repeat- and SOCS box-containing protein 12	300891	REc			
23.342	12	22	00	Xq11.2	SPG16	P	Spastic paraplegia 16, X-linked, complicated	300266	Fd		Spastic paraplegia 16, X-linked, complicated (2)	
23.343	7	1	13	Xq11.2	ZC4H2, KIAA1166, WRWF	C	Zinc finger C4H2 domain-containing protein	300897	REc, R		Wieacker-Wolff syndrome, 314580 (3)	
23.344	3	20	94	Xq12	MSN	P	Moesin	309845	REa, A			X(Msn)
23.345	2	28	08	Xq12	EDAR2, XEDAR, EDAA2R	C	Ectodysplasin A2 receptor	300276	REc			
23.346	6	23	04	Xq13.1	EFNB1, EPLG2, CFNS, CFND	C	eph-related receptor tyrosine kinase ligand 2 (ephrin B1)	300035	REa, A, REc, H, Ch, Fd	?CFNS also on Xp22	Craniofrontonasal dysplasia, 304110 (3)	X(Eplg2)
23.347	3	2	06	Xq13.1	INGX, ING2	P	Inhibitor of growth, X-linked	300452	REc			
23.348	12	3	15	Xq12	LAS1L	P	Las1-like ribosome biogenesis factor	300964	REc			
23.349	3	23	09	Xq12	MIR223, MIRN223	P	Micro RNA 223	300694	REc			
23.350	3	24	06	Xq12	OPHN1, MRX60	P	Oligophrenin-1	300127	Ch, A		Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)	
23.351	8	30	01	Xq12	Z39IG	P	Immunoglobulin superfamily protein Z39IG	300353	REc			
23.352	1	9	13	Xq11-q12	ZC3H12B, MCPIP2	P	Zinc finger CCCH domain-containing protein 12B	300889	REc			
23.353	6	7	10	Xq21.1	ATP7A, MNK, MK, OHS, SMAX3	C	ATPase, Cu++ transporting, alpha polypeptide	300011	Fc, X/A, H	probably Xq13.2-q13.3, ~150kb prox. to PGK1	Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3); Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	X(Mnk)
23.354	5	16	01	Xq13.1	ITGB1BP2	P	Integrin, beta-1, binding protein of, 2	300332	A			X(Itgb1bp2)
23.355	2	6	07	Xp11.4-p11.2	GAGE8	P	G antigen 8	300638	Psh, A			
23.356	12	17	12	Xq13.1	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	C	Ectodysplasin A	300451	X/A, H, Fd		Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3); Tooth agenesis, selective, X-linked 1, 313500 (3)	X(Ta)
23.357	5	13	13	Xq21.1	TBX22, CPX, ABERS	C	T-box 22	300307	REc, Fd	1 ABERS family identified with mutation	Cleft palate with ankyloglossia, 303400 (3); ?Abruzzo-Erickson syndrome, 302905 (3)	
23.358	10	10	02	Xp22.3	FGS3	P	FG syndrome 3	300406	Fd		FG syndrome 3 (2)	
23.359	12	11	03	Xq12-q21.3	MRX77	P	Mental retardation, X-linked 77	300454	Fd		Mental retardation, X-linked 77 (2)	
23.360	6	9	08	Xq12-q21.31	MRXS9	P	Mental retardation, X-linked, syndromic 9	300709	Fd	between DXS1111 and DXS1197	Mental retardation, X-linked, syndromic 9 (2)	
23.361	12	7	07	Xq21.1	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	C	ATR-X gene (helicase 2; X-linked nuclear protein)	300032	RE, Fd		Alpha-thalassemia/mental retardation syndrome, 301040 (3); Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	X(Xh2)
23.362	2	26	10	Xq21.1	BRWD3, MRX93	P	Bromodomain-and WD repeat-containing protein 3	300553	REc		Mental retardation, X-linked 93, 300659 (3)	
23.363	3	1	06	Xq13.1	CXCR3, GPR9, CD182	C	Chemokine, C-X-C motif, receptor 3 (G protein-coupled receptor-9)	300574	A, REc, R	previously assigned to chr.8		
23.364	9	10	12	Xq13.1	DMRTC1	P	Doublesex- and MAB3-related transcription factor C1	300878	REc			
23.365	10	24	12	Xq13.1	HDAC8, WTS, MRXS6, CDLS5	C	Histone deacetylase 8	300269	A, R, Fd		Wilson-Turner syndrome, 309585 (3); Cornelia de Lange syndrome 5, 300882 (3)	
23.366	5	18	95	Xq13.1	IL2RG, SCIDX1, SCIDX, IMD4	C	Interleukin-2 receptor, gamma	308380	Fd	linked to DXS159	Severe combined immunodeficiency, X-linked, 300400 (3); Combined immunodeficiency, X-linked, moderate, 312863 (3)	X(Il2rg)
23.367	5	13	13	Xq13.1	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	C	Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of	300188	REc, Fd		Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3); Ohdo syndrome, X-linked, 300895 (3)	X(Opa1)
23.368	12	16	05	Xq13.1	NLGN3, ASPGX1, AUTSX1	P	Neuroligin 3	300336	REc		{Autism susceptibility, X-linked 1}, 300425 (3); {Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	
23.369	12	11	02	Xq21.1	NSBP1	P	Nucleosomal binding protein 1	300385	R			X(Nsbp1)
23.370	8	14	00	Xq13.1	OGT	P	O-linked N-acetylglucosamine transferase	300255	A, R			X(Ogt)
23.371	10	15	97	Xq13.1	P2RY4, NRU, P2Y4	P	Pyrimidinergic receptor P2Y, G-protein coupled, 4	300038	A			
23.372	7	2	07	Xq21.1	PGK1, PGKA	C	Phosphoglycerate kinase-1	311800	S, R, REb, Fd	?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6	Phosphoglycerate kinase 1 deficiency, 300653 (3)	X(Pgk1)
23.373	5	15	07	Xq13.1	PHKA1	C	Phosphorylase kinase, muscle, alpha polypeptide	311870	REa, A, REn	?proximal and close to PGKA;	Muscle glycogenosis, 300559 (3)	X(Phka)
23.374	2	1	01	Xq13.1	PIN4, PAR14, EPVH	P	Peptidyl-prolyl cis/trans isomerase, nima-interacting, 4	300252	REc			
23.375	1	11	16	Xq13.1	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	C	TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD	313650	S, H	SVA retrotransposon insertion	Dystonia-Parkinsonism, X-linked, 314250 (3); Mental retardation, X-linked, syndromic 33, 300966 (3)	X(Ccg1)
23.376	8	29	02	Xq21.1	CYSLTR1, CYSLT1	P	Cysteinyl leukotriene receptor 1	300201	REa, R			
23.377	2	26	02	Xq13.2	RNF12, RLIM	P	Putative RING zinc finger protein NY-REN-43 antigen	300379	A			X(Rnf12)
23.378	4	24	08	Xq21.1	LPAR4, LPA4, P2RY9, P2Y9, GPR23	P	Lysophosphatidic acid receptor 4	300086	A			
23.379	10	25	11	Xq13-q22	MCS, MRXS4	P	Miles-Carpenter syndrome (mental retardation, X-linked, syndromic 4, with congenital contractures and low fingertip arches)	309605	Fd	linked to DXYS1	Miles-Carpenter syndrome (2)	
23.380	12	27	01	Xq13.1	ACRC	P	Acidic repeat-containing gene	300369	REc			
23.381	7	18	14	Xq13.1	AWAT1, DGA2	P	Acyl-CoA wax alcohol acyltransferase 1	300924	REc			
23.382	7	18	14	Xq13.1	DGAT2L6, DC3	P	Diacylglycerol O-acyltransferase 2-like 6	300926	REc			
23.383	7	18	14	Xq13.1	AWAT2, DC4, MFAT	P	Acyl-CoA wax alcohol acyltransferase 2	300925	REc			X(Awat2)
23.384	8	10	11	Xq13.1	DLG3, NEDLG, SAP102, MRX90	P	Discs large, Drosophila, homolog of, 3	300189	A, R		Mental retardation, X-linked 90, 300850 (3)	
23.385	1	17	08	Xq13.1	ERCC6L, PICH	P	ERCC6-like	300687	REc			
23.386	4	17	13	Xq13.1	FOXO4, MLLT7, AFX1	C	Forkhead box O4	300033	Ch			
23.387	10	27	93	Xq13.1	GJB1, CX32, CMTX1	C	Gap junction protein, beta-1, 32kD (connexin 32)	304040	REa, Fd		Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	X(Gjb1)
23.388	8	11	14	Xq13.1	KIF4A, KIF4, MRX100	P	Kinesin family member 4A	300521	A	mutation identified in 1 MRX100 family	?Mental retardation, X-linked 100, 300923 (3)	
23.389	3	19	09	Xq13.3	MAGEE1, DAMAGE, KIAA1587	P	Melanoma antigen, family E, 1	300759	REc			
23.390	3	19	09	Xq13.3	MAGEE2	P	Melanoma antigen, family E, 2	300760	REc			
23.391	1	13	99	Xq13.1	MSG1	P	Melanocyte-specific gene 1	300149	Psh			X(msg1)
23.392	2	19	16	Xq13.1	NONO, NRB54, MRXS34	C	Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD)	300084	A	2Mb proximal to PHKA1	Mental retardation, X-linked, syndromic 34, 300967 (3)	
23.393	6	5	08	Xq13.1	OTUD6A, DUBA2	P	OTU domain-containing protein 6A	300714	REc			
23.394	1	5	07	Xq13.1	PDZD11, AIPP1, PISP	P	PDZ domain-containing 11	300632	REc			
23.395	6	19	12	Xq13.1	PJA1	P	Praja 1	300420	REc			
23.396	4	4	00	Xq13.1	RPS4X, CCG2, SCAR	C	Ribosomal protein S4, X-linked	312760	A, REa, REn	cen-RPS4X-PHKA1-XIST-qter in 2.6Mb		X(Rps4x)
23.397	5	28	13	Xq13.1	SLC7A3, CAT3	P	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3	300443	REc, R			
23.398	12	10	12	Xq13.1	SNX12	P	Sorting nexin 12	300883	REc			
23.399	1	28	08	Xq13.1	STARD8, DLC3, STARTGAP3, KIAA0189	C	START domain-containing protein 8	300689	R, REc			
23.400	6	18	15	Xq13.1	TEX11, SPGFX2	P	Testis-expressed gene 11	300311	R, REc		Spermatogenic failure, X-linked, 2, 309120 (3)	
23.401	10	12	99	Xq13.1	ZMYM3, ZNF261, DXS6673E	P	Zinc finger, MYM-type 3	300061	REc			
23.402	2	2	14	Xq21.1	MAGT1, IAP, XMEN	P	Magnesium transporter 1	300715	REc, H		Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	X(Magt1)
23.403	10	29	99	Xq13.3	ABCB7, ABC7, ASAT	P	ATP-binding cassette-7	300135	A		Anemia, sideroblastic, with ataxia, 301310 (3)	X(Abc7)
23.404	2	3	04	Xq13.1	IGBP1	P	Immunoglobulin-binding protein 1	300139	A		Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)	
23.405	5	19	06	Xq13.1-q22.1	CFTDX	P	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	Fd	between DXS8019 and DXS99	Myopathy, congenital, with fiber-type disproportion, X-linked (2)	
23.406	12	24	08	Xq21.1	TAF9B, TAF9L, TAFII31L	P	TAF9B RNA polymerase II, TATA box-binding protein-associated factor, 31kD	300754	R, REc			
23.407	9	14	95	Xq13.2	CDX4	P	Caudal type homeo box transcription factor 4	300025	REn			X(Cdx4)
23.408	6	22	14	Xq13.2	CHIC1, BRX	P	Cystein-rich hydrophobic domain protein 1	300922	REc			
23.409	11	24	14	Xq13.2	FTX, LINC00182	P	FTX transcript, XIST regulator, noncoding	300936	REc			X(Ftx)
23.410	11	19	13	Xq13.3	KIAA2022, MRX98	P	KIAA2022 gene	300524	Ch	inv(X)(q13;p22)	Mental retardation, X-linked 98, 300912 (3)	
23.411	10	25	11	Xq13.2	MRXSAB	P	Abidi X-linked mental retardation syndrome	300262	Fd		Mental retardation, X-linked syndromic, Abidi type (2)	
23.412	6	1	12	Xq13.2	NAP1L2, BPX	P	Nucleosome assembly protein 1-like 2	300026	REc			
23.413	2	8	11	Xq13.2	NCRNA00183, JPX, ENOX	P	Noncoding RNA 183	300832	REc			
23.414	6	21	05	Xq13.2	SLC16A2, DXS128, XPCT	C	Solute carrier family 16 (monocarboxylic acid transporters), member 2	300095	RE		Allan-Herndon-Dudley syndrome, 300523 (3)	
23.415	3	29	99	Xq13.2	TSIX	P	X-inactivation-specific transcript-antisense	300181	REn			
23.416	3	17	98	Xq13.2	XIC, XCE, XIST, SXI1	C	X chromosome controlling element (X-inactivation center)	314670	Ch, S, A	q13-q21; metaphase bend, or fold, at q13.3-q21.1	X-inactivation, familial skewed, 300087 (3)	X(Xce)
23.417	8	26	15	Xq13.3	BRAFP1	P	BRAF pseudogene 1	300956	REc			10(Brafrs1)
23.418	4	15	11	Xq21.1	PGAM4, PGAM3	P	Phosphoglycerate mutase family member 4	300567	REn			
23.419	5	21	99	Xq21.1	SH3BGR	P	SH3-binding domain glutamic acid-rich protein-like	300190	A			
23.420	5	26	13	Xq13.3	UPRT	P	Uracil phosphoribosyltransferase, S. cerevisiae, homolog of	300656	REc			
23.421	2	21	06	Xq13.3	ZDHHC15, MRX91	P	Zinc finger DHHC domain-containing protein 15	300576	REc, Ch	disruption of ZDHHC15 identified in 1 patient	?Mental retardation, X-linked 91, 300577 (3)	
23.422	3	8	00	Xq21.1	ITM2A, E25A	P	Integral membrane protein 2A	300222	A			X(Itm2a)
23.423	5	18	12	Xq21	DELXq21, CXDELq21	P	Chromosome Xq21 deletion syndrome	303110	Ch	at least CHM and POU3F4 deleted	Choroideremia, deafness, and mental retardation (4)	
23.424	7	17	06	Xq21.1	FLJ22792, POF1B, POF2B	P	FLJ22792 gene	300603	REc, Ch		Premature ovarian failure 2B, 300604 (3)	
23.425	3	6	01	Xq21.1	RPS6KA6, RSK4	P	Ribosomal protein S6 kinase, 90kD, 6	300303	REc			
23.426	7	17	01	Xq21.33	EPAG	P	Early lymphoid activation gene	300347	A, REa			
23.427	4	10	15	Xq21-q25	PARK12	P	Parkinson disease-12	300557	Fd	max lod with DXS1106, DXS8055, DXS1001	{Parkinson disease 12} (2)	
23.428	3	24	09	Xq21.1	CYLC1	P	Cylicin 1	300768	REc			
23.429	5	13	15	Xq21.1	COX7B, LSDMCA2	P	Cytochrome c oxidase, subunit VIIb	300885	REc		Linear skin defects with multiple congenital anomalies, 300887 (3)	
23.430	10	15	13	Xq21.1	FGF16, MF4	P	Fibroblast growth factor 16	300827	REc	previously mapped to 8q21.3	Metacarpal 4-5 fusion, 309630 (3)	
23.431	8	2	13	Xq21.1	GPR174, GPCR17	P	G protein-coupled receptor 174	300903	REc			X(Gpr174)
23.432	5	28	13	Xq21.1	P2RY10, P2Y10	P	Purinergic receptor P2Y, G protein-coupled, 10	300529	REc			
23.433	3	18	08	Xq21.1	POU3F4, DFN3, DFNX2	P	POU domain, class 3, transcription factor 4	300039	Fd, D, H, REn		Deafness, X-linked 2, 304400 (3)	X(Pou3f4)
23.434	10	29	11	Xq21.1	ZNF711, ZNF6, CMPX1, MRX97	P	Zinc finger protein-711	314990	REa, A		Mental retardation, X-linked 97, 300803 (3)	
23.435	7	28	15	Xq21.1	APOOL, FAM121A, Cxorf33	P	Apolipoprotein O-like	300955	REc			
23.436	5	1	02	Xq21.2	CHM, TCD	C	Rab escort protein 1	300390	Fd, LD, D, A, Ch, X/A		Choroideremia, 303100 (3)	X(rep1)
23.437	2	26	09	Xq21.3	AD16	P	Alzheimer disease 16	300756	Fd	associated with rs5984894	{Alzheimer disease 16} (2)	
23.438	5	26	13	Xq21.2	DACH2	P	Dachshund, Drosophila, homolog of, 2	300608	REc			X(Dach2)
23.439	5	28	13	Xq21.31	KLHL4	P	Kelch-like 4	300348	REc			
23.440	4	30	03	Xq21.31	PABPC5, PABP5	P	Polyadenylate-binding protein, cytoplasmic, 5	300407	REa			
23.441	7	26	02	Xq21.31	PCDH11X, PCDH11, PCDHX	P	Protocadherin 11, X-linked	300246	REc			
23.442	12	24	08	Xq22.1	BTK, AGMX1, IMD1, XLA, AT	C	Bruton agammaglobulinemia tyrosine kinase	300300	H, Fd, A		Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	X(xid, Btp)
23.443	6	29	99	Xq21.32	NAP1L3	P	Nucleosome assembly protein 1-like 3	300117	Psh			
23.444	6	29	99	Xp22.2	TMSB4X, TMSB4, TB4X, PTMB4	P	Thymosin, beta-4, X chromosome	300159	Psh			X(Tmsb4x)
23.445	8	27	01	Xq22.1	NXF3	P	Nuclear RNA export factor 3	300316	REc			
23.446	3	23	09	Xq21.33	RPA4	P	Replication protein A4	300767	REc			
23.447	7	31	08	Xq22.1	SYTL4	P	Synaptotagmin-like 4	300723	REc			
23.448	3	14	06	Xq22.1	ARMCX1, ALEX1	P	Armadillo repeat containing, X-linked 1	300362	R			
23.449	3	14	06	Xq22.1	ARMCX2, ALEX2, KIAA0512	C	Armadillo repeat containing, X-linked 2	300363	R			
23.450	3	14	06	Xq22.1	ARMCX3, ALEX3	P	Armadillo repeat containing, X-linked 3	300364	REc			
23.451	10	28	11	Xq21.33-q23	MRXSCS	P	Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861	Fd	max lod at DXS1120	Mental retardation, X-linked, syndromic, Chudley-Schwartz type, (2)	
23.452	10	16	14	Xq22.1	SRPX2, SRPUL, RESDX	P	SUSHI repeat-containing protein, X-linked, 2	300642	A, REc	mutation identified in 1 RESDX family	?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	
23.453	5	28	13	Xq22.3	ATG4A, APG4A, AUTL2	P	Autophagy 4, S. cerevisiae, homolog of, A	300663	REc			
23.454	2	6	08	Xq22.2	BEX2	P	Brain-expressed X-linked gene 2	300691	R			
23.455	5	8	98	Xq21.33	DIAPH2, DIA, POF2	C	Diaphanous, Drosophila, homolog of, 2	300108	REc, A		Premature ovarian failure, 300511 (3)	
23.456	7	8	96	Xq22.1	DRP2	P	Dystrophin-related protein 2	300052	REc			
23.457	10	21	96	Xq22.1	FSHPRH1, LRPR1	P	FSH primary response, rat, homolog of, 1	300065	REn, REc			
23.458	3	10	62	Xq22.1	GPRASP1, GASP, KIAA0443	P	G protein-coupled receptor-associated sorting protein 1	300417	REc	conflicting assignment to chr.9		
23.459	3	28	07	Xq22.1	GLA	C	Galactosidase, alpha	300644	S, R, A, Fd		Fabry disease, 301500 (3); Fabry disease, cardiac variant, 301500 (3)	X(Ags)
23.460	5	29	98	Xq22-q23	GUCY2F, GUC2F	P	Guanylate cyclase 2F	300041	A			X(Gucy2f)
23.461	7	18	06	Xq22.1	HNRPH2	P	Heterogeneous nuclear ribonucleoprotein H'	300610	A, REc	second signal at 6q25.3-q26, pseudogene?		
23.462	11	4	00	Xq22.3	IL1RAPL2	P	Interleukin 1 receptor accessory protein-like 2	300277	REc			
23.463	6	9	08	Xq23	KKLC1, CXorf61	P	Kita-Kyushu lung cancer antigen 1	300625	REc			
23.464	8	12	14	Xq22.3	MID2, MRX101	P	Midline 2	300204	REc	mutation identified in 1 MRX101 family	?Mental retardation, X-linked 101, 300928 (3)	X(Mid2)
23.465	6	6	03	Xq22.2	MORFL2, MRGX, KIAA0026	P	Mortality factor 4-like 2	300409	A			
23.466	01	03	00	Xq22.1	NOX1, MOX1, NOH1	P	NADPH oxidase 1	300225	REc			
23.467	2	24	10	Xq22.1	PCDH19, KIAA1313, EFMR, EIEE9	C	Protocadherin 19	300460	R, REc, Fd		Epileptic encephalopathy, early infantile, 9, 300088 (3)	
23.468	1	29	13	Xq22.2	PLP1, PMD, HLD1, SPG2	C	Proteolipid protein 1	300401	REa, A, Ch, R, Fd		Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia 2, X-linked, 312920 (3)	X(Plp(jp))
23.469	4	25	08	Xq22.1	TNMD, TEM, CHM1L	P	Tenomodulin	300459	REc			
23.470	1	20	06	Xq22.1	TSPAN6, TM4SF6	P	Tetraspanin 6	300191	A			
23.471	4	21	16	Xq22.1	TIMM8A, DFN1, DDP, MTS, DDP1	C	Translocase of inner mitochondrial membrane 8, yeast, homolog of, A	300356	Fd, REn		Mohr-Tranebjaerg syndrome, 304700 (3)	
23.472	7	8	89	Xq22.3	MYCL2	P	MYCL-related processed gene	310310	REa	pseudogene on Xq27.3		
23.473	4	26	06	Xq24	MCTS1, MCT1	P	Malignant T-cell amplified sequence 1	300587	A			
23.474	5	22	03	Xq24	PGRMC1	P	Progesterone receptor membrane component 1	300435	Psh			
23.475	2	26	10	Xq22.3	PRPS1, CMTX5, DFNX1, DFN2	C	Phosphoribosyl pyrophosphate synthetase-1	311850	S, R, REa, A, Fd		Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1, 304500 (3)	
23.476	7	11	14	Xq22-q28	AI1E2, AIH3	L	Amelogenesis imperfecta, hypomaturation or hypoplastic type, X-linked 2	301201	Fd		?Amelogenesis imperfecta, type IE, X-linked 2 (2)	
23.477	2	11	11	Xq11.1	ARHGEF9, PEM2, KIAA0424, EIEE8	C	Rho guanine nucleotide exchange factor 9	300429	REc		Epileptic encephalopathy, early infantile, 8, 300607 (3)	
23.478	2	6	08	Xq22.1	BEX5, NGFRAP1L1	P	BEX family member 5	300693	REc			
23.479	4	29	14	Xq22.1	BHLHB9, P60TRP, KIAA1701	P	Basic helix-loop-helix domain-containing protein, class B, 9	300921	REc			
23.480	11	1	13	Xq22.1	CSTF64	P	Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD	300907	REc			
23.481	11	19	13	Xq22.1	NXF5	P	Nuclear RNA export factor 5	300319	REc			
23.482	6	26	13	Xq22.1	RPL36A, RPL44	P	Ribosomal protein L36A	300902	REc, R			
23.483	4	04	00	Xq22.2	TCEAL1, P21, SIIR	P	Transcription elongation factor A-like 1	300237	A, REc			
23.484	11	25	14	Xq22.1	TMSB15A, TMSB15, TMSNB	P	Thymosin, beta-15A	300939	REc			
23.485	12	17	07	Xq22.1	XKRX, XPLAC, XKR2, XRG2	P	X Kell blood group precursor-related, X-linked	300684	REc			
23.486	2	6	08	Xq22.1	BEX1	C	Brain-expressed X-linked gene 1	300690	REc, H			X(Bex1)
23.487	5	10	04	Xq22.2	ESX1L, ESXR1	P	ESX1-like protein	300154	REc, H			X(Esx1)
23.488	8	27	01	Xq22.1	NXF4	P	Nuclear RNA export factor 4	300318	REc			
23.489	12	8	00	Xq22.2	RAB9B, RAB9L	P	RAS-associated protein RAB9B	300285	R			
23.490	5	5	09	Xq22.2	TCEAL7	P	Transcription elongation factor A-like 7	300771	REc			
23.491	5	26	13	Xq22.3	VSIG1, GPA34	P	V-set and immunoglobulin domains-containing protein 1	300620	REc			
23.492	4	10	12	Xq23	CHRDL1, VOPT, MGC1	C	Chordin-like 1	300350	REc, Fd		Megalocornea 1, X-linked 309300 (3)	
23.493	10	10	01	Xq22.2	NGFRAP1, BEX3, NADE, DXS6984E	P	Nerve growth factor receptor (TNFRSF16) associated protein 1	300361	REc			
23.494	2	6	08	Xq22.1	BEX4	P	BEX family member 4	300692	REc			X(Bex4)
23.495	5	26	13	Xq22.2	H2BFWT	P	H2B histone family, member W, testis-specific	300507	REc			
23.496	10	12	14	Xq22.1	RAB40AL, RLGP, MRXSMP	P	Ras-associated protein, RAB40A-like	300405	REc			
23.497	12	30	14	Xq22.2	SLC25A53	P	Solute carrier family 25, member 53	300941	REc			
23.498	5	27	05	Xq22.3	TBG	C	Thyroxine-binding globulin	314200	REa, A		Thyroxine-binding globulin deficiency (3)	
23.499	2	20	07	Xq22.3	TSC22D3, DSIPI, GILZ	P	TSC22 domain family, member 3	300506	A			
23.500	4	26	01	Xq22.2-q26	MRX53	P	Mental retardation, X-linked-53	300324	Fd		Mental retardation, X-linked 53 (2)	
23.501	9	18	08	Xq23	ACSL4, FACL4, ACS4, MRX63	C	Acyl-CoA synthetase long-chain family member 4	300157	A, REc, Fd		Mental retardation, X-linked 63, 300387 (3)	
23.502	7	16	10	Xq22.3	AMMEC, DELXq22.3, CXDELq22.3	P	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (AMME complex)	300194	Ch	contiguous gene deletion syndrome	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)	
23.503	7	16	10	Xq23	AMMECR1	P	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis chromosomal region gene 1	300195	Ch			
23.504	4	4	00	Xq22.3	COL4A5, ATS, ASLN	C	Collagen IV, alpha-5 polypeptide	303630	REa, A, Fd	diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6	Alport syndrome, 301050 (3)	X(Col4a5)
23.505	2	2	14	Xq22.3	COL4A6, DELXq22.3, CXDELq22.3, DFNX6	C	Collagen IV, alpha-6 polypeptide	303631	REn, A	mutation identified in 1 DFNX6 family	?Deafness, X-linked 6, 300914 (3)	
23.506	3	14	06	Xq22.3	FGS5	P	FG syndrome 5	300581	Ch		FG syndrome 5 (2)	
23.507	8	7	13	Xq22.3	IRS4	P	Insulin receptor substrate 4	300904	REc			
23.508	4	17	01	Xq23	KCNE1L	P	Potassium voltage-gated channel, Isk-related family, member 1-like	300328	REc			
23.509	4	21	16	Xq22.3	MORC4, ZCW4, ZCWCC2	P	MORC family CW-type zinc finger protein 4	300970	REc			
23.510	8	17	09	Xq22.3	NRK, NESK	P	NIK-related kinase	300791	REc, H			X(Nrk)
23.511	10	12	14	Xq22.3	PIH1D3	P	PIH1 domain-containing protein 3	300933	REc			
23.512	9	24	12	Xq22.3	PSMD10, p28	P	Proteasome 26S subunit, non-ATPase, 10	300880	REc			
23.513	3	22	06	Xq22.3	RIPPLY1	P	Ripply1, zebrafish, homolog of	300575	R, REc			
23.514	5	15	11	Xq22.3	RNF128, GRAIL	C	Ring finger protein 128	300439	R, REc			
23.515	5	28	13	Xq22.3	CLDN2	P	Claudin 2	300520	REc			
23.516	8	25	98	Xq23	DCX, DBCN, LISX	C	Doublecortin	300121	REc, Fd, X/A		Lissencephaly, X-linked, 300067 (3); Subcortical laminal heteropia, X-linked, 300067 (3)	X(Dcx)
23.517	1	24	14	Xq23	AGTR2	C	Angiotensin receptor 2	300034	REa, A			X(Agtr2)
23.518	3	11	16	Xq23	ALG13, GLT28D1, CDG1S, EIEE36	P	Alg13, S. cerevisiae, homolog of	300776	REc		Epileptic encephalopathy, early infantile, 36, 300884 (3)	
23.519	1	7	13	Xq24	C1GALT1C1, COSMC, C1GALT2, TNPS	P	C1GALT1-specific chaperone 1	300611	REc		Tn polyagglutination syndrome, somatic, 300622 (3)	
23.520	5	26	13	Xq23	CAPN6	P	Calpain 6	300146	R			
23.521	1	24	11	Xq24	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	C	Cullin-4B	300304	REc, F		Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	
23.522	5	15	08	Xq23	IHPS4	P	Pyloric stenosis, infantile hypertrophic, 4	300711	Fd	max lod at rs3027802	Pyloric stenosis, infantile hypertrophic, 4 (2)	
23.523	12	28	08	Xq23	LHFPL1	P	LHFP-like protein 1	300566	REc			
23.524	5	28	13	Xq23	LUZP4	P	Leucine zipper protein 4	300616	REc			
23.525	3	23	09	Xq23	MIR448, MIRN448	P	Micro RNA 448	300686	R			
23.526	8	27	01	Xq23	NXT2	P	NTF2-related export protein 2	300320	REc			
23.527	5	23	11	Xq23	PAK3, MRX30, MRX47	C	p21-activated kinase-3	300142	Fd, REc		Mental retardation, X-linked 30/47, 300558 (3)	
23.528	11	11	13	Xq23	PLS3, BMND18	P	Plastin 3	300131	Psh, REc		Bone mineral density QTL18, osteoporosis, 300910 (3)	
23.529	12	22	15	Xq23	RGAG1, MAR9, KIAA1318	P	Retrotransposon GAG domain-containing protein 1	300965	REc, H			X(Rgag1)
23.530	5	7	01	Xq23	TRPC5, TRP5	P	Transient receptor potential channel 5	300334	REc			
23.531	6	26	13	Xq23	XACT	P	Active X chromosome-coating transcript, noncoding	300901	REc			
23.532	9	2	08	Xq24	ZBTB33, KAISO	P	Zinc finger- and BTB domain-containing protein 33	300329	REc			X(Kaiso)
23.533	1	27	04	Xq23-q24	MRX23	P	Mental retardation, X-linked-23	300046	Fd	other MRX in same region MRX27, MRX30, MRX35, MRX47, MRX80	Mental retardation, X-linked 23 (2)	
23.534	10	8	08	Xq23	SLC6A14, OBX, BMIQ11	C	Solute carrier family 6 (neurotransmitter transporter), member 14	300444	REc, Fd		{Obesity, susceptibility to, BMIQ11}, 300306 (3)	
23.535	12	4	03	Xq23-q26	CHDS3	P	Coronary heart disease, susceptibility to, 3	300464	Fd		{Coronary heart disease, susceptibility to, 3} (2)	
23.536	10	28	10	Xq23-q27.2	MYP13	P	Myopia 13	300613	Fd	between DXS1210 and DXS1227	Myopia 13 (2)	
23.537	3	7	05	Xq24	AKAP14, AKAP28	P	A-kinase anchor protein 14	300462	REc			
23.538	7	20	09	Xq24	CT47A1	P	Cancer/testis antigen family 45, member A1	300780	REc			
23.539	7	20	09	Xq24	CT47A2	P	Cancer/testis antigen family 47, member A2	300781	REc			
23.540	7	20	09	Xq24	CT47A3	P	Cancer/testis antigen family 47, member A3	300782	REc			
23.541	7	20	09	Xq24	CT47A4	P	Cancer/testis antigen family 47, member A4	300783	REc			
23.542	7	20	09	Xq24	CT47A5	P	Cancer/testis antigen family 47, member A5	300784	REc			
23.543	7	20	09	Xq24	CT47A6	P	Cancer/testis antigen family 47, member A6	300785	REc			
23.544	7	20	09	Xq24	CT47A7	P	Cancer/testis antigen family 47, member A7	300786	REc			
23.545	7	20	09	Xq24	CT47A8	P	Cancer/testis antigen family 47, member A8	300787	REc			
23.546	7	20	09	Xq24	CT47A9	P	Cancer/testis antigen family 47, member A9	300788	REc			
23.547	7	20	09	Xq24	CT47A10	P	Cancer/testis antigen family 47, member A10	300789	REc			
23.548	5	18	09	Xq24	CT47A11, LOC255313	P	Cancer/testis antigen family 47, member A11	300592	REc			
23.549	7	20	09	Xq24	CT47B1, CT47A13	P	Cancer/testis antigen family 47, member B1	300790	REc			
23.550	5	26	13	Xq24	DOCK11, ACG, ZIZ2	P	Dedicator of cytokinesis 11	300681	REc			
23.551	5	18	95	Xq23	HTR2C	C	5-hydroxytryptamine (serotonin) receptor-2C	312861	REa, A, H, Fd	formerly HTR1C		X(Htr2c)
23.552	8	25	98	Xq23	IL13RA2	P	Interleukin-13 receptor, alpha-2	300130	A			
23.553	5	26	13	Xq24	KLHL13, KIAA1309	P	Kelch-like 13	300655	REc			
23.554	7	28	11	Xq24	LAMP2, LAMPB, LGP110	C	Lysosome-associated membrane protein-2	309060	A, D		Danon disease, 300257 (3)	X(Lamp2)
23.555	3	25	15	Xq24	MRX88	P	Mental retardation, X-linked 88	300852	Ch		Mental retardation, X-linked 88 (2)	
23.556	9	27	01	Xq24	MRSS	P	Mental retardation, X-linked, with short stature	300360	Fd		Mental retardation, X-linked, with short stature (2)	
23.557	11	13	07	Xq24	NDUFA1, MWFE	P	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kD	300078	A		Mitochondrial complex I deficiency, 252010 (3)	
23.558	7	13	09	Xq24	NKAP	P	NFKB-activating protein	300766	R, REc			
23.559	7	20	09	Xq24	NKRF, NRF	P	NFKB-repressing factor	300440	R, REc			
23.560	5	4	12	Xq24	RHOXF1, OTEX, PEPP1	P	RHOX homeobox family, member 1	300446	REc			X(Pem)
23.561	5	4	12	Xq24	RHOXF2, PEPP2	P	RHOX homeobox family, member 2	300447	REc			X(Pem)
23.562	6	18	15	Xq24	RNF113A, ZNF183, TTD5	C	RING finger protein 113A	300951	REc	mutation identified in 1 TTD5 family	?Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	
23.563	5	29	13	Xq24	RPL39	C	Ribosomal protein L39	300899	REc, Psh, R			
23.564	5	12	00	Xq26.1	SLC25A14, BMCP1	P	Solute carrier family 25 (mitochondrial carrier), member 14	300242	REc			X(Slc25a14)
23.565	3	12	07	Xq24	SLC25A43	P	Solute carrier family 25, member 43	300641	REc			X(Slc25a43)
23.566	3	5	08	Xq24	ZCCHC12, SIZN1	P	Zinc finger CCHC domain-containing protein 12	300701	REc			
23.567	2	10	05	Xq24-q25	MRX82	P	Mental retardation, X-linked 82	300518	Fd	between DXS6805 and DXS7346	Mental retardation, X-linked 82 (2)	
23.568	10	4	02	Xq24-q25	RRDX	P	Radial ray deficiency	300378	Fd		Radial ray deficiency (2)	
23.569	11	15	08	Xq24-q25	SPG34	P	Spastic paraplegia 34, X-linked	300750	Fd	max lod at DXS8057	Spastic paraplegia 34, X-linked (2)	
23.570	2	17	09	Xq24-q25	STQTL6	P	Stature quantitative trait locus 6	300591	Fd	max lod at DXS8067	{Stature QTL 6} (2)	
23.571	10	25	11	Xq24	UBE2A, RAD6A, MRXSN, MRXS30	P	Ubiquitin-conjugating enzyme E2A (RAD6 homolog)	312180	A, REa		Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	
23.572	4	20	11	Xq24-q26	ADFN, ALDS	P	Albinism-deafness syndrome	300700	Fd	~8cM proximal to F9	Albinism-deafness syndrome (2)	
23.573	3	6	00	Xq24	SLC25A5, ANT2, T3	C	Solute carrier family 25 (mitochondrial carrier), member 5 (adenine nucleotide translocator-2, fibroblast)	300150	REa			
23.574	10	17	95	Xq24-q27	BZX	P	Bazex syndrome	301845	Fd		Bazex syndrome (2)	
23.575	2	23	08	Xq24	SEPT6, SEP2, KIAA0128	C	Septin 6	300683	REc, Psh			
23.576	5	24	00	Xq24-q27.1	PTOS2, PTOSX	P	Ptosis, hereditary congenital 2	300245	Fd		Ptosis, hereditary congenital 2 (2)	
23.577	9	11	02	Xq24-qter	CND	P	Corneal dermoids	304730	Fd		Dermoids of cornea (2)	
23.578	7	18	06	Xq25	ACTRT1, ARPT1	P	Actin-related protein T1	300487	REc			
23.579	1	22	08	Xq26.1	BCORL1	P	BCL6 corepressor-like 1	300688	REc			
23.580	4	17	07	Xq26.1	ENOX2	P	ECTO-NOX disulfide-thiol exchanger 2	300282	R, REc			
23.581	9	9	98	Xq24	GLUD2	C	Glutamate dehydrogenase-2	300144	A, REn			
23.582	1	14	13	Xq26.1	IGSF1, IGDC1, CHTE	P	Immunoglobulin superfamily, member 1	300137	REn		Hypothyroidism, central, and testicular enlargement, 300888 (3)	
23.583	6	7	04	Xq25	SH2D1A, LYP, IMD5, XLP, XLPD1	C	SH2 domain protein 1A	300490	Fd, D	1cM from DXS42; no recombination with DXS37	Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	X(Sh2d1a)
23.584	11	22	10	Xq25	STAG2, SA2	P	Stromal antigen 2	300826	REc			
23.585	2	5	15	Xq25	TENM1, ODZ1, TNM1	P	Teneurin transmembrane protein 1	300588	REc			
23.586	9	8	15	Xq25	THOC2, THO2, MRX12, MRX35	P	THO complex 2 (Tho2, yeast, homolog of)	300395	R, REc		Mental retardation, X-linked 12/35, 300957 (3)	
23.587	7	16	09	Xq25	XECD	P	Corneal dystrophy, endothelial, X-linked	300779	Fd	between DXS8057 and DXS1047	Corneal dystrophy, endothelial, X-linked (2)	
23.588	1	7	11	Xq25	XIAP, BIRC4, API3, XLP2	C	Inhibitor of apoptosis, X-linked	300079	A		Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	X(Api3)
23.589	11	22	13	Xq26.1	XPNPEP2, AEACEI	C	X-prolyl aminopeptidase 2 (aminopeptidase P)	300145	REa, A		{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)	
23.590	4	1	08	Xq25	GRIA3, GLUR3, MRX94	C	Glutamate receptor, ionotropic, AMPA 3	305915	Psh, A, Ch		Mental retardation, X-linked 94, 300699 (3)	X(Glur3)
23.591	3	29	99	Xq25-q26	SXI2	P	X inactivation, familial skewed, 2	300179	Fd		X inactivation, familial skewed, 2 (2)	
23.592	10	11	07	Xq24	UPF3B, RENT3B, MRXS14	P	UPF3 regulator of nonsense transcripts, yeast, homolog of, B	300298	REc		Mental retardation, X-linked, syndromic 14, 300676 (3)	
23.593	8	25	98	Xq25-q26.1	THAS, TAS	P	Thoracoabdominal syndrome	313850	Fd		Thoracoabdominal syndrome (2)	
23.594	3	1	01	Xq26.1	APLN	P	Apelin	300297	REc			
23.595	6	5	09	Xq25-q27	LKMCD	P	Leukoencephalopathy with metaphyseal chondrodysplasia	300660	Fd	between DXS8093 and DXS1232	Leukoencephalopathy with metaphyseal chondrodysplasia (2)	
23.596	4	23	08	Xq25-q27.1	SCAX5	P	Spinocerebellar ataxia, X-linked 5	300703	Fd	between DXS1047 and DXS1227	Spinocerebellar ataxia, X-linked 5 (2)	
23.597	5	15	03	Xq26.3	ARHGEF6, MRX46, COOL2	C	Rho guanine nucleotide exchange factor-6	300267	Ch, Fd		Mental retardation, X-linked 46, 300436 (3)	
23.598	4	16	03	Xq26	CMTX3	P	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	Fd	between DXS984 and DXS8106	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (2)	
23.599	10	28	99	Xq26.3	CXX1	P	CAAX box protein 1	300213	REc			
23.600	7	13	09	Xq26.1	ELF4, MEF	P	E74-like factor 4	300775	A			
23.601	10	4	02	Xq26.2	GPC3, SDYS, SGBS1	C	Glypican 3	300037	A		Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor, somatic, 194070 (3)	
23.602	2	5	99	Xq26.2	GPC4	P	Glypican 4	300168	A	centromeric to GPC3		
23.603	7	14	93	Xq26	GUST	P	Gustavson mental retardation syndrome (with microcephaly, optic atrophy, deafness)	309555	Fd		Gustavson syndrome (2)	
23.604	2	7	01	Xq27.2	MAGEC1	P	Melanoma antigen, family C, 1	300223	R, A			
23.605	7	11	11	Xq26.2	MASK, MST4	P	MST3- and SOK1-related kinase	300547	A, REc			
23.606	3	14	03	Xq26.2	MBNL3, MBXL	P	Muscleblind-like protein 3	300413	REn			
23.607	1	23	02	Xq26	MRX42	P	Mental retardation, X-linked nonspecific, 42	300372	Fd	?pericentromeric region	Mental retardation, X-linked 42 (2)	
23.608	1	23	01	Xq26.3	PLAC1	P	Placenta-specific gene 1	300296	REc			X(Plac1)
23.609	11	25	15	Xq26.3	RBMX, MRXS11	C	RNA-binding motif protein, X chromosome	300199	REc, Fd	mutation identified in 1 MRXS11 family	?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3)	X(Rbmx)
23.610	10	16	94	Xq26	SHFM2, SHFD2	P	Split hand/foot malformation, type (ectrodactyly) 2	313350	Fd		Split hand/foot malformation 2 (2)	
23.611	4	8	02	Xq26.3	TNFSF5, CD40LG, HIGM1, IGM	C	Tumor necrosis factor ligand superfamily, member 5	300386	Fd, A, Psh	Between DSX144E and DSX300	Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	X(CD40l)
23.612	2	22	10	Xq26.3	ZNF75D, ZNF75	P	Zinc finger protein-75D	314997	REa, A	1Mb distal to HPRT		
23.613	6	2	08	Xq26-q27	CFSS	L	Craniofacioskeletal syndrome	300712	Fd		?Craniofacioskeletal syndrome (2)	
23.614	6	8	89	Xq26-q27	HPT, HPTX, HYPX	C	Hypoparathyroidism	307700	Fd	?mutations in SOX3	Hypoparathyroidism, X-linked (2)	
23.615	11	2	98	Xq26-q27	RP24	P	Retinitis pigmentosa-24	300155	Fd		Retinitis pigmentosa 24 (2)	
23.616	8	25	98	Xq26.2-q26.3	HPRT1, HPRT	C	Hypoxanthine phosphoribosyltransferase 1	308000	S, M, C, R, REa, Fd		Lesch-Nyhan syndrome, 300322 (3); HPRT-related gout, 300323 (3)	X(Hprt)
23.617	6	29	99	Xq26.3	BRS3	P	Bombesin-like receptor 3	300107	Psh			
23.618	11	12	97	Xq26-qter	INDX	P	Immunoneurologic syndrome X-linked, of Wood, Black, and Norbury	300076	Fd		Wood neuroimmunologic syndrome (2)	
23.619	12	1	15	Xq26.1	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	C	Apoptosis-inducing factor, mitochondrion-associated, 1	300169	REc, Fd		Combined oxidative phosphorylation deficiency 6, 300816 (3); Cowchock syndrome, 310490 (3); Deafness, X-linked 5, 300614 (3)	
23.620	11	24	14	Xq26.1	ARHGAP36	P	Rho GTPase-activating protein 36	300937	REc			
23.621	5	26	13	Xq26.1	GPR119, GPCR2	P	G protein-coupled receptor 119	300513	REc			X(Gpr119)
23.622	1	21	09	Xq26.1	OCRL, LOCR, OCRL1, NPHL2	C	Phosphatidylinositol polyphosphate 5-phosphatase (OCRL gene)	300535	X/A, Fd		Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)	
23.623	5	28	13	Xq26.1	SASH3, HACS2, CXorf9, SLY	P	SAM and SH3 domain containing 3	300441	REc			
23.624	8	19	98	Xq25-q26	SMARCA1, SNF2L1	P	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1	300012	RE			
23.625	5	28	13	Xq26.1	UTP14A	P	Utp14, S. cerevisiae, homolog of, A	300508	REc			X(Utp14a)
23.626	12	2	09	Xq26.1	ZDHHC9, DHHC9, MRXSZ	C	Zinc finger DHHC domain-containing protein 9	300646	R, REc		Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	
23.627	3	24	06	Xq26.3	VGLL1, VGL1, TDU	P	Vestigial-like 1	300583	REc			
23.628	11	19	11	Xq26.2	FRMD7, NYS1, XIPAN	P	FERM domain-containing 7	300628	REc		Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	
23.629	6	30	05	Xq26.2	HS6ST2	P	Heparan sulfate 6-O-sulfotransferase 2	300545	R, REc			
23.630	3	23	09	Xq26.2	MIR19B2, MIRN19B2	P	Micro RNA 19B2	300722	REc			
23.631	4	13	15	Xq26.2	MIR20B	P	Micro RNA 20B	300950	REc			
23.632	9	9	09	Xq26.2	MIR106A, MIRN106A	P	Micro RNA 106A	300792	REc			
23.633	5	11	09	Xq26.2	TFDP3, HCA661, CT30, DP4	P	Transcription factor DP family, member 3	300772	REc			
23.634	4	25	05	Xq26.2	USP26	C	Ubiquitin-specific protease 26	300309	R, REc			
23.635	5	4	12	Xq26.3	ZIC3, HTX1, HTX, VACTERLX	C	Zic family member-3	300265	Fd, REc		Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)	
23.636	4	30	09	Xq26.3	CT45A1, CT45	P	Cancer/testis antigen family 45, member A1	300648	REc			
23.637	9	2	09	Xq26.3	CT45A2, CT45.2	P	Cancer/testis antigen family 45, member A2	300793	REn			
23.638	9	2	09	Xq26.3	CT45A3, CT45.3	P	Cancer/testis antigen family 45, member A3	300794	REn			
23.639	9	2	09	Xq26.3	CT45A4, CT45.4	P	Cancer/testis antigen family 45, member A4	300795	REn			
23.640	9	2	09	Xq26.3	CT45A5, CT45.5	P	Cancer/testis antigen family 45, member A5	300796	REn			
23.641	9	2	09	Xq26.3	CT45A6, CT45.6	P	Cancer/testis antigen family 45, member A6	300797	REn			
23.642	2	4	15	Xq26.3	CXDUPq26.3, DUPXq26.3, XLAG	P	Chromosome Xq26.3 duplication syndrome	300942	Ch		Chromosome Xq26.3 duplication syndrome (4)	
23.643	5	28	13	Xq26.3	MOSPD1	P	Motile sperm domain-containing protein 1	300674	REc			X(Mospd1)
23.644	6	16	99	Xq26.2	PHF6, BFLS	C	PHD finger protein 6	300414	Fd, REc		Borjeson-Forssman-Lehmann syndrome, 301900 (3)	
23.645	6	16	99	Xq26.3-q27.1	FGF13, FGF2	C	Fibroblast growth factor-13	300070	REa, H, REc, Ch			X(Fhf2)
23.646	2	4	15	Xq26.3	GPR101, PAGH2	P	G protein-coupled receptor 101	300393	REc		Pituitary adenoma, growth hormone-secreting 2, 300943 (3)	
23.647	5	28	13	Xq26.3	HTATSF1, TATSF1	P	HIV-1 TAT stimulatory factor 1	300346	REc, R			
23.648	9	20	14	Xq26.3	MAP7D3, MDP3	P	MAP7 domain-containing protein 3	300930	REc			
23.649	3	23	09	Xq26.3	MIR424, MIRN424, MIR322	P	Micro RNA 424	300682	REc			
23.650	12	19	11	Xq26.3	MIR503	P	Micro RNA 503	300865	REc			
23.651	5	6	08	Xq26.3	SLC9A6, NHE6	C	Solute carrier family 9 (sodium/hydrogen exchanger), member 6	300231	R		Mental retardation, X-linked syndromic, Christianson type, 300243 (3)	
23.652	6	2	08	Xq27.1	SOX3, MRGH	C	SRY (sex determining region Y)-box 3	313430	REa, H, Fd	P mutant in BFLS	Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3)	X(Sox3)
23.653	3	24	11	Xq26.3	SRXX3	P	46XX sex reversal 3	300833	Ch	due to deletion/duplication/rearrangement upstream of SOX3	46XX sex reversal 3 (4)	
23.654	11	30	06	Xq26.3	ZNF449, ZSCAN19	P	Zinc finger protein 449	300627	REc			
23.655	4	30	01	Xq27.2	SPANXC, CTP11	P	Sperm protein associated with the nucleus, X chromosome, family member C	300330	REa, REc			
23.656	5	26	13	Xq27.1	ATP11C, ATPIQ, ATPIG	P	ATPase, class VI, type 11C	300516	REc			
23.657	5	18	05	Xq27	BMND4	P	Bone mineral density QTL 4	300536	Fd		[Bone mineral density QTL 4] (2)	
23.658	5	7	01	Xq28	CNGA2, CNG2, OCNC1	P	Cyclic nucleotide-gated channel, alpha-2	300338	REc			
23.659	8	5	97	Xq27	COD2	P	Cone dystrophy-2, X-linked	300085	Fd		Cone dystrophy, progressive X-linked, 2 (2)	
23.660	11	28	05	Xq27.3	CXorf1	P	Chromosome X open reading frame 1	300565	REc	between DXS369 and DXS181		
23.661	6	19	15	Xq28	CXorf40A, EOLA1	P	Chromosome X open reading frame 40A	300954	REc			
23.662	4	27	12	Xq27.3	FMR1AS1, ASFMR1	P	FMR1 antisense RNA 1	300805	REc			
23.663	8	27	02	Xq27.1	LDOC1	P	Leucine zipper downregulated in cancer 1	300402	A			
23.664	12	30	03	Xq27.2	MAGEC3	P	Melanoma antigen, family C, 3	300469	REc			
23.665	3	19	09	Xq27.2	MAGEC2, MAGEE1, MAGEC2, CT10, HCA587	C	Melanoma antigen, family C, 2	300468	REa, A, R			
23.666	1	25	91	Xq27.1	MCF2, DBL	C	Oncogene MCF2 (oncogene DBL)	311030	REa, A, RE, D	~60kb telomeric to F9; 5' replacement by chr.15 segment		X(Mcf2)
23.667	12	28	08	Xq27.3	SLITRK2, KIAA1854	C	SLIT- and NTRK-like family, member 2	300561	REc, H			X(Slitrk2)
23.668	12	28	08	Xq27.3	SLITRK4	C	SLIT- and NTRK-like family, member 4	300562	REc, H			X(Slitrk4)
23.669	5	26	13	Xq27.3	SPANXN1	P	SPANX family, member N1	300664	REc			X(Spanxn)
23.670	5	28	13	Xq27.3	SPANXN2	P	SPANX family, member N2	300665	REc			
23.671	5	26	13	Xq27.3	SPANXN3	P	SPANX family, member N3	300666	REc			
23.672	5	28	13	Xq27.3	SPANXN4	P	SPANX family, member N4	300667	REc			
23.673	2	1	00	Xq27	TGCT1	P	Testicular germ cell tumor 1	300228	Fd		Testicular germ cell tumor (2)	
23.674	7	25	06	Xq27-q28	MCOPS4, ANOP1	L	Microphthalmia, syndromic 4	301590	F		?Microphthalmia, syndromic 4 (2)	
23.675	9	29	98	Xq27-q28	HPCX1	P	Prostate cancer, hereditary, X-linked 1	300147	Fd	between D3S2390 and bG82i1.0	{Prostate cancer, hereditary, X-linked 1} (2)	
23.676	5	28	13	Xq27.1	CIRS7, CDR1AS	P	Circular RNA sponge for MIR7	300898	REc			
23.677	9	21	11	Xq27.1	HTC2, HCG, CGH, CXINSq27.1,	P	Hypertrichosis, congenital generalized	307150	Fd	palindrome-mediated interchromosomal insertion at Xq27.1	Hypertrichosis, congenital generalized (4)	
23.678	3	19	01	Xq27.2	SPANXA1, SPANX	P	Sperm protein associated with the nucleus, X chromosome, family member A1	300305	REa, A			
23.679	5	26	13	Xq27.2	SPANXD	P	SPANX family, member D	300670	REc			
23.680	5	26	13	Xq27.2	SPANXE	P	SPANX family, member E	300671	REc			
23.681	7	7	98	Xq27.1	CDR1, CDR62A	C	Cerebellar degeneration-related protein-1, 34kD	302650	REa, A, Fd	between HPRT and F9		X(Cdr)
23.682	3	1	12	Xq27.1	F9, HEMB, THPH8	C	Coagulation factor IX (plasma thromboplastic component)	300746	REa, A, Fd, D, X/A, RE	distal to HPRT; proximal part of Xq27	Hemophilia B, 306900 (3); {Warfarin sensitivity}, 122700 (3); Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Deep venous thrombosis, protection against}, 300807 (3)	X(Cf9)
23.683	5	26	13	Xq27.1	SPANXB1, SPANXB	P	SPANX family, member B1	300669	REc			
23.684	10	28	15	Xq26.3	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	C	Four-and-a-half LIM domains 1	300163	Psh, A, R		Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy, X-linked, with postural muscle atrophy, 300696 (3); Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3); Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	
23.685	4	30	09	Xq27.2-q28	BPP, PMGX, CBPS	P	Polymicrogyria, bilateral perisylvian	300388	Fd	possible genetic heterogeneity	Polymicrogyria, bilateral perisylvian (2)	
23.686	12	23	05	Xq27.2	SPANXA2	P	Sperm protein associated with the nucleus, X chromosome, family member A2	300493	REn			
23.687	10	21	04	Xq27.3	DYX9	P	Dyslexia, susceptibility to, 9	300509	Fd	max lod at DXS8043	{Dyslexia, susceptibility to, 9} (2)	
23.688	9	19	11	Xq27.3	FMR1, FRAXA, POF1	C	FMR1 gene	309550	Ch, F, Fd, RE	8-8.7Mb from telomere	Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome, 300623 (3); Premature ovarian failure 1, 311360 (3)	X(Fmr1)
23.689	9	2	12	Xq27.3	MIR506	P	Micro RNA 506	300877	REc			
23.690	9	2	12	Xq27.3	MIR508	P	Micro RNA 508	300874	REc			
23.691	9	2	12	Xq27.3	MIR509-1	P	Micro RNA 509-2	300875	REc			
23.692	9	2	12	Xq27.3	MIR509-3	P	Micro RNA 509-3	300876	REc			
23.693	12	19	11	Xq27.3	MIR510	P	Micro RNA 510	300866	REc			
23.694	3	28	12	Xq27.3-q28	DUPXq27.3q28, CXDUPq27.3q28	P	Chromosome Xq27.3-q28 duplication syndrome	300869	Ch		Chromosome Xq27.3-q28 duplication syndrome (4)	
23.695	8	3	95	Xq27.3-qter	EBM	P	Epidermolysis bullosa, macular type	302000	Fd			
23.696	6	21	13	Xq28	ABCD1, ALD, AMN	C	ATP-binding cassette, subfamily D, member 1	300371	F, Fd, D	about 650kb from GCP/RCP	Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, adult, 300100 (3)	X(Ald)
23.697	11	11	09	Xq28	AFF2, FMR2, FRAXE, MRX2	P	AF4/FMR2 family, member 2 (fragile site, X-linked, E)	300806	Ch, REn		Mental retardation, X-linked, FRAXE type, 309548 (3)	
23.698	11	1	13	Xq28	BCAP31, BAP31, DXS1357E, DDCH	P	B-cell receptor-associated protein 31	300398	REa		Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	X(Bap31)
23.699	4	26	11	Xq28	BED	P	Bornholm eye disease	300843	Fd	linked to F8	Bornholm eye disease (2)	
23.700	2	14	13	Xq28	ATP2B3, PMCA3, SCAX1	P	ATPase, Ca++ transporting, plasma membrane, 3	300014	REa, A, Fd	mutation identified in 1 family	?Spinocerebellar ataxia, X-linked 1, 302500 (3)	
23.701	7	15	02	Xq28	ATP6IP1, ATP6S1, VATPS1	C	ATPase, H+ transporting, lysosomal interacting protein 1	300197	REc			
23.702	10	4	05	Xq28	AVPR2, DIR, DI1, ADHR	C	Arginine vasopressin receptor-2	300538	Fd, S, REa, Psh		Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	
23.703	4	25	93	Xq28	BGN	C	Biglycan	301870	REa, A	proximal Xq28		X(Bgn)
23.704	6	26	11	Xq28	BRCC3, BRCC36	P	BRCA1/BRCA2-containing complex, subunit 3	300617	Psh			
23.705	9	8	11	Xq28	CD99L2, CD99B	P	CD99 antigen-like 2	300846	REc			X(Cd99l2)
23.706	5	18	95	Xq28	CETN2, CALT	P	Centrin, EF-hand protein, 2 (caltractin)	300006	A			
23.707	2	4	15	Xq28	CLIC2, XAP121, MRXS32	P	Chloride intracellular channel 2	300138	REc	mutation identified in 1 MRXS32 family	?Mental retardation, X-linked, syndromic 32, 300886 (3)	
23.708	3	23	15	Xq28	CSAG1, CSAGE	P	CSAG family, member 1 `	300944	REc			
23.709	5	26	13	Xq28	CTAG1A, LAGE2A	P	Cancer/testis antigen 1A	300657	REc			
23.710	11	5	98	Xq28	CTAG1B, CTAG1	P	Cancer/testis antigen 1B	300156	REa, A			
23.711	5	28	13	Xq28	CTAG2, LAGE1, CAMEL	P	Cancer/testis antigen 2	300396	Psh, A			
23.712	3	29	10	Xq28	DUPXq28, CXq28	P	Chromosome Xq28 duplication syndrome	300815	Ch		Chromosome Xq28 duplication syndrome (4)	
23.713	9	19	13	Xq28	DKC1, DKCX	C	Dyskerin	300126	Fd, REc		Dyskeratosis congenita, X-linked, 305000 (3)	X(Dkc1)
23.714	5	19	97	Xq28	DNASE1L1, DNL1L	P	Deoxyribonuclease I-like 1	300081	RE	between QM and DXS1010E		
23.715	5	28	13	Xq28	DUSP9, MKP4	P	Dual-specificity phosphatase 9	300134	Psh, REc			
23.716	3	22	93	Xq28	DXS522E, F8B	P	DNA segment, single copy, expressed probes, intron 22 probe, F8B	305424	RE			
23.717	4	4	02	Xq28	EMD, EDMD, STA	C	Emerin	300384	F, Fd, H, REn	in distal Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	
23.718	9	13	92	Xq28	F8A, DXS522E, HAP40	C	Factor VIII associated gene 1	305423	RE	3 copies, 1 in intron 22 of F8C		X(F8a)
23.719	9	28	00	Xq28	F8, F8C, HEMA	C	Coagulation factor VIII, procoagulant component	300841	F, Fd, REa, A, RE	cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere	Hemophilia A, 306700 (3)	X(Cf8)
23.720	5	28	13	Xq28	FAM3A	P	Family with sequence similarity 3, member A	300492	REc			
23.721	11	22	09	Xq28	FAM11A, FRAXF	P	Family with sequence similarity 11, member A	300031	REc			
23.722	6	18	12	Xq28	FAM50A, DXS9928E, HXC26	P	Family with sequence similarity 50, member A	300453	REc			
23.723	4	23	08	Xq28	FAM58A, STAR	P	Family with sequence similarity 58, member A	300708	REc		STAR syndrome, 300707 (3)	
23.724	6	19	12	Xq28	FATE1	P	Fetal and adult testis-expressed gene 1	300450	REc			
23.725	10	29	10	Xq28	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	C	Filamin A, alpha (actin-binding protein-280)	300017	REa, A, REn		Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome, type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3); Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3); Congenital short bowel syndrome, 300048 (3)	X(Fln1)
23.726	11	9	13	Xq28	G6PD, G6PD1	C	Glucose-6-phosphate dehydrogenase	305900	F, S, REb, RE		Hemolytic anemia due to G6PD deficiency, 300908 (3); Favism, 134700 (3); {Resistance to malaria due to G6PD deficiency}, 611162 (3)	X(G6pd)
23.727	5	28	13	Xq28	GAB3	P	GRB2-associated binding protein 3	300482	REc, R			
23.728	12	29	89	Xq28	GABRA3	C	Gamma-aminobutyric acid (GABA) A receptor, alpha-3	305660	H, REa, A, RE	4Mb from telomere		X(Gabra3)
23.729	6	9	98	Xq28	GABRE	P	Gamma-aminobutyric acid (GABA) A receptor, epsilon	300093	REn			
23.730	8	30	01	Xq28	GABRQ	P	Gamma-aminobutyric acid receptor, theta	300349	REc			
23.731	9	8	11	Xq28	GDI1, RABGD1A, MRX41, MRX48	P	GDP dissociation inhibitor 1	300104	REn		Mental retardation, X-linked 41, 300849 (3)	
23.732	6		10	Xq28	HAUS7, UCHL5IP, UIP1	P	HAUS augmin-like complex, subunit 7	300540	REc			
23.733	5	14	95	Xq28	HMS1, GAY1	L	Homosexuality, male	306995	Fd		[?Homosexuality, male] (2)	
23.734	2	7	01	Xq28	GPR50	P	G protein-coupled receptor 50	300207	R			X(Gpr50)
23.735	2	8	13	Xq28	H2AFB, H2ABBD	P	H2A histone family, member B	300445	REc			
23.736	11	1	13	Xq28	HCFC1, HCF1, MRX3	C	Host cell factor C1 (VP16-accessory protein)	300019	REn, REa, A, Fd	50kb distal to V2R	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3)	X(Hcfc1)
23.737	7	17	14	Xq28	HMGB3, HMG4, HMG2A, MCOPS13	P	High-mobility group box 3 (high mobility group protein 4)	300193	REc, Fd	mutation identified in 1 MCOPS13 family	?Microphthalmia, syndromic 13, 300915 (3)	
23.738	4	21	99	Xq28	IDH3G	C	Isocitrate dehydrogenase 3 (NAD+), gamma	300089	REc			
23.739	2	9	11	Xq28	IDS, MPS2, SIDS	C	Iduronate 2-sulfatase (Hunter syndrome)	300823	X/A, Fd, F, RE	telomeric IDS2 source of inversion in IDS	Mucopolysaccharidosis II, 309900 (3)	X(Ids)
23.740	5	19	15	Xq28	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	C	Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator)	300248	Fd, REn		Incontinentia pigmenti, 308300 (3); Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency, isolated, 300584 (3); Immunodeficiency 33, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	X(Ikbkg)
23.741	11	6	95	Xq28	IL9R	C	Interleukin-9 receptor	300007	A, REc	in PAR2 pseudoautosomal region		
23.742	2	1	01	Xq28	IRAK1	P	Interleukin 1 receptor-associated kinase 1	300283	R			X(Irak1)
23.743	7	8	96	Xq28	ITBA2	P	ITBA2 gene	300060	RE			
23.744	1	29	13	Xq28	L1CAM, CAML1, HSAS1, MASA, SPG1	C	L1 cell adhesion molecule	308840	A, RE, H, Fd	between RCP/GCP cluster and G6PD	Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome, 303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)	X(L1cam)
23.745	3	14	13	Xq28	LINC00850, KUCG1	P	Long intergenic noncoding RNA 850	300892	REc			
23.746	5	6	08	Xq28	MAFD2, MDX	L	Major affective disorder 2	309200	F	linkage to G6PD,CB in non-Ashkenazi Jews	{?Major affective disorder 2} (2)	
23.747	2	5	96	Xq28	MAGE1	C	Melanoma antigen 1 (directs expression of antigen MZ2-E)	300016	REa, A	cluster of 12 genes		
23.748	6	29	99	Xq28	MAGEA2, MAGE2	P	Melanoma antigen, family A, 2	300173	RE, REn			
23.749	5	26	13	Xq28	MAGEA2B	P	Melanoma antigen, family A, 2B	300549	REc			
23.750	6	29	99	Xq28	MAGEA3, MAGE3	C	Melanoma antigen, family A, 3	300174	RE, REn			
23.751	6	29	99	Xq28	MAGEA4, MAGE4A, MAGE4B	P	Melanoma antigen, family A, 4	300175	RE, REn			
23.752	7	17	01	Xq28	MAGEA5, MAGE5	P	Melanoma antigen, family A, 5	300340	REa, REc			X(Mage5)
23.753	7	17	01	Xq28	MAGEA8, MAGE8	P	Melanoma antigen, family A, 8	300341	REa, REc			X(Mage8)
23.754	7	17	01	Xq28	MAGEA9, MAGE9	P	Melanoma antigen, family A, 9	300342	REa, REc			
23.755	3	19	09	Xq28	MAGEA9B	P	Melanoma antigen, family A, 9B	300764	REc			
23.756	7	17	01	Xq28	MAGEA10, MAGE10	P	Melanoma antigen, family A, 10	300343	REa, REc			
23.757	7	17	01	Xq28	MAGEA11, MAGE11	P	Melanoma antigen, family A, 11	300344	REc, REa			
23.758	6	29	99	Xq28	MAGEA6, MAGE6	P	Melanoma antigen, family A, 6	300176	RE, REn			
23.759	6	29	99	Xq28	MAGEA12, MAGE12	P	Melanoma antigen, family A, 12	300177	RE, REn			
23.760	2	23	09	Xq28	MAMLD1, CXorf6, F18, HYSP2	C	Mastermind-like domain containing 1	300120	REc, D	near MTM1 in microdeletion	Hypospadias 2, X-linked, 300758 (3)	
23.761	7	14	15	Xq28	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	C	Methyl-CpG-binding protein-2	300005	H, REc, Ch, Fd, A	70kb centromeric of RCP/GCP	Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic 13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked 3}, 300496 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3); Rett syndrome, atypical, 312750 (3)	X(Mecp2)
23.762	12	21	09	Xq28	MIR105-1, MIRN105-1	P	Micro RNA 105-1	300811	REc			
23.763	12	21	09	Xq28	MIR105-2, MIRN105-2	P	Micro RNA 105-2	300812	REc			
23.764	9	20	14	Xq28	MIR718	P	Micro RNA 718	300929	REc			
23.765	4	1	09	Xq28	MIR224, MIRN224	P	Micro RNA 224	300769	REc			
23.766	10	21	92	Xq28	MPP1, PEMP, EMP55	P	Membrane protein, palmitoylated-1, 55kD	305360	REa, REn	~30kb 3' and centromeric to F8		X(Emp55)
23.767	10	23	87	Xq28	MRSD, CHRS	P	Mental retardation-skeletal dysplasia	309620	Fd		Mental retardation-skeletal dysplasia (2)	
23.768	9	19	00	Xq28	MRXSA	P	Armfield X-linked mental retardation syndrome	300261	Fd		Mental retardation syndrome, X-linked, Armfield type (2)	
23.769	6	15	99	Xq28	MTCP1	P	Mature T-cell proliferation 1	300116	Ch, A			
23.770	12	20	02	Xq28	MTM1, MTMX	C	Myotubularin	300415	Fd, REc	close to F8	Myotubular myopathy, X-linked, 310400 (3)	
23.771	3	29	99	Xq28	MTMR1	P	Myotubularin-related protein-1	300171	REc			
23.772	6	28	11	Xq28	MYMY4, CXDELq38	P	Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism	300845	Ch	contiguous gene deletion syndrome (3.4kb)	Moyamoya disease 4 (4)	
23.773	11	12	98	Xq28	MYP1	P	Myopia 1, X-linked	310460	Fd		Myopia-1 (2)	
23.774	12	10	15	Xq28	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	P	N-alpha-acetyltransferase 10, NatA catalytic subunit	300013	RE, Fd	mutation identified in 1 MCOPS1 family	Ogden syndrome, 300855 (3); ?Microphthalmia, syndromic 1, 309800 (3)	
23.775	2	11	11	Xq28	NSDHL	P	NAD(P)H steroid dehydrogenase-like protein	300275	REc		CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)	X(Nsdhl)
23.776	9	13	10	Xq28	OPN1C	P	OPN1LW and OPN1MW genes, controller of	300824	REc			
23.777	9	13	10	Xq28	OPN1LW, RCP, CBP, CBBM	C	Red cone pigment (opsin 1, long-wave-sensitive)	300822	F, RE, A, Fd	5' to CBD	Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700 (3)	X(Rsvp)
23.778	8	30	10	Xq28	OPN1MW, GCP, CBD, CBBM	C	Green cone pigment (opsin 1, medium-wave-sensitive)	300821	F, RE, A, Fd	linked to G6PD; multiple genes	Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700 (3)	X(Rsvp)
23.779	1	11	07	Xq28	PDZD4, PDZK4, PDZRN4L, KIAA1444, LU1	C	PDZ domain-containing 4	300634	R, REc, H			X(Pdzd4)
23.780	11	29	99	Xq28	PLXNB3, PLXN6	P	Plexin B3	300214	REn			
23.781	10	9	07	Xq28	PNCK, CAMK1B, BSTK3	P	Pregnancy-upregulated, nonubiquitous, CAM kinase	300680	H, REn			X(Pnck)
23.782	5	26	13	Xq28	PNMA3, MA3	P	Paraneoplastic MA antigen 3	300675	REc			
23.783	3	7	14	Xq28	PNMA5, KIAA1934	C	Paraneoplastic MA antigen family, member 5	300916	REc			
23.784	3	7	14	Xq28	PNMA6A, PNMA6	P	Paraneoplastic MA antigen family, member 6A	300917	REc			
23.785	1	2	08	Xq28	PRRG3, PRGP3, TMG3	P	Proline-rich gamma-carboxyglutamic acid protein 3	300685	REc			
23.786	1	21	15	Xq28	RAB39B, MRX72, WSMN	C	Ras-associated protein RAB39B	300774	Fd, REc	mutation identified in 1 WSMN family	Mental retardation, X-linked 72, 300271 (3); ?Waisman syndrome, 311510 (3)	
23.787	6	14	94	Xq28	RENBP	P	Renin-binding protein	312420	REn, Psh			
23.788	2	15	96	Xq28	RGC1	P	Rho-GAP hematopoietic protein C1	300023	RE			
23.789	7	19	06	Xq28	RP34	P	Retinitis pigmentosa 34	300605	Fd		Retinitis pigmentosa 34 (2)	
23.790	7	1	11	Xq28	RPL10, DXS648, QM, AUTSX5	C	Ribosomal protein L10	312173	S, RE		{Autism, susceptibility to, X-linked 5}, 300847 (3)	
23.791	12	4	03	Xq26.3	SAGE	P	Sarcoma antigen	300359	R			
23.792	2	15	96	Xq28	SEX	P	Sex chromosome X transmembrane protein of HGF receptor family 3	300022	RE			
23.793	7	18	13	Xq28	SLC6A8, CRTR, CCDS1	C	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8	300036	REa, Psh, A	distal to G6PD	Cerebral creatine deficiency syndrome 1, 300352 (3)	X(Slc6a8)
23.794	3	16	10	Xq28	SLC10A3, P3	P	Solute carrier family 10 (sodium/bile acid cotransporter family) member 3 (protein p3)	312090	RE, H	order: G6PD-3'-(7kb)-5'-P3-3'-(0.5kb)-5'-GDX		X(P3)
23.795	2	2	10	Xq28	SLEB15	P	Systemic lupus erythematosus, susceptibility to, 15	300809	Fd	associated with rs17435	{Systemic lupus erthematosus, susceptibility to, 15} (2)	
23.796	5	25	09	Xq28	SPRY3	P	Sprouty, Drosophila, homolog of, 3	300531	REc	in pseudoautosomal region PAR2		
23.797	11	19	14	Xq28	SSR4, TRAPD, CDG1Y	P	Signal sequence receptor, delta	300090	REc	mutation identified in 1 CDG1Y patient	?Congenital disorder of glycosylation, type Iy, 300934 (3)	
23.798	7	17	12	Xq28	TAZ, EFE2, BTHS, CMD3A, LVNCX	C	Tafazzin	300394	Fd		Barth syndrome, 302060 (3)	
23.799	8	13	14	Xq28	TEX28	P	Testis-expressed gene on Xq28	300092	REn			
23.800	8	25	98	Xq28	TKCR, TKC	C	Torticollis, keloids, cryptorchidism and renal dysplasia	314300	X/A	distal to G6PD	Goeminne TKCR syndrome (2)	
23.801	10	15	98	Xq28	TKTL1, TKT2, TKR	P	Transketolase-like 1	300044	REf	between GCP and FLN1		
23.802	5	4	12	Xq28	TMEM187, CXorf12, DXS9878E, ITBA1 gene	P	Transmembrane protein 187	300059	RE			
23.803	4	21	16	Xq28	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	P	Episilon-trimethyllysine hydroxylase	300777	REc		{Autism, susceptibility to, X-linked 6}, 300872 (3)	
23.804	9	10	07	Xq28	UBL4A, GDX, UBL4, DX254E	P	Ubiquitin-like 4A	312070	RE, H	40kb 3' to G6PD		X(Gdx)
23.805	12	11	02	Xq28	TREX2	P	3-prime repair exonuclease 2	300370	REc			
23.806	10	12	09	Xq28	VAMP7, SYBL1, TIVAMP	P	Vesicle-associated membrane protein 7	300053	D			
23.807	7	13	98	Xq28	VBP1	P	Von Hippel-Lindau binding protein-1	300133	REc			X(Vbp1)
23.808	9	11	15	Xq28	VMA21, XMEA	P	Vma21, S. cerevisiae, homolog of	300913	REc		Myopathy, X-linked, with excessive autophagy, 310440 (3)	
23.809	10	23	87	Xq28	XM	P	Xm	314900	F	linked to DCB, PCB		
23.810	3	3	03	Xq28	ZNF185	P	Zinc finger protein 185	300381	REc			
23.811	2	28	03	Xq23	AMOT, KIAA1071	P	Angiomotin	300410	Psh			
23.812	11	3	11	Chr.X	CCCSX	P	Cerebral-cerebellar-coloboma syndrome, X-linked	300864	Fd		Cerebral-cerebellar-coloboma syndrome, X-linked (2)	
23.813	2	3	04	Chr.X	CVMRF	P	Cubitus valgus with mental retardation and unusual facies	300471	Fd		Cubitus valgus with mental retardation and unusual facies (2)	
23.814	6	27	08	Chr.X	DFCTRPS	P	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	Fd		Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)	
23.815	2	7	01	Xp22.12	EIF1A, EIF4C, EIF1AX	P	Eukaryotic translation initiation factor 1A	300186	REa			
23.816	3	9	12	Chr.X	THCYTX	P	Thrombocythemia, X-linked	300331	Fd		Thrombocythemia, X-linked (2)	
23.817	12	13	00	Xp11.22	GAGED2, XAGE1	P	G antigen, family D, 2	300289	REa			
23.818	8	25	98	Xq24	IL13RA1	P	Interleukin-13 receptor, alpha-1	300119	Psh			
23.819	1	30	01	Xp11.21	KLF8, ZNF741, BKLF3	P	Kruppel-like factor 8	300286	R			
23.820	7	26	06	Chr.X	MCOPCB1	P	Microphthalmia, isolated, with coloboma 1	300345	Fd		Microphthalmia with coloboma 1 (2)	
23.821	2	2	14	Chr.X	MRX95	P	Mental retardation, X-linked 95	300716	Fd		Mental retardation, X-linked 95 (2)	
23.822	3	25	15	Chr.X	MRXSBWB	P	Brooks-Wisniewski-Brown syndrome	300612	Fd		Brooks-Wisniewski-Brown syndrome (2)	
23.823	3	25	15	Chr.X	MRXSMP	P	Mental retardation, X-linked, syndromic, Martin-Probst type	300519	Fd		Mental retardation, X-linked, syndromic, Martin-Probst type (2)	
23.824	8	27	01	Xq22.1	NXF2	C	Nuclear RNA export factor 2	300315	REc, R			
23.825	2	1	01	Xp11.23	PIM2	P	Oncogene PIM2	300295	R			
23.826	5	7	01	Xq26.1	RAB33A	P	Ras-associated protein RAB33A	300333	REc			
23.827	8	27	01	Xp22.2	REPS2, POB1	P	RALBP1-associated EPS domain-containing protein 2	300317	R			
23.828	12	5	01	Xq22.1	TAF7L, TAF2Q	P	TAF7-like RNA polymerase II, TATA box-binding protein-associated factor, 50kD	300314	R			
23.829	3	29	01	Xq22.3	TEX13A	P	Testis-expressed gene 13A	300312	R			
23.830	3	29	01	Xq22.3	TEX13B	P	Testis-expressed gene 13B	300313	R			
24.1	12	19	11	Yp11.2	AKAP17A, SFRS17A, XE7Y	P	A kinase (PRKA) anchor protein 17A	465000	REn	see 300015 locus		
24.2	10	4	93	Yp11.2	ASMTY	P	Acetylserotonin methyltransferase (Y chromosome)	402500	REa, Fd	pseudoautosomal		
24.3	3	23	04	Yp11.2	ASMTLY	P	Acetylserotonin methyltransferase-like, Y-linked	400011	REc			
24.4	10	4	93	Yp11.2	MIC2Y	C	Antigen identified by monoclonal 12E7, Y homolog	450000	S, A, D, Fd	pseudoautosomal		
24.5	11	16	09	Yp11.2	SHOXY	P	Short stature homeo box, Y-linked	400020	Ch, A	pseudoautosomal	Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
24.6	10	13	93	Yp11.2	TSPY1, TSPY	P	Testis-specific protein, Y-linked, 1	480100	RE			
24.7	9	5	01	Yp11.2	CRLF2Y	P	Cytokine receptor-like factor 2, Y-linked	400023	A	pseudoautosomal		
24.8	10	4	93	Yp11.2	IL3RA, IL3RY, IL3RAY	P	Interleukin-3 receptor (Y chromosome)	430000	REa, A, REn	308385 = X homolog; pseudoautosomal		
24.9	10	28	08	Yp11.2	RPS4Y1	P	Ribosomal protein S4, Y-linked, 1	470000	REn			
24.10	8	20	09	Yp11.2	SRY, TDF, TDY, SRXX1, SRXY1	C	Sex-determining region Y (testis determining factor)	480000	Ch, Fd		46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)	Yp(Tdy, Sry)
24.11	1	13	95	Yp11.2	ZFY	C	Zinc finger protein, Y-linked	490000	REn, A			
24.12	7	10	02	Yp11.2	PCDH11Y, PCDH22, PCDHY	P	Protocadherin 22	400022	REc			
24.13	8	5	97	Yp11.2	PRKY	P	Protein kinase, Y-linked	400008	A			
24.14	3	23	04	Yp11.2	TBL1Y	P	Transducin-beta-like 1, Y-linked	400033	REc			
24.15	2	28	03	Yp11.2	TGIF2LY, TGIFLY	P	Transforming growth factor-beta-induced factor 2-like, Y-linked	400025	REc			
24.16	10	4	93	Yp11.2	AMELY, AMGL	C	Amelogenin (Y chromosome)	410000	D	301200 = X homolog		
24.17	10	4	93	Yp11.2	CSF2RY	P	Granulocyte-macrophage colony-stimulating factor receptor, alpha subunit (Y chromosome)	425000	A	306250 = X homolog; distal to MIC2Y		
24.18	3	23	04	Yp11	XGR	P	XG regulator	489500	REc	in pseudoautosomal region		
24.19	10	4	93	Yp11.2	ANT3Y	P	Adenine nucleotide translocator-3 (Y chromosome)	403000	REc, REn	300151 = X homolog; proximal to CSF2RY		
24.20	7	8	99	Yq11.223	BPY2	P	Basic protein on Y chromosome, 2	400013	RE			
24.21	3	23	04	Yq	HEY	L	Hairy ears, Y-linked	425500	Fd		?Hairy ears, Y-linked (2)	
24.22	5	14	96	Yq11.223	DAZ	P	Deleted in azoospermia	400003	D	?same as AZF	?Sertoli-cell-only syndrome (1)	17(dazla)
24.23	3	16	09	Yq11.221	DDX3Y, DBY	P	DEAD/H box-3, Y-linked	400010	D			
24.24	11	3	11	Yq11	DELYq11, CYDELq11, SPGFY1	P	Chromosome Yq11 interstitial deletion syndrome	400042	Ch	contiguous gene deletion syndrome	Spermatogenic failure, Y-linked, 1 (4)	
24.25	8	19	09	Yq11.223	KDM5D, JARID1D, SMCY, HYA	P	Lysine-specific demethylase 5D	426000	D, REc	encodes H-Y epitope in mouse		Yp(Smcy)
24.26	7	9	99	Yq11.223	RBMY1A1, RBM1, YRRM1, RBM2	C	RNA binding motif protein, Y chromosome, family 1, member A1	400006	REc			Y(Rbmy)
24.27	8	11	98	Yq11.221	UTY	P	Ubiquitously transcribed TPR gene on Y chromosome	400009	REn			
24.28	3	23	04	Yq11.223	DAZ2	P	Deleted in azoospermia 2	400026	REc			
24.29	3	23	04	Yq11.23	DAZ3	P	Deleted in azoospermia 3	400027	REc			
24.30	3	23	04	Yq11.222-q11.223	CYorf15A	P	Chromosome Y open reading frame 15A	400031	REc			
24.31	3	23	04	Yq11.222	HSFY	P	Heat shock transcription factor, Y-linked	400029	REc			
24.32	3	23	04	Yq11.223	RPS4Y2	P	Ribosomal protein S4, Y-linked	400030	REc			
24.33	3	23	04	Yq11.2	CYorf15B	P	Chromosome Y open reading frame 15B	400032	REc			
24.34	3	23	04	Yq11.221	NLGN4Y, KIAA0951	P	Neuroligin 4, Y-linked	400028	REc			
24.35	11	2	04	Yq11.223	PRY2	P	PTPBL-related gene on Y, 2	400041	REc			
24.36	11	3	11	Yq11.221	USP9Y, DFFRY, SPGFY2	P	Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked)	400005	REa, REc		Spermatogenic failure, Y-linked, 2, 415000 (3)	
24.37	8	19	09	Yq11.222	CDY2	P	Chromodomain protein, Y chromosome, 2	400018	REc			
24.38	8	24	09	Yq11.221	TMSB4Y	P	Thymosin, beta-4, Y chromosome	400017	REc			
24.39	8	24	09	Yq11.221	VCY, BPY1	P	Variably charged, Y chromosome	400012	REc			
24.40	8	24	09	Yq11.222	XKRY	P	XK-related protein on Y chromosome	400015	REc			
24.41	8	19	09	Yq11.223	EIF1AY	P	Eukaryotic translation initiation factor 1A, Y isoform	400014	REc			
24.42	8	24	09	Yq11.223	PRY	P	PTPN13-like, Y-linked	400019	Psh			
24.43	5	28	13	Yq11.223	TTTY4	P	Testis-specific transcript, Y-linked, 4	400037	REc			
24.44	5	28	13	Yq11.223	TTTY5	P	Testis-specific transcript, Y-linked, 5	400038	REc			
24.45	5	28	13	Yq11.223	TTTY6	P	Testis-specific transcript, Y-linked, 6	400039	REc			
24.46	5	28	13	Yq11.223	TTY17	P	Testis-specific transcript, Y-linked, 17	400040	REc			
24.47	8	19	09	Yq11.23	CDY1, CDY	P	Chromodomain protein, Y chromosome	400016	REc			Y(Cdy1)
24.48	5	28	13	Yq11.23	CSPG4LY	P	Chondroitin sulfate proteoglycan 4-like, Y-linked	400034	REc			
24.49	5	28	13	Yq11.23	GOLGA2LY	P	Golgi autoantigen, golgin subfamily A, 2-like, Y-linked	400035	REc			
24.50	5	28	13	Yq11.23	TTTY3	P	Testis-specific transcript, Y-linked, 3	400036	REc			
24.51	8	25	98	Yq12	GCY, TSY, STA	L	Growth control, Y-chromosome influenced	475000	Ch, D			
24.52	3	20	08	Chr.Y	DFNY1	P	Deafness, Y-linked 1	400043	Fd		Deafness, Y-linked 1 (1)	
24.53	2	8	01	Chr.Y	RPY	P	Retinitis pigmentosa, Y-linked	400004	Fd		Retinitis pigmentosa, Y-linked (2)	
#
#
#
#
# Native OMIM data only in this file.  A version of this map integrated
# with NCBI genomic coordinates, HGNC symbols, and more is genemap2.txt
# 
# Confidence Codes :
# ------------------
# 
# The certainty with which assignment of genes/loci to chromosomes or the linkage between 
# two loci has been established has been graded into the following classes:
# 
# C = confirmed - observed in at least two laboratories or in several families.
# P = provisional - based on evidence from one laboratory or one family.
# I = inconsistent - results of different laboratories disagree.
# L = limbo - evidence not as strong as that provisional, but included for 
# 	heuristic reasons. (Same as `tentative'.)
#
# 
# Mapping Method Codes :
# ----------------------
# 
# The methods for mapping genes are symbolized as follows:
# 
# A = in situ DNA-RNA or DNA-DNA annealing (`hybridization'); e.g., 
# ribosomal RNA genes to acrocentric chromosomes;
# kappa light chain genes to chromosome 2.
# 
# AAS = deductions from the amino acid sequence of proteins; e.g., linkage of 
# delta and beta hemoglobin loci from study of hemoglobin Lepore.
# (Includes deductions of hybrid protein  
# structure by monoclonal antibodies; e.g., close linkage of MN and SS from 
# study of Lepore-like MNSs blood group antigen.)
# Also includes examples of hybrid genes as in one form of hypertrophic
# cardiomyopathy and in apolipoprotein (Detroit).
# 
# C = chromosome mediated gene transfer (CMGT); e.g., cotransfer of galactokinase
# and thymidine kinase.
# (In conjunction with this approach fluorescence-activated flow sorting 
# can be used for transfer of specific chromosomes.)
# 
# Ch = chromosomal change associated with particular phenotype and not proved to 
# represent linkage (Fc), deletion (D), or virus effect (V);  e.g., loss of 
# 13q14 band in some cases of retinoblastoma.
# (`Fragile sites,' observed in cultured cells with or without
# folate-deficient medium or BrdU treatment, fall into this class of method; 
# e.g., fragile site at Xq27.3 in one form of X-linked mental retardation.
# Fragile sites have been used as markers in family linkage studies; e.g., 
# FS16q22 and haptoglobin.)
# 
# D = deletion or dosage mapping (concurrence of chromosomal deletion and 
# phenotypic evidence of hemizygosity), trisomy mapping (presence of three 
# alleles in the case of a highly
# polymorphic locus), or gene dosage effects (correlation of trisomic state of 
# part or all of a chromosome with 50% more gene product).
# Includes "loss of heterozygosity" (loss of alleles) in malignancies.
# Examples:  glutathione reductase to chromosome 8.
# Includes DNA dosage; e.g., fibrinogen loci to 4q2.
# Dosage mapping also includes coamplification in tumor cells.
# 
# EM = exclusion mapping, i.e., narrowing the possible location of loci by 
# exclusion of parts of the map by deletion mapping, extended to include 
# negative lod scores from families with marker chromosomes and negative lod 
# scores with other assigned loci; e.g., support for assignment of MNSs to 4q.
# 
# F = linkage study in families; e.g., linkage of ABO blood group and
# nail-patella syndrome.
# (When a chromosomal heteromorphism or rearrangement is one trait, Fc
# is used; e.g., Duffy blood group locus on chromosome 1.
# When 1 or both of the linked loci are identified by a DNA polymorphism,
# Fd is used; e.g., Huntington disease on chromosome 4.  F = L in
# the HGM workshops.)
# 
# H = based on presumed homology; e.g., proposed assignment of TF to 3q.
# Includes Ohno's law of evolutionary conservatism of X chromosome in mammals.
# Mainly heuristic or confirmatory.
# 
# HS = DNA/cDNA molecular hybridization in solution (`Cot analysis'); e.g., 
# assignment of Hb beta to chromosome 11 in derivative hybrid cells.
# 
# L = lyonization; e.g., OTC to X chromosome.  (L = family linkage study in the 
# HGM workshops.)
# 
# LD = linkage disequilibrium; e.g., beta and delta globin genes (HBB, HBD).
# 
# M = Microcell mediated gene transfer (MMGT); e.g., a collagen gene (COL1A1) to 
# chromosome l7.
# 
# OT = ovarian teratoma (centromere mapping); e.g., PGM3 and centromere of 
# chromosome 6.
# 
# Pcm = PCR of microdissected chromosome segments (see REl).
# 
# Psh = PCR of somatic cell hybrid DNA.
# 
# R = irradiation of cells followed by `rescue' through fusion with 
# nonirradiated (nonhuman) cells (Goss-Harris method of radiation-induced gene 
# segregation); e.g., order of genes on  Xq.
# (Also called cotransference. The complement of cotransference = recombination.)
# 
# RE = Restriction endonuclease techniques; e.g., fine structure map of the 
# beta-globin cluster (HBBC) on 11p; physical linkage of 3 fibrinogen genes 
# (on 4q) and APOA1 and APOC3 (on 11p).
# 
# REa = combined with somatic cell hybridization; e.g., NAG (HBBC) to 11p.
# 
# REb = combined with chromosome sorting; e.g., insulin to 11p.
# Includes Lebo's adaptation (dual laser chromosome sorting and spot blot DNA
# analysis); e.g., MGP to 11q.  (For this method, using flow sorted
# chromosomes, W is the symbol adopted by the HGM workshops.)
# 
# REc = hybridization of cDNA to genomic fragment (by YAC, PFGE,
# microdissection, etc.), e.g., A11 on Xq.
# 
# REf = isolation of gene from genomic DNA; includes 'exon trapping'
# 
# REl = isolation of gene from chromosome-specific genomic 
# library (see Pcm).
# 
# REn = neighbor analysis in restriction fragments, e.g., in PFGE.
# 
# S = `segregation' (cosegregation) of human cellular traits and human 
# chromosomes (or segments of chromosomes) in particular clones from interspecies
# somatic cell hybrids; e.g., thymidine kinase to chromosome 17.
# When with restriction enzyme, REa; with hybridization in solution, HS.
# 
# T = TACT = telomere-associated chromosome fragmentation; e.g., 
# interferon-inducible protein 6-16.
# 
# V = induction of microscopically evident chromosomal change by a virus; e.g., 
# adenovirus 12 changes on chromosomes 1 and 17.
# 
# X/A = X-autosome translocation in female with X-linked recessive disorder; 
# e.g., assignment of Duchenne muscular dystrophy to Xp21.
# 
# 
# Phenotypes :
# ------------
# 
# Each Phenotype is followed by its MIM number, if different from 
# that of the locus, preceded by a comma
# Phenotype mapping key in parentheses follows the phenotype MIM 
# number (explanation below). 
# Allelic disorders are separated by a semi-colon following the
# phenotype mapping key.
#
# 
# Phenotype Mapping Key - Appears in parentheses after a disorder :
# -----------------------------------------------------------------
# 
# 1 - the disorder is placed on the map based on its association with
# a gene, but the underlying defect is not known.
# 2 - the disorder has been placed on the map by linkage; no mutation
# has been found.
# 3 - the molecular basis for the disorder is known; a mutation has 
# been found in the gene.
# 4 - a contiguous gene deletion or duplication syndrome, multiple 
# genes are deleted or duplicated causing the phenotype.
# 
# 
